Citrus Sinensis ID: 043957
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 584 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZVM9 | 572 | Probable serine/threonine | no | no | 0.590 | 0.603 | 0.608 | 1e-125 | |
| F4I114 | 714 | Probable serine/threonine | no | no | 0.590 | 0.483 | 0.564 | 1e-114 | |
| Q6I5Y0 | 519 | Cyclin-dependent kinase C | no | no | 0.539 | 0.606 | 0.429 | 2e-76 | |
| Q5JK68 | 513 | Cyclin-dependent kinase C | no | no | 0.638 | 0.727 | 0.386 | 8e-76 | |
| Q9LFT8 | 505 | Cyclin-dependent kinase C | no | no | 0.655 | 0.758 | 0.384 | 2e-75 | |
| Q8W4P1 | 513 | Cyclin-dependent kinase C | no | no | 0.570 | 0.649 | 0.408 | 7e-75 | |
| B5DE93 | 1239 | Cyclin-dependent kinase 1 | yes | no | 0.482 | 0.227 | 0.404 | 1e-62 | |
| Q6ZAG3 | 324 | Cyclin-dependent kinase C | no | no | 0.493 | 0.888 | 0.426 | 3e-62 | |
| Q9NYV4 | 1490 | Cyclin-dependent kinase 1 | yes | no | 0.482 | 0.189 | 0.401 | 5e-62 | |
| Q3MJK5 | 1484 | Cyclin-dependent kinase 1 | no | no | 0.482 | 0.190 | 0.401 | 7e-62 |
| >sp|Q9ZVM9|Y1461_ARATH Probable serine/threonine-protein kinase At1g54610 OS=Arabidopsis thaliana GN=At1g54610 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 450 bits (1157), Expect = e-125, Method: Compositional matrix adjust.
Identities = 216/355 (60%), Positives = 270/355 (76%), Gaps = 10/355 (2%)
Query: 98 KLVNGWPKWLTDNIPREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKK 157
++ GWP WL+D E L G VP+ A++++KIDK+GQGTYSNVYKA D TGKIVALKK
Sbjct: 90 QVAAGWPSWLSDAC-GEALNGWVPRKADTFEKIDKIGQGTYSNVYKAKDMLTGKIVALKK 148
Query: 158 VKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIIS 217
V+FD EP SVKFMAREI++L++LDHPN+VKLEGL TSRM SLYLVF++M DLA + S
Sbjct: 149 VRFDNLEPESVKFMAREILVLRRLDHPNVVKLEGLVTSRMSCSLYLVFQYMDHDLAGLAS 208
Query: 218 NPEGKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS 271
+P K +E + QL+SGL+HCH RG+LHRD+KGSNLLID GVLKIADFGLA F
Sbjct: 209 SPVVKFSESEVKCLMRQLISGLEHCHSRGVLHRDIKGSNLLIDDGGVLKIADFGLATIFD 268
Query: 272 PNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQL 331
PN KRP+TSRVVTLWYRAPELLLGATDYGVGIDLWSAGC+LAE+ GRPIMPGRTEVEQL
Sbjct: 269 PNHKRPMTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCILAELLAGRPIMPGRTEVEQL 328
Query: 332 HRIFKLCGSPSEDYWKKLRLS--TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPA 389
H+I+KLCGSPSEDYWKK + + ++P + YK + E F +FP SSL L+ LL+++P
Sbjct: 329 HKIYKLCGSPSEDYWKKGKFTHGAIYKPREPYKRSIRETFKDFPPSSLPLIDALLSIEPE 388
Query: 390 YRGSAASALKNEFFFTSPLACDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSK 444
R +A++ALK+EFF + P AC+ + LP Y E+ + + RR R +++
Sbjct: 389 DRQTASAALKSEFFTSEPYACEPADLPK-YPPSKEIDAKRRDEETRRQRAASKAQ 442
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|F4I114|Y1960_ARATH Probable serine/threonine-protein kinase At1g09600 OS=Arabidopsis thaliana GN=At1g09600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 412 bits (1058), Expect = e-114, Method: Compositional matrix adjust.
Identities = 200/354 (56%), Positives = 267/354 (75%), Gaps = 9/354 (2%)
Query: 91 SGGGVDGKLVNGWPKWLTDNIPREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTG 150
S G +++ GWP WL ++ E + G +P+ A+S++K++K+GQGTYS+VYKA D +T
Sbjct: 128 SNGERGAQVMAGWPSWLA-SVAGEAINGWIPRKADSFEKLEKIGQGTYSSVYKARDLETN 186
Query: 151 KIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT 210
++VALKKV+F +P SV+FMAREI+IL++LDHPN++KLEGL TSR+ S+YL+FE+M+
Sbjct: 187 QLVALKKVRFANMDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFEYMEH 246
Query: 211 DLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADF 264
DLA + S P +E Q QLL GL+HCH RG+LHRD+KGSNLL+D N LKI DF
Sbjct: 247 DLAGLASTPGINFSEAQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDF 306
Query: 265 GLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPG 324
GLAN++ ++K+PLTSRVVTLWYR PELLLG+TDYGV +DLWS GC+LAE+F G+PIMPG
Sbjct: 307 GLANFYQGHQKQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPG 366
Query: 325 RTEVEQLHRIFKLCGSPSEDYWK--KLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLST 382
RTEVEQLH+IFKLCGSPSE+YWK KL +T F+P Q YK + E F P S+L L+
Sbjct: 367 RTEVEQLHKIFKLCGSPSEEYWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEV 426
Query: 383 LLALDPAYRGSAASALKNEFFFTSPLACDLSGLPVIYDKEDELIEANQQRKIRR 436
LLA++P RG+ ASAL++EFF TSPLA D S LP +++ ++A ++ R+
Sbjct: 427 LLAVEPDARGTTASALESEFFTTSPLASDPSSLPKYQPRKEIDVKAQEEEAKRK 480
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q6I5Y0|CDKC1_ORYSJ Cyclin-dependent kinase C-1 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 287 bits (734), Expect = 2e-76, Method: Compositional matrix adjust.
Identities = 146/340 (42%), Positives = 208/340 (61%), Gaps = 25/340 (7%)
Query: 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL 181
+S + ++K++++G+GTY VY A + +T +IVALKK++ D REI IL+KL
Sbjct: 20 RSVDCFEKLEQIGEGTYGQVYMARETETQEIVALKKIRMDNEREGFPITAIREIKILKKL 79
Query: 182 DHPNIVKLEGLATS---------------RMQYSLYLVFEFMQTDLARIISNPEGKLTEP 226
H N+++L+ + TS + + S+Y+VFE+M DL + P + T P
Sbjct: 80 HHQNVIQLKEIVTSPGPERDEQGKPIHGNKYKGSIYMVFEYMDHDLTGLADRPGMRFTVP 139
Query: 227 Q------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTS 280
Q QLL+GL +CH +LHRD+KGSNLLID G LK+ADFGLA FS + LT+
Sbjct: 140 QIKCYMKQLLTGLHYCHINQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSNDHNGNLTN 199
Query: 281 RVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGS 340
RV+TLWYR PELLLG+T YG +D+WS GC+ AE+ G+PI+PG+ E EQL +IF +CG+
Sbjct: 200 RVITLWYRPPELLLGSTKYGPAVDMWSVGCIFAELLNGKPILPGKNEPEQLSKIFDVCGT 259
Query: 341 PSEDYW---KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASA 397
P E W K+ F+PP+ K R+ E F F +L LL +L LDPA R SA A
Sbjct: 260 PDESNWPGVTKMPWYNNFKPPRQLKRRVKEYFKHFDRLALDLLEKMLTLDPAQRISAQDA 319
Query: 398 LKNEFFFTSPLACDLSGLPVIYDKEDELIEANQQRKIRRA 437
L E+F++ PL CD LP Y+ E +++++R+A
Sbjct: 320 LDAEYFWSDPLPCDPKSLPK-YESSHEFQTKKKRQQMRQA 358
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q5JK68|CDKC2_ORYSJ Cyclin-dependent kinase C-2 OS=Oryza sativa subsp. japonica GN=CDKC-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 285 bits (729), Expect = 8e-76, Method: Compositional matrix adjust.
Identities = 167/432 (38%), Positives = 238/432 (55%), Gaps = 59/432 (13%)
Query: 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL 181
+S + ++K++++G+GTY VY A + +T +IVALKK++ D REI IL+KL
Sbjct: 20 RSVDCFEKLEQIGEGTYGQVYMAKETETNEIVALKKIRMDNEREGFPITAIREIKILKKL 79
Query: 182 DHPNIVKLEGLATS---------------RMQYSLYLVFEFMQTDLARIISNPEGKLTEP 226
H N+++L+ + TS + + S+Y+VFE+M DL + P + T P
Sbjct: 80 HHQNVIQLKEIVTSPGPERDEQGKPIEGNKYKGSIYMVFEYMDHDLTGLADRPGMRFTVP 139
Query: 227 Q------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTS 280
Q QLL+GL +CH +LHRD+KGSNLLID G LK+ADFGLA FS + LT+
Sbjct: 140 QIKCYMRQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSSDHNGNLTN 199
Query: 281 RVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGS 340
RV+TLWYR PELLLG+T YG +D+WS GC+ AE+ G+PI+ G+ E EQL +IF+LCG+
Sbjct: 200 RVITLWYRPPELLLGSTRYGPAVDMWSVGCIFAELLNGKPILTGKNEPEQLSKIFELCGT 259
Query: 341 PSEDYWK---KLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASA 397
P E W K+ F+P + K R+ E+F F + +L LL +L LDP+ R SA A
Sbjct: 260 PDELIWPGVTKMPWYNNFKPQRPMKRRVKESFKHFDQHALDLLEKMLTLDPSQRISAKDA 319
Query: 398 LKNEFFFTSPLACDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQASQ 457
L E+F+T PL CD LP EA+ + + ++ R + R QA +
Sbjct: 320 LDAEYFWTDPLPCDPKSLPK--------YEASHEFQTKKKRQQQR-----------QAEE 360
Query: 458 LTKEETLSNKEDSEKHVELNFQGQEPYSSASSASSGTKANQQSHSPPFVLFPVAA--SHH 515
K + L + + + GQ P+ + Q H+ P PVAA SHH
Sbjct: 361 AAKRQKLQHPPPHSRLPPIQNPGQ-PHQ--------IRPGQPMHNAP----PVAAGPSHH 407
Query: 516 QKMSPRNKGHPN 527
PR G PN
Sbjct: 408 -YAKPRGPGGPN 418
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9LFT8|CDKC1_ARATH Cyclin-dependent kinase C-1 OS=Arabidopsis thaliana GN=CDKC-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 283 bits (725), Expect = 2e-75, Method: Compositional matrix adjust.
Identities = 165/429 (38%), Positives = 235/429 (54%), Gaps = 46/429 (10%)
Query: 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL 181
+S + ++K++++G+GTY VY A + TG+IVALKK++ D REI IL+KL
Sbjct: 21 RSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDNEREGFPITAIREIKILKKL 80
Query: 182 DHPNIVKLEGLATS--------------RMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ 227
H N+++L+ + TS + + +Y+VFE+M DL + P + T PQ
Sbjct: 81 HHENVIQLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQ 140
Query: 228 ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR 281
QLL+GL +CH +LHRD+KGSNLLID G LK+ADFGLA +S + LT+R
Sbjct: 141 IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNR 200
Query: 282 VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSP 341
V+TLWYR PELLLGAT YG ID+WS GC+ AE+ +PI+PG+ E EQL++IF+LCGSP
Sbjct: 201 VITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLHAKPILPGKNEQEQLNKIFELCGSP 260
Query: 342 SEDYW---KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASAL 398
E W K+ F+P + K R+ E F F +L LL +L LDPA R SA AL
Sbjct: 261 DEKLWPGVSKMPWFNNFKPARPLKRRVREFFRHFDRHALELLEKMLVLDPAQRISAKDAL 320
Query: 399 KNEFFFTSPLACDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQASQL 458
E+F+T PL CD LP Y+ E Q K +R + + + + +++ Q
Sbjct: 321 DAEYFWTDPLPCDPKSLPT-YESSHEF-----QTKKKRQQQRQNEEAAKRQKLQHPPLQH 374
Query: 459 TKEETLSNKEDSEKHVELNFQGQEPYSSASSASSGTKANQQSHSPPFVLFPVAASHHQKM 518
++ L + GQ S A+ + +++PP V P SH+
Sbjct: 375 SRLPPLQHG------------GQ---SHAAPHWPAGPNHPTNNAPPQV--PAGPSHNFYG 417
Query: 519 SPRNKGHPN 527
PR PN
Sbjct: 418 KPRGPPGPN 426
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q8W4P1|CDKC2_ARATH Cyclin-dependent kinase C-2 OS=Arabidopsis thaliana GN=CDKC-2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 282 bits (721), Expect = 7e-75, Method: Compositional matrix adjust.
Identities = 148/362 (40%), Positives = 215/362 (59%), Gaps = 29/362 (8%)
Query: 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL 181
+S + ++K++++G+GTY VY A + TG+IVALKK++ D REI IL+KL
Sbjct: 21 RSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDNEREGFPITAIREIKILKKL 80
Query: 182 DHPNIVKLEGLATS--------------RMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ 227
H N++ L+ + TS + + +Y+VFE+M DL + P + T PQ
Sbjct: 81 HHENVIHLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQ 140
Query: 228 ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR 281
QLL+GL +CH +LHRD+KGSNLLID G LK+ADFGLA +S + LT+R
Sbjct: 141 IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNR 200
Query: 282 VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSP 341
V+TLWYR PELLLGAT YG ID+WS GC+ AE+ G+PI+PG+TE EQL++I++LCGSP
Sbjct: 201 VITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLNGKPILPGKTENEQLNKIYELCGSP 260
Query: 342 SEDYWKKLRLSTTFRPPQSYKP---RLFEAFSEFPESSLGLLSTLLALDPAYRGSAASAL 398
E W + + +S +P R+ E + F +L LL +L LDP+ R A AL
Sbjct: 261 DESNWPGVSKMPWYNQMKSSRPLKRRVREIYRHFDRHALELLEKMLVLDPSQRICAKDAL 320
Query: 399 KNEFFFTSPLACDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQASQL 458
E+F+T PL CD LP Y+ E Q K +R +M+H + +++++ Q
Sbjct: 321 DAEYFWTDPLPCDPKSLPT-YESSHEF-----QTKKKRQQMRHNEEAAKKQKLQHPQQQH 374
Query: 459 TK 460
++
Sbjct: 375 SR 376
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|B5DE93|CDK12_XENTR Cyclin-dependent kinase 12 OS=Xenopus tropicalis GN=cdk12 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 241 bits (615), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 121/299 (40%), Positives = 179/299 (59%), Gaps = 17/299 (5%)
Query: 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL 181
+ + +D I +G+GTY VYKA D+DTG++VALKKV+ D + REI IL++L
Sbjct: 705 RCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL 764
Query: 182 DHPNIVKLEGLATSRMQY--------SLYLVFEFMQTDLARIISNPEGKLTEP------Q 227
H ++V ++ + T + + YLVFE+M DL ++ + + +E +
Sbjct: 765 IHKSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVQFSEDHIKSFMK 824
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWY 287
QL+ GL++CH + LHRD+K SN+L++ +G +K+ADFGLA +S + RP T++V+TLWY
Sbjct: 825 QLMEGLEYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYSSEESRPYTNKVITLWY 884
Query: 288 RAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWK 347
R PELLLG Y ID+WS GC+L E+F +PI E+ QL I +LCGSP W
Sbjct: 885 RPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP 944
Query: 348 ---KLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
KL T +P + Y+ RL E FS P +L LL +L LDP+ R +A L+++F
Sbjct: 945 DVIKLPYFNTMKPKKQYRRRLREEFSFVPTPALDLLDHMLTLDPSKRCTAEQTLQSDFL 1003
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit rpb1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating srsf1/sf2. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6ZAG3|CDKC3_ORYSJ Cyclin-dependent kinase C-3 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 240 bits (612), Expect = 3e-62, Method: Compositional matrix adjust.
Identities = 133/312 (42%), Positives = 186/312 (59%), Gaps = 24/312 (7%)
Query: 116 LAGLVPKSAESYD---KIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA 172
LA P A + D +I K+G+GTY V++A+D TG+ ALKK+K D + + +
Sbjct: 13 LADYAPAGARTVDCFRRIRKIGEGTYGEVFEAMDIITGERAALKKIKLDDGKEGFPRQIL 72
Query: 173 REIMILQKLDHPNIVKLEGLATS-------------RMQYSLYLVFEFMQTDLARII--S 217
REI +L+KLDH NI++L+ + S + +Y+VFE+M DL +++ S
Sbjct: 73 REIKLLKKLDHENIIRLKEIVVSPGTAHGAGGSDDYMYRGDIYMVFEYMDHDLKKVLHHS 132
Query: 218 NPEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG-VLKIADFGLANYFSPNKKR 276
P +QLL GL +CH +LHRD+KG+NLLI G +LK+ADFGLA F+ +
Sbjct: 133 TPSQVKYYMEQLLKGLHYCHVNNVLHRDIKGANLLISGGGKLLKLADFGLARPFT--RDG 190
Query: 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFK 336
T+ V+TLWYR PELLLGAT+Y +D+WS GC+ AE L +P+ PGRTE EQL +IF+
Sbjct: 191 SFTNHVITLWYRPPELLLGATNYAEAVDIWSVGCIFAEFLLRKPLFPGRTEQEQLSKIFE 250
Query: 337 LCGSPSEDYW---KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS 393
LCG P+E+ W KL L T RP K RL + F F ++ L+ +L L+P R S
Sbjct: 251 LCGFPNEENWPGVSKLPLYKTIRPTTPTKRRLRDIFHNFDSHAVDLIDRMLILNPTERIS 310
Query: 394 AASALKNEFFFT 405
A AL +F T
Sbjct: 311 AHDALCAAYFIT 322
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9NYV4|CDK12_HUMAN Cyclin-dependent kinase 12 OS=Homo sapiens GN=CDK12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 239 bits (610), Expect = 5e-62, Method: Compositional matrix adjust.
Identities = 120/299 (40%), Positives = 179/299 (59%), Gaps = 17/299 (5%)
Query: 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL 181
+ + +D I +G+GTY VYKA D+DTG++VALKKV+ D + REI IL++L
Sbjct: 722 RCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL 781
Query: 182 DHPNIVKLEGLATSRMQY--------SLYLVFEFMQTDLARIISNPEGKLTEP------Q 227
H ++V ++ + T + + YLVFE+M DL ++ + +E +
Sbjct: 782 IHRSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 841
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWY 287
QL+ GL++CH + LHRD+K SN+L++ +G +K+ADFGLA ++ + RP T++V+TLWY
Sbjct: 842 QLMEGLEYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVITLWY 901
Query: 288 RAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWK 347
R PELLLG Y ID+WS GC+L E+F +PI E+ QL I +LCGSP W
Sbjct: 902 RPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCPAVWP 961
Query: 348 ---KLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
KL T +P + Y+ RL E FS P ++L LL +L LDP+ R +A L+++F
Sbjct: 962 DVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQSDFL 1020
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q3MJK5|CDK12_RAT Cyclin-dependent kinase 12 OS=Rattus norvegicus GN=Cdk12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 239 bits (609), Expect = 7e-62, Method: Compositional matrix adjust.
Identities = 120/299 (40%), Positives = 178/299 (59%), Gaps = 17/299 (5%)
Query: 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL 181
+ + +D I +G+GTY VYKA D+DTG++VALKKV+ D + REI IL++L
Sbjct: 718 RCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL 777
Query: 182 DHPNIVKLEGLATSRMQY--------SLYLVFEFMQTDLARIISNPEGKLTEP------Q 227
H ++V ++ + T + + YLVFE+M DL ++ + +E +
Sbjct: 778 VHQSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 837
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWY 287
QL+ GL +CH + LHRD+K SN+L++ +G +K+ADFGLA ++ + RP T++V+TLWY
Sbjct: 838 QLMEGLDYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVITLWY 897
Query: 288 RAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWK 347
R PELLLG Y ID+WS GC+L E+F +PI E+ QL I +LCGSP W
Sbjct: 898 RPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCPAVWP 957
Query: 348 ---KLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
KL T +P + Y+ RL E FS P ++L LL +L LDP+ R +A L+++F
Sbjct: 958 DVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQSDFL 1016
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors (By similarity). Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 584 | ||||||
| 359493201 | 582 | PREDICTED: probable serine/threonine-pro | 0.969 | 0.972 | 0.659 | 0.0 | |
| 255566684 | 483 | Cell division protein kinase, putative [ | 0.695 | 0.840 | 0.748 | 1e-180 | |
| 359480867 | 587 | PREDICTED: probable serine/threonine-pro | 0.948 | 0.943 | 0.595 | 1e-178 | |
| 255586487 | 572 | Cell division protein kinase 7, putative | 0.919 | 0.938 | 0.592 | 1e-177 | |
| 356574555 | 601 | PREDICTED: probable serine/threonine-pro | 0.977 | 0.950 | 0.575 | 1e-176 | |
| 449441187 | 588 | PREDICTED: probable serine/threonine-pro | 0.929 | 0.923 | 0.563 | 1e-174 | |
| 449520679 | 588 | PREDICTED: probable serine/threonine-pro | 0.929 | 0.923 | 0.563 | 1e-174 | |
| 357443569 | 614 | Cell division protein kinase [Medicago t | 0.962 | 0.915 | 0.555 | 1e-173 | |
| 296081212 | 432 | unnamed protein product [Vitis vinifera] | 0.722 | 0.976 | 0.715 | 1e-171 | |
| 356534035 | 489 | PREDICTED: probable serine/threonine-pro | 0.738 | 0.881 | 0.665 | 1e-166 |
| >gi|359493201|ref|XP_003634541.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 731 bits (1888), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/590 (65%), Positives = 460/590 (77%), Gaps = 24/590 (4%)
Query: 1 MGCVQAKSSMNSPHGGGGLYKLKMENGYVGNKALMGHRRSTGQRYNGKETGRFQKLELPV 60
MG VQAKSSMNSP GL KLK++NGYV A RRSTGQRY K++GR + E
Sbjct: 1 MGSVQAKSSMNSP--PRGLEKLKIDNGYVSKAA---GRRSTGQRYPDKDSGRVLRPESGS 55
Query: 61 NYDDF---ENGGEEKVSGEQRVRDNGTGTGTGKSGGGVDGK-LVNGWPKWLTDNIPREVL 116
N F + GGEEK ++ RD+G G V GK +V+GWP WLTDNIP++ L
Sbjct: 56 NKVLFVSGDGGGEEKSINKEEKRDDG-----GSEVSHVKGKEIVDGWPNWLTDNIPKKAL 110
Query: 117 AGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIM 176
AGLVP+SAES++K+DK+GQGTYSNVYKA D+DTGKIVALKKV+F+T+EP SVKFMAREI
Sbjct: 111 AGLVPRSAESFEKLDKIGQGTYSNVYKARDKDTGKIVALKKVRFETTEPESVKFMAREIT 170
Query: 177 ILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLL 230
IL++LDHPN++KLEGL TSRMQYSLYLVF+FMQ+DLAR+I+ PE +LTEPQ QLL
Sbjct: 171 ILRELDHPNVIKLEGLVTSRMQYSLYLVFDFMQSDLARVIACPE-RLTEPQIKCYMHQLL 229
Query: 231 SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAP 290
SGLQHCH+RGILHRD+KGSNLLIDK+G LKIADFGLA +F PN+K PLTS+VVTLWYRAP
Sbjct: 230 SGLQHCHERGILHRDIKGSNLLIDKDGRLKIADFGLAKHFYPNRKHPLTSKVVTLWYRAP 289
Query: 291 ELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350
ELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQ+HRIFKLCG+PSE+YWKKLR
Sbjct: 290 ELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQIHRIFKLCGTPSEEYWKKLR 349
Query: 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLAC 410
+ TTFRPPQ YKP L EAF +FP SSLGLLSTLLALDP+YRGSA SAL+NEFF T PLAC
Sbjct: 350 MPTTFRPPQMYKPSLVEAFRDFPTSSLGLLSTLLALDPSYRGSARSALQNEFFHTWPLAC 409
Query: 411 DLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQASQLTKEETLSNKEDS 470
DL+GLPVIY ++DE +A + RK RR++MK S+T R+ D ++ K ++ S+KE++
Sbjct: 410 DLTGLPVIYKEDDEATQAREHRKHRRSKMKQHSQTGHRRK--DPTAEKPKGDSGSSKEET 467
Query: 471 EKHVELNFQGQEPYSSASSASSGTKANQQSHSPPFVLFPVAASHHQKMSPRNKGHPNGTK 530
EK E QE +S SASS + Q SPPF+L PVA+S QKMSPR + +PN
Sbjct: 468 EKSTERTSHSQESRNSTGSASSSARPTLQEESPPFLLSPVASS-RQKMSPRTQDYPNAGN 526
Query: 531 NIKNRPPLPNSKTRPTTHNEDSGNMYRLNRVSRSASTREFRKLYQNKQLE 580
NIKN PPLPNSKT T ++++ NMYR N V RSASTREFR L Q K L+
Sbjct: 527 NIKNLPPLPNSKTFATNRSKENNNMYRSNHVHRSASTREFRNLDQRKHLK 576
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255566684|ref|XP_002524326.1| Cell division protein kinase, putative [Ricinus communis] gi|223536417|gb|EEF38066.1| Cell division protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 636 bits (1641), Expect = e-180, Method: Compositional matrix adjust.
Identities = 325/434 (74%), Positives = 367/434 (84%), Gaps = 28/434 (6%)
Query: 24 MENGYVGNKALMGHRRSTGQRYNGKETGRFQKLELPVNYD-DFENGGEEKVSGEQRVRDN 82
MENGY+ L+GHRRS GQR N + L N D F++GG K+S +D
Sbjct: 1 MENGYLSKGGLVGHRRSIGQRLNNSDP-------LLKNCDAGFDSGGGRKLSDRIGEKDR 53
Query: 83 GTGTGTGKSGGGVDGKLVNGWPKWLTDNIPREVLAGLVPKSAESYDKIDKVGQGTYSNVY 142
+ GK VNGWPKWLTDN+P++VLAGL+PKSAE+YDKIDKVGQGTYSNVY
Sbjct: 54 ------------IFGKTVNGWPKWLTDNVPKQVLAGLIPKSAENYDKIDKVGQGTYSNVY 101
Query: 143 KALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202
KA DRDTGKIVALKKVKFDTSEP SV+FMAREIM+LQKLDHPN+VKLEG+ATSRMQYSLY
Sbjct: 102 KARDRDTGKIVALKKVKFDTSEPQSVRFMAREIMMLQKLDHPNVVKLEGIATSRMQYSLY 161
Query: 203 LVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKN 256
LVF+FMQ+DLA II+ PEG+LTEPQ QLLSGLQHCH+RGILHRD+KGSNLLIDKN
Sbjct: 162 LVFDFMQSDLATIITRPEGRLTEPQVKCYMHQLLSGLQHCHERGILHRDIKGSNLLIDKN 221
Query: 257 GVLKIADFGLANYFSPNK-KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEM 315
GVLKIADFGLANY+SP + KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEM
Sbjct: 222 GVLKIADFGLANYYSPERNKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEM 281
Query: 316 FLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPES 375
F GRPIMPGRTEVEQLHRIFKLCG+PSEDYWKKLRLSTTFRPP+SYKP LFEAF EFPES
Sbjct: 282 FAGRPIMPGRTEVEQLHRIFKLCGTPSEDYWKKLRLSTTFRPPKSYKPSLFEAFGEFPES 341
Query: 376 SLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDLSGLPVIYDKEDELIEANQQRKIR 435
SLGLL+TLLALDPAYRGSA+SAL+N+FF+TSPLACDLSGLPVI+ +EDEL +AN+ RK R
Sbjct: 342 SLGLLTTLLALDPAYRGSASSALQNDFFYTSPLACDLSGLPVIWREEDELAQANELRK-R 400
Query: 436 RARMKHRSKTLRER 449
+ R+K ++ +R +
Sbjct: 401 KKRLKSQNSEVRSQ 414
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359480867|ref|XP_003632535.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 632 bits (1629), Expect = e-178, Method: Compositional matrix adjust.
Identities = 352/591 (59%), Positives = 422/591 (71%), Gaps = 37/591 (6%)
Query: 1 MGCVQAKSSMNSPHGGGGLYKLKMENGYV----GNKALMGHRRSTGQRYNGKETGRFQKL 56
MGCVQ + S+ SP GL KLK++NGY G + + R ++ +GK G
Sbjct: 1 MGCVQTRPSVYSP--SEGLVKLKLQNGYAKRGYGGRPI---RHKPPEKLDGKSAGTL--- 52
Query: 57 ELPVNYDDFENGGEEKVSGEQRVRDNGTGTG-----TGKSGGGVDGKLVNGWPKWLTDNI 111
V+ GGEE V E + NG G T K GG +LV+GWPKWL DNI
Sbjct: 53 ---VDGGGGGGGGEEMVGREDENKLNGGGGNVSQKITVKRIGG--DELVDGWPKWLVDNI 107
Query: 112 PREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFM 171
R+ L GLVPKS +SY+K+ KVGQGTYSNVYKA DR+T KIVALKKV+FDTSE SVKFM
Sbjct: 108 HRDALVGLVPKSVDSYEKLAKVGQGTYSNVYKARDRETRKIVALKKVRFDTSEAESVKFM 167
Query: 172 AREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ---- 227
AREIMILQKLDHPNI+KLEGLATSRMQYSLYLVF+FM TDL R+IS P G+LTEPQ
Sbjct: 168 AREIMILQKLDHPNIIKLEGLATSRMQYSLYLVFDFMPTDLTRVISRPNGRLTEPQVKFY 227
Query: 228 --QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTL 285
QLL+G+QHCH+RGILHRD+KGSNLLIDKNGVLKIADFGLAN+ P K+PLTSRVVTL
Sbjct: 228 MQQLLAGVQHCHERGILHRDLKGSNLLIDKNGVLKIADFGLANFLDPKPKKPLTSRVVTL 287
Query: 286 WYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDY 345
WYRAPELLLG+TDYGVGIDLWS GCLLAEMF GRPIMPGRTEVEQLHRIFKLCGSPSEDY
Sbjct: 288 WYRAPELLLGSTDYGVGIDLWSVGCLLAEMFTGRPIMPGRTEVEQLHRIFKLCGSPSEDY 347
Query: 346 WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405
WKKLRL T+FRPPQ YKP +AF +FP SS LL++LLALDPA+RGSAA+AL++ FF +
Sbjct: 348 WKKLRLPTSFRPPQQYKPSFQDAFRDFPSSSFALLTSLLALDPAFRGSAATALESGFFTS 407
Query: 406 SPLACDLSGLP-VIYDKEDELIEANQQRKIRRARMKHRSKTLRE-RRIGDQASQLTKEET 463
SPL CDLSGLP V+Y + DE +AN+++K R +R + +S+T E RR D ++ K ++
Sbjct: 408 SPLPCDLSGLPVVVYKEADEPSQANKRKKHRTSRSRQQSRTHNEGRRKKDPTAEEAKGDS 467
Query: 464 LSNKEDSEKHVELNFQGQEPYSSASSASSGTKANQQSHSPPFVLFPVAASHHQKMSPRNK 523
++ S++ + QE +S SS SS +K +Q P L P SH K +P+ +
Sbjct: 468 GTS---SQEEKSTDPTSQETGNSPSSRSSSSKPMKQEGQLPLSLSPALQSHG-KRAPKTE 523
Query: 524 GHPNGTKNIKNRPPLPNS-KTRPTTHNEDSGNMYRLNRVSRSASTREFRKL 573
GHPN TKNIKN P L NS +T + ++D G RL RS ST +FR L
Sbjct: 524 GHPNATKNIKNLPILYNSFQTDSSNTSQDEGP--RLTFNYRSLSTLDFRTL 572
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255586487|ref|XP_002533885.1| Cell division protein kinase 7, putative [Ricinus communis] gi|223526162|gb|EEF28496.1| Cell division protein kinase 7, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 626 bits (1615), Expect = e-177, Method: Compositional matrix adjust.
Identities = 352/594 (59%), Positives = 408/594 (68%), Gaps = 57/594 (9%)
Query: 1 MGCVQAKSSMNSPHGGGGLYKLKMENGYVGNKALMGHRRSTGQRYNGKET--GRFQKLEL 58
MGC+ K+S SPH G L LK E GYV RR G+ E G +L
Sbjct: 1 MGCILDKNSGRSPHNQG-LETLKQERGYV--------RRPEGENKRVVELNGGDGDGEKL 51
Query: 59 PVNYDDFENGGEEKVSGEQRVRDNGTGTGTGKSGGGVDGKLVNGWPKWLTDNIPREVLAG 118
V + +NG VS +R+ T K GG +LV+GWPKWL DNIP+EVLAG
Sbjct: 52 VVVKEGLKNGDVGNVS--RRI--------TLKKIGG--DELVDGWPKWLVDNIPKEVLAG 99
Query: 119 LVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMIL 178
LVPKSA+SYDK+ K+GQGTYSNVYKA DRDTGKIVALKKV+FDTSE S+ FMAREIMIL
Sbjct: 100 LVPKSADSYDKLAKIGQGTYSNVYKARDRDTGKIVALKKVRFDTSESESINFMAREIMIL 159
Query: 179 QKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSG 232
QKLDHPNI+KLEGLATSRMQYSLYLVF FMQ+DL R+IS P +LTEPQ QLLSG
Sbjct: 160 QKLDHPNIIKLEGLATSRMQYSLYLVFGFMQSDLTRVISRPAHRLTEPQVKCYMQQLLSG 219
Query: 233 LQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPEL 292
LQHCH+RGILHRD+K SNLLIDKNG+LKIADFGLAN F P KRPLTSRVVTLWYRAPEL
Sbjct: 220 LQHCHERGILHRDIKASNLLIDKNGMLKIADFGLANVFIPKPKRPLTSRVVTLWYRAPEL 279
Query: 293 LLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352
LLG+TDYGVGIDLWSAGCLLAEMF GRPIMPGRTEVEQLHRIFKLCGSPSEDYWK +RL
Sbjct: 280 LLGSTDYGVGIDLWSAGCLLAEMFTGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKIMRLQ 339
Query: 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDL 412
T+FRPPQ YKP EAF +FP+SS GLL+TLLAL+PAYRG+A SAL++ FF TSPLAC L
Sbjct: 340 TSFRPPQHYKPSFQEAFRDFPDSSFGLLTTLLALNPAYRGTATSALQSLFFSTSPLACQL 399
Query: 413 SGLPVIYDKEDELIEANQQRKIRRA---------RMKHRSKTLRERRIGDQASQLTKEET 463
SGLPVIY +EDE +AN + K R+ HR KT+ ++Q KE+T
Sbjct: 400 SGLPVIYKEEDEPSQANDRNKKRKKSKILSSGVNHECHRRKTV--------STQQAKEDT 451
Query: 464 LSNKEDSEKHVELNFQGQEPYSSASSASSG----TKANQQSHSPPFVLFPVAASHHQKMS 519
S+KE E+H E N GQE +++ S++S Q+ H P+ S +
Sbjct: 452 ESSKE-LERHSESNMSGQETGNNSGSSTSSSLKPITEKQKMHIIRPSFSPIGPSRQDRSM 510
Query: 520 PRNKGHPNGTKNIKNRPPLPNSKTRPTTHNEDSGNMYRLNRVSRSASTREFRKL 573
R + HPN KN++N L S T HN + YR RS ST +FR L
Sbjct: 511 RRTEAHPNAVKNLQNFTLLQASITDIVNHN-NGMPAYR-----RSLSTLDFRTL 558
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574555|ref|XP_003555411.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 623 bits (1607), Expect = e-176, Method: Compositional matrix adjust.
Identities = 347/603 (57%), Positives = 427/603 (70%), Gaps = 32/603 (5%)
Query: 1 MGCVQAKS-SMNSPHGGGGLYKLKMENGYVGNKALMGHRRSTGQRYN--GKETGRF-QKL 56
MGCVQAK + L +LK++NG V + + HRRSTGQR++ KE R Q+
Sbjct: 1 MGCVQAKPLDLEEGPEYRTLDRLKLDNGCVPSTDFVAHRRSTGQRHHEPNKEYERLHQRR 60
Query: 57 ELP------------VNYDDFENGGEEKVSGEQRVRDNGTGTGTGKSGGGVDGKLVNGWP 104
E P N + + G KV G Q R + + +V+GWP
Sbjct: 61 EQPRKQTNELIESGVANAEGLHHKG--KVVGRQGRRVTRRDDKNLANQCCFEDDMVDGWP 118
Query: 105 KWLTDNIPREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE 164
KWL DN+P +VLAGLVP+SAESY IDKVGQGTYSNVYKALD++TG+IVALKKVKF+TSE
Sbjct: 119 KWLVDNVPTQVLAGLVPRSAESYKMIDKVGQGTYSNVYKALDQETGEIVALKKVKFNTSE 178
Query: 165 PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLT 224
P S+KFMAREIMILQ+LDHPN++KL GLATSRMQYS+YLVF+FMQTDLAR+I+ PE +LT
Sbjct: 179 PESIKFMAREIMILQRLDHPNVLKLIGLATSRMQYSIYLVFDFMQTDLARVIARPEERLT 238
Query: 225 EPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278
EPQ Q LSGLQHCHDRGILHRD+KGSNLLIDKN +LKIADFGLAN++ P + +PL
Sbjct: 239 EPQVKCYMHQFLSGLQHCHDRGILHRDIKGSNLLIDKNRMLKIADFGLANFYGPERHQPL 298
Query: 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLC 338
TSRVVTLWYRAPELLLG T+YGVG+DLWSAGCLLAEMF G PIMPGR E+EQLH+IF+LC
Sbjct: 299 TSRVVTLWYRAPELLLGDTEYGVGVDLWSAGCLLAEMFKGIPIMPGRNEIEQLHKIFRLC 358
Query: 339 GSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASAL 398
G+PSE+YW+KL+LSTTFRPP+SY+P L E P SSLGLL TLLALDPA+RGSA+ AL
Sbjct: 359 GTPSEEYWRKLKLSTTFRPPKSYRPSLVETLKNLPPSSLGLLCTLLALDPAFRGSASKAL 418
Query: 399 KNEFFFTSPLACDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQASQL 458
KN+FF TSPLACDLSGLPVI ++DE ++AN+Q K ++++ RS+T ERR + S+
Sbjct: 419 KNQFFITSPLACDLSGLPVIVSEDDEFVQANEQIKYMNSKIR-RSRTYMERR-KNSTSKS 476
Query: 459 TKEETLSNKEDSEKHVE-LNFQGQEPYSSASSASSGTKANQQSHSPPFVLFPVAASHHQK 517
E T+S+KE+ ++ + F E S SS SS + PF L P A QK
Sbjct: 477 PLEHTVSSKEELTRNAKPETFVPTEDMDSTSSTSSSVNPGEAKDQSPFFLSPFGAL-DQK 535
Query: 518 MSPRNKGHPN-GTKNIKNRPPLPNSKTRPTTHNEDSGNMYRLNRVSRSASTREFRKLYQN 576
+SP+ H N G KN+KN PPLP SK + +E +R + RSAST EFR L +
Sbjct: 536 LSPKTHHHVNGGEKNVKNLPPLPKSKPNASKKDESK---HRPDHFFRSASTIEFRYLKRE 592
Query: 577 KQL 579
++L
Sbjct: 593 ERL 595
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449441187|ref|XP_004138365.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 617 bits (1591), Expect = e-174, Method: Compositional matrix adjust.
Identities = 353/626 (56%), Positives = 439/626 (70%), Gaps = 83/626 (13%)
Query: 1 MGCVQAKSSMNSPHGGGGLYKLKMENGYVGNKALMGHRRSTGQ-RYNGKETGRFQKLELP 59
MGC Q K S+NSP GG+ KLK++NGY G + HRRS GQ R+ G+E+ + E P
Sbjct: 1 MGCAQTKHSVNSP--AGGVEKLKLDNGYAGIDGFVAHRRSVGQRRFVGRES---SEAERP 55
Query: 60 VNYDDFENGGEEKVSGEQRVRDNGTGTGTGKSGGGVDGKLVNGWPKWLTDNIPREVLAGL 119
GG ++ G + +LV+GWPKWLT NIP+ VLAGL
Sbjct: 56 ------HGGGNDQF-------------------GSDNSELVDGWPKWLTSNIPKHVLAGL 90
Query: 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQ 179
VPKS E+YDK+DKVGQG+YSNVYKA DR+TGKIVALKKV+FDT+EP SVKFMAREIMIL
Sbjct: 91 VPKSVEAYDKLDKVGQGSYSNVYKARDRETGKIVALKKVRFDTTEPESVKFMAREIMILL 150
Query: 180 KLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGL 233
KLDHPNIVKLEGLATSRMQ+SLYLVF+FMQTDLAR+IS+P+ +LTEPQ QLLSGL
Sbjct: 151 KLDHPNIVKLEGLATSRMQFSLYLVFDFMQTDLARVISHPDVRLTEPQVKSYMHQLLSGL 210
Query: 234 QHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELL 293
+HCHD+GILHRD+KGSNLLIDKNG+LKIADFGLA +FSP KR LT+RVVTLWYRAPELL
Sbjct: 211 RHCHDKGILHRDIKGSNLLIDKNGMLKIADFGLAIFFSP--KRHLTNRVVTLWYRAPELL 268
Query: 294 LGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353
LGAT+YGVGIDLWSAGCL AEMF GRPI+PGRTEVEQLH+IFKLCG+PSE+YW+KL+L
Sbjct: 269 LGATEYGVGIDLWSAGCLFAEMFTGRPILPGRTEVEQLHKIFKLCGTPSEEYWRKLKLPP 328
Query: 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDLS 413
TFRPPQSY+P L E+F FP SSLGLL+TLLAL+P+YRGSA+SAL NEFF+TSPLAC LS
Sbjct: 329 TFRPPQSYRPSLRESFKHFPSSSLGLLNTLLALEPSYRGSASSALDNEFFYTSPLACSLS 388
Query: 414 GLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQASQLTKEET-----LSNK- 467
LP+I+ + D + NQQ K R A++ RS T RERR D + + KEE+ LS +
Sbjct: 389 DLPIIHSEPDVPDKTNQQ-KSRTAKVTRRSHTHRERRRKDLTAGIPKEESNLPKQLSQQR 447
Query: 468 -EDSEKHVE----------------------------LNFQGQEPYSSASSASSGTKANQ 498
+D E++ E +N G++ S++SS ++G
Sbjct: 448 GDDDEQNEERGSTTTSTSSSVNNGVRKGSTMSSTSSSVNTGGRKTTSTSSSVNTGG-GTG 506
Query: 499 QSHSPPFVLFPVAASHHQKMSPRNKGHPNGTKNIKNRPPLPNSKTRPTTHNEDSGNMYRL 558
SH F+L P++ S+ + S R +GH T N+ N PPLP ++ + + +D +
Sbjct: 507 SSH---FLLSPISYSN--RKSSRIQGHLQVTNNL-NLPPLPKTREYSSFNIKDHHGAHIT 560
Query: 559 NRVSRSASTREFRKLYQNKQLESIYA 584
+V RS STR+FR L + + L+ +YA
Sbjct: 561 GQVRRSVSTRDFRNLERKEHLK-LYA 585
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449520679|ref|XP_004167361.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 617 bits (1590), Expect = e-174, Method: Compositional matrix adjust.
Identities = 353/626 (56%), Positives = 439/626 (70%), Gaps = 83/626 (13%)
Query: 1 MGCVQAKSSMNSPHGGGGLYKLKMENGYVGNKALMGHRRSTGQ-RYNGKETGRFQKLELP 59
MGC Q K S+NSP GG+ KLK++NGY G + HRRS GQ R+ G+E+ + E P
Sbjct: 1 MGCAQTKHSVNSP--AGGVEKLKLDNGYAGIDGFVAHRRSVGQRRFVGRES---SEAERP 55
Query: 60 VNYDDFENGGEEKVSGEQRVRDNGTGTGTGKSGGGVDGKLVNGWPKWLTDNIPREVLAGL 119
GG ++ G + +LV+GWPKWLT NIP+ VLAGL
Sbjct: 56 ------HGGGNDQF-------------------GSDNSELVDGWPKWLTSNIPKHVLAGL 90
Query: 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQ 179
VPKS E+YDK+DKVGQG+YSNVYKA DR+TGKIVALKKV+FDT+EP SVKFMAREIMIL
Sbjct: 91 VPKSVEAYDKLDKVGQGSYSNVYKAQDRETGKIVALKKVRFDTTEPESVKFMAREIMILL 150
Query: 180 KLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGL 233
KLDHPNIVKLEGLATSRMQ+SLYLVF+FMQTDLAR+IS+P+ +LTEPQ QLLSGL
Sbjct: 151 KLDHPNIVKLEGLATSRMQFSLYLVFDFMQTDLARVISHPDVRLTEPQVKSYMHQLLSGL 210
Query: 234 QHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELL 293
+HCHD+GILHRD+KGSNLLIDKNG+LKIADFGLA +FSP KR LT+RVVTLWYRAPELL
Sbjct: 211 RHCHDKGILHRDIKGSNLLIDKNGMLKIADFGLAIFFSP--KRHLTNRVVTLWYRAPELL 268
Query: 294 LGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353
LGAT+YGVGIDLWSAGCL AEMF GRPI+PGRTEVEQLH+IFKLCG+PSE+YW+KL+L
Sbjct: 269 LGATEYGVGIDLWSAGCLFAEMFTGRPILPGRTEVEQLHKIFKLCGTPSEEYWRKLKLPP 328
Query: 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDLS 413
TFRPPQSY+P L E+F FP SSLGLL+TLLAL+P+YRGSA+SAL NEFF+TSPLAC LS
Sbjct: 329 TFRPPQSYRPSLRESFKHFPSSSLGLLNTLLALEPSYRGSASSALDNEFFYTSPLACSLS 388
Query: 414 GLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQASQLTKEET-----LSNK- 467
LP+I+ + D + NQQ K R A++ RS T RERR D + + KEE+ LS +
Sbjct: 389 DLPIIHSEPDVPDKTNQQ-KSRTAKVTRRSHTHRERRRKDLTAGIPKEESNLPKQLSQQR 447
Query: 468 -EDSEKHVE----------------------------LNFQGQEPYSSASSASSGTKANQ 498
+D E++ E +N G++ S++SS ++G
Sbjct: 448 GDDDEQNEERGSTTTSTSSSVNNGVRKGSTMSSTSSSVNTGGRKTTSTSSSVNTGG-GTG 506
Query: 499 QSHSPPFVLFPVAASHHQKMSPRNKGHPNGTKNIKNRPPLPNSKTRPTTHNEDSGNMYRL 558
SH F+L P++ S+ + S R +GH T N+ N PPLP ++ + + +D +
Sbjct: 507 SSH---FLLSPISYSN--RKSSRIQGHLQVTNNL-NLPPLPKTREYSSFNIKDHHGAHIT 560
Query: 559 NRVSRSASTREFRKLYQNKQLESIYA 584
+V RS STR+FR L + + L+ +YA
Sbjct: 561 GQVRRSVSTRDFRNLERKEHLK-LYA 585
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357443569|ref|XP_003592062.1| Cell division protein kinase [Medicago truncatula] gi|355481110|gb|AES62313.1| Cell division protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 615 bits (1585), Expect = e-173, Method: Compositional matrix adjust.
Identities = 349/628 (55%), Positives = 427/628 (67%), Gaps = 66/628 (10%)
Query: 1 MGCVQAKSSMNSPHGGGGLYKLKMENGYVGNKALMGHRRSTGQRYNGKETGRFQKLELPV 60
MGCVQAK + S GL + KMENGYV + + HRRSTGQ G+
Sbjct: 1 MGCVQAKP-LESEANYRGLDRFKMENGYVPSSDFVAHRRSTGQSQKYVAKGK-------- 51
Query: 61 NYDDFENGGEEKVSGEQRVRDNGTGTGTGKSGGGV-----------DGKLVNGWPKWLTD 109
D ++ ++ + +V D G GK G + D ++V+GWPKWL D
Sbjct: 52 ---DIDHHVHQRQPRKHKVVDGNIGGARGKRDGELKDSKKQLNRCFDDEMVDGWPKWLVD 108
Query: 110 NIPREVLAGLVPKSAESYDKIDK-----------------------------VGQGTYSN 140
N+P +VLAG+V KSAESY IDK VGQGTYSN
Sbjct: 109 NVPSQVLAGVVAKSAESYKMIDKFGYLTMLPDIFHDEASFFSKLYFSLLESKVGQGTYSN 168
Query: 141 VYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200
VYKALDRDTG IVALKKV+F+TS+P S+KFMAREI ILQ+LDHPN+VKL+GLATSRMQYS
Sbjct: 169 VYKALDRDTGDIVALKKVRFNTSQPESIKFMAREITILQRLDHPNVVKLKGLATSRMQYS 228
Query: 201 LYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLID 254
+YLVF+FM TDL+RIIS P +LTEPQ QLLSGLQHCHDRGILHRD+KGSNLLID
Sbjct: 229 IYLVFDFMPTDLSRIISRPGERLTEPQVKCYMHQLLSGLQHCHDRGILHRDIKGSNLLID 288
Query: 255 KNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAE 314
KNG+L+IADFGLANY+SPN+ +PLT+RVVTLWYRAPELLLG+TDYGVGIDLWS GCLLAE
Sbjct: 289 KNGMLQIADFGLANYYSPNQDQPLTNRVVTLWYRAPELLLGSTDYGVGIDLWSVGCLLAE 348
Query: 315 MFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPE 374
MF G PIMPGRTEVEQLHRIF+LCG+PS++YW+KL+LSTTF P +SY+P L E F++ P
Sbjct: 349 MFKGIPIMPGRTEVEQLHRIFRLCGTPSQEYWRKLKLSTTFVPLKSYRPSLVETFNDLPP 408
Query: 375 SSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDLSGLPVIYDKEDELIEANQQRKI 434
SSLGLL TLLALDPA+RGSA+ ALKN FFFTSPLACDLSGLP IY +EDE A +Q K
Sbjct: 409 SSLGLLCTLLALDPAFRGSASKALKNPFFFTSPLACDLSGLPAIYKEEDEHTPAKEQIKY 468
Query: 435 RRARMKHRSKTLRERRIGDQASQLTKEETLSNKE--DSEKHVELNFQGQEP-YSSASSAS 491
++++ RS+T ERR + AS E T+S+KE + E +EP +++S++S
Sbjct: 469 INSKIR-RSRTFMERR-KNLASNRPIEHTVSSKEVLRNNAEAETYVPSEEPGSATSSTSS 526
Query: 492 SGTKANQQSHSPPFVLFPVAASHHQKMSPRNKGHPNGTKNIKNRPPLPNSKTRPTTHNED 551
S +A HSP F+ + + Q ++ G KNIKN PPL SK +P +D
Sbjct: 527 SVNQAGVGDHSPLFLSPFLGSDQKQPHKIHSRRANIGEKNIKNLPPL--SKPKPNATKKD 584
Query: 552 SGNMYRLNRVSRSASTREFRKLYQNKQL 579
G YR +++ RS STREFRKL + L
Sbjct: 585 DGR-YRTDQIFRSTSTREFRKLKTEEHL 611
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296081212|emb|CBI18238.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 607 bits (1564), Expect = e-171, Method: Compositional matrix adjust.
Identities = 317/443 (71%), Positives = 366/443 (82%), Gaps = 21/443 (4%)
Query: 1 MGCVQAKSSMNSPHGGGGLYKLKMENGYVGNKALMGHRRSTGQRYNGKETGRFQKLELPV 60
MG VQAKSSMNSP GL KLK++NGYV A RRSTGQRY K++GR + E
Sbjct: 1 MGSVQAKSSMNSP--PRGLEKLKIDNGYVSKAA---GRRSTGQRYPDKDSGRVLRPESGS 55
Query: 61 NYDDF---ENGGEEKVSGEQRVRDNGTGTGTGKSGGGVDGK-LVNGWPKWLTDNIPREVL 116
N F + GGEEK ++ RD+G G V GK +V+GWP WLTDNIP++ L
Sbjct: 56 NKVLFVSGDGGGEEKSINKEEKRDDG-----GSEVSHVKGKEIVDGWPNWLTDNIPKKAL 110
Query: 117 AGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIM 176
AGLVP+SAES++K+DK+GQGTYSNVYKA D+DTGKIVALKKV+F+T+EP SVKFMAREI
Sbjct: 111 AGLVPRSAESFEKLDKIGQGTYSNVYKARDKDTGKIVALKKVRFETTEPESVKFMAREIT 170
Query: 177 ILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLL 230
IL++LDHPN++KLEGL TSRMQYSLYLVF+FMQ+DLAR+I+ PE +LTEPQ QLL
Sbjct: 171 ILRELDHPNVIKLEGLVTSRMQYSLYLVFDFMQSDLARVIACPE-RLTEPQIKCYMHQLL 229
Query: 231 SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAP 290
SGLQHCH+RGILHRD+KGSNLLIDK+G LKIADFGLA +F PN+K PLTS+VVTLWYRAP
Sbjct: 230 SGLQHCHERGILHRDIKGSNLLIDKDGRLKIADFGLAKHFYPNRKHPLTSKVVTLWYRAP 289
Query: 291 ELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350
ELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQ+HRIFKLCG+PSE+YWKKLR
Sbjct: 290 ELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQIHRIFKLCGTPSEEYWKKLR 349
Query: 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLAC 410
+ TTFRPPQ YKP L EAF +FP SSLGLLSTLLALDP+YRGSA SAL+NEFF T PLAC
Sbjct: 350 MPTTFRPPQMYKPSLVEAFRDFPTSSLGLLSTLLALDPSYRGSARSALQNEFFHTWPLAC 409
Query: 411 DLSGLPVIYDKEDELIEANQQRK 433
DL+GLPVIY ++DE +A + RK
Sbjct: 410 DLTGLPVIYKEDDEATQAREHRK 432
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356534035|ref|XP_003535563.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 591 bits (1523), Expect = e-166, Method: Compositional matrix adjust.
Identities = 302/454 (66%), Positives = 361/454 (79%), Gaps = 23/454 (5%)
Query: 1 MGCVQAKS-SMNSPHGGGGLYKLKMENGYVGNKALMGHRRSTGQRYN--GKETGRF---Q 54
MGCVQAKS + L +LK++NGYV + + HRRSTGQR++ KE R Q
Sbjct: 1 MGCVQAKSLDLEESPEYRTLDRLKLDNGYVPSTDFVAHRRSTGQRHHEPNKEYERLHQHQ 60
Query: 55 KLELPVNYDD--FENG---------GEEKVSGEQRVRDNGTGTGTGKSGGGVDGKLVNGW 103
+ E P + E+G + KV G + R ++ + ++V+GW
Sbjct: 61 RREQPRKQTNKLIESGVANGEGLHLNKGKVVGREGRRVTRRDDKKLENKCCFEDEMVDGW 120
Query: 104 PKWLTDNIPREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS 163
PKWL DN+P +VLAGLVP+SAESY IDKVGQGTYSNVYKALDR+TG+IVALKKVKF+TS
Sbjct: 121 PKWLVDNVPTQVLAGLVPRSAESYKMIDKVGQGTYSNVYKALDRETGEIVALKKVKFNTS 180
Query: 164 EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKL 223
EP S+KFMAREIMILQ+LDHPN++KL+GLATSRMQYS+YLVFEFMQTDLAR+I+ PE +L
Sbjct: 181 EPESIKFMAREIMILQRLDHPNVLKLKGLATSRMQYSIYLVFEFMQTDLARVIARPEERL 240
Query: 224 TEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277
TEPQ QLLSGLQHCH+RGILHRD+KGSNLLIDKNG+LKIADFGLAN++ P++ RP
Sbjct: 241 TEPQVKCYMHQLLSGLQHCHERGILHRDIKGSNLLIDKNGMLKIADFGLANFYGPDRHRP 300
Query: 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKL 337
LTSRVVTLWYRAPELLLG TDYGVG+DLWSAGCLLAEMF G PIMPGR EVEQLH+IF+L
Sbjct: 301 LTSRVVTLWYRAPELLLGDTDYGVGVDLWSAGCLLAEMFTGIPIMPGRNEVEQLHKIFRL 360
Query: 338 CGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASA 397
CG+PSE+YW+KL+LSTTFRPP+SY+P L E F + P SSLGLL TLLALDPA+RGSA+ A
Sbjct: 361 CGTPSEEYWRKLKLSTTFRPPKSYRPSLVETFKDLPPSSLGLLCTLLALDPAFRGSASKA 420
Query: 398 LKNEFFFTSPLACDLSGLPVIYDKEDELIEANQQ 431
LKN+FF TSPLACDLSGLPVI ++DEL++AN+Q
Sbjct: 421 LKNQFFITSPLACDLSGLPVIVREDDELVQANEQ 454
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 584 | ||||||
| TAIR|locus:2199491 | 573 | AT1G54610 [Arabidopsis thalian | 0.667 | 0.680 | 0.544 | 1.1e-110 | |
| TAIR|locus:2037042 | 694 | AT1G53050 [Arabidopsis thalian | 0.604 | 0.508 | 0.590 | 1e-109 | |
| TAIR|locus:2019115 | 699 | AT1G74330 [Arabidopsis thalian | 0.631 | 0.527 | 0.511 | 7.3e-105 | |
| TAIR|locus:2012290 | 714 | AT1G09600 [Arabidopsis thalian | 0.578 | 0.473 | 0.553 | 6e-103 | |
| TAIR|locus:2012643 | 614 | AT1G33770 [Arabidopsis thalian | 0.724 | 0.688 | 0.475 | 2e-102 | |
| TAIR|locus:2152740 | 580 | AT5G50860 [Arabidopsis thalian | 0.573 | 0.577 | 0.565 | 5.4e-102 | |
| TAIR|locus:2096199 | 593 | AT3G05050 [Arabidopsis thalian | 0.595 | 0.586 | 0.545 | 8.8e-102 | |
| TAIR|locus:2158715 | 644 | AT5G44290 [Arabidopsis thalian | 0.601 | 0.545 | 0.553 | 8.8e-102 | |
| TAIR|locus:2175743 | 644 | cdc2cAt "CDC2C" [Arabidopsis t | 0.590 | 0.535 | 0.512 | 4.1e-100 | |
| TAIR|locus:2034944 | 709 | IBS1 "IMPAIRED IN BABA-INDUCED | 0.753 | 0.620 | 0.429 | 4.7e-99 |
| TAIR|locus:2199491 AT1G54610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1093 (389.8 bits), Expect = 1.1e-110, P = 1.1e-110
Identities = 219/402 (54%), Positives = 280/402 (69%)
Query: 67 NGGEEKVS--GEQRVRDNXXXXXXXXXXXXXXXKLVNGWPKWLTDNIPREVLAGLVPKSA 124
NG +E+ S G++R ++ GWP WL+D E L G VP+ A
Sbjct: 57 NGDKERKSSKGDRRRSTKPNPRLSNPSKHWRGEQVAAGWPSWLSDACG-EALNGWVPRKA 115
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
++++KIDK+GQGTYSNVYKA D TGKIVALKKV+FD EP SVKFMAREI++L++LDHP
Sbjct: 116 DTFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILVLRRLDHP 175
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHD 238
N+VKLEGL TSRM SLYLVF++M DLA + S+P K +E + QL+SGL+HCH
Sbjct: 176 NVVKLEGLVTSRMSCSLYLVFQYMDHDLAGLASSPVVKFSESEVKCLMRQLISGLEHCHS 235
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATD 298
RG+LHRD+KGSNLLID GVLKIADFGLA F PN KRP+TSRVVTLWYRAPELLLGATD
Sbjct: 236 RGVLHRDIKGSNLLIDDGGVLKIADFGLATIFDPNHKRPMTSRVVTLWYRAPELLLGATD 295
Query: 299 YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS--TTFR 356
YGVGIDLWSAGC+LAE+ GRPIMPGRTEVEQLH+I+KLCGSPSEDYWKK + + ++
Sbjct: 296 YGVGIDLWSAGCILAELLAGRPIMPGRTEVEQLHKIYKLCGSPSEDYWKKGKFTHGAIYK 355
Query: 357 PPQSYKPRLFEAFSEFPEXXXXXXXXXXXXDPAYRGSAASALKNEFFFTSPLACDLSGLP 416
P + YK + E F +FP +P R +A++ALK+EFF + P AC+ + LP
Sbjct: 356 PREPYKRSIRETFKDFPPSSLPLIDALLSIEPEDRQTASAALKSEFFTSEPYACEPADLP 415
Query: 417 VIY-DKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQASQ 457
KE + +++ + +RA K + R+ R D++++
Sbjct: 416 KYPPSKEIDAKRRDEETRRQRAASKAQGDGARKNRHRDRSNR 457
|
|
| TAIR|locus:2037042 AT1G53050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1084 (386.6 bits), Expect = 1.0e-109, P = 1.0e-109
Identities = 215/364 (59%), Positives = 264/364 (72%)
Query: 102 GWPKWLTDNIPREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD 161
GWP WL ++ E + G VP+ A+S++K+DK+GQGTYSNVY+A D D KIVALKKV+FD
Sbjct: 110 GWPPWLA-SVAGEAIRGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFD 168
Query: 162 TSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEG 221
EP SV+FMAREI IL++LDHPNI+KLEGL TSRM SLYLVFE+M+ DLA + S+P
Sbjct: 169 NLEPESVRFMAREIQILRRLDHPNIIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPAI 228
Query: 222 KLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275
K +E Q QLL GL HCH RG+LHRD+KGSNLLID +GVLKIADFGLA++F P +
Sbjct: 229 KFSESQVKCYLQQLLHGLDHCHSRGVLHRDIKGSNLLIDNSGVLKIADFGLASFFDPRQT 288
Query: 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIF 335
+PLTSRVVTLWYR PELLLGAT YG +DLWSAGC+LAE++ G+PIMPGRTEVEQLH+IF
Sbjct: 289 QPLTSRVVTLWYRPPELLLGATRYGAAVDLWSAGCILAELYAGKPIMPGRTEVEQLHKIF 348
Query: 336 KLCGSPSEDYWKKLRL--STTFRPPQSYKPRLFEAFSEFPEXXXXXXXXXXXXDPAYRGS 393
KLCGSP+EDYW K RL +T F+P Q YK + E F EFP+ +P RG+
Sbjct: 349 KLCGSPTEDYWVKSRLPHATIFKPTQPYKRLVGETFKEFPQPALALLETLLSVNPDDRGT 408
Query: 394 AASALKNEFFFTSPLACDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGD 453
A +ALK+EFF T PL CD S LP Y EL + + RR +R + +ERR G
Sbjct: 409 ATAALKSEFFSTRPLPCDPSSLPK-YPPSKELDARMRDEESRRQVGGNRDQRHQERR-GT 466
Query: 454 QASQ 457
+ S+
Sbjct: 467 KESR 470
|
|
| TAIR|locus:2019115 AT1G74330 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1013 (361.7 bits), Expect = 7.3e-105, Sum P(2) = 7.3e-105
Identities = 195/381 (51%), Positives = 261/381 (68%)
Query: 66 ENGGEEKVSGEQRVRDNXXXXXXXXXXXXXXXKLVNGWPKWLTDNIPREVLAGLVPKSAE 125
+ G E S R D+ ++ GWP WL+ N+ E + G VP ++
Sbjct: 61 QKSGSELGSESGRASDSLSFRLGNVSRYLEAEQVAAGWPAWLS-NVAGEAIHGWVPLRSD 119
Query: 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPN 185
+++K++K+GQGTYSNV++A++ +TG+IVALKKV+FD EP SVKFMAREI+IL++L+HPN
Sbjct: 120 AFEKLEKIGQGTYSNVFRAVETETGRIVALKKVRFDNFEPESVKFMAREILILRRLNHPN 179
Query: 186 IVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHDR 239
I+KLEGL TS++ ++ LVFE+M+ DL ++S+P+ K T PQ QLLSGL HCH R
Sbjct: 180 IIKLEGLITSKLSCNIQLVFEYMEHDLTGLLSSPDIKFTTPQIKCYMKQLLSGLDHCHSR 239
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLANYF--SPNKKRPLTSRVVTLWYRAPELLLGAT 297
G++HRD+KGSNLL+ G+LK+ADFGLAN+ S +KK+PLTSRVVTLWYR PELLLGAT
Sbjct: 240 GVMHRDIKGSNLLLSNEGILKVADFGLANFSNSSGHKKKPLTSRVVTLWYRPPELLLGAT 299
Query: 298 DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL--STTF 355
DYG +DLWS GC+ AE+ LG+PI+ GRTEVEQLH+IFKLCGSP EDYWKK +L + F
Sbjct: 300 DYGASVDLWSVGCVFAELLLGKPILRGRTEVEQLHKIFKLCGSPPEDYWKKSKLPHAMLF 359
Query: 356 RPPQSYKPRLFEAFSEFPEXXXXXXXXXXXXDPAYRGSAASALKNEFFFTSPLACDLSGL 415
+P Q+Y L E + E DP RG+A+SAL +++F T P ACD S L
Sbjct: 360 KPQQTYDSCLRETLKDLSETEINLIETLLSIDPHKRGTASSALVSQYFTTKPFACDPSSL 419
Query: 416 PVIYDKEDELIEANQQRKIRR 436
P IY E+ ++ R+
Sbjct: 420 P-IYPPSKEIDTKHRDEAARK 439
|
|
| TAIR|locus:2012290 AT1G09600 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1020 (364.1 bits), Expect = 6.0e-103, P = 6.0e-103
Identities = 192/347 (55%), Positives = 256/347 (73%)
Query: 98 KLVNGWPKWLTDNIPREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKK 157
+++ GWP WL ++ E + G +P+ A+S++K++K+GQGTYS+VYKA D +T ++VALKK
Sbjct: 135 QVMAGWPSWLA-SVAGEAINGWIPRKADSFEKLEKIGQGTYSSVYKARDLETNQLVALKK 193
Query: 158 VKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIIS 217
V+F +P SV+FMAREI+IL++LDHPN++KLEGL TSR+ S+YL+FE+M+ DLA + S
Sbjct: 194 VRFANMDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFEYMEHDLAGLAS 253
Query: 218 NPEGKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS 271
P +E Q QLL GL+HCH RG+LHRD+KGSNLL+D N LKI DFGLAN++
Sbjct: 254 TPGINFSEAQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFYQ 313
Query: 272 PNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQL 331
++K+PLTSRVVTLWYR PELLLG+TDYGV +DLWS GC+LAE+F G+PIMPGRTEVEQL
Sbjct: 314 GHQKQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQL 373
Query: 332 HRIFKLCGSPSEDYWK--KLRLSTTFRPPQSYKPRLFEAFSEFPEXXXXXXXXXXXXDPA 389
H+IFKLCGSPSE+YWK KL +T F+P Q YK + E F P +P
Sbjct: 374 HKIFKLCGSPSEEYWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEPD 433
Query: 390 YRGSAASALKNEFFFTSPLACDLSGLPVIYDKEDELIEANQQRKIRR 436
RG+ ASAL++EFF TSPLA D S LP +++ ++A ++ R+
Sbjct: 434 ARGTTASALESEFFTTSPLASDPSSLPKYQPRKEIDVKAQEEEAKRK 480
|
|
| TAIR|locus:2012643 AT1G33770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 990 (353.6 bits), Expect = 2.0e-102, Sum P(2) = 2.0e-102
Identities = 214/450 (47%), Positives = 286/450 (63%)
Query: 31 NKALMGHRRSTGQRYNGKETGRFQKLELPVNYDDFENGGE---EKVSGEQR---VRDNXX 84
NK H+ G G+ R L +P+ DD +G E+ S QR V DN
Sbjct: 42 NKDDFSHKAVDGSSGGGR---RASGLIVPI--DDSHDGKTVIVERPSRSQRGRRVSDNGK 96
Query: 85 XXXXXXXXXXXXXK---LVNGWPKWLTDNIPREVLAGLVPKSAESYDKIDKVGQGTYSNV 141
+ + GWP WLT ++ E + G VP+ A+S++K+DK+GQGTYS V
Sbjct: 97 GGGLIISNVPRSAEAELIAAGWPYWLT-SVAGEAIKGWVPRRADSFEKLDKIGQGTYSIV 155
Query: 142 YKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201
YKA D +TGKIVA+KKV+F +P SV+FMAREI IL+KLDHPN++KL+ L TS++ SL
Sbjct: 156 YKARDLETGKIVAMKKVRFANMDPESVRFMAREINILRKLDHPNVMKLQCLVTSKLSGSL 215
Query: 202 YLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDK 255
+LVFE+M+ DL+ + P K TEPQ QLL GL+HCH RGILHRD+KGSNLL++
Sbjct: 216 HLVFEYMEHDLSGLALRPGVKFTEPQIKCFMKQLLCGLEHCHSRGILHRDIKGSNLLVNN 275
Query: 256 NGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEM 315
+GVLKI DFGLA+++ P++ +PLTSRVVTLWYRAPELLLG+T+YG IDLWS GC+LAE+
Sbjct: 276 DGVLKIGDFGLASFYKPDQDQPLTSRVVTLWYRAPELLLGSTEYGPAIDLWSVGCILAEL 335
Query: 316 FLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWK--KLRLSTTFRPPQSYKPRLFEAFSEFP 373
F+ +PIMPGRTEVEQ+H+IFKLCGSPSE++W K +T+++P YK L E F
Sbjct: 336 FVCKPIMPGRTEVEQMHKIFKLCGSPSEEFWNTTKFPQATSYKPQHPYKRVLLETFKNLS 395
Query: 374 EXXXXXXXXXXXXDPAYRGSAASALKNEFFFTSPLACDLSGLPVIY-DKEDELIEANQQR 432
+P R SA+S L +EFF T PL C +S LP KE + +++
Sbjct: 396 SSSLDLLDKLLSVEPEKRCSASSTLLSEFFTTEPLPCHISSLPKYPPSKELDAKVRDEEA 455
Query: 433 KIRRAR-MKHRSKTLRERRIGDQASQLTKE 461
K ++A +K R R + D S++T E
Sbjct: 456 KRKKAEAVKWRGHESVRRGLRD--SKVTPE 483
|
|
| TAIR|locus:2152740 AT5G50860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1011 (360.9 bits), Expect = 5.4e-102, P = 5.4e-102
Identities = 195/345 (56%), Positives = 248/345 (71%)
Query: 102 GWPKWLTDNIPREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD 161
GWP WL + + L P+ A +Y+K++K+GQGTYSNVYKA D +GKIVALKKV+FD
Sbjct: 90 GWPPWLIAACG-DSIKDLTPRRATTYEKLEKIGQGTYSNVYKAKDLLSGKIVALKKVRFD 148
Query: 162 TSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEG 221
E SVKFMAREI++L++L+HPN++KL+GL TSR+ SLYLVFE+M+ DL+ + +
Sbjct: 149 NLEAESVKFMAREILVLRRLNHPNVIKLQGLVTSRVSCSLYLVFEYMEHDLSGLAATQGL 208
Query: 222 KLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275
K PQ QLLSGL+HCH RG+LHRD+KGSNLLID +G+LKIADFGLA ++ P +K
Sbjct: 209 KFDLPQVKCFMKQLLSGLEHCHSRGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPKQK 268
Query: 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIF 335
+ +TSRVVTLWYR PELLLGAT YG G+DLWSAGC++AE+ G+P+MPGRTEVEQLH+IF
Sbjct: 269 QTMTSRVVTLWYRPPELLLGATSYGTGVDLWSAGCIMAELLAGKPVMPGRTEVEQLHKIF 328
Query: 336 KLCGSPSEDYWKKLRL--STTFRPPQSYKPRLFEAFSEFPEXXXXXXXXXXXXDPAYRGS 393
KLCGSPS+ YWKK RL +T F+P YK + EAF+ F DPA RG+
Sbjct: 329 KLCGSPSDSYWKKYRLPNATLFKPQHPYKRCVAEAFNGFTPSSVHLVETLLTIDPADRGT 388
Query: 394 AASALKNEFFFTSPLACDLSGLPVIYDKEDELIEANQQRKIRRAR 438
+ SAL +EFF T PL CD S LP Y EL + ++RR +
Sbjct: 389 STSALNSEFFTTEPLPCDPSSLPK-YPPSKELNVKLRDEELRRQK 432
|
|
| TAIR|locus:2096199 AT3G05050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1009 (360.2 bits), Expect = 8.8e-102, P = 8.8e-102
Identities = 197/361 (54%), Positives = 253/361 (70%)
Query: 102 GWPKWLTDNIPREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD 161
GWP WL++ + E L+G +P+ A+S++KIDK+G GTYSNVYKA D TG IVALKKV+ D
Sbjct: 114 GWPSWLSE-VCGEALSGWLPRKADSFEKIDKIGSGTYSNVYKAKDSLTGNIVALKKVRCD 172
Query: 162 TSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEG 221
+E S+KFMAREI+IL++LDHPN++KLEGL TSRM SLYLVF +M DLA + ++PE
Sbjct: 173 VNERESLKFMAREILILRRLDHPNVIKLEGLVTSRMSSSLYLVFRYMDHDLAGLAASPEI 232
Query: 222 KLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275
K TE Q QLLSGL+HCH+RG+LHRD+KGSNLLID GVL+I DFGLA +F +K+
Sbjct: 233 KFTEQQVKCYMKQLLSGLEHCHNRGVLHRDIKGSNLLIDDGGVLRIGDFGLATFFDASKR 292
Query: 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIF 335
+ +T+RVVTLWYR+PELL G +Y VG+DLWSAGC+LAE+ GR IMPGR EVEQLHRI+
Sbjct: 293 QEMTNRVVTLWYRSPELLHGVVEYSVGVDLWSAGCILAELLAGRAIMPGRNEVEQLHRIY 352
Query: 336 KLCGSPSEDYWKKLRLSTTFR-----PPQSYKPRLFEAFSEFPEXXXXXXXXXXXXDPAY 390
KLCGSPSE+YWKK+RL +T + P YK R+ E + +F DPA
Sbjct: 353 KLCGSPSEEYWKKIRLPSTHKHAHHKPLPQYKRRIREVYKDFSPEALSLLDTLLALDPAE 412
Query: 391 RGSAASALKNEFFFTSPLACDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERR 450
R +A L ++FF T PLAC S LP Y E+ + + RR R +++ RR
Sbjct: 413 RQTATDVLMSDFFTTEPLACQPSDLPK-YPPSKEIDAKRRDEEYRRQREARKAQGESGRR 471
Query: 451 I 451
+
Sbjct: 472 M 472
|
|
| TAIR|locus:2158715 AT5G44290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1009 (360.2 bits), Expect = 8.8e-102, P = 8.8e-102
Identities = 201/363 (55%), Positives = 252/363 (69%)
Query: 98 KLVNGWPKWLTDNIPREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKK 157
+L GWP WL ++ E L P+ A +++K++K+GQGTYS+VYKA D KIVALK+
Sbjct: 109 ELAAGWPAWLV-SVAGEALVNWTPRRASTFEKLEKIGQGTYSSVYKARDLTNNKIVALKR 167
Query: 158 VKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIIS 217
V+FD S+ SVKFMAREI+++++LDHPN++KLEGL T+ + SLYLVFE+M DL + S
Sbjct: 168 VRFDLSDLESVKFMAREIIVMRRLDHPNVLKLEGLITASVSSSLYLVFEYMDHDLVGLAS 227
Query: 218 NPEGKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS 271
P K +EPQ QLLSGL HCH RG+LHRD+KGSNLLID NGVLKIADFGLA +F
Sbjct: 228 IPGIKFSEPQVKCYMQQLLSGLHHCHSRGVLHRDIKGSNLLIDSNGVLKIADFGLATFFD 287
Query: 272 PNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQL 331
P PLTSRVVTLWYR PELLLGA YGVG+DLWS GC+L E++ G+PI+ G+TEVEQL
Sbjct: 288 PQNCVPLTSRVVTLWYRPPELLLGACHYGVGVDLWSTGCILGELYSGKPILAGKTEVEQL 347
Query: 332 HRIFKLCGSPSEDYWKKLRL--STTFRPPQSYKPRLFEAFSEFPEXXXXXXXXXXXXDPA 389
H+IFKLCGSP+EDYW+KL+L S FRP Y R+ E F + P DP
Sbjct: 348 HKIFKLCGSPTEDYWRKLKLPPSAAFRPALPYGRRVAEMFKDLPTNVLSLLEALLSIDPD 407
Query: 390 YRGSAASALKNEFFFTSPLACDLSGLPVIY-DKE-DELIEANQQRKIRRARMKHRSKTLR 447
RGSAA AL++E+F T P ACD S LP KE D I + +R+ R + KH + +
Sbjct: 408 RRGSAARALESEYFRTEPFACDPSSLPKYPPSKEIDAKIRDDAKRQ-RPTQEKHERQDSQ 466
Query: 448 ERR 450
RR
Sbjct: 467 TRR 469
|
|
| TAIR|locus:2175743 cdc2cAt "CDC2C" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 966 (345.1 bits), Expect = 4.1e-100, Sum P(2) = 4.1e-100
Identities = 184/359 (51%), Positives = 254/359 (70%)
Query: 102 GWPKWLTDNIPREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD 161
GWP WL + E + G VP AE++ K++K+GQGTYS+V++A + +TGK+VALKKVKFD
Sbjct: 81 GWPAWLC-SAAAEAVHGWVPLKAEAFQKLEKIGQGTYSSVFRAREVETGKMVALKKVKFD 139
Query: 162 TSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEG 221
+P S++FMAREI+IL+KL+HPNI+KLEG+ TSR S+YLVFE+M+ DLA + SNP+
Sbjct: 140 NLQPESIRFMAREILILRKLNHPNIMKLEGIVTSRASSSIYLVFEYMEHDLAGLSSNPDI 199
Query: 222 KLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275
+ TEPQ QLL GL+HCH RG++HRD+K SN+L++ GVLK+ DFGLAN +P+ K
Sbjct: 200 RFTEPQIKCYMKQLLWGLEHCHMRGVIHRDIKASNILVNNKGVLKLGDFGLANVVTPSNK 259
Query: 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIF 335
LTSRVVTLWYRAPELL+G+T YGV +DLWS GC+ AE+ +G+PI+ GRTE+EQLH+I+
Sbjct: 260 NQLTSRVVTLWYRAPELLMGSTSYGVSVDLWSVGCVFAEILMGKPILKGRTEIEQLHKIY 319
Query: 336 KLCGSPSEDYWKKLRL--STTFRPPQSYKPRLFEAFSEFPEXXXXXXXXXXXXDPAYRGS 393
KLCGSP + +WK+ +L +T+F+P +Y+ L E + +P RG+
Sbjct: 320 KLCGSPQDSFWKRTKLPHATSFKPQHTYEATLRERCKDLSATGVYLLETLLSMEPDKRGT 379
Query: 394 AASALKNEFFFTSPLACDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIG 452
A+SAL +E+F T P ACD S LP Y E+ +A + +RR R + LR+ +G
Sbjct: 380 ASSALNSEYFLTRPYACDPSSLPK-YPPNKEM-DAKYRDDMRRKRANLK---LRDSGVG 433
|
|
| TAIR|locus:2034944 IBS1 "IMPAIRED IN BABA-INDUCED STERILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 964 (344.4 bits), Expect = 4.7e-99, Sum P(2) = 4.7e-99
Identities = 203/473 (42%), Positives = 297/473 (62%)
Query: 1 MGCVQAKSSMN-SP---HGG-------GGLYKLKMEN-GYVGNKALMGHRRSTGQRYNGK 48
MGCV +K +++ +P H G G ++ +E+ V L+ +G++ + K
Sbjct: 1 MGCVNSKQTVSVTPAIDHSGVFRDNVCSGSGRIVVEDLPPVTETKLLSWWSKSGKKSSSK 60
Query: 49 ETGRFQKLELPVNYDDFENGGEEKVSGEQRVRDNXXXXXXXXXXXXXXXKLVNGWPKWLT 108
++G EL ++ + G + S R ++ ++ GWP WL+
Sbjct: 61 KSGS----ELGSDFGELSESG--RASSNCR-SESVSFRLGNLSKYLEAEQVAAGWPAWLS 113
Query: 109 DNIPREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSV 168
N+ E + G VP +++++K++K+GQGTYS+V++A + +TG+IVALKKV+FD EP SV
Sbjct: 114 -NVAGEAIHGWVPFRSDAFEKLEKIGQGTYSSVFRARETETGRIVALKKVRFDNFEPESV 172
Query: 169 KFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ- 227
+FMAREI+IL+KL+HPNI+KLEG+ TS++ S++LVFE+M+ DL ++S+P+ T PQ
Sbjct: 173 RFMAREILILRKLNHPNIIKLEGIVTSKLSCSIHLVFEYMEHDLTGLLSSPDIDFTTPQI 232
Query: 228 -----QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN-KKRPLTSR 281
QLLSGL HCH RG++HRD+KGSNLL++ G+LK+ADFGLAN+ + + K+PLTSR
Sbjct: 233 KCYMKQLLSGLDHCHARGVMHRDIKGSNLLVNNEGILKVADFGLANFCNASGNKQPLTSR 292
Query: 282 VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSP 341
VVTLWYR PELLLGAT+YG +DLWS GC+ AE+ +G+P++ GRTEVEQLH+IFKLCGSP
Sbjct: 293 VVTLWYRPPELLLGATEYGASVDLWSVGCVFAELLIGKPVLQGRTEVEQLHKIFKLCGSP 352
Query: 342 SEDYWKKLRL--STTFRPPQSYKPRLFEAFS--EFPEXXXXXXXXXXXXDPAYRGSAASA 397
EDYWKK +L + F+P Q Y L E + P RG+A++A
Sbjct: 353 PEDYWKKSKLPHAMLFKPQQHYDGCLRETLKLKGLSDADINLIETLLSIQPHKRGTASTA 412
Query: 398 LKNEFFFTSPLACDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERR 450
L +++F + P ACD S LPV Y E I+A + R ++ + E R
Sbjct: 413 LVSQYFTSKPFACDPSSLPV-YSPSKE-IDAKHREDTTRKKISGNGRRGTESR 463
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 584 | |||
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-143 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-113 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-110 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-95 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-93 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-92 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-92 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-91 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-90 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-87 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-86 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-84 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-83 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-81 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-81 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-80 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-80 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-79 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-78 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-77 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-76 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-76 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-74 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-72 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-71 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-71 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-66 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-65 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-65 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-64 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-61 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-61 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-61 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-61 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-58 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-58 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-58 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-57 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-57 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-56 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-55 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-53 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-53 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-53 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-51 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-50 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-50 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-49 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-48 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-47 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-46 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-46 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-44 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-44 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-43 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-42 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-41 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-41 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-41 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-40 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-40 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-39 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-39 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-39 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-39 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-38 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-38 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-38 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-37 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-36 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-35 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-35 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-35 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-34 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-33 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-33 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-31 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-31 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-30 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-30 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-30 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-30 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-29 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-27 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-27 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-27 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-27 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-27 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-27 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-27 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-27 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-26 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-26 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-26 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-26 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-26 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-26 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-25 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-24 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-24 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-23 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-23 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-23 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-23 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-22 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-22 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-21 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-21 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-21 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-19 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-19 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-19 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-18 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-18 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-18 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-17 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-17 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-16 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-16 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-16 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-15 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-15 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-14 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-14 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-13 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-12 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-12 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-11 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-10 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 9e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.003 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 414 bits (1067), Expect = e-143
Identities = 146/287 (50%), Positives = 197/287 (68%), Gaps = 10/287 (3%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y+KI ++G+GTY VYKA ++ TG++VALKK++ + + REI +LQKL HPNI
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 187 VKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHDRG 240
V+L+ + TS+ + S+Y+VFE+M DL ++ +PE K TE Q QLL GLQ+ H G
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 241 ILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYG 300
ILHRD+KGSN+LI+ +GVLK+ADFGLA ++ T+RV+TLWYR PELLLGAT YG
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYG 180
Query: 301 VGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW---KKLRLSTTFRP 357
+D+WS GC+LAE+FLG+PI G TE+EQL +IF+LCGSP+++ W KL +P
Sbjct: 181 PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240
Query: 358 PQSYKPRLFEAFSEF-PESSLGLLSTLLALDPAYRGSAASALKNEFF 403
+ YK RL E F S+L LL LL LDP R SA AL++E+F
Sbjct: 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 338 bits (870), Expect = e-113
Identities = 123/289 (42%), Positives = 177/289 (61%), Gaps = 19/289 (6%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE----PHSVKFMAREIMILQKLD 182
Y+K++K+G+GTY VYKA D+ TG+IVALKK++ D E ++ REI +L++L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL----REISLLKELK 56
Query: 183 HPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHC 236
HPNIVKL + + LYLVFE+ DL + + G L+ QLL GL +C
Sbjct: 57 HPNIVKLLDVIHTE--RKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGA 296
H ILHRD+K N+LI+++GVLK+ADFGLA F + T VVTLWYRAPE+LLG+
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVVTLWYRAPEILLGS 173
Query: 297 TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356
Y +D+WS GC+ AEM G+P+ PG +E++QL +IF++ G+P+E+ W + ++
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233
Query: 357 P--PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
P P+ L + + LLS +L +PA R SA ALK+ +F
Sbjct: 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 330 bits (849), Expect = e-110
Identities = 133/305 (43%), Positives = 183/305 (60%), Gaps = 23/305 (7%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD--TSEPHSVKFMA-REIMILQKLDH 183
Y+K K+G+GTY+ VYKA D++TG+IVA+KK+K + F A REI +LQ+L H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHCH 237
PNI+ L + + ++ LVFEFM+TDL ++I + LT L GL++ H
Sbjct: 62 PNIIGLLDVFGHKS--NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYF-SPNKKRPLTSRVVTLWYRAPELLLGA 296
ILHRD+K +NLLI +GVLK+ADFGLA F SPN R +T +VVT WYRAPELL GA
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--RKMTHQVVTRWYRAPELLFGA 177
Query: 297 TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW---KKLRLST 353
YGVG+D+WS GC+ AE+ L P +PG ++++QL +IF+ G+P+E+ W L
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237
Query: 354 TF--RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACD 411
F PP K F + +L LL LL L+P R +A AL++ +F P
Sbjct: 238 EFKPFPPTPLKQI----FPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293
Query: 412 LSGLP 416
S LP
Sbjct: 294 PSQLP 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 292 bits (750), Expect = 3e-95
Identities = 125/301 (41%), Positives = 178/301 (59%), Gaps = 28/301 (9%)
Query: 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD--------TSEPHSVKFMAR 173
+S + Y+K++++ +GTY VY+A D+ TG+IVALKK+K + TS R
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS--------LR 53
Query: 174 EIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEP------Q 227
EI IL KL HPNIV ++ + +Y+V E+++ DL ++ + +
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLML 113
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWY 287
QLLSG+ H HD ILHRD+K SNLL++ G+LKI DFGLA + K P T VVTLWY
Sbjct: 114 QLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-PYTQLVVTLWY 172
Query: 288 RAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW- 346
RAPELLLGA +Y ID+WS GC+ AE+ +P+ PG++E++QL++IFKL G+P+E W
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232
Query: 347 --KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLG--LLSTLLALDPAYRGSAASALKNEF 402
+L + + +L + F S G LL+ LL DPA R SA ALK+ +
Sbjct: 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292
Query: 403 F 403
F
Sbjct: 293 F 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 286 bits (735), Expect = 5e-93
Identities = 131/286 (45%), Positives = 172/286 (60%), Gaps = 12/286 (4%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y K+ K+G+GTY VYKA D+ TG+IVA+KK+K K REI +L++L+HPNI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 187 VKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHDRG 240
+KL L R + LYLVFEFM TDL ++I + + L E QLL GL CH G
Sbjct: 61 IKL--LDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 241 ILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYG 300
ILHRD+K NLLI+ GVLK+ADFGLA F RP T VVT WYRAPELLLG Y
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGS-PVRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 301 VGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK---LRLSTTFRP 357
+D+WS GC+ AE+ RP+ PG++E++QL +IF+ G+P + W K L + F
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237
Query: 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
P+ L + F +L LLS +L DP R +A AL + +F
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 286 bits (734), Expect = 1e-92
Identities = 130/307 (42%), Positives = 185/307 (60%), Gaps = 16/307 (5%)
Query: 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE---PHSVKFMAREIMIL 178
+S ++K++++G+GTY VY+A D +G+IVALKKV+ D P S REI +L
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPIS---SLREITLL 60
Query: 179 QKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSG 232
L HPNIV+L+ + + S++LV E+ + DLA ++ N +E Q QLL G
Sbjct: 61 LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRG 120
Query: 233 LQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPEL 292
LQ+ H+ I+HRD+K SNLL+ G LKIADFGLA + +P+T +VVTLWYRAPEL
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL-PAKPMTPKVVTLWYRAPEL 179
Query: 293 LLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW---KKL 349
LLG T Y ID+W+ GC+LAE+ +P++PG++E+EQL I +L G+P+E W L
Sbjct: 180 LLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239
Query: 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLA 409
L F P+ L F E+ L LL+ LL DP R +A AL++ +F PL
Sbjct: 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299
Query: 410 CDLSGLP 416
C+ +P
Sbjct: 300 CEPEMMP 306
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 286 bits (734), Expect = 1e-92
Identities = 136/298 (45%), Positives = 179/298 (60%), Gaps = 22/298 (7%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQKLDHPN 185
Y+K+ K+GQGT+ V+KA + T +IVALKKV + +E A REI ILQ L H N
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLME-NEKEGFPITALREIKILQLLKHEN 72
Query: 186 IVKL------EGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEP------QQLLSGL 233
+V L + +R + S YLVFEF + DLA ++SN K T + LL+GL
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGL 132
Query: 234 QHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK--KRPL-TSRVVTLWYRAP 290
+ H ILHRD+K +N+LI K+G+LK+ADFGLA FS +K K T+RVVTLWYR P
Sbjct: 133 YYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192
Query: 291 ELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW---K 347
ELLLG DYG ID+W AGC++AEM+ PIM G TE QL I +LCGS + + W
Sbjct: 193 ELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVD 252
Query: 348 KLRLSTTFRPPQSYKPRLFEAFSEFPES--SLGLLSTLLALDPAYRGSAASALKNEFF 403
KL L PQ K ++ E + + +L L+ LL LDPA R A +AL ++FF
Sbjct: 253 KLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 283 bits (725), Expect = 1e-91
Identities = 122/293 (41%), Positives = 165/293 (56%), Gaps = 23/293 (7%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE---PHSVKFMAREIMILQKLDH 183
Y + ++G+G + V+KA DR+TG+ VALKKV E P+ REI LQ H
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQA---LREIKALQACQH 58
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCH 237
P +VKL L LV E+M +DL+ ++ + E L E Q LL G+ + H
Sbjct: 59 PYVVKL--LDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGAT 297
GI+HRD+K +NLLI +GVLKIADFGLA FS + R + +V T WYRAPELL GA
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 298 DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL-----S 352
Y G+DLW+ GC+ AE+ G P+ PG ++EQL +F+ G+P+E+ W L
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236
Query: 353 TTFRPPQSYKP-RLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404
TF KP L E F + +L LL LL DP+ R SAA AL++ +F
Sbjct: 237 ITFPE---SKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 281 bits (720), Expect = 2e-90
Identities = 129/314 (41%), Positives = 178/314 (56%), Gaps = 45/314 (14%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-----REIMILQ 179
Y+ + K+G+GT+ VYKA TG++VALKK+ H+ K REI IL+
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILM-----HNEKDGFPITALREIKILK 62
Query: 180 KLDHPNIVKLEGLA------TSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------ 227
KL HPN+V L +A + R + S+Y+V +M DL+ ++ NP KLTE Q
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYML 122
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA----------NYFSPNKKRP 277
QLL G+ + H+ ILHRD+K +N+LID G+LKIADFGLA R
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKL 337
T+ VVT WYR PELLLG Y +D+W GC+ AEMF RPI+ G+++++QLH IFKL
Sbjct: 183 YTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242
Query: 338 CGSPSEDYW--------KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPA 389
CG+P+E+ W + S T +Y L E F + L LLS LL+LDP
Sbjct: 243 CGTPTEETWPGWRSLPGCEGVHSFT-----NYPRTLEERFGKLGPEGLDLLSKLLSLDPY 297
Query: 390 YRGSAASALKNEFF 403
R +A+ AL++ +F
Sbjct: 298 KRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 272 bits (697), Expect = 2e-87
Identities = 133/288 (46%), Positives = 181/288 (62%), Gaps = 16/288 (5%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQKLDHPN 185
Y K++K+G+GTY VYKA D+ TG+IVALKK++ +T E V A REI +L++L+HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPN 59
Query: 186 IVKLEGLATSRMQYSLYLVFEFMQTDLARII-SNPEGKLTEPQ------QLLSGLQHCHD 238
IV+L + S + LYLVFEF+ DL + + S+P L P QLL G+ +CH
Sbjct: 60 IVRLLDVVHS--ENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYFS-PNKKRPLTSRVVTLWYRAPELLLGAT 297
+LHRD+K NLLID+ G LK+ADFGLA F P R T VVTLWYRAPE+LLG+
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLGSR 175
Query: 298 DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357
Y +D+WS GC+ AEM RP+ PG +E++QL RIF+ G+P ED W + ++P
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235
Query: 358 --PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
P+ + L + E L LLS +L DPA R SA +AL++ +F
Sbjct: 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 270 bits (691), Expect = 2e-86
Identities = 127/299 (42%), Positives = 180/299 (60%), Gaps = 19/299 (6%)
Query: 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQK 180
+ + +D I ++G+GTY VYKA D+DTG++VALKKV+ D +E A REI IL++
Sbjct: 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLD-NEKEGFPITAIREIKILRQ 62
Query: 181 LDHPNIVKLEGLATSRM--------QYSLYLVFEFMQTDLARIISNPEGKLTEPQ----- 227
L+H NIV L+ + T + + + YLVFE+M DL ++ + +E
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 228 -QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLW 286
QLL GL +CH + LHRD+K SN+L++ G +K+ADFGLA ++ + RP T++V+TLW
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182
Query: 287 YRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW 346
YR PELLLG YG ID+WS GC+L E+F +PI E+ QL I +LCGSP W
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242
Query: 347 K---KLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402
KL T +P + Y+ RL E FS P +L LL +L LDP+ R +A AL + +
Sbjct: 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 262 bits (673), Expect = 3e-84
Identities = 104/284 (36%), Positives = 156/284 (54%), Gaps = 37/284 (13%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y+ ++K+G+G++ VY A D+ TGK+VA+K +K + + + REI IL+KL HPNI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERIL-REIKILKKLKHPNI 59
Query: 187 VKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCHDR 239
V+L + LYLV E+ + DL ++ G+L+E + Q+LS L++ H +
Sbjct: 60 VRLYDVFEDE--DKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSK 116
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDY 299
GI+HRD+K N+L+D++G +K+ADFGLA P +K LT+ V T Y APE+LLG Y
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLLG-KGY 173
Query: 300 GVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQ 359
G +D+WS G +L E+ G+P PG +QL +FK G P
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKP------------------ 212
Query: 360 SYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
KP + + L+ LL DP R +A AL++ FF
Sbjct: 213 --KPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 261 bits (669), Expect = 3e-83
Identities = 122/298 (40%), Positives = 169/298 (56%), Gaps = 32/298 (10%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE---PHSVKFMAREIMILQKLD- 182
Y+++ ++G+G Y VYKA D +TG+ VALKKV+ SE P S REI +L++L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS---TLREIALLKQLES 57
Query: 183 --HPNIVKL----EGLATSRMQYSLYLVFEFMQTDLARIISN-PEGKLTEPQ------QL 229
HPNIV+L G T R + L LVFE + DLA +S P+ L QL
Sbjct: 58 FEHPNIVRLLDVCHGPRTDR-ELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 230 LSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRA 289
L G+ H I+HRD+K N+L+ +G +KIADFGLA +S LTS VVTLWYRA
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLWYRA 174
Query: 290 PELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349
PE+LL ++ Y +D+WS GC+ AE+F RP+ G +E +QL +IF + G PSE+ W +
Sbjct: 175 PEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR- 232
Query: 350 RLSTTFRPPQSYKPRLFEAFSEF-PESS---LGLLSTLLALDPAYRGSAASALKNEFF 403
P S+ +F F PE L LL +L +P R SA AL++ +F
Sbjct: 233 ---NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 259 bits (663), Expect = 1e-81
Identities = 106/313 (33%), Positives = 166/313 (53%), Gaps = 28/313 (8%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y+ + +G G Y V A+D+ TG+ VA+KK+ + K + REI +L+ L H NI
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 187 VKLEGLAT--SRMQYS-LYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCH 237
+ L + S ++ +Y+V E M+TDL ++I +P+ LT+ Q+L GL++ H
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH 120
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYF--SPNKKRPLTSRVVTLWYRAPELLLG 295
++HRD+K SN+L++ N LKI DFGLA ++K LT VVT WYRAPELLL
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT- 354
++ Y ID+WS GC+ AE+ +P+ PGR ++QL+ I ++ G+PSE+ K +
Sbjct: 181 SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKAR 240
Query: 355 --FRPPQSYKPRLFEA-FSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACD 411
+ + F ++ LL +L DP R +A AL + +
Sbjct: 241 NYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL-------- 292
Query: 412 LSGLPVIYDKEDE 424
++D EDE
Sbjct: 293 ----AQLHDPEDE 301
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 257 bits (659), Expect = 4e-81
Identities = 130/341 (38%), Positives = 189/341 (55%), Gaps = 50/341 (14%)
Query: 122 KSAESYDKIDK-VGQGTYSNVYKALDRDTGKIVALKKVK------FDTSEPHSV-----K 169
+E Y + +G+GTY V KA D TGKIVA+KKVK T + V
Sbjct: 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH 64
Query: 170 FMA-REIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ- 227
F RE+ I+ ++ H NI+ L + + LV + M +DL +++ + + +LTE Q
Sbjct: 65 FTTLRELKIMNEIKHENIMGLVDVYVE--GDFINLVMDIMASDLKKVV-DRKIRLTESQV 121
Query: 228 -----QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF------------ 270
Q+L+GL H +HRD+ +N+ I+ G+ KIADFGLA +
Sbjct: 122 KCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 271 -SPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVE 329
+ ++ +TS+VVTLWYRAPELL+GA Y +D+WS GC+ AE+ G+P+ PG E++
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241
Query: 330 QLHRIFKLCGSPSEDYW---KKLRLST--TFRPPQSYKPRLFEAFSEFP---ESSLGLLS 381
QL RIF+L G+P+ED W KKL L T T R P+ K + FP + ++ LL
Sbjct: 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-------TIFPNASDDAIDLLQ 294
Query: 382 TLLALDPAYRGSAASALKNEFFFTSPLACDLSGLPVIYDKE 422
+LL L+P R SA ALK+E+F + PL CD S LP + +
Sbjct: 295 SLLKLNPLERISAKEALKHEYFKSDPLPCDPSQLPFNFLTK 335
|
Length = 335 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 252 bits (646), Expect = 6e-80
Identities = 121/289 (41%), Positives = 169/289 (58%), Gaps = 16/289 (5%)
Query: 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPN 185
Y+K++K+G+GTY V+KA +R+T +IVALK+V+ D + REI +L++L H N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 186 IVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHDR 239
IV+L + S L LVFE+ DL + + G + QLL GL CH
Sbjct: 61 IVRLYDVLHS--DKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH 118
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLANYFS-PNKKRPLTSRVVTLWYRAPELLLGATD 298
+LHRD+K NLLI+KNG LK+ADFGLA F P R ++ VVTLWYR P++L GA
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKL 176
Query: 299 YGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357
Y ID+WSAGC+ AE+ GRP+ PG +QL RIF+L G+P+E+ W + ++P
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236
Query: 358 PQSYKPRLFEAFSEFPE-SSLG--LLSTLLALDPAYRGSAASALKNEFF 403
Y P + P+ +S G LL LL +P R SA AL++ +F
Sbjct: 237 YPMY-PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 252 bits (646), Expect = 7e-80
Identities = 128/290 (44%), Positives = 178/290 (61%), Gaps = 19/290 (6%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQKLDHPN 185
Y KI+K+G+GTY VYK ++ TG+IVA+KK++ + SE V A REI +L++L HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLE-SEEEGVPSTAIREISLLKELQHPN 60
Query: 186 IVKLEGLATSRMQYS-LYLVFEFMQTDLARII-SNPEGKLTEPQ-------QLLSGLQHC 236
IV L+ + MQ S LYL+FEF+ DL + + S P+G+ + + Q+L G+ C
Sbjct: 61 IVCLQDVL---MQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS-PNKKRPLTSRVVTLWYRAPELLLG 295
H R +LHRD+K NLLID GV+K+ADFGLA F P R T VVTLWYRAPE+LLG
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VRVYTHEVVTLWYRAPEVLLG 175
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355
+ Y +D+WS G + AEM +P+ G +E++QL RIF++ G+P+ED W + +
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235
Query: 356 RP--PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
+ P+ K L A E L LL +L DPA R SA AL + +F
Sbjct: 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 251 bits (642), Expect = 3e-79
Identities = 128/298 (42%), Positives = 174/298 (58%), Gaps = 23/298 (7%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH- 183
++Y+K++K+G+GTY VYKA D++TGK+VALKK + + E REI +LQ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 184 PNIVKL---EGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ----------QLL 230
IV+L E + + SLYLVFE++ +DL + + + P QLL
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 231 SGLQHCHDRGILHRDVKGSNLLIDKN-GVLKIADFGLANYFS-PNKKRPLTSRVVTLWYR 288
G+ HCH G++HRD+K NLL+DK G+LKIAD GL FS P K T +VTLWYR
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYR 178
Query: 289 APELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW-- 346
APE+LLG+T Y +D+WS GC+ AEM +P+ PG +E++QL IFKL G+P+E W
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238
Query: 347 -KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
KLR F PQ L A + L LL +L DPA R SA +AL + +F
Sbjct: 239 VSKLRDWHEF--PQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 248 bits (636), Expect = 1e-78
Identities = 104/287 (36%), Positives = 148/287 (51%), Gaps = 37/287 (12%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFM--AREIMILQKLDHP 184
Y+ + K+G G++ VYKA + TGKIVA+K +K S K REI IL++L HP
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILK--KRSEKSKKDQTARREIRILRRLSHP 58
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQ------QLLSGLQHCH 237
NIV+L + LYLV E+ + DL +S G L+E + Q+L GL++ H
Sbjct: 59 NIVRLIDAFEDK--DHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLH 115
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGAT 297
GI+HRD+K N+L+D+NGV+KIADFGLA + LT+ V T WY APE+LLG
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSS-SSLTTFVGTPWYMAPEVLLGGN 174
Query: 298 DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFK-LCGSPSEDYWKKLRLSTTFR 356
YG +D+WS G +L E+ G+P G ++QL I + L D K S +
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAK 234
Query: 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
L+ L DP+ R +A L++ +F
Sbjct: 235 ---------------------DLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 245 bits (627), Expect = 4e-77
Identities = 125/289 (43%), Positives = 172/289 (59%), Gaps = 16/289 (5%)
Query: 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQKLDHP 184
++ K++K+G+GTY VYKA ++ TG++VALKK++ DT E V A REI +L++L+HP
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHP 59
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTDLARII-SNPEGKLTEPQ------QLLSGLQHCH 237
NIVKL L + LYLVFEF+ DL + + ++P + P QLL GL CH
Sbjct: 60 NIVKL--LDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS-PNKKRPLTSRVVTLWYRAPELLLGA 296
+LHRD+K NLLI+ G +K+ADFGLA F P R T VVTLWYRAPE+LLG
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLGC 175
Query: 297 TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356
Y +D+WS GC+ AEM R + PG +E++QL RIF+ G+P E W + ++
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235
Query: 357 P--PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
P P+ + + E LLS +L DP R SA +AL + FF
Sbjct: 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 242 bits (619), Expect = 7e-76
Identities = 115/291 (39%), Positives = 173/291 (59%), Gaps = 20/291 (6%)
Query: 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE--PHSVKFMAREIMILQKLDH 183
++ +++K+G+GTY+ VYK +R TG+IVALK++ D E P + REI ++++L H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA---IREISLMKELKH 57
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFMQTDLARII-SNPEGKLTEP-------QQLLSGLQH 235
NIV+L + + + L LVFE+M DL + + ++ +P QLL G+
Sbjct: 58 ENIVRLHDVIHT--ENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS-PNKKRPLTSRVVTLWYRAPELLL 294
CH+ +LHRD+K NLLI+K G LK+ADFGLA F P ++ VVTLWYRAP++LL
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT--FSNEVVTLWYRAPDVLL 173
Query: 295 GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354
G+ Y ID+WS GC++AEM GRP+ PG +QL +IF++ G+P+E W +
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233
Query: 355 FRPP-QSYKPRLFEA-FSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
++P Y P+ + F + LL LL L+P R SA AL++ +F
Sbjct: 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 242 bits (619), Expect = 7e-76
Identities = 103/292 (35%), Positives = 155/292 (53%), Gaps = 17/292 (5%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
Y+ + VG+G Y V K ++ TG+IVA+KK K + K RE+ +L++L H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 185 NIVKLEGLATSRMQYSLYLVFEFM-QTDLARIISNPEGKLTEPQ-------QLLSGLQHC 236
NIV L R + LYLVFE++ +T L + ++P G P QLL + +C
Sbjct: 61 NIVNL--KEAFRRKGRLYLVFEYVERTLLELLEASPGG--LPPDAVRSYIWQLLQAIAYC 116
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGA 296
H I+HRD+K N+L+ ++GVLK+ DFG A PLT V T WYRAPELL+G
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176
Query: 297 TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCG----SPSEDYWKKLRLS 352
T+YG +D+W+ GC++AE+ G P+ PG ++++QL+ I K G S E + R +
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236
Query: 353 TTFRPPQSYKPRLFEAFS-EFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
P S L + + +L L L +DP R + L++ +F
Sbjct: 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 239 bits (611), Expect = 1e-74
Identities = 119/294 (40%), Positives = 176/294 (59%), Gaps = 20/294 (6%)
Query: 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQKLD 182
E+Y K+DK+G+G+Y+ VYK + TG++VALK+++ + E F A RE +L+ L
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLK 61
Query: 183 HPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHC 236
H NIV L + ++ +L LVFE++ TDL + + + G L+ QLL GL +C
Sbjct: 62 HANIVTLHDIIHTKK--TLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC 119
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS-PNKKRPLTSRVVTLWYRAPELLLG 295
H R +LHRD+K NLLI + G LK+ADFGLA S P+K ++ VVTLWYR P++LLG
Sbjct: 120 HQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT--YSNEVVTLWYRPPDVLLG 177
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEV-EQLHRIFKLCGSPSEDYWKKLRLSTT 354
+T+Y +D+W GC+ EM GRP+ PG T+V +QLH+IF++ G+P+E+ W + +
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237
Query: 355 FRPPQS--YKPR-LFEAFS--EFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
F+P Y PR L + L L +P R SAA A+K+ +F
Sbjct: 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 2e-72
Identities = 109/291 (37%), Positives = 169/291 (58%), Gaps = 22/291 (7%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVK---FDTSEPHSVKFMAREIMILQKL-D 182
Y I ++G GT+ +VY A +++TG++VA+KK+K + E ++ RE+ L+KL +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL----REVKSLRKLNE 56
Query: 183 HPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGK-LTEPQ------QLLSGLQH 235
HPNIVKL R LY VFE+M+ +L +++ + +GK +E Q+L GL H
Sbjct: 57 HPNIVKL--KEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLG 295
H G HRD+K NLL+ V+KIADFGLA + P T V T WYRAPE+LL
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRAPEILLR 172
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW---KKLRLS 352
+T Y +D+W+ GC++AE++ RP+ PG +E++QL++I + G+P++ W KL
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232
Query: 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
FR PQ L + ++ L+ +L DP R +A+ AL++ +F
Sbjct: 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 230 bits (587), Expect = 4e-71
Identities = 116/300 (38%), Positives = 176/300 (58%), Gaps = 35/300 (11%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ Y+K++K+G+GTY VYKA DR T + +ALKK++ + + REI +L+++ H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ-------QLLSGLQHCH 237
NIV+L+ + S + LYLVFE++ DL + + + P+ Q+L G+ +CH
Sbjct: 62 NIVRLQDVVHS--EKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 238 DRGILHRDVKGSNLLIDK-NGVLKIADFGLANYFS-PNKKRPLTSRVVTLWYRAPELLLG 295
+LHRD+K NLLID+ LK+ADFGLA F P R T VVTLWYRAPE+LLG
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--VRTFTHEVVTLWYRAPEILLG 177
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355
+ Y +D+WS GC+ AEM +P+ PG +E+++L +IF++ G+P+E+ W
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW--------- 228
Query: 356 RPPQSYKPRLFEAFSEFPESSLG------------LLSTLLALDPAYRGSAASALKNEFF 403
P + P AF ++P L LLS +L LDP+ R +A +AL++E+F
Sbjct: 229 -PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 231 bits (591), Expect = 5e-71
Identities = 118/305 (38%), Positives = 172/305 (56%), Gaps = 33/305 (10%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKL-DHP 184
Y+ + K+G+G Y V+KA+DR T ++VALKK+ FD + REIM LQ+L DHP
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-FDAFRNATDAQRTFREIMFLQELGDHP 67
Query: 185 NIVKLEGLATSRMQ--YSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHC 236
NIVKL L + + +YLVFE+M+TDL +I L + QLL L++
Sbjct: 68 NIVKL--LNVIKAENDKDIYLVFEYMETDLHAVIR--ANILEDVHKRYIMYQLLKALKYI 123
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP---NKKRP-LTSRVVTLWYRAPEL 292
H ++HRD+K SN+L++ + +K+ADFGLA S N + P LT V T WYRAPE+
Sbjct: 124 HSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEI 183
Query: 293 LLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSE--------D 344
LLG+T Y G+D+WS GC+L EM LG+P+ PG + + QL +I ++ G PS
Sbjct: 184 LLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243
Query: 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF- 403
+ + S RP + E + + +L LL LL +P R +A AL++ +
Sbjct: 244 FAATMLDSLPSRPRKPLD----ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299
Query: 404 -FTSP 407
F +P
Sbjct: 300 QFHNP 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 220 bits (562), Expect = 1e-66
Identities = 106/295 (35%), Positives = 156/295 (52%), Gaps = 18/295 (6%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
Y I+ +G G Y V A+D +GK VA+KK+ P K RE+ IL+ H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 185 NIVKLEGLATSRMQY--SLYLVFEFMQTDLARII-SNPEGKLTEPQ------QLLSGLQH 235
NI+ + + +Y+V + M++DL II S+ LTE QLL GL++
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKY 122
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN---KKRPLTSRVVTLWYRAPEL 292
H ++HRD+K SNLL++++ L+I DFG+A S + K +T V T WYRAPEL
Sbjct: 123 IHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182
Query: 293 LLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352
LL +Y ID+WS GC+ AEM R + PG+ V QL I + GSPSE+ ++
Sbjct: 183 LLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242
Query: 353 TTFRPPQSYKPRLFEAFSE-FPESS---LGLLSTLLALDPAYRGSAASALKNEFF 403
+ Q+ + +S+ FP++S L LLS +L DP R + AL++ F
Sbjct: 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 1e-65
Identities = 108/315 (34%), Positives = 157/315 (49%), Gaps = 38/315 (12%)
Query: 127 YDKIDKVGQGTYSNVYKA--LDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQKLDH 183
Y+ +G+GTY VYKA + GK A+KK K D + + A REI +L++L H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFMQTDLARII---SNPEGKLTEPQ-------QLLSGL 233
N+V L + S+YL+F++ + DL +II + P Q+L+G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 234 QHCHDRGILHRDVKGSNLLI----DKNGVLKIADFGLANYFSPNKKRPLTSR--VVTLWY 287
+ H +LHRD+K +N+L+ + GV+KI D GLA F+ K VVT+WY
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181
Query: 288 RAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE---------VEQLHRIFKLC 338
RAPELLLGA Y ID+W+ GC+ AE+ PI GR +QL RIF++
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVL 241
Query: 339 GSPSEDYW---KKL----RLSTTFRPPQSYKPRLFEAFSE-FPESS--LGLLSTLLALDP 388
G+P+E W KK+ L F+ L + + S LL LL DP
Sbjct: 242 GTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDP 301
Query: 389 AYRGSAASALKNEFF 403
R +A AL++ +F
Sbjct: 302 TKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 8e-65
Identities = 119/290 (41%), Positives = 171/290 (58%), Gaps = 17/290 (5%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
E+Y K+DK+G+GTY+ V+K + T +VALK+++ + E + RE+ +L+ L H
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLKHA 63
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ-------QLLSGLQHCH 237
NIV L + + + L LVFE++ +DL + + N G L QLL GL +CH
Sbjct: 64 NIVTLHDIIHT--ERCLTLVFEYLDSDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCH 120
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS-PNKKRPLTSRVVTLWYRAPELLLGA 296
R ILHRD+K NLLI++ G LK+ADFGLA S P K ++ VVTLWYR P++LLG+
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGS 178
Query: 297 TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356
T+Y ID+W GC+L EM GRP+ PG T E+LH IF+L G+P+E+ W + + FR
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238
Query: 357 P---PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
PQ L + LLS+LL + R SA +AL++ +F
Sbjct: 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 211 bits (540), Expect = 3e-64
Identities = 109/297 (36%), Positives = 160/297 (53%), Gaps = 29/297 (9%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE--PHSVKFMAREIMILQKLD 182
E Y+K+ K+G+G+Y V+K +R+TG+IVA+KK F SE P K REI +L++L
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKK--FVESEDDPVIKKIALREIRMLKQLK 58
Query: 183 HPNIVKLEGLATSRMQYSLYLVFEFM-QTDLARIISNPEGKLTEPQ------QLLSGLQH 235
HPN+V L + R + L+LVFE+ T L + NP G + E Q L +
Sbjct: 59 HPNLVNL--IEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKKIIWQTLQAVNF 115
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLG 295
CH +HRDVK N+LI K G +K+ DFG A + T V T WYRAPELL+G
Sbjct: 116 CHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-YTDYVATRWYRAPELLVG 174
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGS---------PSEDYW 346
T YG +D+W+ GC+ AE+ G+P+ PG+++V+QL+ I K G + ++
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234
Query: 347 KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
K L + P++ +P L F +L L L +DP R S L++ +F
Sbjct: 235 KGLSIPE----PETREP-LESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 3e-61
Identities = 109/292 (37%), Positives = 165/292 (56%), Gaps = 19/292 (6%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQKLDH 183
E Y+ + VG+G+Y V K ++TG+IVA+KK ++ + VK +A REI +L++L H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRH 59
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFM-QTDLARIISNPEGKLTEPQ------QLLSGLQHC 236
N+V L + R + LYLVFEF+ T L + P G L E + Q+L G++ C
Sbjct: 60 ENLVNL--IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-LDESRVRKYLFQILRGIEFC 116
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF-SPNKKRPLTSRVVTLWYRAPELLLG 295
H I+HRD+K N+L+ ++GV+K+ DFG A +P + T V T WYRAPELL+G
Sbjct: 117 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YTDYVATRWYRAPELLVG 174
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDY---WKKLRLS 352
T YG +D+W+ GCL+ EM G P+ PG ++++QL+ I K G+ + ++K L
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234
Query: 353 TTFRPPQSYKPRLFEA-FSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
R P+ + E F + L L L +DP R S++ L +EFF
Sbjct: 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 3e-61
Identities = 116/290 (40%), Positives = 166/290 (57%), Gaps = 17/290 (5%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
E+Y K+DK+G+GTY+ VYK + T +VALK+++ + E + RE+ +L+ L H
Sbjct: 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHA 64
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ-------QLLSGLQHCH 237
NIV L + + + SL LVFE++ DL + + + G QLL GL +CH
Sbjct: 65 NIVTLHDIIHT--EKSLTLVFEYLDKDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCH 121
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS-PNKKRPLTSRVVTLWYRAPELLLGA 296
R +LHRD+K NLLI++ G LK+ADFGLA S P K ++ VVTLWYR P++LLG+
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGS 179
Query: 297 TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356
TDY ID+W GC+ EM GRP+ PG T EQLH IF++ G+P+E+ W + + F+
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239
Query: 357 P---PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
P+ L LLS LL + R SA A+K+ +F
Sbjct: 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 4e-61
Identities = 120/296 (40%), Positives = 170/296 (57%), Gaps = 22/296 (7%)
Query: 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQKL 181
+A SY ++K+G+G+Y+ VYK + R G++VALK + T E V F A RE +L+ L
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGL 60
Query: 182 DHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQH 235
H NIV L + ++ +L VFE+M TDLA+ + G L QLL GL +
Sbjct: 61 KHANIVLLHDIIHTKE--TLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAY 118
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS-PNKKRPLTSRVVTLWYRAPELLL 294
H + ILHRD+K NLLI G LK+ADFGLA S P++ +S VVTLWYR P++LL
Sbjct: 119 IHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLL 176
Query: 295 GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEV-EQLHRIFKLCGSPSEDYWKKLRLST 353
GATDY +D+W AGC+ EM G+P PG ++V EQL +I+ + G P+ED W +
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236
Query: 354 TFRPP--QSYKPRLF----EAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
++P KP+ + S P++ L S +L + P R SA AL + +F
Sbjct: 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAE-DLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 202 bits (516), Expect = 9e-61
Identities = 117/291 (40%), Positives = 162/291 (55%), Gaps = 18/291 (6%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL---DH 183
Y+ + ++G G Y VYKA D +G VALK V+ T+E RE+ +L++L DH
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 184 PNIVKLEGL-ATSRM--QYSLYLVFEFMQTDLARIISN--PEGKLTEP-----QQLLSGL 233
PNIV+L + ATSR + + LVFE + DL + P G E +Q L GL
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 234 QHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELL 293
H I+HRD+K N+L+ G +K+ADFGLA +S + LT VVTLWYRAPE+L
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS--CQMALTPVVVTLWYRAPEVL 179
Query: 294 LGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW-KKLRLS 352
L +T Y +D+WS GC+ AEMF +P+ G +E +QL +IF L G P ED W + + L
Sbjct: 180 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238
Query: 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
P+ +P + E ES LL +L +P R SA AL++ FF
Sbjct: 239 RGAFSPRGPRP-VQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 198 bits (506), Expect = 1e-58
Identities = 107/305 (35%), Positives = 160/305 (52%), Gaps = 37/305 (12%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVK--FDTSEPHSVKFMAREIMILQKLDHP 184
Y I +G+G Y V A + +T + VA+KK+ FD K REI +L+ LDH
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI--DAKRTLREIKLLRHLDHE 64
Query: 185 NIVKLEGL--ATSRMQYS-LYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQH 235
N++ ++ + R ++ +Y+V+E M TDL +II + + L++ QLL GL++
Sbjct: 65 NVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQT-LSDDHCQYFLYQLLRGLKY 123
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLG 295
H +LHRD+K SNLL++ N LKI DFGLA + K +T VVT WYRAPELLL
Sbjct: 124 IHSANVLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTRWYRAPELLLN 182
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSED----------- 344
++Y ID+WS GC+ AE+ +P+ PG+ V QL I +L GSPSE+
Sbjct: 183 CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242
Query: 345 -YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
Y + L P + + F ++ LL +L DP+ R + AL + +
Sbjct: 243 RYIRSL--------PYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294
Query: 404 FTSPL 408
+ L
Sbjct: 295 --ASL 297
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 4e-58
Identities = 112/296 (37%), Positives = 158/296 (53%), Gaps = 19/296 (6%)
Query: 118 GLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMI 177
G V + Y + VG G + V A D+ TG+ VA+KK+ S P K RE+ +
Sbjct: 3 GTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKL 62
Query: 178 LQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ-------QLL 230
L+ L H NI+ L + S ++ +Y V E + TDL R++ + E Q Q+L
Sbjct: 63 LKHLRHENIISLSDIFISPLE-DIYFVTELLGTDLHRLL---TSRPLEKQFIQYFLYQIL 118
Query: 231 SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAP 290
GL++ H G++HRD+K SN+LI++N LKI DFGLA P +T V T +YRAP
Sbjct: 119 RGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ----MTGYVSTRYYRAP 174
Query: 291 ELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350
E++L Y V +D+WSAGC+ AEM G+P+ PG+ V Q I L G+P +D +
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234
Query: 351 LSTTFRPPQSYKPRLFEAFSE-FPE---SSLGLLSTLLALDPAYRGSAASALKNEF 402
T R QS R FSE F S++ LL +L DP R SAA AL + +
Sbjct: 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 196 bits (501), Expect = 6e-58
Identities = 106/324 (32%), Positives = 152/324 (46%), Gaps = 46/324 (14%)
Query: 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA----REIMILQ 179
Y + +G+G Y V A + TG VA+KK+ P + REI IL+
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-----SPFEHQTFCQRTLREIKILR 58
Query: 180 KLDHPNIVKLEGLATSRMQYSL---YLVFEFMQTDLARIISNPEGKLTEPQ------QLL 230
+ H NI+ + + S Y+V E M+TDL ++I L+ Q+L
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQ--HLSNDHIQYFLYQIL 116
Query: 231 SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP--LTSRVVTLWYR 288
GL++ H +LHRD+K SNLL++ N LKI DFGLA P LT V T WYR
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 289 APELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPS-EDYW- 346
APE++L + Y ID+WS GC+LAEM RP+ PG+ + QL+ I + G+PS ED
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236
Query: 347 ---KKLR---LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400
+ R S F+P + + F +L LL +L +P R + AL +
Sbjct: 237 IISLRARNYIKSLPFKPKVPWN----KLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292
Query: 401 EFFFTSPLACDLSGLPVIYDKEDE 424
+ L +D DE
Sbjct: 293 PY------------LEQYHDPSDE 304
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 195 bits (499), Expect = 2e-57
Identities = 100/291 (34%), Positives = 154/291 (52%), Gaps = 20/291 (6%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y + VG G Y V A D TG+ VA+KK+ K RE+ +L+ +DH N+
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76
Query: 187 VKLEGL---ATSRMQYS-LYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHC 236
+ L + A+S + +YLV M DL I+ KL++ Q+L GL++
Sbjct: 77 IGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYI 134
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGA 296
H GI+HRD+K SN+ ++++ LKI DFGLA + + +T V T WYRAPE++L
Sbjct: 135 HSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--HTDDE--MTGYVATRWYRAPEIMLNW 190
Query: 297 TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356
Y +D+WS GC++AE+ G+ + PG ++QL RI L G+P E+ +K+ +
Sbjct: 191 MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARN 250
Query: 357 PPQSYKPRLFEAFSE-FPESS---LGLLSTLLALDPAYRGSAASALKNEFF 403
QS + F E F ++ + LL +L LDP R +AA AL + +
Sbjct: 251 YIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 193 bits (491), Expect = 7e-57
Identities = 109/289 (37%), Positives = 168/289 (58%), Gaps = 15/289 (5%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
E+Y K++K+G+GTY+ V+K + T +VALK+++ + E + RE+ +L+ L H
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHA 64
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHD 238
NIV L + + SL LVFE++ DL + + + ++ Q+L GL +CH
Sbjct: 65 NIVTLHDIVHT--DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR 122
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYFS-PNKKRPLTSRVVTLWYRAPELLLGAT 297
R +LHRD+K NLLI++ G LK+ADFGLA S P K ++ VVTLWYR P++LLG++
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSS 180
Query: 298 DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357
+Y ID+W GC+ EM GRP+ PG T ++LH IF+L G+P+E+ W + + F+
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240
Query: 358 PQ--SYKPR-LFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
YKP+ L + LL+ L + R SA A+K+ +F
Sbjct: 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 5e-56
Identities = 108/291 (37%), Positives = 150/291 (51%), Gaps = 23/291 (7%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVK--FDTSEPHSVKFMAREIMILQKL-DH 183
Y + K+G+GT+S V KA R TGK A+K +K F + E V + REI L++L H
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE--QVNNL-REIQALRRLSPH 57
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCH 237
PNI++L + R L LVFE M +L +I + L E + QLL L H H
Sbjct: 58 PNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGAT 297
GI HRD+K N+LI + +LK+ADFG K P T + T WYRAPE LL
Sbjct: 118 RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 298 DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT--- 354
YG +D+W+ GC+ E+ P+ PG E++Q+ +I + G+P + KK R S
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234
Query: 355 FRPPQSYK--PRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
P + +L S L LL LLA DP R +A AL++ +F
Sbjct: 235 NFPSKKGTGLRKLLPNASAE---GLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 5e-55
Identities = 80/191 (41%), Positives = 117/191 (61%), Gaps = 12/191 (6%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGL 192
+G+G + VY A D+ TGK VA+K +K + S ++ + REI IL+KL+HPNIVKL G+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-SLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 193 ATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILHRD 245
+ LYLV E+ + L ++ EGKL+E + Q+L GL++ H GI+HRD
Sbjct: 60 FED--ENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 246 VKGSNLLIDK-NGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGID 304
+K N+L+D NG +K+ADFGL+ + + K L + V T Y APE+LLG Y D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 305 LWSAGCLLAEM 315
+WS G +L E+
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 1e-53
Identities = 115/297 (38%), Positives = 167/297 (56%), Gaps = 18/297 (6%)
Query: 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQKLD 182
A+SY+K++K+G+G+Y+ VYK + GK+VALK ++ E F A RE +L+ L
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLK 61
Query: 183 HPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHC 236
H NIV L + ++ +L LVFE++ TDL + + G L QLL GL +
Sbjct: 62 HANIVLLHDIIHTKE--TLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI 119
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGA 296
H R ILHRD+K NLLI G LK+ADFGLA S ++ VVTLWYR P++LLG+
Sbjct: 120 HQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYRPPDVLLGS 178
Query: 297 TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVE-QLHRIFKLCGSPSEDYWKKLRLSTTF 355
T+Y +D+W GC+ EM G PG +++ QL RIF + G+P+ED W + F
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238
Query: 356 RPPQ---SYKPRLFEAFSE--FPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407
+P + L +A+++ + + L S LL P R SA +AL +E+F P
Sbjct: 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 2e-53
Identities = 114/319 (35%), Positives = 170/319 (53%), Gaps = 32/319 (10%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL-EG 191
+G G+ V+ A+D D K VA+KK+ ++P SVK REI I+++LDH NIVK+ E
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVL--TDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 192 LATSRMQY-----------SLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQ 234
L S S+Y+V E+M+TDLA ++ +G L+E QLL GL+
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLK 128
Query: 235 HCHDRGILHRDVKGSNLLIDKNG-VLKIADFGLANYFSPN--KKRPLTSRVVTLWYRAPE 291
+ H +LHRD+K +N+ I+ VLKI DFGLA P+ K L+ +VT WYR+P
Sbjct: 129 YIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPR 188
Query: 292 LLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFK-LCGSPSEDYWKKLR 350
LLL +Y ID+W+AGC+ AEM G+P+ G E+EQ+ I + + ED + L
Sbjct: 189 LLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLN 248
Query: 351 LSTTFRPPQSYKPR--LFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF--FTS 406
+ +F +PR L + +L L +L +P R +A AL + + ++
Sbjct: 249 VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSC 308
Query: 407 PLACDLSGLPVIYDKEDEL 425
P +S P + EDEL
Sbjct: 309 PFDEPVSLHP--FHIEDEL 325
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 5e-53
Identities = 88/286 (30%), Positives = 140/286 (48%), Gaps = 34/286 (11%)
Query: 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPN 185
+ + + +G+G++ +VY ALD+DTG+++A+K V+ ++ + REI IL L HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 186 IVKLEGLATSRMQYSLYLVFEFM-QTDLARIISNPEGKLTEPQ------QLLSGLQHCHD 238
IV+ G + +L + E++ L+ ++ GKL EP Q+L GL + H
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYF-SPNKKRPLTSRVVTLWYRAPELLLGAT 297
GI+HRD+KG+N+L+D +GV+K+ADFG A S T ++ APE++ G
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG-E 178
Query: 298 DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357
+YG D+WS GC + EM G+P ++K+ S P
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA--LYKIGSSGE--------------P 222
Query: 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
P+ L E +F L L DP R +A L++ F
Sbjct: 223 PE-IPEHLSEEAKDF-------LRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 4e-51
Identities = 107/321 (33%), Positives = 160/321 (49%), Gaps = 23/321 (7%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDT--GKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DH 183
Y+ I ++GQG Y V A + +T + VA+KK+ S+ K RE+ +L+ H
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 184 PNIVKLEGL--ATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQH 235
NI L + LYL E M+ DL +II + LT+ Q+L GL++
Sbjct: 62 KNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKY 120
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP---LTSRVVTLWYRAPEL 292
H +LHRD+K NLL++ + LKI DFGLA FS N +T V T WYRAPE+
Sbjct: 121 IHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180
Query: 293 LLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL--- 349
+L Y ID+WS GC+LAE+ +P+ G+ V+QL++I ++ G+P E+ ++
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSP 240
Query: 350 RLSTTFRPPQSYKPRLFEAFSEFPESS---LGLLSTLLALDPAYRGSAASALKNEFFFTS 406
+ R + + FE S FP ++ L LL LLA DP R S AL++ +
Sbjct: 241 KAQNYIRSLPNIPKKPFE--SIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298
Query: 407 PLACDLSGLPVIYDKEDELIE 427
D +D E +
Sbjct: 299 HDPDDEPVCQKPFDFSFESED 319
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 2e-50
Identities = 107/291 (36%), Positives = 160/291 (54%), Gaps = 25/291 (8%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVK--FD-TSEPHSVKFMAREIMILQKLDHPNIVKL 189
+G+G+Y V A+D TG+ VA+KK+ F+ S+ + REI +L+ L HP+IV++
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRI---LREIKLLRLLRHPDIVEI 64
Query: 190 EG--LATSRMQYS-LYLVFEFMQTDLARIISNPEGKLTEPQ-----QLLSGLQHCHDRGI 241
+ L SR ++ +Y+VFE M++DL ++I + E QLL L++ H +
Sbjct: 65 KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANV 124
Query: 242 LHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL---TSRVVTLWYRAPELLLGA-- 296
HRD+K N+L + + LKI DFGLA + N T V T WYRAPEL G+
Sbjct: 125 FHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWYRAPELC-GSFF 182
Query: 297 TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356
+ Y ID+WS GC+ AE+ G+P+ PG+ V QL I L G+PS + ++R R
Sbjct: 183 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARR 242
Query: 357 PPQSYKPRLFEAFSE-FPES---SLGLLSTLLALDPAYRGSAASALKNEFF 403
S + + FS+ FP + +L LL LLA DP R +A AL + +F
Sbjct: 243 YLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 174 bits (441), Expect = 6e-50
Identities = 109/297 (36%), Positives = 165/297 (55%), Gaps = 25/297 (8%)
Query: 125 ESYDKIDKVGQGTYSNVYKALD-RDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD- 182
+ Y+ + ++G+G Y V+KA D ++ G+ VALK+V+ T E RE+ +L+ L+
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 183 --HPNIVKLEGLAT-SRM--QYSLYLVFEFMQTDLARIISNPEGKLTEPQ-------QLL 230
HPN+V+L + T SR + L LVFE + DL + + QLL
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 231 SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAP 290
GL H ++HRD+K N+L+ +G +K+ADFGLA +S + LTS VVTLWYRAP
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLWYRAP 178
Query: 291 ELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350
E+LL ++ Y +DLWS GC+ AEMF +P+ G ++V+QL +I + G P E+ W +
Sbjct: 179 EVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR-- 235
Query: 351 LSTTFRPPQSYKPRLFEAFSEF-PE-SSLG--LLSTLLALDPAYRGSAASALKNEFF 403
P Q++ + + +F + LG LL L +PA R SA SAL + +F
Sbjct: 236 --DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 5e-49
Identities = 101/282 (35%), Positives = 151/282 (53%), Gaps = 19/282 (6%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVK-LEG 191
+G G + V+ D GK VALKK+ S K + RE+ +L H N++ L+
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 192 LATSRMQY--SLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILH 243
L + +Y+V E MQ+DL +II +P+ L+ Q+L GL++ H GILH
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSAGILH 126
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGI 303
RD+K NLL++ N VLKI DFGLA P++ + +T VVT +YRAPE+L+G+ Y +
Sbjct: 127 RDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAV 186
Query: 304 DLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR-------LSTTFR 356
D+WS GC+ AE+ R + ++ ++QL I L G+PS + + L +
Sbjct: 187 DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHK 246
Query: 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASAL 398
PP P L+ S+ ++ LL +L DP R SAA AL
Sbjct: 247 PPS--LPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 4e-48
Identities = 101/294 (34%), Positives = 157/294 (53%), Gaps = 22/294 (7%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ Y + +VG G Y V ALDR TG VA+KK+ K RE+ +L+ + H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 185 NIVKLEGLATSRMQ----YSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQ 234
N++ L + T + + YLV FM TDL +++ + KL+E + Q+L GL+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE--KLSEDRIQFLVYQMLKGLK 132
Query: 235 HCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLL 294
+ H GI+HRD+K NL ++++ LKI DFGLA +T VVT WYRAPE++L
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTGYVVTRWYRAPEVIL 188
Query: 295 GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354
Y +D+WS GC++AEM G+P+ G ++QL I K+ G+PS+++ +KL+ S
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ-SED 247
Query: 355 FRP-----PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
+ P+ K ++ +L +L LD R +AA AL + +F
Sbjct: 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 3e-47
Identities = 105/297 (35%), Positives = 164/297 (55%), Gaps = 29/297 (9%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA----REIMILQK 180
E Y + +VG G Y +V A+D+ TG+ VA+KK+ S P + A RE+ +L+
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL----SRPFQSEIFAKRAYRELTLLKH 70
Query: 181 LDHPNIVKLEGLATS----RMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLL 230
+ H N++ L + TS YLV +MQTDL +I+ +P L+E + Q+L
Sbjct: 71 MQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP---LSEDKVQYLVYQML 127
Query: 231 SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAP 290
GL++ H GI+HRD+K NL ++++ LKI DFGLA + +T VVT WYRAP
Sbjct: 128 CGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAP 183
Query: 291 ELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350
E++L Y +D+WS GC++AEM G+ + G+ ++QL +I K+ G P ++ +KL
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243
Query: 351 LSTTFRPPQSYKPRLFEAFSE-FPESS---LGLLSTLLALDPAYRGSAASALKNEFF 403
+S + FS FP++S + LL +L LD R +A AL++ +F
Sbjct: 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 1e-46
Identities = 73/217 (33%), Positives = 119/217 (54%), Gaps = 16/217 (7%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y D +G+G + VYK L+ +TG VA+K++ + + ++K + +EI +L+ L HPNI
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 187 VKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCHDR 239
VK G + SLY++ E+ + L +II G E Q+L GL + H++
Sbjct: 62 VKYIGSIET--SDSLYIILEYAENGSLRQII-KKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDY 299
G++HRD+K +N+L K+GV+K+ADFG+A + K + V T ++ APE++ +
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV-VGTPYWMAPEVIEMS--- 174
Query: 300 GVGI--DLWSAGCLLAEMFLGRPIMPGRTEVEQLHRI 334
G D+WS GC + E+ G P + L RI
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI 211
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 3e-46
Identities = 90/288 (31%), Positives = 138/288 (47%), Gaps = 48/288 (16%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
++ ++K+G+G + VYKA + TGK VA+K +K ++ E + + EI IL+K HPNI
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKE--KKEKIINEIQILKKCKHPNI 59
Query: 187 VKLEGLATSRMQY----SLYLVFEFMQ-TDLARIISNPEGKLTEPQ------QLLSGLQH 235
VK G Y L++V EF L ++ + LTE Q +LL GL++
Sbjct: 60 VKYYG------SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEY 113
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLG 295
H GI+HRD+K +N+L+ +G +K+ DFGL+ S K R + V T ++ APE++ G
Sbjct: 114 LHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR--NTMVGTPYWMAPEVING 171
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355
Y D+WS G E+ G+P +L + K L T
Sbjct: 172 -KPYDYKADIWSLGITAIELAEGKPPYS------ELPPM------------KALFKIATN 212
Query: 356 RPPQSYKPRLF-EAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402
PP P + + F +F L L +P R +A LK+ F
Sbjct: 213 GPPGLRNPEKWSDEFKDF-------LKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 3e-44
Identities = 107/286 (37%), Positives = 149/286 (52%), Gaps = 22/286 (7%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQKLDHPNIVKLEG 191
VG+G Y V K ++T +IVA+KK K D+ E VK RE+ +L+ L NIV+L+
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFK-DSEENEEVKETTLRELKMLRTLKQENIVELK- 66
Query: 192 LATSRMQYSLYLVFEFMQTDLARIISN-PEGKLTEP-----QQLLSGLQHCHDRGILHRD 245
R + LYLVFE+++ ++ ++ P G E QL+ + CH I+HRD
Sbjct: 67 -EAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRD 125
Query: 246 VKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDL 305
+K NLLI N VLK+ DFG A S T V T WYR+PELLLGA YG +D+
Sbjct: 126 IKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-YGKAVDM 184
Query: 306 WSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGS-PSED---YWKKLRLSTTFRP---- 357
WS GC+L E+ G+P+ PG +E++QL I K+ G P+E ++ R P
Sbjct: 185 WSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNH 244
Query: 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
PQS + R S L L+ LL L+P R L + F
Sbjct: 245 PQSLERRYLGILSGV---LLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 4e-44
Identities = 86/290 (29%), Positives = 129/290 (44%), Gaps = 46/290 (15%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y+ I ++G+G++ VY + GK+ LK++ + E+ IL+KL+HPNI
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 187 VKL-EGLATSRMQYSLYLVFEFM-QTDLARIISN--PEGK-LTEPQ------QLLSGLQH 235
+K E + L +V E+ DL++ I EGK E Q QL L++
Sbjct: 62 IKYYESFEE---KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV-TLWYRAPELLL 294
H R ILHRD+K N+ + NG++K+ DFG++ S L VV T +Y +PEL
Sbjct: 119 LHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQ 176
Query: 295 GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354
Y D+WS GC+L E+ + G +E +I L
Sbjct: 177 NKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI----------------LKGQ 219
Query: 355 FRP-PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
+ P P Y L L+S+LL DP R S A L++ F
Sbjct: 220 YPPIPSQYSSELRN-----------LVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 101/294 (34%), Positives = 150/294 (51%), Gaps = 22/294 (7%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
E Y + VG G Y +V A D TG VA+KK+ K RE+ +L+ + H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 185 NIVKLEGL---ATSRMQYS-LYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQ 234
N++ L + A S +++ +YLV M DL I+ KLT+ Q+L GL+
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLK 134
Query: 235 HCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLL 294
+ H I+HRD+K SNL ++++ LKI DFGLA + +T V T WYRAPE++L
Sbjct: 135 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIML 190
Query: 295 GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354
Y +D+WS GC++AE+ GR + PG ++QL I +L G+P + KK+ S +
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS-SES 249
Query: 355 FRP-----PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
R Q K F ++ LL +L LD R +AA AL + +F
Sbjct: 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 157 bits (396), Expect = 1e-42
Identities = 108/402 (26%), Positives = 162/402 (40%), Gaps = 49/402 (12%)
Query: 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD-TSEPHSVKFMAREIMILQKLDHP 184
SY + K+G+G++ VY A DR K+VALK + S+ V+ REI IL L+HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 185 -NIVKLEGLATSRMQYSLYLVFEFMQ-TDLARIISNP--EGKLTEP------QQLLSGLQ 234
NIVKL + SLYLV E++ L ++ +G L+E Q+LS L+
Sbjct: 58 PNIVKLYDFFQD--EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115
Query: 235 HCHDRGILHRDVKGSNLLIDKNG-VLKIADFGLANYFSPNK-----KRPLTSRVVTLWYR 288
+ H +GI+HRD+K N+L+D++G V+K+ DFGLA ++ V T Y
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 289 APELLLGATD--YGVGIDLWSAGCLLAEMFLGRPIMPGRTE---VEQLHRIFKLCGSPSE 343
APE+LLG + D+WS G L E+ G P G Q +I +P
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-- 233
Query: 344 DYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
S S + +A S+ L LLA DP R S++S L ++
Sbjct: 234 --------SLASPLSPSNPELISKAASDL-------LKKLLAKDPKNRLSSSSDLSHDLL 278
Query: 404 FTSPLACDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQASQLTKEET 463
L D A + + + S G +
Sbjct: 279 AHLKLKESDL-----SDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFS 333
Query: 464 LSNKEDSEKHVELNFQGQEPYSSASSASSGTKANQQSHSPPF 505
+ N +++S SS K + +S
Sbjct: 334 KELAPNGVSSSPHNSSSLLLSTASSKRSSLPKISARSSPSSL 375
|
Length = 384 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 95/303 (31%), Positives = 140/303 (46%), Gaps = 47/303 (15%)
Query: 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH 183
E Y ++K+G+G VYKA DR TGK VA+KK++ + EI+I++ H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKH 74
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHC 236
PNIV + + L++V E+M L II+ ++ EPQ ++L GL++
Sbjct: 75 PNIVDY--YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK-KRPLTSRVVTLWYRAPELLLG 295
H + ++HRD+K N+L+ K+G +K+ADFG A + K KR S V T ++ APE++
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR--NSVVGTPYWMAPEVIKR 190
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSP--SEDYWKKLRLST 353
DYG +D+WS G + EM G P P E + L L T
Sbjct: 191 -KDYGPKVDIWSLGIMCIEMAEGEP--------------------PYLREPPLRALFLIT 229
Query: 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDLS 413
T P P + EF L+ L DP R SA L++ F AC
Sbjct: 230 TKGIPPLKNPEKWS--PEF----KDFLNKCLVKDPEKRPSAEELLQHPFL---KKACPKE 280
Query: 414 GLP 416
Sbjct: 281 EFA 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 113/377 (29%), Positives = 175/377 (46%), Gaps = 59/377 (15%)
Query: 113 REVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA 172
R+ L V + E Y + VG G Y +V A D + VA+KK+ +
Sbjct: 3 RQELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY 62
Query: 173 REIMILQKLDHPNIVKLEGL---ATSRMQYS-LYLVFEFMQTDLARIISNPEGKLTEPQ- 227
RE+ +L+ + H N++ L + ATS ++ +YLV M DL I+ KL++
Sbjct: 63 RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ--KLSDEHV 120
Query: 228 -----QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRV 282
QLL GL++ H GI+HRD+K SN+ ++++ L+I DFGLA +T V
Sbjct: 121 QFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGYV 176
Query: 283 VTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPS 342
T WYRAPE++L Y +D+WS GC++AE+ G+ + PG ++QL RI ++ G+PS
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236
Query: 343 EDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLG------------LLSTLLALDPAY 390
+ KK+ + + ++ P+ L LL +L LD
Sbjct: 237 PEVLKKIS--------SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDK 288
Query: 391 RGSAASALKNEFFFTSPLACDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERR 450
R SA+ AL + +F +D EDE A S +ER
Sbjct: 289 RISASEALAHPYFSQ------------YHDPEDE----------PEAEPYDESPENKERT 326
Query: 451 IGDQASQLTKEETLSNK 467
I ++ +LT EE S K
Sbjct: 327 I-EEWKELTYEEVSSFK 342
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 7e-41
Identities = 90/282 (31%), Positives = 131/282 (46%), Gaps = 42/282 (14%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKLDHPNIVKLEG 191
+G+G++ V +DTGK+ A+K + K + V+ E IL +++HP IVKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 192 LATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILHR 244
+ + LYLV E+ +L +S EG+ +E + +++ L++ H GI++R
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYR 117
Query: 245 DVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGID 304
D+K N+L+D +G +K+ DFGLA S R + T Y APE+LLG YG +D
Sbjct: 118 DLKPENILLDADGHIKLTDFGLAKELSSEGSRT-NTFCGTPEYLAPEVLLGK-GYGKAVD 175
Query: 305 LWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPR 364
WS G LL EM G+P E +I K LR P
Sbjct: 176 WWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK----------DPLRFPEFLSP------- 218
Query: 365 LFEAFSEFPESSLGLLSTLLALDPAYR-GSA-ASALKNEFFF 404
EA L+S LL DP R GS A +K FF
Sbjct: 219 --EARD--------LISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 2e-40
Identities = 76/220 (34%), Positives = 124/220 (56%), Gaps = 18/220 (8%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKF---DTSEPHSVKFMAREIMILQKLDHPNIVKL 189
+G G++ +VY+ L+ D G A+K+V + +VK + +EI +L KL HPNIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 190 EGLATSRMQYSLYLVFEFM-QTDLARIISNPEGKLTEPQ------QLLSGLQHCHDRGIL 242
G T R + +LY+ E + LA+++ G EP Q+L GL++ HDR +
Sbjct: 68 LG--TEREEDNLYIFLELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTV 124
Query: 243 HRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVG 302
HRD+KG+N+L+D NGV+K+ADFG+A + S + ++ APE++ YG+
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAKQVV--EFSFAKSFKGSPYWMAPEVIAQQGGYGLA 182
Query: 303 IDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPS 342
D+WS GC + EM G+P +++E + +FK+ S
Sbjct: 183 ADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKE 219
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 4e-40
Identities = 69/204 (33%), Positives = 113/204 (55%), Gaps = 19/204 (9%)
Query: 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLE 190
+K+G GT+ VY A++ DTG+++A+K+++ ++P ++K +A E+ +L+ L HPN+VK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 191 GLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQ--------QLLSGLQHCHDRGI 241
G+ R + +Y+ E+ L ++ E + QLL GL + H GI
Sbjct: 66 GVEVHREK--VYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTLQLLEGLAYLHSHGI 120
Query: 242 LHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP---LTSRVVTLWYRAPELLLGATD 298
+HRD+K +N+ +D NGV+K+ DFG A N + S T Y APE++ G
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 299 YGVG--IDLWSAGCLLAEMFLGRP 320
G G D+WS GC++ EM G+
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 2e-39
Identities = 107/315 (33%), Positives = 157/315 (49%), Gaps = 48/315 (15%)
Query: 132 KVGQGTYSNVYKALDRDTG--KIVALKKVKFDTSEPHSVKFMA-REIMILQKLDHPNIVK 188
KVG+GTY +VYKA +D K ALK++ E + A REI +L++L HPN++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI-----EGTGISMSACREIALLRELKHPNVIA 62
Query: 189 LEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ--------------QLLSGLQ 234
L+ + S ++L+F++ + DL II + Q+L G+
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 235 HCHDRGILHRDVKGSNLLI----DKNGVLKIADFGLANYF-SPNKK-RPLTSRVVTLWYR 288
+ H +LHRD+K +N+L+ + G +KIAD G A F SP K L VVT WYR
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 289 APELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE---------VEQLHRIFKLCG 339
APELLLGA Y ID+W+ GC+ AE+ PI R E +QL RIF + G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242
Query: 340 SPSEDYWKKLR-------LSTTFRPPQSYKPRLFEAFSEF---PESSLG-LLSTLLALDP 388
P++ W+ +R L FR L + + P+S + LL LL +DP
Sbjct: 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDP 302
Query: 389 AYRGSAASALKNEFF 403
R ++ AL++ +F
Sbjct: 303 TKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 97/301 (32%), Positives = 152/301 (50%), Gaps = 30/301 (9%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y + +G G V A D TG+ VA+KK+ K RE+++++ ++H NI
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNI 77
Query: 187 VKLEGLATSRMQYS----LYLVFEFMQTDLARIIS---NPEGKLTEPQQLLSGLQHCHDR 239
+ L + T + +YLV E M +L ++I + E Q+L G++H H
Sbjct: 78 IGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSA 137
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDY 299
GI+HRD+K SN+++ + LKI DFGLA + +T VVT +YRAPE++LG Y
Sbjct: 138 GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG-MGY 194
Query: 300 GVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL----RLSTTF 355
+D+WS GC++ EM G + PG ++Q ++I + G+PS+++ +L R
Sbjct: 195 KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVEN 254
Query: 356 RPPQSYKPRLFEA-FSE--FPESS-----------LGLLSTLLALDPAYRGSAASALKNE 401
RP Y FE F + FP S LLS +L +DP R S AL++
Sbjct: 255 RP--KYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312
Query: 402 F 402
+
Sbjct: 313 Y 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 149 bits (376), Expect = 3e-39
Identities = 114/378 (30%), Positives = 184/378 (48%), Gaps = 32/378 (8%)
Query: 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD 182
+SY + +G G++ VY+A+ DT + VA+KKV D ++ RE++I++ L+
Sbjct: 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLN 117
Query: 183 HPNIVKL------EGLATSRMQYSLYLVFEFM-QTDLARIISNPEGKLTEPQ-------- 227
H NI+ L E + L +V EF+ QT + P
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNG-VLKIADFGLANYFSPNKKRPLTSRVVTLW 286
QL L + H + I HRD+K NLLID N LK+ DFG A ++ S + + +
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS--VSYICSRF 235
Query: 287 YRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW 346
YRAPEL+LGAT+Y IDLWS GC++AEM LG PI G++ V+QL RI ++ G+P+ED
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295
Query: 347 KKLRLSTTFRPPQSYKPR-LFEAFSE-FPESSLGLLSTLLALDPAYRGSAASALKNEFF- 403
K++ + KP+ L + F + P+ ++ +S L +P R + AL + FF
Sbjct: 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355
Query: 404 -FTSP---LACDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQASQLT 459
P L + LP +++ D I+ R+ K + +E + D+
Sbjct: 356 DLRDPCIKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIPKCTYEAYKEFLMSDENDANI 415
Query: 460 KEETLSNKEDSEKHVELN 477
+ +S + E +++
Sbjct: 416 IADKISK-DFGESNIDAK 432
|
Length = 440 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 4e-39
Identities = 106/315 (33%), Positives = 159/315 (50%), Gaps = 48/315 (15%)
Query: 132 KVGQGTYSNVYKALDRD--TGKIVALKKVKFDTSEPHSVKFMA-REIMILQKLDHPNIVK 188
KVG+GTY +VYKA +D + ALK++ E + A REI +L++L HPN++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI-----EGTGISMSACREIALLRELKHPNVIS 62
Query: 189 LEGLATSRMQYSLYLVFEFMQTDLARIISN-------------PEGKLTEP-QQLLSGLQ 234
L+ + S ++L+F++ + DL II P G + Q+L G+
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 235 HCHDRGILHRDVKGSNLLI----DKNGVLKIADFGLANYF-SPNKK-RPLTSRVVTLWYR 288
+ H +LHRD+K +N+L+ + G +KIAD G A F SP K L VVT WYR
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 289 APELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE---------VEQLHRIFKLCG 339
APELLLGA Y ID+W+ GC+ AE+ PI R E +QL RIF + G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242
Query: 340 SPSEDYWKKLR-------LSTTFRPPQSYKPRLFEAFSEF---PES-SLGLLSTLLALDP 388
P++ W+ ++ L FR L + + P+S + LL LL +DP
Sbjct: 243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 302
Query: 389 AYRGSAASALKNEFF 403
R ++ A+++ +F
Sbjct: 303 IKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 3e-38
Identities = 102/324 (31%), Positives = 158/324 (48%), Gaps = 32/324 (9%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y ++ +G G V A D G VA+KK+ K RE+++L+ ++H NI
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 187 VKLEGLATSRMQYS----LYLVFEFMQTDLARIIS---NPEGKLTEPQQLLSGLQHCHDR 239
+ L + T + +YLV E M +L ++I + E Q+L G++H H
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA 142
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDY 299
GI+HRD+K SN+++ + LKI DFGLA N +T VVT +YRAPE++LG Y
Sbjct: 143 GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVVTRYYRAPEVILG-MGY 199
Query: 300 GVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR--- 356
+D+WS GC++ E+ G I G ++Q +++ + G+PS ++ RL T R
Sbjct: 200 KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN--RLQPTVRNYV 257
Query: 357 --PPQSYKPRLFEAFSE--FPESS----------LGLLSTLLALDPAYRGSAASALKNEF 402
PQ E F + FP S LLS +L +DP R S AL++ +
Sbjct: 258 ENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317
Query: 403 F--FTSPLACDLSGLPVIYDKEDE 424
+ P + + P IYD + E
Sbjct: 318 ITVWYDPAEAE-APPPQIYDAQLE 340
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 101/322 (31%), Positives = 163/322 (50%), Gaps = 28/322 (8%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ Y + +G G V A D + VA+KK+ K RE+++++ ++H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 185 NIVKLEGLATSRMQYS----LYLVFEFMQTDLARIIS---NPEGKLTEPQQLLSGLQHCH 237
NI+ L + T + +YLV E M +L ++I + E Q+L G++H H
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGAT 297
GI+HRD+K SN+++ + LKI DFGLA + +T VVT +YRAPE++LG
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG-M 193
Query: 298 DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL----RLST 353
Y +D+WS GC++ EM + + PGR ++Q +++ + G+P ++ KKL R
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 354 TFRP-------PQSYKPRLFEAFSEF----PESSLGLLSTLLALDPAYRGSAASALKNEF 402
RP P+ + LF A SE + LLS +L +DPA R S AL++ +
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313
Query: 403 F--FTSPLACDLSGLPVIYDKE 422
+ P + + P IYDK+
Sbjct: 314 INVWYDPAEVE-APPPQIYDKQ 334
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 6e-38
Identities = 74/241 (30%), Positives = 116/241 (48%), Gaps = 34/241 (14%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKV--KFDTSEPHSVKFMAREIMILQKLD-H 183
+ +G+G++S V A +++T K A+K + + E VK++ E +L +L+ H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKK-VKYVKIEKEVLTRLNGH 61
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFM-QTDLARIISNPEGKLTEPQ------QLLSGLQHC 236
P I+KL T + + +LY V E+ +L + I G L E ++L L++
Sbjct: 62 PGIIKL--YYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEYL 118
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN-------------------KKRP 277
H +GI+HRD+K N+L+DK+ +KI DFG A PN +R
Sbjct: 119 HSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKL 337
S V T Y +PELL G DLW+ GC++ +M G+P G E +I KL
Sbjct: 179 FASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237
Query: 338 C 338
Sbjct: 238 E 238
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 5e-37
Identities = 73/202 (36%), Positives = 114/202 (56%), Gaps = 15/202 (7%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVK-FDTSEPHSVKFMAREIMILQKLDH 183
++ K+G+G +S VYKA+ G++VALKKV+ F+ + + + +EI +L++LDH
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGK---LTEPQ------QLLSGL 233
PN++K LA+ L +V E DL+R+I + + + + E QL S L
Sbjct: 62 PNVIKY--LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 234 QHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELL 293
+H H + I+HRD+K +N+ I GV+K+ D GL +FS +K S V T +Y +PE +
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 178
Query: 294 LGATDYGVGIDLWSAGCLLAEM 315
Y D+WS GCLL EM
Sbjct: 179 HE-NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 3e-36
Identities = 73/205 (35%), Positives = 107/205 (52%), Gaps = 18/205 (8%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+++ +GQG+ VYK + TGKI ALKK+ D E K + RE+ L+ + P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR-KQLLRELKTLRSCESP 59
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTD---LARIISNPEGKLTEPQ------QLLSGLQH 235
+VK G + + +V E+M D LA ++ GK+ EP Q+L GL +
Sbjct: 60 YVVKCYGAFYKEGE--ISIVLEYM--DGGSLADLLK-KVGKIPEPVLAYIARQILKGLDY 114
Query: 236 CH-DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLL 294
H R I+HRD+K SNLLI+ G +KIADFG++ + T V T+ Y +PE +
Sbjct: 115 LHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTVTYMSPERIQ 173
Query: 295 GATDYGVGIDLWSAGCLLAEMFLGR 319
G + Y D+WS G L E LG+
Sbjct: 174 GES-YSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 91/300 (30%), Positives = 150/300 (50%), Gaps = 29/300 (9%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y + +G G V A D + VA+KK+ K RE+++++ ++H NI
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 187 VKLEGLATSRMQYS----LYLVFEFMQTDLARIIS---NPEGKLTEPQQLLSGLQHCHDR 239
+ L + T + +Y+V E M +L ++I + E Q+L G++H H
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDY 299
GI+HRD+K SN+++ + LKI DFGLA + +T VVT +YRAPE++LG Y
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG-MGY 202
Query: 300 GVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQ 359
+D+WS GC++ EM G + PG ++Q +++ + G+P ++ KKL+ T R
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ--PTVRTYV 260
Query: 360 SYKPR-------------LFEAFSEF----PESSLGLLSTLLALDPAYRGSAASALKNEF 402
+P+ LF A SE + LLS +L +D + R S AL++ +
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 9e-35
Identities = 75/225 (33%), Positives = 123/225 (54%), Gaps = 29/225 (12%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFD--TSEPHS------VKFMAREIMILQKLDHP 184
+G+GTY VY AL+ TG+++A+K+V+ + H VK + EI L+ LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEP------QQLLSGLQHCH 237
NIV+ G T+ S++L E++ + + G+ E +Q+L GL + H
Sbjct: 69 NIVQYLGFETTEEYLSIFL--EYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLH 125
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGL----ANYFSPNKKRPLTSRVVTLWYRAPELL 293
+GILHRD+K NLL+D +G+ KI+DFG+ + + ++ S ++++ APE++
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN---MSMQGSVFWMAPEVI 182
Query: 294 -LGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKL 337
+ Y +D+WS GC++ EMF GR P E E + +FKL
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGR--RPWSDE-EAIAAMFKL 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 9e-35
Identities = 83/290 (28%), Positives = 143/290 (49%), Gaps = 47/290 (16%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
E +D ++K+G+G+Y +VYKA+ ++TG++VA+K V + ++ + +EI IL++ D P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSP 58
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQ----TDLARIISNPEGKLTEPQ------QLLSGLQ 234
IVK G + L++V E+ +D+ +I + LTE + Q L GL+
Sbjct: 59 YIVKYYG--SYFKNTDLWIVMEYCGAGSVSDIMKITNKT---LTEEEIAAILYQTLKGLE 113
Query: 235 HCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA-NYFSPNKKRPLTSRVVTLWYRAPELL 293
+ H +HRD+K N+L+++ G K+ADFG++ KR + + T ++ APE++
Sbjct: 114 YLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR--NTVIGTPFWMAPEVI 171
Query: 294 LGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353
Y D+WS G EM G+P P +++ + IF + P
Sbjct: 172 QE-IGYNNKADIWSLGITAIEMAEGKP--P-YSDIHPMRAIFMIPNKPPP---------- 217
Query: 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
T P+ + P F++F + L DP R SA L++ F
Sbjct: 218 TLSDPEKWSP----EFNDF-------VKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 81/299 (27%), Positives = 128/299 (42%), Gaps = 59/299 (19%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y+ ++ +G+G++ V K + GKI+ K++ + + + E+ IL++L HPNI
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 187 VKLEGLATSRMQYSLYLVFEFMQT-DLARIISN---PEGKLTEPQ------QLLSGLQHC 236
V+ R +LY+V E+ + DLA++I + E QLL L C
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 237 HDRG-----ILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR-------VVT 284
H+R +LHRD+K +N+ +D N +K+ DFGLA + L V T
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA--------KILGHDSSFAKTYVGT 173
Query: 285 LWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSED 344
+Y +PE L + Y D+WS GCL+ E+ P R QL K+
Sbjct: 174 PYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKIKEGK--- 226
Query: 345 YWKKLRLSTTFRP-PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402
FR P Y L E ++ ++L +DP R S L+
Sbjct: 227 ----------FRRIPYRYSSELNE-----------VIKSMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 72/228 (31%), Positives = 104/228 (45%), Gaps = 31/228 (13%)
Query: 129 KIDKVGQGTYSNVYKA----LDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
K+G+G + VYK T VA+K +K SE +F+ E I++KL HP
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFL-EEASIMKKLSHP 61
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL------SGLQHCH 237
NIV+L G+ T LY+V E+M DL + KLT L G+++
Sbjct: 62 NIVRLLGVCTQ--GEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLA--------NYFSPNKKRPLTSRVVTLWYRA 289
+ +HRD+ N L+ +N V+KI+DFGL+ K P+ + W A
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPI--K----WM-A 172
Query: 290 PELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRIFK 336
PE L + D+WS G LL E+F LG PG + E L +
Sbjct: 173 PESLKDGK-FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED 219
|
Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 6e-33
Identities = 70/208 (33%), Positives = 113/208 (54%), Gaps = 16/208 (7%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
E Y+ I ++G GTY +VYKA D TG++VA+K +K + + + + +EI +L++ HP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHP 60
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCH 237
NIV G + R L++V E+ L I G L+E Q + L GL + H
Sbjct: 61 NIVAYFG-SYLRRDK-LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGL-ANYFSPNKKRPLTSRVVTLWYRAPELLL-- 294
+ G +HRD+KG+N+L+ ++G +K+ADFG+ A + KR S + T ++ APE+
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR--KSFIGTPYWMAPEVAAVE 176
Query: 295 GATDYGVGIDLWSAGCLLAEMFLGRPIM 322
Y D+W+ G E+ +P M
Sbjct: 177 RKGGYDGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 77/292 (26%), Positives = 136/292 (46%), Gaps = 38/292 (13%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ Y+ I+ +G G + VY A+ + VA+K++ + + SV + +E+ + + +HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHP 59
Query: 185 NIVKLEGLATSRMQYSLYLVFEFM-QTDLARII--SNPEGKLTEP------QQLLSGLQH 235
N+VK + L+LV ++ L I+ S P G L E +++L GL++
Sbjct: 60 NVVKYYTSFVVGDE--LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGL-ANYFSP--NKKRPLTSRVVTLWYRAPEL 292
H G +HRD+K N+L+ ++G +KIADFG+ A+ ++ + V T + APE+
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 293 LLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352
+ Y D+WS G E+ G P + + K L L+
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAA--PY-------SKYPPM---------KVLMLT 219
Query: 353 TTFRPPQSYKPRLFEAFS-EFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
PP ++ +S F + ++S L DP+ R +A LK++FF
Sbjct: 220 LQNDPPSLETGADYKKYSKSFRK----MISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 29/206 (14%)
Query: 129 KIDKVGQGTYSNVYKA----LDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
K+G+G + VYK VA+K +K D SE +F+ RE I++KLDHP
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFL-REARIMRKLDHP 61
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL------SGLQHCH 237
N+VKL G+ T + LY+V E+M+ DL + KL+ L G+++
Sbjct: 62 NVVKLLGVCTE--EEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLA-------NYFSPNKKRPLTSRVVTLWYRAP 290
+ +HRD+ N L+ +N V+KI+DFGL+ Y K P+ W AP
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR------WM-AP 172
Query: 291 ELLLGATDYGVGIDLWSAGCLLAEMF 316
E L + D+WS G LL E+F
Sbjct: 173 ESLKEGK-FTSKSDVWSFGVLLWEIF 197
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 85/290 (29%), Positives = 142/290 (48%), Gaps = 51/290 (17%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHS-------VKFMAREIMILQKLDHPN 185
+G G++ +VY ++ +G+++A+K+V+ + S + +AREI +L++L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 186 IVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHCHDR 239
IV+ G + +++L E++ + N G E +Q+L GL + H+R
Sbjct: 68 IVQYLGSSLDADHLNIFL--EYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR 125
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGL-----ANYFSP--NKKRPLTSRVVTLWYRAPEL 292
GI+HRD+KG+N+L+D G +KI+DFG+ AN S N RP S ++++ APE
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP--SLQGSVFWMAPE- 182
Query: 293 LLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352
++ T Y D+WS GCL+ EM G+ P + QL IFK+ + S +
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKIGENASPE-------- 231
Query: 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402
P S ++ L +D R +AA LK+ F
Sbjct: 232 ----IP-----------SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 77/290 (26%), Positives = 133/290 (45%), Gaps = 49/290 (16%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
E + ++ +G+G++ VYKA+D+ T ++VA+K + + +E ++ + +EI L + P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE-DEIEDIQQEIQFLSQCRSP 59
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQ----TDLARIISNPEGKLTEPQ------QLLSGLQ 234
I K G L+++ E+ DL + GKL E ++L GL+
Sbjct: 60 YITKYYGSFLKG--SKLWIIMEYCGGGSCLDLLK-----PGKLDETYIAFILREVLLGLE 112
Query: 235 HCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLL 294
+ H+ G +HRD+K +N+L+ + G +K+ADFG++ + + T V T ++ APE++
Sbjct: 113 YLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF-VGTPFWMAPEVIK 171
Query: 295 GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDY--WKKLRLS 352
+ Y D+WS G E+ G P P D + L L
Sbjct: 172 Q-SGYDEKADIWSLGITAIELAKGEP--------------------PLSDLHPMRVLFLI 210
Query: 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402
PP + + F +F +S L DP R SA LK++F
Sbjct: 211 PKNNPPSLEGNKFSKPFKDF-------VSLCLNKDPKERPSAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 1e-30
Identities = 69/207 (33%), Positives = 98/207 (47%), Gaps = 30/207 (14%)
Query: 129 KIDKVGQGTYSNVYKA----LDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
K+G+G + VYK VA+K +K D SE +F+ RE I++KLDHP
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFL-REARIMRKLDHP 61
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLLS-------GLQHC 236
NIVKL G+ T + L +V E+M DL + K LLS G+++
Sbjct: 62 NIVKLLGVCTE--EEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLA-------NYFSPNKKRPLTSRVVTLWYRA 289
+ +HRD+ N L+ +N V+KI+DFGL+ Y K P+ W A
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR------WM-A 172
Query: 290 PELLLGATDYGVGIDLWSAGCLLAEMF 316
PE L + D+WS G LL E+F
Sbjct: 173 PESLKEGK-FTSKSDVWSFGVLLWEIF 198
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 25/220 (11%)
Query: 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQK 180
P ++ ++ +G+GTY VYKA + TG++VA+K + E +K E IL+K
Sbjct: 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIK---EEYNILRK 58
Query: 181 L-DHPNIVKLEGLATSR----MQYSLYLVFEFMQ----TDLARIISNPEGKLTEPQ---- 227
+HPNI G + L+LV E TDL + + +L E
Sbjct: 59 YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118
Query: 228 --QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGL-ANYFSPNKKRPLTSRVVT 284
+ L GL + H+ ++HRD+KG N+L+ KN +K+ DFG+ A S +R + + T
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR--NTFIGT 176
Query: 285 LWYRAPELLLG----ATDYGVGIDLWSAGCLLAEMFLGRP 320
++ APE++ Y D+WS G E+ G+P
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 27/207 (13%)
Query: 131 DKVGQGTYSNVYKA--LDRDTGKI-VALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIV 187
K+G+G + VYK +D VA+K +K D SE F+ +E +++KL HPN+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFL-KEARVMKKLGHPNVV 59
Query: 188 KLEGLATSRMQYSLYLVFEFM-QTDL--------ARIISNPEGKLTEPQQLLS------- 231
+L G+ T LYLV E+M DL S + L+ + LLS
Sbjct: 60 RLLGVCTEEE--PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLS-LKDLLSFAIQIAK 116
Query: 232 GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA-NYFSPNKKRPLTSRVVTL-WYRA 289
G+++ + +HRD+ N L+ ++ V+KI+DFGL+ + + + R T + + W A
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM-A 175
Query: 290 PELLLGATDYGVGIDLWSAGCLLAEMF 316
PE L + D+WS G LL E+F
Sbjct: 176 PESLKDGI-FTSKSDVWSFGVLLWEIF 201
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 80/289 (27%), Positives = 126/289 (43%), Gaps = 55/289 (19%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKK-VKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEG 191
+G+G + V RDT K+ A+K K E SV+ + E ILQ+L+HP +V
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVN--- 64
Query: 192 LATSRMQYS------LYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCHD 238
+ YS +YLV + + DL +S + K +E Q +++ L++ H
Sbjct: 65 -----LWYSFQDEENMYLVVDLLLGGDLRYHLSQ-KVKFSEEQVKFWICEIVLALEYLHS 118
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATD 298
+GI+HRD+K N+L+D+ G + I DF +A +P+ TS T Y APE+L
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPEVLCRQ-G 175
Query: 299 YGVGIDLWSAGCLLAEMFLGRPIMPG--RTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356
Y V +D WS G E G+ G RT +Q+ + + Y
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE---TADVLYP---------- 222
Query: 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR-GSAASALKNEFFF 404
+ + ++ ++ LL DP R G LKN +F
Sbjct: 223 -------------ATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 5e-30
Identities = 71/225 (31%), Positives = 111/225 (49%), Gaps = 23/225 (10%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHS---VKFMAREIMILQKLDHPNIVKL 189
+GQG + VY D DTG+ +A+K+V FD P + V + EI +L+ L H IV+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 190 EGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILH 243
G +L + E+M + G LTE +Q+L G+++ H I+H
Sbjct: 70 YGCLRDDE--TLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYF-----SPNKKRPLTSRVVTLWYRAPELLLGATD 298
RD+KG+N+L D G +K+ DFG + S + +T T ++ +PE++ G
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG---TPYWMSPEVISGEG- 183
Query: 299 YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSE 343
YG D+WS GC + EM +P E E + IFK+ P+
Sbjct: 184 YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN 225
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 92/293 (31%), Positives = 133/293 (45%), Gaps = 52/293 (17%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKF-DTSEPHSVKFMAREIMILQKLDHPNIVKL-E 190
+ +G Y V+ A + TG I A+K +K D + V + E IL + P +VKL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 191 GLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEP------QQLLSGLQHCHDRGILH 243
+ +LYLV E++ DLA ++ N G L E +++ L++ H GI+H
Sbjct: 61 SFQGKK---NLYLVMEYLPGGDLASLLEN-VGSLDEDVARIYIAEIVLALEYLHSNGIIH 116
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANY------FSPNKKRPLTSRVV-TLWYRAPELLLGA 296
RD+K N+LID NG LK+ DFGL+ + N R+V T Y APE++LG
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG- 175
Query: 297 TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFK--LCGSPSEDYWKKLRLSTT 354
+ +D WS GC+L E +G P G T E IF+ L G
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE----IFQNILNGK-------------- 217
Query: 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASA--LKNEFFFT 405
P+ E + ++ L+S LL DP R A S +KN FF
Sbjct: 218 IEWPE---------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 75/228 (32%), Positives = 124/228 (54%), Gaps = 22/228 (9%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKF---DTSEPHSV-KFMAREIMILQKLDHPNIVK 188
+G G +S+ Y+A D TG ++A+K+V + +SE V + + +EI ++ +L+HP+I++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 189 LEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEP------QQLLSGLQHCHDRGI 241
+ G ++L++ E+M ++ ++S G E +QLL GL + H+ I
Sbjct: 68 MLGATCEDSHFNLFV--EWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 242 LHRDVKGSNLLIDKNG-VLKIADFGLANYFSPNKKRP--LTSRVV-TLWYRAPELLLGAT 297
+HRDVKG+NLLID G L+IADFG A + +++ T+ + APE+L G
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-E 183
Query: 298 DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLC---GSPS 342
YG D+WS GC++ EM +P L IFK+ +PS
Sbjct: 184 QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 129 KIDKVGQGTYSNVYKA----LDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
I ++G+G + V L +TG+ VA+K + E H F REI IL+ LDH
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDF-EREIEILRTLDHE 66
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTDLARI-ISNPEGKLTEPQQLLSGLQHC------H 237
NIVK +G+ SL L+ E++ + R + ++ + LL Q C
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR----VVTLWYRAPELL 293
+ +HRD+ N+L++ ++KI+DFGLA P K + WY APE L
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAK-VLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 294 LGATDYGVGIDLWSAGCLLAEMF-LGRP 320
+ D+WS G L E+F G P
Sbjct: 185 RTSKFSSAS-DVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 41/286 (14%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH--- 183
Y +++ +G+G Y VY+ TG++VALK + DT + V + RE+ +L +L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD-DDVSDIQREVALLSQLRQSQP 61
Query: 184 PNIVKLEGLATSRMQ-YSLYLVFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHC 236
PNI K G S ++ L+++ E+ + R + G + E +++L L++
Sbjct: 62 PNITKYYG---SYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYI 117
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGA 296
H G++HRD+K +N+L+ G +K+ DFG+A + N + T V T ++ APE++
Sbjct: 118 HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF-VGTPYWMAPEVITEG 176
Query: 297 TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356
Y D+WS G + EM G P R L
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSD----VDAFRAMMLI------------------ 214
Query: 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402
P+S PRL + + + + ++ L +P R SA LK+++
Sbjct: 215 -PKSKPPRLED--NGYSKLLREFVAACLDEEPKERLSAEELLKSKW 257
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 32/212 (15%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKF-DTSEPHSVKFMAREIMILQKLDH 183
+ ++ I +G G++ V + +GK ALK + + V+ + E ILQ + H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 184 PNIVKLEGLATSRMQYSLYLVFEF-----MQTDLARIISNPEGKLTEPQ------QLLSG 232
P +V L G + + +LYLV E+ + + L + G+ EP Q++
Sbjct: 61 PFLVNLYG--SFQDDSNLYLVMEYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLA 113
Query: 233 LQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLW----YR 288
L++ H I++RD+K NLL+D +G +KI DFG A KR + R TL Y
Sbjct: 114 LEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFA-------KR-VKGRTYTLCGTPEYL 165
Query: 289 APELLLGATDYGVGIDLWSAGCLLAEMFLGRP 320
APE++L YG +D W+ G L+ EM G P
Sbjct: 166 APEIILS-KGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 81/234 (34%), Positives = 123/234 (52%), Gaps = 19/234 (8%)
Query: 132 KVGQGTYSNVYKALDRDTGKIVALKKVK-FDTSEPHSVKFMAREIMILQKLDHPNIVKLE 190
K+G+G +S VY+A G VALKKV+ FD + + +EI +L++L+HPN++K
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 191 GLATSRMQYSLYLVFEFMQT-DLARIISN-PEGKLTEPQ--------QLLSGLQHCHDRG 240
A+ L +V E DL+R+I + + K P+ QL S L+H H R
Sbjct: 69 --ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126
Query: 241 ILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYG 300
++HRD+K +N+ I GV+K+ D GL +FS +K S V T +Y +PE + Y
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPE-RIHENGYN 184
Query: 301 VGIDLWSAGCLLAEM-FLGRPIMPGRTEVEQLHRIFKLCGS---PSEDYWKKLR 350
D+WS GCLL EM L P + + L + + C PS+ Y ++LR
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 87/287 (30%), Positives = 133/287 (46%), Gaps = 44/287 (15%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
I ++G G + VYKA ++TG A K ++ ++ E FM EI IL + HPNIV L
Sbjct: 10 IGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELE-DFMV-EIDILSECKHPNIVGL 67
Query: 190 EGLATSRMQYSLYLVFEFMQTD-LARIISNPEGKLTEPQ------QLLSGLQHCHDRGIL 242
+ L+++ EF L I+ E LTEPQ Q+L L H ++
Sbjct: 68 --YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVI 125
Query: 243 HRDVKGSNLLIDKNGVLKIADFGL-ANYFSPNKKRPLTSRVVTLWYRAPELLLGATD--- 298
HRD+K N+L+ +G +K+ADFG+ A S +KR + + T ++ APE++ T
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTPYWMAPEVVACETFKDN 183
Query: 299 -YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357
Y D+WS G L E+ P P E+ + + K+ S P
Sbjct: 184 PYDYKADIWSLGITLIELAQMEP--P-HHELNPMRVLLKILKSE---------------P 225
Query: 358 PQSYKPRLFEA-FSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
P +P + + F++F L + L DP R +AA LK+ F
Sbjct: 226 PTLDQPSKWSSSFNDF-------LKSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 78/289 (26%), Positives = 132/289 (45%), Gaps = 45/289 (15%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
D K+G+G+ V A D+ TG+ VA+KK+ + + F E++I++ HP
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF--NEVVIMRDYQHP 76
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCH 237
NIV++ + + L++V EF++ L I++ ++ E Q +L L H
Sbjct: 77 NIVEMYS--SYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLAVLKALSFLH 132
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS---PNKKRPLTSRVVTLWYRAPELLL 294
+G++HRD+K ++L+ +G +K++DFG S P +K S V T ++ APE ++
Sbjct: 133 AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK----SLVGTPYWMAPE-VI 187
Query: 295 GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354
YG +D+WS G ++ EM G P ++ + RI + L
Sbjct: 188 SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI-------------RDNLPPK 234
Query: 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
+ PRL L +L DPA R +AA L + F
Sbjct: 235 LKNLHKVSPRL-----------RSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 70/216 (32%), Positives = 107/216 (49%), Gaps = 18/216 (8%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
+ K+G+G+Y +VYK + ALK+V + + EI IL ++HPNI+
Sbjct: 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISY 64
Query: 190 -EGLATSRMQYSLYLVFEFMQ-TDLARIISNPE--GKLTEPQ-------QLLSGLQHCHD 238
E L +V E+ DL++ IS + KL Q QLL GLQ H+
Sbjct: 65 KEAFLDGN---KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATD 298
+ ILHRD+K +N+L+ N ++KI D G++ KK +++ T Y APE+ G
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEVWKG-RP 177
Query: 299 YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRI 334
Y D+WS GCLL EM P R+ + +++
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 81/289 (28%), Positives = 122/289 (42%), Gaps = 45/289 (15%)
Query: 128 DKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIV 187
+ + ++G G V K L R TGKI+A+K ++ + K + RE+ IL K + P IV
Sbjct: 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSPYIV 62
Query: 188 KLEGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQ------QLLSGLQHCH-DR 239
G + + E+M L +I+ +G++ E +L GL + H
Sbjct: 63 GFYG--AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDY 299
I+HRDVK SN+L++ G +K+ DFG++ + + + V T Y APE + G DY
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK---TFVGTSSYMAPERIQG-NDY 176
Query: 300 GVGIDLWSAGCLLAEMFLGR-----PIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354
V D+WS G L E+ GR P E L I
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------------ 218
Query: 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
PP PRL +F ++ L DP R S L++ F
Sbjct: 219 -EPP----PRL--PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 8e-27
Identities = 75/248 (30%), Positives = 118/248 (47%), Gaps = 27/248 (10%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHS---VKFMAREIMILQKLDHPNIVKL 189
+GQG + VY D DTG+ +A+K+V+FD P + V + EI +L+ L H IV+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 190 EGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILH 243
G M+ +L + E M + G LTE +Q+L G+ + H I+H
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVH 129
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYFSPN--KKRPLTSRVVTLWYRAPELLLGATDYGV 301
RD+KG+N+L D G +K+ DFG + + S T ++ +PE++ G YG
Sbjct: 130 RDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG-EGYGR 188
Query: 302 GIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPS------------EDYWKKL 349
D+WS GC + EM +P E E + IFK+ P+ D+ K++
Sbjct: 189 KADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRI 245
Query: 350 RLSTTFRP 357
+ RP
Sbjct: 246 FVEAKLRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 90/292 (30%), Positives = 135/292 (46%), Gaps = 41/292 (14%)
Query: 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQK 180
KS ++++++G G VYK + R TG++ ALK V + E + + REI IL+
Sbjct: 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALK-VIYGNHEDTVRRQICREIEILRD 128
Query: 181 LDHPNIVKLEGLATSRMQYSLYLVFEFM---QTDLARIISNPEGKLTE-PQQLLSGLQHC 236
++HPN+VK + + + ++ EFM + I E L + +Q+LSG+ +
Sbjct: 129 VNHPNVVKCHDMFDHNGE--IQVLLEFMDGGSLEGTHI--ADEQFLADVARQILSGIAYL 184
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPE----- 291
H R I+HRD+K SNLLI+ +KIADFG++ + P S V T+ Y +PE
Sbjct: 185 HRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSSVGTIAYMSPERINTD 243
Query: 292 LLLGATDYGVGIDLWSAGCLLAEMFLGR-PIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350
L GA D G D+WS G + E +LGR P GR + W L
Sbjct: 244 LNHGAYD-GYAGDIWSLGVSILEFYLGRFPFGVGR-----------------QGDWASLM 285
Query: 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402
+ P F F +S L +PA R SA L++ F
Sbjct: 286 CAICMSQPPEAPATASREFRHF-------ISCCLQREPAKRWSAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 82/249 (32%), Positives = 128/249 (51%), Gaps = 21/249 (8%)
Query: 132 KVGQGTYSNVYKALDRDTGKIVALKKVK-FDTSEPHSVKFMAREIMILQKLDHPNIVKLE 190
K+G+G +S VY+A K VALKKV+ F+ + + + +EI +L++L+HPN++K
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY- 67
Query: 191 GLATSRMQYSLYLVFEFMQT-DLARIISN-PEGKLTEPQ--------QLLSGLQHCHDRG 240
L + L +V E DL+++I + K P+ QL S ++H H R
Sbjct: 68 -LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126
Query: 241 ILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYG 300
++HRD+K +N+ I GV+K+ D GL +FS +K S V T +Y +PE + Y
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPE-RIHENGYN 184
Query: 301 VGIDLWSAGCLLAEM-FLGRPIMPGRTEVEQLHRIFKLCGS---PSEDYWKKLR--LSTT 354
D+WS GCLL EM L P + + L + + C P+E Y +KLR +S
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMC 244
Query: 355 FRPPQSYKP 363
P +P
Sbjct: 245 IYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 73/224 (32%), Positives = 113/224 (50%), Gaps = 21/224 (9%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAR---EIMILQKLDHPNIVKL 189
+GQG + VY D DTG+ +A K+V+FD P + K ++ EI +L+ L H IV+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 190 EGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILH 243
G R + +L + E+M + G LTE +Q+L G+ + H I+H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYF-----SPNKKRPLTSRVVTLWYRAPELLLGATD 298
RD+KG+N+L D G +K+ DFG + S R +T T ++ +PE++ G
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG---TPYWMSPEVISG-EG 185
Query: 299 YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPS 342
YG D+WS GC + EM +P E E + IFK+ P+
Sbjct: 186 YGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPT 226
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 77/254 (30%), Positives = 109/254 (42%), Gaps = 56/254 (22%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDT-SEPHSVKFMA-REIMILQKL 181
+ ++ I +G+G + V+ D+DTG++ A+K + K D A R+I+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILA--DA 58
Query: 182 DHPNIVKLEGLATSRMQYS------LYLVFEFMQT-DLARIISNPEGKLTEPQ------Q 228
D P IVKL YS LYLV E+M DL ++ + E +
Sbjct: 59 DSPWIVKL--------YYSFQDEEHLYLVMEYMPGGDLMNLLIR-KDVFPEETARFYIAE 109
Query: 229 LLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLT--------- 279
L+ L H G +HRD+K N+LID +G +K+ADFGL + K R
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 280 -------------------SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRP 320
S V T Y APE+L G T YG+ D WS G +L EM G P
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFP 228
Query: 321 IMPGRTEVEQLHRI 334
T E ++I
Sbjct: 229 PFYSDTLQETYNKI 242
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 64/198 (32%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y+ I K+G+G++ +Y A + + +K++ + +E+++L K+ HPNI
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 187 VKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLLS-------GLQHCHD 238
V A+ + L++V E+ DL + I+ G L Q+LS GL+H HD
Sbjct: 62 VTF--FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 239 RGILHRDVKGSNLLIDKNG-VLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGAT 297
R ILHRD+K N+ + KNG V K+ DFG+A + + + T V T +Y +PE+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC-VGTPYYLSPEICQNRP 178
Query: 298 DYGVGIDLWSAGCLLAEM 315
Y D+WS GC+L E+
Sbjct: 179 -YNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 20/199 (10%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVK----FDTSEPHSVKFMAREIMILQKLDHPNIVK 188
+G G + V + + ALK VK +T + + E IL++ +HP IVK
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIF---SEKEILEECNHPFIVK 57
Query: 189 LEGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQ------QLLSGLQHCHDRGI 241
L T + + +Y++ E+ +L I+ + G E ++ ++ H+RGI
Sbjct: 58 L--YRTFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGI 114
Query: 242 LHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGV 301
++RD+K NLL+D NG +K+ DFG A + ++ T T Y APE++L Y
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLK-SGQKTWTF-CGTPEYVAPEIILN-KGYDF 171
Query: 302 GIDLWSAGCLLAEMFLGRP 320
+D WS G LL E+ GRP
Sbjct: 172 SVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 78/289 (26%), Positives = 136/289 (47%), Gaps = 36/289 (12%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y + +K+GQG VY A+D TG+ VA+K++ +P + + EI+++++ HPNI
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKK-ELIINEILVMRENKHPNI 78
Query: 187 VKLEGLATSRMQYSLYLVFEFMQ----TDLARIISNPEGKLTEP-QQLLSGLQHCHDRGI 241
V L + + L++V E++ TD+ EG++ ++ L L+ H +
Sbjct: 79 VNY--LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 136
Query: 242 LHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGV 301
+HRD+K N+L+ +G +K+ DFG +P + + ++ V T ++ APE++ YG
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVT-RKAYGP 194
Query: 302 GIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSY 361
+D+WS G + EM G P + L+ I +T P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-----------------ATNGTPELQN 237
Query: 362 KPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF-FTSPLA 409
+L F +F L+ L +D RGSA L++ F PL+
Sbjct: 238 PEKLSAIFRDF-------LNRCLEMDVEKRGSAKELLQHPFLKIAKPLS 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 84/286 (29%), Positives = 126/286 (44%), Gaps = 36/286 (12%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP-HSVKFMAREIMILQKLDHPN 185
+ + +VGQG Y V+ A +DTG+IVALK++K + V+ + E IL
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 186 IVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHDR 239
+VKL L + LYL E++ R + N G L+E ++ + H+
Sbjct: 63 LVKL--LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDY 299
G +HRD+K N LID +G +K+ DFGL+ S V + Y APE+L G Y
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN----SVVGSPDYMAPEVLRG-KGY 175
Query: 300 GVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL-RLSTTFRPP 358
+D WS GC+L E G P GS + W+ L T + P
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFP---------------PFSGSTPNETWENLKYWKETLQRP 220
Query: 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404
PR + + L++ L+ DP+ R + +KN FF
Sbjct: 221 VYDDPR-----FNLSDEAWDLITKLIN-DPSRRFGSLEDIKNHPFF 260
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
+ ++G+G +V K ++TG I ALK + D + P K + RE+ I + P IVK
Sbjct: 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKY 64
Query: 190 EGLATSRMQYSLYLVFEFMQ------------TDLARIISNPEGKLTEPQQLLSGLQHCH 237
G S+ + E+ + RI GK+ E +L GL + H
Sbjct: 65 YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAE--SVLKGLSYLH 122
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGAT 297
R I+HRD+K SN+L+ + G +K+ DFG++ + T T +Y APE + G
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG---TSFYMAPERIQGKP 179
Query: 298 DYGVGIDLWSAGCLLAEMFLGR-PIMP 323
Y + D+WS G L E+ R P P
Sbjct: 180 -YSITSDVWSLGLTLLEVAQNRFPFPP 205
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 71/201 (35%), Positives = 103/201 (51%), Gaps = 20/201 (9%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVK--FMAREIMILQKLDHPNI 186
+ + +G + +VY A R TG A+K + K D + V R IM++Q + P +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQG-ESPYV 59
Query: 187 VKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEP------QQLLSGLQHCHDR 239
KL + + + LYLV E++ D A +I G L E +++ G++ H R
Sbjct: 60 AKL--YYSFQSKDYLYLVMEYLNGGDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQR 116
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDY 299
GI+HRD+K NLLID+ G LK+ DFGL+ NKK V T Y APE +LG D
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-----FVGTPDYLAPETILGVGDD 171
Query: 300 GVGIDLWSAGCLLAEMFLGRP 320
+ D WS GC++ E G P
Sbjct: 172 KMS-DWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 24/208 (11%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKF-DTSEPHSVKFMAREIMILQKLDH 183
+ ++I VG GT+ V+ DR + ALK + + + + E +L+++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 184 PNIVKLEGLATSRMQYSLYLVFEF-----MQTDL--ARIISNPEGKLTEPQQLLSGLQHC 236
P I++L T Q LY++ E+ + + L + SN G L +++ L++
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTG-LFYASEIVCALEYL 117
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLW----YRAPEL 292
H + I++RD+K N+L+DK G +K+ DFG A KK L R TL Y APE
Sbjct: 118 HSKEIVYRDLKPENILLDKEGHIKLTDFGFA------KK--LRDRTWTLCGTPEYLAPE- 168
Query: 293 LLGATDYGVGIDLWSAGCLLAEMFLGRP 320
++ + + +D W+ G L+ EM +G P
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 58/197 (29%), Positives = 101/197 (51%), Gaps = 12/197 (6%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y K+ K+G+G++ ++ GK +K++ P + +E+ +L + HPNI
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 187 VKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLLS-------GLQHCHD 238
V+ + + +LY+V ++ + DL + I+ G L Q+L L+H HD
Sbjct: 62 VQYQ--ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATD 298
R ILHRD+K N+ + K+G +K+ DFG+A + + T + T +Y +PE+
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC-IGTPYYLSPEICENRP- 177
Query: 299 YGVGIDLWSAGCLLAEM 315
Y D+W+ GC+L EM
Sbjct: 178 YNNKSDIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 73/258 (28%), Positives = 119/258 (46%), Gaps = 33/258 (12%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHS---VKFMAREIMILQKLDHPNIVKL 189
+G+G + VY D DTG+ +A+K+V FD + V + EI +L+ L H IV+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 190 EGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILH 243
G + L + E+M + G LTE +Q+L G+ + H I+H
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVH 129
Query: 244 RDVKGSNLLIDKNGVLKIADFGLAN-----YFSPNKKRPLTSRVVTLWYRAPELLLGATD 298
RD+KG+N+L D G +K+ DFG + S + +T T ++ +PE++ G
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG---TPYWMSPEVISG-EG 185
Query: 299 YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSE------------DYW 346
YG D+WS C + EM +P E E + IFK+ P++ D+
Sbjct: 186 YGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPMLPDGVSDACRDFL 242
Query: 347 KKLRLSTTFRPPQSYKPR 364
K++ + RP + R
Sbjct: 243 KQIFVEEKRRPTAEFLLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 2e-23
Identities = 78/285 (27%), Positives = 139/285 (48%), Gaps = 43/285 (15%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSV----KFMAREIMILQKLDHPNIVK 188
+G+G Y VY L + G+++A+K+V+ DTS + + + E+ +L+ L H NIV+
Sbjct: 8 LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 189 LEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHCHDRGIL 242
L T ++ + EF+ I N G L EP +Q+L G+ + H+ ++
Sbjct: 67 Y--LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 243 HRDVKGSNLLIDKNGVLKIADFGLANYF-----SPNKKRPLTSRVVTLWYRAPELLLGAT 297
HRD+KG+N+++ NG++K+ DFG A L S T ++ APE ++ +
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE-VINES 183
Query: 298 DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357
YG D+WS GC + EM G+P + +++L +F +
Sbjct: 184 GYGRKSDIWSIGCTVFEMATGKPPL---ASMDRLAAMFYIGAH----------------- 223
Query: 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402
+ PRL ++FS +++ +++ L D R SA L+++F
Sbjct: 224 -RGLMPRLPDSFS---AAAIDFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 3e-23
Identities = 66/207 (31%), Positives = 113/207 (54%), Gaps = 15/207 (7%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
E ++ I ++G GTY +VYKA + +TG++ A+K +K + E +V + +EI++++ H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV--VQQEIIMMKDCKHS 66
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHD 238
NIV G R + L++ EF + I + G L+E Q + L GL + H
Sbjct: 67 NIVAYFGSYLRRDK--LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS 124
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN-KKRPLTSRVVTLWYRAPEL--LLG 295
+G +HRD+KG+N+L+ NG +K+ADFG++ + KR S + T ++ APE+ +
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR--KSFIGTPYWMAPEVAAVER 182
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIM 322
Y D+W+ G E+ +P M
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-23
Identities = 83/303 (27%), Positives = 141/303 (46%), Gaps = 52/303 (17%)
Query: 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVK--FDTSEPHSVKFMAREIMIL 178
P +++++ I+ +G+GTY V+K L++ G A+K + D E + E IL
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE-----IEAEYNIL 68
Query: 179 QKL-DHPNIVKLEGLATSRMQYS---LYLVFEFMQ----TDLARIISNPEGKLTEP---- 226
+ L DHPN+VK G+ + + L+LV E TDL + ++ EP
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY 128
Query: 227 --QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVT 284
+ L GLQH H +HRDVKG+N+L+ G +K+ DFG++ + + R TS V T
Sbjct: 129 ILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGT 187
Query: 285 LWYRAPELLLGA----TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGS 340
++ APE++ + Y D+WS G E+ G P + ++ + +FK+ +
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFKIPRN 244
Query: 341 PSEDYWKKLRLSTTFRPPQSYKPRLFEA-FSEFPESSLGLLSTLLALDPAYRGSAASALK 399
P PP ++P L+ F++F + L D R + + L+
Sbjct: 245 P---------------PPTLHQPELWSNEFNDF-------IRKCLTKDYEKRPTVSDLLQ 282
Query: 400 NEF 402
+ F
Sbjct: 283 HVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 4e-23
Identities = 83/300 (27%), Positives = 141/300 (47%), Gaps = 39/300 (13%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ Y + +K+GQG VY A+D TG+ VA+K++ +P + + EI+++++ +P
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ-QQPKK-ELIINEILVMRENKNP 76
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQ----TDLARIISNPEGKLTEP-QQLLSGLQHCHDR 239
NIV L + + L++V E++ TD+ EG++ ++ L L H
Sbjct: 77 NIVNY--LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSN 134
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDY 299
++HRD+K N+L+ +G +K+ DFG +P + + ++ V T ++ APE++ Y
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKA-Y 192
Query: 300 GVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQ 359
G +D+WS G + EM G P + L+ I +T P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-----------------ATNGTPEL 235
Query: 360 SYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDLSGL-PVI 418
RL F +F L+ L +D RGSA L++ F LA LS L P+I
Sbjct: 236 QNPERLSAVFRDF-------LNRCLEMDVDRRGSAKELLQHPFL---KLAKPLSSLTPLI 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 5e-23
Identities = 77/246 (31%), Positives = 121/246 (49%), Gaps = 25/246 (10%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
E ++ I ++G G + VYKA +++TG + A K + DT ++ EI IL DHP
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVI--DTKSEEELEDYMVEIDILASCDHP 62
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTD-LARIISNPEGKLTEPQ------QLLSGLQHCH 237
NIVKL L + +L+++ EF + ++ E LTEPQ Q L L + H
Sbjct: 63 NIVKL--LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR---VVTLWYRAPELLL 294
+ I+HRD+K N+L +G +K+ADFG+ S R + R + T ++ APE+++
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGV----SAKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 295 GATD----YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350
T Y D+WS G L EM I P E+ + + K+ S + R
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEM---AQIEPPHHELNPMRVLLKIAKSEPPTLAQPSR 233
Query: 351 LSTTFR 356
S+ F+
Sbjct: 234 WSSEFK 239
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 8e-23
Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 14/198 (7%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGL 192
+G+GTY VY A D T +A+K++ S V+ + EI + L H NIV+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIVQYLGS 73
Query: 193 ATSRMQYSLYL-------VFEFMQTDLARIISNPEGKLTEPQQLLSGLQHCHDRGILHRD 245
+ + +++ + +++ + N + + +Q+L GL++ HD I+HRD
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRD 133
Query: 246 VKGSNLLIDK-NGVLKIADFGLANYFSPNKKRPLTSRVV-TLWYRAPELL-LGATDYGVG 302
+KG N+L++ +GV+KI+DFG + + P T TL Y APE++ G YG
Sbjct: 134 IKGDNVLVNTYSGVVKISDFGTSKRLA--GINPCTETFTGTLQYMAPEVIDKGPRGYGAP 191
Query: 303 IDLWSAGCLLAEMFLGRP 320
D+WS GC + EM G+P
Sbjct: 192 ADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 2e-22
Identities = 76/291 (26%), Positives = 138/291 (47%), Gaps = 36/291 (12%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ Y + +K+GQG VY A+D TG+ VA++++ +P + + EI+++++ +P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKK-ELIINEILVMRENKNP 77
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQ----TDLARIISNPEGKLTEP-QQLLSGLQHCHDR 239
NIV L + + L++V E++ TD+ EG++ ++ L L+ H
Sbjct: 78 NIVNY--LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDY 299
++HRD+K N+L+ +G +K+ DFG +P + + ++ V T ++ APE++ Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKA-Y 193
Query: 300 GVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQ 359
G +D+WS G + EM G P + L+ I +T P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-----------------ATNGTPEL 236
Query: 360 SYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF-FTSPLA 409
+L F +F L+ L +D RGSA L+++F PL+
Sbjct: 237 QNPEKLSAIFRDF-------LNRCLDMDVEKRGSAKELLQHQFLKIAKPLS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 5e-22
Identities = 67/207 (32%), Positives = 112/207 (54%), Gaps = 15/207 (7%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
Y+ I +VG GTY +VYKA + TG++ A+K +K + + S+ + +EI ++++ H
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL--IQQEIFMVKECKHC 66
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHD 238
NIV G SR + L++ E+ + I + G L+E Q + L GL + H
Sbjct: 67 NIVAYFGSYLSREK--LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS 124
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN-KKRPLTSRVVTLWYRAPELLLGAT 297
+G +HRD+KG+N+L+ NG +K+ADFG+A + KR S + T ++ APE+
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR--KSFIGTPYWMAPEVAAVEK 182
Query: 298 DYGVG--IDLWSAGCLLAEMFLGRPIM 322
+ G D+W+ G E+ +P M
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 7e-22
Identities = 76/248 (30%), Positives = 115/248 (46%), Gaps = 34/248 (13%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
ES K+G G + V+ T K VA+K +K T P + +E I++KL H
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEA---FLQEAQIMKKLRHD 61
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGK-LTEPQ------QLLSGLQHC 236
+V+L + + +Y+V E+M L + + EGK L PQ Q+ G+ +
Sbjct: 62 KLVQLYAVCSEEE--PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL 119
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGA 296
R +HRD+ N+L+ +N V KIADFGLA ++ + + APE A
Sbjct: 120 ESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPE----A 175
Query: 297 TDYG---VGIDLWSAGCLLAEMF-LGRPIMPGRT------EVEQLHRIFKLCGSPSEDY- 345
+YG + D+WS G LL E+ GR PG T +VE+ +R+ + P E Y
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYD 235
Query: 346 -----WKK 348
W K
Sbjct: 236 LMLQCWDK 243
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 8e-22
Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 24/218 (11%)
Query: 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLE 190
+K+G+G + +VYK + + + VA+K + KF+ +E IL++ DHPNIVKL
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFL-QEAEILKQYDHPNIVKLI 58
Query: 191 GLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQL------LSGLQHCHDRGILH 243
G+ + +Y+V E + L + + +LT + L +G+++ + +H
Sbjct: 59 GVCVQK--QPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIH 116
Query: 244 RDVKGSNLLIDKNGVLKIADFGLAN------YFSPNKKRPLTSRVVTLWYRAPELLLGAT 297
RD+ N L+ +N VLKI+DFG++ Y + + + + + APE L
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ-----IPIKWTAPE-ALNYG 170
Query: 298 DYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
Y D+WS G LL E F LG PG + + RI
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI 208
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 9e-22
Identities = 68/206 (33%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFD-TSEPHSVKFMAREIMILQKLDHPNIVKLEG 191
VG+G + V ++ TG I A+K +K +V F E IL + P I +L
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL-- 66
Query: 192 LATSRMQY------SLYLVFEFMQT-DLARIISNPEGKLTEP------QQLLSGLQHCHD 238
QY +LYLV E+ DL +++ E + E +L+ + H
Sbjct: 67 ------QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLL---- 294
G +HRD+K N+LID+ G +K+ADFG A + NK V T Y APE+L
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180
Query: 295 -GATDYGVGIDLWSAGCLLAEMFLGR 319
G YGV D WS G + EM GR
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 9e-22
Identities = 74/284 (26%), Positives = 141/284 (49%), Gaps = 38/284 (13%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
E + K++++G+G++ V+K +D T ++VA+K + + +E ++ + +EI +L + D P
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSP 62
Query: 185 NIVKLEGLATSRMQYS-LYLVFEFM----QTDLARIISNPEGKL-TEPQQLLSGLQHCHD 238
+ K G S ++ + L+++ E++ DL R E ++ T +++L GL + H
Sbjct: 63 YVTKYYG---SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATD 298
+HRD+K +N+L+ + G +K+ADFG+A + + + T V T ++ APE++ +
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIQQSA- 177
Query: 299 YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358
Y D+WS G E+ G P P+ D + F P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP--------------------PNSDMHP---MRVLFLIP 214
Query: 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402
++ P L EF + + L DP++R +A LK++F
Sbjct: 215 KNNPPTL---TGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 2e-21
Identities = 82/311 (26%), Positives = 148/311 (47%), Gaps = 38/311 (12%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ Y + +K+GQG V+ A+D TG+ VA+K++ +P + + EI+++++L +P
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ-KQPKK-ELIINEILVMKELKNP 76
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQ----TDLARIISNPEGKLTEP-QQLLSGLQHCHDR 239
NIV L + + L++V E++ TD+ E ++ ++ L L+ H
Sbjct: 77 NIVNF--LDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN 134
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDY 299
++HRD+K N+L+ +G +K+ DFG +P + + ++ V T ++ APE++ Y
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKA-Y 192
Query: 300 GVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQ 359
G +D+WS G + EM G P + L+ I G+P + P+
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPE------------LQNPE 239
Query: 360 SYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDLSGLPVIY 419
P +F F L+ L +D RGSA L++ F LA LS L +
Sbjct: 240 KLSP-IFRDF----------LNRCLEMDVEKRGSAKELLQHPFL---KLAKPLSSLTPLI 285
Query: 420 DKEDELIEANQ 430
E +++N+
Sbjct: 286 LAAKEAMKSNR 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 71/243 (29%), Positives = 118/243 (48%), Gaps = 29/243 (11%)
Query: 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVK--FDTSEPHSVKFMAREIMI 177
+ ++++ I+ +G+GTY VYK ++ G + A+K + D E + E I
Sbjct: 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEE-----IEAEYNI 71
Query: 178 LQKL-DHPNIVKLEGLATSRMQYS---LYLVFEFMQ----TDLARIISNPEGKLTEPQ-- 227
LQ L +HPN+VK G+ + L+LV E T+L + + +L E
Sbjct: 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131
Query: 228 ----QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV 283
L GLQH H+ I+HRDVKG+N+L+ G +K+ DFG++ + + R TS V
Sbjct: 132 YILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VG 190
Query: 284 TLWYRAPELLLGATDYGVG----IDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCG 339
T ++ APE++ Y D+WS G E+ G P + ++ + +FK+
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL---FDMHPVKTLFKIPR 247
Query: 340 SPS 342
+P
Sbjct: 248 NPP 250
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 83/291 (28%), Positives = 122/291 (41%), Gaps = 49/291 (16%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQKLDHPNIVKLEG 191
+G+G + V + TGK+ A KK+ + + MA E IL+K+ IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 192 LATSRMQYSLYLVFEFMQT-DLARIISN-PEGKLTEPQ------QLLSGLQHCHDRGILH 243
++ L LV M DL I N E E + Q++ GL+H H R I++
Sbjct: 61 AFETKDD--LCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGI 303
RD+K N+L+D +G ++I+D GLA KK + R T Y APE+L G Y +
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEV-YDFSV 175
Query: 304 DLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKP 363
D ++ GC L EM GR SP +K+ + K
Sbjct: 176 DWFALGCTLYEMIAGR--------------------SPFRQRKEKVE-------KEELKR 208
Query: 364 RLFEAFSEFPES----SLGLLSTLLALDPA----YRGSAASALKNEFFFTS 406
R E E+P+ + L LL DP RG +A ++ F
Sbjct: 209 RTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 3e-21
Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
++ ++K+G+G++ V+K + + ++ A+K++ + E +L KLD I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 187 VK-----LEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGK-LTEPQ------QLLSGL 233
++ L+ L +V E+ + DL +++ G+ L E Q Q+L GL
Sbjct: 62 IRYYESFLDK-------GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGL 114
Query: 234 QHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELL 293
H H + ILHRD+K NL +D +KI D G+A S N T V T +Y +PE L
Sbjct: 115 AHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPE-L 172
Query: 294 LGATDYGVGIDLWSAGCLLAEMFLGR 319
Y D+W+ G +L E G+
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 87/291 (29%), Positives = 135/291 (46%), Gaps = 44/291 (15%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
E ++ I ++G G + VYKA +++TG + A K + +T ++ EI IL +HP
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYMVEIEILATCNHP 69
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTD-LARIISNPEGKLTEPQ------QLLSGLQHCH 237
IVKL L L+++ EF + I+ + LTEPQ Q+L LQ+ H
Sbjct: 70 YIVKL--LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH 127
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGL-ANYFSPNKKRPLTSRVVTLWYRAPELLLGA 296
I+HRD+K N+L+ +G +K+ADFG+ A ++R S + T ++ APE+++
Sbjct: 128 SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR--DSFIGTPYWMAPEVVMCE 185
Query: 297 T----DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352
T Y D+WS G L EM I P E+ + + K+ S
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEM---AQIEPPHHELNPMRVLLKIAKS------------ 230
Query: 353 TTFRPPQSYKPRLFEA-FSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402
PP +P + F +F L T L P R SAA L++ F
Sbjct: 231 ---EPPTLSQPSKWSMEFRDF-------LKTALDKHPETRPSAAQLLEHPF 271
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 59/216 (27%), Positives = 107/216 (49%), Gaps = 36/216 (16%)
Query: 126 SYDKIDKVGQGTYSNVYKALDRDTG-KIVALKKV--------KFDTSEPHSVKFMAREIM 176
Y ++ +G G + VYK ++ G ++ALK++ K S+ + E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 177 IL-QKLDHPNIVK-----LEGLATSRMQYSLYLVFEFMQ----TDLARIISNPEGKLTEP 226
I+ ++L HPNIV+ LE LY+V + ++ + + + + TE
Sbjct: 61 IIKEQLRHPNIVRYYKTFLEN-------DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE 113
Query: 227 Q------QLLSGLQHCH-DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLT 279
+ Q++ L++ H ++ I+HRD+ +N+++ ++ + I DFGLA P K LT
Sbjct: 114 RIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LT 171
Query: 280 SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEM 315
S V T+ Y PE++ YG D+W+ GC+L +M
Sbjct: 172 SVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-21
Identities = 75/287 (26%), Positives = 142/287 (49%), Gaps = 40/287 (13%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
E + K++K+G+G++ V+K +D T K+VA+K + + +E ++ + +EI +L + D P
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSP 62
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHD 238
+ K G + L+++ E++ A + P G L E Q ++L GL + H
Sbjct: 63 YVTKYYG--SYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHS 119
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK-KRPLTSRVVTLWYRAPELLLGAT 297
+HRD+K +N+L+ ++G +K+ADFG+A + + KR + V T ++ APE ++ +
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPE-VIKQS 176
Query: 298 DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357
Y D+WS G E+ G P +E+ + +F + P +
Sbjct: 177 AYDSKADIWSLGITAIELAKGE---PPHSELHPMKVLFLI---PKNN------------- 217
Query: 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404
P + + + EF E+ L +P++R +A LK++F
Sbjct: 218 PPTLEGNYSKPLKEFVEACLN-------KEPSFRPTAKELLKHKFIV 257
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-21
Identities = 79/308 (25%), Positives = 141/308 (45%), Gaps = 53/308 (17%)
Query: 112 PREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFM 171
PRE L + K+G+G+ V A ++ TGK VA+KK+ D + + +
Sbjct: 20 PREYLDSFI-----------KIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELL 66
Query: 172 AREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTD-LARIIS----NPEGKLTEP 226
E++I++ H N+V + + + L++V EF++ L I++ N E T
Sbjct: 67 FNEVVIMRDYHHENVVDM--YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVC 124
Query: 227 QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS---PNKKRPLTSRVV 283
+L L + H++G++HRD+K ++L+ +G +K++DFG S P +K S V
Sbjct: 125 LSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK----SLVG 180
Query: 284 TLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSE 343
T ++ APE ++ YG +D+WS G ++ EM G P
Sbjct: 181 TPYWMAPE-VISRLPYGTEVDIWSLGIMVIEMIDGEP----------------------- 216
Query: 344 DYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
Y+ + L R + PR+ ++ + G L +L +P+ R +A L++ F
Sbjct: 217 PYFNEPPLQAMRRIRDNLPPRVKDS-HKVSSVLRGFLDLMLVREPSQRATAQELLQHPFL 275
Query: 404 -FTSPLAC 410
P +C
Sbjct: 276 KLAGPPSC 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 7e-21
Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 132 KVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEG 191
K+G G + V++ L ++ + VA+K +K D F +E+ L++L H +++ L
Sbjct: 13 KLGSGYFGEVWEGLWKNRVR-VAIKILKSD-DLLKQQDF-QKEVQALKRLRHKHLISLFA 69
Query: 192 LATSRMQYSLYLVFEFMQT-DLARIISNPEGK-LTEPQ------QLLSGLQHCHDRGILH 243
+ + Y++ E M+ L + +PEG+ L Q+ G+ + ++ +H
Sbjct: 70 VCSVGEPV--YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIH 127
Query: 244 RDVKGSNLLIDKNGVLKIADFGLAN------YFSPNKKRPLTSRVVTLWYRAPELLLGAT 297
RD+ N+L+ ++ V K+ADFGLA Y S +KK P + APE T
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK-------WTAPEAASHGT 180
Query: 298 DYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRI 334
+ D+WS G LL EMF G+ PG E +I
Sbjct: 181 -FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 8e-21
Identities = 73/286 (25%), Positives = 116/286 (40%), Gaps = 42/286 (14%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKF-DTSEPHSVKFMAREIMILQKLDHPN 185
Y I +G+G + + +V K+V SE + EI+IL L HPN
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL-NEIVILSLLQHPN 60
Query: 186 IVKLEGLATSRMQ-YSLYLVFEFMQT-DLARIISNPEGKLTEPQ-------QLLSGLQHC 236
I+ M +L + E+ L I +G+L E + Q++S + +
Sbjct: 61 IIAYYN---HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYI 117
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGA 296
H GILHRD+K N+ + K G++K+ DFG++ ++ + V T +Y +PEL G
Sbjct: 118 HKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG-SEYSMAETVVGTPYYMSPELCQGV 176
Query: 297 TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356
Y D+W+ GC+L E+ L R F +P K ++ + T
Sbjct: 177 -KYNFKSDIWALGCVLYELLT-------------LKRTFD-ATNPLNLVVKIVQGNYTPV 221
Query: 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402
Y L L+ +LL DP R +A L
Sbjct: 222 VSV-YSSELIS-----------LVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 85/297 (28%), Positives = 138/297 (46%), Gaps = 37/297 (12%)
Query: 121 PKSAESY-DKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQ 179
P +Y D K+G+G+ V A + +GK+VA+KK+ D + + + E++I++
Sbjct: 15 PGDPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMR 72
Query: 180 KLDHPNIVKLEGLATSRMQYSLYLVFEFMQTD-LARIIS----NPEGKLTEPQQLLSGLQ 234
H N+V++ + + L++V EF++ L I++ N E +L L
Sbjct: 73 DYQHENVVEMYN--SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALS 130
Query: 235 HCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLL 294
H +G++HRD+K ++L+ +G +K++DFG S R S V T ++ APE L+
Sbjct: 131 VLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR-KSLVGTPYWMAPE-LI 188
Query: 295 GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354
YG +D+WS G ++ EM G P P E P K +R
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGEP--PYFNE-------------PPLKAMKMIR---- 229
Query: 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS-PLAC 410
+ P+L P S G L LL DPA R +AA LK+ F + P +C
Sbjct: 230 ----DNLPPKLKNLHKVSP-SLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSC 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 2e-20
Identities = 77/287 (26%), Positives = 140/287 (48%), Gaps = 44/287 (15%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
E + K++++G+G++ VYK +D T ++VA+K + + +E ++ + +EI +L + D P
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSP 62
Query: 185 NIVKLEG--LATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHC 236
I + G L ++ L+++ E++ A + P G L E +++L GL +
Sbjct: 63 YITRYYGSYLKGTK----LWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYL 117
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK-KRPLTSRVVTLWYRAPELLLG 295
H +HRD+K +N+L+ + G +K+ADFG+A + + KR + V T ++ APE ++
Sbjct: 118 HSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPE-VIK 174
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355
+ Y D+WS G E+ G P LH + L P
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEP------PNSDLHPMRVLFLIPKNS----------- 217
Query: 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402
P + + + + F EF E+ L DP +R +A LK++F
Sbjct: 218 --PPTLEGQYSKPFKEFVEACLN-------KDPRFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 63/202 (31%), Positives = 110/202 (54%), Gaps = 23/202 (11%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKF--MAREIMILQKLDHP 184
+ + ++G G++ VY A D T ++VA+KK+ + + + + K+ + +E+ LQ+L HP
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSY-SGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHD 238
N ++ +G +++ +LV E+ + I+ + L E + L GL + H
Sbjct: 76 NTIEYKGCYLR--EHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATD 298
+HRD+K N+L+ + G +K+ADFG A+ SP S V T ++ APE++L A D
Sbjct: 134 HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-----SFVGTPYWMAPEVIL-AMD 187
Query: 299 ---YGVGIDLWSAG--CL-LAE 314
Y +D+WS G C+ LAE
Sbjct: 188 EGQYDGKVDVWSLGITCIELAE 209
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 58/214 (27%), Positives = 111/214 (51%), Gaps = 16/214 (7%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSV-KFMAREIMILQKLDHPNIVK 188
+ ++G G++ VY A + T ++VA+KK+ + + + + + +E+ LQ+L HPN ++
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 189 LEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHDRGIL 242
+G +++ +LV E+ + ++ + L E + L GL + H ++
Sbjct: 86 YKGCYLK--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 243 HRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATD--YG 300
HRD+K N+L+ + G +K+ADFG S +K P S V T ++ APE++L + Y
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFG-----SASKSSPANSFVGTPYWMAPEVILAMDEGQYD 198
Query: 301 VGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRI 334
+D+WS G E+ +P + + L+ I
Sbjct: 199 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 75/286 (26%), Positives = 139/286 (48%), Gaps = 43/286 (15%)
Query: 132 KVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEG 191
K+G+G+ V A ++ +G+ VA+K + D + + + E++I++ H N+V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHQNVVEM-- 83
Query: 192 LATSRMQYSLYLVFEFMQTD-LARIISNPEGKLTEPQ------QLLSGLQHCHDRGILHR 244
+ + L+++ EF+Q L I+S + +L E Q +L L + H +G++HR
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHR 141
Query: 245 DVKGSNLLIDKNGVLKIADFGLANYFSPN--KKRPLTSRVVTLWYRAPELLLGATDYGVG 302
D+K ++L+ +G +K++DFG S + K++ L V T ++ APE ++ T YG
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL---VGTPYWMAPE-VISRTPYGTE 197
Query: 303 IDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYK 362
+D+WS G ++ EM G P + V+ + K+LR S PP
Sbjct: 198 VDIWSLGIMVIEMVDGEPPYFSDSPVQAM---------------KRLRDS----PP---- 234
Query: 363 PRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPL 408
P+L + + L +L +P R +A L + F + L
Sbjct: 235 PKL-KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 3e-19
Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 18/221 (8%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y+ + VG+G++ ++ + A+K+++ S +V+ +E ++L K+ HPNI
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNI 60
Query: 187 VKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLLS-------GLQHCHD 238
V + + LY+V E+ DL + I GKL +L G+QH H+
Sbjct: 61 VAFK--ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATD 298
+ +LHRD+K N+ + +NG +K+ DFG A + + + V T +Y PE+
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT-SPGAYACTYVGTPYYVPPEIWENMP- 176
Query: 299 YGVGIDLWSAGCLLAEM-FLGRPIMPGRTEVEQLHRIFKLC 338
Y D+WS GC+L E+ L P + + I K+C
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHPFQANSWK----NLILKVC 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 63/199 (31%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y+KI VG+G + V+ + K+V +K++ + E +L+ L HPNI
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 187 VKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ-------QLLSGLQHCHD 238
+ E +L +V E+ LA I L + Q+L L H H
Sbjct: 62 I--EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 239 RGILHRDVKGSNLLIDKNG-VLKIADFGLANYFSPNKKRPLTSRVV-TLWYRAPELLLGA 296
+ ILHRD+K N+L+DK+ V+KI DFG++ S K VV T Y +PEL G
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGK 176
Query: 297 TDYGVGIDLWSAGCLLAEM 315
Y D+W+ GC+L E+
Sbjct: 177 P-YNQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 82/293 (27%), Positives = 127/293 (43%), Gaps = 62/293 (21%)
Query: 132 KVGQGTYSNVYKALDRDTG---KIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVK 188
++G+G++ VY D+ ++ LK++ P+ +E +L KLDHP IVK
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 189 LEGLATSRMQYSLYLVFEFMQ-TDL---ARIISNPEGKLTEPQ------QLLSGLQHCHD 238
A+ + + ++ E+ + DL + + L+E Q QLL G+ + H
Sbjct: 67 FH--ASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYF--SPNKKRPLTSRVVTLWYRAPELLLGA 296
R ILHRD+K N+ + KN +LKI DFG++ S + T T +Y +PE L
Sbjct: 125 RRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTG---TPYYMSPE-ALKH 179
Query: 297 TDYGVGIDLWSAGCLLAEM------FLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350
Y D+WS GC+L EM F G+
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAHAFEGQNF----------------------------- 210
Query: 351 LSTTFRPPQSYKPRLFEAFSEFPESSLG-LLSTLLALDPAYRGSAASALKNEF 402
LS R + P L E +S L ++ ++L DP+ R SAA L+N F
Sbjct: 211 LSVVLRIVEGPTPSLPETYS----RQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 74/244 (30%), Positives = 120/244 (49%), Gaps = 31/244 (12%)
Query: 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQ 179
VP+ E+ + K+G G + V+ K VA+K +K + P + F+A E +++
Sbjct: 3 VPR--ETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEA--FLA-EANLMK 56
Query: 180 KLDHPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEG-KLTEPQ------QLLS 231
+L HP +V+L + T Q +Y++ E+M+ L + PEG KLT + Q+
Sbjct: 57 QLQHPRLVRLYAVVT---QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113
Query: 232 GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPE 291
G+ + +HRD++ +N+L+ + KIADFGLA N+ + + APE
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 173
Query: 292 LLLGATDYG---VGIDLWSAGCLLAEMF-LGRPIMPGRT--EV----EQLHRIFKLCGSP 341
A +YG + D+WS G LL E+ GR PG T EV E+ +R+ + P
Sbjct: 174 ----AINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCP 229
Query: 342 SEDY 345
E Y
Sbjct: 230 EELY 233
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 65/247 (26%), Positives = 123/247 (49%), Gaps = 21/247 (8%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSV-KFMAREIMILQKLDHPN 185
+ + ++G G++ VY A D T ++VA+KK+ + + + + + +E+ LQ++ HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 186 IVKLEGLATSRMQYSLYLVFEFM---QTDLARIISNPEGKL---TEPQQLLSGLQHCHDR 239
++ +G +++ +LV E+ +DL + P ++ L GL + H
Sbjct: 87 SIEYKGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATD- 298
++HRD+K N+L+ + G +K+ADFG A+ S P S V T ++ APE++L +
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIAS-----PANSFVGTPYWMAPEVILAMDEG 199
Query: 299 -YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFK-----LCGSPSEDYWKKLRLS 352
Y +D+WS G E+ +P + + L+ I + L + DY++ S
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDS 259
Query: 353 TTFRPPQ 359
+ PQ
Sbjct: 260 CLQKIPQ 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 64/203 (31%), Positives = 106/203 (52%), Gaps = 22/203 (10%)
Query: 130 IDKVGQGTYSNV----YKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPN 185
I ++G+G + +V Y L +TG++VA+KK++ T+E ++ REI IL+ L H N
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE--HLRDFEREIEILKSLQHDN 66
Query: 186 IVKLEGLATSRMQYSLYLVFEFMQTDLAR-IISNPEGKLTEPQQLL------SGLQHCHD 238
IVK +G+ S + +L LV E++ R + +L + LL G+++
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK-----KRPLTSRVVTLWYRAPELL 293
+ +HRD+ N+L++ +KI DFGL +K + P S + WY APE
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI--FWY-APE-S 182
Query: 294 LGATDYGVGIDLWSAGCLLAEMF 316
L + + V D+WS G +L E+F
Sbjct: 183 LTESKFSVASDVWSFGVVLYELF 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 58/217 (26%), Positives = 109/217 (50%), Gaps = 16/217 (7%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSV-KFMAREIMILQKLDHPN 185
+ + ++G G++ VY A D ++VA+KK+ + + + + + +E+ LQKL HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 186 IVKLEGLATSRMQYSLYLVFEFM---QTDLARIISNPEGKL---TEPQQLLSGLQHCHDR 239
++ G +++ +LV E+ +DL + P ++ L GL + H
Sbjct: 77 TIQYRGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATD- 298
++HRDVK N+L+ + G++K+ DFG A+ + P V T ++ APE++L +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANXFVGTPYWMAPEVILAMDEG 189
Query: 299 -YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRI 334
Y +D+WS G E+ +P + + L+ I
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 66/217 (30%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMIL-QKLDHPNIVKLE 190
+G+G++ V A + T ++ A+K +K D + V+ E +L HP + +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL- 61
Query: 191 GLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILH 243
+ + + L+ V E++ DL I G+ EP+ +++ GLQ H+RGI++
Sbjct: 62 -HSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIY 119
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLW------YRAPELLLGAT 297
RD+K N+L+D G +KIADFG+ K + V T Y APE+L
Sbjct: 120 RDLKLDNVLLDSEGHIKIADFGMC-------KEGILGGVTTSTFCGTPDYIAPEILSY-Q 171
Query: 298 DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRI 334
YG +D W+ G LL EM G+ G E E I
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 68/208 (32%), Positives = 100/208 (48%), Gaps = 13/208 (6%)
Query: 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKL 181
AE +D I +G+G + V + + ++ A+K + KF+ + F E I+
Sbjct: 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100
Query: 182 DHPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISN---PEGKLTE--PQQLLSGLQH 235
+ IV+L A +Y LY+V E+M DL ++SN PE K +++ L
Sbjct: 101 NSEWIVQLH-YAFQDDKY-LYMVMEYMPGGDLVNLMSNYDIPE-KWARFYTAEVVLALDA 157
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLL- 294
H G +HRDVK N+L+DK+G LK+ADFG N + V T Y +PE+L
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS 217
Query: 295 --GATDYGVGIDLWSAGCLLAEMFLGRP 320
G YG D WS G L EM +G
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 129 KIDKVGQGTYSNV----YKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+I +G+G + V Y +TG+ VA+K +K ++ H + +EI IL+ L H
Sbjct: 8 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRNLYHE 66
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLLSGLQHCH------ 237
NIVK +G+ T + L+ EF+ + L + + K+ QQL +Q C
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK-----KRPLTSRVVTLWYRAPEL 292
R +HRD+ N+L++ +KI DFGL +K K L S V WY APE
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV--FWY-APEC 183
Query: 293 LLGATDYGVGIDLWSAGCLLAEMF 316
L+ + Y + D+WS G L E+
Sbjct: 184 LIQSKFY-IASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 67/217 (30%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 128 DKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKF--MAREIMILQKLDHPN 185
+ +D++G+G Y +VYK L R TG +A+K+++ + E KF + E+ IL K P
Sbjct: 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDES---KFNQIIMELDILHKAVSPY 60
Query: 186 IVKLEGLATSRMQYSLYLVFEFMQ--------TDLARIISNPEGKLTE-PQQLLSGLQHC 236
IV G ++ ++Y+ E+M PE L ++ GL+
Sbjct: 61 IVDFYGAFF--IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 237 HDR-GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLT-SRVVTLWYRAPELL- 293
+ I+HRDVK +N+L++ NG +K+ DFG+ S N L + + Y APE +
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGV----SGNLVASLAKTNIGCQSYMAPERIK 174
Query: 294 -LGATD---YGVGIDLWSAGCLLAEMFLGRPIMPGRT 326
G Y V D+WS G + EM LGR P T
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET 211
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 20/225 (8%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
ES I K+G G + V+ K VA+K +K T P S E I++KL H
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPES---FLEEAQIMKKLRHD 61
Query: 185 NIVKLEGLATSRMQYSLYLVFEFM-QTDLARIISNPEGK-LTEPQ------QLLSGLQHC 236
+V+L + + +Y+V E+M + L + + EG+ L P Q+ +G+ +
Sbjct: 62 KLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGA 296
+HRD++ +N+L+ V KIADFGLA N+ + + APE L
Sbjct: 119 ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178
Query: 297 TDYGVGIDLWSAGCLLAEMFL-GR---PIMPGRTEVEQLHRIFKL 337
+ + D+WS G LL E+ GR P M R +EQ+ R +++
Sbjct: 179 R-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 25/213 (11%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH-PN 185
++ ++ VG GTY VYK TG++ A+K + E +K +EI +L+K H N
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSHHRN 64
Query: 186 IVKLEGLATSR----MQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ-------QLLSGL 233
I G + M L+LV EF + +I N +G + + ++L GL
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124
Query: 234 QHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELL 293
H H ++HRD+KG N+L+ +N +K+ DFG++ R T + T ++ APE++
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMAPEVI 183
Query: 294 LGATD------YGVGIDLWSAGCLLAEMFLGRP 320
A D Y DLWS G EM G P
Sbjct: 184 --ACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 68/220 (30%), Positives = 108/220 (49%), Gaps = 40/220 (18%)
Query: 126 SYDKIDKV-GQGTYSNVYKALDRDTGK---IVALKKVKFDTSEPHSVKFMAREIMILQKL 181
SY I+KV G G + V + + GK VA+K +K +S+ + F+ E I+ +
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-TEASIMGQF 62
Query: 182 DHPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL-------SGL 233
DHPNI++LEG+ T + ++ E+M+ L + + +GK T QL+ SG+
Sbjct: 63 DHPNIIRLEGVVTKSR--PVMIITEYMENGSLDKFLRENDGKFT-VGQLVGMLRGIASGM 119
Query: 234 QHCHDRGILHRDVKGSNLLIDKNGVLKIADFGL--------ANYFSPNKKRPLTSRVVTL 285
++ + +HRD+ N+L++ N V K++DFGL A Y + K P+
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPI------R 173
Query: 286 WYRAPELLLGATDYGV---GIDLWSAGCLLAE-MFLG-RP 320
W APE A Y D+WS G ++ E M G RP
Sbjct: 174 W-TAPE----AIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 65/208 (31%), Positives = 94/208 (45%), Gaps = 19/208 (9%)
Query: 134 GQGTYSNVYKALDRDTGKIVALKKVK----FDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
G+G + V A + TG++ A+K +K E S+ R HP +V L
Sbjct: 8 GRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNL 67
Query: 190 EGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCHDRGIL 242
A + + + V E+ DL I +EP+ ++ GLQ+ H+ I+
Sbjct: 68 --FACFQTEDHVCFVMEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIV 123
Query: 243 HRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV-TLWYRAPELLLGATDYGV 301
+RD+K NLL+D G +KIADFGL R TS T + APE+L T Y
Sbjct: 124 YRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPEVLTE-TSYTR 180
Query: 302 GIDLWSAGCLLAEMFLGRPIMPGRTEVE 329
+D W G L+ EM +G PG E E
Sbjct: 181 AVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 78/287 (27%), Positives = 121/287 (42%), Gaps = 41/287 (14%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQKLDHPNIVKLEG 191
+G+G + V R TGK+ A KK++ + + MA E IL+K++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 66
Query: 192 LATSRMQYSLYLVFEFMQT-DLARIISN------PEGK-LTEPQQLLSGLQHCHDRGILH 243
+ +L LV M DL I N E + + ++ GL+ H I++
Sbjct: 67 -YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGI 303
RD+K N+L+D G ++I+D GLA + + RV T+ Y APE ++ Y
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVEIPEGE--TIRGRVGTVGYMAPE-VVKNERYTFSP 182
Query: 304 DLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKP 363
D W GCL+ EM G+ R E + + + E+Y +K
Sbjct: 183 DWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK--------------- 227
Query: 364 RLFEAFSEFPESSLGLLSTLLALDPAYR----GSAASALKNEFFFTS 406
FSE S + LL DP +R G A +K FF +
Sbjct: 228 -----FSEAARS---ICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDT---SEPHSVKFMAREIMILQKLDHPNIVKL 189
+G+G++ V+ A + T + A+K +K D + + + ++ L +HP + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL-AWEHPFLTHL 61
Query: 190 EGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCHDRGIL 242
T + + +L+ V E++ DL I + K P+ +++ GLQ H +GI+
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 243 HRDVKGSNLLIDKNGVLKIADFGLA--NYFSPNKKRPLTSRVVTLWYRAPELLLGATDYG 300
+RD+K N+L+D +G +KIADFG+ N K T Y APE+LLG Y
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG---TPDYIAPEILLG-QKYN 174
Query: 301 VGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRI 334
+D WS G LL EM +G+ G E E I
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 5e-18
Identities = 69/227 (30%), Positives = 110/227 (48%), Gaps = 19/227 (8%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGL 192
+G+G + V+K +D VA+K K D + +KF++ E IL++ DHPNIVKL G+
Sbjct: 3 LGKGNFGEVFKGTLKDKTP-VAVKTCKEDLPQELKIKFLS-EARILKQYDHPNIVKLIGV 60
Query: 193 ATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQL------LSGLQHCHDRGILHRD 245
T R +Y+V E + D + + +L Q + +G+ + + +HRD
Sbjct: 61 CTQRQ--PIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRD 118
Query: 246 VKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDL 305
+ N L+ +N VLKI+DFG++ + + + + APE L Y D+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPE-ALNYGRYSSESDV 177
Query: 306 WSAGCLLAEMF-LGRPIMPG------RTEVEQLHRIFKLCGSPSEDY 345
WS G LL E F LG PG R +VE+ +R+ P + Y
Sbjct: 178 WSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVY 224
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 6e-18
Identities = 63/199 (31%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQK---LDHPNIVK 188
+G+GT+ VY+ +DT +I A+K + K + V E IL + + P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIV- 59
Query: 189 LEGLATS-RMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHDRGI 241
GL S + LYLV ++M EG+ +E + +L+ L+H H I
Sbjct: 60 --GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDI 117
Query: 242 LHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV--TLWYRAPELLLGATDY 299
++RD+K N+L+D G + + DFGL+ N T+ T Y APE+LL Y
Sbjct: 118 VYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNTFCGTTEYLAPEVLLDEKGY 174
Query: 300 GVGIDLWSAGCLLAEMFLG 318
+D WS G L+ EM G
Sbjct: 175 TKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 53/192 (27%), Positives = 96/192 (50%), Gaps = 14/192 (7%)
Query: 132 KVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEG 191
K+G G Y VY+ + + VA+K +K DT E +F+ +E +++++ HPN+V+L G
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE--EFL-KEAAVMKEIKHPNLVQLLG 69
Query: 192 LATSRMQYSLYLVFEFMQ--------TDLARIISNPEGKLTEPQQLLSGLQHCHDRGILH 243
+ T + Y++ EFM + R N L Q+ S +++ + +H
Sbjct: 70 VCTREPPF--YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 127
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGI 303
RD+ N L+ +N ++K+ADFGL+ + + + + APE L + +
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKS 186
Query: 304 DLWSAGCLLAEM 315
D+W+ G LL E+
Sbjct: 187 DVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 6e-18
Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 16/214 (7%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
+ K+G G + V++ L +T VA+K +K T +P F+ E I++KL HP +++L
Sbjct: 11 LRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKD--FL-AEAQIMKKLRHPKLIQL 66
Query: 190 EGLATSRMQYSLYLVFEFM-QTDLARIISNPEGK-LTEPQ------QLLSGLQHCHDRGI 241
+ T ++ +Y+V E M L + G+ L PQ Q+ SG+ + +
Sbjct: 67 YAVCT--LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY 124
Query: 242 LHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGV 301
+HRD+ N+L+ +N + K+ADFGLA + + + APE L + +
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAAL-YNRFSI 183
Query: 302 GIDLWSAGCLLAE-MFLGRPIMPGRTEVEQLHRI 334
D+WS G LL E + GR PG T E L ++
Sbjct: 184 KSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 67/205 (32%), Positives = 100/205 (48%), Gaps = 13/205 (6%)
Query: 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKLD 182
AE YD + +G+G + V + + K+ A+K + KF+ + F E I+ +
Sbjct: 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 183 HPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISN---PE--GKLTEPQQLLSGLQHC 236
P +V+L + LY+V E+M DL ++SN PE K + +L+ L
Sbjct: 102 SPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLA-LDAI 158
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLL-- 294
H G++HRDVK N+L+DK+G LK+ADFG + V T Y +PE+L
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 295 -GATDYGVGIDLWSAGCLLAEMFLG 318
G YG D WS G L EM +G
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 76/251 (30%), Positives = 122/251 (48%), Gaps = 24/251 (9%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ ++KI ++G G V+K + +G I+A K + + +P + RE+ +L + + P
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSP 63
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQQLL--------SGLQHC 236
IV G S + S+ + E M + G++ P+Q+L GL +
Sbjct: 64 YIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYL 119
Query: 237 HDR-GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLG 295
++ I+HRDVK SN+L++ G +K+ DFG++ + S V T Y +PE L G
Sbjct: 120 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQG 176
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGR-PIMPGRTEVEQLHRIF--KLCGSPSEDYWKKLRLS 352
T Y V D+WS G L EM +GR PI P + ++L +F + G P+E R
Sbjct: 177 -THYSVQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMFGCPVEGDPAESETSP-RPR 232
Query: 353 TTFRPPQSYKP 363
RP SY P
Sbjct: 233 PPGRPLSSYGP 243
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 129 KIDKVGQGTYSNV----YKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
KI +G+G + V Y + TG++VA+K +K + + ++ + +EI IL+ L H
Sbjct: 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWK-KEINILKTLYHE 66
Query: 185 NIVKLEGLATSRMQYSLYLVFEF-----MQTDLARIISNPEGKLTEPQQLLSGLQHCHDR 239
NIVK +G + + L L+ E+ ++ L + N L QQ+ G+ + H +
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLAN-------YF--SPNKKRPLTSRVVTLWYRAP 290
+HRD+ N+L+D + ++KI DFGLA Y+ + P+ WY A
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV------FWY-AV 179
Query: 291 ELLLGATDYGVGIDLWSAGCLLAEMF 316
E L + D+WS G L E+
Sbjct: 180 E-CLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 66/197 (33%), Positives = 93/197 (47%), Gaps = 21/197 (10%)
Query: 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLE 190
+ +G G VYKA T +I+A+K + D + K + E+ IL K D P I+
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFY 65
Query: 191 GLATSRMQYSLYLVFEFM---QTDLARIISNPEGKLTE-PQQLLSGLQHCHDRGILHRDV 246
G + S+ EFM D+ R I PE L ++ GL + ILHRDV
Sbjct: 66 GAFFVENRISI--CTEFMDGGSLDVYRKI--PEHVLGRIAVAVVKGLTYLWSLKILHRDV 121
Query: 247 KGSNLLIDKNGVLKIADFG----LANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVG 302
K SN+L++ G +K+ DFG L N + + V T Y APE + G YG+
Sbjct: 122 KPSNMLVNTRGQVKLCDFGVSTQLVNSIA-------KTYVGTNAYMAPERISG-EQYGIH 173
Query: 303 IDLWSAGCLLAEMFLGR 319
D+WS G E+ LGR
Sbjct: 174 SDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 73/283 (25%), Positives = 120/283 (42%), Gaps = 47/283 (16%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGL 192
VG+G+Y V R GK +KK+ + K +E +L +L HPNIV
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV----- 62
Query: 193 ATSRMQYS-----LYLVFEFMQT-DLARIISNPEGKLTEPQQLLS-------GLQHCHDR 239
R + LY+V F + DL + +GKL Q++ LQ+ H++
Sbjct: 63 -AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDY 299
ILHRD+K N+ + + ++K+ D G+A N+ ++ + T +Y +PE L Y
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPE-LFSNKPY 179
Query: 300 GVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQ 359
D+W+ GC + EM + + ++RI + P P+
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPM---------------PK 224
Query: 360 SYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402
Y P L E L++T+L+ P R S S L+ +
Sbjct: 225 DYSPELGE-----------LIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 69/251 (27%), Positives = 103/251 (41%), Gaps = 69/251 (27%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKLDH 183
+ ++ I +G+G + V +DTG I A+KK+ K + E V + E IL + D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 184 PNIVKLEGLATSRMQYS------LYLVFEF-----MQTDLARIISNPEGKLTEPQ----- 227
P +VK + YS LYL+ E+ M T L + + TE +
Sbjct: 61 PWVVK--------LYYSFQDENYLYLIMEYLPGGDMMTLLMK-----KDTFTEEETRFYI 107
Query: 228 -QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF---------------- 270
+ + + H G +HRD+K NLL+D G +K++DFGL
Sbjct: 108 AETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHAL 167
Query: 271 ---------SP-----------NKKRPLT-SRVVTLWYRAPELLLGATDYGVGIDLWSAG 309
P +R L S V T Y APE+ L T Y D WS G
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLG 226
Query: 310 CLLAEMFLGRP 320
++ EM +G P
Sbjct: 227 VIMYEMLVGYP 237
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 80/294 (27%), Positives = 129/294 (43%), Gaps = 55/294 (18%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALK-----KVKFDTSEPHSVKFMAREIMI--LQKLDHPN 185
+G+G + VY DTGK+ A+K ++K E ++ IM+ + D P
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN---ERIMLSLVSTGDCPF 58
Query: 186 IVKLEGLATSRMQYS------LYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSG 232
IV M Y+ L + + M DL +S G +E + +++ G
Sbjct: 59 IVC--------MSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILG 109
Query: 233 LQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPEL 292
L+H H+R +++RD+K +N+L+D++G ++I+D GLA FS KK+P S V T Y APE+
Sbjct: 110 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHAS-VGTHGYMAPEV 166
Query: 293 LLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352
L Y D +S GC+L ++ G H F+ + + ++ L+
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRG-------------HSPFRQHKTKDKHEIDRMTLT 213
Query: 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406
P S+ P L GLL + G A +K FF S
Sbjct: 214 MAVELPDSFSPELRSLLE-------GLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 73/229 (31%), Positives = 109/229 (47%), Gaps = 40/229 (17%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ ++K+ ++G G V K L R +G I+A K + + +P + RE+ +L + + P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSP 59
Query: 185 NIVKLEGLATSR------MQY----SLYLVFEFMQTDLARIISNPEGKLTEPQQLLSGLQ 234
IV G S M++ SL V + RI N GK++ +L GL
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPENILGKIS--IAVLRGLT 113
Query: 235 HCHD-RGILHRDVKGSNLLIDKNGVLKIADFG--------LANYFSPNKKRPLTSRVVTL 285
+ + I+HRDVK SN+L++ G +K+ DFG +AN F V T
Sbjct: 114 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-----------VGTR 162
Query: 286 WYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGR-PI-MPGRTEVEQLH 332
Y +PE L G T Y V D+WS G L EM +GR PI P E+E +
Sbjct: 163 SYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 38/218 (17%)
Query: 133 VGQGTYSNVYKA-----LDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIV 187
+GQG + V++A L + +VA+K +K + S F RE ++ + DHPNIV
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REAALMAEFDHPNIV 71
Query: 188 KLEGLATSRMQYSLYLVFEFMQ----------------------TDLARIISNPEGKLTE 225
KL G+ + + L+FE+M T AR L+
Sbjct: 72 KLLGVCA--VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 226 PQQL------LSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA-NYFSPNKKRPL 278
+QL +G+ + +R +HRD+ N L+ +N V+KIADFGL+ N +S + +
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF 316
+ + + + PE + Y D+W+ G +L E+F
Sbjct: 190 ENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIF 226
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 81/293 (27%), Positives = 131/293 (44%), Gaps = 57/293 (19%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALK---KVKFDTSEPHSVKFMAREIMILQKL-DHPNIVK 188
+G+G + VY DTGK+ A+K K + + ++ R ++ L D P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 189 LEGLATSRMQYSLY------LVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQH 235
M Y+ + + + M DL +S G +E + +++ GL+H
Sbjct: 62 --------MTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEH 112
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLG 295
H+R +++RD+K +N+L+D++G ++I+D GLA FS KK+P S V T Y APE+L
Sbjct: 113 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHAS-VGTHGYMAPEVLQK 169
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355
T Y D +S GC+L ++ G H F+ + + ++ L+
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRG-------------HSPFRQHKTKDKHEIDRMTLTVNV 216
Query: 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR----GSAASALKNEFFF 404
P S+ P L LL LL D + R G A +K FF
Sbjct: 217 ELPDSFSPEL-----------KSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 7e-17
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 20/214 (9%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDT---SEPHSVKFMAREIMILQKLDHPNIVKL 189
+G+G++ V A + T + A+K +K D + + R ++ L +HP + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLAL-AWEHPFLTHL 61
Query: 190 EGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCHDRGIL 242
T + + L+ V E++ DL I + G+ E + +++ GLQ H +GI+
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGII 118
Query: 243 HRDVKGSNLLIDKNGVLKIADFGLA--NYFSPNKKRPLTSRVVTLWYRAPELLLGATDYG 300
+RD+K N+L+DK+G +KIADFG+ N K T Y APE+L G Y
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG---TPDYIAPEILKGQK-YN 174
Query: 301 VGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRI 334
+D WS G LL EM +G+ G E E I
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 8e-17
Identities = 66/224 (29%), Positives = 111/224 (49%), Gaps = 21/224 (9%)
Query: 132 KVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEG 191
K+GQG + V+ T + VA+K +K T P + +E +++KL H +V+L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYA 68
Query: 192 LATSRMQYSLYLVFEFM-QTDLARIISNPEGK-LTEPQ------QLLSGLQHCHDRGILH 243
+ + + +Y+V E+M + L + GK L PQ Q+ SG+ + +H
Sbjct: 69 VVS---EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 125
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGI 303
RD++ +N+L+ +N V K+ADFGLA N+ + + APE L + +
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKS 184
Query: 304 DLWSAGCLLAEMFL-GRPIMPG---RTEVEQLHRIFKLCGSPSE 343
D+WS G LL E+ GR PG R ++Q+ R +++ P E
Sbjct: 185 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-PCPPE 227
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 9e-17
Identities = 68/218 (31%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 132 KVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEG 191
K+GQG + V+ T K VA+K +K T P + +E I++KL H +V L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPLYA 68
Query: 192 LATSRMQYSLYLVFEFM-QTDLARIISNPEGK-LTEPQ------QLLSGLQHCHDRGILH 243
+ + + +Y+V EFM + L + +GK L PQ Q+ G+ + +H
Sbjct: 69 VVS---EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIH 125
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGI 303
RD++ +N+L+ N V KIADFGLA N+ + + APE L + +
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKS 184
Query: 304 DLWSAGCLLAEMFL-GRPIMPG---RTEVEQLHRIFKL 337
D+WS G LL E+ GR PG R +EQ+ R +++
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 24/202 (11%)
Query: 131 DKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
+ +G G++ V A + TG+ A+K + K + + V+ +A+E IL +L HP IV +
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83
Query: 190 EGLATSRMQYSLYLVFEF-----MQTDL--ARIISNPEGKLTEPQQLLSGLQHCHDRGIL 242
+ + + + +Y + EF + T L A N K + +L+ ++ H + I+
Sbjct: 84 --MCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA-FEYLHSKDII 140
Query: 243 HRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLW----YRAPELLLGATD 298
+RD+K NLL+D G +K+ DFG A K+ + R TL Y APE ++ +
Sbjct: 141 YRDLKPENLLLDNKGHVKVTDFGFA-------KK-VPDRTFTLCGTPEYLAPE-VIQSKG 191
Query: 299 YGVGIDLWSAGCLLAEMFLGRP 320
+G +D W+ G LL E G P
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 126 SYDKIDKV-GQGTYSNVYKALDRDTGK---IVALKKVKFDTSEPHSVKFMAREIMILQKL 181
S KI++V G G + V + + GK VA+K +K +E F++ E I+ +
Sbjct: 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS-EASIMGQF 62
Query: 182 DHPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL-------SGL 233
DHPNI+ LEG+ T + ++ EFM+ L + +G+ T QL+ +G+
Sbjct: 63 DHPNIIHLEGVVTKSR--PVMIITEFMENGALDSFLRQNDGQFT-VIQLVGMLRGIAAGM 119
Query: 234 QHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP-----LTSRVVTLWYR 288
++ + +HRD+ N+L++ N V K++DFGL+ + + P L ++ W
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW-T 178
Query: 289 APELLLGATDYGVGIDLWSAGCLLAE-MFLG-RP 320
APE + + D+WS G ++ E M G RP
Sbjct: 179 APE-AIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 65/225 (28%), Positives = 111/225 (49%), Gaps = 24/225 (10%)
Query: 129 KIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMI-LQKLDHPNIV 187
I+++G+G Y V K TG I+A+K+++ T K + ++ I ++ +D P V
Sbjct: 5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRA-TVNSQEQKRLLMDLDISMRSVDCPYTV 63
Query: 188 KLEGLATSRMQYSLYLVFEFMQTDLARIISNP-EGKLTEPQQLL--------SGLQHCHD 238
G A R + +++ E M T L + + LT P+ +L L++ H
Sbjct: 64 TFYG-ALFR-EGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 239 R-GILHRDVKGSNLLIDKNGVLKIADFGLANYF--SPNKKRPLTSRVVTLWYRAPELLLG 295
+ ++HRDVK SN+LI++NG +K+ DFG++ Y S K + Y APE +
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP----YMAPERINP 177
Query: 296 ATD---YGVGIDLWSAGCLLAEMFLGR-PIMPGRTEVEQLHRIFK 336
+ Y V D+WS G + E+ GR P +T +QL ++ +
Sbjct: 178 ELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 66/230 (28%), Positives = 111/230 (48%), Gaps = 29/230 (12%)
Query: 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLE 190
+ +G+G + V + TG+ VA+K +K D + + F+ E ++ KL H N+V+L
Sbjct: 12 EIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVT---AQAFLE-ETAVMTKLHHKNLVRLL 65
Query: 191 GLATSRMQYSLYLVFEFM-QTDLARIISNPEGKLTEPQQLL-------SGLQHCHDRGIL 242
G+ + LY+V E M + +L + L QLL G+++ + ++
Sbjct: 66 GVI---LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLV 122
Query: 243 HRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVG 302
HRD+ N+L+ ++GV K++DFGLA S++ W APE L +
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLA---RVGSMGVDNSKLPVKW-TAPE-ALKHKKFSSK 177
Query: 303 IDLWSAGCLLAEMF-LGRPIMPGRT------EVEQLHRIFKLCGSPSEDY 345
D+WS G LL E+F GR P + VE+ +R+ G P++ Y
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVY 227
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 83/286 (29%), Positives = 124/286 (43%), Gaps = 48/286 (16%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVK----FDTSEPHSVKFMAREIMILQKLDHPNIVK 188
+G+G++ V + RDT +I ALK ++ SE V E +L +++ P IV
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSE---VTHTLAERTVLAQVNCPFIVP 57
Query: 189 LEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHDRGIL 242
L+ S + LYLV F+ EG+ + +LL L++ H ++
Sbjct: 58 LKFSFQSPEK--LYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVI 115
Query: 243 HRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVG 302
+RD+K N+L+D G + + DFGL + + T T Y APELLLG Y
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF-CGTPEYLAPELLLG-HGYTKA 173
Query: 303 IDLWSAGCLLAEMFLGRPIMPGRTE-VEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSY 361
+D W+ G LL EM G P P E V +++R K+ P LR F
Sbjct: 174 VDWWTLGVLLYEMLTGLP--PFYDENVNEMYR--KILQEP-------LRFPDGFD----- 217
Query: 362 KPRLFEAFSEFPESSLGLLSTLLALDPAYR--GSAASALKNEFFFT 405
+ LL LL+ DP R + A +KN FF+
Sbjct: 218 ------------RDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFS 251
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-16
Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKLD 182
AE Y+ + +G+G + V + T K+ A+K + KF+ + F E I+ +
Sbjct: 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 183 HPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPE--GKLTE--PQQLLSGLQHCH 237
P +V+L A +Y LY+V E+M DL ++SN + K +++ L H
Sbjct: 102 SPWVVQL-FYAFQDDRY-LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH 159
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLL--- 294
G +HRDVK N+L+DK+G LK+ADFG + + V T Y +PE+L
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 295 GATDYGVGIDLWSAGCLLAEMFLG 318
G YG D WS G L EM +G
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 66/219 (30%), Positives = 108/219 (49%), Gaps = 21/219 (9%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKK-VKFDTSEPHSVKFMAREIMILQKLDHPNIVK 188
+ ++G GT VYK + TG ++A+K+ + E + M +++ L+ D P IVK
Sbjct: 20 LGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVV-LKSHDCPYIVK 78
Query: 189 LEGLATSRMQYSLYLVFEFMQT---DLARIISN--PE---GKLT-EPQQLLSGLQHCHDR 239
G + +++ E M T L + I PE GK+T + L L+ H
Sbjct: 79 CYGYFIT--DSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH-- 134
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGAT-- 297
G++HRDVK SN+L+D +G +K+ DFG++ +K + ++ Y APE +
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA--YMAPERIDPPDPN 192
Query: 298 -DYGVGIDLWSAGCLLAEMFLGR-PIMPGRTEVEQLHRI 334
Y + D+WS G L E+ G+ P +TE E L +I
Sbjct: 193 PKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 79/320 (24%), Positives = 124/320 (38%), Gaps = 70/320 (21%)
Query: 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKLDHP 184
+ KI +G+G V+ + TGK+ ALK + K + + + VK + E IL LDHP
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 185 NIVKLEG-LATSRMQYSLYLVFEF-MQTDLARII-SNPEGKLTEP------QQLLSGLQH 235
+ L T L LV ++ +L R++ P L+E ++L L++
Sbjct: 62 FLPTLYASFQTETY---LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLA----------------NYFSPNKKRPLT 279
H GI++RD+K N+L+ ++G + ++DF L+ + +
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 280 SRVV------------TLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE 327
T Y APE++ G +G +D W+ G LL EM G G
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237
Query: 328 VEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALD 387
E I K K F S+ L+ LL D
Sbjct: 238 DETFSNILK-------------------------KEVTFPGSPPVSSSARDLIRKLLVKD 272
Query: 388 PAYR-GSA--ASALKNEFFF 404
P+ R GS A+ +K FF
Sbjct: 273 PSKRLGSKRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 69/217 (31%), Positives = 109/217 (50%), Gaps = 21/217 (9%)
Query: 133 VGQGTYSNVY---KALDRDTGKIVALKKVKFDTSEPHSVKFMAREIM---ILQKLDHPNI 186
+GQG++ V+ K D G++ A+K +K T + V+ R M IL +++HP I
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK---VRDRVRTKMERDILAEVNHPFI 60
Query: 187 VKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDR 239
VKL + + LYL+ +F++ DL +S E TE +L L H H
Sbjct: 61 VKLH--YAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSL 117
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDY 299
GI++RD+K N+L+D+ G +K+ DFGL+ ++K+ S T+ Y APE ++ +
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY-SFCGTVEYMAPE-VVNRRGH 175
Query: 300 GVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFK 336
D WS G L+ EM G G+ E + I K
Sbjct: 176 TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH-PN 185
++ ++ VG GTY VYK TG++ A+K + E +K EI +L+K H N
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL---EINMLKKYSHHRN 74
Query: 186 IVKLEGLATSR----MQYSLYLVFEFMQT-DLARIISNPEGKLTEP-------QQLLSGL 233
I G + L+LV EF + ++ N +G + +++L GL
Sbjct: 75 IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGL 134
Query: 234 QHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELL 293
H H ++HRD+KG N+L+ +N +K+ DFG++ R T + T ++ APE++
Sbjct: 135 AHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMAPEVI 193
Query: 294 LGATD------YGVGIDLWSAGCLLAEMFLGRP 320
A D Y D+WS G EM G P
Sbjct: 194 --ACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 74/271 (27%), Positives = 121/271 (44%), Gaps = 34/271 (12%)
Query: 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQ 179
+P+ + +K K+G G + V+ A K VA+K +K + SV+ E +++
Sbjct: 3 IPRESLKLEK--KLGAGQFGEVWMATYNKHTK-VAVKTMKPGSM---SVEAFLAEANVMK 56
Query: 180 KLDHPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEG-KLTEPQ------QLLS 231
L H +VKL + T +Y++ EFM L + + EG K P+ Q+
Sbjct: 57 TLQHDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 113
Query: 232 GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPE 291
G+ R +HRD++ +N+L+ + V KIADFGLA N+ + + APE
Sbjct: 114 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173
Query: 292 LLLGATDYG---VGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQL------HRIFKLCGSP 341
A ++G + D+WS G LL E+ GR PG + E + +R+ + P
Sbjct: 174 ----AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP 229
Query: 342 SEDYWKKLRLSTTF---RPPQSYKPRLFEAF 369
E Y +R RP Y + + F
Sbjct: 230 EELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 30/210 (14%)
Query: 133 VGQGTYSNVYKA-----LDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIV 187
+G+G + V+ + ++VA+K +K +T+ + K RE +L H NIV
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAELLTNFQHENIV 71
Query: 188 KLEGLATSRMQYSLYLVFEFMQT-DLARII-------------SNPEGKLTEPQ------ 227
K G+ T +VFE+M+ DL + + +P G+LT Q
Sbjct: 72 KFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA-NYFSPNKKRPLTSRVVTLW 286
Q+ SG+ + + +HRD+ N L+ + V+KI DFG++ + ++ + R ++ +
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 287 YRAPELLLGATDYGVGIDLWSAGCLLAEMF 316
+ PE ++ + D+WS G +L E+F
Sbjct: 190 WMPPESIMYRK-FTTESDVWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 73/269 (27%), Positives = 120/269 (44%), Gaps = 41/269 (15%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFD-TSEPHSVKFMAREIMIL-QKLDHPNIVKLE 190
+G+G+Y+ V + T +I A+K VK + ++ + ++ E + Q +HP +V L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 191 GLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILHR 244
+ + + L+ V E++ + KL E ++ L + H+RGI++R
Sbjct: 63 --SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 245 DVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP--LTSRVV-TLWYRAPELLLGATDYGV 301
D+K N+L+D G +K+ D+G+ RP TS T Y APE+L G DYG
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGF 175
Query: 302 GIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSP------SEDYWKKLRLSTTF 355
+D W+ G L+ EM GR F + GS +EDY ++ L
Sbjct: 176 SVDWWALGVLMFEMMAGR-------------SPFDIVGSSDNPDQNTEDYLFQVILEKQI 222
Query: 356 RPPQSYKPRLFEAFSEF----PESSLGLL 380
R P+S + F P+ LG
Sbjct: 223 RIPRSLSVKAASVLKSFLNKDPKERLGCH 251
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 59/218 (27%), Positives = 107/218 (49%), Gaps = 26/218 (11%)
Query: 120 VPKSAESYDKIDKVGQGTYSNVYKAL---DRDTGKI-VALKKVKFDTSEPHSVKFMAREI 175
+ K E +KI +G G + VYK + + + KI VA+K ++ +TS + + + E
Sbjct: 3 ILKETE-LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEIL-DEA 60
Query: 176 MILQKLDHPNIVKLEGLA-TSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLLS-- 231
++ +DHP++V+L G+ +S++Q L+ + M L + N + + Q LL+
Sbjct: 61 YVMASVDHPHVVRLLGICLSSQVQ----LITQLMPLGCLLDYVRNHKDNI-GSQYLLNWC 115
Query: 232 -----GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTS--RVVT 284
G+ + ++ ++HRD+ N+L+ +KI DFGLA ++K +V
Sbjct: 116 VQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI 175
Query: 285 LWYRAPELLLGATDYGVGIDLWSAGCLLAEM--FLGRP 320
W A E +L Y D+WS G + E+ F +P
Sbjct: 176 KWM-ALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 68/227 (29%), Positives = 104/227 (45%), Gaps = 39/227 (17%)
Query: 133 VGQGTYSNVY---KALDRDTGKIVA---LKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
+G+G Y V+ K DTGKI A LKK ++ + A E IL+ + HP I
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA-ERNILEAVKHPFI 62
Query: 187 VKLEGLATSRMQYSLYLVFEFMQ-----TDLARIISNPEGKLTEP------QQLLSGLQH 235
V L + + LYL+ E++ L R EG E ++ L+H
Sbjct: 63 VDL--IYAFQTGGKLYLILEYLSGGELFMHLER-----EGIFMEDTACFYLSEISLALEH 115
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV------TLWYRA 289
H +GI++RD+K N+L+D G +K+ DFGL K + V T+ Y A
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLC-------KESIHEGTVTHTFCGTIEYMA 168
Query: 290 PELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFK 336
PE+L+ + +G +D WS G L+ +M G P + + +I K
Sbjct: 169 PEILM-RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 76/264 (28%), Positives = 121/264 (45%), Gaps = 39/264 (14%)
Query: 172 AREIMILQKLDHPNIVKLEGLATSRMQYSLY--LVFEFMQTDLARIISNPEG-----KLT 224
A E IL+ ++HP+I++L+G T Y+ + L+ +TDL ++ L
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFT----YNKFTCLILPRYKTDLYCYLAAKRNIAICDILA 186
Query: 225 EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANY---FSPNKKRPLTSR 281
+ +L +Q+ H+ I+HRD+K N+ I+ G + + DFG A + + NK
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246
Query: 282 VVTLWYRAPELLLGATD-YGVGIDLWSAGCLLAEMFLG------RPIMPGRTEVE-QLHR 333
+ T APELL A D YG +D+WSAG +L EM + + G + + Q+
Sbjct: 247 IAT---NAPELL--ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL 301
Query: 334 IFKLCGS-PSE---DYWKKLR------LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTL 383
I + G+ P+E D L + R P S +P L+ E P L+ +
Sbjct: 302 IIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGS-RP-LWTNLYELPIDLEYLICKM 359
Query: 384 LALDPAYRGSAASALKNEFFFTSP 407
LA D +R SA + L F P
Sbjct: 360 LAFDAHHRPSAEALLDFAAFQDIP 383
|
Length = 391 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 16/214 (7%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEG 191
+G+G++ V A + T ++ A+K +K D + V+ E +L D P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLT-QL 66
Query: 192 LATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILHR 244
+ + LY V E++ DL I GK EPQ ++ GL H RGI++R
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYR 125
Query: 245 DVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV--TLWYRAPELLLGATDYGVG 302
D+K N+++D G +KIADFG+ + +T+R T Y APE ++ YG
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPE-IIAYQPYGKS 181
Query: 303 IDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFK 336
+D W+ G LL EM G+P G E E I +
Sbjct: 182 VDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 66/226 (29%), Positives = 102/226 (45%), Gaps = 14/226 (6%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQKLDHPNIVKLEG 191
+G+G + V R TGK+ A K+++ + + MA E IL+K++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA- 66
Query: 192 LATSRMQYSLYLVFEFMQT-DLARIISN-------PEGKLTEPQQLLSGLQHCHDRGILH 243
+ +L LV M DL I N E L ++L GL+ H ++
Sbjct: 67 -YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGI 303
RD+K N+L+D G ++I+D GLA + + RV T+ Y APE +L Y +
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRVGTVGYMAPE-VLNNQRYTLSP 182
Query: 304 DLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349
D W GCL+ EM G+ GR E + + + E Y K
Sbjct: 183 DYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKF 228
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 28/215 (13%)
Query: 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD 182
+++ +G+G + +V R G+ VA+K +K D++ + F+A E ++ L
Sbjct: 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQA--FLA-EASVMTTLR 58
Query: 183 HPNIVKLEGLATSRMQYSLYLVFEFMQ----TDLARIISNPEGKLTEPQQLL------SG 232
HPN+V+L G+ LY+V E+M D R S +T QQL G
Sbjct: 59 HPNLVQLLGVVLQGN--PLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCEG 114
Query: 233 LQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPEL 292
+++ ++ +HRD+ N+L+ ++ V K++DFGLA S S + + + APE
Sbjct: 115 MEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG----QDSGKLPVKWTAPE- 169
Query: 293 LLGATDYGVGIDLWSAGCLLAEMF-LGR---PIMP 323
L + D+WS G LL E++ GR P +P
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 20/214 (9%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDT---SEPHSVKFMAREIMILQKLDHPNIVKL 189
+G+G++ V A + G+ A+K +K D + + + ++ L ++P + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLAL-AWENPFLTHL 61
Query: 190 EGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGIL 242
T + + L+ V EF+ DL I + +G+ +++ GLQ H +GI+
Sbjct: 62 --YCTFQTKEHLFFVMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGII 118
Query: 243 HRDVKGSNLLIDKNGVLKIADFGLA--NYFSPNKKRPLTSRVVTLWYRAPELLLGATDYG 300
+RD+K N+++D++G +KIADFG+ N F N+ ++ T Y APE+L G Y
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA---STFCGTPDYIAPEILQG-LKYT 174
Query: 301 VGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRI 334
+D WS G LL EM +G+ G E E I
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPN-IVKLE 190
+G+G++ V A + T ++ A+K +K D + V+ E +L P + +L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 191 GLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILH 243
+ + LY V E++ DL I GK EP ++ GL H +GI++
Sbjct: 68 --SCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIY 124
Query: 244 RDVKGSNLLIDKNGVLKIADFGLA--NYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGV 301
RD+K N+++D G +KIADFG+ N F R T Y APE++ YG
Sbjct: 125 RDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCG---TPDYIAPEIIA-YQPYGK 180
Query: 302 GIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRI 334
+D W+ G LL EM G+P G E E I
Sbjct: 181 SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 79/287 (27%), Positives = 120/287 (41%), Gaps = 41/287 (14%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQKLDHPNIVKLEG 191
+G+G + V R TGK+ A KK++ + + MA E IL+K++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA- 66
Query: 192 LATSRMQYSLYLVFEFMQT-DLA-RIISNPEGKLTEPQ------QLLSGLQHCHDRGILH 243
+ +L LV M DL I E E + ++ GL+ H I++
Sbjct: 67 -YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGI 303
RD+K N+L+D +G ++I+D GLA + + + RV T+ Y APE++ Y
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNER-YTFSP 182
Query: 304 DLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKP 363
D W+ GCLL EM G+ SP + KK++ R + +
Sbjct: 183 DWWALGCLLYEMIAGQ--------------------SPFQQRKKKIKREEVERLVKEVQE 222
Query: 364 RLFEAFSEFPESSLGLLSTLLALDPAYR----GSAASALKNEFFFTS 406
E FS S L LL DP R G A +K F
Sbjct: 223 EYSEKFSPDARS---LCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 17/200 (8%)
Query: 129 KIDKV-GQGTYSNVYKALDRDTGK---IVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
KI+KV G G + V + GK VA+K +K +E F++ E I+ + DHP
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLS-EASIMGQFDHP 65
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCH 237
NI+ LEG+ T + +V E+M+ L + +G+ T Q + SG+++
Sbjct: 66 NIIHLEGVVTK--SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR--VVTLWYRAPELLLG 295
D G +HRD+ N+L++ N V K++DFGL+ + + T+R + + + APE +
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE-AIA 182
Query: 296 ATDYGVGIDLWSAGCLLAEM 315
+ D+WS G ++ E+
Sbjct: 183 YRKFTSASDVWSYGIVMWEV 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 63/196 (32%), Positives = 93/196 (47%), Gaps = 14/196 (7%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAR-EIMILQKLDHPNIVKLEG 191
+G+G + V ++TGK+ A KK+ + S + MA E IL+K++ P IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 192 LATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTE-------PQQLLSGLQHCHDRGILH 243
S+ L LV M DL I N + E Q+ G+ H H I++
Sbjct: 61 AFESKTH--LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGI 303
RD+K N+L+D G +++D GLA K +T R T Y APE+L Y +
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEEP-YSYPV 175
Query: 304 DLWSAGCLLAEMFLGR 319
D ++ GC + EM GR
Sbjct: 176 DWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-15
Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 148 DTGKIVALKKVKFDTSE-PHSVKFMAREIMILQKLDHPNIVKL--EGLATSRMQYSLYLV 204
TG VA+K ++ D E H RE + +L HPNIV L G A + L+ V
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL---LFAV 57
Query: 205 FEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGV 258
FE++ R + +G L + Q+L L H++GI+HRD+K N+++ + GV
Sbjct: 58 FEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 259 ---LKIADFGLANYFSPNKKR-----PLTSRVV-TLWYRAPELLLGATDYGVGIDLWSAG 309
K+ DFG+ + T+ V+ T Y APE L G DL++ G
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNS-DLYAWG 176
Query: 310 CLLAEMFLGRPIMPGRTEVEQLHR 333
+ E G+ ++ G + E L++
Sbjct: 177 LIFLECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 63/241 (26%), Positives = 117/241 (48%), Gaps = 28/241 (11%)
Query: 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD 182
ES + K+G G + V+ ++ K VA+K +K T SV+ E +++ L
Sbjct: 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM---SVQAFLEEANLMKTLQ 59
Query: 183 HPNIVKLEGLATSRMQYSLYLVFEFMQTD--LARIISNPEGKLTEPQ------QLLSGLQ 234
H +V+L + T + +Y++ E+M L + S+ GK+ P+ Q+ G+
Sbjct: 60 HDKLVRLYAVVTK--EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117
Query: 235 HCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLL 294
+ + +HRD++ +N+L+ ++ + KIADFGLA N+ + + APE
Sbjct: 118 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE--- 174
Query: 295 GATDYG---VGIDLWSAGCLLAEMF-LGRPIMPGRTE------VEQLHRIFKLCGSPSED 344
A ++G + D+WS G LL E+ G+ PG + +++ +R+ ++ P E
Sbjct: 175 -AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDEL 233
Query: 345 Y 345
Y
Sbjct: 234 Y 234
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 5e-15
Identities = 49/161 (30%), Positives = 82/161 (50%), Gaps = 19/161 (11%)
Query: 174 EIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQQLLS-- 231
E ++ KL H +V+L G+ T Q +Y+V E+M GK +P QLL
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTK--QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMC 106
Query: 232 -----GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLW 286
G+ + + +HRD+ N L+D G +K++DFGL+ Y ++ TS V + +
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKF 163
Query: 287 ---YRAPELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMP 323
+ PE+LL + + D+W+ G L+ E++ LG+ MP
Sbjct: 164 PVRWSPPEVLL-YSKFSSKSDVWAFGVLMWEVYSLGK--MP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 21/199 (10%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEG 191
+G+GT+ V ++ TGK A+K +K + V E +LQ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK- 61
Query: 192 LATSRMQYSLYLVFEFMQ-----TDLARIISNPEGKLTEPQ------QLLSGLQHCHDRG 240
+ + L V E+ L+R E +E + +++S L + H
Sbjct: 62 -YSFQTHDRLCFVMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHSCD 115
Query: 241 ILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYG 300
+++RD+K NL++DK+G +KI DFGL + + + T Y APE +L DYG
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAPE-VLEDNDYG 173
Query: 301 VGIDLWSAGCLLAEMFLGR 319
+D W G ++ EM GR
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 61/256 (23%), Positives = 100/256 (39%), Gaps = 34/256 (13%)
Query: 174 EIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------ 227
E M+LQ ++HP++++++ S + V +DL ++ L Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCM--VLPHYSSDLYTYLTKRSRPLPIDQALIIEK 164
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV-TLW 286
Q+L GL++ H + I+HRDVK N+ I+ + I D G A + P + T+
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLAGTVE 221
Query: 287 YRAPELLLGATDYGVGIDLWSAGCLLAEMFL----------GRPIMPGRTEVEQLHRIFK 336
APE+L Y D+WSAG +L EM P ++ L +I
Sbjct: 222 TNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS 280
Query: 337 LCGSPSEDYWKK---------LRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALD 387
E++ + + ++ R P + P P L+ +L D
Sbjct: 281 TLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCF--QRVNLPIDGEFLVHKMLTFD 338
Query: 388 PAYRGSAASALKNEFF 403
A R SA L F
Sbjct: 339 AAMRPSAEEILNYPMF 354
|
Length = 357 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 72/247 (29%), Positives = 120/247 (48%), Gaps = 20/247 (8%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ +++I ++G G V K + +G I+A K + + +P + RE+ +L + + P
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSP 63
Query: 185 NIVKLEGLATSRMQYSLYL------VFEFMQTDLARIISNPEGKLTEPQQLLSGLQHCHD 238
IV G S + S+ + + + + RI GK++ +L GL + +
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVS--IAVLRGLAYLRE 121
Query: 239 R-GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGAT 297
+ I+HRDVK SN+L++ G +K+ DFG++ + S V T Y +PE L G T
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQG-T 177
Query: 298 DYGVGIDLWSAGCLLAEMFLGR-PIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356
Y V D+WS G L E+ +GR PI P + ++L IF G P D + S + R
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIF---GRPVVDGEEGEPHSISPR 232
Query: 357 PPQSYKP 363
P +P
Sbjct: 233 PRPPGRP 239
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 68/231 (29%), Positives = 105/231 (45%), Gaps = 36/231 (15%)
Query: 125 ESYDKIDK--VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIM----IL 178
+ D D +G+G + V K L + +G I+A+K+++ E K R +M ++
Sbjct: 2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE----KEQKRLLMDLDVVM 57
Query: 179 QKLDHPNIVKLEGLATSR---------MQYSLYLVFEFMQTDLARIISNPE---GKLTEP 226
+ D P IVK G M SL ++++ L +I PE GK+
Sbjct: 58 RSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVI--PEEILGKIA-- 113
Query: 227 QQLLSGLQHC-HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF--SPNKKRPLTSRVV 283
+ L + + I+HRDVK SN+L+D+NG +K+ DFG++ S K R R
Sbjct: 114 VATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRP- 172
Query: 284 TLWYRAPELLL--GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEV-EQL 331
Y APE + Y V D+WS G L E+ G+ P V +QL
Sbjct: 173 ---YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 30/211 (14%)
Query: 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH 183
E + I +G G +V K TG ++A KKV ++ K + RE+ I+ +
Sbjct: 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRS 62
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCH 237
P IV G + + + EFM I G + ++ GL + +
Sbjct: 63 PYIVSFYGAFLNENNICMCM--EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120
Query: 238 DR-GILHRDVKGSNLLIDKNGVLKIADFG--------LANYFSPNKKRPLTSRVVTLWYR 288
+ I+HRD+K SN+L++ G +K+ DFG +A+ F V T Y
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF-----------VGTSTYM 169
Query: 289 APELLLGATDYGVGIDLWSAGCLLAEMFLGR 319
+PE + G Y V D+WS G + E+ LG+
Sbjct: 170 SPERIQGG-KYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 21/219 (9%)
Query: 132 KVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEG 191
++G G + V+ + K VA+K ++ E ++ KL HP +V+L G
Sbjct: 11 EIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI---EEAQVMMKLSHPKLVQLYG 66
Query: 192 LATSRMQYSLYLVFEFMQTD-LARIISNPEGKLTEPQQL------LSGLQHCHDRGILHR 244
+ T R + LVFEFM+ L+ + GK ++ L G+ + ++HR
Sbjct: 67 VCTERS--PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124
Query: 245 DVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGID 304
D+ N L+ +N V+K++DFG+ + ++ T + + +PE + + Y D
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPE-VFSFSKYSSKSD 183
Query: 305 LWSAGCLLAEMFL-GRPIMPGRTE---VEQL---HRIFK 336
+WS G L+ E+F G+ R+ VE + R++K
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK 222
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 66/237 (27%), Positives = 103/237 (43%), Gaps = 37/237 (15%)
Query: 123 SAESYDKIDKVGQGTYSNVYKAL----DRDTGKI-VALKKVKFDTSEPHSVKFMAREIMI 177
+S + +G G + VY+ L D D ++ VA+K + SE F+ E +I
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL-MEALI 62
Query: 178 LQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQQL-LSGLQH 235
+ K +H NIV+L G++ R+ +++ E M DL + + P L + L
Sbjct: 63 MSKFNHQNIVRLIGVSFERLPR--FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 236 C-----------HDRGILHRDVKGSNLLIDKNG---VLKIADFGLA------NYFSPNKK 275
C + +HRD+ N L+ G V KIADFG+A +Y+ +
Sbjct: 121 CARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQL 331
L + + PE L + D+WS G LL E+F LG PGRT E +
Sbjct: 181 AMLPIK-----WMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 28/182 (15%)
Query: 174 EIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTD-LARIISNPEGK------LTEP 226
E ++ KL HPN+V+L G+ T Q +++V E+M L + +GK L
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCTK--QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC 106
Query: 227 QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF-------SPNKKRPLT 279
+ +++ G +HRD+ N L+ ++ V+K++DFGLA Y S K P+
Sbjct: 107 SDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK 166
Query: 280 SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTE---VEQLHRIF 335
+ PE+ + + D+WS G L+ E+F G+ + VE + +
Sbjct: 167 -------WAPPEVFD-YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY 218
Query: 336 KL 337
+L
Sbjct: 219 RL 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-14
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 24/200 (12%)
Query: 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPH-SVKFMAREIMILQKLDHPNIVKL 189
+++G+G + V+ R VA+K + +T P KF+ +E IL++ HPNIV+L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFL-QEARILKQYSHPNIVRL 58
Query: 190 EGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQQLL-------SGLQHCHDRGIL 242
G+ T + +Y+V E +Q EG + ++L+ +G+++ + +
Sbjct: 59 IGVCTQK--QPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCI 116
Query: 243 HRDVKGSNLLIDKNGVLKIADFGLAN------YFSPNKKRPLTSRVVTLWYRAPELLLGA 296
HRD+ N L+ + VLKI+DFG++ Y S + + + + APE L
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK-----WTAPE-ALNY 170
Query: 297 TDYGVGIDLWSAGCLLAEMF 316
Y D+WS G LL E F
Sbjct: 171 GRYSSESDVWSFGILLWEAF 190
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 9e-14
Identities = 70/266 (26%), Positives = 103/266 (38%), Gaps = 70/266 (26%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKLDHPN 185
+ KI +G G + V DT + A+K + K D + + E IL + D+
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 186 IVKL-------EGLATSRMQY-------SLYLVFEFMQTDLARI-ISNPEGKLTEPQQLL 230
+VKL + L M Y SL + + DLAR I+ +L
Sbjct: 63 VVKLYYSFQDKDNLYFV-MDYIPGGDMMSLLIRLGIFEEDLARFYIA----------ELT 111
Query: 231 SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF-------------------- 270
++ H G +HRD+K N+LID++G +K+ DFGL F
Sbjct: 112 CAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSM 171
Query: 271 ---------SPNKKRPLTSR-------------VVTLWYRAPELLLGATDYGVGIDLWSA 308
+ +PL R V T Y APE+LL T Y D WS
Sbjct: 172 EPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSV 230
Query: 309 GCLLAEMFLGRPIMPGRTEVEQLHRI 334
G +L EM +G+P T E ++
Sbjct: 231 GVILYEMLVGQPPFLADTPAETQLKV 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 64/251 (25%), Positives = 107/251 (42%), Gaps = 44/251 (17%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKLDH 183
E ++ + +G+G + V +DTG + A+K + K D E V + E IL + D
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCH 237
+VK+ + + + +LYL+ EF+ + + LTE + + + + H
Sbjct: 61 LWVVKM--FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH 118
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGL------------------------------- 266
G +HRD+K NLL+D G +K++DFGL
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 267 ---ANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMP 323
A + N+++ S V T Y APE+ + T Y D WS G ++ EM +G P
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 324 GRTEVEQLHRI 334
T E ++
Sbjct: 238 SETPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 33/225 (14%)
Query: 131 DKVGQGTYSNVYKA-LDRDTGKI--VALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIV 187
K+G G++ V + GK+ VA+K +K D F+ +E I+ LDH N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL-KEAAIMHSLDHENLI 59
Query: 188 KLEGLATSRMQYSLYLVFEF--MQTDLARIISNPEGKLTEPQ------QLLSGLQHCHDR 239
+L G+ + + L +V E + + L R+ + G Q+ +G+++ +
Sbjct: 60 RLYGVV---LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLA--------NYFS-PNKKRPLTSRVVTLWYRAP 290
+HRD+ N+L+ + +KI DFGL +Y + K P W AP
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA------WC-AP 169
Query: 291 ELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
E L T + D+W G L EMF G G + + L +I
Sbjct: 170 ESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 68/245 (27%), Positives = 111/245 (45%), Gaps = 37/245 (15%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFD-TSEPHSVKFMAREIMIL-QKLDHPNIVKLE 190
+G+G+Y+ V + T +I A+K +K + ++ + ++ E + +HP +V L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 191 GL--ATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHDRGIL 242
SR L+ V EF+ + KL E ++ L H+RGI+
Sbjct: 63 SCFQTESR----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGII 118
Query: 243 HRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV-TLWYRAPELLLGATDYGV 301
+RD+K N+L+D G +K+ D+G+ + TS T Y APE+L G DYG
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRG-EDYGF 175
Query: 302 GIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSP------SEDYWKKLRLSTTF 355
+D W+ G L+ EM M GR+ F + G +EDY ++ L
Sbjct: 176 SVDWWALGVLMFEM------MAGRSP-------FDIVGMSDNPDQNTEDYLFQVILEKQI 222
Query: 356 RPPQS 360
R P+S
Sbjct: 223 RIPRS 227
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 66/252 (26%), Positives = 109/252 (43%), Gaps = 46/252 (18%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKLDH 183
+ ++ + +G+G + V +DTG I A+K + K D E V + E IL + D
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 184 PNIVKLEGLATSRMQYSLYLVFEF-----MQTDLAR--IISNPEGKLTEPQQLLSGLQHC 236
+VK+ + + + +LYL+ EF M T L + +S + + +L+ +
Sbjct: 61 AWVVKM--FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLA-IDAI 117
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGL------------------------------ 266
H G +HRD+K NLL+D G +K++DFGL
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 267 ----ANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIM 322
A + N+++ S V T Y APE+ + T Y D WS G ++ EM +G P
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 323 PGRTEVEQLHRI 334
T E ++
Sbjct: 237 CSETPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 39/210 (18%)
Query: 134 GQGTYSNVY---KALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLE 190
G G Y V+ K D GK+ A+K + ++ I+QK + E
Sbjct: 9 GTGAYGKVFLVRKVGGHDAGKLYAMK--------------VLKKATIVQKAKTAEHTRTE 54
Query: 191 GLATSRMQYSLYLV--FEFMQTD--LARIISNPEG-----------KLTEPQ------QL 229
++ +LV QTD L I+ G TE + ++
Sbjct: 55 RQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEI 114
Query: 230 LSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRA 289
+ L H H GI++RD+K N+L+D G + + DFGL+ F ++ S T+ Y A
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 290 PELLLGATD-YGVGIDLWSAGCLLAEMFLG 318
PE++ G + + +D WS G L E+ G
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 16/214 (7%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQ-KLDHPNIVKLE 190
+G+G++ V A +++G++ A+K +K D + V+ E IL +HP + +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL- 61
Query: 191 GLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILH 243
+ L+ V EF+ DL I + E + ++ S L HD+GI++
Sbjct: 62 -YCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV-TLWYRAPELLLGATDYGVG 302
RD+K N+L+D G K+ADFG+ N K TS T Y APE +L YG
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYIAPE-ILQEMLYGPS 176
Query: 303 IDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFK 336
+D W+ G LL EM G E + I
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 48/223 (21%)
Query: 130 IDKVGQGTYSNVYKA-----LDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
++++G+G + VYK +R + VA+K +K + +EP + +E ++ L HP
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMSDLQHP 68
Query: 185 NIVKLEGLATSRMQYSLYLVFEFM-QTDLAR-IISN--------------------PEGK 222
NIV L G+ T + +FE++ DL ++ N
Sbjct: 69 NIVCLLGVCTKEQPTCM--LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 223 LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGL------ANYFSPNKKR 276
L Q+ +G+++ +HRD+ N L+ + +KI+DFGL A+Y+ K
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 277 PLTSRVVTLWYRAPELLLGATDYG---VGIDLWSAGCLLAEMF 316
L R + PE +L YG D+WS G +L E+F
Sbjct: 187 LLPVR-----WMPPEAIL----YGKFTTESDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 36/213 (16%)
Query: 130 IDKVGQGTYSNVYKAL-----DRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
I ++GQG++ VY+ L + VA+K V + S ++F+ E ++++ +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN-EASVMKEFNCH 69
Query: 185 NIVKLEGLATSRMQYSLYLVFEFM-QTDLARIISN--PEGKLTEPQ-------------Q 228
++V+L G+ S Q +L +V E M + DL + + PE + +
Sbjct: 70 HVVRLLGVV-STGQPTL-VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 229 LLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA------NYFSPNKKRPLTSRV 282
+ G+ + + +HRD+ N ++ ++ +KI DFG+ +Y+ K L R
Sbjct: 128 IADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 186
Query: 283 VTLWYRAPELLLGATDYGVGIDLWSAGCLLAEM 315
W APE L + D+WS G +L EM
Sbjct: 187 ---WM-APESLKDGV-FTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 74/268 (27%), Positives = 118/268 (44%), Gaps = 59/268 (22%)
Query: 104 PKWLTDNIPREVLAGLVPKSAESYDKIDKVGQGTYSNVYKA----LDRDTGKI-VALKKV 158
P+W +PR+ L P +G+G + V KA LD VA+K +
Sbjct: 5 PEW---ELPRDRLTLGKP-----------LGEGAFGQVVKAEAVGLDNPNETSTVAVKML 50
Query: 159 KFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLYLVFEF---------- 207
K D +E + + E+ +++ + H NI+ L G+ T + LY+V E+
Sbjct: 51 KDDATE-KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ--EGPLYVVVEYAAHGNLRDFL 107
Query: 208 -----MQTDLARIIS-NPEGKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDK 255
+ PE LT+ Q+ G++ + +HRD+ N+L+ +
Sbjct: 108 RARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167
Query: 256 NGVLKIADFGLA------NYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAG 309
+ V+KIADFGLA +Y+ ++ R+ W APE L Y D+WS G
Sbjct: 168 DHVMKIADFGLARDIHHIDYY----RKTTNGRLPVKWM-APEALFDRV-YTHQSDVWSFG 221
Query: 310 CLLAEMF-LGRPIMPGRTEVEQLHRIFK 336
LL E+F LG PG VE+L ++ K
Sbjct: 222 VLLWEIFTLGGSPYPG-IPVEELFKLLK 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 9/193 (4%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEG 191
+G+GT+ V ++ TG+ A+K ++ + V E +LQ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 192 LATSRMQYSLYLVFE-----FMQTDLARIISNPEGKLTEPQQLLSGLQHCHDRGILHRDV 246
+ + + + F R+ + + +++S L++ H R +++RD+
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYG-AEIVSALEYLHSRDVVYRDI 121
Query: 247 KGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLW 306
K NL++DK+G +KI DFGL + + + T Y APE +L DYG +D W
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTPEYLAPE-VLEDNDYGRAVDWW 179
Query: 307 SAGCLLAEMFLGR 319
G ++ EM GR
Sbjct: 180 GLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 73/308 (23%), Positives = 122/308 (39%), Gaps = 58/308 (18%)
Query: 134 GQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLA 193
++ K + T +VA+KK+ D+ +K + +EI+ ++L HPNI+
Sbjct: 11 EDLMIVHLAKH--KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 194 TSRMQYSLYLVFEFMQ----TDLARIISN--PEGKLTEP------QQLLSGLQHCHDRGI 241
+ LY+V M DL + PEG L E + +L+ L + H +G
Sbjct: 69 IVDSE--LYVVSPLMAYGSCEDL---LKTHFPEG-LPELAIAFILKDVLNALDYIHSKGF 122
Query: 242 LHRDVKGSNLLIDKNGVLKIADFGLANYF--SPNKKRPL----TSRVVTLWYRAPELL-- 293
+HR VK S++L+ +G + ++ + ++R + S V L + +PE+L
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182
Query: 294 --LGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSP---------- 341
G Y D++S G E+ G +P + + K+ G+
Sbjct: 183 NLQG---YNEKSDIYSVGITACELANG--HVPFKDMPATQMLLEKVRGTVPCLLDKSTYP 237
Query: 342 -SEDYWKKLRLSTT----FRPPQSYKPRLF-EAFSEFPESSLGLLSTLLALDPAYRGSAA 395
ED + R S R F E F +F E L DP R SA+
Sbjct: 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELC-------LQRDPESRPSAS 290
Query: 396 SALKNEFF 403
L + FF
Sbjct: 291 QLLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 9e-13
Identities = 53/181 (29%), Positives = 81/181 (44%), Gaps = 27/181 (14%)
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWY 287
+++ L+H H GI++RD+K N+L+D G + + DFGL+ F +K S T+ Y
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172
Query: 288 RAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWK 347
APE++ G +G +D WS G L+ E+ G P E E+ + SE +
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGAS--PFTLEGER--------NTQSEVSRR 222
Query: 348 KLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR-GSA---ASALKNEFF 403
L+ F + + LL LL DP R G+ AS +K F
Sbjct: 223 ILKCDPPFPSFIGPEAQ-------------DLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269
Query: 404 F 404
F
Sbjct: 270 F 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 64/228 (28%), Positives = 104/228 (45%), Gaps = 30/228 (13%)
Query: 133 VGQGTYSNVYK--ALDRD---TGKI-VALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
+G G + VY+ A D +G I VA+K ++ ++ +F+ E ++ +HPNI
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK-EAHLMSNFNHPNI 61
Query: 187 VKLEGLATSRMQYSLYLVFEFMQT-DL------ARIISNPEGKLTEPQQL---LSGLQHC 236
VKL G+ + Y++ E M+ DL AR+ LT + L L + C
Sbjct: 62 VKLLGVCL--LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 237 H---DRGILHRDVKGSNLLIDKNG-----VLKIADFGLA-NYFSPNKKRPLTSRVVTLWY 287
+HRD+ N L+ + G V+KI DFGLA + + + R ++ + +
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 288 RAPELLLGATDYGVGIDLWSAGCLLAE-MFLGRPIMPGRTEVEQLHRI 334
APE LL + D+WS G L+ E + LG+ P E L +
Sbjct: 180 MAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 126 SYDKIDKVGQGTYSNVY---KALDRDTGKIVALKKVKFDT--SEPHSVKFMAREIMILQK 180
+++ + +G G Y V+ K D+GK+ A+K +K T + + + E +L+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 181 LDH-PNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLLSG-----L 233
+ P +V L + L+L+ +++ +L +S E + Q+ SG L
Sbjct: 61 IRQSPFLVTLH--YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118
Query: 234 QHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELL 293
+H H GI++RD+K N+L+D NG + + DFGL+ F ++ S T+ Y AP+++
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 294 LGA-TDYGVGIDLWSAGCLLAEMFLG 318
G + +D WS G L+ E+ G
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 77/288 (26%), Positives = 125/288 (43%), Gaps = 43/288 (14%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQKLDHPNIVKLEG 191
+G+G + V R TGK+ A KK++ + + MA E IL+K++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA- 66
Query: 192 LATSRMQYSLYLVFEFMQT-DLARIISN-------PEGKLTEPQQLLSGLQHCHDRGILH 243
+ +L LV M DL I N + + +L GL+ I++
Sbjct: 67 -YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGI 303
RD+K N+L+D G ++I+D GLA P + + RV T+ Y APE++ Y
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQI-PEGET-VRGRVGTVGYMAPEVINNEK-YTFSP 182
Query: 304 DLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKP 363
D W GCL+ EM G+ P R E++ R E+ ++++
Sbjct: 183 DWWGLGCLIYEMIQGQS--PFRKRKERVKR---------EEVDRRVKEDQ---------- 221
Query: 364 RLFEAFSE-FPESSLGLLSTLLALDPAYR----GSAASALKNEFFFTS 406
E +SE F E + + LL +P R G+ A+ +K F +
Sbjct: 222 ---EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 64/210 (30%), Positives = 94/210 (44%), Gaps = 31/210 (14%)
Query: 131 DKVGQGTYSNVYKALDRDTG--KIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIV 187
D +G+G + V KA + G A+K++K S+ F A E+ +L KL HPNI+
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF-AGELEVLCKLGHHPNII 71
Query: 188 KLEGLATSRMQYSLYLVFEF---------------MQTDLARIISNPEGKLTEPQQLLS- 231
L G R LYL E+ ++TD A I+N QQLL
Sbjct: 72 NLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 232 ------GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTL 285
G+ + + +HRD+ N+L+ +N V KIADFGL+ K+ + R+
Sbjct: 130 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPVR 188
Query: 286 WYRAPELLLGATDYGVGIDLWSAGCLLAEM 315
W L + Y D+WS G LL E+
Sbjct: 189 WMAIES--LNYSVYTTNSDVWSYGVLLWEI 216
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 12/151 (7%)
Query: 174 EIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTD-LARIISNPEGKLTEPQQLLS- 231
E ++ KL HP +V+L G+ T Q LY+V EFM+ L + +GKL+ LLS
Sbjct: 49 EAKVMMKLSHPKLVQLYGVCTQ--QKPLYIVTEFMENGCLLNYLRQRQGKLS-KDMLLSM 105
Query: 232 ------GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTL 285
G+++ +HRD+ N L+ GV+K++DFG+ Y ++ + +
Sbjct: 106 CQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPV 165
Query: 286 WYRAPELLLGATDYGVGIDLWSAGCLLAEMF 316
+ PE+ + Y D+WS G L+ E+F
Sbjct: 166 KWSPPEVFN-FSKYSSKSDVWSFGVLMWEVF 195
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 28/157 (17%)
Query: 132 KVGQGTYSNVYKAL--DRDTGKI-VALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVK 188
+G+G + +VY+ + + KI VA+K K TS KF+ E I+++ DHP+IVK
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ-EAYIMRQFDHPHIVK 71
Query: 189 LEGLATSRMQYSLYLVFE---------FMQT-----DLARIISNPEGKLTEPQQLLSGLQ 234
L G+ T +++V E ++Q DLA +I QL + L
Sbjct: 72 LIGVITEN---PVWIVMELAPLGELRSYLQVNKYSLDLASLI-------LYSYQLSTALA 121
Query: 235 HCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS 271
+ + +HRD+ N+L+ +K+ DFGL+ Y
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 68/261 (26%), Positives = 115/261 (44%), Gaps = 31/261 (11%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFD-TSEPHSVKFMAREIMIL-QKLDHPNIVKLE 190
+G+G+Y+ V + +I A+K VK + + + ++ E + Q +P +V L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 191 GL--ATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQQLLSGLQHC------HDRGIL 242
TSR L+LV E++ + KL E + C H+RGI+
Sbjct: 63 SCFQTTSR----LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGII 118
Query: 243 HRDVKGSNLLIDKNGVLKIADFGLANY-FSPNKKRPLTSRVVTLWYRAPELLLGATDYGV 301
+RD+K N+L+D +G +K+ D+G+ P ++ T Y APE+L G +YG
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT--STFCGTPNYIAPEILRG-EEYGF 175
Query: 302 GIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSY 361
+D W+ G L+ EM GR T+ ++ +EDY ++ L R P+
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMN---------TEDYLFQVILEKPIRIPRFL 226
Query: 362 KPRLFEAFSEF----PESSLG 378
+ F P+ LG
Sbjct: 227 SVKASHVLKGFLNKDPKERLG 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 20/182 (10%)
Query: 170 FMAREIMILQKLDHPNIVKLEG---------LATSRMQYSLYLVFEFMQTDLARIISNPE 220
+ EI+ L +L+H NI+K+E + T + + LY FM + P
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLY---SFMYDEAFDWKDRPL 265
Query: 221 GKLTEP--QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278
K T +QLL +++ HD+ ++HRD+K N+ ++ +G + + DFG A F ++
Sbjct: 266 LKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFD 325
Query: 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMP----GRTEVEQLHRI 334
V T+ +PE+L G Y D+WS G +L +M L P G +QL +I
Sbjct: 326 YGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDM-LSHDFCPIGDGGGKPGKQLLKI 383
Query: 335 FK 336
Sbjct: 384 ID 385
|
Length = 501 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 73/258 (28%), Positives = 116/258 (44%), Gaps = 54/258 (20%)
Query: 121 PKSAESYDKI---DKVGQGTYSNVYKA----LDRDTGK---IVALKKVKFDTSEPHSVKF 170
P+ S DK+ +G+G + V A +D+D K VA+K +K D +E
Sbjct: 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 67
Query: 171 MAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT-------------------D 211
++ M+ H NI+ L G T LY++ E+ D
Sbjct: 68 VSEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125
Query: 212 LARIISNPEGKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFG 265
+AR+ P+ ++T Q+ G+++ + +HRD+ N+L+ +N V+KIADFG
Sbjct: 126 IARV---PDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 182
Query: 266 LA------NYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF-LG 318
LA +Y+ K+ R+ W APE L Y D+WS G L+ E+F LG
Sbjct: 183 LARDVNNIDYY----KKTTNGRLPVKWM-APEALFDRV-YTHQSDVWSFGVLMWEIFTLG 236
Query: 319 RPIMPGRTEVEQLHRIFK 336
PG VE+L ++ K
Sbjct: 237 GSPYPG-IPVEELFKLLK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 52/185 (28%), Positives = 91/185 (49%), Gaps = 25/185 (13%)
Query: 152 IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT- 210
+VA+K ++ D ++ F+ +EI I+ +L +PNI++L G+ S L ++ E+M+
Sbjct: 46 LVAVKMLRADVTKTARNDFL-KEIKIMSRLKNPNIIRLLGVCVS--DDPLCMITEYMENG 102
Query: 211 DLARIISNPE--GKLTEPQ---------------QLLSGLQHCHDRGILHRDVKGSNLLI 253
DL + +S E T Q+ SG+++ +HRD+ N L+
Sbjct: 103 DLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162
Query: 254 DKNGVLKIADFGLA-NYFSPNKKRPLTSRVVTL-WYRAPELLLGATDYGVGIDLWSAGCL 311
+ +KIADFG++ N +S + R V+ + W +LLG + D+W+ G
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVT 220
Query: 312 LAEMF 316
L EMF
Sbjct: 221 LWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 30/217 (13%)
Query: 133 VGQGTYSNVYKA---LDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
+G+G + +V +A + + + VA+K +K D ++ RE +++ DHPN++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 190 EGLAT-SRMQYSL---YLVFEFMQ-TDL------ARIISNPEGKLTEPQQLL-------- 230
G++ SR + L ++ FM+ DL +RI P T P Q L
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEP---FTLPLQTLVRFMIDIA 123
Query: 231 SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLAN--YFSPNKKRPLTSRVVTLWYR 288
SG+++ + +HRD+ N ++++N + +ADFGL+ Y ++ S++ W
Sbjct: 124 SGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 289 APELLLGATDYGVGIDLWSAGCLLAE-MFLGRPIMPG 324
L Y D+W+ G + E M G+ G
Sbjct: 184 LES--LADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 19/200 (9%)
Query: 129 KIDKVGQGTYSNVYKAL---DRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPN 185
K+ +G G + V+K + + D+ KI K D S + + + ++ + LDH
Sbjct: 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAY 70
Query: 186 IVKLEGLATSRMQYSLYLVFEFM-QTDLARIISNPEGKLTEPQQLLS-------GLQHCH 237
IV+L G+ SL LV + L + L +PQ+LL+ G+ +
Sbjct: 71 IVRLLGICPGA---SLQLVTQLSPLGSLLDHVRQHRDSL-DPQRLLNWCVQIAKGMYYLE 126
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVT--LWYRAPELLLG 295
+ ++HR++ N+L+ + +++IADFG+A+ P+ K+ S T W +L G
Sbjct: 127 EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 296 ATDYGVGIDLWSAGCLLAEM 315
Y D+WS G + EM
Sbjct: 187 R--YTHQSDVWSYGVTVWEM 204
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 50/203 (24%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 133 VGQGTYSNVYKALDRDTGK---IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
+G G + V++ + + G+ VA+K +K +E F++ E I+ + H NI++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-EASIMGQFSHHNIIRL 71
Query: 190 EGLATSRMQYSLYLVFEFMQTD-LARIISNPEGKLTEPQQLL-------SGLQHCHDRGI 241
EG+ T ++ E+M+ L + + + +G+ + QL+ +G+++ D
Sbjct: 72 EGVVTKFKP--AMIITEYMENGALDKYLRDHDGEFS-SYQLVGMLRGIAAGMKYLSDMNY 128
Query: 242 LHRDVKGSNLLIDKNGVLKIADFGLANYFS--PNKKRPLTSRVVTLWYRAPELLLGATDY 299
+HRD+ N+L++ N K++DFGL+ P + + + + APE + +
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE-AIAYRKF 187
Query: 300 GVGIDLWSAGCLLAEM--FLGRP 320
D+WS G ++ E+ F RP
Sbjct: 188 TSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-12
Identities = 77/310 (24%), Positives = 121/310 (39%), Gaps = 58/310 (18%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE-PHSVKFMAREIMILQKLDH 183
+ YD I +G+G VY A D + VALKK++ D SE P K RE I L H
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH 61
Query: 184 PNIVKLEGLATSR--MQYSLYLVFEFMQTDLAR------IISNPEGKLTEPQQLLS---- 231
P IV + + + + Y++ + + L + +S + T LS
Sbjct: 62 PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121
Query: 232 ---GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANY----------FSPNKKRPL 278
+++ H +G+LHRD+K N+L+ G + I D+G A + +++
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 279 TSR-------VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQL 331
S V T Y APE LLG D+++ G +L +M P R +
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLS--FPYRRK---- 234
Query: 332 HRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR 391
+K+ P P + E P + LA+DPA R
Sbjct: 235 -------------KGRKISYRDVILSPIEVAP-----YREIPPFLSQIAMKALAVDPAER 276
Query: 392 GSAASALKNE 401
S+ LK +
Sbjct: 277 YSSVQELKQD 286
|
Length = 932 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 70/264 (26%), Positives = 111/264 (42%), Gaps = 58/264 (21%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKLDHPN 185
+ KI +G G + V A DT + A+K + K D + V + E IL + D+
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 186 IVKLEGLATSRMQYSLYLVFEF-----MQTDLARIISNPEGKLTE--PQQLLSGLQHCHD 238
+V+L + + + +LY V ++ M + L R+ PE L +L ++ H
Sbjct: 63 VVRL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPE-DLARFYIAELTCAVESVHK 119
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYFS--------------------------- 271
G +HRD+K N+LID++G +K+ DFGL F
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 272 ------PNKKRPLTSR-------------VVTLWYRAPELLLGATDYGVGIDLWSAGCLL 312
++ +PL R V T Y APE+LL T Y D WS G +L
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVIL 238
Query: 313 AEMFLGRPIMPGRTEVEQLHRIFK 336
EM +G+P +T +E ++
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 78/286 (27%), Positives = 123/286 (43%), Gaps = 68/286 (23%)
Query: 104 PKWLTDNIPREVLAGLVPKSAESYDKIDKVGQGTYSNVYKA----LDR---DTGKIVALK 156
PKW PR+ L P +G+G + V +A +D+ D VA+K
Sbjct: 5 PKW---EFPRDRLVLGKP-----------LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK 50
Query: 157 KVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSLYLVFEFMQTDLAR- 214
+K D + + + E+ +++ + H NI+ L G+ T + LY++ E+ R
Sbjct: 51 MLK-DNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ--EGPLYVIVEYAAKGNLRE 107
Query: 215 ---------------IISNPEGKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLI 253
I PE +L+ Q+ G+++ R +HRD+ N+L+
Sbjct: 108 FLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167
Query: 254 DKNGVLKIADFGLA------NYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWS 307
++ V+KIADFGLA +Y+ K+ R+ W APE L Y D+WS
Sbjct: 168 TEDNVMKIADFGLARGVHDIDYY----KKTSNGRLPVKWM-APEALFDRV-YTHQSDVWS 221
Query: 308 AGCLLAEMF-LGRPIMPGRTEVEQL-------HRIFKLCGSPSEDY 345
G L+ E+F LG PG VE+L HR+ K E Y
Sbjct: 222 FGILMWEIFTLGGSPYPG-IPVEELFKLLREGHRMDKPSNCTHELY 266
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 8e-12
Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEG 191
+G+GT+ V ++ +GK A+K +K + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK- 61
Query: 192 LATSRMQYSLYLVFE-------FMQTDLARIISNPEGKLTEPQQLLSGLQHCHDRGILHR 244
+ + + L V E F R+ S + +++S L + H I++R
Sbjct: 62 -YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYG-AEIVSALDYLHSGKIVYR 119
Query: 245 DVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGID 304
D+K NL++DK+G +KI DFGL + + T Y APE +L DYG +D
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKE-GITDAATMKTFCGTPEYLAPE-VLEDNDYGRAVD 177
Query: 305 LWSAGCLLAEMFLGR 319
W G ++ EM GR
Sbjct: 178 WWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 16/214 (7%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEG 191
+G+G++ V A + T ++ A+K +K D + V+ E +L P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 192 LATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILHR 244
M LY V E++ DL I G+ EP ++ GL H +GI++R
Sbjct: 68 SCFQTMD-RLYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYR 125
Query: 245 DVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV--TLWYRAPELLLGATDYGVG 302
D+K N+++D G +KIADFG+ N +T++ T Y APE ++ YG
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAPE-IIAYQPYGKS 181
Query: 303 IDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFK 336
+D W+ G LL EM G+ G E E I +
Sbjct: 182 VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 31/210 (14%)
Query: 131 DKVGQGTYSNVYKALDRDTGKIV--ALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIV 187
D +G+G + V +A+ + G + A+K +K SE F A E+ +L KL HPNI+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDF-AGELEVLCKLGHHPNII 66
Query: 188 KLEGLATSRMQYSLYLVFEF---------------MQTDLARIISNPEGKLTEPQQLL-- 230
L G +R LY+ E+ ++TD A + QQLL
Sbjct: 67 NLLGACENRGY--LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 231 -----SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTL 285
+G+Q+ ++ +HRD+ N+L+ +N KIADFGL+ K+ + R+
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM-GRLPVR 183
Query: 286 WYRAPELLLGATDYGVGIDLWSAGCLLAEM 315
W L + Y D+WS G LL E+
Sbjct: 184 WMAIES--LNYSVYTTKSDVWSFGVLLWEI 211
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 16/198 (8%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDT---SEPHSVKFMAREIMILQKLDHPNIVKL 189
+G+G++ V A + T ++ A+K +K D + + I+ L HP + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61
Query: 190 EGLATSRMQYSLYLVFEFM-------QTDLARIISNPEGKLTEPQQLLSGLQHCHDRGIL 242
+ + L+ V E++ Q +R P + ++ L H G++
Sbjct: 62 H--CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFY-AAEVTLALMFLHRHGVI 118
Query: 243 HRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVG 302
+RD+K N+L+D G K+ADFG+ T+ T Y APE +L +YG
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGTPDYIAPE-ILQELEYGPS 176
Query: 303 IDLWSAGCLLAEMFLGRP 320
+D W+ G L+ EM G+P
Sbjct: 177 VDWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGL 192
+G+G + +V R G VA+K +K D + + F+A E ++ +L H N+V+L G+
Sbjct: 14 IGKGEFGDVMLGDYR--GNKVAVKCIKNDAT---AQAFLA-EASVMTQLRHSNLVQLLGV 67
Query: 193 ATSRMQYSLYLVFEFMQT--------DLARIISNPEGKLTEPQQLLSGLQHCHDRGILHR 244
+ LY+V E+M R + + L + +++ +HR
Sbjct: 68 IVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHR 126
Query: 245 DVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGID 304
D+ N+L+ ++ V K++DFGL S + T ++ W APE L + D
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKLPVKW-TAPEALR-EKKFSTKSD 181
Query: 305 LWSAGCLLAEMF-LGR---PIMPGRTEVEQLHRIFKL 337
+WS G LL E++ GR P +P + V ++ + +K+
Sbjct: 182 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 218
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 55/196 (28%), Positives = 91/196 (46%), Gaps = 14/196 (7%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEG 191
+G+GT+ V ++ TG+ A+K +K + V E +LQ HP + L+
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 61
Query: 192 LATSRMQYSLYLVFE-------FMQTDLARIISNPEGKLTEPQQLLSGLQHCH-DRGILH 243
+ + L V E F R+ S + +++S L + H ++ +++
Sbjct: 62 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYG-AEIVSALDYLHSEKNVVY 119
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGI 303
RD+K NL++DK+G +KI DFGL + + T Y APE +L DYG +
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMKTFCGTPEYLAPE-VLEDNDYGRAV 177
Query: 304 DLWSAGCLLAEMFLGR 319
D W G ++ EM GR
Sbjct: 178 DWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 54/196 (27%), Positives = 94/196 (47%), Gaps = 16/196 (8%)
Query: 132 KVGQGTYSNVYKAL--DRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
++G G + V K + + + K VA+K +K D ++P + RE ++Q+LD+P IV++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 190 EGLATSRMQYSLYLVFEF-----MQTDLARIISNPEGKLTE-PQQLLSGLQHCHDRGILH 243
G+ + S LV E + L + E +TE Q+ G+++ + +H
Sbjct: 62 IGICEAE---SWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYFSPNK---KRPLTSRVVTLWYRAPELLLGATDYG 300
RD+ N+L+ KI+DFGL+ ++ K + WY APE + +
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY-APE-CMNYYKFS 176
Query: 301 VGIDLWSAGCLLAEMF 316
D+WS G L+ E F
Sbjct: 177 SKSDVWSFGVLMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 52/150 (34%), Positives = 75/150 (50%), Gaps = 11/150 (7%)
Query: 173 REIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARII--SNP---EGKLTEPQ 227
REI IL+ + H I+ L + R + ++ +V + DL + S P E +T +
Sbjct: 135 REIDILKTISHRAIINL--IHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQR 192
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLT-SRVVTLW 286
+LL L + H RGI+HRDVK N+ +D+ + DFG A + P TL
Sbjct: 193 RLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLE 252
Query: 287 YRAPELLLGATD-YGVGIDLWSAGCLLAEM 315
+PELL A D Y D+WSAG +L EM
Sbjct: 253 TNSPELL--ALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 32/212 (15%)
Query: 132 KVGQGTYSNVYKA----LDRDTGK-IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
++G+G + V+ A L + K +VA+K +K + SE F RE +L L H +I
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQ-REAELLTVLQHQHI 69
Query: 187 VKLEGLATSRMQYSLYLVFEFMQ-TDLARIISN--------------PEGKLTEPQ---- 227
V+ G+ T L +VFE+M+ DL R + + G+LT Q
Sbjct: 70 VRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 228 --QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA-NYFSPNKKRPLTSRVVT 284
Q+ SG+ + +HRD+ N L+ + V+KI DFG++ + +S + R ++
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 285 LWYRAPELLLGATDYGVGIDLWSAGCLLAEMF 316
+ + PE +L + D+WS G +L E+F
Sbjct: 188 IRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 62/198 (31%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKLDHPNIVKLEG 191
+G+G + V R TGK+ A KK+ K + + E IL K+ IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 192 LATSRMQYSLYLVFEFMQT-DLARIISNPEGK---LTEPQ------QLLSGLQHCHDRGI 241
++ L LV M DL I N + + EP+ Q++SGL+H H R I
Sbjct: 61 AFQTKTD--LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRI 118
Query: 242 LHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGV 301
++RD+K N+L+D +G ++I+D GLA + + T + APELL G +Y
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLAVELK-DGQSKTKGYAGTPGFMAPELLQG-EEYDF 176
Query: 302 GIDLWSAGCLLAEMFLGR 319
+D ++ G L EM R
Sbjct: 177 SVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 81/320 (25%), Positives = 138/320 (43%), Gaps = 65/320 (20%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT----SEPHSVKFMAREIMILQK 180
E ++ I + G Y VY ++T + A+KK+ ++ V F+ R+I+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQV-FVERDILTFA- 58
Query: 181 LDHPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISN------PEGKLTEPQQLLSGL 233
++P +V + ++ L +V E+++ D A ++ N ++ + +L+ L
Sbjct: 59 -ENPFVVSMFCSFETKRH--LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLA-L 114
Query: 234 QHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLAN-------------YFSPNKKRPLTS 280
++ H+ GI+HRD+K NLLI G +K+ DFGL+ + + + L
Sbjct: 115 EYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK 174
Query: 281 RVV-TLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCG 339
+V T Y APE++L YG +D W+ G +L E +G G T E ++
Sbjct: 175 QVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI---- 229
Query: 340 SPSEDY-WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR---GSAA 395
S+D W P EA P + L+S LL +P R G A
Sbjct: 230 --SDDIEW----------------PEGDEA---LPADAQDLISRLLRQNPLERLGTGGAF 268
Query: 396 SALKNEFFFTSPLACDLSGL 415
++ FF L D +GL
Sbjct: 269 EVKQHRFF----LGLDWNGL 284
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTG-KIVALKKV-KFDTSEPHSVKFMAREIMILQKLD 182
E ++ I +G G++ V A ++ VA+K+ K + V + E IL ++
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 183 HPNIVKLEGLATSRMQYSLYLVFEFMQ-----TDLAR--IISNPEGKLTEPQQLLSGLQH 235
HP V L G + + + LYLV EF+ T L R N G Q +L ++
Sbjct: 90 HPFCVNLYG--SFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI-FEY 146
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLW----YRAPE 291
I++RD+K NLL+DK+G +K+ DFG A + + +R TL Y APE
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFA--------KVVDTRTYTLCGTPEYIAPE 198
Query: 292 LLLGATDYGVGIDLWSAGCLLAEMFLGRP 320
+LL +G D W+ G + E+ +G P
Sbjct: 199 ILLN-VGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 62/250 (24%), Positives = 103/250 (41%), Gaps = 58/250 (23%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKK-VKFDTSEPHSVKFMAREIMILQKLDH 183
E + + +G+G + V +DTGKI A+K +K + + + + E +L + D
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEP------QQLLSGLQHC 236
P +V L + QY LYL+ EF+ DL ++ + +E + + ++
Sbjct: 61 PWVVSLY-YSFQDAQY-LYLIMEFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAV 117
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF-----SPNKKRPLTSRVVT------- 284
H G +HRD+K N+LID+ G +K++DFGL+ F S ++ L +
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177
Query: 285 ------------------LW----------------YRAPELLLGATDYGVGIDLWSAGC 310
W Y APE+ L YG D WS G
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGA 236
Query: 311 LLAEMFLGRP 320
++ E +G P
Sbjct: 237 IMFECLIGWP 246
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 14/206 (6%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKLDH 183
+ ++ + +G+G + V ++TG++ A+K + K++ + E +L D
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 184 PNIVKLEGLATSRMQYSLYLVFEF-MQTDLARIISNPEGKLTEPQ------QLLSGLQHC 236
I L A LYLV ++ + DL ++S E +L E +++ +
Sbjct: 61 RWITNLH-YAFQDENN-LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGA 296
H G +HRD+K N+L+DKNG +++ADFG + V T Y +PE+L
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM 178
Query: 297 TD----YGVGIDLWSAGCLLAEMFLG 318
D YG D WS G + EM G
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 132 KVGQGTYSNVYKA----LDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIV 187
++G+G + V+ A L + KI+ K D S+ ++ K RE +L L H +IV
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-NARKDFHREAELLTNLQHEHIV 70
Query: 188 KLEGLATSRMQYSLYLVFEFMQ-TDLARII------------SNPEGKLTEPQ------Q 228
K G+ L +VFE+M+ DL + + N +LT+ Q Q
Sbjct: 71 KFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 229 LLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA-NYFSPNKKRPLTSRVVTLWY 287
+ +G+ + + +HRD+ N L+ +N ++KI DFG++ + +S + R ++ + +
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 288 RAPELLLGATDYGVGIDLWSAGCLLAEMF 316
PE ++ + D+WS G +L E+F
Sbjct: 189 MPPESIM-YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 68/240 (28%), Positives = 107/240 (44%), Gaps = 45/240 (18%)
Query: 133 VGQGTYSNVYKA----LDRDT-GKI--VALKKVKFDTSEPHSVKFMAREIMILQKLDHPN 185
+G+G + V A LD++ ++ VA+K +K D +E ++ M+ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 186 IVKLEGLATSRMQYSLYLVFEFMQTDLAR---IISNPEG------KLTEPQQLLS----- 231
I+ L G T LY++ E+ R P G P++ LS
Sbjct: 86 IINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 232 --------GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA------NYFSPNKKRP 277
G+++ + +HRD+ N+L+ ++ V+KIADFGLA +Y+ K+
Sbjct: 144 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY----KKT 199
Query: 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRIFK 336
R+ W APE L Y D+WS G LL E+F LG PG VE+L ++ K
Sbjct: 200 TNGRLPVKWM-APEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLK 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 1e-10
Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 37/228 (16%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y+ I K+G G + V+ + T + K + + + + E+ ++++L H NI
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74
Query: 187 VKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPE---GKLTE------PQQLLSGLQHC 236
V+ ++ LY++ EF DL+R I GK+ E +QLL L +C
Sbjct: 75 VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134
Query: 237 HD-------RGILHRDVKGSNLLIDK---------------NG--VLKIADFGLANYFSP 272
H+ +LHRD+K N+ + NG + KI DFGL+
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194
Query: 273 NKKRPLTSRVVTLWYRAPELLLGAT-DYGVGIDLWSAGCLLAEMFLGR 319
S V T +Y +PELLL T Y D+W+ GC++ E+ G+
Sbjct: 195 ESMA--HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 45/142 (31%), Positives = 72/142 (50%), Gaps = 19/142 (13%)
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLAN--YFSPNKKRPLTSRVVTL 285
Q+ G++ R +HRD+ N+L+ +N V+KI DFGLA Y P+ R ++R+
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241
Query: 286 WYRAPELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRIFKLCGSPSED 344
W APE + Y D+WS G LL E+F LG PG Q+ +E+
Sbjct: 242 WM-APESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGV----QI----------NEE 285
Query: 345 YWKKLRLSTTFRPPQSYKPRLF 366
+ ++L+ T R P++ P ++
Sbjct: 286 FCQRLKDGTRMRAPENATPEIY 307
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 36/205 (17%)
Query: 133 VGQGTYSNVYKALDRDTG---KIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
+G G + +V K + VA+K +K + +F+ RE ++ +LDHP IV+L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFL-REASVMAQLDHPCIVRL 61
Query: 190 EGLATSRMQYSLYLVFE---------FMQTDLARIISNPEGKLTEPQQLLSGLQHCHDRG 240
G+ L LV E +++ R I + K Q+ G+ + +
Sbjct: 62 IGVCKGEP---LMLVMELAPLGPLLKYLKKR--REIPVSDLKELA-HQVAMGMAYLESKH 115
Query: 241 ILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK---------KRPLTSRVVTLWYRAPE 291
+HRD+ N+L+ KI+DFG++ + PL WY APE
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK------WY-APE 168
Query: 292 LLLGATDYGVGIDLWSAGCLLAEMF 316
+ + D+WS G L E F
Sbjct: 169 CINYGK-FSSKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 51/184 (27%), Positives = 90/184 (48%), Gaps = 24/184 (13%)
Query: 152 IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT- 210
+VA+K ++ D ++ F+ +EI I+ +L PNI++L LA L ++ E+M+
Sbjct: 48 LVAVKMLREDANKNARNDFL-KEIKIMSRLKDPNIIRL--LAVCITSDPLCMITEYMENG 104
Query: 211 DLARIISNPEGKLTEPQ----------------QLLSGLQHCHDRGILHRDVKGSNLLID 254
DL + +S E + + Q+ SG+++ +HRD+ N L+
Sbjct: 105 DLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG 164
Query: 255 KNGVLKIADFGLA-NYFSPNKKRPLTSRVVTL-WYRAPELLLGATDYGVGIDLWSAGCLL 312
KN +KIADFG++ N +S + R V+ + W +LLG + D+W+ G L
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTL 222
Query: 313 AEMF 316
E+
Sbjct: 223 WEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 46/213 (21%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVK------FMAREIMILQKLDHPNI 186
+G+G++ V A + GK A+K + + +K MA ++L+ + HP +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVL----QKKAILKKKEQKHIMAERNVLLKNVKHPFL 58
Query: 187 VKLEGLATSRMQYS------LYLVFEFMQ-----TDLARIISNPEGKLTEPQ------QL 229
V L YS LY V +++ L R E EP+ ++
Sbjct: 59 VGL--------HYSFQTADKLYFVLDYVNGGELFFHLQR-----ERSFPEPRARFYAAEI 105
Query: 230 LSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANY-FSPNKKRPLTSRVV-TLWY 287
S L + H I++RD+K N+L+D G + + DFGL +K TS T Y
Sbjct: 106 ASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT---TSTFCGTPEY 162
Query: 288 RAPELLLGATDYGVGIDLWSAGCLLAEMFLGRP 320
APE+L Y +D W G +L EM G P
Sbjct: 163 LAPEVLR-KQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 20/232 (8%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALK----KVKFDTSEPHSVKFMAREIMILQKLDHPNIVK 188
+G+G++ V A + GK A+K K+ + E + MA ++L+ + HP +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHI--MAERNVLLKNVKHPFLVG 60
Query: 189 LEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHDRGIL 242
L + + LY V +F+ E EP+ ++ S L + H I+
Sbjct: 61 LH--YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIV 118
Query: 243 HRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVG 302
+RD+K N+L+D G + + DFGL + T+ T Y APE++ Y
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIR-KQPYDNT 176
Query: 303 IDLWSAGCLLAEMFLGRPIMPGRTEVEQ----LHRIFKLCGSPSEDYWKKLR 350
+D W G +L EM G P R E LH+ L S W L
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILE 228
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 71/257 (27%), Positives = 106/257 (41%), Gaps = 60/257 (23%)
Query: 129 KIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKLDHPNIV 187
KI +G G + V A DT + A+K + K D + V + E IL + D+ +V
Sbjct: 5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVV 64
Query: 188 KLEGLATSRMQYSLYLVFEF-----MQTDLARIISNPEGKLTE--PQQLLSGLQHCHDRG 240
KL + + + +LY V ++ M + L R+ PE L +L ++ H G
Sbjct: 65 KL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPE-VLARFYIAELTLAIESVHKMG 121
Query: 241 ILHRDVKGSNLLIDKNGVLKIADFGLANYF--SPNKK--------RPLTSRVVTLW---- 286
+HRD+K N+LID +G +K+ DFGL F + N K R + LW
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 287 --------------------------------YRAPELLLGATDYGVGIDLWSAGCLLAE 314
Y APE+LL Y D WS G +L E
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVILFE 240
Query: 315 MFLGRP--IMPGRTEVE 329
M +G+P + P TE +
Sbjct: 241 MLVGQPPFLAPTPTETQ 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 45/143 (31%), Positives = 70/143 (48%), Gaps = 19/143 (13%)
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLAN--YFSPNKKRPLTSRVVTL 285
Q+ G++ R +HRD+ N+L+ +N V+KI DFGLA Y P+ R +R+
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246
Query: 286 WYRAPELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRIFKLCGSPSED 344
W APE + Y + D+WS G LL E+F LG PG K+ E+
Sbjct: 247 WM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG----------VKI----DEE 290
Query: 345 YWKKLRLSTTFRPPQSYKPRLFE 367
+ ++L+ T R P P +++
Sbjct: 291 FCRRLKEGTRMRAPDYTTPEMYQ 313
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 133 VGQGTYSNVYKA--LDRDTGKI-VALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
+G+G + VY +D D KI A+K + T +F+ +E +I++ HPN++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFL-KEGIIMKDFSHPNVLSL 61
Query: 190 EGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQQLLSGLQHCH------DRGILH 243
G+ L ++ DL I + T + GLQ + +H
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVH 121
Query: 244 RDVKGSNLLIDKNGVLKIADFGLA------NYFSPNKKRPLTSRVVTLWYRAPELLLGAT 297
RD+ N ++D++ +K+ADFGLA Y+S + +++ W A E L
Sbjct: 122 RDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT--GAKLPVKWM-ALESLQTQK 178
Query: 298 DYGVGIDLWSAGCLLAE-MFLGRPIMP 323
+ D+WS G LL E M G P P
Sbjct: 179 -FTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 44/148 (29%), Positives = 71/148 (47%), Gaps = 10/148 (6%)
Query: 174 EIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------ 227
E +L++L HP ++ L L + LV ++DL + L Q
Sbjct: 210 EARLLRRLSHPAVLAL--LDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVAR 267
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV-TLW 286
QLLS + + H GI+HRD+K N+L++ + + DFG A + + P + T+
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 287 YRAPELLLGATDYGVGIDLWSAGCLLAE 314
APE+L G Y +D+WSAG ++ E
Sbjct: 328 TNAPEVLAG-DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 4e-10
Identities = 64/210 (30%), Positives = 95/210 (45%), Gaps = 31/210 (14%)
Query: 131 DKVGQGTYSNVYKALDRDTGKIV--ALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIV 187
D +G+G + V KA + G + A+K++K S+ F A E+ +L KL HPNI+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF-AGELEVLCKLGHHPNII 59
Query: 188 KLEGLATSRMQYSLYLVFEF---------------MQTDLARIISNPEGKLTEPQQLL-- 230
L G R LYL E+ ++TD A I+N QQLL
Sbjct: 60 NLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 231 -----SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTL 285
G+ + + +HRD+ N+L+ +N V KIADFGL+ K+ + R+
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPVR 176
Query: 286 WYRAPELLLGATDYGVGIDLWSAGCLLAEM 315
W L + Y D+WS G LL E+
Sbjct: 177 WMAIES--LNYSVYTTNSDVWSYGVLLWEI 204
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 44/149 (29%), Positives = 66/149 (44%), Gaps = 29/149 (19%)
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLAN--YFSPNKKRPLTSRVVTL 285
Q+ G++ R +HRD+ N+L+ +N V+KI DFGLA Y P+ R +R+
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240
Query: 286 WYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSP---- 341
W APE + Y D+WS G LL E IF L SP
Sbjct: 241 WM-APESIFDKV-YTTQSDVWSFGVLLWE-------------------IFSLGASPYPGV 279
Query: 342 --SEDYWKKLRLSTTFRPPQSYKPRLFEA 368
E++ ++L+ T R P+ P ++
Sbjct: 280 QIDEEFCRRLKEGTRMRAPEYATPEIYSI 308
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 53/225 (23%), Positives = 107/225 (47%), Gaps = 34/225 (15%)
Query: 120 VPKSAESYDKIDKVGQGTYSNVYKAL----DRDTGKIVALKKVKFDTSEPHSVKFMAREI 175
+P SA + ++++G+ + +YK D ++VA+K +K D + P +E
Sbjct: 2 LPLSAVRF--MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEA 58
Query: 176 MILQKLDHPNIVKLEGLATSRMQYSLYLVFEFM-QTDLARII------------SNPEGK 222
++ +L HPNIV L G+ T + + ++FE++ Q DL + S+ +G
Sbjct: 59 SLMAELHHPNIVCLLGVVTQ--EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116
Query: 223 LTEPQ----------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA-NYFS 271
+ Q+ +G+++ +H+D+ N+LI + +KI+D GL+ +S
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176
Query: 272 PNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF 316
+ R ++ + + PE ++ + D+WS G +L E+F
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 18/224 (8%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKLDH 183
+ ++ I +G+G + V + T +I A+K + K++ + E +L D
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 184 PNIVKLEGLATSRMQYSLYLVFEF-MQTDLARIISNPEGKLTEPQ------QLLSGLQHC 236
I L A Y LYLV ++ + DL ++S E +L E +++ +
Sbjct: 61 QWITTLH-YAFQDENY-LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV--TLWYRAPELLL 294
H +HRD+K N+L+D NG +++ADFG + N+ + S V T Y +PE+L
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEILQ 176
Query: 295 GATD----YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRI 334
D YG D WS G + EM G + VE +I
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 14/223 (6%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKLDH 183
E ++ + +G+G + V ++ K+ A+K + K++ + E +L D+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 184 PNIVKLEGLATSRMQYSLYLVFEF-MQTDLARIISNPEGKLTEPQ------QLLSGLQHC 236
I L + + +LYLV ++ + DL ++S E +L E +++ +
Sbjct: 61 QWITTLH--YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGA 296
H +HRD+K N+L+D NG +++ADFG + + V T Y +PE+L
Sbjct: 119 HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 297 TD----YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIF 335
D YG D WS G + EM G + VE +I
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 49/187 (26%), Positives = 81/187 (43%), Gaps = 32/187 (17%)
Query: 153 VALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFM---- 208
VA+K ++ D S+ F+ +E+ IL +L PNI +L L + L ++ E+M
Sbjct: 49 VAVKVLRPDASDNAREDFL-KEVKILSRLSDPNIARL--LGVCTVDPPLCMIMEYMENGD 105
Query: 209 -----QTDLARIISNPEGKLTEPQQLL--------SGLQHCHDRGILHRDVKGSNLLIDK 255
Q +A + L SG+++ +HRD+ N L+ K
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK 165
Query: 256 NGVLKIADFGL------ANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAG 309
N +KIADFG+ ++Y+ + PL R W +LLG + D+W+ G
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR----WMAWESVLLGK--FTTKSDVWAFG 219
Query: 310 CLLAEMF 316
L E+
Sbjct: 220 VTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 23/156 (14%)
Query: 133 VGQGTYSNVYKA-LDRDTGKI--VALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
+G+G + +V + L +D G VA+K +K D ++ E ++ DHPN++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 190 EGLA---TSRMQYSLYLV-FEFMQT-DL------ARIISNPEGKLTEPQQLL-------S 231
G+ +S + +V FM+ DL +R+ PE KL Q LL
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPE-KLPL-QTLLKFMVDIAL 124
Query: 232 GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA 267
G+++ +R +HRD+ N ++ ++ + +ADFGL+
Sbjct: 125 GMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 69/240 (28%), Positives = 106/240 (44%), Gaps = 45/240 (18%)
Query: 133 VGQGTYSNVYKA----LDRDTGK---IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPN 185
+G+G + V A +D+D VA+K +K D ++ ++ M+ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 186 IVKLEGLATSRMQYSLYLVFEFMQTDLARII---SNPEG--------KLTEPQ------- 227
I+ L G T LY++ E+ R P G KL E Q
Sbjct: 80 IINLLGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 228 ----QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA------NYFSPNKKRP 277
Q+ G+++ + +HRD+ N+L+ ++ V+KIADFGLA +Y+ K+
Sbjct: 138 SCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY----KKT 193
Query: 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRIFK 336
R+ W APE L Y D+WS G LL E+F LG PG VE+L ++ K
Sbjct: 194 TNGRLPVKWM-APEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEELFKLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 127 YDKIDKVGQGTYSNVYKAL---DRDTGKI-VALKKVKFDTSEPHSVKFMAREIMILQKLD 182
+ KI +G G + VYK L + + KI VA+K+++ TS P + K + E ++ +D
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVD 67
Query: 183 HPNIVKLEGLA-TSRMQYSLYL-----VFEFMQTDLARIISNPEGKLTEPQQLLSGLQHC 236
+P++ +L G+ TS +Q L + ++++ I S + L Q+ G+ +
Sbjct: 68 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNYL 125
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK--RPLTSRVVTLWYRAPELLL 294
+R ++HRD+ N+L+ +KI DFGLA ++K +V W A E +L
Sbjct: 126 EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM-ALESIL 184
Query: 295 GATDYGVGIDLWSAGCLLAEM 315
Y D+WS G + E+
Sbjct: 185 HRI-YTHQSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 3e-09
Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 35/168 (20%)
Query: 129 KIDKVGQGTYSNVYKAL---DRDTGKI-VALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
++ +G G + VYK + + +T KI VA+K + T +V+FM E +I+ +DHP
Sbjct: 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFM-DEALIMASMDHP 69
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTE----------PQQLLS--- 231
++V+L G+ S ++ LV + M P G L + Q LL+
Sbjct: 70 HLVRLLGVCLSP---TIQLVTQLM----------PHGCLLDYVHEHKDNIGSQLLLNWCV 116
Query: 232 ----GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275
G+ + +R ++HRD+ N+L+ +KI DFGLA ++K
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 59/226 (26%), Positives = 96/226 (42%), Gaps = 24/226 (10%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALK----KVKFDTSEPHSVKFMAREIMILQKLDHPNIVK 188
+G+G++ V A + G A+K K E + + MA ++L+ L HP +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHI--MAERNVLLKNLKHPFLVG 60
Query: 189 LEGLATSRMQYSLYLVFE-------FMQTDLARIISNPEGKLTEPQQLLSGLQHCHDRGI 241
L + + LY V + F R P + ++ S + + H I
Sbjct: 61 LH--YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFY-AAEVASAIGYLHSLNI 117
Query: 242 LHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGV 301
++RD+K N+L+D G + + DFGL + ++ T Y APE +L Y
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPEETTSTFCGTPEYLAPE-VLRKEPYDR 175
Query: 302 GIDLWSAGCLLAEMFLGRPIMPGRTEVEQ-----LHRIFKLCGSPS 342
+D W G +L EM G P R +V Q LH+ +L G +
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSR-DVSQMYDNILHKPLQLPGGKT 220
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 61/245 (24%), Positives = 97/245 (39%), Gaps = 46/245 (18%)
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV-TLW 286
Q++ L H R ++HRD+K +N+ + G++K+ DFG + +S + + S T +
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236
Query: 287 YRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW 346
Y APEL Y D+WS G +L E+ LHR FK PS+
Sbjct: 237 YLAPELW-ERKRYSKKADMWSLGVILYELL-------------TLHRPFK---GPSQR-- 277
Query: 347 KKLRLSTTFRPPQSYKPRLFEAFSEFP----ESSLGLLSTLLALDPAYRGSAASALKNEF 402
+ + L+ + FP LL LL+ +PA R + L EF
Sbjct: 278 ------------EIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEF 325
Query: 403 F-FTSPLACDLSGLPVIYDKEDELIEANQQRKIRR--ARMKHRSKTLRERRIGDQASQLT 459
+ + L D+ + E I + + +I R R+ R G S +T
Sbjct: 326 LKYVANLFQDIV-------RHSETISPHDREEILRQLQESGERAPPPSSIRYGVVTSDVT 378
Query: 460 KEETL 464
L
Sbjct: 379 HGGYL 383
|
Length = 478 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 53/189 (28%), Positives = 82/189 (43%), Gaps = 27/189 (14%)
Query: 153 VALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLYLVFEF-MQT 210
VA+K +K T+ + + E+ I+ L +H NIV L G T + + ++ E+
Sbjct: 68 VAVKMLK-PTAHSSEREALMSELKIMSHLGNHENIVNLLGACT--IGGPILVITEYCCYG 124
Query: 211 DLARIISNPEGKLTEPQQLLS-------GLQHCHDRGILHRDVKGSNLLIDKNGVLKIAD 263
DL + + LLS G+ + +HRD+ N+L+ ++KI D
Sbjct: 125 DLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICD 184
Query: 264 FGLA-------NYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF 316
FGLA NY R + + + APE + Y D+WS G LL E+F
Sbjct: 185 FGLARDIMNDSNYVVKGNAR------LPVKWMAPESIFNCV-YTFESDVWSYGILLWEIF 237
Query: 317 -LGRPIMPG 324
LG PG
Sbjct: 238 SLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 49/206 (23%), Positives = 84/206 (40%), Gaps = 34/206 (16%)
Query: 135 QGTYSNVYKAL----DRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLE 190
+GT+ ++ + + V +K VK D + V + +E +L L H NI+ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVK-DHASEIQVTLLLQESCLLYGLSHQNILPIL 74
Query: 191 GLATSRMQYSLYLVFEFMQTDLARIISNP-EGKLTEPQ------------QLLSGLQHCH 237
+ + L +L + G+ PQ Q+ G+ + H
Sbjct: 75 HVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP--------NKKRPLTSRVVTLWYRA 289
RG++H+D+ N +ID+ +KI D L+ P N+ RP+ W A
Sbjct: 135 KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK------WM-A 187
Query: 290 PELLLGATDYGVGIDLWSAGCLLAEM 315
E L+ +Y D+WS G LL E+
Sbjct: 188 LESLVN-KEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 14/212 (6%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALK--KVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLE 190
+G+G++ V A + K A+K + K + M+ ++L+ + HP +V L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 191 GLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILHR 244
+ + LY V +++ E EP+ ++ S L + H I++R
Sbjct: 63 --FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 245 DVKGSNLLIDKNGVLKIADFGLANY-FSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGI 303
D+K N+L+D G + + DFGL N ++ T Y APE +L Y +
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTT--STFCGTPEYLAPE-VLHKQPYDRTV 177
Query: 304 DLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIF 335
D W G +L EM G P R E I
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 48/211 (22%), Positives = 94/211 (44%), Gaps = 22/211 (10%)
Query: 125 ESYDKIDKVGQGTYSNVY----KALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQK 180
+ +I +G+G + V+ K ++ + G+ + L K T + + RE+ + +K
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 181 LDHPNIVKLEGLATSRMQYSLYLVFE---------FMQTDLARIISNPEGKLTEPQ---- 227
L H N+V+L GL R Y++ E F++ ++ L+ Q
Sbjct: 65 LSHKNVVRLLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122
Query: 228 --QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTL 285
Q+ G+ H + +HRD+ N L+ +K++ L+ ++ L + ++ L
Sbjct: 123 CTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 286 WYRAPELLLGATDYGVGIDLWSAGCLLAEMF 316
+ APE + D+ D+WS G L+ E+F
Sbjct: 183 RWLAPEAVQ-EDDFSTKSDVWSFGVLMWEVF 212
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 74/293 (25%), Positives = 114/293 (38%), Gaps = 57/293 (19%)
Query: 130 IDKV-GQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVK 188
I +V G G V A G+ A+K V + E+ L D +IVK
Sbjct: 36 ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK 95
Query: 189 L-EGLATS-----RMQYSLYLVFEFMQT-DLARIISNPEGKLTEP----------QQLLS 231
E A + LV ++ DL + I + K Q+L
Sbjct: 96 CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKS-RAKTNRTFREHEAGLLFIQVLL 154
Query: 232 GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGL----ANYFSPNKKRPLTSRVVTLWY 287
+ H H + ++HRD+K +N+L+ NG++K+ DFG A S + R T +Y
Sbjct: 155 AVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG---TPYY 211
Query: 288 RAPELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRIFKLCGSPSEDYW 346
APE+ Y D++S G LL E+ L RP G E +H+
Sbjct: 212 VAPEIWR-RKPYSKKADMFSLGVLLYELLTLKRP-FDGENMEEVMHKT------------ 257
Query: 347 KKLRLSTTFRP-PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASAL 398
L+ + P P S P + E +++ LL+ DP R S++ L
Sbjct: 258 ----LAGRYDPLPPSISPEMQE-----------IVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 49/193 (25%), Positives = 94/193 (48%), Gaps = 32/193 (16%)
Query: 152 IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT- 210
+VA+K ++ D ++ F+ +E+ IL +L PNI++L G+ + L ++ E+M+
Sbjct: 48 LVAVKILRPDANKNARNDFL-KEVKILSRLKDPNIIRLLGVCVD--EDPLCMITEYMENG 104
Query: 211 DLARIISN---------------PEGKLTEPQ---------QLLSGLQHCHDRGILHRDV 246
DL + +S+ P L Q+ SG+++ +HRD+
Sbjct: 105 DLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164
Query: 247 KGSNLLIDKNGVLKIADFGLA-NYFSPNKKRPLTSRVVTLWYRAPE-LLLGATDYGVGID 304
N L+ +N +KIADFG++ N ++ + R V+ + + A E +L+G + D
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASD 222
Query: 305 LWSAGCLLAEMFL 317
+W+ G L E+ +
Sbjct: 223 VWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 34/200 (17%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGL 192
V +G Y K +D VA+K +K + E M RE I+ +LD+P IV++ G+
Sbjct: 11 VKKGVYKMRKKQID------VAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGV 63
Query: 193 ATSRMQYSLYLVFEFMQTD-LARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRD 245
+ +L LV E L + +S + ++T Q+ G+++ + +HRD
Sbjct: 64 CEAE---ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRD 120
Query: 246 VKGSNLLIDKNGVLKIADFGLA-------NYFSPNK--KRPLTSRVVTLWYRAPELLLGA 296
+ N+L+ KI+DFGL+ +Y+ K PL WY APE +
Sbjct: 121 LAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK------WY-APECIN-F 172
Query: 297 TDYGVGIDLWSAGCLLAEMF 316
+ D+WS G + E F
Sbjct: 173 RKFSSRSDVWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 57/230 (24%), Positives = 102/230 (44%), Gaps = 43/230 (18%)
Query: 133 VGQGTYSNVYKAL-----DRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIV 187
+G+G + V KA R VA+K +K + + ++ + E +L++++HP+++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 188 KLEGLATSRMQYSLYLVFEF--------------------MQTDLARIIS---NPEGK-- 222
KL G + L L+ E+ + +D R S NP+ +
Sbjct: 67 KLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 223 -----LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLAN--YFSPNKK 275
++ Q+ G+Q+ + ++HRD+ N+L+ + +KI+DFGL+ Y +
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPG 324
+ R+ W A E L Y D+WS G LL E+ LG PG
Sbjct: 185 KRSKGRIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 9e-08
Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 32/222 (14%)
Query: 153 VALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTD- 211
VA+ ++ S+ F+A E + L + DH NIV+LEG+ T ++ +V E+M
Sbjct: 36 VAIHTLRAGCSDKQRRGFLA-EALTLGQFDHSNIVRLEGVITR--GNTMMIVTEYMSNGA 92
Query: 212 LARIISNPEGKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFG 265
L + EG+L Q L SG+++ + G +H+ + +L++ + V KI+ F
Sbjct: 93 LDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
Query: 266 -LANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYG---VGIDLWSAGCLLAE-MFLG-R 319
L S ++ + LW APE A Y D+WS G ++ E M G R
Sbjct: 153 RLQEDKSEAIYTTMSGKSPVLW-AAPE----AIQYHHFSSASDVWSFGIVMWEVMSYGER 207
Query: 320 PI--MPGRTEVEQLHRIFKL-----CGSPSE----DYWKKLR 350
P M G+ ++ + F+L C + D W+K R
Sbjct: 208 PYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKER 249
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 49/213 (23%), Positives = 99/213 (46%), Gaps = 28/213 (13%)
Query: 130 IDKVGQGTYSNVYKA-----LDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
++++G+ + VYK + + VA+K +K D +E + E M+ +L HP
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEAMMRSRLQHP 68
Query: 185 NIVKLEGLATSRMQYSL------------YLVFEFMQTDLARIISNPEGKLT-EP----- 226
NIV L G+ T S+ +LV +D+ + K T EP
Sbjct: 69 NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128
Query: 227 --QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGL-ANYFSPNKKRPLTSRVV 283
Q+ +G++ ++H+D+ N+L+ +KI+D GL ++ + + + + ++
Sbjct: 129 IVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 284 TLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF 316
+ + +PE ++ + + D+WS G +L E+F
Sbjct: 189 PIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 37/106 (34%), Positives = 50/106 (47%), Gaps = 17/106 (16%)
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA-------NY-FSPNKKRPLT 279
Q+ G+ + +HRDV N+L+ V KI DFGLA NY N + P+
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK 279
Query: 280 SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPG 324
+ APE + Y V D+WS G LL E+F LG+ PG
Sbjct: 280 -------WMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 33/213 (15%)
Query: 132 KVGQGTYSNVYKA----LDRDTGK-IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
++G+G + V+ A L K +VA+K +K T K RE +L L H +I
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHI 69
Query: 187 VKLEGLATSRMQYSLYLVFEFMQ-TDLARII-----------------SNPEGKLTE--- 225
VK G+ L +VFE+M+ DL + + + E L++
Sbjct: 70 VKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 226 -PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA-NYFSPNKKRPLTSRVV 283
Q+ SG+ + + +HRD+ N L+ N ++KI DFG++ + +S + R ++
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 284 TLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF 316
+ + PE ++ + D+WS G +L E+F
Sbjct: 188 PIRWMPPESIM-YRKFTTESDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-07
Identities = 41/163 (25%), Positives = 70/163 (42%), Gaps = 31/163 (19%)
Query: 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD 182
S E + + + +G + VY ++ K+ A VK + + MI + +
Sbjct: 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYA-------------VKVVKKADMINKNMV 48
Query: 183 HPNIVKLEGLATSRMQ------YSL------YLVFEFMQTDLARIISNPEGKLTEP---- 226
H + + LA S+ YSL YLV E++ + + + G E
Sbjct: 49 HQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVK 108
Query: 227 --QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA 267
++ L + H GI+HRD+K N+LI G +K+ DFGL+
Sbjct: 109 YISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 25/200 (12%)
Query: 139 SNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ 198
++VY A TG +V ++ + +K + E+++ HPNI+ + T+
Sbjct: 14 TSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW 73
Query: 199 YSLYLVFEFMQTDLAR-IISN--PEGKLTEPQ------QLLSGLQHCHDRGILHRDVKGS 249
L+++ FM A ++ PEG ++E L GL + H G +HR++K S
Sbjct: 74 --LWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQNGYIHRNIKAS 130
Query: 250 NLLIDKNGVLKIADFGLANYFS--PNKKR-------PLTSRVVTLWYRAPELL-LGATDY 299
++LI +G++ ++ GL++ +S N ++ P S V W +PELL Y
Sbjct: 131 HILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWL-SPELLRQDLYGY 187
Query: 300 GVGIDLWSAGCLLAEMFLGR 319
V D++S G E+ GR
Sbjct: 188 NVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 46/168 (27%)
Query: 136 GTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMI--LQKLDHPNIVKLEGLA 193
G + V + T K+ K +K F A E M+ L K D+PN +K
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIK-----AK--NFNAIEPMVHQLMK-DNPNFIK----- 73
Query: 194 TSRMQYSLY------LVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCHDRG 240
+ YS+ L+ ++++ DL ++ EGKL+E + QL+ L H
Sbjct: 74 ---LYYSVTTLKGHVLIMDYIKDGDLFDLLKK-EGKLSEAEVKKIIRQLVEALNDLHKHN 129
Query: 241 ILHRDVKGSNLLID-KNGVLKIADFGLA-------------NYFSPNK 274
I+H D+K N+L D + + D+GL +YFSP K
Sbjct: 130 IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPEK 177
|
Length = 267 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 51/223 (22%), Positives = 95/223 (42%), Gaps = 31/223 (13%)
Query: 134 GQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVK-----FMA--REIMILQKLDHPNI 186
GQGT++N+YK + R + + + + + +A ++ +L H ++
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHL 63
Query: 187 VKLEGLATSRMQYSLYLVFEFMQ-----TDLARIISNPEG--KLTEPQQLLSGLQHCHDR 239
VKL G+ R + + V E+++ L R +N KL +QL S L + D+
Sbjct: 64 VKLYGV-CVRDENIM--VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK 120
Query: 240 GILHRDVKGSNLLIDKNGV-------LKIADFGLANYFSPNKKRPLTSRVVTLWYRAPEL 292
++H +V G N+L+ + G+ +K++D G+ P RV + + APE
Sbjct: 121 KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI-----PITVLSREERVERIPWIAPEC 175
Query: 293 L-LGATDYGVGIDLWSAGCLLAEMFLGRPI-MPGRTEVEQLHR 333
+ G + D WS G L E+ + + E+
Sbjct: 176 IRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 57/241 (23%), Positives = 93/241 (38%), Gaps = 43/241 (17%)
Query: 153 VALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT-D 211
V +K+++ S +KF+ E + L H N+++ G T Y LV EF D
Sbjct: 25 VVVKELRVSASVQEQMKFLE-EAQPYRSLQHSNLLQCLGQCTEVTPY--LLVMEFCPLGD 81
Query: 212 L------ARIISNPEGKLTEPQQL----LSGLQHCHDRGILHRDVKGSNLLIDKNGVLKI 261
L R T Q++ GL H H +H D+ N L+ + +KI
Sbjct: 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKI 141
Query: 262 ADFGLAN-------YFSPNKKRPLTSRVVTLWYRAPELL------LGATDYGVGIDLWSA 308
D+GL++ Y +P++ V L + APEL+ L D ++WS
Sbjct: 142 GDYGLSHNKYKEDYYVTPDQL------WVPLRWIAPELVDEVHGNLLVVDQTKESNVWSL 195
Query: 309 GCLLAEMF-LGRPIMPGRTEVEQLHRIFK---------LCGSPSEDYWKKLRLSTTFRPP 358
G + E+F LG ++ + L + P D W ++ +P
Sbjct: 196 GVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCWLQPE 255
Query: 359 Q 359
Q
Sbjct: 256 Q 256
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 17/151 (11%)
Query: 129 KIDKVGQGTYSNVYKAL---DRDTGKI-VALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
K+ +G G + VYK + D + KI VA+K ++ +TS P + K + E ++ + P
Sbjct: 11 KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAGVGSP 69
Query: 185 NIVKLEG--------LATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQQLLSGLQHC 236
+ +L G L T M Y L ++++ + RI S + L Q+ G+ +
Sbjct: 70 YVCRLLGICLTSTVQLVTQLMPYGCLL--DYVRENKDRIGS--QDLLNWCVQIAKGMSYL 125
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLA 267
+ ++HRD+ N+L+ +KI DFGLA
Sbjct: 126 EEVRLVHRDLAARNVLVKSPNHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 6e-06
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 33/211 (15%)
Query: 131 DKVGQGTYSNVYKA-LDRDTGKI-VALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVK 188
D++G G + V R K V +K+++ ++ P +E+ ++L+HPN+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELR-ASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 189 LEGLATSRMQYSLYLVFEFMQT-DL-ARIISNPEGKLTEPQQLL---------SGLQHCH 237
G + Y LV EF DL + SN Q+ + SGL H
Sbjct: 60 CLGQCIESIPY--LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLA------NYFSPNKKRPLTSRVVTLWYRAPE 291
+H D+ N + + +KI D+GLA +Y+ V L + APE
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDC-----HAVPLRWLAPE 172
Query: 292 LL------LGATDYGVGIDLWSAGCLLAEMF 316
L+ L D ++WS G + E+F
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 43/158 (27%), Positives = 69/158 (43%), Gaps = 29/158 (18%)
Query: 181 LDHPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL--------- 230
L HPNI++ G + Y LVFE+ + DL +S + Q LL
Sbjct: 52 LQHPNILQCLGQCVEAIPY--LLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIA 109
Query: 231 SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTS---RVVTLWY 287
+G+ H H LH D+ N + + +K+ D+G+ S K+ + + + V L +
Sbjct: 110 AGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIG--PSRYKEDYIETEDDKCVPLRW 167
Query: 288 RAPEL-------LLGA--TDYGVGIDLWSAGCLLAEMF 316
APEL L+ A T ++W+ G L E+F
Sbjct: 168 LAPELVGEFHGGLITAEQTKPS---NVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 47/206 (22%), Positives = 96/206 (46%), Gaps = 28/206 (13%)
Query: 133 VGQGTYSNVYKA-LDRDTGKI-VALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLE 190
+G+G + +V + L++D + VA+K +K ++ E + +++ DHPN+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 191 GLATSRMQYSLY----LVFEFMQ-TDL------ARIISNPEGKLTEPQQLL--------S 231
G+ ++ Y ++ FM+ DL +R+ P P Q+L S
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP---QYLPTQMLVKFMTDIAS 123
Query: 232 GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLAN--YFSPNKKRPLTSRVVTLWYRA 289
G+++ + +HRD+ N ++++N + +ADFGL+ Y ++ +++ W
Sbjct: 124 GMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 290 PELLLGATDYGVGIDLWSAGCLLAEM 315
L Y D+WS G + E+
Sbjct: 184 ES--LADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 37/133 (27%), Positives = 64/133 (48%), Gaps = 12/133 (9%)
Query: 147 RDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFE 206
+ TG+ V ++++ + V F+ E+ + + +HPNIV AT L++V
Sbjct: 22 KPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYR--ATFIADNELWVVTS 79
Query: 207 FMQTDLAR--IISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGV 258
FM A+ I ++ ++E Q +L L + H G +HR VK S++LI +G
Sbjct: 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG- 138
Query: 259 LKIADFGLANYFS 271
K+ GL + S
Sbjct: 139 -KVYLSGLRSNLS 150
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 21/41 (51%), Positives = 30/41 (73%)
Query: 227 QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA 267
+Q+L+GL+ H GI+HRD+K NLL+ +G +KI DFG A
Sbjct: 316 RQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 38/117 (32%), Positives = 55/117 (47%), Gaps = 15/117 (12%)
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA-------NYFSPNKKRPLTS 280
Q+ +G++ + +HRD+ N+LI + ++KI DFGLA NY S S
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKG------S 300
Query: 281 RVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRIFK 336
+ L + APE + Y D+WS G LL E+F LG P EQ + K
Sbjct: 301 TFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIK 356
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 34/105 (32%), Positives = 51/105 (48%), Gaps = 15/105 (14%)
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA-------NYFSPNKKRPLTS 280
Q+ G++ + +HRD+ N+L+ + ++KI DFGLA NY S S
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG------S 298
Query: 281 RVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPG 324
+ + + APE + Y D+WS G LL E+F LG PG
Sbjct: 299 TFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 33/142 (23%), Positives = 66/142 (46%), Gaps = 13/142 (9%)
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFMQ-----TDLARIISNPEGKLTE-PQQLLSGLQHCH 237
PN+V L S + S++LV + + + +++ ++ PE + +++ L H
Sbjct: 45 PNMVCLHKYIVS--EDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALH 102
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGAT 297
GI+ RD+ +N+L+D G +++ F + + + Y APE + G +
Sbjct: 103 REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPE-VGGIS 157
Query: 298 DYGVGIDLWSAGCLLAEMFLGR 319
+ D WS G +L E+ G+
Sbjct: 158 EETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 132 KVGQGTYSNVYKALDRDTGK-----IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
++GQG++ VY+ RD K VA+K V S ++F+ E +++ ++
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHV 71
Query: 187 VKLEGLATSRMQYSLYLVFEFM-QTDLARII-------SNPEGK----LTEPQQLLS--- 231
V+L G+ S+ Q +L +V E M DL + N G+ L E Q+ +
Sbjct: 72 VRLLGV-VSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 232 -GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA-NYFSPNKKRPLTSRVVTLWYRA 289
G+ + + + +HRD+ N ++ + +KI DFG+ + + + R ++ + + A
Sbjct: 130 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 290 PELLLGATDYGVGIDLWSAGCLLAEM 315
PE L + D+WS G +L E+
Sbjct: 190 PESLKDGV-FTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 40/142 (28%), Positives = 59/142 (41%), Gaps = 24/142 (16%)
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA-------NYFSPNKKRPLTS 280
Q+ G+ + +HRD+ N+L+ + KI DFGLA NY R
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNAR---- 277
Query: 281 RVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRIFKLCG 339
+ + + APE + Y D+WS G LL E+F LG PG + +++ K
Sbjct: 278 --LPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK--- 331
Query: 340 SPSEDYWKKLRLSTTFRPPQSY 361
E Y LS P + Y
Sbjct: 332 ---EGY---RMLSPECAPSEMY 347
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 38/144 (26%), Positives = 65/144 (45%), Gaps = 16/144 (11%)
Query: 176 MILQKLDHPNIVKLEGLAT---SRMQYSLYLV---FEFMQTDLARIISNPEGKLTEP--Q 227
+ +DH I K G + RM Y L+ E + RI + KL + +
Sbjct: 75 KNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNK-KLIKNIMK 133
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWY 287
+L+ L++ H+ GI H D+K N+++D N I D+G+A++F + K S+ +
Sbjct: 134 DMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLH 193
Query: 288 RAPELLLGATDYGVGIDLWSAGCL 311
R T Y G+D + C+
Sbjct: 194 R-------GTLYYAGLDAHNGACV 210
|
Length = 294 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 33/135 (24%), Positives = 53/135 (39%), Gaps = 8/135 (5%)
Query: 140 NVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199
VY L V +K + S RE+ ILQ L + + LA+
Sbjct: 13 RVYL-LGTKDEDYV----LKINPSREKGADR-EREVAILQLLARKGLPVPKVLASGESDG 66
Query: 200 SLYLVFEFMQ-TDLARI-ISNPEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG 257
YL+ E+++ L + E + +LL+ L + H D+ N+L+D
Sbjct: 67 WSYLLMEWIEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK 126
Query: 258 VLKIADFGLANYFSP 272
+L I D+ A Y P
Sbjct: 127 ILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 25/207 (12%)
Query: 131 DKVGQGTYSNVYKALDRDTG------KIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ +GQGT++ ++K + R+ G K L KV + +S F M+ Q L H
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQ-LSHK 59
Query: 185 NIVKLEGLATSRMQYSL---YLVFEFMQTDLARIIS--NPEGKLTEPQQLLSGLQHCHDR 239
++V G+ + + Y+ F + T L + + N KL +QL L D+
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK 119
Query: 240 GILHRDVKGSNLLIDKNG--------VLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPE 291
G+ H +V N+L+ + +K++D G++ P K L R+ W PE
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP--KEILLERIP--WV-PPE 174
Query: 292 LLLGATDYGVGIDLWSAGCLLAEMFLG 318
+ + + D WS G L E+F G
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 13/119 (10%)
Query: 222 KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGV-------LKIADFGLANYFSPNK 274
K+T QQL S L + D+ ++H +V N+L+ + G+ +K++D G++ F+
Sbjct: 119 KITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALS 176
Query: 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEM-FLGRPIMPGRTEVEQLH 332
+ RV + + APE + G D WS G L E+ F G + RT E+
Sbjct: 177 RE---ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 43/205 (20%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 132 KVGQGTYSNVYKALDRDTGK-----IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
++GQG++ VY+ + + K VA+K V S ++F+ E ++++ + ++
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNCHHV 71
Query: 187 VKLEGLATSRMQYSLYLVFEFMQTDLARII--------SNPEGKLTEPQQLLS------- 231
V+L G+ S+ Q +L ++ + DL + +NP ++++
Sbjct: 72 VRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 232 GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA-NYFSPNKKRPLTSRVVTLWYRAP 290
G+ + + +HRD+ N ++ ++ +KI DFG+ + + + R ++ + + +P
Sbjct: 131 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 291 ELLLGATDYGVGIDLWSAGCLLAEM 315
E L + D+WS G +L E+
Sbjct: 191 ESLKDGV-FTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 24/66 (36%), Positives = 38/66 (57%), Gaps = 2/66 (3%)
Query: 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFK-L 337
T+ V T YR+PE++LG + D+WS GC++ E++ G+ + +E LH + K L
Sbjct: 303 TAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL 361
Query: 338 CGSPSE 343
PSE
Sbjct: 362 GRLPSE 367
|
Length = 467 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 9e-04
Identities = 18/42 (42%), Positives = 24/42 (57%), Gaps = 1/42 (2%)
Query: 227 QQLLSGLQHCHDRGILHRDVKGSNLLID-KNGVLKIADFGLA 267
+Q+L L H GI+HRDVK N++ +G KI D G A
Sbjct: 262 RQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 52/216 (24%), Positives = 96/216 (44%), Gaps = 45/216 (20%)
Query: 131 DKVGQGTYSNVY------KALDRDTG-----KIVALKKVKFDTSEPHSVKFMAREIMILQ 179
+ +G+GT + +Y K D D G +I + KV + S+ F M+ Q
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 180 KLDHPNIVKLEGLATSRMQYSLYLVFEFMQ---TDL-----ARIISNPEGKLTEPQQLLS 231
+ H +IV L G+ ++ +V EF++ DL + +++ P K +QL S
Sbjct: 61 -VSHKHIVLLYGVCVRDVEN--IMVEEFVEFGPLDLFMHRKSDVLTTP-WKFKVAKQLAS 116
Query: 232 GLQHCHDRGILHRDVKGSNLLIDKNGV-------LKIADFGLANYFSPNKKRPLT----- 279
L + D+ ++H +V N+L+ + G+ +K++D G+ P+T
Sbjct: 117 ALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI----------PITVLSRQ 166
Query: 280 SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEM 315
V + + APE + + + + D WS G L E+
Sbjct: 167 ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 584 | |||
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.98 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.52 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.45 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.36 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.35 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.3 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.25 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.07 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.96 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.96 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.92 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.81 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.7 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.67 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.61 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.44 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.4 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.39 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.38 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.36 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.3 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.11 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.09 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.02 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.0 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.96 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.78 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.77 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.73 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.71 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.71 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.7 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.64 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.61 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.6 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.56 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.46 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.45 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.29 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.2 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.17 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.14 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.03 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.99 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.89 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.86 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.76 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.74 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.62 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.49 | |
| PLN02236 | 344 | choline kinase | 96.46 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.37 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.16 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.92 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.85 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.87 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 94.44 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.43 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 94.42 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.89 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.72 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.71 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.07 |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-65 Score=527.95 Aligned_cols=322 Identities=60% Similarity=1.056 Sum_probs=299.6
Q ss_pred CccccCCCccccCCCchhhhhccCCCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHH
Q 043957 97 GKLVNGWPKWLTDNIPREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIM 176 (584)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~ 176 (584)
.....+||.|+... ..+.+.+..+..++.|+.+++||+|+||.||+|++..+|+.||+|+++++...+.......|||.
T Consensus 90 ~~~~a~~p~~l~~~-~ge~~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ 168 (560)
T KOG0600|consen 90 EQVAAGWPAWLSSV-AGEALHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIK 168 (560)
T ss_pred hhhhccCccccccc-cccccccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHH
Confidence 45678999998753 55667788999999999999999999999999999999999999999998888888888999999
Q ss_pred HHHhCCCCCeeeeeceeeecCcceEEEEEechhhHHHHHhhCCCCCCcHHH------HHHHHHHHHHhCCceeccccccc
Q 043957 177 ILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILHRDVKGSN 250 (584)
Q Consensus 177 iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~g~L~~~l~~~~~~l~~~~------qIl~aL~yLH~~~IvHrDLKp~N 250 (584)
||++|+||||++|.++........+|||+|||+.||..++..+.-.+++.+ ||+.||+|||.+||+|||||.+|
T Consensus 169 ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SN 248 (560)
T KOG0600|consen 169 ILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSN 248 (560)
T ss_pred HHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccc
Confidence 999999999999999999887778999999999999999998877777754 99999999999999999999999
Q ss_pred eeecCCCcEEEEEeccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHH
Q 043957 251 LLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQ 330 (584)
Q Consensus 251 ILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~ 330 (584)
||||.+|.+||+|||||+++.......++..+.|.||+|||+|+|...|+.++|+||+||||.||+.|+|+|++.++.+|
T Consensus 249 iLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ 328 (560)
T KOG0600|consen 249 ILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ 328 (560)
T ss_pred eEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH
Confidence 99999999999999999999888877899999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCChHHHHHh--hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q 043957 331 LHRIFKLCGSPSEDYWKKL--RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPL 408 (584)
Q Consensus 331 ~~~i~~~~~~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~ 408 (584)
+..|++.|+.|.+++|... .....+.+...+...+.+.+..++..+++|+..||..||.+|.||.++|+|+||+..|.
T Consensus 329 l~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~ 408 (560)
T KOG0600|consen 329 LHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPL 408 (560)
T ss_pred HHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCC
Confidence 9999999999999999943 34467778888899999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCccc
Q 043957 409 ACDLSGLPVIY 419 (584)
Q Consensus 409 ~~~~~~~~~~~ 419 (584)
+|+.+.||...
T Consensus 409 ~~~p~~Lp~y~ 419 (560)
T KOG0600|consen 409 PCDPSSLPKYP 419 (560)
T ss_pred CCCcccCCCCC
Confidence 99999999843
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-58 Score=443.16 Aligned_cols=292 Identities=42% Similarity=0.758 Sum_probs=256.5
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|...++||+|.||+||+|++..+|+.||||+|+.............|||+.|+.++|+||+.++++|.... .+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~--~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS--NLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC--ceEEE
Confidence 4799999999999999999999999999999999876555444455779999999999999999999987744 48999
Q ss_pred EechhhHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 205 FEFMQTDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
+|||+.+|..++++....+... .++++||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+.+... ..
T Consensus 80 fEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~-~~ 158 (318)
T KOG0659|consen 80 FEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR-IQ 158 (318)
T ss_pred EEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc-cc
Confidence 9999999999999877666543 4999999999999999999999999999999999999999999875443 34
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p 358 (584)
+..+.|.||+|||.+.|...|+..+||||.|||+.||+.|.|.|+|.++.+|+..|+...++|.++.|.++.....+..-
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 45588999999999999999999999999999999999999999999999999999999999999999998766554433
Q ss_pred CCCC-chhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCccCCCCCCccc
Q 043957 359 QSYK-PRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDLSGLPVIY 419 (584)
Q Consensus 359 ~~~~-~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~~~~~~~~~~~ 419 (584)
+... +.....|+..+.+++||+.+||.+||.+|+||.|+|+|+||++.|.+++...+|...
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p~ 300 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIPS 300 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCCc
Confidence 3222 233347788899999999999999999999999999999999999999888777653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-57 Score=452.98 Aligned_cols=297 Identities=41% Similarity=0.710 Sum_probs=259.2
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
.+++.|+.+..|++|+||+||+|+++.|++.||+|+++.+......--.-.|||.+|.+++|||||.+..+.....-..+
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 45677999999999999999999999999999999998765433322334689999999999999999999888777789
Q ss_pred EEEEechhhHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 202 YLVFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 202 ~lV~Ey~~g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
|||||||+.||..++..-...+... .|+++||+|||.+.|+||||||+|+|++..|.+||+|||+|+.+... .
T Consensus 153 y~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~ 231 (419)
T KOG0663|consen 153 YIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-L 231 (419)
T ss_pred eeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC-c
Confidence 9999999999999887655555443 49999999999999999999999999999999999999999998754 4
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC--
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST-- 353 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-- 353 (584)
.+++..+.|.||+|||.+++...|++++||||+|||+.|||+++|.|+|..+.+++.+|+...+.|.+..|..+....
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 567888999999999999999999999999999999999999999999999999999999999999999998876543
Q ss_pred -CCCCCCCCCchhhhhccC--CcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCccCCCCCCccc
Q 043957 354 -TFRPPQSYKPRLFEAFSE--FPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDLSGLPVIY 419 (584)
Q Consensus 354 -~~~~p~~~~~~~~~~~~~--~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~~~~~~~~~~~ 419 (584)
....+......+...|.. +++...+|++.+|.+||.+|.||+|+|+|.||.+.|.+++...+|.+.
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P 380 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWP 380 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCc
Confidence 233444444445555554 459999999999999999999999999999999999999988888764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-56 Score=434.04 Aligned_cols=276 Identities=36% Similarity=0.611 Sum_probs=236.2
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
+.|+.+.++|+|+||+||+|+++.||+.||||++.-...++...+-..|||++|++|+|||+|.++++|.. ...++||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--krklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--KRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--cceeEEE
Confidence 56999999999999999999999999999999996554555556667799999999999999999988866 4468999
Q ss_pred EechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 205 FEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
+|||+.+++..+......+. ...|++.|+.|||++++|||||||+||||+.+|.+||||||+|+.+.. .....
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~Y 158 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNY 158 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchh
Confidence 99999877766654333332 235999999999999999999999999999999999999999999873 33456
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC---
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF--- 355 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~--- 355 (584)
+.++.|.||+|||.+.|...|+.++|||++||++.||++|.|.|++.++.+++..|.+..+.......+-......|
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 88899999999999999889999999999999999999999999999999999999999998887665544433322
Q ss_pred -CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 356 -RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 356 -~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
.+.......+...++.++.-++||+.+||..||.+|++++|+|.||||
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 122233445666778899999999999999999999999999999999
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-56 Score=461.16 Aligned_cols=279 Identities=39% Similarity=0.695 Sum_probs=251.2
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l~ 202 (584)
.++|.++++||.|+||.||+|+.+.+|..||||+++.....-+.+-. .||+..|++|+ |||||+|.+++.+.+. .+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~-~L~ 86 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDR-ILY 86 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCc-eEe
Confidence 46799999999999999999999999999999999766555443333 47999999998 9999999999988655 799
Q ss_pred EEEechhhHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 203 LVFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
+|||||+.+|++++++++..+++. .||+.||+|+|++|+.||||||||||+.....|||+|||||+.+. ...
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~--Skp 164 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR--SKP 164 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc--cCC
Confidence 999999999999999887666654 499999999999999999999999999988899999999999875 445
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHH---hhccC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK---LRLST 353 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~---~~~~~ 353 (584)
+.+.++.|.||+|||+|+....|+.++|||++|||++|+.+-+|+|+|.++.+++.+|+.++|.|..+.|.. +....
T Consensus 165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~m 244 (538)
T KOG0661|consen 165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAM 244 (538)
T ss_pred CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHh
Confidence 678999999999999999888899999999999999999999999999999999999999999999999976 33345
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.+..|......+...++.++.++.+||.+||.+||.+||||.|+|+||||+..
T Consensus 245 nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 245 NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 66777777778888889999999999999999999999999999999999754
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-56 Score=449.94 Aligned_cols=256 Identities=31% Similarity=0.474 Sum_probs=217.4
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCCh-----HHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP-----HSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 198 (584)
.+.|.+.+.||+|+||.|.+|..+.+|+.||||++.+..... .....+.+|++||++|+|||||+++++|...+
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d- 249 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD- 249 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC-
Confidence 456889999999999999999999999999999997653322 12234679999999999999999999998754
Q ss_pred ceEEEEEechh-hHHHHHhhCCCCCC------cHHHHHHHHHHHHHhCCceeccccccceeecCC---CcEEEEEecccc
Q 043957 199 YSLYLVFEFMQ-TDLARIISNPEGKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKN---GVLKIADFGLAN 268 (584)
Q Consensus 199 ~~l~lV~Ey~~-g~L~~~l~~~~~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~---g~vKL~DFGla~ 268 (584)
+.|||||||+ |+|.+.+... ..+ ..+.||+.||.|||++||+||||||+|||+..+ -.+||+|||+|+
T Consensus 250 -s~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 250 -SSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred -ceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 4699999999 5788777642 222 234699999999999999999999999999665 679999999999
Q ss_pred ccCCCCCCCCccccccccccChhhhhCCC--CCCceeeEecchHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCChHH
Q 043957 269 YFSPNKKRPLTSRVVTLWYRAPELLLGAT--DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVE-QLHRIFKLCGSPSEDY 345 (584)
Q Consensus 269 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~--~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~-~~~~i~~~~~~~~~~~ 345 (584)
... ....+.+.||||.|.|||++.+.. .+..++||||||||||-+|+|++||....... ..++|.++...+....
T Consensus 328 ~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 328 VSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred ccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 875 445678899999999999997532 35568999999999999999999999887666 7888888887777777
Q ss_pred HHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 346 WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 346 ~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
|.+ +++++++||.+||..||++|||++|+|+||||+..+
T Consensus 406 w~~-----------------------Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 406 WDR-----------------------ISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhh-----------------------hhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 765 489999999999999999999999999999998764
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-54 Score=431.69 Aligned_cols=286 Identities=38% Similarity=0.613 Sum_probs=248.8
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeee---cCcceE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATS---RMQYSL 201 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~---~~~~~l 201 (584)
..|..++.||.|+||+|+.|.++.+|+.||||++..........+...||+.+|+.++|+||+.+.+++.. ..-..+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 45777899999999999999999999999999997666677778889999999999999999999998865 334579
Q ss_pred EEEEechhhHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC-C
Q 043957 202 YLVFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN-K 274 (584)
Q Consensus 202 ~lV~Ey~~g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~-~ 274 (584)
|+|+|+|+.+|..+++.... ++.. .|||+||.|+|+.+|+||||||.|+|++.+..+||+|||+|+..... .
T Consensus 102 YiV~elMetDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 102 YLVFELMETDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE 180 (359)
T ss_pred EEehhHHhhHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCc
Confidence 99999999999999986432 4433 39999999999999999999999999999999999999999987532 2
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc--
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS-- 352 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-- 352 (584)
...++.++.|.||+|||+++....|+.++||||+|||+.|||+|++.|+|.+..+++..|+..++.|+.+.+..+...
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a 260 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA 260 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence 344688899999999999998889999999999999999999999999999999999999999999999988887622
Q ss_pred --CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCccC
Q 043957 353 --TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACD 411 (584)
Q Consensus 353 --~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~~~ 411 (584)
.....|......+...|++.++.++|||.+||.+||.+|+|++|+|+||||..-..+.+
T Consensus 261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d 321 (359)
T KOG0660|consen 261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED 321 (359)
T ss_pred HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence 11223444555678889999999999999999999999999999999999976443433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-52 Score=442.83 Aligned_cols=251 Identities=31% Similarity=0.492 Sum_probs=219.5
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.+|...+.||+|+|+.||.+++..+|+.||+|++.+.. ......+.+.+||+|.+.|+|||||+++++|++. .++||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs--~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS--NNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC--CceEE
Confidence 67999999999999999999999999999999996543 3455677889999999999999999999999884 46899
Q ss_pred EEechh-hHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQ-TDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
|.|+|. ++|.++++ ....+++. +||+.||.|||+++|||||||..||||+++.+|||+|||||..+..+..
T Consensus 96 vLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E- 173 (592)
T KOG0575|consen 96 VLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE- 173 (592)
T ss_pred EEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc-
Confidence 999999 56777776 45566654 4999999999999999999999999999999999999999999875433
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
...+.||||.|+||||+.. ..++..+||||+|||||.||+|+|||...+-.+.+.+|.......
T Consensus 174 rk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~--------------- 237 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSM--------------- 237 (592)
T ss_pred ccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccc---------------
Confidence 3467899999999999985 569999999999999999999999999998888888886543222
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
...++.+++|||.+||+.||.+|||++++|.|+||+..-
T Consensus 238 ------------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 238 ------------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF 276 (592)
T ss_pred ------------ccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence 236789999999999999999999999999999996653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-52 Score=418.43 Aligned_cols=249 Identities=33% Similarity=0.494 Sum_probs=209.8
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
.+.+.++.||+|+.|+||+|+++.|++.+|+|+|. ...+....+++.+|+++++.++||+||.+|+.|..... .++|+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~ 156 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISIC 156 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEee
Confidence 45678889999999999999999999999999994 34556678899999999999999999999999998665 69999
Q ss_pred Eechhh-HHHHHhhCCCCCCcHH------HHHHHHHHHHHh-CCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 205 FEFMQT-DLARIISNPEGKLTEP------QQLLSGLQHCHD-RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~~~------~qIl~aL~yLH~-~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
||||++ +|..++.. .+++.+. .+|++||.|||+ ++||||||||+||||+..|.|||||||.+..+...
T Consensus 157 mEYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred hhhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 999995 55555543 3555553 599999999995 99999999999999999999999999999887543
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCC-----ChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGR-----TEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
...+.+||..|||||.+.+. .|+.++||||||++++||++|+.||... ...+++..|+. .++.
T Consensus 233 ~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~ppP-------- 300 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPPP-------- 300 (364)
T ss_pred hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCCC--------
Confidence 45788999999999999885 5999999999999999999999999875 33444444432 2221
Q ss_pred cCCCCCCCCCCchhhhhcc-CCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 352 STTFRPPQSYKPRLFEAFS-EFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~-~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
. ... .+++++.+||..||++||.+|+|+.|+|+|||++..
T Consensus 301 --------~-------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 301 --------R-------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred --------C-------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 1 112 379999999999999999999999999999999864
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=416.03 Aligned_cols=272 Identities=42% Similarity=0.682 Sum_probs=234.2
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc---eEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY---SLY 202 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~---~l~ 202 (584)
.|...+.+|.|+||+||.|....+++.||||++..+... -.+|+.+|+.++|||||++.-+|....+. ++.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 488999999999999999999999999999999654332 23699999999999999998777654433 567
Q ss_pred EEEechhhHHHHHhhC---CCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCC-CcEEEEEeccccccCC
Q 043957 203 LVFEFMQTDLARIISN---PEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKN-GVLKIADFGLANYFSP 272 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~---~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~-g~vKL~DFGla~~~~~ 272 (584)
+|||||+.+|.+.+.. .+.+++.. .||++||.|||+.||+||||||.|||||.+ |.+||||||.|+.+..
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 8999999999998873 12333322 399999999999999999999999999986 8999999999999875
Q ss_pred CCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
++ +..++..|.+|+|||.+.|...|+.+.||||.||++.||+.|+|.|+|++..+++..|++..|.|+.+....+...
T Consensus 179 ~e--pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 179 GE--PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred CC--CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 54 3478889999999999999999999999999999999999999999999999999999999999999988887655
Q ss_pred -CCCCCCCCCCchhhh-hccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 353 -TTFRPPQSYKPRLFE-AFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 353 -~~~~~p~~~~~~~~~-~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
..+..|.-....+.+ ....+++++.+|+.++|+++|.+|.|+.|+|.||||.+
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE 311 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence 334445444445545 45789999999999999999999999999999999975
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-51 Score=412.64 Aligned_cols=284 Identities=45% Similarity=0.751 Sum_probs=241.9
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCC-eeeeeceeeecC----c
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPN-IVKLEGLATSRM----Q 198 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~----~ 198 (584)
...|..+++||+|+||+||+|+++.+|+.||+|+++.+...+..-....+|+.+|+.|+|+| ||.+++++.... .
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34588889999999999999999999999999999877554333344678999999999999 999999887744 2
Q ss_pred ceEEEEEechhhHHHHHhhCCC---CCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccc
Q 043957 199 YSLYLVFEFMQTDLARIISNPE---GKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 199 ~~l~lV~Ey~~g~L~~~l~~~~---~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
..++|||||++.+|...+.... ..+ ....||+.||+|||+++|+||||||.||||+++|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 3689999999999888876533 122 2345999999999999999999999999999999999999999997
Q ss_pred cCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 270 FSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 270 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
+.-. ....+..++|.||+|||++++...|+..+||||+|||++||+++++.|++..+.+++..|++..+.|.+..|+.+
T Consensus 170 ~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 170 FSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred hcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 7533 234678899999999999999888999999999999999999999999999999999999999999999999988
Q ss_pred hccCCCCC--CCCC-CchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q 043957 350 RLSTTFRP--PQSY-KPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPL 408 (584)
Q Consensus 350 ~~~~~~~~--p~~~-~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~ 408 (584)
.....+.. +... ...+...++..+.++.+|+.+||+.||.+|.||+.+|.||||...+.
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 76544442 2222 33455666777789999999999999999999999999999987543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=401.48 Aligned_cols=283 Identities=28% Similarity=0.425 Sum_probs=234.1
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
+.|++.+.||+|.|++||++.+..+|+.+|+|+|..........+.+.+|+.|-+.|+|||||++.+.+.. ....|||
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~--~~~~ylv 88 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYLV 88 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc--cceeEEE
Confidence 56999999999999999999999999999999997776666678889999999999999999999887655 4568999
Q ss_pred Eechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecC---CCcEEEEEeccccccCCCC
Q 043957 205 FEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDK---NGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~---~g~vKL~DFGla~~~~~~~ 274 (584)
+|+|.| +|..-|... ..+++ .+||+.||.|||.++|||||+||+|+|+-. ...+||+|||+|..+. .
T Consensus 89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~ 165 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--D 165 (355)
T ss_pred EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--C
Confidence 999996 565544432 22333 259999999999999999999999999933 3469999999999887 3
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.......+|||.|||||++.. .+|+..+|||+.|||||.||.|++||.+++...++++|.......+..+|
T Consensus 166 g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w-------- 236 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW-------- 236 (355)
T ss_pred ccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc--------
Confidence 345678899999999999986 46999999999999999999999999999999999999988777666555
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCccCCCCCCcccchhHHHHHHHHHHHH
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDLSGLPVIYDKEDELIEANQQRKI 434 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 434 (584)
+++++++++||++||..||.+|+|+.|+|+|||+.+... ....-...+..+.+.+.+.+||.
T Consensus 237 ---------------~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~---~As~~H~~dtvd~lrkfNarRKL 298 (355)
T KOG0033|consen 237 ---------------DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRER---VASAIHRQDTVDCLKKFNARRKL 298 (355)
T ss_pred ---------------CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHH---HHHHhhhHHHHHHHHHhhHHHHH
Confidence 567999999999999999999999999999999976321 11112233555667777766666
Q ss_pred HHHHH
Q 043957 435 RRARM 439 (584)
Q Consensus 435 ~~~~~ 439 (584)
+.+-+
T Consensus 299 KgavL 303 (355)
T KOG0033|consen 299 KGAIL 303 (355)
T ss_pred HHHHH
Confidence 55443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=409.21 Aligned_cols=254 Identities=31% Similarity=0.489 Sum_probs=215.7
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE-PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
...++|++++.||+|+||.||.++.+++++.||+|++++.... ....+.+..|..||.+++||.||.+ +|..++...
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l--~ysFQt~~k 99 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKL--IYSFQTEEK 99 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeee--EEecccCCe
Confidence 3456899999999999999999999999999999999765433 3467788999999999999999999 555666778
Q ss_pred EEEEEechhh-HHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQT-DLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+|||+||+.| .|...+. .++.+.+. .+|+.||.|||++|||||||||+|||||.+|+|+|+|||||+..-..
T Consensus 100 LylVld~~~GGeLf~hL~-~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQ-REGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEEEeccCCccHHHHHH-hcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 9999999996 5666555 45666664 38999999999999999999999999999999999999999864433
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
. ....+.|||+.|||||++.+. .|+..+|+|||||++||||+|.+||.+++.....+.|........
T Consensus 179 ~-~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~----------- 245 (357)
T KOG0598|consen 179 G-DATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLP----------- 245 (357)
T ss_pred C-CccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCC-----------
Confidence 2 334668999999999999975 699999999999999999999999999999988888866431111
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC----CHHHHhcCcCCCCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG----SAASALKNEFFFTS 406 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp----Ta~e~L~Hp~f~~~ 406 (584)
...++.++++||+++|..||.+|. .++++-+||||...
T Consensus 246 ---------------p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 246 ---------------PGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred ---------------CccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 123688999999999999999995 78999999999764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=416.76 Aligned_cols=256 Identities=35% Similarity=0.529 Sum_probs=220.3
Q ss_pred CCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCc
Q 043957 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 121 ~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 198 (584)
.....+|..++.||+|+|++|++|+++.+++.||||++.+.- ..+..++.+.+|-.+|.+| .||.||+|+ +++.++
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy--~TFQD~ 146 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLY--FTFQDE 146 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEE--EEeecc
Confidence 345678999999999999999999999999999999986542 2333456678899999999 799999995 555556
Q ss_pred ceEEEEEechh-hHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccC
Q 043957 199 YSLYLVFEFMQ-TDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS 271 (584)
Q Consensus 199 ~~l~lV~Ey~~-g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~ 271 (584)
..+|+|+||++ |+|+.+|..- +.+.+. .||+.||+|||++|||||||||||||||.||++||+|||.|+.+.
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 77999999998 7899988753 566554 499999999999999999999999999999999999999998875
Q ss_pred CCCCC------------CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 043957 272 PNKKR------------PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCG 339 (584)
Q Consensus 272 ~~~~~------------~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~ 339 (584)
+.... ...+++||..|++||+|.. ...++.+|||+||||||.|+.|.|||.+.++...+++|+....
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y 304 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY 304 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc
Confidence 32211 1256899999999999976 5689999999999999999999999999999999999988755
Q ss_pred CCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 340 SPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
.++ .++++.+.|||.++|..||.+|+|++|+-+||||....
T Consensus 305 ~fp---------------------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 305 EFP---------------------------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred cCC---------------------------CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence 444 46789999999999999999999999999999997643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-49 Score=399.16 Aligned_cols=255 Identities=33% Similarity=0.510 Sum_probs=217.8
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..++|.+.+.||+|+||+||+|+++.++..||||.|.+........+.+..||.||+.|+|||||.++++++.. .++|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~--~~i~ 85 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD--DFIY 85 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC--CeEE
Confidence 45579999999999999999999999999999999988777778888999999999999999999999988874 4799
Q ss_pred EEEechh-hHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCC------CcEEEEEeccccc
Q 043957 203 LVFEFMQ-TDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKN------GVLKIADFGLANY 269 (584)
Q Consensus 203 lV~Ey~~-g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~------g~vKL~DFGla~~ 269 (584)
||||||. |+|..++... +.+.+. .||+.||++||+++||||||||.||||+.. -.+||+|||+|+.
T Consensus 86 lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999 6888888754 355553 499999999999999999999999999664 3589999999999
Q ss_pred cCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 270 FSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 270 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
+.+. ....+.||+|.|||||++.. ..|+.|+|+||+|+|||+|++|++||...+..+.+..+.+.....+
T Consensus 165 L~~~--~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~------- 234 (429)
T KOG0595|consen 165 LQPG--SMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVP------- 234 (429)
T ss_pred CCch--hHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccC-------
Confidence 8743 34578899999999999975 4699999999999999999999999999999888875544322111
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
.....++....+|+..+|+.+|..|.+..+.+.|+++...|
T Consensus 235 -----------------~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 235 -----------------VLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred -----------------chhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 01123456667999999999999999999999999998765
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=416.47 Aligned_cols=272 Identities=33% Similarity=0.552 Sum_probs=221.3
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-C-----CCeeeeeceeeecCc
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-H-----PNIVKLEGLATSRMQ 198 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-H-----pnIv~l~~~~~~~~~ 198 (584)
.+|.+++.||+|+||.|.+|.+..|++.||||+++.. .....+...|+.||..|+ | -|||+++++|.+ .
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r 260 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--R 260 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--c
Confidence 3799999999999999999999999999999999743 334455667999999996 4 389999999988 4
Q ss_pred ceEEEEEechhhHHHHHhhCCCCC-C------cHHHHHHHHHHHHHhCCceeccccccceeecCC--CcEEEEEeccccc
Q 043957 199 YSLYLVFEFMQTDLARIISNPEGK-L------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKN--GVLKIADFGLANY 269 (584)
Q Consensus 199 ~~l~lV~Ey~~g~L~~~l~~~~~~-l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~--g~vKL~DFGla~~ 269 (584)
+++|||+|+++.+|+++++..... + .+..||+.||.+||+.+|||+|||||||||... ..|||+|||+|+.
T Consensus 261 ~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 261 NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 578999999999999999865432 2 233599999999999999999999999999654 3699999999998
Q ss_pred cCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 270 FSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 270 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
.... ..+++-+..|+|||+|+|. +|+.+.||||||||++||++|.|+|+|.++.+++..|+...|.|+...+...
T Consensus 341 ~~q~----vytYiQSRfYRAPEVILGl-pY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 341 ESQR----VYTYIQSRFYRAPEVILGL-PYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cCCc----ceeeeeccccccchhhccC-CCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 6432 3477889999999999985 5999999999999999999999999999999999999999999997666543
Q ss_pred hccCCCCCC-----C--------------------------C----CCchhhhhcc-CCcHhHHHHHHHhcccCCCCCCC
Q 043957 350 RLSTTFRPP-----Q--------------------------S----YKPRLFEAFS-EFPESSLGLLSTLLALDPAYRGS 393 (584)
Q Consensus 350 ~~~~~~~~p-----~--------------------------~----~~~~~~~~~~-~~s~~~~dLI~~~L~~DP~kRpT 393 (584)
.....+... . . ....+...+. .-...++|||.+||.+||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 322111110 0 0 0111112222 22346799999999999999999
Q ss_pred HHHHhcCcCCCCC
Q 043957 394 AASALKNEFFFTS 406 (584)
Q Consensus 394 a~e~L~Hp~f~~~ 406 (584)
+.|+|+||||...
T Consensus 496 p~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 496 PAQALNHPFLTGT 508 (586)
T ss_pred HHHHhcCcccccc
Confidence 9999999999854
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=407.42 Aligned_cols=262 Identities=31% Similarity=0.504 Sum_probs=215.4
Q ss_pred CCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 121 ~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
....++|++++.||+|+||.||+|+.+.||..||+|++++.. .....++.+..|-.+|...++|.||+| ||.+.+..
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKL--yYsFQD~~ 214 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKL--YYSFQDKE 214 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEE--EEEecCCC
Confidence 446789999999999999999999999999999999997653 345667888999999999999999999 55555677
Q ss_pred eEEEEEechhh-HHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQT-DLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~g-~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
++||||||++| ++..++.. .+.+++- .+++.|+.-||+.|+|||||||+|+|||..|++||+|||||..+..
T Consensus 215 ~LYLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred eeEEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 89999999995 66666654 3455443 3899999999999999999999999999999999999999953311
Q ss_pred ----------------------CCC------------------------CCCccccccccccChhhhhCCCCCCceeeEe
Q 043957 273 ----------------------NKK------------------------RPLTSRVVTLWYRAPELLLGATDYGVGIDLW 306 (584)
Q Consensus 273 ----------------------~~~------------------------~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIw 306 (584)
.+. ....+.+|||.||||||+++. +|+..+|+|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k-gY~~~cDwW 372 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK-GYGKECDWW 372 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC-CCCccccHH
Confidence 000 012356899999999999984 599999999
Q ss_pred cchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhccc
Q 043957 307 SAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLAL 386 (584)
Q Consensus 307 SLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~ 386 (584)
|||||+||||.|.|||.+++..+...+|+... .. ...|. -..++++++|||.+||.
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr---------~~-----l~fP~---------~~~~s~eA~DLI~rll~- 428 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWR---------ET-----LKFPE---------EVDLSDEAKDLITRLLC- 428 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh---------hh-----ccCCC---------cCcccHHHHHHHHHHhc-
Confidence 99999999999999999999999999987642 11 01111 12457999999999999
Q ss_pred CCCCCCC---HHHHhcCcCCCCCCCcc
Q 043957 387 DPAYRGS---AASALKNEFFFTSPLAC 410 (584)
Q Consensus 387 DP~kRpT---a~e~L~Hp~f~~~~~~~ 410 (584)
||++|.- ++|+-+||||....+..
T Consensus 429 d~~~RLG~~G~~EIK~HPfF~~v~W~~ 455 (550)
T KOG0605|consen 429 DPENRLGSKGAEEIKKHPFFKGVDWDH 455 (550)
T ss_pred CHHHhcCcccHHHHhcCCccccCCcch
Confidence 9999975 89999999998765543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=393.97 Aligned_cols=276 Identities=41% Similarity=0.722 Sum_probs=227.2
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.+.||.|+||.||+|.+..++..||+|+++..... .....+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 80 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHT--ERCLTL 80 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEE
Confidence 35699999999999999999999999999999999654322 223456789999999999999999998766 346899
Q ss_pred EEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 204 VFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||||+.++|...+......+.+ ..||+.||+|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~ 159 (288)
T cd07871 81 VFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KT 159 (288)
T ss_pred EEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-cc
Confidence 9999999888877654333332 3599999999999999999999999999999999999999997653222 22
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC--
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF-- 355 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-- 355 (584)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....|..+.....+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 345578999999999877666899999999999999999999999999999999999999999999888775432211
Q ss_pred -CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 356 -RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 356 -~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
..+.............++.++++||.+||++||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 112222222334456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=406.69 Aligned_cols=252 Identities=32% Similarity=0.492 Sum_probs=216.4
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCc
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE---PHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQ 198 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~---~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~ 198 (584)
..+.|.+.+.||+|+||.|++|.+..++..||+|++...... ....+.+.+|+.+++.++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456799999999999999999999999999999977654111 234566779999999999 9999999999988554
Q ss_pred ceEEEEEechhh-HHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCC-CcEEEEEecccccc
Q 043957 199 YSLYLVFEFMQT-DLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKN-GVLKIADFGLANYF 270 (584)
Q Consensus 199 ~~l~lV~Ey~~g-~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~-g~vKL~DFGla~~~ 270 (584)
+|||||||.| +|++.+.. .+++.+. +||+.||+|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus 95 --~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 95 --IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred --EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 8999999995 89999987 6677663 499999999999999999999999999999 99999999999987
Q ss_pred CCCCCCCCccccccccccChhhhhCCC-CCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 271 SPNKKRPLTSRVVTLWYRAPELLLGAT-DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 271 ~~~~~~~~~~~~gt~~Y~APEvl~~~~-~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
. .....+.+.+||+.|+|||++.+.. ..+.++|||||||+||.|++|+.||...+....+..|.+.....+
T Consensus 172 ~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p------- 243 (370)
T KOG0583|consen 172 P-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIP------- 243 (370)
T ss_pred C-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCC-------
Confidence 4 2334568889999999999998865 446899999999999999999999999888888777654322211
Q ss_pred hccCCCCCCCCCCchhhhhccCC-cHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEF-PESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~-s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
..+ +.++.+||.+||..||.+|+|+.+++.||||+.
T Consensus 244 --------------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 244 --------------------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred --------------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 233 899999999999999999999999999999987
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-50 Score=388.42 Aligned_cols=243 Identities=31% Similarity=0.520 Sum_probs=208.6
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
.+|+++++||+|+||.||++.+..+|..||+|.|.....+....+.+..|+.+|++|+|||||+++++-..++...++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 35999999999999999999999999999999999888888888999999999999999999999986555556679999
Q ss_pred Eechh-hHHHHHhhC---CCCCCcH------HHHHHHHHHHHHh--CC--ceeccccccceeecCCCcEEEEEecccccc
Q 043957 205 FEFMQ-TDLARIISN---PEGKLTE------PQQLLSGLQHCHD--RG--ILHRDVKGSNLLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 205 ~Ey~~-g~L~~~l~~---~~~~l~~------~~qIl~aL~yLH~--~~--IvHrDLKp~NILl~~~g~vKL~DFGla~~~ 270 (584)
||||. |+|.++++. ....+++ +.|++.||.+||. .. |+||||||.||+|+.+|.|||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999 788888763 2333433 3499999999998 45 999999999999999999999999999998
Q ss_pred CCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 271 SPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 271 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
... .....+.+|||+||+||++.+ .+|+.++|||||||++|||+.-++||.+++-.++-.+|......|-.+
T Consensus 179 ~s~-~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~------ 250 (375)
T KOG0591|consen 179 SSK-TTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD------ 250 (375)
T ss_pred cch-hHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH------
Confidence 643 445678899999999999987 569999999999999999999999999998777777775543221110
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCH
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSA 394 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa 394 (584)
..+|.++..||..|+..||..||+.
T Consensus 251 -------------------~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 -------------------EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred -------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence 2457889999999999999999986
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=355.45 Aligned_cols=277 Identities=43% Similarity=0.761 Sum_probs=243.4
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
.|+..++||+|+||+||+|+++.+++.||+|.++.+...+..-....+||-+|+.|+|.|||+++++... +..+-+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs--dkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--CceeEEeH
Confidence 5888899999999999999999999999999998877666555667799999999999999999998766 44589999
Q ss_pred echhhHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCc
Q 043957 206 EFMQTDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLT 279 (584)
Q Consensus 206 Ey~~g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 279 (584)
|||..+|...+..-++.+... .|+++||.|+|+++++||||||.|+||+.+|.+||+|||+++.+.-.- +..+
T Consensus 81 e~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv-rcys 159 (292)
T KOG0662|consen 81 EFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCYS 159 (292)
T ss_pred HHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce-Eeee
Confidence 999999998887766665433 499999999999999999999999999999999999999999876432 2345
Q ss_pred cccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCC
Q 043957 280 SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358 (584)
Q Consensus 280 ~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p 358 (584)
..+.|.||++|.++.+.+-|+...|+||.|||+.||.. |+|.|++.+..+++.+|+...+.|.++.|..+.....+.+-
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 66789999999999999999999999999999999986 89999999999999999999999999999988766555544
Q ss_pred CCCC--chhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 359 QSYK--PRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 359 ~~~~--~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
+.+. ..+....+++.....||++++|..+|..|++|+++|+||||..
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 4333 3566777888889999999999999999999999999999975
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=384.29 Aligned_cols=276 Identities=34% Similarity=0.583 Sum_probs=220.9
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++.+.||+|+||.||+|++..++..||||++..........+.+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR--RGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec--CCEEEEE
Confidence 36999999999999999999999999999999997654444455678899999999999999999988866 3468999
Q ss_pred EechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 205 FEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
|||+.+++...+......+. +..||+.||.|||+.+|+||||||+|||++.++.+||+|||++..+........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 99999877766654333333 335999999999999999999999999999999999999999987654333333
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC--
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR-- 356 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-- 356 (584)
....||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+....+..+...+........+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 456789999999999764 48999999999999999999999999998888887777777766665554332211110
Q ss_pred -CCC--CCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 357 -PPQ--SYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 357 -~p~--~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
.+. ............++.++.+||.+||++||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 010 01111122234578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-48 Score=377.57 Aligned_cols=250 Identities=27% Similarity=0.446 Sum_probs=215.0
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
...++|++++.||.|+||.|.+++++.+|..||+|++.+... .-..++...+|..+|+.+.||+++++++.+.+ ...
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d--~~~ 118 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD--NSN 118 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc--CCe
Confidence 455789999999999999999999999999999999975432 33456778899999999999999999665554 667
Q ss_pred EEEEEechhhH-HHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQTD-LARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~g~-L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+||||||++|+ |...+. ..+++++. .||+.||+|||+++|++|||||||||||.+|.+||+|||+|+.+...
T Consensus 119 lymvmeyv~GGElFS~Lr-k~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLR-KSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEEEeccCCccHHHHHH-hcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999965 555544 34555553 49999999999999999999999999999999999999999987643
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
..+.||||.|+|||++.. ++|+.++|.|+|||++|||+.|++||...+....+++|+...-.++
T Consensus 198 ----T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP----------- 261 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP----------- 261 (355)
T ss_pred ----EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC-----------
Confidence 367899999999999986 5799999999999999999999999999999999999987644333
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFTS 406 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~~ 406 (584)
+.++.+++|||.++|+.|-.+|. -..++..||||...
T Consensus 262 ----------------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 262 ----------------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred ----------------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 45689999999999999999993 56789999999864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=406.29 Aligned_cols=250 Identities=36% Similarity=0.531 Sum_probs=220.7
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|.+.+.||+|+||.||+|+.+.+.+.||||.+.+........+.+.+|++|++.|+|||||.++++|+. ..++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt--~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET--SAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc--cceEEEE
Confidence 57999999999999999999999999999999998877777788999999999999999999999998877 5569999
Q ss_pred EechhhHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 205 FEFMQTDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
.|||.|+|..++.+ ++.+.+. .+++.||.|||+++|+|||+||.|||++..|.+||||||+|+.+..+ ....
T Consensus 80 te~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vl 157 (808)
T KOG0597|consen 80 TEYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSVL 157 (808)
T ss_pred ehhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC-ceee
Confidence 99999999998875 4455543 48999999999999999999999999999999999999999998753 4456
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p 358 (584)
++..|||.|||||++.+ ..|+..+|+||||||+|||+.|+|||....-......|.+-...+
T Consensus 158 tsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~----------------- 219 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP----------------- 219 (808)
T ss_pred eeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC-----------------
Confidence 78899999999999986 569999999999999999999999999887777777765421111
Q ss_pred CCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 359 ~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
...++..+..||..+|.+||.+|+|=.++|.|||++..
T Consensus 220 ----------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 220 ----------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred ----------cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 13568899999999999999999999999999998754
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=381.68 Aligned_cols=283 Identities=37% Similarity=0.640 Sum_probs=231.1
Q ss_pred CceEEeeecccCceEEEEEEECCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGK----IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
.|++++.||+|+||.||+|..+.++. .+|||+++-............||+.+++.|+||||+.+..++... +..+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~v 103 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-DKKV 103 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-CceE
Confidence 49999999999999999997665543 789999976544333344566899999999999999999988765 5579
Q ss_pred EEEEechhhHHHHHhhCCCCC----C------cHHHHHHHHHHHHHhCCceeccccccceeecCC----CcEEEEEeccc
Q 043957 202 YLVFEFMQTDLARIISNPEGK----L------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKN----GVLKIADFGLA 267 (584)
Q Consensus 202 ~lV~Ey~~g~L~~~l~~~~~~----l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~----g~vKL~DFGla 267 (584)
||++||.+.+|+.+|...... + ++..||+.|+.|||++.|+||||||.||||..+ |.|||+|||++
T Consensus 104 ~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 104 WLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred EEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 999999999999998742221 1 233599999999999999999999999999777 89999999999
Q ss_pred cccCCCCCC--CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCC---------hHHHHHHHHH
Q 043957 268 NYFSPNKKR--PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRT---------EVEQLHRIFK 336 (584)
Q Consensus 268 ~~~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~---------~~~~~~~i~~ 336 (584)
+.+...-.. ....++.|.||+|||.++|...|++++|||++|||+.|||+-.|.|.+.. ..+++.+|++
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~ 263 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFE 263 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHH
Confidence 988643321 13456789999999999999999999999999999999999999998753 3688999999
Q ss_pred hcCCCChHHHHHhhccCCCC-----CC--CCCC---chhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 337 LCGSPSEDYWKKLRLSTTFR-----PP--QSYK---PRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~-----~p--~~~~---~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
+++.|....|..+.....+. .+ .... ..+......-++.+.+||.+||++||.+|+|++++|+|+||...
T Consensus 264 vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d 343 (438)
T KOG0666|consen 264 VLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTED 343 (438)
T ss_pred HcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence 99999999999876554431 01 1111 12333344456779999999999999999999999999999988
Q ss_pred CCc
Q 043957 407 PLA 409 (584)
Q Consensus 407 ~~~ 409 (584)
+.+
T Consensus 344 ~lp 346 (438)
T KOG0666|consen 344 PLP 346 (438)
T ss_pred CCC
Confidence 655
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=382.12 Aligned_cols=276 Identities=37% Similarity=0.628 Sum_probs=218.0
Q ss_pred CCceEEeeecccCceEEEEEEECC-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC---CCCCeeeeeceeee---cC
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRD-TGKIVALKKVKFDTSEPHSVKFMAREIMILQKL---DHPNIVKLEGLATS---RM 197 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~---~~ 197 (584)
.+|++.+.||+|+||.||+|.+.. ++..||||+++...........+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 369999999999999999999854 478899999976544333344556788777766 69999999998753 22
Q ss_pred cceEEEEEechhhHHHHHhhCCC-CCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccccc
Q 043957 198 QYSLYLVFEFMQTDLARIISNPE-GKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 198 ~~~l~lV~Ey~~g~L~~~l~~~~-~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~ 270 (584)
...+++||||+.++|...+.... ..+ .+..||+.||.|||+++|+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 34689999999998888775422 223 23459999999999999999999999999999999999999999876
Q ss_pred CCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 271 SPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 271 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.++.+.+..++...+.+....|....
T Consensus 161 ~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 161 SFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred cCC--cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 433 22345678999999999976 458999999999999999999999999999999999999888877766664432
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
..............+....+.+++.+.+||.+||+.||++|||+.|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 11111111111223334456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=402.62 Aligned_cols=252 Identities=29% Similarity=0.516 Sum_probs=213.6
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
....|...++||+|+.|.||.|....++..||||++.+.... ..+.+.+|+.+|+.++|+|||.+++-|... ..+|
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--deLW 346 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLVG--DELW 346 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhccc--ceeE
Confidence 345799999999999999999999999999999999765544 346688999999999999999999887764 4589
Q ss_pred EEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 203 LVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
+|||||+| +|.+++.. ..+.+ ++++|.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+.....
T Consensus 347 VVMEym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred EEEeecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999995 56666653 22333 45899999999999999999999999999999999999999998875543
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
.-.+.+|||+|||||++.. +.|++++||||||+++.||+.|.|||-.++....+..|.. .+.|..
T Consensus 425 -KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~l------------ 489 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKL------------ 489 (550)
T ss_pred -ccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCc------------
Confidence 3477899999999999976 5699999999999999999999999998887777666533 333332
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.....++..++|||.+||+.|+.+|+||.|+|+||||...
T Consensus 490 -----------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 490 -----------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred -----------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 2234679999999999999999999999999999999643
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=385.77 Aligned_cols=279 Identities=40% Similarity=0.682 Sum_probs=219.3
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.+.||+|+||.||+|.+..+++.||||++....... ....+.+|+.+++.++||||+++++++... ..+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHTK--ETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEecC--CeEEE
Confidence 467999999999999999999999999999999986543222 233567899999999999999999988764 46899
Q ss_pred EEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 204 VFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||||+.++|...+......+.. ..||+.||+|||+++|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 159 (303)
T cd07869 81 VFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HT 159 (303)
T ss_pred EEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-cc
Confidence 9999999988877654433333 3599999999999999999999999999999999999999997543222 22
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE-VEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+..+ .+.+..+....+.+....|........+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 34567899999999987766689999999999999999999999987544 46667777777777777776543221111
Q ss_pred CCC---CCCchhhhhcc--CCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 357 PPQ---SYKPRLFEAFS--EFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 357 ~p~---~~~~~~~~~~~--~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
... .....+...+. .+++.+.+||.+||++||.+|||+.|+|+||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 100 01111122222 356789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=403.59 Aligned_cols=251 Identities=29% Similarity=0.465 Sum_probs=217.2
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecC-CCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD-TSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~-~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
.+-|++.+.||.|+.|.|.+|++..||+.+|||+|.+. .........+.+||-||+.|.||||+++|++++. +.++|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~--~~~ly 88 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN--KQHLY 88 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc--CceEE
Confidence 45599999999999999999999999999999999665 3344445678899999999999999999998877 44689
Q ss_pred EEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 203 LVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 203 lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
+|.||+. |.|.+.+.. .+.+.+ +.||+.||.|||..+|+||||||+|+|||..+.|||+|||+|....++
T Consensus 89 lvlEyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-- 165 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-- 165 (786)
T ss_pred EEEEecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC--
Confidence 9999999 467777764 344433 359999999999999999999999999999999999999999875433
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
..+.+.||+|.|.|||++.|..+.+.++||||+|||||.||+|+.||.+.+...++.++..+.
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~----------------- 228 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV----------------- 228 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc-----------------
Confidence 456788999999999999998888999999999999999999999999888777777765432
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
+++...+|.++.+||.+||..||++|+|.+|+++|||+...
T Consensus 229 ----------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 229 ----------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred ----------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 34446889999999999999999999999999999999654
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=394.46 Aligned_cols=258 Identities=34% Similarity=0.512 Sum_probs=222.4
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcce
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP-HSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~ 200 (584)
....|++.+.||+|.||+||+|+++.+|+.+|+|++.+..... .....+.+|+.||++|. |||||.++++|++.. .
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~--~ 110 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD--S 110 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC--e
Confidence 3456999999999999999999999999999999997654432 34577899999999998 999999999998854 6
Q ss_pred EEEEEechh-hHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecC----CCcEEEEEeccccc
Q 043957 201 LYLVFEFMQ-TDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDK----NGVLKIADFGLANY 269 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~----~g~vKL~DFGla~~ 269 (584)
+|+|||+|. |.|.+.+... .+++. .||+.++.|||+.||+||||||+|||+.. ++.+|++|||++..
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 899999999 5677777654 25553 49999999999999999999999999943 35799999999998
Q ss_pred cCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 270 FSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 270 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
... ...+...+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.+.......|......+...+|
T Consensus 189 ~~~--~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w--- 262 (382)
T KOG0032|consen 189 IKP--GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPW--- 262 (382)
T ss_pred ccC--CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCc---
Confidence 865 345678899999999999975 56999999999999999999999999999999998888877666665555
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCcc
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLAC 410 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~~ 410 (584)
..++..+++||.+||..||.+|+|+.++|+|||+......+
T Consensus 263 --------------------~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~ 303 (382)
T KOG0032|consen 263 --------------------DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEAT 303 (382)
T ss_pred --------------------cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccc
Confidence 55689999999999999999999999999999998754443
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=386.02 Aligned_cols=281 Identities=35% Similarity=0.551 Sum_probs=223.9
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc---ceEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ---YSLY 202 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~---~~l~ 202 (584)
+|++.+.||+|+||.||+|++..+|..||||++............+.+|+.+|+.++||||+++++++..... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5999999999999999999999999999999986543333445568899999999999999999998754322 3589
Q ss_pred EEEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC-
Q 043957 203 LVFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK- 275 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~- 275 (584)
+|||||.++|...+.... .+. ++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELMESDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCCCCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 999999998888776432 333 335999999999999999999999999999999999999999976532221
Q ss_pred -CCCccccccccccChhhhhCC-CCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 276 -RPLTSRVVTLWYRAPELLLGA-TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 276 -~~~~~~~gt~~Y~APEvl~~~-~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+...++..+....+.+....+..+....
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 122446789999999998652 458999999999999999999999999999888888888888888776665543211
Q ss_pred CC----CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 354 TF----RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 354 ~~----~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
.. .............++.+++.+.+||.+||+.||++|||++|+|+||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 00 0001111223344567889999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=399.77 Aligned_cols=277 Identities=35% Similarity=0.584 Sum_probs=220.7
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec-----
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR----- 196 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~----- 196 (584)
....+|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++|||||++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 34567999999999999999999999999999999985332 2245799999999999999998876432
Q ss_pred -CcceEEEEEechhhHHHHHhhC---CCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCC-cEEEEEec
Q 043957 197 -MQYSLYLVFEFMQTDLARIISN---PEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG-VLKIADFG 265 (584)
Q Consensus 197 -~~~~l~lV~Ey~~g~L~~~l~~---~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g-~vKL~DFG 265 (584)
....+++|||||.+++...+.. ....+.+ ..||+.||+|||+++|+||||||+||||+.++ .+||+|||
T Consensus 137 ~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 2235789999999887766542 2333433 34999999999999999999999999998665 79999999
Q ss_pred cccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHH
Q 043957 266 LANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDY 345 (584)
Q Consensus 266 la~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~ 345 (584)
+|+.+.... .....+||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.+..+.+..++...+.+....
T Consensus 217 la~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~ 294 (440)
T PTZ00036 217 SAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ 294 (440)
T ss_pred cchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 998764332 234567899999999988766799999999999999999999999999999999999999999888777
Q ss_pred HHHhhccC-CCCCCCCCCchhhhhc-cCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 346 WKKLRLST-TFRPPQSYKPRLFEAF-SEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 346 ~~~~~~~~-~~~~p~~~~~~~~~~~-~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
+..+.... ....+......+...+ ...++++++||.+||++||.+|||+.|+|+||||...
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 76543211 1111222222232333 3578899999999999999999999999999999753
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=384.55 Aligned_cols=268 Identities=28% Similarity=0.419 Sum_probs=214.5
Q ss_pred CCCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 120 ~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
++...+.|++.+.||.|..++||+|+...+++.||||++..+..... .+.+.+|+..|..++|||||+++..|.. +.
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv--~~ 97 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVV--DS 97 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEe--cc
Confidence 34556789999999999999999999999999999999988876654 8899999999999999999999766665 55
Q ss_pred eEEEEEechh-hHHHHHhhCC-CCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccC
Q 043957 200 SLYLVFEFMQ-TDLARIISNP-EGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS 271 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~-~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~ 271 (584)
.+|+||.||. |++++++... ...+.+ .+++++||.|||.+|.||||||+.||||+.+|.|||+|||.+..+-
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 7999999999 5777777531 112333 3599999999999999999999999999999999999999886554
Q ss_pred CCCCC---CCccccccccccChhh-hhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHH
Q 043957 272 PNKKR---PLTSRVVTLWYRAPEL-LLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWK 347 (584)
Q Consensus 272 ~~~~~---~~~~~~gt~~Y~APEv-l~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 347 (584)
....+ .+.+.+|||+|||||+ +.....|+.|+||||||++..||.+|+.||..-.....+-.- ..+.|+...
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t--Lqn~pp~~~-- 253 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT--LQNDPPTLL-- 253 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH--hcCCCCCcc--
Confidence 33221 1256799999999999 455567999999999999999999999999876665554332 222332110
Q ss_pred HhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 348 KLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 348 ~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
....-.+....++..++.+|..||++||.+||||+++|+|+||+...
T Consensus 254 -------------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 254 -------------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred -------------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 00011123345678999999999999999999999999999998753
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=384.85 Aligned_cols=255 Identities=33% Similarity=0.517 Sum_probs=204.9
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
.+|...+.||+|+||.||++.+..+|..+|||.+...... ..+.+.+|+.+|.+|+|||||+++|.........++|+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 3588889999999999999999999999999999765222 26779999999999999999999997555433357999
Q ss_pred Eechh-hHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecC-CCcEEEEEeccccccCC--CC
Q 043957 205 FEFMQ-TDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDK-NGVLKIADFGLANYFSP--NK 274 (584)
Q Consensus 205 ~Ey~~-g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~-~g~vKL~DFGla~~~~~--~~ 274 (584)
|||+. |+|.+++....+.+++. +||+.||.|||++|||||||||+||||+. ++.+||+|||++..... ..
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999 57888887655456654 49999999999999999999999999999 79999999999987763 22
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGR-TEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
........||+.|||||++........++|||||||++.||+||.+||... ...+.+..+......
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~------------- 241 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSL------------- 241 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCC-------------
Confidence 233456889999999999985222335999999999999999999999763 222222222111100
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
......+|+++++||.+||..||++||||+++|+|||+...
T Consensus 242 ------------P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 242 ------------PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred ------------CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 12334579999999999999999999999999999999764
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=371.06 Aligned_cols=254 Identities=29% Similarity=0.463 Sum_probs=218.9
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC------ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCc
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS------EPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~------~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 198 (584)
.|.-.+.||+|..++|.++.++.+|..+|+|+|..... .....+...+|+.||+++ .||+|+.+.++|+. .
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes--~ 95 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES--D 95 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--c
Confidence 36677789999999999999999999999999954321 123355677899999999 59999999999887 4
Q ss_pred ceEEEEEechh-hHHHHHhhCCC-----CCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 199 YSLYLVFEFMQ-TDLARIISNPE-----GKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 199 ~~l~lV~Ey~~-g~L~~~l~~~~-----~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
..+++|+|+|. |.|.+.+...- ..-.+.+|++.|+.|||.++||||||||+|||++++.++||+|||+|+.+.+
T Consensus 96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 46899999998 77888876421 1123346999999999999999999999999999999999999999999876
Q ss_pred CCCCCCccccccccccChhhhh-----CCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHH
Q 043957 273 NKKRPLTSRVVTLWYRAPELLL-----GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWK 347 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~-----~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 347 (584)
+. .+...||||+|+|||.+. +...|+..+|+|++|||+|.||.|-|||+.+...-.+..|+.+...+....|.
T Consensus 176 Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWa 253 (411)
T KOG0599|consen 176 GE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWA 253 (411)
T ss_pred ch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchh
Confidence 54 467889999999999985 34569999999999999999999999999999999999999998888877775
Q ss_pred HhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 348 KLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 348 ~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
+++..++|||.+||+.||.+|+|++|+|.||||.+-
T Consensus 254 -----------------------dis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 254 -----------------------DISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred -----------------------hccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 458999999999999999999999999999999543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=387.91 Aligned_cols=260 Identities=30% Similarity=0.440 Sum_probs=213.6
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC------------ChHHHHHHHHHHHHHHhCCCCCeeee
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS------------EPHSVKFMAREIMILQKLDHPNIVKL 189 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~------------~~~~~~~~~~Ei~iL~~L~HpnIv~l 189 (584)
...++|++++.||+|.||.|.+|.+..+++.||||++.+... .....+.+.+||.||++|+|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 445789999999999999999999999999999999954311 11124578899999999999999999
Q ss_pred eceeeecCcceEEEEEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEE
Q 043957 190 EGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIAD 263 (584)
Q Consensus 190 ~~~~~~~~~~~l~lV~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~D 263 (584)
+++..+.....+|||+|||..+-....-.....+. .++.++.||+|||.+|||||||||+|+||+.+|+|||+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence 99999988889999999998543333322221122 235899999999999999999999999999999999999
Q ss_pred eccccccCCC----CCCCCccccccccccChhhhhCC---CCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 043957 264 FGLANYFSPN----KKRPLTSRVVTLWYRAPELLLGA---TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFK 336 (584)
Q Consensus 264 FGla~~~~~~----~~~~~~~~~gt~~Y~APEvl~~~---~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~ 336 (584)
||.+..+... ....+...+|||.|+|||.+.+. ...+.+.|||||||+||.|+.|+.||.++...+++.+|+.
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn 333 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN 333 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence 9999876322 12234457999999999999863 3457889999999999999999999999999999999876
Q ss_pred hcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 337 LCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
..-.++ ..+.+.+.++|||.+||++||.+|++..++-.|||....
T Consensus 334 ~pL~fP-------------------------~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 334 DPLEFP-------------------------ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred CcccCC-------------------------CcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 432222 123567899999999999999999999999999999754
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=374.69 Aligned_cols=275 Identities=39% Similarity=0.641 Sum_probs=217.9
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC---CCCCeeeeeceeeec---Ccc
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL---DHPNIVKLEGLATSR---MQY 199 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~~---~~~ 199 (584)
+|++.+.||+|+||+||+|.++.+++.||||.++...........+.+|+.+++.+ +||||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 48999999999999999999999999999999975433332233455677777665 799999999987642 234
Q ss_pred eEEEEEechhhHHHHHhhCCC-CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQTDLARIISNPE-GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~g~L~~~l~~~~-~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
.+++||||+.++|...+.... ..++ ++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 689999999998887775422 2233 235999999999999999999999999999999999999999987643
Q ss_pred CCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
.. ......+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+....+.+..++...+.+....|......
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 161 QM--ALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred cc--cCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 22 23456789999999999764 5899999999999999999999999999999999999888877776666542211
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
.................+.+++.+.+||.+||++||.+|||+.|+|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 111111122223344556788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=380.44 Aligned_cols=279 Identities=37% Similarity=0.687 Sum_probs=228.6
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|.+.++||+|+||.||+|.+..++..||+|+++...... ....+.+|+.++++++||||+++++++... ..+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 81 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIVHTD--KSLTL 81 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC-cchhHHHHHHHHHhCCCCCcceEEEEEeeC--CeEEE
Confidence 457999999999999999999999999999999997543322 234567899999999999999999988764 45899
Q ss_pred EEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 204 VFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||||+.++|...+......+.+ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++....... ..
T Consensus 82 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 160 (309)
T cd07872 82 VFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KT 160 (309)
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc-cc
Confidence 9999999888877654443433 3499999999999999999999999999999999999999997653222 22
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC---
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT--- 354 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--- 354 (584)
.....+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..++...+.+....|..+.....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 23456799999999987666689999999999999999999999999999999999999999998888876543221
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
...+......+......+++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 1112222222334456789999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=389.55 Aligned_cols=278 Identities=35% Similarity=0.561 Sum_probs=225.9
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc---ceEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ---YSLY 202 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~---~~l~ 202 (584)
+|++.+.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+|+.++||||+++++++..... ..+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 3788999999999999999999999999999986544444455678899999999999999999998876431 2589
Q ss_pred EEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 203 LVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
+||||+.++|...+... ..+.+ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus 81 lv~e~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQSDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccccCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 99999999888877543 23333 359999999999999999999999999999999999999999876544433
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc-----
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL----- 351 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~----- 351 (584)
.....++|+.|+|||++.+...++.++|||||||++|||++|++||.+.+...++..+....+.+....+.....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 445567899999999998766689999999999999999999999999999999999999988887765543211
Q ss_pred --cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 352 --STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 352 --~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
......+ ............++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 240 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 240 ILRGPHKPP--SLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHhCCCCCC--chHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 0111111 1111222335668899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=384.90 Aligned_cols=279 Identities=32% Similarity=0.522 Sum_probs=220.7
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc----c
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ----Y 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~----~ 199 (584)
.++|++.+.||+|+||.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++..... .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 467999999999999999999999999999999997554444556678899999999999999999998765332 3
Q ss_pred eEEEEEechhhHHHHHhhCC---CCCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 200 SLYLVFEFMQTDLARIISNP---EGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 200 ~l~lV~Ey~~g~L~~~l~~~---~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
.+|+||||+.++|...+... ........||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~--~ 177 (359)
T cd07876 100 DVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--F 177 (359)
T ss_pred eeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC--c
Confidence 57999999999887766421 111223459999999999999999999999999999999999999999765322 2
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC--
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT-- 354 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-- 354 (584)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..++...+.+...++..+.....
T Consensus 178 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (359)
T cd07876 178 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256 (359)
T ss_pred cCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 2345678999999999976 4589999999999999999999999999998888888888888887766654321100
Q ss_pred -CCCCCCCCchhh------------hhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 355 -FRPPQSYKPRLF------------EAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 355 -~~~p~~~~~~~~------------~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
...+......+. ......++.+.+||.+||+.||.+|||+.|+|+||||..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 257 VENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 000000000011 111234678999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=374.61 Aligned_cols=293 Identities=42% Similarity=0.740 Sum_probs=237.0
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..++|++.+.||.|+||.||+|.+..+|+.||+|++............+.+|+.++++++|+||+++++++.......+|
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 35679999999999999999999999999999999975543333333456799999999999999999998776556789
Q ss_pred EEEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 203 LVFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
+||||+.++|...+......+. +..||+.||.|||+.+|+||||||+|||++.++.+||+|||++..+.... .
T Consensus 85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~ 163 (309)
T cd07845 85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-K 163 (309)
T ss_pred EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-C
Confidence 9999999888777764333333 34599999999999999999999999999999999999999998765332 2
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC---
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST--- 353 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--- 353 (584)
......+++.|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+....+.+....|..+....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 23344568899999998776668999999999999999999999999999999999999998888888776653221
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCccCCCCCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDLSGLP 416 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~~~~~~~~ 416 (584)
.+..+......+...+..+++.+.+||.+||+.||.+|||+.|+|.||||...+.++....+|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~~~ 306 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMP 306 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCCcCC
Confidence 111111112223333455789999999999999999999999999999999888877655554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=382.15 Aligned_cols=251 Identities=29% Similarity=0.497 Sum_probs=208.2
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
..|+.++.||+|+||.||+|.+..+++.||||++..+... ..++.+.+|+.+|.+++++||.++|+.|.. ...+|++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~--g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLK--GTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheee--cccHHHH
Confidence 3588899999999999999999999999999999876544 356778899999999999999999998887 4458999
Q ss_pred Eechhh-HHHHHhhCCCC-----CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 205 FEFMQT-DLARIISNPEG-----KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~-----~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
||||.| ++.+++..... ...+.++++.||.|||.++.+|||||+.||||..+|.|||+|||++..+.......
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr- 168 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR- 168 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc-
Confidence 999995 45555542211 12334699999999999999999999999999999999999999999887655544
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p 358 (584)
.+++|||.||||||+.+ ..|+.++||||||++.|||++|.||+....+...+. ..|
T Consensus 169 ~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-----------------------lIp 224 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-----------------------LIP 224 (467)
T ss_pred ccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-----------------------ecc
Confidence 77899999999999985 569999999999999999999999998766522211 112
Q ss_pred CCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 359 ~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
....|.+. ..+++.+++||..||.+||+.||||.++|+|+|++..
T Consensus 225 k~~PP~L~---~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 225 KSAPPRLD---GDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred CCCCCccc---cccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 22222222 2678999999999999999999999999999999863
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=393.40 Aligned_cols=254 Identities=27% Similarity=0.396 Sum_probs=214.7
Q ss_pred CCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCc
Q 043957 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQ 198 (584)
Q Consensus 121 ~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~ 198 (584)
+...++|+++++||+|+||+|+++..+.+++.||||++++.. .....++.++.|..|+.... ||.++.++..|.. .
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT--~ 441 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT--K 441 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc--C
Confidence 445678999999999999999999999999999999998764 35567888999999998885 9999999776655 6
Q ss_pred ceEEEEEechhhHHHHHhhCCCCCCcHHH------HHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 199 YSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 199 ~~l~lV~Ey~~g~L~~~l~~~~~~l~~~~------qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
.++|+||||+.|+.+..+. ....+.+.+ .|+.||+|||++||||||||.+|||||.+|.+||+|||+++..-.
T Consensus 442 ~~l~fvmey~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred CeEEEEEEecCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 6799999999975533332 345666654 899999999999999999999999999999999999999986432
Q ss_pred CCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
.. ...++.||||.|||||++.+. .|+.++|+|||||+|||||.|.+||+++++.+.+..|+.--..
T Consensus 521 ~g-~~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~------------ 586 (694)
T KOG0694|consen 521 QG-DRTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVR------------ 586 (694)
T ss_pred CC-CccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC------------
Confidence 22 245789999999999999875 5999999999999999999999999999999999888652111
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC-----HHHHhcCcCCCCC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS-----AASALKNEFFFTS 406 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT-----a~e~L~Hp~f~~~ 406 (584)
....++.++++++++||.+||++|.- ++++.+||||...
T Consensus 587 ---------------yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 587 ---------------YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred ---------------CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 11346899999999999999999985 4888899999864
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=380.48 Aligned_cols=277 Identities=34% Similarity=0.563 Sum_probs=224.4
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC----cc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM----QY 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 199 (584)
.++|++++.||.|+||.||+|.+..++..||||++............+.+|+.+|+.++||||+++++++.... ..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 46799999999999999999999999999999998654433344556778999999999999999998875422 23
Q ss_pred eEEEEEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 200 SLYLVFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 200 ~l~lV~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
.+|++|+++.++|..++... .++ ++.||+.||.|||+++|+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~~~~~~~~~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 94 EVYLVTNLMGADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred cEEEEeecCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 57999999988888776532 333 3359999999999999999999999999999999999999999875432
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....+..+....
T Consensus 172 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07878 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247 (343)
T ss_pred ----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence 3456789999999999875668999999999999999999999999999888888888888877766655432211
Q ss_pred C----CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 354 T----FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 354 ~----~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
. ...+......+...+...++.+.+||.+||+.||.+|||+.|+|+||||...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0 0011111223344456678889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=374.43 Aligned_cols=270 Identities=35% Similarity=0.599 Sum_probs=208.6
Q ss_pred EeeecccCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEec
Q 043957 130 IDKVGQGTYSNVYKALDR--DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEF 207 (584)
Q Consensus 130 ~~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey 207 (584)
.++||+|+||+||+|.++ .++..||+|.+..... ...+.+|+.+|++++||||+++++++.......+|+||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 357999999999999865 4678999999864322 2346789999999999999999998877666779999999
Q ss_pred hhhHHHHHhhCCC--------CCCc------HHHHHHHHHHHHHhCCceeccccccceee----cCCCcEEEEEeccccc
Q 043957 208 MQTDLARIISNPE--------GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLI----DKNGVLKIADFGLANY 269 (584)
Q Consensus 208 ~~g~L~~~l~~~~--------~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl----~~~g~vKL~DFGla~~ 269 (584)
+.++|...+.... ..+. +..||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++.
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 9998877764211 1122 34599999999999999999999999999 4567899999999987
Q ss_pred cCCCCC--CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhc
Q 043957 270 FSPNKK--RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE---------VEQLHRIFKLC 338 (584)
Q Consensus 270 ~~~~~~--~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~---------~~~~~~i~~~~ 338 (584)
+..... ......++|+.|+|||++.+...++.++|||||||++|+|++|++||.+... ..++..++...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 643221 1234568899999999998766689999999999999999999999976543 46778888888
Q ss_pred CCCChHHHHHhhccCCCCC-------C----CCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 339 GSPSEDYWKKLRLSTTFRP-------P----QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~-------p----~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
+.+....|..+........ . ......+.......+..+.+||.+||++||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 8888888876542211100 0 000001111112345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=380.53 Aligned_cols=279 Identities=30% Similarity=0.507 Sum_probs=221.6
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC----cc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM----QY 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 199 (584)
.++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 45799999999999999999999999999999999755444455667889999999999999999998875432 23
Q ss_pred eEEEEEechhhHHHHHhhCCC---CCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 200 SLYLVFEFMQTDLARIISNPE---GKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 200 ~l~lV~Ey~~g~L~~~l~~~~---~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
.+|+||||+.++|...+...- .......||+.||+|||+++|+||||||+|||++.++.+||+|||+++..... .
T Consensus 103 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--~ 180 (364)
T cd07875 103 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--F 180 (364)
T ss_pred eEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC--C
Confidence 579999999998887764321 11223469999999999999999999999999999999999999999865432 2
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC--
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT-- 354 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-- 354 (584)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..++...+.+....+..+.....
T Consensus 181 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (364)
T cd07875 181 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259 (364)
T ss_pred cccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHH
Confidence 2345678999999999976 4589999999999999999999999999999999999998888887776665432100
Q ss_pred -CCCCC------------CCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 355 -FRPPQ------------SYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 355 -~~~p~------------~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
...+. ...+...+.....+..+++||.+||+.||.+|||+.|+|+||||..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 00000 0000011111234578899999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=368.88 Aligned_cols=278 Identities=41% Similarity=0.704 Sum_probs=226.2
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|.+.+.||.|+||.||+|.+..++..||+|.+....... ....+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~l 81 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTL 81 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC-chhHHHHHHHHHHhcCCCCcceEEEEEec--CCeEEE
Confidence 467999999999999999999999999999999986543322 23456789999999999999999998876 446899
Q ss_pred EEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 204 VFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||||+.++|...+......+.+ ..||+.||.|||+++|+|+||||+|||++.++.+||+|||++....... ..
T Consensus 82 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~ 160 (301)
T cd07873 82 VFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KT 160 (301)
T ss_pred EEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-Cc
Confidence 9999999888887654443433 3599999999999999999999999999999999999999997653222 22
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC--
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF-- 355 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-- 355 (584)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||...+..+++..+......+....|..+.....+
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 234567899999999877666889999999999999999999999999988888899888888888888765322211
Q ss_pred -CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 356 -RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 356 -~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
..+.............+++.+.+||.+||+.||.+|||++|+|+||||..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 11221122223334578899999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=379.51 Aligned_cols=280 Identities=32% Similarity=0.518 Sum_probs=221.2
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC----cc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM----QY 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 199 (584)
.++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 45799999999999999999999999999999999765555555677889999999999999999999876432 23
Q ss_pred eEEEEEechhhHHHHHhhCCC---CCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 200 SLYLVFEFMQTDLARIISNPE---GKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 200 ~l~lV~Ey~~g~L~~~l~~~~---~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
.+|+||||+.+++...+...- .......||+.||.|||++||+||||||+||||+.++.+||+|||+++..... .
T Consensus 96 ~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 173 (355)
T cd07874 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--F 173 (355)
T ss_pred eeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc--c
Confidence 579999999998877664311 11223459999999999999999999999999999999999999999865432 2
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC---
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST--- 353 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--- 353 (584)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..++...+.+....+..+....
T Consensus 174 ~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (355)
T cd07874 174 MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252 (355)
T ss_pred ccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHH
Confidence 23456789999999999764 58999999999999999999999999999888888888888877766665432110
Q ss_pred -----C---CCCCC----CCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 354 -----T---FRPPQ----SYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 354 -----~---~~~p~----~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
. ...+. ...+.........+..+.+||.+||+.||.+|||+.|+|+||||...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0 00000 00000111122346788999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-47 Score=362.08 Aligned_cols=285 Identities=44% Similarity=0.746 Sum_probs=235.3
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec------Cc
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR------MQ 198 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------~~ 198 (584)
..|+.+.+||+|.||.||+|+.+.+|+.||+|++..+......-....+|+.+|+.|+|+|++.++++|... ..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 458888899999999999999999999999998866544333333456899999999999999998877432 23
Q ss_pred ceEEEEEechhhHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 199 YSLYLVFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 199 ~~l~lV~Ey~~g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
..+|+||.+|+.+|..++.+...+++.. ++++.||.|+|.+.|+|||+|++|+||+.+|.+||+|||+++.+..
T Consensus 97 ~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~ 176 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFST 176 (376)
T ss_pred ceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceec
Confidence 4589999999999999998876666543 4899999999999999999999999999999999999999987754
Q ss_pred CCC---CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 273 NKK---RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 273 ~~~---~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
... ...+..+.|.||++||.++|...|+++.|||..|||+.||+++.|.|.++++..++..|-..|+....+.|.++
T Consensus 177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~ 256 (376)
T KOG0669|consen 177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV 256 (376)
T ss_pred ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence 332 22456778999999999999999999999999999999999999999999999999999999999999999876
Q ss_pred hccCCC------CCCCCCCchhhhhcc--CCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCc
Q 043957 350 RLSTTF------RPPQSYKPRLFEAFS--EFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLA 409 (584)
Q Consensus 350 ~~~~~~------~~p~~~~~~~~~~~~--~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~ 409 (584)
.....+ ..|......+..... .-++++.||+.+||..||.+|+++.++|+|.||+.+|.+
T Consensus 257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 533221 122222222222222 125689999999999999999999999999999988765
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=386.62 Aligned_cols=271 Identities=25% Similarity=0.379 Sum_probs=208.8
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
...+|.+++.||+|+||.||+|.+..+++.||||... ...+.+|+.+|++|+|||||++++++... ...+
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ 159 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYN--KFTC 159 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEEC--CeeE
Confidence 3457999999999999999999999999999999753 23467899999999999999999988763 4579
Q ss_pred EEEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 203 LVFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
+|||++.++|...+.... .+. +..||+.||.|||+++|+||||||+||||+.++.+||+|||+|.........
T Consensus 160 lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 160 LILPRYKTDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred EEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 999999998887775432 232 3459999999999999999999999999999999999999999764332222
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCC-------hHHHHHHHHHhcCCCChHHHHH-
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRT-------EVEQLHRIFKLCGSPSEDYWKK- 348 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~-------~~~~~~~i~~~~~~~~~~~~~~- 348 (584)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.... ...++..++...+.++..++..
T Consensus 239 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 239 KYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred ccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 3345689999999999976 458999999999999999999997775432 3455666766665544322100
Q ss_pred ------h--hcc-CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 349 ------L--RLS-TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 349 ------~--~~~-~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
+ ... .....+. ..........++.++.+||.+||++||.+||||+|+|+||||...+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPG--SRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred hHHHHHHHHHHHhccCCCCC--CCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 0 000 0011111 1111223345678999999999999999999999999999998754
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=364.98 Aligned_cols=275 Identities=41% Similarity=0.728 Sum_probs=223.8
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
+|++.+.||.|+||.||+|.+..+|+.||+|.+............+.+|+.++++++||||+++++++.+. ..+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD--KKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC--CceEEEE
Confidence 48999999999999999999999999999999976544333445677899999999999999999988764 4589999
Q ss_pred echhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCc
Q 043957 206 EFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLT 279 (584)
Q Consensus 206 Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 279 (584)
||+.++|...+......+.+ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++..+.... ....
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~ 157 (284)
T cd07839 79 EYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCYS 157 (284)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCcC
Confidence 99999888877654444443 3599999999999999999999999999999999999999998654322 2234
Q ss_pred cccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCC
Q 043957 280 SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPI-MPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358 (584)
Q Consensus 280 ~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~p-F~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p 358 (584)
...+++.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+..+.+....|..+.....+...
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 456789999999988766689999999999999999998765 6777777888888888888888888765443332211
Q ss_pred CCC--CchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 359 QSY--KPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 359 ~~~--~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
... ...+.+....+++++.+||.+||+.||.+|||++++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 111 122334456789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=374.44 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=203.6
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+|++++||||+++++++.. ...+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 94 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRVY 94 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc--CCEEE
Confidence 4579999999999999999999999999999999964321 22345678899999999999999999988876 44689
Q ss_pred EEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 203 LVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
+||||+.+ +|...+... ..+.+ ..||+.||+|||+++|+||||||+||||+.++.+||+|||++.......
T Consensus 95 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred EEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 99999984 677776543 23332 3599999999999999999999999999999999999999998764322
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+.....
T Consensus 173 ---~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~---------------- 232 (329)
T PTZ00263 173 ---FTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL---------------- 232 (329)
T ss_pred ---ceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc----------------
Confidence 34578999999999976 4589999999999999999999999988877666555533210
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC-----HHHHhcCcCCCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS-----AASALKNEFFFT 405 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT-----a~e~L~Hp~f~~ 405 (584)
.....++..+.+||.+||+.||.+|++ ++++|+||||..
T Consensus 233 -----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 233 -----------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred -----------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 011235788999999999999999997 799999999975
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=384.42 Aligned_cols=277 Identities=21% Similarity=0.298 Sum_probs=210.2
Q ss_pred CCCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCC------CCeeeeecee
Q 043957 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH------PNIVKLEGLA 193 (584)
Q Consensus 120 ~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H------pnIv~l~~~~ 193 (584)
+....++|++++.||+|+||+||+|.+..+++.||||+++... .....+..|+.+++.+.| .+|+.+++++
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3445678999999999999999999999999999999996321 223345667888777754 4588888887
Q ss_pred eecCcceEEEEEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHh-CCceeccccccceeecCCC---------
Q 043957 194 TSRMQYSLYLVFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHD-RGILHRDVKGSNLLIDKNG--------- 257 (584)
Q Consensus 194 ~~~~~~~l~lV~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~-~~IvHrDLKp~NILl~~~g--------- 257 (584)
... ..++|||||++.++|...+... ..+. +..||+.||.|||+ .|||||||||+||||+.++
T Consensus 201 ~~~-~~~~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 201 QNE-TGHMCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred EcC-CceEEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence 654 3468999999988888877643 2333 34599999999997 5999999999999998765
Q ss_pred -------cEEEEEeccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHH
Q 043957 258 -------VLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQ 330 (584)
Q Consensus 258 -------~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~ 330 (584)
.+||+|||++..... .....+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred ccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 499999998864321 23567899999999999874 599999999999999999999999999999999
Q ss_pred HHHHHHhcCCCChHHHHHhhcc--------CCCCCCCCCCchhhhhcc-------CCcHhHHHHHHHhcccCCCCCCCHH
Q 043957 331 LHRIFKLCGSPSEDYWKKLRLS--------TTFRPPQSYKPRLFEAFS-------EFPESSLGLLSTLLALDPAYRGSAA 395 (584)
Q Consensus 331 ~~~i~~~~~~~~~~~~~~~~~~--------~~~~~p~~~~~~~~~~~~-------~~s~~~~dLI~~~L~~DP~kRpTa~ 395 (584)
+..+....+.++..++...... .....+......+..... ...+.+.|||.+||++||.+|||++
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 9999888888776544321100 000000000000000000 1145678999999999999999999
Q ss_pred HHhcCcCCCCC
Q 043957 396 SALKNEFFFTS 406 (584)
Q Consensus 396 e~L~Hp~f~~~ 406 (584)
|+|+||||...
T Consensus 434 e~L~Hp~~~~~ 444 (467)
T PTZ00284 434 QMTTHPYVLKY 444 (467)
T ss_pred HHhcCcccccc
Confidence 99999999864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=369.70 Aligned_cols=246 Identities=25% Similarity=0.396 Sum_probs=203.2
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--CCeEEE
Confidence 369999999999999999999999999999999964322 22345668899999999999999999887765 446899
Q ss_pred EEechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
||||+.+ +|.+.+... ..+. +..||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 79 LMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred EEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 9999984 677776542 2332 3459999999999999999999999999999999999999999876432
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 155 -~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~----------------- 215 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL----------------- 215 (291)
T ss_pred -cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-----------------
Confidence 234578999999999876 4589999999999999999999999998887776666543211
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC-----HHHHhcCcCCCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS-----AASALKNEFFFT 405 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT-----a~e~L~Hp~f~~ 405 (584)
.....++..+.+||.+||+.||.+|++ ++++|+||||..
T Consensus 216 ----------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 216 ----------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred ----------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 011345788999999999999999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=377.05 Aligned_cols=251 Identities=30% Similarity=0.491 Sum_probs=223.3
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
+-|++.+.||+|-|++|-+|++..+|+.||||+|.+...+.-....+..|++.|+.+.|||||++|++.... ..+|||
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ--TKlyLi 95 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ--TKLYLI 95 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc--ceEEEE
Confidence 349999999999999999999999999999999987777766677788999999999999999999887664 358999
Q ss_pred Eechh-hHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceee-cCCCcEEEEEeccccccCCCCCC
Q 043957 205 FEFMQ-TDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLI-DKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 205 ~Ey~~-g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl-~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
+|+-+ |+|.++|...+..+.+. .||+.|+.|||+..||||||||+||.+ .+-|-|||.|||++..+.+...
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k- 174 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK- 174 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch-
Confidence 99988 58999988766655543 499999999999999999999999886 5679999999999999876654
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
+++.||+..|-|||+++|..+..+++||||||||||.|+||++||...++.+.+.+|+......+
T Consensus 175 -L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP-------------- 239 (864)
T KOG4717|consen 175 -LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP-------------- 239 (864)
T ss_pred -hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc--------------
Confidence 68889999999999999988677899999999999999999999999999999999987654333
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
..++.+++|||..||+.||.+|.|.+|+..|+|++..
T Consensus 240 -------------shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 240 -------------SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred -------------hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence 4678999999999999999999999999999999865
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=360.98 Aligned_cols=275 Identities=43% Similarity=0.758 Sum_probs=221.6
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
+|++.+.||.|+||.||+|.+..++..||||++............+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEEE
Confidence 4899999999999999999999999999999997654444445667889999999999999999998876 44689999
Q ss_pred echhhHHHHHhhCCC--CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 206 EFMQTDLARIISNPE--GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 206 Ey~~g~L~~~l~~~~--~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||+.++|...+.... ..+. +..||+.||.|||+++|+|+||||+|||++.++.+||+|||++....... ..
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (285)
T cd07861 79 EFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RV 157 (285)
T ss_pred ecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-cc
Confidence 999988877765322 2333 24599999999999999999999999999999999999999997654322 22
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC-
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR- 356 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~- 356 (584)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||.+....+.+..++...+.+....|........+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 2344678999999998766668899999999999999999999999998888888888777777777765433221111
Q ss_pred -CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 357 -PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 357 -~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
.+.............+++++.+||.+||+.||.+|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 11111222333456689999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=372.34 Aligned_cols=243 Identities=28% Similarity=0.392 Sum_probs=196.8
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechh
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ 209 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~ 209 (584)
+.||+|+||.||+|.+..+|+.||||+++.... .......+.+|+.+|+.++||||+++++++.. ...+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCCC
Confidence 359999999999999999999999999975422 23345567789999999999999999887766 446899999998
Q ss_pred h-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCcccc
Q 043957 210 T-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRV 282 (584)
Q Consensus 210 g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~ 282 (584)
+ +|...+.. ...+.+ ..||+.||+|||++||+||||||+||||+.++.+||+|||+++..... .......+
T Consensus 79 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~ 156 (323)
T cd05571 79 GGELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFC 156 (323)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCccccee
Confidence 5 56666543 233333 359999999999999999999999999999999999999999754222 12234567
Q ss_pred ccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCC
Q 043957 283 VTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYK 362 (584)
Q Consensus 283 gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 362 (584)
||+.|+|||++.+ ..++.++|||||||++|||++|++||...+.......+.....
T Consensus 157 gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~----------------------- 212 (323)
T cd05571 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI----------------------- 212 (323)
T ss_pred cCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 9999999999976 4589999999999999999999999988776655544432110
Q ss_pred chhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCC
Q 043957 363 PRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFT 405 (584)
Q Consensus 363 ~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~ 405 (584)
.....+++++.+||.+||+.||++|| ++.++|+||||..
T Consensus 213 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 213 ----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred ----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 11135688999999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=376.83 Aligned_cols=261 Identities=26% Similarity=0.359 Sum_probs=208.5
Q ss_pred CCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 121 ~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
....++|++.+.||+|+||.||+|.+..++..||||++.... ........+.+|+.+++.++||||+++++++.. ..
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~--~~ 116 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD--DK 116 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence 345678999999999999999999999999999999996432 222334557789999999999999999887765 45
Q ss_pred eEEEEEechh-hHHHHHhhCCCCCC----cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 200 SLYLVFEFMQ-TDLARIISNPEGKL----TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~~~l----~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
.+|+|||||. |+|..++....... .+..||+.||+|||+++|+||||||+||||+.++.+||+|||++.......
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 6899999998 46777765422111 123599999999999999999999999999999999999999998765333
Q ss_pred CCCCccccccccccChhhhhCCC---CCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 275 KRPLTSRVVTLWYRAPELLLGAT---DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~---~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
.......+||+.|+|||++.+.. .++.++|||||||++|||++|++||.+.+....+..+........
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~--------- 267 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT--------- 267 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC---------
Confidence 22234568999999999986532 378999999999999999999999999887766666643211100
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCC--CCCHHHHhcCcCCCCC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAY--RGSAASALKNEFFFTS 406 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~k--RpTa~e~L~Hp~f~~~ 406 (584)
. .....++.++.+||.+||+.+|.+ |+|++|+|+||||...
T Consensus 268 -----~---------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 268 -----F---------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred -----C---------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 0 011346899999999999999998 9999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=374.98 Aligned_cols=249 Identities=26% Similarity=0.460 Sum_probs=206.1
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
.|.-++.||+|+||.||.|++..+.+.||||++.+... .......+..|+.+|++|+|||++.+.++|.... ..|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~--TaWLV 104 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH--TAWLV 104 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc--hHHHH
Confidence 36677889999999999999999999999999987644 3456788999999999999999999999987643 46999
Q ss_pred EechhhH---HHHHhhCCCCCCcH---HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 205 FEFMQTD---LARIISNPEGKLTE---PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 205 ~Ey~~g~---L~~~l~~~~~~l~~---~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
||||-|+ |+++...+-....+ ..+.+.||+|||+++.||||||..|||+++.|.|||+|||.|....+ .
T Consensus 105 MEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----A 179 (948)
T KOG0577|consen 105 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----A 179 (948)
T ss_pred HHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc-----h
Confidence 9999874 55555443222222 24889999999999999999999999999999999999999987654 3
Q ss_pred ccccccccccChhhhh--CCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 279 TSRVVTLWYRAPELLL--GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~--~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
.+++|||+|||||||+ ....|+-++||||||++..||...+||+...+....+..|... ..|.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-esPt-------------- 244 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPT-------------- 244 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-CCCC--------------
Confidence 6789999999999996 3346999999999999999999999998888777666665331 1111
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
-. -..+++.+..||..||++-|..|||++++|.|+|+...
T Consensus 245 ---Lq-------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 245 ---LQ-------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred ---CC-------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 00 13567889999999999999999999999999998754
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=361.83 Aligned_cols=252 Identities=27% Similarity=0.392 Sum_probs=200.0
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE-PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
|++.+.||+|+||.||+|.+..+|+.||||.+...... ......+.+|+.+|..++|+||+.+++++... ..+|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~--~~~~lv~ 79 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK--DALCLVL 79 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC--CeEEEEE
Confidence 88999999999999999999999999999998654322 22334577899999999999999998877653 4689999
Q ss_pred echhh-HHHHHhhCC-CCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 206 EFMQT-DLARIISNP-EGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 206 Ey~~g-~L~~~l~~~-~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
|||.+ +|...+... ...+.+ +.||+.||+|||+++|+||||||+|||++.++.+||+|||++....... .
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 157 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--T 157 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--e
Confidence 99985 666555422 222332 3599999999999999999999999999999999999999998754322 2
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 357 (584)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||...........+........
T Consensus 158 ~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 221 (285)
T cd05631 158 VRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ--------------- 221 (285)
T ss_pred ecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc---------------
Confidence 345678999999999976 4589999999999999999999999987765433333322111100
Q ss_pred CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC-----HHHHhcCcCCCCC
Q 043957 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS-----AASALKNEFFFTS 406 (584)
Q Consensus 358 p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT-----a~e~L~Hp~f~~~ 406 (584)
......++..+.+||.+||+.||.+||| ++++++||||...
T Consensus 222 --------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 222 --------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred --------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 0112457889999999999999999997 8999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=374.85 Aligned_cols=262 Identities=27% Similarity=0.379 Sum_probs=208.0
Q ss_pred CCCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc
Q 043957 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 120 ~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 198 (584)
+....++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.. .
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~ 115 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD--D 115 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--C
Confidence 4455678999999999999999999999999999999986422 222334567789999999999999999988765 4
Q ss_pred ceEEEEEechh-hHHHHHhhCCCCC----CcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 199 YSLYLVFEFMQ-TDLARIISNPEGK----LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 199 ~~l~lV~Ey~~-g~L~~~l~~~~~~----l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
..+|+|||||. |+|..++...... ..+..||+.||+|||+++|+||||||+||||+.++.+||+|||+|..+...
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 56899999998 5777777542211 122359999999999999999999999999999999999999999876533
Q ss_pred CCCCCccccccccccChhhhhCCC---CCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGAT---DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~---~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
........+||+.|+|||++.+.. .++.++|||||||++|+|++|++||.+.+....+..+........
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~-------- 267 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN-------- 267 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC--------
Confidence 322334668999999999997532 378899999999999999999999998887777666654221110
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCC--CCCHHHHhcCcCCCCC
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAY--RGSAASALKNEFFFTS 406 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~k--RpTa~e~L~Hp~f~~~ 406 (584)
.| ....++..+++||.+||..++.+ |+|++|+|+||||...
T Consensus 268 ------~p---------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 268 ------FP---------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred ------CC---------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 00 11246889999999999866554 8999999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=356.14 Aligned_cols=277 Identities=42% Similarity=0.701 Sum_probs=228.7
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
+|++.+.||.|+||.||+|.+..+|..||||++............+.+|+.++++++||||+++++++.. ...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence 4899999999999999999999999999999997655444456678899999999999999999998876 44689999
Q ss_pred echhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCc
Q 043957 206 EFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLT 279 (584)
Q Consensus 206 Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 279 (584)
||+.++|...+......+. +..||+.||.|||+.+|+|+||||+||+++.++.++|+|||++............
T Consensus 79 e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 79 EYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred cccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 9997788887764433333 3459999999999999999999999999999999999999999876544322344
Q ss_pred cccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC---C
Q 043957 280 SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF---R 356 (584)
Q Consensus 280 ~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~ 356 (584)
...++..|+|||++.+...++.++|||||||++|+|++|.++|.+..+...+..+....+.+....|......... .
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 5678999999999876566789999999999999999999999999999999999998888887777664322111 1
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~ 404 (584)
.+......+...+...+..+.+||.+||..||.+|||++++|+||||.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 122222234455667889999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=374.11 Aligned_cols=254 Identities=28% Similarity=0.443 Sum_probs=203.2
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++.. ...+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD--ENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCeEEE
Confidence 36999999999999999999999999999999996532 223345667889999999999999999888776 446899
Q ss_pred EEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
|||||. ++|...+... ..+.+ ..||+.||+|||+++|+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 79 IMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred EECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 999998 5677776543 23433 359999999999999999999999999999999999999998754321100
Q ss_pred -------------------------------------CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCC
Q 043957 277 -------------------------------------PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGR 319 (584)
Q Consensus 277 -------------------------------------~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~ 319 (584)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCC
Confidence 1123579999999999876 45899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC---HHH
Q 043957 320 PIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS---AAS 396 (584)
Q Consensus 320 ~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT---a~e 396 (584)
+||...+..+.+..+....... ..|. ...+++.+.+||.+||. ||.+|++ +.|
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~~~--------------~~~~---------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ 292 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKETL--------------QFPD---------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNE 292 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCCcc--------------CCCC---------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence 9999888776665554321100 0000 12468899999999997 9999998 999
Q ss_pred HhcCcCCCCC
Q 043957 397 ALKNEFFFTS 406 (584)
Q Consensus 397 ~L~Hp~f~~~ 406 (584)
+|+||||...
T Consensus 293 ll~h~~~~~~ 302 (364)
T cd05599 293 IKSHPFFKGV 302 (364)
T ss_pred HhcCCCcCCC
Confidence 9999999753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=368.00 Aligned_cols=254 Identities=30% Similarity=0.450 Sum_probs=206.0
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
+|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|..++||||+++++++.. ...+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~lv 79 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--DEYLYLA 79 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--CCEEEEE
Confidence 69999999999999999999999999999999975422 22345667889999999999999999887765 4468999
Q ss_pred Eechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 205 FEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||||.+ +|..++... ..+. +..||+.||.|||+++|+||||||+|||++.++.+||+|||++..... .
T Consensus 80 ~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~ 154 (333)
T cd05600 80 MEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y 154 (333)
T ss_pred EeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence 999985 677776532 2333 335999999999999999999999999999999999999999986543 2
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 357 (584)
....+||+.|+|||++.+. .++.++|||||||++|||++|.+||...+..+.+..+........ .
T Consensus 155 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------------~ 219 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ--------------R 219 (333)
T ss_pred cCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc--------------C
Confidence 3456799999999999875 689999999999999999999999998877766655543211100 0
Q ss_pred CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 358 p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
|.. ......+++++.+||.+||..+|.+|||+.++++||||...
T Consensus 220 ~~~-----~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 220 PVY-----DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred CCC-----CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 000 00113568999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=365.05 Aligned_cols=270 Identities=37% Similarity=0.616 Sum_probs=207.6
Q ss_pred EeeecccCceEEEEEEECC--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEec
Q 043957 130 IDKVGQGTYSNVYKALDRD--TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEF 207 (584)
Q Consensus 130 ~~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey 207 (584)
..+||+|+||.||+|.+.. ++..||+|.+..... ...+.+|+.+|++++||||+++++++.......+|+||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 3579999999999998654 568899999864322 2346789999999999999999998877666778999999
Q ss_pred hhhHHHHHhhCC--------CCCC------cHHHHHHHHHHHHHhCCceeccccccceee----cCCCcEEEEEeccccc
Q 043957 208 MQTDLARIISNP--------EGKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLI----DKNGVLKIADFGLANY 269 (584)
Q Consensus 208 ~~g~L~~~l~~~--------~~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl----~~~g~vKL~DFGla~~ 269 (584)
+.++|...+... ...+ .+..||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++.
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 82 AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred eCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 999887776421 1122 234599999999999999999999999999 4567899999999987
Q ss_pred cCCCCC--CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhc
Q 043957 270 FSPNKK--RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE---------VEQLHRIFKLC 338 (584)
Q Consensus 270 ~~~~~~--~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~---------~~~~~~i~~~~ 338 (584)
+..... ......++|+.|+|||++.+...++.++|||||||++|||++|++||..... ..++..++...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 643321 1234567899999999998756689999999999999999999999975432 45677788888
Q ss_pred CCCChHHHHHhhccCCCCCC-------CCCCchhh----hhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 339 GSPSEDYWKKLRLSTTFRPP-------QSYKPRLF----EAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~p-------~~~~~~~~----~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
+.+....|..+.....+... ........ ......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 88888888776433211110 00001111 1112345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=371.24 Aligned_cols=248 Identities=25% Similarity=0.366 Sum_probs=203.3
Q ss_pred CCCceEEeeecccCceEEEEEEECCCC-cEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTG-KIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
.++|++.+.||+|+||.||+|.+..++ ..||+|++.... ......+.+.+|+.+++.++|||||++++++... ..+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~ 106 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE--SYL 106 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC--CEE
Confidence 456999999999999999999876654 689999986432 1233456688999999999999999999988764 468
Q ss_pred EEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 202 YLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 202 ~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
|+|||||. |+|...+... ..+.+ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++..+...
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 99999997 4677776543 23333 359999999999999999999999999999999999999999876432
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.......+......
T Consensus 185 ---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~-------------- 246 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY-------------- 246 (340)
T ss_pred ---cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--------------
Confidence 245679999999999976 45899999999999999999999999988776666655432111
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~~ 406 (584)
....+++.+.+||.+||+.||.+|+ |++++++||||...
T Consensus 247 -------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 247 -------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred -------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 1134578899999999999999995 89999999999764
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=373.26 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=201.5
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|++++.||+|+||+||+|.+..+++.||||++..... .......+.+|+.++.+++||||+++++.+.+ ...+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD--KLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCeEEE
Confidence 469999999999999999999999999999999964322 23345678889999999999999999887766 446899
Q ss_pred EEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC-
Q 043957 204 VFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK- 275 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~- 275 (584)
|||||.+ +|...+... ..+.+ ..||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.....
T Consensus 79 v~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 79 IMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred EEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 9999985 677776542 33433 34999999999999999999999999999999999999999976532110
Q ss_pred ---------------------------------CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCC
Q 043957 276 ---------------------------------RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIM 322 (584)
Q Consensus 276 ---------------------------------~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF 322 (584)
......+||+.|+|||++.+ ..++.++|||||||++|||++|++||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 01134589999999999976 45899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCC---CCCCHHHHhc
Q 043957 323 PGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPA---YRGSAASALK 399 (584)
Q Consensus 323 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~---kRpTa~e~L~ 399 (584)
.+.+..+.+..+........ .|. ...+++++++||.+||. +|. .||+++|+|+
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~--------------~p~---------~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 237 CSETPQETYKKVMNWKETLI--------------FPP---------EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT 292 (363)
T ss_pred CCCCHHHHHHHHHcCcCccc--------------CCC---------cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC
Confidence 98887777766654211100 000 12367899999999875 454 4589999999
Q ss_pred CcCCCCC
Q 043957 400 NEFFFTS 406 (584)
Q Consensus 400 Hp~f~~~ 406 (584)
||||...
T Consensus 293 hp~f~~~ 299 (363)
T cd05628 293 NPFFEGV 299 (363)
T ss_pred CCCCCCC
Confidence 9999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=374.69 Aligned_cols=254 Identities=27% Similarity=0.389 Sum_probs=199.8
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
.|++++.||+|+||+||+|.+..+++.||||++.... ........+.+|+.+|+.++|||||++++++.+ ...+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEEE
Confidence 5899999999999999999999999999999996542 233456678899999999999999999988876 4468999
Q ss_pred Eechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC--
Q 043957 205 FEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK-- 275 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-- 275 (584)
||||.+ +|..++... ..+.+ ..||+.||.|||+++|+||||||+||||+.++.+||+|||++..+.....
T Consensus 80 ~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 80 MDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 999985 677776542 23332 35999999999999999999999999999999999999999864321000
Q ss_pred --------------------------------------------CCCccccccccccChhhhhCCCCCCceeeEecchHH
Q 043957 276 --------------------------------------------RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCL 311 (584)
Q Consensus 276 --------------------------------------------~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvi 311 (584)
......+||+.|+|||++.+ ..++.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~i 237 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVI 237 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhH
Confidence 00124579999999999976 458999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhccc--CCC
Q 043957 312 LAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLAL--DPA 389 (584)
Q Consensus 312 lyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~--DP~ 389 (584)
+|||++|.+||...+..+....+........ . .....+++++.+||.+||.. +|.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------~---------~~~~~~s~~~~dli~~ll~~~~~~~ 294 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLH--------------I---------PPQVKLSPEAVDLITKLCCSAEERL 294 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccC--------------C---------CCCCCCCHHHHHHHHHHccCccccc
Confidence 9999999999988776665554432111000 0 01134689999999996654 455
Q ss_pred CCCCHHHHhcCcCCCCC
Q 043957 390 YRGSAASALKNEFFFTS 406 (584)
Q Consensus 390 kRpTa~e~L~Hp~f~~~ 406 (584)
.|+|++++|+||||...
T Consensus 295 ~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 295 GRNGADDIKAHPFFSEV 311 (381)
T ss_pred CCCCHHHHhcCcccCCC
Confidence 59999999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=369.14 Aligned_cols=256 Identities=29% Similarity=0.413 Sum_probs=207.4
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|.+.+.||+|+||.||+|.+..+|+.||||+++.... .......+.+|+.+++.++||||+++++++.. ...+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD--KDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCeEEE
Confidence 369999999999999999999999999999999975432 23345678899999999999999999887765 446899
Q ss_pred EEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
||||+. ++|..++......+.+ ..||+.||.|||+++|+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 999997 5777777654344443 359999999999999999999999999999999999999999876543332
Q ss_pred CCccccccccccChhhhhC-----CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 277 PLTSRVVTLWYRAPELLLG-----ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~-----~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
......||+.|+|||++.. ...++.++|||||||++|+|++|..||...+....+..++......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~---------- 228 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL---------- 228 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc----------
Confidence 2334578999999999863 3457899999999999999999999999887777666654321100
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.. .....++..+.+||.+||. ||.+|||++++++||||...
T Consensus 229 ----~~---------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 229 ----KF---------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred ----CC---------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 00 0113468899999999998 99999999999999999753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=364.40 Aligned_cols=241 Identities=30% Similarity=0.452 Sum_probs=196.2
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechhh-
Q 043957 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT- 210 (584)
Q Consensus 133 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~g- 210 (584)
||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|++++||||+++++++.. ...+|+||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEcCCCCC
Confidence 799999999999999999999999996432 233445677889999999999999999887765 4468999999985
Q ss_pred HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCcccccc
Q 043957 211 DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVT 284 (584)
Q Consensus 211 ~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gt 284 (584)
+|...+.. ...+.+ ..||+.||.|||+++|+||||||+|||++.++.+||+|||+++...... ......+||
T Consensus 79 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 156 (312)
T cd05585 79 ELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGT 156 (312)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCC
Confidence 67666653 233433 3499999999999999999999999999999999999999997643222 223456799
Q ss_pred ccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCch
Q 043957 285 LWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPR 364 (584)
Q Consensus 285 ~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 364 (584)
+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.....
T Consensus 157 ~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~------------------------- 210 (312)
T cd05585 157 PEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL------------------------- 210 (312)
T ss_pred cccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC-------------------------
Confidence 99999999976 4589999999999999999999999998776665555432110
Q ss_pred hhhhccCCcHhHHHHHHHhcccCCCCCC---CHHHHhcCcCCCC
Q 043957 365 LFEAFSEFPESSLGLLSTLLALDPAYRG---SAASALKNEFFFT 405 (584)
Q Consensus 365 ~~~~~~~~s~~~~dLI~~~L~~DP~kRp---Ta~e~L~Hp~f~~ 405 (584)
.....+++.+.+||.+||+.||.+|| ++.|+|+||||..
T Consensus 211 --~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 211 --RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred --CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence 11235688999999999999999997 5899999999975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=364.55 Aligned_cols=247 Identities=29% Similarity=0.526 Sum_probs=214.5
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.+|++.+.||+|+||.|-+|.+...|+.||||.|+++.. .....-.+.+||+||..|+||||+.+|++|+..+ .+.|
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd--KIvi 130 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD--KIVI 130 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc--eEEE
Confidence 479999999999999999999999999999999977644 3455667899999999999999999999988754 5899
Q ss_pred EEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
||||.. |.|++.+.. .+.+.+ ++||..|+.|||.++|+|||||.+|||+|.++++||+||||+.++.. ..
T Consensus 131 vMEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~--~k 207 (668)
T KOG0611|consen 131 VMEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD--KK 207 (668)
T ss_pred EEEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc--cc
Confidence 999998 679988875 345554 35999999999999999999999999999999999999999999864 45
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
.++++||+|.|.+||++.|..+-++.+|.|||||+||.|+.|..||.|.+....+.+|-.+....
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE--------------- 272 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE--------------- 272 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC---------------
Confidence 67899999999999999987767899999999999999999999999999888777775442211
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~ 404 (584)
+.-|.++.-||++||..+|++|.|.+++-.|=|+.
T Consensus 273 -------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 273 -------------PETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred -------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 12366788899999999999999999999996653
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=369.69 Aligned_cols=254 Identities=32% Similarity=0.499 Sum_probs=206.2
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+|..++||||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD--EEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec--CCeEEE
Confidence 369999999999999999999999999999999975422 22345678899999999999999999888765 446899
Q ss_pred EEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC--
Q 043957 204 VFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK-- 274 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-- 274 (584)
||||+. ++|...+... ..+.+ ..||+.||+|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 79 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 79 VMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred EEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 999997 4677776643 33333 3599999999999999999999999999999999999999998765332
Q ss_pred --------------------------CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChH
Q 043957 275 --------------------------KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEV 328 (584)
Q Consensus 275 --------------------------~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~ 328 (584)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|++||...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 1123456799999999999874 6899999999999999999999999988876
Q ss_pred HHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC-HHHHhcCcCCCCC
Q 043957 329 EQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS-AASALKNEFFFTS 406 (584)
Q Consensus 329 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT-a~e~L~Hp~f~~~ 406 (584)
.....+....... ..| ....+++.+.+||.+||. ||.+|++ ++++|+||||...
T Consensus 237 ~~~~~i~~~~~~~--------------~~p---------~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 237 ETYNKIINWKESL--------------RFP---------PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHHHHhccCCcc--------------cCC---------CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 6666554321110 000 012368999999999998 9999999 9999999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=356.78 Aligned_cols=284 Identities=43% Similarity=0.718 Sum_probs=229.0
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE---PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~---~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
+|++.+.||.|+||.||+|.+..+++.||||.+...... ......+..|+.++++++|+||+++++++.. ...+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence 488999999999999999999999999999999755433 2334557789999999999999999998877 45689
Q ss_pred EEEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 203 LVFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
+||||+.++|..++......+. ++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++....... .
T Consensus 79 lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 157 (298)
T cd07841 79 LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-R 157 (298)
T ss_pred EEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC-c
Confidence 9999998788888765432343 34599999999999999999999999999999999999999998765332 2
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
......+++.|+|||++.+...++.++|||||||++|+|++|.++|.+..+.+.+..+......+....|..........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 23344668899999998765668899999999999999999999999999888888888888777777765533221111
Q ss_pred C-CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCccCC
Q 043957 357 P-PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDL 412 (584)
Q Consensus 357 ~-p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~~~~ 412 (584)
. ...........+..++..+.+||.+||.+||.+|||+.|+|+||||...+.++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~ 294 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPP 294 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCC
Confidence 1 1111122334456778999999999999999999999999999999988766543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=373.85 Aligned_cols=253 Identities=28% Similarity=0.412 Sum_probs=200.9
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
.|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|++++|||||++++.+.. ...+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEEEE
Confidence 5999999999999999999999999999999986432 223445678899999999999999999988876 4468999
Q ss_pred Eechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC---
Q 043957 205 FEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK--- 274 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--- 274 (584)
||||.+ +|...+... ..+.+ ..||+.||+|||+++|+||||||+||||+.++.+||+|||++..+....
T Consensus 80 ~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 80 MDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 999985 677776543 23332 3599999999999999999999999999999999999999985331000
Q ss_pred -------------------------------------------CCCCccccccccccChhhhhCCCCCCceeeEecchHH
Q 043957 275 -------------------------------------------KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCL 311 (584)
Q Consensus 275 -------------------------------------------~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvi 311 (584)
.......+||+.|+|||++.+ ..++.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvi 237 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVI 237 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHH
Confidence 000123579999999999976 458999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCC
Q 043957 312 LAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR 391 (584)
Q Consensus 312 lyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kR 391 (584)
+|||++|++||.+.+..+....+........ . .....+++++.+||.+|+ .||.+|
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------~---------p~~~~~s~~~~~li~~l~-~~p~~R 293 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLH--------------I---------PPQAKLSPEASDLIIKLC-RGPEDR 293 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcC--------------C---------CCcccCCHHHHHHHHHHc-cCHhHc
Confidence 9999999999998877666555543211100 0 011356899999999987 599999
Q ss_pred CC---HHHHhcCcCCCCC
Q 043957 392 GS---AASALKNEFFFTS 406 (584)
Q Consensus 392 pT---a~e~L~Hp~f~~~ 406 (584)
++ ++++++||||...
T Consensus 294 ~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 294 LGKNGADEIKAHPFFKTI 311 (382)
T ss_pred CCCCCHHHHhcCCCcCCc
Confidence 97 9999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=344.66 Aligned_cols=249 Identities=30% Similarity=0.440 Sum_probs=212.5
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
.++|++.+.||+|-||.||+|+.+.++-.||+|++.+.. .......++.+|++|-..|+||||+++|++|.+. ..+|
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~--~riy 98 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS--KRIY 98 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc--ceeE
Confidence 457999999999999999999999999999999995442 2223446789999999999999999999999884 4589
Q ss_pred EEEechh-hHHHHHhhCC-CCCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 203 LVFEFMQ-TDLARIISNP-EGKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 203 lV~Ey~~-g~L~~~l~~~-~~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
|++||.. |.++..+... ..++ +...|++.||.|||.++|+||||||+|+|++.++.+||+|||.+.....+
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~- 177 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN- 177 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC-
Confidence 9999998 6677766522 2223 33469999999999999999999999999999999999999999875422
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.-.+.|||..|.+||...+ ..++..+|+|++|++.||+|.|.+||...+..+.+.+|.+.-...+
T Consensus 178 --kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p------------ 242 (281)
T KOG0580|consen 178 --KRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP------------ 242 (281)
T ss_pred --CceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC------------
Confidence 2367899999999999877 4599999999999999999999999999998899988876532222
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
..++..+.|||.+||.++|.+|++..|++.|||+..
T Consensus 243 ---------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 243 ---------------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ---------------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 467899999999999999999999999999999864
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=374.20 Aligned_cols=253 Identities=27% Similarity=0.433 Sum_probs=200.4
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|+.++|||||++++++.. ...+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCeeEE
Confidence 36999999999999999999999999999999986432 123345678899999999999999999988876 446899
Q ss_pred EEechh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC-
Q 043957 204 VFEFMQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK- 275 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~- 275 (584)
|||||. ++|...+... ..+. +..||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.....
T Consensus 79 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 79 IMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999997 5777776542 2333 245999999999999999999999999999999999999999964321000
Q ss_pred ---------------------------------------------CCCccccccccccChhhhhCCCCCCceeeEecchH
Q 043957 276 ---------------------------------------------RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGC 310 (584)
Q Consensus 276 ---------------------------------------------~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGv 310 (584)
......+||+.|+|||++.+ ..++.++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGv 236 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGA 236 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecch
Confidence 00013579999999999976 45899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCC
Q 043957 311 LLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAY 390 (584)
Q Consensus 311 ilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~k 390 (584)
++|||++|.+||.+.+..+.+..+....... ..| ....++.++.+||.+||. +|.+
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------------~~p---------~~~~~s~~~~dli~~lL~-~~~~ 292 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRETL--------------YFP---------DDIHLSVEAEDLIRRLIT-NAEN 292 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCCcc--------------CCC---------CCCCCCHHHHHHHHHHhc-CHhh
Confidence 9999999999999888777666654321100 000 012468899999999998 7776
Q ss_pred C---CCHHHHhcCcCCCC
Q 043957 391 R---GSAASALKNEFFFT 405 (584)
Q Consensus 391 R---pTa~e~L~Hp~f~~ 405 (584)
| +|+.|+|+||||..
T Consensus 293 r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 293 RLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred cCCCCCHHHHhcCCCcCC
Confidence 5 59999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=356.60 Aligned_cols=279 Identities=42% Similarity=0.751 Sum_probs=226.4
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.+.|++.+.||.|+||.||+|.+..+++.||+|.++...........+.+|+.++++++||||+++++++.......+|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 35699999999999999999999999999999999765444333445678999999999999999999887765567999
Q ss_pred EEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 204 VFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||||+.++|..++......+.+ +.||+.||+|||+++|+|+||||+|||++.++.+||+|||++..+.... ..
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~ 162 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KP 162 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-cc
Confidence 9999998888777653333333 3599999999999999999999999999999999999999998765332 22
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC-
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR- 356 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~- 356 (584)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||........+..++..++.+....|..........
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 3445678999999998765557899999999999999999999999999999999999999988888887653221111
Q ss_pred --CCCCCCchhhhhccC--CcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 357 --PPQSYKPRLFEAFSE--FPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 357 --~p~~~~~~~~~~~~~--~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
........+...++. +++.+.+||.+||+.||++|||+.|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 011111122233443 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=374.31 Aligned_cols=253 Identities=27% Similarity=0.392 Sum_probs=200.2
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
+|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|++++||||+++++.+.. ...+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv 79 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEEEE
Confidence 5999999999999999999999999999999985432 122334667899999999999999999888776 4468999
Q ss_pred Eechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC---
Q 043957 205 FEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK--- 274 (584)
Q Consensus 205 ~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~--- 274 (584)
||||. ++|.+++... ..+.+ ..||+.||+|||+++|+||||||+||||+.++.+||+|||+|..+....
T Consensus 80 ~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 80 MDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 99998 5777777543 23332 3599999999999999999999999999999999999999985331000
Q ss_pred ---------------------------------------CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHH
Q 043957 275 ---------------------------------------KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEM 315 (584)
Q Consensus 275 ---------------------------------------~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeL 315 (584)
.......+||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeeeh
Confidence 000123579999999999976 4589999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC---
Q 043957 316 FLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG--- 392 (584)
Q Consensus 316 ltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp--- 392 (584)
++|++||.+.+..+....+....... .. .....++..+.+||.+|+ .+|.+|+
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~--------------~~---------~~~~~~s~~~~~li~~l~-~~p~~R~~~~ 293 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTL--------------HI---------PSQAKLSREASDLILRLC-CGAEDRLGKN 293 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccc--------------cC---------CCCCCCCHHHHHHHHHHh-cCHhhcCCCC
Confidence 99999999887766655443211100 00 011356889999999977 5999999
Q ss_pred CHHHHhcCcCCCCC
Q 043957 393 SAASALKNEFFFTS 406 (584)
Q Consensus 393 Ta~e~L~Hp~f~~~ 406 (584)
|+.++|+||||...
T Consensus 294 t~~ell~h~~~~~~ 307 (376)
T cd05598 294 GADEIKAHPFFKGI 307 (376)
T ss_pred CHHHHhCCCCcCCC
Confidence 99999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=356.40 Aligned_cols=280 Identities=45% Similarity=0.764 Sum_probs=225.5
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC------
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM------ 197 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------ 197 (584)
.++|++.++||.|+||.||+|.+..++..||||++............+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 56899999999999999999999999999999998655433333345678999999999999999998775433
Q ss_pred cceEEEEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccC
Q 043957 198 QYSLYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS 271 (584)
Q Consensus 198 ~~~l~lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~ 271 (584)
...+|+||||+.+++...+......+.+ ..||+.||.|||+++|+|+||||+|||++.++.++|+|||++....
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 2358999999998888877654444544 3499999999999999999999999999999999999999997654
Q ss_pred CCCC----------CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 043957 272 PNKK----------RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSP 341 (584)
Q Consensus 272 ~~~~----------~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~ 341 (584)
.... ...+...+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+...++.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 3221 112345678999999998765568999999999999999999999999999999999999888877
Q ss_pred ChHHHHHhhccCCC---CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 342 SEDYWKKLRLSTTF---RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 342 ~~~~~~~~~~~~~~---~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
....|......... .......+.+...+..++..+.+||.+||+.||.+|||+.|+|.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 77666543222111 112223334444566777899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=364.68 Aligned_cols=244 Identities=28% Similarity=0.396 Sum_probs=196.0
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechh
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ 209 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~ 209 (584)
+.||+|+||.||+|.+..+|..||||++..... .......+.+|+.+|+.++||||+++++++.. ...+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEEEEeCCC
Confidence 359999999999999999999999999975422 23345677889999999999999999887765 446899999998
Q ss_pred h-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCcccc
Q 043957 210 T-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRV 282 (584)
Q Consensus 210 g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~ 282 (584)
+ +|...+.. ...+.+ ..||+.||+|||+++|+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 156 (328)
T cd05593 79 GGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFC 156 (328)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccccccc
Confidence 5 56555543 233333 359999999999999999999999999999999999999998754322 12234567
Q ss_pred ccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCC
Q 043957 283 VTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYK 362 (584)
Q Consensus 283 gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 362 (584)
||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+.......+.....
T Consensus 157 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~----------------------- 212 (328)
T cd05593 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI----------------------- 212 (328)
T ss_pred CCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCc-----------------------
Confidence 9999999999976 4589999999999999999999999988766555444321100
Q ss_pred chhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCCC
Q 043957 363 PRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFTS 406 (584)
Q Consensus 363 ~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~~ 406 (584)
.....+++++.+||.+||+.||.+|+ ++.|+|+||||...
T Consensus 213 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 213 ----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred ----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 11135688999999999999999997 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=349.65 Aligned_cols=273 Identities=38% Similarity=0.621 Sum_probs=219.9
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceEEEEE
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
|+++++||+|+||.||+|.+..++..||+|+++......... ...+|+.++.++. |+||+++++++.+.....+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 788999999999999999999999999999986543333222 3447899999885 99999999998876446789999
Q ss_pred echhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCc
Q 043957 206 EFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLT 279 (584)
Q Consensus 206 Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 279 (584)
||+.+++.+.+......+.+ ..||+.||.|||+.+|+||||||+||+++. +.+||+|||++..+.... ...
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~--~~~ 156 (282)
T cd07831 80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP--PYT 156 (282)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC--CcC
Confidence 99999988887754334443 349999999999999999999999999999 999999999998764322 223
Q ss_pred cccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC--CCCC
Q 043957 280 SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST--TFRP 357 (584)
Q Consensus 280 ~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~~~ 357 (584)
...+++.|+|||++.....++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+....... .+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 45678999999987655567899999999999999999999999999988888888888877765544432221 1222
Q ss_pred CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 358 p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
+......+......++..+.+||.+||+.||++|||++++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 2222233344456789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=365.74 Aligned_cols=254 Identities=25% Similarity=0.401 Sum_probs=196.5
Q ss_pred CceEEeeecccCceEEEEEEEC---CCCcEEEEEEeecCC--CChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcc
Q 043957 126 SYDKIDKVGQGTYSNVYKALDR---DTGKIVALKKVKFDT--SEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~--~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 199 (584)
+|++++.||+|+||.||+|.+. .+++.||+|++.... ......+.+.+|+.+|+.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CC
Confidence 4899999999999999998764 578999999996432 1223345678899999999 59999999877765 44
Q ss_pred eEEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
.+|+|||||.+ +|...+... ..+.+ ..||+.||.|||+++|+||||||+||||+.++.+||+|||+++.+..
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 68999999985 677766532 22332 34999999999999999999999999999999999999999987644
Q ss_pred CCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
.........+||+.|+|||++.+...++.++|||||||++|+|++|..||...........+... +...
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~-----------~~~~ 226 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR-----------ILKC 226 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH-----------HhcC
Confidence 33333345689999999999986556889999999999999999999999754322111111110 0000
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFT 405 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~ 405 (584)
.. .....+++.+.+||.+||+.||++|| +++++|+||||..
T Consensus 227 -~~-----------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 227 -DP-----------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred -CC-----------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 00 01134688999999999999999999 8899999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=346.49 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=207.7
Q ss_pred CCCCceEE-eeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeee--cCc
Q 043957 123 SAESYDKI-DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATS--RMQ 198 (584)
Q Consensus 123 ~~~~Y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~--~~~ 198 (584)
.+++|.+- ++||-|-.|.|..|.++.||+.+|+|++.. ....++|+++.-.. .|||||.++++|+. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 45667764 579999999999999999999999999852 23356788876665 59999999999865 345
Q ss_pred ceEEEEEechhh-HHHHHhhCCC-CCCcHH------HHHHHHHHHHHhCCceeccccccceeecC---CCcEEEEEeccc
Q 043957 199 YSLYLVFEFMQT-DLARIISNPE-GKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDK---NGVLKIADFGLA 267 (584)
Q Consensus 199 ~~l~lV~Ey~~g-~L~~~l~~~~-~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~---~g~vKL~DFGla 267 (584)
.++.||||+|+| .|...+.+.. ..+++. +||+.||.|||+.+|.||||||+|+|+.. +..+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 578999999995 6777776543 335543 49999999999999999999999999954 457999999999
Q ss_pred cccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCCh
Q 043957 268 NYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE----VEQLHRIFKLCGSPSE 343 (584)
Q Consensus 268 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~----~~~~~~i~~~~~~~~~ 343 (584)
+.-.. ...+.+.+.||+|+|||++-. ..|+..+|+||||||+|.||||+|||..... ...-.+|......++.
T Consensus 212 K~t~~--~~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~ 288 (400)
T KOG0604|consen 212 KETQE--PGDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE 288 (400)
T ss_pred cccCC--CccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence 87542 344677899999999999854 5699999999999999999999999987654 3345567777777777
Q ss_pred HHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 344 DYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 344 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
..|.. +|++++|+|++||..+|.+|+|++++++|||+.+.+
T Consensus 289 pEWs~-----------------------VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 289 PEWSC-----------------------VSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hhHhH-----------------------HHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 77755 489999999999999999999999999999998754
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=348.19 Aligned_cols=276 Identities=35% Similarity=0.616 Sum_probs=214.2
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++.+.||+|+||.||+|.++.+|+.||+|++..........+.+.+|+.+++.++||||+++++++.. ...+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEEEE
Confidence 46999999999999999999999999999999986543333334567889999999999999999998876 3467999
Q ss_pred EechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 205 FEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
|||++++++..+......+.+ +.||+.||.|||+++|+|+||||+||+++.++.+||+|||++........ ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DY 157 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cc
Confidence 999998766655433333433 35999999999999999999999999999999999999999987653321 22
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc----CC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS----TT 354 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~----~~ 354 (584)
....++..|+|||++.+...++.++|||||||++|+|++|.+||.+....+.+..+....+............. ..
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34567889999999876556889999999999999999999999998887777766655544332211111000 00
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
..+...........+..++..+.+||.+||+.||++|||+.|+|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0111111222334456789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=360.69 Aligned_cols=257 Identities=24% Similarity=0.369 Sum_probs=203.6
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecC-CCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD-TSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~-~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|++++.||+|+||.||++.+..+++.||||++... .......+.+.+|+.++..++|+||+.+++++.. ...+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD--ENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--CCeEEE
Confidence 4699999999999999999999999999999999642 2223345668889999999999999999888775 456899
Q ss_pred EEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
||||+. ++|..++......+.+ ..||+.||+|||+++|+||||||+|||++.++.+||+|||++..+......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 999997 5787777643344443 359999999999999999999999999999999999999999766433322
Q ss_pred CCccccccccccChhhhhC----CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 277 PLTSRVVTLWYRAPELLLG----ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~----~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
.....+||+.|+|||++.. ...++.++|||||||++|+|++|+.||...+..+.+..+.......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 227 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF----------- 227 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcc-----------
Confidence 2234578999999999863 2357889999999999999999999998887766665553321100
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCC--CCCHHHHhcCcCCCC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAY--RGSAASALKNEFFFT 405 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~k--RpTa~e~L~Hp~f~~ 405 (584)
. +......+++.+.+||.+||..++.+ |+++.++|+||||..
T Consensus 228 ---~--------~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 228 ---Q--------FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred ---c--------CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 0 00112347899999999999765554 889999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=368.54 Aligned_cols=262 Identities=26% Similarity=0.363 Sum_probs=206.7
Q ss_pred CCCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc
Q 043957 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 120 ~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 198 (584)
.....++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.. .
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~ 115 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--D 115 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--C
Confidence 3455678999999999999999999999999999999986422 222334567789999999999999999887765 4
Q ss_pred ceEEEEEechh-hHHHHHhhCCCCCC----cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 199 YSLYLVFEFMQ-TDLARIISNPEGKL----TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 199 ~~l~lV~Ey~~-g~L~~~l~~~~~~l----~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
..+|+|||||. ++|..++....... ....||+.||.|||+++|+||||||+||||+.++.+||+|||++......
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 56899999998 46777765432111 12349999999999999999999999999999999999999999876533
Q ss_pred CCCCCccccccccccChhhhhCCC---CCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGAT---DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~---~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
........+||+.|+|||++.+.. .++.++|||||||++|||++|.+||.+.+....+..|........
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~-------- 267 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT-------- 267 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc--------
Confidence 322334568999999999987532 378999999999999999999999998887766666643211110
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCC--CCCHHHHhcCcCCCCC
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAY--RGSAASALKNEFFFTS 406 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~k--RpTa~e~L~Hp~f~~~ 406 (584)
. .....++..+.+||..||..++.+ |++++|+++||||...
T Consensus 268 ------~---------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 268 ------F---------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred ------C---------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 0 112357899999999999844443 7899999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=361.41 Aligned_cols=246 Identities=28% Similarity=0.381 Sum_probs=197.9
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHH---HhCCCCCeeeeeceeeecCcceEE
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMIL---QKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL---~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
|++++.||+|+||.||+|.+..+++.||||+++... ......+.+.+|+.++ +.++||||+++++++.. ...+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEEE
Confidence 788999999999999999999999999999996432 1222345566676655 56689999999998876 44689
Q ss_pred EEEechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 203 LVFEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
+||||+.+ +|...+.. ..+. +..||+.||.|||+++|+||||||+||||+.++.+||+|||++.......
T Consensus 79 lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG- 155 (324)
T ss_pred EEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-
Confidence 99999985 56555543 2333 33599999999999999999999999999999999999999987543222
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+......
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~--------------- 219 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR--------------- 219 (324)
T ss_pred CcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------------
Confidence 22345679999999999976 45899999999999999999999999988877666655432110
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFT 405 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~ 405 (584)
....++..+.+||.+||+.||.+|| ++.++++||||..
T Consensus 220 ------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 220 ------------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred ------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 1134688899999999999999999 7999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=352.41 Aligned_cols=275 Identities=43% Similarity=0.739 Sum_probs=220.7
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
+|++++.||.|+||.||+|.+..+|..||||++............+.+|++++++++||||+++++++.. ....|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc--CCcEEEEe
Confidence 4899999999999999999999999999999987554444444678899999999999999999998875 34689999
Q ss_pred echhhHHHHHhhCC-CCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 206 EFMQTDLARIISNP-EGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 206 Ey~~g~L~~~l~~~-~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
||+.++|...+... ...+.+ ..||+.||+|||+.+++|+||+|+||+++.++.+||+|||++..+.... ...
T Consensus 79 e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (284)
T cd07860 79 EFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTY 157 (284)
T ss_pred eccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-ccc
Confidence 99998887776532 233333 3599999999999999999999999999999999999999997654322 223
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC--CC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT--FR 356 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~ 356 (584)
....+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.++.+.+.+++...+.+....|........ ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 3446788999999887655578899999999999999999999999998888888888888887766654322110 01
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
.+.............++..+.+||.+||+.||.+|||++++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 11111222333345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=363.35 Aligned_cols=244 Identities=28% Similarity=0.411 Sum_probs=196.9
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechh
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ 209 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~ 209 (584)
+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++... ..+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CEEEEEEeCCC
Confidence 369999999999999999999999999975422 233455677899999999999999998887763 46899999998
Q ss_pred h-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCcccc
Q 043957 210 T-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRV 282 (584)
Q Consensus 210 g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~ 282 (584)
+ +|...+.. ...+.+ ..||+.||.|||++||+||||||+||||+.++.+||+|||++....... .......
T Consensus 79 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 156 (323)
T cd05595 79 GGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFC 156 (323)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccccc
Confidence 5 56655543 223333 3599999999999999999999999999999999999999987542222 2234567
Q ss_pred ccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCC
Q 043957 283 VTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYK 362 (584)
Q Consensus 283 gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 362 (584)
||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 157 gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~----------------------- 212 (323)
T cd05595 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI----------------------- 212 (323)
T ss_pred CCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-----------------------
Confidence 9999999999876 4589999999999999999999999988776665555432110
Q ss_pred chhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCCC
Q 043957 363 PRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFTS 406 (584)
Q Consensus 363 ~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~~ 406 (584)
.....+++++.+||.+||+.||.+|+ ++.++|+||||...
T Consensus 213 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 213 ----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred ----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 01135688999999999999999998 99999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=363.68 Aligned_cols=244 Identities=32% Similarity=0.429 Sum_probs=198.4
Q ss_pred ceEEeeecccCceEEEEEEECCCCcE-EEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKI-VALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~-vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
..+.+.||+|+||+||++... |.. ||||++..........+.|.+|+.+|.+|+|||||+++|++..... .++|||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~iVt 119 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCIVT 119 (362)
T ss_pred hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEEEE
Confidence 345556999999999999766 566 9999997655444447889999999999999999999999987543 579999
Q ss_pred echh-hHHHHHhhC-CCCCCc------HHHHHHHHHHHHHhCC-ceeccccccceeecCCC-cEEEEEeccccccCCCCC
Q 043957 206 EFMQ-TDLARIISN-PEGKLT------EPQQLLSGLQHCHDRG-ILHRDVKGSNLLIDKNG-VLKIADFGLANYFSPNKK 275 (584)
Q Consensus 206 Ey~~-g~L~~~l~~-~~~~l~------~~~qIl~aL~yLH~~~-IvHrDLKp~NILl~~~g-~vKL~DFGla~~~~~~~~ 275 (584)
|||. |+|.+++.. ....+. ++.+|++||.|||+++ ||||||||+||||+.++ ++||+|||+++......
T Consensus 120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 9999 567777765 244443 4459999999999999 99999999999999998 99999999998765322
Q ss_pred CCCccccccccccChhhhhC-CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 276 RPLTSRVVTLWYRAPELLLG-ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~-~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
...+...||+.|||||++.+ ...|+.++|||||||+||||+||..||...........+......+.
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~------------ 266 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP------------ 266 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC------------
Confidence 33456799999999999985 25699999999999999999999999999888555544433222211
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
....+++.+..||..||..||.+||+..+++.
T Consensus 267 -------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 267 -------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred -------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 11236889999999999999999999988875
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=360.66 Aligned_cols=243 Identities=28% Similarity=0.424 Sum_probs=196.3
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEEEEEech
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
+.||+|+||.||+|.++.+++.||||++..... .......+..|+.++..+ +||||+++++++.. ...+|+|||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999964321 223455667888888877 69999999988766 44689999999
Q ss_pred hh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccc
Q 043957 209 QT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR 281 (584)
Q Consensus 209 ~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 281 (584)
.+ +|...+... ..+.+ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++....... ......
T Consensus 79 ~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (320)
T cd05590 79 NGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTF 156 (320)
T ss_pred CCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccccc
Confidence 85 676666432 33333 3599999999999999999999999999999999999999987543222 223456
Q ss_pred cccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCC
Q 043957 282 VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSY 361 (584)
Q Consensus 282 ~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~ 361 (584)
+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+......
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~--------------------- 214 (320)
T cd05590 157 CGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV--------------------- 214 (320)
T ss_pred ccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC---------------------
Confidence 79999999999976 45899999999999999999999999988877766665432110
Q ss_pred CchhhhhccCCcHhHHHHHHHhcccCCCCCCCH------HHHhcCcCCCC
Q 043957 362 KPRLFEAFSEFPESSLGLLSTLLALDPAYRGSA------ASALKNEFFFT 405 (584)
Q Consensus 362 ~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa------~e~L~Hp~f~~ 405 (584)
....++.++.+||.+||+.||.+|+++ +++++||||..
T Consensus 215 ------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 215 ------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred ------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 112367899999999999999999998 99999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=369.62 Aligned_cols=252 Identities=29% Similarity=0.469 Sum_probs=221.2
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.+.|.+++.||+|+||.+++++++..+..||+|+|...............|+.++.++.|||||.+.+.|..... .++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~-~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ-LLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCc-eEEE
Confidence 457999999999999999999999999999999999887777777788899999999999999999998877433 3899
Q ss_pred EEechhh-HHHHHhhCCCCCC-------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 204 VFEFMQT-DLARIISNPEGKL-------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l-------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
||+||+| ++.+.+....+.+ .|+.||+.||.|||++.|+|||||+.|||++.++.|||+|||+|+.+.+..
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 9999995 7888887655332 334599999999999999999999999999999999999999999987544
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
....+++|||.||.||++.+ .+|+.++|||||||++|||++-+++|.+.+-..+..+|+.....|-.
T Consensus 161 ~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp------------ 227 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP------------ 227 (426)
T ss_pred hhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC------------
Confidence 34578899999999999976 56999999999999999999999999999999999998877644432
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~ 404 (584)
..++.++..||..||..+|..||++.++|.+|.+.
T Consensus 228 --------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 228 --------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred --------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 34578899999999999999999999999998875
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=361.90 Aligned_cols=244 Identities=28% Similarity=0.393 Sum_probs=195.4
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechh
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ 209 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~ 209 (584)
+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++.. ...+||||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCCC
Confidence 359999999999999999999999999975422 22345567789999999999999999887766 446899999998
Q ss_pred h-HHHHHhhCCCCCCcH------HHHHHHHHHHHHh-CCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccc
Q 043957 210 T-DLARIISNPEGKLTE------PQQLLSGLQHCHD-RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR 281 (584)
Q Consensus 210 g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~-~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 281 (584)
+ +|...+.. ...+.+ ..||+.||.|||+ ++|+||||||+||||+.++.+||+|||++....... ......
T Consensus 79 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 156 (325)
T cd05594 79 GGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTF 156 (325)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cccccc
Confidence 5 56555543 223333 3599999999997 799999999999999999999999999987543222 223456
Q ss_pred cccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCC
Q 043957 282 VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSY 361 (584)
Q Consensus 282 ~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~ 361 (584)
+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~---------------------- 213 (325)
T cd05594 157 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI---------------------- 213 (325)
T ss_pred cCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC----------------------
Confidence 79999999999976 4589999999999999999999999988776555544422110
Q ss_pred CchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCCC
Q 043957 362 KPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFTS 406 (584)
Q Consensus 362 ~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~~ 406 (584)
.....+++++.+||.+||+.||.+|+ ++.++|+||||...
T Consensus 214 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 214 -----RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 01134688999999999999999997 99999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=352.07 Aligned_cols=279 Identities=43% Similarity=0.747 Sum_probs=220.8
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCc---ce
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQ---YS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~---~~ 200 (584)
++|++.+.||.|+||.||+|.+..+++.||||++............+.+|+.+++.+. ||||+++++++..... ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3699999999999999999999999999999998765443334456788999999995 6999999988765432 23
Q ss_pred EEEEEechhhHHHHHhhCCC----CCCc------HHHHHHHHHHHHHhCCceeccccccceeecC-CCcEEEEEeccccc
Q 043957 201 LYLVFEFMQTDLARIISNPE----GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDK-NGVLKIADFGLANY 269 (584)
Q Consensus 201 l~lV~Ey~~g~L~~~l~~~~----~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~-~g~vKL~DFGla~~ 269 (584)
+|+||||+.++|...+.... ..+. ++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 79999999998887765321 1222 3359999999999999999999999999998 88999999999986
Q ss_pred cCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 270 FSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 270 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
+.... .......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.++...+..++.....+....|...
T Consensus 161 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 161 FSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred cCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 54322 12233467889999999876566899999999999999999999999999998888888888777777666543
Q ss_pred hccCCCC-CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCC
Q 043957 350 RLSTTFR-PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404 (584)
Q Consensus 350 ~~~~~~~-~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~ 404 (584)
.....+. .+.............++..+.+||.+||..||.+|||+.|+|.||||.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 3222111 111112223334457899999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=359.47 Aligned_cols=248 Identities=27% Similarity=0.412 Sum_probs=199.7
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCC-CeeeeeceeeecCcceEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHP-NIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~Hp-nIv~l~~~~~~~~~~~l~l 203 (584)
+|++++.||+|+||.||+|.+..+++.||||++..... .......+..|+.++..+.|+ +|+.+++++.. ...+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEE
Confidence 48999999999999999999999999999999975422 233456677899999999765 57888777765 346899
Q ss_pred EEechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
||||+.+ +|...+... ..+. +..||+.||.|||+++|+||||||+|||++.++.+||+|||++....... .
T Consensus 79 v~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 156 (324)
T cd05587 79 VMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-K 156 (324)
T ss_pred EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-C
Confidence 9999984 676666432 2333 33599999999999999999999999999999999999999987532211 2
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.....
T Consensus 157 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~----------------- 218 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV----------------- 218 (324)
T ss_pred ceeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence 2345679999999999976 4589999999999999999999999998887776666543211
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCH-----HHHhcCcCCCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSA-----ASALKNEFFFT 405 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa-----~e~L~Hp~f~~ 405 (584)
.....++..+.+||.+||..||.+|+++ +++++||||..
T Consensus 219 ----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 219 ----------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred ----------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 0113468899999999999999999986 89999999965
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=357.14 Aligned_cols=258 Identities=28% Similarity=0.368 Sum_probs=213.8
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE-PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
.+.|++++.||.|.-|+||+|..+.++..+|+|++.+.... .........|-+||+.++||.++.||..++. ....|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet--~~~~c 153 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET--DKYSC 153 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec--cceeE
Confidence 45689999999999999999999999999999999765433 4455667789999999999999999888776 55689
Q ss_pred EEEechhh-HHHHHhhCC-CCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC--
Q 043957 203 LVFEFMQT-DLARIISNP-EGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP-- 272 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~-~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~-- 272 (584)
+|||||.| +|..+.+.+ ...+++. .+|+.||+|||-.|||+||||||||||-++|+|.|+||.|+....-
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 99999995 677776644 3345443 3899999999999999999999999999999999999998743210
Q ss_pred -------------------------------C-CC---------------------CCCccccccccccChhhhhCCCCC
Q 043957 273 -------------------------------N-KK---------------------RPLTSRVVTLWYRAPELLLGATDY 299 (584)
Q Consensus 273 -------------------------------~-~~---------------------~~~~~~~gt~~Y~APEvl~~~~~~ 299 (584)
. .. ....+.+||-.|+|||++.|. ..
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~-GH 312 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE-GH 312 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC-CC
Confidence 0 00 112357899999999999985 58
Q ss_pred CceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHH
Q 043957 300 GVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGL 379 (584)
Q Consensus 300 ~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dL 379 (584)
+.++|+|+|||+|||||.|..||.|.+..+.+..|+...-.++. ...++..++||
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~-------------------------~~~vs~~akDL 367 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPE-------------------------EPEVSSAAKDL 367 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCC-------------------------CCcchhHHHHH
Confidence 99999999999999999999999999999999888654322221 12567899999
Q ss_pred HHHhcccCCCCCCC----HHHHhcCcCCCCCCCc
Q 043957 380 LSTLLALDPAYRGS----AASALKNEFFFTSPLA 409 (584)
Q Consensus 380 I~~~L~~DP~kRpT----a~e~L~Hp~f~~~~~~ 409 (584)
|+++|.+||.+|+. |+|+-+||||...-|+
T Consensus 368 Ir~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 368 IRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred HHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 99999999999999 9999999999876554
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=348.90 Aligned_cols=276 Identities=41% Similarity=0.736 Sum_probs=217.9
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.+.||.|+||.||+|.++.+++.||||.+....... ....+.+|+.+++.++||||+++++++.. ....|+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHT--KKTLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEec--CCeEEE
Confidence 467999999999999999999999899999999986543222 22345689999999999999999998875 446899
Q ss_pred EEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 204 VFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||||+.++|...+......+.+ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~ 159 (291)
T cd07844 81 VFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KT 159 (291)
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC-cc
Confidence 9999999888877654333333 3499999999999999999999999999999999999999987543211 11
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRT-EVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||.... ..+.+..+.+..+.+....|..+.......
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 2233568899999998765568899999999999999999999998776 567777788888888877776654322111
Q ss_pred C---CCCCCchhhhhccCCc--HhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 357 P---PQSYKPRLFEAFSEFP--ESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 357 ~---p~~~~~~~~~~~~~~s--~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
. +..........+..++ ..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 1 1111122233334455 888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=352.41 Aligned_cols=282 Identities=46% Similarity=0.724 Sum_probs=218.2
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC----
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM---- 197 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---- 197 (584)
...++|++.++||+|+||.||+|.+..++..||||++............+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 3456799999999999999999999999999999998654433333345668999999999999999999876533
Q ss_pred --cceEEEEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccc
Q 043957 198 --QYSLYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 198 --~~~l~lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
....|+||||+.++|...+......+.+ ..||+.||.|||+++|+|+||||+|||++.++.+||+|||++..
T Consensus 89 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 89 RYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 2357999999999888877654434443 35999999999999999999999999999999999999999986
Q ss_pred cCCCCC---CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHH
Q 043957 270 FSPNKK---RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW 346 (584)
Q Consensus 270 ~~~~~~---~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 346 (584)
+..... .......++..|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+...++..+...|
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 643221 11234567889999999876556789999999999999999999999999888888888887777666555
Q ss_pred HHhhccC---CCCCCCCCCchhhhhc--cCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 347 KKLRLST---TFRPPQSYKPRLFEAF--SEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 347 ~~~~~~~---~~~~p~~~~~~~~~~~--~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
....... ....+..........+ ...+..+.+||.+||..||.+|||++|+|+||||
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 4332111 1111111111111111 1235778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=360.10 Aligned_cols=275 Identities=25% Similarity=0.365 Sum_probs=203.3
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++++.||+|+||.||+|.+..++..||+|.+.... .......+.+|+++|++++||||+++++++... ..+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEEEE
Confidence 357999999999999999999999999999999997542 334456788999999999999999999988764 46899
Q ss_pred EEechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhC-CceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 204 VFEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDR-GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~-~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
||||+.+ +|.+++.... .+. +..||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred EeecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 9999985 6777765422 232 335999999999986 69999999999999999999999999997654322
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc-CC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS-TT 354 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~ 354 (584)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+-..........+..+... ..
T Consensus 159 --~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 159 --ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred --cccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 2455789999999999764 5899999999999999999999999876654433222111100000000000000 00
Q ss_pred C----------CCCCCCCchhh----------hhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 355 F----------RPPQSYKPRLF----------EAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 355 ~----------~~p~~~~~~~~----------~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
. ..+......+. .....+++++++||.+||++||++|||+.|+|+||||...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 0 00000000000 0012467899999999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=351.99 Aligned_cols=281 Identities=43% Similarity=0.802 Sum_probs=226.8
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC-----
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM----- 197 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----- 197 (584)
..++|++.+.||.|+||.||+|.++.+|+.||||+++...........+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 345799999999999999999999999999999999765443334456778999999999999999999886543
Q ss_pred ---cceEEEEEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccc
Q 043957 198 ---QYSLYLVFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLAN 268 (584)
Q Consensus 198 ---~~~l~lV~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~ 268 (584)
...+|+||||+.+++...+......+. +..||+.||+|||+.+|+|+||||+||+++.++.+||+|||++.
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 236899999999988777765433343 33599999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHH
Q 043957 269 YFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK 348 (584)
Q Consensus 269 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 348 (584)
.+............+++.|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+...++.+....|..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD 244 (302)
T ss_pred cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 76543333333445688899999987655678999999999999999999999999999899999998888887776655
Q ss_pred hhccCCCC---CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 349 LRLSTTFR---PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 349 ~~~~~~~~---~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
+.....+. ............+..+|..+.+||.+||+.||.+|||+.++|.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 245 VIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 43221111 11112223334456679999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=368.60 Aligned_cols=255 Identities=30% Similarity=0.442 Sum_probs=196.4
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|+++++||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++|+||+++++++.. ...+|+|
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 150 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQVL 150 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--CCeEEEE
Confidence 45888999999999999999999999999999986432 33445678899999999999999999998866 4468999
Q ss_pred EechhhH-HHHHhhC-CCCCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCcccc
Q 043957 205 FEFMQTD-LARIISN-PEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRV 282 (584)
Q Consensus 205 ~Ey~~g~-L~~~l~~-~~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~ 282 (584)
||||.++ |...... ......+..||+.||.|||+++|+||||||+||||+.++.+||+|||++..+.... ......+
T Consensus 151 ~e~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 229 (353)
T PLN00034 151 LEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DPCNSSV 229 (353)
T ss_pred EecCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-ccccccc
Confidence 9999964 4332211 11123455699999999999999999999999999999999999999998764322 2234568
Q ss_pred ccccccChhhhhCC----CCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCC
Q 043957 283 VTLWYRAPELLLGA----TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358 (584)
Q Consensus 283 gt~~Y~APEvl~~~----~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p 358 (584)
||+.|+|||++... ..++.++|||||||++|||++|+.||......+....+....... .
T Consensus 230 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------~---- 293 (353)
T PLN00034 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ------------P---- 293 (353)
T ss_pred cCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC------------C----
Confidence 99999999987431 234578999999999999999999997433222211111110000 0
Q ss_pred CCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 359 ~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
......++.++.+||.+||+.||++|||+.|+|+||||...
T Consensus 294 -------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 294 -------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred -------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 01123568899999999999999999999999999999765
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=347.69 Aligned_cols=277 Identities=52% Similarity=0.913 Sum_probs=226.8
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEe
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFE 206 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~E 206 (584)
|++.+.||.|+||.||+|.+..++..||+|++............+.+|+.+++.++||||+++++++.......+|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 78899999999999999999999999999999765433444566788999999999999999999887653356899999
Q ss_pred chhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCcc
Q 043957 207 FMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTS 280 (584)
Q Consensus 207 y~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~ 280 (584)
|+.++|...+......+.+ ..||+.||+|||+.+++|+||||+|||+++++.+||+|||++.............
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence 9999888887654334433 3599999999999999999999999999999999999999998765443223344
Q ss_pred ccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc---CCCCC
Q 043957 281 RVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS---TTFRP 357 (584)
Q Consensus 281 ~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~---~~~~~ 357 (584)
..++..|+|||.+.+...++.++|||||||++|+|++|++||...+....+..+...+..+....|..+... .....
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07840 161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240 (287)
T ss_pred cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccc
Confidence 567889999998876556889999999999999999999999999998999999998888887777654321 11112
Q ss_pred CCCCCchhhhhccCC-cHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 358 PQSYKPRLFEAFSEF-PESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 358 p~~~~~~~~~~~~~~-s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
.......+...+... +..+.++|.+||..||.+|||+.++|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 222223333445554 8999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=357.06 Aligned_cols=285 Identities=35% Similarity=0.585 Sum_probs=228.1
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec--CcceEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR--MQYSLY 202 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~l~ 202 (584)
++|++.+.||.|+||.||+|.+..+|..||+|++............+.+|+.+|++++||||+++++++... ....+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 579999999999999999999999999999999975544444566778899999999999999999877543 234689
Q ss_pred EEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC-
Q 043957 203 LVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK- 275 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~- 275 (584)
+||||+.++|...+.... .+.+ +.||+.||.|||+++|+||||||+|||++.++.+||+|||++........
T Consensus 85 lv~e~~~~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 85 VVMDLMESDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEehhhhhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 999999998888875432 2433 34999999999999999999999999999999999999999976543221
Q ss_pred --CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 276 --RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 276 --~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
......+++..|+|||++.+...++.++|||||||++|+|++|++||.+.+...++..+....+.+....+..+....
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence 112345789999999998765568999999999999999999999999999888888888888887766654432111
Q ss_pred C----CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCcc
Q 043957 354 T----FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLAC 410 (584)
Q Consensus 354 ~----~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~~ 410 (584)
. ...+......+...+..+++++.+||.+||+.||.+|||++++|.||||...+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~ 304 (334)
T cd07855 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD 304 (334)
T ss_pred HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence 0 01111222233444567899999999999999999999999999999998655444
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=357.96 Aligned_cols=243 Identities=26% Similarity=0.378 Sum_probs=196.5
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEEEEEech
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
+.||+|+||.||+|.+..+++.||||++..... .......+..|+.++..+ +||||+++++++... ..+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEEeCC
Confidence 359999999999999999999999999975422 233455677899999876 799999999888764 4689999999
Q ss_pred hh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccc
Q 043957 209 QT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR 281 (584)
Q Consensus 209 ~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 281 (584)
.+ +|...+... ..+. +..||+.||.|||+++|+||||||+|||++.++.+||+|||++....... ......
T Consensus 79 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 156 (321)
T cd05591 79 NGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTF 156 (321)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC-cccccc
Confidence 85 666665432 2333 33599999999999999999999999999999999999999997643222 223456
Q ss_pred cccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCC
Q 043957 282 VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSY 361 (584)
Q Consensus 282 ~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~ 361 (584)
+||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+.+..+......
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~--------------------- 214 (321)
T cd05591 157 CGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL--------------------- 214 (321)
T ss_pred ccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---------------------
Confidence 78999999999876 45899999999999999999999999998887777665432110
Q ss_pred CchhhhhccCCcHhHHHHHHHhcccCCCCCC-------CHHHHhcCcCCCC
Q 043957 362 KPRLFEAFSEFPESSLGLLSTLLALDPAYRG-------SAASALKNEFFFT 405 (584)
Q Consensus 362 ~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-------Ta~e~L~Hp~f~~ 405 (584)
....++.++.+||.+||+.||.+|+ +++++++||||..
T Consensus 215 ------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 215 ------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred ------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 0123578899999999999999999 9999999999954
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=357.47 Aligned_cols=257 Identities=23% Similarity=0.350 Sum_probs=203.7
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|++.+.||+|+||.||++.+..+++.||+|++.... ........+.+|+.++..++|+||+++++++.. ...+|+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD--ENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCEEEE
Confidence 46999999999999999999999999999999985321 222334557889999999999999999887765 446899
Q ss_pred EEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
||||+. |+|...+......+.+ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++..+......
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 999997 5788877653334433 359999999999999999999999999999999999999999765433322
Q ss_pred CCccccccccccChhhhhC----CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 277 PLTSRVVTLWYRAPELLLG----ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~----~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
.....+||+.|+|||++.. ...++.++|||||||++|||++|++||...+..+.+..+.......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 227 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF----------- 227 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc-----------
Confidence 2334679999999999863 3458899999999999999999999999887777666654321100
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCC--CCCHHHHhcCcCCCC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAY--RGSAASALKNEFFFT 405 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~k--RpTa~e~L~Hp~f~~ 405 (584)
.+......+++++.+||.+||..++.+ |++++|+++||||..
T Consensus 228 -----------~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 228 -----------QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred -----------cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 001122457899999999999776555 689999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=356.88 Aligned_cols=281 Identities=34% Similarity=0.552 Sum_probs=223.1
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC---cce
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM---QYS 200 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---~~~ 200 (584)
.++|++.+.||+|+||.||+|.+..+|..||||++.... .......+.+|+.++++++||||+++++++.... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 357999999999999999999999999999999986422 2234456778999999999999999998765432 235
Q ss_pred EEEEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 201 LYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 201 l~lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
+|+||||+.+++...+... .+.+ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELMETDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhcccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 8999999999888877542 3332 3599999999999999999999999999999999999999997654322
Q ss_pred C--CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 275 K--RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 275 ~--~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
. .......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+....+.+..+.+..+...
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 1 11234578999999999876556899999999999999999999999998888888888888887776666543321
Q ss_pred CC----CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 353 TT----FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 353 ~~----~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
.. ...+......+....+.+++++.+||.+||+.||.+|||+.|+|+||||....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 10 00111112223334566789999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=364.42 Aligned_cols=254 Identities=26% Similarity=0.417 Sum_probs=202.0
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.++..++||||+++++.+.. ...+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD--KRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 36999999999999999999999999999999996432 223345678889999999999999999887765 446899
Q ss_pred EEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC-
Q 043957 204 VFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK- 275 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~- 275 (584)
|||||.+ +|...+... ..+.+ ..||+.||+|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 79 v~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 79 IMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred EEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 9999985 677776542 23333 35999999999999999999999999999999999999999875432110
Q ss_pred ---------------------------------CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCC
Q 043957 276 ---------------------------------RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIM 322 (584)
Q Consensus 276 ---------------------------------~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF 322 (584)
......+||+.|+|||++.+ ..++.++|||||||++|||++|++||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCC
Confidence 01124579999999999976 45899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC---CHHHHhc
Q 043957 323 PGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG---SAASALK 399 (584)
Q Consensus 323 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp---Ta~e~L~ 399 (584)
.+.+....+..+....... ..|. ...+++++++||.+|+. ||.+|+ +++|+++
T Consensus 237 ~~~~~~~~~~~i~~~~~~~--------------~~p~---------~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 237 CSETPQETYRKVMNWKETL--------------VFPP---------EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCHHHHHHHHHcCCCce--------------ecCC---------CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 9888777666654321000 0000 12367899999999874 999998 5899999
Q ss_pred CcCCCCC
Q 043957 400 NEFFFTS 406 (584)
Q Consensus 400 Hp~f~~~ 406 (584)
||||...
T Consensus 293 hp~f~~~ 299 (360)
T cd05627 293 HPFFEGV 299 (360)
T ss_pred CCCCCCC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=346.79 Aligned_cols=277 Identities=35% Similarity=0.643 Sum_probs=220.5
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++.+.||+|+||.||+|.+..+++.||||+++.........+.+.+|+++++.++|+||+++++++.. ...+|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEE
Confidence 36999999999999999999999999999999987554444456778899999999999999999998876 4468999
Q ss_pred EechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 205 FEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
|||+.+++...+......+.+ ..||+.||.|||+++|+|+||+|+||+++.++.+||+|||++...........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 999998776665543333433 34999999999999999999999999999999999999999987654433234
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC--
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR-- 356 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-- 356 (584)
....++..|+|||++.+...++.++|||||||++|+|++|++||.+....+.+..+....+......+........+.
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 556789999999999875468999999999999999999999999988888877777776666655444332211111
Q ss_pred -CCC-CCCchhhhhcc-CCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 357 -PPQ-SYKPRLFEAFS-EFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 357 -~p~-~~~~~~~~~~~-~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
.+. .........+. .++..+.+||.+||..||++|||++++|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 011 11111122222 348999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=370.79 Aligned_cols=254 Identities=30% Similarity=0.441 Sum_probs=207.0
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
.|.|+..||.|+||.||+|.++.++-..|.|+|. ......++.+.-||.||..++||+||++++.|.+. +.+||+.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe--tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e--nkLwili 108 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE--TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE--NKLWILI 108 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhc--ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc--CceEEEE
Confidence 3788899999999999999999999999999985 34556778888899999999999999999988774 4589999
Q ss_pred echhhHHHHHh-hCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 206 EFMQTDLARII-SNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 206 Ey~~g~L~~~l-~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
|||.|+-.+.+ ..-...+++ +.|+|.||.|||+++|||||||..|||++-+|.|+|+|||.+..... .....
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkR 187 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKR 187 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh-HHhhh
Confidence 99998755443 333334444 35999999999999999999999999999999999999999865432 12234
Q ss_pred ccccccccccChhhhh----CCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 279 TSRVVTLWYRAPELLL----GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~----~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.+++|||+|||||++. ...+|++++||||||++|.||..+.||-..-+..-.+-+|.+. -
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS---e------------- 251 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---E------------- 251 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc---C-------------
Confidence 6789999999999975 3357999999999999999999999998777666555554331 1
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPL 408 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~ 408 (584)
+|. .-....++..+.|||.+||.+||..||+++++|+||||+..+.
T Consensus 252 --PPT------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 252 --PPT------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS 297 (1187)
T ss_pred --CCc------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence 111 1123566888999999999999999999999999999987643
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=345.86 Aligned_cols=274 Identities=41% Similarity=0.773 Sum_probs=224.4
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
+|++.++||.|++|.||+|.+..+|..||||++...... .....+.+|+.++++++||||+++++++... ...||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTE--NKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeC--CcEEEEE
Confidence 489999999999999999999999999999999755332 2345567899999999999999999988774 4579999
Q ss_pred echhhHHHHHhhCCC--CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 206 EFMQTDLARIISNPE--GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 206 Ey~~g~L~~~l~~~~--~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||+.++|...+.... ..+. +..||+.||.|||+.+|+|+||||+||++++++.++|+|||++....... ..
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-~~ 156 (284)
T cd07836 78 EYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-NT 156 (284)
T ss_pred ecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-cc
Confidence 999998888775432 2233 34599999999999999999999999999999999999999997654322 12
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC-
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR- 356 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~- 356 (584)
.....+++.|++||++.+...++.++|||||||++|+|++|++||.+.+..+.+..++.....+....|+.+.....+.
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 2345678999999998775567899999999999999999999999999999999999998889888888776332222
Q ss_pred -CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 357 -PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 357 -~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
.+..........++.++..+.++|.+||+.||.+|||+.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 11222223333445678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=352.11 Aligned_cols=278 Identities=37% Similarity=0.635 Sum_probs=214.9
Q ss_pred CceEEeeecccCceEEEEEEECC--CCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRD--TGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
+|++.++||+|+||.||+|.+.. ++..||||.+.... ........+.+|+.++..++||||+++++++.+.....+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48999999999999999999988 89999999997533 1122345677899999999999999999999886557899
Q ss_pred EEEechhhHHHHHhhCCC----CCCc------HHHHHHHHHHHHHhCCceeccccccceeecC----CCcEEEEEecccc
Q 043957 203 LVFEFMQTDLARIISNPE----GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDK----NGVLKIADFGLAN 268 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~~~----~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~----~g~vKL~DFGla~ 268 (584)
+||||+++++...+.... ..+. ++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 999999988777664221 1222 3459999999999999999999999999999 8999999999998
Q ss_pred ccCCCCC--CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChH---------HHHHHHHHh
Q 043957 269 YFSPNKK--RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEV---------EQLHRIFKL 337 (584)
Q Consensus 269 ~~~~~~~--~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~---------~~~~~i~~~ 337 (584)
.+..... ......++++.|+|||++.+...++.++|||||||++|+|++|++||.+.... ..+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 7643222 11234567899999999877666899999999999999999999999866542 356677777
Q ss_pred cCCCChHHHHHhhccCCCCC----------CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 338 CGSPSEDYWKKLRLSTTFRP----------PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~----------p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
+..+....|..+.....+.. +........+.....+..+.+||.+||+.||.+|||+.|+++||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 77777666654332211111 0000111122223678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=357.03 Aligned_cols=243 Identities=29% Similarity=0.442 Sum_probs=195.1
Q ss_pred eeecccCceEEEEEEEC---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 131 DKVGQGTYSNVYKALDR---DTGKIVALKKVKFDTS--EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
+.||+|+||.||+|.+. .+++.||||+++.... .......+.+|+.+|+.++||||+++++++... ..+|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG--GKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC--CeEEEEE
Confidence 57999999999999864 5789999999964321 222345577899999999999999999888763 4689999
Q ss_pred echhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 206 EFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 206 Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
||+.+ +|...+... ..+. ...||+.||.|||+++|+||||||+||||+.++.+||+|||+++...... ...
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (323)
T cd05584 80 EYLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVT 157 (323)
T ss_pred eCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Ccc
Confidence 99985 676666532 2332 23599999999999999999999999999999999999999987543222 223
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p 358 (584)
...+||+.|+|||++.+ ..++.++|||||||++|||++|++||...+....+..+.....
T Consensus 158 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~------------------- 217 (323)
T cd05584 158 HTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL------------------- 217 (323)
T ss_pred cccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence 44679999999999876 4588999999999999999999999998877666555543210
Q ss_pred CCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCC
Q 043957 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFT 405 (584)
Q Consensus 359 ~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~ 405 (584)
.....+++.+.+||.+||+.||++|| +++++++||||..
T Consensus 218 --------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 218 --------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred --------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 11234678899999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=346.87 Aligned_cols=276 Identities=36% Similarity=0.637 Sum_probs=214.8
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+++++.++||||+++++++.. ....|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEEEE
Confidence 36999999999999999999999899999999986544443445667889999999999999999998865 4468999
Q ss_pred EechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 205 FEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
|||+.++++..+......+.+ ..||+.||.|||+.+|+|+||+|+||++++++.++|+|||++..+.... ...
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVY 157 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-ccc
Confidence 999997655444332323333 3499999999999999999999999999999999999999998764332 233
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc---CCC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS---TTF 355 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~---~~~ 355 (584)
....++..|+|||++.+...++.++|||||||++|+|++|++||......+.+..+...........-...... ...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 45678899999999876556788999999999999999999999988888887777766554432211111000 000
Q ss_pred CCC-CCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 356 RPP-QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 356 ~~p-~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
..+ ..........++.++..+.+||.+||+.||.+|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 011 111122333456789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=357.10 Aligned_cols=280 Identities=32% Similarity=0.526 Sum_probs=220.5
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC----cc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM----QY 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 199 (584)
.++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 35799999999999999999999999999999998654444445566778999999999999999998876432 23
Q ss_pred eEEEEEechhhHHHHHhhCC---CCCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 200 SLYLVFEFMQTDLARIISNP---EGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 200 ~l~lV~Ey~~g~L~~~l~~~---~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
..|+||||+.++|...+... .....++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-- 172 (353)
T cd07850 95 DVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-- 172 (353)
T ss_pred cEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC--
Confidence 57999999999888876532 0111234599999999999999999999999999999999999999998764322
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC-
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF- 355 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~- 355 (584)
......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+....+.+..+++..+......
T Consensus 173 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (353)
T cd07850 173 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNY 251 (353)
T ss_pred CCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHH
Confidence 2344568899999999976 45899999999999999999999999999988889999888888877665554321100
Q ss_pred --CCCCCCCchhhhh-------------ccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 356 --RPPQSYKPRLFEA-------------FSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 356 --~~p~~~~~~~~~~-------------~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
..+......+.+. ....++.+.+||.+||+.||.+|||+.|+|+||||...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 252 VENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred hhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence 0000000000011 12346778999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=355.70 Aligned_cols=284 Identities=36% Similarity=0.580 Sum_probs=224.2
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc---ceE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ---YSL 201 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~---~~l 201 (584)
.+|.+.+.||+|+||+||+|.+..++..||||.+............+.+|+.+++.++||||+++++++..... ..+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 46999999999999999999999999999999987543334445567789999999999999999998765322 358
Q ss_pred EEEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 202 YLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 202 ~lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
|+||||+.++|...+... ..+.+ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 162 (337)
T cd07858 85 YIVYELMDTDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG- 162 (337)
T ss_pred EEEEeCCCCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-
Confidence 999999999888877643 33433 3599999999999999999999999999999999999999998764322
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
.......++..|+|||++.....++.++|||||||++|+|++|++||.+.+....+..+....+.+....|..+......
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence 22345578899999999876455899999999999999999999999998888888888887777666555322111000
Q ss_pred ----CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCcc
Q 043957 356 ----RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLAC 410 (584)
Q Consensus 356 ----~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~~ 410 (584)
..+...........+.+++.+.+||.+||+.||++|||++++|+||||.....+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 0111111222334467899999999999999999999999999999997654333
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=355.49 Aligned_cols=248 Identities=25% Similarity=0.392 Sum_probs=200.3
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~l 203 (584)
+|++++.||+|+||.||+|.+..+++.||||++..... .......+..|..++..+ .|++|+.+++++.. ...+|+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 48999999999999999999999999999999975432 223345567788888887 58999999887766 346899
Q ss_pred EEechh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
||||+. |+|...+... ..+. ++.||+.||+|||+++|+||||||+|||++.++.+||+|||++....... .
T Consensus 79 v~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~ 156 (323)
T cd05616 79 VMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-V 156 (323)
T ss_pred EEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-C
Confidence 999998 4676666432 2333 34599999999999999999999999999999999999999997543222 2
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+....+..+......
T Consensus 157 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~---------------- 219 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA---------------- 219 (323)
T ss_pred ccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------------
Confidence 2345679999999999976 45899999999999999999999999988877776665432111
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCH-----HHHhcCcCCCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSA-----ASALKNEFFFT 405 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa-----~e~L~Hp~f~~ 405 (584)
....++.++.+||.+||+.||.+|+++ .++++||||..
T Consensus 220 -----------~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 220 -----------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred -----------CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 113468899999999999999999984 89999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=355.29 Aligned_cols=257 Identities=24% Similarity=0.344 Sum_probs=203.7
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecC-CCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD-TSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~-~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|++.+.||+|+||.||++.+..+++.||||++... .........+.+|+.++..++|+||+.+++++.. ...+|+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD--ENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 4699999999999999999999999999999998642 1222334567889999999999999999887765 456899
Q ss_pred EEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
||||+. |+|..++......+.+ ..||+.||+|||+++|+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 999998 5777777653344433 359999999999999999999999999999999999999999876543322
Q ss_pred CCccccccccccChhhhhCC----CCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 277 PLTSRVVTLWYRAPELLLGA----TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~----~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...+..+.+..+......+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 227 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF----------- 227 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc-----------
Confidence 22345799999999998642 347889999999999999999999998887766665553321000
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCC--CCCHHHHhcCcCCCC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAY--RGSAASALKNEFFFT 405 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~k--RpTa~e~L~Hp~f~~ 405 (584)
.+...+..+++++.+||.+||..++.+ |++++++++||||..
T Consensus 228 -----------~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 228 -----------QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred -----------cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 011123457899999999999977655 579999999999974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=367.63 Aligned_cols=270 Identities=23% Similarity=0.306 Sum_probs=200.3
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
...|.+.+.||+|+||.||+|.+..++..||||.... ..+.+|+++|++|+|+|||++++++... ...||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~--~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVG--GLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEEE
Confidence 3469999999999999999999999999999996431 2356899999999999999999987763 45799
Q ss_pred EEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC-
Q 043957 204 VFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR- 276 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~- 276 (584)
|||++.++|...+......+. ++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+......
T Consensus 238 v~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 238 VLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 999999988888765433443 3459999999999999999999999999999999999999999876433221
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCC-CCCCC------hHHHHHHHHHhcCCCCh------
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPI-MPGRT------EVEQLHRIFKLCGSPSE------ 343 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~p-F~~~~------~~~~~~~i~~~~~~~~~------ 343 (584)
.....+||+.|+|||++.+. .++.++||||||||||||++|..+ |.... ...++.+++........
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 12345799999999999774 589999999999999999998754 43221 12334444443221110
Q ss_pred --HHHHHhhcc-CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 344 --DYWKKLRLS-TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 344 --~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
.....+... .....+..... .+..+..++..+.+||.+||++||.+|||+.|+|+||||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRP-AWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCc-chhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 111111100 00011111111 12223456788999999999999999999999999999964
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=347.86 Aligned_cols=279 Identities=40% Similarity=0.735 Sum_probs=221.6
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++.+.||.|++|.||+|.+..+|+.||||.+............+.+|+.++++++||||+++++++... ...|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC--CeEEEE
Confidence 469999999999999999999999999999999865544333446678899999999999999999988764 468999
Q ss_pred EechhhHHHHHhhCCCCC-C------cHHHHHHHHHHHHHhCCceeccccccceeecC-CCcEEEEEeccccccCCCCCC
Q 043957 205 FEFMQTDLARIISNPEGK-L------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDK-NGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~~~~~-l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~-~g~vKL~DFGla~~~~~~~~~ 276 (584)
|||+.++|...+...... + .++.||+.||+|||+++|+|+||+|+||+++. ++.+||+|||++...... ..
T Consensus 80 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-~~ 158 (294)
T PLN00009 80 FEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-VR 158 (294)
T ss_pred EecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC-cc
Confidence 999998887776542221 2 23459999999999999999999999999985 557999999999765432 12
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
......+++.|+|||++.+...++.++|||||||++|+|++|.+||...+..+.+..++...+.+....|..........
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 22445678999999998765568899999999999999999999999988888888888888888777775432111110
Q ss_pred --CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 357 --PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 357 --~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.+.............+++.+.+||.+||+.||++||++.++|+||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 11111122223345678999999999999999999999999999999753
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=354.24 Aligned_cols=243 Identities=30% Similarity=0.449 Sum_probs=192.4
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEEEEEech
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
+.||+|+||.||+|.+..+++.||||+++.... .....+.+..|..++..+ +||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999975422 223344556677777654 89999999888765 44689999999
Q ss_pred hh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccc
Q 043957 209 QT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR 281 (584)
Q Consensus 209 ~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 281 (584)
.+ +|...+... ..+.+ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++....... ......
T Consensus 79 ~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~ 156 (316)
T cd05592 79 NGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTF 156 (316)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccccc
Confidence 84 666666432 23333 3599999999999999999999999999999999999999997653222 233456
Q ss_pred cccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCC
Q 043957 282 VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSY 361 (584)
Q Consensus 282 ~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~ 361 (584)
+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 157 ~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~---------------------- 213 (316)
T cd05592 157 CGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP---------------------- 213 (316)
T ss_pred cCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------------------
Confidence 799999999999764 589999999999999999999999998877666555432110
Q ss_pred CchhhhhccCCcHhHHHHHHHhcccCCCCCCCH-HHHhcCcCCCC
Q 043957 362 KPRLFEAFSEFPESSLGLLSTLLALDPAYRGSA-ASALKNEFFFT 405 (584)
Q Consensus 362 ~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa-~e~L~Hp~f~~ 405 (584)
.....++.++.+||.+||+.||.+||++ .++++||||..
T Consensus 214 -----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 214 -----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence 0112467889999999999999999986 58889999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=344.74 Aligned_cols=276 Identities=41% Similarity=0.674 Sum_probs=211.9
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
...|++.+.||+|+||.||+|.+..+|..||||.+...... .....+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCeEEE
Confidence 45799999999999999999999999999999998654322 223356789999999999999999998875 346899
Q ss_pred EEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 204 VFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||||+.+++...+......+. +..||+.||.|||+++|+|+||||+|||++.++.+||+|||+++...... ..
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~ 159 (291)
T cd07870 81 VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-QT 159 (291)
T ss_pred EEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-CC
Confidence 999999888777654333332 33599999999999999999999999999999999999999997643222 12
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE-VEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||..... .+.+..+....+.+....|..+.....+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 23446789999999987655688899999999999999999999976553 45566666666767666665543221111
Q ss_pred CC---CCCCchhhhhcc--CCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 357 PP---QSYKPRLFEAFS--EFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 357 ~p---~~~~~~~~~~~~--~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
.. ..........+. ..+..+.+||.+||..||.+|||+.|+|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 10 000111111111 126788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=355.37 Aligned_cols=243 Identities=26% Similarity=0.369 Sum_probs=192.2
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHH-HHHhCCCCCeeeeeceeeecCcceEEEEEech
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIM-ILQKLDHPNIVKLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
+.||+|+||+||+|.+..+|+.||||++..... .......+..|.. +++.++||||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcCC
Confidence 369999999999999999999999999964321 1222334445544 5678999999999887766 44689999999
Q ss_pred hh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccc
Q 043957 209 QT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR 281 (584)
Q Consensus 209 ~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 281 (584)
.+ +|...+.. ...+. +..||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......
T Consensus 79 ~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 156 (323)
T cd05575 79 NGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTF 156 (323)
T ss_pred CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccccc
Confidence 85 56666553 22333 3359999999999999999999999999999999999999998754222 2223456
Q ss_pred cccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCC
Q 043957 282 VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSY 361 (584)
Q Consensus 282 ~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~ 361 (584)
+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+..+.....
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---------------------- 213 (323)
T cd05575 157 CGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL---------------------- 213 (323)
T ss_pred cCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC----------------------
Confidence 79999999999976 4589999999999999999999999998877666555533210
Q ss_pred CchhhhhccCCcHhHHHHHHHhcccCCCCCCCH----HHHhcCcCCCC
Q 043957 362 KPRLFEAFSEFPESSLGLLSTLLALDPAYRGSA----ASALKNEFFFT 405 (584)
Q Consensus 362 ~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa----~e~L~Hp~f~~ 405 (584)
.....++..+.+||.+||+.||.+||++ .++|+||||..
T Consensus 214 -----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 214 -----RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 1123568899999999999999999998 69999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=354.62 Aligned_cols=243 Identities=29% Similarity=0.425 Sum_probs=192.7
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEEEEEech
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
+.||+|+||.||+|.+..+|+.||||+++.... .......+..|+.++..+ +||||+++++++.. ...+|+|||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence 369999999999999999999999999975321 122345566788888765 89999999988776 44689999999
Q ss_pred hh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccc
Q 043957 209 QT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR 281 (584)
Q Consensus 209 ~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 281 (584)
.+ +|...+.. ...+.+ ..||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......
T Consensus 79 ~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (316)
T cd05620 79 NGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTF 156 (316)
T ss_pred CCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceecc
Confidence 85 67666653 233333 3499999999999999999999999999999999999999987532211 223456
Q ss_pred cccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCC
Q 043957 282 VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSY 361 (584)
Q Consensus 282 ~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~ 361 (584)
+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~---------------------- 213 (316)
T cd05620 157 CGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP---------------------- 213 (316)
T ss_pred CCCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----------------------
Confidence 79999999999976 4589999999999999999999999998877655544422100
Q ss_pred CchhhhhccCCcHhHHHHHHHhcccCCCCCCCH-HHHhcCcCCCC
Q 043957 362 KPRLFEAFSEFPESSLGLLSTLLALDPAYRGSA-ASALKNEFFFT 405 (584)
Q Consensus 362 ~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa-~e~L~Hp~f~~ 405 (584)
.....++.++.+||.+||+.||.+|+++ +++++||||..
T Consensus 214 -----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 214 -----HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence 0112357889999999999999999998 58889999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=351.23 Aligned_cols=249 Identities=29% Similarity=0.509 Sum_probs=205.0
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEe
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFE 206 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~E 206 (584)
|+++++||+|+||.||+|.++.+|..+|||.+..+ ..++++..||.||++++.|+||++||.|... ..+|||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~--sDLWIVME 108 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKH--SDLWIVME 108 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccC--CceEeehh
Confidence 78899999999999999999999999999998543 3567889999999999999999999977653 34899999
Q ss_pred chh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCc
Q 043957 207 FMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLT 279 (584)
Q Consensus 207 y~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 279 (584)
||. |+..+++...+..+.+ .+..++||+|||...-+|||||..|||++.+|..||+|||.|..+.+.- ....
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRN 187 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRN 187 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhC
Confidence 998 6777777655555544 3477899999999999999999999999999999999999998775332 2346
Q ss_pred cccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCC
Q 043957 280 SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQ 359 (584)
Q Consensus 280 ~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~ 359 (584)
+++|||.|||||++.. ..|+.++||||||++..||..|+|||..-.+. ..|+-....| |
T Consensus 188 TVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFMIPT~P----------------P- 246 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---RAIFMIPTKP----------------P- 246 (502)
T ss_pred ccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCccccccc---ceeEeccCCC----------------C-
Confidence 7899999999999986 46999999999999999999999999654332 2222211111 1
Q ss_pred CCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 360 SYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 360 ~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
+.+.....++.++.|||++||.+.|++|-||.++++|||++.++
T Consensus 247 ----PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 247 ----PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred ----CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 11222345688999999999999999999999999999998764
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=344.29 Aligned_cols=274 Identities=46% Similarity=0.803 Sum_probs=220.9
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEe
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFE 206 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~E 206 (584)
|++.+.||.|++|.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++... ...|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEEEEe
Confidence 6788999999999999999999999999999976544433445677899999999999999999988764 56899999
Q ss_pred chhhHHHHHhhCCC-CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCc
Q 043957 207 FMQTDLARIISNPE-GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLT 279 (584)
Q Consensus 207 y~~g~L~~~l~~~~-~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 279 (584)
|+.++|...+.... ..+. +..||+.||.|||+++++|+||+|+|||++.++.++|+|||++..+.... ....
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~ 157 (283)
T cd07835 79 FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RTYT 157 (283)
T ss_pred ccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-cccC
Confidence 99888887775432 2333 33599999999999999999999999999999999999999997654322 1223
Q ss_pred cccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC--C
Q 043957 280 SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR--P 357 (584)
Q Consensus 280 ~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--~ 357 (584)
...+++.|+|||++.+...++.++|||||||++|+|++|.+||...+....+..+++....+....|........+. .
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 44668999999988765557899999999999999999999999998888888888888888877775543222111 1
Q ss_pred CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 358 p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
+.............++..+.+||.+||+.||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 1111222233456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=346.31 Aligned_cols=253 Identities=28% Similarity=0.423 Sum_probs=200.5
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE-PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
.|++.+.||+|+||.||++.+..+++.||||++...... ......+.+|+.+++.++||||+++++++... ..+|+|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC--CeEEEE
Confidence 389999999999999999999999999999999643322 22334567899999999999999998887664 468999
Q ss_pred Eechhh-HHHHHhhCC-CCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 205 FEFMQT-DLARIISNP-EGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~-~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
|||+.+ +|...+... ...+.+ ..||+.||.|||+++|+||||||+|||+++++.++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-- 156 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--
Confidence 999985 566555432 223333 3599999999999999999999999999999999999999998764322
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
.....+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ-------------- 221 (285)
T ss_pred ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc--------------
Confidence 2234578999999999976 4589999999999999999999999988765544433322211000
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFTS 406 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~~ 406 (584)
......+++.+.+||.+||..||.+|| +++++++||||...
T Consensus 222 ---------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 222 ---------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred ---------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 011234688899999999999999999 99999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=364.97 Aligned_cols=270 Identities=25% Similarity=0.353 Sum_probs=204.6
Q ss_pred CCceEEeeecccCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDR--DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
.+|.+++.||.|+||.||+|... .++..||+|.+... ....+|+.+|++|+|||||++++++.. ...+|
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~ 162 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRW--KSTVC 162 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEee--CCEEE
Confidence 47999999999999999999754 35678999987532 234579999999999999999988776 34689
Q ss_pred EEEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 203 LVFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
+|||++.++|...+.. ...+. +..||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 163 lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 163 MVMPKYKCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred EEehhcCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 9999999988887742 23333 3359999999999999999999999999999999999999999766433221
Q ss_pred -CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCChHHHH-----
Q 043957 277 -PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRT---EVEQLHRIFKLCGSPSEDYWK----- 347 (584)
Q Consensus 277 -~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~---~~~~~~~i~~~~~~~~~~~~~----- 347 (584)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.. ....+..+++.++..+..+..
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred ccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 2234679999999999976 458999999999999999999999997654 345566666655543322111
Q ss_pred ---HhhccCCCCCCCCCCchhhhhc--cCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q 043957 348 ---KLRLSTTFRPPQSYKPRLFEAF--SEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPL 408 (584)
Q Consensus 348 ---~~~~~~~~~~p~~~~~~~~~~~--~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~ 408 (584)
.+........+.. .....+ ..++.++.+||.+||+.||.+|||+.|+|.||||...|.
T Consensus 321 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 321 LCKHFKQYAIVLRPPY---TIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred HHHHHHhhcccccCCc---cccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 1110000000000 011111 246788999999999999999999999999999987653
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=355.13 Aligned_cols=243 Identities=30% Similarity=0.407 Sum_probs=196.8
Q ss_pred eeecccCceEEEEEEE---CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEec
Q 043957 131 DKVGQGTYSNVYKALD---RDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEF 207 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~---~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey 207 (584)
+.||+|+||.||++.+ ..+|+.||+|++............+.+|+.+|++++||||+++++++.. ...+|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEEcC
Confidence 5699999999999876 3578999999997543333344557789999999999999999988776 4468999999
Q ss_pred hh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCcc
Q 043957 208 MQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTS 280 (584)
Q Consensus 208 ~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~ 280 (584)
+. ++|...+... ..+. +..||+.||.|||+++|+||||||+||||+.++.+||+|||++....... .....
T Consensus 80 ~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 157 (318)
T cd05582 80 LRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYS 157 (318)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceec
Confidence 98 5677766532 2333 34599999999999999999999999999999999999999998654322 22345
Q ss_pred ccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCC
Q 043957 281 RVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQS 360 (584)
Q Consensus 281 ~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~ 360 (584)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.....
T Consensus 158 ~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~--------------------- 215 (318)
T cd05582 158 FCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL--------------------- 215 (318)
T ss_pred ccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence 678999999999876 4588999999999999999999999998877666655533211
Q ss_pred CCchhhhhccCCcHhHHHHHHHhcccCCCCCCC-----HHHHhcCcCCCC
Q 043957 361 YKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS-----AASALKNEFFFT 405 (584)
Q Consensus 361 ~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT-----a~e~L~Hp~f~~ 405 (584)
.....+++.+.+||.+||+.||.+||| +++++.||||..
T Consensus 216 ------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 216 ------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 011346788999999999999999999 788999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=341.91 Aligned_cols=253 Identities=32% Similarity=0.494 Sum_probs=201.6
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEe
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFE 206 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~E 206 (584)
|++++.||+|+||+||++.+..+++.||+|++..............+|+.++++++||||+++++++.. ...+++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence 889999999999999999999999999999998665444444445679999999999999999998877 446799999
Q ss_pred chhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCc
Q 043957 207 FMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLT 279 (584)
Q Consensus 207 y~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 279 (584)
|+.+ +|.+++. ....+. ...||+.||.+||+++|+|+||||+|||++.++.++|+|||++.... .......
T Consensus 79 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~ 156 (260)
T PF00069_consen 79 YCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFN 156 (260)
T ss_dssp EETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBS
T ss_pred cccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccc
Confidence 9997 7877776 122232 33599999999999999999999999999999999999999997642 2223345
Q ss_pred cccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCC
Q 043957 280 SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQ 359 (584)
Q Consensus 280 ~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~ 359 (584)
...+++.|+|||++.....++.++|||||||++|+|++|..||...........+...........+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------- 223 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS------------- 223 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT-------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc-------------
Confidence 6788999999999873356899999999999999999999999987444444444332211111000
Q ss_pred CCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 360 SYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 360 ~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
......+..+.+||.+||+.||++|||+.++|+||||
T Consensus 224 -------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 224 -------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp -------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred -------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 0001123789999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=353.39 Aligned_cols=281 Identities=39% Similarity=0.659 Sum_probs=226.8
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~ 202 (584)
.++|++.+.||+|+||.||+|.+..++..||||++............+.+|+.+++++ +||||+++++++.......+|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 4579999999999999999999999999999999865433444455677899999999 999999999988765566789
Q ss_pred EEEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC-
Q 043957 203 LVFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK- 275 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~- 275 (584)
+||||+.++|...+... .+. ...||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 86 lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 86 LVFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred EEecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 99999999888877643 222 345999999999999999999999999999999999999999986643321
Q ss_pred ---CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 276 ---RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 276 ---~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
.......+++.|+|||++.+...++.++|||||||++|+|++|++||.+....+.+..+....+.+....|..+...
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence 12344578999999998876566889999999999999999999999999988888888888877776665544311
Q ss_pred CCC----CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 353 TTF----RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 353 ~~~----~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
... .............++.++.++.+||.+||+.||++|||+.++|+||||..-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 100 011111222334456689999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=353.61 Aligned_cols=243 Identities=28% Similarity=0.425 Sum_probs=195.4
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEEEEEech
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
+.||+|+||.||+|.+..++..||||+++.... .......+.+|+.+++.+ +||||+++++++... ..+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~--~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK--DRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcCC
Confidence 369999999999999999999999999975421 223455677899999888 699999999988764 4689999999
Q ss_pred hh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccc
Q 043957 209 QT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR 281 (584)
Q Consensus 209 ~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 281 (584)
.+ +|...+.. ...+.+ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++....... ......
T Consensus 79 ~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (318)
T cd05570 79 NGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTF 156 (318)
T ss_pred CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccccce
Confidence 85 56665543 233433 3599999999999999999999999999999999999999987532222 223445
Q ss_pred cccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCC
Q 043957 282 VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSY 361 (584)
Q Consensus 282 ~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~ 361 (584)
+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 157 ~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~---------------------- 213 (318)
T cd05570 157 CGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV---------------------- 213 (318)
T ss_pred ecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC----------------------
Confidence 78999999999976 4589999999999999999999999988776655554432110
Q ss_pred CchhhhhccCCcHhHHHHHHHhcccCCCCCCCH-----HHHhcCcCCCC
Q 043957 362 KPRLFEAFSEFPESSLGLLSTLLALDPAYRGSA-----ASALKNEFFFT 405 (584)
Q Consensus 362 ~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa-----~e~L~Hp~f~~ 405 (584)
.....+++.+.+||.+||+.||.+|||+ .++++||||..
T Consensus 214 -----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 214 -----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred -----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 0113467899999999999999999999 99999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=352.33 Aligned_cols=247 Identities=26% Similarity=0.426 Sum_probs=189.2
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEEEEEech
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
+.||+|+||.||+|.+..+++.||+|+++.... .......+.+|+.++.++ +||||+++++++... ..+|+|||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEEEEeCC
Confidence 359999999999999999999999999975432 334456677899998877 799999999988764 4689999999
Q ss_pred hh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccc
Q 043957 209 QT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR 281 (584)
Q Consensus 209 ~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 281 (584)
.+ +|...+.. ...+.+ ..||+.||.|||+++|+||||||+||||+.++.+||+|||++....... ......
T Consensus 79 ~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (329)
T cd05618 79 NGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTF 156 (329)
T ss_pred CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cccccc
Confidence 85 56555543 223332 3599999999999999999999999999999999999999997542211 223456
Q ss_pred cccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChH-----HHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 282 VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEV-----EQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 282 ~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~-----~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
+||+.|+|||++.+ ..++.++|||||||++|+|++|++||...... .....+ +..+. ....
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~-----------~~~i~-~~~~- 222 (329)
T cd05618 157 CGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL-----------FQVIL-EKQI- 222 (329)
T ss_pred cCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHH-----------HHHHh-cCCC-
Confidence 79999999999976 45899999999999999999999999531110 000000 01100 0000
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC------HHHHhcCcCCCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS------AASALKNEFFFT 405 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT------a~e~L~Hp~f~~ 405 (584)
.....++..+.+||.+||+.||.+||| ++++++||||..
T Consensus 223 ----------~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 223 ----------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred ----------CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 112356788999999999999999998 589999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=372.35 Aligned_cols=257 Identities=23% Similarity=0.318 Sum_probs=208.9
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc---
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ--- 198 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~--- 198 (584)
...++|++.+.||+|+||+||+|.+..+|+.||||++............+.+|+.+|..++|+||+++++.+.....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34568999999999999999999999999999999998766666667778899999999999999999876654322
Q ss_pred ---ceEEEEEechh-hHHHHHhhCC---CCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEec
Q 043957 199 ---YSLYLVFEFMQ-TDLARIISNP---EGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFG 265 (584)
Q Consensus 199 ---~~l~lV~Ey~~-g~L~~~l~~~---~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFG 265 (584)
..+++||||+. |+|.+.+... ...+.+ ..||+.||.|||+++|+||||||+||||+.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 24789999998 5787776532 122333 3599999999999999999999999999999999999999
Q ss_pred cccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChH
Q 043957 266 LANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSED 344 (584)
Q Consensus 266 la~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~ 344 (584)
+++.+..... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+......
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~---- 263 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD---- 263 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC----
Confidence 9987643221 12245679999999999976 45899999999999999999999999988766665554332110
Q ss_pred HHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 345 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
.....+++++.+||.+||+.||.+|||+.++|+|||+..
T Consensus 264 ----------------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 264 ----------------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 112456889999999999999999999999999999864
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=353.05 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=190.2
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEEEEEech
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
+.||+|+||.||+|.+..+++.||||+++.... .......+.+|+.++..+ +||||+++++++... ..+|||||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEEEEeCC
Confidence 359999999999999999999999999975432 233456688899999998 699999999888763 4689999999
Q ss_pred hh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccc
Q 043957 209 QT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR 281 (584)
Q Consensus 209 ~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 281 (584)
.+ +|...+.. ...+.+ +.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 79 ~~g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 156 (329)
T cd05588 79 SGGDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTSTF 156 (329)
T ss_pred CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccccc
Confidence 85 66665543 233443 3599999999999999999999999999999999999999987532111 223456
Q ss_pred cccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCC
Q 043957 282 VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSY 361 (584)
Q Consensus 282 ~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~ 361 (584)
+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+.. .................
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~-------~~~~~~~~~~~~~~~~~------ 222 (329)
T cd05588 157 CGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP-------DQNTEDYLFQVILEKQI------ 222 (329)
T ss_pred cCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccc-------cccchHHHHHHHHcCCC------
Confidence 89999999999976 45899999999999999999999999632110000 00000000000000000
Q ss_pred CchhhhhccCCcHhHHHHHHHhcccCCCCCCC------HHHHhcCcCCCC
Q 043957 362 KPRLFEAFSEFPESSLGLLSTLLALDPAYRGS------AASALKNEFFFT 405 (584)
Q Consensus 362 ~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT------a~e~L~Hp~f~~ 405 (584)
.....++..+.+||.+||+.||.+|+| ++++++||||..
T Consensus 223 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 223 -----RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred -----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 112346788999999999999999997 799999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=346.23 Aligned_cols=247 Identities=29% Similarity=0.367 Sum_probs=191.9
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechhh-
Q 043957 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSE-PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT- 210 (584)
Q Consensus 133 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~g- 210 (584)
||+|+||+||+|.+..+++.||+|++...... ....+.+..|+.+|+.++||||+++.+++.. ...+|+|||||.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEeCCCCC
Confidence 69999999999999999999999998644222 2234567789999999999999999887765 3458999999985
Q ss_pred HHHHHhhC---CCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccc
Q 043957 211 DLARIISN---PEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR 281 (584)
Q Consensus 211 ~L~~~l~~---~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 281 (584)
+|...+.. ....+.+ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++..+..... .....
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 157 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGY 157 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccccc
Confidence 56555422 2223333 35999999999999999999999999999999999999999976643322 23345
Q ss_pred cccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCC
Q 043957 282 VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSY 361 (584)
Q Consensus 282 ~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~ 361 (584)
.||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+....... +
T Consensus 158 ~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------~--- 217 (280)
T cd05608 158 AGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND----------------S--- 217 (280)
T ss_pred CCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc----------------C---
Confidence 789999999999864 58999999999999999999999998654322222211110000 0
Q ss_pred CchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCCC
Q 043957 362 KPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFTS 406 (584)
Q Consensus 362 ~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~~ 406 (584)
......+++.+.+||.+||+.||++|| |++++|+||||+..
T Consensus 218 ----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 218 ----VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred ----CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 011235788999999999999999999 89999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=357.23 Aligned_cols=266 Identities=25% Similarity=0.345 Sum_probs=197.1
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
..|++++.||+|+||.||+|.+..++..||+|+.... ....|+.+|++++||||+++++++... ...|+|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 135 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSG--AITCMV 135 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeC--CeeEEE
Confidence 4699999999999999999999999999999975321 134689999999999999999988764 457999
Q ss_pred EechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 205 FEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
|||+.++|...+......+.+ +.||+.||.|||+++|+||||||+|||++.++.+||+|||++...... ...
T Consensus 136 ~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~ 213 (357)
T PHA03209 136 LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAF 213 (357)
T ss_pred EEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--ccc
Confidence 999999988887654444443 359999999999999999999999999999999999999999753322 123
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCC-CCCCCCCh---------HHHHHHHHHhcCCCChHHH--
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGR-PIMPGRTE---------VEQLHRIFKLCGSPSEDYW-- 346 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~-~pF~~~~~---------~~~~~~i~~~~~~~~~~~~-- 346 (584)
....||+.|+|||++.+. .++.++|||||||++|||+++. ++|..... ...+..++...+..+..+.
T Consensus 214 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 292 (357)
T PHA03209 214 LGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD 292 (357)
T ss_pred ccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence 456789999999999764 5899999999999999999854 44443211 2233333333332221111
Q ss_pred ------HHh-hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 347 ------KKL-RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 347 ------~~~-~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
... ........+...... .....++.++.+||.+||+.||.+||||.|+|+||||++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 293 PGSRLVRGFIEYASLERQPYTRYPC--FQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CccHHHHHHHhhcccCCCcccccHH--HhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 000 000000111100000 111356788999999999999999999999999999974
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=350.62 Aligned_cols=279 Identities=36% Similarity=0.613 Sum_probs=223.2
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc---
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ--- 198 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~--- 198 (584)
...++|++++.||+|+||.||+|.+..++..||||++............+.+|+.+|++++||||+++++++.....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 34568999999999999999999999999999999986544344445567899999999999999999998765432
Q ss_pred -ceEEEEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccC
Q 043957 199 -YSLYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS 271 (584)
Q Consensus 199 -~~l~lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~ 271 (584)
..+|+||||+.++|..++... .+.+ +.||+.||+|||+.+|+||||||+|||++.++.++|+|||++....
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 92 FHDFYLVMPFMGTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred cceEEEEEecCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 246999999987787776532 2333 3599999999999999999999999999999999999999998654
Q ss_pred CCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 272 PNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 272 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
.. .....+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+++....+...++..+..
T Consensus 170 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 170 SE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred cC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 32 23456789999999987645588999999999999999999999999888888888888777776666655432
Q ss_pred cCC----CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 352 STT----FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 352 ~~~----~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
... ...+......+......++..+.+||.+||+.||.+|||+.++|.||||...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 111 0011111222334456788999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=352.46 Aligned_cols=243 Identities=25% Similarity=0.357 Sum_probs=191.8
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHH-HHHHhCCCCCeeeeeceeeecCcceEEEEEech
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREI-MILQKLDHPNIVKLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei-~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
+.||+|+||+||+|.+..+++.||+|++..... .......+..|. .+++.++||||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEEEEeCC
Confidence 369999999999999999999999999964321 111223334444 45788999999999888766 34689999999
Q ss_pred hh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccc
Q 043957 209 QT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR 281 (584)
Q Consensus 209 ~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 281 (584)
.+ +|...+... ..+. +..||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......
T Consensus 79 ~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 156 (325)
T cd05602 79 NGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTF 156 (325)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcccc
Confidence 85 666666532 2232 33599999999999999999999999999999999999999997543222 223456
Q ss_pred cccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCC
Q 043957 282 VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSY 361 (584)
Q Consensus 282 ~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~ 361 (584)
+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~---------------------- 213 (325)
T cd05602 157 CGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL---------------------- 213 (325)
T ss_pred cCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc----------------------
Confidence 79999999999976 4589999999999999999999999998887766655543210
Q ss_pred CchhhhhccCCcHhHHHHHHHhcccCCCCCCCHH----HHhcCcCCCC
Q 043957 362 KPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAA----SALKNEFFFT 405 (584)
Q Consensus 362 ~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~----e~L~Hp~f~~ 405 (584)
.....++..+.+||.+||+.||.+|+++. ++++|+||..
T Consensus 214 -----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 214 -----QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 11235788999999999999999999876 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=341.33 Aligned_cols=274 Identities=46% Similarity=0.792 Sum_probs=225.9
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEe
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFE 206 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~E 206 (584)
|++.+.||.|++|.||+|.+..+++.+|+|.+............+.+|+.+|+.++|+||+++++++... ..+|+|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CCEEEEEe
Confidence 6788899999999999999999999999999876554444556788899999999999999999988764 46899999
Q ss_pred chhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCcc
Q 043957 207 FMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTS 280 (584)
Q Consensus 207 y~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~ 280 (584)
|+.+++...+......+. +..||+.||.|||+++|+|+||||+||+++.++.++|+|||.+....... .....
T Consensus 79 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~ 157 (283)
T cd05118 79 FMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTH 157 (283)
T ss_pred ccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccC
Confidence 999988888766434443 33599999999999999999999999999999999999999998765433 22344
Q ss_pred ccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc---CCCCC
Q 043957 281 RVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS---TTFRP 357 (584)
Q Consensus 281 ~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~---~~~~~ 357 (584)
..++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+....+.+....|..+... .....
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 567889999999987546899999999999999999999999999999998888888888777766654321 11122
Q ss_pred CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 358 p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
+.............++..+.+||.+||+.||.+||++.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 2222233344556789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=355.38 Aligned_cols=243 Identities=28% Similarity=0.417 Sum_probs=191.4
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhC---CCCCeeeeeceeeecCcceEEEEEech
Q 043957 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKL---DHPNIVKLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 133 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
||+|+||+||+|.+..+++.||||++..... .......+..|..++..+ +||||+.+++++.. ...+|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCC
Confidence 7999999999999999999999999864321 222334455677777665 69999999887766 34689999999
Q ss_pred hh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccc
Q 043957 209 QT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR 281 (584)
Q Consensus 209 ~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 281 (584)
.+ +|...+.. ...+.+ ..||+.||+|||+++|+||||||+||||+.++.+||+|||++....... ......
T Consensus 79 ~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~ 156 (330)
T cd05586 79 SGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTF 156 (330)
T ss_pred CCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCc
Confidence 84 67666653 233433 3599999999999999999999999999999999999999997643222 223456
Q ss_pred cccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCC
Q 043957 282 VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSY 361 (584)
Q Consensus 282 ~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~ 361 (584)
+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+..... ..+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------------~~~--- 217 (330)
T cd05586 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV----------------RFP--- 217 (330)
T ss_pred cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC----------------CCC---
Confidence 7999999999997655689999999999999999999999988776655554432110 000
Q ss_pred CchhhhhccCCcHhHHHHHHHhcccCCCCCC----CHHHHhcCcCCCC
Q 043957 362 KPRLFEAFSEFPESSLGLLSTLLALDPAYRG----SAASALKNEFFFT 405 (584)
Q Consensus 362 ~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp----Ta~e~L~Hp~f~~ 405 (584)
...+++++.+||.+||+.||.+|| +++++|+||||..
T Consensus 218 -------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 218 -------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred -------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 023578899999999999999998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=349.57 Aligned_cols=291 Identities=40% Similarity=0.682 Sum_probs=228.3
Q ss_pred CCCCceE-EeeecccCceEEEEEEECCCCcEEEEEEeecCCCChH------------HHHHHHHHHHHHHhCCCCCeeee
Q 043957 123 SAESYDK-IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPH------------SVKFMAREIMILQKLDHPNIVKL 189 (584)
Q Consensus 123 ~~~~Y~~-~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~------------~~~~~~~Ei~iL~~L~HpnIv~l 189 (584)
..++|.. .+.||.|+||+||+|.+..+++.||||++........ ....+.+|+.+++.++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 4567865 4679999999999999999999999999865432210 01246789999999999999999
Q ss_pred eceeeecCcceEEEEEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEE
Q 043957 190 EGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIAD 263 (584)
Q Consensus 190 ~~~~~~~~~~~l~lV~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~D 263 (584)
++++... ..+|+||||+.++|...+... ..+. ++.||+.||.|||+.+|+|+||||+|||++.++.++|+|
T Consensus 86 ~~~~~~~--~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 86 VDVYVEG--DFINLVMDIMASDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred eEEEecC--CcEEEEEeccccCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECC
Confidence 9988764 468999999999888887542 2233 345999999999999999999999999999999999999
Q ss_pred eccccccCCC-------------CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHH
Q 043957 264 FGLANYFSPN-------------KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQ 330 (584)
Q Consensus 264 FGla~~~~~~-------------~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~ 330 (584)
||++...... .........+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 242 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999765411 111223445688999999997755678999999999999999999999999999999
Q ss_pred HHHHHHhcCCCChHHHHHhhccCCCCC-CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCc
Q 043957 331 LHRIFKLCGSPSEDYWKKLRLSTTFRP-PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLA 409 (584)
Q Consensus 331 ~~~i~~~~~~~~~~~~~~~~~~~~~~~-p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~ 409 (584)
+..++...+.+....|........+.. ...........+...++.+.+||.+||+.||.+|||++|+|.||||...+..
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 999988888887766654322111111 1112233444556778999999999999999999999999999999988766
Q ss_pred cCCCCCC
Q 043957 410 CDLSGLP 416 (584)
Q Consensus 410 ~~~~~~~ 416 (584)
.+...+|
T Consensus 323 ~~~~~~~ 329 (335)
T PTZ00024 323 CDPSQLP 329 (335)
T ss_pred CCcccCC
Confidence 6554444
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=349.93 Aligned_cols=280 Identities=37% Similarity=0.625 Sum_probs=228.6
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC---cceEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM---QYSLY 202 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---~~~l~ 202 (584)
+|++.+.||.|+||.||+|.+..++..||||++..........+.+.+|+.+++.++||||+++++++.... ...+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 589999999999999999999999999999999755433445667889999999999999999999877643 23589
Q ss_pred EEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC-
Q 043957 203 LVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK- 275 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~- 275 (584)
+||||+.++|.+.+.... .+.+ ..||+.||.|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 81 lv~e~~~~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELMETDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchhhhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 999999998888876532 3333 35999999999999999999999999999999999999999987654321
Q ss_pred -CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 276 -RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 276 -~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....|........
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 2234567899999999998754689999999999999999999999999999999999999888888766653221110
Q ss_pred C----CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 355 F----RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 355 ~----~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
. ..+......+...+..++..+.+||.+||++||.+|||++++|+||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 0 011222233444566789999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=352.24 Aligned_cols=281 Identities=36% Similarity=0.606 Sum_probs=227.8
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc----
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ---- 198 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~---- 198 (584)
..++|++.+.||+|+||.||+|.+..++..||||++............+.+|+.++++++||||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567999999999999999999999999999999986544344445667789999999999999999887755332
Q ss_pred ceEEEEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 199 YSLYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 199 ~~l~lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
..+|+|+||+.++|.+++... .+.+ ..||+.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 93 ~~~~lv~e~~~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred ccEEEEEecCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 348999999998888887642 3333 35999999999999999999999999999999999999999987543
Q ss_pred CCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
. .....+++.|+|||++.+...++.++|||||||++|+|++|++||.+......+..+....+.+.+..|.++...
T Consensus 171 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07851 171 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE 246 (343)
T ss_pred c----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence 2 344577899999999876556889999999999999999999999999988889999988888887777655321
Q ss_pred CC----CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCc
Q 043957 353 TT----FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLA 409 (584)
Q Consensus 353 ~~----~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~ 409 (584)
.. ...+......+...+..+++.+.+||.+||..||.+|||+.++|+||||......
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 11 0111222223344455678999999999999999999999999999999865433
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=352.09 Aligned_cols=243 Identities=26% Similarity=0.343 Sum_probs=191.2
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHH-HHHhCCCCCeeeeeceeeecCcceEEEEEech
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIM-ILQKLDHPNIVKLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
+.||+|+||.||+|.+..+|+.||||++..... .......+..|.. +++.++||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcCC
Confidence 359999999999999999999999999964322 2223344555554 5677999999999887766 44689999999
Q ss_pred hh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccc
Q 043957 209 QT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR 281 (584)
Q Consensus 209 ~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 281 (584)
.+ +|...+.. ...+. +..||+.||+|||++||+||||||+||||+.++.+||+|||++....... ......
T Consensus 79 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (325)
T cd05604 79 NGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTF 156 (325)
T ss_pred CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcccc
Confidence 85 56555543 23333 33599999999999999999999999999999999999999987542221 223456
Q ss_pred cccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCC
Q 043957 282 VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSY 361 (584)
Q Consensus 282 ~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~ 361 (584)
+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+..+.....
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~---------------------- 213 (325)
T cd05604 157 CGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL---------------------- 213 (325)
T ss_pred cCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc----------------------
Confidence 79999999999976 4589999999999999999999999998877666555432100
Q ss_pred CchhhhhccCCcHhHHHHHHHhcccCCCCCCCH----HHHhcCcCCCC
Q 043957 362 KPRLFEAFSEFPESSLGLLSTLLALDPAYRGSA----ASALKNEFFFT 405 (584)
Q Consensus 362 ~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa----~e~L~Hp~f~~ 405 (584)
.....++..+.+||.+||+.||.+||++ .++++||||..
T Consensus 214 -----~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 214 -----VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred -----cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 0113467889999999999999999987 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.42 Aligned_cols=249 Identities=28% Similarity=0.425 Sum_probs=198.8
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l~l 203 (584)
+|+..+.||+|+||.||+|.+..+|+.||||++..... .....+.+..|+.+++.+. |++|+++++++.. ...+|+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEE
Confidence 37889999999999999999999999999999975322 2234456778999998886 5778888877765 346899
Q ss_pred EEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
||||+.+ +|...+... ..+.+ +.||+.||.|||+++|+||||||+|||++.++.+||+|||++....... .
T Consensus 79 v~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~ 156 (323)
T cd05615 79 VMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-V 156 (323)
T ss_pred EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-c
Confidence 9999984 676666432 23333 3599999999999999999999999999999999999999987643222 1
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+......
T Consensus 157 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~---------------- 219 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS---------------- 219 (323)
T ss_pred cccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------------
Confidence 2234578999999999976 45899999999999999999999999988777666665432110
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC-----HHHHhcCcCCCCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS-----AASALKNEFFFTS 406 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT-----a~e~L~Hp~f~~~ 406 (584)
....++.++.+||.+||+.||.+|++ .+++++||||...
T Consensus 220 -----------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 220 -----------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred -----------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 11346788999999999999999997 5799999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=349.67 Aligned_cols=244 Identities=28% Similarity=0.421 Sum_probs=192.7
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEEEEEech
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
+.||+|+||.||+|.+..+++.||||+++.... .......+..|..++..+ +||||+++++++... ..+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEEeCC
Confidence 369999999999999999999999999975421 122334566788888764 899999999888764 4689999999
Q ss_pred h-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccc
Q 043957 209 Q-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR 281 (584)
Q Consensus 209 ~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 281 (584)
. ++|...+... ..+. ++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....... ......
T Consensus 79 ~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (316)
T cd05619 79 NGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTF 156 (316)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceeee
Confidence 8 4777776532 2232 34599999999999999999999999999999999999999987532221 123456
Q ss_pred cccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCC
Q 043957 282 VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSY 361 (584)
Q Consensus 282 ~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~ 361 (584)
+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~--------------------- 214 (316)
T cd05619 157 CGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPC--------------------- 214 (316)
T ss_pred cCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------------------
Confidence 78999999999976 45899999999999999999999999887766555444211000
Q ss_pred CchhhhhccCCcHhHHHHHHHhcccCCCCCCCHH-HHhcCcCCCCC
Q 043957 362 KPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAA-SALKNEFFFTS 406 (584)
Q Consensus 362 ~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~-e~L~Hp~f~~~ 406 (584)
....++.++.+||.+||+.||.+||++. ++++||||...
T Consensus 215 ------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 215 ------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred ------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence 0123578899999999999999999996 89999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=357.64 Aligned_cols=246 Identities=27% Similarity=0.415 Sum_probs=207.5
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechhh
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT 210 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~g 210 (584)
+.||.|.||+||-|+++.+|+.||||+|.+..........+++|+.||+.+.||.||.+.-.|+. ...+++|||-+.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET--~ervFVVMEKl~G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET--PERVFVVMEKLHG 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC--CceEEEEehhhcc
Confidence 68999999999999999999999999997665555556889999999999999999999766666 4458999999999
Q ss_pred HHHHHhh-CCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCC---CcEEEEEeccccccCCCCCCCCcc
Q 043957 211 DLARIIS-NPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKN---GVLKIADFGLANYFSPNKKRPLTS 280 (584)
Q Consensus 211 ~L~~~l~-~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~---g~vKL~DFGla~~~~~~~~~~~~~ 280 (584)
+.++.|. ...+++.+. .||+.||.|||-++|+|+||||+|||+... -++||||||+|+.+... ....+
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--sFRrs 725 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--SFRRS 725 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh--hhhhh
Confidence 9887765 455677664 399999999999999999999999999654 46999999999998643 34578
Q ss_pred ccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCC
Q 043957 281 RVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQS 360 (584)
Q Consensus 281 ~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~ 360 (584)
++|||.|+|||++.. +.|+..-||||+|||+|--|+|..||....+ +-.+|.+.....+...|
T Consensus 726 VVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~PW-------------- 788 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPNPW-------------- 788 (888)
T ss_pred hcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCCch--------------
Confidence 899999999999986 5699999999999999999999999975443 33445444433343334
Q ss_pred CCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 361 YKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 361 ~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.+++..++|||..+|+..-.+|.|.++.|.|||++.-
T Consensus 789 ---------~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 789 ---------SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred ---------hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 4578999999999999999999999999999999753
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=385.33 Aligned_cols=257 Identities=27% Similarity=0.445 Sum_probs=206.3
Q ss_pred CCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 121 ~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
+...++|++++.||.|+||+||+|.+..++..||+|++............+..|+.+|++|+|||||+++++|.......
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 34456899999999999999999999999999999999766555566678899999999999999999999887766677
Q ss_pred EEEEEechh-hHHHHHhhCC---CCCCc------HHHHHHHHHHHHHhC-------CceeccccccceeecC--------
Q 043957 201 LYLVFEFMQ-TDLARIISNP---EGKLT------EPQQLLSGLQHCHDR-------GILHRDVKGSNLLIDK-------- 255 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~---~~~l~------~~~qIl~aL~yLH~~-------~IvHrDLKp~NILl~~-------- 255 (584)
+|||||||. ++|..++... ...+. ++.||+.||.|||+. +||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 999999998 4777766531 12233 345999999999984 4999999999999954
Q ss_pred ---------CCcEEEEEeccccccCCCCCCCCccccccccccChhhhhCC-CCCCceeeEecchHHHHHHHhCCCCCCCC
Q 043957 256 ---------NGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGA-TDYGVGIDLWSAGCLLAEMFLGRPIMPGR 325 (584)
Q Consensus 256 ---------~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~-~~~~~~sDIwSLGvilyeLltG~~pF~~~ 325 (584)
.+.+||+|||++..+.... .....+||+.|+|||++.+. ..++.++||||||||||+|++|.+||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2358999999998764322 23456799999999998643 35889999999999999999999999876
Q ss_pred ChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 326 TEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 326 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
.....+...+... +. ..+..++.++.+||..||++||.+|||+.|+|.|+||..
T Consensus 247 ~~~~qli~~lk~~--p~------------------------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 247 NNFSQLISELKRG--PD------------------------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred CcHHHHHHHHhcC--CC------------------------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 6554443332211 00 011345788999999999999999999999999999963
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=337.81 Aligned_cols=274 Identities=45% Similarity=0.795 Sum_probs=226.5
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEe
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFE 206 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~E 206 (584)
|++.+.||+|.||.||+|.+..+++.||+|++..........+.+..|+.+++.++|+||+++++++... ..+|+|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEEEec
Confidence 6778899999999999999999999999999976543344456677899999999999999999988764 46899999
Q ss_pred chhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCcc
Q 043957 207 FMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTS 280 (584)
Q Consensus 207 y~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~ 280 (584)
|+.++|...+......+.+ +.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++........ ....
T Consensus 79 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (282)
T cd07829 79 YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTH 157 (282)
T ss_pred CcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCc
Confidence 9999888888754333333 35999999999999999999999999999999999999999987643321 2344
Q ss_pred ccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC--CCCCC
Q 043957 281 RVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST--TFRPP 358 (584)
Q Consensus 281 ~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~~~p 358 (584)
..++..|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+....+.+....|..+.... ....+
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 5667889999998765468999999999999999999999999999999999999999999988887664332 11222
Q ss_pred CCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 359 ~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
..........++.++..+.+||.+||..||.+||++++++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 222223334556678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=350.80 Aligned_cols=279 Identities=35% Similarity=0.597 Sum_probs=220.8
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc----ce
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ----YS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~----~~ 200 (584)
.+|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++..... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 57999999999999999999999999999999986543333344567889999999999999999998765322 35
Q ss_pred EEEEEechhhHHHHHhhCC---CCCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 201 LYLVFEFMQTDLARIISNP---EGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 201 l~lV~Ey~~g~L~~~l~~~---~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
+|+||||+..+|....... ........||+.||+|||+++|+||||||+|||++.++.+||+|||++......
T Consensus 95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~---- 170 (342)
T cd07879 95 FYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE---- 170 (342)
T ss_pred EEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC----
Confidence 6999999987766654211 011123359999999999999999999999999999999999999999765321
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC--
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF-- 355 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-- 355 (584)
.....+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.+....+..+......
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (342)
T cd07879 171 MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSY 250 (342)
T ss_pred CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHH
Confidence 234577899999999876556889999999999999999999999998888888888888877776666554321110
Q ss_pred --CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 356 --RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 356 --~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
..+......+...++.++..+.+||.+||+.||.+|||++++|.||||....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 251 IKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 1111222333344566788999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=349.24 Aligned_cols=243 Identities=25% Similarity=0.342 Sum_probs=189.6
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHH-HHHHhCCCCCeeeeeceeeecCcceEEEEEech
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREI-MILQKLDHPNIVKLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei-~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
+.||+|+||.||+|.+..+++.||||++..... .......+..|+ .+++.++||||+++++++.. ...+|+|||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999964321 122233444554 46788999999999887765 44689999999
Q ss_pred hh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccc
Q 043957 209 QT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR 281 (584)
Q Consensus 209 ~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 281 (584)
.+ +|...+.. ...+. +..||+.||.|||+++|+||||||+||||+.++.+||+|||++....... ......
T Consensus 79 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (321)
T cd05603 79 NGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTF 156 (321)
T ss_pred CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccccc
Confidence 85 56555543 22333 34599999999999999999999999999999999999999987532221 223456
Q ss_pred cccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCC
Q 043957 282 VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSY 361 (584)
Q Consensus 282 ~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~ 361 (584)
+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+.....
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~---------------------- 213 (321)
T cd05603 157 CGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL---------------------- 213 (321)
T ss_pred cCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCC----------------------
Confidence 78999999999876 4589999999999999999999999988876555544432100
Q ss_pred CchhhhhccCCcHhHHHHHHHhcccCCCCCCCH----HHHhcCcCCCC
Q 043957 362 KPRLFEAFSEFPESSLGLLSTLLALDPAYRGSA----ASALKNEFFFT 405 (584)
Q Consensus 362 ~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa----~e~L~Hp~f~~ 405 (584)
......+..+.+||.+||+.||.+|+++ .++++|+||..
T Consensus 214 -----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 214 -----QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 1113457889999999999999999976 59999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=340.03 Aligned_cols=254 Identities=30% Similarity=0.408 Sum_probs=211.2
Q ss_pred CCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 121 ~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
....++|+.++.||+|.||.|-+|+.+.+|+.||||+++++.. ....+.....|-++|+..+||.+..+. |......
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LK--YsFQt~d 241 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLK--YSFQTQD 241 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhh--hhhccCc
Confidence 3456789999999999999999999999999999999987643 345566677899999999999998884 3444567
Q ss_pred eEEEEEechhhH-HHHHhhCCCCCCcHHH------HHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQTD-LARIISNPEGKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~g~-L~~~l~~~~~~l~~~~------qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
.+|+||||..|+ |...+. ....+++.+ .|+.||.|||+++||+||||.+|+|+|.+|+|||+||||++.--.
T Consensus 242 rlCFVMeyanGGeLf~HLs-rer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLS-RERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred eEEEEEEEccCceEeeehh-hhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 899999999965 444443 344455543 899999999999999999999999999999999999999975322
Q ss_pred CCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
....+.+.||||.|+|||++.. ..|+.++|.|.+||++|||+||+.||...+...++..|+..--
T Consensus 321 -~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~------------- 385 (516)
T KOG0690|consen 321 -YGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL------------- 385 (516)
T ss_pred -ccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc-------------
Confidence 2234578899999999999975 6799999999999999999999999999888877777754321
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCCC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFTS 406 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~~ 406 (584)
.....++++++.||..+|.+||.+|. .|.|+.+|+||...
T Consensus 386 --------------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 386 --------------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred --------------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 22356789999999999999999996 47999999999764
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=337.09 Aligned_cols=260 Identities=28% Similarity=0.386 Sum_probs=213.3
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceEEEEEechh
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSLYLVFEFMQ 209 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l~lV~Ey~~ 209 (584)
+.||+|+|+.|--|+...+|..||||+|.+. ..+....+.+|++++.++. |+||+++++||++.. .+|||||-|.
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~--~FYLVfEKm~ 159 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT--RFYLVFEKMR 159 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc--eEEEEEeccc
Confidence 5699999999999999999999999999654 5566788899999999995 999999999998854 4799999999
Q ss_pred h-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCC---CcEEEEEeccccccCC------C
Q 043957 210 T-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKN---GVLKIADFGLANYFSP------N 273 (584)
Q Consensus 210 g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~---g~vKL~DFGla~~~~~------~ 273 (584)
| .|+..|.... .+++ .+.|+.||.|||.+||.||||||+|||-... .-||||||.|...+.. .
T Consensus 160 GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 160 GGPLLSHIQKRK-HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred CchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 5 5777666422 2333 3489999999999999999999999998554 3589999998865432 2
Q ss_pred CCCCCccccccccccChhhhh----CCCCCCceeeEecchHHHHHHHhCCCCCCCCC---------------hHHHHHHH
Q 043957 274 KKRPLTSRVVTLWYRAPELLL----GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRT---------------EVEQLHRI 334 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~----~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~---------------~~~~~~~i 334 (584)
....+.+.+|+..|||||+.. ....|+.++|.||||||||.||+|++||.|.- ...+++.|
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI 318 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI 318 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence 233456789999999999863 23469999999999999999999999997752 24567788
Q ss_pred HHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCccCCCC
Q 043957 335 FKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDLSG 414 (584)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~~~~~~ 414 (584)
..+...+++..|.. ++.+++|||..+|..|+..|.+|.++|+|||+..-...+.++.
T Consensus 319 QEGkYeFPdkdWah-----------------------IS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalpt 375 (463)
T KOG0607|consen 319 QEGKYEFPDKDWAH-----------------------ISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPT 375 (463)
T ss_pred hccCCcCChhhhHH-----------------------hhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCC
Confidence 88888888888865 5899999999999999999999999999999987655555555
Q ss_pred CCcc
Q 043957 415 LPVI 418 (584)
Q Consensus 415 ~~~~ 418 (584)
.+++
T Consensus 376 p~v~ 379 (463)
T KOG0607|consen 376 PQVL 379 (463)
T ss_pred Cccc
Confidence 4544
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=351.39 Aligned_cols=274 Identities=27% Similarity=0.423 Sum_probs=201.0
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.++||.|+||.||+|.+..++..+|+|++.... .......+.+|+++|+.++|||||++++++... ..+||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC--CEEEE
Confidence 357999999999999999999999999999999987543 334456788999999999999999999988774 46899
Q ss_pred EEechhh-HHHHHhhCCCCCC------cHHHHHHHHHHHHHhC-CceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 204 VFEFMQT-DLARIISNPEGKL------TEPQQLLSGLQHCHDR-GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l------~~~~qIl~aL~yLH~~-~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
||||+.+ +|.+++... ..+ .+..||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 81 CMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred EEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 9999984 777776542 222 2335999999999975 79999999999999999999999999997653221
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhc--CCCChHHHH------
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLC--GSPSEDYWK------ 347 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~--~~~~~~~~~------ 347 (584)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .++... +.+......
T Consensus 159 --~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 159 --ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred --cccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCcccCCc
Confidence 234578999999999976 45899999999999999999999999876543332 221110 000000000
Q ss_pred --HhhccCCCCCCCCCCchhhh----------hccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 348 --KLRLSTTFRPPQSYKPRLFE----------AFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 348 --~~~~~~~~~~p~~~~~~~~~----------~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
..........|......+.. ....++.++.+||.+||++||++|||++|+|+||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 00000000000000000000 001357889999999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=335.80 Aligned_cols=274 Identities=41% Similarity=0.678 Sum_probs=216.3
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC---CCCCeeeeeceeeecCc---ce
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL---DHPNIVKLEGLATSRMQ---YS 200 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~~~~---~~ 200 (584)
|++.+.||.|+||.||+|.++.++..||||+++...........+.+|+.+++++ +||||+++++++..... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7889999999999999999998899999999975544333345566788877766 59999999998876432 24
Q ss_pred EEEEEechhhHHHHHhhCCC-CCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQTDLARIISNPE-GKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~g~L~~~l~~~~-~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
++++|||+.++|...+.... ..+.+ ..||+.||.|||+++|+|+||+|+|||++.++.+||+|||++..+...
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 89999999988877665422 23333 359999999999999999999999999999999999999999876433
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
. ......++..|+|||++.+. .++.++|||||||++|+|++|++||...+..+.+..++.....+....|.......
T Consensus 161 ~--~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 161 M--ALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred c--ccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 2 22344678899999999764 58899999999999999999999999999999999888877666555543322111
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
....+.............+++.+.+||.+||+.||.+||++.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 11112222233344456778899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=344.92 Aligned_cols=273 Identities=28% Similarity=0.421 Sum_probs=213.1
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCC--C----CeeeeeceeeecC
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH--P----NIVKLEGLATSRM 197 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H--p----nIv~l~~~~~~~~ 197 (584)
..+|.+++.+|+|+||.|..+.+..++..||||+++... ...++..-|+++|++|.+ | -+|.+.+||..
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy-- 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY-- 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc--
Confidence 568999999999999999999999999999999996322 233445569999999942 2 37788888876
Q ss_pred cceEEEEEechhhHHHHHhhCCCCC-CcH------HHHHHHHHHHHHhCCceeccccccceeecC---------------
Q 043957 198 QYSLYLVFEFMQTDLARIISNPEGK-LTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDK--------------- 255 (584)
Q Consensus 198 ~~~l~lV~Ey~~g~L~~~l~~~~~~-l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~--------------- 255 (584)
.++++||+|.++-++.+++...... +.. ..||+.+++|||+.+++|.||||||||+..
T Consensus 163 rghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 163 RGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred cCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 4568999999998999998864432 322 249999999999999999999999999821
Q ss_pred -----CCcEEEEEeccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHH
Q 043957 256 -----NGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQ 330 (584)
Q Consensus 256 -----~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~ 330 (584)
...|+|+|||.|+..... .++.+.|..|+|||++++. +++.++||||+||||+||.+|..+|++.++.+.
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgL-GwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGL-GWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eccCCCcceEEEecCCcceeccC----cceeeeccccCCchheecc-CcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 236899999999875432 3677889999999999985 599999999999999999999999999999999
Q ss_pred HHHHHHhcCCCChHHHHHhhccCCCCCC----------------CCCCchhhhhccC---CcHhHHHHHHHhcccCCCCC
Q 043957 331 LHRIFKLCGSPSEDYWKKLRLSTTFRPP----------------QSYKPRLFEAFSE---FPESSLGLLSTLLALDPAYR 391 (584)
Q Consensus 331 ~~~i~~~~~~~~~~~~~~~~~~~~~~~p----------------~~~~~~~~~~~~~---~s~~~~dLI~~~L~~DP~kR 391 (584)
++.+...++.++.....+.+....+..- ......+...... -...+.|||.+||.+||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 9999999998876655554211111000 0001111111111 12357899999999999999
Q ss_pred CCHHHHhcCcCCCCC
Q 043957 392 GSAASALKNEFFFTS 406 (584)
Q Consensus 392 pTa~e~L~Hp~f~~~ 406 (584)
+|+.|+|.||||+..
T Consensus 398 iTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 398 ITLREALSHPFFARL 412 (415)
T ss_pred ccHHHHhcCHHhhcC
Confidence 999999999999754
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=330.94 Aligned_cols=249 Identities=26% Similarity=0.394 Sum_probs=201.6
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
.|++.+.||+|++|.||++.+..+++.||+|++..........+.+.+|+.++++++|+||+++++.+... ...+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEe
Confidence 48999999999999999999999999999999976555555567788999999999999999998876543 34589999
Q ss_pred echh-hHHHHHhhCCC-CCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 206 EFMQ-TDLARIISNPE-GKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 206 Ey~~-g~L~~~l~~~~-~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||+. ++|.+.+.... ..+ .++.||+.||.|||+++|+|+||||+||+++.++.++|+|||++..+.... ..
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~ 158 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DM 158 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC-Cc
Confidence 9998 46777665422 223 334599999999999999999999999999999999999999998764322 22
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 357 (584)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~------------------ 219 (257)
T cd08223 159 ASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL------------------ 219 (257)
T ss_pred cccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC------------------
Confidence 345578999999999876 4588999999999999999999999987765544433322110
Q ss_pred CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 358 p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
......+++.+.+||.+||+.||.+|||+.++|+||||
T Consensus 220 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 220 --------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred --------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00113467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=348.62 Aligned_cols=280 Identities=35% Similarity=0.551 Sum_probs=213.4
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc------
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ------ 198 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~------ 198 (584)
.+|.+.+.||.|+||.||+|.+..+|..||+|++..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 579999999999999999999999999999999865433 345668889999999999999999887655322
Q ss_pred ------ceEEEEEechhhHHHHHhhCCCC----CCcHHHHHHHHHHHHHhCCceeccccccceeecC-CCcEEEEEeccc
Q 043957 199 ------YSLYLVFEFMQTDLARIISNPEG----KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDK-NGVLKIADFGLA 267 (584)
Q Consensus 199 ------~~l~lV~Ey~~g~L~~~l~~~~~----~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~-~g~vKL~DFGla 267 (584)
..+|+||||+.++|...+..... ...++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~ 162 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA 162 (342)
T ss_pred ccccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccc
Confidence 35799999999888777653211 1223359999999999999999999999999975 567899999999
Q ss_pred cccCCCCC--CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHH
Q 043957 268 NYFSPNKK--RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDY 345 (584)
Q Consensus 268 ~~~~~~~~--~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~ 345 (584)
........ .......++..|+|||++.+...++.++|||||||++|+|++|+.||...+..+....+...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07854 163 RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242 (342)
T ss_pred eecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 76532211 1122346788999999887655688999999999999999999999999888888777776654444322
Q ss_pred HHHhhccCC--CC-CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 346 WKKLRLSTT--FR-PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 346 ~~~~~~~~~--~~-~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
+........ .. ............+..++.++.+||.+||+.||.+|||+.++|.||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 243 RNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred hhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 222110000 00 00111122333456788999999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=347.92 Aligned_cols=280 Identities=35% Similarity=0.558 Sum_probs=220.1
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC----
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM---- 197 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---- 197 (584)
...++|.+.+.||+|+||.||+|.+..++..||+|++..........+.+.+|+.++++++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 3457899999999999999999999999999999998754333334566788999999999999999998875432
Q ss_pred cceEEEEEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccC
Q 043957 198 QYSLYLVFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS 271 (584)
Q Consensus 198 ~~~l~lV~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~ 271 (584)
...+|++++++.++|..++... .+. ++.||+.||+|||+++|+||||||+||+++.++.+||+|||++....
T Consensus 94 ~~~~~lv~~~~~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 94 FNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred cccEEEEehhcccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 2347899999988887776532 233 34599999999999999999999999999999999999999997643
Q ss_pred CCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 272 PNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 272 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
.. .....+++.|+|||++.+...++.++|||||||++|+|++|++||........+..+....+.+....+..+..
T Consensus 172 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 172 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred cc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 21 23457789999999987655688999999999999999999999998888888888887777666655544321
Q ss_pred cCC----CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 352 STT----FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 352 ~~~----~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
... ...+......+...+...++.+.+||.+||+.||.+|||+.++|.||||.+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 100 00000011112222335688899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=332.73 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=199.2
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE---PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~---~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
+.|.+.+.||+|+||.||+|.+..++..||||.+...... ......+.+|+.++++++||||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD--ETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC--CeE
Confidence 4699999999999999999999999999999998654322 22346788999999999999999999988764 378
Q ss_pred EEEEechhh-HHHHHhhCCCC-----CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 202 YLVFEFMQT-DLARIISNPEG-----KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~-----~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
|+||||+.+ +|.+.+..... ...+..||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++........
T Consensus 80 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 999999985 66666653221 123345999999999999999999999999999999999999999976543221
Q ss_pred CCC--ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 276 RPL--TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 276 ~~~--~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
... ....++..|+|||++.+. .++.++|||||||++|+|++|++||...+.......+.....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------------- 224 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT-------------- 224 (263)
T ss_pred ccccccCCCcCccccCcceeccC-CCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC--------------
Confidence 111 335678899999999764 489999999999999999999999977655444333211100
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
.......++..+.+||.+||..||.+|||+.++|+||||
T Consensus 225 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 225 -----------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred -----------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 001123568889999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=341.16 Aligned_cols=252 Identities=27% Similarity=0.406 Sum_probs=196.7
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE-PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
.|++.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.+++.++|+||+.+++.+... ..+|+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC--CEEEEE
Confidence 378899999999999999999999999999998654322 23345567899999999999999998877663 468999
Q ss_pred Eechhh-HHHHHhhCC-CCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 205 FEFMQT-DLARIISNP-EGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~-~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
|||+.+ +|...+... ...+. ++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++.......
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 999984 676665322 12233 34599999999999999999999999999999999999999997654322
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
......|++.|+|||++.+. .++.++|||||||++|+|++|++||...........+........
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-------------- 221 (285)
T ss_pred cccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh--------------
Confidence 22345789999999999764 589999999999999999999999987543211111111000000
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC-----HHHHhcCcCCCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS-----AASALKNEFFFT 405 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT-----a~e~L~Hp~f~~ 405 (584)
......+++++.+||.+||+.||.+||| ++|+++||||.+
T Consensus 222 ---------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 222 ---------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred ---------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 0112356788999999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=363.77 Aligned_cols=249 Identities=25% Similarity=0.356 Sum_probs=201.9
Q ss_pred CceEEeeecccCceEEEEEEECCC-CcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDT-GKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
.|.+.+.||+|+||.||+|.+..+ +..||+|.+... .......+.+|+.+|+.++|||||++++++... ..+|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~lv 143 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSD--DKLLLI 143 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC--CEEEEE
Confidence 499999999999999999998877 788999987533 334455678899999999999999999988764 468999
Q ss_pred Eechh-hHHHHHhhC---CCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 205 FEFMQ-TDLARIISN---PEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 205 ~Ey~~-g~L~~~l~~---~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
|||+. ++|...+.. ....+. +..||+.||.|||+++|+||||||+||||+.++.+||+|||+++.+....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 99998 567665532 122233 33599999999999999999999999999999999999999998765332
Q ss_pred C-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 275 K-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 275 ~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+......+
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~------------ 290 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP------------ 290 (478)
T ss_pred ccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------------
Confidence 1 12345679999999999876 458999999999999999999999998887766665554321110
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
....++..+.+||.+||+.||++|||++++|.|+|+..
T Consensus 291 --------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 291 --------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred --------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 11346788999999999999999999999999999853
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=369.84 Aligned_cols=278 Identities=23% Similarity=0.325 Sum_probs=198.3
Q ss_pred CCCceEEeeecccCceEEEEEEECCCC-cEEEEEEe---------------ecCCCChHHHHHHHHHHHHHHhCCCCCee
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTG-KIVALKKV---------------KFDTSEPHSVKFMAREIMILQKLDHPNIV 187 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i---------------~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 187 (584)
.++|+++++||+|+||.||+|..+... ..+++|.+ +...........+.+|+.+|++++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 467999999999999999998765432 22222211 00111223445678999999999999999
Q ss_pred eeeceeeecCcceEEEEEechhhHHHHHhhCCCC----C------CcHHHHHHHHHHHHHhCCceeccccccceeecCCC
Q 043957 188 KLEGLATSRMQYSLYLVFEFMQTDLARIISNPEG----K------LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG 257 (584)
Q Consensus 188 ~l~~~~~~~~~~~l~lV~Ey~~g~L~~~l~~~~~----~------l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g 257 (584)
++++++.... ..|+|||++.++|...+..... . ..+..||+.||.|||+++||||||||+||||+.++
T Consensus 227 ~l~~~~~~~~--~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 227 KIEEILRSEA--NTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred cEeEEEEECC--eeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 9999887743 5799999999888776643211 1 12446999999999999999999999999999999
Q ss_pred cEEEEEeccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCC-CCC--CChHHHHHHH
Q 043957 258 VLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPI-MPG--RTEVEQLHRI 334 (584)
Q Consensus 258 ~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~p-F~~--~~~~~~~~~i 334 (584)
.+||+|||++..+...........+||+.|+|||++.+. .++.++|||||||++|||++|..+ |.. .....++..+
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 999999999987754433333456899999999999764 599999999999999999998754 432 2344555555
Q ss_pred HHhcCCCCh-------HHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 335 FKLCGSPSE-------DYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 335 ~~~~~~~~~-------~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
+........ ..|..+........+... +.+.. -..++.++.++|.+||++||.+|||+.|+|.||||...
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~-~~~~~-~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSV-PPLIR-NLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccch-hhHHH-hcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 554432222 122222111111111111 11111 12467889999999999999999999999999999754
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=349.15 Aligned_cols=248 Identities=26% Similarity=0.375 Sum_probs=189.5
Q ss_pred CCCceEEeeecccCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecC
Q 043957 124 AESYDKIDKVGQGTYSNVYKALD-----RDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRM 197 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 197 (584)
.++|++.+.||+|+||.||+|.+ ..++..||||++... ........+.+|+.+|+.+ +|||||++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 45799999999999999999975 244678999998643 2333456788999999999 899999999987653
Q ss_pred cceEEEEEechh-hHHHHHhhCCCC-------------------------------------------------------
Q 043957 198 QYSLYLVFEFMQ-TDLARIISNPEG------------------------------------------------------- 221 (584)
Q Consensus 198 ~~~l~lV~Ey~~-g~L~~~l~~~~~------------------------------------------------------- 221 (584)
...+|+|||||. |+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 335899999998 567766643210
Q ss_pred ------CCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC-CCCcccccccccc
Q 043957 222 ------KLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK-RPLTSRVVTLWYR 288 (584)
Q Consensus 222 ------~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~ 288 (584)
.+. +..||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+..... .......+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 111 235999999999999999999999999999999999999999986532221 1112334567899
Q ss_pred ChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhh
Q 043957 289 APELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFE 367 (584)
Q Consensus 289 APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 367 (584)
|||++.+ ..++.++|||||||++|||++ |.+||.+....+.+...+... ... .
T Consensus 244 aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~--------------~~~-----------~ 297 (338)
T cd05102 244 APESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG--------------TRM-----------R 297 (338)
T ss_pred CcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcC--------------CCC-----------C
Confidence 9999976 458999999999999999997 999998765433322221110 000 0
Q ss_pred hccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 368 AFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 368 ~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
....+++.+.+||.+||+.||.+|||+.|+++
T Consensus 298 ~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 298 APENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=354.18 Aligned_cols=254 Identities=30% Similarity=0.495 Sum_probs=200.3
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l 201 (584)
....|+++++||+||.+.||++.... ...||+|++.....+...+.-+.+|+..|.+|+ |.+||+|++|... +..+
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~l 435 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGYL 435 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--CceE
Confidence 34569999999999999999997654 467788887777777778889999999999995 9999999998766 5579
Q ss_pred EEEEechhhHHHHHhhCCCCCCc--HH----HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 202 YLVFEFMQTDLARIISNPEGKLT--EP----QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 202 ~lV~Ey~~g~L~~~l~~~~~~l~--~~----~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
||||||-+.+|..++........ +. .|||.|+.++|++||||.||||.|+|+- .|.+||+|||+|..+..+..
T Consensus 436 YmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 436 YMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred EEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence 99999999999999987655444 22 4999999999999999999999999984 57999999999998876543
Q ss_pred CC-CccccccccccChhhhhCCC----------CCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChH
Q 043957 276 RP-LTSRVVTLWYRAPELLLGAT----------DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSED 344 (584)
Q Consensus 276 ~~-~~~~~gt~~Y~APEvl~~~~----------~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~ 344 (584)
.. ..+.+||+.||+||.+.... ..+.++||||||||||+|+.|++||..-. ..+.++... ..|..
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI-~~P~~- 590 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAI-TDPNH- 590 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhh-cCCCc-
Confidence 22 24679999999999986321 25678999999999999999999995321 122222111 11110
Q ss_pred HHHHhhccCCCCCCCCCCchhhhhccCCc--HhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFP--ESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 345 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~s--~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
.-.|+.+| .+++++++.||..||.+|||+.++|+|||++-
T Consensus 591 ---------------------~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 591 ---------------------EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ---------------------cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 00112222 23899999999999999999999999999874
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=344.54 Aligned_cols=245 Identities=26% Similarity=0.413 Sum_probs=190.6
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEEEEEech
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
+.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.++.++ +||||+.+++++... ..+|+|||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEEeCC
Confidence 369999999999999999999999999975432 233456688999999888 699999999887663 4689999999
Q ss_pred hh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccc
Q 043957 209 QT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR 281 (584)
Q Consensus 209 ~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 281 (584)
.+ +|...+... ..+.+ +.||+.||+|||+++|+||||||+|||++.++.+||+|||++....... ......
T Consensus 79 ~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (327)
T cd05617 79 NGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTF 156 (327)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceecc
Confidence 85 666655432 23433 3599999999999999999999999999999999999999997532211 223456
Q ss_pred cccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCCh------HHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 282 VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE------VEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 282 ~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||..... .+.+..+... ...
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------~~~ 220 (327)
T cd05617 157 CGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE---------------KPI 220 (327)
T ss_pred cCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh---------------CCC
Confidence 79999999999976 4589999999999999999999999964321 1111111100 000
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC------HHHHhcCcCCCCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS------AASALKNEFFFTS 406 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT------a~e~L~Hp~f~~~ 406 (584)
.....++..+.+||.+||+.||.+|++ .+++++||||...
T Consensus 221 -----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 221 -----------RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred -----------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 112346788999999999999999998 5799999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=342.16 Aligned_cols=279 Identities=37% Similarity=0.581 Sum_probs=222.6
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..++|++.+.||.|+||.||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++.... ...|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL-EDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC-CcEE
Confidence 456899999999999999999999999999999998654444444567788999999999999999999876533 3579
Q ss_pred EEEechhhHHHHHhhCCCCC----CcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 203 LVFEFMQTDLARIISNPEGK----LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~~~~~----l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
+||||+.++|...+...... .....||+.||.|||+++|+|+||+|.|||++.++.++|+|||++...... .
T Consensus 87 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~----~ 162 (328)
T cd07856 87 FVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ----M 162 (328)
T ss_pred EEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC----c
Confidence 99999998888777532211 123459999999999999999999999999999999999999999764322 2
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC----
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT---- 354 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~---- 354 (584)
....+++.|+|||++.+...++.++|||||||++|+|++|++||........+..+.+..+.+..+.+..+.....
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd07856 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242 (328)
T ss_pred CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence 3456788999999987645689999999999999999999999999888777777878888777666554321110
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
...+........+.+..+++.+.+||.+||+.||++|||++++|.||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 0111111222334456788999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=344.94 Aligned_cols=275 Identities=22% Similarity=0.299 Sum_probs=196.8
Q ss_pred EEeeeccc--CceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEe
Q 043957 129 KIDKVGQG--TYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFE 206 (584)
Q Consensus 129 ~~~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~E 206 (584)
++++||+| +|++||++.++.+|+.||||++............+.+|+.+++.++|||||++++++... ..+|+|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CEEEEEEe
Confidence 45679999 788999999999999999999976655555667788999999999999999999988764 45899999
Q ss_pred chh-hHHHHHhhCC-CCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC---
Q 043957 207 FMQ-TDLARIISNP-EGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK--- 275 (584)
Q Consensus 207 y~~-g~L~~~l~~~-~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~--- 275 (584)
|+. ++|.+++... ...++ +..||+.||+|||+++|+||||||+|||++.++.++|+||+.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 998 4676666432 12233 335999999999999999999999999999999999999987544321110
Q ss_pred ---CCCccccccccccChhhhhCC-CCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC--------CCh
Q 043957 276 ---RPLTSRVVTLWYRAPELLLGA-TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGS--------PSE 343 (584)
Q Consensus 276 ---~~~~~~~gt~~Y~APEvl~~~-~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~--------~~~ 343 (584)
.......++..|+|||++.+. ..++.++|||||||++|+|++|+.||.................. +..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 001223567789999999753 35899999999999999999999999876544433332221100 000
Q ss_pred HHHHHhhc---------cCC--CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 344 DYWKKLRL---------STT--FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 344 ~~~~~~~~---------~~~--~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
........ ... ...+.............+++.+.+||.+||+.||++|||++|+|+||||.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 00000000 000 000000011111223456789999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=336.66 Aligned_cols=247 Identities=30% Similarity=0.391 Sum_probs=189.3
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechhh-
Q 043957 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSE-PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT- 210 (584)
Q Consensus 133 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~g- 210 (584)
||+|+||.||++.++.+|+.||+|++...... ......+..|++++++++||||+++++++.. ...+|+||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEecCCCC
Confidence 79999999999999999999999998643222 2223445679999999999999999887765 4468999999985
Q ss_pred HHHHHhhCCC-CCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccccc
Q 043957 211 DLARIISNPE-GKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV 283 (584)
Q Consensus 211 ~L~~~l~~~~-~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~g 283 (584)
+|...+.... ..+ ....||+.||+|||+.+|+||||||+|||++.++.++|+|||++..+.... ......|
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~ 156 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAG 156 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccCC
Confidence 6665554322 112 233599999999999999999999999999999999999999998764322 2234578
Q ss_pred cccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCc
Q 043957 284 TLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKP 363 (584)
Q Consensus 284 t~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 363 (584)
++.|+|||++.+.. ++.++|||||||++|+|++|++||...........+...... ..
T Consensus 157 ~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------------~~--------- 214 (277)
T cd05607 157 TNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE------------DE--------- 214 (277)
T ss_pred CCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc------------cc---------
Confidence 99999999997654 999999999999999999999999765432211111111000 00
Q ss_pred hhhhhccCCcHhHHHHHHHhcccCCCCCCCH----HHHhcCcCCCCC
Q 043957 364 RLFEAFSEFPESSLGLLSTLLALDPAYRGSA----ASALKNEFFFTS 406 (584)
Q Consensus 364 ~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa----~e~L~Hp~f~~~ 406 (584)
.......+++++.+||.+||++||.+|||+ ++++.||||...
T Consensus 215 -~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 215 -VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred -cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence 000113578899999999999999999999 778899999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=326.06 Aligned_cols=248 Identities=25% Similarity=0.390 Sum_probs=203.3
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
+|.+.+.||+|+||.||+|.+..+++.|++|.+............+.+|+.+++.++||||+++++++... ...|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK--GKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC--CEEEEEE
Confidence 48899999999999999999999999999999976555556677888999999999999999999887764 4689999
Q ss_pred echh-hHHHHHhhCC-CCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 206 EFMQ-TDLARIISNP-EGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 206 Ey~~-g~L~~~l~~~-~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||+. ++|...+... ...+. +..||+.||.|||+.+|+|+||||+||+++.++.++|+|||++..+..... .
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-~ 157 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-F 157 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-h
Confidence 9997 4777776542 22232 345999999999999999999999999999999999999999987653322 2
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 357 (584)
.....+++.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 219 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP----------------- 219 (256)
T ss_pred hhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-----------------
Confidence 2345788999999998764 5889999999999999999999999887765554444321100
Q ss_pred CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 358 p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
.....++..+.++|.+||+.+|++||++.++|+|||+
T Consensus 220 ---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 220 ---------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ---------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 0112467889999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=340.37 Aligned_cols=280 Identities=36% Similarity=0.552 Sum_probs=220.7
Q ss_pred CceEEeeecccCceEEEEEEECCC--CcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeee--cCcce
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDT--GKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATS--RMQYS 200 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~--g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~--~~~~~ 200 (584)
+|++.+.||+|+||.||++.+..+ +..||||++..........+.+.+|+.+++++ +||||++++++... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 489999999999999999999888 89999999865433333456678899999999 59999999886432 22345
Q ss_pred EEEEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 201 LYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 201 l~lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
+|++|||+.++|...+... ..+.+ ..||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~e~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELMEADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEecccCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 7999999998888887542 23333 3599999999999999999999999999999999999999998654322
Q ss_pred C---CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 275 K---RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 275 ~---~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
. .......||+.|+|||++.+...++.++|||||||++|+|++|.+||...+....+..++...+.+....+..+..
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 1 1123457899999999987655689999999999999999999999999998999999999888887766555432
Q ss_pred cCCC----CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 352 STTF----RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 352 ~~~~----~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.... .........+......++..+.+||.+||+.||.+|||+.++|.||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 1100 000011112233345668899999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=332.00 Aligned_cols=251 Identities=27% Similarity=0.447 Sum_probs=197.4
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecC----c
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRM----Q 198 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~----~ 198 (584)
.+.|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++++ +||||+++++++.... .
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 4569999999999999999999999999999999865432 235677899999998 6999999999886532 2
Q ss_pred ceEEEEEechhh-HHHHHhhCCC-CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccccc
Q 043957 199 YSLYLVFEFMQT-DLARIISNPE-GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 199 ~~l~lV~Ey~~g-~L~~~l~~~~-~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~ 270 (584)
..+|+||||+.+ +|..++.... ..+. +..||+.||+|||+++|+|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 468999999985 6777666422 2344 3359999999999999999999999999999999999999999865
Q ss_pred CCCCCCCCccccccccccChhhhhC----CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHH
Q 043957 271 SPNKKRPLTSRVVTLWYRAPELLLG----ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW 346 (584)
Q Consensus 271 ~~~~~~~~~~~~gt~~Y~APEvl~~----~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 346 (584)
.... .......|++.|+|||++.+ ...++.++|||||||++|+|++|.+||...........+... +
T Consensus 162 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~----- 232 (272)
T cd06637 162 DRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P----- 232 (272)
T ss_pred cccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---C-----
Confidence 4322 22345678999999999863 234788999999999999999999999765443332221100 0
Q ss_pred HHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 347 KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 347 ~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
. . ......++..+.+||.+||..||.+|||+.++|.||||
T Consensus 233 --------~---~------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 --------A---P------RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred --------C---C------CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0 0 00113467889999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=334.87 Aligned_cols=252 Identities=28% Similarity=0.418 Sum_probs=199.9
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE-PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
|++.+.||.|+||+||+|.+..+++.||+|.+...... ......+.+|+.+|+.++|+||+.+++++.. ...+|+||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~ 79 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEEEE
Confidence 78899999999999999999999999999998654322 2234557789999999999999999887766 34689999
Q ss_pred echhh-HHHHHhhCC-CCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 206 EFMQT-DLARIISNP-EGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 206 Ey~~g-~L~~~l~~~-~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||+.+ +|...+... ...+. ++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++....... .
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--~ 157 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--S 157 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--c
Confidence 99985 566555432 12233 33599999999999999999999999999999999999999997653221 2
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 357 (584)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.........
T Consensus 158 ~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~-------------- 222 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE-------------- 222 (285)
T ss_pred ccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc--------------
Confidence 245578999999999976 45899999999999999999999999887665444443222111110
Q ss_pred CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC-----HHHHhcCcCCCCC
Q 043957 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS-----AASALKNEFFFTS 406 (584)
Q Consensus 358 p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT-----a~e~L~Hp~f~~~ 406 (584)
.....++..+.+||.+||+.||++||| +.+++.|+||...
T Consensus 223 ---------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 223 ---------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred ---------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 112356788999999999999999999 8999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=332.33 Aligned_cols=251 Identities=28% Similarity=0.401 Sum_probs=199.5
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEe
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFE 206 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~E 206 (584)
|++.+.||.|+||.||++.+..++..+++|.+... .......+.+|+.+++.++||||+++++++... ...|+|||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~~v~e 82 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWILIE 82 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC--CEEEEEEE
Confidence 78899999999999999999999999999998533 334556788899999999999999999988764 46799999
Q ss_pred chhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCc
Q 043957 207 FMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLT 279 (584)
Q Consensus 207 y~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 279 (584)
|+.+ +|...+......+.+ ..||+.||.|||+.+|+||||||+|||++.++.+||+|||++....... ....
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 161 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 161 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence 9986 455555433333433 3599999999999999999999999999999999999999997653221 2234
Q ss_pred cccccccccChhhhhC----CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 280 SRVVTLWYRAPELLLG----ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 280 ~~~gt~~Y~APEvl~~----~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
...+++.|+|||++.. ...++.++|||||||++|+|++|++||...+....+..+.......
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 227 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-------------- 227 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC--------------
Confidence 4578999999999842 2347789999999999999999999998876655544442211000
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
......++..+.+||.+||+.||.+|||++++|+||||...
T Consensus 228 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 228 ----------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred ----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 00113467899999999999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=378.86 Aligned_cols=263 Identities=27% Similarity=0.379 Sum_probs=221.4
Q ss_pred CCCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecC-CCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc
Q 043957 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD-TSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 120 ~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~-~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 198 (584)
+....++|++++.||+|+||.|.+++++.+++.||+|++.+- .........|..|-.+|.--+.+=||.++ |.+.++
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lh--yAFQD~ 147 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLH--YAFQDE 147 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHH--HHhcCc
Confidence 456678999999999999999999999999999999999642 23344556788899999988999999995 444557
Q ss_pred ceEEEEEechh-hHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccC
Q 043957 199 YSLYLVFEFMQ-TDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS 271 (584)
Q Consensus 199 ~~l~lV~Ey~~-g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~ 271 (584)
.++|+|||||. |+|+.++.... .+++- ..|+.||.-||+.|+|||||||+|||||..|+|||+|||.|-.+.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 78999999998 57888887655 55543 389999999999999999999999999999999999999999887
Q ss_pred CCCCCCCccccccccccChhhhhC----CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHH
Q 043957 272 PNKKRPLTSRVVTLWYRAPELLLG----ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWK 347 (584)
Q Consensus 272 ~~~~~~~~~~~gt~~Y~APEvl~~----~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 347 (584)
.+........+|||.|++||+|.. ...|+..||+|||||++||||.|..||...+-.+.+.+|+.....+.
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~----- 301 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS----- 301 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC-----
Confidence 666666677899999999999962 24689999999999999999999999999999999999987621111
Q ss_pred HhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC---HHHHhcCcCCCCCCCc
Q 043957 348 KLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS---AASALKNEFFFTSPLA 409 (584)
Q Consensus 348 ~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT---a~e~L~Hp~f~~~~~~ 409 (584)
.|. ...+|+++++||.++|. +|..|.. ++++-.||||....|.
T Consensus 302 ---------FP~---------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 302 ---------FPD---------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWD 347 (1317)
T ss_pred ---------CCc---------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChh
Confidence 110 12479999999999875 7899998 9999999999887764
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=334.08 Aligned_cols=254 Identities=29% Similarity=0.432 Sum_probs=202.6
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.+.||.|+||.||++.+..++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ...+|+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFY--ENKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec--CCeEEE
Confidence 45699999999999999999999889999999998643 34455678899999999999999999998876 346899
Q ss_pred EEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
||||+.+ +|..++......+.+ +.||+.||.|||+++|+|+||||+||+++.++.++|+|||++....... .
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~ 158 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-Q 158 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc-c
Confidence 9999986 666666543333333 3599999999999999999999999999999999999999987654322 1
Q ss_pred CCccccccccccChhhhhC----CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 277 PLTSRVVTLWYRAPELLLG----ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~----~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
......+++.|+|||++.. ...++.++|||||||++|+|++|++||...+....+..+.....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------- 225 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP------------- 225 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCC-------------
Confidence 2234578999999999852 23477899999999999999999999987765544433322100
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
........++..+.+||.+||+.||.+|||+.++|+||||...
T Consensus 226 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 226 -----------PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred -----------CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 0001123467889999999999999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=333.74 Aligned_cols=253 Identities=31% Similarity=0.428 Sum_probs=199.2
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
+.|+++++||.|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++||||+++++++... ..+|+|
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 87 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD--GKLWIM 87 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC--CeEEEE
Confidence 5699999999999999999999999999999998643 344567788999999999999999999987763 468999
Q ss_pred EechhhH-HHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 205 FEFMQTD-LARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 205 ~Ey~~g~-L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
|||+.++ |...+......+.+ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++....... ..
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 166 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QR 166 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-cc
Confidence 9999964 54444433333333 3599999999999999999999999999999999999999987643221 12
Q ss_pred CccccccccccChhhhhC----CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 278 LTSRVVTLWYRAPELLLG----ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~----~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
.....+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+....+..+..... +
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~------------ 233 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-P------------ 233 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCC-c------------
Confidence 234567899999999852 23478899999999999999999999987665444333321100 0
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.......++.++.+||.+||..||++||+++++|+||||...
T Consensus 234 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 234 -----------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred -----------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 001123467889999999999999999999999999999753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=326.52 Aligned_cols=255 Identities=27% Similarity=0.451 Sum_probs=203.1
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++.+.||.|+||+||+|....++..||+|++....... ....+.+|+.+|+.++|+||+++++.+.. ....|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEE
Confidence 36999999999999999999998899999999986544333 56778999999999999999999887766 4468999
Q ss_pred Eechhh-HHHHHhhCCC--CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 205 FEFMQT-DLARIISNPE--GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~--~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
|||+.+ +|...+.... ..+. +..||+.||.|||+++|+|+||||+||++++++.++|+|||++..+.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999985 6666664321 2233 335999999999999999999999999999999999999999977654322
Q ss_pred C---CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 276 R---PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 276 ~---~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
. .....++++.|+|||++.....++.++|+|||||++|+|++|+.||...+....+..+.... .
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~---~---------- 224 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND---P---------- 224 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC---C----------
Confidence 1 12345689999999998765468999999999999999999999998766654444432210 0
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
..... ...+..+++.+.+||.+||..||.+|||++++|+||||
T Consensus 225 ------~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 225 ------PSLET--GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ------CCcCC--ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 00000 01134678899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=325.45 Aligned_cols=250 Identities=28% Similarity=0.487 Sum_probs=204.4
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
+|++.+.||.|+||.||+|.+..++..||+|.+..........+.+.+|+.+++.++||||+++++++.......+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 48999999999999999999999999999999976655666677888999999999999999999988766666789999
Q ss_pred echhh-HHHHHhhCC---CCCCc------HHHHHHHHHHHHH-----hCCceeccccccceeecCCCcEEEEEecccccc
Q 043957 206 EFMQT-DLARIISNP---EGKLT------EPQQLLSGLQHCH-----DRGILHRDVKGSNLLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 206 Ey~~g-~L~~~l~~~---~~~l~------~~~qIl~aL~yLH-----~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~ 270 (584)
||+.+ +|...+... ...+. ++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99984 666666432 23333 3459999999999 999999999999999999999999999999876
Q ss_pred CCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 271 SPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 271 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
..... ......+++.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.....
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------- 227 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF----------- 227 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC-----------
Confidence 54332 12345789999999998764 488999999999999999999999988764443333211100
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
......++..+.+||.+||+.||.+|||+.++|+|||+
T Consensus 228 ---------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 228 ---------------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ---------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 01113567899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=329.83 Aligned_cols=272 Identities=38% Similarity=0.683 Sum_probs=218.0
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceEEEEE
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
|++.+.||.|+||+||+|.+..+++.||||++....... ......+|+..+++++ ||||+++++++.. ....|+||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEE
Confidence 678899999999999999999899999999986543322 2233457999999999 9999999998877 44689999
Q ss_pred echhhHHHHHhhCCC-CCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 206 EFMQTDLARIISNPE-GKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 206 Ey~~g~L~~~l~~~~-~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
||+.++|.+.+.... ..+.+ ..||+.+|.|||+++|+|+||+|+||+++.++.++|+|||++....... ..
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~~ 155 (283)
T cd07830 78 EYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--PY 155 (283)
T ss_pred ecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC--Cc
Confidence 999888888776543 23333 3499999999999999999999999999999999999999998764322 23
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc---CCC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS---TTF 355 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~---~~~ 355 (584)
....++..|+|||++.+...++.++|||||||++|+|++|++||+.....+.+..+....+.+....|...... ...
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 44578899999999866556889999999999999999999999999999999999888888877666543211 111
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
..+..........+...+..+.+||.+||+.||.+|||+.|++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 111222222333444557899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=329.50 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=193.8
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHH-HHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMI-LQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~i-L~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|++.+.||+|+||.||+|.+..+|+.||||+++........ ..+..|+.+ ++.++||||+++++++... ..+|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~--~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFRE--GDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecC--CcEEE
Confidence 3699999999999999999999999999999999765443333 334456654 6667899999999988753 45899
Q ss_pred EEechhhHHHHHhhC---CCCCCcH------HHHHHHHHHHHHhC-CceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 204 VFEFMQTDLARIISN---PEGKLTE------PQQLLSGLQHCHDR-GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~---~~~~l~~------~~qIl~aL~yLH~~-~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
||||++++|...+.. ....+++ +.||+.||+|||++ +++||||||+|||++.++.+||+|||++..+...
T Consensus 78 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 78 CMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred EhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999887766543 2223333 35999999999997 9999999999999999999999999999876422
Q ss_pred CCCCCccccccccccChhhhhCC---CCCCceeeEecchHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCChHHHHHh
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGA---TDYGVGIDLWSAGCLLAEMFLGRPIMPGR-TEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~---~~~~~~sDIwSLGvilyeLltG~~pF~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
. ..+...++..|+|||++.+. ..++.++|||||||++|+|++|+.||... ...+.+..+.....
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------- 225 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS---------- 225 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC----------
Confidence 1 12335678999999988642 34788999999999999999999999643 22233322221100
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
... ....+|.++.+||.+||..||.+|||+.++|+||||...
T Consensus 226 -----~~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 226 -----PQL----------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred -----CCC----------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 000 012468899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=334.73 Aligned_cols=257 Identities=25% Similarity=0.341 Sum_probs=196.1
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++++.||+|+||.||+|.+..++..||||.+.... .......+.+|+.++++++||||+++++++... ...++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE--NRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC--CEEEEE
Confidence 35889999999999999999999999999999986543 333456788999999999999999999988774 457999
Q ss_pred EechhhHHHHHhhCCC--CCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCcccc
Q 043957 205 FEFMQTDLARIISNPE--GKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRV 282 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~~~--~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~ 282 (584)
|||+.++.+....... .......||+.||.|||+++|+|+||||+|||++.++.++|+|||++..+.... ....+
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~~~~~ 154 (279)
T cd06619 78 TEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---AKTYV 154 (279)
T ss_pred EecCCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---ccCCC
Confidence 9999975444332111 112344699999999999999999999999999999999999999998654322 24457
Q ss_pred ccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCC
Q 043957 283 VTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYK 362 (584)
Q Consensus 283 gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 362 (584)
+|..|+|||++.+ ..++.++|||||||++|+|++|..||........... .......+.... +..
T Consensus 155 ~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~--------~~~~~~~~~~~~----~~~-- 219 (279)
T cd06619 155 GTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM--------PLQLLQCIVDED----PPV-- 219 (279)
T ss_pred CChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc--------hHHHHHHHhccC----CCC--
Confidence 8999999999976 4589999999999999999999999965322110000 000000000000 000
Q ss_pred chhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 363 PRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 363 ~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.....+++++.+||.+||+.||.+||+++|+|+||||...
T Consensus 220 ----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 220 ----LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred ----CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 0113467889999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=325.21 Aligned_cols=248 Identities=27% Similarity=0.470 Sum_probs=202.5
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
+|++.+.||+|+||.||++.+..+|+.||+|.+............+.+|+.++++++||||+++++++.. ....|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE--NGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CCeEEEEE
Confidence 4899999999999999999999999999999997654444556678899999999999999999988765 44689999
Q ss_pred echhh-HHHHHhhCCC-CC------CcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 206 EFMQT-DLARIISNPE-GK------LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 206 Ey~~g-~L~~~l~~~~-~~------l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||+.+ +|...+.... .. +.+..||+.||.|||+++++|+||+|+|||++.++.++|+|||++..+..... .
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~ 157 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-L 157 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-h
Confidence 99974 6777665322 12 23445999999999999999999999999999999999999999987643221 1
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 357 (584)
.....|++.|+|||++.+. .++.++|||||||++|+|++|..||...+..+.+..+......
T Consensus 158 ~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~----------------- 219 (256)
T cd08218 158 ARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP----------------- 219 (256)
T ss_pred hhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC-----------------
Confidence 2334678899999998764 5889999999999999999999999877766655554322110
Q ss_pred CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 358 p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
.....++.++.++|.+||+.||.+||++.++|+||||
T Consensus 220 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 220 ---------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ---------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 0113467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=322.83 Aligned_cols=248 Identities=25% Similarity=0.416 Sum_probs=205.6
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
+|++++.||.|+||.||.+.+..++..+++|.+............+.+|+.++++++|+||+++++++.. ...+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEE
Confidence 5999999999999999999999999999999997665555666778899999999999999999998876 44689999
Q ss_pred echh-hHHHHHhhCC-CCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 206 EFMQ-TDLARIISNP-EGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 206 Ey~~-g~L~~~l~~~-~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
|||. ++|.+.+... ...++ +..|++.||.|||+.+|+|+||+|+||+++.++.+||+|||++........ .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~ 157 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M 157 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence 9998 4788777643 22333 235899999999999999999999999999999999999999987643321 2
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 357 (584)
.....+++.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+......
T Consensus 158 ~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~----------------- 219 (256)
T cd08221 158 AETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT----------------- 219 (256)
T ss_pred ccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-----------------
Confidence 3456789999999998764 4889999999999999999999999887766666555321110
Q ss_pred CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 358 p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
.....++..+.+||.+||..||.+|||+.++|+|||+
T Consensus 220 ---------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 220 ---------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ---------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 0113567889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=327.00 Aligned_cols=251 Identities=28% Similarity=0.476 Sum_probs=196.7
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE---PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~---~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
+|++.+.||+|+||.||+|.+..++..||+|++...... ......+.+|+.+++.++||||+++++++.......++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 589999999999999999999999999999998654322 23456788999999999999999999988765556789
Q ss_pred EEEechhh-HHHHHhhCCCCCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC-
Q 043957 203 LVFEFMQT-DLARIISNPEGKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK- 274 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~- 274 (584)
++|||+.+ +|...+.... .+ ....||+.||.|||+++|+|+||||+||+++.++.+||+|||++.......
T Consensus 83 l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999985 6776665322 22 234599999999999999999999999999999999999999997653211
Q ss_pred -CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 275 -KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 275 -~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
........++..|+|||++.+ ..++.++|||||||++|+|++|++||...........+......+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 228 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNP------------ 228 (266)
T ss_pred cCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCC------------
Confidence 111223457889999999876 458899999999999999999999997665443333221110000
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~ 404 (584)
.....+++.+.+|| +||..||++|||++|+|+||||.
T Consensus 229 -------------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 229 -------------QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred -------------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 11124577888898 57778999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=327.75 Aligned_cols=255 Identities=26% Similarity=0.455 Sum_probs=200.2
Q ss_pred CCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecC--
Q 043957 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRM-- 197 (584)
Q Consensus 121 ~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~-- 197 (584)
+...++|++.+.||.|+||.||+|.+..++..|++|++..... ....+.+|+.+++++ +|+||+++++++....
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 4566889999999999999999999998999999999864432 345688999999999 7999999999887643
Q ss_pred --cceEEEEEechhh-HHHHHhhCC---CCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEec
Q 043957 198 --QYSLYLVFEFMQT-DLARIISNP---EGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFG 265 (584)
Q Consensus 198 --~~~l~lV~Ey~~g-~L~~~l~~~---~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFG 265 (584)
...+|+||||+.+ +|.+++... ...+.+ ..||+.||.|||+++|+|+||+|+||+++.++.++|+|||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 4568999999995 565554321 233333 3599999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCccccccccccChhhhhCC----CCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 043957 266 LANYFSPNKKRPLTSRVVTLWYRAPELLLGA----TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSP 341 (584)
Q Consensus 266 la~~~~~~~~~~~~~~~gt~~Y~APEvl~~~----~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~ 341 (584)
++....... .......+++.|+|||++... ..++.++|||||||++|+|++|++||........+..+....
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--- 234 (275)
T cd06608 159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP--- 234 (275)
T ss_pred cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC---
Confidence 987654322 222445789999999988532 346789999999999999999999997655544443332110
Q ss_pred ChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 342 SEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 342 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
. + . ......++..+.+||.+||..||.+|||+.++|+|||+
T Consensus 235 ~---------------~-~-----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 235 P---------------P-T-----LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred C---------------C-C-----CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0 0 0 00112367889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=351.86 Aligned_cols=253 Identities=30% Similarity=0.474 Sum_probs=214.8
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
.....|.+.++||+|.|+.|.+|.+..++..||||.|.+...+......+.+|+++|..|+|||||+++.+... ...+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t--~~~l 130 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET--EATL 130 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee--ccee
Confidence 34556999999999999999999999999999999998877777666678999999999999999999988877 4458
Q ss_pred EEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 202 YLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 202 ~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
|+||||+. |.+.+.+... ++..+ +.|++.|++|||+++|||||||.+||||+.+..+||+|||++..+...
T Consensus 131 ylV~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~- 208 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG- 208 (596)
T ss_pred EEEEEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc-
Confidence 99999998 5677766542 33322 249999999999999999999999999999999999999999998743
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
..+.+.||++.|.|||++.+....++.+|+||||++||.|++|..||.+.+-.+.-.+.+.....
T Consensus 209 -~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r-------------- 273 (596)
T KOG0586|consen 209 -LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR-------------- 273 (596)
T ss_pred -ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeec--------------
Confidence 45688999999999999999887899999999999999999999999988765554443322111
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
..--++-++.+||+++|.++|.+|+++++++.|.|....
T Consensus 274 -------------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 274 -------------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred -------------ccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 112357788999999999999999999999999998654
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=332.52 Aligned_cols=253 Identities=26% Similarity=0.483 Sum_probs=202.3
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
..+|++.+.||.|+||.||+|.+..+++.||||.+...... ..+.+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 93 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLV--GDELFV 93 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEec--CceEEE
Confidence 35699999999999999999999999999999998654322 34667899999999999999999998876 446899
Q ss_pred EEechhh-HHHHHhhCCCC----CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 204 VFEFMQT-DLARIISNPEG----KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~----~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
||||+.+ +|...+..... ......||+.||.|||+++|+|+||||+||+++.++.+||+|||++........ ..
T Consensus 94 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 172 (296)
T cd06655 94 VMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR 172 (296)
T ss_pred EEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence 9999985 56665543211 112234899999999999999999999999999999999999999887643322 22
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p 358 (584)
....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+....+..+.... .+.
T Consensus 173 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~-~~~---------------- 234 (296)
T cd06655 173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPE---------------- 234 (296)
T ss_pred CCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-Ccc----------------
Confidence 34578899999999875 458899999999999999999999998877655544332210 000
Q ss_pred CCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 359 ~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
......+++.+.+||.+||..||.+|||+.++|+||||...
T Consensus 235 -------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 235 -------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred -------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 01123567889999999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=334.35 Aligned_cols=257 Identities=29% Similarity=0.392 Sum_probs=205.6
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP-HSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|++.+.||+|+||.||+|.+..+++.||||.+....... .....+.+|+++++.++||||+++++.+.. ....|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEEE
Confidence 36999999999999999999999999999999997654332 355678899999999999999999988765 446899
Q ss_pred EEechhh-HHHHHhhCC-CCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 204 VFEFMQT-DLARIISNP-EGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~-~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
||||+.+ +|.+++... ...+.+ +.||+.||.|||+.+|+|+||||+||||+.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 9999985 777776542 233332 35999999999999999999999999999999999999999876532211
Q ss_pred C----------------------------CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCCh
Q 043957 276 R----------------------------PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE 327 (584)
Q Consensus 276 ~----------------------------~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~ 327 (584)
. .....+||..|+|||++.+. .++.++|||||||++|+|++|..||.+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 0 11234688999999999764 589999999999999999999999988877
Q ss_pred HHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC----HHHHhcCcCC
Q 043957 328 VEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS----AASALKNEFF 403 (584)
Q Consensus 328 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT----a~e~L~Hp~f 403 (584)
...+..+....... .....+++.+.+||.+||+.||++||| ++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~ 292 (316)
T cd05574 238 DETFSNILKKEVTF-------------------------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292 (316)
T ss_pred HHHHHHHhcCCccC-------------------------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchh
Confidence 66655443211000 011226889999999999999999999 9999999999
Q ss_pred CCCCCc
Q 043957 404 FTSPLA 409 (584)
Q Consensus 404 ~~~~~~ 409 (584)
....++
T Consensus 293 ~~~~~~ 298 (316)
T cd05574 293 RGVNWA 298 (316)
T ss_pred hcCChh
Confidence 876544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=344.65 Aligned_cols=239 Identities=28% Similarity=0.435 Sum_probs=200.3
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEe
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFE 206 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~E 206 (584)
+++++.||+|-||.||.|.... ...||+|.++..... .+.+.+|+++|++|+|+|||++++++.... .+|||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--piyIVtE 281 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQE--PIYIVTE 281 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecCC--ceEEEEE
Confidence 5667889999999999997763 347999999754333 355779999999999999999999998754 5899999
Q ss_pred chh-hHHHHHhhCCC-CCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 207 FMQ-TDLARIISNPE-GKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 207 y~~-g~L~~~l~~~~-~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
||. |+|++.+.... ..+ .++.||+.|++||+++++|||||-..||||+++..+||+|||||+.+.++.....
T Consensus 282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~ 361 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS 361 (468)
T ss_pred ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence 999 78999988633 333 2345999999999999999999999999999999999999999997665554433
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 357 (584)
...--...|.|||.+.- ..++.+||||||||+||||+| |+.|+++.+..+.+..+.++...|..
T Consensus 362 ~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P-------------- 426 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP-------------- 426 (468)
T ss_pred CCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC--------------
Confidence 33344567999999975 459999999999999999998 89999999999999988776544432
Q ss_pred CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHh
Q 043957 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASAL 398 (584)
Q Consensus 358 p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L 398 (584)
..+|+.+.+++..|+..+|++|||.+.+.
T Consensus 427 ------------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 427 ------------EGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ------------CCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 46799999999999999999999998665
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=328.66 Aligned_cols=252 Identities=27% Similarity=0.442 Sum_probs=197.4
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeec----C
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSR----M 197 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~----~ 197 (584)
..+.|++.+.||.|+||.||+|.+..+++.||+|++... ......+..|+.+++++ +|+||+++++++... .
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 346799999999999999999999999999999998643 22345678899999998 699999999987542 2
Q ss_pred cceEEEEEechhh-HHHHHhhCCC-CCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccc
Q 043957 198 QYSLYLVFEFMQT-DLARIISNPE-GKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 198 ~~~l~lV~Ey~~g-~L~~~l~~~~-~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
...+|+||||+.+ +|..++.... ..+.+ ..||+.||.|||+.+|+|+||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 4568999999985 6777665322 22333 34999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCccccccccccChhhhhC----CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHH
Q 043957 270 FSPNKKRPLTSRVVTLWYRAPELLLG----ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDY 345 (584)
Q Consensus 270 ~~~~~~~~~~~~~gt~~Y~APEvl~~----~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~ 345 (584)
..... .......|++.|+|||++.. ...++.++|||||||++|+|++|.+||........+..+....
T Consensus 171 ~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~------- 242 (282)
T cd06636 171 LDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP------- 242 (282)
T ss_pred hhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC-------
Confidence 54222 12244578999999999853 2357889999999999999999999997665443332221100
Q ss_pred HHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 346 WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 346 ~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
+. ......++..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 243 ------------~~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 243 ------------PP------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ------------CC------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 00 00113568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=330.06 Aligned_cols=247 Identities=28% Similarity=0.445 Sum_probs=202.0
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|++.+.||+|+||.||++.+..+++.||+|++..... .....+.+.+|+++|++++||||+++++++.. ...+|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCeEEE
Confidence 369999999999999999999999999999999864322 23345678899999999999999999998876 446899
Q ss_pred EEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
||||+. ++|...+... ..+++ ..||+.||.|||+++|+|+||+|.||||+.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 79 VMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 999995 6777776543 33333 359999999999999999999999999999999999999999876533
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
.....+++.|+|||.+.+. .++.++|||||||++|+|++|..||...........+.....
T Consensus 155 -~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------- 215 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV----------------- 215 (290)
T ss_pred -CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc-----------------
Confidence 2345689999999998764 588999999999999999999999988775554444432110
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFTS 406 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~~ 406 (584)
.....++..+.++|.+||+.||.+|+ +++|+++||||...
T Consensus 216 ----------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 216 ----------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred ----------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence 01124578899999999999999999 99999999999754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=330.26 Aligned_cols=253 Identities=26% Similarity=0.453 Sum_probs=199.0
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++++.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.++++++||||+++++++.. ...+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEE
Confidence 36899999999999999999999999999999986542 33345678899999999999999999998776 4468999
Q ss_pred Eechhh-HHHHHhhCC--CCCCcH------HHHHHHHHHHHHh-CCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 205 FEFMQT-DLARIISNP--EGKLTE------PQQLLSGLQHCHD-RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~--~~~l~~------~~qIl~aL~yLH~-~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
|||+.+ +|..++... ...+.+ ..||+.||.|||+ .+|+|+||||+|||++.++.+||+|||++..+....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 999996 565555432 123333 3499999999996 599999999999999999999999999997653222
Q ss_pred CCCCccccccccccChhhhhCCC-----CCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 275 KRPLTSRVVTLWYRAPELLLGAT-----DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~-----~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
.....+++.|+|||++.+.. .++.++|||||||++|+|++|+.||...........+........
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 227 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------- 227 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC-------
Confidence 23456888999999985432 357899999999999999999999976654443333222111100
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
......+++++.+||.+||+.||.+||++.++++||||...
T Consensus 228 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 228 ----------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred ----------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 01123468899999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=325.12 Aligned_cols=248 Identities=31% Similarity=0.561 Sum_probs=196.5
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCCh-------HHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP-------HSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 198 (584)
+|.+...||.|+||.||+|.+..++..||+|.+....... ...+.+.+|+.++++++||||+++++++...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-- 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--
Confidence 3778889999999999999999899999999986543221 2345688999999999999999999987663
Q ss_pred ceEEEEEechhh-HHHHHhhCCCCCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccC
Q 043957 199 YSLYLVFEFMQT-DLARIISNPEGKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS 271 (584)
Q Consensus 199 ~~l~lV~Ey~~g-~L~~~l~~~~~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~ 271 (584)
...++||||+.+ +|...+... ..+ ....||+.||+|||+++|+||||+|+|||++.++.++|+|||++..+.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 467999999985 666666432 222 234599999999999999999999999999999999999999998765
Q ss_pred CCCC-----CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHH
Q 043957 272 PNKK-----RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW 346 (584)
Q Consensus 272 ~~~~-----~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 346 (584)
.... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------- 229 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS------- 229 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC-------
Confidence 2211 11123457889999999876 4588999999999999999999999987665444333222100
Q ss_pred HHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 347 KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 347 ~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
......++..+.+||.+||+.||.+||++.|+|+||||
T Consensus 230 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 230 -------------------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred -------------------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 01123468899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=332.39 Aligned_cols=269 Identities=28% Similarity=0.425 Sum_probs=199.6
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
+|++.+.||+|+||.||++.+..++..||+|.+.... .......+.+|++++++++||||+++++++.. ...+|+||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 78 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEISICM 78 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEEEEe
Confidence 6999999999999999999999999999999986442 33445668899999999999999999998876 44689999
Q ss_pred echhh-HHHHHhhCCCCCC------cHHHHHHHHHHHHHh-CCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 206 EFMQT-DLARIISNPEGKL------TEPQQLLSGLQHCHD-RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 206 Ey~~g-~L~~~l~~~~~~l------~~~~qIl~aL~yLH~-~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||+.+ +|..++... ..+ .+..||+.||.|||+ .+|+|+||||+|||++.++.+||+|||++.......
T Consensus 79 ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 79 EHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred eccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 99985 677776542 233 334599999999997 699999999999999999999999999987653221
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChH--HHHHhhccCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSED--YWKKLRLSTTF 355 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~~~ 355 (584)
....++++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.... ..++......... ....... ...
T Consensus 155 ~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~ 231 (308)
T cd06615 155 ANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEAKESHRPVSG-HPP 231 (308)
T ss_pred cccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccccCCcccccC-CCC
Confidence 244578999999999876 4588999999999999999999999987653332 2222211100000 0000000 000
Q ss_pred CCCC-------------CCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 356 RPPQ-------------SYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 356 ~~p~-------------~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
..+. ...+. .....++.++.+||.+||..||++|||+.|+|+||||...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPK--LPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CccchhhHHHHHHHHhcCCCcc--CcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 0000 00000 0011367889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=327.83 Aligned_cols=250 Identities=28% Similarity=0.472 Sum_probs=195.2
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|.+.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--~~~~~lv 84 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLR--RDKLWIC 84 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEEE
Confidence 468899999999999999999999999999999875432 234567889999999999999999988766 3468999
Q ss_pred Eechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 205 FEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
|||+++ +|.+++... ..+.+ ..||+.||.|||++||+|+||||+|||++.++.++|+|||++....... ..
T Consensus 85 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06645 85 MEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK 162 (267)
T ss_pred EeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence 999985 677766432 23333 3599999999999999999999999999999999999999987654221 22
Q ss_pred CccccccccccChhhhh--CCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 278 LTSRVVTLWYRAPELLL--GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~--~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
.....|++.|+|||++. ....++.++|||||||++|+|++|.+||........+..+......+
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~-------------- 228 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP-------------- 228 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCC--------------
Confidence 24457899999999874 22347889999999999999999999987655433322221110000
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~ 402 (584)
. .......++..+.+||.+||+.||++|||++++|+|||
T Consensus 229 ---~-----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 229 ---P-----KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ---C-----cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 0 00111246788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=325.43 Aligned_cols=279 Identities=34% Similarity=0.541 Sum_probs=228.1
Q ss_pred eEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc---ceEEEE
Q 043957 128 DKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ---YSLYLV 204 (584)
Q Consensus 128 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~---~~l~lV 204 (584)
+-.+.||-|+||+||.+.|..+|+.||+|++......-...+.+.+|+.+|.-++|.|++..+++.....- ..+|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34467999999999999999999999999986544445566788899999999999999998876543221 247899
Q ss_pred EechhhHHHHHhhCCCCC----C-cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCc
Q 043957 205 FEFMQTDLARIISNPEGK----L-TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLT 279 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~~~~~----l-~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 279 (584)
.|+|..+|..+|..+... + -...||++||.|||+.+|+||||||.|+|++.+..+||||||+|+..+.++...++
T Consensus 136 TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMT 215 (449)
T KOG0664|consen 136 TELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMT 215 (449)
T ss_pred HHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhH
Confidence 999999999998765432 1 22359999999999999999999999999999999999999999998888888888
Q ss_pred cccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc-------c
Q 043957 280 SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL-------S 352 (584)
Q Consensus 280 ~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-------~ 352 (584)
..+.|.+|+|||+++|...|+.++||||+|||+.|||..+-.|...+..++++.|.+.+++|..+..+.-.. .
T Consensus 216 qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR 295 (449)
T KOG0664|consen 216 HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLR 295 (449)
T ss_pred HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhc
Confidence 889999999999999999999999999999999999999999999999999999999999999765543221 1
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
...+.|....-........-..++.+++..||.+||.+|++.+++|.|+|+-+.
T Consensus 296 ~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 296 AGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred cCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 122222211100011112334577899999999999999999999999998654
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=330.85 Aligned_cols=254 Identities=26% Similarity=0.491 Sum_probs=201.9
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
...+|++.+.||+|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.++||||+++++.+.. ....|
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~ 93 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELW 93 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCEEE
Confidence 346799999999999999999999999999999998754333 34668899999999999999999998876 34689
Q ss_pred EEEechhh-HHHHHhhCCCC----CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 203 LVFEFMQT-DLARIISNPEG----KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~~----~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
+||||+.+ +|..++..... ...++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||++........ .
T Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~ 172 (296)
T cd06654 94 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (296)
T ss_pred EeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence 99999985 67776653211 123345999999999999999999999999999999999999999876543321 2
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 357 (584)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|++||........+..+... ..+.
T Consensus 173 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~--------------- 235 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPE--------------- 235 (296)
T ss_pred cCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCC---------------
Confidence 234578999999999876 45889999999999999999999999877654433222110 0000
Q ss_pred CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 358 p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
......++..+.+||.+||..||++|||+.++|+||||...
T Consensus 236 --------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 236 --------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred --------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 01123467889999999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=326.87 Aligned_cols=250 Identities=30% Similarity=0.494 Sum_probs=194.4
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++++++||||+++++++... ..+|+|
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~--~~~~iv 84 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSR--EKLWIC 84 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--CEEEEE
Confidence 469999999999999999999999999999999864432 2345678899999999999999999888764 467999
Q ss_pred Eechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 205 FEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
|||+.+ +|.+.+... ..+.+ ..||+.||.|||+.+|+||||||+|||++.++.+||+|||++..+..... .
T Consensus 85 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06646 85 MEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K 162 (267)
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence 999985 676666532 23332 35999999999999999999999999999999999999999987643221 1
Q ss_pred CccccccccccChhhhhC--CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 278 LTSRVVTLWYRAPELLLG--ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~--~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
.....+++.|+|||++.. ...++.++|||||||++|+|++|++||...........+... .+
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~----------------~~ 226 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS----------------NF 226 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC----------------CC
Confidence 234568899999998852 234788999999999999999999998654432221111000 00
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~ 402 (584)
..+ .......++..+.+||.+||..||++|||++++|+|+|
T Consensus 227 ~~~------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 227 QPP------KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CCC------CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 000 00112356789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=326.53 Aligned_cols=255 Identities=29% Similarity=0.443 Sum_probs=198.6
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecC---
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRM--- 197 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~--- 197 (584)
...++|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++++ +||||+++++++....
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 45678999999999999999999999999999999985432 2235677899999999 7999999999886533
Q ss_pred cceEEEEEechhh-HHHHHhhC---CCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccc
Q 043957 198 QYSLYLVFEFMQT-DLARIISN---PEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA 267 (584)
Q Consensus 198 ~~~l~lV~Ey~~g-~L~~~l~~---~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla 267 (584)
...+|+||||+.+ +|.+++.. ....+.+ ..||+.||.|||+.+|+|+||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 2468999999985 66665532 2223333 359999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCccccccccccChhhhhCCC----CCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 043957 268 NYFSPNKKRPLTSRVVTLWYRAPELLLGAT----DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSE 343 (584)
Q Consensus 268 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~----~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~ 343 (584)
......... .....++..|+|||++.... .++.++|||||||++|+|++|++||........+..+.... ..
T Consensus 176 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~---~~ 251 (291)
T cd06639 176 AQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP---PP 251 (291)
T ss_pred hhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC---CC
Confidence 875432211 23356889999999985432 36789999999999999999999998776554444332110 00
Q ss_pred HHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCC
Q 043957 344 DYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404 (584)
Q Consensus 344 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~ 404 (584)
. ......++..+.+||.+||+.||++|||+.|+|+||||+
T Consensus 252 ---------------~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 252 ---------------T------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ---------------C------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 0 001123567899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=326.13 Aligned_cols=250 Identities=28% Similarity=0.473 Sum_probs=201.4
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++.+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++|+||+++++++... ..+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEEEE
Confidence 36889999999999999999999999999999987543 233456688999999999999999999887764 568999
Q ss_pred Eechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 205 FEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
+||+.+ +|.+.+... .+.+ ..||+.||.|||+++|+|+||+|+||+++.++.++|+|||++..+.... ..
T Consensus 78 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 154 (274)
T cd06609 78 MEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SK 154 (274)
T ss_pred EEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-cc
Confidence 999985 677776643 3332 3599999999999999999999999999999999999999998775432 12
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 357 (584)
.....+++.|+|||++.+. .++.++|||||||++|+|++|.+||...+.......+....
T Consensus 155 ~~~~~~~~~y~~PE~~~~~-~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~------------------- 214 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQS-GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN------------------- 214 (274)
T ss_pred cccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC-------------------
Confidence 3445788999999999764 48999999999999999999999997765444333222110
Q ss_pred CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 358 p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.+... ...++..+.++|.+||..||.+|||++++|+||||...
T Consensus 215 ----~~~~~--~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 215 ----PPSLE--GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred ----CCCCc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 00000 01267889999999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=326.31 Aligned_cols=257 Identities=27% Similarity=0.469 Sum_probs=198.3
Q ss_pred cCCCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeee--
Q 043957 119 LVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATS-- 195 (584)
Q Consensus 119 ~~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~-- 195 (584)
..+...++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 34566788999999999999999999999999999999875321 1234577899999999 69999999998753
Q ss_pred -cCcceEEEEEechhh-HHHHHhh---CCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEe
Q 043957 196 -RMQYSLYLVFEFMQT-DLARIIS---NPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADF 264 (584)
Q Consensus 196 -~~~~~l~lV~Ey~~g-~L~~~l~---~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DF 264 (584)
.....+|+||||+++ +|.+++. .....+. ...||+.||.|||+++|+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccC
Confidence 234568999999985 5665543 1223343 3459999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCccccccccccChhhhhC----CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 043957 265 GLANYFSPNKKRPLTSRVVTLWYRAPELLLG----ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGS 340 (584)
Q Consensus 265 Gla~~~~~~~~~~~~~~~gt~~Y~APEvl~~----~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~ 340 (584)
|++..+..... ......|++.|+|||++.. ...++.++|||||||++|+|++|++||........+..+...
T Consensus 169 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--- 244 (286)
T cd06638 169 GVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--- 244 (286)
T ss_pred CceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc---
Confidence 99987643221 2234578999999998753 134788999999999999999999999776544333221110
Q ss_pred CChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 341 PSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 341 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
. .+.. .....++..+.+||.+||+.||.+|||+.|+|+|+||
T Consensus 245 ~---------------~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 245 P---------------PPTL------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred C---------------CCcc------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0 0000 0112356789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=322.72 Aligned_cols=252 Identities=27% Similarity=0.464 Sum_probs=198.4
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS---EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
.+|++.+.||+|+||.||++.+..++..||||++..... .....+.+.+|+.++++++||||+++++++.......+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 469999999999999999999999999999999864422 22345678899999999999999999998776555678
Q ss_pred EEEEechhh-HHHHHhhCCCC-----CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 202 YLVFEFMQT-DLARIISNPEG-----KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~-----~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
|+||||+.+ +|.+.+..... .+.++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 999999984 67776653221 123345999999999999999999999999999999999999999976532111
Q ss_pred --CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 276 --RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 276 --~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
.......++..|+|||++.+ ..++.++|||||||++|+|++|++||........+..+.. .+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~---------- 227 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPTN---------- 227 (265)
T ss_pred cccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCCC----------
Confidence 11233568899999999876 4589999999999999999999999976654443332211 1100
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
......++..+.++|.+||. +|++|||++|+|+|||+
T Consensus 228 ------------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 228 ------------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV 264 (265)
T ss_pred ------------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence 00113457788999999995 99999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=322.43 Aligned_cols=247 Identities=30% Similarity=0.502 Sum_probs=198.8
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++.+.||.|+||.||+|.+..++..||+|.+.... ..+.+.+|+.++++++||||+++++++... ..+|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKN--TDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CcEEEE
Confidence 56999999999999999999999889999999986432 257788999999999999999999988764 468999
Q ss_pred Eechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 205 FEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
|||+.+ +|.+.+......++ +..||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++........ .
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 999995 67776654333333 335999999999999999999999999999999999999999987653321 2
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 357 (584)
.....++..|+|||++.+. .++.++|||||||++|+|++|++||...........+... .
T Consensus 156 ~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~---------------- 215 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---P---------------- 215 (256)
T ss_pred cccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---C----------------
Confidence 2345678899999998764 5899999999999999999999999876554332221110 0
Q ss_pred CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 358 p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
.........++..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 216 -----~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 216 -----PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred -----CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 00011123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=332.14 Aligned_cols=254 Identities=26% Similarity=0.484 Sum_probs=200.7
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
..+|++.+.||.|+||.||+|.+..++..||||.+...... ..+.+.+|+.+++.++||||+++++++.. ....|+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l 93 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 93 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEE
Confidence 46799999999999999999999999999999999654332 34567889999999999999999998876 346899
Q ss_pred EEechhh-HHHHHhhCCCC----CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 204 VFEFMQT-DLARIISNPEG----KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~----~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
||||+.+ +|...+..... ......|++.||.|||+.+|+||||||+|||++.++.++|+|||++........ ..
T Consensus 94 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~ 172 (297)
T cd06656 94 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 172 (297)
T ss_pred eecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-Cc
Confidence 9999985 66666643221 122345899999999999999999999999999999999999999976543322 22
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p 358 (584)
....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+....+..+... +.+.
T Consensus 173 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-~~~~---------------- 234 (297)
T cd06656 173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE---------------- 234 (297)
T ss_pred CcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-CCCC----------------
Confidence 34578899999999876 45889999999999999999999999776543322211100 0000
Q ss_pred CCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 359 ~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
......++..+.+||.+||..||++|||++++|+||||....
T Consensus 235 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 235 -------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred -------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 011234678889999999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=328.87 Aligned_cols=237 Identities=20% Similarity=0.231 Sum_probs=190.2
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHhCCCCCeeeeeceeee--cCcceEEEEEec
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP-HSVKFMAREIMILQKLDHPNIVKLEGLATS--RMQYSLYLVFEF 207 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~~~~l~lV~Ey 207 (584)
..||+|+++.||+|.. +|+.||||.+....... ...+.+.+|+.+|++++|||||++++++.+ .....+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5689999999999976 68999999996543322 335678899999999999999999998876 444568999999
Q ss_pred hhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHh-CCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCc
Q 043957 208 MQT-DLARIISNPEGKLT------EPQQLLSGLQHCHD-RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLT 279 (584)
Q Consensus 208 ~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~-~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 279 (584)
|.+ +|.+.+... ..+. ++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++..+.... .
T Consensus 104 ~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----~ 178 (283)
T PHA02988 104 CTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----F 178 (283)
T ss_pred CCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----c
Confidence 995 677776543 2333 34599999999998 499999999999999999999999999998654321 3
Q ss_pred cccccccccChhhhhCC-CCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCC
Q 043957 280 SRVVTLWYRAPELLLGA-TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358 (584)
Q Consensus 280 ~~~gt~~Y~APEvl~~~-~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p 358 (584)
..++++.|+|||++.+. ..++.++|||||||++|||++|..||...+..+.+..+......+.
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~---------------- 242 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK---------------- 242 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC----------------
Confidence 45788999999998652 4589999999999999999999999998876666555533211111
Q ss_pred CCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 359 ~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
....+++.+.+||.+||+.||.+|||+.|+|+
T Consensus 243 ---------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 243 ---------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred ---------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 01246789999999999999999999999986
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=320.42 Aligned_cols=251 Identities=30% Similarity=0.494 Sum_probs=199.5
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++.+.||.|+||.||+|.+..++..+|+|++...... ..+.+.+|+.++++++||||+++++++.. ...+|++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLR--RDKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEe--CCEEEEE
Confidence 5799999999999999999999999999999999754332 45778899999999999999999988776 4468999
Q ss_pred Eechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 205 FEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
|||+.+ .|..++......+.+ ..||+.||.|||+++|+|+||||+||+++.++.+||+|||++..+..... .
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 157 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K 157 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence 999996 566655543234433 34999999999999999999999999999999999999999987643221 1
Q ss_pred CccccccccccChhhhhCC--CCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 278 LTSRVVTLWYRAPELLLGA--TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~--~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
.....++..|+|||++.+. ..++.++|||||||++|+|++|.+||...+.......+......+.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~------------- 224 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP------------- 224 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc-------------
Confidence 2345788899999998653 2578899999999999999999999987765554433321100000
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~ 402 (584)
.......++.++.+||.+||..||..|||+.++|.|+|
T Consensus 225 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 225 ---------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ---------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 00011245678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=322.45 Aligned_cols=249 Identities=29% Similarity=0.506 Sum_probs=195.8
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC----hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE----PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
+|++.+.||.|+||.||+|.+. ++..+|+|.+...... ......+.+|+.+|++++|+||+++++++... ..+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeE
Confidence 4888999999999999999864 7889999998654321 23345688999999999999999999988764 568
Q ss_pred EEEEechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC-
Q 043957 202 YLVFEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN- 273 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~- 273 (584)
|+||||+.+ +|.+.+... ..+. ...||+.||+|||+.+|+|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 78 SIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 999999985 677766542 2232 2359999999999999999999999999999999999999998764311
Q ss_pred ----CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 274 ----KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 274 ----~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
.........++..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 227 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM-------- 227 (265)
T ss_pred ccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC--------
Confidence 1112234568999999999876 458899999999999999999999998765544332222110000
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
......++..+.+||.+||+.||.+|||+.++|+||||
T Consensus 228 ----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 228 ----------------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 01123568899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=317.26 Aligned_cols=252 Identities=25% Similarity=0.422 Sum_probs=201.2
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
+.+.+..||.|+.|+||+++.+.+|...|||.+... .+.+..+.+...+.++... ++|+||+.+|+|.... .++|.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~--dV~Ic 169 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT--DVFIC 169 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc--hHHHH
Confidence 345667799999999999999999999999999644 4445566777778877666 4999999999998744 47999
Q ss_pred EechhhHHHHHhhCCCCCCcHH------HHHHHHHHHHHh-CCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 205 FEFMQTDLARIISNPEGKLTEP------QQLLSGLQHCHD-RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~-~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||.|..-+..++..-...+.+. ..++.||.||.+ ++|+|||+||+|||+|+.|+|||||||++..+-+.. .
T Consensus 170 MelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--A 247 (391)
T KOG0983|consen 170 MELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--A 247 (391)
T ss_pred HHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc--c
Confidence 9999865555544333444443 278899999995 689999999999999999999999999998775332 3
Q ss_pred CccccccccccChhhhhC--CCCCCceeeEecchHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 278 LTSRVVTLWYRAPELLLG--ATDYGVGIDLWSAGCLLAEMFLGRPIMPGR-TEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~--~~~~~~~sDIwSLGvilyeLltG~~pF~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.+...|.+.|||||.+.- ...|+..+||||||++++||.||+.||.+. ++.+.+..|++. .|+
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--ePP------------ 313 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--EPP------------ 313 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--CCC------------
Confidence 456688999999999863 246899999999999999999999999874 567777777552 111
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
. ...-..+++.+.+|+..||++|+.+||.-.++|+|||+..-
T Consensus 314 -----~-----L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 314 -----L-----LPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred -----C-----CCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 0 01112479999999999999999999999999999998653
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=329.29 Aligned_cols=250 Identities=27% Similarity=0.461 Sum_probs=201.4
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
..|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++... ...|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~--~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE--HTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC--CeEEE
Confidence 46999999999999999999999999999999986443 2334456788999999999999999999988764 35799
Q ss_pred EEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 204 VFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||||+.+++...+......+.+ ..||+.||.|||+++|+|+||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---- 168 (307)
T cd06607 93 VMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---- 168 (307)
T ss_pred EHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence 9999999887776543333333 359999999999999999999999999999999999999999765422
Q ss_pred CccccccccccChhhhhC--CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 278 LTSRVVTLWYRAPELLLG--ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~--~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
....+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+.......+... .+
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~-------------- 231 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS-------------- 231 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CC--------------
Confidence 34567889999998752 245889999999999999999999999877655443332110 00
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
+. . ....++..+.+||.+||..||.+|||+.+++.||||...
T Consensus 232 --~~-~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 232 --PT-L------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred --CC-C------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 00 0 012357889999999999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=338.27 Aligned_cols=263 Identities=30% Similarity=0.427 Sum_probs=210.4
Q ss_pred ccCCCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec
Q 043957 118 GLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSR 196 (584)
Q Consensus 118 ~~~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 196 (584)
...|...+.|+..+.||+|+||.||-|+-+.||+.||+|++.+... .........+|-.||.+++.+.||.+ .|..+
T Consensus 178 E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVsl--aYAfe 255 (591)
T KOG0986|consen 178 ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSL--AYAFE 255 (591)
T ss_pred HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEE--eeeec
Confidence 4467888899999999999999999999999999999999854422 22334556789999999999999999 45555
Q ss_pred CcceEEEEEechhh-HHHHHhhCCC-CCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccc
Q 043957 197 MQYSLYLVFEFMQT-DLARIISNPE-GKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLAN 268 (584)
Q Consensus 197 ~~~~l~lV~Ey~~g-~L~~~l~~~~-~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~ 268 (584)
....+++||..|.| +|...|.+-. ..+.+. .+|+.||++||+.+||+|||||+|||+|+.|+|+|+|+|||.
T Consensus 256 Tkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 256 TKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAV 335 (591)
T ss_pred CCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEE
Confidence 56679999999995 5655554322 244443 499999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHH
Q 043957 269 YFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK 348 (584)
Q Consensus 269 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 348 (584)
.+... .+....+||.+|||||++.+.. |+...|.|||||+||||+.|+.||....+....+.+-.....-+
T Consensus 336 ei~~g--~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~------ 406 (591)
T KOG0986|consen 336 EIPEG--KPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP------ 406 (591)
T ss_pred ecCCC--CccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch------
Confidence 88644 4567789999999999998765 99999999999999999999999976654333222211111111
Q ss_pred hhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC-----HHHHhcCcCCCCCCC
Q 043957 349 LRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS-----AASALKNEFFFTSPL 408 (584)
Q Consensus 349 ~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT-----a~e~L~Hp~f~~~~~ 408 (584)
.+....+++++++|...+|++||.+|.. ++++-+||||+...+
T Consensus 407 -----------------~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 407 -----------------EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred -----------------hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 1222568999999999999999999964 579999999987544
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=317.04 Aligned_cols=247 Identities=27% Similarity=0.400 Sum_probs=200.6
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
+|++.+.||+|+||.||+|.+..++..||||.+............+.+|+.+|+.++||||+++++.+.. ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEEE
Confidence 4899999999999999999999999999999997665555567788999999999999999999987765 44689999
Q ss_pred echhh-HHHHHhhCCCC-CCc------HHHHHHHHHHHHHhCCceeccccccceeecCC-CcEEEEEeccccccCCCCCC
Q 043957 206 EFMQT-DLARIISNPEG-KLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKN-GVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 206 Ey~~g-~L~~~l~~~~~-~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~-g~vKL~DFGla~~~~~~~~~ 276 (584)
||+.+ +|.+.+..... .+. +..||+.||.|||+++|+|+||||+||+++.+ +.+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-- 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-- 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--
Confidence 99985 67777654221 232 23599999999999999999999999999865 468999999998764332
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~---------------- 219 (256)
T cd08220 157 KAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA---------------- 219 (256)
T ss_pred cccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC----------------
Confidence 2234568899999999876 45889999999999999999999999887665554444321100
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
.....++..+.+||.+||..||.+|||+.|+|+||||
T Consensus 220 ----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 220 ----------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ----------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 0113467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=318.85 Aligned_cols=252 Identities=31% Similarity=0.531 Sum_probs=198.5
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
+|.+.+.||+|+||.||+|.+..++..||+|.+..........+.+.+|+.+++.++|+||+++++++.. ...+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH--REKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec--CCEEEEEE
Confidence 5899999999999999999999899999999997665555577889999999999999999999987665 44689999
Q ss_pred echhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC-
Q 043957 206 EFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP- 277 (584)
Q Consensus 206 Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~- 277 (584)
||+.+ +|.+.+... ..+. +..||+.||.|||+.+|+|+||+|+||+++.++.+||+|||++..........
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 79 EYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred ecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 99984 677766542 2222 23599999999999999999999999999999999999999998765333211
Q ss_pred --CccccccccccChhhhhCCC--CCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 278 --LTSRVVTLWYRAPELLLGAT--DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 278 --~~~~~gt~~Y~APEvl~~~~--~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
.....+++.|+|||++.+.. .++.++|||||||++|+|++|+.||..................+
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 225 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP------------ 225 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCC------------
Confidence 11356788999999987532 37889999999999999999999997653322221111110000
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
. ......++..+.+||.+||+.||.+|||+.+++.|||+
T Consensus 226 --~---------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 226 --P---------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred --C---------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 01113457888999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=322.70 Aligned_cols=245 Identities=19% Similarity=0.264 Sum_probs=192.0
Q ss_pred CCceEEeeecccCceEEEEEEEC---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDR---DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
.+|++.+.||+|+||.||+|.+. ..+..||+|.++... .......+.+|+.++++++||||+++++++... ..+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 81 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG--NTM 81 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC--CCc
Confidence 46999999999999999999765 456789999986542 233456788999999999999999999988763 458
Q ss_pred EEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 202 YLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
||||||+.+ +|.+++......+.+ +.||+.||+|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 999999985 566666554344443 3499999999999999999999999999999999999999876543221
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
........++..|+|||++.+ ..++.++|||||||++|||++ |.+||......+.+..+......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~------------- 227 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL------------- 227 (266)
T ss_pred hhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC-------------
Confidence 111112344678999999876 458999999999999999775 99999888776655554321110
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....++..+.++|.+||+.||.+|||++++++
T Consensus 228 -------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 228 -------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 012346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=328.03 Aligned_cols=256 Identities=27% Similarity=0.368 Sum_probs=201.0
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
+|++.+.||+|+||.||++.+..+++.||||.+..... .......+.+|+.+++.++||||+++++.+.. ...+|+|
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 79 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCMV 79 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEEE
Confidence 69999999999999999999999999999999865432 22345677899999999999999999987765 4468999
Q ss_pred Eechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC--
Q 043957 205 FEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK-- 275 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-- 275 (584)
|||+.| +|...+... ..+.+ ..||+.||.|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 80 MEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999985 676666542 23322 34899999999999999999999999999999999999999864211100
Q ss_pred ------------CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 043957 276 ------------RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSE 343 (584)
Q Consensus 276 ------------~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~ 343 (584)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~- 236 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP- 236 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC-
Confidence 00112457889999999876 4589999999999999999999999988776655554433211000
Q ss_pred HHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC---HHHHhcCcCCCCCCCc
Q 043957 344 DYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS---AASALKNEFFFTSPLA 409 (584)
Q Consensus 344 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT---a~e~L~Hp~f~~~~~~ 409 (584)
.....++.++.+||.+||+.||.+||| +.++|+||||.....+
T Consensus 237 -----------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~ 282 (305)
T cd05609 237 -----------------------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN 282 (305)
T ss_pred -----------------------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHH
Confidence 001246888999999999999999998 7999999999765443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=353.69 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=197.7
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeec-eeee---cC
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEG-LATS---RM 197 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~-~~~~---~~ 197 (584)
...+++|.+.|.+|||+.||+|.+...|..||+|++... +....+.+.+||++|++|. |+|||.+++ .+.. ..
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 344689999999999999999999988899999998644 6678889999999999997 999999998 3322 22
Q ss_pred -cceEEEEEechh-hHHHHHhhC-------CCCCCcHHHHHHHHHHHHHhCC--ceeccccccceeecCCCcEEEEEecc
Q 043957 198 -QYSLYLVFEFMQ-TDLARIISN-------PEGKLTEPQQLLSGLQHCHDRG--ILHRDVKGSNLLIDKNGVLKIADFGL 266 (584)
Q Consensus 198 -~~~l~lV~Ey~~-g~L~~~l~~-------~~~~l~~~~qIl~aL~yLH~~~--IvHrDLKp~NILl~~~g~vKL~DFGl 266 (584)
.+.++|+||||. |+|.+++.. ....+.++.++++||++||... |||||||-|||||+.+|.+||||||.
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 356899999999 688887752 1223445569999999999987 99999999999999999999999999
Q ss_pred ccccCCCCCCC--------CccccccccccChhhhh--CCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 043957 267 ANYFSPNKKRP--------LTSRVVTLWYRAPELLL--GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFK 336 (584)
Q Consensus 267 a~~~~~~~~~~--------~~~~~gt~~Y~APEvl~--~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~ 336 (584)
|+..-...... -....-|+.|+|||++. .....++|+|||+|||+||-|+....||....... |+.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----Iln 268 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----ILN 268 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----EEe
Confidence 97532221100 01224599999999974 33468999999999999999999999997654332 222
Q ss_pred hcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 337 LCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
....++ .++.++..+++||..||+.||.+||++.|++.+-+.
T Consensus 269 g~Y~~P-------------------------~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 269 GNYSFP-------------------------PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred ccccCC-------------------------CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 222221 125678999999999999999999999999987554
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=321.67 Aligned_cols=254 Identities=30% Similarity=0.531 Sum_probs=196.4
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC--------hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE--------PHSVKFMAREIMILQKLDHPNIVKLEGLATSRM 197 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 197 (584)
+|.+.+.||.|+||.||+|.+..+|+.||||.+...... ....+.+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE- 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence 488999999999999999999999999999998643211 11245678899999999999999999887663
Q ss_pred cceEEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccccc
Q 043957 198 QYSLYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 198 ~~~l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~ 270 (584)
..+++||||+.+ +|...+... ..+.+ ..||+.||.|||+++++|+||+|+||+++.++.++|+|||++...
T Consensus 81 -~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 81 -EYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred -CceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 468999999984 677666543 33332 359999999999999999999999999999999999999999765
Q ss_pred CCCCC-CCCccccccccccChhhhhCCC-CCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHH
Q 043957 271 SPNKK-RPLTSRVVTLWYRAPELLLGAT-DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK 348 (584)
Q Consensus 271 ~~~~~-~~~~~~~gt~~Y~APEvl~~~~-~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 348 (584)
..... .......++..|+|||++.... .++.++|+|||||++|+|++|..||........+..+......
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------- 230 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA-------- 230 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC--------
Confidence 32211 1123446788999999987543 4789999999999999999999999765544333222110000
Q ss_pred hhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 349 LRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 349 ~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
...+ ......++..+.+||.+||..||.+|||++++|+||||
T Consensus 231 ------~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 231 ------PPIP-------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ------CcCC-------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0000 01224578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=343.31 Aligned_cols=246 Identities=31% Similarity=0.503 Sum_probs=195.1
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechhh-
Q 043957 132 KVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT- 210 (584)
Q Consensus 132 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~g- 210 (584)
+||+|+||+||-|+|..+....|||.|... .....+-+..||.+.++|+|.|||+++|.+.. +.++-|.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEEeecCCCC
Confidence 599999999999999999999999998532 33456778999999999999999999998654 4478899999985
Q ss_pred HHHHHhhCCCCCC--cH------HHHHHHHHHHHHhCCceeccccccceeecC-CCcEEEEEeccccccCCCCCCCCccc
Q 043957 211 DLARIISNPEGKL--TE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDK-NGVLKIADFGLANYFSPNKKRPLTSR 281 (584)
Q Consensus 211 ~L~~~l~~~~~~l--~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~-~g~vKL~DFGla~~~~~~~~~~~~~~ 281 (584)
+|..++...-+.+ .+ -+||+.||.|||++.|||||||-+||||+. .|.+||+|||.++.+.. -.....++
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETF 736 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETF 736 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccccc
Confidence 5666666444444 11 259999999999999999999999999964 78999999999988753 23334567
Q ss_pred cccccccChhhhh-CCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCC
Q 043957 282 VVTLWYRAPELLL-GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQS 360 (584)
Q Consensus 282 ~gt~~Y~APEvl~-~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~ 360 (584)
.||..|||||++. |...|+.++|||||||++.||.||+|||........ .++++- .+..
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--AMFkVG---------------myKv--- 796 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--AMFKVG---------------MYKV--- 796 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--hhhhhc---------------ceec---
Confidence 8999999999996 445799999999999999999999999975433221 122110 0000
Q ss_pred CCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 361 YKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 361 ~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
. ..+...++.+++.||.+|+..||.+||+|.++|+.||++..
T Consensus 797 -H---P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 797 -H---PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred -C---CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 0 01223567889999999999999999999999999999865
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=329.39 Aligned_cols=255 Identities=26% Similarity=0.437 Sum_probs=200.1
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
.|.....||.|+||.||++.+..++..||||++.... ....+.+.+|+.+++.++||||+++++.+... ...|+||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~lv~ 98 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVG--DELWVVM 98 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecC--CeEEEEE
Confidence 4666778999999999999999999999999986432 33456688999999999999999999887763 4679999
Q ss_pred echhh-HHHHHhhCCCC----CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCcc
Q 043957 206 EFMQT-DLARIISNPEG----KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTS 280 (584)
Q Consensus 206 Ey~~g-~L~~~l~~~~~----~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~ 280 (584)
||+.+ +|..++..... ...+..||+.||.|||+++|+||||||+||+++.++.++|+|||++....... .....
T Consensus 99 e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~ 177 (292)
T cd06658 99 EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKS 177 (292)
T ss_pred eCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCce
Confidence 99986 55555543211 12233599999999999999999999999999999999999999997653222 22234
Q ss_pred ccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCC
Q 043957 281 RVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQS 360 (584)
Q Consensus 281 ~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~ 360 (584)
..+++.|+|||++.+ ..++.++|||||||++|||++|..||........+..+.......
T Consensus 178 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------------- 237 (292)
T cd06658 178 LVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR------------------- 237 (292)
T ss_pred eecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc-------------------
Confidence 578999999999875 458899999999999999999999998876655544332211000
Q ss_pred CCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCcc
Q 043957 361 YKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLAC 410 (584)
Q Consensus 361 ~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~~ 410 (584)
......++..+.+||.+||..||.+|||++++|+||||.....+.
T Consensus 238 -----~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 238 -----VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred -----cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 001124578899999999999999999999999999998654443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=319.85 Aligned_cols=246 Identities=28% Similarity=0.433 Sum_probs=198.3
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
+|++.+.||.|+||.||+|.+..++..||+|++..... .....+.+.+|++++++++||||+++++++.. ...+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD--EENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--CCeEEEE
Confidence 48999999999999999999999999999999975433 22456788999999999999999999887765 4468999
Q ss_pred Eechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 205 FEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
|||+.+ +|...+... ..+. +..||+.||.|||+++|+|+||+|+||+++.++.++|+|||++....... .
T Consensus 79 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~ 155 (258)
T cd05578 79 VDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--L 155 (258)
T ss_pred EeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--c
Confidence 999985 666666543 2333 34599999999999999999999999999999999999999998764332 2
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE--VEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
.....++..|+|||++.. ..++.++|+|||||++|+|++|..||...+. .+.+...... .
T Consensus 156 ~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~-------------- 217 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---A-------------- 217 (258)
T ss_pred ccccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---c--------------
Confidence 244567889999999876 4489999999999999999999999987664 2222111110 0
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCH--HHHhcCcCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSA--ASALKNEFF 403 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa--~e~L~Hp~f 403 (584)
.......++..+.+||.+||..||.+||++ .|+++||||
T Consensus 218 ---------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 218 ---------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ---------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 001123467899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=320.66 Aligned_cols=253 Identities=31% Similarity=0.530 Sum_probs=196.3
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC----hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE----PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
+|+..+.||+|+||.||++.+..++..||+|++...... ....+.+.+|+.++++++|+||+++++++... ..+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED--SHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC--CeE
Confidence 378889999999999999999999999999999644321 22456788999999999999999999988763 468
Q ss_pred EEEEechhh-HHHHHhhCCCCCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCC-cEEEEEeccccccCCC
Q 043957 202 YLVFEFMQT-DLARIISNPEGKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG-VLKIADFGLANYFSPN 273 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g-~vKL~DFGla~~~~~~ 273 (584)
++||||+.+ +|.+++... ..+ .+..||+.||.|||++||+|+||||+||+++.++ .+||+|||++..+...
T Consensus 79 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 999999985 566666432 222 3346999999999999999999999999998776 5999999999776432
Q ss_pred CC---CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 274 KK---RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 274 ~~---~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
.. .......++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 227 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT--------- 227 (268)
T ss_pred cccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC---------
Confidence 11 11123467889999999876 458899999999999999999999997654333332222111000
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCC
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~ 404 (584)
. .......++.++.+||.+||..||.+|||+.++|+||||.
T Consensus 228 ---~----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 228 ---T----------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ---C----------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 0 0011134678899999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=327.17 Aligned_cols=255 Identities=24% Similarity=0.393 Sum_probs=194.1
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|...+.||+|+||.||++.+..++..||||.+...... .....+.+|+.++.++. ||||+++++++... ...|+
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~--~~~~~ 80 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE--GDCWI 80 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC--CcEEE
Confidence 3567778899999999999999999999999998654333 44566888999999996 99999999987663 35799
Q ss_pred EEechhhHHHHH---hh-CCCCCCcH------HHHHHHHHHHHHhC-CceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 204 VFEFMQTDLARI---IS-NPEGKLTE------PQQLLSGLQHCHDR-GILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 204 V~Ey~~g~L~~~---l~-~~~~~l~~------~~qIl~aL~yLH~~-~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
+|||+..++..+ +. .....+.+ ..|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 ~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 81 CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999998654332 21 11233332 35899999999974 999999999999999999999999999976543
Q ss_pred CCCCCCccccccccccChhhhhCC--CCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGA--TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~--~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
.. ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||..... ....+........
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~-------- 228 (288)
T cd06616 161 SI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDP-------- 228 (288)
T ss_pred CC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCC--------
Confidence 22 12334678999999999765 3689999999999999999999999976542 2222222111100
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
+ ... ......++.++.+||.+||+.||++|||++++++||||..
T Consensus 229 -------~-~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 229 -------P-ILS---NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred -------C-cCC---CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 0 000 0111357889999999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=322.95 Aligned_cols=276 Identities=32% Similarity=0.549 Sum_probs=226.1
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc----ce
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ----YS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~----~~ 200 (584)
.+|.-+..+|.|.- .|..|.|.-+++.||+|++..........+...+|..++..+.|+||++++.+|+.... ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46888999999998 88889999999999999986665555566778899999999999999999998865332 35
Q ss_pred EEEEEechhhHHHHHhhCCCCC---CcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 201 LYLVFEFMQTDLARIISNPEGK---LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 201 l~lV~Ey~~g~L~~~l~~~~~~---l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
+|+|||||..+|...+...-.. -.+..|++.|++|||+.||+||||||+||++..++.+||.|||+|+..... -.
T Consensus 96 ~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~ 173 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FM 173 (369)
T ss_pred HHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc--cc
Confidence 7999999999988877632222 223459999999999999999999999999999999999999999875433 45
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC---
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT--- 354 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--- 354 (584)
++.++.|.+|+|||++.+.. |...+||||+|||+.||++|+-.|+|.+..+++.++....+.|...+..++.....
T Consensus 174 mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv 252 (369)
T KOG0665|consen 174 MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYV 252 (369)
T ss_pred cCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHh
Confidence 78889999999999999865 99999999999999999999999999999999999999999999998887643210
Q ss_pred --------CCCCCCCCchhh----hhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCC
Q 043957 355 --------FRPPQSYKPRLF----EAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404 (584)
Q Consensus 355 --------~~~p~~~~~~~~----~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~ 404 (584)
+......+...+ +.-+--+..+.||+.+||..||++|.+++++|+||||+
T Consensus 253 ~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 253 ENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 111111111111 11111235678999999999999999999999999997
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=316.23 Aligned_cols=248 Identities=32% Similarity=0.559 Sum_probs=197.7
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS---EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
+|+..+.||+|+||.||+|.+..++..|++|.+..... .....+.+.+|+.+++.++|+||+++++++... ..+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE--DNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC--CeEE
Confidence 47888999999999999999998999999999865432 234556788999999999999999999887653 4689
Q ss_pred EEEechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 203 LVFEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
+||||+.+ +|...+... ..+. +..||+.||.|||+.+|+|+||+|+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 79 IFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 99999985 676666532 2233 23589999999999999999999999999999999999999997754332
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
......+++.|+|||.+.....++.++|+|||||++|+|++|++||...........+.....
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~---------------- 219 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE---------------- 219 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc----------------
Confidence 234567899999999986543488999999999999999999999977654443332211000
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
.......+++.+.+||.+||+.||.+|||+.++|.||||
T Consensus 220 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 220 ---------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ---------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 001123467889999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=318.09 Aligned_cols=248 Identities=29% Similarity=0.487 Sum_probs=198.8
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
+|.+.+.||.|+||.||++.+..+|..||+|.+..........+.+.+|+.+++.++|+||+++++++.. ...+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE--NGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc--CCeEEEEE
Confidence 4899999999999999999999999999999997654333445678899999999999999999988766 44689999
Q ss_pred echhh-HHHHHhhCCCC-CCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCc-EEEEEeccccccCCCCCC
Q 043957 206 EFMQT-DLARIISNPEG-KLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGV-LKIADFGLANYFSPNKKR 276 (584)
Q Consensus 206 Ey~~g-~L~~~l~~~~~-~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~-vKL~DFGla~~~~~~~~~ 276 (584)
||+.+ +|...+..... .+. +..||+.||.|||+++|+|+||||+||++++++. +||+|||++....... .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~ 157 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-E 157 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-c
Confidence 99974 67776654222 233 3359999999999999999999999999988864 6999999998765322 2
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
......|++.|+|||++.+. .++.++|+|||||++|+|++|..||...+.......+.....
T Consensus 158 ~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------- 219 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF----------------- 219 (257)
T ss_pred cccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC-----------------
Confidence 22345689999999998764 488999999999999999999999987665544433321100
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
......++.++.++|.+||..+|++|||+.++|+||||
T Consensus 220 ---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 220 ---------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 01123467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=328.35 Aligned_cols=253 Identities=26% Similarity=0.455 Sum_probs=200.1
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEe
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFE 206 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~E 206 (584)
|+....||+|+||.||+|.+..++..||||++...... ..+.+.+|+.+++.++||||+++++++.. ....|+|||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~iv~e 98 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELWVLME 98 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEEEEEe
Confidence 55566799999999999999999999999998654322 34567899999999999999999998876 346899999
Q ss_pred chhh-HHHHHhhCCCC----CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccc
Q 043957 207 FMQT-DLARIISNPEG----KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR 281 (584)
Q Consensus 207 y~~g-~L~~~l~~~~~----~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 281 (584)
|+.+ +|..++..... ...+..||+.||.|||+++|+|+||||+|||++.++.+||+|||++..+.... ......
T Consensus 99 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~ 177 (297)
T cd06659 99 FLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSL 177 (297)
T ss_pred cCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccce
Confidence 9985 56555543211 12334599999999999999999999999999999999999999997654322 122446
Q ss_pred cccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCC
Q 043957 282 VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSY 361 (584)
Q Consensus 282 ~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~ 361 (584)
.+++.|+|||++.+ ..++.++|||||||++|+|++|++||........+..+... +.
T Consensus 178 ~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~------------------- 234 (297)
T cd06659 178 VGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PP------------------- 234 (297)
T ss_pred ecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CC-------------------
Confidence 78999999999976 45899999999999999999999999877766555433211 00
Q ss_pred CchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCc
Q 043957 362 KPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLA 409 (584)
Q Consensus 362 ~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~ 409 (584)
........++..+.+||.+||+.||.+|||++++++||||.....+
T Consensus 235 --~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~ 280 (297)
T cd06659 235 --PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLP 280 (297)
T ss_pred --CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCc
Confidence 0011224567889999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=326.21 Aligned_cols=253 Identities=21% Similarity=0.293 Sum_probs=189.8
Q ss_pred CCCceEEeeecccCceEEEEEEECC----------------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCee
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRD----------------TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIV 187 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~----------------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 187 (584)
.++|++.++||+|+||.||+|.+.. ++..||||.+... ........+.+|+.+|.+++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-ANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC-CCHHHHHHHHHHHHHHhhcCCCCee
Confidence 3579999999999999999997532 3457999998643 2344556788999999999999999
Q ss_pred eeeceeeecCcceEEEEEechh-hHHHHHhhCCCC------------------------CCcHHHHHHHHHHHHHhCCce
Q 043957 188 KLEGLATSRMQYSLYLVFEFMQ-TDLARIISNPEG------------------------KLTEPQQLLSGLQHCHDRGIL 242 (584)
Q Consensus 188 ~l~~~~~~~~~~~l~lV~Ey~~-g~L~~~l~~~~~------------------------~l~~~~qIl~aL~yLH~~~Iv 242 (584)
++++++... ...|+||||+. ++|.+++..... .+.+..||+.||.|||+++|+
T Consensus 83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 83 RLLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred EEEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 999988764 35799999997 467766643110 123456999999999999999
Q ss_pred eccccccceeecCCCcEEEEEeccccccCCCCCC-CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh--CC
Q 043957 243 HRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR-PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL--GR 319 (584)
Q Consensus 243 HrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt--G~ 319 (584)
||||||+|||++.++.+||+|||++..+...... ......++..|+|||++.+. .++.++|||||||++|+|++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999865432211 11233457889999998764 58999999999999999987 55
Q ss_pred CCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 320 PIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 320 ~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.||...+..+.+..+......... .. .......++..+.+||.+||+.||.+|||+.++.+
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~---------~~----------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGR---------QV----------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccc---------cc----------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 788776655554433221110000 00 00011346788999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=325.20 Aligned_cols=249 Identities=26% Similarity=0.442 Sum_probs=201.2
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
.|...+.||+|+||.||++.+..++..||||++..... .......+.+|+.+++.++||||+++++++... ...|+|
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 103 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE--HTAWLV 103 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--CeEEEE
Confidence 48889999999999999999999999999999865422 334456788999999999999999999988764 357999
Q ss_pred EechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 205 FEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
|||+.|++.+.+......+.+ ..||+.||.|||+++|+||||+|+||+++.++.+||+|||++..... .
T Consensus 104 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-----~ 178 (317)
T cd06635 104 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-----A 178 (317)
T ss_pred EeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----c
Confidence 999999887776543333433 35899999999999999999999999999999999999999876432 2
Q ss_pred ccccccccccChhhhhC--CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 279 TSRVVTLWYRAPELLLG--ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~--~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
....+++.|+|||++.. ...++.++|||||||++|+|++|.+||........+..+......+
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 243 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--------------- 243 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC---------------
Confidence 34568899999999752 2357899999999999999999999998766555554443311100
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.....+++.+.+||.+||+.||.+|||+.++++|+|+...
T Consensus 244 ----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 244 ----------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred ----------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 0012457789999999999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=321.71 Aligned_cols=256 Identities=28% Similarity=0.419 Sum_probs=197.4
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|+..+.||.|++|.||+|.+..++..||+|.+..... ......+.+|+++++.++||||+++++++.......+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 368999999999999999999999999999999875433 2445678899999999999999999998877666678999
Q ss_pred Eechhh-HHHHHhh---CCCCCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 205 FEFMQT-DLARIIS---NPEGKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~---~~~~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
|||+++ +|.+++. .....+ .++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999985 5655432 222233 244599999999999999999999999999999999999999987653222
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCCh-----HHHHHHHHHhcCCCChHHHHHh
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE-----VEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~-----~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... .+....+... ..
T Consensus 160 ---~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~------- 225 (287)
T cd06621 160 ---AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM---PN------- 225 (287)
T ss_pred ---cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC---Cc-------
Confidence 123457889999999876 4589999999999999999999999976522 2221111110 00
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
...+.. ...-..+++.+.+||.+||..||.+|||+.|+++||||..
T Consensus 226 -----~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 226 -----PELKDE-----PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred -----hhhccC-----CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 000000 0000134678899999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=326.51 Aligned_cols=250 Identities=28% Similarity=0.456 Sum_probs=201.9
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
.|...++||+|+||.||+|.+..++..||||++..... .......+.+|+.+++.++||||+++++++.+. ...|+|
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 99 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE--HTAWLV 99 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEEEE
Confidence 37778889999999999999999999999999965433 333456688899999999999999999988774 457999
Q ss_pred EechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 205 FEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
|||+.+++...+......+.+ ..||+.||.|||++||+|+||+|+||+++.++.+||+|||++..... .
T Consensus 100 ~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~ 174 (313)
T cd06633 100 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----A 174 (313)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----C
Confidence 999999888777654444433 35899999999999999999999999999999999999999864321 2
Q ss_pred ccccccccccChhhhhC--CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 279 TSRVVTLWYRAPELLLG--ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~--~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
....|+..|+|||++.. ...++.++|||||||++|+|++|.+||...+....+..+.... .
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~---------------- 237 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-S---------------- 237 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-C----------------
Confidence 34578899999999852 2457889999999999999999999998877655554442210 0
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
+. .....++..+.+||.+||+.||.+|||+.++|.||||...+
T Consensus 238 -~~-------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 238 -PT-------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred -CC-------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 00 01134567899999999999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=321.19 Aligned_cols=247 Identities=32% Similarity=0.488 Sum_probs=197.6
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
+|++.+.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++... ..+|+||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 78 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISICM 78 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEEEE
Confidence 58888999999999999999999999999999875433 34556788999999999999999999888764 5689999
Q ss_pred echh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHh-CCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 206 EFMQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHD-RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 206 Ey~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~-~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||+. ++|.+++......+. +..||+.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 9999 577777764323333 34599999999999 9999999999999999999999999999876542221
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCC-----hHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRT-----EVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
....++..|+|||++.+. .++.++|||||||++|+|++|..||.... ..+.+..+... ..
T Consensus 157 -~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~---------- 221 (265)
T cd06605 157 -KTFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE---PP---------- 221 (265)
T ss_pred -hcccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC---CC----------
Confidence 126788999999998764 68999999999999999999999997642 12222222110 00
Q ss_pred CCCCCCCCCCchhhhhcc-CCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 353 TTFRPPQSYKPRLFEAFS-EFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~-~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
+. ... .+++.+.+||.+||..||.+|||+.++|.||||+.
T Consensus 222 -----~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 222 -----PR--------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred -----CC--------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 00 001 16888999999999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=316.89 Aligned_cols=248 Identities=29% Similarity=0.418 Sum_probs=190.8
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEe
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFE 206 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~E 206 (584)
......||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.+++.++|+||+++++++... ..+++|||
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 85 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN--GFFKIFME 85 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC--CEEEEEEe
Confidence 44456799999999999999999999999988643 233456788999999999999999999987763 46899999
Q ss_pred chh-hHHHHHhhCCCCCC--------cHHHHHHHHHHHHHhCCceeccccccceeecC-CCcEEEEEeccccccCCCCCC
Q 043957 207 FMQ-TDLARIISNPEGKL--------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDK-NGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 207 y~~-g~L~~~l~~~~~~l--------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~-~g~vKL~DFGla~~~~~~~~~ 276 (584)
|+. ++|...+......+ .+..||+.||.|||+++|+||||||+||+++. ++.++|+|||++....... .
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-~ 164 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-P 164 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC-C
Confidence 998 46777765432222 23359999999999999999999999999976 6789999999997654322 2
Q ss_pred CCccccccccccChhhhhCC-CCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGA-TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~-~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
......+++.|+|||++.+. ..++.++|||||||++|+|++|++||................ .
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~-------------~--- 228 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF-------------K--- 228 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh-------------c---
Confidence 22344678999999998643 247899999999999999999999996543221110000000 0
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
........+++++.+||.+||+.+|.+|||+.|++.||||
T Consensus 229 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 229 --------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred --------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 0001123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=314.42 Aligned_cols=244 Identities=25% Similarity=0.422 Sum_probs=196.3
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
+|++.+.||.|+||.||++.+..++..||+|.++.... ....+.+.+|+.+++.++||||+++++.+.. ...+|+||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEE
Confidence 48999999999999999999999999999999865432 3355678889999999999999999988876 44689999
Q ss_pred echh-hHHHHHhhCCC-CCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 206 EFMQ-TDLARIISNPE-GKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 206 Ey~~-g~L~~~l~~~~-~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||+. ++|...+.... ..+ .+..||+.||.|||+++|+|+||||+|||++.++.++|+|||++....... ..
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 156 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY 156 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence 9998 46777664322 222 334699999999999999999999999999999999999999997664322 22
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 357 (584)
.....+++.|+|||++.+. .++.++|||||||++|+|++|.+||...+.......+......
T Consensus 157 ~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 218 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK----------------- 218 (255)
T ss_pred cccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC-----------------
Confidence 2345789999999998764 5899999999999999999999999877655544443221110
Q ss_pred CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 358 p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.....++..+.+||.+||+.||.+|||+.++|.-
T Consensus 219 ---------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 ---------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0112457788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=322.13 Aligned_cols=246 Identities=24% Similarity=0.376 Sum_probs=194.4
Q ss_pred CCceEEeeecccCceEEEEEEECCCC-----cEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTG-----KIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
++|++.+.||+|+||.||+|.+...+ ..||+|.+... ........+.+|+.++..++||||+++++++... .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--Q 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC--C
Confidence 46899999999999999999876554 67999998643 2334456788999999999999999999987753 4
Q ss_pred eEEEEEechh-hHHHHHhhCCC---------------CCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCC
Q 043957 200 SLYLVFEFMQ-TDLARIISNPE---------------GKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG 257 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~---------------~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g 257 (584)
..|++|||+. ++|.+.+.... ..+ .+..||+.||.|||+++|+|+||||+|||+++++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 5799999998 57777765321 112 2345999999999999999999999999999999
Q ss_pred cEEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 043957 258 VLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIF 335 (584)
Q Consensus 258 ~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~ 335 (584)
.+||+|||++........ .......+++.|+|||++.+. .++.++|||||||++|||++ |..||.+....+....+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999976532221 122344668899999998764 58999999999999999998 999998877665544432
Q ss_pred HhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 336 KLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.... ......+|.++.+|+.+||+.||.+|||+.|++++
T Consensus 241 ~~~~--------------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQL--------------------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCc--------------------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2110 01124578999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=322.23 Aligned_cols=257 Identities=26% Similarity=0.391 Sum_probs=197.5
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++++.||+|+||+||++.+..+|..||+|++.... .....+.+.+|+++++.++||||+++++++... ..+|+|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 81 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNICMC 81 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEEEEE
Confidence 56999999999999999999999999999999986543 233456788999999999999999999988764 468999
Q ss_pred Eechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHh-CCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 205 FEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHD-RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~-~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
|||+.+ +|...+.. ...+. ...+|+.||.|||+ .+|+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 82 MEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred EecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 999985 56555543 22232 23589999999997 699999999999999999999999999987543221
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHH----HHHHHHhcCCCChHHHHHhhcc
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQ----LHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
.....|+..|+|||++.+. .++.++|||||||++|+|++|..||........ ...+.. .+..+...
T Consensus 159 -~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~ 228 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD--------LLQQIVQE 228 (284)
T ss_pred -cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHH--------HHHHHhhc
Confidence 1345789999999998764 588999999999999999999999986554211 001100 00110000
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
.. .... ...++..+.+||.+||+.||.+|||+.|+++|+||.+..
T Consensus 229 ~~----~~~~------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 229 PP----PRLP------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred cC----CCCC------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 00 0000 012678899999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=314.46 Aligned_cols=252 Identities=25% Similarity=0.442 Sum_probs=199.3
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC---CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT---SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~---~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
.+|++.+.||+|+||.||+|.+..++..||+|.+.... ........+.+|+.++++++|+||+++++++.+.....+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46999999999999999999999999999999985432 123455678899999999999999999998877656678
Q ss_pred EEEEechhh-HHHHHhhCCCC-----CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC-
Q 043957 202 YLVFEFMQT-DLARIISNPEG-----KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK- 274 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~-----~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~- 274 (584)
++||||+.+ +|...+..... ...+..||+.||.|||+++|+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 999999985 67666653221 12234599999999999999999999999999999999999999998653211
Q ss_pred -CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 275 -KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 275 -~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
........++..|+|||++.+ ..++.++|||||||++|+|++|++||........+..+.. .+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~---------- 227 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTK---------- 227 (264)
T ss_pred cCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCCC----------
Confidence 111234568899999999876 4588999999999999999999999987655444333221 1100
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
......+++.+.++|.+||+ +|.+|||+.++|.|||.
T Consensus 228 ------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 228 ------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 01124568899999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=320.18 Aligned_cols=248 Identities=25% Similarity=0.482 Sum_probs=199.6
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
.|+.++.||.|+||.||+|.+..++..||||.+..... ......+.+|+.++++++||||+++++++.. ....|+||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 81 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GTKLWIIM 81 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEEE
Confidence 48889999999999999999999999999999875432 3445778899999999999999999998876 44689999
Q ss_pred echhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 206 EFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 206 Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
||+.+ +|.+.+... .+. ...|++.||+|||+.+++|+||+|+||+++.++.++|+|||++..+.... ...
T Consensus 82 e~~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06640 82 EYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred ecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-ccc
Confidence 99985 677766532 232 23589999999999999999999999999999999999999997764322 122
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p 358 (584)
....++..|+|||++.+ ..++.++|+|||||++|+|++|.+||...+.......+....
T Consensus 159 ~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-------------------- 217 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN-------------------- 217 (277)
T ss_pred ccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC--------------------
Confidence 34567889999999876 458899999999999999999999998766544332221100
Q ss_pred CCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 359 ~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.+ .....++..+.+||.+||+.||++|||+.++|+|+||...
T Consensus 218 ---~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 218 ---PP---TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ---CC---CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 00 1123457888999999999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=310.40 Aligned_cols=248 Identities=30% Similarity=0.476 Sum_probs=203.1
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
+|++.+.||.|+||.||++.+..++..||+|++............+.+|+++++.++|||++++++.+... ...++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEEE
Confidence 48999999999999999999999999999999976655556677788999999999999999999887764 5689999
Q ss_pred echhh-HHHHHhhCCC---CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 206 EFMQT-DLARIISNPE---GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 206 Ey~~g-~L~~~l~~~~---~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
||+++ +|...+.... ..+. +..+|+.||.|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 99985 6777765431 3333 34599999999999999999999999999999999999999998765432
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
.......+++.|+|||.+.+. .++.++||||||+++|+|++|..||...+.......+.....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 220 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY---------------- 220 (258)
T ss_pred ceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC----------------
Confidence 122345789999999998764 588999999999999999999999987765544443322110
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
......++..+.++|.+||..||.+|||+.++|+||||
T Consensus 221 ----------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 221 ----------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred ----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 00112567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=316.34 Aligned_cols=243 Identities=25% Similarity=0.406 Sum_probs=192.7
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
..|.+.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.++||||+++++++... ..+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCC--CCcEEE
Confidence 3589999999999999999999999999999998632 22356688999999999999999999887663 357999
Q ss_pred Eechh-hHHHHHhhCCC-CCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 205 FEFMQ-TDLARIISNPE-GKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 205 ~Ey~~-g~L~~~l~~~~-~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
|||+. ++|.+.+.... ..+.+ ..||+.||+|||+++|+||||||+|||+++++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 99997 56777765322 22332 359999999999999999999999999999999999999999876533222
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||++.+..+....+.....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---------------- 223 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---------------- 223 (263)
T ss_pred ccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC----------------
Confidence 1122234567999999876 458899999999999999998 9999988766554444322100
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
......++.++.+||.+||..||++|||+.++++
T Consensus 224 ----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 224 ----------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ----------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0112356889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=314.46 Aligned_cols=242 Identities=24% Similarity=0.371 Sum_probs=191.3
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++.+.||+|+||.||++.... +..+|+|.+..... ....+.+|+.+|++++||||+++++++... ..+|+|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ--KPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEEccC--CCEEEE
Confidence 458999999999999999997754 56899998763322 235678899999999999999999887664 457999
Q ss_pred Eechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 205 FEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 205 ~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
|||+. ++|.+.+......+.+ ..||+.||.|||+++|+||||||+||+++.++.+||+|||++..........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99998 5787777643333433 3599999999999999999999999999999999999999998654332222
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+.+..+.......
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~--------------- 221 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY--------------- 221 (256)
T ss_pred cCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC---------------
Confidence 223345668999999875 458999999999999999999 899998887766666553321100
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....+..+.+||.+||..||.+|||++++++
T Consensus 222 -----------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 222 -----------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred -----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 01124678899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=373.24 Aligned_cols=258 Identities=30% Similarity=0.516 Sum_probs=207.0
Q ss_pred CCCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 120 ~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
+....-++.....||.|.||.||.|.+..+|+..|+|.|+.........+.+.+|+.+|..|+|||+|++||+..+++.
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek- 1308 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK- 1308 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH-
Confidence 3344446777888999999999999999999999999998776666677889999999999999999999999887554
Q ss_pred eEEEEEechhh-HHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQT-DLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~g-~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
++|.||||++ +|.+++. ..+...+. .|++.||+|||++|||||||||+||||+.+|.+|++|||.|..+..
T Consensus 1309 -v~IFMEyC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1309 -VYIFMEYCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred -HHHHHHHhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecC
Confidence 7999999995 4555544 23233332 3999999999999999999999999999999999999999988865
Q ss_pred CC---CCCCccccccccccChhhhhCCC--CCCceeeEecchHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChHHH
Q 043957 273 NK---KRPLTSRVVTLWYRAPELLLGAT--DYGVGIDLWSAGCLLAEMFLGRPIMPGRTE-VEQLHRIFKLCGSPSEDYW 346 (584)
Q Consensus 273 ~~---~~~~~~~~gt~~Y~APEvl~~~~--~~~~~sDIwSLGvilyeLltG~~pF~~~~~-~~~~~~i~~~~~~~~~~~~ 346 (584)
+. ...+...+||+.|||||++.+.+ +..-+.|||||||++.||+||+.||..-+. ...+..+-.+
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~g--------- 1457 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAG--------- 1457 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhcc---------
Confidence 42 12245679999999999998754 466789999999999999999999965433 2222222111
Q ss_pred HHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 347 KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 347 ~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.. | .+...++.+..|||.+||+.||.+|+++.|+|+|.|-+..
T Consensus 1458 ------h~--------P---q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1458 ------HK--------P---QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred ------CC--------C---CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 00 0 1223478999999999999999999999999999997654
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=324.01 Aligned_cols=249 Identities=25% Similarity=0.464 Sum_probs=196.2
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
.|++.+.||.|+||.||+|.+..++..||+|.+..... ....+.+.+|+.++++++||||+++++++... ...|+||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 81 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKG--TKLWIIM 81 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccC--CceEEEE
Confidence 47888899999999999999999999999999865433 23456788999999999999999999988763 4589999
Q ss_pred echhh-HHHHHhhCCCCC----CcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCcc
Q 043957 206 EFMQT-DLARIISNPEGK----LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTS 280 (584)
Q Consensus 206 Ey~~g-~L~~~l~~~~~~----l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~ 280 (584)
||+.+ +|...+...... ...+.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++..+..... ....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~ 160 (277)
T cd06642 82 EYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNT 160 (277)
T ss_pred EccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch-hhhc
Confidence 99985 666666432111 12235999999999999999999999999999999999999999987643221 1233
Q ss_pred ccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCC
Q 043957 281 RVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQS 360 (584)
Q Consensus 281 ~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~ 360 (584)
..++..|+|||++.+. .++.++|||||||++|+|++|++||...........+... .
T Consensus 161 ~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~------------------~---- 217 (277)
T cd06642 161 FVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN------------------S---- 217 (277)
T ss_pred ccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC------------------C----
Confidence 4678899999998764 5889999999999999999999999755443322211000 0
Q ss_pred CCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 361 YKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 361 ~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
.+ .....++..+.+||.+||+.+|.+|||+.++|+||||..
T Consensus 218 -~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 218 -PP---TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred -CC---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 00 011245788999999999999999999999999999853
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=317.86 Aligned_cols=248 Identities=33% Similarity=0.528 Sum_probs=201.2
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l~ 202 (584)
++|.+.+.||.|+||.||+|.+..++..||+|++..... .......+.+|+.+++++. ||||+++++++.. ...++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEE
Confidence 369999999999999999999999999999999865322 2334567888999999998 9999999988766 34689
Q ss_pred EEEechh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 203 LVFEFMQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 203 lV~Ey~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
+||||+. ++|.+.+.... .+. +..||+.||.|||+++++|+||+|+||+++.++.++|+|||++........
T Consensus 79 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 9999995 67877776432 333 335999999999999999999999999999999999999999987643321
Q ss_pred -------------------CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 043957 276 -------------------RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFK 336 (584)
Q Consensus 276 -------------------~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~ 336 (584)
.......++..|+|||++.. ..++.++|||||||++|+|++|+.||...+....+..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 236 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK 236 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence 11233467899999998876 4588999999999999999999999988776555544432
Q ss_pred hcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCH----HHHhcCcCC
Q 043957 337 LCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSA----ASALKNEFF 403 (584)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa----~e~L~Hp~f 403 (584)
... .....+++.+.+||.+||+.||.+|||+ +++|+||||
T Consensus 237 ~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 237 LEY---------------------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred cCC---------------------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 111 1113457889999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=320.32 Aligned_cols=245 Identities=29% Similarity=0.431 Sum_probs=183.4
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEeecCCCCh-HHHHHHHHHHHHHH---hCCCCCeeeeeceeeecCcceEEEEEec
Q 043957 132 KVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP-HSVKFMAREIMILQ---KLDHPNIVKLEGLATSRMQYSLYLVFEF 207 (584)
Q Consensus 132 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-~~~~~~~~Ei~iL~---~L~HpnIv~l~~~~~~~~~~~l~lV~Ey 207 (584)
.||+|+||.||++.+..+++.||+|.+....... .......+|..+++ ..+||||+.+++++... ...|+||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEEEEec
Confidence 3899999999999999999999999986543221 12223344544443 34799999998877663 457999999
Q ss_pred hhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCcc
Q 043957 208 MQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTS 280 (584)
Q Consensus 208 ~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~ 280 (584)
+.+ +|...+... ..+.+ +.||+.||.|||+++|+||||||+|||++.++.++|+|||++....... ...
T Consensus 79 ~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 154 (279)
T cd05633 79 MNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHA 154 (279)
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccC
Confidence 985 566665432 33433 3599999999999999999999999999999999999999997654222 233
Q ss_pred ccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCC
Q 043957 281 RVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQS 360 (584)
Q Consensus 281 ~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~ 360 (584)
..|++.|+|||++.....++.++|||||||++|+|++|..||......... .+.... ....
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~------------~~~~------ 215 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMT------------LTVN------ 215 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHh------------hcCC------
Confidence 578999999999865455889999999999999999999999754321111 110000 0000
Q ss_pred CCchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCCC
Q 043957 361 YKPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFTS 406 (584)
Q Consensus 361 ~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~~ 406 (584)
......+++++.+||.+||..||.+|+ |+.++++||||...
T Consensus 216 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 216 -----VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred -----cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence 011235688999999999999999999 69999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=335.72 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=188.9
Q ss_pred CCCceEEeeecccCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecC
Q 043957 124 AESYDKIDKVGQGTYSNVYKALD-----RDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRM 197 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 197 (584)
.++|++.+.||+|+||.||+|.+ ..++..||||+++.... ....+.+.+|+.+|+.+ +|||||++++++....
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 34799999999999999999964 35677899999864332 23456788999999999 8999999999887643
Q ss_pred cceEEEEEechh-hHHHHHhhCCCC-------------------------------------------------------
Q 043957 198 QYSLYLVFEFMQ-TDLARIISNPEG------------------------------------------------------- 221 (584)
Q Consensus 198 ~~~l~lV~Ey~~-g~L~~~l~~~~~------------------------------------------------------- 221 (584)
..|+|||||. |+|...+.....
T Consensus 113 --~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 113 --PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred --cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 5799999998 567766643211
Q ss_pred -------------------CC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 222 -------------------KL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 222 -------------------~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
.+ .+..||+.||.|||+++|+||||||+|||++.++.+||+|||++..+......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 11 23359999999999999999999999999999999999999999866433221
Q ss_pred C-CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 277 P-LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 277 ~-~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
. .....++..|+|||++.+. .++.++|||||||++|+|++ |.+||........+..++.... .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~--------------~ 335 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY--------------R 335 (375)
T ss_pred cccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc--------------c
Confidence 1 1223345679999999764 58999999999999999998 8899977654433322222100 0
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
. ......+.++.+||.+||+.||++|||+.|+++.
T Consensus 336 ~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 336 M-----------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred C-----------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0 0012346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=318.21 Aligned_cols=252 Identities=28% Similarity=0.482 Sum_probs=199.9
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
.|...+.||.|++|.||++.+..++..||+|++.... ....+.+.+|+.+++.++||||+++++++.. ....|+|+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GDELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEc--CCeEEEEE
Confidence 4667789999999999999999899999999986432 2334567899999999999999999998765 34579999
Q ss_pred echhh-HHHHHhhCCCC----CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCcc
Q 043957 206 EFMQT-DLARIISNPEG----KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTS 280 (584)
Q Consensus 206 Ey~~g-~L~~~l~~~~~----~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~ 280 (584)
||+.+ +|.+.+..... ...+..||+.||+|||+++|+||||+|+||+++.++.++|+|||++........ ....
T Consensus 96 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 174 (285)
T cd06648 96 EFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKS 174 (285)
T ss_pred eccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cccc
Confidence 99975 67666654211 122346999999999999999999999999999999999999999876543221 2234
Q ss_pred ccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCC
Q 043957 281 RVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQS 360 (584)
Q Consensus 281 ~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~ 360 (584)
..|++.|+|||++.+. .++.++|||||||++|+|++|..||...+....+..+.... .+
T Consensus 175 ~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~------------------- 233 (285)
T cd06648 175 LVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PP------------------- 233 (285)
T ss_pred ccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CC-------------------
Confidence 5689999999998764 58999999999999999999999998776655554442210 00
Q ss_pred CCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 361 YKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 361 ~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
.......++..+.+||.+||+.||.+|||+.++|+||||....
T Consensus 234 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 234 ----KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred ----CCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 0011123678899999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=335.73 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=202.6
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..+...+.+.||+|.||+||+|.+.. .||||+++.+...+...+.|++|+.+|++-+|.||+-+.|++.... +.
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~---~A 463 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP---LA 463 (678)
T ss_pred CHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc---ee
Confidence 34556788999999999999997763 5999999988888889999999999999999999999999987643 48
Q ss_pred EEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC-CC
Q 043957 203 LVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP-NK 274 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~-~~ 274 (584)
||..+|+| +|+..++..+.++.. ++||+.|+.|||.++|||||||..||||.++++|||+||||+..-.- ..
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 99999997 688888776666544 46999999999999999999999999999999999999999964321 11
Q ss_pred CCCCccccccccccChhhhhC--CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 275 KRPLTSRVVTLWYRAPELLLG--ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~--~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
...+....|...|||||++.. ..+|++.+|||||||++|||+||..||........+.++-.+..
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l------------- 610 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYL------------- 610 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccccc-------------
Confidence 223344567889999999863 34799999999999999999999999985443333322222211
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.+.......+.+.++++|+..|+.+++++||+..++|.
T Consensus 611 ---------~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 611 ---------MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ---------CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 22334455678889999999999999999999999987
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=336.58 Aligned_cols=247 Identities=24% Similarity=0.330 Sum_probs=187.6
Q ss_pred CCCceEEeeecccCceEEEEEEECCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecC
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDT-----GKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRM 197 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 197 (584)
.++|++.+.||+|+||.||+|.+... +..||||+++.... ......+.+|+.+|+.+ +|+|||++++++...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~- 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHG- 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCC-
Confidence 34699999999999999999986443 45799999965432 33456788999999999 899999999987764
Q ss_pred cceEEEEEechh-hHHHHHhhCCC--------------------------------------------------------
Q 043957 198 QYSLYLVFEFMQ-TDLARIISNPE-------------------------------------------------------- 220 (584)
Q Consensus 198 ~~~l~lV~Ey~~-g~L~~~l~~~~-------------------------------------------------------- 220 (584)
..+|+|||||. |+|.+.+....
T Consensus 115 -~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 115 -GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred -CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 45899999998 46766653211
Q ss_pred -------------CCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC-Ccc
Q 043957 221 -------------GKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP-LTS 280 (584)
Q Consensus 221 -------------~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~-~~~ 280 (584)
..+ .+..||+.||.|||+++|+||||||+|||+++++.+||+|||+++.+....... ...
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 011 233599999999999999999999999999999999999999997654322111 112
Q ss_pred ccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCC
Q 043957 281 RVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQ 359 (584)
Q Consensus 281 ~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~ 359 (584)
..+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||........+..+......+ .
T Consensus 274 ~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~--------------~--- 335 (374)
T cd05106 274 ARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM--------------S--- 335 (374)
T ss_pred CCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc--------------c---
Confidence 234567999999876 458999999999999999997 999998755433332322211000 0
Q ss_pred CCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 360 SYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 360 ~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
....+++++.+||.+||+.||.+|||+.++++
T Consensus 336 --------~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 336 --------RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred --------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01235789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=313.27 Aligned_cols=242 Identities=29% Similarity=0.422 Sum_probs=193.9
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechh-h
Q 043957 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ-T 210 (584)
Q Consensus 133 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~-g 210 (584)
||.|+||.||+|.+..++..||+|++..... .....+.+.+|+.+++.++||||+++++++.+. ..+|+||||+. +
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK--KYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC--CccEEEEecCCCC
Confidence 6899999999999999999999999975432 234557789999999999999999999987653 45899999998 5
Q ss_pred HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCcccccc
Q 043957 211 DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVT 284 (584)
Q Consensus 211 ~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gt 284 (584)
+|.+.+... ..++ +..||+.||.|||+++++|+||+|+||+++.++.++|+|||++....... ......++
T Consensus 79 ~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~ 155 (262)
T cd05572 79 ELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGT 155 (262)
T ss_pred cHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCC
Confidence 777777543 2233 33599999999999999999999999999999999999999998765332 12345788
Q ss_pred ccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCC--hHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCC
Q 043957 285 LWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRT--EVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYK 362 (584)
Q Consensus 285 ~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 362 (584)
+.|++||++.+ ..++.++|+|||||++|+|++|..||.... ....+..+......+
T Consensus 156 ~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------- 213 (262)
T cd05572 156 PEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL--------------------- 213 (262)
T ss_pred cCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCC---------------------
Confidence 99999999875 458899999999999999999999998766 333333332110000
Q ss_pred chhhhhccCCcHhHHHHHHHhcccCCCCCCC-----HHHHhcCcCCCC
Q 043957 363 PRLFEAFSEFPESSLGLLSTLLALDPAYRGS-----AASALKNEFFFT 405 (584)
Q Consensus 363 ~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT-----a~e~L~Hp~f~~ 405 (584)
.....+++++.+||.+||+.||.+||| ++|+++||||..
T Consensus 214 ----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 214 ----EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred ----CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 011234788999999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=322.23 Aligned_cols=255 Identities=27% Similarity=0.491 Sum_probs=201.6
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
...++|++.+.||+|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++... ...
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~ 91 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVG--DEL 91 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeC--CcE
Confidence 33468999999999999999999999899999999986432 22346678999999999999999999988764 357
Q ss_pred EEEEechhh-HHHHHhhCCCCC----CcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 202 YLVFEFMQT-DLARIISNPEGK----LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~~----l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
|+||||+.+ +|.+.+...... .....||+.||.|||+++++|+||||+||+++.++.++|+|||++........
T Consensus 92 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred EEEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 999999984 677776542211 22345899999999999999999999999999999999999999876643322
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...+....+..+... ..+
T Consensus 171 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~~--------------- 233 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTP--------------- 233 (293)
T ss_pred ccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-CCC---------------
Confidence 2234568899999999876 45889999999999999999999999876654433222110 000
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.......++..+.+||.+||..||.+||++.++|.|+||...
T Consensus 234 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 234 --------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred --------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 001123467889999999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=313.97 Aligned_cols=243 Identities=23% Similarity=0.387 Sum_probs=192.3
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|+++++||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTK--EEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCcEE
Confidence 457999999999999999999865 46779999875432 235678899999999999999999887765 345799
Q ss_pred EEechh-hHHHHHhhCC-CCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 204 VFEFMQ-TDLARIISNP-EGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~-~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
||||+. ++|.+.+... ...+. +..||+.||+|||+.+++||||||+|||++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 999997 5787776532 22222 345999999999999999999999999999999999999999987653322
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 223 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM-------------- 223 (261)
T ss_pred eccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 22233345678999999876 458899999999999999998 99999887766655544321100
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....++.++.+||.+||..||++|||++++++
T Consensus 224 ------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 224 ------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 112346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=314.14 Aligned_cols=247 Identities=20% Similarity=0.274 Sum_probs=192.2
Q ss_pred ceEEeeecccCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc----c
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDT---GKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ----Y 199 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~----~ 199 (584)
|.+.+.||+|+||.||+|....+ +..||||+++...........+.+|+.+++.++||||+++++++..... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999987643 4789999997665555566788999999999999999999987755332 3
Q ss_pred eEEEEEechh-hHHHHHhhCC-----CCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccc
Q 043957 200 SLYLVFEFMQ-TDLARIISNP-----EGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA 267 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~-----~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla 267 (584)
..++||||+. ++|...+... ...++ +..||+.||.|||+++|+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 4799999998 4666665321 12333 3459999999999999999999999999999999999999999
Q ss_pred cccCCCCCC-CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHH
Q 043957 268 NYFSPNKKR-PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDY 345 (584)
Q Consensus 268 ~~~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~ 345 (584)
+.+...... ......++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+.+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------ 233 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR------ 233 (273)
T ss_pred eeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------
Confidence 866433211 1112234678999999865 458999999999999999999 8999988776655544422110
Q ss_pred HHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 346 WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 346 ~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
......++..+.++|.+||+.||.+|||+.|++++
T Consensus 234 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 234 --------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred --------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=317.33 Aligned_cols=250 Identities=27% Similarity=0.482 Sum_probs=198.7
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC---CCCeeeeeceeeecCcceEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD---HPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~~~l~ 202 (584)
.|++.+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.+. ||||+++++++.. ....|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEE
Confidence 4888999999999999999999999999999986543 2334566888999999996 9999999998765 34679
Q ss_pred EEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 203 LVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
+||||+.+ +|.+.+... .+.+ ..||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++..+.....
T Consensus 79 lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EEEecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 99999985 676666432 3333 35999999999999999999999999999999999999999987654332
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
......|+..|+|||.+.+...++.++|||||||++|+|++|.+||...........+...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------------ 217 (277)
T cd06917 157 -KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------------------ 217 (277)
T ss_pred -ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC------------------
Confidence 2244578999999999876556789999999999999999999999776543322111000
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.+.... ...++.++.+||.+||+.||.+|||+.+++.|+||...
T Consensus 218 -~~~~~~------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 218 -KPPRLE------DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred -CCCCCC------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 000000 11267899999999999999999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.03 Aligned_cols=245 Identities=22% Similarity=0.355 Sum_probs=190.4
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcE----EEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKI----VALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
.+|++.+.||+|+||.||+|.+..++.. ||||+++.. ........+.+|+.+++.++||||+++++++... .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~---~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---C
Confidence 4699999999999999999988766654 899998643 2334456788999999999999999999988653 3
Q ss_pred EEEEEechh-hHHHHHhhCCCCCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQ-TDLARIISNPEGKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
.++|+||+. |+|.+.+......+ .+..||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+...
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 589999988 57877776544333 33459999999999999999999999999999999999999999876533
Q ss_pred CCCC-CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 274 KKRP-LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 274 ~~~~-~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
.... .....++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+.. .++.....+
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~---------- 230 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERL---------- 230 (316)
T ss_pred CcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCC----------
Confidence 2211 122234678999999876 458999999999999999997 99999876544432 222211000
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
+ ....++.++.++|.+||..||.+|||+.+++.+
T Consensus 231 ------~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 231 ------P---------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ------C---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 012356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.02 Aligned_cols=273 Identities=32% Similarity=0.513 Sum_probs=215.6
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC------CCCeeeeeceeeecC
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD------HPNIVKLEGLATSRM 197 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~------HpnIv~l~~~~~~~~ 197 (584)
-.+|.+....|+|-|++|..|.+..-|..||||+|... +...+.=.+|++||++|. --|+++|+..|..
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h-- 505 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH-- 505 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh--
Confidence 45899999999999999999999999999999999632 223344567999999994 3478888776665
Q ss_pred cceEEEEEechhhHHHHHhhCCCCC--C------cHHHHHHHHHHHHHhCCceeccccccceeecCC-CcEEEEEecccc
Q 043957 198 QYSLYLVFEFMQTDLARIISNPEGK--L------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKN-GVLKIADFGLAN 268 (584)
Q Consensus 198 ~~~l~lV~Ey~~g~L~~~l~~~~~~--l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~-g~vKL~DFGla~ 268 (584)
.+++|||||-+.-+|.++++..... + ..++|++.||..|...||+|.||||+||||++. ..+||||||.|.
T Consensus 506 knHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 506 KNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred cceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence 5689999999999999988753321 1 223599999999999999999999999999875 568999999998
Q ss_pred ccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHH
Q 043957 269 YFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK 348 (584)
Q Consensus 269 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 348 (584)
....+. ++.+..+..|+|||+|+|. .|+...|+||+||+||||.||+-.|+|.++...+...+.+.+.++...+.+
T Consensus 586 ~~~ene---itPYLVSRFYRaPEIiLG~-~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 586 FASENE---ITPYLVSRFYRAPEIILGL-PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred cccccc---ccHHHHHHhccCcceeecC-cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 876554 4666778899999999985 599999999999999999999999999999999999999999888665543
Q ss_pred hhcc-CCC-------------------------CCCCCCCchhhhhccCCc-------HhHHHHHHHhcccCCCCCCCHH
Q 043957 349 LRLS-TTF-------------------------RPPQSYKPRLFEAFSEFP-------ESSLGLLSTLLALDPAYRGSAA 395 (584)
Q Consensus 349 ~~~~-~~~-------------------------~~p~~~~~~~~~~~~~~s-------~~~~dLI~~~L~~DP~kRpTa~ 395 (584)
-... ..| ..|...........+.++ ..+.+||.+||.+||++|.|+.
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 2211 000 011100001111112233 3579999999999999999999
Q ss_pred HHhcCcCCCC
Q 043957 396 SALKNEFFFT 405 (584)
Q Consensus 396 e~L~Hp~f~~ 405 (584)
++|.||||+.
T Consensus 742 qAL~HpFi~~ 751 (752)
T KOG0670|consen 742 QALKHPFITE 751 (752)
T ss_pred HHhcCCcccC
Confidence 9999999974
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=360.24 Aligned_cols=255 Identities=29% Similarity=0.462 Sum_probs=193.0
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC------
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM------ 197 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------ 197 (584)
..+|+.++.||+|+||.||+|+++-+|+.||||+|.... .......+.+|+.+|.+|+|||||+++..+....
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 346888999999999999999999999999999998766 5556677889999999999999999853111000
Q ss_pred --------------------------------------------------------------------------------
Q 043957 198 -------------------------------------------------------------------------------- 197 (584)
Q Consensus 198 -------------------------------------------------------------------------------- 197 (584)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred -----------------------c--------ceEEEEEechhhHHHHHhhCCCCC-------CcHHHHHHHHHHHHHhC
Q 043957 198 -----------------------Q--------YSLYLVFEFMQTDLARIISNPEGK-------LTEPQQLLSGLQHCHDR 239 (584)
Q Consensus 198 -----------------------~--------~~l~lV~Ey~~g~L~~~l~~~~~~-------l~~~~qIl~aL~yLH~~ 239 (584)
+ ..+||=||||+..+++.+.+.+.. ...+++|+.||.|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0 247999999998777666544332 23346999999999999
Q ss_pred CceeccccccceeecCCCcEEEEEeccccccC-----------------CCCCCCCccccccccccChhhhhCCC--CCC
Q 043957 240 GILHRDVKGSNLLIDKNGVLKIADFGLANYFS-----------------PNKKRPLTSRVVTLWYRAPELLLGAT--DYG 300 (584)
Q Consensus 240 ~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~-----------------~~~~~~~~~~~gt~~Y~APEvl~~~~--~~~ 300 (584)
|||||||||.||+|++++.|||+|||+|+... .......++.+||..|+|||++.+.. .|+
T Consensus 717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999999999999999999998621 01122467889999999999997766 699
Q ss_pred ceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHH
Q 043957 301 VGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLL 380 (584)
Q Consensus 301 ~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI 380 (584)
.|+||||||||||||+. ||... .+-...+.. +..+. ...+ ...+..--+.-..+|
T Consensus 797 ~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~-LR~g~------------iP~~-------~~f~~~~~~~e~slI 851 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLY---PFGTS--MERASILTN-LRKGS------------IPEP-------ADFFDPEHPEEASLI 851 (1351)
T ss_pred chhhhHHHHHHHHHHhc---cCCch--HHHHHHHHh-cccCC------------CCCC-------cccccccchHHHHHH
Confidence 99999999999999984 46543 222222211 11111 0000 011112223446899
Q ss_pred HHhcccCCCCCCCHHHHhcCcCCC
Q 043957 381 STLLALDPAYRGSAASALKNEFFF 404 (584)
Q Consensus 381 ~~~L~~DP~kRpTa~e~L~Hp~f~ 404 (584)
.+||+.||++||||.|+|++.||-
T Consensus 852 ~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 852 RWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHhcCCCccCCCHHHHhhccCCC
Confidence 999999999999999999999984
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=348.12 Aligned_cols=272 Identities=24% Similarity=0.285 Sum_probs=184.5
Q ss_pred CCCCceEEeeecccCceEEEEEEECCC----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceee----
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDT----GKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLAT---- 194 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~----g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~---- 194 (584)
..++|.+.+.||+|+||.||+|.+..+ +..||||++..... .+....| .++...+.+++.+...+.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 567899999999999999999999988 99999998753211 1111111 122222333333222211
Q ss_pred ecCcceEEEEEechhh-HHHHHhhCCCCC-------------------------CcHHHHHHHHHHHHHhCCceeccccc
Q 043957 195 SRMQYSLYLVFEFMQT-DLARIISNPEGK-------------------------LTEPQQLLSGLQHCHDRGILHRDVKG 248 (584)
Q Consensus 195 ~~~~~~l~lV~Ey~~g-~L~~~l~~~~~~-------------------------l~~~~qIl~aL~yLH~~~IvHrDLKp 248 (584)
......+||||||+.+ +|.+++...... ..+..||+.||.|||+++|+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 1234468999999984 566666532210 02345899999999999999999999
Q ss_pred cceeecC-CCcEEEEEeccccccCCCCCCCCccccccccccChhhhhCCC---------------------CCCceeeEe
Q 043957 249 SNLLIDK-NGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGAT---------------------DYGVGIDLW 306 (584)
Q Consensus 249 ~NILl~~-~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~---------------------~~~~~sDIw 306 (584)
+||||+. ++.+||+|||+|+.+...........++|+.|+|||++.... .++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999986 579999999999876443333345678899999999764221 234567999
Q ss_pred cchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhccc
Q 043957 307 SAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLAL 386 (584)
Q Consensus 307 SLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~ 386 (584)
|||||||||+++. |........+..++..+... ...|....... . ........+.+...+..+++||.+||++
T Consensus 364 SlGviL~el~~~~--~~~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~---~-~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 364 SAGLIFLQMAFPN--LRSDSNLIQFNRQLKRNDYD-LVAWRKLVEPR---A-SPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHHhCc--CCCchHHHHHHHHHHhcCCc-HHHHHHhhccc---c-chhhhhhhhhccccchHHHHHHHHHccC
Confidence 9999999999864 45555566666666554433 23343321111 0 0000112233344456778999999999
Q ss_pred CCCCCCCHHHHhcCcCCCCCC
Q 043957 387 DPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 387 DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
||.+|||+.|+|+||||....
T Consensus 437 dP~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 437 KGRQRISAKAALAHPYFDREG 457 (566)
T ss_pred CcccCCCHHHHhCCcCcCCCC
Confidence 999999999999999997643
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=307.60 Aligned_cols=247 Identities=32% Similarity=0.535 Sum_probs=201.6
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
+|++.+.||+|++|.||++.+..++..||+|.+............+.+|++++++++||||+++++++... ...|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--DSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEEEEE
Confidence 48899999999999999999999999999999976655445677899999999999999999999887763 5689999
Q ss_pred echhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 206 EFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 206 Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
||+.+ +|.+.+... ..+. ...|++.||.|||++||+|+||||+||+++.++.++|+|||++........ ..
T Consensus 79 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 156 (254)
T cd06627 79 EYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-DD 156 (254)
T ss_pred ecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-cc
Confidence 99985 677666543 3333 335999999999999999999999999999999999999999987654332 12
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p 358 (584)
....++..|+|||.+.+. .++.++||||||+++|+|++|.+||...........+... ..
T Consensus 157 ~~~~~~~~y~~pe~~~~~-~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------------~~---- 216 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMS-GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD---------------DH---- 216 (254)
T ss_pred cccccchhhcCHhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc---------------CC----
Confidence 345678999999998764 4889999999999999999999999876644433332110 00
Q ss_pred CCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 359 ~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
......+++.+.+||.+||..||++|||+.++|.||||
T Consensus 217 -------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 217 -------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred -------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 01123567899999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=317.76 Aligned_cols=247 Identities=21% Similarity=0.293 Sum_probs=190.2
Q ss_pred ceEEeeecccCceEEEEEEECCCCc--EEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC----cce
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGK--IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM----QYS 200 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~~ 200 (584)
|.+.+.||+|+||.||+|.+..++. .||+|.++.........+.+.+|+.+++.++||||+++++++.... ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567889999999999999887765 6999998766555666778889999999999999999998764321 224
Q ss_pred EEEEEechh-hHHHHHhhCC-----CCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccc
Q 043957 201 LYLVFEFMQ-TDLARIISNP-----EGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLAN 268 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~-----~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~ 268 (584)
.++||||+. ++|...+... ...+. +..||+.||+|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 689999998 5666655321 11222 23599999999999999999999999999999999999999998
Q ss_pred ccCCCCCCC-CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHH
Q 043957 269 YFSPNKKRP-LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYW 346 (584)
Q Consensus 269 ~~~~~~~~~-~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 346 (584)
.+....... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |++||.+.........+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-------- 231 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-------- 231 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--------
Confidence 764332111 122345678999999876 458999999999999999999 899998876655444332110
Q ss_pred HHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 347 KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 347 ~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
. ......++..+.++|.+||+.||.+|||+.+++++
T Consensus 232 -------~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 232 -------R-----------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -------C-----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 00113467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=322.07 Aligned_cols=250 Identities=26% Similarity=0.455 Sum_probs=199.3
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
..|...+.||.|+||.||+|.+..++..||||.+.... ........+.+|+.+++.++|+||+++++++... ...|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 92 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWL 92 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CeeEE
Confidence 34888899999999999999999999999999986532 2334456678899999999999999999988764 45799
Q ss_pred EEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 204 VFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||||+.+++...+......+.+ ..||+.||.|||+++++||||||+|||++.++.++|+|||++......
T Consensus 93 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---- 168 (308)
T cd06634 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (308)
T ss_pred EEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence 9999998887776543333433 348999999999999999999999999999999999999998765432
Q ss_pred CccccccccccChhhhhC--CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 278 LTSRVVTLWYRAPELLLG--ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~--~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
....+++.|+|||++.+ ...++.++|||||||++|+|++|..||...+..+....+..... +
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~-------------- 232 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-P-------------- 232 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-C--------------
Confidence 34467899999999853 23478899999999999999999999977654444333321100 0
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
. .....++..+.+||.+||..+|.+|||++++++|||+...
T Consensus 233 ---~-------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 233 ---A-------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ---C-------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 0 0012467889999999999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=316.54 Aligned_cols=250 Identities=25% Similarity=0.460 Sum_probs=198.3
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
-|++++.||.|+||.||+|.+..++..||||.+..... ......+.+|+.++.+++||||+++++++... ...|+||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC--CeEEEEE
Confidence 38889999999999999999998999999999864332 33456788999999999999999999988763 4579999
Q ss_pred echhh-HHHHHhhCCCCC----CcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCcc
Q 043957 206 EFMQT-DLARIISNPEGK----LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTS 280 (584)
Q Consensus 206 Ey~~g-~L~~~l~~~~~~----l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~ 280 (584)
||+.+ +|...+...... .....||+.||.|||+.+|+|+||||+||+++.++.++|+|||++..+.... .....
T Consensus 82 e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~ 160 (277)
T cd06641 82 EYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNT 160 (277)
T ss_pred EeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhhcc
Confidence 99985 666666532211 2233589999999999999999999999999999999999999987664322 11234
Q ss_pred ccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCC
Q 043957 281 RVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQS 360 (584)
Q Consensus 281 ~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~ 360 (584)
..++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||...........+.... + .
T Consensus 161 ~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~-----------------~- 219 (277)
T cd06641 161 FVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN--P-----------------P- 219 (277)
T ss_pred ccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC--C-----------------C-
Confidence 567899999999865 457889999999999999999999997665544333321110 0 0
Q ss_pred CCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 361 YKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 361 ~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.....++.++.++|.+||+.||.+||++.++|+||||...
T Consensus 220 ------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 220 ------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 0113467889999999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=316.31 Aligned_cols=245 Identities=28% Similarity=0.419 Sum_probs=184.1
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEeecCCCCh-HHHHHHHHH---HHHHHhCCCCCeeeeeceeeecCcceEEEEEec
Q 043957 132 KVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP-HSVKFMARE---IMILQKLDHPNIVKLEGLATSRMQYSLYLVFEF 207 (584)
Q Consensus 132 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-~~~~~~~~E---i~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey 207 (584)
.||+|+||.||+|.+..+++.||||++....... .....+..| +.+++...||||+.+++++... ..+|+||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEEEEec
Confidence 3899999999999999999999999986543221 111223333 3445556899999998877764 468999999
Q ss_pred hhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCcc
Q 043957 208 MQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTS 280 (584)
Q Consensus 208 ~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~ 280 (584)
+.| +|...+.. ...+.+ +.|++.||.|||+.+|+||||||+|||++.++.+||+|||++..+.... ...
T Consensus 79 ~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~ 154 (278)
T cd05606 79 MNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHA 154 (278)
T ss_pred CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcC
Confidence 985 56555543 333433 3599999999999999999999999999999999999999997654322 234
Q ss_pred ccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCC
Q 043957 281 RVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQS 360 (584)
Q Consensus 281 ~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~ 360 (584)
..|+..|+|||++.+...++.++|||||||++|+|++|+.||.......... +..... ...
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~------------~~~------ 215 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTL------------TMA------ 215 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHHHhh------------ccC------
Confidence 5789999999999755568999999999999999999999997753221111 000000 000
Q ss_pred CCchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCCC
Q 043957 361 YKPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFTS 406 (584)
Q Consensus 361 ~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~~ 406 (584)
......++..+.+||.+||..||.+|| ++.++++||||...
T Consensus 216 -----~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 216 -----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred -----CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 011124578999999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=327.41 Aligned_cols=236 Identities=26% Similarity=0.366 Sum_probs=190.5
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEe
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFE 206 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~E 206 (584)
..-++-||.|+.|.||+++.. ++.||||+++ +.-..+|+-|++|+||||+.|.|+|.. .-++|||||
T Consensus 126 IsELeWlGSGaQGAVF~Grl~--netVAVKKV~---------elkETdIKHLRkLkH~NII~FkGVCtq--sPcyCIiME 192 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH--NETVAVKKVR---------ELKETDIKHLRKLKHPNIITFKGVCTQ--SPCYCIIME 192 (904)
T ss_pred hhhhhhhccCcccceeeeecc--CceehhHHHh---------hhhhhhHHHHHhccCcceeeEeeeecC--CceeEEeee
Confidence 344677999999999999654 7899999985 122357889999999999999999986 446799999
Q ss_pred chh-hHHHHHhhCCCCCC-----cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCcc
Q 043957 207 FMQ-TDLARIISNPEGKL-----TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTS 280 (584)
Q Consensus 207 y~~-g~L~~~l~~~~~~l-----~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~ 280 (584)
||. |.|..+++...... .|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++....- ....+
T Consensus 193 fCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMS 270 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMS 270 (904)
T ss_pred ccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhh
Confidence 998 77888887654432 45569999999999999999999999999999999999999999876533 33567
Q ss_pred ccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCC
Q 043957 281 RVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQS 360 (584)
Q Consensus 281 ~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~ 360 (584)
++||..|||||+|.. .+.+.++|||||||+|||||||.-||..-+...++.. .+....
T Consensus 271 FaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG----VGsNsL----------------- 328 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG----VGSNSL----------------- 328 (904)
T ss_pred hhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeEEe----ccCCcc-----------------
Confidence 899999999999987 5699999999999999999999999965443322211 111000
Q ss_pred CCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 361 YKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 361 ~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
-......+|+.++-||+.||.-.|..||+..++|.|-=+
T Consensus 329 ----~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 329 ----HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred ----cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 011235678999999999999999999999999999444
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=304.64 Aligned_cols=246 Identities=33% Similarity=0.555 Sum_probs=198.8
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
+|++.+.||.|++|.||++.+..++..|++|++..... .....+.+|+.+++.++|+||+++++++... ...++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEEE
Confidence 48899999999999999999998999999999965433 3557788999999999999999999988764 4579999
Q ss_pred echh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 206 EFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 206 Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
||+. ++|.+.+......+.+ ..||+.||.|||.++++|+||+|+||+++.++.++|+|||++........ .
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 9999 5777776654333333 34999999999999999999999999999999999999999987654332 3
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p 358 (584)
....++..|+|||++.+. .++.++|||||||++|+|++|.+||...+.......+.... .+.
T Consensus 155 ~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~---------------- 216 (253)
T cd05122 155 NTMVGTPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG-PPG---------------- 216 (253)
T ss_pred cceecCCcccCHHHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC-CCC----------------
Confidence 455788999999998764 48899999999999999999999998775544433322100 000
Q ss_pred CCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcC
Q 043957 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402 (584)
Q Consensus 359 ~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~ 402 (584)
......++..+.+||.+||+.||.+|||+.++|+|||
T Consensus 217 -------~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 217 -------LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred -------cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0001124788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=306.42 Aligned_cols=252 Identities=33% Similarity=0.573 Sum_probs=201.8
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
+|++.+.||+|++|.||+|.+..++..|++|++..........+.+.+|+.++++++||||+++++++.......+++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 48899999999999999999999999999999976655455678899999999999999999999888765336789999
Q ss_pred echh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC-C
Q 043957 206 EFMQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR-P 277 (584)
Q Consensus 206 Ey~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~-~ 277 (584)
||+. ++|.+.+.... .+. +..|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+......... .
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 9996 56777765432 333 3459999999999999999999999999999999999999999876543320 1
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 357 (584)
.....++..|+|||.+.+. .++.++|||||||++|+|++|..||...... ...+......
T Consensus 160 ~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~----------------- 219 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAALYKIGSS----------------- 219 (260)
T ss_pred ccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHhcccc-----------------
Confidence 2345678999999998764 4899999999999999999999999876621 1111111100
Q ss_pred CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 358 p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
.........++..+.+||.+||+.||.+|||+.++|+||||
T Consensus 220 -----~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 220 -----GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred -----CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 00011223457899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=330.98 Aligned_cols=248 Identities=25% Similarity=0.356 Sum_probs=188.8
Q ss_pred CCceEEeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCc
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDR-----DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 198 (584)
++|++.+.||+|+||.||+|.+. .+++.||+|+++... .....+.+.+|+.+++++ +|+||+++++++... .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP-G 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-C
Confidence 46999999999999999999743 345789999986433 233456678899999999 799999999877654 3
Q ss_pred ceEEEEEechhh-HHHHHhhCCCC--------------------------------------------------------
Q 043957 199 YSLYLVFEFMQT-DLARIISNPEG-------------------------------------------------------- 221 (584)
Q Consensus 199 ~~l~lV~Ey~~g-~L~~~l~~~~~-------------------------------------------------------- 221 (584)
..++++|||+.+ +|...+.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 468999999985 56665532110
Q ss_pred ----CCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC-CCCccccccccccCh
Q 043957 222 ----KLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAP 290 (584)
Q Consensus 222 ----~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~AP 290 (584)
.+. +..||+.||.|||+++|+||||||+|||++.++.+||+|||++..+..... .......++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 122 235999999999999999999999999999999999999999987643221 112234556789999
Q ss_pred hhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhc
Q 043957 291 ELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAF 369 (584)
Q Consensus 291 Evl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 369 (584)
|++.+ ..++.++|||||||++|+|++ |.+||.+....+.+...+... ... ...
T Consensus 245 E~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~--------------~~~-----------~~~ 298 (337)
T cd05054 245 ESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG--------------TRM-----------RAP 298 (337)
T ss_pred HHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc--------------CCC-----------CCC
Confidence 99976 459999999999999999998 999998754433332222110 000 011
Q ss_pred cCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 370 SEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 370 ~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
..+++++.+++.+||+.+|++|||+.|+++|
T Consensus 299 ~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 299 EYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=326.78 Aligned_cols=272 Identities=22% Similarity=0.305 Sum_probs=193.0
Q ss_pred eeccc--CceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechh
Q 043957 132 KVGQG--TYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ 209 (584)
Q Consensus 132 ~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~ 209 (584)
.||+| +||+||+|.+..+|+.||||++..........+.+.+|+.+++.++||||+++++++... ..+|+||||+.
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~~v~e~~~ 82 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG--SWLWVISPFMA 82 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC--CceEEEEeccc
Confidence 46666 999999999999999999999976655555668899999999999999999999998774 45799999998
Q ss_pred h-HHHHHhhCCC-CCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC----
Q 043957 210 T-DLARIISNPE-GKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP---- 277 (584)
Q Consensus 210 g-~L~~~l~~~~-~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~---- 277 (584)
+ ++..++.... ..+ .+..||+.||+|||+++|+||||||+|||++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 5 6666655321 123 234599999999999999999999999999999999999998654332111100
Q ss_pred --CccccccccccChhhhhCC-CCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh---------HH
Q 043957 278 --LTSRVVTLWYRAPELLLGA-TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSE---------DY 345 (584)
Q Consensus 278 --~~~~~gt~~Y~APEvl~~~-~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~---------~~ 345 (584)
.....++..|+|||++.+. ..++.++|||||||++|+|++|.+||........+..++......+. ..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 0112345679999998753 34789999999999999999999999887665544443332111000 00
Q ss_pred HHHhhccCC------CCC---CCCC--CchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 346 WKKLRLSTT------FRP---PQSY--KPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 346 ~~~~~~~~~------~~~---p~~~--~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
+........ ... .... ..........+++.+.+||.+||+.||++|||+.|+|+||||..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 000000000 000 0000 00001112346788999999999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=310.81 Aligned_cols=248 Identities=34% Similarity=0.496 Sum_probs=200.3
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
+|++.+.||.|++|.||+|.+..+++.||||++...... .....+.+|+.++..++|+||+++++++... ..+|+||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 78 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEISIVL 78 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEEEEE
Confidence 589999999999999999999999999999998755432 4567788999999999999999999887764 5689999
Q ss_pred echh-hHHHHHhhCCCCCC------cHHHHHHHHHHHHHh-CCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 206 EFMQ-TDLARIISNPEGKL------TEPQQLLSGLQHCHD-RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 206 Ey~~-g~L~~~l~~~~~~l------~~~~qIl~aL~yLH~-~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||+. ++|...+... ..+ .+..||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 79 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~ 156 (264)
T cd06623 79 EYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-Q 156 (264)
T ss_pred EecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-c
Confidence 9999 5777777542 233 334599999999999 9999999999999999999999999999987653332 1
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE---VEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.....++..|+|||.+... .++.++|||||||++|+|++|.+||..... .+....+... ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---~~------------ 220 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG---PP------------ 220 (264)
T ss_pred ccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC---CC------------
Confidence 2345678999999998764 688999999999999999999999977642 2222222110 00
Q ss_pred CCCCCCCCchhhhhccC-CcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 355 FRPPQSYKPRLFEAFSE-FPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~-~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
...... ++..+.+||.+||..+|.+|||+.++|+||||..
T Consensus 221 -----------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 221 -----------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred -----------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 001123 6889999999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=304.42 Aligned_cols=275 Identities=30% Similarity=0.562 Sum_probs=216.2
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l 201 (584)
..++|++++++|+|.|+.||.|.+..+.+.++||+++.. ..+.+.+|+.||+.|. ||||++++++..+......
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 356799999999999999999999999999999998632 3466899999999997 9999999999998888788
Q ss_pred EEEEechhh-HHHHH---hhCCCCCCcHHHHHHHHHHHHHhCCceeccccccceeecCC-CcEEEEEeccccccCCCCCC
Q 043957 202 YLVFEFMQT-DLARI---ISNPEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKN-GVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~---l~~~~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~-g~vKL~DFGla~~~~~~~~~ 276 (584)
.||+||+.. +...+ +.+.+ ..-...+++.||.|||++||+|||+||.|++||.. -.++|+|+|||.++.+...
T Consensus 111 aLiFE~v~n~Dfk~ly~tl~d~d-IryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e- 188 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYPTLTDYD-IRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE- 188 (338)
T ss_pred hhHhhhhccccHHHHhhhhchhh-HHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCce-
Confidence 999999985 33322 22211 11123499999999999999999999999999875 5699999999999875543
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCCh-HHHHHhhcc--
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGR-PIMPGRTEVEQLHRIFKLCGSPSE-DYWKKLRLS-- 352 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~-~pF~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~-- 352 (584)
....+.+.+|--||.+.....|+..-|+|||||+|..|+..+ |.|.|.++.+++.+|.+.++.-.. .+..+....
T Consensus 189 -YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ld 267 (338)
T KOG0668|consen 189 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLD 267 (338)
T ss_pred -eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence 456678999999999998888999999999999999999876 667899999999999999886442 223332211
Q ss_pred CCCCC--CCCCCchhhhhc----c-CCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 353 TTFRP--PQSYKPRLFEAF----S-EFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 353 ~~~~~--p~~~~~~~~~~~----~-~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
..+.. -......|...+ . -.+++++|||.++|..|..+|+||.|++.||||..
T Consensus 268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 11110 011111222222 1 24689999999999999999999999999999963
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=318.03 Aligned_cols=246 Identities=22% Similarity=0.364 Sum_probs=192.0
Q ss_pred CCceEEeeecccCceEEEEEEEC----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDR----DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
..|++.+.||+|+||.||+|... .++..||+|.+... ........+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE--QP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--Cc
Confidence 46899999999999999999853 45678999998643 2334456788999999999999999999887664 35
Q ss_pred EEEEEechh-hHHHHHhhCCC----------------CCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCC
Q 043957 201 LYLVFEFMQ-TDLARIISNPE----------------GKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG 257 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~----------------~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g 257 (584)
.|+||||+. ++|.+++.... ..+ ....||+.||.|||+++|+||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 799999998 46777664211 112 2345999999999999999999999999999999
Q ss_pred cEEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 043957 258 VLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIF 335 (584)
Q Consensus 258 ~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~ 335 (584)
.+||+|||+++....... .......++..|+|||++.+. .++.++|||||||++|||++ |.+||.+.........+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999986543221 112334456789999998764 58999999999999999998 999998876655544442
Q ss_pred HhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 336 KLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.... ......+++.+.+||.+||+.||.+||++.+++++
T Consensus 241 ~~~~--------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 241 KRQL--------------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCc--------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 2110 01123467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.14 Aligned_cols=246 Identities=30% Similarity=0.416 Sum_probs=191.0
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechhh-
Q 043957 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSE-PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT- 210 (584)
Q Consensus 133 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~g- 210 (584)
||+|+||+||+|.+..+|+.||+|.+...... ......+.+|+.+|+.++||||+++++++... ..+|+||||+.+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK--DDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC--CeEEEEEecCCCC
Confidence 68999999999999999999999998643222 22344567899999999999999998887664 467999999984
Q ss_pred HHHHHhhCCC-CCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccccc
Q 043957 211 DLARIISNPE-GKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV 283 (584)
Q Consensus 211 ~L~~~l~~~~-~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~g 283 (584)
+|...+.... ..+.+ ..||+.||.|||+++|+|+||+|+|||++.++.++|+|||++...... .......+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 156 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRAG 156 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC--CccccccC
Confidence 6776665432 13333 349999999999999999999999999999999999999999765432 22344567
Q ss_pred cccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCc
Q 043957 284 TLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKP 363 (584)
Q Consensus 284 t~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 363 (584)
+..|+|||++.+.. ++.++|||||||++|+|++|+.||...........+...... .
T Consensus 157 ~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------~------ 213 (277)
T cd05577 157 TPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE----------------M------ 213 (277)
T ss_pred CCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc----------------c------
Confidence 88999999987644 889999999999999999999999765542111111111000 0
Q ss_pred hhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCCC
Q 043957 364 RLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFTS 406 (584)
Q Consensus 364 ~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~~ 406 (584)
.......+++.+.+||.+||+.||.+|| ++.++|+||||...
T Consensus 214 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 214 -AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred -cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcC
Confidence 0011234688999999999999999999 99999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=313.87 Aligned_cols=248 Identities=30% Similarity=0.461 Sum_probs=192.6
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecC-CCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD-TSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~-~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|++.+.||+|+||.||+|.+..+++.||||.+... .........+.+|+.+++.++||||+++++++... ...|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED--NELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC--CeEEE
Confidence 4699999999999999999999999999999988643 23344556788999999999999999999988764 46799
Q ss_pred EEechhh-HHHHHhhC---CCCCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 204 VFEFMQT-DLARIISN---PEGKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~---~~~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
||||+.+ +|..++.. ....+ .++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999995 66655532 12222 33459999999999999999999999999999999999999999876432
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE-VEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
.. ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ...+...+.....++
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 227 (267)
T cd08228 160 TT-AAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP---------- 227 (267)
T ss_pred hH-HHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC----------
Confidence 21 1234568899999999876 4588999999999999999999999865432 111111111111110
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.....++..+.+||.+||..||.+|||+.++|+.
T Consensus 228 --------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 228 --------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred --------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 0012457889999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=316.68 Aligned_cols=253 Identities=20% Similarity=0.308 Sum_probs=194.2
Q ss_pred CCCCceEEeeecccCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRD-----TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM 197 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 197 (584)
..++|++.+.||+|+||.||+|.++. .+..||+|.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45679999999999999999997652 355899998864332 233445778999999999999999999876643
Q ss_pred cceEEEEEechh-hHHHHHhhCCCC---------------CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEE
Q 043957 198 QYSLYLVFEFMQ-TDLARIISNPEG---------------KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKI 261 (584)
Q Consensus 198 ~~~l~lV~Ey~~-g~L~~~l~~~~~---------------~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL 261 (584)
..|+||||+. ++|.+.+..... ......||+.||.|||+++|+||||||+|||++.++.++|
T Consensus 83 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 83 --PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred --CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 5799999998 577777753211 0123459999999999999999999999999999999999
Q ss_pred EEeccccccCCCCCC-CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 043957 262 ADFGLANYFSPNKKR-PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCG 339 (584)
Q Consensus 262 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~ 339 (584)
+|||+++........ ......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+....+....+.....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 239 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999865332211 1122345678999999876 458999999999999999998 7899987766554443322100
Q ss_pred CCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc------CcCCCC
Q 043957 340 SPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK------NEFFFT 405 (584)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~------Hp~f~~ 405 (584)
......+++.+.+||.+||+.||.+|||+.++++ ||||..
T Consensus 240 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 240 --------------------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 0011245788999999999999999999999987 899865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=316.08 Aligned_cols=248 Identities=18% Similarity=0.293 Sum_probs=190.9
Q ss_pred CCCCceEEeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDR-----DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM 197 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 197 (584)
..++|++.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~- 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG- 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-
Confidence 4567999999999999999999764 245789999985432 223455688999999999999999999887653
Q ss_pred cceEEEEEechh-hHHHHHhhCCCC---------------CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEE
Q 043957 198 QYSLYLVFEFMQ-TDLARIISNPEG---------------KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKI 261 (584)
Q Consensus 198 ~~~l~lV~Ey~~-g~L~~~l~~~~~---------------~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL 261 (584)
...++||||+. ++|.+.+..... .+.+..||+.||.|||+.+++|+||||+|||++.++.++|
T Consensus 82 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 82 -QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred -CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 45799999998 467776653211 1123458999999999999999999999999999999999
Q ss_pred EEeccccccCCCCCC-CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 043957 262 ADFGLANYFSPNKKR-PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCG 339 (584)
Q Consensus 262 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~ 339 (584)
+|||++..+...... ......+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.+......+..+.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL 239 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 999999765322211 1122345778999999876 458999999999999999999 7899988766555443322100
Q ss_pred CCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 340 SPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
+ .....+++.+.+||.+||+.||.+|||+.|+|++
T Consensus 240 -~-------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 240 -L-------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred -C-------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 0113457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=338.58 Aligned_cols=243 Identities=32% Similarity=0.464 Sum_probs=195.8
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l 201 (584)
..+.|.+...||.|+|++|..+.+..++...++|++..... ...+|+.++... +||||+++++.+.+ ..++
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~--~~~~ 391 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYED--GKEI 391 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecC--Ccee
Confidence 46789999999999999999999999999999999965421 233567666555 69999999998877 4468
Q ss_pred EEEEechhhH-HHH-HhhCCCCC---CcHHHHHHHHHHHHHhCCceeccccccceee-cCCCcEEEEEeccccccCCCCC
Q 043957 202 YLVFEFMQTD-LAR-IISNPEGK---LTEPQQLLSGLQHCHDRGILHRDVKGSNLLI-DKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 202 ~lV~Ey~~g~-L~~-~l~~~~~~---l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl-~~~g~vKL~DFGla~~~~~~~~ 275 (584)
|+|||++.|. +++ ++..+... ..|+.+|+.||.|||++|||||||||+|||+ +..|+++|+|||.++.....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999963 333 33332221 1355699999999999999999999999999 68999999999999876543
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEV-EQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
+.+.+-|..|.|||++.. ..|+.+|||||||++||+||+|+.||...... +++.+| +.+...
T Consensus 470 --~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s---------- 532 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFS---------- 532 (612)
T ss_pred --hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccc----------
Confidence 345567899999999974 67999999999999999999999999876655 333332 222110
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
..+|+.++|||+.||+.||.+|+++.+++.||||.+.+
T Consensus 533 ---------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~ 570 (612)
T KOG0603|consen 533 ---------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSHP 570 (612)
T ss_pred ---------------cccCHHHHHHHHHhccCChhhCcChhhhccCcchhcCC
Confidence 45799999999999999999999999999999994443
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=311.27 Aligned_cols=247 Identities=21% Similarity=0.347 Sum_probs=193.3
Q ss_pred CCCceEEeeecccCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDT---GKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
.++|++.+.||+|+||.||+|.+..+ ...||||.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS--RP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC--Cc
Confidence 35699999999999999999988654 4579999886433 333456688899999999999999999987663 45
Q ss_pred EEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
.|+||||+.+ +|.+.+......+.+ ..|++.||.|||+++|+|+||||+|||++.++.++|+|||++..+...
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 7999999985 677777654444433 359999999999999999999999999999999999999999877422
Q ss_pred CCC-CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 274 KKR-PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 274 ~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
... ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+......+
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 228 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP---------- 228 (266)
T ss_pred ccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC----------
Confidence 111 1112234678999999875 458999999999999999998 999997766555544442211000
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
....+++.+.+||.+||+.||++|||+.+++++
T Consensus 229 ----------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 229 ----------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ----------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 012457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=311.50 Aligned_cols=243 Identities=21% Similarity=0.329 Sum_probs=190.3
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++.+.||+|+||.||++.... +..||||.+..... ....+.+|+.++++++||||+++++++... ..+|+|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ--RPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccC--CCcEEE
Confidence 469999999999999999997654 45699999864322 235678899999999999999999988654 357999
Q ss_pred Eechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 205 FEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
|||+.+ +|...+......+. ...||+.||+|||+.+|+|+||||+|||++.++.+||+|||++..........
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999974 67777654333333 34599999999999999999999999999999999999999998654332211
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
.....++..|+|||++.+. .++.++|||||||++|+|++ |..||......+....+......+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY--------------- 221 (256)
T ss_pred cCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC---------------
Confidence 1223456789999999764 48999999999999999998 999998776655554443221100
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.....++.+.++|.+||+.||.+|||+.++|.+
T Consensus 222 -----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 222 -----------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred -----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 012347889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=321.89 Aligned_cols=268 Identities=22% Similarity=0.283 Sum_probs=188.7
Q ss_pred CceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechhh-HHHHH
Q 043957 137 TYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARI 215 (584)
Q Consensus 137 ~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~g-~L~~~ 215 (584)
+++.||.+++..+++.||||++............+.+|+.+++.++||||+++++++... ...|++|||+.+ +|..+
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~--~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD--SELYVVSPLMAYGSCEDL 89 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC--CeEEEEEeccCCCCHHHH
Confidence 445566666677899999999986655556678899999999999999999999988763 457999999984 56666
Q ss_pred hhCC-CCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC------CCCcccc
Q 043957 216 ISNP-EGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK------RPLTSRV 282 (584)
Q Consensus 216 l~~~-~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~------~~~~~~~ 282 (584)
+... ...+. .+.||+.||.|||+++|+||||||+|||++.++.+||+|||.+..+..... .......
T Consensus 90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 90 LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccc
Confidence 5532 12232 235999999999999999999999999999999999999999865532211 1123345
Q ss_pred ccccccChhhhhCC-CCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC--hHHHHHhhccCC-----
Q 043957 283 VTLWYRAPELLLGA-TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPS--EDYWKKLRLSTT----- 354 (584)
Q Consensus 283 gt~~Y~APEvl~~~-~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~~~~----- 354 (584)
++..|+|||++.+. ..++.++|||||||++|+|++|..||........+........... ...+........
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS 249 (314)
T ss_pred ccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccc
Confidence 67889999998653 3588999999999999999999999987655443322222111000 000000000000
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
...+.............++.++.+||.+||+.||++|||+.++|+||||...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred ccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 0000000011111123456788999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.62 Aligned_cols=245 Identities=24% Similarity=0.353 Sum_probs=192.4
Q ss_pred CCceEEeeecccCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRD-----TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
+.|.+.+.||+|+||.||+|.+.. ++..||||.++... .....+.+.+|+++|+.++||||+++++++... .
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEG--D 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC--C
Confidence 468999999999999999998753 36789999986432 233457788999999999999999999988764 4
Q ss_pred eEEEEEechh-hHHHHHhhCCC-------------CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcE
Q 043957 200 SLYLVFEFMQ-TDLARIISNPE-------------GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVL 259 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~-------------~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~v 259 (584)
..|+||||+. ++|...+.... ..+. +..||+.||.|||+++|+||||||+|||++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 5899999998 46776665321 1122 23599999999999999999999999999999999
Q ss_pred EEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 043957 260 KIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKL 337 (584)
Q Consensus 260 KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~ 337 (584)
||+|||++........ .......+++.|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 9999999976432221 112233457889999999764 58999999999999999998 99999887766655444321
Q ss_pred cCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 338 CGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
... .....++..+.+||.+||+.||.+|||+.|+|+
T Consensus 241 ~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 RLL--------------------------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CcC--------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 100 011346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=309.35 Aligned_cols=239 Identities=25% Similarity=0.388 Sum_probs=184.5
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechhh
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT 210 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~g 210 (584)
+.||+|+||.||+|.+..+++.||+|.+... ........+.+|+++++.++||||+++++++... ..+|+||||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCeEEEEeeccC
Confidence 3599999999999999999999999988543 2334456788999999999999999999988764 457999999984
Q ss_pred -HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC-cccc
Q 043957 211 -DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL-TSRV 282 (584)
Q Consensus 211 -~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~-~~~~ 282 (584)
+|.+.+......+.+ ..||+.||.|||+++|+|+||||+|||++.++.+||+|||++........... ....
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 677777543333433 35999999999999999999999999999999999999999876542211110 1112
Q ss_pred ccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCC
Q 043957 283 VTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSY 361 (584)
Q Consensus 283 gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~ 361 (584)
.+..|+|||.+.+. .++.++|||||||++|+|++ |.+||...........+......
T Consensus 158 ~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~--------------------- 215 (252)
T cd05084 158 IPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL--------------------- 215 (252)
T ss_pred CceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---------------------
Confidence 24569999998764 48999999999999999998 88899766554433322211000
Q ss_pred CchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 362 KPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 362 ~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....++..+.+||.+||+.||++|||+.++++
T Consensus 216 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 216 -----PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011245788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=306.77 Aligned_cols=246 Identities=28% Similarity=0.449 Sum_probs=199.6
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
+|++.+.||+|+||.||++.+..++..||+|.+............+.+|+.+++.++|+||+++++++... ...|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEEEEe
Confidence 48999999999999999999999999999999976554555566778899999999999999999888764 5689999
Q ss_pred echhh-HHHHHhhCC---CCCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 206 EFMQT-DLARIISNP---EGKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 206 Ey~~g-~L~~~l~~~---~~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
||+.+ +|...+... ...+ .++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 99975 666655431 1223 33359999999999999999999999999999999999999999876543
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
......+++.|++||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+......
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 219 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP--------------- 219 (256)
T ss_pred -CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC---------------
Confidence 2234568899999999876 45889999999999999999999999887655443333211100
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
.....++.++.++|.+||+.+|.+|||+.++|+||++
T Consensus 220 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 220 -----------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred -----------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 0112457889999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=312.85 Aligned_cols=244 Identities=25% Similarity=0.387 Sum_probs=195.6
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
...+|++.+.||.|+||.||+|.+.. +..+|+|.+.... ......+.+|+.+++.++||||+++++++... ...|
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 78 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVG--EPVY 78 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecC--CCeE
Confidence 44569999999999999999999887 8899999986432 22355688999999999999999999887664 3579
Q ss_pred EEEechhh-HHHHHhhCCC-CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 203 LVFEFMQT-DLARIISNPE-GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~-~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
+||||+.+ +|.+.+.... ..+. +..||+.||.|||+++|+|+||||+||||+.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999985 7888876532 2233 33599999999999999999999999999999999999999998764322
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
.. .....++..|+|||++.. ..++.++|||||||++|+|++ |+.||......+.+..+......
T Consensus 159 ~~-~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------- 223 (261)
T cd05148 159 YL-SSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM------------- 223 (261)
T ss_pred cc-ccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC-------------
Confidence 11 223345678999999876 458899999999999999998 89999887766666554321110
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....+++.+.++|.+||+.||.+|||+.++++
T Consensus 224 -------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 -------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 011356788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=314.25 Aligned_cols=254 Identities=32% Similarity=0.539 Sum_probs=204.1
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
...+.|++.+.||.|+||.||+|.+..++..||+|++..... ....+.+|+.+++.++|+||+++++.+... ...
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 90 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG--DEL 90 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC--CEE
Confidence 345569999999999999999999998899999999975433 456688899999999999999999988774 568
Q ss_pred EEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 202 YLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 202 ~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
|+||||+. ++|.+++......+++ ..||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999 6788877654323333 3599999999999999999999999999999999999999987654322
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
. ......+++.|++||++.+. .++.++|||||||++|+|++|..||...........+.... .+.
T Consensus 171 ~-~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~------------ 235 (286)
T cd06614 171 S-KRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG-IPP------------ 235 (286)
T ss_pred h-hhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCC------------
Confidence 1 22334578899999998764 58999999999999999999999998776654444332110 000
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
......++..+.+||.+||+.||.+|||+.++|+|+||...
T Consensus 236 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 236 -----------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred -----------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 01113367889999999999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=311.58 Aligned_cols=241 Identities=28% Similarity=0.390 Sum_probs=189.2
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++.++||+|+||.||+|.+..+ ..||||++..... ..+.+.+|+.+++.++||||+++++++.. ...|+|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv 78 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV 78 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC---CCcEEE
Confidence 5699999999999999999988765 4699999864332 23567889999999999999999887643 346999
Q ss_pred Eechhh-HHHHHhhCCC-CCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 205 FEFMQT-DLARIISNPE-GKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~-~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
|||+.+ +|.+.+.... ..+ .+..||+.||+|||+.+|+|+||||+|||++.++.+||+|||++..+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999984 7877776422 222 23459999999999999999999999999999999999999999876533322
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...........+......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~--------------- 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------------- 222 (262)
T ss_pred cccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC---------------
Confidence 2223445678999998865 458999999999999999999 88999887665554443221000
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....++..+.+||.+||+.||++|||+.++++
T Consensus 223 -----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 223 -----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred -----------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 011346788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=338.55 Aligned_cols=248 Identities=25% Similarity=0.357 Sum_probs=202.7
Q ss_pred eEEeeecccCceEEEEEEECCCCcEEEEEEeecC--CCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 128 DKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD--TSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 128 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~--~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
+....||+|+|-+||+|.|..+|..||+-.++.. ...+...+.|..|+.+|+.|+|||||++|+.+.+.....+.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4456799999999999999999999998776544 34556678999999999999999999999999888888899999
Q ss_pred echh-hHHHHHhhCCC-----CCCcHHHHHHHHHHHHHhCC--ceeccccccceeecC-CCcEEEEEeccccccCCCCCC
Q 043957 206 EFMQ-TDLARIISNPE-----GKLTEPQQLLSGLQHCHDRG--ILHRDVKGSNLLIDK-NGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 206 Ey~~-g~L~~~l~~~~-----~~l~~~~qIl~aL~yLH~~~--IvHrDLKp~NILl~~-~g~vKL~DFGla~~~~~~~~~ 276 (584)
|+|. |+|..++++.. ....|++|||+||.|||++. |||||||-+||||+. .|.|||+|+|||+......
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-- 200 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-- 200 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence 9998 56766665322 12367789999999999884 999999999999976 5899999999999875433
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCChHHHHHhhccCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQ-LHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
..+++|||.|||||++. ..|+..+||||||+.++||+|+..||..-....+ +.++..+.. + .-+.++
T Consensus 201 -aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK--P-~sl~kV------ 268 (632)
T KOG0584|consen 201 -AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK--P-AALSKV------ 268 (632)
T ss_pred -cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC--H-HHhhcc------
Confidence 35589999999999886 4699999999999999999999999976655544 444443321 1 011111
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
-.+++++||.+||.. ...|+|+.|+|+||||...
T Consensus 269 ----------------~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 269 ----------------KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ----------------CCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 157899999999999 9999999999999999875
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=352.76 Aligned_cols=249 Identities=29% Similarity=0.376 Sum_probs=192.8
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|++.++||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.++|||||++++++.. ....|+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--GDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--CCEEEE
Confidence 579999999999999999999999999999999965432 23345678899999999999999999988776 346899
Q ss_pred EEechhh-HHHHHhhCC----------CCC------CcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecc
Q 043957 204 VFEFMQT-DLARIISNP----------EGK------LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGL 266 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~----------~~~------l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGl 266 (584)
||||++| +|..++... ... +.+..||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 9999985 666665421 011 22345999999999999999999999999999999999999999
Q ss_pred ccccCCCCC-----------------CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHH
Q 043957 267 ANYFSPNKK-----------------RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVE 329 (584)
Q Consensus 267 a~~~~~~~~-----------------~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~ 329 (584)
+........ ......+||+.|+|||++.+. .++.++|||||||++|||++|.+||.......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 986521110 011235799999999999764 58999999999999999999999997754332
Q ss_pred HHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 330 QLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 330 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
..... .... |. .......+|+.+.+++.+||..||.+|++..+.|.+
T Consensus 239 i~~~~--~i~~-----------------P~-----~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 239 ISYRD--VILS-----------------PI-----EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhh--hccC-----------------hh-----hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 21110 0000 00 001124678899999999999999999988777754
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=309.96 Aligned_cols=241 Identities=27% Similarity=0.388 Sum_probs=189.5
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++.+.||+|+||.||+|.+. .+..||+|.+...... ...+.+|+.++++++|+||+++++++.. ...|+|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv 78 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYIV 78 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC---CCcEEE
Confidence 46999999999999999999766 5677999998654332 3458899999999999999999987643 346999
Q ss_pred Eechh-hHHHHHhhCCC-CCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 205 FEFMQ-TDLARIISNPE-GKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 205 ~Ey~~-g~L~~~l~~~~-~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
|||+. ++|.+.+.... ..+++ ..||+.||.|||+++|+||||||+|||+++++.++|+|||++..+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 99998 47877775422 22333 459999999999999999999999999999999999999999876433322
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM--------------- 222 (260)
T ss_pred cccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence 2222345668999999875 458899999999999999999 89999887766655544221100
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
......+..+.+||.+||..||.+|||+.++++
T Consensus 223 -----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 223 -----------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred -----------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 011345788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=308.54 Aligned_cols=243 Identities=26% Similarity=0.393 Sum_probs=190.5
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.+.||+|+||.||+|.+.. +..||||.++.... ..+.+.+|+.++++++||||+++++++... ..+|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE--EPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecC--CCeee
Confidence 3569999999999999999998754 57899999864332 245678899999999999999999887653 45799
Q ss_pred EEechh-hHHHHHhhCCC-CCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 204 VFEFMQ-TDLARIISNPE-GKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~-~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
||||+. ++|.+.+.... ..+.+ ..||+.||.|||+++|+|+||||+|||++.++.+||+|||++..+.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999995 67888876433 22333 34899999999999999999999999999999999999999987653222
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
........+..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 223 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM-------------- 223 (261)
T ss_pred cccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 11112223457999998876 458999999999999999999 99999887766555444221100
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....++..+.+||.+||+.||.+||++.++++
T Consensus 224 ------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 224 ------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 011245788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=312.68 Aligned_cols=248 Identities=26% Similarity=0.375 Sum_probs=191.7
Q ss_pred CCCCceEEeeecccCceEEEEEEECCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeec
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDT-----GKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSR 196 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~ 196 (584)
..++|++.+.||+|+||.||++..... ...||+|.+..... ......+.+|+.+++++ +|+||+++++++...
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 345799999999999999999987643 37899999865433 33456688999999999 799999999987664
Q ss_pred CcceEEEEEechh-hHHHHHhhCC---------------CCCCc------HHHHHHHHHHHHHhCCceeccccccceeec
Q 043957 197 MQYSLYLVFEFMQ-TDLARIISNP---------------EGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLID 254 (584)
Q Consensus 197 ~~~~l~lV~Ey~~-g~L~~~l~~~---------------~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~ 254 (584)
..+|+||||+. ++|...+... ...+. +..||+.||.|||+++|+||||||+|||++
T Consensus 89 --~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 89 --GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred --CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 35799999997 5677766421 12222 345999999999999999999999999999
Q ss_pred CCCcEEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHH
Q 043957 255 KNGVLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLH 332 (584)
Q Consensus 255 ~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~ 332 (584)
.++.+||+|||+++.+..... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+...
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 999999999999987643221 11122234567999999876 458999999999999999997 999998776655444
Q ss_pred HHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 333 RIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 333 ~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.+..... ......++..+.+||.+||..||.+|||+.|+|++
T Consensus 246 ~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 246 LLKEGYR--------------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHcCCc--------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 3321100 01113457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=309.58 Aligned_cols=244 Identities=31% Similarity=0.431 Sum_probs=187.1
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHH-HhCCCCCeeeeeceeeecCcceEEEEEech
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMIL-QKLDHPNIVKLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL-~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
+.||.|+||.||+|.+..+++.||||.+..... .......+..|..++ ..++|+||+++++++.. ...+|+||||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence 569999999999999999999999999864322 122223344555444 45589999999988875 44689999999
Q ss_pred hh-HHHHHhhCCCC-----CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCcccc
Q 043957 209 QT-DLARIISNPEG-----KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRV 282 (584)
Q Consensus 209 ~g-~L~~~l~~~~~-----~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~ 282 (584)
.+ +|..++..... ...+..||+.||.|||+.+|+|+||+|+|||++.++.+||+|||++..... .....
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~ 154 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFV 154 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCC
Confidence 85 66666643221 123345999999999999999999999999999999999999999876432 13346
Q ss_pred ccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCC
Q 043957 283 VTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYK 362 (584)
Q Consensus 283 gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 362 (584)
+++.|+|||.+.+.. ++.++|||||||++|+|++|.+||...+....+..+........
T Consensus 155 ~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------- 213 (260)
T cd05611 155 GTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWP-------------------- 213 (260)
T ss_pred CCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCC--------------------
Confidence 788999999987644 89999999999999999999999988776555444322110000
Q ss_pred chhhhhccCCcHhHHHHHHHhcccCCCCCCCH---HHHhcCcCCCC
Q 043957 363 PRLFEAFSEFPESSLGLLSTLLALDPAYRGSA---ASALKNEFFFT 405 (584)
Q Consensus 363 ~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa---~e~L~Hp~f~~ 405 (584)
......++..+.+||.+||+.||++|||+ +|+|.||||..
T Consensus 214 ---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 214 ---EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred ---CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 01123578999999999999999999954 89999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=310.17 Aligned_cols=243 Identities=22% Similarity=0.334 Sum_probs=189.1
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
.+|++.+.||+|+||.||++.+. ++..+|+|.+...... ...+.+|+.+++.++||||+++++++... ...|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQ--RPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCC--CceEEE
Confidence 35889999999999999999876 4678999998643222 24577899999999999999999887654 457999
Q ss_pred Eechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 205 FEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
|||+.+ +|.+.+......+. +..||+.||+|||+++|+||||||+|||++.++.+||+|||+++.........
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 999974 67777754333333 34599999999999999999999999999999999999999997654322111
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+......
T Consensus 158 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL---------------- 220 (256)
T ss_pred cCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC----------------
Confidence 112223457999999876 458999999999999999999 89999877665554443221100
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.....++..+.+||.+||..+|++|||+.|+|+.
T Consensus 221 ----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 221 ----------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0112368899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.52 Aligned_cols=246 Identities=21% Similarity=0.326 Sum_probs=191.7
Q ss_pred CCceEEeeecccCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRD-----TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
.+|++.+.||.|+||.||+|.+.. .+..||||+++... .......+.+|+.++..++||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-- 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ-- 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC--
Confidence 358888999999999999998754 35789999986443 3334566889999999999999999999887643
Q ss_pred eEEEEEechh-hHHHHHhhCC---------------CCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCC
Q 043957 200 SLYLVFEFMQ-TDLARIISNP---------------EGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG 257 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~---------------~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g 257 (584)
.+++++||+. ++|...+... ...+. ...||+.||.|||+++|+||||||+|||+++++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 4799999998 4566665311 11122 335999999999999999999999999999999
Q ss_pred cEEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 043957 258 VLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIF 335 (584)
Q Consensus 258 ~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~ 335 (584)
.+||+|||+++....... .......+++.|+|||++.+. .++.++|||||||++|||++ |.+||.+....+.+..+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999886543221 112334557899999998764 48999999999999999998 889998877666655543
Q ss_pred HhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 336 KLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
..... .....++..+.+||..||+.||.+|||+.+++..
T Consensus 241 ~~~~~--------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQVL--------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCcC--------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 32110 0123568889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=316.80 Aligned_cols=252 Identities=28% Similarity=0.455 Sum_probs=198.3
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEe
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFE 206 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~E 206 (584)
|+...+||+|+||.||++.+..++..||||++... .......+.+|+.+++.++|+||+++++++... ...|+|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 97 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVVME 97 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeC--CEEEEEEe
Confidence 44456799999999999999999999999998533 233456688999999999999999999988764 46899999
Q ss_pred chhh-HHHHHhhCCCC----CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccc
Q 043957 207 FMQT-DLARIISNPEG----KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR 281 (584)
Q Consensus 207 y~~g-~L~~~l~~~~~----~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 281 (584)
|+.+ +|.+++..... ......||+.||+|||++||+|+||+|+||+++.++.++|+|||++....... ......
T Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 176 (292)
T cd06657 98 FLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSL 176 (292)
T ss_pred cCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccc
Confidence 9986 56555533211 12234599999999999999999999999999999999999999987654322 122345
Q ss_pred cccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCC
Q 043957 282 VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSY 361 (584)
Q Consensus 282 ~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~ 361 (584)
.+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+......+..+.....
T Consensus 177 ~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~---------------------- 233 (292)
T cd06657 177 VGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---------------------- 233 (292)
T ss_pred ccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC----------------------
Confidence 68899999998865 4588999999999999999999999988766555443322110
Q ss_pred CchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q 043957 362 KPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPL 408 (584)
Q Consensus 362 ~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~ 408 (584)
.....+..++..+.++|.+||+.||.+||++.++|+||||.....
T Consensus 234 --~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 234 --PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred --cccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 001122456788999999999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=311.92 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=191.1
Q ss_pred CCCceEEeeecccCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRD-----TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 198 (584)
.+.|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL- 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-
Confidence 4569999999999999999999887 77889999885432 2334456788999999999999999998776643
Q ss_pred ceEEEEEechh-hHHHHHhhCCC------CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCC---cEEEE
Q 043957 199 YSLYLVFEFMQ-TDLARIISNPE------GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG---VLKIA 262 (584)
Q Consensus 199 ~~l~lV~Ey~~-g~L~~~l~~~~------~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g---~vKL~ 262 (584)
..|+||||+. ++|..++.... ..+. +..||+.||+|||+++++||||||+|||++.++ .+||+
T Consensus 83 -~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 83 -PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred -CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 4699999997 56777765322 1233 345999999999999999999999999998754 59999
Q ss_pred EeccccccCCCCCC-CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 043957 263 DFGLANYFSPNKKR-PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGS 340 (584)
Q Consensus 263 DFGla~~~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~ 340 (584)
|||+++.+...... .......++.|+|||++.+. .++.++|||||||++|+|++ |+.||...+.......+.... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~ 239 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG-R 239 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-c
Confidence 99999876322111 11122335679999999764 48999999999999999997 999998877665544332110 0
Q ss_pred CChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 341 PSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 341 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
+ .....++..+.+||.+||+.||++|||+.++|+|
T Consensus 240 ~-------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 L-------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C-------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 0123467889999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=315.14 Aligned_cols=254 Identities=24% Similarity=0.390 Sum_probs=195.1
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l 201 (584)
..+.|++.+.||.|+||.||+|.+..++..||||.++..... .....+.+|+.++.++ +||||+++++++... ..+
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~ 89 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITD--SDV 89 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecC--CeE
Confidence 446799999999999999999999988999999999754332 2344556677777666 499999999988763 458
Q ss_pred EEEEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHh-CCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 202 YLVFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHD-RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 202 ~lV~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~-~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
|+||||+.+.+..++......++ .+.||+.||+|||+ .+|+||||+|+|||++.++.+||+|||++..+....
T Consensus 90 ~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 90 FICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred EEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 99999998866666554333443 34599999999997 699999999999999999999999999997654322
Q ss_pred CCCCccccccccccChhhhhCC---CCCCceeeEecchHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChHHHHHhh
Q 043957 275 KRPLTSRVVTLWYRAPELLLGA---TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE-VEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~---~~~~~~sDIwSLGvilyeLltG~~pF~~~~~-~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
. .....+++.|+|||.+.+. ..++.++|||||||++|+|++|+.||..... .+.+..++....
T Consensus 170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----------- 236 (296)
T cd06618 170 A--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP----------- 236 (296)
T ss_pred c--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC-----------
Confidence 1 2334578899999998653 2378899999999999999999999965332 222322221100
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
.. ......+++++.+||.+||..||.+|||++++|+||||..
T Consensus 237 ----~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 237 ----PS---------LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred ----CC---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 00 0011246788999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=307.94 Aligned_cols=244 Identities=33% Similarity=0.492 Sum_probs=194.8
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechhh-
Q 043957 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT- 210 (584)
Q Consensus 133 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~g- 210 (584)
||.|+||.||++.+..+|+.||+|.+..... .......+.+|++++++++||||+++++.+.. ...+|+||||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCCC
Confidence 6899999999999999999999999864432 23456678899999999999999999887765 4468999999985
Q ss_pred HHHHHhhCCCCCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC-------CC
Q 043957 211 DLARIISNPEGKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK-------RP 277 (584)
Q Consensus 211 ~L~~~l~~~~~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-------~~ 277 (584)
+|..++.... .+ .+..||+.||.|||+++|+|+||+|+|||++.++.++|+|||++........ ..
T Consensus 79 ~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 79 DLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 7777765432 33 3446999999999999999999999999999999999999999876533211 12
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 357 (584)
.....++..|+|||++... .++.++|||||||++|+|++|..||......+....+......+
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 220 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQ-GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEW---------------- 220 (265)
T ss_pred ccCcccCccccCHHHhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCC----------------
Confidence 2345678899999998764 48899999999999999999999998877665554443211000
Q ss_pred CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCH---HHHhcCcCCCC
Q 043957 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSA---ASALKNEFFFT 405 (584)
Q Consensus 358 p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa---~e~L~Hp~f~~ 405 (584)
+. ...++..+.+||.+||+.||.+|||+ .++|+||||..
T Consensus 221 ~~---------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 221 PE---------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred Cc---------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 00 01258899999999999999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=304.74 Aligned_cols=240 Identities=30% Similarity=0.471 Sum_probs=193.4
Q ss_pred eeecccCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEec
Q 043957 131 DKVGQGTYSNVYKALDRDT---GKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEF 207 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey 207 (584)
+.||+|+||.||+|.+... +..||+|.+....... ....+.+|+.+++.++|+||+++++++.. ...+++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEe
Confidence 3699999999999998866 8899999997554333 46778899999999999999999998876 4568999999
Q ss_pred hh-hHHHHHhhCC--------CCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 208 MQ-TDLARIISNP--------EGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 208 ~~-g~L~~~l~~~--------~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
+. ++|...+... ...+++ ..||+.||.|||+++|+|+||||+|||++.++.+||+|||.+.....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 95 6788877654 234444 34999999999999999999999999999999999999999987654
Q ss_pred CCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 273 NKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 273 ~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
... .......+++.|+|||++... .++.++|||||||++|+|++ |.+||...........+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~------------ 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY------------ 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------
Confidence 321 122345678899999998764 58999999999999999999 699998886655554443210
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
. ......++.++.++|.+||..||.+|||+.|++++
T Consensus 225 ---~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 225 ---R-----------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ---C-----------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0 01123458899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=312.12 Aligned_cols=239 Identities=24% Similarity=0.403 Sum_probs=183.6
Q ss_pred CceEEeee--cccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEE
Q 043957 126 SYDKIDKV--GQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 126 ~Y~~~~~L--G~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~ 202 (584)
.|++.+.+ |.|+||.||++.++.++..+|+|.+....... .|+.....+ +||||+++++.+.... .+|
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~--~~~ 85 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLK--GHV 85 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCC--eeE
Confidence 46676666 99999999999999999999999986432211 122222222 7999999998887743 689
Q ss_pred EEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCC-cEEEEEeccccccCCCC
Q 043957 203 LVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG-VLKIADFGLANYFSPNK 274 (584)
Q Consensus 203 lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g-~vKL~DFGla~~~~~~~ 274 (584)
+||||+. ++|.+.+.... .+.+ ..||+.||.|||+.+|+||||||+||+++.++ .++|+|||++......
T Consensus 86 iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~- 163 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP- 163 (267)
T ss_pred EEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence 9999997 57887776432 3333 35999999999999999999999999999988 9999999999765422
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCChHHHHHhhccC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQ-LHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
....++..|+|||++.+ ..++.++|||||||++|+|++|..||........ ...+.... .
T Consensus 164 ----~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~------------- 224 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-Q------------- 224 (267)
T ss_pred ----ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-c-------------
Confidence 23467899999999976 4589999999999999999999999985543321 11111000 0
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC-HHHHhcCcCCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS-AASALKNEFFF 404 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT-a~e~L~Hp~f~ 404 (584)
.....++.++..+.+||.+||+.||.+|++ ++++|+||||.
T Consensus 225 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 225 ----------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred ----------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 000122357899999999999999999996 59999999996
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=310.57 Aligned_cols=246 Identities=21% Similarity=0.336 Sum_probs=192.1
Q ss_pred CCCceEEeeecccCceEEEEEEECCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDT-----GKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 198 (584)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+|+.++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-- 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--
Confidence 35799999999999999999987643 4789999985432 233445678999999999999999999988764
Q ss_pred ceEEEEEechh-hHHHHHhhCCCC---------------CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEE
Q 043957 199 YSLYLVFEFMQ-TDLARIISNPEG---------------KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIA 262 (584)
Q Consensus 199 ~~l~lV~Ey~~-g~L~~~l~~~~~---------------~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~ 262 (584)
...|+||||+. ++|...+..... .+.+..||+.||.|||+++|+||||||+|||++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 45799999997 577776643211 12234599999999999999999999999999999999999
Q ss_pred EeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 043957 263 DFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGS 340 (584)
Q Consensus 263 DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~ 340 (584)
|||+++.+..... .......++..|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+.......+....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-- 238 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG-- 238 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC--
Confidence 9999976543321 122334567889999998754 58999999999999999998 999998777655544332100
Q ss_pred CChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 341 PSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 341 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.. .....++..+.+||.+||+.||++|||+.++++
T Consensus 239 -------------~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 239 -------------HL-----------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred -------------CC-----------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 011235788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=310.83 Aligned_cols=245 Identities=20% Similarity=0.310 Sum_probs=190.7
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGK----IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
..+|++++.||.|+||+||+|.+..++. .||+|++.... .......+.+|+.+++.+.||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS--- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC---
Confidence 3569999999999999999998877766 48999986443 334456788999999999999999999887642
Q ss_pred eEEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
..+++|||+. |+|.+.+......+.+ ..||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 3689999998 5788777654444433 45999999999999999999999999999999999999999987643
Q ss_pred CCCC-CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 273 NKKR-PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 273 ~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
.... ......+++.|+|||++.+. .++.++|||||||++|||++ |.+||...........+.. ...+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~--------- 230 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GERL--------- 230 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcC---------
Confidence 2221 11223346789999998764 58999999999999999998 8999976654443322211 1000
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....++.++.++|.+||..||++|||+.+++.
T Consensus 231 ----------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 231 ----------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ----------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011345788999999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=308.33 Aligned_cols=241 Identities=29% Similarity=0.395 Sum_probs=189.6
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++.+.||+|+||.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++||||+++++++.. ...|+|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcEEE
Confidence 4699999999999999999987654 4699998754322 23567889999999999999999887643 346999
Q ss_pred Eechhh-HHHHHhhCCCC-CC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 205 FEFMQT-DLARIISNPEG-KL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~-~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
|||+.+ +|.+.+..... .+ .+..||+.||.|||+.+|+|+||||+|||+++++.++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999985 78887754322 22 23459999999999999999999999999999999999999999876433322
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
......++..|+|||++.+ ..++.++|||||||++|+|++ |++||.+....+....+......
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------------- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM--------------- 222 (260)
T ss_pred ccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence 2223345678999998876 458999999999999999999 99999887766655444221100
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....++..+.+||.+||.+||.+|||++++++
T Consensus 223 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 223 -----------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred -----------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011346788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=313.43 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=195.2
Q ss_pred CceEEeeecccCceEEEEEEEC---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcc
Q 043957 126 SYDKIDKVGQGTYSNVYKALDR---DTGKIVALKKVKFDTS--EPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 199 (584)
.|++.+.||.|+||.||+|.+. .+|..||+|++..... .....+.+.+|+.+|+++ +|+||+.+++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence 4889999999999999999875 4789999999864322 222345678899999999 59999999887765 34
Q ss_pred eEEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
.+|+||||+.+ +|.+.+... ..+.+ ..||+.||.|||+.+|+||||||+|||++.++.+||+|||++..+..
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 68999999994 677766532 22332 23899999999999999999999999999999999999999987654
Q ss_pred CCCCCCccccccccccChhhhhCC-CCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGA-TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~-~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
..........|+..|+|||.+.+. ..++.++|||||||++|+|++|..||...........+.......
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---------- 227 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS---------- 227 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc----------
Confidence 333333456789999999998643 246789999999999999999999997543322222222111000
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCCC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFTS 406 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~~ 406 (584)
. . .....++..+.+||.+||+.||.+|| ++++++.||||...
T Consensus 228 --~--~---------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 228 --E--P---------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred --C--C---------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 0 0 01124678889999999999999997 89999999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=314.32 Aligned_cols=253 Identities=21% Similarity=0.316 Sum_probs=192.2
Q ss_pred CCCceEEeeecccCceEEEEEEECCCC----------------cEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCee
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTG----------------KIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIV 187 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g----------------~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 187 (584)
..+|++.+.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|++++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 357999999999999999999876544 568999986443 234567788999999999999999
Q ss_pred eeeceeeecCcceEEEEEechh-hHHHHHhhCCC----------CCCc------HHHHHHHHHHHHHhCCceeccccccc
Q 043957 188 KLEGLATSRMQYSLYLVFEFMQ-TDLARIISNPE----------GKLT------EPQQLLSGLQHCHDRGILHRDVKGSN 250 (584)
Q Consensus 188 ~l~~~~~~~~~~~l~lV~Ey~~-g~L~~~l~~~~----------~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~N 250 (584)
++++++... ...++||||+. ++|...+.... ..+. +..||+.||.|||+++|+||||||+|
T Consensus 83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 999888764 45799999998 46776665322 1222 33599999999999999999999999
Q ss_pred eeecCCCcEEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh--CCCCCCCCCh
Q 043957 251 LLIDKNGVLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL--GRPIMPGRTE 327 (584)
Q Consensus 251 ILl~~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt--G~~pF~~~~~ 327 (584)
||++.++.++|+|||++........ .......+++.|+|||++.+. .++.++|||||||++|+|++ +..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999976533221 112334567889999998763 58999999999999999998 6788877665
Q ss_pred HHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 328 VEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 328 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
...+..+......... .........+++++.+||.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDGR-------------------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhccccccc-------------------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 5554444322111000 0000112346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=317.12 Aligned_cols=245 Identities=28% Similarity=0.349 Sum_probs=188.0
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcE--EEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcce
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKI--VALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~ 200 (584)
.++|++.+.||+|+||.||+|.+..++.. +|+|.+.. .........+.+|+.++.++ +||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~--~~ 82 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GY 82 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc-cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC--CC
Confidence 34699999999999999999998877765 57776642 22334556788999999999 899999999987664 45
Q ss_pred EEEEEechh-hHHHHHhhCCC---------------CCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCc
Q 043957 201 LYLVFEFMQ-TDLARIISNPE---------------GKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGV 258 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~---------------~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~ 258 (584)
+|+||||+. ++|..++.... ..+ ....||+.||+|||++||+||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 799999998 57777765321 112 23359999999999999999999999999999999
Q ss_pred EEEEEeccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 043957 259 LKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKL 337 (584)
Q Consensus 259 vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~ 337 (584)
+||+|||++........ .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+...
T Consensus 163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 163 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred EEeCccccCcccchhhh--cccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 99999999864321111 112234567999998865 458999999999999999998 99999877665544333110
Q ss_pred cCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 338 CGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
. . ......+++++.+||.+||+.||.+|||++++|++
T Consensus 240 ~-----------------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 Y-----------------R---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred C-----------------c---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 0 00112457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=314.94 Aligned_cols=244 Identities=24% Similarity=0.344 Sum_probs=190.5
Q ss_pred CCceEEeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDR-----DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
.+|.+.+.||+|+||.||++.+. .++..||+|.+... .......+.+|+.++++++||||+++++++... .
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG--D 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--C
Confidence 35899999999999999999753 34567999988532 334566788999999999999999999988763 4
Q ss_pred eEEEEEechh-hHHHHHhhCCC------------CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEE
Q 043957 200 SLYLVFEFMQ-TDLARIISNPE------------GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLK 260 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~------------~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vK 260 (584)
.+|+||||+. ++|.+++.... ..++ +..||+.||+|||+++|+||||||+|||+++++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 5799999998 56776665221 1233 235999999999999999999999999999999999
Q ss_pred EEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 043957 261 IADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLC 338 (584)
Q Consensus 261 L~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~ 338 (584)
|+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+.+..+....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999986543221 11223345778999999876 458999999999999999998 999998877665555443211
Q ss_pred CCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 339 GSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.. .....++.++.+||.+||+.||.+|||+.+++.
T Consensus 240 ~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 VL--------------------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cC--------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00 011246788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.54 Aligned_cols=261 Identities=25% Similarity=0.361 Sum_probs=189.5
Q ss_pred CCceEEeeecccCceEEEEEE----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 125 ESYDKIDKVGQGTYSNVYKAL----DRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
.+|++++.||+|+||.||+|. +..++..||||++... .....+.+.+|+++|+.++||||+++++++.......
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 368999999999999999997 4467889999998643 3344567889999999999999999999876655556
Q ss_pred EEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+|+||||+. ++|.+.+......+.+ ..||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 899999997 5788777643333333 359999999999999999999999999999999999999999876432
Q ss_pred CCCC--CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CCChHHHHHhh
Q 043957 274 KKRP--LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCG-SPSEDYWKKLR 350 (584)
Q Consensus 274 ~~~~--~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~-~~~~~~~~~~~ 350 (584)
.... .....++..|+|||++.+ ..++.++|||||||++|||++|..++..... .....+..... .........+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccccccchHHHHHHH
Confidence 2111 111223456999999876 4589999999999999999998876643321 11111100000 00000000000
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.. ... ......++..+.+||.+||..||++|||+.|+++
T Consensus 240 ~~-~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 240 KN-NGR---------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hc-CCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00 000 0112456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=315.93 Aligned_cols=244 Identities=26% Similarity=0.331 Sum_probs=188.1
Q ss_pred CCceEEeeecccCceEEEEEEECCCCc--EEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGK--IVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l 201 (584)
++|++.+.||+|+||.||+|.+..++. .+++|.++.. ......+.+.+|+.++.++ +||||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENR--GYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--Ccc
Confidence 469999999999999999999887765 4688887532 2333456788999999999 799999999887664 357
Q ss_pred EEEEechh-hHHHHHhhCCC---------------CC------CcHHHHHHHHHHHHHhCCceeccccccceeecCCCcE
Q 043957 202 YLVFEFMQ-TDLARIISNPE---------------GK------LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVL 259 (584)
Q Consensus 202 ~lV~Ey~~-g~L~~~l~~~~---------------~~------l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~v 259 (584)
|+||||+. ++|.+.+.... .. ..+..||+.||+|||+++|+||||||+|||++.++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 99999998 57777765321 11 2234599999999999999999999999999999999
Q ss_pred EEEEeccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 043957 260 KIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLC 338 (584)
Q Consensus 260 KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~ 338 (584)
||+|||++........ ......+..|+|||++.+ ..++.++|||||||++|+|++ |.+||......+....+....
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 9999999864321111 111223457999999876 458999999999999999997 999998877665554432210
Q ss_pred CCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 339 GSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
. ......++..+.+||.+||+.||.+|||++++++.
T Consensus 236 ~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 R--------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred C--------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 00113467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=347.39 Aligned_cols=143 Identities=27% Similarity=0.415 Sum_probs=120.2
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
.++|.++++||.|+||.||+|.+..+++.||||+++... ........+.+|+.++..++||||+++++++.. ...+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEEE
Confidence 467999999999999999999999999999999996532 234445678899999999999999999877665 44689
Q ss_pred EEEechh-hHHHHHhhCCCC-----CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccc
Q 043957 203 LVFEFMQ-TDLARIISNPEG-----KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLAN 268 (584)
Q Consensus 203 lV~Ey~~-g~L~~~l~~~~~-----~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~ 268 (584)
|||||+. ++|..++..... ...++.||+.||.|||.++||||||||+||||+.++.+||+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999997 467777653221 12334599999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.71 Aligned_cols=241 Identities=26% Similarity=0.418 Sum_probs=190.3
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
+.|+++++||+|+||.||+|... ++..||+|.+..... ....+.+|+.++++++|+||+++++++.. ...|+|
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPIYII 78 (260)
T ss_pred HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCcEEE
Confidence 46999999999999999999865 578899999864333 23567889999999999999999987643 347999
Q ss_pred Eechh-hHHHHHhhCCC-CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 205 FEFMQ-TDLARIISNPE-GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 205 ~Ey~~-g~L~~~l~~~~-~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
|||+. ++|.+.+.... ..+. +..||+.||+|||+.+|+|+||||+||+++.++.++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 99997 57777765322 2333 3459999999999999999999999999999999999999999876533222
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
......++..|+|||++.+ ..++.++|||||||++|+|++ |++||.+.+..+....+......
T Consensus 159 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 222 (260)
T cd05067 159 AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM--------------- 222 (260)
T ss_pred cccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC---------------
Confidence 2223345678999999875 458899999999999999999 99999887766555443221100
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....++.++.+||.+||..||++|||+++++.
T Consensus 223 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 -----------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111345788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=324.01 Aligned_cols=263 Identities=26% Similarity=0.388 Sum_probs=190.6
Q ss_pred CCCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 120 ~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
+...++.|.-...||+|+||.||+|.... |..||||++....... ..+|.+|+.+|.+++|||||+|+|||.+...
T Consensus 70 l~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~- 145 (361)
T KOG1187|consen 70 LRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE- 145 (361)
T ss_pred HHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-
Confidence 44566788888999999999999998665 5899999886544332 3459999999999999999999999987554
Q ss_pred eEEEEEechh-hHHHHHhhCCCC-CCcH------HHHHHHHHHHHHhCC---ceeccccccceeecCCCcEEEEEecccc
Q 043957 200 SLYLVFEFMQ-TDLARIISNPEG-KLTE------PQQLLSGLQHCHDRG---ILHRDVKGSNLLIDKNGVLKIADFGLAN 268 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~~-~l~~------~~qIl~aL~yLH~~~---IvHrDLKp~NILl~~~g~vKL~DFGla~ 268 (584)
..+||+|||. |+|.+.+..... .++| +.+++.||+|||+.. ||||||||+|||||++..+||+|||+|+
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~ 225 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK 225 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence 5799999999 788888776554 4444 458999999999853 9999999999999999999999999997
Q ss_pred ccCCCCCCCCccc-cccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCChH
Q 043957 269 YFSPNKKRPLTSR-VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRT---EVEQLHRIFKLCGSPSED 344 (584)
Q Consensus 269 ~~~~~~~~~~~~~-~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~---~~~~~~~i~~~~~~~~~~ 344 (584)
..... ....... .||.+|+|||++.. ...+.++|||||||+|.||++|+.+..... ...........
T Consensus 226 ~~~~~-~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~------- 296 (361)
T KOG1187|consen 226 LGPEG-DTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL------- 296 (361)
T ss_pred cCCcc-ccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH-------
Confidence 65431 2122222 89999999999975 458999999999999999999998776432 11111111111
Q ss_pred HHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 345 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
|.+.. .....+|.-........ ..-..+..+..+|++.+|.+||++.|+++
T Consensus 297 -~~~~~-~~eiiD~~l~~~~~~~~--~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 297 -LEEGK-LREIVDPRLKEGEYPDE--KEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred -HHCcc-hhheeCCCccCCCCChH--HHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 11100 00111111000000000 11123678899999999999999999754
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=306.47 Aligned_cols=238 Identities=24% Similarity=0.334 Sum_probs=186.4
Q ss_pred eecccCceEEEEEEE--CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechh
Q 043957 132 KVGQGTYSNVYKALD--RDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ 209 (584)
Q Consensus 132 ~LG~G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~ 209 (584)
+||+|+||.||+|.. ..++..||+|+++.........+.+.+|+.+++.++||||+++++++.. ...++||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEecCC
Confidence 589999999999964 4568899999987665555567788999999999999999999987753 24689999998
Q ss_pred -hHHHHHhhCCCC-----CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC--CCccc
Q 043957 210 -TDLARIISNPEG-----KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR--PLTSR 281 (584)
Q Consensus 210 -g~L~~~l~~~~~-----~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~--~~~~~ 281 (584)
++|...+..... ...+..||+.||.|||+++|+||||||.|||++.++.+||+|||++..+...... .....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 467777653221 1233459999999999999999999999999999999999999999876433221 11222
Q ss_pred cccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCC
Q 043957 282 VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQS 360 (584)
Q Consensus 282 ~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~ 360 (584)
.+++.|+|||++.. ..++.++|||||||++|||++ |.+||......+....+..... +
T Consensus 159 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~------------------- 217 (257)
T cd05116 159 KWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-M------------------- 217 (257)
T ss_pred CCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-C-------------------
Confidence 34578999998865 458899999999999999998 9999988776655554422110 0
Q ss_pred CCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 361 YKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 361 ~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....+++++.+||.+||+.||++|||+.++..
T Consensus 218 ------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 218 ------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred ------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 011346889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=302.91 Aligned_cols=246 Identities=33% Similarity=0.502 Sum_probs=192.3
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecC-CCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD-TSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~-~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|++.+.||.|+||.||+|.+..+|+.||+|.++.. .......+.+.+|+.++++++|+||+++++++... ...++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~--~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN--NELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEEE
Confidence 4699999999999999999999999999999998643 23334467788999999999999999999988764 46799
Q ss_pred EEechhh-HHHHHhhC---CCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 204 VFEFMQT-DLARIISN---PEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~---~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
||||+.+ +|...+.. ....+. +..||+.||.|||+.||+|+||||+||+++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999984 67766642 122232 3459999999999999999999999999999999999999999866432
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCChHHHHHhhc
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEV--EQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
. .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...... +....+....
T Consensus 160 ~-~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------- 224 (267)
T cd08224 160 T-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD------------- 224 (267)
T ss_pred C-cccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC-------------
Confidence 2 12234568899999999876 45899999999999999999999999654321 1111111100
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
. .+. ....++..+.++|.+||..+|++|||+.++++
T Consensus 225 --~--~~~--------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 225 --Y--PPL--------PADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred --C--CCC--------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0 000 01245788999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=308.89 Aligned_cols=258 Identities=24% Similarity=0.348 Sum_probs=188.3
Q ss_pred Cc-eEEeeecccCceEEEEEE----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 126 SY-DKIDKVGQGTYSNVYKAL----DRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 126 ~Y-~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
+| ++++.||+|+||+||++. ...++..||+|.+.... .......+.+|+.+|+.++||||+++++++.......
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 45 899999999999998764 34578899999986542 2234566788999999999999999999887665667
Q ss_pred EEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+|+||||+.+ +|.+.+... .+++ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++..+...
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 8999999985 666666532 2333 359999999999999999999999999999999999999999876432
Q ss_pred CCC--CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CCChHHHHHhh
Q 043957 274 KKR--PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCG-SPSEDYWKKLR 350 (584)
Q Consensus 274 ~~~--~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~-~~~~~~~~~~~ 350 (584)
... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...... +..+..... ......+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhhh
Confidence 211 1122345667999999876 45899999999999999999999888654321 111111110 00001111100
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.. ... ......++..+.+||..||+.||++|||++++++
T Consensus 238 ~~-~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 238 ER-GMR---------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hc-CCC---------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 000 0112356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=304.31 Aligned_cols=244 Identities=28% Similarity=0.397 Sum_probs=192.4
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..++|++.+.||+|+||.||+|.+. .+..||||.+..... ..+.+.+|+.++++++|+||+++++++... ..+|
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE--EPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecC--CceE
Confidence 3467999999999999999999876 457899999864332 245688999999999999999999887653 4579
Q ss_pred EEEechhh-HHHHHhhCCC-CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 203 LVFEFMQT-DLARIISNPE-GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~-~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
+||||+.+ +|.+.+.... ..+. +..||+.||.|||+++|+|+||||+||+++.++.+||+|||++..+....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999984 7877776432 2233 34599999999999999999999999999999999999999998765322
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
.........+..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+......+
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~------------ 224 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP------------ 224 (261)
T ss_pred hhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 211122234568999999876 458999999999999999998 999998877766665553321100
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
....++..+.++|.+||..||.+|||++++++
T Consensus 225 --------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 225 --------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred --------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 01234788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=307.47 Aligned_cols=246 Identities=24% Similarity=0.374 Sum_probs=192.2
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGK---IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
..+|++.+.||+|+||.||+|.+..++. .||+|.++... .......+.+|+.++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 79 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--KP 79 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--Cc
Confidence 3569999999999999999998865443 79999986433 233456788999999999999999999988653 45
Q ss_pred EEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+|+||||+.+ +|.+.+......+.+ ..||+.||.|||+++|+||||||+|||++.++.++|+|||++..+...
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 8999999985 677777654444333 358999999999999999999999999999999999999999876533
Q ss_pred CCCCC--ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 274 KKRPL--TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 274 ~~~~~--~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
..... ....++..|+|||++.+ ..++.++|+|||||++|++++ |..||......+....+.....
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~----------- 227 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR----------- 227 (267)
T ss_pred cceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-----------
Confidence 22111 11223568999999976 458999999999999999886 9999987766555444432110
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.+ ....+++.+.+||.+||+.+|.+|||+.++++
T Consensus 228 ------~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 228 ------LP---------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ------CC---------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 00 11345788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=328.32 Aligned_cols=248 Identities=23% Similarity=0.313 Sum_probs=188.0
Q ss_pred CCCCceEEeeecccCceEEEEEEECCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeec
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDT-----GKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSR 196 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~ 196 (584)
..++|++.+.||+|+||.||+|.+... +..||||++.... .....+.+.+|+.+|+++. |||||++++++..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~- 112 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK- 112 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc-
Confidence 345799999999999999999986432 4579999986443 3334567889999999996 9999999998866
Q ss_pred CcceEEEEEechh-hHHHHHhhCCC-------------------------------------------------------
Q 043957 197 MQYSLYLVFEFMQ-TDLARIISNPE------------------------------------------------------- 220 (584)
Q Consensus 197 ~~~~l~lV~Ey~~-g~L~~~l~~~~------------------------------------------------------- 220 (584)
...+|||||||. |+|.+.+....
T Consensus 113 -~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 113 -SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred -CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 345899999998 56766554211
Q ss_pred ----------------------------------------CCC------cHHHHHHHHHHHHHhCCceeccccccceeec
Q 043957 221 ----------------------------------------GKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLID 254 (584)
Q Consensus 221 ----------------------------------------~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~ 254 (584)
..+ .+..||+.||.|||+++|+||||||+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~ 271 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence 011 1334899999999999999999999999999
Q ss_pred CCCcEEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHH
Q 043957 255 KNGVLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLH 332 (584)
Q Consensus 255 ~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~ 332 (584)
.++.+||+|||+++.+..... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||........+.
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 999999999999986543221 11223456788999999876 458999999999999999997 999997754433322
Q ss_pred HHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 333 RIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 333 ~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
..+... . .. .....++..+.+||.+||+.||++|||+.++.+
T Consensus 351 ~~~~~~--------------~--~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 351 NKIKSG--------------Y--RM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHhcC--------------C--CC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 221110 0 00 011356889999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=304.76 Aligned_cols=246 Identities=22% Similarity=0.372 Sum_probs=192.1
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGK---IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
..+|+..+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+..|+.++++++||||+++++++... ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF--KP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC--CC
Confidence 3468999999999999999999876654 79999886432 233456788999999999999999999988764 35
Q ss_pred EEEEEechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
.|+||||+.+ +|...+......++ +..|++.||+|||+.+|+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 7999999985 67667654433433 3358999999999999999999999999999999999999999766432
Q ss_pred CCCCCc--cccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 274 KKRPLT--SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 274 ~~~~~~--~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
...... ....++.|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+......+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~--------- 230 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP--------- 230 (268)
T ss_pred cccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC---------
Confidence 221111 1123457999999876 458999999999999999997 999998877666555543221110
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
....++..+.+||.+||+.||.+||++.++++
T Consensus 231 -----------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 -----------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -----------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01245788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=303.76 Aligned_cols=237 Identities=25% Similarity=0.392 Sum_probs=187.2
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
.+|++.+.||+|+||.||++... |..||+|.++... ..+.+.+|+.++++++|+||+++++++... ...+|+|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv 78 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIV 78 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEEE
Confidence 46999999999999999999654 7889999985332 345688999999999999999999876543 3457999
Q ss_pred Eechh-hHHHHHhhCCCC-C------CcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 205 FEFMQ-TDLARIISNPEG-K------LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 205 ~Ey~~-g~L~~~l~~~~~-~------l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
|||+. ++|.+.+..... . +.+..||+.||+|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99998 478877764332 1 2334599999999999999999999999999999999999999987653222
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
....++..|+|||++.+ ..++.++|||||||++|+|++ |++||...........+.....
T Consensus 157 --~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------------- 217 (256)
T cd05082 157 --DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---------------- 217 (256)
T ss_pred --CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC----------------
Confidence 23344668999999875 458899999999999999997 9999987665444433321100
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 218 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 218 ----------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112356889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=308.16 Aligned_cols=244 Identities=21% Similarity=0.309 Sum_probs=187.7
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcE----EEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKI----VALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
++|++.+.||+|+||+||+|.+..++.. |++|.+... ........+..|+.++.+++||||+++++++.. ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---AS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---Cc
Confidence 4689999999999999999998877764 677776422 223344667788999999999999999987643 24
Q ss_pred EEEEEechh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
.++++||+. ++|.+.+......+. +..||+.||.|||+++++||||||+|||++.++.+||+|||+++.+...
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 688999998 678888765433333 3459999999999999999999999999999999999999999876433
Q ss_pred CCC-CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 274 KKR-PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 274 ~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
... ......++..|+|||++.+. .++.++|||||||++|||++ |..||.+.........+ .....+.
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~--------- 231 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLA--------- 231 (279)
T ss_pred CcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCC---------
Confidence 221 12234567789999998764 58999999999999999998 99999877654432222 1110000
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
....++.++.+++.+||..||++|||+.|+++
T Consensus 232 ----------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 232 ----------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ----------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01124667889999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=306.31 Aligned_cols=246 Identities=30% Similarity=0.467 Sum_probs=191.2
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|++.+.||.|+||.||+|.+..++..||||.+.... ........+.+|+.+++.++||||+++++++... ...++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC--CeEEE
Confidence 46899999999999999999999999999999886432 2334456788999999999999999999988763 46799
Q ss_pred EEechhh-HHHHHhhC---CCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 204 VFEFMQT-DLARIISN---PEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~---~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
||||+.+ +|.+++.. ....+.+ ..||+.||.|||+++|+|+||||+||+++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999985 66666542 1223332 359999999999999999999999999999999999999998876432
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCChHHHHHhhc
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEV--EQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
. .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... .....+...
T Consensus 160 ~-~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------- 223 (267)
T cd08229 160 T-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-------------- 223 (267)
T ss_pred C-cccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--------------
Confidence 2 22234578899999999876 45889999999999999999999999764321 111111100
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
. .+. .....+++.+.+||.+||..||.+|||+.++++
T Consensus 224 -~---~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 224 -D---YPP-------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred -C---CCC-------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 0 000 011246788999999999999999999998775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=310.13 Aligned_cols=244 Identities=23% Similarity=0.332 Sum_probs=186.5
Q ss_pred CceEEeeecccCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRD-----TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.++||||+++++.+... ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD--GP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CC
Confidence 37888999999999999998753 23578888886432 334456788999999999999999999887664 34
Q ss_pred EEEEEechh-hHHHHHhhCCC-----------------------CC------CcHHHHHHHHHHHHHhCCceeccccccc
Q 043957 201 LYLVFEFMQ-TDLARIISNPE-----------------------GK------LTEPQQLLSGLQHCHDRGILHRDVKGSN 250 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~-----------------------~~------l~~~~qIl~aL~yLH~~~IvHrDLKp~N 250 (584)
.|+||||+. ++|...+.... .. +.+..||+.||.|||+++|+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 799999998 56666654211 01 2334599999999999999999999999
Q ss_pred eeecCCCcEEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChH
Q 043957 251 LLIDKNGVLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEV 328 (584)
Q Consensus 251 ILl~~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~ 328 (584)
||+++++.+||+|||++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999999999976532221 11122345678999999876 458999999999999999998 99999877655
Q ss_pred HHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 329 EQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 329 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....+.... .. .....++.++.+||..||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~-----------------~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 237 RLFNLLKTGY-----------------RM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHhCCC-----------------CC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 4433221110 00 011346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=304.49 Aligned_cols=246 Identities=23% Similarity=0.358 Sum_probs=192.0
Q ss_pred CCCceEEeeecccCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDT---GKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
.++|.+.+.||+|+||.||+|.+... ...||||.+.... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN---P 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC---C
Confidence 34689999999999999999987644 3468999885432 234556788999999999999999999987653 3
Q ss_pred EEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
.|+||||+. ++|.+.+......+.+ ..||+.||.|||+++++|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 689999998 5788877653333333 359999999999999999999999999999999999999999876433
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
.....+...+++.|+|||.+.. ..++.++|||||||++|+|++ |.+||...+..+.+..+......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~------------ 227 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL------------ 227 (270)
T ss_pred cceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC------------
Confidence 2211122234568999999865 458999999999999999996 99999888766555443221100
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.....++..+.+||.+||..+|.+|||+.+++..
T Consensus 228 --------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 228 --------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred --------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1123568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=312.00 Aligned_cols=252 Identities=22% Similarity=0.318 Sum_probs=189.7
Q ss_pred CCceEEeeecccCceEEEEEEECCC--------------CcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeee
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDT--------------GKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLE 190 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~--------------g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 190 (584)
.+|++.+.||+|+||.||+|.+..+ ...||||.+.... .......+.+|+++|++++||||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4699999999999999999987543 2358999986542 344556788999999999999999999
Q ss_pred ceeeecCcceEEEEEechhh-HHHHHhhCCCC-----------CC------cHHHHHHHHHHHHHhCCceecccccccee
Q 043957 191 GLATSRMQYSLYLVFEFMQT-DLARIISNPEG-----------KL------TEPQQLLSGLQHCHDRGILHRDVKGSNLL 252 (584)
Q Consensus 191 ~~~~~~~~~~l~lV~Ey~~g-~L~~~l~~~~~-----------~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NIL 252 (584)
+++... ...|+||||+.+ +|...+..... .+ ....||+.||+|||+++++|+||||+|||
T Consensus 84 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 84 GVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 988764 457999999984 67666643210 11 23459999999999999999999999999
Q ss_pred ecCCCcEEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh--CCCCCCCCChHH
Q 043957 253 IDKNGVLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL--GRPIMPGRTEVE 329 (584)
Q Consensus 253 l~~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt--G~~pF~~~~~~~ 329 (584)
++.++.+||+|||++..+..... .......+++.|+|||++.+. .++.++|||||||++|+|++ |..||...+..+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999976533221 111233456789999998764 58999999999999999988 667887766655
Q ss_pred HHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 330 QLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 330 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.+..+......... .........+|+.+.+||.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGR-------------------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccc-------------------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 54443321100000 0000112346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=307.84 Aligned_cols=261 Identities=22% Similarity=0.354 Sum_probs=190.1
Q ss_pred CceEEeeecccCceEEEEEEE----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 126 SYDKIDKVGQGTYSNVYKALD----RDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
.|++++.||+|+||.||+|.. ..++..||+|.++... .......+.+|+.+++.+.||||+++++++........
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 478999999999999999974 4578899999986443 33445678899999999999999999998877655668
Q ss_pred EEEEechh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 202 YLVFEFMQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 202 ~lV~Ey~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
|+||||+. ++|...+......+. +..||+.||+|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 99999997 467777654322333 33599999999999999999999999999999999999999998764322
Q ss_pred C--CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHH-hcCCCChHHHHHhhc
Q 043957 275 K--RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFK-LCGSPSEDYWKKLRL 351 (584)
Q Consensus 275 ~--~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~ 351 (584)
. .......++..|+|||++.+. .++.++|||||||++|+|+++..|+..... ....... ..+......+.....
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT--LFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred cceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc--hhhhhcccccccccHHHHHHHHH
Confidence 1 111234567789999998764 588999999999999999998766533211 1101000 000000000100000
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
... .......++..+.+||.+||+.||.+|||+.++|++
T Consensus 241 -~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 241 -EGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred -cCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 000 011224578899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.10 Aligned_cols=244 Identities=24% Similarity=0.350 Sum_probs=189.7
Q ss_pred CCceEEeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDR-----DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+.. ......+.+.+|+.++++++||||+++++++... .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG--D 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC--ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC--C
Confidence 45899999999999999999754 3456789998753 2233456788999999999999999999988763 4
Q ss_pred eEEEEEechh-hHHHHHhhCCC---------------CCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCC
Q 043957 200 SLYLVFEFMQ-TDLARIISNPE---------------GKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG 257 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~---------------~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g 257 (584)
..++||||+. ++|.+.+.... ..+ .+..||+.||+|||+++|+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 5799999997 57777764321 112 2345999999999999999999999999999999
Q ss_pred cEEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 043957 258 VLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIF 335 (584)
Q Consensus 258 ~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~ 335 (584)
.++|+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+.+..+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 999999999976543221 11233456788999999876 458999999999999999998 999998776655444332
Q ss_pred HhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 336 KLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.... ......+|..+.+||.+||+.||.+|||+.++++
T Consensus 240 ~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 240 QGRV--------------------------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCC--------------------------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 1100 0011245788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=300.02 Aligned_cols=239 Identities=27% Similarity=0.401 Sum_probs=185.2
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechh-
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ- 209 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~- 209 (584)
+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.+++.++||||+++++++.... ..|+||||+.
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ--PIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC--ccEEEEECCCC
Confidence 35899999999999865 68899999986443 3334456889999999999999999999887643 5799999998
Q ss_pred hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccccc
Q 043957 210 TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV 283 (584)
Q Consensus 210 g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~g 283 (584)
++|.+.+......+. +..||+.||.|||+++++|+||||+||+++.++.+||+|||++...............+
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 567776654333333 33589999999999999999999999999999999999999997653322211122234
Q ss_pred cccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCC
Q 043957 284 TLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYK 362 (584)
Q Consensus 284 t~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 362 (584)
++.|+|||++.+ ..++.++|||||||++|+|++ |..||...........+.....
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~----------------------- 212 (250)
T cd05085 157 PIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR----------------------- 212 (250)
T ss_pred cccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 567999999875 458899999999999999998 9999988766554443322100
Q ss_pred chhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 363 PRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 363 ~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
......++..+.+||.+||..||++|||+.++++.
T Consensus 213 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 213 ---MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 01123467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=317.37 Aligned_cols=251 Identities=28% Similarity=0.416 Sum_probs=206.5
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l 201 (584)
+.+|..+..||+|+||.|.+|..+.+.+.||||+++++.. ....++-...|-++|... +-|.+|+++.+|..- ..+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm--DRL 425 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM--DRL 425 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh--hhe
Confidence 4468899999999999999999999999999999976643 223445555677788776 477889998877764 458
Q ss_pred EEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 202 YLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
|+||||+.| +|...+++ -+++.+ +..|+.||-|||++|||+||||.+|||||.+|+|||+|||+++.--- .
T Consensus 426 yFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~-~ 503 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF-D 503 (683)
T ss_pred eeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc-C
Confidence 999999995 67766653 344443 35899999999999999999999999999999999999999975321 1
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.....+.||||.|+|||++.- .+|+.++|+||+||+|||||.|++||.++++.++++.|.......+
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP------------ 570 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP------------ 570 (683)
T ss_pred CcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc------------
Confidence 223467899999999999864 6799999999999999999999999999999999999876543222
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCH-----HHHhcCcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSA-----ASALKNEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa-----~e~L~Hp~f~~~ 406 (584)
..+|.++.+++..+|.+.|.+|..+ .++-.||||...
T Consensus 571 ---------------KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 571 ---------------KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred ---------------ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence 4568999999999999999999765 678889999754
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=312.58 Aligned_cols=247 Identities=23% Similarity=0.355 Sum_probs=190.4
Q ss_pred CCCCceEEeeecccCceEEEEEEEC-------CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceee
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDR-------DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLAT 194 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~-------~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 194 (584)
..++|.+.+.||+|+||.||+|.+. .....||+|.++... .......+.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 3457999999999999999999763 234579999986432 334456788999999999 6999999999887
Q ss_pred ecCcceEEEEEechh-hHHHHHhhCCC---------------CCCc------HHHHHHHHHHHHHhCCceecccccccee
Q 043957 195 SRMQYSLYLVFEFMQ-TDLARIISNPE---------------GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLL 252 (584)
Q Consensus 195 ~~~~~~l~lV~Ey~~-g~L~~~l~~~~---------------~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NIL 252 (584)
.. ..+|+||||+. ++|..++.... ..+. +..||+.||.|||++||+||||||+|||
T Consensus 89 ~~--~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 89 QE--GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred cC--CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 63 45799999998 57777765321 1222 2459999999999999999999999999
Q ss_pred ecCCCcEEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHH
Q 043957 253 IDKNGVLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQ 330 (584)
Q Consensus 253 l~~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~ 330 (584)
++.++.+||+|||+++....... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999986643221 11122234567999999876 458999999999999999999 8999987766555
Q ss_pred HHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 331 LHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 331 ~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
+..+..... ......++.++.+||.+||..||.+|||+.++++
T Consensus 246 ~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 246 FKLLREGHR--------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHcCCC--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 544321100 0112356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=302.10 Aligned_cols=237 Identities=23% Similarity=0.313 Sum_probs=184.7
Q ss_pred eeecccCceEEEEEEECCCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEec
Q 043957 131 DKVGQGTYSNVYKALDRDTG---KIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEF 207 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey 207 (584)
++||+|+||.||+|....++ ..||+|.+...... ...+.+.+|+.+++.++|||||++++++.. ...++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEEEe
Confidence 36999999999999876554 78999998754433 445678899999999999999999987653 247999999
Q ss_pred hh-hHHHHHhhCCCCCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC--
Q 043957 208 MQ-TDLARIISNPEGKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL-- 278 (584)
Q Consensus 208 ~~-g~L~~~l~~~~~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~-- 278 (584)
+. ++|.+.+.... .+ .+..||+.||.|||..+|+|+||||+|||++.++.+||+|||+++.+........
T Consensus 77 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 77 APLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 97 57887776433 23 3345999999999999999999999999999999999999999987643332111
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 357 (584)
....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+.....
T Consensus 156 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~------------------ 216 (257)
T cd05060 156 TAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER------------------ 216 (257)
T ss_pred cCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc------------------
Confidence 11123467999999876 458999999999999999998 9999987766554443321100
Q ss_pred CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 358 p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
......++..+.+||.+||..||.+|||+.++++
T Consensus 217 --------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 --------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred --------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=303.52 Aligned_cols=245 Identities=23% Similarity=0.393 Sum_probs=190.8
Q ss_pred CCceEEeeecccCceEEEEEEECCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGK---IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
..|++.+.||+|+||.||+|.+..+++ .||||.+... ........+..|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC--CCce
Confidence 358999999999999999999887665 6999998643 234456778999999999999999999988765 3457
Q ss_pred EEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 202 YLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
++||||+.+ +|...+......+.+ ..|++.||.|||+++++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999985 677666544444433 3589999999999999999999999999999999999999987654322
Q ss_pred CCC-Ccccc---ccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 275 KRP-LTSRV---VTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 275 ~~~-~~~~~---gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
... ..... .+..|+|||++.+ ..++.++|||||||++|||++ |.+||......+....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~---------- 229 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR---------- 229 (269)
T ss_pred cccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc----------
Confidence 111 11111 2457999999875 458999999999999999886 9999987766555444421110
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
. .....++..+.++|.+||..+|.+||++.+++.
T Consensus 230 -------~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 230 -------L---------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred -------C---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 011345788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=300.87 Aligned_cols=243 Identities=24% Similarity=0.385 Sum_probs=189.4
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
.+|++.+.||.|+||.||+|.+. .+..+|+|.+...... ...+.+|++++++++||||+++++++... ...|+|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTER--SPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccC--CceEEE
Confidence 46899999999999999999875 4678999988643322 34578899999999999999999887654 357999
Q ss_pred Eechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 205 FEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
|||+.+ .|.+.+......+.+ ..|++.||.|||+.+++|+||||+||+++.++.+||+|||++..........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 999985 676666543333332 3489999999999999999999999999999999999999987654322211
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||........+..+.......
T Consensus 158 ~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 221 (256)
T cd05112 158 STGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY--------------- 221 (256)
T ss_pred cCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCC---------------
Confidence 122334678999999876 458899999999999999998 999998777655554432210000
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.....+..+.+|+.+||+.||++|||+.++|++
T Consensus 222 -----------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 222 -----------KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred -----------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 012247889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=311.92 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=191.8
Q ss_pred CCCCceEEeeecccCceEEEEEEEC-------CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceee
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDR-------DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLAT 194 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~-------~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 194 (584)
..++|.+.+.||+|+||.||+|.+. ..+..||+|.+.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 3457999999999999999999752 234579999886432 234456788999999999 8999999999887
Q ss_pred ecCcceEEEEEechh-hHHHHHhhCCC---------------CCCc------HHHHHHHHHHHHHhCCceecccccccee
Q 043957 195 SRMQYSLYLVFEFMQ-TDLARIISNPE---------------GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLL 252 (584)
Q Consensus 195 ~~~~~~l~lV~Ey~~-g~L~~~l~~~~---------------~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NIL 252 (584)
.. ..+|+||||+. ++|..++.... ..+. +..||+.||.|||++||+||||||+|||
T Consensus 92 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 92 QD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred cC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 64 45799999998 47777765421 1122 2459999999999999999999999999
Q ss_pred ecCCCcEEEEEeccccccCCCCCC-CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHH
Q 043957 253 IDKNGVLKIADFGLANYFSPNKKR-PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQ 330 (584)
Q Consensus 253 l~~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~ 330 (584)
++.++.+||+|||+++.+...... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 999999999999999876432211 1122345678999999876 458999999999999999998 8899987766555
Q ss_pred HHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 331 LHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 331 ~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
...+..... ......++..+.+||.+||..+|.+|||+.|+|+.
T Consensus 249 ~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 249 FKLLKEGHR--------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHcCCc--------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 443321100 00113567899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=313.08 Aligned_cols=246 Identities=24% Similarity=0.341 Sum_probs=189.1
Q ss_pred CCceEEeeecccCceEEEEEEECC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeec
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRD-------TGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSR 196 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~ 196 (584)
++|.+.+.||+|+||.||+|.+.. +...||+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 579999999999999999997643 23579999987543 233456688899999999 799999999988764
Q ss_pred CcceEEEEEechh-hHHHHHhhCCC---------------CCCc------HHHHHHHHHHHHHhCCceeccccccceeec
Q 043957 197 MQYSLYLVFEFMQ-TDLARIISNPE---------------GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLID 254 (584)
Q Consensus 197 ~~~~l~lV~Ey~~-g~L~~~l~~~~---------------~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~ 254 (584)
..+|+||||+. ++|..++.... ..+. +..||+.||+|||++||+||||||+|||++
T Consensus 97 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 97 --GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 35799999998 57877775421 1233 345999999999999999999999999999
Q ss_pred CCCcEEEEEeccccccCCCCCCC-CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHH
Q 043957 255 KNGVLKIADFGLANYFSPNKKRP-LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLH 332 (584)
Q Consensus 255 ~~g~vKL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~ 332 (584)
.++.+||+|||++..+....... .....+++.|+|||++.+. .++.++|||||||++|+|++ |.+||.+....+...
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 99999999999997654221111 1122345689999998764 58999999999999999998 889997765444333
Q ss_pred HHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 333 RIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 333 ~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.+.... . .+....++.++.+||.+||..+|.+|||+.+++++
T Consensus 254 ~~~~~~-~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 254 LLKEGH-R-------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHcCC-C-------------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 321100 0 01123567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.55 Aligned_cols=249 Identities=27% Similarity=0.376 Sum_probs=187.4
Q ss_pred CCCceEEeeecccCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecC
Q 043957 124 AESYDKIDKVGQGTYSNVYKALD-----RDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRM 197 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 197 (584)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++.... ......+.+|+.+|.++ +||||+++++++....
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 45799999999999999999974 35678999999964432 33456788999999999 6899999998776543
Q ss_pred cceEEEEEechh-hHHHHHhhCCCC-------------------------------------------------------
Q 043957 198 QYSLYLVFEFMQ-TDLARIISNPEG------------------------------------------------------- 221 (584)
Q Consensus 198 ~~~l~lV~Ey~~-g~L~~~l~~~~~------------------------------------------------------- 221 (584)
..+++|||||. |+|..++.....
T Consensus 85 -~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 85 -GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred -CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 35799999998 467666542110
Q ss_pred -----------CCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC-CCCccccc
Q 043957 222 -----------KLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK-RPLTSRVV 283 (584)
Q Consensus 222 -----------~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-~~~~~~~g 283 (584)
.++ +..||+.||+|||+++|+||||||+|||++.++.+||+|||++..+..... .......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 111 234999999999999999999999999999999999999999976532211 11122345
Q ss_pred cccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCC
Q 043957 284 TLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYK 362 (584)
Q Consensus 284 t~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 362 (584)
++.|+|||++.+ ..++.++|||||||++|+|++ |..||........+...+... ....
T Consensus 244 ~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------------~~~~------ 302 (343)
T cd05103 244 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG--------------TRMR------ 302 (343)
T ss_pred CcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhcc--------------CCCC------
Confidence 677999999876 458999999999999999997 999997654332222211100 0000
Q ss_pred chhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 363 PRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 363 ~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
....+++.+.+++..||+.||.+|||+.|+++|
T Consensus 303 -----~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 303 -----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred -----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 011246788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=307.39 Aligned_cols=244 Identities=25% Similarity=0.356 Sum_probs=189.0
Q ss_pred CCceEEeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDR-----DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
.+|++.++||+|+||.||++... .++..+|+|.+.. ........+.+|+++++.++|+||+++++++... .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTVLQHQHIVRFYGVCTEG--R 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc--CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC--C
Confidence 46888999999999999999643 3567899998753 2334556789999999999999999999887764 3
Q ss_pred eEEEEEechh-hHHHHHhhCCC--------------CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCc
Q 043957 200 SLYLVFEFMQ-TDLARIISNPE--------------GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGV 258 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~--------------~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~ 258 (584)
..|+||||+. ++|..++.... ..+. +..||+.||+|||+++|+||||||+|||+++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 5799999998 46766664321 1122 2359999999999999999999999999999999
Q ss_pred EEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 043957 259 LKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFK 336 (584)
Q Consensus 259 vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~ 336 (584)
+||+|||++..+..... .......+++.|+|||++.+. .++.++|||||||++|+|++ |.+||......+.+..+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 99999999976532221 111223456789999998764 58999999999999999998 9999987766655444422
Q ss_pred hcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 337 LCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.... .....+++.+.+||.+||+.||.+||++.++++
T Consensus 240 ~~~~--------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GREL--------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccC--------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1100 111346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=302.11 Aligned_cols=237 Identities=24% Similarity=0.322 Sum_probs=183.3
Q ss_pred eecccCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechh
Q 043957 132 KVGQGTYSNVYKALDR--DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ 209 (584)
Q Consensus 132 ~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~ 209 (584)
.||+|+||.||+|.+. ..+..||+|++... ......+.+.+|+.++++++||||+++++++.. ...|+||||+.
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeCC
Confidence 3899999999999765 44667999998644 233445678899999999999999999987743 24799999998
Q ss_pred -hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC--Ccc
Q 043957 210 -TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP--LTS 280 (584)
Q Consensus 210 -g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~--~~~ 280 (584)
++|.+.+......+++ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++..+....... ...
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 4677776543334333 3599999999999999999999999999999999999999998654332211 112
Q ss_pred ccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCC
Q 043957 281 RVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQ 359 (584)
Q Consensus 281 ~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~ 359 (584)
..+++.|+|||++.. ..++.++|||||||++|+|++ |.+||......+....+..... +
T Consensus 158 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~------------------ 217 (257)
T cd05115 158 GKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR-L------------------ 217 (257)
T ss_pred CCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-C------------------
Confidence 233578999999875 458999999999999999996 9999988776655443322110 0
Q ss_pred CCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 360 SYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 360 ~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
......++++.+||.+||..||++||++.++++
T Consensus 218 -------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 218 -------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011345789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=300.23 Aligned_cols=242 Identities=26% Similarity=0.385 Sum_probs=190.2
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.+.||+|+||.||++.+. .+..+|+|.+... ......+.+|+.+++.++|+||+++++++.. ...|+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEE
Confidence 457999999999999999999755 4567999988632 2234668889999999999999999888765 34799
Q ss_pred EEechh-hHHHHHhhCCC-CCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 204 VFEFMQ-TDLARIISNPE-GKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~-~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
+|||+. ++|.+.+.... ..+ .+..||+.||.|||+.+++|+||||+||+++.++.+||+|||++..+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 999997 57888776422 222 2345999999999999999999999999999999999999999987643322
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.......++..|+|||++.. ..++.++|||||||++|+|++ |++||.+.+.......+.....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------------- 221 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR--------------- 221 (260)
T ss_pred ccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC---------------
Confidence 22223345677999999875 458999999999999999998 9999988776555443321100
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
. .....++.++.++|.+||+.||++||++.++++
T Consensus 222 --~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 222 --M---------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred --C---------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0 111356789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=299.71 Aligned_cols=243 Identities=30% Similarity=0.440 Sum_probs=191.8
Q ss_pred ceEEeeecccCceEEEEEEECCCC----cEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTG----KIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
+++.+.||.|+||.||+|.+...+ ..||+|++..... ....+.+..|+.+++.++|+||+++++++... ...|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--CeeE
Confidence 356788999999999999998766 8999999864432 22567788999999999999999999888764 4689
Q ss_pred EEEechhh-HHHHHhhCCCCC-CcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 203 LVFEFMQT-DLARIISNPEGK-LTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~~~-l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
++|||+.+ +|.+.+...... +.+ ..||+.||+|||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999985 677776543322 333 3599999999999999999999999999999999999999998765432
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
........+++.|+|||.+.+ ..++.++|||||||++|+|++ |++||...+....+..+......
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------- 223 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL------------- 223 (258)
T ss_pred ccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-------------
Confidence 211112236789999999854 458999999999999999998 88999887665555544321100
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....++.++.++|.+||..||.+|||+.|+++
T Consensus 224 -------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 224 -------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred -------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 011236889999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=299.44 Aligned_cols=238 Identities=29% Similarity=0.429 Sum_probs=184.9
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechh-
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ- 209 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~- 209 (584)
++||.|+||.||+|.+.. ++.||+|++...... .....+.+|++++++++|+||+++++++... ...|+||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQK--QPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CCeEEEEEcCCC
Confidence 369999999999999887 999999998654333 3556788999999999999999999887664 45799999997
Q ss_pred hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC-cccc
Q 043957 210 TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL-TSRV 282 (584)
Q Consensus 210 g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~-~~~~ 282 (584)
++|.+.+......+. +..+++.||.|||+++|+||||||+|||++.++.+||+|||++........... ....
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 467777654333333 234899999999999999999999999999999999999999976542211111 1123
Q ss_pred ccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCC
Q 043957 283 VTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSY 361 (584)
Q Consensus 283 gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~ 361 (584)
.+..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+..... .
T Consensus 157 ~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~-----------------~---- 214 (251)
T cd05041 157 IPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR-----------------M---- 214 (251)
T ss_pred ceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC-----------------C----
Confidence 3567999999876 458999999999999999999 8899987765444333321100 0
Q ss_pred CchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 362 KPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 362 ~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....++..+.+||.+||+.+|.+|||+.|+|+
T Consensus 215 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 215 -----PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 011345788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=309.85 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=191.3
Q ss_pred CCCCceEEeeecccCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeec
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALD-----RDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSR 196 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~ 196 (584)
..++|.+.+.||+|+||.||+|.+ ..++..||||+++... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 345799999999999999999975 3346689999986432 233456788999999999 799999999887664
Q ss_pred CcceEEEEEechh-hHHHHHhhCCCC-CCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccc
Q 043957 197 MQYSLYLVFEFMQ-TDLARIISNPEG-KLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLAN 268 (584)
Q Consensus 197 ~~~~l~lV~Ey~~-g~L~~~l~~~~~-~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~ 268 (584)
..+|+||||+. ++|...+..... .+++ ..||+.||.|||+++|+|+||||+|||++.++.++|+|||++.
T Consensus 112 --~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 112 --GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred --CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 35899999998 578777754322 1333 3599999999999999999999999999999999999999998
Q ss_pred ccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHH
Q 043957 269 YFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYW 346 (584)
Q Consensus 269 ~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 346 (584)
.+..... .......+++.|+|||++.+. .++.++|||||||++|+|++ |.+||......+.+........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~------- 261 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY------- 261 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC-------
Confidence 6543221 111223457789999998764 48999999999999999998 9999987665444333322100
Q ss_pred HHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 347 KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 347 ~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.. .....+++.+.+||.+||..||++|||+.|+++
T Consensus 262 ---------~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 262 ---------RM---------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ---------cC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00 011245788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=305.82 Aligned_cols=242 Identities=30% Similarity=0.449 Sum_probs=186.4
Q ss_pred eEEeeecccCceEEEEEEEC----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 128 DKIDKVGQGTYSNVYKALDR----DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 128 ~~~~~LG~G~fg~Vy~a~~~----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.+.+.||.|.||.||+|... ..+..|+||.++. .......+.+.+|++++++++||||+++++++... ..+++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~--~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN--EPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS--SSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccc--ccccc
Confidence 46788999999999999887 4567899999954 33444577889999999999999999999999843 34899
Q ss_pred EEechh-hHHHHHhhCC-CCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 204 VFEFMQ-TDLARIISNP-EGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~-~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
|||||. |+|.+.+... ...++ ++.||+.||.|||+++|+|+||++.|||++.++.+||+|||++........
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999998 5788877654 33443 345999999999999999999999999999999999999999987632211
Q ss_pred -CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 276 -RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 276 -~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
...........|+|||.+.... ++.++||||||+++|||++ |+.||...+..+....+.+....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~------------- 224 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRL------------- 224 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEET-------------
T ss_pred ccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccc-------------
Confidence 1122345677899999997644 8999999999999999999 78999888776666655332111
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....++..+.++|..||..||.+|||+.++++
T Consensus 225 -------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 225 -------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp -------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred -------------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 112356889999999999999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=298.35 Aligned_cols=253 Identities=25% Similarity=0.374 Sum_probs=190.8
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec---Ccc
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR---MQY 199 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~---~~~ 199 (584)
..++|++.+.||+|+|+.||++.+..++..||+|++.... .+..+...+|++..++++||||++++++.... ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3468999999999999999999999999999999997655 34567788999999999999999998876432 334
Q ss_pred eEEEEEechh-hHHHHHhhCC---CCCCcH------HHHHHHHHHHHHhCC--ceeccccccceeecCCCcEEEEEeccc
Q 043957 200 SLYLVFEFMQ-TDLARIISNP---EGKLTE------PQQLLSGLQHCHDRG--ILHRDVKGSNLLIDKNGVLKIADFGLA 267 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~---~~~l~~------~~qIl~aL~yLH~~~--IvHrDLKp~NILl~~~g~vKL~DFGla 267 (584)
..||+++|.. |+|++.+... ...+++ ..+|++||.+||+.. ++||||||.|||+.+++.++|.|||.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 6899999987 6788776532 223333 358999999999998 999999999999999999999999999
Q ss_pred cccCCCCC--------CCCccccccccccChhhhhCC--CCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 043957 268 NYFSPNKK--------RPLTSRVVTLWYRAPELLLGA--TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKL 337 (584)
Q Consensus 268 ~~~~~~~~--------~~~~~~~gt~~Y~APEvl~~~--~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~ 337 (584)
+...-.-. ......-.|..|+|||.+.-. ...+.++|||||||+||+|+.|..||... +..
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~~~ 247 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------YQQ 247 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------hhc
Confidence 76431100 001223458889999987532 24689999999999999999999999421 110
Q ss_pred cCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 338 CGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
-++..... .......|. -..+|+.+.+||..||+.||.+||++.++|.+
T Consensus 248 GgSlaLAv-----~n~q~s~P~---------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 248 GGSLALAV-----QNAQISIPN---------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CCeEEEee-----eccccccCC---------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 00000000 000000011 12378999999999999999999999999975
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=309.13 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=188.0
Q ss_pred CCceEEeeecccCceEEEEEEECC----------------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeee
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRD----------------TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVK 188 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~----------------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 188 (584)
++|++.+.||+|+||.||+|.+.. ++..||+|.+... ........+.+|+.+|+.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 469999999999999999985432 3457999998643 23344567889999999999999999
Q ss_pred eeceeeecCcceEEEEEechh-hHHHHHhhCCCC----------------CCcHHHHHHHHHHHHHhCCceeccccccce
Q 043957 189 LEGLATSRMQYSLYLVFEFMQ-TDLARIISNPEG----------------KLTEPQQLLSGLQHCHDRGILHRDVKGSNL 251 (584)
Q Consensus 189 l~~~~~~~~~~~l~lV~Ey~~-g~L~~~l~~~~~----------------~l~~~~qIl~aL~yLH~~~IvHrDLKp~NI 251 (584)
+++++... ...|+||||+. ++|...+..... ......||+.||+|||+++|+|+||||+||
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecC--CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 99988664 35799999998 577777654211 122345999999999999999999999999
Q ss_pred eecCCCcEEEEEeccccccCCCCCCC-CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh--CCCCCCCCChH
Q 043957 252 LIDKNGVLKIADFGLANYFSPNKKRP-LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL--GRPIMPGRTEV 328 (584)
Q Consensus 252 Ll~~~g~vKL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt--G~~pF~~~~~~ 328 (584)
|++.++.++|+|||++..+....... .....+++.|++||++.+. .++.++|||||||++|||++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999998654322111 1223346789999988764 58999999999999999998 67888776655
Q ss_pred HHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 329 EQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 329 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
+.+...... +..... ... ......+++.+.+||.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~--------~~~~~~-~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEF--------FRDQGR-QVY----------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHH--------Hhhccc-ccc----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 544332111 000000 000 0111345788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=307.51 Aligned_cols=246 Identities=26% Similarity=0.398 Sum_probs=190.3
Q ss_pred CCCceEEeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDR-----DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 198 (584)
.++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~-- 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG-- 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--
Confidence 356999999999999999999874 367889999986432 334456788999999999999999999987764
Q ss_pred ceEEEEEechhh-HHHHHhhCCCC---------------------------CCcHHHHHHHHHHHHHhCCceeccccccc
Q 043957 199 YSLYLVFEFMQT-DLARIISNPEG---------------------------KLTEPQQLLSGLQHCHDRGILHRDVKGSN 250 (584)
Q Consensus 199 ~~l~lV~Ey~~g-~L~~~l~~~~~---------------------------~l~~~~qIl~aL~yLH~~~IvHrDLKp~N 250 (584)
...|+||||+.+ +|.+.+..... .+.++.||+.||.|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 357999999984 77777652110 12345699999999999999999999999
Q ss_pred eeecCCCcEEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChH
Q 043957 251 LLIDKNGVLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEV 328 (584)
Q Consensus 251 ILl~~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~ 328 (584)
||++.++.++|+|||++..+..... ........++.|+|||++.+. .++.++|||||||++|+|++ |..||.+....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999876532211 111222346679999998764 58999999999999999997 88888776665
Q ss_pred HHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 329 EQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 329 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
+....+..... ......++..+.+||.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGNV--------------------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCCC--------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 55443322110 0011345788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=299.80 Aligned_cols=239 Identities=26% Similarity=0.371 Sum_probs=188.7
Q ss_pred eeecccCceEEEEEEECC-CCc--EEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEec
Q 043957 131 DKVGQGTYSNVYKALDRD-TGK--IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEF 207 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~-~g~--~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey 207 (584)
+.||+|++|+||+|.+.. .+. .||||.+...... ...+.+.+|+.++++++||||+++++++.. ..+++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEe
Confidence 358999999999998765 333 6999999755443 556788899999999999999999988776 468999999
Q ss_pred hh-hHHHHHhhCCC-CCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC--C
Q 043957 208 MQ-TDLARIISNPE-GKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR--P 277 (584)
Q Consensus 208 ~~-g~L~~~l~~~~-~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~--~ 277 (584)
+. ++|...+.... ..+.+ ..||+.||+|||+++++|+||||+|||++.++.+||+|||++..+...... .
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 97 57887776543 23333 349999999999999999999999999999999999999999876432211 1
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+.+..+.......
T Consensus 157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL--------------- 220 (257)
T ss_pred ccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC---------------
Confidence 123456788999999875 458999999999999999998 999998777766555543210000
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....+|..+.+||.+||..+|++|||+.++++
T Consensus 221 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 221 ----------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ----------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 011245788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=306.82 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=191.9
Q ss_pred CceEEeeecccCceEEEEEEEC---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcc
Q 043957 126 SYDKIDKVGQGTYSNVYKALDR---DTGKIVALKKVKFDTS--EPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 199 (584)
+|++.+.||+|+||.||++.+. .++..||||.++.... .......+.+|+.++.++ +||||+++++.+.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CC
Confidence 4889999999999999999864 4678999999864321 122345678899999999 59999999887765 44
Q ss_pred eEEEEEechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
.+|+||||+.+ +|...+... ..+. +..|++.||.|||+.+++|+||||.|||++.++.++|+|||++..+..
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 68999999985 676666532 2232 234999999999999999999999999999999999999999977644
Q ss_pred CCCCCCccccccccccChhhhhCCC-CCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGAT-DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~~-~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
..........+++.|+|||.+.+.. ..+.++|||||||++|+|++|..||...........+......
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~----------- 226 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK----------- 226 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-----------
Confidence 3322223456889999999986532 3678999999999999999999999654322111111111000
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC---HHHHhcCcCCCCC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS---AASALKNEFFFTS 406 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT---a~e~L~Hp~f~~~ 406 (584)
.. ......++..+.+||.+||+.||++||| +.++|+||||...
T Consensus 227 -~~-----------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 227 -SK-----------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred -cC-----------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 00 0011335788999999999999999998 5778999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=304.55 Aligned_cols=248 Identities=22% Similarity=0.321 Sum_probs=192.1
Q ss_pred CCCCceEEeeecccCceEEEEEEECC----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRD----TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 198 (584)
..++|++.+.||+|+||.||+|.+.. ++..|++|.+.. .........+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-G 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-C
Confidence 45679999999999999999998876 357899998853 33445567788999999999999999999877653 3
Q ss_pred ceEEEEEechh-hHHHHHhhCCC-------CCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEe
Q 043957 199 YSLYLVFEFMQ-TDLARIISNPE-------GKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADF 264 (584)
Q Consensus 199 ~~l~lV~Ey~~-g~L~~~l~~~~-------~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DF 264 (584)
...++++||+. ++|...+.... ..+.+ ..||+.||+|||+++|+|+||||+|||++.++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 45799999998 56776664321 12332 349999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCC-CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 043957 265 GLANYFSPNKKRP-LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPS 342 (584)
Q Consensus 265 Gla~~~~~~~~~~-~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~ 342 (584)
|+++.+....... .....++..|+|||++.+. .++.++|||||||++|++++ |++||...+..+....+....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---- 236 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY---- 236 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC----
Confidence 9998664332211 1223456779999998764 58999999999999999998 999998776554433222110
Q ss_pred hHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 343 EDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 343 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.. .....+++++.++|.+||..||++|||+.++++
T Consensus 237 -------------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 237 -------------RL---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -------------CC---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 011245788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=303.22 Aligned_cols=245 Identities=24% Similarity=0.345 Sum_probs=191.4
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGK----IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
..+|++.+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.++++++||||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS---S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---C
Confidence 3569999999999999999999877665 58999875443 24455678899999999999999999998875 3
Q ss_pred eEEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
..++||||+. ++|.+.+......+.+ ..||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 5799999997 5788777654444433 35999999999999999999999999999999999999999987653
Q ss_pred CCCCC-CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 273 NKKRP-LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 273 ~~~~~-~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
..... .....++..|+|||.+.. ..++.++|||||||++|||++ |.+||.+....+....+..... .
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~--------- 230 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-L--------- 230 (279)
T ss_pred cccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-C---------
Confidence 32211 112223567999998865 458899999999999999998 9999988765554443322100 0
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
......+..+.++|.+||..||.+|||+.++++
T Consensus 231 ----------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 231 ----------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ----------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 011234678899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=302.41 Aligned_cols=247 Identities=30% Similarity=0.449 Sum_probs=190.6
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecC---CCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD---TSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~---~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
+|.+.+.||+|+||.||++.+..++..+++|.++.. .........+..|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD--AFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC--ceE
Confidence 589999999999999999999887777777766432 222233445667999999999999999998887643 579
Q ss_pred EEEechhh-HHHHHhhC---CCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 203 LVFEFMQT-DLARIISN---PEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~---~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
+||||+.+ +|...+.. ....+.+ ..||+.||.|||+++++|+||||+||+++. +.++|+|||++.....
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999985 56555432 2223333 359999999999999999999999999975 5799999999977643
Q ss_pred CCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+.... +.
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~--~~---------- 223 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP--TP---------- 223 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC--CC----------
Confidence 221 2234567889999998865 457889999999999999999999998766554444332110 00
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
.....++.++.+||.+||..||++||++.|+|+||||
T Consensus 224 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 224 --------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred --------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0113567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=301.33 Aligned_cols=238 Identities=26% Similarity=0.410 Sum_probs=189.8
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.+.||.|+||.||+|... |+.||||.+..... ..+.+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEE
Confidence 456899999999999999999764 78999999964432 45678899999999999999999998876 445799
Q ss_pred EEechh-hHHHHHhhCCCC-CC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 204 VFEFMQ-TDLARIISNPEG-KL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~-~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
||||+. ++|.+.+..... .+ .+..||+.||.|||+++|+|+||||+|||++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 999998 578887754332 22 334599999999999999999999999999999999999999998763221
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.....+..|+|||++.. ..++.++|||||||++|+|++ |..||......+....+....
T Consensus 157 ---~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---------------- 216 (256)
T cd05039 157 ---DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY---------------- 216 (256)
T ss_pred ---ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC----------------
Confidence 22334567999999875 458899999999999999997 999998766554433332110
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
. ......+++.+.+||.+||..+|.+|||+.++++
T Consensus 217 -~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 217 -R---------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred -C---------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0 0112346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=313.77 Aligned_cols=277 Identities=30% Similarity=0.458 Sum_probs=210.0
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-----C---CCeeeeeceeee-
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-----H---PNIVKLEGLATS- 195 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-----H---pnIv~l~~~~~~- 195 (584)
.+|.+.++||-|-|++||+|.|..+.+.||+|+.+ ......+....||.+|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK---SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK---SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEe---hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 57999999999999999999999999999999986 33444566778999999983 3 469999999865
Q ss_pred -cCcceEEEEEechhhHHHHHhhCCCCC-C------cHHHHHHHHHHHHHh-CCceeccccccceeec------------
Q 043957 196 -RMQYSLYLVFEFMQTDLARIISNPEGK-L------TEPQQLLSGLQHCHD-RGILHRDVKGSNLLID------------ 254 (584)
Q Consensus 196 -~~~~~l~lV~Ey~~g~L~~~l~~~~~~-l------~~~~qIl~aL~yLH~-~~IvHrDLKp~NILl~------------ 254 (584)
....+++||+|++...|+.+|.....+ + .+++|||.||.|||. .||||.||||+|||+.
T Consensus 155 GpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~ 234 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDARE 234 (590)
T ss_pred CCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhh
Confidence 345689999999999999999865432 2 334699999999995 6999999999999982
Q ss_pred --------------------------------------------------------------------------------
Q 043957 255 -------------------------------------------------------------------------------- 254 (584)
Q Consensus 255 -------------------------------------------------------------------------------- 254 (584)
T Consensus 235 a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~ 314 (590)
T KOG1290|consen 235 AGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNES 314 (590)
T ss_pred hccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcccc
Confidence
Q ss_pred ----------------------CC----------------------------------------------------CcEE
Q 043957 255 ----------------------KN----------------------------------------------------GVLK 260 (584)
Q Consensus 255 ----------------------~~----------------------------------------------------g~vK 260 (584)
.. -.||
T Consensus 315 ~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vK 394 (590)
T KOG1290|consen 315 TVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVK 394 (590)
T ss_pred chhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEE
Confidence 00 0256
Q ss_pred EEEeccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCC------ChHHHHHHH
Q 043957 261 IADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGR------TEVEQLHRI 334 (584)
Q Consensus 261 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~------~~~~~~~~i 334 (584)
|+|||-|+.+. ..++.-+.|..|+||||+++. .|++.+||||++|++|||+||..+|... .+.+.++.|
T Consensus 395 IaDlGNACW~~----khFT~DIQTRQYRapEVllGs-gY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i 469 (590)
T KOG1290|consen 395 IADLGNACWVH----KHFTEDIQTRQYRAPEVLLGS-GYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI 469 (590)
T ss_pred Eeeccchhhhh----hhhchhhhhhhccCcceeecC-CCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence 77777766542 124555679999999999985 5999999999999999999999888543 467889999
Q ss_pred HHhcCCCChHHHHHhhccCC-------CCCCCCCCc-hhhhhc---cCCc----HhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 335 FKLCGSPSEDYWKKLRLSTT-------FRPPQSYKP-RLFEAF---SEFP----ESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~-------~~~p~~~~~-~~~~~~---~~~s----~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
+..++..+......-..+.. .+....+++ .+.+.+ -.+| .++.|||.-||+++|++|+||.++|+
T Consensus 470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 99998877543322211111 111122222 122222 1233 46789999999999999999999999
Q ss_pred CcCCCCCCCc
Q 043957 400 NEFFFTSPLA 409 (584)
Q Consensus 400 Hp~f~~~~~~ 409 (584)
|||+...+.+
T Consensus 550 hPwLn~~~~~ 559 (590)
T KOG1290|consen 550 HPWLNPVAGP 559 (590)
T ss_pred CccccCCCCC
Confidence 9999876544
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=298.11 Aligned_cols=239 Identities=32% Similarity=0.488 Sum_probs=193.0
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechh-h
Q 043957 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ-T 210 (584)
Q Consensus 133 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~-g 210 (584)
||.|+||.||++.+..+++.||+|++..... .......+.+|+.+++.++||||+++++.+.. ...+|+||||+. +
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEecCCCC
Confidence 6899999999999998899999999865432 22355678899999999999999999887765 456899999995 6
Q ss_pred HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCcccccc
Q 043957 211 DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVT 284 (584)
Q Consensus 211 ~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gt 284 (584)
+|.+.+.... .+. +..||+.||.|||+.+++|+||+|+||+++.++.++|+|||++....... .......++
T Consensus 79 ~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05123 79 ELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGT 156 (250)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCC
Confidence 7877776432 233 23599999999999999999999999999999999999999998764332 123455778
Q ss_pred ccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCch
Q 043957 285 LWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPR 364 (584)
Q Consensus 285 ~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 364 (584)
..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+.....
T Consensus 157 ~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------------- 210 (250)
T cd05123 157 PEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPL------------------------- 210 (250)
T ss_pred ccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC-------------------------
Confidence 899999998764 478899999999999999999999987766444444322100
Q ss_pred hhhhccCCcHhHHHHHHHhcccCCCCCCCH---HHHhcCcCC
Q 043957 365 LFEAFSEFPESSLGLLSTLLALDPAYRGSA---ASALKNEFF 403 (584)
Q Consensus 365 ~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa---~e~L~Hp~f 403 (584)
.....++..+.+||.+||..||.+|||+ +++++||||
T Consensus 211 --~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 211 --RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred --CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 1112347889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=300.59 Aligned_cols=240 Identities=22% Similarity=0.328 Sum_probs=181.9
Q ss_pred eecccCceEEEEEEECC---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEech
Q 043957 132 KVGQGTYSNVYKALDRD---TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 132 ~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
.||+|+||.||+|.+.. ....||||.+... ......+.+.+|+.+++.++||||+++++++.... ...|+||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv~e~~ 79 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-GSPLVVLPYM 79 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-CCcEEEEecC
Confidence 58999999999998653 3457999987532 23344667889999999999999999998765433 3468999999
Q ss_pred h-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC---CCC
Q 043957 209 Q-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK---RPL 278 (584)
Q Consensus 209 ~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~---~~~ 278 (584)
. ++|..++........ +..||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.+..... ...
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 8 577777754333222 335999999999999999999999999999999999999999976532211 111
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 357 (584)
....+++.|+|||++.+ ..++.++|||||||++|||++ |.+||...+..+....+.... ..
T Consensus 160 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~---------------~~-- 221 (262)
T cd05058 160 TGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR---------------RL-- 221 (262)
T ss_pred ccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC---------------CC--
Confidence 23345778999999876 458999999999999999999 577887766554443332110 00
Q ss_pred CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 358 p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.....+++.+.++|.+||..||++|||+.++|+.
T Consensus 222 ---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 222 ---------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred ---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0012357889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=330.42 Aligned_cols=261 Identities=28% Similarity=0.475 Sum_probs=208.8
Q ss_pred ccCCCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeec
Q 043957 118 GLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSR 196 (584)
Q Consensus 118 ~~~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~ 196 (584)
+.+|...+.|++.+.||.|.+|.||+++++.+++.+|+|++...... .+++..|.+||+.+ +|||++.+|++|...
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---EEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 45677788899999999999999999999999999999998654333 34566789999988 599999999988653
Q ss_pred C---cceEEEEEechhh-HHHHHhhCC-CCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEec
Q 043957 197 M---QYSLYLVFEFMQT-DLARIISNP-EGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFG 265 (584)
Q Consensus 197 ~---~~~l~lV~Ey~~g-~L~~~l~~~-~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFG 265 (584)
. ...+|||||||.| +..++++.- ..++.|. +.+|.||.+||.+.++|||||-.|||++.++.|||+|||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeee
Confidence 2 3469999999995 444554421 3445443 488999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCccccccccccChhhhhCC----CCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 043957 266 LANYFSPNKKRPLTSRVVTLWYRAPELLLGA----TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSP 341 (584)
Q Consensus 266 la~~~~~~~~~~~~~~~gt~~Y~APEvl~~~----~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~ 341 (584)
++..+..... ...+.+|||+|||||++-.. ..|+..+|+||||++..||.-|.||+......-.+ +.....|
T Consensus 169 vSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL---F~IpRNP 244 (953)
T KOG0587|consen 169 VSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL---FLIPRNP 244 (953)
T ss_pred eeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh---ccCCCCC
Confidence 9988764433 34667999999999998532 24788999999999999999999999776654333 2222222
Q ss_pred ChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 342 SEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 342 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
+. ....+..++..+.|||..||.+|-.+||+..++|+|||++..
T Consensus 245 PP---------------------kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 245 PP---------------------KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred Cc---------------------cccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 21 112234568899999999999999999999999999999743
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=312.65 Aligned_cols=246 Identities=24% Similarity=0.336 Sum_probs=190.2
Q ss_pred CCceEEeeecccCceEEEEEEECCC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeec
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDT-------GKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSR 196 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~-------g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~ 196 (584)
.+|++.+.||+|+||.||+|.+... +..||+|.++.. ........+.+|+.+++++ +||||+++++++...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3699999999999999999976432 236899987643 3334567788999999999 799999999988764
Q ss_pred CcceEEEEEechh-hHHHHHhhCCC---------------CCCc------HHHHHHHHHHHHHhCCceeccccccceeec
Q 043957 197 MQYSLYLVFEFMQ-TDLARIISNPE---------------GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLID 254 (584)
Q Consensus 197 ~~~~l~lV~Ey~~-g~L~~~l~~~~---------------~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~ 254 (584)
..+|+||||+. ++|.+.+.... ..+. ...||+.||.|||++||+||||||+|||++
T Consensus 91 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 91 --GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 35899999998 47777765321 1222 345999999999999999999999999999
Q ss_pred CCCcEEEEEeccccccCCCCCC-CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHH
Q 043957 255 KNGVLKIADFGLANYFSPNKKR-PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLH 332 (584)
Q Consensus 255 ~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~ 332 (584)
.++.+||+|||+++.+...... ......++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999999865432211 1122334567999999976 458899999999999999998 889998877655544
Q ss_pred HHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 333 RIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 333 ~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.+..... ......++..+.+||.+||+.+|.+|||+.|+|++
T Consensus 248 ~~~~~~~--------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 248 LLKEGHR--------------------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHcCCC--------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 4322100 01123457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=303.04 Aligned_cols=243 Identities=22% Similarity=0.337 Sum_probs=180.2
Q ss_pred eecccCceEEEEEEECC--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechh
Q 043957 132 KVGQGTYSNVYKALDRD--TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ 209 (584)
Q Consensus 132 ~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~ 209 (584)
.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+... ..+|+||||+.
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~--~~~~lv~e~~~ 78 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES--IPYLLVLEFCP 78 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC--CceEEEEEeCC
Confidence 58999999999996432 34578888875432 333445678899999999999999999887764 45799999998
Q ss_pred -hHHHHHhhCCCCC----------CcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC-CC
Q 043957 210 -TDLARIISNPEGK----------LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK-RP 277 (584)
Q Consensus 210 -g~L~~~l~~~~~~----------l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-~~ 277 (584)
++|.+++...... ..+..||+.||+|||+++|+||||||+|||++.++.+||+|||++........ ..
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 4777776543221 23345999999999999999999999999999999999999999865432211 11
Q ss_pred CccccccccccChhhhhC------CCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 278 LTSRVVTLWYRAPELLLG------ATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~------~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
.....+++.|+|||++.. ...++.++|||||||++|||++ |.+||....+.+.+..+.......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~--------- 229 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK--------- 229 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc---------
Confidence 123345678999999753 2346889999999999999999 788998777666555443321100
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.+. ......++..+.+++..|+ .||++|||++++++
T Consensus 230 ------~~~------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 230 ------LPK------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ------CCC------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 000 0112356788889999998 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=304.42 Aligned_cols=233 Identities=19% Similarity=0.335 Sum_probs=177.7
Q ss_pred eeecccCceEEEEEEECCCCc-------EEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 131 DKVGQGTYSNVYKALDRDTGK-------IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~-------~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
+.||.|+||.||+|.+...+. .||+|.+... .....+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD--ESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC--CcEE
Confidence 359999999999998865544 3888877432 2334566788999999999999999999887643 4799
Q ss_pred EEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCc--------EEEEEecccc
Q 043957 204 VFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGV--------LKIADFGLAN 268 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~--------vKL~DFGla~ 268 (584)
||||+.+ +|...+......+.+ ..||+.||.|||+++|+||||||+|||++.++. ++|+|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 9999985 677777654433333 459999999999999999999999999987664 6999999987
Q ss_pred ccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCChHHHH
Q 043957 269 YFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGR-PIMPGRTEVEQLHRIFKLCGSPSEDYWK 347 (584)
Q Consensus 269 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~-~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 347 (584)
..... ....+++.|+|||++.+...++.++|||||||++|+|++|. +||...+...... +.....
T Consensus 157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~-------- 222 (258)
T cd05078 157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRH-------- 222 (258)
T ss_pred ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccc--------
Confidence 65322 33467889999999976556889999999999999999994 6665544433221 111000
Q ss_pred HhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 348 KLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 348 ~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
......+.++.+||.+||+.||++|||++++|+.
T Consensus 223 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 223 -------------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred -------------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 0112345678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=323.75 Aligned_cols=254 Identities=24% Similarity=0.347 Sum_probs=214.2
Q ss_pred CCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecC-CCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD-TSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 121 ~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~-~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
.....+++++..||-|+||.|-++........+|+|++++. ..+....+.+..|-+||..++.|.||++|..|.+ ..
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd--~k 493 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD--SK 493 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc--ch
Confidence 44556788899999999999999977665556999998654 3344456778899999999999999999877665 56
Q ss_pred eEEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
++||+||-|- |.++.++.+ .+.+.. ...++.|++|||++|||+|||||+|+|++.+|-+||.|||+|+.+..
T Consensus 494 yvYmLmEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhhhhHHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 7899999987 567777764 334432 34889999999999999999999999999999999999999999876
Q ss_pred CCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
+.. .-++||||.|+|||+++. +..+.++|.||||+++||||+|.|||.+.+....+..|++.+..
T Consensus 573 g~K--TwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~------------ 637 (732)
T KOG0614|consen 573 GRK--TWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK------------ 637 (732)
T ss_pred CCc--eeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh------------
Confidence 554 457899999999999997 45899999999999999999999999999999999999886421
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC-----HHHHhcCcCCCC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS-----AASALKNEFFFT 405 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT-----a~e~L~Hp~f~~ 405 (584)
.+....++..+.+||.++...+|.+|.. +.++-+|.||..
T Consensus 638 -------------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 638 -------------IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred -------------hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 2334678899999999999999999986 799999999964
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=301.90 Aligned_cols=247 Identities=21% Similarity=0.310 Sum_probs=188.8
Q ss_pred ceEEeeecccCceEEEEEEECC---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc----c
Q 043957 127 YDKIDKVGQGTYSNVYKALDRD---TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ----Y 199 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~----~ 199 (584)
|++.+.||+|+||.||+|.+.. ++..||||++..+.......+.+.+|+.++++++||||+++++++..... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6778899999999999998653 57899999997665555566778899999999999999999998765322 1
Q ss_pred eEEEEEechh-hHHHHHhhCC-----CCCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccc
Q 043957 200 SLYLVFEFMQ-TDLARIISNP-----EGKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA 267 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~-----~~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla 267 (584)
..++++||+. ++|...+... ...+ .+..||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 3478899987 5665554311 1122 23459999999999999999999999999999999999999999
Q ss_pred cccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHH
Q 043957 268 NYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDY 345 (584)
Q Consensus 268 ~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~ 345 (584)
+....... .......+++.|++||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------ 233 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR------ 233 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc------
Confidence 86543221 11122345678999999876 458899999999999999999 8999987766554443322100
Q ss_pred HHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 346 WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 346 ~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
. .....++..+.+|+.+||..+|.+|||+.+++++
T Consensus 234 ---------~-----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 234 ---------L-----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred ---------C-----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 0012457889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=301.04 Aligned_cols=233 Identities=21% Similarity=0.308 Sum_probs=174.7
Q ss_pred eeecccCceEEEEEEECC------------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc
Q 043957 131 DKVGQGTYSNVYKALDRD------------TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~------------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 198 (584)
+.||+|+||.||+|.... ....||+|.+... .......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~- 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV- 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 358999999999997432 2335888887532 2334456788999999999999999999887643
Q ss_pred ceEEEEEechhhH-HHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCc-------EEEEEe
Q 043957 199 YSLYLVFEFMQTD-LARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGV-------LKIADF 264 (584)
Q Consensus 199 ~~l~lV~Ey~~g~-L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~-------vKL~DF 264 (584)
..++||||+.++ |..++......+. ++.||+.||+|||+++|+||||||+||||+.++. ++|+||
T Consensus 78 -~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 78 -ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred -CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 469999999964 4444443333333 3459999999999999999999999999987664 899999
Q ss_pred ccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCCh
Q 043957 265 GLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRIFKLCGSPSE 343 (584)
Q Consensus 265 Gla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLl-tG~~pF~~~~~~~~~~~i~~~~~~~~~ 343 (584)
|++...... ....++..|+|||++.....++.++|||||||++|+|+ .|..||......+.. .+....
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~----- 225 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQ----- 225 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcC-----
Confidence 998765322 23467888999999875566899999999999999998 588888765433321 111100
Q ss_pred HHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 344 DYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 344 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
. ......++++.+||.+||+.||.+||++.++|++
T Consensus 226 -----------~-----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 226 -----------C-----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -----------c-----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0 0012235778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=302.44 Aligned_cols=236 Identities=28% Similarity=0.362 Sum_probs=180.7
Q ss_pred eecccCceEEEEEEECCCCc--EEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEEEEEech
Q 043957 132 KVGQGTYSNVYKALDRDTGK--IVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 132 ~LG~G~fg~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
.||+|+||.||+|.+..++. .+|+|.++.. ........+.+|+.+++++ +||||+++++++... ..+|+||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~e~~ 78 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEYA 78 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEEEeC
Confidence 58999999999999988776 4688877532 2334456788999999999 799999999988764 3579999999
Q ss_pred h-hHHHHHhhCCC---------------CCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecc
Q 043957 209 Q-TDLARIISNPE---------------GKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGL 266 (584)
Q Consensus 209 ~-g~L~~~l~~~~---------------~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGl 266 (584)
. ++|.+++.... ..+ .+..||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 8 57877775321 112 2235899999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHH
Q 043957 267 ANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDY 345 (584)
Q Consensus 267 a~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~ 345 (584)
+........ ......++.|+|||++.. ..++.++|||||||++|+|++ |..||.+.+..+.+..+....
T Consensus 159 ~~~~~~~~~--~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~------- 228 (270)
T cd05047 159 SRGQEVYVK--KTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY------- 228 (270)
T ss_pred ccccchhhh--ccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-------
Confidence 864321111 111223567999999865 458999999999999999997 999998766555444331100
Q ss_pred HHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 346 WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 346 ~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
. ......++.++.+||.+||..||.+|||+.++|+
T Consensus 229 ----------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 229 ----------R---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ----------C---------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 0 0011245788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=323.81 Aligned_cols=253 Identities=27% Similarity=0.433 Sum_probs=199.9
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecC-CCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD-TSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~-~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
-|..++.||-|+||.|.++...+|...||+|.+++. ......+..++.|-.||..-+.+-||+| ||.+.+...+|+|
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrL--yySFQDkdnLYFV 707 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRL--YYSFQDKDNLYFV 707 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEE--EEEeccCCceEEE
Confidence 478899999999999999999999999999999643 3445567778899999999999999999 5566667789999
Q ss_pred Eechhh-HHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC-----
Q 043957 205 FEFMQT-DLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP----- 272 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~----- 272 (584)
|||+.| ++..++.. -+.+.+. .++..|+++.|..|+|||||||+|||||.+|+|||+|||||+-+..
T Consensus 708 MdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred EeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 999995 67766653 3445442 3889999999999999999999999999999999999999964421
Q ss_pred ----CCC--------------------------------CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHH
Q 043957 273 ----NKK--------------------------------RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF 316 (584)
Q Consensus 273 ----~~~--------------------------------~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLl 316 (584)
++. ....+.+||+.|+|||+|.. ..|+..||+||.|||||||+
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHHHh
Confidence 100 00124689999999999986 56999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC---C
Q 043957 317 LGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG---S 393 (584)
Q Consensus 317 tG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp---T 393 (584)
.|++||...+..+...+|+. |...- . +....+++.++.+||.++. .+++.|+ -
T Consensus 866 ~g~~pf~~~tp~~tq~kv~n---------w~~~l----~----------~~~~~~ls~e~~~li~kLc-~sad~RLGkng 921 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVIN---------WRNFL----H----------IPYQGNLSKEALDLIQKLC-CSADSRLGKNG 921 (1034)
T ss_pred hCCCCccCCCCCcceeeeee---------hhhcc----c----------cccccccCHHHHHHHHHHh-cChhhhhcccc
Confidence 99999988877666555433 22210 0 0112467899999998864 5778886 4
Q ss_pred HHHHhcCcCCCCC
Q 043957 394 AASALKNEFFFTS 406 (584)
Q Consensus 394 a~e~L~Hp~f~~~ 406 (584)
++|+-.||||+..
T Consensus 922 ~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 922 ADQVKAHPFFKGI 934 (1034)
T ss_pred hhhhhcCcccccc
Confidence 5779999999864
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=300.25 Aligned_cols=247 Identities=23% Similarity=0.387 Sum_probs=190.9
Q ss_pred CCceEEeeecccCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRD-----TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
++|++++.||.|+||.||+|..+. ....|++|.+... ........+.+|++++++++|+||+++++++... .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA--E 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC--C
Confidence 469999999999999999998754 3467999987532 2233456788999999999999999999887653 4
Q ss_pred eEEEEEechh-hHHHHHhhCCCC--------CCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEe
Q 043957 200 SLYLVFEFMQ-TDLARIISNPEG--------KLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADF 264 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~~--------~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DF 264 (584)
..|+||||+. ++|.+++..... .+.+ ..||+.||+|||+++|+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 5799999998 577777754321 2333 349999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCh
Q 043957 265 GLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSE 343 (584)
Q Consensus 265 Gla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~ 343 (584)
|++...............+++.|+|||.+.+. .++.++|||||||++|+|++ |..||........+..+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~--- 237 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE--- 237 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcC---
Confidence 99875433222223344667889999998764 47899999999999999998 78899766554443333110000
Q ss_pred HHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 344 DYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 344 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
......++..+.++|.+||+.||.+|||+.|+|.+
T Consensus 238 ----------------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 238 ----------------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 00123567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=320.66 Aligned_cols=248 Identities=23% Similarity=0.314 Sum_probs=190.1
Q ss_pred CCCceEEeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecC
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDR-----DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRM 197 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~ 197 (584)
.++|.+.+.||+|+||.||+|++. .++..||||+++.... ......+.+|+.+|.++. |||||++++++...
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~- 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKG- 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC-
Confidence 346888999999999999999854 3457899999975432 333456889999999997 99999999988764
Q ss_pred cceEEEEEechh-hHHHHHhhCCCC-------------------------------------------------------
Q 043957 198 QYSLYLVFEFMQ-TDLARIISNPEG------------------------------------------------------- 221 (584)
Q Consensus 198 ~~~l~lV~Ey~~-g~L~~~l~~~~~------------------------------------------------------- 221 (584)
..+|+|||||. |+|.+.+.....
T Consensus 114 -~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 114 -GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred -CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 35899999998 577776643210
Q ss_pred ------------------------------------------CCc------HHHHHHHHHHHHHhCCceeccccccceee
Q 043957 222 ------------------------------------------KLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLI 253 (584)
Q Consensus 222 ------------------------------------------~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl 253 (584)
.+. +..||+.||.|||+.+|+||||||+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl 272 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence 011 23499999999999999999999999999
Q ss_pred cCCCcEEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHH
Q 043957 254 DKNGVLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQL 331 (584)
Q Consensus 254 ~~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~ 331 (584)
+.++.+||+|||+++.+..... .......+++.|+|||++.+ ..++.++|||||||++|||++ |..||......+.+
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 9999999999999986532221 11223456788999999976 458999999999999999998 88999776554443
Q ss_pred HHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 332 HRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 332 ~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
...+.....+ .....++..+.+||.+||..||.+||++.++|+.
T Consensus 352 ~~~~~~~~~~-------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 352 YNAIKRGYRM-------------------------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHcCCCC-------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3322210000 0113457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.90 Aligned_cols=256 Identities=18% Similarity=0.172 Sum_probs=182.3
Q ss_pred CCCceEEeeecccCceEEEEEEECCC---CcEEEEEEeecCCCChHHH---------HHHHHHHHHHHhCCCCCeeeeec
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDT---GKIVALKKVKFDTSEPHSV---------KFMAREIMILQKLDHPNIVKLEG 191 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~---------~~~~~Ei~iL~~L~HpnIv~l~~ 191 (584)
..+|++.+.||+|+||.||+|.+..+ +..+|+|+........... .....++..+..++|+||+.+++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 45799999999999999999998877 6677888654332211000 11223344556678999999988
Q ss_pred eeeecC--cceEEEEEechhhHHHHHhhCCC-----CCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEe
Q 043957 192 LATSRM--QYSLYLVFEFMQTDLARIISNPE-----GKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADF 264 (584)
Q Consensus 192 ~~~~~~--~~~l~lV~Ey~~g~L~~~l~~~~-----~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DF 264 (584)
+..... ....+++||++..++...+.... ....+..||+.||+|||+++|+||||||+|||++.++.++|+||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence 655432 23457889988765555443211 11234569999999999999999999999999999999999999
Q ss_pred ccccccCCCCC------CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 043957 265 GLANYFSPNKK------RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLC 338 (584)
Q Consensus 265 Gla~~~~~~~~------~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~ 338 (584)
|+|+.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+......+.....
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~-- 247 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK-- 247 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH--
Confidence 99987643221 11233579999999999876 4589999999999999999999999987743222211111
Q ss_pred CCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 339 GSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.+++..+.... ..+..+++.+.+++..|+..||.+||+..++++
T Consensus 248 ----~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 248 ----CDFIKRLHEGK-------------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ----HHHHHHhhhhh-------------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11122211000 012456888999999999999999999999875
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.87 Aligned_cols=232 Identities=24% Similarity=0.326 Sum_probs=174.5
Q ss_pred eecccCceEEEEEEECCC------------------------CcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCee
Q 043957 132 KVGQGTYSNVYKALDRDT------------------------GKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIV 187 (584)
Q Consensus 132 ~LG~G~fg~Vy~a~~~~~------------------------g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 187 (584)
.||+|+||.||+|....+ ...||+|++... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 599999999999974321 235888887532 223345678899999999999999
Q ss_pred eeeceeeecCcceEEEEEechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCC---
Q 043957 188 KLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG--- 257 (584)
Q Consensus 188 ~l~~~~~~~~~~~l~lV~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g--- 257 (584)
++++++.... ..|+||||+.+ +|..++......+. +..||+.||+|||+++|+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVRGS--ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEeCC--ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 9999887643 57999999995 46555544334433 345999999999999999999999999997643
Q ss_pred ----cEEEEEeccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHH-hCCCCCCCCChHHHHH
Q 043957 258 ----VLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLH 332 (584)
Q Consensus 258 ----~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLl-tG~~pF~~~~~~~~~~ 332 (584)
.+||+|||++...... ....++..|+|||++.+...++.++|||||||++|||+ +|.+||......+...
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 3899999998654221 23356788999999876556899999999999999985 6999998765543322
Q ss_pred HHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 333 RIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 333 ~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
++.... . .....+..+.+||.+||+.||.+|||+.++|++
T Consensus 233 -~~~~~~----------------~-----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 -FYEKKH----------------R-----------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -HHHhcc----------------C-----------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 111000 0 001234678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=304.85 Aligned_cols=245 Identities=21% Similarity=0.318 Sum_probs=188.0
Q ss_pred CCceEEeeecccCceEEEEEEECCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGK----IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
++|++.+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---~ 82 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---T 82 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---C
Confidence 468999999999999999999887776 46888875432 233345678999999999999999999987653 2
Q ss_pred EEEEEechh-hHHHHHhhCCCCCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQ-TDLARIISNPEGKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
.++++||+. |+|.+.+......+ .+..||+.||.|||+++|+||||||+|||++.++.+||+|||++..+...
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 579999998 56877776543333 33459999999999999999999999999999999999999999876432
Q ss_pred CCC-CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 274 KKR-PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 274 ~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....... .++.....+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~---------- 230 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-DLLEKGERL---------- 230 (303)
T ss_pred ccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHCCCCC----------
Confidence 221 1123345778999999876 458999999999999999997 88999776543332 222111000
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.....++..+.++|..||..||++|||+.++++.
T Consensus 231 ---------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 231 ---------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112356788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=299.74 Aligned_cols=260 Identities=24% Similarity=0.361 Sum_probs=191.1
Q ss_pred CCceEEeeecccCceEEEEEEEC----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDR----DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
+.|++.+.||+|+||.||+|... .++..||||.+...... .....+.+|+.+++.+.||||+++++++.......
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 45888899999999999999854 34889999999754333 35677899999999999999999999887766667
Q ss_pred EEEEEechh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
.|+||||+. ++|...+......+. +..||+.||+|||+++|+|+||||+|||++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 899999997 578777765433333 3459999999999999999999999999999999999999999876532
Q ss_pred CCCC--CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CCChHHH-HHh
Q 043957 274 KKRP--LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCG-SPSEDYW-KKL 349 (584)
Q Consensus 274 ~~~~--~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~-~~~~~~~-~~~ 349 (584)
.... .....++..|+|||.+.+. .++.++|||||||++|+|++|..||........ .+..... ......+ ..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL--RMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhc--cccccccccccHHHHHHHH
Confidence 2111 1122345679999998764 588999999999999999999988865332110 0000000 0000000 011
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.... .. .....++.++.+||.+||+.||.+|||+.|+++
T Consensus 240 ~~~~--~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 240 KEGE--RL---------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HcCC--cC---------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000 00 011345788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=299.02 Aligned_cols=243 Identities=22% Similarity=0.273 Sum_probs=178.8
Q ss_pred eecccCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechh
Q 043957 132 KVGQGTYSNVYKALDR--DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ 209 (584)
Q Consensus 132 ~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~ 209 (584)
.||+|+||.||+|... .++..+|+|.++.... ......+.+|+.++++++||||+++++++... ..+|+||||+.
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~ 78 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV--TPYLLVMEFCP 78 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--CCcEEEEECCC
Confidence 5899999999999754 3556799999865433 23345678899999999999999999887664 34799999998
Q ss_pred -hHHHHHhhCCC----CCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC-CC
Q 043957 210 -TDLARIISNPE----GKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK-RP 277 (584)
Q Consensus 210 -g~L~~~l~~~~----~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-~~ 277 (584)
++|.+.+.... ... .+..||+.||+|||+.+|+|+||||+|||++.++.+||+|||++........ ..
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 57777664311 111 2345999999999999999999999999999999999999999975432211 11
Q ss_pred CccccccccccChhhhhCCC------CCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 278 LTSRVVTLWYRAPELLLGAT------DYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~------~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
.....+++.|+|||++.+.. .++.++|||||||++|||++ |.+||......+..........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------- 227 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ----------- 227 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhccc-----------
Confidence 12345678899999985421 35789999999999999996 9999987665544332211100
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
...+. + .....+++.+.++|..|+ .||++|||++|++.
T Consensus 228 ----~~~~~---~---~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 228 ----LKLPK---P---RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ----CCCCC---C---ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 00000 0 011235678899999998 68999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=295.91 Aligned_cols=235 Identities=27% Similarity=0.424 Sum_probs=185.7
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++.+.||+|+||.||++. .+++.||+|.+.... ....+.+|+.+++.++||||+++++++... ..|+|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN---GLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC---CcEEE
Confidence 469999999999999999985 468899999986432 235678899999999999999999887543 36999
Q ss_pred Eechh-hHHHHHhhCCCC-CCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 205 FEFMQ-TDLARIISNPEG-KLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 205 ~Ey~~-g~L~~~l~~~~~-~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
|||+. ++|...+..... .+. +..||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 99998 478777754322 233 3459999999999999999999999999999999999999999764321
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
......+..|+|||.+.+ ..++.++|||||||++|+|++ |++||...+..+....+....
T Consensus 154 -~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----------------- 214 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY----------------- 214 (254)
T ss_pred -CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC-----------------
Confidence 122334578999999875 458899999999999999997 999998776554433332110
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.. .....+++.+.+||.+||..+|.+|||+++++.
T Consensus 215 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 215 RM---------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CC---------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 011356889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=328.74 Aligned_cols=196 Identities=34% Similarity=0.574 Sum_probs=165.2
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC----cceEE
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM----QYSLY 202 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~~l~ 202 (584)
+...+.||+|+||.||+++++.+|+.||||.++... .....+.+.+|+++|++|+|||||+++++-+... ...-.
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 566677999999999999999999999999997543 3445677889999999999999999988776655 44568
Q ss_pred EEEechh-hHHHHHhhCCCCC--CcH------HHHHHHHHHHHHhCCceeccccccceee--cCCC--cEEEEEeccccc
Q 043957 203 LVFEFMQ-TDLARIISNPEGK--LTE------PQQLLSGLQHCHDRGILHRDVKGSNLLI--DKNG--VLKIADFGLANY 269 (584)
Q Consensus 203 lV~Ey~~-g~L~~~l~~~~~~--l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl--~~~g--~vKL~DFGla~~ 269 (584)
+|||||. |+|...+..++.. +++ ...+..||.|||++||+||||||+||++ ..+| ..||+|||.|+-
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 9999999 5788887765542 333 3488899999999999999999999998 3344 479999999999
Q ss_pred cCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCC
Q 043957 270 FSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGR 325 (584)
Q Consensus 270 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~ 325 (584)
++++. .+.+.+||+.|.+||++.....|+..+|.|||||++|+++||..||-..
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 87554 6789999999999999875467999999999999999999999998543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=299.40 Aligned_cols=255 Identities=25% Similarity=0.370 Sum_probs=193.1
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
+.+-+..||.|+||+|++..++.+|+..|||+|+..... ...+++..|.+...+- ++||||++||....+. ..||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~-keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG--dcWiC 141 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE-KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG--DCWIC 141 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch-HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC--ceeee
Confidence 344556799999999999999999999999999866553 3445667777765544 7999999999876643 47999
Q ss_pred EechhhHHHHHhhC----CCCCCcHH------HHHHHHHHHHHh-CCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 205 FEFMQTDLARIISN----PEGKLTEP------QQLLSGLQHCHD-RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~----~~~~l~~~------~qIl~aL~yLH~-~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
||+|+-++..+.+. .+..+.+. ...+.||.||.+ ..|||||+||+||||+..|.|||||||++..+...
T Consensus 142 MELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 142 MELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred HHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 99999766554431 12233322 145789999995 58999999999999999999999999999876432
Q ss_pred CCCCCccccccccccChhhhhCCC-CCCceeeEecchHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChHHHHHhhc
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGAT-DYGVGIDLWSAGCLLAEMFLGRPIMPGRTE-VEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~-~~~~~sDIwSLGvilyeLltG~~pF~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
-..+.-+|...|||||.+.... .|+.++|+||||++|||+.||..|+.+.+. .+++..++. +.|+.-
T Consensus 222 --iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~l------- 290 (361)
T KOG1006|consen 222 --IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPIL------- 290 (361)
T ss_pred --HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCee-------
Confidence 2234557888999999996433 499999999999999999999988876544 344444322 222210
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.. ....-+++..+..||..||.+|-..||...+++++||+..-
T Consensus 291 ----------~~--~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 291 ----------LF--DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred ----------cC--cccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 00 01113578899999999999999999999999999998653
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.25 Aligned_cols=244 Identities=27% Similarity=0.409 Sum_probs=197.3
Q ss_pred CceEEeeecccCceEEEEEEECCCCc---E-EEEEEeecC-CCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGK---I-VALKKVKFD-TSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~---~-vAiK~i~~~-~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
+-.+.++||+|+||.||+|..+..+. . ||||..+.. .........+.+|+++|++++|||||++||++..+. .
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~--P 235 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE--P 235 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--c
Confidence 34456899999999999998775432 3 899998753 356677888999999999999999999999998854 4
Q ss_pred EEEEEechhh-HHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQT-DLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+|||||+|.| +|.+.+......++.. .+.+.||+|||++++|||||-..|+|++.++.+||+|||+++.....
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY 315 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence 7999999995 7888888765555554 38899999999999999999999999999999999999999765311
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHh-cCCCChHHHHHhhc
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKL-CGSPSEDYWKKLRL 351 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ 351 (584)
.... ...--...|+|||.+... -|+.++|||||||++||+++ |..||++....+....|... ...+.
T Consensus 316 ~~~~-~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~--------- 384 (474)
T KOG0194|consen 316 VMKK-FLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI--------- 384 (474)
T ss_pred eecc-ccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC---------
Confidence 1111 011234689999999865 69999999999999999999 88899999999888887442 11111
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
....|..+..++..|+..||+.|||+.++.+
T Consensus 385 -----------------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 385 -----------------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred -----------------CCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 1245778889999999999999999998876
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=299.11 Aligned_cols=238 Identities=26% Similarity=0.402 Sum_probs=182.9
Q ss_pred eecccCceEEEEEEECCCC------cEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 132 KVGQGTYSNVYKALDRDTG------KIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 132 ~LG~G~fg~Vy~a~~~~~g------~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
.||+|+||.||+|.+.... ..||||.+.... .......+.+|+.+++.++||||+++++++... ...|+||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 78 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN--EPQYIIM 78 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC--CCeEEEE
Confidence 5899999999999876543 689999885432 223456688899999999999999999988764 3579999
Q ss_pred echh-hHHHHHhhCC------CCCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCC-----cEEEEEeccc
Q 043957 206 EFMQ-TDLARIISNP------EGKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG-----VLKIADFGLA 267 (584)
Q Consensus 206 Ey~~-g~L~~~l~~~------~~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g-----~vKL~DFGla 267 (584)
||+. ++|...+... ...+ .++.||+.||.|||+.+++|+||||+|||++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9998 5777766531 1112 2345999999999999999999999999998877 8999999999
Q ss_pred cccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHH
Q 043957 268 NYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDY 345 (584)
Q Consensus 268 ~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~ 345 (584)
..+..... .......++..|+|||++.+. .++.++|||||||++|+|++ |+.||...+..+....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~------- 230 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG------- 230 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC-------
Confidence 76532211 111233456789999998764 58999999999999999998 999998777655544331110
Q ss_pred HHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 346 WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 346 ~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.......+|..+.+||.+||..+|.+|||+.++++
T Consensus 231 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 231 -------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred -------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00112346788999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=294.92 Aligned_cols=230 Identities=24% Similarity=0.348 Sum_probs=175.1
Q ss_pred eeecccCceEEEEEEECCCC----------cEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 131 DKVGQGTYSNVYKALDRDTG----------KIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g----------~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
+.||+|+||.||+|.+..++ ..|++|.+..... ....+.+|+.+|+.++||||+++++++.. . .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~--~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-D--E 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-C--C
Confidence 36999999999999998776 3578887653321 15678899999999999999999998766 2 3
Q ss_pred EEEEEechhh-HHHHHhhCCCCCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCC-------cEEEEEecc
Q 043957 201 LYLVFEFMQT-DLARIISNPEGKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG-------VLKIADFGL 266 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g-------~vKL~DFGl 266 (584)
.|+||||+.+ +|..++......+ .+..||+.||.|||+++|+||||||+|||++.++ .+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 5999999984 6666665433233 3345999999999999999999999999999887 799999999
Q ss_pred ccccCCCCCCCCccccccccccChhhhhCC-CCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChH
Q 043957 267 ANYFSPNKKRPLTSRVVTLWYRAPELLLGA-TDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSED 344 (584)
Q Consensus 267 a~~~~~~~~~~~~~~~gt~~Y~APEvl~~~-~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~ 344 (584)
+..... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+..........
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-------- 221 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-------- 221 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc--------
Confidence 987543 1234567789999998764 368899999999999999999 5777766543222111100
Q ss_pred HHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 345 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
... .+ ......+.+||.+||..||.+|||+.++|+
T Consensus 222 -------~~~--~~-----------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 222 -------QHR--LP-----------MPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -------CCC--CC-----------CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000 00 011267889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=293.51 Aligned_cols=245 Identities=25% Similarity=0.462 Sum_probs=190.5
Q ss_pred CceEEeeecccCceEEEEEEECC-CCcEEEEEEeecCC--------CChHHHHHHHHHHHHHHh-CCCCCeeeeeceeee
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRD-TGKIVALKKVKFDT--------SEPHSVKFMAREIMILQK-LDHPNIVKLEGLATS 195 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~--------~~~~~~~~~~~Ei~iL~~-L~HpnIv~l~~~~~~ 195 (584)
.|++.+.||+|+||.||+|.+.. ++..+|+|.+.... ........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 38889999999999999999887 68899999985432 122344567788888875 799999999998876
Q ss_pred cCcceEEEEEechhh-HHHHHhh---CCCCCCcH------HHHHHHHHHHHHh-CCceeccccccceeecCCCcEEEEEe
Q 043957 196 RMQYSLYLVFEFMQT-DLARIIS---NPEGKLTE------PQQLLSGLQHCHD-RGILHRDVKGSNLLIDKNGVLKIADF 264 (584)
Q Consensus 196 ~~~~~l~lV~Ey~~g-~L~~~l~---~~~~~l~~------~~qIl~aL~yLH~-~~IvHrDLKp~NILl~~~g~vKL~DF 264 (584)
....|+||||+.+ +|.+.+. .....+.+ ..||+.||.|||+ .+|+|+||||+|||++.++.+||+||
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence 4468999999985 5555442 22233333 3599999999996 78999999999999999999999999
Q ss_pred ccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChH
Q 043957 265 GLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSED 344 (584)
Q Consensus 265 Gla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~ 344 (584)
|++....... ......++..|+|||++.+ ..++.++|||||||++|+|++|++||...........+......+.
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 233 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL-- 233 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--
Confidence 9998765432 3345678999999999976 4589999999999999999999999977665554444332111100
Q ss_pred HHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 345 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
....+++.+.+||.+||+.||.+|||+.|+..+
T Consensus 234 -----------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 -----------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -----------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 012357889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=331.58 Aligned_cols=248 Identities=27% Similarity=0.404 Sum_probs=200.9
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCc-----EEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGK-----IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR 196 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~-----~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 196 (584)
..-..-++...||+|.||.||.|....... .||||.++. ..+......|.+|..+|..++|||||+++|++.+.
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~-~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR-LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc-cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 445567788999999999999998664322 489998864 44556778899999999999999999999999884
Q ss_pred CcceEEEEEechh-hHHHHHhhCC------CCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEE
Q 043957 197 MQYSLYLVFEFMQ-TDLARIISNP------EGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIAD 263 (584)
Q Consensus 197 ~~~~l~lV~Ey~~-g~L~~~l~~~------~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~D 263 (584)
. ..+|++|||+ |+|..++.+. ...++ .+.+|++|+.||+++++|||||-..|+||+....|||+|
T Consensus 768 ~--~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 768 G--PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred C--CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 3 4699999999 6899998865 33333 335999999999999999999999999999999999999
Q ss_pred eccccccCCCCCCCCccc-cccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 043957 264 FGLANYFSPNKKRPLTSR-VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSP 341 (584)
Q Consensus 264 FGla~~~~~~~~~~~~~~-~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~ 341 (584)
||+|+.+-..+....... .-...|||||.+.. ..++.++|||||||+|||+++ |..||+..++.+.+..++..-..
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL- 923 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL- 923 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc-
Confidence 999994332222111111 22357999999986 459999999999999999998 89999999999888766554211
Q ss_pred ChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 342 SEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 342 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....+|+.+.+|+..||+.+|++||+...+++
T Consensus 924 -------------------------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 924 -------------------------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -------------------------CCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 223567899999999999999999999999997
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=293.12 Aligned_cols=243 Identities=21% Similarity=0.291 Sum_probs=178.8
Q ss_pred eecccCceEEEEEEECCC--CcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechh
Q 043957 132 KVGQGTYSNVYKALDRDT--GKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ 209 (584)
Q Consensus 132 ~LG~G~fg~Vy~a~~~~~--g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~ 209 (584)
.||+|+||.||++..... ...+++|.+.... .....+.+.+|+.+++.++||||+++++.+... ...|+||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA--IPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCC--CccEEEEecCC
Confidence 599999999999975433 3356677765432 233456788999999999999999999988764 45799999999
Q ss_pred -hHHHHHhhCCCC---CC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC-CCCC
Q 043957 210 -TDLARIISNPEG---KL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK-KRPL 278 (584)
Q Consensus 210 -g~L~~~l~~~~~---~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~~~ 278 (584)
++|...+..... .. .+..||+.||+|||+.+|+||||||+|||++.++.+||+|||++....... ....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 577777654211 11 234599999999999999999999999999999999999999986432111 1112
Q ss_pred ccccccccccChhhhhCC------CCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 279 TSRVVTLWYRAPELLLGA------TDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~------~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
...++++.|+|||++... ..++.++|||||||++|||++ |.+||...++.+.+..+.......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---------- 228 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK---------- 228 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc----------
Confidence 345678899999987431 235788999999999999997 577888777766666553321100
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.+ .+ .....+++.+.++|..|+ .||.+|||++++++
T Consensus 229 -----~~---~~---~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 229 -----LF---KP---QLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred -----cC---CC---ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 00 00 111236788899999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=292.65 Aligned_cols=222 Identities=25% Similarity=0.340 Sum_probs=172.8
Q ss_pred cCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechhh-HHHH
Q 043957 136 GTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT-DLAR 214 (584)
Q Consensus 136 G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~g-~L~~ 214 (584)
|.||.||+|.+..+++.||+|.+.... ...+|...+....||||+++++++... ...|+||||+.+ +|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSE--DSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecC--CeEEEEEecCCCCCHHH
Confidence 889999999999999999999996432 223455555566799999999988763 468999999985 6777
Q ss_pred HhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCcccccccccc
Q 043957 215 IISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYR 288 (584)
Q Consensus 215 ~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~ 288 (584)
.+.... .++ +..||+.||.|||+++|+||||||+||+++.++.++|+|||++..+... .....++..|+
T Consensus 75 ~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~ 149 (237)
T cd05576 75 HISKFL-NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYC 149 (237)
T ss_pred HHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcccc
Confidence 665322 233 3359999999999999999999999999999999999999988765432 23345577899
Q ss_pred ChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhh
Q 043957 289 APELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEA 368 (584)
Q Consensus 289 APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 368 (584)
|||.+.+ ..++.++|||||||++|+|++|+.||...... + .. ... ...
T Consensus 150 aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~------------~~---~~~-----------~~~ 197 (237)
T cd05576 150 APEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I------------NT---HTT-----------LNI 197 (237)
T ss_pred CCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c------------cc---ccc-----------cCC
Confidence 9998865 45889999999999999999999877432110 0 00 000 011
Q ss_pred ccCCcHhHHHHHHHhcccCCCCCCCH-----HHHhcCcCC
Q 043957 369 FSEFPESSLGLLSTLLALDPAYRGSA-----ASALKNEFF 403 (584)
Q Consensus 369 ~~~~s~~~~dLI~~~L~~DP~kRpTa-----~e~L~Hp~f 403 (584)
...+++.+.+||.+||+.||.+|+|+ +++++||||
T Consensus 198 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 198 PEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 13467889999999999999999996 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=325.16 Aligned_cols=243 Identities=26% Similarity=0.394 Sum_probs=197.8
Q ss_pred CceEEeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 126 SYDKIDKVGQGTYSNVYKALDR-----DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
+-+..+.||+|.||.||+|+.. .....||||.++. ..+....++|++|+++|..|+|||||+|+|++...+ .
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd-~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~--P 563 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD-KAENQARQDFRREAELLAELQHPNIVRLLGVCREGD--P 563 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc-cccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC--e
Confidence 3556788999999999999643 2345799999864 344456788999999999999999999999998744 5
Q ss_pred EEEEEechh-hHHHHHhhCCCC-------------------CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEE
Q 043957 201 LYLVFEFMQ-TDLARIISNPEG-------------------KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLK 260 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~~-------------------~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vK 260 (584)
+|||+|||. |||.+++..... .+.++.||+.|+.||-++.+|||||-..|+||.++..||
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEE
Confidence 799999999 899988863110 122345999999999999999999999999999999999
Q ss_pred EEEeccccccCCCCCCCCc-cccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 043957 261 IADFGLANYFSPNKKRPLT-SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLC 338 (584)
Q Consensus 261 L~DFGla~~~~~~~~~~~~-~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~ 338 (584)
|+||||++.+=..++.... ...-...||+||.|+- .+|+.+|||||+||+|||+++ |.-|+.+-++.+.++.|....
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~ 722 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ 722 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC
Confidence 9999999865333322222 2223568999999986 459999999999999999998 889999999999998885532
Q ss_pred CCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHh
Q 043957 339 GSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASAL 398 (584)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L 398 (584)
+.+...++|.++.+|+..|++..|.+||+..|+-
T Consensus 723 --------------------------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 723 --------------------------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred --------------------------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 1233467899999999999999999999998864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=313.74 Aligned_cols=270 Identities=25% Similarity=0.339 Sum_probs=181.6
Q ss_pred CCCCCceEEeeecccCceEEEEEEEC----------------CCCcEEEEEEeecCCCChH------------HHHHHHH
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDR----------------DTGKIVALKKVKFDTSEPH------------SVKFMAR 173 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~----------------~~g~~vAiK~i~~~~~~~~------------~~~~~~~ 173 (584)
...++|++.++||+|+||+||+|... ..++.||||++........ ..+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 34678999999999999999999752 3456799999864322110 1122334
Q ss_pred HHHHHHhCCCCCe-----eeeeceeeec------CcceEEEEEechhh-HHHHHhhCCCCC-------------------
Q 043957 174 EIMILQKLDHPNI-----VKLEGLATSR------MQYSLYLVFEFMQT-DLARIISNPEGK------------------- 222 (584)
Q Consensus 174 Ei~iL~~L~HpnI-----v~l~~~~~~~------~~~~l~lV~Ey~~g-~L~~~l~~~~~~------------------- 222 (584)
|+.++.+++|.++ +.+++++... .....||||||+.+ +|.+++......
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7778888876654 5666666432 12357999999984 666665421110
Q ss_pred ----------CcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccccccccccChhh
Q 043957 223 ----------LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPEL 292 (584)
Q Consensus 223 ----------l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEv 292 (584)
..+..||+.||.|||+.+|+||||||+|||++.++.+||+|||++..+............+|+.|+|||+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 1123589999999999999999999999999999999999999997654322211122345899999998
Q ss_pred hhCCCC-------------------C--CceeeEecchHHHHHHHhCCC-CCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 293 LLGATD-------------------Y--GVGIDLWSAGCLLAEMFLGRP-IMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 293 l~~~~~-------------------~--~~~sDIwSLGvilyeLltG~~-pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
+..... | ....||||+|||+|+|++|.. ||....... ..+.. .......|..+.
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~---~~~~~-~~~~~~~~r~~~ 457 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFN---TELRQ-YDNDLNRWRMYK 457 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhh---hHHhh-ccchHHHHHhhc
Confidence 853210 1 134799999999999999874 664322111 11111 011122233221
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCC---CCCCCHHHHhcCcCCCC
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDP---AYRGSAASALKNEFFFT 405 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP---~kRpTa~e~L~Hp~f~~ 405 (584)
... ..+..+..+++.++|||.+||..+| .+|+|++|+|+||||..
T Consensus 458 ~~~----------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 458 GQK----------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred ccC----------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 110 0112356678999999999999876 68999999999999964
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=317.47 Aligned_cols=242 Identities=28% Similarity=0.424 Sum_probs=186.4
Q ss_pred EEeeecccCceE-EEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceEEEEEe
Q 043957 129 KIDKVGQGTYSN-VYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSLYLVFE 206 (584)
Q Consensus 129 ~~~~LG~G~fg~-Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l~lV~E 206 (584)
--+.+|.|+-|+ ||+|.. .|+.||||.+.. .......+||..|+.-+ |||||++ ||...+..++||..|
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRy--yc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY--EGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRY--YCSEQDRQFLYIALE 583 (903)
T ss_pred cHHHcccCCCCcEEEEEee--CCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEE--EeeccCCceEEEEeh
Confidence 345689999874 799954 588999999852 24456789999999995 9999999 556666778999999
Q ss_pred chhhHHHHHhhCC--CC-------CCcHHHHHHHHHHHHHhCCceeccccccceeecC---CC--cEEEEEeccccccCC
Q 043957 207 FMQTDLARIISNP--EG-------KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDK---NG--VLKIADFGLANYFSP 272 (584)
Q Consensus 207 y~~g~L~~~l~~~--~~-------~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~---~g--~vKL~DFGla~~~~~ 272 (584)
+|..+|.+++... +. ...+..|++.||+|||+.+||||||||.||||+. ++ .++|+|||+++.+..
T Consensus 584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 9999999888763 11 1233459999999999999999999999999965 34 689999999999865
Q ss_pred CCC--CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 273 NKK--RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLG-RPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 273 ~~~--~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG-~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
+.. .......||-+|+|||++.... -+.++|||||||++|..++| ..||...... -..|+......
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L-------- 732 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTL-------- 732 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccce--------
Confidence 543 2245678999999999998754 57799999999999999986 7899654332 22333321110
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
...-+.-..++.|||.+||.+||..||+|.++|.||||+..
T Consensus 733 ----------------~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 733 ----------------VHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred ----------------eeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 00001111278999999999999999999999999999864
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=299.07 Aligned_cols=264 Identities=23% Similarity=0.353 Sum_probs=200.5
Q ss_pred CCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-----ChHHHHHHHHHHHHHHhCCCCCeeeeeceeee
Q 043957 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-----EPHSVKFMAREIMILQKLDHPNIVKLEGLATS 195 (584)
Q Consensus 121 ~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 195 (584)
|...++|-++..||+|+|+.||+|.|....+.||||+-..... .....+...+|..|.+.|+||.||++|+++.-
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 4455789999999999999999999999999999998744322 22334567789999999999999999999976
Q ss_pred cCcceEEEEEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhC--Cceeccccccceeec---CCCcEEEEEe
Q 043957 196 RMQYSLYLVFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDR--GILHRDVKGSNLLID---KNGVLKIADF 264 (584)
Q Consensus 196 ~~~~~l~lV~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~--~IvHrDLKp~NILl~---~~g~vKL~DF 264 (584)
.. ..+|-|+|||+|+-+++.......+. +..||+.||.||.+. .|||-||||.||||. .-|.|||+||
T Consensus 539 Dt-dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 539 DT-DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cc-ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 53 46899999999854444433333333 334999999999976 599999999999994 3578999999
Q ss_pred ccccccCCCCCC------CCccccccccccChhhhhC---CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHH
Q 043957 265 GLANYFSPNKKR------PLTSRVVTLWYRAPELLLG---ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIF 335 (584)
Q Consensus 265 Gla~~~~~~~~~------~~~~~~gt~~Y~APEvl~~---~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~ 335 (584)
||++.++.+... ..+...||.||++||.+.- ....+.++||||+|||+|..|.|+.||..+.... .|+
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ---dIL 694 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ---DIL 694 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---HHH
Confidence 999998755432 1234689999999998753 2357899999999999999999999997653321 222
Q ss_pred HhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 336 KLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
....... ......| .-+.++.++++||++||++--+.|..+.++-.||||...
T Consensus 695 qeNTIlk---------AtEVqFP---------~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 695 QENTILK---------ATEVQFP---------PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred hhhchhc---------ceeccCC---------CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 2111000 0000011 113568899999999999999999999999999999643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=281.19 Aligned_cols=258 Identities=26% Similarity=0.449 Sum_probs=198.7
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcce
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE-PHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~ 200 (584)
...+|+++..||+|+|+.|.+++.+.|.+.||+|+++++... .+.++-+..|-.+..+- +||.+|.++.+|.. +..
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt--esr 325 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ESR 325 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cce
Confidence 456799999999999999999999999999999999876433 34455666777777665 69999999988876 446
Q ss_pred EEEEEechhh-HHHHHhhCCCCCCcHHH------HHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~l~~~~------qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+++|.||+.| +|...+. ...++++.. .|+.||.|||+.|||+||||.+|||||..|.+||+|+|+++.-- .
T Consensus 326 lffvieyv~ggdlmfhmq-rqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l-~ 403 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-G 403 (593)
T ss_pred EEEEEEEecCcceeeehh-hhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC-C
Confidence 8999999996 5555444 344565543 89999999999999999999999999999999999999997532 1
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCC--CChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPG--RTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
.....++.||||.|+|||++.+. .|+..+|+|+|||+++||+.|+.||.- ..+.+ ...++|+-.+-+
T Consensus 404 ~gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d----------~ntedylfqvil 472 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD----------MNTEDYLFQVIL 472 (593)
T ss_pred CCcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcc----------cchhHHHHHHHh
Confidence 22335778999999999999885 599999999999999999999999942 11110 011222222222
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC------HHHHhcCcCCCCC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS------AASALKNEFFFTS 406 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT------a~e~L~Hp~f~~~ 406 (584)
....+.| ..++-.+..+++..|.+||.+|.. ..++-.|+||...
T Consensus 473 ekqirip-----------rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 473 EKQIRIP-----------RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred hhccccc-----------ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 2222222 234566778999999999999965 4788999999743
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=271.99 Aligned_cols=237 Identities=38% Similarity=0.597 Sum_probs=187.5
Q ss_pred CceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechhh-HHHHH
Q 043957 137 TYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARI 215 (584)
Q Consensus 137 ~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~g-~L~~~ 215 (584)
+||.||+|.+..+|+.||+|++........ .+.+.+|+.++++++|+||+++++++... ...+++|||+.+ +|...
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHHHH
Confidence 589999999998899999999865433321 57888999999999999999999988764 457999999997 78777
Q ss_pred hhCCCC-----CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccccccccccCh
Q 043957 216 ISNPEG-----KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAP 290 (584)
Q Consensus 216 l~~~~~-----~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~AP 290 (584)
+..... ...+..+++.+|.|||+.+|+|+||+|.||+++.++.++|+|||++....... ......++..|++|
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~p 155 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAP 155 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCH
Confidence 654322 12334589999999999999999999999999999999999999998765432 23456778999999
Q ss_pred hhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHH-hcCCCChHHHHHhhccCCCCCCCCCCchhhhhc
Q 043957 291 ELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFK-LCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAF 369 (584)
Q Consensus 291 Evl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 369 (584)
|.+.+ ..++.++||||||+++|+|++|..||............+. ....+. ...
T Consensus 156 E~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~------------------------~~~ 210 (244)
T smart00220 156 EVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP------------------------PPE 210 (244)
T ss_pred HHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc------------------------ccc
Confidence 99875 4588899999999999999999999977433333222221 110000 001
Q ss_pred cCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 370 SEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 370 ~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
..++..+.++|.+||..||.+||++.++++||||
T Consensus 211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 1167889999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=300.81 Aligned_cols=239 Identities=24% Similarity=0.419 Sum_probs=195.1
Q ss_pred EEeeecccCceEEEEEEECC--CC--cEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 129 KIDKVGQGTYSNVYKALDRD--TG--KIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 129 ~~~~LG~G~fg~Vy~a~~~~--~g--~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
+.+.||.|-||.||+|+... .| -.||||..+.+ ......+.|..|..+|+.++|||||+++|++... .+|||
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~---P~Wiv 468 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ---PMWIV 468 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccC-CChhhHHHHHHHHHHHHhCCCcchhheeeeeecc---ceeEE
Confidence 45679999999999997543 23 35899988654 3444577788999999999999999999999864 47999
Q ss_pred Eechh-hHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 205 FEFMQ-TDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 205 ~Ey~~-g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||++. |.|..++......+... .||+.||+|||+.+.|||||-..||||.....|||+||||++.++++....
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk 548 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK 548 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence 99999 78988888777766554 499999999999999999999999999999999999999999987665443
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
.+...-..-|||||-+. ...++.++|||-|||.+||+|. |..||.+-.+.+.+..|.++-+.|
T Consensus 549 aS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP--------------- 612 (974)
T KOG4257|consen 549 ASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP--------------- 612 (974)
T ss_pred ccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC---------------
Confidence 33333456799999885 4569999999999999999886 899999988777665554432222
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHh
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASAL 398 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L 398 (584)
..+++|+.+..|+.+|+.+||.+||+..|+-
T Consensus 613 -----------~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 613 -----------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred -----------CCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 2357899999999999999999999986653
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=289.70 Aligned_cols=282 Identities=31% Similarity=0.496 Sum_probs=203.8
Q ss_pred hhccCCCCCCCceEEeeecccCceEEEEEEECC---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeec
Q 043957 116 LAGLVPKSAESYDKIDKVGQGTYSNVYKALDRD---TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEG 191 (584)
Q Consensus 116 ~~~~~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~ 191 (584)
+...+|.....|.++++||.|+|++||++.+.. ..+.||+|.|..... ...+.+|+++|..+. +.||+++.+
T Consensus 27 l~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~ 102 (418)
T KOG1167|consen 27 LRQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNG 102 (418)
T ss_pred HHhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchh
Confidence 334456667789999999999999999999887 788999999864322 245789999999995 999999987
Q ss_pred eeeecCcceEEEEEechhhH-HHHHhhCCCCCCcH----HHHHHHHHHHHHhCCceeccccccceeecC-CCcEEEEEec
Q 043957 192 LATSRMQYSLYLVFEFMQTD-LARIISNPEGKLTE----PQQLLSGLQHCHDRGILHRDVKGSNLLIDK-NGVLKIADFG 265 (584)
Q Consensus 192 ~~~~~~~~~l~lV~Ey~~g~-L~~~l~~~~~~l~~----~~qIl~aL~yLH~~~IvHrDLKp~NILl~~-~g~vKL~DFG 265 (584)
++.. +....+||||++.. ..+++..- .+.+ .+.++.||.++|.+|||||||||.|+|++. .+.-.|+|||
T Consensus 103 ~~rn--nd~v~ivlp~~~H~~f~~l~~~l--~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 103 CFRN--NDQVAIVLPYFEHDRFRDLYRSL--SLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred hhcc--CCeeEEEecccCccCHHHHHhcC--CHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEech
Confidence 7655 45689999999853 33333321 1222 358999999999999999999999999976 4678999999
Q ss_pred cccccCCCC-------------------------------------------CCCCccccccccccChhhhhCCCCCCce
Q 043957 266 LANYFSPNK-------------------------------------------KRPLTSRVVTLWYRAPELLLGATDYGVG 302 (584)
Q Consensus 266 la~~~~~~~-------------------------------------------~~~~~~~~gt~~Y~APEvl~~~~~~~~~ 302 (584)
||...+... ........||++|+|||++......+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 996211000 0001235789999999999988888999
Q ss_pred eeEecchHHHHHHHhCCCCC-CCCChHHHHHHHHHhcCCCC--------hH--HHHHhhc------cCCCCCC---CCCC
Q 043957 303 IDLWSAGCLLAEMFLGRPIM-PGRTEVEQLHRIFKLCGSPS--------ED--YWKKLRL------STTFRPP---QSYK 362 (584)
Q Consensus 303 sDIwSLGvilyeLltG~~pF-~~~~~~~~~~~i~~~~~~~~--------~~--~~~~~~~------~~~~~~p---~~~~ 362 (584)
+||||.|||+..+++++.|| ...++.+.+..|....+... .. +|..... ...+... ....
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 99999999999999998665 55666666666665554321 11 3331100 0000000 0000
Q ss_pred -----chhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 363 -----PRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 363 -----~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
.........++..+.||+.+||+.||.+|+||+++|+||||..
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 1111222345668999999999999999999999999999973
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.29 Aligned_cols=247 Identities=23% Similarity=0.368 Sum_probs=209.4
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGK---IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
+..-.|.+.||.|.||.||+++.+..|+ .||||.++.- -.+.....|..|+.||-+++||||++|.|+.+.. .-
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks--~P 704 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS--KP 704 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC--ce
Confidence 3445788899999999999999887664 5999999643 3344556788999999999999999999998763 45
Q ss_pred EEEEEechh-hHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQ-TDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+.||.|||+ |.|..++...++++++. +.|+.|+.||-++++|||||-..||||+.+-.+|++||||++.++++
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 899999999 78888998888887765 48999999999999999999999999999999999999999988765
Q ss_pred CCCCCccccc--cccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 274 KKRPLTSRVV--TLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 274 ~~~~~~~~~g--t~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
.....++.-| ...|.|||.|.- .+++.++||||+||+|||.++ |..||...++.+.+..|....+.|+.
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP------- 856 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP------- 856 (996)
T ss_pred CCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC-------
Confidence 5333333333 468999999975 459999999999999999886 99999999999999999877665543
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
-++|..+..|+..|+++|-.+||...|++.+
T Consensus 857 -------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 857 -------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred -------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 3578999999999999999999999998863
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=283.45 Aligned_cols=251 Identities=23% Similarity=0.310 Sum_probs=197.2
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
...+.++||+|-||.|.+|.- ..+..||+|+++... ..+....|.+||++|.+|+|||||.++++|...+ .++||+
T Consensus 539 ~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De--PicmI~ 614 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD--PLCMIT 614 (807)
T ss_pred heehhhhhcCcccceeEEEEe-cCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC--chHHHH
Confidence 357889999999999999964 347999999997543 3445678999999999999999999999998744 479999
Q ss_pred echh-hHHHHHhhCCC-------CCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC-C
Q 043957 206 EFMQ-TDLARIISNPE-------GKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK-R 276 (584)
Q Consensus 206 Ey~~-g~L~~~l~~~~-------~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-~ 276 (584)
|||+ |+|..++.... ..+.++.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++.+-..+. +
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 9999 78988887542 1234567999999999999999999999999999999999999999985433332 2
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHH--hCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF--LGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLl--tG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.....+-...|||+|.|+-. +++.++|+|+|||++||++ |...||...++....+..-........
T Consensus 695 vqgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~----------- 762 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR----------- 762 (807)
T ss_pred eecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc-----------
Confidence 22234556789999998864 5999999999999999976 567899877776665544333222111
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
........-+|..+.+||.+|+..|-.+|||.+++-.|
T Consensus 763 --------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 763 --------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLF 800 (807)
T ss_pred --------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence 00111224568889999999999999999999998653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-33 Score=300.29 Aligned_cols=256 Identities=29% Similarity=0.468 Sum_probs=204.4
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|+++..+|.|+||.||+|+++.+++..|+|+++.+... ...-+..|+-+++..+|||||.+++-|...+ .+||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~h~nivay~gsylr~d--klwi 89 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD--KLWI 89 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--cccccccceeeeecCCCcChHHHHhhhhhhc--CcEE
Confidence 45799999999999999999999999999999999876443 4566778999999999999999999887644 4799
Q ss_pred EEechhhHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 204 VFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
+||||.|+.++-+..--+.+++. +..+.||+|||+.|-+|||||-.|||+++.|.+||+|||.+..+...- ..
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~K 168 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AK 168 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh-hh
Confidence 99999976555444444555544 378899999999999999999999999999999999999997765322 22
Q ss_pred CccccccccccChhhhh--CCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 278 LTSRVVTLWYRAPELLL--GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~--~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
..+++|||+|||||+.. ....|...+|||++|++..||-.-+||.........+..+.+.. +
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~----------------~ 232 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSG----------------F 232 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccC----------------C
Confidence 35789999999999863 22469999999999999999988888876555544443333222 1
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.+|.. +.-..+++.+.+|++.+|.++|.+|||++.+|+|||..+.
T Consensus 233 qpp~l------kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 233 QPPTL------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred CCCcc------cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 22221 1223567888999999999999999999999999998754
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=289.00 Aligned_cols=240 Identities=25% Similarity=0.402 Sum_probs=199.1
Q ss_pred eEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEec
Q 043957 128 DKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEF 207 (584)
Q Consensus 128 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey 207 (584)
.+..+||.|.||.||.+.++.-.-.||||.++-+. -.+++|..|+.+|+.++|||+|+|+|+|..+. .+|||.||
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep--PFYIiTEf 344 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP--PFYIITEF 344 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC--CeEEEEec
Confidence 45578999999999999999988999999987443 35678999999999999999999999998854 47999999
Q ss_pred hh-hHHHHHhhCCCCC-------CcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCc
Q 043957 208 MQ-TDLARIISNPEGK-------LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLT 279 (584)
Q Consensus 208 ~~-g~L~~~l~~~~~~-------l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 279 (584)
|. |+|++.+...+.. +..+.||..|+.||..+++|||||-..|+||.++..||++||||++++..+.+....
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA 424 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA 424 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc
Confidence 87 8899988754332 223459999999999999999999999999999999999999999999876654444
Q ss_pred cccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCC
Q 043957 280 SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358 (584)
Q Consensus 280 ~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p 358 (584)
......-|.|||-|- ...++.++|||+|||+|||+.| |-.||++-+-...+..+.+....
T Consensus 425 GAKFPIKWTAPEsLA-yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM------------------ 485 (1157)
T KOG4278|consen 425 GAKFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRM------------------ 485 (1157)
T ss_pred CccCcccccCccccc-ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccc------------------
Confidence 444467799999875 4568999999999999999998 88999998766555544332211
Q ss_pred CCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 359 ~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
+....+|+.+.+|+..||++.|..||+.+|+-+
T Consensus 486 --------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 486 --------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred --------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 223578999999999999999999999998765
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=291.40 Aligned_cols=245 Identities=24% Similarity=0.341 Sum_probs=197.6
Q ss_pred ceEEeeecccCceEEEEEEECC-CCc--EEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 127 YDKIDKVGQGTYSNVYKALDRD-TGK--IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~-~g~--~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.+++++||+|+||+|++|.+.. +|+ .||||+++...... ....|.+|+.+|.+|+|||+++|||+..+. .+.|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~q---p~mM 187 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQ---PAMM 187 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccc---hhhH
Confidence 4677889999999999998764 333 58999997655444 677899999999999999999999998873 3689
Q ss_pred EEechh-hHHHHHhhC-CCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 204 VFEFMQ-TDLARIISN-PEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~-~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
|||++. |+|++.+.+ ....+-. +.||+.|+.||..+++|||||-..||||-....|||+||||.+.+..++.
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999999 788888876 3333322 35999999999999999999999999998888999999999998876554
Q ss_pred CCCc--cccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 276 RPLT--SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 276 ~~~~--~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
.... ...-...|.|||.|.. ..++.++|||++||+||||++ |.-||.|.....+++.|-+.-.
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er------------- 333 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER------------- 333 (1039)
T ss_pred ceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc-------------
Confidence 3211 1223567999999976 459999999999999999998 7799999998888877632211
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~ 402 (584)
....+.+++++.+++..||..+|+.|||...+-+.-+
T Consensus 334 -------------LpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 334 -------------LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred -------------CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 1122467899999999999999999999988864433
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=253.05 Aligned_cols=207 Identities=28% Similarity=0.453 Sum_probs=164.7
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~l 203 (584)
+....+..||+|++|+|-+.++..+|...|+|.+...... ...+.+.+|+++..+. .+|.+|.+||.+.. +..+||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~-q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--egdvwI 122 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS-QEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--EGDVWI 122 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh-HHHHHHHHhhhhhccCCCCCeEEEeehhhhc--cccEEE
Confidence 3445566799999999999999999999999999755443 3445667788887665 69999999997665 345899
Q ss_pred EEechhhHHHHHhh---CCCCCCcHH------HHHHHHHHHHHhC-CceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 204 VFEFMQTDLARIIS---NPEGKLTEP------QQLLSGLQHCHDR-GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 204 V~Ey~~g~L~~~l~---~~~~~l~~~------~qIl~aL~yLH~~-~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
.||.|..+|..+.. +......+. -.|+.||.|||++ .|+|||+||+||||+.+|+||+||||++..+.+.
T Consensus 123 cME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 123 CMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred eHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 99999987665443 344445443 3789999999975 8999999999999999999999999999887533
Q ss_pred CCCCCccccccccccChhhhhC---CCCCCceeeEecchHHHHHHHhCCCCCC-CCChHHHHHHHHH
Q 043957 274 KKRPLTSRVVTLWYRAPELLLG---ATDYGVGIDLWSAGCLLAEMFLGRPIMP-GRTEVEQLHRIFK 336 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~---~~~~~~~sDIwSLGvilyeLltG~~pF~-~~~~~~~~~~i~~ 336 (584)
-. .+-..|.-.|||||.+.. ...|+.++||||||+++.||.+++.||. +.++.+++.++++
T Consensus 203 iA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 203 IA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 22 233467788999999853 2369999999999999999999998886 4567788877765
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=314.31 Aligned_cols=249 Identities=23% Similarity=0.328 Sum_probs=176.6
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
.|...+.||+|+||.||+|.+..++..||||++...... ...|+.++++++|||||++++++.... ..|+||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~--~~~lv~ 762 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEK--GAYLIH 762 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCC--CCEEEE
Confidence 456677899999999999999999999999998532211 134688999999999999999987643 479999
Q ss_pred echh-hHHHHHhhC--CCCCCcHHHHHHHHHHHHH---hCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCc
Q 043957 206 EFMQ-TDLARIISN--PEGKLTEPQQLLSGLQHCH---DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLT 279 (584)
Q Consensus 206 Ey~~-g~L~~~l~~--~~~~l~~~~qIl~aL~yLH---~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 279 (584)
|||+ |+|.+++.. ......++.||+.||+||| +.+|+||||||+|||++.++..++. ||.+...... .
T Consensus 763 Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~ 836 (968)
T PLN00113 763 EYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----T 836 (968)
T ss_pred eCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----C
Confidence 9998 577777753 1223344569999999999 6699999999999999998888775 7766543211 2
Q ss_pred cccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCC-CChHHHHHhhccCCCCC
Q 043957 280 SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEV-EQLHRIFKLCGS-PSEDYWKKLRLSTTFRP 357 (584)
Q Consensus 280 ~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~-~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~ 357 (584)
...+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+......... .....| ..
T Consensus 837 ~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~ 906 (968)
T PLN00113 837 KCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW---------ID 906 (968)
T ss_pred CccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhe---------eC
Confidence 3467899999999876 45999999999999999999999998532210 011111111100 000000 00
Q ss_pred CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 358 p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
+.. .... ........++.+++.+||+.||++|||+.|+++.
T Consensus 907 ~~~-~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 907 PSI-RGDV-SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ccc-cCCC-CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000 0000 0001123467789999999999999999999975
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=265.70 Aligned_cols=257 Identities=25% Similarity=0.310 Sum_probs=178.4
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC--CCCCeeeeeceeeecC--cceE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL--DHPNIVKLEGLATSRM--QYSL 201 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L--~HpnIv~l~~~~~~~~--~~~l 201 (584)
...+++.||+|.||.||+|.. +++.||||++.. ...+.+.+|-+|.... +|+||+++++...... .-.+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred chhhHHHhhcCccceeehhhc--cCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 356778899999999999954 469999999853 3456677787777654 7999999987654322 3357
Q ss_pred EEEEechh-hHHHHHhhCCCCCC----cHHHHHHHHHHHHHhC---------CceeccccccceeecCCCcEEEEEeccc
Q 043957 202 YLVFEFMQ-TDLARIISNPEGKL----TEPQQLLSGLQHCHDR---------GILHRDVKGSNLLIDKNGVLKIADFGLA 267 (584)
Q Consensus 202 ~lV~Ey~~-g~L~~~l~~~~~~l----~~~~qIl~aL~yLH~~---------~IvHrDLKp~NILl~~~g~vKL~DFGla 267 (584)
|||++|-+ |+|.++++..-..+ .++..|++||+|||+. .|+|||||..||||..|++..|+|||||
T Consensus 284 wLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 99999988 78998887533222 2335889999999963 5999999999999999999999999999
Q ss_pred cccCCCCC-CCCccccccccccChhhhhCCCCCC-----ceeeEecchHHHHHHHhCCCCCC-CCChHHHHHHHHHhcCC
Q 043957 268 NYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYG-----VGIDLWSAGCLLAEMFLGRPIMP-GRTEVEQLHRIFKLCGS 340 (584)
Q Consensus 268 ~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~-----~~sDIwSLGvilyeLltG~~pF~-~~~~~~~~~~i~~~~~~ 340 (584)
..+.+... ......+||..|||||+|.+...+. .+.||||+|.|||||++.-..+. +..+.-++---..+-..
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 88865432 2234579999999999998766555 45899999999999998643332 22111111000011122
Q ss_pred CChHHHHHhhccCCCCCCCCCCchhhhhcc--CCcHhHHHHHHHhcccCCCCCCCHH
Q 043957 341 PSEDYWKKLRLSTTFRPPQSYKPRLFEAFS--EFPESSLGLLSTLLALDPAYRGSAA 395 (584)
Q Consensus 341 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~--~~s~~~~dLI~~~L~~DP~kRpTa~ 395 (584)
|..+....+-.... .+|.+...+. .-...+.+.|..|+..||+.|.||.
T Consensus 444 Pt~e~mq~~VV~kK------~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 444 PTLEEMQELVVRKK------QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred CCHHHHHHHHHhhc------cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 22222222211111 1111112221 2235678999999999999999984
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=281.24 Aligned_cols=243 Identities=30% Similarity=0.386 Sum_probs=188.7
Q ss_pred ceEEeeecccCceEEEEEEEC----C---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCc
Q 043957 127 YDKIDKVGQGTYSNVYKALDR----D---TGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~----~---~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 198 (584)
..+.+.||+|.||.|++|... . ....||||.++..... ...+.+..|+++|+.+ .|+|||.+++++.. .
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~--~ 374 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ--D 374 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc--C
Confidence 356668999999999999643 1 1457999998755544 6778899999999999 59999999999887 5
Q ss_pred ceEEEEEechh-hHHHHHhhCCC---------------CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCC
Q 043957 199 YSLYLVFEFMQ-TDLARIISNPE---------------GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKN 256 (584)
Q Consensus 199 ~~l~lV~Ey~~-g~L~~~l~~~~---------------~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~ 256 (584)
..+++|+|||. |+|..++.... ..+. .+.||+.|++||++..+|||||-..||||..+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKN 454 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCC
Confidence 56899999998 78888876544 1132 23599999999999999999999999999999
Q ss_pred CcEEEEEeccccccCCCCCCCCccccc--cccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCC-hHHHHH
Q 043957 257 GVLKIADFGLANYFSPNKKRPLTSRVV--TLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRT-EVEQLH 332 (584)
Q Consensus 257 g~vKL~DFGla~~~~~~~~~~~~~~~g--t~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~-~~~~~~ 332 (584)
..+||+|||+|+..............+ ...|||||.+.. ..|+.++||||+||+||||++ |..|+++-. ..+.+.
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~ 533 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE 533 (609)
T ss_pred CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH
Confidence 999999999998654333221121122 335999999987 569999999999999999998 779998744 333333
Q ss_pred HHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 333 RIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 333 ~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.+..+... +....+++++.+++..|++.+|++||+..++.+
T Consensus 534 ~l~~G~r~--------------------------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 534 FLKEGNRM--------------------------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHhcCCCC--------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 33222111 122456889999999999999999999999876
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-30 Score=269.18 Aligned_cols=197 Identities=31% Similarity=0.488 Sum_probs=164.4
Q ss_pred CCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCCh------HHHHHHHHHHHHHHhCC---CCCeeeeec
Q 043957 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP------HSVKFMAREIMILQKLD---HPNIVKLEG 191 (584)
Q Consensus 121 ~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~------~~~~~~~~Ei~iL~~L~---HpnIv~l~~ 191 (584)
+....+|..++.+|.|+||.|++|+++.+...|+||.|.++..-. ...-.+-.||.||..|+ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 455567999999999999999999999999999999996542110 11112445999999997 999999999
Q ss_pred eeeecCcceEEEEEechhh--HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEE
Q 043957 192 LATSRMQYSLYLVFEFMQT--DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIAD 263 (584)
Q Consensus 192 ~~~~~~~~~l~lV~Ey~~g--~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~D 263 (584)
+|++.+ ++||+||--.. +|.++|... .++.+ ++||..|+++||++||||||||-+||.++.+|-+||+|
T Consensus 637 fFEddd--~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 637 FFEDDD--YYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred eeecCC--eeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEee
Confidence 998844 57999997663 677777642 23333 35999999999999999999999999999999999999
Q ss_pred eccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCC
Q 043957 264 FGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMP 323 (584)
Q Consensus 264 FGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~ 323 (584)
||.|.+... .++..++||..|.|||++.|.++.+..-|||+||++||.++....||.
T Consensus 714 fgsaa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999988653 356788999999999999988878999999999999999998888875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-28 Score=231.33 Aligned_cols=207 Identities=42% Similarity=0.656 Sum_probs=170.9
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechh-hH
Q 043957 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ-TD 211 (584)
Q Consensus 133 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~-g~ 211 (584)
||.|.+|.||++.+..+++.+++|++....... ....+.+|+.+++.+.|++|+++++++... ...+++|||+. ++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCCCc
Confidence 689999999999998889999999987543322 356788999999999999999999888764 46799999999 67
Q ss_pred HHHHhhCCCCCC------cHHHHHHHHHHHHHhCCceeccccccceeecC-CCcEEEEEeccccccCCCCCCCCcccccc
Q 043957 212 LARIISNPEGKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDK-NGVLKIADFGLANYFSPNKKRPLTSRVVT 284 (584)
Q Consensus 212 L~~~l~~~~~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~-~g~vKL~DFGla~~~~~~~~~~~~~~~gt 284 (584)
|..++......+ .+..+++.+|.+||+.+++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 777776432222 23459999999999999999999999999999 89999999999987643321 12345678
Q ss_pred ccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCch
Q 043957 285 LWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPR 364 (584)
Q Consensus 285 ~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 364 (584)
..|++||.+.....++.+.|+|+||+++|+|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 8999999987643688999999999999999
Q ss_pred hhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCc
Q 043957 365 LFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNE 401 (584)
Q Consensus 365 ~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp 401 (584)
..+.++|..||..||.+||++.++++|+
T Consensus 188 ---------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1335799999999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=271.28 Aligned_cols=242 Identities=23% Similarity=0.310 Sum_probs=192.2
Q ss_pred ceEEeeecccCceEEEEEEECCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGK----IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
.+..++||.|+||+||+|.....|+ +||||++.. ........++.+|+.+|.+|+|||+++|++++.... +.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~-~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~---~q 773 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE-FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST---LQ 773 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeec-cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch---HH
Confidence 4456789999999999998765554 589998753 344445677889999999999999999999987643 68
Q ss_pred EEEechh-hHHHHHhhCCCCC------CcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 203 LVFEFMQ-TDLARIISNPEGK------LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 203 lV~Ey~~-g~L~~~l~~~~~~------l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
||++||+ |.|++.+...... +.|..||++||.|||++++|||||-..||||..-..+||.|||+++.+..+..
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 9999999 6788888764443 45667999999999999999999999999999999999999999999876665
Q ss_pred CCCccc-cccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 276 RPLTSR-VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 276 ~~~~~~-~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
...... .-.+-|||-|.+.. ..|+.++||||+||++|||+| |..|+.+....++-..+.+...
T Consensus 854 ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-------------- 918 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-------------- 918 (1177)
T ss_pred cccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc--------------
Confidence 433221 22567999999876 459999999999999999998 8888888765544332222111
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
....+..+-++.-++.+||..|+..||+++++..
T Consensus 919 ------------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 919 ------------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ------------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 1122456778889999999999999999998765
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=292.51 Aligned_cols=198 Identities=19% Similarity=0.245 Sum_probs=136.8
Q ss_pred hCCC-CCeeeeeceeeec-----CcceEEEEEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceecccc
Q 043957 180 KLDH-PNIVKLEGLATSR-----MQYSLYLVFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVK 247 (584)
Q Consensus 180 ~L~H-pnIv~l~~~~~~~-----~~~~l~lV~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLK 247 (584)
.+.| +||+.+++++... ....++++|||+.++|...+......+. ++.||+.||.|||++||+|||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 3445 5777777765211 1235788999999999999875444343 34599999999999999999999
Q ss_pred ccceeecCCC-------------------cEEEEEeccccccCCCCC---------------CCCccccccccccChhhh
Q 043957 248 GSNLLIDKNG-------------------VLKIADFGLANYFSPNKK---------------RPLTSRVVTLWYRAPELL 293 (584)
Q Consensus 248 p~NILl~~~g-------------------~vKL~DFGla~~~~~~~~---------------~~~~~~~gt~~Y~APEvl 293 (584)
|+||||+..+ .+||+|||+++....... ......+||++|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 9999996544 455666666543211000 001124689999999999
Q ss_pred hCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCc
Q 043957 294 LGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFP 373 (584)
Q Consensus 294 ~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s 373 (584)
.+. .|+.++|||||||+||||++|.+||.... ..+..+.... .+. . ... ..
T Consensus 188 ~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~-~-----------------------~~~-~~ 238 (793)
T PLN00181 188 NGS-SSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPP-Q-----------------------ILL-NW 238 (793)
T ss_pred ccC-CCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cCh-h-----------------------hhh-cC
Confidence 874 58999999999999999999998875321 1111111100 000 0 001 13
Q ss_pred HhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 374 ESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 374 ~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
....+++.+||++||.+|||+.|+|+||||...
T Consensus 239 ~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 239 PKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred HHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 445789999999999999999999999999753
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=254.36 Aligned_cols=245 Identities=27% Similarity=0.345 Sum_probs=171.8
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHh--CCCCCeeeeeceeeecC--cce
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQK--LDHPNIVKLEGLATSRM--QYS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIv~l~~~~~~~~--~~~ 200 (584)
.+-.+.+.||+|.||.||+|..+ |+.||||++.-. ....+.+|.+|.+. |+|+||+.|++...... --.
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred heeEEEEEecCccccceeecccc--CCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 35688999999999999999665 899999998522 22446677777765 59999999976543222 125
Q ss_pred EEEEEechh-hHHHHHhhCCC----CCCcHHHHHHHHHHHHHhC--------CceeccccccceeecCCCcEEEEEeccc
Q 043957 201 LYLVFEFMQ-TDLARIISNPE----GKLTEPQQLLSGLQHCHDR--------GILHRDVKGSNLLIDKNGVLKIADFGLA 267 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~----~~l~~~~qIl~aL~yLH~~--------~IvHrDLKp~NILl~~~g~vKL~DFGla 267 (584)
+|||.+|-+ |+|.+++.... .-+..+..++.||+|||.. .|.|||||..||||..+|...|+|+|||
T Consensus 284 LwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 899999998 89999987521 1233445889999999942 4999999999999999999999999999
Q ss_pred cccCCCC---CCCCccccccccccChhhhhCCCCC-----CceeeEecchHHHHHHHhC----------CCCCCCCCh--
Q 043957 268 NYFSPNK---KRPLTSRVVTLWYRAPELLLGATDY-----GVGIDLWSAGCLLAEMFLG----------RPIMPGRTE-- 327 (584)
Q Consensus 268 ~~~~~~~---~~~~~~~~gt~~Y~APEvl~~~~~~-----~~~sDIwSLGvilyeLltG----------~~pF~~~~~-- 327 (584)
....... .......+||-.|||||+|...... =..+||||||.|+||++.. ++||..-.+
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 8765442 2234668999999999998643211 1348999999999999852 367754322
Q ss_pred --HHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCc--HhHHHHHHHhcccCCCCCCCHHHH
Q 043957 328 --VEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFP--ESSLGLLSTLLALDPAYRGSAASA 397 (584)
Q Consensus 328 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s--~~~~dLI~~~L~~DP~kRpTa~e~ 397 (584)
.+.+.+++-. +...|.....+...+ ..+..|++.|+..+|.-|.||-.+
T Consensus 444 Ps~eeMrkVVCv---------------------~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 444 PSFEEMRKVVCV---------------------QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred CCHHHHhcceee---------------------cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 2222222111 111111111122111 234678999999999999987543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=233.83 Aligned_cols=205 Identities=39% Similarity=0.621 Sum_probs=165.5
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEe
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFE 206 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~E 206 (584)
|++.+.||.|++|.||++.+..+++.+|||.+...... ...+.+.+|+..++.++|+||+++++++... ...++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP--EPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC--CceEEEEe
Confidence 67788999999999999999988999999998754332 2467888999999999999999999887654 45799999
Q ss_pred chhh-HHHHHhhCCCCCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCc
Q 043957 207 FMQT-DLARIISNPEGKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLT 279 (584)
Q Consensus 207 y~~g-~L~~~l~~~~~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 279 (584)
|+.+ +|...+......+ ....+++.+|.+||+++++|+||+|.||+++.++.++|+|||++..+.........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9997 7887776433212 23458999999999999999999999999999999999999999876543211234
Q ss_pred cccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCC-CChH-HHHHHH
Q 043957 280 SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPG-RTEV-EQLHRI 334 (584)
Q Consensus 280 ~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~-~~~~-~~~~~i 334 (584)
...++..|++||.+.+...++.++|||+|||++|+|++|++||.. .+.. ...+.|
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 457788999999884345678899999999999999999999977 4444 344443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=231.09 Aligned_cols=241 Identities=24% Similarity=0.317 Sum_probs=176.6
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l~ 202 (584)
.+.|.+.+.||+|.||.+.+|.++.+...+++|.+... ......|.+|..---.|. |.||+.-|++.... ...++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT-SDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhc-CceEE
Confidence 45799999999999999999999999999999998533 334567888887766664 99999988765433 33578
Q ss_pred EEEechh-hHHHHHhhCCCC----CCcHHHHHHHHHHHHHhCCceeccccccceee-cC-CCcEEEEEeccccccCCCCC
Q 043957 203 LVFEFMQ-TDLARIISNPEG----KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLI-DK-NGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 203 lV~Ey~~-g~L~~~l~~~~~----~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl-~~-~g~vKL~DFGla~~~~~~~~ 275 (584)
++|||++ |+|..-+....- ...+..|++.||.|||++++||||||.+|||| +. ...|||||||+.+..+..-
T Consensus 99 F~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV- 177 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV- 177 (378)
T ss_pred EeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee-
Confidence 9999999 788887764211 12234599999999999999999999999999 32 3479999999987653211
Q ss_pred CCCccccccccccChhhhhCCC----CCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 276 RPLTSRVVTLWYRAPELLLGAT----DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~----~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
...--+..|.+||++.... ...+.+|||.||+|+|.+|||.+||+.....+ ..||.-+..
T Consensus 178 ---~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-------------~~Y~~~~~w 241 (378)
T KOG1345|consen 178 ---KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-------------KPYWEWEQW 241 (378)
T ss_pred ---hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-------------chHHHHHHH
Confidence 1122355689999875321 24678999999999999999999997432211 122222111
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR 391 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kR 391 (584)
. ....+.+...|..+++.+..+.++-|..+|++|
T Consensus 242 ~------~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 242 L------KRKNPALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred h------cccCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 0 011123344567789999999999999999998
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=237.11 Aligned_cols=180 Identities=21% Similarity=0.269 Sum_probs=135.8
Q ss_pred CCCCCCCceEEeeecccCceEEEEEEECC-CCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHhCCCCCeee-eeceee
Q 043957 120 VPKSAESYDKIDKVGQGTYSNVYKALDRD-TGKIVALKKVKFDTS---EPHSVKFMAREIMILQKLDHPNIVK-LEGLAT 194 (584)
Q Consensus 120 ~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv~-l~~~~~ 194 (584)
.+...+.|++.+.||+|+||+||+|.+.. ++..||||++..... .......+.+|+++|++|+|+||+. ++++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 34456789999999999999999998876 678889998753211 2334567899999999999999985 4321
Q ss_pred ecCcceEEEEEechhhHHHHHhhCCCCCCcHHHHHHHHHHHHHhCCceeccc-cccceeecCCCcEEEEEeccccccCCC
Q 043957 195 SRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQQLLSGLQHCHDRGILHRDV-KGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 195 ~~~~~~l~lV~Ey~~g~L~~~l~~~~~~l~~~~qIl~aL~yLH~~~IvHrDL-Kp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
...|||||||.|..+..+. ......+..|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+.+...
T Consensus 91 ----~~~~LVmE~~~G~~L~~~~-~~~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~ 165 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHLAR-PHGDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR 165 (365)
T ss_pred ----CCcEEEEEccCCCCHHHhC-ccchHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence 2369999999975444332 2223456779999999999999999999 999999999999999999999876533
Q ss_pred CC-------CCCccccccccccChhhhhCCC-----CCCceeeEe
Q 043957 274 KK-------RPLTSRVVTLWYRAPELLLGAT-----DYGVGIDLW 306 (584)
Q Consensus 274 ~~-------~~~~~~~gt~~Y~APEvl~~~~-----~~~~~sDIw 306 (584)
.. ...+...+++.|+|||.+.... ..+...|-|
T Consensus 166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 166 GALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 21 1224567888999999885321 233446666
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.8e-27 Score=260.83 Aligned_cols=257 Identities=27% Similarity=0.350 Sum_probs=192.4
Q ss_pred eEEeeecccCceEEEEEEECCCCcEEEEEEeecC----CCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 128 DKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD----TSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 128 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~----~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.....+|.|++|.|+.+......+.++.|.++.. .........+..|+.+-..|.||||+.....+..... .+-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~--~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG--ILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc--chh
Confidence 4567799999999999888777777777766421 1122222336678888889999999887766655433 244
Q ss_pred EEechhhHHHHHhhCCCCCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC--
Q 043957 204 VFEFMQTDLARIISNPEGKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK-- 275 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-- 275 (584)
+||||.++|..++... +.+ ...+|++.||.|||..||.||||||+|+|++.+|.+||+|||.+..+.....
T Consensus 399 ~mE~~~~Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 399 SMEYCPYDLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hhhcccHHHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 4999999888887753 122 2235999999999999999999999999999999999999999987653332
Q ss_pred -CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHH-HHHHhcCCCChHHHHHhhccC
Q 043957 276 -RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLH-RIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 276 -~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~~~ 353 (584)
......+|+..|+|||++.+...-....||||.|++++.|++|+.||......+... .+
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~------------------- 538 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN------------------- 538 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-------------------
Confidence 345667899999999999886644567899999999999999999996544332211 00
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
...............+..+|...+.+|.+||++||.+|.|++++|+.+||+..
T Consensus 539 ~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 539 NYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred ccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 00001111222334556778899999999999999999999999999999864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=227.72 Aligned_cols=251 Identities=21% Similarity=0.318 Sum_probs=194.3
Q ss_pred CCCCCCCceEEeeecccCceEEEEEEECCCC-----cEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceee
Q 043957 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDTG-----KIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLAT 194 (584)
Q Consensus 120 ~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 194 (584)
+...-++++....+-+|+||.||.|+.++.. +.|-+|.++.. ..+-.+..+..|-.+|..+.|||+..+.++..
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 3445567888888999999999999776433 34566666433 34456777888999999999999999998876
Q ss_pred ecCcceEEEEEechh-hHHHHHhh-----CCCCCCc--------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEE
Q 043957 195 SRMQYSLYLVFEFMQ-TDLARIIS-----NPEGKLT--------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLK 260 (584)
Q Consensus 195 ~~~~~~l~lV~Ey~~-g~L~~~l~-----~~~~~l~--------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vK 260 (584)
.. ....++++.++. |+|..++. ++....+ .+.|++.|++|||+++|||.||-..|++||+.-.||
T Consensus 358 e~-~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 358 ED-YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred ec-cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEE
Confidence 64 334688888888 77877776 3322211 234999999999999999999999999999999999
Q ss_pred EEEeccccccCCCCCCCCcccc-ccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 043957 261 IADFGLANYFSPNKKRPLTSRV-VTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLC 338 (584)
Q Consensus 261 L~DFGla~~~~~~~~~~~~~~~-gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~ 338 (584)
|+|=.+++.+-+.+...+...- -...||+||.+.. ..|+.++|+|||||+||||+| |+.|+..-++.+...-+.++.
T Consensus 437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy 515 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY 515 (563)
T ss_pred eccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc
Confidence 9999999877655543332221 2456999999986 569999999999999999998 888998877777766554442
Q ss_pred CCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 339 GSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
+. ...-++|+++..++..|+..+|++||+.+|+..
T Consensus 516 Rl--------------------------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 516 RL--------------------------AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ee--------------------------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 21 112468999999999999999999999999764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=212.80 Aligned_cols=160 Identities=23% Similarity=0.297 Sum_probs=117.0
Q ss_pred hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccccc
Q 043957 210 TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV 283 (584)
Q Consensus 210 g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~g 283 (584)
|+|.+++......+++ ..||+.||.|||+++ ||+|||++.++.+|+ ||++...... ...|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE------QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc------cCCC
Confidence 4566666543333444 359999999999998 999999999999999 9999875432 2268
Q ss_pred cccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCChHHHHHhhccCCCCCCCCCC
Q 043957 284 TLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVE-QLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYK 362 (584)
Q Consensus 284 t~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 362 (584)
|+.|||||++.+ ..|+.++|||||||++|||++|++||....... .+..+........ +.. .
T Consensus 67 ~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------------~~~-~ 129 (176)
T smart00750 67 DPYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD---------------PRD-R 129 (176)
T ss_pred cccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC---------------ccc-c
Confidence 999999999976 458999999999999999999999997654432 2222222111000 000 0
Q ss_pred chhhhhccCCcH--hHHHHHHHhcccCCCCCCCHHHHhcCcCCC
Q 043957 363 PRLFEAFSEFPE--SSLGLLSTLLALDPAYRGSAASALKNEFFF 404 (584)
Q Consensus 363 ~~~~~~~~~~s~--~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~ 404 (584)
.....+++ .+.+||.+||..||.+|||+.|+++|+|+.
T Consensus 130 ----~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 130 ----SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred ----ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 00112233 689999999999999999999999999974
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.8e-24 Score=213.78 Aligned_cols=257 Identities=36% Similarity=0.551 Sum_probs=192.9
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChH-HHHHHHHHHHHHHhCCCC-CeeeeeceeeecCcceEEEE
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPH-SVKFMAREIMILQKLDHP-NIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-~~~~~~~Ei~iL~~L~Hp-nIv~l~~~~~~~~~~~l~lV 204 (584)
|.+.+.||.|+|+.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+++++++.. ....+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec--CCEEEEE
Confidence 788999999999999999887 7899999976544443 567788999999999988 79999988844 3347999
Q ss_pred Eechhh-HHHHHhhCCCC--CCc------HHHHHHHHHHHHHhCCceeccccccceeecCCC-cEEEEEeccccccCCCC
Q 043957 205 FEFMQT-DLARIISNPEG--KLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG-VLKIADFGLANYFSPNK 274 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~--~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g-~vKL~DFGla~~~~~~~ 274 (584)
++|+.+ .+...+..... .+. ...|++.++.|+|+.+++||||||+|||++..+ .++++|||++..+....
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999996 45544443221 222 234999999999999999999999999999988 79999999998654333
Q ss_pred CC-----CCccccccccccChhhhhCC--CCCCceeeEecchHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCChH
Q 043957 275 KR-----PLTSRVVTLWYRAPELLLGA--TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE---VEQLHRIFKLCGSPSED 344 (584)
Q Consensus 275 ~~-----~~~~~~gt~~Y~APEvl~~~--~~~~~~sDIwSLGvilyeLltG~~pF~~~~~---~~~~~~i~~~~~~~~~~ 344 (584)
.. .....+||..|+|||++.+. ..+....|+||+|++++++++|..||..... .......+.....+.
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 234 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS-- 234 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc--
Confidence 21 34677899999999999863 4688999999999999999999999887764 233333332222110
Q ss_pred HHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 345 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
...+. ..... ......+.+++..|+..+|..|.++.+...++|...
T Consensus 235 ----------~~~~~--~~~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 235 ----------LASPL--SPSNP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred ----------ccccc--Ccccc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 00000 00000 122357789999999999999999999999977654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-22 Score=208.74 Aligned_cols=248 Identities=24% Similarity=0.280 Sum_probs=176.1
Q ss_pred CceEEeeecccCceEEEEEEECCCC-cEEEEEEeecCCCChHHHHHHHHHHHHHHhCCC----CCeeeeeceeeecCcce
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTG-KIVALKKVKFDTSEPHSVKFMAREIMILQKLDH----PNIVKLEGLATSRMQYS 200 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H----pnIv~l~~~~~~~~~~~ 200 (584)
+|.+.++||+|+||.||+|.+..++ ..+|+|........... .+..|+.+|..+.. .++..+++... .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCce
Confidence 7999999999999999999988764 67899987654333221 56778889888863 57888876664 23445
Q ss_pred EEEEEechhhHHHHHhhCCC-CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCC-----CcEEEEEecccc
Q 043957 201 LYLVFEFMQTDLARIISNPE-GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKN-----GVLKIADFGLAN 268 (584)
Q Consensus 201 l~lV~Ey~~g~L~~~l~~~~-~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~-----g~vKL~DFGla~ 268 (584)
-||||+.+..+|.++..... .+++ +..|++.+|.+||+.|++||||||+|+++... ..+.|.|||+|+
T Consensus 96 ~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 96 NFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred eEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 69999999998888774332 3443 33599999999999999999999999999754 469999999998
Q ss_pred --ccCCCCC------CC-CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 043957 269 --YFSPNKK------RP-LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCG 339 (584)
Q Consensus 269 --~~~~~~~------~~-~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~ 339 (584)
.+..... +. .....||..|.++.+..+. ..+.+.|+||++.++.+|+.|..||.+.........+.....
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 3321111 11 1234599999999988774 589999999999999999999999977654333333222111
Q ss_pred CCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 340 SPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
..... ......+..+..+...+-..+...+|....+..
T Consensus 255 ~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 255 KLLTD----------------------RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred hhccc----------------------cccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 00000 011223456666666666677777776655543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-24 Score=237.15 Aligned_cols=226 Identities=27% Similarity=0.409 Sum_probs=170.1
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
..+|..++.|-.|+||.||.++++.+.+.+|+| |.+... +.+- ||.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc--cccccCCccee----------------
Confidence 346999999999999999999999999999994 432211 1110 22222333333
Q ss_pred EEechhhHHHHHhhCCCCCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC--------
Q 043957 204 VFEFMQTDLARIISNPEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK-------- 275 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-------- 275 (584)
|+-...++.. + ....+++.+++|||+.+|+|||+||+|+||+.-|.+|+.|||+++...-...
T Consensus 136 ------gDc~tllk~~-g--~lPvdmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I 206 (1205)
T KOG0606|consen 136 ------GDCATLLKNI-G--PLPVDMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHI 206 (1205)
T ss_pred ------chhhhhcccC-C--CCcchhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcch
Confidence 4444444321 1 2223568999999999999999999999999999999999999865321100
Q ss_pred -----C-CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 276 -----R-PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 276 -----~-~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
. .-...+|||.|+||||+.. ..|+..+|+|+||+|+||++-|.-||.+++..+++..++......++.
T Consensus 207 ~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~----- 280 (1205)
T KOG0606|consen 207 EKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE----- 280 (1205)
T ss_pred HHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc-----
Confidence 0 0124589999999999986 469999999999999999999999999999999998887654333322
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC---CHHHHhcCcCCCCCCCc
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG---SAASALKNEFFFTSPLA 409 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp---Ta~e~L~Hp~f~~~~~~ 409 (584)
-..+++++.++|..+|+.+|..|. .+-++-+|+||+.-.+.
T Consensus 281 -------------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 281 -------------------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred -------------------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 234688999999999999999994 66788899999764443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=195.38 Aligned_cols=238 Identities=21% Similarity=0.280 Sum_probs=174.9
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCC-CCeeeeeceeeecCcceEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH-PNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~~~~~~l~ 202 (584)
...|+++++||.|+||.+|+|....+|+.||||+-...... .++..|..+.+.|.+ ..|..+..+... ..+-.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e--~~ynv 87 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTE--KDYNV 87 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccc--cccce
Confidence 35699999999999999999999999999999987644433 346678899998864 456566544444 33458
Q ss_pred EEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecC---CCcEEEEEeccccccCCC
Q 043957 203 LVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDK---NGVLKIADFGLANYFSPN 273 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~---~g~vKL~DFGla~~~~~~ 273 (584)
||||++..+|.+++.-....++. +.|++.-|+|+|.++.|||||||+|+|..- -..+.|+|||+|+.+.+.
T Consensus 88 lVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 88 LVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred eeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 99999998887776644444443 359999999999999999999999999843 346999999999887543
Q ss_pred CCC------CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHH
Q 043957 274 KKR------PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWK 347 (584)
Q Consensus 274 ~~~------~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 347 (584)
... .-....||..|.+-....+. ..+...|+-|+|.+|..+..|..||++-......++..+...
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~-eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E-------- 238 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGI-EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE-------- 238 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhh-hhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH--------
Confidence 321 22446789999998777653 367889999999999999999999998765544433322210
Q ss_pred HhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccC
Q 043957 348 KLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALD 387 (584)
Q Consensus 348 ~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~D 387 (584)
.............+|.++.-.|.-|=..-
T Consensus 239 -----------kK~s~~ie~LC~G~P~EF~myl~Y~R~L~ 267 (341)
T KOG1163|consen 239 -----------KKMSTPIEVLCKGFPAEFAMYLNYCRGLG 267 (341)
T ss_pred -----------hhcCCCHHHHhCCCcHHHHHHHHHHhhcC
Confidence 00112233345677888877777775554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-24 Score=229.24 Aligned_cols=232 Identities=30% Similarity=0.420 Sum_probs=182.7
Q ss_pred ecccCceEEEEEE---ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceEEEEEech
Q 043957 133 VGQGTYSNVYKAL---DRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 133 LG~G~fg~Vy~a~---~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
+|.|+||.|+++. ..+.|..||+|+.++.............|..++..++ ||.+|.++-.+.. ...++++++|.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT--DGKLYLILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc--ccchhHhhhhc
Confidence 7899999998773 3355788999998765433332334556888898887 9999999755555 44579999999
Q ss_pred hh-HHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccc
Q 043957 209 QT-DLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR 281 (584)
Q Consensus 209 ~g-~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 281 (584)
.| +|...+... ..+.+. ..++.+++++|+.+|+|||+|++||+++.+|.+++.|||+++..-.... .
T Consensus 80 rgg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----A 153 (612)
T ss_pred ccchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-----c
Confidence 86 555555432 233322 2788999999999999999999999999999999999999987643322 2
Q ss_pred cccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCC
Q 043957 282 VVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSY 361 (584)
Q Consensus 282 ~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~ 361 (584)
|||..|||||++. .+..++|.||||+++|+|++|..||.+ +.+..|.+.....+
T Consensus 154 cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p------------------- 207 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP------------------- 207 (612)
T ss_pred ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc-------------------
Confidence 8999999999987 367899999999999999999999987 66777766443333
Q ss_pred CchhhhhccCCcHhHHHHHHHhcccCCCCCCCH-----HHHhcCcCCCCC
Q 043957 362 KPRLFEAFSEFPESSLGLLSTLLALDPAYRGSA-----ASALKNEFFFTS 406 (584)
Q Consensus 362 ~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa-----~e~L~Hp~f~~~ 406 (584)
..++..+.+++..|+..+|.+|.-+ .|+++|+||+..
T Consensus 208 --------~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 208 --------RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred --------hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheee
Confidence 3446778899999999999999755 899999999764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.3e-23 Score=207.33 Aligned_cols=231 Identities=21% Similarity=0.309 Sum_probs=148.9
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCC----------CCeeeeecee-
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDH----------PNIVKLEGLA- 193 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~H----------pnIv~l~~~~- 193 (584)
.+...+.||.|+++.||.+++..||+.+|||++..... .....+.+.+|.-....+.+ -.++-.++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 36778899999999999999999999999999865543 23456777777655555322 1222211211
Q ss_pred --------eecC---cc---eEEEEEechhhHHHHHhh---CCCCC---------CcHHHHHHHHHHHHHhCCceecccc
Q 043957 194 --------TSRM---QY---SLYLVFEFMQTDLARIIS---NPEGK---------LTEPQQLLSGLQHCHDRGILHRDVK 247 (584)
Q Consensus 194 --------~~~~---~~---~l~lV~Ey~~g~L~~~l~---~~~~~---------l~~~~qIl~aL~yLH~~~IvHrDLK 247 (584)
.-.. .+ ..+++|+-+.++|..++. ..... +..-.|+++.+++||..||||+|||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 1111 11 247788888887766543 11111 1111388999999999999999999
Q ss_pred ccceeecCCCcEEEEEeccccccCCCCCCCCccccccccccChhhhhCC-------CCCCceeeEecchHHHHHHHhCCC
Q 043957 248 GSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGA-------TDYGVGIDLWSAGCLLAEMFLGRP 320 (584)
Q Consensus 248 p~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~-------~~~~~~sDIwSLGvilyeLltG~~ 320 (584)
|+|+|++.+|.++|+||+........ ......+..|.+||+.... ..++.+.|.|+||+++|.|+||+.
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999999999999988764321 1113446789999987432 247889999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCC
Q 043957 321 IMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR 391 (584)
Q Consensus 321 pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kR 391 (584)
||......... ...+....++|+.+++||..||+.||.+|
T Consensus 249 Pf~~~~~~~~~-------------------------------~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADP-------------------------------EWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTS-------------------------------GGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccc-------------------------------cccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 99765332110 00122334789999999999999999988
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=194.77 Aligned_cols=195 Identities=20% Similarity=0.279 Sum_probs=157.1
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l~lV 204 (584)
.|++.++||+|+||+++.+.+..+++.||||.-..... ..++..|.+..+.|. .+.|...| |......+-.||
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vY--YFGqeG~~NiLV 102 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVY--YFGQEGKYNILV 102 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCcee--eeccccchhhhh
Confidence 49999999999999999999999999999997643332 345777888888885 78998884 444445556899
Q ss_pred EechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCC-----CcEEEEEeccccccCCC
Q 043957 205 FEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKN-----GVLKIADFGLANYFSPN 273 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~-----g~vKL~DFGla~~~~~~ 273 (584)
||++..+|.+++.-...+++. +.|++.-++|+|++.+|+|||||+|+||... ..|.|+|||+|+.+.+.
T Consensus 103 idLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 103 IDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 999998777766544444443 3599999999999999999999999999643 35999999999987544
Q ss_pred CC------CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCCh
Q 043957 274 KK------RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE 327 (584)
Q Consensus 274 ~~------~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~ 327 (584)
.. +...+..||..||+-...+|. .-+...|+-|||-+++.+|.|..||.+-..
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGr-EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred cccccCccccccccccceeeeEeeccccc-hhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 32 223466899999998888874 478899999999999999999999988543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.4e-22 Score=196.39 Aligned_cols=173 Identities=14% Similarity=0.181 Sum_probs=130.3
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChH-HHHH------HHHHHHHHHhCCCCCeeeeeceeeec
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPH-SVKF------MAREIMILQKLDHPNIVKLEGLATSR 196 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-~~~~------~~~Ei~iL~~L~HpnIv~l~~~~~~~ 196 (584)
.++|++++.||.|+||.||++.+ ++..+|||++........ .... +.+|+..+.+|.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 46899999999999999999754 466899999965433322 2222 67999999999999999998886643
Q ss_pred C------cceEEEEEechhh-HHHHHhhCCCCCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccc
Q 043957 197 M------QYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 197 ~------~~~l~lV~Ey~~g-~L~~~l~~~~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
. ....+|||||++| +|.+.... ......+|+.+|..||+.||+|||+||+||+++.+| ++|+|||....
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~~---~~~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~ 183 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPEI---SEDVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRC 183 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhhc---cHHHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCccc
Confidence 2 1247999999997 45554221 122345999999999999999999999999999988 99999998876
Q ss_pred cCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHH
Q 043957 270 FSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF 316 (584)
Q Consensus 270 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLl 316 (584)
....... ..+++. ..|+.++|||||||++..+.
T Consensus 184 ~~e~~a~-------------d~~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 184 TAQRKAK-------------DRIDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ccchhhH-------------HHHHHH-hHhcccccccceeEeehHHH
Confidence 5322111 012333 34778999999999887654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-22 Score=224.80 Aligned_cols=244 Identities=26% Similarity=0.392 Sum_probs=171.4
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS--EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.|...+.||.+.|=.|.+|++.+ |. |+||++-+... .-....+...|++ ...++|||++++.-+... ....||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--DKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh--hHHHHH
Confidence 68889999999999999998764 54 89999854432 2233344445666 566689999999766443 334689
Q ss_pred EEechhhHHHHHhhCCCCCC----c-HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccc--cCCCCCC
Q 043957 204 VFEFMQTDLARIISNPEGKL----T-EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANY--FSPNKKR 276 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~l----~-~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~--~~~~~~~ 276 (584)
|-+|+..+|++.+..+.... . ++-||+.||.-+|..||+|+|||.+||||+.-.-+.|+||..-+. +..++..
T Consensus 99 vRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 99 VRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 99999999999887543211 1 123999999999999999999999999999999999999987643 2222222
Q ss_pred CCcccc----ccccccChhhhhCCC---------C-CCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 043957 277 PLTSRV----VTLWYRAPELLLGAT---------D-YGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSP 341 (584)
Q Consensus 277 ~~~~~~----gt~~Y~APEvl~~~~---------~-~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~ 341 (584)
..+.+. --.+|+|||.+.... . .+++-||||+||+++||++ |+|||. ..++-.........
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~~~~ 254 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSGNADD 254 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhccCccC
Confidence 222211 234699999885421 1 5678999999999999988 799993 33332221111111
Q ss_pred ChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 342 SEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 342 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
......+ +. +.....||..|++.||.+|.+|++.|+.
T Consensus 255 ~e~~Le~--------------------Ie--d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 255 PEQLLEK--------------------IE--DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHHh--------------------Cc--CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1111111 11 2367889999999999999999999986
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.6e-21 Score=183.88 Aligned_cols=189 Identities=16% Similarity=0.144 Sum_probs=137.2
Q ss_pred eEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceEEEE
Q 043957 128 DKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS--EPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 128 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l~lV 204 (584)
.+...|++|+||+||.+.. .+..++.+.+..... ..-....+.+|+++|++|. |++|++++++ ...|++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lv 76 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLD 76 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEE
Confidence 4567799999999998744 577888777653322 1112235789999999995 5889998765 125999
Q ss_pred EechhhH-HHHHhhCCCCCCcHHHHHHHHHHHHHhCCceeccc-cccceeecCCCcEEEEEeccccccCCCCCC------
Q 043957 205 FEFMQTD-LARIISNPEGKLTEPQQLLSGLQHCHDRGILHRDV-KGSNLLIDKNGVLKIADFGLANYFSPNKKR------ 276 (584)
Q Consensus 205 ~Ey~~g~-L~~~l~~~~~~l~~~~qIl~aL~yLH~~~IvHrDL-Kp~NILl~~~g~vKL~DFGla~~~~~~~~~------ 276 (584)
|||+.|. |...+. ...+....|++.+|.+||++||+|||| ||+|||++.++.++|+|||+|.........
T Consensus 77 meyI~G~~L~~~~~--~~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~ 154 (218)
T PRK12274 77 RSYLAGAAMYQRPP--RGDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAR 154 (218)
T ss_pred EeeecCccHHhhhh--hhhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHH
Confidence 9999985 433322 123455679999999999999999999 799999999999999999999865432210
Q ss_pred -CC-----ccccccccccChhhhhCCCCCC-ceeeEecchHHHHHHHhCCCCCCCCC
Q 043957 277 -PL-----TSRVVTLWYRAPELLLGATDYG-VGIDLWSAGCLLAEMFLGRPIMPGRT 326 (584)
Q Consensus 277 -~~-----~~~~gt~~Y~APEvl~~~~~~~-~~sDIwSLGvilyeLltG~~pF~~~~ 326 (584)
.+ .-...++.|++|+...-....+ ...+.++.|+-+|.++|+..++.+..
T Consensus 155 rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 155 EDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 00 0122478899998654322233 55688899999999999998776544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.9e-21 Score=186.01 Aligned_cols=134 Identities=23% Similarity=0.223 Sum_probs=97.5
Q ss_pred EeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHH------------------------HHHHHHHHHHHHhCCCCC
Q 043957 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHS------------------------VKFMAREIMILQKLDHPN 185 (584)
Q Consensus 130 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~------------------------~~~~~~Ei~iL~~L~Hpn 185 (584)
.+.||+|+||.||+|.+. +|+.||||+++........ .....+|+.+|.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 356999999999999987 8999999999754221111 122345999999998877
Q ss_pred eeeeeceeeecCcceEEEEEechhhHHH-HHhhCCCCCCc------HHHHHHHHHHHH-HhCCceeccccccceeecCCC
Q 043957 186 IVKLEGLATSRMQYSLYLVFEFMQTDLA-RIISNPEGKLT------EPQQLLSGLQHC-HDRGILHRDVKGSNLLIDKNG 257 (584)
Q Consensus 186 Iv~l~~~~~~~~~~~l~lV~Ey~~g~L~-~~l~~~~~~l~------~~~qIl~aL~yL-H~~~IvHrDLKp~NILl~~~g 257 (584)
|.....+... . .||||||++|+.+ ..... ...++ ...||+.+|.|| |+.||+||||||+|||++ ++
T Consensus 81 v~~p~~~~~~--~--~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 81 IPCPEPILLK--S--HVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCCcEEEec--C--CEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CC
Confidence 6443322211 2 2899999997533 22121 22333 235899999999 799999999999999998 57
Q ss_pred cEEEEEecccccc
Q 043957 258 VLKIADFGLANYF 270 (584)
Q Consensus 258 ~vKL~DFGla~~~ 270 (584)
.++|+|||+|...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.8e-21 Score=195.30 Aligned_cols=252 Identities=27% Similarity=0.362 Sum_probs=167.1
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCC-----------------------------------cEEEEEEee-cC--CCC
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTG-----------------------------------KIVALKKVK-FD--TSE 164 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g-----------------------------------~~vAiK~i~-~~--~~~ 164 (584)
..++|++.+.||+|.-..||.|.....| -+.|||.+. ++ ...
T Consensus 155 tiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~ 234 (598)
T KOG4158|consen 155 TIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGD 234 (598)
T ss_pred chhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCch
Confidence 3567999999999999999988643211 034666552 11 122
Q ss_pred hHHHHHHHHHHH------HH--------Hh--------CCCCCeeeeeceeeecC-------------------------
Q 043957 165 PHSVKFMAREIM------IL--------QK--------LDHPNIVKLEGLATSRM------------------------- 197 (584)
Q Consensus 165 ~~~~~~~~~Ei~------iL--------~~--------L~HpnIv~l~~~~~~~~------------------------- 197 (584)
....+.+.+|+- .+ +. -+|||||++.++|.+..
T Consensus 235 ~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~ 314 (598)
T KOG4158|consen 235 AHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGE 314 (598)
T ss_pred HHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCC
Confidence 223333434421 11 11 26999999988765531
Q ss_pred cceEEEEEechhhHHHHHhhCCCCCC----cHHHHHHHHHHHHHhCCceeccccccceee--cCCC--cEEEEEeccccc
Q 043957 198 QYSLYLVFEFMQTDLARIISNPEGKL----TEPQQLLSGLQHCHDRGILHRDVKGSNLLI--DKNG--VLKIADFGLANY 269 (584)
Q Consensus 198 ~~~l~lV~Ey~~g~L~~~l~~~~~~l----~~~~qIl~aL~yLH~~~IvHrDLKp~NILl--~~~g--~vKL~DFGla~~ 269 (584)
...+|+||--...+|..++....... -+..|+++|+.|||++||.|||||.+|||| |+|+ .+.|+|||.+-.
T Consensus 315 ~~tlylvMkrY~~tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLA 394 (598)
T KOG4158|consen 315 PKTLYLVMKRYRQTLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLA 394 (598)
T ss_pred CceEEEehhcchhhHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeee
Confidence 23689999998888888876433221 223599999999999999999999999998 5554 489999998754
Q ss_pred cCCCCC-----CCCccccccccccChhhhhCCCC-----CCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 043957 270 FSPNKK-----RPLTSRVVTLWYRAPELLLGATD-----YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCG 339 (584)
Q Consensus 270 ~~~~~~-----~~~~~~~gt~~Y~APEvl~~~~~-----~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~ 339 (584)
.+.... ......-|.-.-||||+...... .-.++|.|+.|.+.||++....||.+..+...-.+-.
T Consensus 395 d~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y---- 470 (598)
T KOG4158|consen 395 DDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY---- 470 (598)
T ss_pred ccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh----
Confidence 221110 01123356777899999864321 1146899999999999999999998744322111100
Q ss_pred CCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCH---HHHhc
Q 043957 340 SPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSA---ASALK 399 (584)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa---~e~L~ 399 (584)
. ...+......+|+.+.+||-.+|+.||+||+++ +.+|+
T Consensus 471 -------q--------------e~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 471 -------Q--------------ESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred -------h--------------hhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 0 001112235678999999999999999999986 45554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-20 Score=180.79 Aligned_cols=136 Identities=21% Similarity=0.252 Sum_probs=101.4
Q ss_pred EeeecccCceEEEEEEECCCCcEEEEEEeecCCCChH------------------------HHHHHHHHHHHHHhCCCCC
Q 043957 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPH------------------------SVKFMAREIMILQKLDHPN 185 (584)
Q Consensus 130 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~------------------------~~~~~~~Ei~iL~~L~Hpn 185 (584)
.+.||+|+||.||+|.+. +|+.||||+++....... ....+.+|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 457999999999999987 899999999975422100 0223467999999999998
Q ss_pred eeeeeceeeecCcceEEEEEechhhH-HHH-HhhCCC----CCCcHHHHHHHHHHHHHh-CCceeccccccceeecCCCc
Q 043957 186 IVKLEGLATSRMQYSLYLVFEFMQTD-LAR-IISNPE----GKLTEPQQLLSGLQHCHD-RGILHRDVKGSNLLIDKNGV 258 (584)
Q Consensus 186 Iv~l~~~~~~~~~~~l~lV~Ey~~g~-L~~-~l~~~~----~~l~~~~qIl~aL~yLH~-~~IvHrDLKp~NILl~~~g~ 258 (584)
|.....+... . .||||||++|. +.. .+.... .......|++.+|.+||+ .||+||||||+|||++ ++.
T Consensus 81 i~~p~~~~~~--~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 81 VPVPEPILLK--K--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCCceEEEec--C--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 7554433332 2 38999999975 222 222111 112334599999999999 9999999999999998 889
Q ss_pred EEEEEeccccccC
Q 043957 259 LKIADFGLANYFS 271 (584)
Q Consensus 259 vKL~DFGla~~~~ 271 (584)
++|+|||+|....
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=171.29 Aligned_cols=132 Identities=19% Similarity=0.209 Sum_probs=101.9
Q ss_pred EEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-----CCCCeeeeeceeeecCc-ce-E
Q 043957 129 KIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-----DHPNIVKLEGLATSRMQ-YS-L 201 (584)
Q Consensus 129 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-----~HpnIv~l~~~~~~~~~-~~-l 201 (584)
-.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.| +||||+++++++..... .. +
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 346799999999995 6776665 6998865332 2346789999999999 67999999999987542 23 4
Q ss_pred EEEEechh---hHHHHHhhCCCCCCcH----HHHHHHHH-HHHHhCCceeccccccceeecCC----CcEEEEEeccc
Q 043957 202 YLVFEFMQ---TDLARIISNPEGKLTE----PQQLLSGL-QHCHDRGILHRDVKGSNLLIDKN----GVLKIADFGLA 267 (584)
Q Consensus 202 ~lV~Ey~~---g~L~~~l~~~~~~l~~----~~qIl~aL-~yLH~~~IvHrDLKp~NILl~~~----g~vKL~DFGla 267 (584)
.+||||+. ++|.+++.+. .+.+ ..|++.++ +|||+++|+||||||+|||++.. +.++|+||+.+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~--~~~e~~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC--RYEEDVAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc--cccHhHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 48999954 5888888653 3333 45888777 99999999999999999999743 37999995544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.2e-19 Score=188.91 Aligned_cols=171 Identities=26% Similarity=0.479 Sum_probs=125.1
Q ss_pred eEEEEEechh-hHHHHHhhCCCC--------CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccccc
Q 043957 200 SLYLVFEFMQ-TDLARIISNPEG--------KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~~--------~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~ 270 (584)
++||.|++|. ..|.+++..+.. .+.+..|+..|+.| ++.+|||+||.||++..+..+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 5899999999 467777753221 23445699999999 99999999999999999999999999999876
Q ss_pred CCCC-----CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHh-cCCCChH
Q 043957 271 SPNK-----KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKL-CGSPSED 344 (584)
Q Consensus 271 ~~~~-----~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~-~~~~~~~ 344 (584)
.... ....+..+||.+||+||.|.+. .|+.++||||||+|||||+.- |.. ..+........ .+..+..
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~---f~T--~~er~~t~~d~r~g~ip~~ 480 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQ---FST--QFERIATLTDIRDGIIPPE 480 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHH---hcc--HHHHHHhhhhhhcCCCChH
Confidence 5444 2345677999999999999874 599999999999999999972 221 11111111110 1111212
Q ss_pred HHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 345 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
+| .+. +.-.+|+.+||.+.|.+||++.+.--|.|.
T Consensus 481 ~~-----------------------~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 481 FL-----------------------QDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred Hh-----------------------hcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 22 222 334589999999999999988888778775
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.9e-18 Score=169.42 Aligned_cols=139 Identities=24% Similarity=0.249 Sum_probs=102.7
Q ss_pred CceEEeeecccCceEEEEEE-ECCCCcEEEEEEeecCCCCh----------------------HHHHHHHHHHHHHHhCC
Q 043957 126 SYDKIDKVGQGTYSNVYKAL-DRDTGKIVALKKVKFDTSEP----------------------HSVKFMAREIMILQKLD 182 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~-~~~~g~~vAiK~i~~~~~~~----------------------~~~~~~~~Ei~iL~~L~ 182 (584)
.|.+.+.||+|+||.||+|. +..+|+.||||+++...... .....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 66789999999997542110 01134568999999997
Q ss_pred CCC--eeeeeceeeecCcceEEEEEechhhHHH-HHh-hCCCCC----CcHHHHHHHHHHHHHhCC-ceeccccccceee
Q 043957 183 HPN--IVKLEGLATSRMQYSLYLVFEFMQTDLA-RII-SNPEGK----LTEPQQLLSGLQHCHDRG-ILHRDVKGSNLLI 253 (584)
Q Consensus 183 Hpn--Iv~l~~~~~~~~~~~l~lV~Ey~~g~L~-~~l-~~~~~~----l~~~~qIl~aL~yLH~~~-IvHrDLKp~NILl 253 (584)
+.. +..+++ .. . .||||||+.|..+ ... ...... ..+..||+.+|.+||.+| |+||||||+|||+
T Consensus 109 ~~~i~~p~~~~---~~-~--~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIA---WR-R--NVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeE---ec-C--ceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 533 333332 21 2 3899999998533 322 111111 234569999999999999 9999999999999
Q ss_pred cCCCcEEEEEeccccccC
Q 043957 254 DKNGVLKIADFGLANYFS 271 (584)
Q Consensus 254 ~~~g~vKL~DFGla~~~~ 271 (584)
+ ++.++|+|||+|....
T Consensus 183 ~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred E-CCCEEEEEChhhhccC
Confidence 9 8899999999987543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.2e-18 Score=163.55 Aligned_cols=140 Identities=22% Similarity=0.230 Sum_probs=104.7
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCCh--------------------HHHHHHHHHHHHHHhCCCCC
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP--------------------HSVKFMAREIMILQKLDHPN 185 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~--------------------~~~~~~~~Ei~iL~~L~Hpn 185 (584)
.|.+.+.||.|+||.||++... +|+.||||++....... .......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888899999999999999875 79999999986432110 01123567899999998774
Q ss_pred --eeeeeceeeecCcceEEEEEechhhHHHHHhhCCCCCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEE
Q 043957 186 --IVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIAD 263 (584)
Q Consensus 186 --Iv~l~~~~~~~~~~~l~lV~Ey~~g~L~~~l~~~~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~D 263 (584)
++..++. ...++||||+.|..+..+...........+|+.++.++|+.+|+||||||+||||+.++.++|+|
T Consensus 95 i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liD 168 (198)
T cd05144 95 FPVPKPIDW------NRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIID 168 (198)
T ss_pred CCCCceeec------CCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEE
Confidence 3444321 12489999999753333322122334556999999999999999999999999999999999999
Q ss_pred eccccccCC
Q 043957 264 FGLANYFSP 272 (584)
Q Consensus 264 FGla~~~~~ 272 (584)
||++.....
T Consensus 169 fg~~~~~~~ 177 (198)
T cd05144 169 WPQMVSTDH 177 (198)
T ss_pred CCccccCCC
Confidence 999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.5e-19 Score=198.59 Aligned_cols=258 Identities=28% Similarity=0.392 Sum_probs=194.8
Q ss_pred CCCceEEeeecccCceEEEEEEECC-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRD-TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l 201 (584)
...|.+.+.||+|+|+.|-.+.... ....+|+|.+............+..|..+-..+. |.|++.+++...... ..
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~--~~ 96 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR--SY 96 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc--cc
Confidence 3458889999999999999887643 3456787877655444455566677888888887 999999988776643 46
Q ss_pred EEEEechhh-HHHHHhhCCCC-------CCcHHHHHHHHHHHHH-hCCceeccccccceeecCCC-cEEEEEeccccccC
Q 043957 202 YLVFEFMQT-DLARIISNPEG-------KLTEPQQLLSGLQHCH-DRGILHRDVKGSNLLIDKNG-VLKIADFGLANYFS 271 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~-------~l~~~~qIl~aL~yLH-~~~IvHrDLKp~NILl~~~g-~vKL~DFGla~~~~ 271 (584)
+++++|..| ++...+..... .-....|+..+|.|+| ..++.||||||+|.+++..+ .+++.|||+|..+.
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 999999775 55555522221 1122359999999999 99999999999999999999 99999999998876
Q ss_pred C--CCCCCCccccc-cccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHH
Q 043957 272 P--NKKRPLTSRVV-TLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK 348 (584)
Q Consensus 272 ~--~~~~~~~~~~g-t~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 348 (584)
. +........+| ++.|+|||+..+.....+..|+||+|+++..+++|..|+......... ...|..
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-----------~~~~~~ 245 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-----------YSSWKS 245 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-----------ceeecc
Confidence 5 23334456688 999999999987556788999999999999999999888554332210 000110
Q ss_pred hhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 349 LRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 349 ~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
.. .......+..++..+.+++.++|..+|..|.+.+++-.+||+..
T Consensus 246 ~~-----------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 246 NK-----------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cc-----------cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 00 01112345677889999999999999999999999999999977
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=4e-17 Score=187.04 Aligned_cols=190 Identities=23% Similarity=0.345 Sum_probs=140.8
Q ss_pred CCCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC---CCCeeeeeceeeec
Q 043957 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD---HPNIVKLEGLATSR 196 (584)
Q Consensus 120 ~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~ 196 (584)
++...+.|.|-+.||+|+||.||+|.... |+.||||+-+....-+ |.=-.+++.+|+ -+-|..+...+...
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 45556789999999999999999999887 9999999875432211 111123444444 23445554444443
Q ss_pred CcceEEEEEechh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecC-------CCcEEEE
Q 043957 197 MQYSLYLVFEFMQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDK-------NGVLKIA 262 (584)
Q Consensus 197 ~~~~l~lV~Ey~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~-------~g~vKL~ 262 (584)
+ .-+||+||.+ |+|++++.. ...+. ...|||..|++||..+|||+||||+|+||.. .-.++|+
T Consensus 767 ~--~S~lv~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 767 N--ASVLVSEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred C--cceeeeeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence 3 3489999998 789988863 22232 2359999999999999999999999999821 2359999
Q ss_pred EeccccccCCC-CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCC
Q 043957 263 DFGLANYFSPN-KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGR 319 (584)
Q Consensus 263 DFGla~~~~~~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~ 319 (584)
|||.+.-+..- +...+...++|-.+-.+|+..| ..|++.+|.|.|..++|-||.|+
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHH
Confidence 99998644321 1234667788999999998877 56999999999999999999996
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.8e-16 Score=155.09 Aligned_cols=134 Identities=19% Similarity=0.282 Sum_probs=102.6
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCCCh------HHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP------HSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
+.||+|++|.||+|.. .|..|++|+........ .....+.+|+.++..+.|++|+....++.... ..++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--NFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC--CCEEE
Confidence 4699999999999976 67889999865332211 11245778999999999998876655554433 35899
Q ss_pred Eechhh-HHHHHhhCCC-CCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccc
Q 043957 205 FEFMQT-DLARIISNPE-GKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~-~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
|||++| +|...+.... .......+|+.+|.+||+.+++|+||+|.|||++ ++.++|+|||++..
T Consensus 78 ~e~~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNGMEELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999986 5666654321 1234556899999999999999999999999999 78999999999865
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-17 Score=161.00 Aligned_cols=237 Identities=16% Similarity=0.199 Sum_probs=174.9
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.....++-+|.+...|..|+++.. |..+++|++............|..|.-.|+-+.||||+.+++.+.... .+.+
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp--nlv~ 264 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP--NLVI 264 (448)
T ss_pred hhhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC--CceE
Confidence 344556677889999999999665 566778888766555555667888999999999999999999887753 4799
Q ss_pred EEechh-hHHHHHhhCCC-------CCCcHHHHHHHHHHHHHhCC--ceeccccccceeecCCCcEEEE--EeccccccC
Q 043957 204 VFEFMQ-TDLARIISNPE-------GKLTEPQQLLSGLQHCHDRG--ILHRDVKGSNLLIDKNGVLKIA--DFGLANYFS 271 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~-------~~l~~~~qIl~aL~yLH~~~--IvHrDLKp~NILl~~~g~vKL~--DFGla~~~~ 271 (584)
+..||+ |+|+.++.... .....+..|++|++|||+.. |.---|....|+||++.+.+|. |--++-.
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq-- 342 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-- 342 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee--
Confidence 999999 78888876432 23455669999999999874 4455688999999998876654 3222211
Q ss_pred CCCCCCCccccccccccChhhhhCCCC--CCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 272 PNKKRPLTSRVVTLWYRAPELLLGATD--YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 272 ~~~~~~~~~~~gt~~Y~APEvl~~~~~--~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
. ....-.|.||+||.+..... .-.++|+|||.+++|||.|...||..-.+.+.--+|.-.
T Consensus 343 --e----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale------------ 404 (448)
T KOG0195|consen 343 --E----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE------------ 404 (448)
T ss_pred --c----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc------------
Confidence 1 12334789999999975432 235789999999999999999999887766553333110
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHH
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASA 397 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~ 397 (584)
. -.....+.++.....|+.-|+..||.+||....+
T Consensus 405 ---g----------lrv~ippgis~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 405 ---G----------LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred ---c----------ccccCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence 0 0112345778889999999999999999986544
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.2e-16 Score=153.10 Aligned_cols=131 Identities=18% Similarity=0.238 Sum_probs=99.4
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEeecCCCCh------HHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEe
Q 043957 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP------HSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFE 206 (584)
Q Consensus 133 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~E 206 (584)
||+|+||.||++. ..|..|++|......... .....+.+|+++++.+.|+++....-++.... ..++|||
T Consensus 2 ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~e 77 (199)
T TIGR03724 2 IAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD--NKTIVME 77 (199)
T ss_pred CCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC--CCEEEEE
Confidence 8999999999997 457889999864322111 12356778999999999887554433333322 3589999
Q ss_pred chhh-HHHHHhhCCCCCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccccc
Q 043957 207 FMQT-DLARIISNPEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 207 y~~g-~L~~~l~~~~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~ 270 (584)
|++| +|...+.... .....+|+.+|.+||+.+|+|+|++|.|||++ ++.++|+|||++...
T Consensus 78 ~~~g~~l~~~~~~~~--~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 78 YIEGKPLKDVIEEGN--DELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EECCccHHHHHhhcH--HHHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9986 5655554321 15677999999999999999999999999999 889999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.5e-16 Score=152.66 Aligned_cols=134 Identities=25% Similarity=0.290 Sum_probs=94.3
Q ss_pred EeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHH----------------------HHHHHHHHHhCCCCC--
Q 043957 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKF----------------------MAREIMILQKLDHPN-- 185 (584)
Q Consensus 130 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~----------------------~~~Ei~iL~~L~Hpn-- 185 (584)
.+.||+|+||.||+|.+. +|+.||||++............ ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 456999999999999876 7999999998654322111111 135666666665432
Q ss_pred eeeeeceeeecCcceEEEEEechhh-----HHHHHhhCCCCCCcHHHHHHHHHHHHHh-CCceeccccccceeecCCCcE
Q 043957 186 IVKLEGLATSRMQYSLYLVFEFMQT-----DLARIISNPEGKLTEPQQLLSGLQHCHD-RGILHRDVKGSNLLIDKNGVL 259 (584)
Q Consensus 186 Iv~l~~~~~~~~~~~l~lV~Ey~~g-----~L~~~l~~~~~~l~~~~qIl~aL~yLH~-~~IvHrDLKp~NILl~~~g~v 259 (584)
+.+++++. ..++||||+.+ .++..............+++.++.++|. .+|+|+||||+||+++ ++.+
T Consensus 81 ~~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDLN------RHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEecC------CCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 33443221 24899999997 3222222112233445699999999999 9999999999999999 8999
Q ss_pred EEEEeccccccC
Q 043957 260 KIADFGLANYFS 271 (584)
Q Consensus 260 KL~DFGla~~~~ 271 (584)
+|+|||.+....
T Consensus 154 ~liDfg~a~~~~ 165 (187)
T cd05119 154 YIIDVPQAVEID 165 (187)
T ss_pred EEEECccccccc
Confidence 999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.9e-16 Score=169.24 Aligned_cols=200 Identities=28% Similarity=0.376 Sum_probs=146.6
Q ss_pred HHhCCCCCeeeeeceeeecCcceEEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCc-eecccccc
Q 043957 178 LQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGI-LHRDVKGS 249 (584)
Q Consensus 178 L~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~I-vHrDLKp~ 249 (584)
|+.+.|.|+.+++|.+.+. ..+++|.+||. |+|.+.+......+.+ .+.|+.||.|||.-.| .|+.|++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 4678999999999998886 45799999998 7888888765554443 4699999999998766 99999999
Q ss_pred ceeecCCCcEEEEEeccccccCCC-CCCCCccccccccccChhhhhCCC--C----CCceeeEecchHHHHHHHhCCCCC
Q 043957 250 NLLIDKNGVLKIADFGLANYFSPN-KKRPLTSRVVTLWYRAPELLLGAT--D----YGVGIDLWSAGCLLAEMFLGRPIM 322 (584)
Q Consensus 250 NILl~~~g~vKL~DFGla~~~~~~-~~~~~~~~~gt~~Y~APEvl~~~~--~----~~~~sDIwSLGvilyeLltG~~pF 322 (584)
|+++|....+||+|||+....... .........-..-|.|||.+.+.. . .+.+.||||+|+++||+++-..||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998776421 111112222356699999987632 1 366799999999999999999999
Q ss_pred CCCChH----HHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHh
Q 043957 323 PGRTEV----EQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASAL 398 (584)
Q Consensus 323 ~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L 398 (584)
...... +.+..+.+ . ......|.+.... .+++++..++..|+.-+|..||+++++-
T Consensus 159 ~~~~~~~~~~eii~~~~~-~------------------~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK-G------------------GSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred ccccccCChHHHHHHHHh-c------------------CCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHH
Confidence 763322 22222222 0 0011122222111 5567899999999999999999998876
Q ss_pred c
Q 043957 399 K 399 (584)
Q Consensus 399 ~ 399 (584)
.
T Consensus 219 ~ 219 (484)
T KOG1023|consen 219 S 219 (484)
T ss_pred h
Confidence 4
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.4e-16 Score=172.67 Aligned_cols=139 Identities=17% Similarity=0.235 Sum_probs=104.7
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CC-----hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SE-----PHSVKFMAREIMILQKLDHPNIVKLEGLATSRM 197 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~-----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 197 (584)
...|...+.||+|+||+||++.... ..+++|+..... .. ....+.+.+|+.+++.++|++|+..+.++....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 3446678899999999999997653 344555432111 11 122356789999999999999987765555433
Q ss_pred cceEEEEEechhh-HHHHHhhCCCCCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccccc
Q 043957 198 QYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 198 ~~~l~lV~Ey~~g-~L~~~l~~~~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~ 270 (584)
..++||||++| +|.+.+. .......+|+.+|.|||+.+|+||||||+|||+ .++.++|+|||+++..
T Consensus 410 --~~~lv~E~~~g~~L~~~l~---~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 410 --EKTIVMEYIGGKDLKDVLE---GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred --CCEEEEEecCCCcHHHHHH---HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 35899999986 5666554 234456799999999999999999999999999 6788999999999763
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-15 Score=153.03 Aligned_cols=137 Identities=18% Similarity=0.221 Sum_probs=100.6
Q ss_pred eeec-ccCceEEEEEEECCCCcEEEEEEeecCCC-----------ChHHHHHHHHHHHHHHhCCCCCe--eeeeceeeec
Q 043957 131 DKVG-QGTYSNVYKALDRDTGKIVALKKVKFDTS-----------EPHSVKFMAREIMILQKLDHPNI--VKLEGLATSR 196 (584)
Q Consensus 131 ~~LG-~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-----------~~~~~~~~~~Ei~iL~~L~HpnI--v~l~~~~~~~ 196 (584)
..|| .|+.|+||.+... +..++||.+..... .......+.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3476 7888888888553 77899998853210 11233557889999999998875 5565554332
Q ss_pred Cc--ceEEEEEechhh--HHHHHhhCCCCCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccc
Q 043957 197 MQ--YSLYLVFEFMQT--DLARIISNPEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 197 ~~--~~l~lV~Ey~~g--~L~~~l~~~~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
.. +..+|||||++| +|...+...........+|+.+|.+||++||+||||||+|||++.++.++|+|||.+..
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 22 123699999996 67777654322223356999999999999999999999999999989999999998875
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=7.2e-15 Score=133.73 Aligned_cols=133 Identities=25% Similarity=0.254 Sum_probs=102.3
Q ss_pred EEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCC--CCeeeeeceeeecCcceEEEEEe
Q 043957 129 KIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH--PNIVKLEGLATSRMQYSLYLVFE 206 (584)
Q Consensus 129 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~~~~~~~~~~~l~lV~E 206 (584)
+++.||.|.++.||++... +..+++|.+..... ...+.+|+.+++.+.| .++++++.+.... ...|++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEEE
Confidence 4567999999999999864 37899999854332 3567889999999976 5888887666543 45799999
Q ss_pred chhhHHHHHhhCCCCCCcHHHHHHHHHHHHHhC---CceeccccccceeecCCCcEEEEEecccccc
Q 043957 207 FMQTDLARIISNPEGKLTEPQQLLSGLQHCHDR---GILHRDVKGSNLLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 207 y~~g~L~~~l~~~~~~l~~~~qIl~aL~yLH~~---~IvHrDLKp~NILl~~~g~vKL~DFGla~~~ 270 (584)
|+.+.....+ ..........+++.+|.+||.. +++|+||+|+|||++..+.++|+|||++...
T Consensus 74 ~~~g~~~~~~-~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 74 WIEGETLDEV-SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecCCeecccC-CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 9987533322 1112233456899999999985 6999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=7.8e-15 Score=158.43 Aligned_cols=250 Identities=25% Similarity=0.303 Sum_probs=182.7
Q ss_pred CceEEeeecc--cCceEEEEEEE--CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcce
Q 043957 126 SYDKIDKVGQ--GTYSNVYKALD--RDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 126 ~Y~~~~~LG~--G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~ 200 (584)
.+-+.+.+|. |.+|.||.+.. ..++..+|+|.-+.....+.....-.+|+.....++ |+|.|+.+..+.. ...
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~~~ 192 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--SGI 192 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc--CCc
Confidence 3566777999 99999999988 889999999985544433333333456777777775 9999997666555 446
Q ss_pred EEEEEechhhHHHHHhhCCCCCCcH------HHHHHH----HHHHHHhCCceeccccccceeecCC-CcEEEEEeccccc
Q 043957 201 LYLVFEFMQTDLARIISNPEGKLTE------PQQLLS----GLQHCHDRGILHRDVKGSNLLIDKN-GVLKIADFGLANY 269 (584)
Q Consensus 201 l~lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~----aL~yLH~~~IvHrDLKp~NILl~~~-g~vKL~DFGla~~ 269 (584)
+|+-+|+|...|..........+.. ..++.. ||.++|..+|+|-|+||+||++..+ ...+++|||+...
T Consensus 193 lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~ 272 (524)
T KOG0601|consen 193 LFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK 272 (524)
T ss_pred ceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence 7999999998888777654432222 236666 9999999999999999999999988 7899999999988
Q ss_pred cCCCCCCCC----ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHH
Q 043957 270 FSPNKKRPL----TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDY 345 (584)
Q Consensus 270 ~~~~~~~~~----~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~ 345 (584)
+....-... ....|...|++||++.+ -++...|||+||.++.+-.++..++..... ..
T Consensus 273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~----------------~~ 334 (524)
T KOG0601|consen 273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKN----------------SS 334 (524)
T ss_pred ccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCC----------------CC
Confidence 865442111 11256778999998875 388999999999999999988765543310 01
Q ss_pred HHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 346 WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 346 ~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
|..++... --.+.+...+.++...+..||+.||..|++++.++.|+++..
T Consensus 335 W~~~r~~~----------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 335 WSQLRQGY----------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred cccccccc----------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 11111100 001223455666667999999999999999999999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.7e-14 Score=162.94 Aligned_cols=261 Identities=23% Similarity=0.256 Sum_probs=187.5
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
.+.+.+.+.+.+-+|+++.++.+.-..+|...++|....... .....+.+..+-.++-...+|-++...- .......
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~--s~~~rsP 878 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFP--SFPCRSP 878 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccC--CCCCCCC
Confidence 356778888899999999999998777887777776643221 1122333444444444455677776532 2223345
Q ss_pred EEEEEechhh-HHHHHhhCCCCCC-----cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC--
Q 043957 201 LYLVFEFMQT-DLARIISNPEGKL-----TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP-- 272 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~l-----~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~-- 272 (584)
++|||+|+.+ +|...+......- .....+..+++|||...++|+|++|.|+|+..+|..++.|||+.....-
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence 7999999974 5666655432111 1224678899999999999999999999999999999999984432210
Q ss_pred ----C------------------------CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCC
Q 043957 273 ----N------------------------KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPG 324 (584)
Q Consensus 273 ----~------------------------~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~ 324 (584)
. +...-...++|+.|.+||.+++. .....+|+|++|++++|.++|.+||..
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~-~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR-RHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc-cCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 00112345789999999999875 478899999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHH---HHhcCc
Q 043957 325 RTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAA---SALKNE 401 (584)
Q Consensus 325 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~---e~L~Hp 401 (584)
.+....++.|..... .+..-....+..+.+++..+|..+|.+|..+. ++-.|+
T Consensus 1038 ~tpq~~f~ni~~~~~------------------------~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~ 1093 (1205)
T KOG0606|consen 1038 ETPQQIFENILNRDI------------------------PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHP 1093 (1205)
T ss_pred cchhhhhhccccCCC------------------------CCCCCccccChhhhhhhhhhhccCchhccCcccccccccCC
Confidence 888777766543221 11222345678899999999999999999987 888999
Q ss_pred CCCCCCCc
Q 043957 402 FFFTSPLA 409 (584)
Q Consensus 402 ~f~~~~~~ 409 (584)
||+...+.
T Consensus 1094 ~~~~~~~~ 1101 (1205)
T KOG0606|consen 1094 FFQDVDWE 1101 (1205)
T ss_pred ccCCCCcc
Confidence 99876543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.3e-12 Score=121.26 Aligned_cols=128 Identities=18% Similarity=0.142 Sum_probs=92.1
Q ss_pred EeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCee-eeeceeeecCcceEEEEEech
Q 043957 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIV-KLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 130 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv-~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
++.|+.|.++.||++... +..|++|....... ....+.+|+.+++.+.+.+++ +++.+ +... -++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~--~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYF--DPET--GVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEE--eCCC--CeEEEEec
Confidence 467899999999999754 78899998753321 122456899999998655544 34332 2222 38999999
Q ss_pred hhHHHHHhhCCCCCCcHHHHHHHHHHHHHhCCc-----eeccccccceeecCCCcEEEEEeccccc
Q 043957 209 QTDLARIISNPEGKLTEPQQLLSGLQHCHDRGI-----LHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 209 ~g~L~~~l~~~~~~l~~~~qIl~aL~yLH~~~I-----vHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
+|...... .........+++.+|+.||..++ +|+|++|.||+++ ++.++|+|||.+..
T Consensus 74 ~G~~l~~~--~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 74 EGSELLTE--DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCCccccc--cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 97433211 11122345699999999999885 9999999999998 67899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.3e-12 Score=138.10 Aligned_cols=139 Identities=22% Similarity=0.264 Sum_probs=90.6
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCCChH----------------------------HH----H------HHH
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPH----------------------------SV----K------FMA 172 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~----------------------------~~----~------~~~ 172 (584)
+.||.|++|.||+|+.+ +|+.||||+.+......- .. . .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 56999999999999865 689999999864321100 00 0 134
Q ss_pred HHHHHHHhC----CCCCeeeeeceeeecCcceEEEEEechhhH-HHHHhhCCC---CCCcHHHHHHH-HHHHHHhCCcee
Q 043957 173 REIMILQKL----DHPNIVKLEGLATSRMQYSLYLVFEFMQTD-LARIISNPE---GKLTEPQQLLS-GLQHCHDRGILH 243 (584)
Q Consensus 173 ~Ei~iL~~L----~HpnIv~l~~~~~~~~~~~l~lV~Ey~~g~-L~~~l~~~~---~~l~~~~qIl~-aL~yLH~~~IvH 243 (584)
+|+..+.++ .|.+-|.+-.++..... ..+|||||++|. +.+...... ........++. .+..+|..|++|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~-~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g~~H 280 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTS-ERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDGFFH 280 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcC-CceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCcee
Confidence 455555554 23333333333332222 259999999973 433332111 11223334554 478899999999
Q ss_pred ccccccceeecCCCcEEEEEeccccccC
Q 043957 244 RDVKGSNLLIDKNGVLKIADFGLANYFS 271 (584)
Q Consensus 244 rDLKp~NILl~~~g~vKL~DFGla~~~~ 271 (584)
+|+||.||+++.++.++|+|||++..+.
T Consensus 281 ~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 281 ADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999997764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.1e-11 Score=135.58 Aligned_cols=181 Identities=22% Similarity=0.340 Sum_probs=127.3
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEe
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFE 206 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~E 206 (584)
|++ +...-++.+..-.|..+.++.+|.|..++.... .......+-++.|+.|+||||+++++.+... ..+|||+|
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~--~~~ylvTE 89 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEE--GTLYLVTE 89 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhccc--CceEEEee
Confidence 555 444444444333566778899999998875544 3455677788999999999999998877664 47899999
Q ss_pred chhh--HHHHHhhCCCCCCc-HHHHHHHHHHHHH-hCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCcccc
Q 043957 207 FMQT--DLARIISNPEGKLT-EPQQLLSGLQHCH-DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRV 282 (584)
Q Consensus 207 y~~g--~L~~~l~~~~~~l~-~~~qIl~aL~yLH-~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~ 282 (584)
-+.. ..+..+. ...+. -+.||+.||.||| +.+++|++|.-.-|+|+..|..||++|-++........ +.....
T Consensus 90 rV~Pl~~~lk~l~--~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~ 166 (690)
T KOG1243|consen 90 RVRPLETVLKELG--KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLY 166 (690)
T ss_pred ccccHHHHHHHhH--HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccch
Confidence 9862 2222221 11111 1359999999998 67899999999999999999999999999876543221 111222
Q ss_pred ccccccChhhhhCCCCCCceeeEecchHHHHHHHhC
Q 043957 283 VTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLG 318 (584)
Q Consensus 283 gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG 318 (584)
---.|..|+.+.. -.-..|.|-|||++++++.|
T Consensus 167 ~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 167 LIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence 2234677775532 12457999999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.30 E-value=3e-12 Score=141.41 Aligned_cols=145 Identities=15% Similarity=0.216 Sum_probs=91.8
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC----------------------------h----HHHHHH--
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE----------------------------P----HSVKFM-- 171 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~----------------------------~----~~~~~~-- 171 (584)
.|+. +.||.|++|.||+|+.+.+|+.||||+++..... . +..+.+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4666 7899999999999999888999999999643110 0 111223
Q ss_pred ----HHHHHHHHhC----CCCCeeeeeceeeecCcceEEEEEechhhH-HHHH--hhCCCCCC-cHHH-HHHHHHHHHHh
Q 043957 172 ----AREIMILQKL----DHPNIVKLEGLATSRMQYSLYLVFEFMQTD-LARI--ISNPEGKL-TEPQ-QLLSGLQHCHD 238 (584)
Q Consensus 172 ----~~Ei~iL~~L----~HpnIv~l~~~~~~~~~~~l~lV~Ey~~g~-L~~~--l~~~~~~l-~~~~-qIl~aL~yLH~ 238 (584)
.+|+..+.++ .+.+.|.+-.+|.+-.. ..+||||||.|. +.++ +....... .... .+-.-+..++.
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st-~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~ 278 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCS-ETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFR 278 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCC-CceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHh
Confidence 3344344443 23333443334433212 348999999973 4332 22111111 1112 22233445668
Q ss_pred CCceeccccccceeecCCC----cEEEEEeccccccCC
Q 043957 239 RGILHRDVKGSNLLIDKNG----VLKIADFGLANYFSP 272 (584)
Q Consensus 239 ~~IvHrDLKp~NILl~~~g----~vKL~DFGla~~~~~ 272 (584)
.|++|+|+||.||+|+.+| .++++|||++..+..
T Consensus 279 ~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 279 DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 9999999999999999888 999999999987754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.29 E-value=7.8e-12 Score=121.02 Aligned_cols=134 Identities=18% Similarity=0.202 Sum_probs=91.4
Q ss_pred eeecccCceEEEEEEECC------CCcEEEEEEeecCC------------C--------ChHHHHHHH----HHHHHHHh
Q 043957 131 DKVGQGTYSNVYKALDRD------TGKIVALKKVKFDT------------S--------EPHSVKFMA----REIMILQK 180 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~------~g~~vAiK~i~~~~------------~--------~~~~~~~~~----~Ei~iL~~ 180 (584)
..||.|--+.||.|.... .+..+|||+.+... . .......+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 458999999999997654 35789999885321 0 011223333 89999999
Q ss_pred CCC--CCeeeeeceeeecCcceEEEEEechhhH-HH-HHhhCCCC----CCcHHHHHHHHHHHH-HhCCceeccccccce
Q 043957 181 LDH--PNIVKLEGLATSRMQYSLYLVFEFMQTD-LA-RIISNPEG----KLTEPQQLLSGLQHC-HDRGILHRDVKGSNL 251 (584)
Q Consensus 181 L~H--pnIv~l~~~~~~~~~~~l~lV~Ey~~g~-L~-~~l~~~~~----~l~~~~qIl~aL~yL-H~~~IvHrDLKp~NI 251 (584)
+.. -++..++++ . . -+|||||++++ +. ..+.+... ......+++.+|..| |+.||||+||++.||
T Consensus 83 l~~~Gv~vP~pi~~--~--~--~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVL--K--K--HVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEe--c--C--CEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 853 344555433 1 2 28999999863 11 11221111 112235899999998 899999999999999
Q ss_pred eecCCCcEEEEEeccccccC
Q 043957 252 LIDKNGVLKIADFGLANYFS 271 (584)
Q Consensus 252 Ll~~~g~vKL~DFGla~~~~ 271 (584)
|++ ++.+.|+|||.+....
T Consensus 157 L~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEE-CCcEEEEECCCceeCC
Confidence 996 4789999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.3e-12 Score=138.19 Aligned_cols=245 Identities=21% Similarity=0.229 Sum_probs=170.3
Q ss_pred CCCceEEeeecccCceEEEEEEEC-CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDR-DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~-~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l 201 (584)
..+|..+..||.|.|+.|+.+.-+ .++..|++|.+............-..|+.+...+. |.+++.++..+..-. ..
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r--~~ 341 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR--QG 341 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc--cc
Confidence 356888999999999999998655 67889999988654433322223345777777774 888888655443322 34
Q ss_pred EEEEechhhHH---HHH---hhCCCCCCcHHHHHHHHHHHHHhCCceeccccccceeecCC-CcEEEEEeccccccCCCC
Q 043957 202 YLVFEFMQTDL---ARI---ISNPEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKN-GVLKIADFGLANYFSPNK 274 (584)
Q Consensus 202 ~lV~Ey~~g~L---~~~---l~~~~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~-g~vKL~DFGla~~~~~~~ 274 (584)
||--|||.+.. ... ..+....+....|++.++.++|+..++|+|+||+||++..+ +..++.|||.+..+.-.
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~- 420 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS- 420 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee-
Confidence 79999997532 221 22344556666799999999999999999999999999776 77899999998753211
Q ss_pred CCCCcccccccccc-ChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 275 KRPLTSRVVTLWYR-APELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~-APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
......+-++. ..|++.....+..+.|++|||..+++.++|.+.-..... |..++..
T Consensus 421 ---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------------------~~~i~~~- 478 (524)
T KOG0601|consen 421 ---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------------------SLTIRSG- 478 (524)
T ss_pred ---cccccccccccccchhhccccccccccccccccccccccccCcccCccccc------------------ceeeecc-
Confidence 12223344455 366676666789999999999999999999754322211 1111100
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~ 404 (584)
...........+..+...++..|+..|+.+.++..|.-|.
T Consensus 479 -----------~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 479 -----------DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred -----------cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0111223346677899999999999999999999987664
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.1e-13 Score=135.93 Aligned_cols=237 Identities=20% Similarity=0.231 Sum_probs=148.3
Q ss_pred EEEEEEECCCCcEEEEEEeecCCCCh--HHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc---ceEEEEEechh-hHHH
Q 043957 140 NVYKALDRDTGKIVALKKVKFDTSEP--HSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ---YSLYLVFEFMQ-TDLA 213 (584)
Q Consensus 140 ~Vy~a~~~~~g~~vAiK~i~~~~~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~---~~l~lV~Ey~~-g~L~ 213 (584)
.||++.+...|.+|+.-.+.+...+. ........-...|-++.|-|||+++.|+.+... ....++.|||. |.+.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 47888888888888766553221111 111111222344566789999999988876432 35788999998 5565
Q ss_pred HHhhC---CCCC------CcHHHHHHHHHHHHHhC--CceeccccccceeecCCCcEEEEEeccccc---cCCCCCCCCc
Q 043957 214 RIISN---PEGK------LTEPQQLLSGLQHCHDR--GILHRDVKGSNLLIDKNGVLKIADFGLANY---FSPNKKRPLT 279 (584)
Q Consensus 214 ~~l~~---~~~~------l~~~~qIl~aL~yLH~~--~IvHrDLKp~NILl~~~g~vKL~DFGla~~---~~~~~~~~~~ 279 (584)
.+++. .... -.|..||+.||.|||+. -|+|++|..+-|++..+|-||+.----... +.........
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~ 240 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKS 240 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhh
Confidence 55542 1111 13445999999999987 599999999999999999888752111100 0000000112
Q ss_pred cccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCC-CCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCC
Q 043957 280 SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRP-IMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358 (584)
Q Consensus 280 ~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~-pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p 358 (584)
...+-++|.|||.=.. ...+.++|||++|....+|..+.- +-.+....+.-..|........
T Consensus 241 ~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le---------------- 303 (458)
T KOG1266|consen 241 VNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE---------------- 303 (458)
T ss_pred ccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc----------------
Confidence 2345688999996433 346788999999999999987752 1222222222111211110000
Q ss_pred CCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 359 ~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
..--.++|.+||+-.|..||+|.++|.||.+.+.+
T Consensus 304 --------------n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh 338 (458)
T KOG1266|consen 304 --------------NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH 338 (458)
T ss_pred --------------CccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence 01124689999999999999999999999988764
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.5e-11 Score=131.19 Aligned_cols=166 Identities=23% Similarity=0.288 Sum_probs=118.9
Q ss_pred HHHHHHHHHHh-CCceeccccccceeecCCCcEEEEEeccccccCCCCCCC--------CccccccccccChhhhhCCCC
Q 043957 228 QLLSGLQHCHD-RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP--------LTSRVVTLWYRAPELLLGATD 298 (584)
Q Consensus 228 qIl~aL~yLH~-~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~--------~~~~~gt~~Y~APEvl~~~~~ 298 (584)
++..||.|+|. .++||++|.|++|.++..+..||+.|+++.........+ .....-...|.|||++.+ ..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 44589999995 599999999999999999999999999986554311111 111233667999999987 55
Q ss_pred CCceeeEecchHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHH
Q 043957 299 YGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSL 377 (584)
Q Consensus 299 ~~~~sDIwSLGvilyeLl-tG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~ 377 (584)
.+.++|+|||||++|.+. .|++.|...........-...... .....-.++|.+++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~-----------------------~~~~~s~~~p~el~ 242 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNA-----------------------GAFGYSNNLPSELR 242 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccc-----------------------ccccccccCcHHHH
Confidence 889999999999999999 677777665433322211111000 00011157899999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcCCCCCCCccCCCCCCcc
Q 043957 378 GLLSTLLALDPAYRGSAASALKNEFFFTSPLACDLSGLPVI 418 (584)
Q Consensus 378 dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~~~~~~~~~~ 418 (584)
+=|.++|..|+..||++.+++..|||.... ...+..+..+
T Consensus 243 ~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~-~~aLrfLD~l 282 (700)
T KOG2137|consen 243 ESLKKLLNGDSAVRPTLDLLLSIPFFSDPG-LKALRFLDDL 282 (700)
T ss_pred HHHHHHhcCCcccCcchhhhhcccccCCch-hhhhhhcccc
Confidence 999999999999999999999999997653 3334444433
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.1e-09 Score=103.33 Aligned_cols=130 Identities=19% Similarity=0.275 Sum_probs=90.9
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEeecCCC--Ch-----HHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 132 KVGQGTYSNVYKALDRDTGKIVALKKVKFDTS--EP-----HSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 132 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
.|++|+-+.+|.+.. -|..+++|.= ..+. .+ -......+|+.+|.++.--.|..-+=++.+... ..|+
T Consensus 3 ~i~~GAEa~i~~~~~--~g~~av~K~R-i~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~--~~I~ 77 (204)
T COG3642 3 LIKQGAEAIIYLTDF--LGLPAVVKER-IPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN--GLIV 77 (204)
T ss_pred hhhCCcceeEEeeec--cCcceEEEee-cCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CEEE
Confidence 478899999999844 3555666642 2211 11 123456789999998854333222213334333 4899
Q ss_pred EechhhHHHH-HhhCCCCCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccc
Q 043957 205 FEFMQTDLAR-IISNPEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 205 ~Ey~~g~L~~-~l~~~~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
|||++|.++. .+... .......|-.-+.-||..||+|+||.++||++..++ +.++||||+..
T Consensus 78 me~I~G~~lkd~l~~~--~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 78 MEYIEGELLKDALEEA--RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEeCChhHHHHHHhc--chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999997665 55433 456677888889999999999999999999997655 99999999975
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.1e-09 Score=102.49 Aligned_cols=123 Identities=24% Similarity=0.318 Sum_probs=77.2
Q ss_pred EEEEEEECCCCcEEEEEEeecCC--------------C----------ChHHHHHHHHHHHHHHhCCCC--Ceeeeecee
Q 043957 140 NVYKALDRDTGKIVALKKVKFDT--------------S----------EPHSVKFMAREIMILQKLDHP--NIVKLEGLA 193 (584)
Q Consensus 140 ~Vy~a~~~~~g~~vAiK~i~~~~--------------~----------~~~~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~ 193 (584)
.||.|... .|..+|||+.+... . .........+|.+.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 48999765 57899999885321 0 001124467899999999765 44555433
Q ss_pred eecCcceEEEEEechh--hHHHHHhhCC----CCCCcHHHHHHHHHHH-HHhCCceeccccccceeecCCCcEEEEEecc
Q 043957 194 TSRMQYSLYLVFEFMQ--TDLARIISNP----EGKLTEPQQLLSGLQH-CHDRGILHRDVKGSNLLIDKNGVLKIADFGL 266 (584)
Q Consensus 194 ~~~~~~~l~lV~Ey~~--g~L~~~l~~~----~~~l~~~~qIl~aL~y-LH~~~IvHrDLKp~NILl~~~g~vKL~DFGl 266 (584)
. .+ +|||||++ |..+..+... ........+++..+.. +|..||+|+||.+.|||++++ .+.|+|||.
T Consensus 79 -~--~~--~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 79 -N--RN--VIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp -E--TT--EEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred -e--CC--EEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2 22 89999999 6433333221 1222334577775555 579999999999999999877 899999998
Q ss_pred cccc
Q 043957 267 ANYF 270 (584)
Q Consensus 267 a~~~ 270 (584)
+...
T Consensus 153 av~~ 156 (188)
T PF01163_consen 153 AVDS 156 (188)
T ss_dssp EEET
T ss_pred ceec
Confidence 8754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=3e-09 Score=100.10 Aligned_cols=137 Identities=20% Similarity=0.260 Sum_probs=93.7
Q ss_pred EEeeecccCceEEEEEEECCCCcEEEEEEeecCC------CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 129 KIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT------SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 129 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~------~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
.+..|-+|+-+.|+++. ..|+.++||.=.... ...-......+|+++|.++.--.|.--.=++.+...+ .
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~--~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGG--Q 86 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCC--e
Confidence 45678899999999984 458888888531111 1122345677899999988533333222244443333 7
Q ss_pred EEEechhh--HHHHHhhC----CC---CCCcHHHHHHHHHHHHHhCCceeccccccceeecCCC---cEEEEEeccccc
Q 043957 203 LVFEFMQT--DLARIISN----PE---GKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG---VLKIADFGLANY 269 (584)
Q Consensus 203 lV~Ey~~g--~L~~~l~~----~~---~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g---~vKL~DFGla~~ 269 (584)
|+|||++| .+...+.. .. .....++.|-..|.-||.++|+|+||..+||+|..++ .+.|+|||++..
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99999998 55555432 11 1124456888999999999999999999999996654 468999999854
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.4e-09 Score=104.80 Aligned_cols=137 Identities=21% Similarity=0.276 Sum_probs=88.6
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCC--CeeeeeceeeecC-cceEEEEEec
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP--NIVKLEGLATSRM-QYSLYLVFEF 207 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~~~~~-~~~l~lV~Ey 207 (584)
+.|+.|.++.||++.... |..|++|+....... .....+.+|+.+++.+.+. ++.+++.+..... ....|+||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 568999999999997643 688999987543221 1345678899999999753 3455654443321 1245899999
Q ss_pred hhhH-HHHHhhCC----CCCCcHHHHHHHHHHHHHh--------------------------------------------
Q 043957 208 MQTD-LARIISNP----EGKLTEPQQLLSGLQHCHD-------------------------------------------- 238 (584)
Q Consensus 208 ~~g~-L~~~l~~~----~~~l~~~~qIl~aL~yLH~-------------------------------------------- 238 (584)
++|. +...+... ........+++.+|.+||+
T Consensus 82 i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 82 VDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred eCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9864 22221100 0001112344444444442
Q ss_pred ------------CCceeccccccceeecC--CCcEEEEEeccccc
Q 043957 239 ------------RGILHRDVKGSNLLIDK--NGVLKIADFGLANY 269 (584)
Q Consensus 239 ------------~~IvHrDLKp~NILl~~--~g~vKL~DFGla~~ 269 (584)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 34799999999999988 66789999998865
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.6e-08 Score=100.96 Aligned_cols=137 Identities=24% Similarity=0.285 Sum_probs=98.7
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC------------------C--hHHHHHHHHHHHHHHhCCCC--
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS------------------E--PHSVKFMAREIMILQKLDHP-- 184 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~------------------~--~~~~~~~~~Ei~iL~~L~Hp-- 184 (584)
+.+..+||-|--+.||.|.+. .|..+|||.-+.-.. + .-......+|.++|++|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 567788999999999999877 589999996542110 0 11234467899999999644
Q ss_pred CeeeeeceeeecCcceEEEEEechhhHHHHHhh-CCCCCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEE
Q 043957 185 NIVKLEGLATSRMQYSLYLVFEFMQTDLARIIS-NPEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIAD 263 (584)
Q Consensus 185 nIv~l~~~~~~~~~~~l~lV~Ey~~g~L~~~l~-~~~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~D 263 (584)
.|.+.+++- .-.+||||++|-.+..+. +....-.+...|+.-+..+-..||||+||.+-|||++++|.+.++|
T Consensus 172 ~VP~P~~~n------RHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vID 245 (304)
T COG0478 172 KVPKPIAWN------RHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVID 245 (304)
T ss_pred CCCCccccc------cceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEe
Confidence 566664432 238999999985443333 2222223344677777777799999999999999999999999999
Q ss_pred ecccccc
Q 043957 264 FGLANYF 270 (584)
Q Consensus 264 FGla~~~ 270 (584)
|--+...
T Consensus 246 wPQ~v~~ 252 (304)
T COG0478 246 WPQAVPI 252 (304)
T ss_pred CcccccC
Confidence 9877654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.4e-07 Score=99.18 Aligned_cols=225 Identities=19% Similarity=0.215 Sum_probs=152.7
Q ss_pred CCCCCCCceEEeeecc--c-CceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec
Q 043957 120 VPKSAESYDKIDKVGQ--G-TYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR 196 (584)
Q Consensus 120 ~~~~~~~Y~~~~~LG~--G-~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 196 (584)
.|..++.|.-+..+-- + .-.+.|+|....+|..|++|++........ .....-+++++++.|+|||++.+++...
T Consensus 268 ~p~lv~~~~~L~pl~~~~~~~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--nk~t~lve~wkkl~h~NvV~frevf~t~ 345 (655)
T KOG3741|consen 268 IPSLVESFVNLYPLELLNDLFSITTYKATSNVDGNAYVLKRLHGDRDQST--NKDTSLVEAWKKLCHTNVVPFREVFLTY 345 (655)
T ss_pred CCcchhhhhceeecccccccccceeEeeeeccCCceeeeeeeccccccCc--ccchHHHHHHHHhccCceeehhhhhhhh
Confidence 3445555554443322 2 345789999999999999999943221111 1122347789999999999999987632
Q ss_pred --CcceEEEEEechh--hHHHHHhhCCC-C-------------CCc------HHHHHHHHHHHHHhCCceecccccccee
Q 043957 197 --MQYSLYLVFEFMQ--TDLARIISNPE-G-------------KLT------EPQQLLSGLQHCHDRGILHRDVKGSNLL 252 (584)
Q Consensus 197 --~~~~l~lV~Ey~~--g~L~~~l~~~~-~-------------~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NIL 252 (584)
....+++|++|.+ ++|.+..-... . ... .+.||..||.++|+.|+..+-|.|.+||
T Consensus 346 tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIl 425 (655)
T KOG3741|consen 346 TFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKIL 425 (655)
T ss_pred ccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeE
Confidence 2347899999988 46776654211 1 111 1239999999999999999999999999
Q ss_pred ecCCCcEEEEEeccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCC-CCChHHH-
Q 043957 253 IDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMP-GRTEVEQ- 330 (584)
Q Consensus 253 l~~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~-~~~~~~~- 330 (584)
++.+..|+|...|+...+..+.. |-+.+. .+-|.=-||.+++.|.||..--. .......
T Consensus 426 v~G~~RIriS~C~i~Dvl~~d~~---------------~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~ 486 (655)
T KOG3741|consen 426 VTGKMRIRISGCGIMDVLQEDPT---------------EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSH 486 (655)
T ss_pred eeCcceEEEecccceeeecCCCC---------------cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHH
Confidence 99988999988887766654331 112221 34577789999999999953211 1111111
Q ss_pred HHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 331 LHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 331 ~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
+.. .-..++.++.++|.-+...++.. -+..++|.|
T Consensus 487 ~~~----------------------------------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 487 LTR----------------------------------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHH----------------------------------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 111 22456788889999999999887 788888876
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.7e-07 Score=94.07 Aligned_cols=127 Identities=16% Similarity=0.115 Sum_probs=80.9
Q ss_pred EEEEEECCCCcEEEEEEeecCCCCh---------HHHHHHHHHHHHHHhCCCCCe--eeeeceeeec---CcceEEEEEe
Q 043957 141 VYKALDRDTGKIVALKKVKFDTSEP---------HSVKFMAREIMILQKLDHPNI--VKLEGLATSR---MQYSLYLVFE 206 (584)
Q Consensus 141 Vy~a~~~~~g~~vAiK~i~~~~~~~---------~~~~~~~~Ei~iL~~L~HpnI--v~l~~~~~~~---~~~~l~lV~E 206 (584)
|+++. ..|+.|.||......... .....+.+|...+.+|..-+| ..++.+.+.. ....-+||||
T Consensus 38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 55553 357789999763221110 001136688888877743222 2223233221 1234689999
Q ss_pred chhh--HHHHHhhCCC-CC------CcHHHHHHHHHHHHHhCCceeccccccceeecC-------CCcEEEEEeccccc
Q 043957 207 FMQT--DLARIISNPE-GK------LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDK-------NGVLKIADFGLANY 269 (584)
Q Consensus 207 y~~g--~L~~~l~~~~-~~------l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~-------~g~vKL~DFGla~~ 269 (584)
++++ +|.+++.... .. .....+|+..+.-||..||+|+||++.||||+. +..+.|+||+.+..
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 9997 5666664211 11 123358899999999999999999999999975 46799999998853
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.7e-07 Score=91.97 Aligned_cols=101 Identities=25% Similarity=0.368 Sum_probs=71.9
Q ss_pred HHHHHHHHHHHhCCCCC--eeeeeceeeecC--cceEEEEEechhh--HHHHHhhC-----CCCCCcHHHHHHHHHHHHH
Q 043957 169 KFMAREIMILQKLDHPN--IVKLEGLATSRM--QYSLYLVFEFMQT--DLARIISN-----PEGKLTEPQQLLSGLQHCH 237 (584)
Q Consensus 169 ~~~~~Ei~iL~~L~Hpn--Iv~l~~~~~~~~--~~~l~lV~Ey~~g--~L~~~l~~-----~~~~l~~~~qIl~aL~yLH 237 (584)
....+|...+..|..-. +...+.+.+... ....+||+|++++ +|.+++.. .........+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 34667888777774222 223333333321 2346899999986 57777764 2223344568999999999
Q ss_pred hCCceeccccccceeecCCC---cEEEEEeccccc
Q 043957 238 DRGILHRDVKGSNLLIDKNG---VLKIADFGLANY 269 (584)
Q Consensus 238 ~~~IvHrDLKp~NILl~~~g---~vKL~DFGla~~ 269 (584)
.+||+|+||++.||||+.++ .+.|+||+.+..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999998887 899999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=8e-07 Score=93.07 Aligned_cols=246 Identities=15% Similarity=0.109 Sum_probs=142.6
Q ss_pred EeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeece----eee-cCcceEEE
Q 043957 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGL----ATS-RMQYSLYL 203 (584)
Q Consensus 130 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~----~~~-~~~~~l~l 203 (584)
...||+|+-+-+|-.-.- +. .+.|++...... .... -+..|... .||-+-.=+.| ... .....+-+
T Consensus 16 gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa--~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPA--AQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CccccCCccceeeecchh--hc-hhheeecCCCch--HHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 456999999999966222 22 345766533221 1111 22334333 56643321111 111 12223678
Q ss_pred EEechhhH--HHHHhhC-----------CCCCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccccc
Q 043957 204 VFEFMQTD--LARIISN-----------PEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 204 V~Ey~~g~--L~~~l~~-----------~~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~ 270 (584)
+|..+.|- ...++.- +...+...+.|+.+.+.||+.|.+-+|+.++|||+.+++.|.|+|-..-...
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec
Confidence 88888752 2222211 1111233458999999999999999999999999999999999985443322
Q ss_pred CCCCCCCCccccccccccChhhhhCC----CCCCceeeEecchHHHHHHHhC-CCCCCCCCh----HHHHH-HHHHhcCC
Q 043957 271 SPNKKRPLTSRVVTLWYRAPELLLGA----TDYGVGIDLWSAGCLLAEMFLG-RPIMPGRTE----VEQLH-RIFKLCGS 340 (584)
Q Consensus 271 ~~~~~~~~~~~~gt~~Y~APEvl~~~----~~~~~~sDIwSLGvilyeLltG-~~pF~~~~~----~~~~~-~i~~~~~~ 340 (584)
.......+.+|.+.|.+||.-.-. -.-+...|.|.|||++|+||.| +.||.+-.. ...++ .|......
T Consensus 168 --~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 168 --ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred --cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 223345677899999999975311 1246678999999999999987 899976321 00011 11111100
Q ss_pred CChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccC--CCCCCCHHH
Q 043957 341 PSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALD--PAYRGSAAS 396 (584)
Q Consensus 341 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~D--P~kRpTa~e 396 (584)
-. .. ..+....+...-.+.-+++++..|..+|+..- +.-|||++-
T Consensus 246 ya----------~~-~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 246 YA----------SD-QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred ec----------hh-ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 00 00 01111111222234556888889999998743 678999853
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.6e-06 Score=83.11 Aligned_cols=134 Identities=14% Similarity=0.170 Sum_probs=92.6
Q ss_pred cccCceEEEEEEECCCCcEEEEEEeecC---C-CChHHHHHHHHHHHHHHhCCCCC--eeeee--ceeeecCcceEEEEE
Q 043957 134 GQGTYSNVYKALDRDTGKIVALKKVKFD---T-SEPHSVKFMAREIMILQKLDHPN--IVKLE--GLATSRMQYSLYLVF 205 (584)
Q Consensus 134 G~G~fg~Vy~a~~~~~g~~vAiK~i~~~---~-~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~--~~~~~~~~~~l~lV~ 205 (584)
|+|+-+.|+.... .|..+-+|.-... . .-+.....+.+|+..|++|..-+ +.++. +.-.....+..+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5688889998743 3456888876311 1 11334567889999999885322 33333 111223345679999
Q ss_pred echh--hHHHHHhhCCCC-C------CcHHHHHHHHHHHHHhCCceeccccccceeecCCCc--EEEEEeccccc
Q 043957 206 EFMQ--TDLARIISNPEG-K------LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGV--LKIADFGLANY 269 (584)
Q Consensus 206 Ey~~--g~L~~~l~~~~~-~------l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~--vKL~DFGla~~ 269 (584)
|-+. .+|...+..... . ..+..+|+.+|.-||..|+.|+|+-+.|||++.++. |+++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9988 478777654221 1 234458999999999999999999999999987777 99999987653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.39 E-value=3e-06 Score=83.09 Aligned_cols=140 Identities=19% Similarity=0.233 Sum_probs=87.6
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHH-H------HHHHHHHHHHHhCC---CCCeeeeecee
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHS-V------KFMAREIMILQKLD---HPNIVKLEGLA 193 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~-~------~~~~~Ei~iL~~L~---HpnIv~l~~~~ 193 (584)
...|.+.+.+-......|.+. .-.|..+++|..+......+. . ....+++..+.++. .-.+..++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 346889999988888877776 345788999987643322111 1 11234444444442 22333322222
Q ss_pred eec---CcceEEEEEechhhH-HHHHhhCCCCCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccc
Q 043957 194 TSR---MQYSLYLVFEFMQTD-LARIISNPEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 194 ~~~---~~~~l~lV~Ey~~g~-L~~~l~~~~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
.-. .....+|||||++|- |.+...-. -.....|..++.-||+.|++|+|..|.|+++++++ ++++||+..+.
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~i~---e~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIEDID---EDLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchhcC---HHHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECccccc
Confidence 211 122457899999983 33322100 01235788999999999999999999999998654 99999986653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=8.6e-08 Score=104.70 Aligned_cols=240 Identities=19% Similarity=0.137 Sum_probs=155.6
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCC-eeeeeceeeecCcceEEEEE
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPN-IVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~~~l~lV~ 205 (584)
|.....+++|+++.+++.+...+...+ .+.+... ....-++++|.+++||| .+.. +.....+...+++|
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~--~~d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRY--LEDYDGEDYLWIPM 313 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccc--cccCCcccccchhh
Confidence 455667899999999999776655444 6666432 23445789999999999 4433 33334455789999
Q ss_pred echhhH--HHHHhhCCCCCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 206 EFMQTD--LARIISNPEGKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 206 Ey~~g~--L~~~l~~~~~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
+++.+. ........+..+ ...+.-+++|++||+.-=+|+| |||..+ +..++.||+....+.... .
T Consensus 314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~ 386 (829)
T KOG0576|consen 314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--K 386 (829)
T ss_pred hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc--c
Confidence 999854 211111111111 1122456789999988778999 887755 679999999988765432 2
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 357 (584)
..+..+++.++|||+... ..+....|.|++|+-..+|.-|-+|-... ......+ +..+ ..
T Consensus 387 ~~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~----g~~p-------------~s 446 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMI----GNGP-------------NS 446 (829)
T ss_pred cccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCCC--ccccCCC----CCCC-------------Cc
Confidence 356788999999999876 45889999999999877887777665431 0000000 0000 00
Q ss_pred CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q 043957 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPL 408 (584)
Q Consensus 358 p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~ 408 (584)
+.-... ..+... .-.++...||..-|..|++...++.|.+|..-|+
T Consensus 447 ~~L~~~---~aw~~~--~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 447 PMLTDK---SAWSPV--FHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred cccchh---hhcCcc--cccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 000000 011100 0115788999999999999999999999976543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.5e-06 Score=95.89 Aligned_cols=140 Identities=21% Similarity=0.333 Sum_probs=86.0
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCCCh----------------------------HHH----H------HHH
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP----------------------------HSV----K------FMA 172 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~----------------------------~~~----~------~~~ 172 (584)
+.|+.++-|.||+|+.+. |+.||||+.+...... ..+ + .+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 568999999999998775 9999999986431100 001 1 134
Q ss_pred HHHHHHHhC-----CCCCeeeeeceeeecCcceEEEEEechhhH-HHHH--hhCCCCCCcHH-HHHH-HHHHHHHhCCce
Q 043957 173 REIMILQKL-----DHPNIVKLEGLATSRMQYSLYLVFEFMQTD-LARI--ISNPEGKLTEP-QQLL-SGLQHCHDRGIL 242 (584)
Q Consensus 173 ~Ei~iL~~L-----~HpnIv~l~~~~~~~~~~~l~lV~Ey~~g~-L~~~--l~~~~~~l~~~-~qIl-~aL~yLH~~~Iv 242 (584)
+|...+.++ +.++| .+=.+|++-.. .-.|+|||++|- +.+. +.......... ..++ .-+..+-..|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~-~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYTT-RRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-EeceeehhccC-CcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhcCcc
Confidence 455555554 23333 22223332111 238999999983 3332 22211111121 2222 224444568999
Q ss_pred eccccccceeecCCCcEEEEEeccccccCCC
Q 043957 243 HRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 243 HrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
|.|..|.||+++.+|.+.+.|||+...+.+.
T Consensus 288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 288 HADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 9999999999999999999999999877543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.30 E-value=6.7e-06 Score=81.59 Aligned_cols=135 Identities=22% Similarity=0.267 Sum_probs=87.9
Q ss_pred EEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHH----------------------HHHHHHHHHHHHhCC--CC
Q 043957 129 KIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHS----------------------VKFMAREIMILQKLD--HP 184 (584)
Q Consensus 129 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~----------------------~~~~~~Ei~iL~~L~--Hp 184 (584)
+...|..|--+.||+|.. ..+..||+|+++.....-.. ..-..+|+.-|.++. +=
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 344688888899999964 45889999998643211111 112346777787774 33
Q ss_pred CeeeeeceeeecCcceEEEEEechhhHH--HHHhhCCCCCC----cHHHHHHHHHHHHHh-CCceeccccccceeecCCC
Q 043957 185 NIVKLEGLATSRMQYSLYLVFEFMQTDL--ARIISNPEGKL----TEPQQLLSGLQHCHD-RGILHRDVKGSNLLIDKNG 257 (584)
Q Consensus 185 nIv~l~~~~~~~~~~~l~lV~Ey~~g~L--~~~l~~~~~~l----~~~~qIl~aL~yLH~-~~IvHrDLKp~NILl~~~g 257 (584)
.+.+-+.+.. -.|||||+.... .-.+.+..... ....+++..+.-|-. .++||+||..-|||+. ++
T Consensus 131 rvP~Pi~~~~------nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 131 RVPEPIAFRN------NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG 203 (268)
T ss_pred CCCCceeecC------CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC
Confidence 3334433221 289999998531 11122111111 113477888877776 8999999999999998 88
Q ss_pred cEEEEEeccccccC
Q 043957 258 VLKIADFGLANYFS 271 (584)
Q Consensus 258 ~vKL~DFGla~~~~ 271 (584)
.+.|+|||-|....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 99999999887654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.11 E-value=9.8e-06 Score=80.68 Aligned_cols=128 Identities=20% Similarity=0.208 Sum_probs=76.8
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCe--eeeeceeeecCcceEEEEEech
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI--VKLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI--v~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
..||.|..+.||+. .|..+++|...... ....+.+|.++++.+..-.+ .+.+++... ....++|||++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeeeeec
Confidence 45899999999984 25567888875322 23446789999988853333 344444433 33367899999
Q ss_pred hhH--HHHHh---------------------hC---CCCCCcHHH---------------HHHHH-HHHHHh----CCce
Q 043957 209 QTD--LARII---------------------SN---PEGKLTEPQ---------------QLLSG-LQHCHD----RGIL 242 (584)
Q Consensus 209 ~g~--L~~~l---------------------~~---~~~~l~~~~---------------qIl~a-L~yLH~----~~Iv 242 (584)
+|. +...+ +. ....+.... .+... ..+|.. ..++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 873 11111 11 000000000 11111 222221 2478
Q ss_pred eccccccceeecCCCcEEEEEeccccc
Q 043957 243 HRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 243 HrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
|+|+.|.||++++++ +.|+||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.1e-05 Score=79.15 Aligned_cols=134 Identities=23% Similarity=0.371 Sum_probs=77.3
Q ss_pred EeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCC--Ceeeeeceeeec-CcceEEEEEe
Q 043957 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP--NIVKLEGLATSR-MQYSLYLVFE 206 (584)
Q Consensus 130 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~~~~-~~~~l~lV~E 206 (584)
++.|+.|..+.||++.... ..+++|..... .....+.+|+.+++.|... .+.+++.+.... .....+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 5679999999999997664 48999987422 3456778899999888533 244555433222 2334799999
Q ss_pred chhhH-HHH----------------H---hhCC--C-CCCcH-H--------------------------HHHHH-HHHH
Q 043957 207 FMQTD-LAR----------------I---ISNP--E-GKLTE-P--------------------------QQLLS-GLQH 235 (584)
Q Consensus 207 y~~g~-L~~----------------~---l~~~--~-~~l~~-~--------------------------~qIl~-aL~y 235 (584)
++.|. +.. . +... . ..... . ..+.. .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 98752 111 0 0000 0 00000 0 01122 3333
Q ss_pred HHh-------CCceeccccccceeec-CCCcEEEEEeccccc
Q 043957 236 CHD-------RGILHRDVKGSNLLID-KNGVLKIADFGLANY 269 (584)
Q Consensus 236 LH~-------~~IvHrDLKp~NILl~-~~g~vKL~DFGla~~ 269 (584)
+++ ..++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 332 3599999999999999 566678999987653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.02 E-value=3.5e-05 Score=77.14 Aligned_cols=70 Identities=16% Similarity=0.113 Sum_probs=44.1
Q ss_pred ecccCc-eEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceEEEEEechhh
Q 043957 133 VGQGTY-SNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSLYLVFEFMQT 210 (584)
Q Consensus 133 LG~G~f-g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l~lV~Ey~~g 210 (584)
|-.|.. +.||++... +..++||+..... ...+.+|+.+++.+. +--+.+++++.... ..-++|||+++|
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i~G 76 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSAVPG 76 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEeeCC
Confidence 444555 789998542 4678888764221 234667999988884 43344565544432 345899999986
Q ss_pred H
Q 043957 211 D 211 (584)
Q Consensus 211 ~ 211 (584)
.
T Consensus 77 ~ 77 (244)
T cd05150 77 V 77 (244)
T ss_pred c
Confidence 3
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.00 E-value=2.5e-05 Score=86.24 Aligned_cols=140 Identities=17% Similarity=0.213 Sum_probs=82.8
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCCCh-----------------------------HHHHHH------HHHH
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP-----------------------------HSVKFM------AREI 175 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-----------------------------~~~~~~------~~Ei 175 (584)
+.||.-+.|.||+|+.+. |+.||||+-+...... +..+.+ .+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 579999999999998776 9999999875331111 001112 2233
Q ss_pred HHHH----hCCCCC---eeeeeceeeecCcceEEEEEechhh----HHHHHhhCCCC-CCcHHHHHHHHH-HHHHhCCce
Q 043957 176 MILQ----KLDHPN---IVKLEGLATSRMQYSLYLVFEFMQT----DLARIISNPEG-KLTEPQQLLSGL-QHCHDRGIL 242 (584)
Q Consensus 176 ~iL~----~L~Hpn---Iv~l~~~~~~~~~~~l~lV~Ey~~g----~L~~~l~~~~~-~l~~~~qIl~aL-~yLH~~~Iv 242 (584)
+-.. .+.|-+ =|.+-.+|++-.. .-.|+||||+| ++. .+....- ...+...+..+. .-|-..|++
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st-~RVLtME~~~G~~i~Dl~-~i~~~gi~~~~i~~~l~~~~~~qIf~~Gff 323 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLST-KRVLTMEYVDGIKINDLD-AIDKRGISPHDILNKLVEAYLEQIFKTGFF 323 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCc-ceEEEEEecCCccCCCHH-HHHHcCCCHHHHHHHHHHHHHHHHHhcCCc
Confidence 2222 233444 1112223333211 34899999997 343 3332211 122222333332 223367999
Q ss_pred eccccccceeecC----CCcEEEEEeccccccCCC
Q 043957 243 HRDVKGSNLLIDK----NGVLKIADFGLANYFSPN 273 (584)
Q Consensus 243 HrDLKp~NILl~~----~g~vKL~DFGla~~~~~~ 273 (584)
|+|=.|.|||+.. ++.+.|.|||+...+...
T Consensus 324 HaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 324 HADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred cCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 9999999999984 678999999999877543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.96 E-value=5.3e-05 Score=73.51 Aligned_cols=129 Identities=26% Similarity=0.316 Sum_probs=91.0
Q ss_pred CCceEEeeecccCc-eEEEEEEECCCCcEEEEEEeec---CC-------CCh---------HHHHHHHHHHHHHHhC---
Q 043957 125 ESYDKIDKVGQGTY-SNVYKALDRDTGKIVALKKVKF---DT-------SEP---------HSVKFMAREIMILQKL--- 181 (584)
Q Consensus 125 ~~Y~~~~~LG~G~f-g~Vy~a~~~~~g~~vAiK~i~~---~~-------~~~---------~~~~~~~~Ei~iL~~L--- 181 (584)
..++.++.||.|.- |.||++.. .|..||||+++. .. ... ....-|..|.+...+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 56899999999999 99999954 478999999421 10 000 1223467777776666
Q ss_pred CCCCe--eeeeceeeecC----------------cceEEEEEechhhHHHHHhhCCCCCCcHHHHHHHHHHHHHhCCcee
Q 043957 182 DHPNI--VKLEGLATSRM----------------QYSLYLVFEFMQTDLARIISNPEGKLTEPQQLLSGLQHCHDRGILH 243 (584)
Q Consensus 182 ~HpnI--v~l~~~~~~~~----------------~~~l~lV~Ey~~g~L~~~l~~~~~~l~~~~qIl~aL~yLH~~~IvH 243 (584)
.+.++ |+++||..-.. .....||.||+...- .....-..+|++-|..+|..||+-
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------~~~~~~~~~~~~dl~~~~k~gI~~ 187 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------PLQIRDIPQMLRDLKILHKLGIVP 187 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------ccchhHHHHHHHHHHHHHHCCeee
Confidence 45666 89998874321 012357888776432 123334568999999999999999
Q ss_pred ccccccceeecCCCcEEEEEeccc
Q 043957 244 RDVKGSNLLIDKNGVLKIADFGLA 267 (584)
Q Consensus 244 rDLKp~NILl~~~g~vKL~DFGla 267 (584)
+|+++.|.. .=||+|||.+
T Consensus 188 ~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 188 RDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ccCcccccc-----CCEEEecccC
Confidence 999999985 3489999965
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.78 E-value=9.2e-05 Score=69.94 Aligned_cols=128 Identities=20% Similarity=0.229 Sum_probs=86.9
Q ss_pred eEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeee-eeceeeecCcceEEEEEe
Q 043957 128 DKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVK-LEGLATSRMQYSLYLVFE 206 (584)
Q Consensus 128 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~-l~~~~~~~~~~~l~lV~E 206 (584)
.+.+.|++|.+|.||++... |..+|+|+-+.+. ....+..|+++|..+.-.++-+ +|. .+. .++.||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~--yg~----~~i~me 92 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYF--YGE----DFIRME 92 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEE--ech----hhhhhh
Confidence 45677999999999999654 6789999865332 3456888999999997655543 432 221 256799
Q ss_pred chhh-HHHHHhhCCCCCCcHHHHHHHHHHHHHhCCceecccc-ccceeecCCCcEEEEEeccccc
Q 043957 207 FMQT-DLARIISNPEGKLTEPQQLLSGLQHCHDRGILHRDVK-GSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 207 y~~g-~L~~~l~~~~~~l~~~~qIl~aL~yLH~~~IvHrDLK-p~NILl~~~g~vKL~DFGla~~ 269 (584)
|+.| .|....... .-.....++.+---|-..||-|..|. |..++|..++.+.|+||..|+.
T Consensus 93 ~i~G~~L~~~~~~~--~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 93 YIDGRPLGKLEIGG--DRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhcCcchhhhhhcc--cHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 9998 455443311 11112244555445667899999985 5666666666999999999874
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.77 E-value=3.3e-06 Score=99.82 Aligned_cols=254 Identities=11% Similarity=-0.055 Sum_probs=157.7
Q ss_pred CCCCCCCceEEeeecccCceEEEEEEECCCCc-EEEEEEe---ecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeee
Q 043957 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDTGK-IVALKKV---KFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATS 195 (584)
Q Consensus 120 ~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~-~vAiK~i---~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 195 (584)
++...+.|++.--|+.+.++. +....... -+.+|+. ......+...+.+..|..-++...|++++..+.-...
T Consensus 1224 M~s~~e~~EV~l~i~~~~~~R---~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~p 1300 (2724)
T KOG1826|consen 1224 MFSAMEHSEVNLGISNHFHFR---NKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPP 1300 (2724)
T ss_pred HHHHhhhhheeeecccceeec---cchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCC
Confidence 345566777776666655543 32221111 1233333 3333444445556667777788899999887665555
Q ss_pred cCcceEEEEEechh-hHHHHHhhCCCCCCcHH--------HHH-HHHHHHHHhC-----CceeccccccceeecCCCcEE
Q 043957 196 RMQYSLYLVFEFMQ-TDLARIISNPEGKLTEP--------QQL-LSGLQHCHDR-----GILHRDVKGSNLLIDKNGVLK 260 (584)
Q Consensus 196 ~~~~~l~lV~Ey~~-g~L~~~l~~~~~~l~~~--------~qI-l~aL~yLH~~-----~IvHrDLKp~NILl~~~g~vK 260 (584)
......|.+++||. |.+..++...-...... .++ +.+..-+|.. -.+|++||+-|.+|..+..+|
T Consensus 1301 s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~ 1380 (2724)
T KOG1826|consen 1301 SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVK 1380 (2724)
T ss_pred CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccc
Confidence 55556799999998 56777776432222111 133 5555566643 278999999999999999999
Q ss_pred EEEeccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 043957 261 IADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGS 340 (584)
Q Consensus 261 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~ 340 (584)
++++|+.+... .........++++.|++|++... -.++.++|+|..|+.+|++..|.++|-. .+..+++....
T Consensus 1381 ~gk~gLdKIkn-p~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~rs~~n~~fi~-----flq~~Lkgiid 1453 (2724)
T KOG1826|consen 1381 LGKGGLDKIKN-PVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLRSDGNAYFIF-----FLQPALKGIID 1453 (2724)
T ss_pred ccccccccccC-chHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHHhcccHHHHH-----HHHHHHcCccc
Confidence 99999998433 23333456678999999998765 4578889999999999999999877722 12222211100
Q ss_pred CChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCC
Q 043957 341 PSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404 (584)
Q Consensus 341 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~ 404 (584)
- ...+ +...-.|.++-.....+|-+.-..||.-...+.-+.|.
T Consensus 1454 n----------~tf~-----------sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1454 N----------HTFF-----------SIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred c----------cccc-----------cccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 0 0000 00011233444455556666667888888888877764
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.73 E-value=2.4e-05 Score=80.18 Aligned_cols=139 Identities=19% Similarity=0.226 Sum_probs=95.6
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC----------------hH----HHHHHHHHHHHHHhCC-CC
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE----------------PH----SVKFMAREIMILQKLD-HP 184 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~----------------~~----~~~~~~~Ei~iL~~L~-Hp 184 (584)
-|.+...||-|.-+.||.+-+. .|.+.++|.-+.-... .. ..-...+|...|..|. |.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 3778899999999999999766 4888999864321100 00 1123457888888884 43
Q ss_pred Cee-eeeceeeecCcceEEEEEechhhHHHHHhhCCCCCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEE
Q 043957 185 NIV-KLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIAD 263 (584)
Q Consensus 185 nIv-~l~~~~~~~~~~~l~lV~Ey~~g~L~~~l~~~~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~D 263 (584)
.=| +.+++. .-++|||++.|--+..+..-...-+....++.-+.-|-.+|+||+|..--||+|++++.++++|
T Consensus 172 fpVPkpiD~~------RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vID 245 (465)
T KOG2268|consen 172 FPVPKPIDHN------RHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVID 245 (465)
T ss_pred CCCCCccccc------ceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEee
Confidence 323 333322 2489999999754433332223334445666777888899999999999999999999999999
Q ss_pred eccccccC
Q 043957 264 FGLANYFS 271 (584)
Q Consensus 264 FGla~~~~ 271 (584)
|--+...+
T Consensus 246 FPQmvS~s 253 (465)
T KOG2268|consen 246 FPQMVSTS 253 (465)
T ss_pred chHhhccC
Confidence 98765443
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00052 Score=73.79 Aligned_cols=77 Identities=19% Similarity=0.195 Sum_probs=51.5
Q ss_pred EeeecccCceEEEEEEECCCCcEEEEEEeecCCC---C--hHHHHHHHHHHHHHHhCC---CCCeeeeeceeeecCcceE
Q 043957 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS---E--PHSVKFMAREIMILQKLD---HPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 130 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~---~--~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~~~l 201 (584)
.+.||.|.+..||++.+...++.|+||.-..... . +-..+....|.+.|+.+. -.++.+++.+ +.. ..
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~--~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEE--LA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCC--CC
Confidence 4679999999999998865446899998532111 1 123456677888888873 3456667544 322 24
Q ss_pred EEEEechhh
Q 043957 202 YLVFEFMQT 210 (584)
Q Consensus 202 ~lV~Ey~~g 210 (584)
++||||+++
T Consensus 107 ~lVME~L~~ 115 (401)
T PRK09550 107 VTVMEDLSD 115 (401)
T ss_pred EEEEecCCC
Confidence 899999863
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00045 Score=67.30 Aligned_cols=128 Identities=20% Similarity=0.279 Sum_probs=86.1
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCC--------------CChHHHHHHHHHHHHHHhCC------CCCeeeee
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDT--------------SEPHSVKFMAREIMILQKLD------HPNIVKLE 190 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~--------------~~~~~~~~~~~Ei~iL~~L~------HpnIv~l~ 190 (584)
..||+|+.=.||.- . .....+||++.... ......++..+|+.-...+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 35899999999953 4 34557889886554 11122455667777666665 88899999
Q ss_pred ceeeecCcceEEEEEechh---h----HHHHHhhCCCCCCcHHHHHHHHHHHHHhCCceeccccccceeecCC--C--cE
Q 043957 191 GLATSRMQYSLYLVFEFMQ---T----DLARIISNPEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKN--G--VL 259 (584)
Q Consensus 191 ~~~~~~~~~~l~lV~Ey~~---g----~L~~~l~~~~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~--g--~v 259 (584)
|+..... .+-+|+|.+. | +|.+++............+-.-..||-+++|+.+||+|.||++... + .+
T Consensus 84 G~veT~~--G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~l 161 (199)
T PF10707_consen 84 GFVETNL--GLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRL 161 (199)
T ss_pred EEEecCC--ceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEE
Confidence 9887744 4688888874 2 5667765332222122234444578889999999999999999432 2 57
Q ss_pred EEEE
Q 043957 260 KIAD 263 (584)
Q Consensus 260 KL~D 263 (584)
.|+|
T Consensus 162 vlID 165 (199)
T PF10707_consen 162 VLID 165 (199)
T ss_pred EEEe
Confidence 7887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00013 Score=72.71 Aligned_cols=30 Identities=27% Similarity=0.434 Sum_probs=25.8
Q ss_pred CceeccccccceeecCCCcEEEEEeccccc
Q 043957 240 GILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 240 ~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
.++|+|+.+.|||++.++..-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 489999999999998766667999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.0002 Score=84.56 Aligned_cols=82 Identities=21% Similarity=0.312 Sum_probs=54.6
Q ss_pred EEeeecccCceEEEEEEECCCC--cEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCe--eeeeceeeecC-cceEE
Q 043957 129 KIDKVGQGTYSNVYKALDRDTG--KIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNI--VKLEGLATSRM-QYSLY 202 (584)
Q Consensus 129 ~~~~LG~G~fg~Vy~a~~~~~g--~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnI--v~l~~~~~~~~-~~~l~ 202 (584)
.++.|+.|.+..+|+......+ ..+++|+....... .....+.+|+.+|+.|. |.+| .+++.++.+.. ....|
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 4677899999999998665432 46788875332211 12346789999999995 6665 56665554421 12468
Q ss_pred EEEechhhH
Q 043957 203 LVFEFMQTD 211 (584)
Q Consensus 203 lV~Ey~~g~ 211 (584)
+||||++|.
T Consensus 121 lVME~v~G~ 129 (822)
T PLN02876 121 YIMEYLEGR 129 (822)
T ss_pred EEEEecCCc
Confidence 999998864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.61 E-value=7.9e-05 Score=87.00 Aligned_cols=198 Identities=24% Similarity=0.249 Sum_probs=125.3
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeceeeecCcce--EEEEEechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHh
Q 043957 168 VKFMAREIMILQKLDHPNIVKLEGLATSRMQYS--LYLVFEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHD 238 (584)
Q Consensus 168 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~--l~lV~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~ 238 (584)
......|+..+..+.|+|++.++.|-..+.... +.+..++|.. ++...+..- .... +..+++.||.|+|+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHHH
Confidence 344556778888889999999976654432211 2233345553 333333321 1111 22488999999999
Q ss_pred CCceecccccc---ceeecCCCcEEEE--EeccccccCCCCCCCCccccccccccChhhhhCCCCCCc--eeeEecchHH
Q 043957 239 RGILHRDVKGS---NLLIDKNGVLKIA--DFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGV--GIDLWSAGCL 311 (584)
Q Consensus 239 ~~IvHrDLKp~---NILl~~~g~vKL~--DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~--~sDIwSLGvi 311 (584)
....|.-|... +..++.++.+.+. ||+.+..+..... .........|.++|.... ..+.. ..|+|++|..
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCcccccccccccc-ccchhhhhhHHHHHHHH
Confidence 97666666555 4445666777777 9998877654333 233344667888887754 22333 3699999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccC-CcHhHHHHHHHhcccCCCC
Q 043957 312 LAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSE-FPESSLGLLSTLLALDPAY 390 (584)
Q Consensus 312 lyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~-~s~~~~dLI~~~L~~DP~k 390 (584)
+..+..|..+-.... .... .+.. ......+++.+|+.-|+++
T Consensus 382 ~~~~~~~~~i~~~~~---~~~~----------------------------------~l~~~~~~~~~d~~~~~~~~~~~~ 424 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSA---VPVS----------------------------------LLDVLSTSELLDALPKCLDEDSEE 424 (1351)
T ss_pred HhhhhhcCccccccc---chhh----------------------------------hhccccchhhhhhhhhhcchhhhh
Confidence 999988864321100 0000 0011 1125678999999999999
Q ss_pred CCCHHHHhcCcCCCCC
Q 043957 391 RGSAASALKNEFFFTS 406 (584)
Q Consensus 391 RpTa~e~L~Hp~f~~~ 406 (584)
|+++.++|.|+|....
T Consensus 425 Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 425 RLSALELLTHPFLRFP 440 (1351)
T ss_pred ccchhhhhhchhcccc
Confidence 9999999999998643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00023 Score=71.89 Aligned_cols=126 Identities=20% Similarity=0.254 Sum_probs=71.4
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCee-eeeceeeecCcceEEEEEechhhH
Q 043957 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIV-KLEGLATSRMQYSLYLVFEFMQTD 211 (584)
Q Consensus 133 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv-~l~~~~~~~~~~~l~lV~Ey~~g~ 211 (584)
+..|-.+.+|++. .++..+++|........- .. ...+|..+++.+..-.++ +++. .+. . ++||||++|.
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~-~~-~r~~E~~~l~~l~~~g~~P~~i~--~~~-~---~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL-GV-DRQREYQILQALSALGLAPKPIL--VNE-H---WLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccc-cC-cHHHHHHHHHHHHhcCCCCceEE--EeC-C---EEEEEeccCc
Confidence 5567888999885 456788888754221111 01 246788899888643332 2322 221 1 7899999863
Q ss_pred HHH---------------H---hhCC---CCCCcHHH----------------HHHHHHHHHHh--------CCceeccc
Q 043957 212 LAR---------------I---ISNP---EGKLTEPQ----------------QLLSGLQHCHD--------RGILHRDV 246 (584)
Q Consensus 212 L~~---------------~---l~~~---~~~l~~~~----------------qIl~aL~yLH~--------~~IvHrDL 246 (584)
... . ++.. ...+.... .+...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 211 1 1110 00111110 11111222211 14899999
Q ss_pred cccceeecCCCcEEEEEeccccc
Q 043957 247 KGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 247 Kp~NILl~~~g~vKL~DFGla~~ 269 (584)
.|.|||+++++ +.|+||..|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00038 Score=69.13 Aligned_cols=72 Identities=19% Similarity=0.259 Sum_probs=44.6
Q ss_pred EeeecccCceEEEEEEECC-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCe-eeeeceeeecCcceEEEEEec
Q 043957 130 IDKVGQGTYSNVYKALDRD-TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI-VKLEGLATSRMQYSLYLVFEF 207 (584)
Q Consensus 130 ~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~~l~lV~Ey 207 (584)
++.|..|-...||++.... .+..|++|+...... ..-...+|+.+++.+....+ .+++. ... . .+||||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~--~~~-~---~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYA--TFQ-N---GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEE--EeC-C---cEEEEe
Confidence 4567888889999986443 356888997643211 11223478889988854333 34432 221 2 479999
Q ss_pred hhh
Q 043957 208 MQT 210 (584)
Q Consensus 208 ~~g 210 (584)
++|
T Consensus 74 i~G 76 (235)
T cd05157 74 IPG 76 (235)
T ss_pred eCC
Confidence 875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00029 Score=72.57 Aligned_cols=133 Identities=17% Similarity=0.164 Sum_probs=79.0
Q ss_pred EeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCC--eeeeecee----eecCcceEEE
Q 043957 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPN--IVKLEGLA----TSRMQYSLYL 203 (584)
Q Consensus 130 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~~----~~~~~~~l~l 203 (584)
++.|..|....+|++.. .+..+++|+... . ....+..|+.++..|.+-. +.+++... ........++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~ 91 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK--V---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA 91 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC--C---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence 56688888889999853 344688998753 1 2345667888888884322 34443211 0111234689
Q ss_pred EEechhhHHH------------H---Hhh----CCC------CCCcHH----------------HHHHHHHHHHHh----
Q 043957 204 VFEFMQTDLA------------R---IIS----NPE------GKLTEP----------------QQLLSGLQHCHD---- 238 (584)
Q Consensus 204 V~Ey~~g~L~------------~---~l~----~~~------~~l~~~----------------~qIl~aL~yLH~---- 238 (584)
||+|++|... + .++ ... ....+. ..+..++.++..
T Consensus 92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~ 171 (296)
T cd05153 92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS 171 (296)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9999875211 0 011 000 000111 012334455443
Q ss_pred ---CCceeccccccceeecCCCcEEEEEeccccc
Q 043957 239 ---RGILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 239 ---~~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
.+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4699999999999999887789999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00019 Score=77.58 Aligned_cols=172 Identities=24% Similarity=0.348 Sum_probs=114.1
Q ss_pred HHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechhhHHHHHhhCCCCCCcHHHHHHHHHHHHHhCCceeccccccc
Q 043957 171 MAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQQLLSGLQHCHDRGILHRDVKGSN 250 (584)
Q Consensus 171 ~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~g~L~~~l~~~~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~N 250 (584)
+.--..+++.+.|+|...++++-.... ....+|||++..+|.+.+.... +.. .+++ .+++.|- |
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~~-~r~IVV~e~~~~Sled~~~~~~--l~~-~s~~-------~~~~~~~-----~ 92 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGKH-ERVIVVMEHYTMSLEDILKTGN--LKD-ESLL-------AHGVLHL-----N 92 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCcc-ceEEEEehhhccchHHHHHhcc--cch-hhhc-------cccccee-----h
Confidence 444578899999999999987655443 3489999999999988876433 211 1222 2222221 2
Q ss_pred eeecCCCcEEEEEeccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHH
Q 043957 251 LLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQ 330 (584)
Q Consensus 251 ILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~ 330 (584)
| ++++| -++.. | |- ...+++||||+|.|+.++..|...+......++
T Consensus 93 ~-------~~~td-~~~t~-----------------~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~ 139 (725)
T KOG1093|consen 93 I-------IYITD-HFLTK-----------------Y--PS------PIGPKSDVWSLGFIILELYLGISLEAELTESEY 139 (725)
T ss_pred h-------hhccc-ccccc-----------------C--CC------CCCcchhhhhHHHHHHHHHHhhHHHHHHHHHHH
Confidence 2 23333 00000 1 11 112499999999999999999999988888888
Q ss_pred HHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 331 LHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 331 ~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
+..+.+....+.....-.. .....-.++..+..++.+|+-..|..||...++++|+-|.+.
T Consensus 140 l~~i~k~~~~d~~~~~~a~---------------e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 140 LEILLKYYTDDQELLSTAM---------------EHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHhccCchhHHHHHH---------------HHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 8887776554443211110 001223557778899999999999999999999999988653
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0011 Score=68.65 Aligned_cols=30 Identities=30% Similarity=0.478 Sum_probs=26.6
Q ss_pred CceeccccccceeecCC----CcEEEEEeccccc
Q 043957 240 GILHRDVKGSNLLIDKN----GVLKIADFGLANY 269 (584)
Q Consensus 240 ~IvHrDLKp~NILl~~~----g~vKL~DFGla~~ 269 (584)
.++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 57999999999999875 8899999998854
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0028 Score=66.15 Aligned_cols=31 Identities=29% Similarity=0.500 Sum_probs=26.6
Q ss_pred CCceeccccccceeecCCCcEEEEEeccccc
Q 043957 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 239 ~~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
.+++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3799999999999998766568999998854
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.002 Score=66.97 Aligned_cols=137 Identities=18% Similarity=0.179 Sum_probs=78.5
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCC--eeeeecee----eecCcce
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPN--IVKLEGLA----TSRMQYS 200 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~~----~~~~~~~ 200 (584)
...++.|+.|....||++.. .+| .+++|+..... . ...+..|+.++..|.... +.+++... .......
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred ceeccccCCccccceEEEEe-CCC-cEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 33466788888889999853 334 68889875321 1 233456777777774222 33332211 1111234
Q ss_pred EEEEEechhhHH------------HH---HhhC------CC--C--CCc-H------------------HHHHHHHHHHH
Q 043957 201 LYLVFEFMQTDL------------AR---IISN------PE--G--KLT-E------------------PQQLLSGLQHC 236 (584)
Q Consensus 201 l~lV~Ey~~g~L------------~~---~l~~------~~--~--~l~-~------------------~~qIl~aL~yL 236 (584)
.++||+|++|.. .. .++. .. . ... + ...+...++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 689999987511 00 0110 00 0 000 0 00123345555
Q ss_pred Hh-------CCceeccccccceeecCCCcEEEEEeccccc
Q 043957 237 HD-------RGILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 237 H~-------~~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
.. .+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 42 5799999999999999888778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0018 Score=67.28 Aligned_cols=77 Identities=14% Similarity=0.191 Sum_probs=51.0
Q ss_pred eEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCC---CCeeeeeceeeec-CcceEEE
Q 043957 128 DKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH---PNIVKLEGLATSR-MQYSLYL 203 (584)
Q Consensus 128 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H---pnIv~l~~~~~~~-~~~~l~l 203 (584)
.-.+.||.|..+.||...... + .+++|..+ ... ....+..|...|+.|.- -.+.++++++.+. ....-+|
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~-~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ-G-NPMPLMAR-SFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred heeeecCCccceeEEEEEcCC-C-CEEEEEec-ccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 345679999999999985432 3 46777743 211 12467889999998852 3566676665442 1234699
Q ss_pred EEechhh
Q 043957 204 VFEFMQT 210 (584)
Q Consensus 204 V~Ey~~g 210 (584)
|||+++|
T Consensus 91 VmE~i~G 97 (297)
T PRK10593 91 LLERLRG 97 (297)
T ss_pred EEeccCC
Confidence 9999875
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0033 Score=66.48 Aligned_cols=74 Identities=18% Similarity=0.179 Sum_probs=46.8
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEeecC-----CCChHHHHHHHHHHHHHHhCC--CC-CeeeeeceeeecCcceEEE
Q 043957 132 KVGQGTYSNVYKALDRDTGKIVALKKVKFD-----TSEPHSVKFMAREIMILQKLD--HP-NIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 132 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~-----~~~~~~~~~~~~Ei~iL~~L~--Hp-nIv~l~~~~~~~~~~~l~l 203 (584)
.||.|....||++.+...++.|+||.-... ..-+-......-|...|+... .| .+.++|. .++.. ..+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~--~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEM--AVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Ecccc--cee
Confidence 489999999999987644468999976311 111223344556788887763 45 4555643 33222 379
Q ss_pred EEechh
Q 043957 204 VFEFMQ 209 (584)
Q Consensus 204 V~Ey~~ 209 (584)
|||+++
T Consensus 78 vMEdL~ 83 (370)
T TIGR01767 78 VMEDLS 83 (370)
T ss_pred hHhhCc
Confidence 999984
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.00073 Score=65.31 Aligned_cols=93 Identities=24% Similarity=0.249 Sum_probs=71.5
Q ss_pred HHHHHHHHhCCC-CCeeeeeceeeecCcceEEEEEechhh-HHH-------HHhh-CCCCCCcHHHHHHHHHHHHHh---
Q 043957 172 AREIMILQKLDH-PNIVKLEGLATSRMQYSLYLVFEFMQT-DLA-------RIIS-NPEGKLTEPQQLLSGLQHCHD--- 238 (584)
Q Consensus 172 ~~Ei~iL~~L~H-pnIv~l~~~~~~~~~~~l~lV~Ey~~g-~L~-------~~l~-~~~~~l~~~~qIl~aL~yLH~--- 238 (584)
..|.-+|+.+.+ +++.+++|.+-. ++|.||+.. .+. .... .+..+..++.+++..+.+|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC------EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 358888999975 699999998733 788999984 332 2221 223445566799999999987
Q ss_pred CCceeccccccceeecCCCcEEEEEecccccc
Q 043957 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 239 ~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~ 270 (584)
..+.-.|++++|+-|+++|.+|++|...+...
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 45889999999999999999999999987554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0057 Score=65.53 Aligned_cols=76 Identities=18% Similarity=0.185 Sum_probs=49.5
Q ss_pred EeeecccCceEEEEEEECCCCcEEEEEEeecCC----CChHHHHHHHHHHHHHHhCC--CC-CeeeeeceeeecCcceEE
Q 043957 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT----SEPHSVKFMAREIMILQKLD--HP-NIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 130 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~----~~~~~~~~~~~Ei~iL~~L~--Hp-nIv~l~~~~~~~~~~~l~ 202 (584)
++.||.|.-..||++.+...++.|+||.-.... .-+-..+...-|..+|+.+. .| ++.++| +.++.. ..
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy--~~D~e~--~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY--LFDSVM--NC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE--EECcHH--hh
Confidence 678999999999999875445679999763211 11223455666888888773 45 455564 333322 37
Q ss_pred EEEechh
Q 043957 203 LVFEFMQ 209 (584)
Q Consensus 203 lV~Ey~~ 209 (584)
+|||+++
T Consensus 110 ~vMEdL~ 116 (409)
T PRK12396 110 CVMEDLS 116 (409)
T ss_pred HHHHhCc
Confidence 8999874
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0057 Score=64.18 Aligned_cols=136 Identities=25% Similarity=0.325 Sum_probs=84.4
Q ss_pred eEEeeecccCceEEEEEEECCCCcEEEEEEeecCC--------------------C--Ch-HHHH-HHHHHHHHHHhCCC
Q 043957 128 DKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT--------------------S--EP-HSVK-FMAREIMILQKLDH 183 (584)
Q Consensus 128 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~--------------------~--~~-~~~~-~~~~Ei~iL~~L~H 183 (584)
.+-.+|..|--+.||.|... .|..+|||+++... . .+ ..++ ....|++-|.+|..
T Consensus 147 ~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 45567888999999999754 58889999885220 0 11 1111 23468888888865
Q ss_pred CCeeeeeceeeecCcceEEEEEechhhHH--HHHhhCCCCCCcHH----HHHHHHHHHH-HhCCceeccccccceeecCC
Q 043957 184 PNIVKLEGLATSRMQYSLYLVFEFMQTDL--ARIISNPEGKLTEP----QQLLSGLQHC-HDRGILHRDVKGSNLLIDKN 256 (584)
Q Consensus 184 pnIv~l~~~~~~~~~~~l~lV~Ey~~g~L--~~~l~~~~~~l~~~----~qIl~aL~yL-H~~~IvHrDLKp~NILl~~~ 256 (584)
..|.-..-+.. .. -.|||+|+..+- .-.+.+..-....+ .|++.-+.-| |.+++||.||.--|+|+ .+
T Consensus 226 aGIP~PePIlL-k~---hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hd 300 (520)
T KOG2270|consen 226 AGIPCPEPILL-KN---HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HD 300 (520)
T ss_pred cCCCCCCceee-ec---ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-EC
Confidence 54332211111 11 289999998432 12222211111122 3555555555 46799999999999999 56
Q ss_pred CcEEEEEeccccc
Q 043957 257 GVLKIADFGLANY 269 (584)
Q Consensus 257 g~vKL~DFGla~~ 269 (584)
|.+.|+|.+-+.-
T Consensus 301 G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 301 GKLYIIDVSQSVE 313 (520)
T ss_pred CEEEEEEcccccc
Confidence 7899999887754
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.012 Score=61.53 Aligned_cols=141 Identities=18% Similarity=0.222 Sum_probs=80.4
Q ss_pred eEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCC--CCeeeeeceeeecCcceEEEEE
Q 043957 128 DKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH--PNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 128 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~~~~~~~~~~~l~lV~ 205 (584)
.+++.+-.|..-.+|...+. ++.+++. ...............+|..+|+.+.- --+...++++....-...|.||
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 44555544444455655443 7788887 32112223345566788888888742 1122334444443323569999
Q ss_pred echhhH-------------------HHHHhh---C-C------CC--------CCc-HHH--------------HHHHHH
Q 043957 206 EFMQTD-------------------LARIIS---N-P------EG--------KLT-EPQ--------------QLLSGL 233 (584)
Q Consensus 206 Ey~~g~-------------------L~~~l~---~-~------~~--------~l~-~~~--------------qIl~aL 233 (584)
+|++|. +.+++. . . .+ .+. +.. .+..-.
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 999861 111111 0 0 00 000 000 223334
Q ss_pred HHHHhC--------CceeccccccceeecCCCcEEEEEeccccccC
Q 043957 234 QHCHDR--------GILHRDVKGSNLLIDKNGVLKIADFGLANYFS 271 (584)
Q Consensus 234 ~yLH~~--------~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~ 271 (584)
.+|+.+ .++|+|+.+.||+|+..+.+=|+||+++..-+
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 555543 48999999999999998889999999997644
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.017 Score=59.72 Aligned_cols=73 Identities=18% Similarity=0.239 Sum_probs=44.6
Q ss_pred eEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC---CCCeeeeeceeeecCcceEEEE
Q 043957 128 DKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD---HPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 128 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~~~l~lV 204 (584)
+-.+.|+.|....+|+.. .++..+.||+-. ......+..|..-|+.|. --.+.+++.+...... -|||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-----~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~--~fLl 90 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS-----ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD--AFLL 90 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE-----GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC--CEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecC-----hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC--ceEE
Confidence 456778999999999985 668889999865 122345777888888883 3345567666555433 3999
Q ss_pred Eechh
Q 043957 205 FEFMQ 209 (584)
Q Consensus 205 ~Ey~~ 209 (584)
|||++
T Consensus 91 le~l~ 95 (288)
T PF03881_consen 91 LEFLE 95 (288)
T ss_dssp EE---
T ss_pred EEeec
Confidence 99986
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.013 Score=63.12 Aligned_cols=76 Identities=14% Similarity=0.208 Sum_probs=48.7
Q ss_pred EEeeecccCceEEEEEEECCCCcEEEEEEeecCCC--C---hHHHHHHHHHHHHHHhCC---CCCeeeeeceeeecCcce
Q 043957 129 KIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS--E---PHSVKFMAREIMILQKLD---HPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 129 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~---~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~~~ 200 (584)
..+.||.|....||++.+. +..|+||.-..... . +........|+..|+.+. ..++.+++.++.+ .
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~-- 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--M-- 109 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--C--
Confidence 4677999999999999763 45689997642111 0 112344445677777664 2467777655543 2
Q ss_pred EEEEEechhh
Q 043957 201 LYLVFEFMQT 210 (584)
Q Consensus 201 l~lV~Ey~~g 210 (584)
.+++|||+++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 3789999965
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.014 Score=59.91 Aligned_cols=31 Identities=23% Similarity=0.342 Sum_probs=25.9
Q ss_pred CceeccccccceeecCCCc-EEEEEecccccc
Q 043957 240 GILHRDVKGSNLLIDKNGV-LKIADFGLANYF 270 (584)
Q Consensus 240 ~IvHrDLKp~NILl~~~g~-vKL~DFGla~~~ 270 (584)
.++|+|+.|.|||+++++. .-|+||+.+..-
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999987555 569999988653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.015 Score=61.72 Aligned_cols=30 Identities=33% Similarity=0.688 Sum_probs=26.4
Q ss_pred CceeccccccceeecC-CCcEEEEEeccccc
Q 043957 240 GILHRDVKGSNLLIDK-NGVLKIADFGLANY 269 (584)
Q Consensus 240 ~IvHrDLKp~NILl~~-~g~vKL~DFGla~~ 269 (584)
.++|+||++.|||+++ ++.+.|+||..|..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 5899999999999976 47899999998864
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.014 Score=60.38 Aligned_cols=30 Identities=27% Similarity=0.493 Sum_probs=26.0
Q ss_pred CCceeccccccceeecCCCcEEEEEeccccc
Q 043957 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 239 ~~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
.+++|+|+.+.|||++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47899999999999987 6789999997653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.031 Score=58.74 Aligned_cols=133 Identities=23% Similarity=0.346 Sum_probs=77.2
Q ss_pred EeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-C--CC---eeeeeceeeecCcc--eE
Q 043957 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-H--PN---IVKLEGLATSRMQY--SL 201 (584)
Q Consensus 130 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-H--pn---Iv~l~~~~~~~~~~--~l 201 (584)
...|.+ .-..||++.... |. +++|+.... . ...++..|+.+|+.|. + += |..+-|-....-.. ..
T Consensus 31 ~~~l~s-~eN~~f~~~~~~-g~-~iLki~~~~-~---~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~ 103 (331)
T COG2334 31 LRGLNS-EENSNFRVQTED-GR-YILKIYRPG-W---TRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRP 103 (331)
T ss_pred cccccc-ccCceEEEEecC-CC-eEEEEecCC-C---CHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCcee
Confidence 344555 567789886543 44 489988643 2 3355667888888883 2 21 22222211111122 56
Q ss_pred EEEEechhhHHHHH----------------hh----C-----CCC--CCcHH-------------------HHHHHHHHH
Q 043957 202 YLVFEFMQTDLARI----------------IS----N-----PEG--KLTEP-------------------QQLLSGLQH 235 (584)
Q Consensus 202 ~lV~Ey~~g~L~~~----------------l~----~-----~~~--~l~~~-------------------~qIl~aL~y 235 (584)
+-|++|++|..... +. . +.. ...|. .++...+..
T Consensus 104 a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~ 183 (331)
T COG2334 104 AALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDR 183 (331)
T ss_pred EEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHH
Confidence 78889988643321 00 0 000 11111 145555666
Q ss_pred HHhC--------C--ceeccccccceeecCCCc-EEEEEeccccc
Q 043957 236 CHDR--------G--ILHRDVKGSNLLIDKNGV-LKIADFGLANY 269 (584)
Q Consensus 236 LH~~--------~--IvHrDLKp~NILl~~~g~-vKL~DFGla~~ 269 (584)
+.+. + |||+|+.|.|||++.+.. +.++||+-|..
T Consensus 184 ~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 184 LLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred HHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 5542 3 999999999999998875 89999998753
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.041 Score=58.00 Aligned_cols=29 Identities=31% Similarity=0.645 Sum_probs=25.4
Q ss_pred ceeccccccceeecC-CCcEEEEEeccccc
Q 043957 241 ILHRDVKGSNLLIDK-NGVLKIADFGLANY 269 (584)
Q Consensus 241 IvHrDLKp~NILl~~-~g~vKL~DFGla~~ 269 (584)
++|.||.+.|||+++ ++.++|+||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 689999999999975 57899999998864
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.068 Score=55.60 Aligned_cols=30 Identities=20% Similarity=0.263 Sum_probs=28.0
Q ss_pred CceeccccccceeecCCCcEEEEEeccccc
Q 043957 240 GILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 240 ~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
+++|+|+.+.|||++.++.+.|+||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999999999999998875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.87 E-value=0.35 Score=58.63 Aligned_cols=31 Identities=29% Similarity=0.537 Sum_probs=26.4
Q ss_pred CCceeccccccceeecCCC--cEE-EEEeccccc
Q 043957 239 RGILHRDVKGSNLLIDKNG--VLK-IADFGLANY 269 (584)
Q Consensus 239 ~~IvHrDLKp~NILl~~~g--~vK-L~DFGla~~ 269 (584)
.++||.|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999998875 555 999998864
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=94.44 E-value=0.16 Score=52.25 Aligned_cols=29 Identities=34% Similarity=0.582 Sum_probs=24.6
Q ss_pred ceeccccccceeecCC--C---cEEEEEeccccc
Q 043957 241 ILHRDVKGSNLLIDKN--G---VLKIADFGLANY 269 (584)
Q Consensus 241 IvHrDLKp~NILl~~~--g---~vKL~DFGla~~ 269 (584)
++|+|++..|||+..+ | .++++||-+++.
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeeccccccC
Confidence 8999999999999654 3 599999998764
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.43 E-value=0.16 Score=54.69 Aligned_cols=29 Identities=24% Similarity=0.258 Sum_probs=24.0
Q ss_pred CceeccccccceeecCCCcEEEEEeccccc
Q 043957 240 GILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 240 ~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
..+|.||-+.|||+++ +.+.|+||-.|..
T Consensus 228 VfCHNDL~~gNIL~~~-~~l~lID~EYA~~ 256 (383)
T PTZ00384 228 LFCHNDLFFTNILDFN-QGIYFIDFDFAGF 256 (383)
T ss_pred eeeeccCCcccEEecC-CCEEEEEeccccC
Confidence 4689999999999755 4599999987753
|
|
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=94.42 E-value=0.088 Score=57.19 Aligned_cols=29 Identities=31% Similarity=0.487 Sum_probs=23.1
Q ss_pred ceeccccccceeecCCC-----cEEEEEeccccc
Q 043957 241 ILHRDVKGSNLLIDKNG-----VLKIADFGLANY 269 (584)
Q Consensus 241 IvHrDLKp~NILl~~~g-----~vKL~DFGla~~ 269 (584)
++|+||...|||++.++ ...|+||-.+..
T Consensus 270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~ 303 (414)
T PF07914_consen 270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHR 303 (414)
T ss_pred eecCCccHHheeeecCCchhHHHHHHHHHHHhhc
Confidence 78999999999998743 257888877654
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.89 E-value=0.38 Score=50.49 Aligned_cols=29 Identities=24% Similarity=0.188 Sum_probs=24.4
Q ss_pred CCceeccccccceeecCCCcEEEEEeccccc
Q 043957 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 239 ~~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
.++||+|+.+.|||++ + .+.|+||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 3689999999999995 4 578999998753
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.72 E-value=0.25 Score=48.77 Aligned_cols=100 Identities=19% Similarity=0.239 Sum_probs=64.8
Q ss_pred EEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEechhhHHHHHhhCCCCCCcHHHHH-H
Q 043957 152 IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQQL-L 230 (584)
Q Consensus 152 ~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~g~L~~~l~~~~~~l~~~~qI-l 230 (584)
...+|++..-... -....+..+..++.++. .|+++. -+ ..+.+-++.|+|..- ...+.-..-. +
T Consensus 87 ~L~lKKi~slp~~-~~~~~y~nky~v~Armh--GilrL~---ND-n~~~yGvIlE~Cy~~--------~i~~~N~i~agi 151 (308)
T PF07387_consen 87 PLFLKKIRSLPCC-INDALYFNKYRVFARMH--GILRLK---ND-NNYKYGVILERCYKI--------KINFSNFITAGI 151 (308)
T ss_pred hhhhhhccCCCcc-cchhhhhhhhhHHHHhh--heeEee---cC-CCceeEEEEeeccCc--------ccchhHHHHHhH
Confidence 4556666422221 12345678888888874 577774 22 455678999998531 0000001112 5
Q ss_pred HHHHHHHh--CCceeccccccceeecCCCcEEEEEecc
Q 043957 231 SGLQHCHD--RGILHRDVKGSNLLIDKNGVLKIADFGL 266 (584)
Q Consensus 231 ~aL~yLH~--~~IvHrDLKp~NILl~~~g~vKL~DFGl 266 (584)
.+|.-.|+ .+.+|+|-.|+||+-|..|.+||.|=+.
T Consensus 152 ~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 152 KDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 66777883 4799999999999999999999999764
|
The function of this family is unknown. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.71 E-value=0.32 Score=53.36 Aligned_cols=73 Identities=10% Similarity=0.130 Sum_probs=43.0
Q ss_pred EEeeecccCceEEEEEEECCC--------CcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCee-eeeceeeecCcc
Q 043957 129 KIDKVGQGTYSNVYKALDRDT--------GKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIV-KLEGLATSRMQY 199 (584)
Q Consensus 129 ~~~~LG~G~fg~Vy~a~~~~~--------g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv-~l~~~~~~~~~~ 199 (584)
-++.|..|-.-.+|++..... ++.|.+++...... ... .-..|..+++.+..-+|- ++++.+. .
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te--~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~---g- 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD--ELY-NPISEFEVYKTMSKYRIAPQLLNTFS---G- 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc--cee-CHHHHHHHHHHHHHCCCCCceEEEeC---C-
Confidence 667777788888999865421 46788888743221 111 234577777777543443 3433332 1
Q ss_pred eEEEEEechhh
Q 043957 200 SLYLVFEFMQT 210 (584)
Q Consensus 200 ~l~lV~Ey~~g 210 (584)
+.|.||++|
T Consensus 182 --g~I~efi~g 190 (442)
T PTZ00296 182 --GRIEEWLYG 190 (442)
T ss_pred --CEEEEeeCC
Confidence 567788764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.07 E-value=0.11 Score=54.85 Aligned_cols=72 Identities=28% Similarity=0.314 Sum_probs=46.4
Q ss_pred CcceEEEEEechhhHHHHHhh-CCCCCCcHHHHHHHHHHHHHh-CCceeccccccceeecCCCcEEEEEeccccc
Q 043957 197 MQYSLYLVFEFMQTDLARIIS-NPEGKLTEPQQLLSGLQHCHD-RGILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 197 ~~~~l~lV~Ey~~g~L~~~l~-~~~~~l~~~~qIl~aL~yLH~-~~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
+..+.|++|++-.+.+..+-. +....+..+.+.+..++-+.. -..-||||.-.||||+ +|+|-|+||-+++.
T Consensus 297 e~~y~yl~~kdhgt~is~ik~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 297 ETLYLYLHFKDHGTPISIIKADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEEEecCCceeeeeecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 344678899887665443211 111122223333333333332 3678999999999999 99999999999984
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 584 | ||||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-55 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-54 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-54 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-54 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-54 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-54 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-54 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-54 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-54 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-54 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-54 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-54 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-54 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-54 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-54 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-54 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-54 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-54 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-53 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-53 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-53 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-53 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-53 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-53 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-53 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-53 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-53 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-53 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-53 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-53 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-53 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-53 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-53 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-53 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-53 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-53 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-53 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-53 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-53 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-52 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-52 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-52 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-51 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-51 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-51 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-51 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-51 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-49 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-47 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-43 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-41 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-41 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-41 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-41 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-41 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-41 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-41 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-41 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-39 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-39 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-39 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-38 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-38 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-38 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-38 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-38 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-38 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-38 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-38 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-38 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-38 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-38 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-38 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-38 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-38 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-38 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-38 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-38 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-37 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-37 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-37 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-37 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-37 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-37 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-37 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-36 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-35 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-35 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-35 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-35 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-35 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-35 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-35 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-35 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-35 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-35 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-35 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-35 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-35 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-35 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-35 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-35 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-35 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-35 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-35 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-35 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-35 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-35 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-35 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-35 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-35 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-35 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-35 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-35 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-34 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-34 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-34 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-34 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-34 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-34 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-34 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-34 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-34 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-34 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-34 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-34 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-34 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-34 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-34 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-34 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-34 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-34 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-34 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-34 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-34 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-34 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-34 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-34 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-34 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-34 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-34 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-34 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-34 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-34 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-34 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-34 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-34 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-34 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-34 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-34 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-34 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-34 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-34 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-34 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-34 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-34 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-34 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-34 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-34 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-34 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-34 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-34 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-34 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-34 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-34 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-34 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-34 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-33 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-33 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-33 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-33 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-33 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-33 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-32 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-32 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-32 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-32 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-31 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-31 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-31 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-31 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-31 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-31 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-31 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-31 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-31 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-31 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-31 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-31 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-31 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-31 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-31 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-31 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-31 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-31 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-31 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-31 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-30 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-30 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-30 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-30 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-30 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-30 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-30 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-30 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-30 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-30 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-30 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-29 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-29 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-29 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-29 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-29 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-29 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-28 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-27 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-27 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-25 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-25 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-24 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-24 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-24 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-23 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-23 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-23 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-23 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-23 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-23 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-23 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-23 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-23 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-23 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-23 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-22 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-22 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-22 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-22 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-22 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 5e-22 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-22 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-22 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-22 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-22 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-22 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 6e-22 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-22 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 6e-22 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 6e-22 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-22 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-22 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-22 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-22 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-22 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-22 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-22 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 8e-22 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-22 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 9e-22 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-22 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-22 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-21 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-21 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-21 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-21 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-21 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-21 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-21 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-21 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-21 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-21 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-21 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-21 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-21 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-21 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-21 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-21 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-21 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-21 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-21 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-21 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-21 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-21 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-21 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-21 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-21 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-21 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-21 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-20 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-20 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-20 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-20 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-20 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 7e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-20 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 7e-20 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 7e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-20 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 8e-20 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 8e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-20 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 8e-20 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 8e-20 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 8e-20 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 8e-20 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-20 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 9e-20 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 9e-20 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 9e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-20 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-19 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-19 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-19 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-19 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-19 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-19 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-19 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-19 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-19 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-19 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-19 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-19 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-19 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-19 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-18 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-18 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-18 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-18 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-18 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-18 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-18 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-18 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-17 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-17 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-17 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-17 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-17 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-17 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-17 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-17 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-17 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-17 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-17 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-17 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-17 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-17 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-17 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-17 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-17 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-17 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-17 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-16 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-16 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-16 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-16 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-16 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-16 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-16 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-16 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-16 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-16 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-16 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-15 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-15 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-15 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-15 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-15 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-15 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-15 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-15 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-15 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-15 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-15 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-14 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-14 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-14 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-14 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-14 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-14 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-14 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-14 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-14 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-14 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-14 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 9e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-13 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-13 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-13 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-13 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-13 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-13 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-13 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-12 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-12 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-12 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-12 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-10 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-09 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-09 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 5e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-08 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 6e-08 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 7e-08 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 8e-08 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 9e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-07 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-07 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-07 |
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 464 bits (1196), Expect = e-161
Identities = 135/335 (40%), Positives = 184/335 (54%), Gaps = 22/335 (6%)
Query: 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQKL 181
Y+K+ K+GQGT+ V+KA R TG+ VALKKV + +E A REI ILQ L
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME-NEKEGFPITALREIKILQLL 73
Query: 182 DHPNIVKLEGLATSRM------QYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QL 229
H N+V L + ++ + S+YLVF+F + DLA ++SN K T + L
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 133
Query: 230 LSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK---RPLTSRVVTLW 286
L+GL + H ILHRD+K +N+LI ++GVLK+ADFGLA FS K T+RVVTLW
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 193
Query: 287 YRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW 346
YR PELLLG DYG IDLW AGC++AEM+ PIM G TE QL I +LCGS + + W
Sbjct: 194 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253
Query: 347 ---KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLG--LLSTLLALDPAYRGSAASALKNE 401
L + K ++ + + L+ LL LDPA R + AL ++
Sbjct: 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313
Query: 402 FFFTSPLACDLSGLPVIYDKEDELIEANQQRKIRR 436
FF++ P+ DL G+ + A +RK
Sbjct: 314 FFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKHHH 348
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 429 bits (1106), Expect = e-148
Identities = 135/352 (38%), Positives = 191/352 (54%), Gaps = 25/352 (7%)
Query: 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE--PHSVKFMA-REIM 176
V A+ Y+K+D +G+G ++ VYKA D++T +IVA+KK+K + A REI
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 177 ILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLL 230
+LQ+L HPNI+ L + ++ LVF+FM+TDL II + LT L
Sbjct: 65 LLQELSHPNIIGLLDAFGHKS--NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 231 SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF-SPNKKRPLTSRVVTLWYRA 289
GL++ H ILHRD+K +NLL+D+NGVLK+ADFGLA F SPN R T +VVT WYRA
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRA 180
Query: 290 PELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW--- 346
PELL GA YGVG+D+W+ GC+LAE+ L P +PG ++++QL RIF+ G+P+E+ W
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240
Query: 347 KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406
L TF P L FS + L L+ L +P R +A ALK ++F
Sbjct: 241 CSLPDYVTF-KSFPGIP-LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298
Query: 407 PLACDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQASQL 458
P LP + L ++ + + K G +L
Sbjct: 299 PGPTPGCQLPRPNCPVETL------KEQSNPALAIKRKRTEALEQGGLPKKL 344
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 377 bits (970), Expect = e-128
Identities = 120/330 (36%), Positives = 177/330 (53%), Gaps = 22/330 (6%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE--PHSVKFMAREIMILQKLD 182
E+Y K+DK+G+GTY+ VYK + T +VALK+++ + E P + RE+ +L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA---IREVSLLKDLK 58
Query: 183 HPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHC 236
H NIV L + + SL LVFE++ DL + + + + QLL GL +C
Sbjct: 59 HANIVTLHDIIHTEK--SLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS-PNKKRPLTSRVVTLWYRAPELLLG 295
H + +LHRD+K NLLI++ G LK+ADFGLA S P + + VVTLWYR P++LLG
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTYDNEVVTLWYRPPDILLG 174
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW---KKLRLS 352
+TDY ID+W GC+ EM GRP+ PG T EQLH IF++ G+P+E+ W
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234
Query: 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLAC-D 411
T+ P+ L LL+ LL + R SA A+K+ FF +
Sbjct: 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK 294
Query: 412 LSGLPVIYDKEDELIEANQQRKIRRARMKH 441
L I+ ++ I+ ++ +R A H
Sbjct: 295 LPDTTSIFALKE--IQLQKEASLRSAHHHH 322
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 369 bits (951), Expect = e-125
Identities = 123/298 (41%), Positives = 170/298 (57%), Gaps = 17/298 (5%)
Query: 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQ 179
E Y K++KVG+GTY VYKA D G+IVALK+++ D +E + A REI +L+
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLD-AEDEGIPSTAIREISLLK 74
Query: 180 KLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGL 233
+L HPNIV L + S L LVFEFM+ DL +++ + L + Q QLL G+
Sbjct: 75 ELHHPNIVSLIDVIHSER--CLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 234 QHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS-PNKKRPLTSRVVTLWYRAPEL 292
HCH ILHRD+K NLLI+ +G LK+ADFGLA F P R T VVTLWYRAP++
Sbjct: 133 AHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV--RSYTHEVVTLWYRAPDV 190
Query: 293 LLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW---KKL 349
L+G+ Y +D+WS GC+ AEM G+P+ PG T+ +QL +IF + G+P+ W ++L
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250
Query: 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407
L K F + + LLS +L DP R SA A+ + +F
Sbjct: 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 369 bits (950), Expect = e-125
Identities = 121/317 (38%), Positives = 170/317 (53%), Gaps = 30/317 (9%)
Query: 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE--PHSVKFMA-REIMILQ 179
S+ + +++K+G GTY+ VYK L++ TG VALK+VK D+ E P + A REI +++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPST----AIREISLMK 58
Query: 180 KLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARII-----SNPEGKLTEPQ------Q 228
+L H NIV+L + + L LVFEFM DL + + N L Q
Sbjct: 59 ELKHENIVRLYDVIHTEN--KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 229 LLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS-PNKKRPLTSRVVTLWY 287
LL GL CH+ ILHRD+K NLLI+K G LK+ DFGLA F P +S VVTLWY
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV--NTFSSEVVTLWY 174
Query: 288 RAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW- 346
RAP++L+G+ Y ID+WS GC+LAEM G+P+ PG + EQL IF + G+P+E W
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234
Query: 347 --KKLRLSTTFRPPQSYKP--RLFEAFSEFPESSLG--LLSTLLALDPAYRGSAASALKN 400
KL + + ++ + ++ P L LL L+P R SA AL +
Sbjct: 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294
Query: 401 EFFFTSPLACDLSGLPV 417
+F + G
Sbjct: 295 PWFAEYYHHASMGGSRS 311
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 368 bits (947), Expect = e-125
Identities = 122/296 (41%), Positives = 168/296 (56%), Gaps = 18/296 (6%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQKLDH 183
+ Y+K++K+G+GTY V+KA +R+T +IVALK+V+ D + V A REI +L++L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD-DDDEGVPSSALREICLLKELKH 60
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCH 237
NIV+L + S L LVFEF DL + + G L QLL GL CH
Sbjct: 61 KNIVRLHDVLHSDK--KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS-PNKKRPLTSRVVTLWYRAPELLLGA 296
R +LHRD+K NLLI++NG LK+A+FGLA F P R ++ VVTLWYR P++L GA
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGA 176
Query: 297 TDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRIFKLCGSPSEDYW---KKLRLS 352
Y ID+WSAGC+ AE+ GRP+ PG +QL RIF+L G+P+E+ W KL
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPL 408
+ P L + + LL LL +P R SA AL++ +F
Sbjct: 237 KPY-PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 367 bits (945), Expect = e-124
Identities = 104/302 (34%), Positives = 148/302 (49%), Gaps = 19/302 (6%)
Query: 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKF---MAREIMIL 178
+ Y+ + ++G G Y VYKA D +G VALK V+ RE+ +L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 179 QKL---DHPNIVKLEGLATSR---MQYSLYLVFEFMQTDLARIISN-PEGKLTEPQ---- 227
++L +HPN+V+L + + + + LVFE + DL + P L
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 228 --QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTL 285
Q L GL H I+HRD+K N+L+ G +K+ADFGLA +S LT VVTL
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALTPVVVTL 183
Query: 286 WYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDY 345
WYRAPE+LL +T Y +D+WS GC+ AEMF +P+ G +E +QL +IF L G P ED
Sbjct: 184 WYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242
Query: 346 WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405
W + P + E ES LL +L +P R SA AL++ +
Sbjct: 243 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302
Query: 406 SP 407
Sbjct: 303 DE 304
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 363 bits (935), Expect = e-123
Identities = 119/290 (41%), Positives = 166/290 (57%), Gaps = 18/290 (6%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQKLDH 183
E Y ++K+G+GTY VYKA + G+ ALKK++ + E + REI IL++L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLE-KEDEGIPSTTIREISILKELKH 59
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCH 237
NIVKL + ++ L LVFE + DL +++ EG L QLL+G+ +CH
Sbjct: 60 SNIVKLYDVIHTKK--RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS-PNKKRPLTSRVVTLWYRAPELLLGA 296
DR +LHRD+K NLLI++ G LKIADFGLA F P R T +VTLWYRAP++L+G+
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGS 175
Query: 297 TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW---KKLRLST 353
Y ID+WS GC+ AEM G P+ PG +E +QL RIF++ G+P+ W +L
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
P ES + LLS +L LDP R +A AL++ +F
Sbjct: 236 PNFTVYEPLP-WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 364 bits (937), Expect = e-123
Identities = 100/303 (33%), Positives = 156/303 (51%), Gaps = 15/303 (4%)
Query: 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQK 180
+S E Y+ + VG+G+Y V K ++DTG+IVA+KK + VK +A REI +L++
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES-DDDKMVKKIAMREIKLLKQ 80
Query: 181 LDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQ 234
L H N+V L L + + YLVFEF+ + + L Q+++G+
Sbjct: 81 LRHENLVNL--LEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 235 HCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLL 294
CH I+HRD+K N+L+ ++GV+K+ DFG A + V T WYRAPELL+
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVATRWYRAPELLV 197
Query: 295 GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW---KKLRL 351
G YG +D+W+ GCL+ EMF+G P+ PG ++++QL+ I G+ + K +
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257
Query: 352 STTFRPPQSYKPRLFE-AFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLAC 410
R P+ + E + + E + L L +DP R A L ++FF A
Sbjct: 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAE 317
Query: 411 DLS 413
S
Sbjct: 318 RFS 320
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 363 bits (934), Expect = e-122
Identities = 103/304 (33%), Positives = 155/304 (50%), Gaps = 17/304 (5%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQKLDH 183
E Y+KI K+G+G+Y V+K +RDTG+IVA+KK + +K +A REI +L++L H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES-EDDPVIKKIALREIRMLKQLKH 61
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCH 237
PN+V L L R + L+LVFE+ + + + + E Q L + CH
Sbjct: 62 PNLVNL--LEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGAT 297
+HRDVK N+LI K+ V+K+ DFG A + V T WYR+PELL+G T
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVATRWYRSPELLVGDT 178
Query: 298 DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW---KKLRL--S 352
YG +D+W+ GC+ AE+ G P+ PG+++V+QL+ I K G + +
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238
Query: 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDL 412
P+ +P L F +LGLL L +DP R + L + +F DL
Sbjct: 239 VKIPDPEDMEP-LELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDL 297
Query: 413 SGLP 416
+
Sbjct: 298 AKEH 301
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 361 bits (928), Expect = e-121
Identities = 105/303 (34%), Positives = 164/303 (54%), Gaps = 22/303 (7%)
Query: 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQK 180
S + Y +I K+G+GTY VYKA+D T + VA+K+++ + E V A RE+ +L++
Sbjct: 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE-HEEEGVPGTAIREVSLLKE 89
Query: 181 LDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQ 234
L H NI++L+ + L+L+FE+ + DL + + ++ QL++G+
Sbjct: 90 LQHRNIIELKSVIHHNH--RLHLIFEYAENDLKKYMDKN-PDVSMRVIKSFLYQLINGVN 146
Query: 235 HCHDRGILHRDVKGSNLLIDKN-----GVLKIADFGLANYFS-PNKKRPLTSRVVTLWYR 288
CH R LHRD+K NLL+ + VLKI DFGLA F P R T ++TLWYR
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI--RQFTHEIITLWYR 204
Query: 289 APELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW-- 346
PE+LLG+ Y +D+WS C+ AEM + P+ PG +E++QL +IF++ G P + W
Sbjct: 205 PPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264
Query: 347 -KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405
L P K + + L LL+ +L +DP R SA +AL++ +F
Sbjct: 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324
Query: 406 SPL 408
+
Sbjct: 325 NDF 327
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 356 bits (916), Expect = e-120
Identities = 104/313 (33%), Positives = 160/313 (51%), Gaps = 25/313 (7%)
Query: 122 KSAESYDKIDKVGQGTYSNVYKALD-RDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQ 179
++ + Y+ + ++G+G Y V+KA D ++ G+ VALK+V+ + + RE+ +L+
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ-TGEEGMPLSTIREVAVLR 66
Query: 180 KL---DHPNIVKLEGLATSRMQY---SLYLVFEFMQTDLARIISN-PEGKLTEPQ----- 227
L +HPN+V+L + T L LVFE + DL + PE +
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 228 -QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLW 286
QLL GL H ++HRD+K N+L+ +G +K+ADFGLA +S LTS VVTLW
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLW 184
Query: 287 YRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW 346
YRAPE+LL ++ Y +DLWS GC+ AEMF +P+ G ++V+QL +I + G P E+ W
Sbjct: 185 YRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243
Query: 347 ---KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
L + + ++ E LL L +PA R SA SAL + +F
Sbjct: 244 PRDVALPRQAFHSKS---AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300
Query: 404 FTSPLACDLSGLP 416
+
Sbjct: 301 QDLERCKENLDSH 313
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 359 bits (922), Expect = e-119
Identities = 113/394 (28%), Positives = 179/394 (45%), Gaps = 49/394 (12%)
Query: 109 DNIPREVLAGLVPKSAESYDKID-KVGQGTYSNVYKALDRD--TGKIVALKKVKFDTSEP 165
D + L+ + + ++ KVG+GTY +VYKA +D K ALK+++
Sbjct: 4 DYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM 63
Query: 166 HSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARII--------S 217
+ REI +L++L HPN++ L+ + S ++L+F++ + DL II +
Sbjct: 64 SAC----REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN 119
Query: 218 NPEGKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLI----DKNGVLKIADFGLA 267
+L Q+L G+ + H +LHRD+K +N+L+ + G +KIAD G A
Sbjct: 120 KKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179
Query: 268 NYF-SPNKKRP-LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGR 325
F SP K L VVT WYRAPELLLGA Y ID+W+ GC+ AE+ PI R
Sbjct: 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239
Query: 326 TEV---------EQLHRIFKLCGSPSEDYW---KKLRLSTTFRPPQSYKP--------RL 365
E +QL RIF + G P++ W KK+ +T +
Sbjct: 240 QEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYM 299
Query: 366 FEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACD--LSGLPVIYDKED 423
+ + + LL LL +DP R ++ A+++ +F PL +G + Y K +
Sbjct: 300 EKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKRE 359
Query: 424 ELIEANQQRKIRRARMKHRSKTLRERRIGDQASQ 457
L E K + + + G +Q
Sbjct: 360 FLTEEEPDDKGDKKNQQQQQGNNHTNGTGHPGNQ 393
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 314 bits (807), Expect = e-102
Identities = 119/392 (30%), Positives = 182/392 (46%), Gaps = 42/392 (10%)
Query: 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQK 180
SY +G G++ VY+A D+G++VA+KKV D +F RE+ I++K
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRK 103
Query: 181 LDHPNIVKLEGLATS----RMQYSLYLVFEFMQTDLARII---SNPEGKLTEPQ------ 227
LDH NIV+L S + + L LV +++ + R+ S + L
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKN-GVLKIADFGLANYFSPNKKRPLTSRVVTLW 286
QL L + H GI HRD+K NLL+D + VLK+ DFG A P S + + +
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRY 221
Query: 287 YRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW 346
YRAPEL+ GATDY ID+WSAGC+LAE+ LG+PI PG + V+QL I K+ G+P+ +
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281
Query: 347 KKLR-LSTTFRPPQSYKPRLFEAF-SEFPESSLGLLSTLLALDPAYRGSAASALKNEFF- 403
+++ T F+ PQ + F P ++ L S LL P R + A + FF
Sbjct: 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341
Query: 404 -FTSPLACDLSG--LPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQASQLTK 460
P +G P +++ + + +N L I A
Sbjct: 342 ELRDPNVKLPNGRDTPALFNFTTQELSSNPP--------------LATILIPPHARIQAA 387
Query: 461 EETLSNKEDSEKHVELNFQGQEPYSSASSASS 492
T +N + + +SAS+++S
Sbjct: 388 ASTPTNATAASDANTGDRGQTNNAASASASNS 419
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 302 bits (775), Expect = 9e-98
Identities = 96/295 (32%), Positives = 149/295 (50%), Gaps = 25/295 (8%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+Y +G G++ V++A ++ + VA+KKV D +F RE+ I++ + HP
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK------RFKNRELQIMRIVKHP 92
Query: 185 NIVKLEGLATSRMQYS----LYLVFEFMQTDLARII---SNPEGKLTEPQ------QLLS 231
N+V L+ S L LV E++ + R + + + QLL
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 232 GLQHCHDRGILHRDVKGSNLLIDKN-GVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAP 290
L + H GI HRD+K NLL+D GVLK+ DFG A P S + + +YRAP
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EPNVSYICSRYYRAP 210
Query: 291 ELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350
EL+ GAT+Y ID+WS GC++AE+ G+P+ PG + ++QL I K+ G+PS + K +
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270
Query: 351 -LSTTFRPPQSYKPRLFEAFS-EFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
+ PQ + F P ++ L+S LL P+ R +A AL + FF
Sbjct: 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 284 bits (730), Expect = 2e-91
Identities = 94/317 (29%), Positives = 140/317 (44%), Gaps = 35/317 (11%)
Query: 113 REVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA 172
K + + GQGT+ V ++ TG VA+KKV D F
Sbjct: 11 AAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR------FRN 64
Query: 173 REIMILQKL---DHPNIVKL------EGLATSRMQYSLYLVFEFMQTDLARII-SNPEGK 222
RE+ I+Q L HPNIV+L G R Y L +V E++ L R + +
Sbjct: 65 RELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY-LNVVMEYVPDTLHRCCRNYYRRQ 123
Query: 223 LTEPQ--------QLLSGLQHCHDR--GILHRDVKGSNLLIDK-NGVLKIADFGLANYFS 271
+ P QL+ + H + HRD+K N+L+++ +G LK+ DFG A S
Sbjct: 124 VAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
Query: 272 PNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQL 331
P+ P + + + +YRAPEL+ G Y +D+WS GC+ AEM LG PI G QL
Sbjct: 184 PS--EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL 241
Query: 332 HRIFKLCGSPSEDYWKKL-----RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLAL 386
H I ++ G PS + +KL + + + + + + LLS LL
Sbjct: 242 HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQY 301
Query: 387 DPAYRGSAASALKNEFF 403
P R AL + +F
Sbjct: 302 LPEERMKPYEALCHPYF 318
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 283 bits (725), Expect = 2e-90
Identities = 91/331 (27%), Positives = 149/331 (45%), Gaps = 56/331 (16%)
Query: 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQK 180
S++ Y +G G++ V + D ++GK ALKKV D ++ RE+ I++
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKV 56
Query: 181 LDHPNIVKL------------------------------------EGLATSRMQYSLYLV 204
LDH NI+KL + L ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 205 FEFMQTDLARII---SNPEGKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLID- 254
E++ L +++ + QL + H GI HRD+K NLL++
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 255 KNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAE 314
K+ LK+ DFG A P+ P + + + +YRAPEL+LGAT+Y IDLWS GC+ E
Sbjct: 177 KDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 315 MFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR-LSTTFRPPQSYKPRLFEAFSEF- 372
+ LG+P+ G T ++QL RI ++ G+P+++ ++ T R P + E
Sbjct: 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGT 294
Query: 373 PESSLGLLSTLLALDPAYRGSAASALKNEFF 403
P ++ LL +L +P R + A+ + FF
Sbjct: 295 PSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 8e-86
Identities = 104/326 (31%), Positives = 155/326 (47%), Gaps = 48/326 (14%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y + +G G V+ A+D D K VA+KK+ P SVK REI I+++LDH NI
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNI 70
Query: 187 VKL-----------EGLATSRMQYS-LYLVFEFMQTDLARIISNPEGKLTEPQ------Q 228
VK+ S + + +Y+V E+M+TDLA ++ G L E Q
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQ 128
Query: 229 LLSGLQHCHDRGILHRDVKGSNLLID-KNGVLKIADFGLANYFSPN--KKRPLTSRVVTL 285
LL GL++ H +LHRD+K +NL I+ ++ VLKI DFGLA P+ K L+ +VT
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 286 WYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDY 345
WYR+P LLL +Y ID+W+AGC+ AEM G+ + G E+EQ+ I + E+
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248
Query: 346 WKKLR-------LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASAL 398
++L + P + L + ++ L +L P R +A AL
Sbjct: 249 RQELLSVIPVYIRNDMTEPHKP----LTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304
Query: 399 KNEFFFTSPLACDLSGLPVIYDKEDE 424
+ + S DE
Sbjct: 305 SHPYM--SIY----------SFPMDE 318
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 267 bits (686), Expect = 2e-85
Identities = 90/299 (30%), Positives = 143/299 (47%), Gaps = 31/299 (10%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DH 183
+ Y + K+G+G YS V++A++ + V +K +K P K + REI IL+ L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGG 90
Query: 184 PNIVKLEGLATSRMQYSLYLVFEF-MQTDLARIISNPEGKLTEPQ------QLLSGLQHC 236
PNI+ L + + + LVFE TD ++ LT+ ++L L +C
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYC 146
Query: 237 HDRGILHRDVKGSNLLID-KNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLG 295
H GI+HRDVK N++ID ++ L++ D+GLA ++ P + RV + +++ PELL+
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVD 204
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGR-PIMPGRTEVEQLHRIFKLCGSPS-EDYWKKLRLST 353
Y +D+WS GC+LA M + P G +QL RI K+ G+ DY K +
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264
Query: 354 T-----FRPPQSYKP--RLF--EAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
S K R E +L L LL D R +A A+++ +F
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 5e-84
Identities = 102/320 (31%), Positives = 160/320 (50%), Gaps = 45/320 (14%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVK--FDTSEPHSVKFMAREIMILQKLD 182
++Y VG G Y +V A+D+ +G+ VA+KK+ F + K RE+++L+ +
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS--EIFAKRAYRELLLLKHMQ 81
Query: 183 HPNIVKLEGLATSRMQYS----LYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSG 232
H N++ L + T YLV FMQTDL +I+ +E + Q+L G
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK---FSEEKIQYLVYQMLKG 138
Query: 233 LQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPEL 292
L++ H G++HRD+K NL ++++ LKI DFGLA + +T VVT WYRAPE+
Sbjct: 139 LKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEV 194
Query: 293 LLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR-- 350
+L Y +D+WS GC++AEM G+ + G+ ++QL +I K+ G P ++ +KL
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254
Query: 351 ------LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404
S P + + + F + LL +L LD R +AA AL + FF
Sbjct: 255 AAKSYIQSLPQTPRKDFT----QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF- 309
Query: 405 TSPLACDLSGLPVIYDKEDE 424
P D E+E
Sbjct: 310 -EPF----------RDPEEE 318
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 9e-84
Identities = 105/326 (32%), Positives = 153/326 (46%), Gaps = 48/326 (14%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVK-FDTSEPHSVKFMAREIMILQKLDHPN 185
+ +G+G Y V A + TG+IVA+KK++ FD P REI IL+ H N
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRTLREIKILKHFKHEN 70
Query: 186 IVKLEGL--ATSRMQYS-LYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHC 236
I+ + + S ++ +Y++ E MQTDL R+IS L++ Q L ++
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVL 128
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP---------LTSRVVTLWY 287
H ++HRD+K SNLLI+ N LK+ DFGLA + + V T WY
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 288 RAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSED--- 344
RAPE++L + Y +D+WS GC+LAE+FL RPI PGR QL IF + G+P D
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 345 ------YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASAL 398
++ S P L + F + LL +L DPA R +A AL
Sbjct: 249 RCIESPRAREYIKSLPMYPAAP----LEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL 304
Query: 399 KNEFFFTSPLACDLSGLPVIYDKEDE 424
++ + +D DE
Sbjct: 305 EHPYL--QTY----------HDPNDE 318
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 2e-83
Identities = 101/319 (31%), Positives = 149/319 (46%), Gaps = 42/319 (13%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVK-FDTSEPHSVKFMAREIMILQKLDHPN 185
Y + +G+G Y V A D VA+KK+ F+ + REI IL + H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHEN 86
Query: 186 IVKLEGL--ATSRMQYS-LYLVFEFMQTDLARII-SNPEGKLTEPQ------QLLSGLQH 235
I+ + + A + Q +Y+V + M+TDL +++ + L+ Q+L GL++
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKY 143
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP--LTSRVVTLWYRAPELL 293
H +LHRD+K SNLL++ LKI DFGLA P+ LT V T WYRAPE++
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 294 LGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR--- 350
L + Y ID+WS GC+LAEM RPI PG+ ++QL+ I + GSPS++ +
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263
Query: 351 -----LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405
LS + F +L LL +L +P R AL + +
Sbjct: 264 ARNYLLSLPHKNKVP----WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL-- 317
Query: 406 SPLACDLSGLPVIYDKEDE 424
YD DE
Sbjct: 318 EQY----------YDPSDE 326
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 267 bits (683), Expect = 3e-83
Identities = 99/351 (28%), Positives = 152/351 (43%), Gaps = 79/351 (22%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y+ +G G+Y +V +A D+ ++VA+KK+ + K + REI IL +L+H ++
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 187 VKLEGLATSRMQYS---LYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCH 237
VK+ + + LY+V E +D ++ P LTE LL G+++ H
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVH 173
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLA--------------------------NYFS 271
GILHRD+K +N L++++ +K+ DFGLA +
Sbjct: 174 SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233
Query: 272 PNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-----------GRP 320
N KR LT VVT WYRAPEL+L +Y ID+WS GC+ AE+ P
Sbjct: 234 KNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293
Query: 321 IMPG--------------------RTEVEQLHRIFKLCGSPSEDYWKKLR--------LS 352
+ PG R +QL+ IF + G+PSE+ + L
Sbjct: 294 LFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRI 353
Query: 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
R L E F ++ LL +L +P R + L + FF
Sbjct: 354 FPKREGTD----LAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF 400
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 3e-83
Identities = 84/300 (28%), Positives = 133/300 (44%), Gaps = 26/300 (8%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-----KFDTSEPHSVKFMA----REIMI 177
Y + G+Y V +D G VA+K+V T S F+ REI +
Sbjct: 24 YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 178 LQKLDHPNIVKLEGL--ATSRMQYS-LYLVFEFMQTDLARIISNPEGKLTEPQ------Q 228
L HPNI+ L + LYLV E M+TDLA++I + ++
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH 142
Query: 229 LLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYR 288
+L GL H+ G++HRD+ N+L+ N + I DF LA + + T V WYR
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYR 200
Query: 289 APELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK 348
APEL++ + +D+WSAGC++AEMF + + G T QL++I ++ G+P +
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260
Query: 349 LRLSTTFR-----PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
+ +L L++ +L +P R S AL++ +F
Sbjct: 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 4e-83
Identities = 99/320 (30%), Positives = 153/320 (47%), Gaps = 44/320 (13%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVK--FDTSEPHSVKFMAREIMILQKLD 182
Y + VG G Y V A+D TG VA+KK+ F + K RE+ +L+ +
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHMR 82
Query: 183 HPNIVKLEGLATSRMQYS----LYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSG 232
H N++ L + T YLV FM TDL +++ + KL E + Q+L G
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKG 140
Query: 233 LQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPEL 292
L++ H GI+HRD+K NL ++++ LKI DFGLA +T VVT WYRAPE+
Sbjct: 141 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEV 196
Query: 293 LLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR-- 350
+L Y +D+WS GC++AEM G+ + G ++QL I K+ G+P ++ ++L+
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256
Query: 351 ------LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404
+ + + ++ LL +L LD R +A AL + +F
Sbjct: 257 EAKNYMKGLPELEKKDFA----SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF- 311
Query: 405 TSPLACDLSGLPVIYDKEDE 424
L +D EDE
Sbjct: 312 -ESL----------HDTEDE 320
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 1e-81
Identities = 97/296 (32%), Positives = 145/296 (48%), Gaps = 30/296 (10%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y + VG G Y +V A D TG VA+KK+ K RE+ +L+ + H N+
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 187 VKLEGLATSRMQYS----LYLVFEFMQTDLARII-SNPEGKLTEPQ------QLLSGLQH 235
+ L + T +YLV M DL I+ LT+ Q+L GL++
Sbjct: 91 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKY 147
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLG 295
H I+HRD+K SNL ++++ LKI DFGLA + + +T V T WYRAPE++L
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYRAPEIMLN 203
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR----- 350
Y +D+WS GC++AE+ GR + PG ++QL I +L G+P + KK+
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263
Query: 351 ---LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
S T P ++ F ++ LL +L LD R +AA AL + +F
Sbjct: 264 NYIQSLTQMPKMNFA----NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 3e-80
Identities = 109/327 (33%), Positives = 162/327 (49%), Gaps = 55/327 (16%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVK--FDTSEPHSVKFMAREIMILQKL-DH 183
Y+ + K+G+G Y V+K++DR TG++VA+KK+ F + REIMIL +L H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN--STDAQRTFREIMILTELSGH 68
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFMQTDLARII-SNPEGKLTEPQ------QLLSGLQHC 236
NIV L + + +YLVF++M+TDL +I +N L QL+ +++
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANI---LEPVHKQYVVYQLIKVIKYL 125
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP------------------- 277
H G+LHRD+K SN+L++ +K+ADFGL+ F ++
Sbjct: 126 HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 278 -LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFK 336
LT V T WYRAPE+LLG+T Y GID+WS GC+L E+ G+PI PG + + QL RI
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245
Query: 337 LCGSPSED------------------YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLG 378
+ PS + ++R S +K L + + +
Sbjct: 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA 305
Query: 379 --LLSTLLALDPAYRGSAASALKNEFF 403
LL LL +P R SA ALK+ F
Sbjct: 306 LDLLDKLLQFNPNKRISANDALKHPFV 332
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 5e-78
Identities = 86/302 (28%), Positives = 146/302 (48%), Gaps = 31/302 (10%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y + +G G V A D + VA+KK+ K RE+++++ ++H NI
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 187 VKLEGLATSRMQYS----LYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHC 236
+ L + T + +Y+V E M +L ++I L + Q+L G++H
Sbjct: 87 IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHL 143
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGA 296
H GI+HRD+K SN+++ + LKI DFGLA + +T VVT +YRAPE++LG
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILG- 200
Query: 297 TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR------ 350
Y +D+WS GC++ EM G + PG ++Q +++ + G+P ++ KKL+
Sbjct: 201 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 260
Query: 351 -LSTTFRPPQSYK--------PRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNE 401
+ S++ P E + LLS +L +D + R S AL++
Sbjct: 261 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320
Query: 402 FF 403
+
Sbjct: 321 YI 322
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 3e-77
Identities = 99/405 (24%), Positives = 176/405 (43%), Gaps = 55/405 (13%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y + +G G V A D + VA+KK+ K RE+++++ ++H NI
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 187 VKLEGLATSRMQYS----LYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHC 236
+ L + T + +YLV E M +L ++I L + Q+L G++H
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHL 180
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGA 296
H GI+HRD+K SN+++ + LKI DFGLA + +T VVT +YRAPE++LG
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILG- 237
Query: 297 TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR------ 350
Y +D+WS GC++ EM + + PGR ++Q +++ + G+P ++ KKL+
Sbjct: 238 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297
Query: 351 -LSTTFRPPQSYKPRLFEAFSEFPESSLG---------LLSTLLALDPAYRGSAASALKN 400
+ ++ +LF +S LLS +L +DPA R S AL++
Sbjct: 298 VENRPKYAGLTFP-KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356
Query: 401 EFFFTSPLACDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQASQLTK 460
+ + YD + Q + +H + +E L
Sbjct: 357 PYI--NVW----------YDPAEVEAPPPQIYDKQLDEREHTIEEWKE---------LIY 395
Query: 461 EETLS-NKEDSEKHVELNFQGQEPYSSASSASSGTKANQQSHSPP 504
+E ++ ++ V+ ++S + + + S
Sbjct: 396 KEVMNSEEKTKNGVVKGQPSPSGAAVNSSESLPPSSSVNDISSMS 440
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 1e-76
Identities = 101/345 (29%), Positives = 156/345 (45%), Gaps = 75/345 (21%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVK--FDTSEPHSVKFMAREIMILQKLDHP 184
Y +G+G+Y VY A D++T K VA+KKV F+ K + REI IL +L
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED--LIDCKRILREITILNRLKSD 85
Query: 185 NIVKLEGL--ATSRMQYS-LYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQH 235
I++L L +++ LY+V E +DL ++ P LTE LL G
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPI-FLTEEHIKTILYNLLLGENF 144
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLA---------------------NYFSPNK 274
H+ GI+HRD+K +N L++++ +K+ DFGLA + N
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLG-----------RPIMP 323
K+ LTS VVT WYRAPEL+L +Y ID+WS GC+ AE+ P+ P
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264
Query: 324 G-----------------RTEVEQLHRIFKLCGSPSEDYWKKLR--------LSTTFRPP 358
G ++ +QL+ IF + G+P+ED K + R P
Sbjct: 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP 324
Query: 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
+ L + + + + LL ++L +P R + AL + +
Sbjct: 325 IN----LKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 2e-59
Identities = 65/298 (21%), Positives = 117/298 (39%), Gaps = 48/298 (16%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
Y + ++G G S V++ L+ + +I A+K V + ++ ++ EI L KL
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86
Query: 185 N--IVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHC 236
+ I++L + +Y+V E DL + + + + +L +
Sbjct: 87 SDKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTI 143
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP-LTSRVVTLWYRAPELLLG 295
H GI+H D+K +N LI +G+LK+ DFG+AN P+ S+V T+ Y PE +
Sbjct: 144 HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 296 A----------TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDY 345
+ D+WS GC+L M G+ P + + Q+ ++
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLH---------- 250
Query: 346 WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
+ + P + +L L DP R S L + +
Sbjct: 251 -AIIDPNHEIEFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 1e-58
Identities = 76/365 (20%), Positives = 138/365 (37%), Gaps = 56/365 (15%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
Y + ++G G S V++ L+ +I A+K V + ++ ++ EI L KL
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 185 N--IVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHC 236
+ I++L + +Y+V E DL + + + + +L +
Sbjct: 68 SDKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTI 124
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP-LTSRVVTLWYRAPELLLG 295
H GI+H D+K +N LI +G+LK+ DFG+AN P+ S+V T+ Y PE +
Sbjct: 125 HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 296 ----------ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDY 345
+ D+WS GC+L M G+ P + + Q+ ++
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLH---------- 231
Query: 346 WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405
+ + P + +L L DP R S L + +
Sbjct: 232 -AIIDPNHEIEFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279
Query: 406 SPLACDLSGLPVIYDKE---DELIEANQQRKIRRARMKHRSKTLRERRIGDQASQLTKEE 462
+ + + +L+ N I +A +KTL E G ++ + +
Sbjct: 280 QTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKA-----AKTLYEHYSGGESHNSSSSK 334
Query: 463 TLSNK 467
T K
Sbjct: 335 TFEKK 339
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 3e-58
Identities = 68/311 (21%), Positives = 124/311 (39%), Gaps = 59/311 (18%)
Query: 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH 183
A +++I +GQG + V KA + + A+KK++ + ++ E+M+L L+H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL---SEVMLLASLNH 61
Query: 184 PNIVKL-----------EGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEP----- 226
+V+ + + + + +L++ E+ + L +I +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 227 -QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP-------- 277
+Q+L L + H +GI+HRD+K N+ ID++ +KI DFGLA +
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 278 -----LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLH 332
LTS + T Y A E+L G Y ID++S G + EM P G V L
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILK 239
Query: 333 RIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG 392
++ + D+ + ++ L+ DP R
Sbjct: 240 KLRSVSIEFPPDFDDN--KMKVEK---------------------KIIRLLIDHDPNKRP 276
Query: 393 SAASALKNEFF 403
A + L + +
Sbjct: 277 GARTLLNSGWL 287
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-56
Identities = 72/362 (19%), Positives = 136/362 (37%), Gaps = 50/362 (13%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
Y + ++G G S V++ L+ + +I A+K V + ++ ++ EI L KL
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 185 N--IVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHC 236
+ I++L + +Y+V E DL + + + + +L +
Sbjct: 115 SDKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTI 171
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR-PLTSRVVTLWYRAPELLLG 295
H GI+H D+K +N LI +G+LK+ DFG+AN P+ S+V + Y PE +
Sbjct: 172 HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 296 ATD----------YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDY 345
+ D+WS GC+L M G+ P + + Q+ ++
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLH---------- 278
Query: 346 WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405
+ + P + +L L DP R S L + +
Sbjct: 279 -AIIDPNHEIEFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV-- 324
Query: 406 SPLACDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQASQLTKEETLS 465
++ + +E + + + +KTL E G ++ + +T
Sbjct: 325 QIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFE 384
Query: 466 NK 467
K
Sbjct: 385 KK 386
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 4e-56
Identities = 68/292 (23%), Positives = 106/292 (36%), Gaps = 45/292 (15%)
Query: 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQK 180
+S+ ++ ++G G+Y V+K ++ G++ A+K+ P E+ +K
Sbjct: 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112
Query: 181 L-DHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGL 233
+ HP V+LE LYL E L + L E Q L L
Sbjct: 113 VGQHPCCVRLEQAWEEG--GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLAL 170
Query: 234 QHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELL 293
H H +G++H DVK +N+ + G K+ DFGL + Y APELL
Sbjct: 171 AHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQEGDPRYMAPELL 228
Query: 294 LGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSE-DYWKKLRLS 352
G YG D++S G + E+ P + W++LR
Sbjct: 229 QG--SYGTAADVFSLGLTILEVACNME-------------------LPHGGEGWQQLRQG 267
Query: 353 TTFRPPQSYKPRLFEAFS-EFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
P S E +L +L DP R +A + L
Sbjct: 268 -------YLPPEFTAGLSSEL----RSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 7e-56
Identities = 68/297 (22%), Positives = 108/297 (36%), Gaps = 29/297 (9%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
+ D +GQG +NV++ + TG + A+K + S V RE +L+KL+H NI
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFN-NISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 187 VKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPE--GKLTEP------QQLLSGLQHCH 237
VKL + L+ EF L ++ P L E + ++ G+ H
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 238 DRGILHRDVKGSNLLI----DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELL 293
+ GI+HR++K N++ D V K+ DFG A +++ S T Y P++
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMY 187
Query: 294 LGATD-------YGVGIDLWSAGCLLAEMFLGRP----IMPGRTEVEQLHRIFKLCGSPS 342
A YG +DLWS G G R E +++I G PS
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--GKPS 245
Query: 343 EDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
+ P +L+ +L D
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 9e-55
Identities = 82/419 (19%), Positives = 137/419 (32%), Gaps = 64/419 (15%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
+ D +GQG +NV++ + TG + A+K + S V RE +L+KL+H NI
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFN-NISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 187 VKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPE--GKLTEP------QQLLSGLQHCH 237
VKL + L+ EF L ++ P L E + ++ G+ H
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 238 DRGILHRDVKGSNLLI----DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELL 293
+ GI+HR++K N++ D V K+ DFG A +++ S T Y P++
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMY 187
Query: 294 LGATD-------YGVGIDLWSAGCLLAEMFLGRP----IMPGRTEVEQLHRIFKLCGSPS 342
A YG +DLWS G G R E +++I G PS
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--GKPS 245
Query: 343 EDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402
+ P +L+ +L D ++F
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF-----DQF 300
Query: 403 FFTSPLACDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQASQLTKEE 462
F R + + + + + E
Sbjct: 301 F--------------------AETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHEL 340
Query: 463 TLSNKEDSEKHVELNFQGQ----EPYSSASSASSGTKANQQSHSPPFVLFPVAASHHQK 517
+ + EL ++G+ EP A T+ N P + + H
Sbjct: 341 VYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEEN------PIFVVSREGNSHHH 393
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-54
Identities = 74/306 (24%), Positives = 121/306 (39%), Gaps = 64/306 (20%)
Query: 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQK 180
+ + +I+ +G G + V+KA R GK +K+VK++ + RE+ L K
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE------REVKALAK 60
Query: 181 LDHPNIVKL--------------EGLATSRMQYSLYLVFEFMQT-DLARIISNPEGK-LT 224
LDH NIV ++ L++ EF L + I G+ L
Sbjct: 61 LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120
Query: 225 EPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278
+ Q+ G+ + H + +++RD+K SN+ + +KI DFGL + KR
Sbjct: 121 KVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-- 178
Query: 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLC 338
T TL Y +PE + DYG +DL++ G +LAE+ + T E L
Sbjct: 179 TRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAEL-----LHVCDTAFETSKFFTDLR 232
Query: 339 -GSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASA 397
G S+ + KK + LL LL+ P R + +
Sbjct: 233 DGIISDIFDKKEK---------------------------TLLQKLLSKKPEDRPNTSEI 265
Query: 398 LKNEFF 403
L+
Sbjct: 266 LRTLTV 271
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 7e-54
Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 45/299 (15%)
Query: 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQK 180
P AE Y+ + +G G+Y K + GKI+ K++ + + + + E+ +L++
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 181 LDHPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGK---LTEPQ------QLL 230
L HPNIV+ R +LY+V E+ + DLA +I+ + L E QL
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 231 SGLQHCHDRG-----ILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTL 285
L+ CH R +LHRD+K +N+ +D +K+ DFGLA + + + V T
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKTFVGTP 180
Query: 286 WYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDY 345
+Y +PE + Y D+WS GCLL E+ P ++ E +I
Sbjct: 181 YYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI----------- 228
Query: 346 WKKLRLSTTFRP-PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
FR P Y L E +++ +L L +R S L+N
Sbjct: 229 -----REGKFRRIPYRYSDELNE-----------IITRMLNLKDYHRPSVEEILENPLI 271
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 7e-53
Identities = 71/289 (24%), Positives = 125/289 (43%), Gaps = 42/289 (14%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
E Y ++ K+G+G++ + G+ +K++ + RE+ +L + HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 185 NIVK-LEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGK-LTEPQ------QLLSGLQH 235
NIV+ E + SLY+V ++ + DL + I+ +G E Q Q+ L+H
Sbjct: 84 NIVQYRESFEENG---SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLG 295
HDR ILHRD+K N+ + K+G +++ DFG+A + + + + T +Y +PE+
Sbjct: 141 VHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL-ARACIGTPYYLSPEICEN 199
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355
Y D+W+ GC+L E+ + + + +I +S +F
Sbjct: 200 -KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI----------------ISGSF 242
Query: 356 RP-PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
P Y L L+S L +P R S S L+ F
Sbjct: 243 PPVSLHYSYDLRS-----------LVSQLFKRNPRDRPSVNSILEKGFI 280
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 2e-52
Identities = 66/306 (21%), Positives = 115/306 (37%), Gaps = 48/306 (15%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ Y I K+G+G +S V G ALK++ E + RE + + +HP
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHP 86
Query: 185 NIVKLEG--LATSRMQYSLYLVFEFMQT-DLARII---SNPEGKLTEPQ------QLLSG 232
NI++L L ++ +L+ F + L I + LTE Q + G
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 233 LQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV--------T 284
L+ H +G HRD+K +N+L+ G + D G N + + + + T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 285 LWYRAPELLLGATDYGVG--IDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPS 342
+ YRAPEL + + D+WS GC+L M G P + +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG--P-----------YDMVFQKG 253
Query: 343 EDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402
+ ++ + + L++ LL++++ +DP R L
Sbjct: 254 DSVALAVQNQLSIPQSPRHSSALWQ-----------LLNSMMTVDPHQRPHIPLLLSQLE 302
Query: 403 FFTSPL 408
P
Sbjct: 303 ALQPPA 308
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-52
Identities = 73/299 (24%), Positives = 121/299 (40%), Gaps = 23/299 (7%)
Query: 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQK 180
++ ++ +++G G + V + + +DTG+ VA+K+ + + S P + + EI I++K
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS-PKNRERWCLEIQIMKK 68
Query: 181 LDHPNIVKL----EGLATSRMQYSLYLVFEFMQT-DLARIISNPE--GKLTEP------Q 227
L+HPN+V +GL L E+ + DL + ++ E L E
Sbjct: 69 LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNG---VLKIADFGLANYFSPNKKRPLTSRVVT 284
+ S L++ H+ I+HRD+K N+++ + KI D G A + T V T
Sbjct: 129 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--CTEFVGT 186
Query: 285 LWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSED 344
L Y APELL Y V +D WS G L E G + Q H + +
Sbjct: 187 LQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245
Query: 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
+ L + F L + E L +L RG+ F
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLER---WLQCMLMWHQRQRGTDPQNPNVGCF 301
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-52
Identities = 63/310 (20%), Positives = 120/310 (38%), Gaps = 62/310 (20%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
++ I +G+G + V++A ++ A+K+++ E K M RE+ L KL+HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM-REVKALAKLEHP 63
Query: 185 NIVK----------LEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEP------- 226
IV+ E L S + LY+ + + +L ++
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 227 -QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA-----------NYFSPNK 274
Q+ ++ H +G++HRD+K SN+ + V+K+ DFGL
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRI 334
T +V T Y +PE + G Y +D++S G +L E+ + P T++E++ +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFEL-----LYPFSTQMERVRTL 237
Query: 335 FKLC-GSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS 393
+ P + ++ +L+ P R
Sbjct: 238 TDVRNLKFPPL-------------FTQKYPCEYV-----------MVQDMLSPSPMERPE 273
Query: 394 AASALKNEFF 403
A + ++N F
Sbjct: 274 AINIIENAVF 283
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-51
Identities = 91/336 (27%), Positives = 155/336 (46%), Gaps = 47/336 (13%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKLDH 183
+ Y +G+G++ V D+ TG+ A+K + K + + + RE+ +L++LDH
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFMQ-TDL-ARIISNPEGKLTEP------QQLLSGLQH 235
PNI+KL + + YLV E +L IIS + +E +Q+LSG+ +
Sbjct: 86 PNIMKLYEFFEDKGYF--YLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITY 141
Query: 236 CHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPEL 292
H I+HRD+K NLL+ K+ ++I DFGL+ +F +KK + ++ T +Y APE+
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MKDKIGTAYYIAPEV 199
Query: 293 LLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPS--EDYWKKLR 350
L G Y D+WS G +L + G P G E + L ++ K G + WKK+
Sbjct: 200 LHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--GKYTFELPQWKKV- 254
Query: 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLAC 410
ES+ L+ +L P+ R SA AL +E+ T
Sbjct: 255 ----------------------SESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQ 292
Query: 411 DLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTL 446
+P + + + + +K+ +A + + L
Sbjct: 293 ISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKL 328
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 1e-50
Identities = 92/337 (27%), Positives = 147/337 (43%), Gaps = 49/337 (14%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
E Y ++ K+G G Y V D+ T A+K ++ + S + E+ +L+ LDHP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQ-TDL-ARIISNPEGKLTEP------QQLLSGLQHC 236
NI+KL + Y YLV E + +L II K E +Q+LSG+ +
Sbjct: 97 NIMKLYDFFEDKRNY--YLVMECYKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYL 152
Query: 237 HDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELL 293
H I+HRD+K NLL+ +K+ ++KI DFGL+ F KK + R+ T +Y APE+L
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK--MKERLGTAYYIAPEVL 210
Query: 294 LGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353
Y D+WS G +L + G P G+T+ E L ++ K + WK +
Sbjct: 211 RK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV---- 264
Query: 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK----NEFFFTSPLA 409
E + L+ +L D R SA AL+ E
Sbjct: 265 -------------------SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESG 305
Query: 410 CDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTL 446
+L L + + + +K+ +A + + + L
Sbjct: 306 IELPSLANAIEN---MRKFQNSQKLAQAALLYMASKL 339
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-50
Identities = 92/356 (25%), Positives = 159/356 (44%), Gaps = 62/356 (17%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALK---KVKFDTSEPHSVKFMAREIMILQKL 181
E Y+ + +G+G++ V K DR T + A+K K + ++ RE+ +L+KL
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL---REVELLKKL 78
Query: 182 DHPNIVKLEGLATSRMQYSLYLVFEFMQ-TDL-ARIISNPEGKLTEP------QQLLSGL 233
DHPNI+KL + + Y+V E +L II + +E +Q+ SG+
Sbjct: 79 DHPNIMKLFEILEDSSSF--YIVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGI 134
Query: 234 QHCHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAP 290
+ H I+HRD+K N+L+ +K+ +KI DFGL+ F N K + R+ T +Y AP
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRIGTAYYIAP 192
Query: 291 ELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPS--EDYWKK 348
E+L G Y D+WSAG +L + G P G+ E + L R+ G + W+
Sbjct: 193 EVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--GKYAFDLPQWRT 248
Query: 349 LRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK----NEFFF 404
+ + + L+ +L P+ R +A L+ ++
Sbjct: 249 I-----------------------SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285
Query: 405 TSPLACDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQASQLTK 460
+P DL L + + ++K+ +A + + + L D+ QLT+
Sbjct: 286 ETPTISDLPSLESAMTN---IRQFQAEKKLAQAALLYMASKLTTL---DETKQLTE 335
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-50
Identities = 79/290 (27%), Positives = 125/290 (43%), Gaps = 38/290 (13%)
Query: 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQ 179
+ ++ K+G+G +S VY+A G VALKKV+ + +EI +L+
Sbjct: 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLK 87
Query: 180 KLDHPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISN---PEGKLTEPQ------QL 229
+L+HPN++K + L +V E DL+R+I + + + E QL
Sbjct: 88 QLNHPNVIKYYA--SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 230 LSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRA 289
S L+H H R ++HRD+K +N+ I GV+K+ D GL +FS +K S V T +Y +
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMS 204
Query: 290 PELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349
PE + Y D+WS GCLL EM + P + L+ + K K
Sbjct: 205 PERIHE-NGYNFKSDIWSLGCLLYEMAALQS--PFYGDKMNLYSLCK----------KIE 251
Query: 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
+ P Y L + L++ + DP R
Sbjct: 252 QCDYPPLPSDHYSEELRQ-----------LVNMCINPDPEKRPDVTYVYD 290
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 3e-49
Identities = 83/338 (24%), Positives = 147/338 (43%), Gaps = 53/338 (15%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVK-----------FDTSEPHSVKFMAR 173
ESY K+ K+G G Y V +++ A+K +K + + + +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 174 EIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ-TDL-ARIISNPEGKLTEPQ---- 227
EI +L+ LDHPNI+KL + + + YLV EF + +L +II+ K E
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYF--YLVTEFYEGGELFEQIIN--RHKFDECDAANI 151
Query: 228 --QLLSGLQHCHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNKKRPLTSRV 282
Q+LSG+ + H I+HRD+K N+L+ + +KI DFGL+++FS + K L R+
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK--LRDRL 209
Query: 283 VTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPS 342
T +Y APE+L Y D+WS G ++ + G P G+ + + + ++ K
Sbjct: 210 GTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267
Query: 343 EDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402
+ WK + + + L+ +L D R +A AL + +
Sbjct: 268 FNDWKNI-----------------------SDEAKELIKLMLTYDYNKRCTAEEALNSRW 304
Query: 403 FFTSPLACDLSGLPVIYDKEDELIEANQQRKIRRARMK 440
+ S + + + +K+ +A +
Sbjct: 305 IKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAIL 342
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 4e-49
Identities = 75/296 (25%), Positives = 129/296 (43%), Gaps = 50/296 (16%)
Query: 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQ 179
P+S Y + +G+G ++ ++ D DT ++ A K V K +PH + M+ EI I +
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 180 KLDHPNIVKLEG-LATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEP------QQLLS 231
L H ++V G + +++V E + L + LTEP +Q++
Sbjct: 71 SLAHQHVVGFHGFFEDND---FVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVL 126
Query: 232 GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPE 291
G Q+ H ++HRD+K NL ++++ +KI DFGLA + +R T Y APE
Sbjct: 127 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPE 185
Query: 292 LLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351
+L + +D+WS GC++ + +G+P P E L
Sbjct: 186 VLSK-KGHSFEVDVWSIGCIMYTLLVGKP--------------------PFETS----CL 220
Query: 352 STTFRPPQSYKPRLFEAFSEFPES-SLG---LLSTLLALDPAYRGSAASALKNEFF 403
T+ R+ + P+ + L+ +L DP R + L +EFF
Sbjct: 221 KETYL-------RIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 269
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-49
Identities = 88/352 (25%), Positives = 142/352 (40%), Gaps = 73/352 (20%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALK---KVKFDTSEPHSVKFMA---REIMIL 178
+ Y +G G V A +R T K VA+K K KF EI IL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 179 QKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT----DLARIISNPEGKLTEP------QQ 228
+KL+HP I+K++ + Y+V E M+ D +++ N +L E Q
Sbjct: 70 KKLNHPCIIKIKNFFDAE---DYYIVLELMEGGELFD--KVVGN--KRLKEATCKLYFYQ 122
Query: 229 LLSGLQHCHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNKKRPLTSRVVTL 285
+L +Q+ H+ GI+HRD+K N+L+ +++ ++KI DFG + + + T
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--MRTLCGTP 180
Query: 286 WYRAPELLLGATD--YGVGIDLWSAGCLLAEMFLGRPIMP---GRTEVEQLHRIFKLCGS 340
Y APE+L+ Y +D WS G +L G P P RT+V +I G
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI--TSGK 236
Query: 341 ---PSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASA 397
E W + +S E +L L+ LL +DP R + A
Sbjct: 237 YNFIPE-VWAE--VS---------------------EKALDLVKKLLVVDPKARFTTEEA 272
Query: 398 LKNEFFFTSPLACDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRER 449
L++ + + +D L E N+ + + + + R R
Sbjct: 273 LRHPWL---------QDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPR 315
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-48
Identities = 82/293 (27%), Positives = 134/293 (45%), Gaps = 56/293 (19%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALK---KVKFDTSEPHSVKFMAREIMILQKL 181
E Y+ + +G+G++ V K DR T + A+K K + ++ RE+ +L+KL
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL---REVELLKKL 78
Query: 182 DHPNIVKLEGLATSRMQYSLYLVFEFMQT----DLARIISNPEGKLTEP------QQLLS 231
DHPNI+KL + + Y+V E D II + +E +Q+ S
Sbjct: 79 DHPNIMKLFEILEDSSSF--YIVGELYTGGELFD--EIIK--RKRFSEHDAARIIKQVFS 132
Query: 232 GLQHCHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYR 288
G+ + H I+HRD+K N+L+ +K+ +KI DFGL+ F N K + R+ T +Y
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRIGTAYYI 190
Query: 289 APELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPS--EDYW 346
APE+L G Y D+WSAG +L + G P G+ E + L R+ G + W
Sbjct: 191 APEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYAFDLPQW 246
Query: 347 KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
+ +S + + L+ +L P+ R +A L+
Sbjct: 247 RT--IS---------------------DDAKDLIRKMLTFHPSLRITATQCLE 276
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-48
Identities = 44/317 (13%), Positives = 84/317 (26%), Gaps = 60/317 (18%)
Query: 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHP 184
++ + G S V+ D + + ALK + ++ + +L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 185 N------------------------IVKLEGLATSRMQYSLYLVFEFMQTDLARIIS--- 217
+ +L + L+ DL + S
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 218 ---NPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLAN 268
G QL+ + +G++H NL I +G L + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 269 YFSPNKKRPLTSRVVTLWYRAPELLLG-ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE 327
+ V + Y E L + ++ W G + ++ P
Sbjct: 243 KVG----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL--P---- 292
Query: 328 VEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALD 387
F L + WK+ L + F + + P+ L+ L D
Sbjct: 293 -------FGLVTPGIKGSWKRPSLRVPGTDSLA-----FGSCTPLPDFVKTLIGRFLNFD 340
Query: 388 PAYRGSAASALKNEFFF 404
R A++ F
Sbjct: 341 RRRRLLPLEAMETPEFL 357
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-48
Identities = 75/296 (25%), Positives = 129/296 (43%), Gaps = 50/296 (16%)
Query: 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQ 179
P+S Y + +G+G ++ ++ D DT ++ A K V K +PH + M+ EI I +
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96
Query: 180 KLDHPNIVKLEG-LATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEP------QQLLS 231
L H ++V G + +++V E + L + LTEP +Q++
Sbjct: 97 SLAHQHVVGFHGFFEDND---FVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVL 152
Query: 232 GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPE 291
G Q+ H ++HRD+K NL ++++ +KI DFGLA + +R T Y APE
Sbjct: 153 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPE 211
Query: 292 LLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351
+L + +D+WS GC++ + +G+P P E L
Sbjct: 212 VLSK-KGHSFEVDVWSIGCIMYTLLVGKP--------------------PFETS----CL 246
Query: 352 STTFRPPQSYKPRLFEAFSEFPES-SLG---LLSTLLALDPAYRGSAASALKNEFF 403
T+ R+ + P+ + L+ +L DP R + L +EFF
Sbjct: 247 KETYL-------RIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 295
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-48
Identities = 80/297 (26%), Positives = 134/297 (45%), Gaps = 41/297 (13%)
Query: 116 LAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMARE 174
LA + + E + + +G+G+++ VY+A TG VA+K + K + V+ + E
Sbjct: 2 LATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNE 61
Query: 175 IMILQKLDHPNIVKLEG-LATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEP------ 226
+ I +L HP+I++L S +YLV E ++ R + N +E
Sbjct: 62 VKIHCQLKHPSILELYNYFEDSNY---VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFM 118
Query: 227 QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLW 286
Q+++G+ + H GILHRD+ SNLL+ +N +KIADFGLA ++ T T
Sbjct: 119 HQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-CGTPN 177
Query: 287 YRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW 346
Y +PE+ + +G+ D+WS GC+ + +GRP T L+++
Sbjct: 178 YISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL---------- 226
Query: 347 KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
+ P S + L+ LL +PA R S +S L + F
Sbjct: 227 ------ADYEMP-----------SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 7e-48
Identities = 77/351 (21%), Positives = 125/351 (35%), Gaps = 62/351 (17%)
Query: 74 SGEQRVRDNGTGTGTGKSGGGVDGKLVNGWPKWLTDNIPREVLAGLVPKSAES------Y 127
SG + K+ KL P+ DN + L P E
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPE-TEDNEGVLLTEKLKPVDYEYREEVHWM 60
Query: 128 DKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIV 187
+VG+G++ V++ D+ TG A+KKV+ + E++ L P IV
Sbjct: 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIV 113
Query: 188 KLEGLATSRMQYSLYLVFEFMQ----TDLARIISNPEGKLTEPQ------QLLSGLQHCH 237
L G R + + E ++ L + G L E + Q L GL++ H
Sbjct: 114 PLYG--AVREGPWVNIFMELLEGGSLGQLIK----QMGCLPEDRALYYLGQALEGLEYLH 167
Query: 238 DRGILHRDVKGSNLLIDKNGVL-KIADFGLANYFSPNKKRPLTSRVVTL----WYRAPEL 292
R ILH DVK N+L+ +G + DFG A P+ + + APE+
Sbjct: 168 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 293 LLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352
++G +D+WS+ C++ M G P T+ + K+ P
Sbjct: 228 VMG-KPCDAKVDIWSSCCMMLHMLNGCH--P-WTQYFRGPLCLKIASEP----------- 272
Query: 353 TTFRPPQSYKPRLF-EAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402
PP P ++ + L +P +R SA +
Sbjct: 273 ----PPIREIPPSCAPLTAQA-------IQEGLRKEPVHRASAMELRRKVG 312
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-47
Identities = 61/311 (19%), Positives = 109/311 (35%), Gaps = 70/311 (22%)
Query: 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-D 182
+ +++K+G G + +V+K + R G I A+K+ K + + RE+ L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 183 HPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIIS---NPEGKLTEPQ------QLLSG 232
H ++V+ + + E+ LA IS E + Q+ G
Sbjct: 70 HSHVVRYFS--AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 233 LQHCHDRGILHRDVKGSNLLIDKNGVL-------------------KIADFGLANYFSPN 273
L++ H ++H D+K SN+ I + + KI D G S
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187
Query: 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHR 333
+ + A E+L + D+++ + P+
Sbjct: 188 Q-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL------------ 230
Query: 334 IFKLCGSPSE-DYWKKLRLSTTFRPPQSYKPRLFEAFS-EFPESSLGLLSTLLALDPAYR 391
P D W ++R Q PR+ + S EF E LL ++ DP R
Sbjct: 231 -------PRNGDQWHEIR--------QGRLPRIPQVLSQEFTE----LLKVMIHPDPERR 271
Query: 392 GSAASALKNEF 402
SA + +K+
Sbjct: 272 PSAMALVKHSV 282
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-47
Identities = 74/297 (24%), Positives = 129/297 (43%), Gaps = 55/297 (18%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALK---KVKFDTSEPHSVKFMAREIMILQKL 181
++YD +++G+G +S V + + + TG A K K + ++ RE I +KL
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKL 62
Query: 182 DHPNIVKLEGLATSRMQYSLYLVFEFMQT-DLA-RIISNPEGKLTEP------QQLLSGL 233
HPNIV+L + YLVF+ + +L I++ +E QQ+L +
Sbjct: 63 QHPNIVRLHDSIQEESFH--YLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESI 118
Query: 234 QHCHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAP 290
+CH GI+HR++K NLL+ K +K+ADFGLA + ++ T Y +P
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLSP 176
Query: 291 ELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMP--GRTEVEQLHRIFKLCGSPS--EDYW 346
E+L Y +D+W+ G +L + +G P P + +I G+ W
Sbjct: 177 EVLKK-DPYSKPVDIWACGVILYILLVGYP--PFWDEDQHRLYAQI--KAGAYDYPSPEW 231
Query: 347 KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
++ + L+ ++L ++P R +A ALK +
Sbjct: 232 DT--VT---------------------PEAKSLIDSMLTVNPKKRITADQALKVPWI 265
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 1e-47
Identities = 80/303 (26%), Positives = 131/303 (43%), Gaps = 58/303 (19%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALK---KVKFDTSEPHSVKFMA---REIMIL 178
+ Y +G G V A +R T K VA++ K KF EI IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 179 QKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT-DL-ARIISNPEGKLTEP------QQLL 230
+KL+HP I+K++ + Y+V E M+ +L +++ N +L E Q+L
Sbjct: 195 KKLNHPCIIKIKNFFDAE---DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQML 249
Query: 231 SGLQHCHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWY 287
+Q+ H+ GI+HRD+K N+L+ +++ ++KI DFG + + + T Y
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--MRTLCGTPTY 307
Query: 288 RAPELLLGATD--YGVGIDLWSAGCLLAEMFLGRPIMP---GRTEVEQLHRIFKLCGSPS 342
APE+L+ Y +D WS G +L G P P RT+V +I G +
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI--TSGKYN 363
Query: 343 --EDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400
+ W + +S E +L L+ LL +DP R + AL++
Sbjct: 364 FIPEVWAE--VS---------------------EKALDLVKKLLVVDPKARFTTEEALRH 400
Query: 401 EFF 403
+
Sbjct: 401 PWL 403
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-47
Identities = 85/377 (22%), Positives = 152/377 (40%), Gaps = 54/377 (14%)
Query: 112 PREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALK---KVKFDTSEPHSV 168
E + K +++YD +++G+G +S V + + + TG A K K + +
Sbjct: 16 GSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL 75
Query: 169 KFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT-DLA-RIISNPEGKLTEP 226
+ RE I +KL HPNIV+L YLVF+ + +L I++ +E
Sbjct: 76 E---REARICRKLQHPNIVRLHDSIQEES--FHYLVFDLVTGGELFEDIVA--REFYSEA 128
Query: 227 ------QQLLSGLQHCHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNKKRP 277
QQ+L + +CH GI+HR++K NLL+ K +K+ADFGLA + ++
Sbjct: 129 DASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-- 186
Query: 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKL 337
T Y +PE+L Y +D+W+ G +L + +G P + +I
Sbjct: 187 WHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--K 243
Query: 338 CGSPS--EDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAA 395
G+ W ++ + L+ ++L ++P R +A
Sbjct: 244 AGAYDYPSPEWDT--VT---------------------PEAKSLIDSMLTVNPKKRITAD 280
Query: 396 SALKNEFFFTSPLACDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQA 455
ALK + D L + N +RK++ A + T +G
Sbjct: 281 QALKVPWICNRERVASAIHRQDT---VDCLKKFNARRKLKGAILTTMIATRNLSNLGRNL 337
Query: 456 SQLTKEETLSNKEDSEK 472
++ S ++S +
Sbjct: 338 LNKKEQGPPSTIKESSE 354
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-47
Identities = 74/304 (24%), Positives = 128/304 (42%), Gaps = 58/304 (19%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALK---KVKFDTSEPHSVK----FMAREIMI 177
E+Y+ + +G+G S V + + + T K A+K + V+ +E+ I
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 178 LQKLD-HPNIVKLEGLATSRMQYSLYLVFEFMQT----DLARIISNPEGKLTEP------ 226
L+K+ HPNI++L+ + +LVF+ M+ D + L+E
Sbjct: 77 LRKVSGHPNIIQLKDTYETNT--FFFLVFDLMKKGELFD--YLTEK--VTLSEKETRKIM 130
Query: 227 QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLW 286
+ LL + H I+HRD+K N+L+D + +K+ DFG + P +K L T
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPS 188
Query: 287 YRAPELLLGATD-----YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSP 341
Y APE++ + + YG +D+WS G ++ + G P R ++ L I + G+
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--MSGNY 246
Query: 342 S--EDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
W S ++ L+S L + P R +A AL
Sbjct: 247 QFGSPEWDD--YS---------------------DTVKDLVSRFLVVQPQKRYTAEEALA 283
Query: 400 NEFF 403
+ FF
Sbjct: 284 HPFF 287
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-47
Identities = 94/362 (25%), Positives = 152/362 (41%), Gaps = 71/362 (19%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALK---KVKFDTSEPHSVKFMAREIMILQKL 181
+ Y+ + +G+G +S V + ++R+TG+ A+K KF +S S + + RE I L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 182 DHPNIVKLEGLATSRMQYSLYLVFEFMQ-TDLA-RIIS--NPEGKLTEP------QQLLS 231
HP+IV+L +S LY+VFEFM DL I+ + +E +Q+L
Sbjct: 84 KHPHIVELLETYSSDG--MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 232 GLQHCHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYR 288
L++CHD I+HRDVK +L+ + + +K+ FG+A + RV T +
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-AGGRVGTPHFM 200
Query: 289 APELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK 348
APE++ YG +D+W G +L I+ L G
Sbjct: 201 APEVVKR-EPYGKPVDVWGCGVILF-------IL--------------LSGCL------- 231
Query: 349 LRLSTTFRPPQSYKPRLFEA-------FS--EFPESSLG---LLSTLLALDPAYRGSAAS 396
P K RLFE + ++ S L+ +L LDPA R +
Sbjct: 232 --------PFYGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYE 283
Query: 397 ALKNEFFFTSPLACDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQAS 456
AL + + LP ++L + N +RK++ A + S GD
Sbjct: 284 ALNHPWLKERDRYAYKIHLPETV---EQLRKFNARRKLKGAVLAAVSSHKFNSFYGDPPE 340
Query: 457 QL 458
+L
Sbjct: 341 EL 342
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 7e-47
Identities = 69/328 (21%), Positives = 138/328 (42%), Gaps = 51/328 (15%)
Query: 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPH-SVKFMAREIMILQKLD 182
+ + + ++G G++ VY A D ++VA+KK+ + + + + + +E+ LQKL
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 183 HPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHC 236
HPN ++ G +++ +LV E+ + ++ + L E + L GL +
Sbjct: 113 HPNTIQYRG--CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGA 296
H ++HRDVK N+L+ + G++K+ DFG A+ + S V T ++ APE++L
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---PA--NSFVGTPYWMAPEVILAM 225
Query: 297 TD--YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354
+ Y +D+WS G E+ +P P + + ++ + +
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKP--P-LFNMNAMSALYHIAQNE------------- 269
Query: 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDLSG 414
P E F F + + L P R ++ LK+ F +
Sbjct: 270 --SPALQSGHWSEYFRNF-------VDSCLQKIPQDRPTSEVLLKHRFVLR---ERPPTV 317
Query: 415 LPVIYDKEDELIEANQQRKIRRARMKHR 442
+ +LI+ + +++R
Sbjct: 318 IM-------DLIQRTKDAVRELDNLQYR 338
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 7e-47
Identities = 84/380 (22%), Positives = 153/380 (40%), Gaps = 58/380 (15%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
E Y +++G+G +S V + + G+ A + + + RE I + L HP
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQ-TDLA-RIISNPEGKLTEP------QQLLSGLQHC 236
NIV+L + + YL+F+ + +L I++ +E QQ+L + HC
Sbjct: 71 NIVRLHDSISEEGHH--YLIFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHC 126
Query: 237 HDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELL 293
H G++HR++K NLL+ K +K+ADFGLA ++ T Y +PE+L
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA-WFGFAGTPGYLSPEVL 185
Query: 294 LGATDYGVGIDLWSAGCLLAEMFLGRPIMP--GRTEVEQLHRIFKLCGSPS--EDYWKKL 349
YG +DLW+ G +L + +G P P + +I G+ W
Sbjct: 186 RK-DPYGKPVDLWACGVILYILLVGYP--PFWDEDQHRLYQQI--KAGAYDFPSPEWDT- 239
Query: 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLA 409
++ + L++ +L ++P+ R +AA ALK+ +
Sbjct: 240 -VT---------------------PEAKDLINKMLTINPSKRITAAEALKHPWISHRSTV 277
Query: 410 CDLSGLPVIYDKEDELIEANQQRKIRRA--RMKHRSKTLRERRIGDQASQLTKEETLSNK 467
D L + N +RK++ A + ++ R+ ++ K +
Sbjct: 278 ASCMHRQETVDC---LKKFNARRKLKGAILTVMLATRNFSVRKQ-----EIIKVTEQLIE 329
Query: 468 EDSEKHVELNFQGQEPYSSA 487
S E + +P +A
Sbjct: 330 AISNGDFESYTKMCDPGMTA 349
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-46
Identities = 70/320 (21%), Positives = 113/320 (35%), Gaps = 57/320 (17%)
Query: 104 PKWLTDNIPREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS 163
P D+ E +V K S+ D +G G + + VA+K++
Sbjct: 5 PSLEQDDGDEETSVVIVGK--ISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRIL---- 57
Query: 164 EPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGK 222
P F RE+ +L++ D HPN+++ R Y+ E L + +
Sbjct: 58 -PECFSFADREVQLLRESDEHPNVIRYFCTEKDRQ--FQYIAIELCAATLQEYVEQKDFA 114
Query: 223 LTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNG-----VLKIADFGLANYFS 271
QQ SGL H H I+HRD+K N+LI I+DFGL +
Sbjct: 115 HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174
Query: 272 PNKK--RPLTSRVVTLWYRAPELLLGATD--YGVGIDLWSAGCLLAEMFL-GRPIMPGRT 326
+ + T + APE+L +D++SAGC+ + G
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234
Query: 327 EVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLG---LLSTL 383
+ + L G+ S + + L+ +
Sbjct: 235 Q----RQANILLGACS-----------------------LDCLHPEKHEDVIARELIEKM 267
Query: 384 LALDPAYRGSAASALKNEFF 403
+A+DP R SA LK+ FF
Sbjct: 268 IAMDPQKRPSAKHVLKHPFF 287
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-46
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 129 KIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVK 188
+G+GTY VY D +A+K++ S + + EI + + L H NIV+
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR--YSQPLHEEIALHKHLKHKNIVQ 83
Query: 189 LEGLATSRMQYSLYLVFEFMQTD-LARIISNPEGKL--TEPQ------QLLSGLQHCHDR 239
G + + + E + L+ ++ + G L E Q+L GL++ HD
Sbjct: 84 YLG--SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 240 GILHRDVKGSNLLID-KNGVLKIADFGLANYFSPNKKRPLTSRVV-TLWYRAPELLLGAT 297
I+HRD+KG N+LI+ +GVLKI+DFG + + T TL Y APE++
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGP 199
Query: 298 D-YGVGIDLWSAGCLLAEMFLGRP 320
YG D+WS GC + EM G+P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKP 223
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 5e-46
Identities = 75/290 (25%), Positives = 122/290 (42%), Gaps = 52/290 (17%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ Y + +G+G++ V A+ + T A KK+ V +EI I++ LDHP
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKI--PKYFVEDVDRFKQEIEIMKSLDHP 66
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQT----DLARIISNPEGKLTEP------QQLLSGLQ 234
NI++L YLV E + R++ + E + +LS +
Sbjct: 67 NIIRLYETFEDNTDI--YLVMELCTGGELFE--RVVH--KRVFRESDAARIMKDVLSAVA 120
Query: 235 HCHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPE 291
+CH + HRD+K N L + LK+ DFGLA F P K + ++V T +Y +P+
Sbjct: 121 YCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRTKVGTPYYVSPQ 178
Query: 292 LLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPS--EDYWKKL 349
+L G YG D WSAG ++ + G P T+ E + +I G+ + E W
Sbjct: 179 VLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFTFPEKDWLN- 233
Query: 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
+S + L+ LL P R ++ AL+
Sbjct: 234 -VS---------------------PQAESLIRRLLTKSPKQRITSLQALE 261
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 5e-46
Identities = 72/311 (23%), Positives = 127/311 (40%), Gaps = 58/311 (18%)
Query: 110 NIPREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALK-----KVKFDT-S 163
+ E LA + ++ Y + +G G + V+ A+D++ K V +K KV D
Sbjct: 9 AVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWI 68
Query: 164 EPHSVKFMAREIMILQKLDHPNIVKL-EGLATSRMQYSLYLVFEFMQT--DL-ARIISNP 219
E + + EI IL +++H NI+K+ + LV E + DL A I +
Sbjct: 69 EDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF---FQLVMEKHGSGLDLFAFIDRH- 124
Query: 220 EGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273
+L EP +QL+S + + + I+HRD+K N++I ++ +K+ DFG A Y
Sbjct: 125 -PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183
Query: 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHR 333
K + T+ Y APE+L+G G +++WS G L +
Sbjct: 184 KL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTL------------------ 223
Query: 334 IFKLCGS-PSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG 392
+ P + + + PP + + L+S LL P R
Sbjct: 224 ---VFEENPFCELEE--TVEAAIHPP-----------YLVSKELMSLVSGLLQPVPERRT 267
Query: 393 SAASALKNEFF 403
+ + + +
Sbjct: 268 TLEKLVTDPWV 278
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 6e-46
Identities = 82/293 (27%), Positives = 125/293 (42%), Gaps = 58/293 (19%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+++ ++ +G G +S V+ R TGK+ ALK +K S + EI +L+K+ H
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK--KSPAFRDSSLENEIAVLKKIKHE 66
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTDLA-------RIISNPEGKLTEP------QQLLS 231
NIV LE + S Y YLV + L RI+ G TE QQ+LS
Sbjct: 67 NIVTLEDIYESTTHY--YLVMQ-----LVSGGELFDRILE--RGVYTEKDASLVIQQVLS 117
Query: 232 GLQHCHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYR 288
+++ H+ GI+HRD+K NLL ++N + I DFGL+ +++ T Y
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---MSTACGTPGYV 174
Query: 289 APELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPS--EDYW 346
APE+L Y +D WS G + + G P TE + +I + G +W
Sbjct: 175 APEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE--GYYEFESPFW 231
Query: 347 KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
+S ES+ + LL DP R + AL
Sbjct: 232 DD--IS---------------------ESAKDFICHLLEKDPNERYTCEKALS 261
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 6e-46
Identities = 66/286 (23%), Positives = 112/286 (39%), Gaps = 42/286 (14%)
Query: 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLE 190
++G+G++ VYK LD +T VA +++ + E +L+ L HPNIV+
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 191 G--LATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCHDRG- 240
+T + + + LV E M + L + + Q+L GLQ H R
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 241 -ILHRDVKGSNLLID-KNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATD 298
I+HRD+K N+ I G +KI D GLA + + + + T + APE +
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPE--MYEEK 205
Query: 299 YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358
Y +D+++ G + EM P +E + +I++ S P
Sbjct: 206 YDESVDVYAFGMCMLEMATSEY--PY-SECQNAAQIYRRVTSGV--------------KP 248
Query: 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404
S+ E + + + R S L + FF
Sbjct: 249 ASFDKVAIPEVKEI-------IEGCIRQNKDERYSIKDLLNHAFFQ 287
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-45
Identities = 63/310 (20%), Positives = 113/310 (36%), Gaps = 49/310 (15%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVK---------------FDTSEPHSVKFM 171
Y I + QG ++ + K ALKK + S
Sbjct: 33 YRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 172 AREIMILQKLDHPNIVKL-EGLATSRMQYSLYLVFEFMQ--------TDLARIISNPEGK 222
E+ I+ + + + + +Y+++E+M+ + N
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYD---EVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 223 LTEP------QQLLSGLQHCHD-RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275
+ + +L+ + H+ + I HRDVK SN+L+DKNG +K++DFG + Y K
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK- 206
Query: 276 RPLTSRVVTLWYRAPELLLGATDY-GVGIDLWSAGCLLAEMFLGR-PIMPGRTEVEQLHR 333
+ T + PE + Y G +D+WS G L MF P + VE +
Sbjct: 207 --IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264
Query: 334 IFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS 393
I ++ + L + + + + L L +PA R +
Sbjct: 265 IRT------KNI--EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT 316
Query: 394 AASALKNEFF 403
+ ALK+E+
Sbjct: 317 SEDALKHEWL 326
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-45
Identities = 80/290 (27%), Positives = 128/290 (44%), Gaps = 46/290 (15%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALK---KVKFDTSEPHSVKFMAREIMILQKLDH 183
+D + +G+G Y V A++R T + VA+K + + +K +EI I + L+H
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IK---KEICINKMLNH 64
Query: 184 PNIVKL-EGLATSRMQYSLYLVFEFMQT-DL-ARIISNPEGKLTEP------QQLLSGLQ 234
N+VK + YL E+ +L RI + + EP QL++G+
Sbjct: 65 ENVVKFYGHRREGNI---QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVV 119
Query: 235 HCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELL 293
+ H GI HRD+K NLL+D+ LKI+DFGLA F N + R L TL Y APELL
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 294 LGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353
+ +D+WS G +L M G +P + ++Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LP-----------WDQPSDSCQEYSDWKE-KK 225
Query: 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
T+ P + + + L LL +L +P+ R + K+ ++
Sbjct: 226 TYLNP----------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 6e-45
Identities = 82/305 (26%), Positives = 128/305 (41%), Gaps = 61/305 (20%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALK---KVKFDTSE---PHSVKFMAREIMIL 178
+ YD D +G+G S V + + R TG A+K S + RE IL
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 179 QKL-DHPNIVKLEGLATSRMQYSLYLVFEFMQT----DLARIISNPEGKLTEP------Q 227
+++ HP+I+ L S ++LVF+ M+ D + L+E +
Sbjct: 154 RQVAGHPHIITLIDSYESSS--FMFLVFDLMRKGELFD--YLTEK--VALSEKETRSIMR 207
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWY 287
LL + H I+HRD+K N+L+D N ++++DFG + + P +K L T Y
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPGY 265
Query: 288 RAPELLLGATD-----YGVGIDLWSAGCLLAEMFLGRPIMP--GRTEVEQLHRIFKLCGS 340
APE+L + D YG +DLW+ G +L + G P P R ++ L I + G
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP--PFWHRRQILMLRMI--MEGQ 321
Query: 341 PS--EDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASAL 398
W S + L+S LL +DP R +A AL
Sbjct: 322 YQFSSPEWDD--RS---------------------STVKDLISRLLQVDPEARLTAEQAL 358
Query: 399 KNEFF 403
++ FF
Sbjct: 359 QHPFF 363
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 8e-45
Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 52/290 (17%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKLDHPN 185
++ +G+G + NVY A ++ + I+ALK + K + + RE+ I L HPN
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 186 IVKLEG-LATSRMQYSLYLVFEF-----MQTDLARIISNPEGKLTEP------QQLLSGL 233
I++L G + +YL+ E+ + +L + K E +L + L
Sbjct: 71 ILRLYGYFHDAT---RVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANAL 122
Query: 234 QHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELL 293
+CH + ++HRD+K NLL+ G LKIADFG + + +P+ +R T TL Y PE++
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRR--TDLCGTLDYLPPEMI 179
Query: 294 LGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353
G + +DLWS G L E +G+P T E RI ++
Sbjct: 180 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------- 222
Query: 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
F P E + L+S LL +P+ R L++ +
Sbjct: 223 EFTFPDF-----------VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 9e-45
Identities = 70/292 (23%), Positives = 123/292 (42%), Gaps = 52/292 (17%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKLDH 183
+ + K+G G + +V+ +R +G +K + K + P ++ + EI +L+ LDH
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDH 79
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFMQT----DLARIISNP--EGKLTEP------QQLLS 231
PNI+K+ + Y+V E + + RI+S L+E +Q+++
Sbjct: 80 PNIIKIFEVFEDYHNM--YIVMETCEGGELLE--RIVSAQARGKALSEGYVAELMKQMMN 135
Query: 232 GLQHCHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYR 288
L + H + ++H+D+K N+L + +KI DFGLA F ++ T+ T Y
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYM 193
Query: 289 APELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPS-EDYWK 347
APE+ D D+WSAG ++ + G G + E + P+ +
Sbjct: 194 APEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA--TYKEPNYAVECR 249
Query: 348 KLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
L+ ++ LL +L DP R SAA L
Sbjct: 250 P--LT---------------------PQAVDLLKQMLTKDPERRPSAAQVLH 278
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-44
Identities = 85/340 (25%), Positives = 148/340 (43%), Gaps = 61/340 (17%)
Query: 108 TDNIPREVLAGLVPKS--AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP 165
+D E L +V + Y + +K+GQG VY A+D TG+ VA++++
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP- 59
Query: 166 HSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ----TDLARIISNPEG 221
+ + EI+++++ +PNIV + + L++V E++ TD+ E
Sbjct: 60 -KKELIINEILVMRENKNPNIVNYLD--SYLVGDELWVVMEYLAGGSLTDVVT-----ET 111
Query: 222 KLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK- 274
+ E Q + L L+ H ++HRD+K N+L+ +G +K+ DFG +P +
Sbjct: 112 CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171
Query: 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRI 334
KR ++ V T ++ APE++ YG +D+WS G + EM G P P L +
Sbjct: 172 KR--STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEP--P-YLNENPLRAL 225
Query: 335 FKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLF-EAFSEFPESSLGLLSTLLALDPAYRGS 393
+ + + P+ P F +F L+ L +D RGS
Sbjct: 226 YLIATNG---------------TPELQNPEKLSAIFRDF-------LNRCLEMDVEKRGS 263
Query: 394 AASALKNEFFFTSPLACDLSGLPVIYDKEDELIEANQQRK 433
A L+++F +A LS L LI A ++
Sbjct: 264 AKELLQHQFL---KIAKPLSSLT-------PLIAAAKEAT 293
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-44
Identities = 74/308 (24%), Positives = 127/308 (41%), Gaps = 52/308 (16%)
Query: 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQK 180
+ + Y+ + +G G + V A + VA+K++ + + S+ + +EI + +
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT-SMDELLKEIQAMSQ 69
Query: 181 LDHPNIVKLEGLATSRMQYSLYLVFEFMQ----TDLARIISN----PEGKLTEPQ----- 227
HPNIV + L+LV + + D+ + I G L E
Sbjct: 70 CHHPNIVSYYTSFVVK--DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 228 -QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFG----LANYFSPNKKRPLTSRV 282
++L GL++ H G +HRDVK N+L+ ++G ++IADFG LA + + + V
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 283 VTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPS 342
T + APE++ Y D+WS G E+ G P
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--------------------PY 227
Query: 343 EDY--WKKLRLSTTFRPPQ----SYKPRLFEAFS-EFPESSLGLLSTLLALDPAYRGSAA 395
Y K L L+ PP + + + F + ++S L DP R +AA
Sbjct: 228 HKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRK----MISLCLQKDPEKRPTAA 283
Query: 396 SALKNEFF 403
L+++FF
Sbjct: 284 ELLRHKFF 291
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-44
Identities = 80/290 (27%), Positives = 128/290 (44%), Gaps = 46/290 (15%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALK---KVKFDTSEPHSVKFMAREIMILQKLDH 183
+D + +G+G Y V A++R T + VA+K + + +K +EI I + L+H
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IK---KEICINKMLNH 64
Query: 184 PNIVKL-EGLATSRMQYSLYLVFEFMQT-DL-ARIISNPEGKLTEP------QQLLSGLQ 234
N+VK + YL E+ +L RI + + EP QL++G+
Sbjct: 65 ENVVKFYGHRREGNI---QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVV 119
Query: 235 HCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELL 293
+ H GI HRD+K NLL+D+ LKI+DFGLA F N + R L TL Y APELL
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 294 LGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353
+ +D+WS G +L M G +P + ++Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LP-----------WDQPSDSCQEYSDWKE-KK 225
Query: 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
T+ P + + + L LL +L +P+ R + K+ ++
Sbjct: 226 TYLNP----------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-44
Identities = 77/341 (22%), Positives = 144/341 (42%), Gaps = 61/341 (17%)
Query: 107 LTDNIPREVLAGLVPKS--AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE 164
+T + L +V + D K+G+G+ V A ++ +G+ VA+K + +
Sbjct: 25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ 84
Query: 165 PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ----TDLARIISNPE 220
+ + E++I++ H N+V++ + + L+++ EF+Q TD+ +
Sbjct: 85 --RRELLFNEVVIMRDYQHFNVVEMYK--SYLVGEELWVLMEFLQGGALTDIVS-----Q 135
Query: 221 GKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274
+L E Q +L L + H +G++HRD+K ++L+ +G +K++DFG S +
Sbjct: 136 VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 195
Query: 275 -KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHR 333
KR S V T ++ APE++ + Y +D+WS G ++ EM G P P +
Sbjct: 196 PKR--KSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEP--P-YFSDSPVQA 249
Query: 334 IFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLF-EAFSEFPESSLGLLSTLLALDPAYRG 392
+ +L SP PP+ +F L +L DP R
Sbjct: 250 MKRLRDSP---------------PPKLKNSHKVSPVLRDF-------LERMLVRDPQERA 287
Query: 393 SAASALKNEFFFTSPLACDLSGLPVIYDKEDELIEANQQRK 433
+A L + F L LI+ +++
Sbjct: 288 TAQELLDHPFL---LQTGLPECLV-------PLIQLYRKQT 318
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 3e-44
Identities = 81/289 (28%), Positives = 134/289 (46%), Gaps = 49/289 (16%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALK---KVKFDTSEPHSVKFMAREIMILQKLDH 183
Y + +G+G ++ V A TG+ VA+K K + + + + RE+ I++ L+H
Sbjct: 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF---REVRIMKILNH 73
Query: 184 PNIVKL-EGLATSRMQYSLYLVFEFMQT-DL-ARIISNPEGKLTEP------QQLLSGLQ 234
PNIVKL E + T + LYL+ E+ ++ ++++ G++ E +Q++S +Q
Sbjct: 74 PNIVKLFEVIETEKT---LYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQ 128
Query: 235 HCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLL 294
+CH + I+HRD+K NLL+D + +KIADFG +N F+ K L + Y APEL
Sbjct: 129 YCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDAFCGAPPYAAPELFQ 186
Query: 295 GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354
G G +D+WS G +L + G G+ E R+ L
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV----------------LRGK 230
Query: 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
+R P LL L L+P RG+ +K+ +
Sbjct: 231 YRIP-----------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 7e-44
Identities = 81/326 (24%), Positives = 150/326 (46%), Gaps = 57/326 (17%)
Query: 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH 183
E + K++K+G+G++ V+K +D T K+VA+K + + +E ++ + +EI +L + D
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-EIEDIQQEITVLSQCDS 79
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFMQ----TDLARIISNPEGKLTEPQ------QLLSGL 233
P + K G + L+++ E++ DL G L E Q ++L GL
Sbjct: 80 PYVTKYYG--SYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGL 132
Query: 234 QHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELL 293
+ H +HRD+K +N+L+ ++G +K+ADFG+A + + + T V T ++ APE++
Sbjct: 133 DYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVI 191
Query: 294 LGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353
+ Y D+WS G E+ G P P + + +
Sbjct: 192 KQS-AYDSKADIWSLGITAIELARGEP--P---------------------HSELHPMKV 227
Query: 354 TFRPPQSYKPRLFEAFS-EFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDL 412
F P++ P L +S E + L +P++R +A LK++F + A
Sbjct: 228 LFLIPKNNPPTLEGNYSKPLKE----FVEACLNKEPSFRPTAKELLKHKFILRN--AKKT 281
Query: 413 SGLPVIYDKEDELIEANQQRKIRRAR 438
S L ELI+ ++ K ++
Sbjct: 282 SYLT-------ELIDRYKRWKAEQSH 300
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 9e-44
Identities = 76/286 (26%), Positives = 124/286 (43%), Gaps = 44/286 (15%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKLDHPN 185
+D +G+G + NVY A ++ I+ALK + K + + REI I L HPN
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 186 IVKLEG-LATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEP------QQLLSGLQHCH 237
I+++ + +YL+ EF +L + + G+ E ++L L +CH
Sbjct: 76 ILRMYNYFHDRKR---IYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCH 131
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGAT 297
+R ++HRD+K NLL+ G LKIADFG + + +P+ +R + TL Y PE++ G
Sbjct: 132 ERKVIHRDIKPENLLMGYKGELKIADFGWSVH-APSLRR--RTMCGTLDYLPPEMIEG-K 187
Query: 298 DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357
+ +DLW AG L E +G P + E RI + +
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV----------------DLKF 231
Query: 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
P + S L+S LL P R +++ +
Sbjct: 232 P-----------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 90/330 (27%), Positives = 155/330 (46%), Gaps = 59/330 (17%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
E +D ++K+G+G+Y +VYKA+ ++TG+IVA+K+V + ++ + +EI I+Q+ D P
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSP 84
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQ----TDLARIISNPEGKLTEPQ------QLLSGLQ 234
++VK G + L++V E+ +D II LTE + L GL+
Sbjct: 85 HVVKYYG--SYFKNTDLWIVMEYCGAGSVSD---IIRLRNKTLTEDEIATILQSTLKGLE 139
Query: 235 HCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK-KRPLTSRVVTLWYRAPELL 293
+ H +HRD+K N+L++ G K+ADFG+A + KR + + T ++ APE++
Sbjct: 140 YLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR--NTVIGTPFWMAPEVI 197
Query: 294 LGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353
Y D+WS G EM G+P +H + + + +
Sbjct: 198 QEI-GYNCVADIWSLGITAIEMAEGKPPY------ADIHPM------------RAIFMIP 238
Query: 354 TFRPPQSYKPRLF-EAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDL 412
T PP KP L+ + F++F + L P R +A L++ F + A +
Sbjct: 239 TNPPPTFRKPELWSDNFTDF-------VKQCLVKSPEQRATATQLLQHPFVRS---AKGV 288
Query: 413 SGLPVIYDKEDELIEANQQRKIRRARMKHR 442
S L +LI K++R + R
Sbjct: 289 SIL-------RDLINEAMDVKLKRQESQQR 311
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-43
Identities = 81/338 (23%), Positives = 134/338 (39%), Gaps = 85/338 (25%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAR----EIMILQKL- 181
Y+ + +G+G++ V KA D + VALK V+ + K R EI IL+ L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-------NEKRFHRQAAEEIRILEHLR 151
Query: 182 -----DHPNIVKLEG---------LATSRMQYSLYLVFEFMQ--------TDLARIISNP 219
+ N++ + + + +LY E ++ L R +
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLY---ELIKKNKFQGFSLPLVRKFA-- 206
Query: 220 EGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLI--DKNGVLKIADFGLANYFSPNKKRP 277
+L L H I+H D+K N+L+ +K+ DFG + Y +
Sbjct: 207 -------HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH----QR 255
Query: 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKL 337
+ + + + +YRAPE++LGA YG+ ID+WS GC+LAE+ G P++PG E +QL + +L
Sbjct: 256 VYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL 314
Query: 338 CGSPSEDYWKKLRLSTTF------------------RPPQSYKPRLFEAFSEFPESSLG- 378
G PS+ + + F + PES
Sbjct: 315 LGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWG 374
Query: 379 -------------LLSTLLALDPAYRGSAASALKNEFF 403
L L DPA R + AL++ +
Sbjct: 375 NALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-43
Identities = 70/295 (23%), Positives = 126/295 (42%), Gaps = 54/295 (18%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALK---KVKFDTSE-PHSVKFMAREIMILQK 180
+ Y+ +++G G ++ V K + TGK A K K + +S S + + RE+ IL++
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 181 LDHPNIVKLEGLATSRMQYSLYLVFEFMQT----DLARIISNPEGKLTEP------QQLL 230
+ HPNI+ L + ++ + L+ E + D + + LTE +Q+L
Sbjct: 65 IRHPNIITLHDIFENKT--DVVLILELVSGGELFD--FLAE--KESLTEDEATQFLKQIL 118
Query: 231 SGLQHCHDRGILHRDVKGSNLLI----DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLW 286
G+ + H + I H D+K N+++ N +K+ DFG+A+ + + T
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FKNIFGTPE 176
Query: 287 YRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMP--GRTEVEQLHRIFKLCGSPSED 344
+ APE++ G+ D+WS G + + G P G T+ E L I + E+
Sbjct: 177 FVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGETKQETLTNISAVNYDFDEE 233
Query: 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
Y+ S E + + LL DP R + A +L+
Sbjct: 234 YFSN--TS---------------------ELAKDFIRRLLVKDPKRRMTIAQSLE 265
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-43
Identities = 74/336 (22%), Positives = 122/336 (36%), Gaps = 84/336 (25%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALK---KVKFDTSEPHSVKFMAREIMILQKL 181
+ Y +GQG+Y V A++ T I A+K K K P V+ + E+ +++KL
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 182 DHPNIVKLEGLATSRMQYSLYLVFEFMQ-------------------------------- 209
HPNI +L + + LV E
Sbjct: 86 HHPNIARLYEVYEDEQ--YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 210 --------TDLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLI-- 253
+ + + E Q+ S L + H++GI HRD+K N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203
Query: 254 DKNGVLKIADFGLANYFSPNKK---RPLTSRVVTLWYRAPELLLGATD-YGVGIDLWSAG 309
+K+ +K+ DFGL+ F +T++ T ++ APE+L + YG D WSAG
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 310 CLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPS--EDYWKKLRLSTTFRPPQSYKPRLFE 367
LL + +G PG + + + ++ + L
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQVLN--KKLCFENPNYNVL------------------ 303
Query: 368 AFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
+ LLS LL + R A AL++ +
Sbjct: 304 -----SPLARDLLSNLLNRNVDERFDAMRALQHPWI 334
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-43
Identities = 63/328 (19%), Positives = 110/328 (33%), Gaps = 56/328 (17%)
Query: 121 PKSAESYDKIDKVGQG--TYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMIL 178
Y+ + +G+G V A + TG+ V ++++ + V F+ E+ +
Sbjct: 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVS 80
Query: 179 QKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ----TDLARIISNPEGKLTEPQ------Q 228
+ +HPNIV + L++V FM DL I ++ + E
Sbjct: 81 KLFNHPNIVPYRATFIAD--NELWVVTSFMAYGSAKDL--ICTHFMDGMNELAIAYILQG 136
Query: 229 LLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR------PLTSRV 282
+L L + H G +HR VK S++LI +G + ++ + +R V
Sbjct: 137 VLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 283 VTLWYRAPELLL-GATDYGVGIDLWSAGCLLAEMFLGRP--------------------- 320
L + +PE+L Y D++S G E+ G
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256
Query: 321 ----IMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLF-EAFSEFPES 375
E+ S+ + P R F F F
Sbjct: 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHF--- 313
Query: 376 SLGLLSTLLALDPAYRGSAASALKNEFF 403
+ L +P R SA++ L + FF
Sbjct: 314 ----VEQCLQRNPDARPSASTLLNHSFF 337
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-43
Identities = 73/361 (20%), Positives = 137/361 (37%), Gaps = 41/361 (11%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ YD ++++G G + V++ +++ TG++ K + T P + EI I+ +L HP
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN--TPYPLDKYTVKNEISIMNQLHHP 108
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQ-TDL-ARIISNPEGKLTEP------QQLLSGLQHC 236
++ L + + L+ EF+ +L RI + + K++E +Q GL+H
Sbjct: 109 KLINLHDAFEDKYEM--VLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHM 165
Query: 237 HDRGILHRDVKGSNLLI--DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLL 294
H+ I+H D+K N++ K +KI DFGLA +P++ + T + APE++
Sbjct: 166 HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAAPEIVD 223
Query: 295 GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354
G D+W+ G L + G G ++E L + + ED + +S
Sbjct: 224 R-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS--VS-- 278
Query: 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDLSG 414
+ + LL +P R + AL++ +
Sbjct: 279 -------------------PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI 319
Query: 415 LPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQASQLTKEETLSNKEDSEKHV 474
Y+K + I+ R R + KE +
Sbjct: 320 PSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYDSYFDRKEAVPRFK 379
Query: 475 E 475
Sbjct: 380 L 380
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 6e-43
Identities = 84/320 (26%), Positives = 141/320 (44%), Gaps = 52/320 (16%)
Query: 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH 183
E ++ + ++G G + VYKA +++TG + A K ++ + E ++ EI IL DH
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE--ELEDYIVEIEILATCDH 75
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFMQ----TDLARIISNPEGKLTEPQ------QLLSGL 233
P IVKL G L+++ EF I+ + LTEPQ Q+L L
Sbjct: 76 PYIVKLLG--AYYHDGKLWIMIEFCPGGAVDA---IMLELDRGLTEPQIQVVCRQMLEAL 130
Query: 234 QHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELL 293
H + I+HRD+K N+L+ G +++ADFG++ ++ + + T ++ APE++
Sbjct: 131 NFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF-IGTPYWMAPEVV 189
Query: 294 LGAT----DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349
+ T Y D+WS G L EM P P E+ + + K+ S
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEP--P-HHELNPMRVLLKIAKSD-------- 238
Query: 350 RLSTTFRPPQSYKPRLF-EAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPL 408
PP P + F +F L L +P R SAA L++ F +
Sbjct: 239 -------PPTLLTPSKWSVEFRDF-------LKIALDKNPETRPSAAQLLEHPFVSS--- 281
Query: 409 ACDLSGL-PVIYDKEDELIE 427
L ++ + + E++E
Sbjct: 282 ITSNKALRELVAEAKAEVME 301
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-43
Identities = 65/295 (22%), Positives = 121/295 (41%), Gaps = 54/295 (18%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALK---KVKFDTSE-PHSVKFMAREIMILQK 180
+ YD +++G G ++ V K ++ TG A K K + S S + + RE+ IL++
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 181 LDHPNIVKLEGLATSRMQYSLYLVFEFMQT----DLARIISNPEGKLTEP------QQLL 230
+ H N++ L + +R + L+ E + D + + L+E +Q+L
Sbjct: 72 VLHHNVITLHDVYENRT--DVVLILELVSGGELFD--FLAQ--KESLSEEEATSFIKQIL 125
Query: 231 SGLQHCHDRGILHRDVKGSNLLI----DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLW 286
G+ + H + I H D+K N+++ +K+ DFGLA+ + + T
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPE 183
Query: 287 YRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMP--GRTEVEQLHRIFKLCGSPSED 344
+ APE++ G+ D+WS G + + G P G T+ E L I + E+
Sbjct: 184 FVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANITSVSYDFDEE 240
Query: 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
++ S E + + LL + R + AL+
Sbjct: 241 FFSH--TS---------------------ELAKDFIRKLLVKETRKRLTIQEALR 272
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 7e-43
Identities = 66/227 (29%), Positives = 108/227 (47%), Gaps = 38/227 (16%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALK------------------------KVKFDT 162
Y D++G+G+Y V A + + A+K
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 163 SEPHSVKFMAREIMILQKLDHPNIVKL-EGLATSRMQYSLYLVFEFMQT-DLARIISNPE 220
++ + +EI IL+KLDHPN+VKL E L + LY+VFE + + + +
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDP-NEDHLYMVFELVNQGPVMEVPTL-- 131
Query: 221 GKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274
L+E Q L+ G+++ H + I+HRD+K SNLL+ ++G +KIADFG++N F +
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 275 KRPLTSRVVTLWYRAPELLLGAT-DY-GVGIDLWSAGCLLAEMFLGR 319
L++ V T + APE L + G +D+W+ G L G+
Sbjct: 192 AL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 8e-43
Identities = 66/295 (22%), Positives = 123/295 (41%), Gaps = 54/295 (18%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALK---KVKFDTSE-PHSVKFMAREIMILQK 180
+ YD +++G G ++ V K ++ TG A K K + +S S + + RE+ IL++
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 181 LDHPNIVKLEGLATSRMQYSLYLVFEFMQT----DLARIISNPEGKLTEP------QQLL 230
+ HPN++ L + ++ + L+ E + D + + LTE +Q+L
Sbjct: 71 IQHPNVITLHEVYENKT--DVILILELVAGGELFD--FLAE--KESLTEEEATEFLKQIL 124
Query: 231 SGLQHCHDRGILHRDVKGSNLLI----DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLW 286
+G+ + H I H D+K N+++ +KI DFGLA+ + + T
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPE 182
Query: 287 YRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMP--GRTEVEQLHRIFKLCGSPSED 344
+ APE++ G+ D+WS G + + G P G T+ E L + + ++
Sbjct: 183 FVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANVSAVNYEFEDE 239
Query: 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
Y+ S + + LL DP R + +L+
Sbjct: 240 YFSN--TS---------------------ALAKDFIRRLLVKDPKKRMTIQDSLQ 271
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-42
Identities = 69/347 (19%), Positives = 122/347 (35%), Gaps = 57/347 (16%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
E Y + +G+G + V++ ++ + K K VK ++ VK +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQT----DLARIISNPEGKLTEP------QQLLSGLQ 234
NI+ L S L ++FEF+ + RI ++ +L E Q+ LQ
Sbjct: 62 NILHLHESFESME--ELVMIFEFISGLDIFE--RINTS-AFELNEREIVSYVHQVCEALQ 116
Query: 235 HCHDRGILHRDVKGSNLLI--DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPEL 292
H I H D++ N++ ++ +KI +FG A P Y APE+
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEV 174
Query: 293 LLGATDYGVGIDLWSAGCLLAEMFLGRPIMP--GRTEVEQLHRIFKLCGSPSEDYWKKLR 350
D+WS G L+ + G P T + + I + E+ +K+
Sbjct: 175 HQH-DVVSTATDMWSLGTLVYVLLSGIN--PFLAETNQQIIENIMNAEYTFDEEAFKE-- 229
Query: 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLAC 410
+S ++ + LL + R +A+ AL++ +
Sbjct: 230 IS---------------------IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERV 268
Query: 411 DLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQASQ 457
+ L + + + R G SQ
Sbjct: 269 STKVIR-------TLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQ 308
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 68/295 (23%), Positives = 109/295 (36%), Gaps = 53/295 (17%)
Query: 125 ESYDKIDKV-GQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-D 182
+ Y +V G G V + R TG+ ALK + +E+ +
Sbjct: 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASG 80
Query: 183 HPNIVKLEGL--ATSRMQYSLYLVFEFMQTD--LARIISNPEGKLTEPQ------QLLSG 232
P+IV + + + L ++ E M+ +RI + TE + + +
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 233 LQHCHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRA 289
+Q H I HRDVK NLL +K+ VLK+ DFG A + N L + T +Y A
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPCYTPYYVA 197
Query: 290 PELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFK--LCGSPS--EDY 345
PE +LG Y D+WS G ++ + G P T + + G
Sbjct: 198 PE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256
Query: 346 WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400
W + +S E + L+ LL DP R + + +
Sbjct: 257 WSE--VS---------------------EDAKQLIRLLLKTDPTERLTITQFMNH 288
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-42
Identities = 76/335 (22%), Positives = 126/335 (37%), Gaps = 87/335 (25%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALK---KVKFDTSEPHSVKFMAREIMILQKLDH 183
Y D +G+G+Y V + LD +T A+K K K P+ + +EI +L++L H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLR-RIPNGEANVKKEIQLLRRLRH 65
Query: 184 PNIVKLE---GLATSRMQYSLYLVFEFM---QTDLARIISNPEGKLTEP------QQLLS 231
N+++L + +Y+V E+ ++ + PE + QL+
Sbjct: 66 KNVIQLVDVLYNEEKQK---MYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQLID 120
Query: 232 GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF--------------SPNKKRP 277
GL++ H +GI+H+D+K NLL+ G LKI+ G+A SP
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA---- 176
Query: 278 LTSRVVTLWYRAPELLLGATDY-GVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFK 336
++ PE+ G + G +D+WSAG L +
Sbjct: 177 ---------FQPPEIANGLDTFSGFKVDIWSAGVTLYNI--------------------- 206
Query: 337 LCGS-PSEDY-WKKLR---LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR 391
G P E KL ++ P + LL +L +PA R
Sbjct: 207 TTGLYPFEGDNIYKLFENIGKGSYAIP-----------GDCGPPLSDLLKGMLEYEPAKR 255
Query: 392 GSAASALKNEFFFTS-PLACDLSGLPVIYDKEDEL 425
S ++ +F P A +P D +D
Sbjct: 256 FSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRW 290
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-42
Identities = 74/307 (24%), Positives = 118/307 (38%), Gaps = 66/307 (21%)
Query: 134 GQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGL 192
G+G ++ V ++ T + A+K + + H + RE+ +L + H N+++L
Sbjct: 22 GEGAHARVQTCINLITSQEYAVKII--EKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 193 ATSRMQYSLYLVFEFMQ--TDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHR 244
+ YLVFE M+ + L+ I E Q + S L H++GI HR
Sbjct: 80 FEE--EDRFYLVFEKMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHNKGIAHR 135
Query: 245 DVKGSNLLI---DKNGVLKIADFGLANYFSPNK------KRPLTSRVVTLWYRAPELLLG 295
D+K N+L ++ +KI DF L + N L + + Y APE++
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195
Query: 296 ----ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSP---SEDYWKK 348
A+ Y DLWS G +L I+ L G P
Sbjct: 196 FSEEASIYDKRCDLWSLGVILY-------IL--------------LSGYPPFVGRC--GS 232
Query: 349 LRLSTTFRPPQSYKPRLFEAFS----EFPES-----SLG---LLSTLLALDPAYRGSAAS 396
+ + LFE+ EFP+ S L+S LL D R SAA
Sbjct: 233 DCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQ 292
Query: 397 ALKNEFF 403
L++ +
Sbjct: 293 VLQHPWV 299
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-42
Identities = 72/385 (18%), Positives = 149/385 (38%), Gaps = 59/385 (15%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALK---KVKFDTSE-PHSVKFMAREIMILQK 180
+ YD +++G G ++ V K ++ TG A K K + S + + RE+ IL++
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 181 LDHPNIVKLEGLATSRMQYSLYLVFEFMQT----DLARIISNPEGKLTEP------QQLL 230
+ HPNI+ L + +R L+ E + D + + L+E +Q+L
Sbjct: 72 VLHPNIITLHDVYENRTDV--VLILELVSGGELFD--FLAQ--KESLSEEEATSFIKQIL 125
Query: 231 SGLQHCHDRGILHRDVKGSNLLI----DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLW 286
G+ + H + I H D+K N+++ +K+ DFGLA+ + + T
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPE 183
Query: 287 YRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMP--GRTEVEQLHRIFKLCGSPSED 344
+ APE++ G+ D+WS G + + G P G T+ E L I + E+
Sbjct: 184 FVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANITAVSYDFDEE 240
Query: 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404
++ + S E + + LL + R + AL++ +
Sbjct: 241 FFSQ--TS---------------------ELAKDFIRKLLVKETRKRLTIQEALRHP-WI 276
Query: 405 TSPLACDLSGLPVIYDKEDELIEANQQRKIRRA----RMKHRSKTLRERRIGDQASQLTK 460
T + + +R+ + + + + +++ + S+ +
Sbjct: 277 TPVDTQQAMVRRESVVNLENFKKQYVRRRWKLSFSIVSLCNHLTRSLMKKVHLRTSEDLR 336
Query: 461 EETLSNKEDSEKHVELNFQGQEPYS 485
+E+ + L+ + + S
Sbjct: 337 NCESDTEENIARRKALHPRRRSSTS 361
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 8e-42
Identities = 78/348 (22%), Positives = 135/348 (38%), Gaps = 92/348 (26%)
Query: 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAR----EIMILQ 179
+ Y+ +G+G++ V KA DR + VA+K +K + K E+ +L+
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-------NKKAFLNQAQIEVRLLE 105
Query: 180 KL------DHPNIVKLEG---------LATSRMQYSLYLVFEFMQ--------TDLARII 216
+ IV L+ L + Y+LY + ++ +L R
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLY---DLLRNTNFRGVSLNLTRKF 162
Query: 217 SNPEGKLTEPQQLLSGLQHCHDR--GILHRDVKGSNLLI--DKNGVLKIADFGLANYFSP 272
+ QQ+ + L I+H D+K N+L+ K +KI DFG +
Sbjct: 163 A---------QQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG- 212
Query: 273 NKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLH 332
+ + + + +YR+PE+LLG Y + ID+WS GC+L EM G P+ G EV+Q++
Sbjct: 213 ---QRIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN 268
Query: 333 RIFKLCGSPSEDYWKKLRLSTTF-----------RPPQSYKPRLFEAFSEFPESSLG--- 378
+I ++ G P + + F + + K + + LG
Sbjct: 269 KIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVET 328
Query: 379 -----------------------LLSTLLALDPAYRGSAASALKNEFF 403
L+ +L DP R AL++ FF
Sbjct: 329 GGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFF 376
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-41
Identities = 75/303 (24%), Positives = 119/303 (39%), Gaps = 63/303 (20%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-H 183
+ K +G+G++S K + + + + A+K + + + +EI L+ + H
Sbjct: 11 DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQ---KEITALKLCEGH 65
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFMQTD--LARIISNPEGKLTEP------QQLLSGLQH 235
PNIVKL + ++ +LV E + RI + +E ++L+S + H
Sbjct: 66 PNIVKLHEVFHDQL--HTFLVMELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSH 121
Query: 236 CHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPEL 292
HD G++HRD+K NLL + N +KI DFG A P+ + PL + TL Y APE
Sbjct: 122 MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLKTPCFTLHYAAPE- 179
Query: 293 LLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352
LL Y DLWS G +L M L G + S
Sbjct: 180 LLNQNGYDESCDLWSLGVILY-------TM--------------LSGQVP--FQ-----S 211
Query: 353 TTFRPPQSYKPRLFEAFS----EFPES-----SLG---LLSTLLALDPAYRGSAASALKN 400
+ + + F S L+ LL +DP R + N
Sbjct: 212 HDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271
Query: 401 EFF 403
E+
Sbjct: 272 EWL 274
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 70/288 (24%), Positives = 103/288 (35%), Gaps = 64/288 (22%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALK-----KVKFDTSEPHSVKFMAREIMILQKL 181
Y +G+G + V+ VA+K +V + SV E+ +L K+
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT-CPLEVALLWKV 91
Query: 182 D----HPNIVKL-EGLATSRMQYSLYLVFEFMQT--DL-ARIISNPEGKLTEP------Q 227
HP +++L + T LV E DL I G L E
Sbjct: 92 GAGGGHPGVIRLLDWFETQEG---FMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFG 146
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLID-KNGVLKIADFGLANYFSPNKKRPLTSRVVTLW 286
Q+++ +QHCH RG++HRD+K N+LID + G K+ DFG P T T
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFDGTRV 203
Query: 287 YRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGS-PSEDY 345
Y PE + + + +WS G LL +M +CG P E
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDM---------------------VCGDIPFERD 242
Query: 346 WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS 393
+ L P L+ LA P+ R S
Sbjct: 243 QEILE--AELHFPAH-----------VSPDCCALIRRCLAPKPSSRPS 277
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 92/383 (24%), Positives = 148/383 (38%), Gaps = 68/383 (17%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
YD + +G G + D+ T ++VA+K ++ + +V+ REI+ + L HPNI
Sbjct: 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNI 78
Query: 187 VKL-EGLATSRMQYSLYLVFEFMQT-DL-ARIISNPEGKLTEP------QQLLSGLQHCH 237
V+ E + T L ++ E+ +L RI + G+ +E QQLLSG+ +CH
Sbjct: 79 VRFKEVILTPTH---LAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCH 133
Query: 238 DRGILHRDVKGSNLLIDKNGV--LKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLG 295
I HRD+K N L+D + LKI DFG + + + S V T Y APE+LL
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLR 191
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGS-PSED-----YWKKL 349
G D+WS G L M L G+ P ED ++K
Sbjct: 192 QEYDGKIADVWSCGVTLYVM---------------------LVGAYPFEDPEEPRDYRKT 230
Query: 350 R---LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406
LS + P L+S + DPA R S + +F
Sbjct: 231 IQRILSVKYSIPDDI---------RISPECCHLISRIFVADPATRISIPEIKTHSWF--- 278
Query: 407 PLACDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQASQLTKEETLSN 466
L LP E Q+ + + + + E I ++ + N
Sbjct: 279 -----LKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDN 333
Query: 467 KEDSEKHVELNFQGQEPYSSASS 489
+ + + + + + S+
Sbjct: 334 LDLDDDMDDFDSESEIDIDSSGE 356
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-41
Identities = 65/284 (22%), Positives = 114/284 (40%), Gaps = 39/284 (13%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ YD +++G G + V++ +R TG A K V T + + +EI + L HP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM--TPHESDKETVRKEIQTMSVLRHP 214
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEP------QQLLSGLQHCH 237
+V L + +++EFM +L +++ K++E +Q+ GL H H
Sbjct: 215 TLVNLHDAFEDDNEM--VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 238 DRGILHRDVKGSNLLI--DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLG 295
+ +H D+K N++ ++ LK+ DFGL + P + + T + APE+ G
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEG 330
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355
G D+WS G L + G G + E L + + + + +S
Sbjct: 331 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG--IS--- 384
Query: 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
E + LL DP R + AL+
Sbjct: 385 ------------------EDGKDFIRKLLLADPNTRMTIHQALE 410
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-41
Identities = 66/313 (21%), Positives = 113/313 (36%), Gaps = 66/313 (21%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPN 185
+G G+ V G+ VA+K++ EI +L + D HPN
Sbjct: 17 VVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRML-----IDFCDIALMEIKLLTESDDHPN 70
Query: 186 IVKLEGLATSRMQYSLYLVFEFMQTDLARII------SNPEGKLTEP------QQLLSGL 233
+++ T+ LY+ E +L ++ E +Q+ SG+
Sbjct: 71 VIRYYCSETTDR--FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 234 QHCHDRGILHRDVKGSNLLID-------------KNGVLKIADFGLANYFSPNK---KRP 277
H H I+HRD+K N+L+ +N + I+DFGL + +
Sbjct: 129 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 278 LTSRVVTLWYRAPELLLGATD------YGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQ 330
L + T +RAPELL + + ID++S GC+ + G+ P + +
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH--PFGDKYSR 246
Query: 331 LHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAY 390
I + G S D K + L+S ++ DP
Sbjct: 247 ESNIIR--GIFSLDEMK------------------CLHDRSLIAEATDLISQMIDHDPLK 286
Query: 391 RGSAASALKNEFF 403
R +A L++ F
Sbjct: 287 RPTAMKVLRHPLF 299
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 79/295 (26%), Positives = 127/295 (43%), Gaps = 62/295 (21%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ ++ ++G+G S VY+ + T K ALK +K T + V+ EI +L +L HP
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK-KTVDKKIVR---TEIGVLLRLSHP 108
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTDLA-------RIISNPEGKLTEP------QQLLS 231
NI+KL+ + + + LV E L RI+ +G +E +Q+L
Sbjct: 109 NIIKLKEIFETPTEI--SLVLE-----LVTGGELFDRIVE--KGYYSERDAADAVKQILE 159
Query: 232 GLQHCHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYR 288
+ + H+ GI+HRD+K NLL + LKIADFGL+ + + T Y
Sbjct: 160 AVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL--MKTVCGTPGYC 217
Query: 289 APELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFK--LCGSPS--ED 344
APE+L G YG +D+WS G + + G P E +F+ L
Sbjct: 218 APEILRG-CAYGPEVDMWSVGIITYILLCGFE--PFYDERGD-QFMFRRILNCEYYFISP 273
Query: 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
+W + +S ++ L+ L+ LDP R + AL+
Sbjct: 274 WWDE--VS---------------------LNAKDLVRKLIVLDPKKRLTTFQALQ 305
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 152 bits (384), Expect = 5e-41
Identities = 43/320 (13%), Positives = 91/320 (28%), Gaps = 88/320 (27%)
Query: 134 GQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKL----------- 181
GQ +A D++TG+ + + +++K M E++ L+ L
Sbjct: 82 GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141
Query: 182 --------------DHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARII------SNPEG 221
++++ S + ++ MQ++L S+
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201
Query: 222 KLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275
L Q++ L H G++H ++ ++++D+ G + + F
Sbjct: 202 SLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---- 257
Query: 276 RPLTSRVVTLWYRAPELL----------LGATDYGVGIDLWSAGCLLAEMFLGRPIMP-- 323
V+ + PEL T D W+ G ++ ++ P
Sbjct: 258 -ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL--PIT 314
Query: 324 GRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTL 383
+ IF+ C P+ LL
Sbjct: 315 KDAALGGSEWIFRSC-------------------------------KNIPQPVRALLEGF 343
Query: 384 LALDPAYRGSAASALKNEFF 403
L R A++ +
Sbjct: 344 LRYPKEDRLLPLQAMETPEY 363
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-41
Identities = 80/339 (23%), Positives = 131/339 (38%), Gaps = 61/339 (17%)
Query: 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-D 182
A ++ ++ VG GTY VYK TG++ A+K + E + + +EI +L+K
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSH 79
Query: 183 HPNIVKLEG----LATSRMQYSLYLVFEFMQ----TDLARIISNPEGKLTEPQ------Q 228
H NI G M L+LV EF TDL + L E +
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICRE 137
Query: 229 LLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYR 288
+L GL H H ++HRD+KG N+L+ +N +K+ DFG++ R T + T ++
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWM 196
Query: 289 APELLLGATD----YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSED 344
APE++ + Y DLWS G EM G P + + L I +
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-------- 248
Query: 345 YWKKLRLSTTFRPPQSYKPRLF-EAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
P K + + + F F + + L + + R + +K+ F
Sbjct: 249 -----------NPAPRLKSKKWSKKFQSF-------IESCLVKNHSQRPATEQLMKHPFI 290
Query: 404 FTSPLACDLSGLPVIYDKEDELIEANQQRKIRRARMKHR 442
P + +L + + K +R
Sbjct: 291 RDQPNERQVR---------IQLKDHIDRTKKKRGEKDET 320
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-41
Identities = 57/292 (19%), Positives = 107/292 (36%), Gaps = 49/292 (16%)
Query: 125 ESYDKIDKV-GQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH 183
Y K G+G ++ V + + + TG+ A K +K + EI +L+
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 184 -PNIVKLEGLATSRMQYSLYLVFEFMQT----DLARIISNPEGKLTEP------QQLLSG 232
P ++ L + + + L+ E+ + ++E +Q+L G
Sbjct: 88 CPRVINLHEVYENTSEI--ILILEYAAGGEIFS--LCLPELAEMVSENDVIRLIKQILEG 143
Query: 233 LQHCHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRA 289
+ + H I+H D+K N+L+ G +KI DFG++ + L + T Y A
Sbjct: 144 VYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--LREIMGTPEYLA 201
Query: 290 PELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMP--GRTEVEQLHRIFKLCGSPSEDYWK 347
PE+L D+W+ G + + P G E I ++ SE+ +
Sbjct: 202 PEILNY-DPITTATDMWNIGIIAYMLLTHTS--PFVGEDNQETYLNISQVNVDYSEETFS 258
Query: 348 KLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
+S + + + +LL +P R +A L
Sbjct: 259 S--VS---------------------QLATDFIQSLLVKNPEKRPTAEICLS 287
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 6e-41
Identities = 77/325 (23%), Positives = 131/325 (40%), Gaps = 56/325 (17%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL----- 181
Y + K+G G +S V+ A D VA+K V+ + + EI +LQ++
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDADN 77
Query: 182 ------DHPNIVKLEG--LATSRMQYSLYLVFEFMQTDLARII-SNPEGKLTEP------ 226
+I+KL + +VFE + +L +I +
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 137
Query: 227 QQLLSGLQHCHDR-GILHRDVKGSNLLID------KNGVLKIADFGLANYFSPNKKRPLT 279
+QLL GL + H R GI+H D+K N+L++ +KIAD G A + T
Sbjct: 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW----YDEHYT 193
Query: 280 SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRT------EVEQLHR 333
+ + T YR+PE+LLGA +G G D+WS CL+ E+ G + + + + +
Sbjct: 194 NSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252
Query: 334 IFKLCGSPSEDYWKKLRLSTTF---------------RPPQSYKPRLFEAFSEFPESSLG 378
I +L G + + + TF P + ++ + +
Sbjct: 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312
Query: 379 LLSTLLALDPAYRGSAASALKNEFF 403
LS +L LDP R A + + +
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPWL 337
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-40
Identities = 68/286 (23%), Positives = 107/286 (37%), Gaps = 62/286 (21%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALK-----KVKFDTSEPHSVKFMAREIMILQKL 181
Y +G G + +VY + VA+K ++ P+ + + E+++L+K+
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVLLKKV 103
Query: 182 DH--PNIVKL-EGLATSRMQYSLYLVFEFMQT--DL-ARIISNPEGKLTEP------QQL 229
+++L + L+ E + DL I G L E Q+
Sbjct: 104 SSGFSGVIRLLDWFERPDS---FVLILERPEPVQDLFDFITER--GALQEELARSFFWQV 158
Query: 230 LSGLQHCHDRGILHRDVKGSNLLIDKN-GVLKIADFGLANYFSPNKKRPLTSRVVTLWYR 288
L ++HCH+ G+LHRD+K N+LID N G LK+ DFG K T T Y
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 215
Query: 289 APELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGS-PSEDYWK 347
PE + +G +WS G LL +M +CG P E +
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDM---------------------VCGDIPFEHDEE 254
Query: 348 KLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS 393
+R Q L+ LAL P+ R +
Sbjct: 255 IIR--GQVFFRQR-----------VSSECQHLIRWCLALRPSDRPT 287
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 32/224 (14%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPN 185
+ +G ++ VY+A D +G+ ALK++ ++E + + +E+ ++KL HPN
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAIIQEVCFMKKLSGHPN 87
Query: 186 IVKLEGLATSRM------QYSLYLVFEFMQTDLARIISNPE--GKLTEPQ------QLLS 231
IV+ A+ Q L+ E + L + E G L+ Q
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 232 GLQHCHDRG--ILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTS--------- 280
+QH H + I+HRD+K NLL+ G +K+ DFG A S ++
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 281 --RVVTLWYRAPEL--LLGATDYGVGIDLWSAGCLLAEMFLGRP 320
R T YR PE+ L G D+W+ GC+L + +
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-40
Identities = 49/213 (23%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 132 KVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEG 191
+G+G + K R+TG+++ +K++ E + + +E+ +++ L+HPN++K G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE--TQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 192 LATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL------SGLQHCHDRGILHR 244
+ + L + E+++ L II + + + Q++ SG+ + H I+HR
Sbjct: 75 VLYKDKR--LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHR 132
Query: 245 DVKGSNLLIDKNGVLKIADFGLA-------------NYFSPNKKRPLTSRVVTLWYRAPE 291
D+ N L+ +N + +ADFGLA ++ + V ++ APE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 292 LLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPG 324
++ G Y +D++S G +L E+ P
Sbjct: 193 MING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-40
Identities = 75/301 (24%), Positives = 122/301 (40%), Gaps = 63/301 (20%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALK---KVKFDTSEPHSVKFMAREIMILQKL 181
+ Y+ + +G G+YS + + + T A+K K K D + EI IL +
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT---------EEIEILLRY 72
Query: 182 -DHPNIVKLEGLATSRMQYSLYLVFEFMQTD--LARIISNPEGKLTEP------QQLLSG 232
HPNI+ L+ + +Y+V E M+ L +I+ + +E +
Sbjct: 73 GQHPNIITLKDVYDDGK--YVYVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKT 128
Query: 233 LQHCHDRGILHRDVKGSNLLI----DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYR 288
+++ H +G++HRD+K SN+L ++I DFG A L + T +
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG-LLMTPCYTANFV 187
Query: 289 APELLLGATDYGVGIDLWSAGCLLAEMFLGRP---IMPGRTEVEQLHRIFKLCGS---PS 342
APE+L Y D+WS G LL M G P T E L RI G
Sbjct: 188 APEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI--GSGKFSLSG 244
Query: 343 EDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402
YW +S +++ L+S +L +DP R +AA L++ +
Sbjct: 245 G-YWNS--VS---------------------DTAKDLVSKMLHVDPHQRLTAALVLRHPW 280
Query: 403 F 403
Sbjct: 281 I 281
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-40
Identities = 57/243 (23%), Positives = 95/243 (39%), Gaps = 29/243 (11%)
Query: 125 ESYDKIDKV-GQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-D 182
+ Y +V G G V + ++ T + ALK ++ RE+ + +
Sbjct: 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQ 113
Query: 183 HPNIVKLEGL--ATSRMQYSLYLVFEFMQ--TDLARIISNPEGKLTEP------QQLLSG 232
P+IV++ + + L +V E + +RI + TE + +
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173
Query: 233 LQHCHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRA 289
+Q+ H I HRDVK NLL N +LK+ DFG A + + LT+ T +Y A
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVA 231
Query: 290 PELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFK--LCGSPS--EDY 345
PE +LG Y D+WS G ++ + G P + + G
Sbjct: 232 PE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 290
Query: 346 WKK 348
W +
Sbjct: 291 WSE 293
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 75/341 (21%), Positives = 126/341 (36%), Gaps = 88/341 (25%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGK-IVALKKVKFDTSEPHSVKFMAR----EIMILQKL 181
Y+ + +G+GT+ V + LD GK VALK ++ +V EI +L+K+
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-------NVGKYREAARLEINVLKKI 73
Query: 182 ------DHPNIVKLEG---------LATSRMQYSLYLVFEFMQ--------TDLARIISN 218
+ V + +A + + + EF++ R ++
Sbjct: 74 KEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTF---EFLKENNFQPYPLPHVRHMA- 129
Query: 219 PEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLI-------------------DKNGVL 259
QL L+ H+ + H D+K N+L KN +
Sbjct: 130 --------YQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181
Query: 260 KIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGR 319
++ADFG A + + T+ V T YR PE++L + D+WS GC+L E + G
Sbjct: 182 RVADFGSATFDHEH----HTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGF 236
Query: 320 PIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF------RPPQSYKPRLFEAFSEFP 373
+ E L + K+ G + R F S R + +
Sbjct: 237 TLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL 296
Query: 374 ESSLG-----------LLSTLLALDPAYRGSAASALKNEFF 403
+S + L+ +L DPA R + A AL + FF
Sbjct: 297 KSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 337
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-40
Identities = 80/294 (27%), Positives = 130/294 (44%), Gaps = 58/294 (19%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALK---KVKFDTSEPHSVKFMAREIMILQKLDH 183
Y D +G GT+ V + TG VA+K + K + + V + REI L+ H
Sbjct: 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLD--VVGKIKREIQNLKLFRH 70
Query: 184 PNIVKL-EGLATSRMQYSLYLVFEFMQT-DL-ARIISNPEGKLTEP------QQLLSGLQ 234
P+I+KL + ++T ++V E++ +L I + G++ E QQ+LS +
Sbjct: 71 PHIIKLYQVISTPTD---FFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVD 125
Query: 235 HCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLL 294
+CH ++HRD+K N+L+D + KIADFGL+N S + L + + Y APE++
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF--LRTSCGSPNYAAPEVIS 183
Query: 295 GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGS-PSED-YWKKLR-- 350
G G +D+WS G +L + LCG+ P +D + L
Sbjct: 184 GRLYAGPEVDIWSCGVILYAL---------------------LCGTLPFDDEHVPTLFKK 222
Query: 351 -LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
F P S LL +L +DP R + ++E+F
Sbjct: 223 IRGGVFYIP-----------EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 8e-40
Identities = 66/205 (32%), Positives = 106/205 (51%), Gaps = 22/205 (10%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALK---KVKFDTSE-PHSVKFMAREIMILQKLD 182
Y + +G+G++ V A T + VALK + S+ V+ REI L+ L
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE---REISYLKLLR 67
Query: 183 HPNIVKL-EGLATSRMQYSLYLVFEFMQTDL-ARIISNPEGKLTEP------QQLLSGLQ 234
HP+I+KL + + T + +V E+ +L I+ ++TE QQ++ ++
Sbjct: 68 HPHIIKLYDVITTPTD---IVMVIEYAGGELFDYIVEK--KRMTEDEGRRFFQQIICAIE 122
Query: 235 HCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLL 294
+CH I+HRD+K NLL+D N +KIADFGL+N + L + + Y APE++
Sbjct: 123 YCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF--LKTSCGSPNYAAPEVIN 180
Query: 295 GATDYGVGIDLWSAGCLLAEMFLGR 319
G G +D+WS G +L M +GR
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 149 bits (376), Expect = 9e-40
Identities = 41/313 (13%), Positives = 88/313 (28%), Gaps = 73/313 (23%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHS-VKFMAREIMILQKL---------- 181
+GQ +A D++TG+ + F P + +K M E++ L+ L
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 182 ---------------DHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEP 226
++++ S + ++ MQ++L +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 227 ------------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274
Q++ L H G++H ++ ++++D+ G + + F +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASA 265
Query: 275 KRPLTSRVVTLWYRAPELLLGA----TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQ 330
P+ A +L T D W+ G + ++ +
Sbjct: 266 VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG 325
Query: 331 LHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAY 390
IF+ C P+ LL L
Sbjct: 326 SEWIFRSC-------------------------------KNIPQPVRALLEGFLRYPKED 354
Query: 391 RGSAASALKNEFF 403
R A++ +
Sbjct: 355 RLLPLQAMETPEY 367
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 9e-40
Identities = 76/347 (21%), Positives = 124/347 (35%), Gaps = 94/347 (27%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAR----EIMILQKL- 181
+ I K+G GT+ V D K A+K V+ ++K R E IL+K+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-------NIKKYTRSAKIEADILKKIQ 89
Query: 182 ----DHPNIVKLEG---------LATSRMQYSLYLVFEFMQ--------TDLARIISNPE 220
++ NIVK G L + SLY E + + ++
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLY---EIITRNNYNGFHIEDIKLYC--- 143
Query: 221 GKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLI-------------------------DK 255
++L L + + H D+K N+L+ K
Sbjct: 144 ------IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 256 NGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEM 315
+ +K+ DFG A + S S + T YRAPE++L + V D+WS GC+LAE+
Sbjct: 198 STGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAEL 252
Query: 316 FLGRPIMPGRTEVEQLHRIFKLCGSPSED------------YWKKLRLSTTFRPPQSYKP 363
+ G + +E L + + ++ Y K L + S
Sbjct: 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSIN 312
Query: 364 RLFEAFSEFPESS-------LGLLSTLLALDPAYRGSAASALKNEFF 403
+ P L ++L +DP R S A LK++F
Sbjct: 313 SIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 74/341 (21%), Positives = 123/341 (36%), Gaps = 88/341 (25%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTG-KIVALKKVKFDTSEPHSVKFMAR----EIMILQKL 181
Y+ +D +G+G + V + +D G + VA+K VK +V EI +L+ L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-------NVDRYCEAARSEIQVLEHL 68
Query: 182 ------DHPNIVKLEG---------LATSRMQYSLYLVFEFMQ--------TDLARIISN 218
V++ + + S Y +F++ D R ++
Sbjct: 69 NTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTY---DFIKENGFLPFRLDHIRKMA- 124
Query: 219 PEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGV-------------------L 259
Q+ + H + H D+K N+L ++ +
Sbjct: 125 --------YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 260 KIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGR 319
K+ DFG A Y + ++ V T YRAPE++L + D+WS GC+L E +LG
Sbjct: 177 KVVDFGSATYDDEH----HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGF 231
Query: 320 PIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR------PPQSYKPRLFEAFS--- 370
+ P E L + ++ G + +K R F S R
Sbjct: 232 TVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPL 291
Query: 371 --------EFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
E L+ +L DPA R + ALK+ FF
Sbjct: 292 KEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 9e-39
Identities = 99/450 (22%), Positives = 173/450 (38%), Gaps = 82/450 (18%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALK---KVKFDTSEPHSVKFMAREIMILQKLDH 183
Y D +G GT+ V TG VA+K + K + + V + REI L+ H
Sbjct: 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLD--VVGKIRREIQNLKLFRH 75
Query: 184 PNIVKL-EGLATSRMQYSLYLVFEFMQT-DL-ARIISNPEGKLTEP------QQLLSGLQ 234
P+I+KL + ++T +++V E++ +L I N G+L E QQ+LSG+
Sbjct: 76 PHIIKLYQVISTPSD---IFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVD 130
Query: 235 HCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLL 294
+CH ++HRD+K N+L+D + KIADFGL+N S + L + + Y APE++
Sbjct: 131 YCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF--LRTSCGSPNYAAPEVIS 188
Query: 295 GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGS-PSED-YWKKLR-- 350
G G +D+WS+G +L + LCG+ P +D + L
Sbjct: 189 GRLYAGPEVDIWSSGVILYAL---------------------LCGTLPFDDDHVPTLFKK 227
Query: 351 -LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLA 409
F P S + LL +L +DP R + ++E+F
Sbjct: 228 ICDGIFYTP-----------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWF------ 270
Query: 410 CDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQASQLTKEETLSNKED 469
LP ED + + + ++ N +D
Sbjct: 271 --KQDLPKYLFPEDPSYSSTMIDDEALKEVCE--------KFECSEEEVLSCLYNRNHQD 320
Query: 470 SEK--------HVELNFQGQEPYSSASSASSGTKANQQSHSPPFVLFPVAASHHQKMSPR 521
+ + + ++ Y + S S + + P + + A +
Sbjct: 321 PLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTL 380
Query: 522 NKGHPNGTKNIKNRPPLPNSKTRPTTHNED 551
++ +P +K+ R + R + D
Sbjct: 381 DELNPQKSKHQGVRKAKWHLGIRSQSRPND 410
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 75/289 (25%), Positives = 121/289 (41%), Gaps = 47/289 (16%)
Query: 125 ESYD--KIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD 182
Y K + +G G + V+K + TG +A K +K T + + EI ++ +LD
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK--TRGMKDKEEVKNEISVMNQLD 144
Query: 183 HPNIVKLEGLATSRMQYSLYLVFEFMQT----DLARIISNPEGKLTEP------QQLLSG 232
H N+++L S+ LV E++ D RII LTE +Q+ G
Sbjct: 145 HANLIQLYDAFESKNDI--VLVMEYVDGGELFD--RIIDE-SYNLTELDTILFMKQICEG 199
Query: 233 LQHCHDRGILHRDVKGSNLLI--DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAP 290
++H H ILH D+K N+L +KI DFGLA + P +K L T + AP
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNFGTPEFLAP 257
Query: 291 ELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350
E++ D+WS G + + G G + E L+ I ++ ++
Sbjct: 258 EVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQD-- 314
Query: 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
+S E + +S LL + ++R SA+ ALK
Sbjct: 315 IS---------------------EEAKEFISKLLIKEKSWRISASEALK 342
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 67/297 (22%), Positives = 121/297 (40%), Gaps = 44/297 (14%)
Query: 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQK 180
+ + ++G GT V+K R TG ++A+K+++ ++ K + ++ ++ K
Sbjct: 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLK 79
Query: 181 L-DHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGL 233
D P IV+ G + +++ E M T ++ +G + E ++ L
Sbjct: 80 SHDCPYIVQCFGTFIT--NTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKAL 137
Query: 234 QHCHD-RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPE- 291
+ + G++HRDVK SN+L+D+ G +K+ DFG++ +K + Y APE
Sbjct: 138 YYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSAGCAAYMAPER 195
Query: 292 ---LLLGATDYGVGIDLWSAGCLLAEMFLGR-PIMPGRTEVEQLHRIFKLCGSPSEDYWK 347
DY + D+WS G L E+ G+ P +T+ E L ++ E+
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV------LQEE--- 246
Query: 348 KLRLSTTFRPPQSYKPRLF-EAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
PP F F F + L D R L++ F
Sbjct: 247 ---------PPLLPGHMGFSGDFQSF-------VKDCLTKDHRKRPKYNKLLEHSFI 287
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 81/299 (27%), Positives = 133/299 (44%), Gaps = 45/299 (15%)
Query: 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQK 180
K E + +G+G++S V A + T + A+K + K + + V ++ RE ++ +
Sbjct: 27 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 181 LDHPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGL 233
LDHP VKL T + LY + + +L + I G E +++S L
Sbjct: 87 LDHPFFVKLYF--TFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSAL 143
Query: 234 QHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV-TLWYRAPEL 292
++ H +GI+HRD+K N+L++++ ++I DFG A SP K+ + V T Y +PEL
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203
Query: 293 LLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352
L DLW+ GC++ ++ G P P F+ G+ + K ++L
Sbjct: 204 LTE-KSACKSSDLWALGCIIYQLVAGLP--P-----------FR-AGNEYLIFQKIIKLE 248
Query: 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR-GSA----ASALKNEFFFTS 406
F P +F + L+ LL LD R G LK FF S
Sbjct: 249 YDF-PE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 63/254 (24%), Positives = 107/254 (42%), Gaps = 14/254 (5%)
Query: 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD 182
+ ++KI ++G G V+K + +G ++A K + + +P + RE+ +L + +
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECN 89
Query: 183 HPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHC 236
P IV G S + + E M + G++ E ++ GL +
Sbjct: 90 SPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 147
Query: 237 HDRG-ILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLG 295
++ I+HRDVK SN+L++ G +K+ DFG++ + S V T Y +PE L G
Sbjct: 148 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQG 204
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355
T Y V D+WS G L EM +GR +P E + + + R
Sbjct: 205 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263
Query: 356 RPPQSYKPRLFEAF 369
R A
Sbjct: 264 LNKFGMDSRPPMAI 277
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 7e-37
Identities = 73/300 (24%), Positives = 130/300 (43%), Gaps = 49/300 (16%)
Query: 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL- 181
+AE + ++G+G Y +V K + + +G+I+A+K+++ E K + ++ ++ +
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE-KEQKQLLMDLDVVMRSS 78
Query: 182 DHPNIVKLEGLATSRMQYSLYLVFEFMQT----DLARIISNPEGKLTEPQ------QLLS 231
D P IV+ G A R + ++ E M T + S + + E +
Sbjct: 79 DCPYIVQFYG-ALFR-EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 232 GLQHCHD-RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAP 290
L H + I+HRD+K SN+L+D++G +K+ DFG++ + + T Y AP
Sbjct: 137 ALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAP 194
Query: 291 ELLLGATD---YGVGIDLWSAGCLLAEMFLGR-PIMPGRTEVEQLHRIFKLCGSPSEDYW 346
E + + Y V D+WS G L E+ GR P + +QL ++ D
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV------VKGD-- 246
Query: 347 KKLRLSTTFRPPQ--SYKPRLF-EAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
PPQ + + R F +F F ++ L D + R LK+ F
Sbjct: 247 ----------PPQLSNSEEREFSPSFINF-------VNLCLTKDESKRPKYKELLKHPFI 289
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 68/296 (22%), Positives = 121/296 (40%), Gaps = 45/296 (15%)
Query: 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL- 181
A+ + I ++G+G Y V K +G+I+A+K+++ T K + ++ I +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA-TVNSQEQKRLLMDLDISMRTV 63
Query: 182 DHPNIVKLEGLATSRMQYSLYLVFEFMQT---DLARIISNPEGKLTEPQ------QLLSG 232
D P V G A R + +++ E M T + + + + E ++
Sbjct: 64 DCPFTVTFYG-ALFR-EGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 233 LQHCHD-RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPE 291
L+H H ++HRDVK SN+LI+ G +K+ DFG++ Y + + Y APE
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK--DIDAGCKPYMAPE 179
Query: 292 LLLGATD---YGVGIDLWSAGCLLAEMFLGR-PIMPGRTEVEQLHRIFKLCGSPSEDYWK 347
+ + Y V D+WS G + E+ + R P T +QL ++ E
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV------VEEP--- 230
Query: 348 KLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
PQ + F +F S L + R + +++ FF
Sbjct: 231 ---------SPQLPADKFSAEFVDF-------TSQCLKKNSKERPTYPELMQHPFF 270
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 46/199 (23%), Positives = 89/199 (44%), Gaps = 16/199 (8%)
Query: 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLE 190
++G G++ VYK VA+K + P ++ E+ +L+K H NI+
Sbjct: 30 QRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 191 GLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL------SGLQHCHDRGILH 243
G + L +V ++ + L + E K + + G+ + H + I+H
Sbjct: 87 G-YS--TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIH 143
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYFSP-NKKRPLTSRVVTLWYRAPELLLGATD--YG 300
RD+K +N+ + ++ +KI DFGLA S + ++ + APE++ Y
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 301 VGIDLWSAGCLLAEMFLGR 319
D+++ G +L E+ G+
Sbjct: 204 FQSDVYAFGIVLYELMTGQ 222
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-36
Identities = 56/297 (18%), Positives = 94/297 (31%), Gaps = 77/297 (25%)
Query: 125 ESYDKIDKV-GQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-D 182
+ Y +V G G V + ++ T + ALK ++ RE+ + +
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQ 69
Query: 183 HPNIVKLEGL--ATSRMQYSLYLVFEFMQ----TDLARIISNPEGKLTEP------QQLL 230
P+IV++ + + L +V E + RI + TE + +
Sbjct: 70 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS--RIQDRGDQAFTEREASEIMKSIG 127
Query: 231 SGLQHCHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWY 287
+Q+ H I HRDVK NLL N +LK+ DFG
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------- 166
Query: 288 RAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFK--LCGSPS--E 343
A E Y D+WS G ++ + G P + + G
Sbjct: 167 -AKETT--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223
Query: 344 DYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400
W + +S E L+ LL +P R + + +
Sbjct: 224 PEWSE--VS---------------------EEVKMLIRNLLKTEPTQRMTITEFMNH 257
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 43/261 (16%), Positives = 86/261 (32%), Gaps = 40/261 (15%)
Query: 120 VPKSAESYDKIDKVGQGTYSNVYKALDRD-----TGKIVALKKVKFDTSEPHSVKFMARE 174
++ +G+G ++ VY+A D + LK K + P +
Sbjct: 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK--PANPWEFYIGTQL 117
Query: 175 IMILQKLDHPNIVKLEGLATSRMQYSLYLVFEF-----MQTDLARIISNPEGKLTEP--- 226
+ L+ +K Q LV E + + + PE + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 227 ---QQLLSGLQHCHDRGILHRDVKGSNLLI-----------DKNGVLKIADFGLA---NY 269
++L ++ HD I+H D+K N ++ D + L + D G +
Sbjct: 176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 270 FSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPI-MPGRTEV 328
F T++ T ++ E+L + ID + + M G + +
Sbjct: 236 FPKGTI--FTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292
Query: 329 EQLHRIFKLCGSPSEDYWKKL 349
+ +F+ P D W +
Sbjct: 293 CKPEGLFR--RLPHLDMWNEF 311
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 34/200 (17%), Positives = 69/200 (34%), Gaps = 20/200 (10%)
Query: 132 KVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEG 191
K+ + ++K + G + +K +K + E L+ HPN++ + G
Sbjct: 17 KLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 192 LATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLLS-------GLQ--HCHDRGI 241
S L+ +M L ++ + + Q + G+ H + I
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLI 134
Query: 242 LHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLG--ATDY 299
+ +++ID++ +I+ + F R+ + APE L
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPEDTN 188
Query: 300 GVGIDLWSAGCLLAEMFLGR 319
D+WS LL E+
Sbjct: 189 RRSADMWSFAVLLWELVTRE 208
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 47/209 (22%), Positives = 84/209 (40%), Gaps = 28/209 (13%)
Query: 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKF-----DTSEPHSVKFMAREIMILQKLDHPN 185
++G+G + V+K +VA+K + +T + RE+ I+ L+HPN
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 186 IVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLLSGLQ--------HC 236
IVKL GL + +V EF+ DL + + + +L L
Sbjct: 85 IVKLYGLMHN----PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 237 HDRGILHRDVKGSNLLIDKNG-----VLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPE 291
+ I+HRD++ N+ + K+ADFGL+ ++ + + APE
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAPE 196
Query: 292 LLLGATD-YGVGIDLWSAGCLLAEMFLGR 319
+ + Y D +S +L + G
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 69/306 (22%), Positives = 116/306 (37%), Gaps = 53/306 (17%)
Query: 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKL 181
+ ++ + +G+G +S V + TG++ A+K + K+D + V E +L
Sbjct: 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG 118
Query: 182 DHPNIVKLEGLATSRMQYS------LYLVFEFMQT-DLARIISNPEGKLTEPQ------Q 228
D I +L ++ LYLV E+ DL ++S ++ +
Sbjct: 119 DRRWITQL--------HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170
Query: 229 LLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYR 288
++ + H G +HRD+K N+L+D+ G +++ADFG + V T Y
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230
Query: 289 APELLLG------ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPS 342
+PE+L YG D W+ G EMF G+ P + S +
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT--PFYAD------------STA 276
Query: 343 EDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR-GSA-ASALKN 400
E Y K + P + PE + + LL P R G A +
Sbjct: 277 ETYGKIVHYKEHLSLPLVDE--------GVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327
Query: 401 EFFFTS 406
FF
Sbjct: 328 HPFFFG 333
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 132 KVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEG 191
K+G G++ V++A G VA+K + V RE+ I+++L HPNIV G
Sbjct: 44 KIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 192 LATSRMQYSLYLVFEFM-QTDLARIISNPEGK--LTEPQQLLSGLQ--------HCHDRG 240
T L +V E++ + L R++ + L E ++L H +
Sbjct: 102 AVTQPPN--LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 241 ILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYG 300
I+HR++K NLL+DK +K+ DFGL+ + S T + APE+L
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRD-EPSN 217
Query: 301 VGIDLWSAGCLLAEMFLGR 319
D++S G +L E+ +
Sbjct: 218 EKSDVYSFGVILWELATLQ 236
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 43/208 (20%), Positives = 84/208 (40%), Gaps = 25/208 (12%)
Query: 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLE 190
+ +G+G + VY VA++ + + +K RE+M ++ H N+V
Sbjct: 39 ELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 191 GLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL------SGLQHCHDRGILH 243
G S L ++ + L ++ + + L + G+ + H +GILH
Sbjct: 96 GACMSPPH--LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILH 153
Query: 244 RDVKGSNLLIDKNGVLKIADFGLA----NYFSPNKKRPLTSRVVTLWYRAPELLLGATDY 299
+D+K N+ D NG + I DFGL + ++ L + L + APE++ +
Sbjct: 154 KDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 300 GVGI--------DLWSAGCLLAEMFLGR 319
D+++ G + E+
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 56/355 (15%), Positives = 113/355 (31%), Gaps = 107/355 (30%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTG-----KIVAL------------------------ 155
++ I +G+G + V++A ++ K + L
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 156 ---------------------------KKVKFDTSEPHSVKFMAREIMILQKLDHPNIVK 188
+ + S P + + +I + N V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 189 LEGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEP--------QQLLSGLQHCHDR 239
L S + LY+ + + +L ++ Q+ ++ H +
Sbjct: 126 --QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLA-----------NYFSPNKKRPLTSRVVTLWYR 288
G++HRD+K SN+ + V+K+ DFGL T +V T Y
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243
Query: 289 APELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK 348
+PE + G +Y +D++S G +L E+ T++E++ I + +
Sbjct: 244 SPEQIHG-NNYSHKVDIFSLGLILFELL-----YSFSTQMERVRIITDV---------RN 288
Query: 349 LRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
L+ P+ ++ +L+ P R A ++N F
Sbjct: 289 LKFP---LLFTQKYPQEHM-----------MVQDMLSPSPTERPEATDIIENAIF 329
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 26/216 (12%)
Query: 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKL 181
E ++ + +G+G + V ++ K+ A+K + K++ + E +L
Sbjct: 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG 131
Query: 182 DHPNIVKLEGLATSRMQYS------LYLVFEFMQT-DLARIISNPEGKLTEPQ------Q 228
D I L Y+ LYLV ++ DL ++S E +L E +
Sbjct: 132 DSKWITTL--------HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE 183
Query: 229 LLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYR 288
++ + H +HRD+K N+L+D NG +++ADFG + + V T Y
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 289 APELLLGATD----YGVGIDLWSAGCLLAEMFLGRP 320
+PE+L YG D WS G + EM G
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
+ VG+G + V KA R K VA+K+++ SE F+ E+ L +++HPNIVKL
Sbjct: 13 EEVVGRGAFGVVCKAKWR--AKDVAIKQIE---SESERKAFI-VELRQLSRVNHPNIVKL 66
Query: 190 EGLATSRMQYSLYLVFEFMQT-DLARII--SNPEGKLTEPQQLL------SGLQHCHDR- 239
G + + LV E+ + L ++ + P T + G+ + H
Sbjct: 67 YGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 240 --GILHRDVKGSNLLIDKNG-VLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGA 296
++HRD+K NLL+ G VLKI DFG + + + +T+ + + APE+ G
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGT----ACDIQTHMTNNKGSAAWMAPEVFEG- 177
Query: 297 TDYGVGIDLWSAGCLLAEMFLGR 319
++Y D++S G +L E+ R
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRR 200
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-33
Identities = 71/289 (24%), Positives = 110/289 (38%), Gaps = 42/289 (14%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEG 191
+G+G + V+ + TGK+ A KK+ + + E IL K+ IV L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251
Query: 192 LATSRMQYSLYLVFEFMQT-DL---ARIISNPEGKLTEPQ------QLLSGLQHCHDRGI 241
+ L LV M D+ + EP+ Q++SGL+H H R I
Sbjct: 252 -YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 242 LHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGV 301
++RD+K N+L+D +G ++I+D GLA + + T + APELLLG +Y
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTPGFMAPELLLG-EEYDF 368
Query: 302 GIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSY 361
+D ++ G L EM R R E + + + L P
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELK------------QRVLEQAVTYPDK- 415
Query: 362 KPRLFEAFSEFPESSLGLLSTLLALDPAYR----GSAASALKNEFFFTS 406
F +S LL DP R + L+ F
Sbjct: 416 ----------FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-33
Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 27/215 (12%)
Query: 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKL 181
AE Y+ + +G+G + V + T K+ A+K + KF+ + F E I+
Sbjct: 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 126
Query: 182 DHPNIVKLEGLATSRMQYS------LYLVFEFMQ-TDLARIISNPEGKLTEPQ------Q 228
+ P +V+L Y+ LY+V E+M DL ++S + E +
Sbjct: 127 NSPWVVQL--------FYAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAE 176
Query: 229 LLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYR 288
++ L H G +HRDVK N+L+DK+G LK+ADFG + + V T Y
Sbjct: 177 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236
Query: 289 APELLL---GATDYGVGIDLWSAGCLLAEMFLGRP 320
+PE+L G YG D WS G L EM +G
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 67/293 (22%), Positives = 116/293 (39%), Gaps = 57/293 (19%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEG 191
+G+G++ V DT K+ A+K + E + V+ + +E+ I+Q L+HP +V L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81
Query: 192 LATSRMQYS------LYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCHD 238
YS +++V + + DL + E +L+ L + +
Sbjct: 82 -------YSFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQN 133
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLL--GA 296
+ I+HRD+K N+L+D++G + I DF +A + +T+ T Y APE+
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTMAGTKPYMAPEMFSSRKG 191
Query: 297 TDYGVGIDLWSAGCLLAEMFLGRP---IMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353
Y +D WS G E+ GR I + E +H + +
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----------TVVTYPS 241
Query: 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406
+ E S LL LL +P R S S ++N +
Sbjct: 242 AWSQ---------EMVS--------LLKKLLEPNPDQRFSQLSDVQNFPYMND 277
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 66/300 (22%), Positives = 116/300 (38%), Gaps = 47/300 (15%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
++ +G + V+KA + VA+K F + S + E+ L + H NI++
Sbjct: 29 LEVKARGRFGCVWKAQLL--NEYVAVKI--FPIQDKQSWQN-EYEVYSLPGMKHENILQF 83
Query: 190 EG--LATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQL------LSGLQHCHDR- 239
G + + L+L+ F + L+ + ++ + GL + H+
Sbjct: 84 IGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDI 141
Query: 240 ---------GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV-TLWYRA 289
I HRD+K N+L+ N IADFGLA F K T V T Y A
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMA 201
Query: 290 PELLLGA----TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDY 345
PE+L GA D + ID+++ G +L E+ G + L ++ PS +
Sbjct: 202 PEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLED 261
Query: 346 WKKLRLSTTFRP--PQSYKPRLFEAFSEFPESSLGLLSTLLAL----DPAYRGSAASALK 399
+++ + RP ++ + + +L + D R SA +
Sbjct: 262 MQEVVVHKKKRPVLRDYWQKH----------AGMAMLCETIEECWDHDAEARLSAGCVGE 311
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-32
Identities = 63/208 (30%), Positives = 93/208 (44%), Gaps = 30/208 (14%)
Query: 132 KVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFM--AREIMILQKLDHPNIVKL 189
+G G + VY+A G VA+K + D E S +E + L HPNI+ L
Sbjct: 14 IIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 190 EGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL------SGLQHCHDRG-- 240
G+ L LV EF + L R++S ++ + G+ + HD
Sbjct: 72 RGVCLKEPN--LCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 241 -ILHRDVKGSNLLIDK--------NGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPE 291
I+HRD+K SN+LI + N +LKI DFGLA + K S + APE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPE 184
Query: 292 LLLGATDYGVGIDLWSAGCLLAEMFLGR 319
++ + + G D+WS G LL E+ G
Sbjct: 185 VIRASM-FSKGSDVWSYGVLLWELLTGE 211
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-31
Identities = 75/287 (26%), Positives = 119/287 (41%), Gaps = 41/287 (14%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEG 191
+G+G + V R TGK+ A KK++ + E IL+K++ +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 250
Query: 192 LATSRMQYSLYLVFEFMQT-DLARIISNP-EGKLTEPQ------QLLSGLQHCHDRGILH 243
+ +L LV M DL I + + E + ++ GL+ H I++
Sbjct: 251 -YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGI 303
RD+K N+L+D +G ++I+D GLA + + + RV T+ Y APE++ Y
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKN-ERYTFSP 366
Query: 304 DLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKP 363
D W+ GCLL EM G+ R + + + +L P+ Y
Sbjct: 367 DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL----------------VKEVPEEYSE 410
Query: 364 RLFEAFSEFPESSLGLLSTLLALDPAYR----GSAASALKNEFFFTS 406
R F + L S LL DPA R G +A +K F
Sbjct: 411 R-------FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 71/210 (33%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD-TSEPHSVKFMAREIMILQKLDHPN 185
Y +DK+G G S VY A D VA+K + + ++K RE+ +L H N
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 186 IVKL------EGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQ------QLLSG 232
IV + + YLV E+++ L+ I + G L+ Q+L G
Sbjct: 73 IVSMIDVDEEDDCY--------YLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDG 123
Query: 233 LQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV-TLWYRAPE 291
++H HD I+HRD+K N+LID N LKI DFG+A S T+ V+ T+ Y +PE
Sbjct: 124 IKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET-SLTQTNHVLGTVQYFSPE 182
Query: 292 LLLG-ATDYGVGIDLWSAGCLLAEMFLGRP 320
G ATD D++S G +L EM +G P
Sbjct: 183 QAKGEATDECT--DIYSIGIVLYEMLVGEP 210
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 6e-31
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD-TSEPHSVKFMAREIMILQKLDHPN 185
Y+ + +G G S V+ A D + VA+K ++ D +P RE L+HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 186 IVKL--EGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQ------QLLSGLQHC 236
IV + G A + Y+V E++ L I+ EG +T + L
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFS 132
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLT--SRVV-TLWYRAPELL 293
H GI+HRDVK +N++I +K+ DFG+A + + +T + V+ T Y +PE
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN-SVTQTAAVIGTAQYLSPEQA 191
Query: 294 LGATDYGVGI--DLWSAGCLLAEMFLGRP 320
G + V D++S GC+L E+ G P
Sbjct: 192 RGDS---VDARSDVYSLGCVLYEVLTGEP 217
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 69/254 (27%), Positives = 105/254 (41%), Gaps = 33/254 (12%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
+ ++G+G Y V+ R G+ VA+K F T+E S F EI + H NI+
Sbjct: 42 VKQIGKGRYGEVWMGKWR--GEKVAVKV--FFTTEEAS-WFRETEIYQTVLMRHENILGF 96
Query: 190 EGLAT--SRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQL------LSGLQHCHDR- 239
+ LYL+ ++ + L + + L L +SGL H H
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 240 -------GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR---PLTSRVVTLWYRA 289
I HRD+K N+L+ KNG IAD GLA F + P +RV T Y
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 290 PELLLGAT-----DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSED 344
PE+L + + D++S G +L E+ R + G E QL + PS +
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEV-ARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 345 YWKKLRLSTTFRPP 358
+++ RP
Sbjct: 274 DMREIVCIKKLRPS 287
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 72/290 (24%), Positives = 116/290 (40%), Gaps = 56/290 (19%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD-TSEPHSVKFMAREIMILQKLDHPN 185
Y VG+G +VY+A D +IVALK + +S+P M RE +L P+
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 186 IVKL------EGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQ------QLLSG 232
+V + +G LY+ + DLA ++ +G L P+ Q+ S
Sbjct: 96 VVPIHDFGEIDGQ--------LYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSA 146
Query: 233 LQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTS--RVV-TLWYRA 289
L H G HRDVK N+L+ + + DFG+A+ + K LT V TL+Y A
Sbjct: 147 LDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK---LTQLGNTVGTLYYMA 203
Query: 290 PELLLGAT-DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK 348
PE + Y D+++ C+L E G P G + +
Sbjct: 204 PERFSESHATYRA--DIYALTCVLYECLTGSPPYQGDQ-LSVMGA--------------- 245
Query: 349 LRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASAL 398
++ P + +P + AF +++ +A +P R L
Sbjct: 246 -HINQAIPRPSTVRPGIPVAFDA-------VIARGMAKNPEDRYVTCGDL 287
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-30
Identities = 76/298 (25%), Positives = 119/298 (39%), Gaps = 63/298 (21%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKL---DHPNIVK 188
+G+G + VY DTGK+ A+K + E ++L + D P IV
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 189 LEGLATSRMQYS------LYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQH 235
+ Y+ L + + M DL +S G +E +++ GL+H
Sbjct: 257 MS--------YAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEH 307
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLG 295
H+R +++RD+K +N+L+D++G ++I+D GLA FS K + V T Y APE+L
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQK 364
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRP---IMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352
Y D +S GC+L ++ G + + E + L
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----------MAVELP 414
Query: 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR----GSAASALKNEFFFTS 406
+F P E S LL LL D R G A +K FF S
Sbjct: 415 DSFSP---------ELRS--------LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 57/212 (26%), Positives = 87/212 (41%), Gaps = 32/212 (15%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
++ VG+G Y V++ + G+ VA+K F + + S F E+ L H NI+
Sbjct: 13 LECVGKGRYGEVWRGSWQ--GENVAVKI--FSSRDEKSW-FRETELYNTVMLRHENILGF 67
Query: 190 EG--LATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQL------LSGLQHCHDR- 239
+ + L+L+ + + L + L L SGL H H
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 240 -------GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR---PLTSRVVTLWYRA 289
I HRD+K N+L+ KNG IAD GLA S + + RV T Y A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 290 PELLLGATDYGVG-----IDLWSAGCLLAEMF 316
PE+L +D+W+ G +L E+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-30
Identities = 57/289 (19%), Positives = 107/289 (37%), Gaps = 62/289 (21%)
Query: 127 YDKIDKVGQGTYSNVYKALDRD-TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPN 185
Y+ + G +Y ALDR+ G+ V LK + + + + E L ++ HP+
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLV-HSGDAEAQAMAMAERQFLAEVVHPS 140
Query: 186 IVKL--EGLATSRMQYSL-YLVFEFMQ-TDLARIISNPEGKLTEPQ------QLLSGLQH 235
IV++ T R + Y+V E++ L R KL + ++L L +
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSY 197
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR---VVTLWYRAPEL 292
H G+++ D+K N+++ + + K+ D G + S T ++APE+
Sbjct: 198 LHSIGLVYNDLKPENIMLTEEQL-KLIDLGAV--------SRINSFGYLYGTPGFQAPEI 248
Query: 293 LLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352
+ V D+++ G LA + L P GR
Sbjct: 249 VRTGPT--VATDIYTVGRTLAALTLDLPTRNGRYVDG----------------------- 283
Query: 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNE 401
P + ++++ LL + DP R + A + +
Sbjct: 284 ---LPEDDPVLKTYDSYGR-------LLRRAIDPDPRQRFTTAEEMSAQ 322
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 82/369 (22%), Positives = 133/369 (36%), Gaps = 104/369 (28%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL----- 181
Y I K+G G +S V+ + D K VA+K VK S H + EI +L+ +
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK---SAEHYTETALDEIRLLKSVRNSDP 95
Query: 182 DHPN---IVKL------EGLATSRMQYSLYLVFEFMQTDLARII-SNPEGKLTEP----- 226
+ PN +V+L G+ + + +VFE + L + I + L P
Sbjct: 96 NDPNREMVVQLLDDFKISGVNGTHI----CMVFEVLGHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 227 -QQLLSGLQHCHDR-GILHRDVKGSNLLI------------------------------- 253
QQ+L GL + H + I+H D+K N+L+
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 254 ------------------DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLG 295
+ +KIAD G A + + T + T YR+ E+L+G
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH----KHFTEDIQTRQYRSLEVLIG 267
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRT------EVEQLHRIFKLCGSPSEDYWKKL 349
+ Y D+WS C+ E+ G + + + + + I +L G
Sbjct: 268 S-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAG 326
Query: 350 RLSTTF--------RPPQSYKPRLFEAFSEFPESS-------LGLLSTLLALDPAYRGSA 394
+ S F + LFE E E S L +L L P R +A
Sbjct: 327 KYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATA 386
Query: 395 ASALKNEFF 403
A L++ +
Sbjct: 387 AECLRHPWL 395
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 61/264 (23%), Positives = 106/264 (40%), Gaps = 43/264 (16%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA-REIMILQKLDHPNIVK 188
++ +G+G Y VYK + VA+K F + + F+ + I + ++H NI +
Sbjct: 18 LELIGRGRYGAVYKGSLD--ERPVAVKV--FSFANRQN--FINEKNIYRVPLMEHDNIAR 71
Query: 189 L-----EGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL----SGLQHCHD 238
A RM+Y L V E+ L + +S +L GL + H
Sbjct: 72 FIVGDERVTADGRMEYLL--VMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHT 129
Query: 239 ---------RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL-------TSRV 282
I HRD+ N+L+ +G I+DFGL+ + N+ S V
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 283 VTLWYRAPELLLGATD------YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIF- 335
T+ Y APE+L GA + +D+++ G + E+F+ + V + F
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249
Query: 336 -KLCGSPSEDYWKKLRLSTTFRPP 358
++ P+ + + L RP
Sbjct: 250 TEVGNHPTFEDMQVLVSREKQRPK 273
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 33/217 (15%)
Query: 121 PK-SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMIL 178
PK S + + + +G G++ V+ R G+ A+K + K V+ E ++L
Sbjct: 1 PKYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 60
Query: 179 QKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ-----TDLARIISNPEGKLTEPQ------ 227
+ HP I+++ G T + ++++ ++++ + L + + P
Sbjct: 61 SIVTHPFIIRMWG--TFQDAQQIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAA 113
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLW- 286
++ L++ H + I++RD+K N+L+DKNG +KI DFG A K + TL
Sbjct: 114 EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA------KY--VPDVTYTLCG 165
Query: 287 ---YRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRP 320
Y APE++ Y ID WS G L+ EM G
Sbjct: 166 TPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYT 201
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 79/306 (25%), Positives = 120/306 (39%), Gaps = 80/306 (26%)
Query: 133 VGQGTYSNVY---KALDRDTGKIVALKKVKFDT--SEPHSVKFMAREIMILQKLDHPNIV 187
+G+G Y V+ K +TGKI A+K +K E IL+++ HP IV
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 188 KLEGLATSRMQYS------LYLVFEFMQ-----TDLARIISNPEGKLTEPQ------QLL 230
L Y+ LYL+ E++ L R EG E ++
Sbjct: 85 DL--------IYAFQTGGKLYLILEYLSGGELFMQLER-----EGIFMEDTACFYLAEIS 131
Query: 231 SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV------T 284
L H H +GI++RD+K N++++ G +K+ DFGL K + V T
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC-------KESIHDGTVTHTFCGT 184
Query: 285 LWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSED 344
+ Y APE+L+ + + +D WS G L+ +M G P G + + +I K
Sbjct: 185 IEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK-------- 235
Query: 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR-GSA---ASALKN 400
KL L EA LL LL + A R G+ A ++
Sbjct: 236 --CKLNLPPYLTQ---------EARD--------LLKKLLKRNAASRLGAGPGDAGEVQA 276
Query: 401 EFFFTS 406
FF
Sbjct: 277 HPFFRH 282
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 59/214 (27%), Positives = 104/214 (48%), Gaps = 32/214 (14%)
Query: 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKL 181
+ +D+I +G G++ V +++G A+K + K + ++ E ILQ +
Sbjct: 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 182 DHPNIVKLEGLATSRMQYSLYLVFEFMQ-----TDLARIISNPEGKLTEPQ------QLL 230
+ P +VKLE + + +LY+V E++ + L R G+ +EP Q++
Sbjct: 99 NFPFLVKLEF--SFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIV 151
Query: 231 SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTL----W 286
++ H +++RD+K NLLID+ G +++ DFG A K+ + R TL
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KR--VKGRTWTLCGTPE 203
Query: 287 YRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRP 320
APE++L Y +D W+ G L+ EM G P
Sbjct: 204 ALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 66/255 (25%), Positives = 103/255 (40%), Gaps = 35/255 (13%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
+ +G+G + V++ R G+ VA+K F + E S F EI L H NI+
Sbjct: 47 QESIGKGRFGEVWRGKWR--GEEVAVKI--FSSREERSW-FREAEIYQTVMLRHENILGF 101
Query: 190 EGLATSRMQYS---LYLVFEFMQT-DLARIISNPEGKLTEPQQLL------SGLQHCHDR 239
A ++ + L+LV ++ + L ++ +T + SGL H H
Sbjct: 102 IA-ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHME 158
Query: 240 --------GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK---KRPLTSRVVTLWYR 288
I HRD+K N+L+ KNG IAD GLA RV T Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 289 APELLLGATDYGVG-----IDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSE 343
APE+L + + D+++ G + E+ R + G E QL + PS
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEI-ARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 344 DYWKKLRLSTTFRPP 358
+ +K+ RP
Sbjct: 278 EEMRKVVCEQKLRPN 292
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 77/292 (26%), Positives = 120/292 (41%), Gaps = 56/292 (19%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEG 191
+G+GT+ V ++ TG+ A+K ++ + V E +LQ HP + L+
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 192 LATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILHR 244
+ L V E+ +L +S E TE + +++S L++ H R +++R
Sbjct: 72 -YAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 245 DVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV------TLWYRAPELLLGATD 298
D+K NL++DK+G +KI DFGL K ++ T Y APE+L D
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLC-------KEGISDGATMKTFCGTPEYLAPEVLED-ND 181
Query: 299 YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358
YG +D W G ++ EM GR + I +++R T P
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----------EEIRFPRTLSP- 230
Query: 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR-GSA---ASALKNEFFFTS 406
EA S LL+ LL DP R G A + FF S
Sbjct: 231 --------EAKS--------LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 82/300 (27%), Positives = 124/300 (41%), Gaps = 70/300 (23%)
Query: 133 VGQGTYSNVY---KALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
+GQG++ V+ K D ++ A+K +K T + E IL +++HP IVKL
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 190 EGLATSRMQYS------LYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHC 236
Y+ LYL+ +F++ DL +S E TE +L L H
Sbjct: 92 H--------YAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHL 142
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV------TLWYRAP 290
H GI++RD+K N+L+D+ G +K+ DFGL+ K + T+ Y AP
Sbjct: 143 HSLGIIYRDLKPENILLDEEGHIKLTDFGLS-------KESIDHEKKAYSFCGTVEYMAP 195
Query: 291 ELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350
E++ + D WS G L+ EM G G+ E + I K KL
Sbjct: 196 EVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK----------AKLG 244
Query: 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR-GSA---ASALKNEFFFTS 406
+ P EA S LL L +PA R G+ +K FF++
Sbjct: 245 MPQFLSP---------EAQS--------LLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 35/211 (16%)
Query: 129 KIDKVGQGTYSNVYKA----LDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+I +G+G + V +TG+ VA+K +K ++ H +EI IL+ L H
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-KEIEILRNLYHE 83
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL------SGLQHCH 237
NIVK +G+ T + L+ EF+ + L + + K+ QQL G+ +
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK---------KRPLTSRVVTLWYR 288
R +HRD+ N+L++ +KI DFGL +K P+ WY
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF------WY- 196
Query: 289 APELLLGATDYGV---GIDLWSAGCLLAEMF 316
APE L+ D+WS G L E+
Sbjct: 197 APECLM----QSKFYIASDVWSFGVTLHELL 223
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 76/293 (25%), Positives = 120/293 (40%), Gaps = 57/293 (19%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEG 191
+G+GT+ V ++ TG+ A+K +K + V E +LQ HP + L+
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 192 LATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCH-DRGILH 243
+ + L V E+ +L +S E +E + +++S L + H ++ +++
Sbjct: 215 -YSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVY 272
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV------TLWYRAPELLLGAT 297
RD+K NL++DK+G +KI DFGL K + T Y APE+L
Sbjct: 273 RDLKLENLMLDKDGHIKITDFGLC-------KEGIKDGATMKTFCGTPEYLAPEVLED-N 324
Query: 298 DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357
DYG +D W G ++ EM GR + + I +++R T P
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM----------EEIRFPRTLGP 374
Query: 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR-GSA---ASALKNEFFFTS 406
EA S LLS LL DP R G A + FF
Sbjct: 375 ---------EAKS--------LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 30/208 (14%)
Query: 129 KIDKVGQGTYSNVYKA----LDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ ++G+G + +V L +TG++VA+KK++ T E F REI IL+ L H
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFE-REIEILKSLQHD 71
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL------SGLQHCH 237
NIVK +G+ S + +L L+ E++ L + + ++ + L G+++
Sbjct: 72 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK---------KRPLTSRVVTLWYR 288
+ +HRD+ N+L++ +KI DFGL +K + P+ WY
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF------WY- 184
Query: 289 APELLLGATDYGVGIDLWSAGCLLAEMF 316
APE L + + V D+WS G +L E+F
Sbjct: 185 APESLTESK-FSVASDVWSFGVVLYELF 211
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 129 KIDKVGQGTYSNVYKA----LDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ ++G+G + +V L +TG++VA+KK++ T E F REI IL+ L H
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFE-REIEILKSLQHD 102
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL------SGLQHCH 237
NIVK +G+ S + +L L+ E++ L + + ++ + L G+++
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 162
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK---KRPLTSRVVTLWYRAPELLL 294
+ +HRD+ N+L++ +KI DFGL +K K WY APE L
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-APESLT 221
Query: 295 GATDYGVGIDLWSAGCLLAEMF 316
+ + V D+WS G +L E+F
Sbjct: 222 ESK-FSVASDVWSFGVVLYELF 242
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 69/298 (23%), Positives = 109/298 (36%), Gaps = 68/298 (22%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMIL-QKLDHPNIVKLE 190
+G+G++ V A + A+K ++ + K + E +L + + HP +V L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 191 GLATSRMQYS------LYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCH 237
+S LY V +++ +L + E EP+ ++ S L + H
Sbjct: 106 --------FSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLH 156
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV------TLWYRAPE 291
I++RD+K N+L+D G + + DFGL K + T Y APE
Sbjct: 157 SLNIVYRDLKPENILLDSQGHIVLTDFGLC-------KENIEHNSTTSTFCGTPEYLAPE 209
Query: 292 LLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351
+L Y +D W G +L EM G P R E I K L+L
Sbjct: 210 VLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN----------KPLQL 258
Query: 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR---GSAASALKNEFFFTS 406
P S+ LL LL D R +K+ FF+
Sbjct: 259 -----KPN------------ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 29/222 (13%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
+++G+G + V+ R +VA+K + KF+ +E IL++ HPNIV+L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL-QEARILKQYSHPNIVRL 177
Query: 190 EGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL------SGLQHCHDRGIL 242
G+ T + +Y+V E +Q D + +L L +G+++ + +
Sbjct: 178 IGVCT--QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 243 HRDVKGSNLLIDKNGVLKIADFGLA------NYFSPNKKRPLTSRVVTLWYRAPELLLGA 296
HRD+ N L+ + VLKI+DFG++ Y + R + + W APE A
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK----WT-APE----A 286
Query: 297 TDYGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
+YG D+WS G LL E F LG P + + +
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV 328
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 25/222 (11%)
Query: 130 IDKVGQGTYSNVYKALDRDTGK---IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
+G G V R G+ VA+K +K +E F+ E I+ + DHPNI
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL-SEASIMGQFDHPNI 112
Query: 187 VKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL------SGLQHCHDR 239
++LEG+ T +V E+M+ L + +G+ T Q + +G+++ D
Sbjct: 113 IRLEGVVTRGR--LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTL---WYRAPELLLGA 296
G +HRD+ N+L+D N V K++DFGL+ + T+ + W APE A
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-APE----A 225
Query: 297 TDYGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
+ D+WS G ++ E+ G T + + +
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 53/289 (18%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQK-LDHPNIVKLE 190
+G+G++ V+ A + T + A+K +K D V+ E +L +HP + +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM- 83
Query: 191 GLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILH 243
T + + +L+ V E++ DL I + K + +++ GLQ H +GI++
Sbjct: 84 -FCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVY 141
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLW------YRAPELLLGAT 297
RD+K N+L+DK+G +KIADFG+ K + T Y APE+LLG
Sbjct: 142 RDLKLDNILLDKDGHIKIADFGMC-------KENMLGDAKTNTFCGTPDYIAPEILLG-Q 193
Query: 298 DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357
Y +D WS G LL EM +G+ G+ E E H I
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM----------DNPFY------ 237
Query: 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406
PR + + LL L +P R ++ F
Sbjct: 238 -----PR------WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 74/300 (24%), Positives = 117/300 (39%), Gaps = 70/300 (23%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQK-LDHPNIVKLE 190
+G+G++ V A ++TG + A+K +K D + V+ E IL +HP + +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 191 GLATSRMQYS------LYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCH 237
L+ V EF+ DL I + E + +++S L H
Sbjct: 91 --------CCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLH 141
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLW------YRAPE 291
D+GI++RD+K N+L+D G K+ADFG+ K + + V T Y APE
Sbjct: 142 DKGIIYRDLKLDNVLLDHEGHCKLADFGMC-------KEGICNGVTTATFCGTPDYIAPE 194
Query: 292 LLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351
+L YG +D W+ G LL EM G E + I ++
Sbjct: 195 ILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN----------DEVVY 243
Query: 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR-GS----AASALKNEFFFTS 406
P E + G+L + + +P R GS A+ FF
Sbjct: 244 -----------PT------WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 64/298 (21%), Positives = 121/298 (40%), Gaps = 64/298 (21%)
Query: 112 PREVLAGLVPKSAESYDKIDKVGQGTYSNVYKAL---DRDTGKI-VALKKVKFDTSEPHS 167
P + L ++ + + KI +G G + VYK L + + KI VA+K+++ TS +
Sbjct: 4 PNQALLRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN 61
Query: 168 VKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEP 226
+ + E ++ +D+P++ +L G+ + ++ L+ + M L + + +
Sbjct: 62 KEIL-DEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 227 Q------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA--------NYFSP 272
Q+ G+ + DR ++HRD+ N+L+ +KI DFGLA Y +
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 273 NKKRPLTSRVVTLWYRAPELLLGATDYGV---GIDLWSAGCLLAEMF-LGR---PIMPGR 325
K P+ W A E +L + + D+WS G + E+ G +P
Sbjct: 178 GGKVPIK------WM-ALESIL----HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226
Query: 326 ---TEVEQLHRIFKLCGSPSEDY------WKK------------LRLSTTFRPPQSYK 362
+ +E+ R+ + + Y W + S R PQ Y
Sbjct: 227 EISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYL 284
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 25/222 (11%)
Query: 130 IDKVGQGTYSNVYKALDRDTGK---IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
VG G + V + K VA+K +K +E F+ E I+ + DHPNI
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPNI 108
Query: 187 VKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL------SGLQHCHDR 239
++LEG+ T + +V E+M+ L + + + T Q + SG+++ D
Sbjct: 109 IRLEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTL---WYRAPELLLGA 296
G +HRD+ N+LI+ N V K++DFGL + + T+R + W +PE A
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT-SPE----A 221
Query: 297 TDYGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
Y D+WS G +L E+ G + + + +
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 38/291 (13%), Positives = 78/291 (26%), Gaps = 58/291 (19%)
Query: 112 PREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKF- 170
+ V + + Y + G ++ALD + VAL V P V
Sbjct: 20 VQLVPGARI--ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQE 77
Query: 171 MAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ-TDLARIISN---PEGKLTEP 226
+ L ++D P + ++ L + +V E+++ L + P G +
Sbjct: 78 TLSRTLRLSRIDKPGVARV--LDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAM 135
Query: 227 QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLW 286
Q L + H G+ S + + +G + +A +
Sbjct: 136 QSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM--------PDANPQD---- 183
Query: 287 YRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW 346
D+ G L + + R +P L +
Sbjct: 184 -----------------DIRGIGASLYALLVNRWPLPEAGVRSGLAPAER---------- 216
Query: 347 KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASA 397
+ P + S + + + D R ++
Sbjct: 217 ---DTAGQPIEPADIDRDIPFQISA-------VAARSVQGDGGIRSASTLL 257
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-26
Identities = 68/291 (23%), Positives = 114/291 (39%), Gaps = 57/291 (19%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQK-LDHPNIVKLE 190
+G+G++ V + + T ++ A+K +K D + V+ E +L P + +L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL- 407
Query: 191 GLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILH 243
+ + LY V E++ DL I G+ EP ++ GL +GI++
Sbjct: 408 -HSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIY 465
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV------TLWYRAPELLLGAT 297
RD+K N+++D G +KIADFG+ K + V T Y APE++
Sbjct: 466 RDLKLDNVMLDSEGHIKIADFGMC-------KENIWDGVTTKTFCGTPDYIAPEIIAY-Q 517
Query: 298 DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357
YG +D W+ G LL EM G+ G E E I + +
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----------HNVAY------ 561
Query: 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR-GSA---ASALKNEFFF 404
P+ + ++ + L+ P R G +K FF
Sbjct: 562 -----PK------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 68/291 (23%), Positives = 114/291 (39%), Gaps = 57/291 (19%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLD-HPNIVKLE 190
+G+G++ V + + T ++ A+K +K D + V+ E +L P + +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL- 86
Query: 191 GLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILH 243
+ + LY V E++ DL I G+ EP ++ GL +GI++
Sbjct: 87 -HSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIY 144
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV------TLWYRAPELLLGAT 297
RD+K N+++D G +KIADFG+ K + V T Y APE++
Sbjct: 145 RDLKLDNVMLDSEGHIKIADFGMC-------KENIWDGVTTKTFCGTPDYIAPEIIAY-Q 196
Query: 298 DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357
YG +D W+ G LL EM G+ G E E I + +
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----------HNVAY------ 240
Query: 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR-GSA---ASALKNEFFF 404
P+ + ++ + L+ P R G +K FF
Sbjct: 241 -----PK------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 54/220 (24%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
+ ++G G + V+ + K VA+K ++ F+ E ++ KL HP +V+L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEE--DFI-EEAEVMMKLSHPKLVQL 68
Query: 190 EGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL------SGLQHCHDRGIL 242
G+ Q + LV EFM+ L+ + G L G+ + + ++
Sbjct: 69 YGVCLE--QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 126
Query: 243 HRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTL----WYRAPELLLGATD 298
HRD+ N L+ +N V+K++DFG+ + ++ TS T W +PE+
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWA-SPEVFS---- 178
Query: 299 YGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
+ D+WS G L+ E+F G+ R+ E + I
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 38/209 (18%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQK-LDHPNIVKLE 190
+G+G+Y+ V + T +I A+K VK + ++ + ++ E + ++ +HP +V L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL- 75
Query: 191 GLATSRMQYS------LYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCH 237
L+ V E++ DL + + KL E ++ L + H
Sbjct: 76 -------HSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLH 127
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV------TLWYRAPE 291
+RGI++RD+K N+L+D G +K+ D+G+ K L T Y APE
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLRPGDTTSTFCGTPNYIAPE 180
Query: 292 LLLGATDYGVGIDLWSAGCLLAEMFLGRP 320
+L G DYG +D W+ G L+ EM GR
Sbjct: 181 ILRG-EDYGFSVDWWALGVLMFEMMAGRS 208
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 57/236 (24%), Positives = 103/236 (43%), Gaps = 29/236 (12%)
Query: 119 LVPKSAESYDKIDKVGQGTYSNVYKALDRDTGK---IVALKKVKFDTSEPHSVKFMAREI 175
L+P +G+G + VY D + A+K + T F+ RE
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL-REG 73
Query: 176 MILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------Q 228
++++ L+HPN++ L G+ + +++ +M DL + I +P+ T Q
Sbjct: 74 LLMRGLNHPNVLALIGIMLPP-EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 229 LLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA------NYFSPNKKRPLTSRV 282
+ G+++ ++ +HRD+ N ++D++ +K+ADFGLA Y+S + R +R+
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR--HARL 190
Query: 283 VTLWYRAPELLLGATDYGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
W A E L D+WS G LL E+ G P + H +
Sbjct: 191 PVKWT-ALESLQ----TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL 241
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 53/226 (23%), Positives = 99/226 (43%), Gaps = 36/226 (15%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKI---VALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
+G+G + +V++ + VA+K K TS+ KF+ +E + +++ DHP+I
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEALTMRQFDHPHI 78
Query: 187 VKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCHDR 239
VKL G+ T + ++++ E +L + + L QL + L + +
Sbjct: 79 VKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 135
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLA------NYFSPNKKR-PLTSRVVTLWYRAPEL 292
+HRD+ N+L+ N +K+ DFGL+ Y+ +K + P+ W APE
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI------KWM-APES 188
Query: 293 LLGATDYGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
+ + D+W G + E+ G G + + RI
Sbjct: 189 IN----FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 38/229 (16%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKI----VALKKVKFDTSEPHSVKFMAREIMILQKLDHPN 185
+G G + VYK + + + VA+K +K +E V F+ E I+ + H N
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQFSHHN 107
Query: 186 IVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL------SGLQHCHD 238
I++LEG+ + + ++ E+M+ L + + +G+ + Q + +G+++ +
Sbjct: 108 IIRLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLA---------NYFSPNKKRPLTSRVVTLWYRA 289
+HRD+ N+L++ N V K++DFGL+ Y + K P+ W A
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI------RWT-A 218
Query: 290 PELLLGATDYGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
PE + Y D+WS G ++ E+ G + E + I
Sbjct: 219 PEAIS----YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 38/209 (18%)
Query: 133 VGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQK-LDHPNIVKLE 190
+G+G+Y+ V + T +I A++ VK + ++ + ++ E + ++ +HP +V L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL- 118
Query: 191 GLATSRMQYS------LYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCH 237
L+ V E++ DL + + KL E ++ L + H
Sbjct: 119 -------HSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLH 170
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV------TLWYRAPE 291
+RGI++RD+K N+L+D G +K+ D+G+ K L T Y APE
Sbjct: 171 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLRPGDTTSTFCGTPNYIAPE 223
Query: 292 LLLGATDYGVGIDLWSAGCLLAEMFLGRP 320
+L G DYG +D W+ G L+ EM GR
Sbjct: 224 ILRG-EDYGFSVDWWALGVLMFEMMAGRS 251
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 73/303 (24%), Positives = 121/303 (39%), Gaps = 66/303 (21%)
Query: 133 VGQGTYSNVY---KALDRDTGKIVALKKVKFDT--SEPHSVKFMAREIMILQKLDH-PNI 186
+G G Y V+ K DTGK+ A+K +K T + + + E +L+ + P +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 187 VKLEGLATSRMQYS------LYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGL 233
V L Y+ L+L+ +++ +L +S + TE + +++ L
Sbjct: 122 VTLH--------YAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLAL 172
Query: 234 QHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELL 293
+H H GI++RD+K N+L+D NG + + DFGL+ F ++ T+ Y AP+++
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232
Query: 294 LGATDYGVG--IDLWSAGCLLAEMFLGRP----IMPGRTEVEQLHRIFKLCGSPSEDYWK 347
G D G +D WS G L+ E+ G ++ E RI K
Sbjct: 233 RG-GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK----------S 281
Query: 348 KLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR-GSA---ASALKNEFF 403
+ A L+ LL DP R G A +K F
Sbjct: 282 EPPYPQEMSA---------LAKD--------LIQRLLMKDPKKRLGCGPRDADEIKEHLF 324
Query: 404 FTS 406
F
Sbjct: 325 FQK 327
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 54/220 (24%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
+ ++G G + V R VA+K +K + +F+ E ++ L H +V+L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSED--EFI-EEAKVMMNLSHEKLVQL 84
Query: 190 EGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL------SGLQHCHDRGIL 242
G+ T Q ++++ E+M L + + Q L +++ + L
Sbjct: 85 YGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 243 HRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTL----WYRAPELLLGATD 298
HRD+ N L++ GV+K++DFGL+ Y ++ TS V + W PE+L+
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWS-PPEVLM---- 194
Query: 299 YGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
Y D+W+ G L+ E++ LG+ T E I
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 29/225 (12%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKI---VALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
+ +G+G + VY D A+K + T +F+ E +I++ HPN+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEGIIMKDFSHPNV 88
Query: 187 VKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL------SGLQHCHDR 239
+ L G+ R + S +V +M+ DL I N T + G+++ +
Sbjct: 89 LSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLA------NYFSPNKKRPLTSRVVTLWYRAPELL 293
+HRD+ N ++D+ +K+ADFGLA Y+S + K +++ W A E L
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT--GAKLPVKWM-ALESL 204
Query: 294 LGATDYGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
D+WS G LL E+ G P P + +
Sbjct: 205 Q----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 51/254 (20%), Positives = 98/254 (38%), Gaps = 50/254 (19%)
Query: 102 GWPKWLTDNIPREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKI---VALKKV 158
G P++ I RE + +G+G + VY+ + + VA+K
Sbjct: 3 GGPQY---GIAREDVV-----------LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC 48
Query: 159 KFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIIS 217
K D + + KFM E +I++ LDHP+IVKL G+ + +++ E +L +
Sbjct: 49 KKDCTLDNKEKFM-SEAVIMKNLDHPHIVKLIGIIE---EEPTWIIMELYPYGELGHYLE 104
Query: 218 NPEGKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA---- 267
+ L Q+ + + +HRD+ N+L+ +K+ DFGL+
Sbjct: 105 RNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164
Query: 268 ---NYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGV---GIDLWSAGCLLAEMF-LGRP 320
Y + + P+ W +PE + + D+W + E+ G+
Sbjct: 165 DEDYYKASVTRLPIK------WM-SPESIN----FRRFTTASDVWMFAVCMWEILSFGKQ 213
Query: 321 IMPGRTEVEQLHRI 334
+ + +
Sbjct: 214 PFFWLENKDVIGVL 227
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 36/211 (17%)
Query: 129 KIDKVGQGTYSNVYKA----LDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
I ++G+G + +V L +TG +VA+K+++ + F REI IL+ L
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD-QQRDFQ-REIQILKALHSD 84
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL------SGLQHCH 237
IVK G++ + SL LV E++ + L + +L + LL G+++
Sbjct: 85 FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG 144
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK---------KRPLTSRVVTLWYR 288
R +HRD+ N+L++ +KIADFGLA +K + P+ WY
Sbjct: 145 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF------WY- 197
Query: 289 APELLLGATDYGV---GIDLWSAGCLLAEMF 316
APE L + D+WS G +L E+F
Sbjct: 198 APESLS----DNIFSRQSDVWSFGVVLYELF 224
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-25
Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
K+G G Y VY+ + + VA+K +K DT E +F+ E +++++ HPN+V+L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE--EFLK-EAAVMKEIKHPNLVQL 281
Query: 190 EGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL-------SGLQHCHDRGI 241
G+ T + Y++ EFM +L + + LL S +++ +
Sbjct: 282 LGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 339
Query: 242 LHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGV 301
+HR++ N L+ +N ++K+ADFGL+ + + + + APE L + +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSI 398
Query: 302 GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
D+W+ G LL E+ G PG + +
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-25
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 17/214 (7%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
K+GQG + V+ T + VA+K +K T P F+ +E +++KL H +V+L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMKKLRHEKLVQL 244
Query: 190 EGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQQLL-------SGLQHCHDRGI 241
+ + + +Y+V E+M L + GK QL+ SG+ +
Sbjct: 245 YAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 242 LHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGV 301
+HRD++ +N+L+ +N V K+ADFGLA N+ + + APE L + +
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTI 360
Query: 302 GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
D+WS G LL E+ GR PG E L ++
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 54/270 (20%), Positives = 101/270 (37%), Gaps = 52/270 (19%)
Query: 94 GVDGKLVNGWPKWLTDNIPREVLAGLVPKSAESYDKIDKVGQGTYSNVYKAL--DRDTGK 151
G+ +L L IP + +G+G + +V +A D
Sbjct: 6 GISDELKEKLEDVL---IPEQQFT-----------LGRMLGKGEFGSVREAQLKQEDGSF 51
Query: 152 I-VALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLAT----SRMQYSLYLVFE 206
+ VA+K +K D ++ RE +++ DHP++ KL G++ ++
Sbjct: 52 VKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILP 111
Query: 207 FMQT-DL-----ARIISNPEGKLTEPQQLL------SGLQHCHDRGILHRDVKGSNLLID 254
FM+ DL A I L + G+++ R +HRD+ N ++
Sbjct: 112 FMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA 171
Query: 255 KNGVLKIADFGLA------NYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGV---GIDL 305
++ + +ADFGL+ +Y+ L + W A E L + D+
Sbjct: 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK----WL-ALESLA----DNLYTVHSDV 222
Query: 306 WSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
W+ G + E+ G+ G E + +
Sbjct: 223 WAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 37/225 (16%)
Query: 132 KVGQGTYSNVYKALDRDTGKI--VALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
++G G + +V + + R K VA+K +K T + + + M RE I+ +LD+P IV+L
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRL 75
Query: 190 EGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL------SGLQHCHDRGIL 242
G+ + +L LV E L + + ++ G+++ ++ +
Sbjct: 76 IGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 243 HRDVKGSNLLIDKNGVLKIADFGLA-------NYF--SPNKKRPLTSRVVTLWYRAPELL 293
HRD+ N+L+ KI+DFGL+ +Y+ K PL WY APE
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL------KWY-APE-- 183
Query: 294 LGATDYGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
++ D+WS G + E G+ E + I
Sbjct: 184 --CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 33/220 (15%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
+ +G+G + +V R G VA+K +K D + F+ E ++ +L H N+V+L
Sbjct: 26 LQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQ---AFL-AEASVMTQLRHSNLVQL 79
Query: 190 EGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL-------SGLQHCHDRGI 241
G+ + LY+V E+M L + + + LL +++
Sbjct: 80 LGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 138
Query: 242 LHRDVKGSNLLIDKNGVLKIADFGLA---NYFSPNKKRPLTSRVVTLWYRAPELLLGATD 298
+HRD+ N+L+ ++ V K++DFGL + K P+ W APE L
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WT-APEALR---- 187
Query: 299 YGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
D+WS G LL E++ GR P + + R+
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 64/221 (28%), Positives = 103/221 (46%), Gaps = 31/221 (14%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
++++G G + V+ K VA+K +K + P F+A E ++++L H +V+L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPD--AFLA-EANLMKQLQHQRLVRL 73
Query: 190 EGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL-------SGLQHCHDRGI 241
+ T Q +Y++ E+M+ L + P G +LL G+ +R
Sbjct: 74 YAVVT---QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 242 LHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTL----WYRAPELLLGAT 297
+HRD++ +N+L+ KIADFGLA N+ T+R W APE A
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWT-APE----AI 182
Query: 298 DYGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
+YG D+WS G LL E+ GR PG T E + +
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 29/221 (13%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
K+G G Y VY+ + + VA+K +K DT E +F+ +E +++++ HPN+V+L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE--EFL-KEAAVMKEIKHPNLVQL 74
Query: 190 EGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL-------SGLQHCHDRGI 241
G+ T + Y++ EFM +L + + LL S +++ +
Sbjct: 75 LGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 242 LHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTL----WYRAPELLLGAT 297
+HRD+ N L+ +N ++K+ADFGL+ + + T+ W APE L
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWT-APESLA--- 185
Query: 298 DYGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
Y D+W+ G LL E+ G PG + +
Sbjct: 186 -YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (256), Expect = 3e-24
Identities = 46/345 (13%), Positives = 96/345 (27%), Gaps = 90/345 (26%)
Query: 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD------TSEPHSVKFMAREIM 176
E + +K+G+G + V++ VA+K + + S + + + EI+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQT--IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 177 ILQKL---------DHPNIVKLEGLATSRMQYS--------------------------- 200
I ++L + L + + Y
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 201 -LYLVFEFMQ--TDLARIISNPEGKLTEPQ------QLLSGLQHCHDR-GILHRDVKGSN 250
L++V EF DL ++ + + QL + L HRD+ N
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192
Query: 251 LLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGC 310
+L+ K + K+ P V++ DY +
Sbjct: 193 VLLKKTSLKKLHYTLNGKSS----TIPSCGLQVSII-----------DYTLSRLERDGIV 237
Query: 311 LLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT-----------FRPPQ 359
+ ++ + + G + + I++L + + W + + +
Sbjct: 238 VFCDVSMDEDLFTG--DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT 295
Query: 360 SYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404
A + T+L SA L F
Sbjct: 296 FKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLF 335
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 63/266 (23%), Positives = 100/266 (37%), Gaps = 52/266 (19%)
Query: 90 KSGGGVDGKLVNGWPKWLTDNIPREVLAGLVPKSAESYDKIDKVGQGTYSNVYKA----L 145
G ++ + + L KI +G+G + V
Sbjct: 10 HHHGALEVLFQGPGDPTV---FHKRYLK-----------KIRDLGEGHFGKVSLYCYDPT 55
Query: 146 DRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205
+ TG++VA+K +K D H + +EI IL+ L H +I+K +G SL LV
Sbjct: 56 NDGTGEMVAVKALKADAGPQHRSGWK-QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVM 114
Query: 206 EFMQT-DLARIISNPEGKLTEPQQLL------SGLQHCHDRGILHRDVKGSNLLIDKNGV 258
E++ L + + Q LL G+ + H + +HRD+ N+L+D + +
Sbjct: 115 EYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL 172
Query: 259 LKIADFGLANYFSPNK---------KRPLTSRVVTLWYRAPELLLGATDYGV---GIDLW 306
+KI DFGLA P+ WY APE L D+W
Sbjct: 173 VKIGDFGLAKAVPEGHEYYRVREDGDSPVF------WY-APECLK----EYKFYYASDVW 221
Query: 307 SAGCLLAEMF-LGRPIMPGRTEVEQL 331
S G L E+ T+ +L
Sbjct: 222 SFGVTLYELLTHCDSSQSPPTKFLEL 247
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 35/223 (15%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
+ ++G G + V + VA+K +K + +F +E + KL HP +VK
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSED--EFF-QEAQTMMKLSHPKLVKF 68
Query: 190 EGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL------SGLQHCHDRGIL 242
G+ + +Y +Y+V E++ L + + L Q L G+ +
Sbjct: 69 YGVCSK--EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFI 126
Query: 243 HRDVKGSNLLIDKNGVLKIADFGLA-------NYFSPNKKRPLTSRVVTLWYRAPELLLG 295
HRD+ N L+D++ +K++DFG+ S K P+ W APE+
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK------WS-APEVFH- 178
Query: 296 ATDYGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
Y D+W+ G L+ E+F LG+ T E + ++
Sbjct: 179 ---YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 66/320 (20%), Positives = 115/320 (35%), Gaps = 37/320 (11%)
Query: 35 MGHRRSTGQRYNGKETGRFQKLELPVNYDDFENGGEEKVSGEQRVRDNGTGTGTGKSGGG 94
MGH R D + E S + + G +
Sbjct: 7 MGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTS-LYKKAGSENLYFQGANTVH 65
Query: 95 VDGKLVNGWPKWLTDNIPREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKI-- 152
+D +N + + V ++ S+ + +G+G + VY D
Sbjct: 66 IDLSALN-------PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKI 118
Query: 153 -VALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT- 210
A+K + T +F+ E +I++ HPN++ L G+ R + S +V +M+
Sbjct: 119 HCAVKSLNRITDIGEVSQFL-TEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHG 176
Query: 211 DLARIISNPEGKLTEPQQLL------SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADF 264
DL I N T + G++ + +HRD+ N ++D+ +K+ADF
Sbjct: 177 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADF 236
Query: 265 GLA------NYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGV---GIDLWSAGCLLAEM 315
GLA + S + K +++ W A E L D+WS G LL E+
Sbjct: 237 GLARDMYDKEFDSVHNKT--GAKLPVKWM-ALESLQ----TQKFTTKSDVWSFGVLLWEL 289
Query: 316 F-LGRPIMPGRTEVEQLHRI 334
G P P + +
Sbjct: 290 MTRGAPPYPDVNTFDITVYL 309
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 17/214 (7%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
K+GQG + V+ T + VA+K +K T P F+ +E +++KL H +V+L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMKKLRHEKLVQL 327
Query: 190 EGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQQLL-------SGLQHCHDRGI 241
+ + + +Y+V E+M L + GK QL+ SG+ +
Sbjct: 328 YAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384
Query: 242 LHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGV 301
+HRD++ +N+L+ +N V K+ADFGLA N+ + + APE L + +
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTI 443
Query: 302 GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
D+WS G LL E+ GR PG E L ++
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 55/260 (21%), Positives = 102/260 (39%), Gaps = 51/260 (19%)
Query: 117 AGLVPK-SAESYDKIDKV-------------GQGTYSNVYKALDRDTGKI---VALKKVK 159
+GLVP+ S E +K++ V G+G + +V + + VA+K +K
Sbjct: 12 SGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMK 71
Query: 160 FDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLAT---SRMQYSLYLVFEFMQT-DL--- 212
D S ++ E ++ HPN+++L G+ S+ ++ FM+ DL
Sbjct: 72 LDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTY 131
Query: 213 --ARIISNPEGKLTEPQQLL------SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADF 264
+ + L G+++ +R LHRD+ N ++ + + +ADF
Sbjct: 132 LLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191
Query: 265 GLA------NYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGV---GIDLWSAGCLLAEM 315
GL+ +Y+ + + + W A E L V D+W+ G + E+
Sbjct: 192 GLSKKIYSGDYYRQGRIAKMPVK----WI-AIESLA----DRVYTSKSDVWAFGVTMWEI 242
Query: 316 F-LGRPIMPGRTEVEQLHRI 334
G PG E +
Sbjct: 243 ATRGMTPYPGVQNHEMYDYL 262
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 60/246 (24%), Positives = 104/246 (42%), Gaps = 45/246 (18%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
+ +G+G + +V R G VA+K +K D + F+ E ++ +L H N+V+L
Sbjct: 198 LQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQ---AFL-AEASVMTQLRHSNLVQL 251
Query: 190 EGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL-------SGLQHCHDRGI 241
G+ + LY+V E+M L + + + LL +++
Sbjct: 252 LGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 310
Query: 242 LHRDVKGSNLLIDKNGVLKIADFGLA---NYFSPNKKRPLTSRVVTLWYRAPELLLGATD 298
+HRD+ N+L+ ++ V K++DFGL + K P+ W APE A
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WT-APE----ALR 359
Query: 299 YGV---GIDLWSAGCLLAEMF-LGR---PIMPGRTEVEQL---HRIFKLCGSPSEDY--- 345
D+WS G LL E++ GR P +P + V ++ +++ G P Y
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVM 419
Query: 346 ---WKK 348
W
Sbjct: 420 KNCWHL 425
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 64/298 (21%), Positives = 121/298 (40%), Gaps = 64/298 (21%)
Query: 112 PREVLAGLVPKSAESYDKIDKVGQGTYSNVYKAL---DRDTGKI-VALKKVKFDTSEPHS 167
P + L ++ + + KI +G G + VYK L + + KI VA+K+++ TS +
Sbjct: 4 PNQALLRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN 61
Query: 168 VKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEP 226
+ + E ++ +D+P++ +L G+ + ++ L+ + M L + + +
Sbjct: 62 KEIL-DEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 227 Q------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA--------NYFSP 272
Q+ G+ + DR ++HRD+ N+L+ +KI DFGLA Y +
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 273 NKKRPLTSRVVTLWYRAPELLLGATDYGV---GIDLWSAGCLLAEMF-LGR---PIMPGR 325
K P+ W A E +L + + D+WS G + E+ G +P
Sbjct: 178 GGKVPIK------WM-ALESIL----HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226
Query: 326 ---TEVEQLHRIFKLCGSPSEDY------WKK------------LRLSTTFRPPQSYK 362
+ +E+ R+ + + Y W + S R PQ Y
Sbjct: 227 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 284
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 43/230 (18%), Positives = 85/230 (36%), Gaps = 36/230 (15%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKI-------VALKKVKFDTSEPHSVKFMAREIMILQKLD 182
+ +GQGT++ ++K + R+ G V LK + +S F ++ KL
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-KAHRNYSESFF-EAASMMSKLS 70
Query: 183 HPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQH 235
H ++V G+ LV EF++ L + + + QL + +
Sbjct: 71 HKHLVLNYGVCV--CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHF 128
Query: 236 CHDRGILHRDVKGSNLLIDK--------NGVLKIADFGLANYFSPN--KKRPLTSRVVTL 285
+ ++H +V N+L+ + +K++D G++ P + +
Sbjct: 129 LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP------ 182
Query: 286 WYRAPELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
W PE + + + D WS G L E+ G + +L
Sbjct: 183 WV-PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 4e-23
Identities = 53/226 (23%), Positives = 98/226 (43%), Gaps = 36/226 (15%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKI---VALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
+G+G + +V++ + VA+K K TS+ KF+ +E + +++ DHP+I
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL-QEALTMRQFDHPHI 453
Query: 187 VKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCHDR 239
VKL G+ T + ++++ E +L + + L QL + L + +
Sbjct: 454 VKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK 510
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLA-------NYFSPNKKRPLTSRVVTLWYRAPEL 292
+HRD+ N+L+ N +K+ DFGL+ Y + K P+ W APE
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI------KWM-APE- 562
Query: 293 LLGATDYGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
+ ++ D+W G + E+ G G + + RI
Sbjct: 563 ---SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-23
Identities = 53/224 (23%), Positives = 86/224 (38%), Gaps = 28/224 (12%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKI---VALKKVKFDTSEPHSV--KFMAREIMILQKLDHP 184
++K+G G++ V + VA+K +K D F+ RE+ + LDH
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDHR 81
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL------SGLQHCH 237
N+++L G+ + + +V E L + +G G+ +
Sbjct: 82 NLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTL---WYRAPELLL 294
+ +HRD+ NLL+ ++KI DFGL N + + W APE L
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC-APESLK 197
Query: 295 GATDYGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
D W G L EMF G+ G + LH+I
Sbjct: 198 ----TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-23
Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 31/221 (14%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
K+G G + V+ A K VA+K +K + F+ E +++ L H +VKL
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVE--AFL-AEANVMKTLQHDKLVKL 248
Query: 190 EGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL-------SGLQHCHDRGI 241
+ T + +Y++ EFM L + + EG +L+ G+ R
Sbjct: 249 HAVVT---KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 305
Query: 242 LHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTL----WYRAPELLLGAT 297
+HRD++ +N+L+ + V KIADFGLA N+ T+R W APE A
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWT-APE----AI 357
Query: 298 DYGV-GI--DLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
++G I D+WS G LL E+ GR PG + E + +
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 50/229 (21%), Positives = 92/229 (40%), Gaps = 38/229 (16%)
Query: 129 KIDKVGQGTYSNVYKAL---DRDTGKI-VALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
K+ +G G + V+K + + ++ KI V +K ++ + ++ + LDH
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT-DHMLAIGSLDHA 75
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCH 237
+IV+L GL SL LV +++ L + G L Q+ G+ +
Sbjct: 76 HIVRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 132
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLA--------NYFSPNKKRPLTSRVVTLWYRA 289
+ G++HR++ N+L+ +++ADFG+A K P+ W A
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI------KWM-A 185
Query: 290 PELLLGATDYGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
E + +G D+WS G + E+ G G E +
Sbjct: 186 LESIH----FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 4e-22
Identities = 53/225 (23%), Positives = 95/225 (42%), Gaps = 37/225 (16%)
Query: 132 KVGQGTYSNVYKA-LDRDTGKI-VALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
++G G + +V + +I VA+K +K T + + + M RE I+ +LD+P IV+L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRL 401
Query: 190 EGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLL------SGLQHCHDRGIL 242
G+ + +L LV E L + + ++ G+++ ++ +
Sbjct: 402 IGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 243 HRDVKGSNLLIDKNGVLKIADFGLA-------NYF--SPNKKRPLTSRVVTLWYRAPELL 293
HR++ N+L+ KI+DFGL+ +Y+ K PL WY APE
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL------KWY-APE-- 509
Query: 294 LGATDYGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
++ D+WS G + E G+ E + I
Sbjct: 510 --CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 6e-22
Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 35/217 (16%)
Query: 132 KVGQGTYSNVYK-ALDRDTGKIVALKKVKFDTSEPHSVK----FMAREIMILQKLDHPNI 186
K+G+G + VYK ++ VA+KK+ + + + F EI ++ K H N+
Sbjct: 38 KMGEGGFGVVYKGYVN---NTTVAVKKLA-AMVDITTEELKQQFDQ-EIKVMAKCQHENL 92
Query: 187 VKLEGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQQLLS-------------G 232
V+L G ++ L LV+ +M L +S +G LS G
Sbjct: 93 VELLGFSSDGDD--LCLVYVYMPNGSLLDRLSCLDG-----TPPLSWHMRCKIAQGAANG 145
Query: 233 LQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV-TLWYRAPE 291
+ H+ +HRD+K +N+L+D+ KI+DFGLA + +TSR+V T Y APE
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE 205
Query: 292 LLLGATDYGVGIDLWSAGCLLAEMFLGR-PIMPGRTE 327
L G + D++S G +L E+ G + R
Sbjct: 206 ALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 51/236 (21%), Positives = 99/236 (41%), Gaps = 43/236 (18%)
Query: 130 IDKVGQGTYSNVYKALDRDTGK-----IVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
++GQG++ VY+ + + K VA+K V S ++F+ E ++++ +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNCH 88
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQT-DL--------ARIISNPEGKLTEPQQLL----- 230
++V+L G+ + ++ E M DL + +NP +++
Sbjct: 89 HVVRLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 231 --SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA------NYFSPNKKRPLTSRV 282
G+ + + +HRD+ N ++ ++ +KI DFG+ +Y+ K L R
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 205
Query: 283 VTLWYRAPELLLGATDYGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
W +PE L GV D+WS G +L E+ L G + + L +
Sbjct: 206 ---WM-SPESLK----DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 53/229 (23%), Positives = 96/229 (41%), Gaps = 45/229 (19%)
Query: 132 KVGQGTYSNVYKA-LDRDTGKI-VALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
++G G + V K VA+K +K + ++P + E ++Q+LD+P IV++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 190 EGLATSRMQYSLYLVFEFMQ----TDLARIISNPEGKLTEPQQLL-------SGLQHCHD 238
G+ + S LV E + + + + + + ++ G+++ +
Sbjct: 84 IGICEAE---SWMLVMEMAELGPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLA-------NYF--SPNKKRPLTSRVVTLWYRA 289
+HRD+ N+L+ KI+DFGL+ NY+ + K P+ WY A
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK------WY-A 188
Query: 290 PELLLGATDYGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
PE +Y D+WS G L+ E F G+ G E +
Sbjct: 189 PE----CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 51/227 (22%), Positives = 88/227 (38%), Gaps = 49/227 (21%)
Query: 130 IDKVGQGTYSNVYKALDRDTGK-----IVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
++++G+ + VYK VA+K +K P +F E M+ +L HP
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR-HEAMLRARLQHP 72
Query: 185 NIVKLEGLATSRMQYSLYLVFEFM----------------QTDLARIISNPEGKLTEPQQ 228
N+V L G+ T L ++F + + L P
Sbjct: 73 NVVCLLGVVTKDQP--LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 229 LL------SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA------NYFSPNKKR 276
+ +G+++ ++H+D+ N+L+ +KI+D GL +Y+
Sbjct: 131 VHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 277 PLTSRVVTLWYRAPELLLGATDYGV---GIDLWSAGCLLAEMF-LGR 319
L R W APE ++ YG D+WS G +L E+F G
Sbjct: 191 LLPIR----WM-APEAIM----YGKFSIDSDIWSYGVVLWEVFSYGL 228
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 71/237 (29%), Positives = 102/237 (43%), Gaps = 44/237 (18%)
Query: 130 IDKVGQGTYSNVYKA-LDRDTGKI-VALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNI 186
D +G+G + V KA + +D ++ A+K++K S+ F E+ +L KL HPNI
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVLCKLGHHPNI 88
Query: 187 VKLEGLATSRMQYSLYLVFEFM---------------QTDLARIISNPEGKLTEPQQLL- 230
+ L G R LYL E+ +TD A I+N QQLL
Sbjct: 89 INLLGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 231 ------SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA---NYFSPNKKRPLTSR 281
G+ + + +HRD+ N+L+ +N V KIADFGL+ + L R
Sbjct: 147 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 206
Query: 282 VVTLWYRAPELLLGATDYGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
W A E L Y V D+WS G LL E+ LG G T E ++
Sbjct: 207 ----WM-AIESLN----YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 56/242 (23%), Positives = 86/242 (35%), Gaps = 55/242 (22%)
Query: 130 IDKVGQGTYSNVYKA----LDRDTGKI-VALKKVKFDTSEPHSVKFMAREIMILQKL-DH 183
+G G + V +A L + + VA+K +K M E+ +L L +H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SELKVLSYLGNH 86
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFM------------------QTDLARIISNPEGKLTE 225
NIV L G T ++ E+ I+ + E L
Sbjct: 87 MNIVNLLGACTIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 226 PQQLL------SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA------NYFSPN 273
L G+ + +HRD+ N+L+ + KI DFGLA + +
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 274 KKRPLTSRVVTLWYRAPELLLGATDYGV---GIDLWSAGCLLAEMF-LGR---PIMPGRT 326
L + W APE + V D+WS G L E+F LG P MP +
Sbjct: 205 GNARLPVK----WM-APESIF----NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 327 EV 328
+
Sbjct: 256 KF 257
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 56/240 (23%), Positives = 89/240 (37%), Gaps = 52/240 (21%)
Query: 130 IDKVGQGTYSNVYKA----LDRDTGKI-VALKKVKFDTSEPHSVKFMAREIMILQKLD-H 183
+G+G + V +A +D+ VA+K +K + M E+ IL + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM-SELKILIHIGHH 90
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFM---------------QTDLARIISNPEGKLTEPQQ 228
N+V L G A ++ L ++ EF + +
Sbjct: 91 LNVVNLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 229 LLS-------GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA------NYFSPNKK 275
L+ G++ R +HRD+ N+L+ + V+KI DFGLA +
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 276 RPLTSRVVTLWYRAPELLLGATDYGV---GIDLWSAGCLLAEMF-LGR---PIMPGRTEV 328
L + W APE + V D+WS G LL E+F LG P + E
Sbjct: 210 ARLPLK----WM-APETIF----DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 65/232 (28%), Positives = 100/232 (43%), Gaps = 50/232 (21%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
+D +G G + VYK + RD G VALK+ ++S+ +F EI L HP++
Sbjct: 41 FDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIE-EFET-EIETLSFCRHPHL 97
Query: 187 VKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTE-------PQQLLS-------- 231
V L G R + + L++++M G L P +S
Sbjct: 98 VSLIGFCDERNE--MILIYKYM----------ENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 232 -----GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV-TL 285
GL + H R I+HRDVK N+L+D+N V KI DFG++ + + L++ V TL
Sbjct: 146 IGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205
Query: 286 WYRAPE------LLLGATDYGVGIDLWSAGCLLAEMFLGR-PIMPGRTEVEQ 330
Y PE L + D++S G +L E+ R I+
Sbjct: 206 GYIDPEYFIKGRLTEKS-------DVYSFGVVLFEVLCARSAIVQSLPREMV 250
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 64/256 (25%), Positives = 119/256 (46%), Gaps = 41/256 (16%)
Query: 96 DGKLVNGWPKWLTDNIPREVLAGLVPKSA-ESYDKIDKVGQGTYSNVYKALDRDTGKIVA 154
D ++ G K + RE+ + A +++ + +G+G + VYK D G +VA
Sbjct: 9 DPEVHLGQLKRFSL---REL------QVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVA 58
Query: 155 LKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGL---ATSRMQYSLYLVFEFMQTD 211
+K++K + ++ ++F E+ ++ H N+++L G T R+ LV+ +M
Sbjct: 59 VKRLKEERTQGGELQFQT-EVEMISMAVHRNLLRLRGFCMTPTERL-----LVYPYMANG 112
Query: 212 -LARII---SNPEGKLTEPQQL------LSGLQHCHDRG---ILHRDVKGSNLLIDKNGV 258
+A + + L P++ GL + HD I+HRDVK +N+L+D+
Sbjct: 113 SVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 172
Query: 259 LKIADFGLANYFSPNKKRPLTSRVV-TLWYRAPE-LLLG-ATDYGVGIDLWSAGCLLAEM 315
+ DFGLA K +T+ V T+ + APE L G +++ D++ G +L E+
Sbjct: 173 AVVGDFGLAKLM-DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT---DVFGYGVMLLEL 228
Query: 316 FLGR-PIMPGRTEVEQ 330
G+ R +
Sbjct: 229 ITGQRAFDLARLANDD 244
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 60/236 (25%), Positives = 93/236 (39%), Gaps = 43/236 (18%)
Query: 130 IDKVGQGTYSNVYKALDRDTGK-----IVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
I +G G + VY+ VA+K + SE + F+ E +I+ K +H
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQ 93
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQT-DL------ARIISNPEGKLTEPQQLL------S 231
NIV+ G++ + +++ E M DL R + L L
Sbjct: 94 NIVRCIGVSLQSL--PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 232 GLQHCHDRGILHRDVKGSNLLIDKNG---VLKIADFGLA------NYFSPNKKRPLTSRV 282
G Q+ + +HRD+ N L+ G V KI DFG+A +Y+ L +
Sbjct: 152 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK- 210
Query: 283 VTLWYRAPELLLGATDYGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
W PE + G+ D WS G LL E+F LG P ++ E L +
Sbjct: 211 ---WM-PPEAFM----EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 53/250 (21%), Positives = 100/250 (40%), Gaps = 57/250 (22%)
Query: 130 IDKVGQGTYSNVYKA----LDRDTGKI-VALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+G+G + V KA L G VA+K +K + S + E +L++++HP
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL-SEFNVLKQVNHP 86
Query: 185 NIVKLEGLATSRMQYSLYLVFEFM-----------------------QTDLARIISNPEG 221
+++KL G + L L+ E+ + + + +P+
Sbjct: 87 HVIKLYGACSQDG--PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 222 KLTEPQQLLS-------GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA------N 268
+ L+S G+Q+ + ++HRD+ N+L+ + +KI+DFGL+ +
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 269 YFSPNKKRPLTSRVVTLWYRAPELLLGATDYGV---GIDLWSAGCLLAEMF-LGRPIMPG 324
+ + + + W A E L + D+WS G LL E+ LG PG
Sbjct: 205 SYVKRSQGRIPVK----WM-AIESLF----DHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255
Query: 325 RTEVEQLHRI 334
+ +
Sbjct: 256 IPPERLFNLL 265
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 60/236 (25%), Positives = 92/236 (38%), Gaps = 43/236 (18%)
Query: 130 IDKVGQGTYSNVYKALDRDTGK-----IVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
I +G G + VY+ VA+K + SE + F+ E +I+ K +H
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQ 134
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQT-DL------ARIISNPEGKLTEPQQLL------S 231
NIV+ G++ + +++ E M DL R + L L
Sbjct: 135 NIVRCIGVSLQSL--PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 232 GLQHCHDRGILHRDVKGSNLLIDKNG---VLKIADFGLA------NYFSPNKKRPLTSRV 282
G Q+ + +HRD+ N L+ G V KI DFG+A Y+ L +
Sbjct: 193 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK- 251
Query: 283 VTLWYRAPELLLGATDYGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRI 334
W PE + G+ D WS G LL E+F LG P ++ E L +
Sbjct: 252 ---WM-PPEAFM----EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 50/225 (22%)
Query: 132 KVGQGTYSNVYKALDRDTGK-----IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
++G+G + V+ A + +VA+K +K D + F RE +L L H +I
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQ-REAELLTNLQHEHI 79
Query: 187 VKLEGLATSRMQYSLYLVFEFM----------------QTDLARIISNPEGKLTEPQQLL 230
VK G+ L +VFE+M + +G+L Q L
Sbjct: 80 VKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 231 ------SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA------NYFSPNKKRPL 278
SG+ + + +HRD+ N L+ N ++KI DFG++ +Y+ L
Sbjct: 138 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 279 TSRVVTLWYRAPELLLGATDYGV---GIDLWSAGCLLAEMF-LGR 319
R W PE ++ Y D+WS G +L E+F G+
Sbjct: 198 PIR----WM-PPESIM----YRKFTTESDVWSFGVILWEIFTYGK 233
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 59/224 (26%), Positives = 94/224 (41%), Gaps = 49/224 (21%)
Query: 132 KVGQGTYSNVYKALDRDTGK-----IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
++G+G + V+ A + +VA+K +K + SE F RE +L L H +I
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQ-REAELLTMLQHQHI 105
Query: 187 VKLEGLATSRMQYSLYLVFEFMQ---------------TDLARIISNPEGKLTEPQQLL- 230
V+ G+ T L +VFE+M+ LA G L Q L
Sbjct: 106 VRFFGVCTEGRP--LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 231 -----SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA------NYFSPNKKRPLT 279
+G+ + +HRD+ N L+ + V+KI DFG++ +Y+ + L
Sbjct: 164 ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 280 SRVVTLWYRAPELLLGATDYGV---GIDLWSAGCLLAEMF-LGR 319
R W PE +L Y D+WS G +L E+F G+
Sbjct: 224 IR----WM-PPESIL----YRKFTTESDVWSFGVVLWEIFTYGK 258
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 55/238 (23%), Positives = 84/238 (35%), Gaps = 51/238 (21%)
Query: 130 IDKVGQGTYSNVYKALDRDTGK-----IVALKKVKFDTSEPHSVKFMAREIMILQKLD-H 183
+G G + V +A GK VA+K +K M E+ I+ L H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM-SELKIMSHLGQH 109
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFM--------------QTDLARIISNPEGKLTEPQ-- 227
NIV L G T + ++ E+ + + +
Sbjct: 110 ENIVNLLGACTHGG--PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 228 ----QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA------NYFSPNKKRP 277
Q+ G+ + +HRDV N+L+ V KI DFGLA + +
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 278 LTSRVVTLWYRAPELLLGATDYGV---GIDLWSAGCLLAEMF-LGR---PIMPGRTEV 328
L + W APE + V D+WS G LL E+F LG P + ++
Sbjct: 228 LPVK----WM-APESIF----DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 60/245 (24%), Positives = 99/245 (40%), Gaps = 52/245 (21%)
Query: 130 IDKVGQGTYSNVYKALDRDTGK-------IVALKKVKFDTSEPHSVKFMAREIMILQKL- 181
+G+G + V A K VA+K +K D +E + E+ +++ +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEMMKMIG 98
Query: 182 DHPNIVKLEGLATSRMQYSLYLVFEFM---------------QTDLARIISNPEGKLTEP 226
H NI+ L G T LY++ E+ + + I+ +
Sbjct: 99 KHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 227 QQLLS-------GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA------NYFSPN 273
+ L+S G+++ + +HRD+ N+L+ +N V+KIADFGLA +Y+
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 274 KKRPLTSRVVTLWYRAPELLLGATDYGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVE 329
L + W APE L V D+WS G L+ E+F LG PG E
Sbjct: 217 TNGRLPVK----WM-APEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 330 QLHRI 334
+
Sbjct: 268 LFKLL 272
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 60/252 (23%), Positives = 93/252 (36%), Gaps = 60/252 (23%)
Query: 130 IDKVGQGTYSNVYKALDRDTGK-----IVALKKVKFDTSEPHSVKFMAREIMILQKL-DH 183
+G G + V A K VA+K +K M E+ ++ +L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SELKMMTQLGSH 108
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFMQ----------------------TDLARIISNPEG 221
NIV L G T +YL+FE+ + R+ +
Sbjct: 109 ENIVNLLGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 222 KLTEPQQLLS-------GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA------N 268
+ + LL G++ + +HRD+ N+L+ V+KI DFGLA +
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 269 YFSPNKKRPLTSRVVTLWYRAPELLLGATDYGV---GIDLWSAGCLLAEMF-LGR---PI 321
+ L + W APE L G+ D+WS G LL E+F LG P
Sbjct: 227 NYVVRGNARLPVK----WM-APESLF----EGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277
Query: 322 MPGRTEVEQLHR 333
+P +L +
Sbjct: 278 IPVDANFYKLIQ 289
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 8e-19
Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 57/235 (24%)
Query: 130 IDKVGQGTYSNVYKA----LDRDTGKI-VALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ +G+G + V++A L VA+K +K + S F RE ++ + D+P
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REAALMAEFDNP 110
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQ------------------------TDLARIISNPE 220
NIVKL G+ + L+FE+M + AR+ S
Sbjct: 111 NIVKLLGVCAVGK--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 221 GKLTEPQQLL------SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA------N 268
L+ +QL +G+ + +R +HRD+ N L+ +N V+KIADFGL+ +
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 269 YFSPNKKRPLTSRVVTLWYRAPELLLGATDYGV---GIDLWSAGCLLAEMF-LGR 319
Y+ + + R W PE + Y D+W+ G +L E+F G
Sbjct: 229 YYKADGNDAIPIR----WM-PPESIF----YNRYTTESDVWAYGVVLWEIFSYGL 274
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 60/245 (24%), Positives = 99/245 (40%), Gaps = 52/245 (21%)
Query: 130 IDKVGQGTYSNVYKALDRDTGK-------IVALKKVKFDTSEPHSVKFMAREIMILQKL- 181
+G+G + V A K VA+K +K D +E + E+ +++ +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEMMKMIG 144
Query: 182 DHPNIVKLEGLATSRMQYSLYLVFEFM---------------QTDLARIISNPEGKLTEP 226
H NI+ L G T LY++ E+ + + I+ +
Sbjct: 145 KHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 227 QQLLS-------GLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA------NYFSPN 273
+ L+S G+++ + +HRD+ N+L+ +N V+KIADFGLA +Y+
Sbjct: 203 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 274 KKRPLTSRVVTLWYRAPELLLGATDYGV---GIDLWSAGCLLAEMF-LGRPIMPGRTEVE 329
L + W APE L V D+WS G L+ E+F LG PG E
Sbjct: 263 TNGRLPVK----WM-APEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313
Query: 330 QLHRI 334
+
Sbjct: 314 LFKLL 318
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 60/253 (23%), Positives = 97/253 (38%), Gaps = 68/253 (26%)
Query: 130 IDKVGQGTYSNVYKALDRDTGKI-------VALKKVKFDTSEPHSVKFMAREIMILQKL- 181
+G+G + V A K VA+K +K D +E + E+ +++ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIG 132
Query: 182 DHPNIVKLEGLATSRMQYSLYLVFEFM----------------QTDLARIISNPEGKLTE 225
H NI+ L G T LY++ E+ NPE +L+
Sbjct: 133 KHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 226 PQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLT 279
Q+ G+++ + +HRD+ N+L+ ++ V+KIADFGLA
Sbjct: 191 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA------------ 238
Query: 280 SRVV--TLWYR------------APELLLGATDYGV---GIDLWSAGCLLAEMF-LGRPI 321
R + +Y+ APE L + D+WS G LL E+F LG
Sbjct: 239 -RDIHHIDYYKKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSP 293
Query: 322 MPGRTEVEQLHRI 334
PG E +
Sbjct: 294 YPGVPVEELFKLL 306
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 8e-15
Identities = 67/281 (23%), Positives = 105/281 (37%), Gaps = 49/281 (17%)
Query: 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH 183
Y K+G G++ ++Y D G+ VA+K T P + E I + +
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQG 63
Query: 184 -PNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHC 236
I + +V E + L + + K + Q++S +++
Sbjct: 64 GVGIPTIRWCGAEGDYN--VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 237 HDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELL 293
H + +HRDVK N L+ K ++ I DFGLA + + YR + L
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP------YRENKNL 175
Query: 294 LGATDYG-----VGI------DLWSAGCLLAEMFLGR---PIMPGRTEVEQLHRIFK--- 336
G Y +GI DL S G +L LG + T+ ++ RI +
Sbjct: 176 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235
Query: 337 ------LC-GSPSE--DYWKKLR-LSTTFRPPQSYKPRLFE 367
LC G PSE Y R L +P SY +LF
Sbjct: 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 276
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 35/169 (20%), Positives = 67/169 (39%), Gaps = 29/169 (17%)
Query: 132 KVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLE- 190
K+G G + +Y A + + A VK E + E+ Q++ + +K
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKV---EYQENGPLFSELKFYQRVAKKDCIKKWI 100
Query: 191 ----------------GLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEP------QQ 228
GL + + ++V E + DL +I G + +
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKIS-GQNGTFKKSTVLQLGIR 159
Query: 229 LLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKI--ADFGLANYFSPNKK 275
+L L++ H+ +H D+K +NLL+ ++ AD+GL+ + PN
Sbjct: 160 MLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 55/284 (19%), Positives = 102/284 (35%), Gaps = 53/284 (18%)
Query: 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH 183
Y ++G+G++ +++ + + VA+K + P + E + L
Sbjct: 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAG 64
Query: 184 -PNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHC 236
I + + LV + + L ++ K + +Q+L+ +Q
Sbjct: 65 CTGIPNVYYFGQEGLHN--VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 237 HDRGILHRDVKGSNLLIDKNG-----VLKIADFGLA-NYFSPNKKRPLTSRVVTLWYRAP 290
H++ +++RD+K N LI + ++ + DFG+ Y P K+ + YR
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP-------YREK 175
Query: 291 ELLLGATDYG-----VGI------DLWSAGCLLAEMFLGR---PIMPGRTEVEQLHRIFK 336
+ L G Y +G DL + G + G + T ++ RI +
Sbjct: 176 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235
Query: 337 ---------LC-GSPSE--DYWKKLR-LSTTFRPPQSYKPRLFE 367
LC G P E Y R L+ P Y LF
Sbjct: 236 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 279
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 30/169 (17%), Positives = 56/169 (33%), Gaps = 26/169 (15%)
Query: 132 KVGQGTYSNVYKALDRDTGKI--------VALKKVKFDTSEPHSVKFMAREI-------- 175
+ +Y+A T +LK D + F R
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 176 MILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARII-SNPEGKLTEP------QQ 228
L I G + +Y +LV + L + +P+ L+E +
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYR-FLVLPSLGRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 229 LLSGLQHCHDRGILHRDVKGSNLLI--DKNGVLKIADFGLANYFSPNKK 275
LL L+ H+ +H +V N+ + + + +A +G A + P+ K
Sbjct: 168 LLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 45/217 (20%), Positives = 79/217 (36%), Gaps = 37/217 (17%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH-PN 185
+ K+G G + + + T + VA+K + P + E ++L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ----LHLEYRFYKQLGSGDG 66
Query: 186 IVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHCHDR 239
I ++ +V E + L + + + QL+S +++ H +
Sbjct: 67 IPQVYYFGPCGKYN--AMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 240 GILHRDVKGSNLLIDKNG-----VLKIADFGLA-NYFSPNKKRPLTSRVVTLWYRAPELL 293
+++RDVK N LI + G V+ I DF LA Y P K+ + YR + L
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIP-------YREHKSL 177
Query: 294 LGATDYG-----VGI------DLWSAGCLLAEMFLGR 319
G Y +G DL + G + G
Sbjct: 178 TGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 34/170 (20%), Positives = 67/170 (39%), Gaps = 26/170 (15%)
Query: 132 KVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIV---- 187
+GQG + +Y A D ++ + V EP + E+ Q+ P +
Sbjct: 42 PIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 188 ---KLEGLATSRMQYSL----------YLVFEFMQTDLARIISNPEGKLTEP------QQ 228
KL+ L + S +++ + +DL +I + + +
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 229 LLSGLQHCHDRGILHRDVKGSNLLID--KNGVLKIADFGLANYFSPNKKR 276
+L L++ H+ +H D+K SNLL++ + + D+GLA + P
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 64/282 (22%), Positives = 104/282 (36%), Gaps = 51/282 (18%)
Query: 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-D 182
+ K+G G++ +Y + T + VA+K T P + E I + L
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKIYRILQG 61
Query: 183 HPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHC 236
I + LV + + L + + KL+ Q+++ ++
Sbjct: 62 GTGIPNVRWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 237 HDRGILHRDVKGSNLLIDKNG---VLKIADFGLA-NYFSPNKKRPLTSRVVTLWYRAPEL 292
H + LHRD+K N L+ + I DFGLA Y + + + YR +
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP-------YRENKN 172
Query: 293 LLGATDYG-----VGI------DLWSAGCLLAEMFLGR---PIMPGRTEVEQLHRIFK-- 336
L G Y +GI DL S G +L G + T+ ++ +I +
Sbjct: 173 LTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
Query: 337 -------LC-GSPSE--DYWKKLR-LSTTFRPPQSYKPRLFE 367
LC G P+E Y+ R L +P SY RLF
Sbjct: 233 VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFR 274
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 63.3 bits (153), Expect = 2e-10
Identities = 74/440 (16%), Positives = 133/440 (30%), Gaps = 110/440 (25%)
Query: 52 RFQKLELPVNYDDFENGGEEKVSGEQRVRDNGTGTGTGKSGGGVDGKLVNGWPKWLTDNI 111
+F + L +NY F + + T D +L N + N+
Sbjct: 81 KFVEEVLRINYK-F-------LMSPIKTEQRQPSMMTRMYIEQRD-RLYNDNQVFAKYNV 131
Query: 112 PREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALD--RDTGKIV----ALKKVKFDTSEP 165
R + Y K+ + +D +GK K
Sbjct: 132 SRL----------QPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMD 181
Query: 166 HSVKFM-------AREIM-ILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIIS 217
+ ++ ++ +LQKL + + + S ++ L +Q +L R++
Sbjct: 182 FKIFWLNLKNCNSPETVLEMLQKLLY--QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLK 239
Query: 218 NPEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277
+ LL +L +V+ + N F+ + K
Sbjct: 240 SKPY----ENCLL----------VL-LNVQNAKAW---------------NAFNLSCKIL 269
Query: 278 LTSR--VVTLWYRAPELLLGATDYGVGIDLWSAGC-------LLAEMFLGRPIMPGRTEV 328
LT+R VT + L AT + +D S LL + +L EV
Sbjct: 270 LTTRFKQVT------DFLSAATTTHISLDHHSMTLTPDEVKSLLLK-YLDCRPQDLPREV 322
Query: 329 EQLH-RIFKLCGS-----PSE-DYWKKL---RLSTTFR------PPQSYKPRLFEAFSEF 372
+ R + + D WK + +L+T P Y+ ++F+ S F
Sbjct: 323 LTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR-KMFDRLSVF 381
Query: 373 PES---SLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACD----LSGLPVIYDKEDEL 425
P S LLS L+ D N+ S + +P IY +
Sbjct: 382 PPSAHIPTILLS-LIWFDVIKSDVMVVV--NKLHKYSLVEKQPKESTISIPSIYLELKVK 438
Query: 426 IEANQQ--RKIRRARMKHRS 443
+E R I ++
Sbjct: 439 LENEYALHRSIVDHYNIPKT 458
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 5e-07
Identities = 76/493 (15%), Positives = 139/493 (28%), Gaps = 183/493 (37%)
Query: 145 LDRDTGKI---------VALKKVK--FDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLA 193
+D +TG+ V FD + V+ M + I+ +++DH I+ A
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKD---VQDMPKSILSKEEIDH--IIM-SKDA 60
Query: 194 TSRMQYSLYL--------VFEFMQTDLAR----IISNPEGKLTEPQQLLSGLQHCHDRGI 241
S + V +F++ L ++S + + +P + DR
Sbjct: 61 VSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR-- 118
Query: 242 LHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGV 301
L+ D + + K V + L ++ L A +L+ GV
Sbjct: 119 LYNDNQ----VFAKYNVSR-----------LQPYLKLRQALLEL-RPAKNVLI----DGV 158
Query: 302 GIDLWSAGCLLAEMFLGRPIMPGRT----EVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357
G G+T +V +++ C + +W L+ +
Sbjct: 159 L------GS-------------GKTWVALDVCLSYKV--QCKMDFKIFWLNLKNCNS--- 194
Query: 358 PQSYKPRLFEAFSEFPESSLGLLSTLLA-LDPAY--RGSAASALK----------NEFFF 404
PE+ L +L LL +DP + R +S +K
Sbjct: 195 ---------------PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLK 239
Query: 405 TSPLACDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTL---RERRIGDQASQ---- 457
+ P L L + + + A K L R +++ D S
Sbjct: 240 SKPYENCLLVLLNVQNAK--AWNA----------FNLSCKILLTTRFKQVTDFLSAATTT 287
Query: 458 ----------LTKEETLSNKEDSEKHVELNFQGQEPYSSASSASSGTKANQQSHSPPFVL 507
LT +E S + L + P + P L
Sbjct: 288 HISLDHHSMTLTPDEVKS--------LLLKYLDCRPQDLPREVLTTN---------PRRL 330
Query: 508 FPVAASHHQKMSPRNKGHPNGTKNIKNRPPLPNSKTRPTTHNEDSGNMYRLNRVSRSA-- 565
+A S N K+ N +L + S+
Sbjct: 331 SIIAESIRD--------GLATWDNWKHV------------------NCDKLTTIIESSLN 364
Query: 566 --STREFRKLYQN 576
E+RK++
Sbjct: 365 VLEPAEYRKMFDR 377
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 37/112 (33%), Positives = 56/112 (50%), Gaps = 8/112 (7%)
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLAN--YFSPNKKRPLTSRVVTL 285
Q+ G++ R +HRD+ N+L+ + V+KI DFGLA Y P+ R +R+
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260
Query: 286 WYRAPELLLGATDYGVGIDLWSAGCLLAEMF-LGR---PIMPGRTEVEQLHR 333
W APE + Y + D+WS G LL E+F LG P + E + +
Sbjct: 261 WM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 310
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 27/106 (25%), Positives = 43/106 (40%), Gaps = 21/106 (19%)
Query: 111 IPREVLAGLVPKSAESYDKIDKV-GQGTYSNVYKALDRDTGK-----IVALKKVKFDTSE 164
PR+ L K+ K G+G + V +A K VA+K +K +
Sbjct: 19 FPRDRL------------KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH 66
Query: 165 PHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSLYLVFEFMQ 209
M E+ IL + H N+V L G A ++ L ++ EF +
Sbjct: 67 SEHRALM-SELKILIHIGHHLNVVNLLG-ACTKPGGPLMVIVEFCK 110
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 584 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.86 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.73 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.39 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.38 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.29 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.27 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.18 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.17 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.78 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.75 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.53 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.5 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.38 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.25 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.24 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.97 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.95 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.88 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.85 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.81 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.67 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.66 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.97 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.61 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.29 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 92.55 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.91 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-59 Score=501.67 Aligned_cols=287 Identities=34% Similarity=0.546 Sum_probs=240.5
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec----Ccc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR----MQY 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~----~~~ 199 (584)
.++|++++.||+|+||+||+|+++.+|+.||||+++.........+.+.+|+.+|+.|+|||||++++++... ...
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 3579999999999999999999999999999999976666666677888999999999999999999987643 335
Q ss_pred eEEEEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 200 SLYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 200 ~l~lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
.+|||||||+|+|...+... ..+++ ..||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 133 ~~~ivmE~~~g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLMESDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCSEEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 79999999999999988753 44554 359999999999999999999999999999999999999999876432
Q ss_pred ---CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 274 ---KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 274 ---~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
......+.+||++|||||++.+...|+.++||||||||+|||++|++||.+.+..+++..|+...+.+....|..+.
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 12335678999999999999887778999999999999999999999999999999999999999999887765432
Q ss_pred ccC----CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCccC
Q 043957 351 LST----TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACD 411 (584)
Q Consensus 351 ~~~----~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~~~ 411 (584)
... ....+......+...++.++++++|||.+||++||.+||||+|+|+||||+....+.+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~ 356 (398)
T 4b99_A 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDD 356 (398)
T ss_dssp --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGG
T ss_pred hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCcc
Confidence 111 1112333344566677889999999999999999999999999999999987654443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-59 Score=488.52 Aligned_cols=254 Identities=29% Similarity=0.489 Sum_probs=215.5
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.+.|+++++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.|+|||||++++++.+. ..+||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~i 148 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWV 148 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEE
Confidence 35699999999999999999999999999999999754333 235578999999999999999999998874 46899
Q ss_pred EEechhh-HHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQT-DLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
|||||+| +|.+++.. ..+.+. .||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.... .
T Consensus 149 vmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 225 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-P 225 (346)
T ss_dssp EECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-C
T ss_pred EEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-C
Confidence 9999995 67777764 345443 499999999999999999999999999999999999999999875432 3
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
...+.+||+.|||||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|..... +.
T Consensus 226 ~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~-------------- 289 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PR-------------- 289 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CC--------------
T ss_pred cccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CC--------------
Confidence 3567899999999999976 4699999999999999999999999999998888877754321 10
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCc
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLA 409 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~ 409 (584)
...+..+++++++||.+||++||++|||++|+|+||||++...+
T Consensus 290 ---------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 290 ---------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp ---------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred ---------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 12235679999999999999999999999999999999876443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-59 Score=490.16 Aligned_cols=253 Identities=26% Similarity=0.453 Sum_probs=212.9
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
+.++|++++.||+|+||+||+|+++.+|+.||||++..........+.+.+|+.+|++|+|||||++++++.+ ...+|
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~--~~~~y 99 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE--NGSLY 99 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEE
Confidence 3578999999999999999999999999999999998776677777889999999999999999999999887 44689
Q ss_pred EEEechh-hHHHHHhhCCC-CCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 203 LVFEFMQ-TDLARIISNPE-GKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 203 lV~Ey~~-g~L~~~l~~~~-~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
||||||+ |+|.+++.... ..+.+ ..||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999998 58888886432 33443 3599999999999999999999999999999999999999998764321
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
....+.+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|......+
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~------------- 244 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP------------- 244 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-------------
T ss_pred -ccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-------------
Confidence 12356789999999999987 469999999999999999999999999999988888876542211
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
....+|+++.+||.+||++||.+|||++|+|+||||+.
T Consensus 245 -------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 245 -------------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred -------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 12357899999999999999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-59 Score=472.66 Aligned_cols=251 Identities=29% Similarity=0.445 Sum_probs=200.0
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE-PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.... ......+.+|+.+|++|+|||||++++++.+ ...+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~ 89 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS--KDEII 89 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEE
Confidence 45799999999999999999999999999999999765432 3345678999999999999999999999876 44689
Q ss_pred EEEechhhHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 203 LVFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
||||||+|+|.+.+... ..+++. .||+.||+|||++||+||||||+||||+.++.+||+|||+|+......
T Consensus 90 ivmEy~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 166 (275)
T 3hyh_A 90 MVIEYAGNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-- 166 (275)
T ss_dssp EEEECCCEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC--
Confidence 99999999999888653 445543 499999999999999999999999999999999999999998765332
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
...+.+||+.|||||++.+...++.++|||||||++|+|++|++||.+.+..+.+..|.......
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~--------------- 231 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL--------------- 231 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---------------
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC---------------
Confidence 34567999999999999876656789999999999999999999999988887777765432111
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
...+|+++++||.+||++||++|||++|+|+||||+..
T Consensus 232 ------------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 232 ------------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp ------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred ------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence 13468999999999999999999999999999999753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-58 Score=490.23 Aligned_cols=254 Identities=29% Similarity=0.486 Sum_probs=216.1
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.+.|+++++||+|+||.||+|+++.+|+.||||++...... ..+.+.+|+.+|+.|+|||||+++++|.+. ..+||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~i 225 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWV 225 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEEC--CEEEE
Confidence 35799999999999999999999999999999999765433 235678999999999999999999998874 46899
Q ss_pred EEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
|||||.| +|.+++.. ..+.+ +.||+.||+|||++|||||||||+||||+.+|.|||+|||+|+.+.... .
T Consensus 226 VmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 302 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-P 302 (423)
T ss_dssp EEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-C
T ss_pred EEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-c
Confidence 9999995 67777753 33544 3599999999999999999999999999999999999999998875432 3
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
...+.+||++|||||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|..... +.
T Consensus 303 ~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~-------------- 366 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PR-------------- 366 (423)
T ss_dssp CBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CC--------------
T ss_pred cccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CC--------------
Confidence 3567899999999999976 4699999999999999999999999999998888877754311 10
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCc
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLA 409 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~ 409 (584)
...+..+++++++||.+||++||.+|||++|+|+||||+....+
T Consensus 367 ---------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p 410 (423)
T 4fie_A 367 ---------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 410 (423)
T ss_dssp ---------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred ---------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence 12235679999999999999999999999999999999876433
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-58 Score=476.78 Aligned_cols=255 Identities=28% Similarity=0.425 Sum_probs=216.0
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
..++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+++|++|+|||||++++++.+ ...+
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~ 107 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKL 107 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEE
Confidence 34679999999999999999999999999999999964321 22345678999999999999999999998876 4468
Q ss_pred EEEEechhh-HHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 202 YLVFEFMQT-DLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
|||||||.| +|.+.+.. .+.+.+. .||+.||+|||+++||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 108 yivmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred EEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999985 78888764 3345543 499999999999999999999999999999999999999999875433
Q ss_pred -CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 275 -KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 275 -~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
.....+.+||+.|||||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+..|.+....+
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~------------ 253 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDF------------ 253 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC------------
T ss_pred CcccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 233567899999999999987 459999999999999999999999999999988888886642211
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHH------HhcCcCCCCCCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAAS------ALKNEFFFTSPL 408 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e------~L~Hp~f~~~~~ 408 (584)
...+++++++||.+||++||.+|||++| +++||||....+
T Consensus 254 ---------------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw 299 (311)
T 4aw0_A 254 ---------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 299 (311)
T ss_dssp ---------------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred ---------------CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence 1356899999999999999999999987 588999976433
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-57 Score=461.96 Aligned_cols=249 Identities=25% Similarity=0.298 Sum_probs=205.7
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec--CcceEEEE
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR--MQYSLYLV 204 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~l~lV 204 (584)
|++.++||+|+||+||+|.++.++..||||++..........+.+.+|+.+|++|+|||||++++++.+. ....+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 4778889999999999999999999999999987666666778899999999999999999999988653 34568999
Q ss_pred Eechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCC--ceeccccccceeecC-CCcEEEEEeccccccCCCC
Q 043957 205 FEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRG--ILHRDVKGSNLLIDK-NGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 205 ~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~--IvHrDLKp~NILl~~-~g~vKL~DFGla~~~~~~~ 274 (584)
||||. |+|.+++.. ...+++ ..||+.||+|||+++ ||||||||+||||+. +|.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-- 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-- 184 (290)
T ss_dssp EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC--
Confidence 99998 578877754 233433 459999999999998 999999999999974 79999999999986532
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
....+.+||+.|||||++.+ .|+.++|||||||+||||+||++||.+......+...+.....+.
T Consensus 185 -~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~------------ 249 (290)
T 3fpq_A 185 -SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA------------ 249 (290)
T ss_dssp -TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG------------
T ss_pred -CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC------------
Confidence 23467799999999999865 499999999999999999999999987666554433322111110
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
.....+++++.+||.+||++||.+|||++|+|+||||++
T Consensus 250 ------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 250 ------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 112456789999999999999999999999999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-57 Score=467.73 Aligned_cols=251 Identities=29% Similarity=0.402 Sum_probs=204.2
Q ss_pred CCCceEEeeecccCceEEEEEEEC---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDR---DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
.++|++++.||+|+||+||+|++. .+++.||||+++...........+.+|+.+|++|+|||||++++++.+ ...
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~ 100 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT--EGK 100 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE--TTE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCE
Confidence 467999999999999999999874 468899999997543333233457789999999999999999999887 446
Q ss_pred EEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+|||||||. |+|.+.+.. ...+++ ..||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 101 ~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 899999999 478887764 234544 349999999999999999999999999999999999999999875433
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
. ....+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|.+....+
T Consensus 180 ~-~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~------------ 245 (304)
T 3ubd_A 180 E-KKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM------------ 245 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------------
T ss_pred C-ccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC------------
Confidence 2 33466799999999999987 469999999999999999999999999999988888876532111
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC-----HHHHhcCcCCCCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS-----AASALKNEFFFTS 406 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT-----a~e~L~Hp~f~~~ 406 (584)
...+|+++.+||.+||++||++||| ++|+|+||||+..
T Consensus 246 ---------------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 246 ---------------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp ---------------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred ---------------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 1357899999999999999999998 5899999999764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-55 Score=462.79 Aligned_cols=281 Identities=27% Similarity=0.416 Sum_probs=216.0
Q ss_pred hhccCCCCCCCceEEeeecccCceEEEEEEEC---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeec
Q 043957 116 LAGLVPKSAESYDKIDKVGQGTYSNVYKALDR---DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEG 191 (584)
Q Consensus 116 ~~~~~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~ 191 (584)
+...+|...++|++.++||+|+||+||+|+++ .+++.||||++.... ....+.+|+++|+.+ +|||||++++
T Consensus 12 l~~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~ 87 (361)
T 4f9c_A 12 LYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKY 87 (361)
T ss_dssp HHHHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSE
T ss_pred HHHhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEE
Confidence 33445667788999999999999999999875 467899999985432 234577899999998 6999999999
Q ss_pred eeeecCcceEEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCC-CcEEEEE
Q 043957 192 LATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKN-GVLKIAD 263 (584)
Q Consensus 192 ~~~~~~~~~l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~-g~vKL~D 263 (584)
++.+ ..++|||||||+ ++|.+++.. +++ ..||+.||+|||++||+||||||+||||+.+ +.+||+|
T Consensus 88 ~~~~--~~~~~lvmE~~~g~~L~~~~~~----l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~D 161 (361)
T 4f9c_A 88 CFRK--NDHVVIAMPYLEHESFLDILNS----LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVD 161 (361)
T ss_dssp EEEE--TTEEEEEEECCCCCCHHHHHTT----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred EEEE--CCEEEEEEeCCCcccHHHHHcC----CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECc
Confidence 8876 456899999998 578877742 333 3499999999999999999999999999876 8999999
Q ss_pred eccccccCCCC---------------------------CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHH
Q 043957 264 FGLANYFSPNK---------------------------KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF 316 (584)
Q Consensus 264 FGla~~~~~~~---------------------------~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLl 316 (584)
||+|+...... ....++.+||++|||||++.+...|+.++||||||||+|||+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell 241 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence 99997654321 112345689999999999988767999999999999999999
Q ss_pred hCCCCC-CCCChHHHHHHHHHhcCCCChHHHHHhhccC---CCC-------------------CCC-----CCCchhhhh
Q 043957 317 LGRPIM-PGRTEVEQLHRIFKLCGSPSEDYWKKLRLST---TFR-------------------PPQ-----SYKPRLFEA 368 (584)
Q Consensus 317 tG~~pF-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---~~~-------------------~p~-----~~~~~~~~~ 368 (584)
+|++|| .+.++.+++..|+...+.+....+....... ... .|. .......+.
T Consensus 242 ~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 321 (361)
T 4f9c_A 242 SGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEG 321 (361)
T ss_dssp HTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------
T ss_pred HCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccc
Confidence 999887 5677889999999888765543333211000 000 000 001112234
Q ss_pred ccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 369 FSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 369 ~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
+..+|++++|||.+||++||.+|+||+|+|+||||++-
T Consensus 322 ~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 322 WNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred cccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 56789999999999999999999999999999999763
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=460.64 Aligned_cols=248 Identities=26% Similarity=0.349 Sum_probs=204.4
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.+.|++.++||+|+||.||+|+++.+|+.||||+++.+... .+|+.+|+.|+|||||++++++.+ ...+||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~--~~~~~i 127 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVRE--GPWVNI 127 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 45699999999999999999999999999999999765332 469999999999999999998877 446899
Q ss_pred EEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCC-cEEEEEeccccccCCCCC
Q 043957 204 VFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG-VLKIADFGLANYFSPNKK 275 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g-~vKL~DFGla~~~~~~~~ 275 (584)
|||||+| +|.+++.. .+.+++ ..||+.||+|||+++||||||||+||||+.+| .+||+|||+|+.+.....
T Consensus 128 vmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp EECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred EEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999994 78888764 234554 35999999999999999999999999999988 599999999988754321
Q ss_pred C----CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 276 R----PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 276 ~----~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
. .....+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|....
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------------- 272 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP------------- 272 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC-------------
T ss_pred ccceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC-------------
Confidence 1 1234689999999999987 469999999999999999999999999887766666664421
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHH-------------hcCcCCCCC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASA-------------LKNEFFFTS 406 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~-------------L~Hp~f~~~ 406 (584)
+...+..+.+++.+.+||.+||++||.+|||+.|+ |+|||+.+.
T Consensus 273 -----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 273 -----------PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp -----------CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred -----------CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 11123345789999999999999999999999997 679998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=446.64 Aligned_cols=251 Identities=22% Similarity=0.390 Sum_probs=190.7
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc-------
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ------- 198 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~------- 198 (584)
+|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+|++|+|||||++++++.....
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 5999999999999999999999999999999997543 34455678899999999999999999998875432
Q ss_pred ---ceEEEEEechh-hHHHHHhhCCCC--------CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecc
Q 043957 199 ---YSLYLVFEFMQ-TDLARIISNPEG--------KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGL 266 (584)
Q Consensus 199 ---~~l~lV~Ey~~-g~L~~~l~~~~~--------~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGl 266 (584)
..+|||||||. |+|.+++..... ...+..||+.||+|||++|||||||||+||||+.++.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 25799999998 578887764321 112446999999999999999999999999999999999999999
Q ss_pred ccccCCCCC-----------CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHH
Q 043957 267 ANYFSPNKK-----------RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIF 335 (584)
Q Consensus 267 a~~~~~~~~-----------~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~ 335 (584)
|+.+..... ...++.+||+.|||||++.+ ..|+.++||||||||+|||++ ||.+. .+....+.
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~~ 238 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTLT 238 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHHH
Confidence 988754321 12345689999999999987 469999999999999999996 67543 33333332
Q ss_pred HhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 336 KLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
......... .+...++.+.+||.+||++||.+|||+.|+|+||||..-
T Consensus 239 ~~~~~~~p~-----------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 239 DVRNLKFPP-----------------------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHTTCCCH-----------------------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHhcCCCCC-----------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 222111111 122346778899999999999999999999999999764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=473.76 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=222.6
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++++.||+|+||+||+|.++.+|+.||||++... .....+.+.+|+.+|+.|+|||||++++++.+ ...+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~i 231 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVM 231 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEE
Confidence 46899999999999999999999999999999999753 33445778899999999999999999998876 456899
Q ss_pred EEechh-hHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCC--CcEEEEEeccccccCCCC
Q 043957 204 VFEFMQ-TDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKN--GVLKIADFGLANYFSPNK 274 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~--g~vKL~DFGla~~~~~~~ 274 (584)
|||||. |+|.+.+......+++. .||+.||.|||+++|+||||||+||||+.+ +.+||+|||+|+.+....
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 999998 57888887666666554 499999999999999999999999999754 899999999999876433
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.....+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|......+...
T Consensus 312 --~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~---------- 378 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS---------- 378 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSG----------
T ss_pred --ceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcc----------
Confidence 3466799999999999987 469999999999999999999999999999999988887654443322
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCccC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACD 411 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~~~ 411 (584)
.+..+++++++||.+||++||.+|||+.|+|+||||+....+..
T Consensus 379 -------------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~ 422 (573)
T 3uto_A 379 -------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422 (573)
T ss_dssp -------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTT
T ss_pred -------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCc
Confidence 23567999999999999999999999999999999987655443
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-53 Score=435.79 Aligned_cols=250 Identities=23% Similarity=0.325 Sum_probs=200.4
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.++||+|+||+||+|+.. ..||||+++.........+.|.+|+.+|++|+|||||++++++.. ..+||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~~i 108 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNLAI 108 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeEEE
Confidence 456899999999999999999754 359999997666667778889999999999999999999998754 24799
Q ss_pred EEechh-hHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC-C
Q 043957 204 VFEFMQ-TDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK-K 275 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~ 275 (584)
|||||+ |+|.+.+......+++. .||+.||+|||+++||||||||+||||+.++.+||+|||+|+...... .
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 999999 58888887666666653 599999999999999999999999999999999999999998764322 2
Q ss_pred CCCccccccccccChhhhhCC--CCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 276 RPLTSRVVTLWYRAPELLLGA--TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~--~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
......+||+.|||||++.+. ..|+.++|||||||+||||+||++||.+.+....+..++.....+
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~------------ 256 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS------------ 256 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC------------
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC------------
Confidence 334567899999999999743 358999999999999999999999999877766655544321111
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
+........+|+.+.+||.+||+.||++|||+.|++++
T Consensus 257 ---------p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 257 ---------PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp ---------CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred ---------CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 11122345688999999999999999999999987544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=431.00 Aligned_cols=246 Identities=24% Similarity=0.343 Sum_probs=195.8
Q ss_pred CCCceEEeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDR-----DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 198 (584)
.++|.+.++||+|+||+||+|..+ .++..||||+++. ......+.|.+|+.+|++|+|||||++++++.+.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-- 115 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQHQHIVRFFGVCTEG-- 115 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC--CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--
Confidence 356899999999999999999865 3688999999963 3455667899999999999999999999998764
Q ss_pred ceEEEEEechh-hHHHHHhhCCC--------------CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCC
Q 043957 199 YSLYLVFEFMQ-TDLARIISNPE--------------GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG 257 (584)
Q Consensus 199 ~~l~lV~Ey~~-g~L~~~l~~~~--------------~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g 257 (584)
..+|||||||+ |+|.+++.... ..++ ++.||+.||+|||+++||||||||+||||+.++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence 35899999999 57888876432 2233 345999999999999999999999999999999
Q ss_pred cEEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 043957 258 VLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIF 335 (584)
Q Consensus 258 ~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~ 335 (584)
.+||+|||+|+.+..... ...+..+||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+..+.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999987644332 22345689999999999987 459999999999999999999 899999998888777765
Q ss_pred HhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 336 KLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.....+ ....+|+++.+||.+||+.||++|||+.|++++
T Consensus 275 ~g~~~~--------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 275 QGRELE--------------------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HTCCCC--------------------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred cCCCCC--------------------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 432111 123578999999999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=462.44 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=206.4
Q ss_pred CCCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC----CChHHHHHHHHHHHHHHhCCCCCeeeeeceeee
Q 043957 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT----SEPHSVKFMAREIMILQKLDHPNIVKLEGLATS 195 (584)
Q Consensus 120 ~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~----~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 195 (584)
.+.+.++|++++.||+|+||.||+|+++.+|+.||||++.+.. ...........++.+++.++|||||+++++|.+
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 4778899999999999999999999999999999999996431 222223333445677788899999999988876
Q ss_pred cCcceEEEEEechh-hHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccc
Q 043957 196 RMQYSLYLVFEFMQ-TDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLAN 268 (584)
Q Consensus 196 ~~~~~l~lV~Ey~~-g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~ 268 (584)
...+|||||||. |+|..++.. .+.+.+. .||+.||+|||++|||||||||+||||+.+|.|||+|||+|+
T Consensus 264 --~~~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 264 --PDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp --SSEEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred --CCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceee
Confidence 456899999999 478887764 3455553 499999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCChHH
Q 043957 269 YFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEV---EQLHRIFKLCGSPSEDY 345 (584)
Q Consensus 269 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~---~~~~~i~~~~~~~~~~~ 345 (584)
.+.... ..+.+||+.|||||++.+...|+.++||||||||||||++|++||.+.+.. .....+.....
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~------ 411 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV------ 411 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC------
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC------
Confidence 875432 356799999999999975557999999999999999999999999764322 22222222110
Q ss_pred HHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC-----HHHHhcCcCCCCC
Q 043957 346 WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS-----AASALKNEFFFTS 406 (584)
Q Consensus 346 ~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT-----a~e~L~Hp~f~~~ 406 (584)
.....+|+++++||.+||++||.+|++ ++|+++||||...
T Consensus 412 ---------------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 412 ---------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred ---------------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 112457899999999999999999998 7999999999764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-52 Score=426.62 Aligned_cols=247 Identities=23% Similarity=0.339 Sum_probs=201.0
Q ss_pred CCceEEeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDR-----DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
++|.+.++||+|+||.||+|.+. .++..||||+++. ......+.|.+|+.+|++|+|||||++++++.+. .
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~--~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG--D 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--S
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC--CChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC--C
Confidence 46999999999999999999865 3588999999964 3445667899999999999999999999998874 3
Q ss_pred eEEEEEechh-hHHHHHhhCC------------CCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEE
Q 043957 200 SLYLVFEFMQ-TDLARIISNP------------EGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLK 260 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~------------~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vK 260 (584)
.+|||||||+ |+|.+++... ...+++ +.||+.||+|||+++||||||||+||||+.++.+|
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence 5899999998 5788877532 223443 45999999999999999999999999999999999
Q ss_pred EEEeccccccCCCCCC-CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 043957 261 IADFGLANYFSPNKKR-PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLC 338 (584)
Q Consensus 261 L~DFGla~~~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~ 338 (584)
|+|||+|+........ .....+||+.|||||++.+. .|+.++|||||||+||||+| |++||.+.+..+.+..+....
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999876433221 12345789999999999874 59999999999999999998 999999998888877775532
Q ss_pred CCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCC
Q 043957 339 GSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404 (584)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~ 404 (584)
..+ ....+|+++.+||.+||+.||++|||+.|++ +|+.
T Consensus 248 ~~~--------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 248 VLQ--------------------------RPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp CCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred CCC--------------------------CCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 111 1235789999999999999999999999994 4653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=426.76 Aligned_cols=247 Identities=22% Similarity=0.333 Sum_probs=202.0
Q ss_pred CCCceEEeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDR-----DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 198 (584)
...+++.++||+|+||+||+|... .+++.||||+++... .....+.|.+|+.+|++|+|||||++++++....
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~- 102 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ- 102 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC-
Confidence 456889999999999999999853 467899999996443 3344577999999999999999999999987643
Q ss_pred ceEEEEEechh-hHHHHHhhCCC---------------CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCC
Q 043957 199 YSLYLVFEFMQ-TDLARIISNPE---------------GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKN 256 (584)
Q Consensus 199 ~~l~lV~Ey~~-g~L~~~l~~~~---------------~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~ 256 (584)
.+|||||||+ |+|.+++.... ..++ ++.||+.||+|||+++||||||||+||||+++
T Consensus 103 -~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 103 -PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp -SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred -EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence 4799999998 68888885421 1233 34699999999999999999999999999999
Q ss_pred CcEEEEEeccccccCCCC-CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHH
Q 043957 257 GVLKIADFGLANYFSPNK-KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRI 334 (584)
Q Consensus 257 g~vKL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i 334 (584)
+.+||+|||+|+.+.... ....+..+||+.|||||++.+. .|+.++|||||||+||||+| |.+||.+.+..+.+..+
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i 260 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999998764332 2334567899999999999874 59999999999999999998 89999999888777666
Q ss_pred HHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 335 FKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
......+ ....+|+.+.+||.+||+.||.+|||+.|++++
T Consensus 261 ~~~~~~~--------------------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 261 RNRQVLP--------------------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HTTCCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCC--------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4322111 124578999999999999999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=409.85 Aligned_cols=279 Identities=41% Similarity=0.731 Sum_probs=234.4
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+|++++||||+++++++.. ...+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe--CCEEEEE
Confidence 57999999999999999999999999999999998766666666788899999999999999999998876 4468999
Q ss_pred EechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 205 FEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
||||.+++...+......+.+ ..||+.||+|||++||+||||||+||||+.++.+||+|||++....... ...
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 158 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCY 158 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-SCC
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-ccc
Confidence 999999888877654555544 3599999999999999999999999999999999999999998765332 234
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGR-PIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~-~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 357 (584)
...+||+.|+|||++.+...++.++|||||||++|+|++|. |+|.+.+..+.+..++...+.+....|..+........
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 56688999999999987666899999999999999999776 55788888899999999999998888776654332221
Q ss_pred CC--CCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 358 PQ--SYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 358 p~--~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.. .....+......+++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 11 11223344556789999999999999999999999999999999763
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=415.21 Aligned_cols=279 Identities=42% Similarity=0.737 Sum_probs=228.0
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++++.||+|+||+||+|.+. +|+.||||++............+.+|+.+|++++|||||++++++... ..+|+
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~l 96 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE--RCLTL 96 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS--SCEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC--CEEEE
Confidence 357999999999999999999986 589999999976555444567788999999999999999999988764 46899
Q ss_pred EEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 204 VFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
|||||.++|...+......+.+ ..||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... ..
T Consensus 97 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~ 175 (311)
T 3niz_A 97 VFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RS 175 (311)
T ss_dssp EEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-C-
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc-cc
Confidence 9999999999888765555554 3599999999999999999999999999999999999999998765332 23
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC---C
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST---T 354 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---~ 354 (584)
....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....|....... .
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence 4556889999999999876678999999999999999999999999999999999999998888877665543211 0
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
..........+......+++++.+||.+||++||.+|||++|+|+||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 0111112233445567889999999999999999999999999999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=426.33 Aligned_cols=280 Identities=38% Similarity=0.617 Sum_probs=219.8
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.+. |||||++++++.......+||
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 4799999999999999999999999999999999766566667778889999999997 999999999988766667999
Q ss_pred EEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC----
Q 043957 204 VFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN---- 273 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~---- 273 (584)
|||||.++|...+... .+. +..||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+...
T Consensus 89 v~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 166 (388)
T 3oz6_A 89 VFDYMETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166 (388)
T ss_dssp EEECCSEEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCC
T ss_pred EecccCcCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccc
Confidence 9999999998888642 333 2359999999999999999999999999999999999999999865321
Q ss_pred ----------------CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 043957 274 ----------------KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKL 337 (584)
Q Consensus 274 ----------------~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~ 337 (584)
.....+..+||++|+|||++.+...|+.++||||||||+|||++|++||.+.+..+++..|+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 246 (388)
T 3oz6_A 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246 (388)
T ss_dssp CCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 1122455789999999999987667999999999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhccCC--------------CCCCCCCCchhh------hhccCCcHhHHHHHHHhcccCCCCCCCHHHH
Q 043957 338 CGSPSEDYWKKLRLSTT--------------FRPPQSYKPRLF------EAFSEFPESSLGLLSTLLALDPAYRGSAASA 397 (584)
Q Consensus 338 ~~~~~~~~~~~~~~~~~--------------~~~p~~~~~~~~------~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~ 397 (584)
.+.|....+..+..... ........+.+. .....+++++.+||.+||++||.+|||++|+
T Consensus 247 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~ 326 (388)
T 3oz6_A 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDA 326 (388)
T ss_dssp HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHH
Confidence 99998876654321100 000000000000 0112678999999999999999999999999
Q ss_pred hcCcCCCCC
Q 043957 398 LKNEFFFTS 406 (584)
Q Consensus 398 L~Hp~f~~~ 406 (584)
|+||||..-
T Consensus 327 l~Hp~~~~~ 335 (388)
T 3oz6_A 327 LKHPFVSIF 335 (388)
T ss_dssp TTSTTTTTT
T ss_pred hCCHHHHHh
Confidence 999999653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=436.70 Aligned_cols=285 Identities=34% Similarity=0.576 Sum_probs=222.5
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC---cce
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM---QYS 200 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---~~~ 200 (584)
.++|++++.||+|+||+||+|.+..+++.||||++..........+.+.+|+.+|+.|+|||||++++++.... ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36799999999999999999999999999999999766666667788999999999999999999999885432 246
Q ss_pred EEEEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 201 LYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 201 l~lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
+||||||+.++|..++... ..+.+ ..||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+....
T Consensus 132 ~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EEEEECCCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEEEEeccccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 8999999999999988753 33443 3599999999999999999999999999999999999999998764321
Q ss_pred C--------------------------CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-----------
Q 043957 275 K--------------------------RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL----------- 317 (584)
Q Consensus 275 ~--------------------------~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt----------- 317 (584)
. ...+..+||++|+|||++.....|+.++||||||||||||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~ 290 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence 1 134567899999999988666679999999999999999999
Q ss_pred CCCCCCCCC--------------------hHHHHHHHHHhcCCCChHHHHHhhcc----CCCCCCCCCCchhhhhccCCc
Q 043957 318 GRPIMPGRT--------------------EVEQLHRIFKLCGSPSEDYWKKLRLS----TTFRPPQSYKPRLFEAFSEFP 373 (584)
Q Consensus 318 G~~pF~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~----~~~~~p~~~~~~~~~~~~~~s 373 (584)
|+++|++.. ..+++..|+..++.+....|..+... .....+......+.+.++.++
T Consensus 291 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 370 (458)
T 3rp9_A 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASS 370 (458)
T ss_dssp CCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSC
T ss_pred ccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCC
Confidence 788898765 36888999999999998877654321 011223333445666778889
Q ss_pred HhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCc
Q 043957 374 ESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLA 409 (584)
Q Consensus 374 ~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~ 409 (584)
+++++||.+||++||.+|||++|+|+||||......
T Consensus 371 ~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~ 406 (458)
T 3rp9_A 371 ADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406 (458)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred HHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence 999999999999999999999999999999876443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=408.39 Aligned_cols=277 Identities=42% Similarity=0.737 Sum_probs=226.6
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++++.||+|+||.||+|.+ .+|+.||||++............+.+|+.+|+.++||||+++++++... ..+|+|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC--CeEEEE
Confidence 5799999999999999999998 6789999999975543333446678999999999999999999988764 458999
Q ss_pred EechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 205 FEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
|||+.++|...+......+.+ ..||+.||.|||++||+||||||+||||+.++.+||+|||++....... ...
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (288)
T 1ob3_A 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKY 157 (288)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-ccc
Confidence 999999999888765555544 3599999999999999999999999999999999999999998764322 223
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCC-
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP- 357 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~- 357 (584)
...+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..++...+.+....|..+.....+..
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 4567899999999998766689999999999999999999999999999999999999888887777765543322211
Q ss_pred -CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 358 -PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 358 -p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
.......+...+..+++++.+||.+||+.||.+|||++|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 111122344455788999999999999999999999999999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=434.79 Aligned_cols=280 Identities=31% Similarity=0.515 Sum_probs=222.5
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC----cc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM----QY 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 199 (584)
.++|++++.||+|+||+||+|.+..+|+.||||++..........+.+.+|+.+|+.++|||||++++++.... ..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 45799999999999999999999999999999999765555666778899999999999999999999886543 24
Q ss_pred eEEEEEechhhHHHHHhhCCCC---CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 200 SLYLVFEFMQTDLARIISNPEG---KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 200 ~l~lV~Ey~~g~L~~~l~~~~~---~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
.+|||||||.++|...+...-. ...+..||+.||+|||++||+||||||+||||+.++.+||+|||+|+..... .
T Consensus 141 ~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~ 218 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--F 218 (464)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C--C
T ss_pred eEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC--c
Confidence 6899999999998888753210 1123459999999999999999999999999999999999999999876532 2
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC---
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST--- 353 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--- 353 (584)
..+..+||++|+|||++.+. .|+.++||||||||+|||++|++||.+.+..+++..|+...+.+...+|..+....
T Consensus 219 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~ 297 (464)
T 3ttj_A 219 MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297 (464)
T ss_dssp CC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHH
T ss_pred ccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhH
Confidence 34667899999999999874 69999999999999999999999999999999999999999999888776542110
Q ss_pred CCCCCCCCCchhhhhcc------------CCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 354 TFRPPQSYKPRLFEAFS------------EFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~------------~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
....+......+...++ ..++++++||.+||++||.+|||++|+|+||||...
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 298 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 00011111111111111 126789999999999999999999999999999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=427.17 Aligned_cols=284 Identities=35% Similarity=0.577 Sum_probs=232.2
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc---ce
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ---YS 200 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~---~~ 200 (584)
.++|++.+.||+|+||.||+|.+..+++.||||++..........+.+.+|+.+|+.++|||||++++++..... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 457999999999999999999999999999999997665666677889999999999999999999998876432 46
Q ss_pred EEEEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 201 LYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 201 l~lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
+||||||++++|...+... ..+++ ..||+.||.|||++||+||||||+||||+.++.+||+|||+|+......
T Consensus 105 ~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp EEEEEECCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred EEEEEecCCcCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence 8999999999999988753 33433 3599999999999999999999999999999999999999998765332
Q ss_pred C---------------------CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-----------CCCCC
Q 043957 275 K---------------------RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-----------GRPIM 322 (584)
Q Consensus 275 ~---------------------~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-----------G~~pF 322 (584)
. ...+..+||++|+|||++.....|+.++||||||||+|||++ |.++|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f 263 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSC
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccC
Confidence 1 124677899999999998666679999999999999999998 66777
Q ss_pred CCCC-----------------hHHHHHHHHHhcCCCChHHHHHhhccC----CCCCCCCCCchhhhhccCCcHhHHHHHH
Q 043957 323 PGRT-----------------EVEQLHRIFKLCGSPSEDYWKKLRLST----TFRPPQSYKPRLFEAFSEFPESSLGLLS 381 (584)
Q Consensus 323 ~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~----~~~~p~~~~~~~~~~~~~~s~~~~dLI~ 381 (584)
++.+ ..+++..|+..++.|....+..+.... ....+......+...++.+++++++||.
T Consensus 264 ~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~ 343 (432)
T 3n9x_A 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLE 343 (432)
T ss_dssp CCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred CCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH
Confidence 7765 478899999999999988776543211 0112223334455667789999999999
Q ss_pred HhcccCCCCCCCHHHHhcCcCCCCCCC
Q 043957 382 TLLALDPAYRGSAASALKNEFFFTSPL 408 (584)
Q Consensus 382 ~~L~~DP~kRpTa~e~L~Hp~f~~~~~ 408 (584)
+||++||.+|||++|+|+||||.....
T Consensus 344 ~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 344 SMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHhcCCcccCCCHHHHhcChhhhhccC
Confidence 999999999999999999999987543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=422.97 Aligned_cols=249 Identities=24% Similarity=0.334 Sum_probs=199.0
Q ss_pred CCCceEEeeecccCceEEEEEEECCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCC-CCeeeeeceeeecC
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDT-----GKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH-PNIVKLEGLATSRM 197 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~~~ 197 (584)
.++|++.+.||+|+||.||+|.+..+ ++.||||++... ......+.+.+|+.+|.+++| ||||++++++....
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 35799999999999999999987643 468999999643 334456778999999999975 99999999886543
Q ss_pred cceEEEEEechh-hHHHHHhhCCC---------------CCCc------HHHHHHHHHHHHHhCCceeccccccceeecC
Q 043957 198 QYSLYLVFEFMQ-TDLARIISNPE---------------GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDK 255 (584)
Q Consensus 198 ~~~l~lV~Ey~~-g~L~~~l~~~~---------------~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~ 255 (584)
..+|||||||+ |+|.+++.... ..++ ++.||+.||+|||+++||||||||+||||+.
T Consensus 142 -~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 142 -GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp -SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred -CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 35799999999 57888775321 1233 3459999999999999999999999999999
Q ss_pred CCcEEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHH
Q 043957 256 NGVLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHR 333 (584)
Q Consensus 256 ~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~ 333 (584)
++.+||+|||+|+.+..... ......+||+.|||||++.+. .|+.++|||||||+||||+| |++||.+....+.+..
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999987654332 223456889999999999874 59999999999999999998 9999998765444433
Q ss_pred HHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 334 IFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 334 i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
++.....+ .....+++++.+||.+||+.||.+|||+.|+++|
T Consensus 300 ~i~~g~~~-------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEGTRM-------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTCCC-------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCC-------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 33221111 1123568899999999999999999999999987
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=414.63 Aligned_cols=289 Identities=45% Similarity=0.719 Sum_probs=234.1
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC-----
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM----- 197 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----- 197 (584)
..++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 346799999999999999999999999999999999665544444556778999999999999999999887643
Q ss_pred -cceEEEEEechhhHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccccc
Q 043957 198 -QYSLYLVFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 198 -~~~l~lV~Ey~~g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~ 270 (584)
...+|+|||||.++|...+......+.+. .||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 34689999999999888887655555543 49999999999999999999999999999999999999999876
Q ss_pred CCCC---CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHH
Q 043957 271 SPNK---KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWK 347 (584)
Q Consensus 271 ~~~~---~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 347 (584)
.... .......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+...++.+....|.
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 254 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 4222 2223556889999999999876668999999999999999999999999999999999999999888877776
Q ss_pred HhhccCCCC---CCCCCCchhhhhcc--CCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCccC
Q 043957 348 KLRLSTTFR---PPQSYKPRLFEAFS--EFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACD 411 (584)
Q Consensus 348 ~~~~~~~~~---~p~~~~~~~~~~~~--~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~~~ 411 (584)
.+.....+. ............+. ..++.+.+||.+||+.||.+|||++|+|+||||+..+.+.+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 323 (351)
T 3mi9_A 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 323 (351)
T ss_dssp TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccc
Confidence 543221111 11111111111111 24788999999999999999999999999999998766554
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=418.03 Aligned_cols=279 Identities=34% Similarity=0.570 Sum_probs=229.0
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc----c
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ----Y 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~----~ 199 (584)
.++|++++.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+|+.++||||+++++++..... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 357999999999999999999999999999999997655556667788999999999999999999998876432 3
Q ss_pred eEEEEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 200 SLYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 200 ~l~lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
.+|+||||+.++|..++.. ..+.+ ..||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 104 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181 (367)
T ss_dssp CCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred eEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc
Confidence 5699999998888888764 23433 359999999999999999999999999999999999999999876432
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
.+..++|++|+|||++.+...++.++||||||||+|+|++|++||.+.+..+++..|+...+.++...+..+....
T Consensus 182 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 257 (367)
T 1cm8_A 182 ----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257 (367)
T ss_dssp ----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred ----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence 3566889999999999876679999999999999999999999999999999999999999999988776543210
Q ss_pred C----CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q 043957 354 T----FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPL 408 (584)
Q Consensus 354 ~----~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~ 408 (584)
. ...+......+...+..+++.+.+||.+||+.||.+|||++|+|+||||.....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 0 011222233455566788999999999999999999999999999999986543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=406.35 Aligned_cols=280 Identities=36% Similarity=0.624 Sum_probs=226.2
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHhC---CCCCeeeeeceeeecC
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE---PHSVKFMAREIMILQKL---DHPNIVKLEGLATSRM 197 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~---~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~~~ 197 (584)
.++|++++.||+|+||+||+|.+..+++.||||++...... ......+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 45799999999999999999999999999999999643321 11223456777777766 4999999999887643
Q ss_pred c---ceEEEEEechhhHHHHHhhCCCC-CCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccc
Q 043957 198 Q---YSLYLVFEFMQTDLARIISNPEG-KLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA 267 (584)
Q Consensus 198 ~---~~l~lV~Ey~~g~L~~~l~~~~~-~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla 267 (584)
. ..+++||||+.++|...+..... .+++ ..||+.||+|||+++|+||||||+||||+.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 2 25899999999999988875432 2433 359999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHH
Q 043957 268 NYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWK 347 (584)
Q Consensus 268 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 347 (584)
..+... ......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..++...+.+....|.
T Consensus 168 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 168 RIYSYQ--MALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp TTSTTC--CCSGGGGCCCSSCCHHHHHTS-CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred cccCCC--cccCCccccccccCchHHcCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 876533 234667899999999999874 58999999999999999999999999999999999999999888877775
Q ss_pred HhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 348 KLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 348 ~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
..........+.............+++.+.+||.+||++||.+|||+.|+|+||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 43222222223333344556667899999999999999999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=409.63 Aligned_cols=280 Identities=41% Similarity=0.730 Sum_probs=214.4
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..++|++++.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+|++++|||||++++++.. ...+|
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 79 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHT--ENKLT 79 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECC--TTEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEE--CCeEE
Confidence 34679999999999999999999999999999999975532 2233567789999999999999999998876 44689
Q ss_pred EEEechhhHHHHHhhCC-----CCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccC
Q 043957 203 LVFEFMQTDLARIISNP-----EGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS 271 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~~-----~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~ 271 (584)
||||||.++|.+.+... ...+.+ ..||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 99999999888776532 122333 3499999999999999999999999999999999999999998765
Q ss_pred CCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 272 PNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 272 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
... ......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..++...+.+....|..+..
T Consensus 160 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 322 2235568899999999998756689999999999999999999999999999999999999999988888876543
Q ss_pred cCCCCCC--CCCCchhhh-----hccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 352 STTFRPP--QSYKPRLFE-----AFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 352 ~~~~~~p--~~~~~~~~~-----~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
...+... ......+.. ....++.++.+||.+||+.||.+|||++|+|+||||.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 300 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcc
Confidence 3222111 111111111 123678999999999999999999999999999999764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=408.12 Aligned_cols=252 Identities=30% Similarity=0.485 Sum_probs=214.8
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++++.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+|+.++||||+++++++.. ...+|+
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 91 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET--EKTLYL 91 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEE
Confidence 457999999999999999999999999999999997766666677788999999999999999999998876 446899
Q ss_pred EEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
|||||. ++|.+.+... ..+.+ ..||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 92 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 168 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-- 168 (328)
T ss_dssp EECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--
T ss_pred EEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--
Confidence 999997 4777776532 23433 3599999999999999999999999999999999999999998765432
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
.....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....+.......
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--------------- 233 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI--------------- 233 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---------------
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------------
Confidence 34667899999999999876545689999999999999999999999998887777665432111
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
...+++++.+||.+||+.||.+|||++|+|+||||....
T Consensus 234 ------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 234 ------------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp ------------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred ------------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 123688999999999999999999999999999998653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=410.08 Aligned_cols=292 Identities=42% Similarity=0.691 Sum_probs=230.7
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCCh---HHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP---HSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~---~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 198 (584)
...++|++++.||+|+||.||+|.+..+|+.||||++....... .....+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 84 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-- 84 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC--
Confidence 34568999999999999999999999999999999996532221 1124577899999999999999999988764
Q ss_pred ceEEEEEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 199 YSLYLVFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 199 ~~l~lV~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
..+|+||||+.++|...+......++ +..||+.||.|||+++|+||||||+||||+.++.+||+|||++..+..
T Consensus 85 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 85 SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred CceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 45799999999998888876443333 345999999999999999999999999999999999999999987653
Q ss_pred CCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
.. ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++...+.+....|......
T Consensus 165 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 165 PN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp CC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred Cc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccC
Confidence 32 23456688999999999977666899999999999999999999999999999999999999988887777654322
Q ss_pred CCCCCC-CCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCccCCCCCC
Q 043957 353 TTFRPP-QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDLSGLP 416 (584)
Q Consensus 353 ~~~~~p-~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~~~~~~~~ 416 (584)
...... ......+...+..+++++.+||.+||+.||.+|||++|+|+||||...+.+.....+|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~~~~~~ 308 (346)
T 1ua2_A 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 308 (346)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSC
T ss_pred cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCCcccCC
Confidence 211111 1111233445678899999999999999999999999999999999876655443333
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=411.47 Aligned_cols=278 Identities=40% Similarity=0.706 Sum_probs=223.4
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++++.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+|+.++||||+++++++... ..+|+|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECS--SCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeC--CEEEEE
Confidence 5799999999999999999999999999999999644321 1112345799999999999999999988764 458999
Q ss_pred EechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 205 FEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
||||.++|...+......+.+ ..||+.||.|||++||+||||||+||||+.++.+||+|||++....... ...
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~ 157 (324)
T 3mtl_A 79 FEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTY 157 (324)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred ecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-ccc
Confidence 999999998888755444543 3599999999999999999999999999999999999999998654322 233
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC---CC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST---TF 355 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---~~ 355 (584)
...+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....|....... ..
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 456889999999999876678999999999999999999999999999999999999999988887776543221 11
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
..+.............+++++.+||.+||+.||.+|||++|+|+||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 222333334455567889999999999999999999999999999999764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=393.94 Aligned_cols=280 Identities=35% Similarity=0.608 Sum_probs=221.7
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++++.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.++++++||||+++++++.. ...+|+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 79 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR--KRRLHL 79 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec--CCeEEE
Confidence 357999999999999999999999999999999997666566667778899999999999999999999876 446899
Q ss_pred EEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 204 VFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
|||||.++++..+......+.+ ..||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 158 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-DY 158 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-cc
Confidence 9999997544443332333433 3599999999999999999999999999999999999999998765322 22
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC--
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF-- 355 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-- 355 (584)
....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+.+..+....+......+........+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 355688999999999987667899999999999999999999999999999999888888877766554443322111
Q ss_pred -CCC-CCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 356 -RPP-QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 356 -~~p-~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
..+ ..........+..+++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 111 111223344457889999999999999999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=408.90 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=216.2
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP----HSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
.+.|++.+.||+|+||.||+|.++.+|+.||||++....... ...+.+.+|+.+|+.++||||+++++++.. ..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~ 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN--RT 88 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SS
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe--CC
Confidence 356999999999999999999999999999999997654321 135678899999999999999999998876 44
Q ss_pred eEEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCC----cEEEEEecccc
Q 043957 200 SLYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG----VLKIADFGLAN 268 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g----~vKL~DFGla~ 268 (584)
.+|||||||. ++|.+.+.. ...+++ ..||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 6899999997 578887764 334444 35999999999999999999999999998776 79999999998
Q ss_pred ccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHH
Q 043957 269 YFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK 348 (584)
Q Consensus 269 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 348 (584)
.+.... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..|......+....|
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-- 242 (361)
T 2yab_A 168 EIEDGV--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF-- 242 (361)
T ss_dssp ECCTTC--CCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH--
T ss_pred EcCCCC--ccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc--
Confidence 875432 3456789999999999976 45999999999999999999999999999998888888776555554444
Q ss_pred hhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 349 LRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 349 ~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
..+++.+++||.+||..||.+|||++|+|+||||..
T Consensus 243 ---------------------~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 243 ---------------------SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp ---------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred ---------------------cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 456899999999999999999999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=405.59 Aligned_cols=280 Identities=36% Similarity=0.697 Sum_probs=219.1
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+|++++||||+++++++.. ...+|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 109 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH--NHRLH 109 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE--TTEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec--CCEEE
Confidence 4567999999999999999999999999999999997665555555677899999999999999999998876 44689
Q ss_pred EEEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeec-----CCCcEEEEEeccccccC
Q 043957 203 LVFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLID-----KNGVLKIADFGLANYFS 271 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~-----~~g~vKL~DFGla~~~~ 271 (584)
||||||.++|.+.+.... .+. +..||+.||.|||+++|+||||||+||||+ .++.+||+|||++..+.
T Consensus 110 lv~e~~~~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCSEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 999999999988876432 233 345999999999999999999999999994 45569999999998765
Q ss_pred CCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 272 PNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 272 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
... ......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..++...+.+....|.....
T Consensus 189 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 189 IPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred Ccc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 332 2345567899999999998766689999999999999999999999999999999999999988888777765433
Q ss_pred cCCCC--CCCCCCchhhhhc-cCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 352 STTFR--PPQSYKPRLFEAF-SEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 352 ~~~~~--~p~~~~~~~~~~~-~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
...+. .+......+...+ ..+++++.+||.+||+.||.+|||++|+|+||||...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 22211 1111111222222 3478999999999999999999999999999999865
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=413.36 Aligned_cols=280 Identities=35% Similarity=0.558 Sum_probs=217.2
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec----Ccc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR----MQY 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~----~~~ 199 (584)
.++|++++.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+|+.++||||+++++++... ...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 3579999999999999999999999999999999976555556677888999999999999999999988653 124
Q ss_pred eEEEEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 200 SLYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 200 ~l~lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
.+|+||||+.++|..++.. ..+++ ..||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 108 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~ 185 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185 (367)
T ss_dssp CCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred eEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc
Confidence 5799999998888887764 33443 359999999999999999999999999999999999999999875432
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
....+||++|+|||++.+...++.++||||||||+|+|++|++||.+.+..+++..|++..+.+....+..+....
T Consensus 186 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 186 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred ----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 3567899999999999875679999999999999999999999999999999999999999999887776543110
Q ss_pred ----CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCc
Q 043957 354 ----TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLA 409 (584)
Q Consensus 354 ----~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~ 409 (584)
....+......+...+..+++.+.+||.+||++||.+|||++|+|+||||.....+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~ 321 (367)
T 2fst_X 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 321 (367)
T ss_dssp HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence 00111122234455667889999999999999999999999999999999875433
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=407.49 Aligned_cols=276 Identities=33% Similarity=0.576 Sum_probs=224.8
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec-----
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR----- 196 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~----- 196 (584)
...++|++++.||+|+||+||+|.+..+|+.||||++...... ..+|+.+|+.++|||||++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 3456899999999999999999999999999999999654322 23699999999999999999988542
Q ss_pred -------------------------------CcceEEEEEechhhHHHHHhhC---CCCCCcH------HHHHHHHHHHH
Q 043957 197 -------------------------------MQYSLYLVFEFMQTDLARIISN---PEGKLTE------PQQLLSGLQHC 236 (584)
Q Consensus 197 -------------------------------~~~~l~lV~Ey~~g~L~~~l~~---~~~~l~~------~~qIl~aL~yL 236 (584)
....+++|||||.++|.+.+.. ....+++ ..||+.||.||
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp --------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 2335899999999887666542 2334433 35999999999
Q ss_pred HhCCceeccccccceeec-CCCcEEEEEeccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHH
Q 043957 237 HDRGILHRDVKGSNLLID-KNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEM 315 (584)
Q Consensus 237 H~~~IvHrDLKp~NILl~-~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeL 315 (584)
|++||+||||||+||||+ .++.+||+|||+|+.+.... .....++|+.|+|||++.+...++.++|||||||++|+|
T Consensus 158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 999999999999999997 68899999999998765433 235668899999999998766799999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC-CCCCCCCCchhhhhc-cCCcHhHHHHHHHhcccCCCCCCC
Q 043957 316 FLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT-FRPPQSYKPRLFEAF-SEFPESSLGLLSTLLALDPAYRGS 393 (584)
Q Consensus 316 ltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~-~~~s~~~~dLI~~~L~~DP~kRpT 393 (584)
++|++||.+.+..+++..++...+.+....|..+..... ...+......+...+ ..+++++.+||.+||++||.+|||
T Consensus 236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (383)
T 3eb0_A 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN 315 (383)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 999999999999999999999999999988877643321 222222223333333 468999999999999999999999
Q ss_pred HHHHhcCcCCCC
Q 043957 394 AASALKNEFFFT 405 (584)
Q Consensus 394 a~e~L~Hp~f~~ 405 (584)
+.|+|+||||..
T Consensus 316 ~~e~l~hp~f~~ 327 (383)
T 3eb0_A 316 PYEAMAHPFFDH 327 (383)
T ss_dssp HHHHHTSGGGHH
T ss_pred HHHHhcCHHHHH
Confidence 999999999964
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=405.97 Aligned_cols=283 Identities=33% Similarity=0.528 Sum_probs=233.5
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC---cc
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM---QY 199 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---~~ 199 (584)
..++|++++.||+|+||.||+|.+..++..||||++... ........+.+|+.+|++++||||+++++++.... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 345799999999999999999999999999999999643 34445677889999999999999999999886542 24
Q ss_pred eEEEEEechhhHHHHHhhCCCCC----CcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 200 SLYLVFEFMQTDLARIISNPEGK----LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 200 ~l~lV~Ey~~g~L~~~l~~~~~~----l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
.+|+||||+.++|...+...... ..+..||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 104 ~~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 183 (364)
T 3qyz_A 104 DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183 (364)
T ss_dssp CEEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred eEEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence 58999999999998888643211 12345999999999999999999999999999999999999999987653221
Q ss_pred --CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc-
Q 043957 276 --RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS- 352 (584)
Q Consensus 276 --~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~- 352 (584)
......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..++...+.+....|..+...
T Consensus 184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 263 (364)
T 3qyz_A 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263 (364)
T ss_dssp BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 12345689999999999877667899999999999999999999999999999999999999999988776543210
Q ss_pred ---CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 353 ---TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 353 ---~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.....+......+...+..+++++.+||.+||++||.+|||++|+|+||||.+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 264 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 001122223334556667889999999999999999999999999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=413.00 Aligned_cols=274 Identities=38% Similarity=0.621 Sum_probs=223.8
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec----Ccce
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR----MQYS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~----~~~~ 200 (584)
.+|++.+.||+|+||.||+|.+..+|+.||||++..... ...+|+.+|+.|+|||||++++++... ....
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 359999999999999999999999999999999964322 234699999999999999999887542 2345
Q ss_pred EEEEEechhhHHHHHhhC---CCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCC-CcEEEEEecccccc
Q 043957 201 LYLVFEFMQTDLARIISN---PEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKN-GVLKIADFGLANYF 270 (584)
Q Consensus 201 l~lV~Ey~~g~L~~~l~~---~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~-g~vKL~DFGla~~~ 270 (584)
+++||||+.+++.+.+.. ....+.+ ..||+.||.|||++||+||||||+||||+.+ +.+||+|||+++.+
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 789999999877665542 2333433 4599999999999999999999999999965 57899999999876
Q ss_pred CCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 271 SPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 271 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
.... .....+||++|+|||++.+...|+.++||||||||+|||++|++||.+.+..+++..+++..+.+..+.|..+.
T Consensus 208 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~ 285 (420)
T 1j1b_A 208 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285 (420)
T ss_dssp CTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred ccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 5332 23556889999999999876679999999999999999999999999999999999999999999998887764
Q ss_pred ccC-CCCCCCCCCchhhhhc-cCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 351 LST-TFRPPQSYKPRLFEAF-SEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 351 ~~~-~~~~p~~~~~~~~~~~-~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
... .+..+......+...+ ..+++++++||.+||++||.+|||+.|+|+||||...
T Consensus 286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 321 1222222222333333 4678999999999999999999999999999999753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=404.31 Aligned_cols=252 Identities=27% Similarity=0.440 Sum_probs=214.3
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++.+.||+|+||.||+|.+..+|..||||++..........+.+.+|+.+|+.|+|||||++++++.. ...+|+|
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~lv 106 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYLV 106 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEEE
Confidence 46999999999999999999999999999999998766666677889999999999999999999998876 4468999
Q ss_pred Eechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCC---CcEEEEEeccccccCCCC
Q 043957 205 FEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKN---GVLKIADFGLANYFSPNK 274 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~---g~vKL~DFGla~~~~~~~ 274 (584)
||||.+ +|.+.+... ..+.+ ..||+.||.|||+++|+||||||+||||+.+ +.+||+|||++.......
T Consensus 107 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp ECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 999985 777777643 33433 3599999999999999999999999999765 459999999998765332
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.....+||+.|+|||++.+ ..|+.++||||||||+|+|++|++||.+.+....+..+......++..
T Consensus 186 --~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---------- 252 (362)
T 2bdw_A 186 --AWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP---------- 252 (362)
T ss_dssp --SCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT----------
T ss_pred --ccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcc----------
Confidence 3456789999999999976 459999999999999999999999999998888777776554333322
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
.+..+++++.+||.+||+.||.+|||+.|+|+||||..
T Consensus 253 -------------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 253 -------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp -------------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred -------------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 23457899999999999999999999999999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=399.74 Aligned_cols=253 Identities=24% Similarity=0.343 Sum_probs=217.5
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+|+.++||||+++++++.+. ..+|+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESM--EELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecC--CEEEE
Confidence 46799999999999999999999999999999998633 33456688999999999999999999988764 46899
Q ss_pred EEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecC--CCcEEEEEeccccccCCCC
Q 043957 204 VFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDK--NGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~--~g~vKL~DFGla~~~~~~~ 274 (584)
|||||.+ +|.+.+......+++ ..||+.||.|||++||+||||||+|||++. ++.+||+|||++..+....
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 9999985 788888765445554 359999999999999999999999999987 7899999999998875432
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+....+..+......+....|
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 227 (321)
T 1tki_A 159 --NFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF-------- 227 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH--------
T ss_pred --ccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhh--------
Confidence 24566899999999999764 5899999999999999999999999999998888888776555544333
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
..+++++.+||.+||..||.+|||+.|+|+||||.+..
T Consensus 228 ---------------~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 228 ---------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp ---------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred ---------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 45789999999999999999999999999999998653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=417.63 Aligned_cols=253 Identities=27% Similarity=0.433 Sum_probs=213.7
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++.+.||+|+||+||+|.+..+|+.||+|++..........+.+.+|+.+|+.++|||||++++++.+ ...+|+|
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lv 88 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE--EGHHYLI 88 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC--SSEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE--CCEEEEE
Confidence 46999999999999999999999999999999998766656667788999999999999999999998876 4468999
Q ss_pred Eechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeec---CCCcEEEEEeccccccCCCC
Q 043957 205 FEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLID---KNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~---~~g~vKL~DFGla~~~~~~~ 274 (584)
||||.| +|.+.+... ..+++ ..||+.||.|||++||+||||||+||||+ .++.+||+|||++.......
T Consensus 89 ~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp ECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred EEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 999985 777776543 23433 35999999999999999999999999998 46789999999998765432
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..+......++...
T Consensus 168 -~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------- 236 (444)
T 3soa_A 168 -QAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE--------- 236 (444)
T ss_dssp -CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTT---------
T ss_pred -ceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccc---------
Confidence 33456789999999999976 4599999999999999999999999999998888887766544333222
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
+..+++++.+||.+||+.||.+|||+.|+|+||||..
T Consensus 237 --------------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 237 --------------WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp --------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred --------------cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 2457899999999999999999999999999999964
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=413.83 Aligned_cols=281 Identities=35% Similarity=0.602 Sum_probs=208.5
Q ss_pred CceE-EeeecccCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 126 SYDK-IDKVGQGTYSNVYKALDR--DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 126 ~Y~~-~~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
.|++ .++||+|+||.||+|.++ .+++.||||++...... ..+.+|+.+|++|+|||||++++++.......+|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 4666 457999999999999976 56889999999644332 3577899999999999999999999776677899
Q ss_pred EEEechhhHHHHHhhCC--------CCCCc------HHHHHHHHHHHHHhCCceeccccccceee----cCCCcEEEEEe
Q 043957 203 LVFEFMQTDLARIISNP--------EGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLI----DKNGVLKIADF 264 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~~--------~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl----~~~g~vKL~DF 264 (584)
|||||+.++|...+... ...+. ++.||+.||.|||+++|+||||||+|||| +.++.+||+||
T Consensus 97 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp EEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred EEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 99999999888776521 11232 34599999999999999999999999999 67789999999
Q ss_pred ccccccCCCCC--CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCCh---------HHHHHH
Q 043957 265 GLANYFSPNKK--RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE---------VEQLHR 333 (584)
Q Consensus 265 Gla~~~~~~~~--~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~---------~~~~~~ 333 (584)
|+|+.+..... ......+||+.|+|||++.+...++.++||||||||+|+|++|++||.+... .+++..
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~ 256 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence 99987653221 2235578999999999998766699999999999999999999999987665 588899
Q ss_pred HHHhcCCCChHHHHHhhccCCC-------CC----CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcC
Q 043957 334 IFKLCGSPSEDYWKKLRLSTTF-------RP----PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402 (584)
Q Consensus 334 i~~~~~~~~~~~~~~~~~~~~~-------~~----p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~ 402 (584)
++...+.+....|..+...... .. .......+.......++.+.+||.+||++||.+|||++|+|+|||
T Consensus 257 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~ 336 (405)
T 3rgf_A 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336 (405)
T ss_dssp HHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 9999999988877665321110 00 000000111111234788999999999999999999999999999
Q ss_pred CCCCCCcc
Q 043957 403 FFTSPLAC 410 (584)
Q Consensus 403 f~~~~~~~ 410 (584)
|...+.+.
T Consensus 337 f~~~~~~~ 344 (405)
T 3rgf_A 337 FLEDPLPT 344 (405)
T ss_dssp GTSSSCCC
T ss_pred hccCCCCc
Confidence 99876654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=395.00 Aligned_cols=281 Identities=33% Similarity=0.620 Sum_probs=224.5
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
...++|++++.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.++++++||||+++++++.. ...+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 99 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK--KKRW 99 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec--CCEE
Confidence 34567999999999999999999999999999999997666666666778899999999999999999998876 4468
Q ss_pred EEEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 202 YLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 202 ~lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
|+||||+.++++..+......+.+ ..||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 178 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 178 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence 999999997655544332333433 3599999999999999999999999999999999999999998764332
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc---
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS--- 352 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--- 352 (584)
......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+......+......
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 22345678999999999987657899999999999999999999999999999999999888887766554433221
Q ss_pred CCCCCCC-CCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 353 TTFRPPQ-SYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 353 ~~~~~p~-~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
.....+. .........+..+++.+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 1111111 1222344455688999999999999999999999999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=389.58 Aligned_cols=255 Identities=25% Similarity=0.459 Sum_probs=210.8
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
...++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.+++.++||||+++++++... ..+
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~ 92 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVG--DEL 92 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEEC--CEE
Confidence 3456799999999999999999999999999999999754333 245688999999999999999999988774 458
Q ss_pred EEEEechh-hHHHHHhhCCCC----CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 202 YLVFEFMQ-TDLARIISNPEG----KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 202 ~lV~Ey~~-g~L~~~l~~~~~----~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
|+|||||. ++|.+++..... ...+..||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp EEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred EEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 99999997 577777754321 122345999999999999999999999999999999999999999987654332
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+....+..+........
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 236 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-------------- 236 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC--------------
T ss_pred ccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------------
Confidence 34566899999999999874 589999999999999999999999998887776665543221100
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.....+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 237 ----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 237 ----------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp ----------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ----------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 1124578899999999999999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=400.79 Aligned_cols=276 Identities=35% Similarity=0.600 Sum_probs=227.4
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc----
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY---- 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~---- 199 (584)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 3579999999999999999999999999999999976666666678889999999999999999999988764432
Q ss_pred eEEEEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 200 SLYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 200 ~l~lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
.+|+||||+.++|...+... +++ ..||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 121 ~~~lv~e~~~~~l~~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIMGME---FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp CCEEEEECCCEEHHHHTTSC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEccccccHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 34999999999888877432 333 359999999999999999999999999999999999999999865432
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..++...+.+....+..+....
T Consensus 198 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 198 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred ----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 3456789999999999875679999999999999999999999999999999999999999988877665432100
Q ss_pred ----CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 354 ----TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 354 ----~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
....+......+...+..+++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 00111222334455567889999999999999999999999999999999754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=405.36 Aligned_cols=273 Identities=35% Similarity=0.584 Sum_probs=222.3
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC----cce
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM----QYS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~~ 200 (584)
.+|++.+.||+|+||+||+|.+..++. ||+|++...... ..+|+.+|+.++|||||++++++.... ...
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 369999999999999999999987666 888888543221 236999999999999999999886532 334
Q ss_pred EEEEEechhhHHHHHhhC---CCCCCcH------HHHHHHHHHHHHhCCceeccccccceeec-CCCcEEEEEecccccc
Q 043957 201 LYLVFEFMQTDLARIISN---PEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLID-KNGVLKIADFGLANYF 270 (584)
Q Consensus 201 l~lV~Ey~~g~L~~~l~~---~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~-~~g~vKL~DFGla~~~ 270 (584)
+|+|||||.+++...+.. ....+.+ ..||+.||.|||++||+||||||+||||+ .++.+||+|||+|+.+
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 889999999876655431 1233333 35999999999999999999999999998 7899999999999876
Q ss_pred CCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 271 SPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 271 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
.... .....+||+.|+|||++.+...|+.++|||||||++|+|++|++||.+.+..+++..+++..+.+....+..+.
T Consensus 193 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 193 IAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp CTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 4333 23566889999999999876679999999999999999999999999999999999999999999988887664
Q ss_pred ccC-CCCCCCCCCchhhhhc-cCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 351 LST-TFRPPQSYKPRLFEAF-SEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 351 ~~~-~~~~p~~~~~~~~~~~-~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
... ....+......+...+ ..+++++.+||.+||++||.+|||+.|+|+||||...
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 332 1222332333343444 3589999999999999999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=392.74 Aligned_cols=253 Identities=26% Similarity=0.407 Sum_probs=213.2
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP----HSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
+.|++.+.||+|+||.||+|.+..+|..||||++....... ...+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 88 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTD 88 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCE
Confidence 45999999999999999999999999999999997653321 235678899999999999999999998876 446
Q ss_pred EEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCC----cEEEEEeccccc
Q 043957 201 LYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG----VLKIADFGLANY 269 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g----~vKL~DFGla~~ 269 (584)
+|+|||||. ++|.+++... ..+++ ..||+.||.|||+++|+||||||+||||+.++ .+||+|||++..
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 899999997 5788877643 33443 35999999999999999999999999998877 799999999987
Q ss_pred cCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 270 FSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 270 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
+.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+.+..+......+....
T Consensus 168 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---- 240 (326)
T 2y0a_A 168 IDFGN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY---- 240 (326)
T ss_dssp CCTTS--CCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHH----
T ss_pred CCCCC--ccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccc----
Confidence 75332 2355689999999999976 4589999999999999999999999999988888777766544443332
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
+..++..+.+||.+||+.||.+|||+.|+|+||||...
T Consensus 241 -------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 241 -------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp -------------------HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred -------------------cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 34568999999999999999999999999999999753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=402.34 Aligned_cols=264 Identities=23% Similarity=0.247 Sum_probs=182.9
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc--ceEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ--YSLY 202 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~--~~l~ 202 (584)
.+|.+.++||+|+||+||+|++ +|+.||||++... .........|+.++.+|+|||||++++++..... ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 4689999999999999999976 5899999998532 1222233456667778999999999999876543 3689
Q ss_pred EEEechh-hHHHHHhhCCCC----CCcHHHHHHHHHHHHHhC--------CceeccccccceeecCCCcEEEEEeccccc
Q 043957 203 LVFEFMQ-TDLARIISNPEG----KLTEPQQLLSGLQHCHDR--------GILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 203 lV~Ey~~-g~L~~~l~~~~~----~l~~~~qIl~aL~yLH~~--------~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
||||||+ |+|.+.+..... .+.+..||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.
T Consensus 78 lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 9999999 578888764321 123345999999999987 999999999999999999999999999987
Q ss_pred cCCCCC---CCCccccccccccChhhhhCCC-----CCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 043957 270 FSPNKK---RPLTSRVVTLWYRAPELLLGAT-----DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSP 341 (584)
Q Consensus 270 ~~~~~~---~~~~~~~gt~~Y~APEvl~~~~-----~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~ 341 (584)
...... ......+||+.|||||++.+.. .|+.++|||||||+||||+||.+||...........- .....+
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~-~~~~~~ 236 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LVPSDP 236 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-TSCSSC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh-cccccc
Confidence 653322 1223468999999999997532 3678999999999999999998877543221000000 000001
Q ss_pred ChHHHHHhhccCCCCCCCCCCchhhhhc--cCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 342 SEDYWKKLRLSTTFRPPQSYKPRLFEAF--SEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 342 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~--~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
....+.........++ .+...+ ...++.+.+||.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~rp------~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRP------NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CHHHHHHHHTTSCCCC------CCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHhcccCCC------CCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1111111111111111 111111 1234578899999999999999999999863
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=418.08 Aligned_cols=252 Identities=31% Similarity=0.488 Sum_probs=213.7
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE-PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|++.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+|++++|||||++++++.. ...+|+
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 103 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGYFYL 103 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEEE
Confidence 4699999999999999999999999999999999755332 3346778899999999999999999998876 446899
Q ss_pred EEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceee---cCCCcEEEEEeccccccCCC
Q 043957 204 VFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl---~~~g~vKL~DFGla~~~~~~ 273 (584)
|||||. ++|.+.+... ..+++ ..||+.||.|||++||+||||||+|||| +.++.+||+|||++..+...
T Consensus 104 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999998 4677777643 33443 4599999999999999999999999999 56789999999999877543
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
. .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......+....
T Consensus 183 ~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-------- 250 (484)
T 3nyv_A 183 K--KMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ-------- 250 (484)
T ss_dssp C--SHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGG--------
T ss_pred c--ccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcc--------
Confidence 2 3456789999999999976 489999999999999999999999999999888888766544333222
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
+..+++.+++||.+||++||.+|||+.|+|+||||+..
T Consensus 251 ---------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 251 ---------------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp ---------------GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred ---------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 34578999999999999999999999999999999754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=402.95 Aligned_cols=280 Identities=30% Similarity=0.504 Sum_probs=215.1
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC----cc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM----QY 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 199 (584)
.++|++++.||+|+||.||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++.... ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 45799999999999999999999999999999999866556666778889999999999999999999887643 23
Q ss_pred eEEEEEechhhHHHHHhhCCCC---CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 200 SLYLVFEFMQTDLARIISNPEG---KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 200 ~l~lV~Ey~~g~L~~~l~~~~~---~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
.+|+|||||.++|...+...-. ...+..||+.||.|||++||+||||||+||||+.++.+||+|||++...... .
T Consensus 104 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~--~ 181 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--F 181 (371)
T ss_dssp EEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----------
T ss_pred ceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc--c
Confidence 6899999999998888763211 1123459999999999999999999999999999999999999999876432 2
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC---
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST--- 353 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--- 353 (584)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..++...+.+....+..+....
T Consensus 182 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 260 (371)
T 2xrw_A 182 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 260 (371)
T ss_dssp --------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHH
T ss_pred ccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence 2355689999999999987 458999999999999999999999999999999999999988888877665432100
Q ss_pred CCCCCCCCCchhhhhc------------cCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 354 TFRPPQSYKPRLFEAF------------SEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~------------~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
....+......+...+ ...++++++||.+||+.||.+|||++|+|+||||...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 261 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 0000000000111111 1236789999999999999999999999999999753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=398.08 Aligned_cols=252 Identities=27% Similarity=0.415 Sum_probs=208.5
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
..++|++++.||+|+||.||+|.++.+|+.||||+++.... .......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~ 80 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRL 80 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe--CCEE
Confidence 35679999999999999999999999999999999964311 12234667899999999999999999988876 4468
Q ss_pred EEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 202 YLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
|+|||||.| +|...+.. ...+.+ ..||+.||.|||++||+||||||+||||+.+|.+||+|||+++......
T Consensus 81 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 999999985 67666653 223333 3599999999999999999999999999999999999999998643222
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+....+..+......
T Consensus 160 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-------------- 223 (337)
T 1o6l_A 160 -ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-------------- 223 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------------
T ss_pred -CcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 23456789999999999976 45899999999999999999999999998877776666542111
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~~ 406 (584)
....+++++.+||.+||+.||.+|| +++|+++||||...
T Consensus 224 -------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 224 -------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred -------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 1135689999999999999999999 99999999999753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=389.96 Aligned_cols=253 Identities=28% Similarity=0.404 Sum_probs=201.3
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCCh------------------------HHHHHHHHHHHHHH
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP------------------------HSVKFMAREIMILQ 179 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~------------------------~~~~~~~~Ei~iL~ 179 (584)
.++|++.+.||+|+||.||+|.+..+++.||||++....... ...+.+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 357999999999999999999999999999999996543211 12356889999999
Q ss_pred hCCCCCeeeeeceeeecCcceEEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceecccccccee
Q 043957 180 KLDHPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLL 252 (584)
Q Consensus 180 ~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NIL 252 (584)
+++||||+++++++.......+|+||||+.+ +|.+++.. ..+.+ ..||+.||.|||+++|+||||||+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 9999999999999887666789999999985 45444332 23433 359999999999999999999999999
Q ss_pred ecCCCcEEEEEeccccccCCCCCCCCccccccccccChhhhhCCCC--CCceeeEecchHHHHHHHhCCCCCCCCChHHH
Q 043957 253 IDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATD--YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQ 330 (584)
Q Consensus 253 l~~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~--~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~ 330 (584)
|+.++.+||+|||++..+.... ......+||+.|+|||++.+... ++.++|||||||++|+|++|++||........
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 248 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence 9999999999999998765332 22345689999999999876432 47889999999999999999999988776655
Q ss_pred HHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCC
Q 043957 331 LHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404 (584)
Q Consensus 331 ~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~ 404 (584)
...+....... .....+++.+.+||.+||+.||.+|||+.|+|+||||+
T Consensus 249 ~~~~~~~~~~~-------------------------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 249 HSKIKSQALEF-------------------------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHCCCCC-------------------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHhcccCCC-------------------------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 54443321110 01245789999999999999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=405.64 Aligned_cols=273 Identities=30% Similarity=0.512 Sum_probs=220.9
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC------CCCCeeeeeceeeecC
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL------DHPNIVKLEGLATSRM 197 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L------~HpnIv~l~~~~~~~~ 197 (584)
..+|++++.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+++.+ +|+||+++++++...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~- 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR- 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET-
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC---ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC-
Confidence 4579999999999999999999999999999999963 234456677899888887 577999999988774
Q ss_pred cceEEEEEechhhHHHHHhhCCC-CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCc--EEEEEecccc
Q 043957 198 QYSLYLVFEFMQTDLARIISNPE-GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGV--LKIADFGLAN 268 (584)
Q Consensus 198 ~~~l~lV~Ey~~g~L~~~l~~~~-~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~--vKL~DFGla~ 268 (584)
..+||||||+.++|.+.+.... ..+. ++.||+.||+|||+++|+||||||+||||+.++. +||+|||+++
T Consensus 172 -~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 172 -NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp -TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred -CeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 4689999999999888876433 2243 3459999999999999999999999999999887 9999999997
Q ss_pred ccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHH
Q 043957 269 YFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK 348 (584)
Q Consensus 269 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 348 (584)
..... ....+||+.|+|||++.+. .|+.++||||||||+|||++|++||.+.+..+++..++...+.+....+..
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ecCCc----ccccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 65422 3456899999999999874 599999999999999999999999999999999999999999998877754
Q ss_pred hhccCCCCCC-------------------------------CCCCchhhhhc-cCCcHhHHHHHHHhcccCCCCCCCHHH
Q 043957 349 LRLSTTFRPP-------------------------------QSYKPRLFEAF-SEFPESSLGLLSTLLALDPAYRGSAAS 396 (584)
Q Consensus 349 ~~~~~~~~~p-------------------------------~~~~~~~~~~~-~~~s~~~~dLI~~~L~~DP~kRpTa~e 396 (584)
......+... ......+...+ ...++.+.+||.+||++||.+|||++|
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 3221110000 00011111222 345788999999999999999999999
Q ss_pred HhcCcCCCCC
Q 043957 397 ALKNEFFFTS 406 (584)
Q Consensus 397 ~L~Hp~f~~~ 406 (584)
+|+||||+..
T Consensus 406 ~L~Hpw~~~~ 415 (429)
T 3kvw_A 406 ALRHPWLRRR 415 (429)
T ss_dssp HHTSTTTC--
T ss_pred HhCChhhccC
Confidence 9999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=403.74 Aligned_cols=251 Identities=28% Similarity=0.425 Sum_probs=204.7
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l 201 (584)
.++|++++.||+|+||.||+|+++.+|+.||||+++.... .......+.+|+.+|+.+ +|||||++++++.. ...+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~ 99 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PDRL 99 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CCEE
Confidence 4679999999999999999999999999999999964321 223456678899999998 69999999988876 4468
Q ss_pred EEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 202 YLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
|||||||.| +|...+... ..+.+ ..||+.||+|||++||+||||||+||||+.+|.+||+|||+|+......
T Consensus 100 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 999999985 677766532 33443 3599999999999999999999999999999999999999998643222
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..|.......
T Consensus 179 -~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~------------- 243 (353)
T 3txo_A 179 -VTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY------------- 243 (353)
T ss_dssp --------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------
T ss_pred -ccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 234567899999999999864 58999999999999999999999999999888888876532211
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCH------HHHhcCcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSA------ASALKNEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa------~e~L~Hp~f~~~ 406 (584)
...+++++.+||.+||++||.+||++ +|+|+||||...
T Consensus 244 --------------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 244 --------------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred --------------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 12368899999999999999999999 999999999753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=403.08 Aligned_cols=253 Identities=31% Similarity=0.446 Sum_probs=204.8
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC---CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT---SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~---~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
++|++.+.||+|+||.||+|.++.+|+.||||++.... ......+.+.+|+.+|+.++|||||++++++.. ...+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~ 101 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS--DGML 101 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEE
Confidence 35999999999999999999999999999999986321 111235678899999999999999999998876 4468
Q ss_pred EEEEechh-hHHHHHhhCC---CCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCc---EEEEEecccc
Q 043957 202 YLVFEFMQ-TDLARIISNP---EGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGV---LKIADFGLAN 268 (584)
Q Consensus 202 ~lV~Ey~~-g~L~~~l~~~---~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~---vKL~DFGla~ 268 (584)
|||||||. ++|...+... ...++ +..||+.||.|||+++|+||||||+||||+.++. +||+|||++.
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 99999998 4676555321 12233 3459999999999999999999999999976654 9999999998
Q ss_pred ccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHH
Q 043957 269 YFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK 348 (584)
Q Consensus 269 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 348 (584)
.+.... ......+||+.|+|||++.+ ..++.++||||||||+|+|++|.+||.+. ....+..+...........
T Consensus 182 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~--- 255 (351)
T 3c0i_A 182 QLGESG-LVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQ--- 255 (351)
T ss_dssp ECCTTS-CBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHH---
T ss_pred EecCCC-eeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccc---
Confidence 775432 22355689999999999976 45899999999999999999999999875 3445555544433333322
Q ss_pred hhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 349 LRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 349 ~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
+..+++.+.+||.+||+.||.+|||+.|+|+||||..
T Consensus 256 --------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 256 --------------------WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp --------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred --------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 3467899999999999999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=419.92 Aligned_cols=252 Identities=31% Similarity=0.508 Sum_probs=209.3
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+|++++|||||++++++.. ...+|+|
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv 99 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYIV 99 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc--CCEEEEE
Confidence 46999999999999999999999999999999996432222345678899999999999999999998876 4468999
Q ss_pred Eechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeec---CCCcEEEEEeccccccCCCC
Q 043957 205 FEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLID---KNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~---~~g~vKL~DFGla~~~~~~~ 274 (584)
||||.+ +|.+.+... ..+++ ..||+.||.|||++||+||||||+||||+ .++.+||+|||++..+....
T Consensus 100 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 999985 676666432 23333 45999999999999999999999999995 45679999999998765432
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.....+||+.|+|||++.+ .|+.++||||||||+|+|++|++||.+.+..+.+..+......+....
T Consensus 179 --~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--------- 245 (486)
T 3mwu_A 179 --KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ--------- 245 (486)
T ss_dssp -----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGG---------
T ss_pred --ccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcc---------
Confidence 3456789999999999975 489999999999999999999999999998888888766544333222
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
+..+++++++||.+||+.||.+|||+.|+|+||||...
T Consensus 246 --------------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 246 --------------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp --------------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred --------------cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 34578999999999999999999999999999999764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=392.41 Aligned_cols=275 Identities=36% Similarity=0.607 Sum_probs=225.0
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc----ce
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ----YS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~----~~ 200 (584)
++|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++..... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57999999999999999999999999999999997665556667788999999999999999999998876433 24
Q ss_pred EEEEEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 201 LYLVFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 201 l~lV~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
+|+||||+.++|...+.. .++ +..||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 104 ~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~- 179 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 179 (353)
T ss_dssp CEEEEECCSEEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred EEEEeccccCCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-
Confidence 699999999988877643 233 3459999999999999999999999999999999999999999875432
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC-
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST- 353 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~- 353 (584)
....++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.+....+..+....
T Consensus 180 ---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 256 (353)
T 3coi_A 180 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred ---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence 3456789999999999875678999999999999999999999999999999999999998888876664432110
Q ss_pred ---CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 354 ---TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 354 ---~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
....+......+...+..+++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 00011111223334456789999999999999999999999999999999764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=395.18 Aligned_cols=280 Identities=32% Similarity=0.468 Sum_probs=214.3
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC-----c
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM-----Q 198 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~-----~ 198 (584)
.++|++.+.||+|+||.||+|.+..+|..||||++...... .....+|+..+..++||||+++++++.... .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 45799999999999999999999999999999998654322 234567888889999999999999886532 2
Q ss_pred ceEEEEEechhhHHHHHhh---CCCCCCc------HHHHHHHHHHHHH--hCCceeccccccceeecC-CCcEEEEEecc
Q 043957 199 YSLYLVFEFMQTDLARIIS---NPEGKLT------EPQQLLSGLQHCH--DRGILHRDVKGSNLLIDK-NGVLKIADFGL 266 (584)
Q Consensus 199 ~~l~lV~Ey~~g~L~~~l~---~~~~~l~------~~~qIl~aL~yLH--~~~IvHrDLKp~NILl~~-~g~vKL~DFGl 266 (584)
..+|+||||+.++|...+. .....+. +..||+.||.||| ++||+||||||+||||+. ++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 3479999999987765543 2233333 3459999999999 999999999999999987 89999999999
Q ss_pred ccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHH
Q 043957 267 ANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW 346 (584)
Q Consensus 267 a~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 346 (584)
+..+.... .....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+....+.+....|
T Consensus 179 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 179 AKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp CBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 98775433 2345678999999999977666899999999999999999999999999999999999999999999888
Q ss_pred HHhhccCCCC-CCCCCCchhhhhc----cCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q 043957 347 KKLRLSTTFR-PPQSYKPRLFEAF----SEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPL 408 (584)
Q Consensus 347 ~~~~~~~~~~-~p~~~~~~~~~~~----~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~ 408 (584)
..+....... ........+...+ ...++++.+||.+||+.||.+|||+.|+|+||||.....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 7764322111 0111111122222 236789999999999999999999999999999987543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=392.05 Aligned_cols=283 Identities=29% Similarity=0.466 Sum_probs=222.1
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC---------hHHHHHHHHHHHHHHhCCCCCeeeeece
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE---------PHSVKFMAREIMILQKLDHPNIVKLEGL 192 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~---------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 192 (584)
...++|++.+.||+|+||.||+|.+.. |..||||++...... ....+.+.+|+.+|++++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 345689999999999999999998865 999999998543221 2234778999999999999999999998
Q ss_pred eeec---CcceEEEEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEE
Q 043957 193 ATSR---MQYSLYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIAD 263 (584)
Q Consensus 193 ~~~~---~~~~l~lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~D 263 (584)
+... ....+|+||||+.++|...+......+.+ ..||+.||.|||++||+||||||+||||+.++.+||+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 8652 33468999999999999988866555554 35999999999999999999999999999999999999
Q ss_pred eccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 043957 264 FGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSE 343 (584)
Q Consensus 264 FGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~ 343 (584)
||++....... .....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+..
T Consensus 178 fg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 255 (362)
T 3pg1_A 178 FNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255 (362)
T ss_dssp TTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred cCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 99998654322 2355688999999999987567999999999999999999999999999999999999999988887
Q ss_pred HHHHHhhcc-----CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 344 DYWKKLRLS-----TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 344 ~~~~~~~~~-----~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
..+...... ............+......+++.+.+||.+||+.||.+|||+.|+|+||||....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 655432110 0000111112234455677899999999999999999999999999999998753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=409.53 Aligned_cols=262 Identities=26% Similarity=0.385 Sum_probs=213.4
Q ss_pred CCCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc
Q 043957 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 120 ~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 198 (584)
+....++|++++.||+|+||.||+|.++.+++.||||++..... .......+.+|+.+|+.++|||||++++++.+ .
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~ 141 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--D 141 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE--C
Confidence 34567789999999999999999999999999999999964210 01112347789999999999999999988876 4
Q ss_pred ceEEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccC
Q 043957 199 YSLYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS 271 (584)
Q Consensus 199 ~~l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~ 271 (584)
..+|||||||. |+|..++... .+.+ ..||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.+.
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 56899999997 5787777642 3433 3499999999999999999999999999999999999999998765
Q ss_pred CCCCCCCccccccccccChhhhhCCCC---CCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHH
Q 043957 272 PNKKRPLTSRVVTLWYRAPELLLGATD---YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK 348 (584)
Q Consensus 272 ~~~~~~~~~~~gt~~Y~APEvl~~~~~---~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 348 (584)
..........+||+.|+|||++.+... |+.++|||||||++|||++|++||.+.+..+.+..|+.......
T Consensus 220 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~------ 293 (410)
T 3v8s_A 220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT------ 293 (410)
T ss_dssp TTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC------
T ss_pred cCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc------
Confidence 443323456789999999999986432 78899999999999999999999999998888888765321000
Q ss_pred hhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCC--CCCHHHHhcCcCCCCCCC
Q 043957 349 LRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAY--RGSAASALKNEFFFTSPL 408 (584)
Q Consensus 349 ~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~k--RpTa~e~L~Hp~f~~~~~ 408 (584)
. .....+++++++||.+||+.+|.+ |++++|+++||||+...+
T Consensus 294 --------~---------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w 338 (410)
T 3v8s_A 294 --------F---------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 338 (410)
T ss_dssp --------C---------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred --------C---------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence 0 011357899999999999999998 999999999999987543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=391.14 Aligned_cols=249 Identities=24% Similarity=0.409 Sum_probs=209.0
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
..++|++++.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+|+.++||||+++++++.+ ...+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~ 81 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQI 81 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe--CCEE
Confidence 34679999999999999999999999999999999964321 11234667889999999999999999998876 4468
Q ss_pred EEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 202 YLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
|+|||||.| +|...+... ..+.+ ..||+.||.|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 82 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp EEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 999999985 787777542 33433 359999999999999999999999999999999999999999876432
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+....+..+.......
T Consensus 160 ---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~------------- 222 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF------------- 222 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC-------------
T ss_pred ---cccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-------------
Confidence 245689999999999976 458999999999999999999999999988888777775532111
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~~ 406 (584)
...+++++.+||.+||+.||.+|| +++|+++||||...
T Consensus 223 --------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 223 --------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred --------------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 134688999999999999999999 99999999999764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=410.67 Aligned_cols=263 Identities=24% Similarity=0.350 Sum_probs=215.3
Q ss_pred CCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 121 ~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
....++|+++++||+|+||.||+|.++.+++.||||++..... .......+.+|+.+|..++|||||++++++.+ ..
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~ 147 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD--DN 147 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC--SS
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CC
Confidence 3456789999999999999999999999999999999964211 11112337789999999999999999988876 44
Q ss_pred eEEEEEechh-hHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQ-TDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
.+|||||||. |+|..++......+.+. .||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.+..
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 6899999997 57888887655556543 4999999999999999999999999999999999999999987654
Q ss_pred CCCCCCccccccccccChhhhh----CCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHH
Q 043957 273 NKKRPLTSRVVTLWYRAPELLL----GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK 348 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~----~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 348 (584)
.........+||+.|+|||++. +...|+.++|||||||++|||++|++||.+.+..+.+..|+......
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~------- 300 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF------- 300 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC-------
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc-------
Confidence 4433345578999999999997 23458999999999999999999999999999888888876431100
Q ss_pred hhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCC--CCCHHHHhcCcCCCCCC
Q 043957 349 LRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAY--RGSAASALKNEFFFTSP 407 (584)
Q Consensus 349 ~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~k--RpTa~e~L~Hp~f~~~~ 407 (584)
..| ..+..+++++++||.+||..+|.+ |++++|+++||||....
T Consensus 301 -------~~p--------~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 301 -------QFP--------TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp -------CCC--------SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred -------cCC--------cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence 000 112457899999999999999998 99999999999997643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=385.51 Aligned_cols=281 Identities=37% Similarity=0.617 Sum_probs=223.5
Q ss_pred CCCCceEEeeecccCceEEEEEEEC-CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC---CCCCeeeeeceeee---
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDR-DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL---DHPNIVKLEGLATS--- 195 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~-~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~--- 195 (584)
..++|++++.||+|+||.||+|.+. .+|+.||||++............+.+|+.+++.+ +||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3467999999999999999999995 6789999999965433322223455677777666 89999999998763
Q ss_pred cCcceEEEEEechhhHHHHHhhCCC-CCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccc
Q 043957 196 RMQYSLYLVFEFMQTDLARIISNPE-GKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLAN 268 (584)
Q Consensus 196 ~~~~~l~lV~Ey~~g~L~~~l~~~~-~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~ 268 (584)
.....+|+||||+.++|...+.... ..+.+ ..||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 2355789999999999888876432 22433 3599999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHH
Q 043957 269 YFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK 348 (584)
Q Consensus 269 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 348 (584)
...... ......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..++...+.+....|..
T Consensus 169 ~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (326)
T 1blx_A 169 IYSFQM--ALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245 (326)
T ss_dssp CCCGGG--GGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred cccCCC--CccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence 764322 23456789999999999764 589999999999999999999999999999999999999888887766643
Q ss_pred hhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 349 LRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 349 ~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.......................+++.+.+||.+||+.||.+|||+.|+|+||||...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 2211111111111223445557889999999999999999999999999999999764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=389.04 Aligned_cols=271 Identities=27% Similarity=0.359 Sum_probs=217.4
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-----CCCeeeeeceeeecCc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-----HPNIVKLEGLATSRMQ 198 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-----HpnIv~l~~~~~~~~~ 198 (584)
.++|+++++||+|+||.||+|.+..+++.||||++.. .......+..|+.+++.+. |||||++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-- 108 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-- 108 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET--
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC--
Confidence 3579999999999999999999999999999999863 2344566778999999996 99999999988774
Q ss_pred ceEEEEEechhhHHHHHhhCCC-CCCcH------HHHHHHHHHHHHhCCceeccccccceeecC----------------
Q 043957 199 YSLYLVFEFMQTDLARIISNPE-GKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDK---------------- 255 (584)
Q Consensus 199 ~~l~lV~Ey~~g~L~~~l~~~~-~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~---------------- 255 (584)
..+||||||+.++|.+++.... ..+.+ ..||+.||+|||++||+||||||+||||+.
T Consensus 109 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 109 DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccc
Confidence 4689999999888988886433 22333 459999999999999999999999999975
Q ss_pred ---------CCcEEEEEeccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCC
Q 043957 256 ---------NGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRT 326 (584)
Q Consensus 256 ---------~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~ 326 (584)
++.+||+|||++...... ....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 788999999999875432 2456889999999999874 59999999999999999999999999999
Q ss_pred hHHHHHHHHHhcCCCChHHHHHhhccCCC----------CCCCCCCc--hh-------hhhccCCcHhHHHHHHHhcccC
Q 043957 327 EVEQLHRIFKLCGSPSEDYWKKLRLSTTF----------RPPQSYKP--RL-------FEAFSEFPESSLGLLSTLLALD 387 (584)
Q Consensus 327 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~----------~~p~~~~~--~~-------~~~~~~~s~~~~dLI~~~L~~D 387 (584)
..+.+..+......++...+......... ..|..... .. .......++.+.+||.+||+.|
T Consensus 264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 343 (360)
T 3llt_A 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID 343 (360)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence 99999999998888887766554321100 00000000 00 0001123477889999999999
Q ss_pred CCCCCCHHHHhcCcCCC
Q 043957 388 PAYRGSAASALKNEFFF 404 (584)
Q Consensus 388 P~kRpTa~e~L~Hp~f~ 404 (584)
|.+|||++|+|+||||+
T Consensus 344 P~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 344 PTLRPSPAELLKHKFLE 360 (360)
T ss_dssp GGGSCCHHHHTTSGGGC
T ss_pred hhhCCCHHHHhcCcccC
Confidence 99999999999999985
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=397.47 Aligned_cols=253 Identities=26% Similarity=0.469 Sum_probs=212.7
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.+.|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+|+.|+|||||++++++.. ...+||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~l 125 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVL 125 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe--CCEEEE
Confidence 457999999999999999999999999999999997432 3345678899999999999999999998876 446899
Q ss_pred EEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecC--CCcEEEEEeccccccCCCC
Q 043957 204 VFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDK--NGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~--~g~vKL~DFGla~~~~~~~ 274 (584)
|||||. ++|.+.+......+++ ..||+.||.|||++||+||||||+||||+. ++.+||+|||++..+....
T Consensus 126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 999998 4788887765545554 359999999999999999999999999974 4779999999998875432
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......+..
T Consensus 206 --~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 271 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE----------- 271 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS-----------
T ss_pred --ceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----------
Confidence 2345689999999999976 45899999999999999999999999999888777776553222211
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
..+..+++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 272 ------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 272 ------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp ------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 1234678999999999999999999999999999999865
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=387.78 Aligned_cols=255 Identities=31% Similarity=0.434 Sum_probs=203.0
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++++.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++.++|||||++++++.. ....|+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 82 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYL 82 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEEE
Confidence 46799999999999999999999999999999999654322 234567899999999999999999998876 446899
Q ss_pred EEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC-C
Q 043957 204 VFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK-K 275 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~ 275 (584)
|||||.+ +|.+.+... ..+.+ ..||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... .
T Consensus 83 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999985 677776542 33433 3599999999999999999999999999999999999999998654222 2
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
......+||+.|+|||++.+...++.++|||||||++|+|++|++||.................
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~---------------- 225 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK---------------- 225 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC----------------
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc----------------
Confidence 2334678999999999998765458899999999999999999999987655322211111100
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.....+..+++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus 226 --------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 226 --------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp --------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred --------ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 0011235678999999999999999999999999999999764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=385.00 Aligned_cols=283 Identities=35% Similarity=0.538 Sum_probs=222.9
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec---Ccc
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR---MQY 199 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~---~~~ 199 (584)
..++|++.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+|+.++||||+++++++... ...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 346799999999999999999999999999999999533 3444566788999999999999999999887543 234
Q ss_pred eEEEEEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 200 SLYLVFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 200 ~l~lV~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
.+|+||||+.++|.+.+... .++ +..||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 88 ~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 88 EVYIIQELMQTDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp CEEEEECCCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred eEEEEEeccCccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 68999999999988887642 333 3459999999999999999999999999999999999999999876432
Q ss_pred CCC---------CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChH
Q 043957 274 KKR---------PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSED 344 (584)
Q Consensus 274 ~~~---------~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~ 344 (584)
... .....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+....+.+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 211 12345789999999998765679999999999999999999999999999999888888877766522
Q ss_pred HHHHhhcc-----CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q 043957 345 YWKKLRLS-----TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPL 408 (584)
Q Consensus 345 ~~~~~~~~-----~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~ 408 (584)
........ .....+......+...+..+++++.+||.+||+.||.+|||++|+|+||||.....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 11000000 00000111122344556788999999999999999999999999999999986543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=409.91 Aligned_cols=254 Identities=31% Similarity=0.490 Sum_probs=211.2
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCCh-----------HHHHHHHHHHHHHHhCCCCCeeeeec
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP-----------HSVKFMAREIMILQKLDHPNIVKLEG 191 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-----------~~~~~~~~Ei~iL~~L~HpnIv~l~~ 191 (584)
..++|+++++||+|+||+||+|.++.++..||||++....... ...+.+.+|+.+|++|+|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3567999999999999999999999999999999997543221 23567889999999999999999999
Q ss_pred eeeecCcceEEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCC---cEEE
Q 043957 192 LATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG---VLKI 261 (584)
Q Consensus 192 ~~~~~~~~~l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g---~vKL 261 (584)
++.. ...+|||||||.+ +|.+.+... ..+++ ..||+.||.|||++||+||||||+||||+.++ .+||
T Consensus 114 ~~~~--~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 114 VFED--KKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEC--SSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEc--CCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 9876 4468999999985 677766532 23433 45999999999999999999999999998776 6999
Q ss_pred EEeccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 043957 262 ADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSP 341 (584)
Q Consensus 262 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~ 341 (584)
+|||++..+.... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......+
T Consensus 191 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 191 VDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266 (504)
T ss_dssp CCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred EECCCCEEcCCCC--ccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999998775432 3456789999999999864 48999999999999999999999999999988888887765544
Q ss_pred ChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 342 SEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 342 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
....| ..+++++++||.+||++||.+|||++|+|+||||+..
T Consensus 267 ~~~~~-----------------------~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 267 DFNDW-----------------------KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp CHHHH-----------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred Ccccc-----------------------CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 44433 4578999999999999999999999999999999764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=396.98 Aligned_cols=282 Identities=22% Similarity=0.313 Sum_probs=207.9
Q ss_pred CCCCceEEeeeccc--CceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 123 SAESYDKIDKVGQG--TYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
..++|++++.||+| +||.||+|.+..+|+.||||++..........+.+.+|+.+|+.++|||||++++++... ..
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 100 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NE 100 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC--CE
Confidence 34579999999999 999999999999999999999987766666778899999999999999999999998864 46
Q ss_pred EEEEEechh-hHHHHHhhCC-CCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 201 LYLVFEFMQ-TDLARIISNP-EGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~-~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
+|||||||. ++|.+++... ...+.+ ..||+.||.|||+++|+||||||+||||+.++.+||+|||++.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 899999998 4677766532 233433 35999999999999999999999999999999999999999865421
Q ss_pred CC------CCCCccccccccccChhhhhCC-CCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC-----
Q 043957 273 NK------KRPLTSRVVTLWYRAPELLLGA-TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGS----- 340 (584)
Q Consensus 273 ~~------~~~~~~~~gt~~Y~APEvl~~~-~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~----- 340 (584)
.. .......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+......+..++.....
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 11 1112335789999999999763 45899999999999999999999999887766555444322111
Q ss_pred ---CChHHHHHhh-----------ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 341 ---PSEDYWKKLR-----------LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 341 ---~~~~~~~~~~-----------~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
+....+.... .......+.............+++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 0000000000 00000001111111222345688999999999999999999999999999999764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=415.92 Aligned_cols=251 Identities=31% Similarity=0.485 Sum_probs=206.4
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++++.||+|+||+||+|.+..++..||||++............+.+|+.+|+.++|||||++++++.. ...+|+|
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv 114 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED--KRNYYLV 114 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEEE
Confidence 46999999999999999999999999999999997654444445678899999999999999999999876 4468999
Q ss_pred Eechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecC---CCcEEEEEeccccccCCCC
Q 043957 205 FEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDK---NGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~---~g~vKL~DFGla~~~~~~~ 274 (584)
||||.+ +|.+.+... ..+. +..||+.||.|||++||+||||||+||||+. ++.+||+|||++..+....
T Consensus 115 ~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred EecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 999985 676666432 2333 3459999999999999999999999999976 4559999999998765332
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......+....
T Consensus 194 --~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--------- 260 (494)
T 3lij_A 194 --KMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE--------- 260 (494)
T ss_dssp --CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGG---------
T ss_pred --cccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchh---------
Confidence 3456789999999999864 589999999999999999999999999999888888766544443322
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
+..+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 261 --------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 261 --------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp --------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred --------------cccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 3467899999999999999999999999999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=389.58 Aligned_cols=253 Identities=27% Similarity=0.437 Sum_probs=204.0
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcc
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 199 (584)
...++|++++.||+|+||.||+|+++.+++.||||++..... .......+.+|+.+|.++ +|||||++++++.. ..
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~ 83 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ES 83 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SS
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CC
Confidence 345679999999999999999999999999999999976533 345567788999999988 89999999998876 44
Q ss_pred eEEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
.+|+|||||.+ +|...+... ..+.+ ..||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 68999999985 777766532 23433 35999999999999999999999999999999999999999986432
Q ss_pred CCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCC---------hHHHHHHHHHhcCCCCh
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRT---------EVEQLHRIFKLCGSPSE 343 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~---------~~~~~~~i~~~~~~~~~ 343 (584)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.... .......+...
T Consensus 163 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~------ 234 (345)
T 3a8x_A 163 PG-DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------ 234 (345)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC------
T ss_pred CC-CcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC------
Confidence 22 23456789999999999986 458999999999999999999999997532 11222222211
Q ss_pred HHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCH------HHHhcCcCCCCC
Q 043957 344 DYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSA------ASALKNEFFFTS 406 (584)
Q Consensus 344 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa------~e~L~Hp~f~~~ 406 (584)
... ....++..+.+||.+||+.||.+||++ +|+++||||...
T Consensus 235 ----------~~~-----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 235 ----------QIR-----------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp ----------CCC-----------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred ----------CCC-----------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 000 113568899999999999999999995 899999999754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=401.64 Aligned_cols=253 Identities=27% Similarity=0.423 Sum_probs=204.5
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE-PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
...++|++.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+|+.++||||+++++++... ..
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~ 83 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP--TD 83 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS--SE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CE
Confidence 3456899999999999999999999999999999998643111 11234688999999999999999999988774 46
Q ss_pred EEEEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 201 LYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 201 l~lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
+|+||||+.|+|.+.+... ..+++ ..||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~lv~E~~~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 84 IVMVIEYAGGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEEEEECCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 8999999998888877542 23333 4599999999999999999999999999999999999999998765432
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.........+
T Consensus 163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-------------------- 220 (336)
T 3h4j_B 163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-------------------- 220 (336)
T ss_dssp --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--------------------
T ss_pred --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--------------------
Confidence 3456689999999999987554478999999999999999999999765432111100
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
..........+++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus 221 -------~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 221 -------NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp -------CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred -------HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 000111224578999999999999999999999999999999764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=381.36 Aligned_cols=282 Identities=35% Similarity=0.580 Sum_probs=220.3
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec-------
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR------- 196 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------- 196 (584)
.++|++++.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 35799999999999999999999999999999998743 345667788999999999999999999887432
Q ss_pred -----CcceEEEEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeec-CCCcEEEEEe
Q 043957 197 -----MQYSLYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLID-KNGVLKIADF 264 (584)
Q Consensus 197 -----~~~~l~lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~-~~g~vKL~DF 264 (584)
....+|+||||+.++|.+.+... .+.+ ..||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 88 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYMETDLANVLEQG--PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp ---CCSCSEEEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cccccccCceeEEeeccCCCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 23568999999999999888642 3333 35999999999999999999999999997 5679999999
Q ss_pred ccccccCCCC--CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 043957 265 GLANYFSPNK--KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPS 342 (584)
Q Consensus 265 Gla~~~~~~~--~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~ 342 (584)
|++....... ........+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+........
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 9998764321 12234557799999999988756799999999999999999999999999999999999988877777
Q ss_pred hHHHHHhhccCCC---CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCc
Q 043957 343 EDYWKKLRLSTTF---RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLA 409 (584)
Q Consensus 343 ~~~~~~~~~~~~~---~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~ 409 (584)
...+..+...... .........+......++.++.+||.+||+.||.+|||++|+|+||||.....+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 6666554211000 000011122344556789999999999999999999999999999999865443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=385.71 Aligned_cols=247 Identities=25% Similarity=0.359 Sum_probs=198.4
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|+++++||+|+||+||+|.+..+|+.||||++...............|+..+..+ .|||||++++++.. ...+||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEEE
Confidence 369999999999999999999999999999999876555555555555666666555 89999999998876 446899
Q ss_pred EEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 204 VFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
|||||.++|...+......+++ +.||+.||.|||+++|+||||||+||||+.++.+||+|||++....... .
T Consensus 135 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--~ 212 (311)
T 3p1a_A 135 QTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG--A 212 (311)
T ss_dssp EEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred EEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC--C
Confidence 9999999988887655444554 3599999999999999999999999999999999999999998765332 2
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCC
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 357 (584)
.....||+.|+|||++.+ .++.++|||||||++|||++|..||.+..... .+... ...
T Consensus 213 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~~--~~~--------------- 270 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQG--YLP--------------- 270 (311)
T ss_dssp --CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTTT--CCC---------------
T ss_pred CcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhcc--CCC---------------
Confidence 345679999999999876 48999999999999999999987765532221 11110 000
Q ss_pred CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 358 p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
......+++++.+||.+||+.||.+|||++|+|+||||++
T Consensus 271 --------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 271 --------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp --------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred --------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 1223567899999999999999999999999999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=398.62 Aligned_cols=252 Identities=26% Similarity=0.433 Sum_probs=200.5
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcce
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~ 200 (584)
..++|++++.||+|+||.||+|+++.+++.||||+++.... .......+.+|+.+|.++ +|||||++++++.. ...
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~ 127 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESR 127 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CCE
Confidence 34679999999999999999999999999999999975432 223345677899999887 89999999988876 446
Q ss_pred EEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+|||||||.| +|...+... ..+.+ ..||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.....
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 8999999985 676666532 33443 359999999999999999999999999999999999999999863322
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChH---------HHHHHHHHhcCCCChH
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEV---------EQLHRIFKLCGSPSED 344 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~---------~~~~~i~~~~~~~~~~ 344 (584)
.......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||...... .....+...
T Consensus 207 -~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~------- 277 (396)
T 4dc2_A 207 -GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------- 277 (396)
T ss_dssp -TCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-------
T ss_pred -CCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-------
Confidence 223466789999999999987 45999999999999999999999999653221 122222211
Q ss_pred HHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCH------HHHhcCcCCCCC
Q 043957 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSA------ASALKNEFFFTS 406 (584)
Q Consensus 345 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa------~e~L~Hp~f~~~ 406 (584)
.. .....++.++.+||.+||++||.+||++ +|+++||||...
T Consensus 278 ---------~~-----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 278 ---------QI-----------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp ---------CC-----------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred ---------cc-----------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 00 1113568999999999999999999995 899999999764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=394.87 Aligned_cols=253 Identities=28% Similarity=0.399 Sum_probs=207.7
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcc
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 199 (584)
...++|++.+.||+|+||.||+|+++.+|+.||||+++.... .......+..|..+|..+ +||||+++++++.+ ..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~~ 91 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KE 91 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SS
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--CC
Confidence 356789999999999999999999999999999999964311 112345677899999877 89999999988876 44
Q ss_pred eEEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
.+|+|||||.| +|...+... ..+.+ ..||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 68999999975 777776532 23433 35999999999999999999999999999999999999999986532
Q ss_pred CCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|......
T Consensus 171 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~------------ 236 (345)
T 1xjd_A 171 GD-AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF------------ 236 (345)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------------
T ss_pred CC-CcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCC------------
Confidence 22 23456789999999999987 45899999999999999999999999998888777766442111
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHH-HHhcCcCCCCC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAA-SALKNEFFFTS 406 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~-e~L~Hp~f~~~ 406 (584)
....+++++.+||.+||+.||.+||++. ++++||||...
T Consensus 237 ---------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 237 ---------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp ---------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred ---------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 0124689999999999999999999998 99999999764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=392.84 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=210.3
Q ss_pred CCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 121 ~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
....++|++++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+|+.++||||+++++++.+ ..
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~ 114 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NS 114 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SS
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CC
Confidence 3456789999999999999999999999999999999964321 11234668899999999999999999988876 44
Q ss_pred eEEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
.+|||||||. ++|...+... ..+.+ ..||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 6899999997 5777777542 23433 35999999999999999999999999999999999999999987643
Q ss_pred CCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..|......
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~------------ 256 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR------------ 256 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------------
T ss_pred C----cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence 2 245689999999999986 45899999999999999999999999998888777777553211
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC-----HHHHhcCcCCCCC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS-----AASALKNEFFFTS 406 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT-----a~e~L~Hp~f~~~ 406 (584)
....+++++.+||.+||+.||.+||+ ++|+++||||...
T Consensus 257 ---------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 257 ---------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp ---------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred ---------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 11356899999999999999999998 9999999999753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=403.82 Aligned_cols=264 Identities=25% Similarity=0.383 Sum_probs=212.9
Q ss_pred CCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 121 ~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
....++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|..++|||||++++++.+ ..
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~ 134 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD--EN 134 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC--SS
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CC
Confidence 4566789999999999999999999999999999999964211 11223457889999999999999999988876 44
Q ss_pred eEEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
.+|||||||. |+|..++......+.+ ..||+.||+|||+++|+||||||+||||+.+|.+||+|||+++.+..
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 6899999996 5788887653334443 34999999999999999999999999999999999999999987754
Q ss_pred CCCCCCccccccccccChhhhhC------CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHH
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLG------ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW 346 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~------~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 346 (584)
.........+||+.|+|||++.. ...|+.++|||||||++|||++|++||.+.+..+.+..|+.......
T Consensus 215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---- 290 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS---- 290 (412)
T ss_dssp TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC----
T ss_pred CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC----
Confidence 43322345689999999999973 24589999999999999999999999999998888877764210000
Q ss_pred HHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCC---CCHHHHhcCcCCCCCCCc
Q 043957 347 KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR---GSAASALKNEFFFTSPLA 409 (584)
Q Consensus 347 ~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kR---pTa~e~L~Hp~f~~~~~~ 409 (584)
.| .....+|+++++||.+||. ||.+| ++++|+++||||....+.
T Consensus 291 ----------~p--------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~ 337 (412)
T 2vd5_A 291 ----------LP--------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWD 337 (412)
T ss_dssp ----------CC------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred ----------CC--------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 00 0124578999999999999 99998 599999999999865443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=392.16 Aligned_cols=255 Identities=29% Similarity=0.411 Sum_probs=190.2
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..++|++++.||+|+||+||+|.+..+++.||||++...... .+.+.+|+.+++.++|||||++++++... ..+|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 92 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTP--THLA 92 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeC--CEEE
Confidence 456899999999999999999999999999999999754332 24577999999999999999999988764 4689
Q ss_pred EEEechh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCc--EEEEEeccccccCCC
Q 043957 203 LVFEFMQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGV--LKIADFGLANYFSPN 273 (584)
Q Consensus 203 lV~Ey~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~--vKL~DFGla~~~~~~ 273 (584)
+|||||. ++|...+... ..+. +..||+.||.|||++||+||||||+||||+.++. +||+|||+++.....
T Consensus 93 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 93 IIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999997 4777776532 2333 3459999999999999999999999999987765 999999999754322
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
......+||+.|+|||++.+....+.++|||||||++|+|++|++||.+......+..++..... .
T Consensus 172 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~------------~ 237 (361)
T 3uc3_A 172 --SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS------------V 237 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT------------T
T ss_pred --CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc------------C
Confidence 22345689999999999987654455599999999999999999999875543222222211100 0
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
....+ ....+++.+.+||.+||+.||.+|||+.|+|+||||...
T Consensus 238 ~~~~~---------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 238 KYSIP---------DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp CCCCC---------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred CCCCC---------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 00000 112568999999999999999999999999999999654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=387.32 Aligned_cols=251 Identities=29% Similarity=0.429 Sum_probs=189.9
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.+|++++||||+++++++... ..+|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 124 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETP--TEIS 124 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecC--CeEE
Confidence 3467999999999999999999999999999999997432 235677899999999999999999988764 4689
Q ss_pred EEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecC---CCcEEEEEeccccccCC
Q 043957 203 LVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDK---NGVLKIADFGLANYFSP 272 (584)
Q Consensus 203 lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~---~g~vKL~DFGla~~~~~ 272 (584)
+||||+. ++|.+.+... ..+.+ ..||+.||.|||+++|+||||||+||||+. ++.+||+|||++.....
T Consensus 125 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp EEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 9999998 4787777643 33433 359999999999999999999999999975 88999999999987643
Q ss_pred CCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCChHHHHHhhc
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVE-QLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
. ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||....... .+..+.........
T Consensus 204 ~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~-------- 272 (349)
T 2w4o_A 204 Q--VLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFIS-------- 272 (349)
T ss_dssp -----------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCT--------
T ss_pred c--cccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCC--------
Confidence 2 223556899999999999864 58999999999999999999999998766544 34444332111111
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
..+..++..+.+||.+||+.||.+|||+.|+|+||||...
T Consensus 273 ---------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 273 ---------------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp ---------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred ---------------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 1234678999999999999999999999999999999865
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=375.09 Aligned_cols=254 Identities=27% Similarity=0.427 Sum_probs=212.5
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.+.||+|+||.||+|.+..+|..||+|++..........+.+.+|+.++++++||||+++++++.. ....|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc--CCEEEE
Confidence 467999999999999999999999999999999998766666677888999999999999999999998875 445799
Q ss_pred EEechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCc---EEEEEeccccccCCC
Q 043957 204 VFEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGV---LKIADFGLANYFSPN 273 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~---vKL~DFGla~~~~~~ 273 (584)
||||+.+ +|...+... ..+. +..||+.||.|||+++|+||||||+||||+.++. +||+|||++......
T Consensus 83 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999985 666665432 2233 3459999999999999999999999999976655 999999999876533
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.........+.........
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------- 228 (284)
T 3kk8_A 162 E--AWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS---------- 228 (284)
T ss_dssp C--BCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----------
T ss_pred c--cccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc----------
Confidence 2 2345689999999999976 45899999999999999999999999998887777766554322221
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
..+..+++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus 229 -------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 229 -------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp -------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred -------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 1224578999999999999999999999999999999764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=388.68 Aligned_cols=250 Identities=26% Similarity=0.450 Sum_probs=209.0
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE-PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
+.|++++.||+|+||.||+|.+..+|+.||||++...... ....+.+.+|+.+|++++|||||++++++... ..+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CeEEE
Confidence 4599999999999999999999999999999999765433 34456788999999999999999999988764 46899
Q ss_pred EEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 204 VFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
|||||.|+|.+.+......+.+ ..||+.||.|||+++|+||||||+||||+.++.+||+|||++......
T Consensus 132 v~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---- 207 (348)
T 1u5q_A 132 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 207 (348)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred EEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC----
Confidence 9999999888877543344443 359999999999999999999999999999999999999999876432
Q ss_pred CccccccccccChhhhhC--CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 278 LTSRVVTLWYRAPELLLG--ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~--~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
...+||+.|+|||++.+ ...++.++|||||||++|||++|++||.+.+....+..+.......
T Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 272 (348)
T 1u5q_A 208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA-------------- 272 (348)
T ss_dssp -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------------
T ss_pred -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------------
Confidence 35679999999999863 3458999999999999999999999999888776665554321100
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.....+++.+.+||.+||+.||.+|||++++|+||||...
T Consensus 273 -----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 273 -----------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred -----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 0113568899999999999999999999999999999764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=381.84 Aligned_cols=251 Identities=22% Similarity=0.374 Sum_probs=196.5
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc------
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ------ 198 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~------ 198 (584)
++|++++.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+|++|+|||||++++++.....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 46999999999999999999999999999999997544 33356778999999999999999999998755322
Q ss_pred -------------------------------------------------ceEEEEEechhh-HHHHHhhCCCC-------
Q 043957 199 -------------------------------------------------YSLYLVFEFMQT-DLARIISNPEG------- 221 (584)
Q Consensus 199 -------------------------------------------------~~l~lV~Ey~~g-~L~~~l~~~~~------- 221 (584)
..+|+|||||.+ +|.+++.....
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 248999999985 77777764322
Q ss_pred -CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC-----------CCCccccccccccC
Q 043957 222 -KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK-----------RPLTSRVVTLWYRA 289 (584)
Q Consensus 222 -~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-----------~~~~~~~gt~~Y~A 289 (584)
.+.+..||+.||.|||++||+||||||+||||+.++.+||+|||++........ ......+||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 123456999999999999999999999999999999999999999987754321 12345679999999
Q ss_pred hhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhc
Q 043957 290 PELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAF 369 (584)
Q Consensus 290 PEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 369 (584)
||++.+. .++.++|||||||++|+|++|..|+.. ....+......... ..+
T Consensus 245 PE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~-----------------------~~~ 295 (332)
T 3qd2_B 245 PEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFP-----------------------LLF 295 (332)
T ss_dssp HHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCC-----------------------HHH
T ss_pred hHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCC-----------------------ccc
Confidence 9999874 589999999999999999998766521 11111111111111 112
Q ss_pred cCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 370 SEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 370 ~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
...++.+.+||.+||+.||.+|||++|+|+||||.+
T Consensus 296 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 296 TQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred ccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 334678899999999999999999999999999974
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=392.48 Aligned_cols=272 Identities=28% Similarity=0.402 Sum_probs=215.5
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC--------CCCeeeeeceeeec
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD--------HPNIVKLEGLATSR 196 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~--------HpnIv~l~~~~~~~ 196 (584)
++|++++.||+|+||.||+|.+..+++.||||++.. .....+.+.+|+.+|+.+. |+||+++++++...
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 579999999999999999999999999999999963 2445667889999999985 78899999987642
Q ss_pred --CcceEEEEEechhhHHHHHhhCCC-CCCcH------HHHHHHHHHHHHhC-CceeccccccceeecCCC---------
Q 043957 197 --MQYSLYLVFEFMQTDLARIISNPE-GKLTE------PQQLLSGLQHCHDR-GILHRDVKGSNLLIDKNG--------- 257 (584)
Q Consensus 197 --~~~~l~lV~Ey~~g~L~~~l~~~~-~~l~~------~~qIl~aL~yLH~~-~IvHrDLKp~NILl~~~g--------- 257 (584)
....+||||||+.++|...+.... ..+.+ +.||+.||.|||++ ||+||||||+||||+.++
T Consensus 114 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 114 GVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp ETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred CCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence 345789999999988877765432 33443 35999999999998 999999999999998775
Q ss_pred ----------------------------------------cEEEEEeccccccCCCCCCCCccccccccccChhhhhCCC
Q 043957 258 ----------------------------------------VLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGAT 297 (584)
Q Consensus 258 ----------------------------------------~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~ 297 (584)
.+||+|||++...... ....+||+.|+|||++.+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~- 268 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGS- 268 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTS-
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCC-
Confidence 7999999999876432 3556899999999999874
Q ss_pred CCCceeeEecchHHHHHHHhCCCCCCCCC------hHHHHHHHHHhcCCCChHHHHHhhccCCCCCCC-------CC-Cc
Q 043957 298 DYGVGIDLWSAGCLLAEMFLGRPIMPGRT------EVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQ-------SY-KP 363 (584)
Q Consensus 298 ~~~~~sDIwSLGvilyeLltG~~pF~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~-------~~-~~ 363 (584)
.++.++|||||||++|+|++|++||.+.+ ..+.+..+....+.++...+........+.... .. ..
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 59999999999999999999999998765 567788888888888877664433221111000 00 00
Q ss_pred hhh-------hhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCC
Q 043957 364 RLF-------EAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404 (584)
Q Consensus 364 ~~~-------~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~ 404 (584)
... ......++.+.+||.+||+.||.+|||++|+|+||||+
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 000 01123456789999999999999999999999999996
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=392.08 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=208.4
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcce
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~ 200 (584)
..++|++++.||+|+||.||+|.++.+|+.||||++..... .......+.+|..+|..+ +||||+++++++.. ...
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~ 95 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR 95 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC--SSE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc--CCE
Confidence 45679999999999999999999999999999999964321 112345678899999988 79999999988876 446
Q ss_pred EEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+|||||||.| +|...+... ..+.+ ..||+.||.|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 8999999985 777776532 23443 359999999999999999999999999999999999999999864322
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
. ......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..|.......
T Consensus 175 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~------------ 240 (353)
T 2i0e_A 175 G-VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY------------ 240 (353)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------------
T ss_pred C-cccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC------------
Confidence 2 23456789999999999976 458999999999999999999999999998888877776532111
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFTS 406 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~~ 406 (584)
...+++++.+||.+||+.||.+|| +++++++||||...
T Consensus 241 ---------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 241 ---------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp ---------------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred ---------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 135689999999999999999999 47999999999754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=383.93 Aligned_cols=252 Identities=27% Similarity=0.426 Sum_probs=197.8
Q ss_pred CCCCceEEeeecccCceEEEEEEEC---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDR---DTGKIVALKKVKFDTS--EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM 197 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 197 (584)
..++|++++.||+|+||.||+|.+. .+|+.||||+++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 92 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT-- 92 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc--
Confidence 3467999999999999999999885 6899999999975432 22334567889999999999999999988876
Q ss_pred cceEEEEEechh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccccc
Q 043957 198 QYSLYLVFEFMQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 198 ~~~l~lV~Ey~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~ 270 (584)
...+|||||||. ++|...+... ..+. +..||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred CCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 345899999998 4677766532 2333 3459999999999999999999999999999999999999999764
Q ss_pred CCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 271 SPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 271 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
.... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+.......
T Consensus 172 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~--------- 240 (327)
T 3a62_A 172 IHDG-TVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL--------- 240 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---------
T ss_pred ccCC-ccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC---------
Confidence 3222 22345689999999999976 458999999999999999999999999988887777775532111
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCCC
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFTS 406 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~~ 406 (584)
...+++.+.+||.+||+.||.+|| +++|+|+||||...
T Consensus 241 ------------------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 241 ------------------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp ------------------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred ------------------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 134688999999999999999999 89999999999754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=393.11 Aligned_cols=248 Identities=29% Similarity=0.421 Sum_probs=203.1
Q ss_pred eEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEec
Q 043957 128 DKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEF 207 (584)
Q Consensus 128 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey 207 (584)
...+.||+|+||.||+|.+..+|..||||+++... ....+.+.+|+.+|++|+|||||++++++... ..+||||||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~E~ 167 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESK--NDIVLVMEY 167 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEEEC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEEEEeC
Confidence 33678999999999999999999999999997532 34557788999999999999999999988764 468999999
Q ss_pred hhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceee--cCCCcEEEEEeccccccCCCCCCCC
Q 043957 208 MQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLI--DKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 208 ~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl--~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
|.+ +|.+.+......+.+ ..||+.||.|||+++|+||||||+|||| +.++.+||+|||++..+.... ..
T Consensus 168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~ 245 (373)
T 2x4f_A 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KL 245 (373)
T ss_dssp CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cc
Confidence 985 677766543333443 3599999999999999999999999999 567889999999998875433 23
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p 358 (584)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..++.....+..
T Consensus 246 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~--------------- 309 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED--------------- 309 (373)
T ss_dssp CCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS---------------
T ss_pred ccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh---------------
Confidence 45679999999999876 45899999999999999999999999999988888887765333221
Q ss_pred CCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 359 ~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
..+..+++++.+||.+||+.||.+|||+.|+|+||||..
T Consensus 310 --------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 310 --------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp --------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred --------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 223567899999999999999999999999999999965
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=379.52 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=212.2
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP----HSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
++|++.+.||+|+||.||+|.+..+|+.||||++....... ...+.+.+|+.+|++++||||+++++++.. ...
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 89 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN--RTD 89 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCE
Confidence 46999999999999999999999999999999997653322 135678899999999999999999998876 446
Q ss_pred EEEEEechh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCC----cEEEEEeccccc
Q 043957 201 LYLVFEFMQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG----VLKIADFGLANY 269 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g----~vKL~DFGla~~ 269 (584)
+|+||||+. ++|.+++... ..++ +..||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 899999997 5788877643 3333 345999999999999999999999999999887 799999999987
Q ss_pred cCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 270 FSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 270 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......+...
T Consensus 169 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~----- 240 (321)
T 2a2a_A 169 IEDGV--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE----- 240 (321)
T ss_dssp CCTTC--CCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH-----
T ss_pred cCccc--cccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChh-----
Confidence 65432 2355679999999999976 458999999999999999999999999988888777776544333322
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.+..+++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus 241 ------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 241 ------------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp ------------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred ------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 234678999999999999999999999999999999753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=390.28 Aligned_cols=257 Identities=28% Similarity=0.424 Sum_probs=205.6
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC---CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT---SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~---~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
++|++.+.||+|+||.||+|.+..++..||||++.... ......+.+.+|+.+|++++|||||++++++.. ...+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~ 103 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED--EQYI 103 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc--CCeE
Confidence 46999999999999999999999999999999986431 233456778999999999999999999998876 4468
Q ss_pred EEEEechh-hHHHHHhhCC---------------------------------------C------CCCcHHHHHHHHHHH
Q 043957 202 YLVFEFMQ-TDLARIISNP---------------------------------------E------GKLTEPQQLLSGLQH 235 (584)
Q Consensus 202 ~lV~Ey~~-g~L~~~l~~~---------------------------------------~------~~l~~~~qIl~aL~y 235 (584)
|+|||||. ++|.+.+... . ....+..||+.||.|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 99999997 5677766310 0 011234599999999
Q ss_pred HHhCCceeccccccceeecCCC--cEEEEEeccccccCCCC---CCCCccccccccccChhhhhCC-CCCCceeeEecch
Q 043957 236 CHDRGILHRDVKGSNLLIDKNG--VLKIADFGLANYFSPNK---KRPLTSRVVTLWYRAPELLLGA-TDYGVGIDLWSAG 309 (584)
Q Consensus 236 LH~~~IvHrDLKp~NILl~~~g--~vKL~DFGla~~~~~~~---~~~~~~~~gt~~Y~APEvl~~~-~~~~~~sDIwSLG 309 (584)
||+++|+||||||+||||+.++ .+||+|||++..+.... ........||+.|+|||++.+. ..++.++||||||
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 9999999999999999998776 89999999998653221 1223566899999999999752 4689999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCC
Q 043957 310 CLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPA 389 (584)
Q Consensus 310 vilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~ 389 (584)
|++|+|++|++||.+.+..+.+..+......+.. ..+..+++.+.+||.+||+.||.
T Consensus 264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN-----------------------PNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS-----------------------GGGGGSCHHHHHHHHHHSCSCTT
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC-----------------------cccccCCHHHHHHHHHHcCCChh
Confidence 9999999999999999988887777654322221 12245789999999999999999
Q ss_pred CCCCHHHHhcCcCCCCC
Q 043957 390 YRGSAASALKNEFFFTS 406 (584)
Q Consensus 390 kRpTa~e~L~Hp~f~~~ 406 (584)
+|||+.|+|+||||...
T Consensus 321 ~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 321 ERFDAMRALQHPWISQF 337 (345)
T ss_dssp TSCCHHHHHHSHHHHTT
T ss_pred HCCCHHHHhcChhhccC
Confidence 99999999999999764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=392.92 Aligned_cols=253 Identities=25% Similarity=0.386 Sum_probs=204.5
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
...++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|+.++|||||++++++.+. ..
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~ 89 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE--ED 89 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CE
Confidence 34567999999999999999999999999999999996432 1122356788999999999999999999888764 46
Q ss_pred EEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+|+|||||.| +|...+.. ...+.+ +.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+...
T Consensus 90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 8999999975 67777764 334443 359999999999999999999999999999999999999999876533
Q ss_pred CCCCCccccccccccChhhhhCC--CCCCceeeEecchHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCChHHHHH
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGA--TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE---VEQLHRIFKLCGSPSEDYWKK 348 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~--~~~~~~sDIwSLGvilyeLltG~~pF~~~~~---~~~~~~i~~~~~~~~~~~~~~ 348 (584)
......+||+.|+|||++.+. ..|+.++|||||||++|+|++|++||..... ...+..+.....
T Consensus 169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------- 237 (384)
T 4fr4_A 169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV--------- 237 (384)
T ss_dssp --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC---------
T ss_pred --CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc---------
Confidence 234677899999999998642 3589999999999999999999999975433 222222211100
Q ss_pred hhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC-HHHHhcCcCCCCC
Q 043957 349 LRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS-AASALKNEFFFTS 406 (584)
Q Consensus 349 ~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT-a~e~L~Hp~f~~~ 406 (584)
.....+++.+.+||.+||+.||.+||+ ++++++||||...
T Consensus 238 ------------------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 238 ------------------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp ------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred ------------------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 111356899999999999999999998 8999999999754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=402.49 Aligned_cols=252 Identities=27% Similarity=0.385 Sum_probs=199.2
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
..++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++... ..+
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~ 223 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRL 223 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET--TEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC--CEE
Confidence 4567999999999999999999999999999999996432 1223445677899999999999999999988764 468
Q ss_pred EEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHh-CCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 202 YLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHD-RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~-~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
|||||||.+ +|...+... ..+.+ ..||+.||+|||+ +||+||||||+||||+.++.+||+|||+|+.....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp EEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 999999985 666666432 23333 3599999999998 99999999999999999999999999999864332
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
.......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+....+..+......
T Consensus 303 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~------------- 367 (446)
T 4ejn_A 303 -GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR------------- 367 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------------
T ss_pred -CcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-------------
Confidence 223456789999999999976 45999999999999999999999999998887777666542211
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFTS 406 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~~ 406 (584)
....+++++.+||.+||++||.+|| |++|+|+||||...
T Consensus 368 --------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 368 --------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred --------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 1134688999999999999999999 99999999999764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=377.02 Aligned_cols=251 Identities=26% Similarity=0.447 Sum_probs=207.2
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
.|+..+.||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.+|+.++||||+++++++... ..+|+||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 121 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVG--EELWVLM 121 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEEE
Confidence 488899999999999999999999999999999754333 346688999999999999999999988774 4589999
Q ss_pred echhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 206 EFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 206 Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
||+.+ +|.+++.. ..+.+ ..||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... ...
T Consensus 122 e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 198 (321)
T 2c30_A 122 EFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR 198 (321)
T ss_dssp CCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCB
T ss_pred ecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-ccc
Confidence 99985 67666653 23433 3599999999999999999999999999999999999999998765432 223
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p 358 (584)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|++||........+..+.......
T Consensus 199 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 260 (321)
T 2c30_A 199 KSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK----------------- 260 (321)
T ss_dssp CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-----------------
T ss_pred ccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----------------
Confidence 55689999999999976 458999999999999999999999999888776665554321100
Q ss_pred CCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q 043957 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPL 408 (584)
Q Consensus 359 ~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~ 408 (584)
......+++.+.+||.+||+.||.+|||+.|+|+||||.+...
T Consensus 261 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 303 (321)
T 2c30_A 261 -------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGL 303 (321)
T ss_dssp -------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCC
T ss_pred -------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCC
Confidence 0112356889999999999999999999999999999986543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=387.73 Aligned_cols=271 Identities=29% Similarity=0.507 Sum_probs=214.1
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CC-----CeeeeeceeeecC
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HP-----NIVKLEGLATSRM 197 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-Hp-----nIv~l~~~~~~~~ 197 (584)
.++|++.+.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+++.+. |+ +|+.+++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~- 128 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR- 128 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET-
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC-
Confidence 4679999999999999999999999999999999963 2344566778999998885 55 489998888764
Q ss_pred cceEEEEEechhhHHHHHhhCCC-CCCcH------HHHHHHHHHHHH--hCCceeccccccceeec--CCCcEEEEEecc
Q 043957 198 QYSLYLVFEFMQTDLARIISNPE-GKLTE------PQQLLSGLQHCH--DRGILHRDVKGSNLLID--KNGVLKIADFGL 266 (584)
Q Consensus 198 ~~~l~lV~Ey~~g~L~~~l~~~~-~~l~~------~~qIl~aL~yLH--~~~IvHrDLKp~NILl~--~~g~vKL~DFGl 266 (584)
..+||||||+.++|.+.+.... ..+.+ +.||+.||.||| +.+|+||||||+||||+ .++.+||+|||+
T Consensus 129 -~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 129 -NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp -TEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred -CceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 4689999999999988886533 22333 359999999999 57999999999999994 477899999999
Q ss_pred ccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHH
Q 043957 267 ANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW 346 (584)
Q Consensus 267 a~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 346 (584)
++..... ....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+++..+....+.++...+
T Consensus 208 a~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 208 SCQLGQR----IYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ceecccc----cccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9876432 3456899999999999874 5999999999999999999999999999999999999999888887665
Q ss_pred HHhhcc-----C----------------CCCCCCCCCchhhhhcc------------------CCcHhHHHHHHHhcccC
Q 043957 347 KKLRLS-----T----------------TFRPPQSYKPRLFEAFS------------------EFPESSLGLLSTLLALD 387 (584)
Q Consensus 347 ~~~~~~-----~----------------~~~~p~~~~~~~~~~~~------------------~~s~~~~dLI~~~L~~D 387 (584)
...... . .+..+. ...+...+. ...+.+++||.+||++|
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 360 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPG--TRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD 360 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTT--CSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcc--hhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence 432100 0 000000 001111110 01147899999999999
Q ss_pred CCCCCCHHHHhcCcCCCCC
Q 043957 388 PAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 388 P~kRpTa~e~L~Hp~f~~~ 406 (584)
|++|||++|+|+||||+..
T Consensus 361 P~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 361 PKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TTTSCCHHHHTTSGGGCC-
T ss_pred hhhCCCHHHHhcCcccccC
Confidence 9999999999999999763
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=379.82 Aligned_cols=274 Identities=29% Similarity=0.510 Sum_probs=210.9
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l~ 202 (584)
.++|++++.||+|+||.||+|.+..+++.||||++... ..+.+.+|+.+|+.+. ||||+++++++........+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 46799999999999999999999999999999998632 2356889999999997 99999999999876666789
Q ss_pred EEEechhh-HHHHHhhCCC--CCCcHHHHHHHHHHHHHhCCceeccccccceeecCCC-cEEEEEeccccccCCCCCCCC
Q 043957 203 LVFEFMQT-DLARIISNPE--GKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG-VLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~--~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g-~vKL~DFGla~~~~~~~~~~~ 278 (584)
+||||+.+ +|...+.... ....+..||+.||.|||++||+||||||+||||+.++ .+||+|||++..+.... ..
T Consensus 110 lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~ 187 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EY 187 (330)
T ss_dssp EEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC--CC
T ss_pred EEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC--cc
Confidence 99999985 5655553211 1122345999999999999999999999999999776 89999999998765433 23
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCC-CCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIM-PGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 357 (584)
...++|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+....+.+..+....+.+....+ +........
T Consensus 188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~~~~~~~ 265 (330)
T 3nsz_A 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY--IDKYNIELD 265 (330)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH--HHHTTCCCC
T ss_pred ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhH--HHHhccccc
Confidence 55688999999999987567999999999999999999999888 455666777766665553322111 110000000
Q ss_pred -----------CCCCCch-hhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 358 -----------PQSYKPR-LFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 358 -----------p~~~~~~-~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
...+... .......+++++.+||.+||++||.+|||++|+|+||||+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 0000000 011123478999999999999999999999999999999863
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=373.65 Aligned_cols=254 Identities=24% Similarity=0.397 Sum_probs=191.2
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..++|++++.||+|+||.||+|.+..+|+.||||++............+.++..+++.++||||+++++++... ...|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--~~~~ 82 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE--GDVW 82 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SSEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc--CCEE
Confidence 45689999999999999999999999999999999976544444455555666668889999999999988764 3579
Q ss_pred EEEechhhHHHHHhhC---CCCCCcH------HHHHHHHHHHHHhC-CceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 203 LVFEFMQTDLARIISN---PEGKLTE------PQQLLSGLQHCHDR-GILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~---~~~~l~~------~~qIl~aL~yLH~~-~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
+||||+.++|...+.. ....+++ ..||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 83 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred EEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9999999887665542 2334443 45999999999998 999999999999999999999999999987654
Q ss_pred CCCCCCccccccccccChhhh---hCCCCCCceeeEecchHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCChHHHHH
Q 043957 273 NKKRPLTSRVVTLWYRAPELL---LGATDYGVGIDLWSAGCLLAEMFLGRPIMPGR-TEVEQLHRIFKLCGSPSEDYWKK 348 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl---~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~-~~~~~~~~i~~~~~~~~~~~~~~ 348 (584)
... .....||+.|+|||++ .....++.++|||||||++|+|++|+.||... .....+..+.......
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 233 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ------- 233 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC-------
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC-------
Confidence 322 2445789999999997 23456899999999999999999999999863 3334333332211000
Q ss_pred hhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 349 LRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 349 ~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
.....+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 234 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 234 ------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp ------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 011356889999999999999999999999999999974
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=402.83 Aligned_cols=252 Identities=29% Similarity=0.434 Sum_probs=210.8
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
..++|.+.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+|+.++||||+++++++... ..+
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~ 91 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP--SDI 91 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEE
Confidence 34679999999999999999999999999999999964321 112346788999999999999999999988764 468
Q ss_pred EEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 202 YLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 202 ~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
|||||||. ++|.+.+.. ...+++ ..||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 92 ~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~- 169 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 169 (476)
T ss_dssp EEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence 99999997 578777764 334443 359999999999999999999999999999999999999999886543
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+.......
T Consensus 170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------- 235 (476)
T 2y94_A 170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYT------------- 235 (476)
T ss_dssp -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCC-------------
T ss_pred -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCC-------------
Confidence 234567899999999999875545789999999999999999999999988777776665432111
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
...+++++.+||.+||+.||.+|||++|+|+||||...
T Consensus 236 --------------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 236 --------------PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp --------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred --------------CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 13468899999999999999999999999999999764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=369.88 Aligned_cols=249 Identities=30% Similarity=0.477 Sum_probs=210.2
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++.+.||+|+||.||+|.+..++..||+|++...... ..+.+.+|+.++++++||||+++++++.. ...+|+|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 84 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFED--NTDIYLV 84 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeEEEE
Confidence 4699999999999999999999999999999999754332 35678899999999999999999998876 4468999
Q ss_pred Eechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceee---cCCCcEEEEEeccccccCCCC
Q 043957 205 FEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl---~~~g~vKL~DFGla~~~~~~~ 274 (584)
|||+.+ +|.+.+... ..+. +..||+.||.|||+++|+||||||+|||+ +.++.+||+|||++..+....
T Consensus 85 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 85 MELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred EeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 999975 676666532 2233 34599999999999999999999999999 778899999999998765432
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
......||+.|+|||++.+ .++.++|||||||++|+|++|++||......+....+......++...|
T Consensus 164 --~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 231 (277)
T 3f3z_A 164 --MMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW-------- 231 (277)
T ss_dssp --CBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH--------
T ss_pred --chhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh--------
Confidence 3355689999999999865 3899999999999999999999999999888888777665544444333
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
..+++.+.+||.+||+.||.+|||+.|+|+||||..
T Consensus 232 ---------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 232 ---------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp ---------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred ---------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 356899999999999999999999999999999965
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=371.92 Aligned_cols=258 Identities=28% Similarity=0.469 Sum_probs=212.7
Q ss_pred CCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 121 ~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
|...++|++++.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.++++++||||+++++++.......
T Consensus 2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 55677899999999999999999999999999999999876666667788999999999999999999999887766678
Q ss_pred EEEEEechhh-HHHHHhhCC---CCCCc------HHHHHHHHHHHHHhCC-----ceeccccccceeecCCCcEEEEEec
Q 043957 201 LYLVFEFMQT-DLARIISNP---EGKLT------EPQQLLSGLQHCHDRG-----ILHRDVKGSNLLIDKNGVLKIADFG 265 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~---~~~l~------~~~qIl~aL~yLH~~~-----IvHrDLKp~NILl~~~g~vKL~DFG 265 (584)
+|+||||+.+ +|.+.+... ...++ +..||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999985 787776531 11233 3459999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHH
Q 043957 266 LANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDY 345 (584)
Q Consensus 266 la~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~ 345 (584)
++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+..+....+......
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~----- 234 (279)
T 2w5a_A 162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR----- 234 (279)
T ss_dssp HHHHC---C-HHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----
T ss_pred hheeecccc-ccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc-----
Confidence 998764322 112345789999999999864 5899999999999999999999999988776666555432110
Q ss_pred HHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 346 WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 346 ~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.....+++.+.+||.+||+.||.+|||+.|+|+|+|+...
T Consensus 235 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 235 ---------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ---------------------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 0113568899999999999999999999999999999764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=390.81 Aligned_cols=252 Identities=24% Similarity=0.344 Sum_probs=200.2
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHH-HHhCCCCCeeeeeceeeecCcce
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMI-LQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~i-L~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
..++|++++.||+|+||.||+|+++.+++.||||++..... .......+.+|..+ ++.++|||||++++++.. ...
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~--~~~ 113 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADK 113 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC--SSE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe--CCE
Confidence 34679999999999999999999999999999999975432 22334556677776 567899999999988876 446
Q ss_pred EEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+|||||||.| +|...+... ..+.+ ..||+.||+|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 8999999985 677766532 23333 359999999999999999999999999999999999999999864322
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
. ......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..|+.....
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~------------- 257 (373)
T 2r5t_A 193 N-STTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ------------- 257 (373)
T ss_dssp C-CCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC-------------
T ss_pred C-CccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC-------------
Confidence 2 23456789999999999986 45999999999999999999999999999888887777553111
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCH----HHHhcCcCCCCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSA----ASALKNEFFFTS 406 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa----~e~L~Hp~f~~~ 406 (584)
....++..+.+||.+||+.||.+||++ +++++||||...
T Consensus 258 --------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 258 --------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp --------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred --------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 113578999999999999999999997 699999999764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=373.18 Aligned_cols=250 Identities=27% Similarity=0.417 Sum_probs=198.4
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|.+.+.||+|+||.||+|.+..++..||+|++..... ....+.+.+|+.+|++++||||+++++++.. ...+|+|
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv 98 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFED--YHNMYIV 98 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheec--CCeEEEE
Confidence 469999999999999999999999999999999975432 2235678899999999999999999998876 4468999
Q ss_pred Eechhh-HHHHHhhCC---CCCCc------HHHHHHHHHHHHHhCCceeccccccceee---cCCCcEEEEEeccccccC
Q 043957 205 FEFMQT-DLARIISNP---EGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFS 271 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~---~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl---~~~g~vKL~DFGla~~~~ 271 (584)
||||.+ +|.+.+... ...+. ++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+.
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999985 677666321 12333 34599999999999999999999999999 446789999999998765
Q ss_pred CCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 272 PNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 272 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+........
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------- 245 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA--------- 245 (285)
T ss_dssp ----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------
T ss_pred Ccc--cCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc---------
Confidence 332 2355678999999999864 589999999999999999999999998876665544432211110
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
.....+++.+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 246 ---------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 246 ---------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ---------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ---------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 112346889999999999999999999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=386.68 Aligned_cols=248 Identities=28% Similarity=0.419 Sum_probs=199.6
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~ 202 (584)
.++|++.+.||+|+||.||+|.++.+|+.||||++...... ..+|+++|.++ +|||||++++++.+ ...+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~ 92 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDD--GKYVY 92 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEE
Confidence 34699999999999999999999999999999999754322 34688888888 79999999998876 45689
Q ss_pred EEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCC----CcEEEEEeccccccC
Q 043957 203 LVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKN----GVLKIADFGLANYFS 271 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~----g~vKL~DFGla~~~~ 271 (584)
+|||||.| +|.+.+... ..+.+ ..||+.||.|||++||+||||||+|||+..+ +.+||+|||++..+.
T Consensus 93 lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999984 788777643 33443 3599999999999999999999999998443 359999999998765
Q ss_pred CCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCC---ChHHHHHHHHHhcCCCChHHHHH
Q 043957 272 PNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGR---TEVEQLHRIFKLCGSPSEDYWKK 348 (584)
Q Consensus 272 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~---~~~~~~~~i~~~~~~~~~~~~~~ 348 (584)
... ......+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+. +..+.+..+......+..
T Consensus 172 ~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~----- 244 (342)
T 2qr7_A 172 AEN-GLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG----- 244 (342)
T ss_dssp CTT-CCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCS-----
T ss_pred CCC-CceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCc-----
Confidence 332 234567899999999999763 4899999999999999999999999863 344444444432222111
Q ss_pred hhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 349 LRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 349 ~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
..+..+++++.+||.+||+.||.+|||+.|+|+||||..
T Consensus 245 ------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 245 ------------------GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp ------------------TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 123467899999999999999999999999999999965
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=380.54 Aligned_cols=252 Identities=30% Similarity=0.483 Sum_probs=209.5
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC--h----HHHHHHHHHHHHHHhC-CCCCeeeeeceeeecC
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE--P----HSVKFMAREIMILQKL-DHPNIVKLEGLATSRM 197 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~----~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 197 (584)
++|++.+.||+|+||.||+|.+..+|+.||||++...... . ...+.+.+|+.+++++ +||||+++++++..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 171 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-- 171 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence 4699999999999999999999999999999999754321 1 2245678999999999 79999999998876
Q ss_pred cceEEEEEechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccccc
Q 043957 198 QYSLYLVFEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 198 ~~~l~lV~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~ 270 (584)
...+|+|||||.+ +|.+.+... ..+. +..||+.||.|||+.||+||||||+||||+.++.+||+|||++..+
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 4468999999986 677776532 2233 3459999999999999999999999999999999999999999877
Q ss_pred CCCCCCCCccccccccccChhhhhCC-----CCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHH
Q 043957 271 SPNKKRPLTSRVVTLWYRAPELLLGA-----TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDY 345 (584)
Q Consensus 271 ~~~~~~~~~~~~gt~~Y~APEvl~~~-----~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~ 345 (584)
.... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||........+..+......+....
T Consensus 251 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 328 (365)
T 2y7j_A 251 EPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE 328 (365)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred CCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 5432 24567899999999998632 3478899999999999999999999999888777777765544333322
Q ss_pred HHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCC
Q 043957 346 WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404 (584)
Q Consensus 346 ~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~ 404 (584)
+..++..+.+||.+||+.||.+|||++|+|+||||.
T Consensus 329 -----------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 329 -----------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp -----------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred -----------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 245688999999999999999999999999999996
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=391.51 Aligned_cols=250 Identities=26% Similarity=0.360 Sum_probs=192.7
Q ss_pred CCCceEE-eeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHH-hCCCCCeeeeeceeee--cCcc
Q 043957 124 AESYDKI-DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQ-KLDHPNIVKLEGLATS--RMQY 199 (584)
Q Consensus 124 ~~~Y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~-~L~HpnIv~l~~~~~~--~~~~ 199 (584)
.++|.+. +.||+|+||+||+|.+..+|+.||||++... ..+.+|+.++. .++||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 4568887 7899999999999999999999999999621 34668888874 4589999999998764 3345
Q ss_pred eEEEEEechh-hHHHHHhhCCC-CCCcH------HHHHHHHHHHHHhCCceeccccccceeecC---CCcEEEEEecccc
Q 043957 200 SLYLVFEFMQ-TDLARIISNPE-GKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDK---NGVLKIADFGLAN 268 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~-~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~---~g~vKL~DFGla~ 268 (584)
.+|||||||. |+|.+.+.... ..+.+ ..||+.||.|||+++|+||||||+||||+. ++.+||+|||+++
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 7899999998 48888887543 23443 359999999999999999999999999987 7899999999998
Q ss_pred ccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHH----HHHHHHHhcCCCChH
Q 043957 269 YFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVE----QLHRIFKLCGSPSED 344 (584)
Q Consensus 269 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~----~~~~i~~~~~~~~~~ 344 (584)
..... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|++||.+..... ....+......+.
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~-- 287 (400)
T 1nxk_A 213 ETTSH--NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP-- 287 (400)
T ss_dssp ECC-------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC--
T ss_pred ccCCC--CccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC--
Confidence 76432 23456789999999999876 469999999999999999999999998765322 1222221111111
Q ss_pred HHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 345 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
. ..+..+++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 288 --------------~-------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 288 --------------N-------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp --------------T-------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred --------------C-------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 0 1234678999999999999999999999999999999764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=381.57 Aligned_cols=248 Identities=31% Similarity=0.492 Sum_probs=181.6
Q ss_pred CceEE---eeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceE
Q 043957 126 SYDKI---DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 126 ~Y~~~---~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l 201 (584)
+|++. +.||+|+||.||+|.+..+++.||||++... ....+.+|+.+|+.+. |||||++++++.+ ...+
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~~ 81 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHD--QLHT 81 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCEE
Confidence 46665 7899999999999999999999999999632 3456778999999997 9999999998876 4468
Q ss_pred EEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCC---cEEEEEeccccccC
Q 043957 202 YLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG---VLKIADFGLANYFS 271 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g---~vKL~DFGla~~~~ 271 (584)
|||||||.+ +|.+.+... ..+.+ ..||+.||.|||+++|+||||||+||||+.++ .+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp EEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 999999985 787777643 33433 45999999999999999999999999997765 89999999998765
Q ss_pred CCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCCh-------HHHHHHHHHhcCCCChH
Q 043957 272 PNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE-------VEQLHRIFKLCGSPSED 344 (584)
Q Consensus 272 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~-------~~~~~~i~~~~~~~~~~ 344 (584)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+... .+.+..+......+...
T Consensus 161 ~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (325)
T 3kn6_A 161 PDN-QPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238 (325)
T ss_dssp C------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred CCC-CcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence 332 33456688999999999976 4599999999999999999999999987543 23333333322222222
Q ss_pred HHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 345 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.+..+++++.+||.+||+.||.+|||++|+|+||||...
T Consensus 239 -----------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 239 -----------------------AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp -----------------------HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred -----------------------cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 234678999999999999999999999999999999865
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=379.31 Aligned_cols=255 Identities=26% Similarity=0.414 Sum_probs=199.2
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCC--CCeeeeeceeeecCcc
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH--PNIVKLEGLATSRMQY 199 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~~~~~~~~~~ 199 (584)
...++|++++.||+|+||.||+|.+. ++..||||++..........+.+.+|+.+|+.+.| |||+++++++.. ..
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~ 82 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQ 82 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SS
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee--CC
Confidence 34567999999999999999999874 68999999998776677777889999999999986 999999998876 44
Q ss_pred eEEEEEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 200 SLYLVFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 200 ~l~lV~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
.+||||||+.++|.+++... ..+. +..||+.||.|||+++|+||||||+||||+ ++.+||+|||+++.+...
T Consensus 83 ~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 83 YIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEEEECCCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 68999998888998888653 2333 345999999999999999999999999996 678999999999876543
Q ss_pred CCC-CCccccccccccChhhhhC----------CCCCCceeeEecchHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCC
Q 043957 274 KKR-PLTSRVVTLWYRAPELLLG----------ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEV-EQLHRIFKLCGSP 341 (584)
Q Consensus 274 ~~~-~~~~~~gt~~Y~APEvl~~----------~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~-~~~~~i~~~~~~~ 341 (584)
... .....+||+.|+|||++.+ ...++.++|||||||++|+|++|++||...... ..+..++....
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-- 238 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH-- 238 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS--
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc--
Confidence 321 2345689999999999864 245899999999999999999999999765432 22222221100
Q ss_pred ChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 342 SEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 342 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
. .......+..+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 239 ------------~-----------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 239 ------------E-----------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp ------------C-----------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ------------c-----------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 0 01112346789999999999999999999999999999754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=386.42 Aligned_cols=252 Identities=26% Similarity=0.413 Sum_probs=199.5
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC--CCCeeeeeceeeecCcceEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD--HPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~~~~~~l~ 202 (584)
.+|++++.||+|+||.||+|.+.. ++.||||++..........+.+.+|+.+|++|. |||||++++++... ..+|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~--~~~~ 132 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYIY 132 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC--CEEE
Confidence 459999999999999999998765 899999999877666677788999999999996 59999999988764 3589
Q ss_pred EEEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 203 LVFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
||||++.++|.+++.... .+. +..||+.||.|||+++|+||||||+||||+ ++.+||+|||+++.+......
T Consensus 133 lv~E~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 133 MVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EEEECCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred EEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 999987788988876432 333 345999999999999999999999999995 589999999999877543321
Q ss_pred -CCccccccccccChhhhhCC----------CCCCceeeEecchHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCChH
Q 043957 277 -PLTSRVVTLWYRAPELLLGA----------TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEV-EQLHRIFKLCGSPSED 344 (584)
Q Consensus 277 -~~~~~~gt~~Y~APEvl~~~----------~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~-~~~~~i~~~~~~~~~~ 344 (584)
.....+||+.|+|||++.+. ..++.++||||||||+|+|++|++||...... ..+..++......
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~--- 287 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI--- 287 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC---
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC---
Confidence 23456899999999999752 35899999999999999999999999875432 3333332211000
Q ss_pred HHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 345 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
......+..+.+||.+||+.||.+|||+.|+|+||||...
T Consensus 288 ----------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 288 ----------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp ----------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ----------------------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 0112346789999999999999999999999999999754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=367.15 Aligned_cols=253 Identities=25% Similarity=0.290 Sum_probs=205.8
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec--CcceE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR--MQYSL 201 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~l 201 (584)
...|++.+.||+|+||.||+|.+..++..||+|++..........+.+.+|+.+|+.++||||+++++++... ....+
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 3458999999999999999999999999999999987666666778899999999999999999999987653 34568
Q ss_pred EEEEechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCC--ceeccccccceeec-CCCcEEEEEeccccccC
Q 043957 202 YLVFEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRG--ILHRDVKGSNLLID-KNGVLKIADFGLANYFS 271 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~--IvHrDLKp~NILl~-~~g~vKL~DFGla~~~~ 271 (584)
|+||||+.+ +|.+.+... ..+. +..||+.||.|||+++ |+||||||+||||+ .++.+||+|||++....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 999999975 777777532 2232 3459999999999999 99999999999997 78999999999997654
Q ss_pred CCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 272 PNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 272 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||............+.....+
T Consensus 184 ~~---~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 248 (290)
T 1t4h_A 184 AS---FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP---------- 248 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC----------
T ss_pred cc---ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc----------
Confidence 32 2345679999999998864 48999999999999999999999998866554443322211100
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
......+++.+.+||.+||+.||.+|||++|+|+||||++.
T Consensus 249 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 249 --------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp --------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred --------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 01223457889999999999999999999999999999753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=374.72 Aligned_cols=255 Identities=26% Similarity=0.354 Sum_probs=194.9
Q ss_pred CCCceEE-eeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceE
Q 043957 124 AESYDKI-DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 124 ~~~Y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l 201 (584)
.+.|++. +.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+|.++ +||||+++++++... ..+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~--~~~ 86 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEE--DRF 86 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CEE
Confidence 3468885 789999999999999999999999999975432 2356788999999995 799999999998764 468
Q ss_pred EEEEechh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCc---EEEEEeccccccC
Q 043957 202 YLVFEFMQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGV---LKIADFGLANYFS 271 (584)
Q Consensus 202 ~lV~Ey~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~---vKL~DFGla~~~~ 271 (584)
|+|||||. ++|.+.+... ..+. +..||+.||+|||+++|+||||||+||||+.++. +||+|||++..+.
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999998 5777777532 2333 3459999999999999999999999999988765 9999999997654
Q ss_pred CCC------CCCCccccccccccChhhhhCC----CCCCceeeEecchHHHHHHHhCCCCCCCCCh--------------
Q 043957 272 PNK------KRPLTSRVVTLWYRAPELLLGA----TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE-------------- 327 (584)
Q Consensus 272 ~~~------~~~~~~~~gt~~Y~APEvl~~~----~~~~~~sDIwSLGvilyeLltG~~pF~~~~~-------------- 327 (584)
... .......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+...
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 221 1122345799999999998641 2478899999999999999999999987642
Q ss_pred -HHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 328 -VEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 328 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
...+..+......++. ..+..+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 246 ~~~~~~~i~~~~~~~~~-----------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPD-----------------------KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHHCCCCCCH-----------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHHHHHhccCcccCc-----------------------hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 1222233222211111 1234678999999999999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=368.63 Aligned_cols=250 Identities=30% Similarity=0.444 Sum_probs=203.3
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE-PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
..++|++.+.||+|+||.||+|.+..++..||||++...... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 84 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRV 84 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC--CEE
Confidence 456799999999999999999999999999999998543211 12245688999999999999999999988764 468
Q ss_pred EEEEechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 202 YLVFEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
|+||||+.+ +|...+... ..+. +..||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 85 ~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 999999984 676666532 2233 34599999999999999999999999999999999999999987654322
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+....+.......
T Consensus 164 ---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 226 (279)
T 3fdn_A 164 ---RTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF------------- 226 (279)
T ss_dssp -------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC-------------
T ss_pred ---ccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCC-------------
Confidence 245678999999999976 458999999999999999999999999888777766664432111
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
...+++.+.+||.+||+.||.+|||+.|+|+||||...
T Consensus 227 --------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 227 --------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp --------------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred --------------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 13467889999999999999999999999999999754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=373.83 Aligned_cols=272 Identities=26% Similarity=0.428 Sum_probs=216.2
Q ss_pred CCCceEEeeecccCceEEEEEEE-CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCC------Ceeeeeceeeec
Q 043957 124 AESYDKIDKVGQGTYSNVYKALD-RDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP------NIVKLEGLATSR 196 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~-~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hp------nIv~l~~~~~~~ 196 (584)
.++|++.+.||+|+||.||+|.+ ..+++.||||++.. .....+.+.+|+.+++.++|+ +|+++++++...
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec---CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 35799999999999999999998 56889999999863 234556788999999998765 499999888764
Q ss_pred CcceEEEEEechhhHHHHHhhCCC-CCCc------HHHHHHHHHHHHHhCCceeccccccceeecC--------------
Q 043957 197 MQYSLYLVFEFMQTDLARIISNPE-GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDK-------------- 255 (584)
Q Consensus 197 ~~~~l~lV~Ey~~g~L~~~l~~~~-~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~-------------- 255 (584)
..+|+||||+.++|.+.+.... ..++ +..||+.||+|||++||+||||||+||||+.
T Consensus 90 --~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 90 --GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp --TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred --CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 4689999999888888876433 2233 3459999999999999999999999999987
Q ss_pred -----CCcEEEEEeccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHH
Q 043957 256 -----NGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQ 330 (584)
Q Consensus 256 -----~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~ 330 (584)
++.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 668999999999875432 245688999999999986 4589999999999999999999999999999999
Q ss_pred HHHHHHhcCCCChHHHHHhhccCCCCCCC-CCC----------------chhhhhccCCcHhHHHHHHHhcccCCCCCCC
Q 043957 331 LHRIFKLCGSPSEDYWKKLRLSTTFRPPQ-SYK----------------PRLFEAFSEFPESSLGLLSTLLALDPAYRGS 393 (584)
Q Consensus 331 ~~~i~~~~~~~~~~~~~~~~~~~~~~~p~-~~~----------------~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT 393 (584)
+..+....+.++...+........+.... .+. ..........++.+.+||.+||+.||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 98898888888877776543221110000 000 0000011233578899999999999999999
Q ss_pred HHHHhcCcCCCC
Q 043957 394 AASALKNEFFFT 405 (584)
Q Consensus 394 a~e~L~Hp~f~~ 405 (584)
++|+|+||||..
T Consensus 323 ~~ell~hp~f~~ 334 (339)
T 1z57_A 323 LREALKHPFFDL 334 (339)
T ss_dssp HHHHTTSGGGGG
T ss_pred HHHHhcCHHHHH
Confidence 999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=376.35 Aligned_cols=255 Identities=22% Similarity=0.341 Sum_probs=207.9
Q ss_pred CceEE-eeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceEEE
Q 043957 126 SYDKI-DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 126 ~Y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l~l 203 (584)
+|.+. +.||+|+||.||+|.+..+++.||||++............+.+|+.+++.+. ||||+++++++.. ...+|+
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~~~~~l 106 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TSEIIL 106 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--CCeEEE
Confidence 48887 8999999999999999999999999999765555555677889999999995 7999999998876 445899
Q ss_pred EEechhh-HHHHHhhCC-CCCCcH------HHHHHHHHHHHHhCCceeccccccceeecC---CCcEEEEEeccccccCC
Q 043957 204 VFEFMQT-DLARIISNP-EGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDK---NGVLKIADFGLANYFSP 272 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~-~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~---~g~vKL~DFGla~~~~~ 272 (584)
|||||.+ +|..++... ...+.+ ..||+.||+|||++||+||||||+||||+. ++.+||+|||++.....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 9999986 677776532 233433 359999999999999999999999999987 78999999999987653
Q ss_pred CCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.........
T Consensus 187 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--------- 254 (327)
T 3lm5_A 187 AC--ELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE--------- 254 (327)
T ss_dssp ---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT---------
T ss_pred cc--ccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc---------
Confidence 32 2345689999999999976 45899999999999999999999999999888877776554332221
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPL 408 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~ 408 (584)
..+..+++.+.+||.+||+.||.+|||++|+|+||||+...+
T Consensus 255 --------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 255 --------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp --------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred --------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 223467899999999999999999999999999999986543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=392.19 Aligned_cols=253 Identities=29% Similarity=0.442 Sum_probs=193.1
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC------ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS------EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM 197 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~------~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 197 (584)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|++++|||||++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 4679999999999999999999999999999999965321 11223357899999999999999999998753
Q ss_pred cceEEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCC---CcEEEEEeccc
Q 043957 198 QYSLYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKN---GVLKIADFGLA 267 (584)
Q Consensus 198 ~~~l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~---g~vKL~DFGla 267 (584)
..+|+|||||.+ +|.+.+.. ...+.+ ..||+.||+|||+++|+||||||+||||+.+ +.+||+|||++
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred -CceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 247999999985 67776654 334443 3599999999999999999999999999654 45999999999
Q ss_pred cccCCCCCCCCccccccccccChhhhhC--CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHH-HHHHHhcCCCChH
Q 043957 268 NYFSPNKKRPLTSRVVTLWYRAPELLLG--ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQL-HRIFKLCGSPSED 344 (584)
Q Consensus 268 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~--~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~-~~i~~~~~~~~~~ 344 (584)
+.+... ......+||+.|+|||++.+ ...|+.++|||||||++|+|++|++||........+ ..+......+.
T Consensus 290 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~-- 365 (419)
T 3i6u_A 290 KILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI-- 365 (419)
T ss_dssp TSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCC--
T ss_pred eecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCC--
Confidence 886532 23456789999999999853 345889999999999999999999999875443222 22222211111
Q ss_pred HHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 345 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
.+.+..+++.+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 366 ---------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 366 ---------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp ---------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ---------------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 1234567899999999999999999999999999999974
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=387.28 Aligned_cols=260 Identities=16% Similarity=0.201 Sum_probs=189.0
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhC--CCCCeeeee-------cee
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKL--DHPNIVKLE-------GLA 193 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L--~HpnIv~l~-------~~~ 193 (584)
...|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3459999999999999999999999999999999986654 334566777885555544 699988854 333
Q ss_pred eecCc---------------ceEEEEEechhhHHHHHhhCC----CCC--------CcHHHHHHHHHHHHHhCCceeccc
Q 043957 194 TSRMQ---------------YSLYLVFEFMQTDLARIISNP----EGK--------LTEPQQLLSGLQHCHDRGILHRDV 246 (584)
Q Consensus 194 ~~~~~---------------~~l~lV~Ey~~g~L~~~l~~~----~~~--------l~~~~qIl~aL~yLH~~~IvHrDL 246 (584)
..... ..+|||||||.++|.+++... ... +.++.||+.||+|||++||+||||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 22211 458999999999998887631 111 233479999999999999999999
Q ss_pred cccceeecCCCcEEEEEeccccccCCCCCCCCccccccccccChhhhhCC-CCCCceeeEecchHHHHHHHhCCCCCCCC
Q 043957 247 KGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGA-TDYGVGIDLWSAGCLLAEMFLGRPIMPGR 325 (584)
Q Consensus 247 Kp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~-~~~~~~sDIwSLGvilyeLltG~~pF~~~ 325 (584)
||+||||+.++.+||+|||+|+..... .....+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999999876422 1245677999999999751 35899999999999999999999999876
Q ss_pred ChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 326 TEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 326 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
..... ..|...... ..............+++.+.+||.+||+.||++|||+.|+|+||||..
T Consensus 297 ~~~~~-------------~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 297 TPGIK-------------GSWKRPSLR-----VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp CTTCT-------------TCCCBCCTT-----SCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred Ccccc-------------cchhhhhhh-----hccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 43210 000000000 000001111223578999999999999999999999999999999964
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=365.01 Aligned_cols=246 Identities=21% Similarity=0.262 Sum_probs=197.8
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.++..+ +||||+++++++... ..+|+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~~~~l 88 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--DHMLI 88 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--TEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEEE
Confidence 469999999999999999999999999999999987655556667788999999999 899999999988764 46899
Q ss_pred EEechhh-HHHHHhhCCC---CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCC-----------------
Q 043957 204 VFEFMQT-DLARIISNPE---GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKN----------------- 256 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~---~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~----------------- 256 (584)
||||+.+ +|.+.+.... ..++ +..||+.||.|||+++|+||||||+||||+.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 9999985 7887775321 2233 34599999999999999999999999999844
Q ss_pred --CcEEEEEeccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHH
Q 043957 257 --GVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRI 334 (584)
Q Consensus 257 --g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i 334 (584)
..+||+|||++...... ....||+.|+|||++.+...++.++|||||||++|+|++|.++|..... ...+
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~ 240 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEI 240 (289)
T ss_dssp -CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHH
T ss_pred CceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHH
Confidence 47999999999876532 2346899999999998765677899999999999999999987754432 2222
Q ss_pred HHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 335 FKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.... . ......+++.+.+||.+||+.||.+|||+.|+|+||||...
T Consensus 241 ~~~~---------------~-----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 241 RQGR---------------L-----------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HTTC---------------C-----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HcCC---------------C-----------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 1110 0 01123578999999999999999999999999999999764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=375.83 Aligned_cols=257 Identities=25% Similarity=0.374 Sum_probs=203.8
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc--e
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY--S 200 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~--~ 200 (584)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.++++++||||+++++++...... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 4579999999999999999999999999999999976533 344566788999999999999999999988764332 4
Q ss_pred EEEEEechh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
.|+|||||. ++|.+++... ..+. +..||+.||.|||+++|+||||||+||||+.++.+||+|||++..+...
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred cEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 699999997 5777776532 2333 3459999999999999999999999999999999999999999876533
Q ss_pred CC--CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 274 KK--RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 274 ~~--~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
.. ......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+....+....+......+..
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-------- 240 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS-------- 240 (311)
T ss_dssp ------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH--------
T ss_pred ccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc--------
Confidence 22 122345789999999999874 5899999999999999999999999998887776655443222211
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
.....+++++.+||.+||+.||.+||++.++|.|+|+..
T Consensus 241 ---------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 241 ---------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ---------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 223467899999999999999999999999999999863
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=370.60 Aligned_cols=257 Identities=26% Similarity=0.390 Sum_probs=207.2
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS--EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
.++|++.+.||+|+||.||+|.+..++..||||++..... .......+.+|+.+++.++||||+++++++.......+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4579999999999999999999999999999999964321 12345678899999999999999999998866556678
Q ss_pred EEEEechhhHHHHHhhC-CCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 202 YLVFEFMQTDLARIISN-PEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 202 ~lV~Ey~~g~L~~~l~~-~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
|+|||||.++|.+.+.. ....+.+ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 99999999877766653 2233433 3599999999999999999999999999999999999999998764322
Q ss_pred -CCCCccccccccccChhhhhCCC-CCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 275 -KRPLTSRVVTLWYRAPELLLGAT-DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 275 -~~~~~~~~gt~~Y~APEvl~~~~-~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
........||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~------------- 230 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY------------- 230 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-------------
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC-------------
Confidence 12234557899999999987533 247899999999999999999999998877766655543211
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
.....+++.+.+||.+||+.||.+|||++|+|+||||....
T Consensus 231 --------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 231 --------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp --------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred --------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 01135688999999999999999999999999999997653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=397.91 Aligned_cols=248 Identities=17% Similarity=0.248 Sum_probs=194.0
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHH---HHHhCCCCCeeeee-------
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIM---ILQKLDHPNIVKLE------- 190 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~---iL~~L~HpnIv~l~------- 190 (584)
...++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+. +|+.++|||||+++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 34567999999999999999999999999999999997542 23445677889994 55555899999998
Q ss_pred ceeeecCc----------c-----eEEEEEechhhHHHHHhhCCC------------CCCcHHHHHHHHHHHHHhCCcee
Q 043957 191 GLATSRMQ----------Y-----SLYLVFEFMQTDLARIISNPE------------GKLTEPQQLLSGLQHCHDRGILH 243 (584)
Q Consensus 191 ~~~~~~~~----------~-----~l~lV~Ey~~g~L~~~l~~~~------------~~l~~~~qIl~aL~yLH~~~IvH 243 (584)
+++..... . ..|||||||.|+|.+++.... ..+.++.||+.||+|||++||+|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 44443211 0 278999999998888876321 12234569999999999999999
Q ss_pred ccccccceeecCCCcEEEEEeccccccCCCCCCCCccccccccccChhhhhCC----------CCCCceeeEecchHHHH
Q 043957 244 RDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGA----------TDYGVGIDLWSAGCLLA 313 (584)
Q Consensus 244 rDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~----------~~~~~~sDIwSLGvily 313 (584)
|||||+||||+.++.+||+|||+|+.... .....+| +.|+|||++.+. ..++.++|||||||++|
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 99999999999999999999999986432 2355677 999999999864 25899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC
Q 043957 314 EMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS 393 (584)
Q Consensus 314 eLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT 393 (584)
||++|++||.+......+.. .......+++++.+||.+||+.||.+|||
T Consensus 305 elltg~~Pf~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt 353 (377)
T 3byv_A 305 WIWCADLPITKDAALGGSEW-------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLL 353 (377)
T ss_dssp HHHHSSCCC------CCSGG-------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred HHHHCCCCCcccccccchhh-------------------------------hhhhccCCCHHHHHHHHHHcCCCchhCCC
Confidence 99999999976543221111 11122567899999999999999999999
Q ss_pred HHHHhcCcCCCC
Q 043957 394 AASALKNEFFFT 405 (584)
Q Consensus 394 a~e~L~Hp~f~~ 405 (584)
+.|+|+||||..
T Consensus 354 ~~e~l~hp~f~~ 365 (377)
T 3byv_A 354 PLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHTSHHHHH
T ss_pred HHHHhhChHHHH
Confidence 999999999953
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=366.58 Aligned_cols=257 Identities=26% Similarity=0.396 Sum_probs=211.2
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.. ...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 89 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDF 89 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc--CCE
Confidence 45567999999999999999999999999999999996543 334556778899999999999999999998876 446
Q ss_pred EEEEEechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+|+||||+.+ +|.+.+... ..+. +..||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 90 VFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 8999999984 666665432 2333 3459999999999999999999999999999999999999999876533
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+.....
T Consensus 169 ~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------- 232 (294)
T 2rku_A 169 G-ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-------------- 232 (294)
T ss_dssp T-CCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC--------------
T ss_pred c-cccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC--------------
Confidence 2 22345678999999999976 4589999999999999999999999998877666554432110
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCcc
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLAC 410 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~~ 410 (584)
.....+++.+.+||.+||+.||.+|||++|+|+||||.....+.
T Consensus 233 -------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 233 -------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred -------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 01134678899999999999999999999999999998765443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=375.09 Aligned_cols=256 Identities=27% Similarity=0.409 Sum_probs=211.6
Q ss_pred CCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 121 ~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
+...++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.. ..
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 114 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--ND 114 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SS
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--CC
Confidence 345678999999999999999999999999999999996543 344556778899999999999999999998876 44
Q ss_pred eEEEEEechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
.+|+|||||.+ +|.+++... ..+. +..||+.||.|||+++|+||||||+|||++.++.+||+|||++..+..
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 68999999984 676665432 2333 345999999999999999999999999999999999999999987653
Q ss_pred CCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+.+..+......
T Consensus 194 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------ 259 (335)
T 2owb_A 194 DG-ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS------------ 259 (335)
T ss_dssp TT-CCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC------------
T ss_pred Cc-ccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC------------
Confidence 32 22345678999999999986 45899999999999999999999999988776665555332110
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPL 408 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~ 408 (584)
....+++.+.+||.+||+.||.+|||++|+|+||||.....
T Consensus 260 ---------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 260 ---------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp ---------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred ---------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 11346788999999999999999999999999999987643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=368.80 Aligned_cols=255 Identities=29% Similarity=0.464 Sum_probs=183.5
Q ss_pred CCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 121 ~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
....++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 84 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED--SN 84 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC--SS
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc--CC
Confidence 3445679999999999999999999999999999999964311 11224678899999999999999999998876 44
Q ss_pred eEEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
.+|+||||+.+ +|...+......+++ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 68999999974 787777754444443 35999999999999999999999999999999999999999987653
Q ss_pred CCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||........+..+..
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------- 226 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL---------------- 226 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS----------------
T ss_pred CCC-cceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh----------------
Confidence 222 2245678999999999876 4589999999999999999999999987654333221100
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.. ......++.++.+||.+||+.||.+|||++++|+||||...
T Consensus 227 ~~-----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 227 AD-----------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp SC-----------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred cc-----------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 00 01123468899999999999999999999999999999764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=373.66 Aligned_cols=273 Identities=26% Similarity=0.388 Sum_probs=215.5
Q ss_pred CCCceEEeeecccCceEEEEEEECCCC-cEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCC------eeeeeceeeec
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTG-KIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPN------IVKLEGLATSR 196 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn------Iv~l~~~~~~~ 196 (584)
.++|++.+.||+|+||.||+|.+..++ ..||||++.. .......+.+|+.+++.+.|++ |+.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~- 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF- 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-
Confidence 357999999999999999999998777 7899999863 2345567888999999997665 8888887776
Q ss_pred CcceEEEEEechhhHHHHHhhCCC-CCCcH------HHHHHHHHHHHHhCCceeccccccceee----------------
Q 043957 197 MQYSLYLVFEFMQTDLARIISNPE-GKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLI---------------- 253 (584)
Q Consensus 197 ~~~~l~lV~Ey~~g~L~~~l~~~~-~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl---------------- 253 (584)
...+||||||+.+++.+.+.... ..+++ +.||+.||.|||+++|+||||||+||||
T Consensus 94 -~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 94 -HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp -TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred -CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 34689999999988887775433 23433 3599999999999999999999999999
Q ss_pred ---cCCCcEEEEEeccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHH
Q 043957 254 ---DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQ 330 (584)
Q Consensus 254 ---~~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~ 330 (584)
+.++.+||+|||++...... ....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+....+.
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56789999999999875432 2456899999999999864 589999999999999999999999999999999
Q ss_pred HHHHHHhcCCCChHHHHHhhccCCCCCCC-CCC---c-------------hhhhhccCCcHhHHHHHHHhcccCCCCCCC
Q 043957 331 LHRIFKLCGSPSEDYWKKLRLSTTFRPPQ-SYK---P-------------RLFEAFSEFPESSLGLLSTLLALDPAYRGS 393 (584)
Q Consensus 331 ~~~i~~~~~~~~~~~~~~~~~~~~~~~p~-~~~---~-------------~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT 393 (584)
+..+....+.++...+........+.... .+. . .........+..+.+||.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 99999988888877766543221110000 000 0 000001122467899999999999999999
Q ss_pred HHHHhcCcCCCCC
Q 043957 394 AASALKNEFFFTS 406 (584)
Q Consensus 394 a~e~L~Hp~f~~~ 406 (584)
++|+|+||||...
T Consensus 328 ~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 328 LAEALLHPFFAGL 340 (355)
T ss_dssp HHHHTTSGGGGGC
T ss_pred HHHHhcChhhcCC
Confidence 9999999999753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=361.40 Aligned_cols=253 Identities=31% Similarity=0.445 Sum_probs=203.8
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++.+.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.. ....|+|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 83 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLF 83 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEc--CCEEEEE
Confidence 4699999999999999999999999999999999754332 345678899999999999999999998876 4467999
Q ss_pred Eechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC-CC
Q 043957 205 FEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK-KR 276 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~~ 276 (584)
|||+.+ +|.+.+.. ...+++ ..||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... ..
T Consensus 84 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 84 LEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 999985 77777653 233433 3599999999999999999999999999999999999999998654222 12
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCChHHHHHhhccCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQ-LHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
......||+.|+|||++.+...++.++|||||||++|+|++|..||........ +..+.... .
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------~- 226 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK---------------T- 226 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC---------------T-
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc---------------c-
Confidence 234567899999999998655457899999999999999999999987654322 22211100 0
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
....+..+++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus 227 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 227 ---------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp ---------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ---------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 011234678999999999999999999999999999999764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=363.99 Aligned_cols=252 Identities=27% Similarity=0.409 Sum_probs=205.7
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP----HSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
++|++.+.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.+|++++||||+++++++.. ...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~ 82 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN--KTD 82 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC--CCe
Confidence 46999999999999999999999999999999997653221 235778899999999999999999998876 346
Q ss_pred EEEEEechh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCC----cEEEEEeccccc
Q 043957 201 LYLVFEFMQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG----VLKIADFGLANY 269 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g----~vKL~DFGla~~ 269 (584)
+|+||||+. ++|.+.+... ..++ +..||+.||.|||+++|+||||||+|||++.++ .+||+|||++..
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 899999997 5777776532 2333 345999999999999999999999999998877 899999999987
Q ss_pred cCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 270 FSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 270 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+.+..+.........
T Consensus 162 ~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 232 (283)
T 3bhy_A 162 IEAGN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE------ 232 (283)
T ss_dssp CC----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH------
T ss_pred ccCCC--cccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc------
Confidence 65332 2345678999999999876 45899999999999999999999999998887776666543322222
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
..+..+++.+.+||.+||+.||.+|||+.|+|+||||..
T Consensus 233 -----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 233 -----------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp -----------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred -----------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 223567899999999999999999999999999999964
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=365.44 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=209.9
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC---C----hHHHHHHHHHHHHHHhCC-CCCeeeeeceeee
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS---E----PHSVKFMAREIMILQKLD-HPNIVKLEGLATS 195 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~---~----~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~ 195 (584)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... . ....+.+.+|+.+|+++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 4579999999999999999999999999999999975431 1 123456789999999995 9999999998866
Q ss_pred cCcceEEEEEechh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccc
Q 043957 196 RMQYSLYLVFEFMQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLAN 268 (584)
Q Consensus 196 ~~~~~l~lV~Ey~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~ 268 (584)
...+|+||||+. ++|.+.+... ..++ +..||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 96 --~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 96 --NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred --CCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 456899999998 4777776532 2333 34599999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCccccccccccChhhhh-----CCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 043957 269 YFSPNKKRPLTSRVVTLWYRAPELLL-----GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSE 343 (584)
Q Consensus 269 ~~~~~~~~~~~~~~gt~~Y~APEvl~-----~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~ 343 (584)
.+.... ......+|+.|+|||++. ....++.++|||||||++|+|++|..||...+.......+......+..
T Consensus 173 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 173 QLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred hcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 765432 235567899999999986 2345889999999999999999999999988887777666554322211
Q ss_pred HHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 344 DYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 344 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
..+..+++.+.+||.+||+.||.+|||+.|+|+||||.+.
T Consensus 251 -----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 251 -----------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp -----------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred -----------------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 1224578999999999999999999999999999999764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=380.51 Aligned_cols=245 Identities=26% Similarity=0.392 Sum_probs=200.2
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChH------HHHHHHHHHHHHHhCCCCCeeeeeceeeecC
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPH------SVKFMAREIMILQKLDHPNIVKLEGLATSRM 197 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 197 (584)
.++|++++.||+|+||.||+|.+..+++.||||++........ ....+.+|+.+|++++||||+++++++..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-- 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-- 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--
Confidence 3579999999999999999999999999999999976532211 23456789999999999999999998876
Q ss_pred cceEEEEEechh-h-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccc
Q 043957 198 QYSLYLVFEFMQ-T-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 198 ~~~l~lV~Ey~~-g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
...+|+||||+. | +|...+... ..+.+ ..||+.||.|||+++|+||||||+||||+.++.+||+|||++..
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 446899999986 4 677777643 23433 45999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 270 FSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 270 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
+.... .....+||+.|+|||++.+...++.++|||||||++|+|++|..||...... ..
T Consensus 180 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~------------- 238 (335)
T 3dls_A 180 LERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE------------- 238 (335)
T ss_dssp CCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT-------------
T ss_pred CCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh-------------
Confidence 75432 2456789999999999987554589999999999999999999999652210 00
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
... .....+++++.+||.+||+.||.+|||++|+|+||||.+.
T Consensus 239 ---~~~-----------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 239 ---AAI-----------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp ---TCC-----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred ---hcc-----------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 000 1112468899999999999999999999999999999764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=400.30 Aligned_cols=255 Identities=29% Similarity=0.416 Sum_probs=206.6
Q ss_pred CCCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc
Q 043957 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 120 ~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 198 (584)
.+...++|++++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+|+.++|||||++++++.+ .
T Consensus 179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~ 256 (576)
T 2acx_A 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--K 256 (576)
T ss_dssp SCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred cCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee--C
Confidence 34667889999999999999999999999999999999964311 11234567889999999999999999988876 4
Q ss_pred ceEEEEEechh-hHHHHHhhCCC-CCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccccc
Q 043957 199 YSLYLVFEFMQ-TDLARIISNPE-GKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 199 ~~l~lV~Ey~~-g~L~~~l~~~~-~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~ 270 (584)
..+|||||||. |+|...+.... ..+.+ ..||+.||.|||++||+||||||+||||+.+|.+||+|||++..+
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 46899999997 57877776432 22444 349999999999999999999999999999999999999999876
Q ss_pred CCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCChHHH
Q 043957 271 SPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE----VEQLHRIFKLCGSPSEDYW 346 (584)
Q Consensus 271 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~----~~~~~~i~~~~~~~~~~~~ 346 (584)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+... ......+....
T Consensus 337 ~~~~--~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~-------- 405 (576)
T 2acx_A 337 PEGQ--TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP-------- 405 (576)
T ss_dssp CTTC--CEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC--------
T ss_pred ccCc--cccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc--------
Confidence 5332 2355689999999999986 4589999999999999999999999987643 22222221110
Q ss_pred HHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCCC
Q 043957 347 KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFTS 406 (584)
Q Consensus 347 ~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~~ 406 (584)
. .....+++++.+||.+||+.||.+|| +++|+++||||...
T Consensus 406 ------------~-------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 406 ------------E-------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp ------------C-------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred ------------c-------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 0 01135789999999999999999999 89999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=371.75 Aligned_cols=252 Identities=29% Similarity=0.440 Sum_probs=197.2
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC------ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS------EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~------~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 198 (584)
++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 469999999999999999999999999999999964421 1122345789999999999999999999886532
Q ss_pred ceEEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCc---EEEEEecccc
Q 043957 199 YSLYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGV---LKIADFGLAN 268 (584)
Q Consensus 199 ~~l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~---vKL~DFGla~ 268 (584)
+|+||||+.+ +|.+.+... ..+.+ ..||+.||.|||+++|+||||||+||||+.++. +||+|||++.
T Consensus 89 --~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 --YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp --EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred --eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 7999999985 777776542 33443 359999999999999999999999999987654 9999999998
Q ss_pred ccCCCCCCCCccccccccccChhhhh--CCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCChHH
Q 043957 269 YFSPNKKRPLTSRVVTLWYRAPELLL--GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQ-LHRIFKLCGSPSEDY 345 (584)
Q Consensus 269 ~~~~~~~~~~~~~~gt~~Y~APEvl~--~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~-~~~i~~~~~~~~~~~ 345 (584)
...... ......||+.|+|||++. +...++.++|||||||++|+|++|.+||........ ...+........
T Consensus 166 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--- 240 (322)
T 2ycf_A 166 ILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI--- 240 (322)
T ss_dssp ECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC---
T ss_pred eccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC---
Confidence 764321 224567899999999984 234689999999999999999999999976544322 222222211111
Q ss_pred HHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 346 WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 346 ~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
...+..+++.+.+||.+||+.||.+|||++++|+||||..
T Consensus 241 --------------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 241 --------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp --------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred --------------------chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 1233567899999999999999999999999999999964
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=377.35 Aligned_cols=275 Identities=29% Similarity=0.455 Sum_probs=212.9
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-----------CCCeeeeece
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-----------HPNIVKLEGL 192 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-----------HpnIv~l~~~ 192 (584)
.++|++.+.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+++++. ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 4579999999999999999999999999999999863 3344567889999999886 8999999998
Q ss_pred eeecC--cceEEEEEechhhHHHHHhhCC-CCCCc------HHHHHHHHHHHHHhC-Cceeccccccceeec------CC
Q 043957 193 ATSRM--QYSLYLVFEFMQTDLARIISNP-EGKLT------EPQQLLSGLQHCHDR-GILHRDVKGSNLLID------KN 256 (584)
Q Consensus 193 ~~~~~--~~~l~lV~Ey~~g~L~~~l~~~-~~~l~------~~~qIl~aL~yLH~~-~IvHrDLKp~NILl~------~~ 256 (584)
+.... ...+++||||+.++|.+++... ...+. +..||+.||.|||++ ||+||||||+||||+ ..
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred hhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence 87643 3368999999988888887642 22243 335999999999998 999999999999994 34
Q ss_pred CcEEEEEeccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCC------hHHH
Q 043957 257 GVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRT------EVEQ 330 (584)
Q Consensus 257 g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~------~~~~ 330 (584)
+.+||+|||++...... ....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.. ..+.
T Consensus 175 ~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceEEEcccccccccCCC----CCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 47999999999876432 3455889999999999874 58999999999999999999999998654 5677
Q ss_pred HHHHHHhcCCCChHHHHHhhccCCC-------CCCCCCC-chh-------hhhccCCcHhHHHHHHHhcccCCCCCCCHH
Q 043957 331 LHRIFKLCGSPSEDYWKKLRLSTTF-------RPPQSYK-PRL-------FEAFSEFPESSLGLLSTLLALDPAYRGSAA 395 (584)
Q Consensus 331 ~~~i~~~~~~~~~~~~~~~~~~~~~-------~~p~~~~-~~~-------~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~ 395 (584)
+..++...+.++...+........+ ....... ..+ ......+++++.+||.+||+.||.+|||++
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 7888888888887666543211000 0000000 000 011134567889999999999999999999
Q ss_pred HHhcCcCCCCC
Q 043957 396 SALKNEFFFTS 406 (584)
Q Consensus 396 e~L~Hp~f~~~ 406 (584)
|+|+||||+..
T Consensus 330 ell~hp~f~~~ 340 (373)
T 1q8y_A 330 GLVNHPWLKDT 340 (373)
T ss_dssp HHHTCGGGTTC
T ss_pred HHhhChhhhcc
Confidence 99999999865
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=369.70 Aligned_cols=250 Identities=30% Similarity=0.442 Sum_probs=205.2
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+|+.++||||+++++++.. ...+|+|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 84 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYES--TTHYYLV 84 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhccc--CCEEEEE
Confidence 469999999999999999999999999999999975432 233568899999999999999999998876 4468999
Q ss_pred Eechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceee---cCCCcEEEEEeccccccCCCC
Q 043957 205 FEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl---~~~g~vKL~DFGla~~~~~~~ 274 (584)
|||+.+ +|.+.+... ..++ +..||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 85 MQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp ECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred EEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 999974 777776532 2233 34599999999999999999999999999 77889999999999765322
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+....+..+......+..
T Consensus 163 --~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----------- 228 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFES----------- 228 (304)
T ss_dssp --TTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCT-----------
T ss_pred --ccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc-----------
Confidence 2345678999999999876 45899999999999999999999999998887777766554322211
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
..+..+++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus 229 ------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 229 ------------PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp ------------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 1224678999999999999999999999999999999754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=396.96 Aligned_cols=256 Identities=28% Similarity=0.390 Sum_probs=207.0
Q ss_pred CCCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc
Q 043957 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 120 ~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 198 (584)
.+...++|++++.||+|+||.||+|+++.+|+.||||++..... .......+.+|+.+|++++|||||++++++.. .
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~ 257 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET--K 257 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee--C
Confidence 34567889999999999999999999999999999999964321 11234567899999999999999999888776 4
Q ss_pred ceEEEEEechhh-HHHHHhhCC---CCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccc
Q 043957 199 YSLYLVFEFMQT-DLARIISNP---EGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLAN 268 (584)
Q Consensus 199 ~~l~lV~Ey~~g-~L~~~l~~~---~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~ 268 (584)
..+|||||||.| +|...+... ...+.+ ..||+.||.|||++||+||||||+||||+.+|.+||+|||+++
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceee
Confidence 468999999984 677776543 223443 3599999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCChH
Q 043957 269 YFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE----VEQLHRIFKLCGSPSED 344 (584)
Q Consensus 269 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~----~~~~~~i~~~~~~~~~~ 344 (584)
.+..... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+... .+....+.....
T Consensus 338 ~~~~~~~-~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~----- 410 (543)
T 3c4z_A 338 ELKAGQT-KTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV----- 410 (543)
T ss_dssp ECCTTCC-CBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC-----
T ss_pred eccCCCc-ccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc-----
Confidence 7654332 2345689999999999987 4699999999999999999999999987642 333333332110
Q ss_pred HHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC-----HHHHhcCcCCCCC
Q 043957 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS-----AASALKNEFFFTS 406 (584)
Q Consensus 345 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT-----a~e~L~Hp~f~~~ 406 (584)
.....+++.+.+||.+||+.||.+||+ ++++++||||...
T Consensus 411 ----------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 411 ----------------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred ----------------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 011357899999999999999999995 5999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=411.21 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=209.5
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcce
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~ 200 (584)
..++|++++.||+|+||.||+|.++.+++.||||+++.... .......+..|..+|..+ +||||+.+++++.+ ...
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~~ 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR 416 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SSE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CCE
Confidence 45789999999999999999999999999999999974311 122345677899999988 69999999887765 446
Q ss_pred EEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+|||||||.| +|...+... ..+.+ +.||+.||+|||+++||||||||+||||+.++.+||+|||+|+.....
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 8999999985 677776542 33443 359999999999999999999999999999999999999999864322
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
. ......+||+.|+|||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|+.....+
T Consensus 496 ~-~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~------------ 561 (674)
T 3pfq_A 496 G-VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY------------ 561 (674)
T ss_dssp T-CCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCC------------
T ss_pred C-cccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC------------
Confidence 2 23456789999999999976 469999999999999999999999999999888888776532111
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCH-----HHHhcCcCCCCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSA-----ASALKNEFFFTS 406 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa-----~e~L~Hp~f~~~ 406 (584)
...+++++.+||.+||++||.+||++ +|+++||||...
T Consensus 562 ---------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 562 ---------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp ---------------CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred ---------------CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 13578999999999999999999997 999999999764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=364.28 Aligned_cols=250 Identities=28% Similarity=0.451 Sum_probs=206.1
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
..++|++.+.||+|+||.||+|.+..++..||||++..... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 89 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD--RKRI 89 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc--CCEE
Confidence 34679999999999999999999999999999999864311 11124568899999999999999999998876 4468
Q ss_pred EEEEechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 202 YLVFEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
|+||||+.+ +|.+.+... ..+. +..||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 999999985 777776532 2233 34599999999999999999999999999999999999999997654322
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|.+||......+....+......
T Consensus 169 ---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------- 230 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK-------------- 230 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--------------
T ss_pred ---cccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccC--------------
Confidence 245678999999999976 45899999999999999999999999988877766555432110
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
....+++.+.+||.+||+.||.+|||++++|+||||...
T Consensus 231 -------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 231 -------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp -------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred -------------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 113468899999999999999999999999999999754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=365.09 Aligned_cols=255 Identities=30% Similarity=0.433 Sum_probs=200.7
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
.++|++++.||+|+||.||+|.+..++..||||++..... .....+.+.+|+.++++++||||+++++++.. ...+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 87 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE--DDCYY 87 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC--SSEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee--CCeEE
Confidence 3579999999999999999999999999999999965433 44556788999999999999999999998765 44689
Q ss_pred EEEechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 203 LVFEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
+||||+.+ +|.+++... ..+. +..||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 88 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999985 777776532 2333 345999999999999999999999999999999999999999987754443
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+........+.... +
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-~-------------- 230 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-P-------------- 230 (294)
T ss_dssp --------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC-C--------------
T ss_pred cccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC-C--------------
Confidence 334556799999999999874 589999999999999999999999999887665544332110 0
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~ 404 (584)
.........+|+.+.++|.+||+.||.+||+..+.|.+.|..
T Consensus 231 -------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 231 -------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp -------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred -------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 011123356789999999999999999999777777776643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=367.31 Aligned_cols=258 Identities=26% Similarity=0.438 Sum_probs=201.9
Q ss_pred CCCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecC-
Q 043957 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRM- 197 (584)
Q Consensus 120 ~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~- 197 (584)
+....++|++++.||+|+||.||+|.+..+|+.||||++..... ....+.+|+.+++++ +||||+++++++....
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 34567789999999999999999999999999999999975432 235678899999999 7999999999987643
Q ss_pred ---cceEEEEEechhh-HHHHHhhCCC-CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecc
Q 043957 198 ---QYSLYLVFEFMQT-DLARIISNPE-GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGL 266 (584)
Q Consensus 198 ---~~~l~lV~Ey~~g-~L~~~l~~~~-~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGl 266 (584)
...+|+||||+.+ +|.+++.... ..+. +..||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 4578999999985 7877776422 2333 345999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCccccccccccChhhhhC----CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 043957 267 ANYFSPNKKRPLTSRVVTLWYRAPELLLG----ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPS 342 (584)
Q Consensus 267 a~~~~~~~~~~~~~~~gt~~Y~APEvl~~----~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~ 342 (584)
+..+.... .......||+.|+|||++.. ...++.++|||||||++|+|++|.+||........+..+.....
T Consensus 176 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--- 251 (326)
T 2x7f_A 176 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA--- 251 (326)
T ss_dssp TC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---
T ss_pred ceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc---
Confidence 98764322 12345678999999999862 24588999999999999999999999988877665544432110
Q ss_pred hHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 343 EDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 343 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
+. .....+++.+.+||.+||..||.+|||++++|+||||...
T Consensus 252 ---------------~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 252 ---------------PR-------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp ---------------CC-------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred ---------------cc-------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 00 0124568899999999999999999999999999999764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=361.49 Aligned_cols=251 Identities=28% Similarity=0.401 Sum_probs=197.4
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++... ..+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 87 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP--TDFF 87 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC--CeEE
Confidence 4579999999999999999999999999999999964311 112345788999999999999999999988763 4689
Q ss_pred EEEechh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 203 LVFEFMQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 203 lV~Ey~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
+||||+. ++|.+.+... ..+. +..||+.||.|||+++|+|+||||+|||++.++.+||+|||++.......
T Consensus 88 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 165 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 165 (276)
T ss_dssp EEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc-
Confidence 9999997 4787777532 2233 34599999999999999999999999999999999999999998765432
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
......+|+.|+|||++.+....+.++|||||||++|+|++|+.||........+..+......
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 229 (276)
T 2h6d_A 166 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY--------------- 229 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------
T ss_pred -ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc---------------
Confidence 2345678999999999987554578999999999999999999999887776665554332110
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
....++..+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 230 ------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 230 ------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp ------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 113457889999999999999999999999999999764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=363.22 Aligned_cols=252 Identities=26% Similarity=0.405 Sum_probs=193.2
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec--------
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR-------- 196 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~-------- 196 (584)
++|++++.||+|+||.||+|.+..+++.||||++.. .......+.+|+.++++++||||+++++++...
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 469999999999999999999999999999999963 234567788999999999999999999987653
Q ss_pred ---CcceEEEEEechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecc
Q 043957 197 ---MQYSLYLVFEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGL 266 (584)
Q Consensus 197 ---~~~~l~lV~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGl 266 (584)
....+|+||||+.+ +|.+++......+. +..||+.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 24578999999974 88888764333332 345999999999999999999999999999999999999999
Q ss_pred ccccCCCC-------------CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCC-ChHHHHH
Q 043957 267 ANYFSPNK-------------KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGR-TEVEQLH 332 (584)
Q Consensus 267 a~~~~~~~-------------~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~-~~~~~~~ 332 (584)
+....... ........||+.|+|||++.+...++.++|||||||++|+|++ ||... .....+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~ 239 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence 98764221 1223456789999999999865568999999999999999998 44322 2222222
Q ss_pred HHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 333 RIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 333 ~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
.+..... ..+. ......++.+.+||.+||+.||.+|||+.++|+||||..
T Consensus 240 ~~~~~~~----------------~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 240 KLRSVSI----------------EFPP-------DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHSTTC----------------CCCT-------TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred hcccccc----------------ccCc-------cccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 2221111 0111 112355788999999999999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=361.92 Aligned_cols=254 Identities=29% Similarity=0.490 Sum_probs=201.1
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
...++|++++.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.++||||+++++++.. ...+
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 99 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFK--NTDL 99 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEE
Confidence 345679999999999999999999999999999999975432 3567889999999999999999998876 3468
Q ss_pred EEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 202 YLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
|+||||+.+ +|.+++......+.+ ..||+.||.|||++||+|+||||+|||++.++.+||+|||++..+....
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 999999986 777776533334443 4599999999999999999999999999999999999999998764332
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+..... +
T Consensus 180 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~------------- 243 (314)
T 3com_A 180 -AKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-P------------- 243 (314)
T ss_dssp -SCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C-------------
T ss_pred -cccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-c-------------
Confidence 223456789999999999764 589999999999999999999999988776555443322110 0
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
.......+++.+.+||.+||..||.+|||+.++|+||||....
T Consensus 244 ----------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 244 ----------TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp ----------CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred ----------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 0011234688999999999999999999999999999998653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=371.73 Aligned_cols=272 Identities=23% Similarity=0.312 Sum_probs=203.6
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+|++++||||+++++++.......+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 4579999999999999999999999999999999964322 223566789999999999999999999988776667899
Q ss_pred EEechh-hHHHHHhhCCCCC--CcH------HHHHHHHHHHHHhCCceeccccccceee----cCCCcEEEEEecccccc
Q 043957 204 VFEFMQ-TDLARIISNPEGK--LTE------PQQLLSGLQHCHDRGILHRDVKGSNLLI----DKNGVLKIADFGLANYF 270 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~~--l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl----~~~g~vKL~DFGla~~~ 270 (584)
|||||. ++|..++...... +.+ ..||+.||.|||+++|+||||||+|||| +.++.+||+|||++..+
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 999998 5788877653221 333 3599999999999999999999999999 77888999999999877
Q ss_pred CCCCCCCCccccccccccChhhhhC-------CCCCCceeeEecchHHHHHHHhCCCCCCCCC----hHHHHHHHHHhcC
Q 043957 271 SPNKKRPLTSRVVTLWYRAPELLLG-------ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRT----EVEQLHRIFKLCG 339 (584)
Q Consensus 271 ~~~~~~~~~~~~gt~~Y~APEvl~~-------~~~~~~~sDIwSLGvilyeLltG~~pF~~~~----~~~~~~~i~~~~~ 339 (584)
.... .....+||+.|+|||++.. ...++.++|||||||++|+|++|++||.... ..+.+..++....
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred CCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 5433 2355679999999999862 2468999999999999999999999997433 2344444443321
Q ss_pred CCChHHHHHhhccCCCC-CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCc
Q 043957 340 SPSEDYWKKLRLSTTFR-PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNE 401 (584)
Q Consensus 340 ~~~~~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp 401 (584)
.. .|..+....... ......+........+++.+.+||.+||+.||++|||++|+|+||
T Consensus 245 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 245 SG---AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp TT---CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred cc---cchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 11 111110000000 000000000011234567889999999999999999999999996
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=364.48 Aligned_cols=254 Identities=29% Similarity=0.423 Sum_probs=200.3
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++++.||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.+++.++||||+++++++... ..+|+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 93 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHD--GKLWI 93 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC---CEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC--CeEEE
Confidence 457999999999999999999999999999999986442 23456788999999999999999999988764 45899
Q ss_pred EEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
|||||.+ +|..++......+++ ..||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 172 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-Q 172 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-H
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-c
Confidence 9999985 566655433333443 3599999999999999999999999999999999999999975432111 1
Q ss_pred CCccccccccccChhhhh----CCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 277 PLTSRVVTLWYRAPELLL----GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~----~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
......||+.|+|||++. ....++.++|||||||++|+|++|.+||...+....+..+.......
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 241 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT----------- 241 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----------
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-----------
Confidence 123457899999999984 33568899999999999999999999999888776655554321100
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
......++..+.+||.+||+.||.+|||+.++|+||||...
T Consensus 242 -------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 242 -------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp -------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred -------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 01124568899999999999999999999999999999764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=374.84 Aligned_cols=277 Identities=26% Similarity=0.375 Sum_probs=203.9
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
...++|++++.||+|+||.||+|.+..++..||+|++.... .....+.+.+|+.+|+.++||||+++++++... ..+
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 106 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEI 106 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET--TEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC--CEE
Confidence 34568999999999999999999999999999999997543 445567789999999999999999999988763 468
Q ss_pred EEEEechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhC-CceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 202 YLVFEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDR-GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~-~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
|+|||||.+ +|.+++... ..+. +..||+.||.|||+. +|+||||||+||||+.++.+||+|||++..+...
T Consensus 107 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999985 787777542 2233 345999999999985 9999999999999999999999999999765322
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC-CChHHHHHhhcc
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGS-PSEDYWKKLRLS 352 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~ 352 (584)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+...... .....+......
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ---C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ---cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 1245678999999999986 45999999999999999999999999987765543322111100 000000000000
Q ss_pred ---CCC---CCCCCCCchh----------hhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 353 ---TTF---RPPQSYKPRL----------FEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 353 ---~~~---~~p~~~~~~~----------~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
..+ ..+....... ......++.++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 000 0000000000 00012468899999999999999999999999999999753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=379.85 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=198.8
Q ss_pred CCCCCceEEeeecccCceEEEEEEEC---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeee
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDR---DTGKIVALKKVKFDTS--EPHSVKFMAREIMILQKL-DHPNIVKLEGLATS 195 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~ 195 (584)
...++|++++.||+|+||.||+|.+. .+++.||||+++.... .......+.+|+.+|+.+ .||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 34578999999999999999999984 5899999999854321 112234466799999999 69999999988876
Q ss_pred cCcceEEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccc
Q 043957 196 RMQYSLYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLAN 268 (584)
Q Consensus 196 ~~~~~l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~ 268 (584)
. ..+|||||||.+ +|.+.+... ..+.+ ..||+.||.|||+++|+||||||+||||+.++.+||+|||+++
T Consensus 131 ~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 131 E--TKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp T--TEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred C--ceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 3 468999999985 777776532 23333 3599999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCccccccccccChhhhhCC-CCCCceeeEecchHHHHHHHhCCCCCCCCChH----HHHHHHHHhcCCCCh
Q 043957 269 YFSPNKKRPLTSRVVTLWYRAPELLLGA-TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEV----EQLHRIFKLCGSPSE 343 (584)
Q Consensus 269 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~-~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~----~~~~~i~~~~~~~~~ 343 (584)
.+...........+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...... .....+.....
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---- 283 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP---- 283 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC----
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC----
Confidence 7654333334456899999999999753 34789999999999999999999999754322 22222211100
Q ss_pred HHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCCC
Q 043957 344 DYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFTS 406 (584)
Q Consensus 344 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~~ 406 (584)
.....++..+.+||.+||+.||.+|| |++|+|+||||...
T Consensus 284 -----------------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 284 -----------------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp -----------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred -----------------------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 01235688999999999999999999 99999999999753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=365.54 Aligned_cols=252 Identities=24% Similarity=0.317 Sum_probs=196.9
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..++|++.+.||+|+||+||+|.+ +|..||||++..........+.+.+|+.+|++++||||+++++++.... .+|
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~ 110 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP--NLS 110 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT--CCE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--ceE
Confidence 456799999999999999999976 5889999999776666667788999999999999999999999887643 479
Q ss_pred EEEechhh-HHHHHhhCCCC--CCc------HHHHHHHHHHHHHhCC--ceeccccccceeecCCCcEEEEEeccccccC
Q 043957 203 LVFEFMQT-DLARIISNPEG--KLT------EPQQLLSGLQHCHDRG--ILHRDVKGSNLLIDKNGVLKIADFGLANYFS 271 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~~--~l~------~~~qIl~aL~yLH~~~--IvHrDLKp~NILl~~~g~vKL~DFGla~~~~ 271 (584)
+|||||.+ +|.+++..... .+. +..||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999985 78887765321 133 3459999999999999 9999999999999999999999999998654
Q ss_pred CCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 272 PNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 272 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.......
T Consensus 191 ~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~---------- 258 (309)
T 3p86_A 191 STF-LSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL---------- 258 (309)
T ss_dssp ------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC----------
T ss_pred ccc-cccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----------
Confidence 322 223456899999999999864 58999999999999999999999999888776655543221111
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc--CcCCCC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK--NEFFFT 405 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~--Hp~f~~ 405 (584)
.....+++.+.+||.+||+.||.+|||++++++ ++|+..
T Consensus 259 ---------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 259 ---------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ---------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ---------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 112457889999999999999999999999998 566554
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=367.49 Aligned_cols=264 Identities=25% Similarity=0.402 Sum_probs=184.4
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.++++++||||+++++++.... .+|
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 89 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD--ELW 89 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSS--CEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC--CcE
Confidence 34679999999999999999999988999999999864432 234566789999999999999999999887644 579
Q ss_pred EEEechhh-HHHHHhhC-------CCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccc
Q 043957 203 LVFEFMQT-DLARIISN-------PEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLAN 268 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~-------~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~ 268 (584)
+||||+.+ +|.+++.. ....+++ ..||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999974 67666642 1233433 3599999999999999999999999999999999999999997
Q ss_pred ccCCCCC----CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChH
Q 043957 269 YFSPNKK----RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSED 344 (584)
Q Consensus 269 ~~~~~~~----~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~ 344 (584)
.+..... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||........+...........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-- 247 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL-- 247 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT--
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc--
Confidence 6643211 1123457899999999987544589999999999999999999999988766554433322111000
Q ss_pred HHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 345 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
............+++.+.+||.+||+.||.+|||+.|+|+||||...
T Consensus 248 ---------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 248 ---------------ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp ---------------TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred ---------------ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 00001122345788999999999999999999999999999999764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=358.78 Aligned_cols=250 Identities=26% Similarity=0.493 Sum_probs=207.1
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.+.|++++.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++... ..+|+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 97 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWI 97 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEE
Confidence 35699999999999999999999999999999999755432 3467788999999999999999999988763 46899
Q ss_pred EEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
||||+.+ +|.+++.. ..+++ ..||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... .
T Consensus 98 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 174 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I 174 (303)
T ss_dssp EEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-C
T ss_pred EEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc-c
Confidence 9999985 67777654 23333 3599999999999999999999999999999999999999998765332 2
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+.....
T Consensus 175 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------- 236 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP----------------- 236 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----------------
T ss_pred ccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC-----------------
Confidence 2345678999999999976 4588999999999999999999999988776665544432110
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
. .....++..+.+||.+||+.||.+|||+.|+|+||||...
T Consensus 237 --~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 237 --P-------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp --C-------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred --C-------CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 0 1124578899999999999999999999999999999754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=361.83 Aligned_cols=251 Identities=30% Similarity=0.500 Sum_probs=207.1
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.++++++||||+++++++.. ...+|+|
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 99 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYIV 99 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC--CCeEEEE
Confidence 46999999999999999999999999999999997654444456778899999999999999999998876 4468999
Q ss_pred Eechh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCC---CcEEEEEeccccccCCCC
Q 043957 205 FEFMQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKN---GVLKIADFGLANYFSPNK 274 (584)
Q Consensus 205 ~Ey~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~---g~vKL~DFGla~~~~~~~ 274 (584)
|||+. ++|.+.+... ..++ +..||+.||.|||++||+||||||+||||+.+ +.+||+|||++.......
T Consensus 100 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 100 GELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred EEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 99997 4676665432 2233 34599999999999999999999999999654 479999999998765332
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
......+|+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+......+..
T Consensus 179 --~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------- 243 (287)
T 2wei_A 179 --KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL----------- 243 (287)
T ss_dssp --SCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-----------
T ss_pred --ccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-----------
Confidence 2345578999999999875 3899999999999999999999999998887776666543222211
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
..+..+++++.+||.+||+.||.+|||+.|+|+||||.+
T Consensus 244 ------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 244 ------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp ------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred ------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 123467899999999999999999999999999999964
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=360.27 Aligned_cols=255 Identities=24% Similarity=0.395 Sum_probs=186.6
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..++|++++.||+|+||.||+|.+..+|+.||||++............+.++..+++.++||||+++++++... ..+|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~ 100 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN--TDVF 100 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcEE
Confidence 35679999999999999999999999999999999976554444445555666678888999999999988764 4689
Q ss_pred EEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhC-CceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 203 LVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDR-GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~-~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
+||||+.+.+..+.......+.+ ..||+.||.|||++ ||+||||||+|||++.++.+||+|||++..+....
T Consensus 101 lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (318)
T 2dyl_A 101 IAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK- 179 (318)
T ss_dssp EEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence 99999965555554432333433 35999999999995 99999999999999999999999999997764332
Q ss_pred CCCccccccccccChhhhhC----CCCCCceeeEecchHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 276 RPLTSRVVTLWYRAPELLLG----ATDYGVGIDLWSAGCLLAEMFLGRPIMPGR-TEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~----~~~~~~~sDIwSLGvilyeLltG~~pF~~~-~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
......+|+.|+|||++.. ...++.++|||||||++|+|++|+.||... ...+.+..+.......
T Consensus 180 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------- 249 (318)
T 2dyl_A 180 -AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL--------- 249 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC---------
T ss_pred -cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC---------
Confidence 2345578999999999852 345889999999999999999999999874 4444444443321100
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
......+++++.+||.+||+.||.+|||++|+|+||||..
T Consensus 250 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 250 ---------------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp ---------------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred ---------------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 0111357899999999999999999999999999999964
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=365.59 Aligned_cols=257 Identities=21% Similarity=0.301 Sum_probs=185.4
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGK---IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
..++|++.+.||+|+||.||+|.+..++. .||||++..........+.+.+|+.++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 45679999999999999999999887665 899999976655556678899999999999999999999988764332
Q ss_pred ----eEEEEEechhh-HHHHHhhCC-----CCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEE
Q 043957 200 ----SLYLVFEFMQT-DLARIISNP-----EGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIAD 263 (584)
Q Consensus 200 ----~l~lV~Ey~~g-~L~~~l~~~-----~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~D 263 (584)
..|+||||+.+ +|...+... ...+. +..||+.||.|||++||+||||||+||||+.++.+||+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEee
Confidence 24999999985 677666421 11233 345999999999999999999999999999999999999
Q ss_pred eccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 043957 264 FGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSP 341 (584)
Q Consensus 264 FGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~ 341 (584)
||++........ .......+++.|+|||++.+. .++.++|||||||++|+|++ |.+||.+....+....+......
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~- 258 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL- 258 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-
T ss_pred ccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC-
Confidence 999987643322 122344567899999999874 58999999999999999999 99999988877666555432111
Q ss_pred ChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC-------HHHHhcCcCCCCC
Q 043957 342 SEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS-------AASALKNEFFFTS 406 (584)
Q Consensus 342 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT-------a~e~L~Hp~f~~~ 406 (584)
.....+++.+.+||.+||+.||.+||| .+++|+|||+...
T Consensus 259 -------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 259 -------------------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp -------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred -------------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 112356889999999999999999999 8889999999753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=352.73 Aligned_cols=244 Identities=21% Similarity=0.343 Sum_probs=201.0
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.+.||+|+||.||+|.+. ++..||||++...... .+.+.+|+.++++++||||+++++++... ..+|+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~l 82 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICL 82 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecC--CceEE
Confidence 357999999999999999999987 4778999999754333 35688999999999999999999988764 35799
Q ss_pred EEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
||||+.+ +|.+.+......+.+ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 9999985 688887665544443 359999999999999999999999999999999999999999876543322
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
......+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||......+....+.......
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 227 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-------------- 227 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC--------------
T ss_pred cccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCC--------------
Confidence 33445678899999999764 59999999999999999999 999999988877766654321111
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
....+++.+.+||.+||+.||.+|||+.|+|+|
T Consensus 228 ------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 228 ------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 113457889999999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=360.91 Aligned_cols=246 Identities=25% Similarity=0.355 Sum_probs=199.9
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGK---IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
.++|++.+.||+|+||.||+|.+..++. .||||++... ......+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 124 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR--GRL 124 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG--GGC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCc
Confidence 4579999999999999999999986554 5999999643 344556778999999999999999999998866 345
Q ss_pred EEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+|||||||.+ +|.+++......+.+ ..||+.||.|||+++|+||||||+||||+.++.+||+|||++..+...
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 7999999975 888888665555554 349999999999999999999999999999999999999999877543
Q ss_pred CCCC--CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 274 KKRP--LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 274 ~~~~--~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
.... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+......+
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 274 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP--------- 274 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---------
T ss_pred ccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC---------
Confidence 2221 2233557889999999764 58999999999999999999 999999988877766664432111
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
....+++.+.+||.+||..||.+|||+.++++
T Consensus 275 -----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 275 -----------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp -----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11357889999999999999999999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=353.07 Aligned_cols=252 Identities=28% Similarity=0.403 Sum_probs=194.7
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVF 205 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~ 205 (584)
.|.....||+|+||.||+|.+..++..||||++.... ....+.+.+|+.+++.++||||+++++++... ..+++||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 98 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN--GFIKIFM 98 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC--CcEEEEE
Confidence 3555568999999999999999999999999997543 23456788999999999999999999988763 4689999
Q ss_pred echh-hHHHHHhhCCCC--CCc------HHHHHHHHHHHHHhCCceeccccccceeecC-CCcEEEEEeccccccCCCCC
Q 043957 206 EFMQ-TDLARIISNPEG--KLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDK-NGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 206 Ey~~-g~L~~~l~~~~~--~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~-~g~vKL~DFGla~~~~~~~~ 275 (584)
||+. ++|..++..... .+. +..||+.||.|||+++|+|+||||+||||+. ++.+||+|||++.......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 9997 577777654322 222 2459999999999999999999999999987 8999999999998765322
Q ss_pred CCCccccccccccChhhhhCC-CCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGA-TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~-~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||................. ..
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------~~ 244 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK-------------VH 244 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC-------------CC
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc-------------cc
Confidence 223456789999999998753 2378999999999999999999999976443322111100000 00
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
......+++.+.+||.+||+.||.+|||++++|+||||...
T Consensus 245 -----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 245 -----------PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp -----------CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred -----------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 01123568899999999999999999999999999999754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=368.01 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=199.7
Q ss_pred CCCCceEEeeecccCceEEEEEEEC-------CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceee
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDR-------DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLAT 194 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~-------~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 194 (584)
..++|++.+.||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+|+.+ +|||||++++++.
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 3467999999999999999999874 34668999999644 3445567789999999999 8999999999887
Q ss_pred ecCcceEEEEEechhh-HHHHHhhCCC---------------CCCc------HHHHHHHHHHHHHhCCceecccccccee
Q 043957 195 SRMQYSLYLVFEFMQT-DLARIISNPE---------------GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLL 252 (584)
Q Consensus 195 ~~~~~~l~lV~Ey~~g-~L~~~l~~~~---------------~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NIL 252 (584)
.. ..+|+||||+.+ +|.+++.... ..+. +..||+.||.|||+++|+||||||+|||
T Consensus 158 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 158 QD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp SS--SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred cC--CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 64 357999999985 7887775422 1233 3459999999999999999999999999
Q ss_pred ecCCCcEEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHH
Q 043957 253 IDKNGVLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQ 330 (584)
Q Consensus 253 l~~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~ 330 (584)
|+.++.+||+|||+++.+..... .......+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+.
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999999987653322 22344567889999999987 459999999999999999999 9999998776655
Q ss_pred HHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 331 LHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 331 ~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
+..+...... .....+++++.+||.+||+.||.+|||+.|++++
T Consensus 315 ~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 315 FKLLKEGHRM--------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHTTCCC--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCC--------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5444322100 1123568899999999999999999999999974
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=366.28 Aligned_cols=268 Identities=24% Similarity=0.368 Sum_probs=203.9
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCCh---------------HHHHHHHHHHHHHHhCCCCCeee
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP---------------HSVKFMAREIMILQKLDHPNIVK 188 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~---------------~~~~~~~~Ei~iL~~L~HpnIv~ 188 (584)
.++|++.+.||+|+||.||+|.+ +|+.||||++....... .....+.+|+.++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46799999999999999999988 89999999996432111 11267889999999999999999
Q ss_pred eeceeeecCcceEEEEEechhh-HHHHH------hhCC-CCCCcH------HHHHHHHHHHHHh-CCceeccccccceee
Q 043957 189 LEGLATSRMQYSLYLVFEFMQT-DLARI------ISNP-EGKLTE------PQQLLSGLQHCHD-RGILHRDVKGSNLLI 253 (584)
Q Consensus 189 l~~~~~~~~~~~l~lV~Ey~~g-~L~~~------l~~~-~~~l~~------~~qIl~aL~yLH~-~~IvHrDLKp~NILl 253 (584)
+++++... ..+|+||||+.+ +|.++ +... ...+++ ..||+.||.|||+ +||+||||||+||||
T Consensus 108 ~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 108 CEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CSEEEESS--SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred EEEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 99988764 468999999986 77776 4321 233433 3599999999999 999999999999999
Q ss_pred cCCCcEEEEEeccccccCCCCCCCCccccccccccChhhhhCCCCCCc-eeeEecchHHHHHHHhCCCCCCCCCh-HHHH
Q 043957 254 DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGV-GIDLWSAGCLLAEMFLGRPIMPGRTE-VEQL 331 (584)
Q Consensus 254 ~~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~-~sDIwSLGvilyeLltG~~pF~~~~~-~~~~ 331 (584)
+.++.+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|.+||..... .+.+
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 99999999999999876433 2355678999999999987545666 99999999999999999999998776 5555
Q ss_pred HHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 332 HRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 332 ~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
..+.......+... .... ..............++..+.+||.+||+.||.+|||++|+|+||||...
T Consensus 263 ~~i~~~~~~~~~~~-------~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 263 NNIRTKNIEYPLDR-------NHFL-YPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHTSCCCCCCCSS-------SSST-TTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHhccCcCCccch-------hhhh-ccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 54433211111000 0000 0000001112235688999999999999999999999999999999764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=353.72 Aligned_cols=247 Identities=23% Similarity=0.366 Sum_probs=196.1
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.+.||+|+||.||+|.+..+++.||+|++.. ......+.+.+|+.+|++++||||+++++++... ..+|+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~l 84 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD--KRLNF 84 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC--CeeEE
Confidence 4579999999999999999999999999999999843 3455677899999999999999999999998764 46899
Q ss_pred EEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
|||||.+ +|.+++......+.+ ..||+.||+|||+++|+||||||+||||+.++.+||+|||++..+......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999985 788887654445544 359999999999999999999999999999999999999999876433221
Q ss_pred C-------------CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 043957 277 P-------------LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSE 343 (584)
Q Consensus 277 ~-------------~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~ 343 (584)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||........... ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~------~~~~ 237 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG------LNVR 237 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS------BCHH
T ss_pred ccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh------hhhh
Confidence 1 125679999999999986 4589999999999999999999998865322100000 0000
Q ss_pred HHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 344 DYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 344 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.... ......+++.+.+||.+||+.||.+|||+.++++
T Consensus 238 ~~~~------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 238 GFLD------------------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHH------------------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccc------------------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0000 0112467889999999999999999999999987
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=352.65 Aligned_cols=247 Identities=21% Similarity=0.342 Sum_probs=188.9
Q ss_pred CCCCceEEeeecccCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDT---GKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
..++|++.+.||+|+||.||+|.+..+ +..||||++... ......+.+.+|+.++++++||||+++++++.. .
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~ 88 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---N 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---S
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---C
Confidence 345799999999999999999998653 567999998643 344556778899999999999999999998743 3
Q ss_pred eEEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
.+|+||||+.+ +|.+++......+++ ..||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 46999999985 788877654434443 35999999999999999999999999999999999999999987754
Q ss_pred CCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
..........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+.+..+......
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~----------- 236 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----------- 236 (281)
T ss_dssp ----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-----------
T ss_pred ccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC-----------
Confidence 43333344567889999999976 458999999999999999996 99999988776666555332110
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.....+++.+.+||.+||+.||.+|||+.|++++
T Consensus 237 ---------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 237 ---------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1124578999999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=348.90 Aligned_cols=245 Identities=20% Similarity=0.304 Sum_probs=198.9
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..++|++++.||+|+||.||+|.+. ++..||||++...... .+.+.+|+.++++++||||+++++++.. ...+|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSK--EYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCceE
Confidence 4567999999999999999999776 5778999999754333 3568899999999999999999998865 34579
Q ss_pred EEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 203 LVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
+||||+.+ +|.+.+......+++ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++........
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 99999974 577776543333333 45999999999999999999999999999999999999999987654433
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.......+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||...........+........
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 226 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR------------ 226 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC------------
T ss_pred hcccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC------------
Confidence 333445567889999999764 48999999999999999999 9999998887776655533211110
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
...+++.+.+||.+||+.||.+|||+.|+|+|
T Consensus 227 --------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 227 --------------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp --------------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12357889999999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=369.07 Aligned_cols=253 Identities=22% Similarity=0.337 Sum_probs=201.8
Q ss_pred CCCCCceEEeeecccCceEEEEEE-----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKAL-----DRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR 196 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~-----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 196 (584)
...++|++++.||+|+||.||+|. +..++..||||++... ........+.+|+.+|++++|||||++++++...
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 345679999999999999999998 4567889999998643 3444556788999999999999999999988764
Q ss_pred CcceEEEEEechh-hHHHHHhhCCC------CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCC---cEE
Q 043957 197 MQYSLYLVFEFMQ-TDLARIISNPE------GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG---VLK 260 (584)
Q Consensus 197 ~~~~l~lV~Ey~~-g~L~~~l~~~~------~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g---~vK 260 (584)
. ..|||||||. ++|.+++.... ..+. ++.||+.||.|||++||+||||||+||||+.++ .+|
T Consensus 147 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 147 L--PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp S--SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred C--CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 3 4699999997 47887775322 2233 346999999999999999999999999998555 599
Q ss_pred EEEeccccccCCC-CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 043957 261 IADFGLANYFSPN-KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLC 338 (584)
Q Consensus 261 L~DFGla~~~~~~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~ 338 (584)
|+|||+++.+... .........+|+.|+|||++.+. .++.++|||||||++|||++ |.+||.+....+.+..+....
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999754221 11223456789999999999764 59999999999999999998 999999988877766654432
Q ss_pred CCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCC
Q 043957 339 GSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404 (584)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~ 404 (584)
... ....+++.+.+||.+||+.||.+|||+.++|+|.|+.
T Consensus 304 ~~~--------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 304 RMD--------------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC--------------------------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 110 1235688999999999999999999999999998874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=359.20 Aligned_cols=245 Identities=20% Similarity=0.216 Sum_probs=196.1
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+.+|+.+++.| +||||+++++++.. ....||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~l 82 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNAM 82 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccEE
Confidence 5799999999999999999999999999999998754322 3477899999999 89999999998877 446899
Q ss_pred EEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCc-----EEEEEeccccccCC
Q 043957 204 VFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGV-----LKIADFGLANYFSP 272 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~-----vKL~DFGla~~~~~ 272 (584)
||||+.++|.+++......+++ +.||+.||+|||+++|+||||||+||||+.++. +||+|||+++.+..
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 83 VLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred EEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 9999987888888754444544 359999999999999999999999999998887 99999999987643
Q ss_pred CCCC------CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCCh
Q 043957 273 NKKR------PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE---VEQLHRIFKLCGSPSE 343 (584)
Q Consensus 273 ~~~~------~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~---~~~~~~i~~~~~~~~~ 343 (584)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+... .+.+..+.........
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 3221 1246789999999999987 4589999999999999999999999987543 3334443322111111
Q ss_pred HHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 344 DYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 344 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
......+| ++.+||..||+.||.+|||++++++
T Consensus 242 ----------------------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 242 ----------------------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp ----------------------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ----------------------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11123455 8999999999999999999999886
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=363.37 Aligned_cols=250 Identities=25% Similarity=0.352 Sum_probs=199.5
Q ss_pred CCCCceEEeeecccCceEEEEEE-----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeec
Q 043957 123 SAESYDKIDKVGQGTYSNVYKAL-----DRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSR 196 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~-----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~ 196 (584)
..++|++.+.||+|+||.||+|. +..+++.||||++... ......+.+.+|+.+|.++ +|||||++++++...
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 45689999999999999999998 5567799999999643 3444567789999999999 799999999988764
Q ss_pred CcceEEEEEechhh-HHHHHhhCCCCC-----------------------------------------------------
Q 043957 197 MQYSLYLVFEFMQT-DLARIISNPEGK----------------------------------------------------- 222 (584)
Q Consensus 197 ~~~~l~lV~Ey~~g-~L~~~l~~~~~~----------------------------------------------------- 222 (584)
.. .+|+|||||.+ +|.+++......
T Consensus 99 ~~-~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 99 GG-PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TS-CCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CC-ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 33 47999999985 788877643221
Q ss_pred ------------Cc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC-CCCccccc
Q 043957 223 ------------LT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK-RPLTSRVV 283 (584)
Q Consensus 223 ------------l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-~~~~~~~g 283 (584)
+. +..||+.||.|||+++|+||||||+||||+.++.+||+|||++..+..... .......|
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 22 335999999999999999999999999999999999999999987643322 22345678
Q ss_pred cccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCC
Q 043957 284 TLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYK 362 (584)
Q Consensus 284 t~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 362 (584)
|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+.+...+.....+
T Consensus 258 t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--------------------- 315 (359)
T 3vhe_A 258 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--------------------- 315 (359)
T ss_dssp CGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC---------------------
T ss_pred CceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC---------------------
Confidence 999999999986 459999999999999999998 999998876554444333321111
Q ss_pred chhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 363 PRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 363 ~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.....+++++.+||.+||+.||.+|||+.|+++|
T Consensus 316 ----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 316 ----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 0113468899999999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=350.75 Aligned_cols=245 Identities=20% Similarity=0.309 Sum_probs=197.9
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..++|++++.||+|+||.||+|.+. ++..||||++...... .+.+.+|+.++++++||||+++++++... ..+|
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 95 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIF 95 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecC--CCeE
Confidence 3457999999999999999999876 5778999999754333 35678999999999999999999988663 4579
Q ss_pred EEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 203 LVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 203 lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
+||||+. ++|.+.+......+.+ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++........
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 9999997 5788887654444443 35999999999999999999999999999999999999999987654332
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.......+|+.|+|||++.+. .++.++|||||||++|+|++ |++||...+.......+........
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 242 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR------------ 242 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC------------
T ss_pred ccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC------------
Confidence 223445668889999999864 58999999999999999998 9999998887777666644321111
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
...+++.+.+||.+||+.||.+|||+.++|+|
T Consensus 243 --------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 243 --------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp --------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 12457889999999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=348.48 Aligned_cols=247 Identities=18% Similarity=0.234 Sum_probs=199.1
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~ 202 (584)
.++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+.+|+.+++.+ +|+||+.+++++.. ....|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 82 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNV 82 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeE
Confidence 35799999999999999999999999999999998644322 3467899999999 79999999988765 44689
Q ss_pred EEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCc-----EEEEEeccccccC
Q 043957 203 LVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGV-----LKIADFGLANYFS 271 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~-----vKL~DFGla~~~~ 271 (584)
+||||+.++|.+++......+++ +.||+.||.|||+++|+||||||+||||+.++. +||+|||++..+.
T Consensus 83 lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 83 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999988898888754444444 359999999999999999999999999987776 9999999998765
Q ss_pred CCCC------CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCC
Q 043957 272 PNKK------RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRT---EVEQLHRIFKLCGSPS 342 (584)
Q Consensus 272 ~~~~------~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~---~~~~~~~i~~~~~~~~ 342 (584)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.. ....+..+......+.
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 4322 12345679999999999976 458999999999999999999999998743 3344444332211111
Q ss_pred hHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 343 EDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 343 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.......+|+.+.+||.+||+.||.+|||++++++
T Consensus 242 ----------------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 242 ----------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp ----------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ----------------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 12233567999999999999999999999999886
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=354.85 Aligned_cols=260 Identities=22% Similarity=0.372 Sum_probs=194.0
Q ss_pred CCCceEEeeecccCceEEEEEE----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 124 AESYDKIDKVGQGTYSNVYKAL----DRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
.++|++++.||+|+||.||+|. +..+++.||||++.. ......+.+.+|+.+|++++||||+++++++......
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 4579999999999999999998 567899999999863 3445567889999999999999999999988765555
Q ss_pred eEEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
.+|+|||||. ++|.+++......+.+ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++..+..
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 6899999997 4888887654433443 45999999999999999999999999999999999999999987653
Q ss_pred CCC--CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh---HHHH
Q 043957 273 NKK--RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSE---DYWK 347 (584)
Q Consensus 273 ~~~--~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~---~~~~ 347 (584)
... .......+++.|+|||++.+. .++.++|||||||++|+|++|..||..... .............. ....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPA--EFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHH--HHHHHHCTTCCTHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChH--HHHhhhcCccccchhHHHHHH
Confidence 321 112334578889999999864 589999999999999999999998865321 11111111000000 0011
Q ss_pred HhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 348 KLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 348 ~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.+...... .....+++++.+||.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 244 LLKNNGRL-----------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHTTCCC-----------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhccCcC-----------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11101010 112457899999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=354.82 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=198.7
Q ss_pred CCCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC--CCCeeeeeceeeecC
Q 043957 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD--HPNIVKLEGLATSRM 197 (584)
Q Consensus 120 ~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~~~ 197 (584)
+....++|++++.||+|+||.||+|.+. +++.||||++..........+.+.+|+.+++++. ||||+++++++...
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~- 100 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD- 100 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS-
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC-
Confidence 3445567999999999999999999886 4899999999876666667788999999999997 59999999988763
Q ss_pred cceEEEEEechhhHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccC
Q 043957 198 QYSLYLVFEFMQTDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS 271 (584)
Q Consensus 198 ~~~l~lV~Ey~~g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~ 271 (584)
..+|+|||++.++|.+.+.... .+. +..||+.||.|||+++|+||||||+|||++ ++.+||+|||++..+.
T Consensus 101 -~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 101 -QYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177 (313)
T ss_dssp -SEEEEEECCCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred -CEEEEEEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence 4689999988888988876432 333 345999999999999999999999999996 4899999999998765
Q ss_pred CCCCC-CCccccccccccChhhhhCC----------CCCCceeeEecchHHHHHHHhCCCCCCCCChH-HHHHHHHHhcC
Q 043957 272 PNKKR-PLTSRVVTLWYRAPELLLGA----------TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEV-EQLHRIFKLCG 339 (584)
Q Consensus 272 ~~~~~-~~~~~~gt~~Y~APEvl~~~----------~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~-~~~~~i~~~~~ 339 (584)
..... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...... ..+..+.....
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 257 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 257 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc
Confidence 33221 22345789999999998652 35889999999999999999999999765432 22222211100
Q ss_pred CCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 340 SPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.. ......++.+.+||.+||+.||.+|||+.|+|+||||...
T Consensus 258 --------------~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 258 --------------EI-----------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp --------------CC-----------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred --------------cc-----------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 00 0112347889999999999999999999999999999764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=358.96 Aligned_cols=254 Identities=28% Similarity=0.379 Sum_probs=172.5
Q ss_pred CCCceEEe-eecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec--Ccce
Q 043957 124 AESYDKID-KVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR--MQYS 200 (584)
Q Consensus 124 ~~~Y~~~~-~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~ 200 (584)
.++|.+.+ .||+|+||.||+|.+..+|+.||||++... . ....+....++.+.||||+++++++... ....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 35799966 599999999999999999999999998632 1 1222233446777999999999988652 2446
Q ss_pred EEEEEechhh-HHHHHhhCCC-CCCcH------HHHHHHHHHHHHhCCceeccccccceeecC---CCcEEEEEeccccc
Q 043957 201 LYLVFEFMQT-DLARIISNPE-GKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDK---NGVLKIADFGLANY 269 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~-~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~---~g~vKL~DFGla~~ 269 (584)
+|||||||.+ +|.+.+.... ..+++ ..||+.||.|||++||+||||||+||||+. ++.+||+|||++..
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 8999999985 8888887543 23443 359999999999999999999999999976 45699999999987
Q ss_pred cCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 270 FSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 270 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
.... .....++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+....
T Consensus 181 ~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----------- 245 (336)
T 3fhr_A 181 TTQN---ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI----------- 245 (336)
T ss_dssp C--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred cccc---ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhh-----------
Confidence 6432 2345678999999999865 458999999999999999999999997765443321111100
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
... ....+ ...+..+++.+.+||.+||+.||.+|||++|+|+||||.+.
T Consensus 246 ~~~-~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 246 RLG-QYGFP-------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ------CCC-------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred hcc-ccccC-------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 000 00000 01234678999999999999999999999999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=373.67 Aligned_cols=252 Identities=25% Similarity=0.368 Sum_probs=189.5
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~ 202 (584)
.+.|.+.+.||+|+||+||.+ ...+|+.||||++... ..+.+.+|+.+|+++ +|||||++++++.. ...+|
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~ 85 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLY 85 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEE
T ss_pred hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEE
Confidence 345777899999999999875 4567999999998642 235577899999876 89999999887765 45689
Q ss_pred EEEechhhHHHHHhhCCCCC------------CcHHHHHHHHHHHHHhCCceeccccccceeecCC-------------C
Q 043957 203 LVFEFMQTDLARIISNPEGK------------LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKN-------------G 257 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~~~~~------------l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~-------------g 257 (584)
||||||.++|.+++...... +.++.||+.||+|||+++|+||||||+||||+.+ +
T Consensus 86 lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 86 IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 99999999999888653211 1256799999999999999999999999999654 4
Q ss_pred cEEEEEeccccccCCCCCC---CCccccccccccChhhhhC------CCCCCceeeEecchHHHHHHHh-CCCCCCCCCh
Q 043957 258 VLKIADFGLANYFSPNKKR---PLTSRVVTLWYRAPELLLG------ATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTE 327 (584)
Q Consensus 258 ~vKL~DFGla~~~~~~~~~---~~~~~~gt~~Y~APEvl~~------~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~ 327 (584)
.+||+|||++..+...... .....+||+.|+|||++.+ ...++.++|||||||++|||++ |.+||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 8999999999887543321 2235689999999999965 2458999999999999999999 9999976654
Q ss_pred HHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 328 VEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 328 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
.. ..+........ ..... ....+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 246 ~~--~~i~~~~~~~~--------------~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 246 RE--SNIIRGIFSLD--------------EMKCL------HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HH--HHHHHTCCCCC--------------CCTTC------CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred hH--HHHhcCCCCcc--------------ccccc------ccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 33 22322211110 00000 01234678999999999999999999999999999964
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=357.58 Aligned_cols=256 Identities=27% Similarity=0.447 Sum_probs=178.6
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHH-HHHhCCCCCeeeeeceeeecCcceE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIM-ILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
..++|++++.||+|+||.||+|.+..+|+.||||++...... .....+..|+. +++.++||||+++++++... ...
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~--~~~ 96 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE-KEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE--GDC 96 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH-HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS--SEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc-hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC--Cce
Confidence 456899999999999999999999999999999999755333 33344555655 77778999999999988764 468
Q ss_pred EEEEechhhHHHHHhhC----CCCCCcH------HHHHHHHHHHHHhC-CceeccccccceeecCCCcEEEEEecccccc
Q 043957 202 YLVFEFMQTDLARIISN----PEGKLTE------PQQLLSGLQHCHDR-GILHRDVKGSNLLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 202 ~lV~Ey~~g~L~~~l~~----~~~~l~~------~~qIl~aL~yLH~~-~IvHrDLKp~NILl~~~g~vKL~DFGla~~~ 270 (584)
|+||||+.++|...+.. ....+.+ ..||+.||.|||++ +|+||||||+||||+.++.+||+|||++..+
T Consensus 97 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 97 WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp EEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99999999887766542 1233333 35999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCCCccccccccccChhhhh---CCCCCCceeeEecchHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCChHHH
Q 043957 271 SPNKKRPLTSRVVTLWYRAPELLL---GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEV-EQLHRIFKLCGSPSEDYW 346 (584)
Q Consensus 271 ~~~~~~~~~~~~gt~~Y~APEvl~---~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~-~~~~~i~~~~~~~~~~~~ 346 (584)
.... ......||+.|+|||++. ....++.++|||||||++|+|++|+.||...... +.+..+ .
T Consensus 177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~-------- 243 (327)
T 3aln_A 177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV---V-------- 243 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC---C--------
T ss_pred cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH---h--------
Confidence 4332 223457899999999983 2245889999999999999999999999764321 111000 0
Q ss_pred HHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 347 KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 347 ~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
....+ ... ......+++.+.+||.+||+.||.+|||+.++|+||||..
T Consensus 244 -------~~~~~-~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 244 -------KGDPP-QLS---NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp -------CSCCC-CCC---CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred -------cCCCC-CCC---CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 00000 000 0112457899999999999999999999999999999964
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=347.23 Aligned_cols=249 Identities=23% Similarity=0.356 Sum_probs=190.0
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.+.||+|+||.||+|.+.. .||||+++.........+.+.+|+.+|++++||||++++++... ..+++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~l 96 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAI 96 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC---CccEE
Confidence 4579999999999999999997543 59999998776677777889999999999999999999986543 24699
Q ss_pred EEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC-C
Q 043957 204 VFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK-K 275 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~ 275 (584)
|||||. ++|...+......+.+ ..||+.||.|||+++|+||||||+||||+.++.+||+|||++....... .
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 999998 5787777655444543 3599999999999999999999999999999999999999997654321 2
Q ss_pred CCCccccccccccChhhhhC--CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 276 RPLTSRVVTLWYRAPELLLG--ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~--~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
.......||+.|+|||++.. ...++.++|||||||++|+|++|+.||......+.+..++......
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 244 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS------------ 244 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCC------------
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccC------------
Confidence 22345678999999999862 3458889999999999999999999998877766655544321111
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
+........+|+.+.+||.+||+.||.+|||+.++|+
T Consensus 245 ---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 245 ---------PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp ---------CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1111223467899999999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=342.23 Aligned_cols=244 Identities=16% Similarity=0.203 Sum_probs=202.3
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..++|++.+.||+|+||.||+|.+. +..||||++..........+.+.+|+.+|++++||||+++++++.......+|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 4567999999999999999999875 88999999987766667778899999999999999999999998876556789
Q ss_pred EEEechhh-HHHHHhhCCCC-CCcH------HHHHHHHHHHHHhCC--ceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 203 LVFEFMQT-DLARIISNPEG-KLTE------PQQLLSGLQHCHDRG--ILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~~-~l~~------~~qIl~aL~yLH~~~--IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
+||||+.+ +|.+++..... .+++ ..||+.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999985 88888875432 2433 359999999999999 99999999999999999999999998765322
Q ss_pred CCCCCCccccccccccChhhhhCCC--CCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGAT--DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~~--~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.+.+.......+......+
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 230 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP--------- 230 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC---------
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC---------
Confidence 3457899999999998643 23347999999999999999999999888777655554321111
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....+++.+.+||.+||+.||.+|||++|+++
T Consensus 231 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 231 ----------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112457899999999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=361.16 Aligned_cols=265 Identities=24% Similarity=0.267 Sum_probs=195.9
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC--cceE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM--QYSL 201 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~--~~~l 201 (584)
.++|++.+.||+|+||.||+|.+. ++.||||++... ........+|+.+|++++|||||++++++.... ...+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 356999999999999999999765 799999998532 233445567999999999999999999987654 3458
Q ss_pred EEEEechhh-HHHHHhhCCCCC----CcHHHHHHHHHHHHHhC----------CceeccccccceeecCCCcEEEEEecc
Q 043957 202 YLVFEFMQT-DLARIISNPEGK----LTEPQQLLSGLQHCHDR----------GILHRDVKGSNLLIDKNGVLKIADFGL 266 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~~----l~~~~qIl~aL~yLH~~----------~IvHrDLKp~NILl~~~g~vKL~DFGl 266 (584)
|+|||||.+ +|.+++...... ..+..||+.||.|||+. +|+||||||+||||+.++.+||+|||+
T Consensus 98 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 999999985 888887643211 22345999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC-CCCccccccccccChhhhhCC----CCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 043957 267 ANYFSPNKK-RPLTSRVVTLWYRAPELLLGA----TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSP 341 (584)
Q Consensus 267 a~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~----~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~ 341 (584)
++.+..... ......+||+.|+|||++.+. ..++.++|||||||++|||++|++||.+..+.............+
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 987654322 223446899999999999763 235678899999999999999999998765432222222222333
Q ss_pred ChHHHHHhhccCCCCCCCCCCchhhhhc--cCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 342 SEDYWKKLRLSTTFRPPQSYKPRLFEAF--SEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 342 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~--~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
....+..........+ .+...+ ...++.+.+||.+||+.||.+|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRP------VLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CHHHHHHHHTTSCCCC------CCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhhhhhhhhcccCCC------CccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 3333332221111111 011111 123466899999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=345.51 Aligned_cols=244 Identities=22% Similarity=0.318 Sum_probs=195.2
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHH-----HHHHHHHHHHHhCCCCCeeeeeceeeecC
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSV-----KFMAREIMILQKLDHPNIVKLEGLATSRM 197 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~-----~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 197 (584)
..++|++.+.||+|+||.||+|.+..+++.||||++.......... +.+.+|+.++++++||||+++++++....
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3467999999999999999999999999999999986544332211 67889999999999999999999876532
Q ss_pred cceEEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCC--ceeccccccceeecCCCc-----EEEEE
Q 043957 198 QYSLYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRG--ILHRDVKGSNLLIDKNGV-----LKIAD 263 (584)
Q Consensus 198 ~~~l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~--IvHrDLKp~NILl~~~g~-----vKL~D 263 (584)
++||||+. ++|.+.+......+.+ ..||+.||.|||+++ |+||||||+||||+.++. +||+|
T Consensus 97 ----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 ----RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp ----EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred ----eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 79999998 6788887665555544 359999999999999 999999999999988776 99999
Q ss_pred eccccccCCCCCCCCccccccccccChhhhhC-CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHH--HHHHHHhcCC
Q 043957 264 FGLANYFSPNKKRPLTSRVVTLWYRAPELLLG-ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQ--LHRIFKLCGS 340 (584)
Q Consensus 264 FGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~-~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~--~~~i~~~~~~ 340 (584)
||++..... ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||........ ...+......
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 248 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC
Confidence 999985432 2355689999999999843 23478999999999999999999999986554322 2222111000
Q ss_pred CChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 341 PSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 341 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
+ .....+++.+.+||.+||+.||.+|||++|+++
T Consensus 249 ~-------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 249 P-------------------------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp C-------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-------------------------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0 112457899999999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=356.60 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=200.8
Q ss_pred CCCCCCceEEeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeee
Q 043957 121 PKSAESYDKIDKVGQGTYSNVYKALDR-----DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATS 195 (584)
Q Consensus 121 ~~~~~~Y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 195 (584)
....++|++++.||+|+||.||+|.+. .+++.||||+++... .......+.+|+.+|++++||||+++++++..
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 345678999999999999999999987 456899999996443 44456778999999999999999999998876
Q ss_pred cCcceEEEEEechhh-HHHHHhhCCC-----------------------CCCc------HHHHHHHHHHHHHhCCceecc
Q 043957 196 RMQYSLYLVFEFMQT-DLARIISNPE-----------------------GKLT------EPQQLLSGLQHCHDRGILHRD 245 (584)
Q Consensus 196 ~~~~~l~lV~Ey~~g-~L~~~l~~~~-----------------------~~l~------~~~qIl~aL~yLH~~~IvHrD 245 (584)
. ..+|+||||+.+ +|.+++.... ..+. +..||+.||.|||+++|+|||
T Consensus 122 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 122 G--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp S--SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred C--CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 4 357999999985 7887775421 2233 345999999999999999999
Q ss_pred ccccceeecCCCcEEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCC
Q 043957 246 VKGSNLLIDKNGVLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMP 323 (584)
Q Consensus 246 LKp~NILl~~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~ 323 (584)
|||+||||+.++.+||+|||++..+..... .......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 999999999999999999999976542221 222445778999999999864 59999999999999999999 999999
Q ss_pred CCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 324 GRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 324 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
+....+....+...... .....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 279 ~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 279 GMAHEEVIYYVRDGNIL--------------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TSCHHHHHHHHHTTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCChHHHHHHHhCCCcC--------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 88877666555332110 1123568899999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=366.94 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=198.7
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..++|++.+.||+|+||.||+|.+..+++.||||+++.. ........+.+|+.+|++++|||||++++++.... .+|
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~ 188 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ--PIY 188 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS--SCE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC--CcE
Confidence 346799999999999999999999999999999998643 33444567889999999999999999999887643 479
Q ss_pred EEEechh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 203 LVFEFMQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 203 lV~Ey~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
||||||. ++|.+.+......+. ++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.......
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 9999998 578777764333333 345999999999999999999999999999999999999999986543221
Q ss_pred CC-CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 276 RP-LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 276 ~~-~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
.. .....+++.|+|||++.+. .++.++|||||||++|||++ |.+||.+....+....+......+
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------------ 335 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP------------ 335 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCC------------
T ss_pred eecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 11 1223457789999999764 58999999999999999998 999999887766554443221110
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
....+|+.+.+||.+||+.||.+|||++++++
T Consensus 336 --------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 336 --------------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp --------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 11346889999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=360.46 Aligned_cols=247 Identities=23% Similarity=0.348 Sum_probs=200.8
Q ss_pred CCCceEEeeecccCceEEEEEEECC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeee
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRD-------TGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATS 195 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~ 195 (584)
.++|.+.+.||+|+||.||+|.+.. .+..||||++... ........+.+|+.+++++ +|||||++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4579999999999999999998753 3467999999654 3445567788999999999 89999999998876
Q ss_pred cCcceEEEEEechhh-HHHHHhhCCC---------------CCCcH------HHHHHHHHHHHHhCCceeccccccceee
Q 043957 196 RMQYSLYLVFEFMQT-DLARIISNPE---------------GKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLI 253 (584)
Q Consensus 196 ~~~~~l~lV~Ey~~g-~L~~~l~~~~---------------~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl 253 (584)
.. .+|+|||||.+ +|.+++.... ..+.+ +.||+.||.|||+++|+||||||+||||
T Consensus 147 ~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 147 DG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp SS--SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred CC--ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 43 47999999985 7888776432 22333 3599999999999999999999999999
Q ss_pred cCCCcEEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHH
Q 043957 254 DKNGVLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQL 331 (584)
Q Consensus 254 ~~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~ 331 (584)
+.++.+||+|||+++....... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999987653322 22344567899999999987 459999999999999999999 99999988776665
Q ss_pred HHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 332 HRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 332 ~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
..+...... .....+++++.+||.+||+.||.+|||+.|++++
T Consensus 304 ~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 304 KLLKEGHRM--------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHTTCCC--------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCC--------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 554332110 1124578999999999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=359.54 Aligned_cols=245 Identities=26% Similarity=0.358 Sum_probs=198.2
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhCC--CCCeeeeeceeeec
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP----HSVKFMAREIMILQKLD--HPNIVKLEGLATSR 196 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~~ 196 (584)
..++|++.+.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+++++. ||||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 4567999999999999999999999999999999997543221 12234667999999996 59999999988764
Q ss_pred CcceEEEEEechh--hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeec-CCCcEEEEEeccc
Q 043957 197 MQYSLYLVFEFMQ--TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLID-KNGVLKIADFGLA 267 (584)
Q Consensus 197 ~~~~l~lV~Ey~~--g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~-~~g~vKL~DFGla 267 (584)
..+++||||+. ++|.+.+... ..+. +..||+.||.|||+++|+||||||+||||+ .++.+||+|||++
T Consensus 121 --~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 121 --DSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp --SEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred --CcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 46899999997 6788777542 2333 345999999999999999999999999998 7899999999999
Q ss_pred cccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHH
Q 043957 268 NYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWK 347 (584)
Q Consensus 268 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 347 (584)
..+.... .....||+.|+|||++.+...++.++|||||||++|+|++|+.||..... +....
T Consensus 198 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~--------- 259 (320)
T 3a99_A 198 ALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQ--------- 259 (320)
T ss_dssp EECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCC---------
T ss_pred ccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhccc---------
Confidence 8765332 34567999999999998755457899999999999999999999965321 11100
Q ss_pred HhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 348 KLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 348 ~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
. .....+++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus 260 ------~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 260 ------V------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp ------C------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ------c------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 0 0113578999999999999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=347.17 Aligned_cols=245 Identities=25% Similarity=0.403 Sum_probs=201.1
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..++|++.+.||+|+||.||+|.+..++..||||++... ....+.+.+|+.++++++||||+++++++... ..+|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 85 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFY 85 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--CCEE
Confidence 345799999999999999999999999999999999643 23456788999999999999999999988764 4579
Q ss_pred EEEechh-hHHHHHhhCC-CCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 203 LVFEFMQ-TDLARIISNP-EGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 203 lV~Ey~~-g~L~~~l~~~-~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
+||||+. ++|.+.+... ...+.+ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 9999998 5788877542 222333 3599999999999999999999999999999999999999998876444
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
........+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+.......+......
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~------------- 231 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM------------- 231 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-------------
T ss_pred cccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC-------------
Confidence 3333455678899999999764 58999999999999999999 99999887765554444321110
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....+++.+.+||.+||..||.+|||++++++
T Consensus 232 -------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 232 -------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp -------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 112456899999999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=352.79 Aligned_cols=248 Identities=24% Similarity=0.340 Sum_probs=199.1
Q ss_pred CCCCceEEeeecccCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALD-----RDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM 197 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 197 (584)
..++|++.+.||+|+||.||+|.+ ..++..||||++... ......+.+.+|+.+|+.++||||+++++++....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 356799999999999999999988 345689999998643 34556678899999999999999999999887643
Q ss_pred cceEEEEEechh-hHHHHHhhCCCC-----------------------CCc------HHHHHHHHHHHHHhCCceecccc
Q 043957 198 QYSLYLVFEFMQ-TDLARIISNPEG-----------------------KLT------EPQQLLSGLQHCHDRGILHRDVK 247 (584)
Q Consensus 198 ~~~l~lV~Ey~~-g~L~~~l~~~~~-----------------------~l~------~~~qIl~aL~yLH~~~IvHrDLK 247 (584)
.+|+||||+. ++|.+++..... .+. +..||+.||.|||+++|+|||||
T Consensus 100 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 100 --PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp --SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred --ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 4799999998 578777754221 122 34599999999999999999999
Q ss_pred ccceeecCCCcEEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCC
Q 043957 248 GSNLLIDKNGVLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGR 325 (584)
Q Consensus 248 p~NILl~~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~ 325 (584)
|+||||+.++.+||+|||++........ .......+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987643321 122344678899999999864 58999999999999999999 99999887
Q ss_pred ChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 326 TEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 326 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
........+...... .....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 257 PPERLFNLLKTGHRM--------------------------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CGGGHHHHHHTTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHhhcCCcC--------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 765554443221100 1124578999999999999999999999999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=341.50 Aligned_cols=244 Identities=30% Similarity=0.438 Sum_probs=185.7
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC--hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE--PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
...++|++.+.||+|+||.||+|.+. +..||||++...... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 79 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE--P 79 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC---
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC--C
Confidence 34568999999999999999999874 889999998654322 23356788999999999999999999988764 3
Q ss_pred eEEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCC---ceeccccccceeecC--------CCcEEE
Q 043957 200 SLYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRG---ILHRDVKGSNLLIDK--------NGVLKI 261 (584)
Q Consensus 200 ~l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~---IvHrDLKp~NILl~~--------~g~vKL 261 (584)
.+|+||||+.+ +|.+++... .+.+ ..||+.||.|||+++ |+||||||+|||++. ++.+||
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp -CEEEEECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred ceEEEEEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 57999999974 666666432 3333 359999999999999 899999999999986 678999
Q ss_pred EEeccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 043957 262 ADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSP 341 (584)
Q Consensus 262 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~ 341 (584)
+|||++..+.... .....||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+......+
T Consensus 158 ~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 233 (271)
T 3dtc_A 158 TDFGLAREWHRTT---KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 233 (271)
T ss_dssp CCCCC----------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCC
T ss_pred ccCCccccccccc---ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCC
Confidence 9999998764332 2355789999999999864 58999999999999999999999999887766554443211100
Q ss_pred ChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 342 SEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 342 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.....+++.+.+||.+||+.||.+|||+.|+|+|
T Consensus 234 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 234 -------------------------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 1124568899999999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=371.24 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=186.3
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.+|.+.+.||+|+||+||. ....+|+.||||++..... ..+.+|+.+|+.+ +|||||++++++.+ ...+||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~l 95 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKD--RQFQYI 95 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEec--CCEEEE
Confidence 3599999999999999764 3456799999999864322 2246799999999 79999999988765 446899
Q ss_pred EEechhhHHHHHhhCCCCC------CcHHHHHHHHHHHHHhCCceeccccccceeecC---C--CcEEEEEeccccccCC
Q 043957 204 VFEFMQTDLARIISNPEGK------LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDK---N--GVLKIADFGLANYFSP 272 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~------l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~---~--g~vKL~DFGla~~~~~ 272 (584)
|||||.++|.+.+...... ..+..||+.||.|||+++|+||||||+||||+. + ..+||+|||+|+.+..
T Consensus 96 v~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 96 AIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred EEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 9999999999988764432 234569999999999999999999999999953 2 3588999999987653
Q ss_pred CCC--CCCccccccccccChhhhhC--CCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHH
Q 043957 273 NKK--RPLTSRVVTLWYRAPELLLG--ATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWK 347 (584)
Q Consensus 273 ~~~--~~~~~~~gt~~Y~APEvl~~--~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 347 (584)
... ......+||+.|+|||++.+ ...++.++|||||||++|+|++ |.+||........ ..+... ...
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~~~~---~~~---- 247 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NILLGA---CSL---- 247 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHHTTC---CCC----
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHHhcc---CCc----
Confidence 321 22345689999999999974 2457889999999999999999 8999965543322 111110 000
Q ss_pred HhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 348 KLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 348 ~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
. ........+..+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 248 -----------~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 248 -----------D-----CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp -----------T-----TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred -----------c-----ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 0 00001223566889999999999999999999999999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=356.76 Aligned_cols=246 Identities=23% Similarity=0.344 Sum_probs=189.4
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEE----EEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIV----ALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~v----AiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
.++|++++.||+|+||.||+|.+..+++.+ |+|.+... ......+.+.+|+.+|++++|||||++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS--
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--
Confidence 356999999999999999999998887765 77776432 22334567889999999999999999999887632
Q ss_pred eEEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
.++||||+. ++|.+.+......+.+ ..||+.||.|||+++|+||||||+||||+.++.+||+|||+++.+..
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 678899988 5788777654444443 45999999999999999999999999999999999999999987654
Q ss_pred CCCC-CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 273 NKKR-PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 273 ~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |++||.+.........+......+
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--------- 239 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP--------- 239 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---------
T ss_pred CcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC---------
Confidence 3321 2234456889999999987 459999999999999999999 999998877655544432221110
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
....++..+.+||.+||+.||.+|||+.|+|++
T Consensus 240 -----------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 240 -----------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -----------------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -----------------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 113457889999999999999999999999975
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=345.84 Aligned_cols=247 Identities=20% Similarity=0.302 Sum_probs=195.1
Q ss_pred CCCCceEEeeecccCceEEEEEEECC---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRD---TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
..++|++.+.||+|+||.||+|.+.. ++..||||++... ......+.+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 85 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE--- 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS---
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC---
Confidence 44679999999999999999998653 3456999998654 2344567789999999999999999999987643
Q ss_pred eEEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
..|+||||+. ++|.+.+......+.+ ..||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 3589999998 4777777644433443 35999999999999999999999999999999999999999987654
Q ss_pred CCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
..........+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||......+....+......+
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~---------- 234 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP---------- 234 (281)
T ss_dssp -------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC----------
T ss_pred ccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC----------
Confidence 43333344567889999999976 458999999999999999998 999998776665554443321111
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
....+++.+.+||.+||..||.+|||+.|++++
T Consensus 235 ----------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 235 ----------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 113468899999999999999999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=348.89 Aligned_cols=240 Identities=19% Similarity=0.294 Sum_probs=191.7
Q ss_pred CCCceEEeeecccCceEEEEEEECCCC-------cEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTG-------KIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR 196 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g-------~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 196 (584)
.++|++.+.||+|+||.||+|.+..++ ..||+|++... .....+.+.+|+.+|++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 457999999999999999999998877 47999998543 234557788999999999999999999988764
Q ss_pred CcceEEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCc--------EEE
Q 043957 197 MQYSLYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGV--------LKI 261 (584)
Q Consensus 197 ~~~~l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~--------vKL 261 (584)
. ..|+||||+. ++|.+++......+++ ..||+.||.|||+++|+||||||+||||+.++. +||
T Consensus 85 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 85 D--ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp T--CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred C--CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence 3 4699999998 5788887654333433 459999999999999999999999999988887 999
Q ss_pred EEeccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCC
Q 043957 262 ADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLG-RPIMPGRTEVEQLHRIFKLCGS 340 (584)
Q Consensus 262 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG-~~pF~~~~~~~~~~~i~~~~~~ 340 (584)
+|||++..... .....+|+.|+|||++.+...++.++|||||||++|+|++| .+||......... .+.....
T Consensus 163 ~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~~~- 235 (289)
T 4fvq_A 163 SDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYEDRH- 235 (289)
T ss_dssp CCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTTC-
T ss_pred ccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhccC-
Confidence 99999976532 13456899999999998755699999999999999999995 4555554443332 2221100
Q ss_pred CChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 341 PSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 341 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.....+++.+.+||.+||+.||.+|||+.|+|+|
T Consensus 236 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 236 --------------------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp --------------------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0112346788999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=343.66 Aligned_cols=248 Identities=21% Similarity=0.245 Sum_probs=196.3
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+.+|+.+++.+.|++++..+.++... ....|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCC-CCceEE
Confidence 46799999999999999999999999999999998754433 3477899999999998877776555443 456899
Q ss_pred EEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceee---cCCCcEEEEEeccccccCCCC
Q 043957 204 VFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl---~~~g~vKL~DFGla~~~~~~~ 274 (584)
||||+.++|.+++......+++ ..||+.||.|||+++|+||||||+|||| +.++.+||+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 9999988888888644444444 3599999999999999999999999999 478899999999998765432
Q ss_pred C------CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCChHH
Q 043957 275 K------RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE---VEQLHRIFKLCGSPSEDY 345 (584)
Q Consensus 275 ~------~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~---~~~~~~i~~~~~~~~~~~ 345 (584)
. .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+... ...+..+......+.
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred cccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc---
Confidence 2 123456899999999999874 589999999999999999999999986432 222333322111111
Q ss_pred HHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 346 WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 346 ~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.......+|+.+.+||.+||+.||.+|||++++++
T Consensus 239 -------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 -------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -------------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 11223567899999999999999999999999886
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=340.40 Aligned_cols=244 Identities=21% Similarity=0.333 Sum_probs=199.0
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.+.||+|+||.||+|.+. ++..||||++...... .+.+.+|+.+++.++||||+++++++.... .+|+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSS--SCEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCC--CeEE
Confidence 457999999999999999999887 5788999999754333 356889999999999999999999887643 4799
Q ss_pred EEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
||||+.+ +|.+++......+.+ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 9999984 788877654444443 359999999999999999999999999999999999999999876433222
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
......+++.|+|||++.+ ..++.++|||||||++|+|++ |++||......+....+.......
T Consensus 161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~-------------- 225 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-------------- 225 (267)
T ss_dssp STTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC--------------
T ss_pred ccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC--------------
Confidence 2344567889999999976 458999999999999999999 899999888777666554321100
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
....++..+.+||.+||+.||.+|||+.+++++
T Consensus 226 ------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 226 ------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------CCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112457889999999999999999999999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=347.48 Aligned_cols=257 Identities=24% Similarity=0.408 Sum_probs=194.2
Q ss_pred CCceEEeeecccCceEEEEEE----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 125 ESYDKIDKVGQGTYSNVYKAL----DRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
..|++++.||+|+||.||+|. +..+++.||||++.... .......+.+|+.+|+.++||||+++++++.......
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 459999999999999999998 56789999999996543 2334567889999999999999999999988766667
Q ss_pred EEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+|+||||+.+ +|.+++......+.+ ..||+.||+|||+++|+||||||+||||+.++.+||+|||++..+...
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 8999999985 788887544444443 459999999999999999999999999999999999999999877543
Q ss_pred CC--CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChH-H----H
Q 043957 274 KK--RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSED-Y----W 346 (584)
Q Consensus 274 ~~--~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~-~----~ 346 (584)
.. .......+|+.|+|||++.+. .++.++|||||||++|+|++|..|+... ... +.......... . .
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~---~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSP--MAL---FLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSH--HHH---HHHHHCSCCGGGHHHHHH
T ss_pred CcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcch--hhH---HhhccCCcccccCHHHHH
Confidence 32 123445788899999999764 4889999999999999999999886432 111 11111111111 0 1
Q ss_pred HHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 347 KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 347 ~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
..+...... .....+++.+.+||.+||+.||.+|||+.++++
T Consensus 254 ~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 254 NTLKEGKRL-----------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHTTCCC-----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHhccCCC-----------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 111111100 112467899999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=342.74 Aligned_cols=248 Identities=23% Similarity=0.300 Sum_probs=200.6
Q ss_pred CCCceEEe-eecccCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 124 AESYDKID-KVGQGTYSNVYKALDR--DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 124 ~~~Y~~~~-~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
.++|.+.+ .||+|+||.||+|.+. .++..||||++... ......+.+.+|+.+++.++||||+++++++.. ..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 83 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EA 83 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---CC
Confidence 45688877 9999999999999864 46888999999754 344567788999999999999999999998843 34
Q ss_pred EEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+|+||||+.+ +|.+++......+++ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 7999999985 788877654444544 359999999999999999999999999999999999999999876533
Q ss_pred CC--CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 274 KK--RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 274 ~~--~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
.. .......+|+.|+|||++.+. .++.++|||||||++|+|++ |++||......+....+......
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~---------- 232 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---------- 232 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC----------
T ss_pred cceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC----------
Confidence 22 112334568999999999764 58999999999999999998 99999988777666555332100
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcC
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~ 402 (584)
.....+++.+.+||.+||+.||.+|||+.++++|.+
T Consensus 233 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 233 ----------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp ----------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ----------------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 112357899999999999999999999999998754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=355.90 Aligned_cols=246 Identities=21% Similarity=0.313 Sum_probs=192.9
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcE----EEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKI----VALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
.++|++++.||+|+||.||+|.+..++.. ||+|.+.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG---S 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB---S
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---C
Confidence 45799999999999999999999888876 7777764332 22223456789999999999999999998753 3
Q ss_pred eEEEEEechh-hHHHHHhhCCCCCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQ-TDLARIISNPEGKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
.+++||||+. ++|.+.+......+ .+..||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 4799999998 57887776543333 3345999999999999999999999999999999999999999988754
Q ss_pred CCCC-CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 273 NKKR-PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 273 ~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
.... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+....+....+.......
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 237 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA--------- 237 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCC---------
T ss_pred ccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC---------
Confidence 4322 23455678899999999864 59999999999999999999 999999877665554443221100
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
....++.++.+||.+||+.||.+|||+.++++|
T Consensus 238 -----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 238 -----------------QPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp -----------------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred -----------------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112356778899999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=343.67 Aligned_cols=248 Identities=21% Similarity=0.246 Sum_probs=193.1
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.+.|++++..+.++... ....|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCC-CCceEE
Confidence 46799999999999999999999999999999987654332 2467899999999988888776665443 446899
Q ss_pred EEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceee---cCCCcEEEEEeccccccCCCC
Q 043957 204 VFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl---~~~g~vKL~DFGla~~~~~~~ 274 (584)
||||+.++|.+++......+++ ..||+.||.|||+++|+||||||+|||| +.++.+||+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 9999988888888744444444 3599999999999999999999999999 788999999999998765432
Q ss_pred C------CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCChHH
Q 043957 275 K------RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEV---EQLHRIFKLCGSPSEDY 345 (584)
Q Consensus 275 ~------~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~---~~~~~i~~~~~~~~~~~ 345 (584)
. .......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.... ..+..+.......
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---- 237 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST---- 237 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS----
T ss_pred cCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc----
Confidence 2 123456889999999999864 5899999999999999999999999875432 2222222111000
Q ss_pred HHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 346 WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 346 ~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
........+|+.+.+||.+||+.||.+|||+.++++
T Consensus 238 ------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 238 ------------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ------------------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ------------------hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 111223567899999999999999999999999987
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=354.68 Aligned_cols=251 Identities=25% Similarity=0.328 Sum_probs=197.8
Q ss_pred CCCCceEEeeecccCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeec
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALD-----RDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSR 196 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~ 196 (584)
..++|++.+.||+|+||.||+|.+ ..++..||||++.... .....+.+.+|+.+|+++ +||||+++++++...
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 346799999999999999999997 3456789999996432 233456788999999999 899999999988764
Q ss_pred CcceEEEEEechhh-HHHHHhhCCCCC----------------------Cc------HHHHHHHHHHHHHhCCceecccc
Q 043957 197 MQYSLYLVFEFMQT-DLARIISNPEGK----------------------LT------EPQQLLSGLQHCHDRGILHRDVK 247 (584)
Q Consensus 197 ~~~~l~lV~Ey~~g-~L~~~l~~~~~~----------------------l~------~~~qIl~aL~yLH~~~IvHrDLK 247 (584)
..+|+|||||.+ +|.+.+...... +. +..||+.||.|||++||+|||||
T Consensus 122 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 122 --GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp --SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred --CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 347999999974 888888754322 22 34599999999999999999999
Q ss_pred ccceeecCCCcEEEEEeccccccCCCCCC-CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCC
Q 043957 248 GSNLLIDKNGVLKIADFGLANYFSPNKKR-PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGR 325 (584)
Q Consensus 248 p~NILl~~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~ 325 (584)
|+||||+.++.+||+|||++..+...... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999876433221 12345678899999999764 58999999999999999998 99999887
Q ss_pred ChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcC
Q 043957 326 TEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402 (584)
Q Consensus 326 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~ 402 (584)
.....+..++.....+ .....+++.+.+||.+||+.||.+|||+.++++|-.
T Consensus 279 ~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 279 PVDANFYKLIQNGFKM-------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp CCSHHHHHHHHTTCCC-------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CcHHHHHHHHhcCCCC-------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 6555444443321110 011346889999999999999999999999998743
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=359.13 Aligned_cols=260 Identities=17% Similarity=0.168 Sum_probs=192.4
Q ss_pred CCCCceEEeeecccCceEEEEEEECCC-----CcEEEEEEeecCCCChH-H--------HHHHHHHHHHHHhCCCCCeee
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDT-----GKIVALKKVKFDTSEPH-S--------VKFMAREIMILQKLDHPNIVK 188 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~-~--------~~~~~~Ei~iL~~L~HpnIv~ 188 (584)
..++|++.+.||+|+||.||+|.+..+ ++.||||++........ . ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 445799999999999999999998765 57899999865421100 0 012334566677788999999
Q ss_pred eeceeeecC--cceEEEEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeec--CCCc
Q 043957 189 LEGLATSRM--QYSLYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLID--KNGV 258 (584)
Q Consensus 189 l~~~~~~~~--~~~l~lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~--~~g~ 258 (584)
+++++.... ...+|||||||.++|.+++......+++ +.||+.||.|||+++|+||||||+||||+ .++.
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 999887643 2568999999977888888755445554 35999999999999999999999999998 8899
Q ss_pred EEEEEeccccccCCCCC------CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHH
Q 043957 259 LKIADFGLANYFSPNKK------RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLH 332 (584)
Q Consensus 259 vKL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~ 332 (584)
+||+|||+++.+..... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+........
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 99999999977643221 112345699999999999864 59999999999999999999999998643332222
Q ss_pred HHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 333 RIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 333 ~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.............+.... + ....+|+++.+||..||..||.+|||+.++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~--------------~--~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKC--------------F--PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHCHHHHHHHH--------------S--CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhhhhHHHHHHHh--------------c--ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 222111000100000000 0 01467899999999999999999999999886
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=352.93 Aligned_cols=244 Identities=25% Similarity=0.367 Sum_probs=190.5
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhC----CCCCeeeeeceeee
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP----HSVKFMAREIMILQKL----DHPNIVKLEGLATS 195 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~Ei~iL~~L----~HpnIv~l~~~~~~ 195 (584)
.++|++.+.||+|+||.||+|.+..+++.||||++....... .....+.+|+.++.++ +||||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 457999999999999999999999999999999996543221 1223456799999998 89999999998876
Q ss_pred cCcceEEEEEec-hh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeec-CCCcEEEEEecc
Q 043957 196 RMQYSLYLVFEF-MQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLID-KNGVLKIADFGL 266 (584)
Q Consensus 196 ~~~~~l~lV~Ey-~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~-~~g~vKL~DFGl 266 (584)
. ...++|||| +. ++|.+.+... ..+. +..||+.||.|||+++|+||||||+|||++ .++.+||+|||+
T Consensus 110 ~--~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 110 Q--EGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred C--CeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 4 356999998 55 5787777542 2233 345999999999999999999999999998 789999999999
Q ss_pred ccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHH
Q 043957 267 ANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW 346 (584)
Q Consensus 267 a~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 346 (584)
+....... .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.... .+.....
T Consensus 187 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~------- 250 (312)
T 2iwi_A 187 GALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAEL------- 250 (312)
T ss_dssp CEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCC-------
T ss_pred hhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhcc-------
Confidence 98765432 3556789999999999865545668999999999999999999996532 1111100
Q ss_pred HHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 347 KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 347 ~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.....++..+.+||.+||+.||.+|||++|+|+||||...
T Consensus 251 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 251 --------------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred --------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 0113568899999999999999999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=352.00 Aligned_cols=247 Identities=25% Similarity=0.385 Sum_probs=178.7
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeee------c
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATS------R 196 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~------~ 196 (584)
..+|++.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+++++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 34799999999999999999999999999999998543 3445667889999999996 9999999988742 3
Q ss_pred CcceEEEEEechhhHHHHHhhC--CCCCCcH------HHHHHHHHHHHHhCC--ceeccccccceeecCCCcEEEEEecc
Q 043957 197 MQYSLYLVFEFMQTDLARIISN--PEGKLTE------PQQLLSGLQHCHDRG--ILHRDVKGSNLLIDKNGVLKIADFGL 266 (584)
Q Consensus 197 ~~~~l~lV~Ey~~g~L~~~l~~--~~~~l~~------~~qIl~aL~yLH~~~--IvHrDLKp~NILl~~~g~vKL~DFGl 266 (584)
....+|+||||+.|+|.+.+.. ....+.+ +.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 3456899999999988887753 2233433 359999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCC-----------CCccccccccccChhhhh--CCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHH
Q 043957 267 ANYFSPNKKR-----------PLTSRVVTLWYRAPELLL--GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHR 333 (584)
Q Consensus 267 a~~~~~~~~~-----------~~~~~~gt~~Y~APEvl~--~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~ 333 (584)
+..+...... ......||+.|+|||++. ....++.++|||||||++|+|++|+.||........+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 9876533221 112456899999999983 234588999999999999999999999976543322111
Q ss_pred HHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCc
Q 043957 334 IFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNE 401 (584)
Q Consensus 334 i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp 401 (584)
.. .. .....++..+.+||.+||+.||.+|||+.|+|+|-
T Consensus 265 ~~--------------------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 265 KY--------------------SI---------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp -C--------------------CC---------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred cc--------------------cC---------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 00 00 01134567789999999999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=346.92 Aligned_cols=251 Identities=19% Similarity=0.271 Sum_probs=192.1
Q ss_pred CCCCceEEeeecccCceEEEEEEECC---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRD---TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
..++|++.+.||+|+||.||+|.+.. ++..||||++..........+.+.+|+.++++++||||+++++++......
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 45679999999999999999998765 566899999987666666778899999999999999999999988765433
Q ss_pred ---eEEEEEechhh-HHHHHhhC-----CCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEe
Q 043957 200 ---SLYLVFEFMQT-DLARIISN-----PEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADF 264 (584)
Q Consensus 200 ---~l~lV~Ey~~g-~L~~~l~~-----~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DF 264 (584)
..|+||||+.+ +|...+.. ....+.+ ..||+.||.|||+++|+||||||+||||+.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence 46999999985 77776631 2233433 359999999999999999999999999999999999999
Q ss_pred ccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 043957 265 GLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPS 342 (584)
Q Consensus 265 Gla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~ 342 (584)
|++..+..... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.........+......
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-- 268 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL-- 268 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC--
T ss_pred CcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC--
Confidence 99987643321 12234466889999999976 458999999999999999999 99999888776665554332110
Q ss_pred hHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 343 EDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 343 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.....+++.+.+||.+||..||.+|||+.+++++
T Consensus 269 ------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 269 ------------------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ------------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1124578899999999999999999999999975
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=354.38 Aligned_cols=260 Identities=24% Similarity=0.335 Sum_probs=198.3
Q ss_pred CCceEEeeecccCceEEEEEE----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 125 ESYDKIDKVGQGTYSNVYKAL----DRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
++|++++.||+|+||.||+|. +..++..||||++... .....+.+.+|+.+|++++||||+++++++.......
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 569999999999999999998 5678999999998643 3455677899999999999999999999888766778
Q ss_pred EEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+|+||||+. ++|.+++......+.+ ..||+.||.|||+++|+||||||+||||+.++.+||+|||++......
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 999999996 5777777543333433 359999999999999999999999999999999999999999876533
Q ss_pred CC--CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC--hHHHHHh
Q 043957 274 KK--RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPS--EDYWKKL 349 (584)
Q Consensus 274 ~~--~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~--~~~~~~~ 349 (584)
.. .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||......... ......... ......+
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR--MMGCERDVPALSRLLELL 257 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH--HCC----CCHHHHHHHHH
T ss_pred CccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhh--hcccccccccHHHHHHHh
Confidence 22 122345678899999999764 5899999999999999999999998754322111 000000000 0111111
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
...... .....+++.+.+||.+||+.||.+|||+.|++++
T Consensus 258 ~~~~~~-----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 258 EEGQRL-----------PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HTTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcccCC-----------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111100 1124578999999999999999999999999764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=360.64 Aligned_cols=246 Identities=23% Similarity=0.359 Sum_probs=188.7
Q ss_pred CCCceEEeeecccCceEEEEEEEC---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDR---DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
..+|++.+.||+|+||.||+|.+. .++..||||+++... .....+.+.+|+.+|++++|||||++++++... ..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS--KP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--Cc
Confidence 457999999999999999999876 467789999986542 445567789999999999999999999988764 35
Q ss_pred EEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+|||||||. ++|.+++......+.+ ..||+.||.|||+++|+||||||+||||+.++.+||+|||+++.+...
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 799999997 5888888765545544 359999999999999999999999999999999999999999876543
Q ss_pred CCCCC--ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 274 KKRPL--TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 274 ~~~~~--~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
..... ....+++.|+|||++.+ ..++.++|||||||++|||++ |+.||......+....+......+
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~--------- 270 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP--------- 270 (373)
T ss_dssp -------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC---------
T ss_pred CccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence 22111 22345778999999986 459999999999999999998 999999888776665553321111
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
....++..+.+||.+||+.||.+|||+.++++
T Consensus 271 -----------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 271 -----------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp -----------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 11356889999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=348.90 Aligned_cols=248 Identities=26% Similarity=0.353 Sum_probs=187.8
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.++++++||||+++++++.. ...+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 110 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI--DGQLY 110 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee--CCeEE
Confidence 4679999999999999999999999999999999865432 33445778899999999999999999998877 44689
Q ss_pred EEEechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 203 LVFEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
+||||+.+ +|.+++... ..+. +..||+.||.|||+++|+||||||+|||++.++.+||+|||++........
T Consensus 111 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 99999985 777777532 2233 345999999999999999999999999999999999999999987654433
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...... ...+.....
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~--------------- 252 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVM-GAHINQAIP--------------- 252 (309)
T ss_dssp -------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH-HHHHHSCCC---------------
T ss_pred ccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH-HHHhccCCC---------------
Confidence 33456689999999999876 4589999999999999999999999987655422 222211100
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC-CHHHHhc
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG-SAASALK 399 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-Ta~e~L~ 399 (584)
........+|+.+.+||.+||+.||.+|| |++++++
T Consensus 253 --------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 253 --------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp --------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred --------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 01122356789999999999999999999 7777775
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=345.07 Aligned_cols=249 Identities=23% Similarity=0.325 Sum_probs=199.4
Q ss_pred CCCCceEEeeecccCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeec
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALD-----RDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSR 196 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~ 196 (584)
..++|++.+.||+|+||.||+|.+ ..++..||||++... ......+.+.+|+.+|+++ +||||+++++++...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 345799999999999999999985 457889999999644 3334567789999999999 899999999988764
Q ss_pred CcceEEEEEechhh-HHHHHhhCCCC-----------------CCcH------HHHHHHHHHHHHhCCceecccccccee
Q 043957 197 MQYSLYLVFEFMQT-DLARIISNPEG-----------------KLTE------PQQLLSGLQHCHDRGILHRDVKGSNLL 252 (584)
Q Consensus 197 ~~~~l~lV~Ey~~g-~L~~~l~~~~~-----------------~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NIL 252 (584)
. ..|+||||+.+ +|.+.+..... .+.+ ..||+.||.|||+++|+||||||+|||
T Consensus 100 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 100 G--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (313)
T ss_dssp S--SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred C--CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence 3 46999999985 78887764322 1332 359999999999999999999999999
Q ss_pred ecCCCcEEEEEeccccccCCCCCC-CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHH
Q 043957 253 IDKNGVLKIADFGLANYFSPNKKR-PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQ 330 (584)
Q Consensus 253 l~~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~ 330 (584)
++.++.+||+|||++......... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+......
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 999999999999999876543321 12345678899999999764 59999999999999999999 9999988765554
Q ss_pred HHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 331 LHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 331 ~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
+..++.....+ .....+++.+.+||.+||+.||.+|||+.|++++
T Consensus 257 ~~~~~~~~~~~-------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 257 FYKMIKEGFRM-------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHTCCC-------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccCCCC-------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 44443321110 0113568899999999999999999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=342.15 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=197.7
Q ss_pred CCCCCCCceEEeeecccCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec
Q 043957 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDT---GKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR 196 (584)
Q Consensus 120 ~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 196 (584)
++....+|++.+.||+|+||.||+|.+..+ ...||+|.+.. .......+.+.+|+.++++++||||+++++++...
T Consensus 20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred cCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc-CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 455566799999999999999999987543 34689998864 33445667789999999999999999999986543
Q ss_pred CcceEEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccc
Q 043957 197 MQYSLYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 197 ~~~~l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
....|+||||+.+ +|.+++......+.+ ..||+.||.|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 99 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 99 -EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp -SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred -CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccc
Confidence 3357999999986 888888765544443 35999999999999999999999999999999999999999987
Q ss_pred cCCCCC---CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHH
Q 043957 270 FSPNKK---RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDY 345 (584)
Q Consensus 270 ~~~~~~---~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~ 345 (584)
+..... .......+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||......+....+.......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 252 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL---- 252 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCC----
T ss_pred ccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCC----
Confidence 643221 122345678899999999764 58999999999999999999 678888776665555443321111
Q ss_pred HHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 346 WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 346 ~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
....+++.+.+||.+||+.||.+|||+.|+++
T Consensus 253 ----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 253 ----------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp ----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11346788999999999999999999999987
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=349.65 Aligned_cols=252 Identities=22% Similarity=0.339 Sum_probs=196.6
Q ss_pred CCCCceEEeeecccCceEEEEEE-----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC
Q 043957 123 SAESYDKIDKVGQGTYSNVYKAL-----DRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM 197 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~-----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 197 (584)
..++|++++.||+|+||.||+|. +..++..||||++... ........+.+|+.++++++||||+++++++....
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 44679999999999999999998 5667889999998633 34455667889999999999999999999887643
Q ss_pred cceEEEEEechh-hHHHHHhhCCC------CCCc------HHHHHHHHHHHHHhCCceeccccccceeecC---CCcEEE
Q 043957 198 QYSLYLVFEFMQ-TDLARIISNPE------GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDK---NGVLKI 261 (584)
Q Consensus 198 ~~~l~lV~Ey~~-g~L~~~l~~~~------~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~---~g~vKL 261 (584)
..|+|||||. ++|.+++.... ..+. ++.||+.||.|||+++|+||||||+||||+. +..+||
T Consensus 107 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 107 --PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp --SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred --CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 4699999996 57888776432 2233 3459999999999999999999999999984 446999
Q ss_pred EEeccccccCCCC-CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 043957 262 ADFGLANYFSPNK-KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCG 339 (584)
Q Consensus 262 ~DFGla~~~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~ 339 (584)
+|||++....... ........+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||......+.+..+.....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 9999997543222 1223445779999999999764 58999999999999999998 9999998877766655533211
Q ss_pred CCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCC
Q 043957 340 SPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404 (584)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~ 404 (584)
. .....+++.+.+||.+||+.||.+|||+.++|+|.|+.
T Consensus 264 ~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 264 M--------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp C--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C--------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0 01235688999999999999999999999999998874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=352.22 Aligned_cols=256 Identities=16% Similarity=0.179 Sum_probs=190.1
Q ss_pred CCCCceEEeeecccCceEEEEEEECC---CCcEEEEEEeecCCCChH---------HHHHHHHHHHHHHhCCCCCeeeee
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRD---TGKIVALKKVKFDTSEPH---------SVKFMAREIMILQKLDHPNIVKLE 190 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~---------~~~~~~~Ei~iL~~L~HpnIv~l~ 190 (584)
..++|++.+.||+|+||.||+|.+.. ++..||||++........ ....+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 34679999999999999999999987 788999999975432111 112356788999999999999999
Q ss_pred ceeeec--CcceEEEEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCC--cEE
Q 043957 191 GLATSR--MQYSLYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG--VLK 260 (584)
Q Consensus 191 ~~~~~~--~~~~l~lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g--~vK 260 (584)
+++... ....+|||||||.++|.+++.... .+++ ..||+.||.|||+++|+||||||+||||+.++ .+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 988763 345789999999778888876432 3433 35999999999999999999999999998877 999
Q ss_pred EEEeccccccCCCCC------CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCC--ChHHHHH
Q 043957 261 IADFGLANYFSPNKK------RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGR--TEVEQLH 332 (584)
Q Consensus 261 L~DFGla~~~~~~~~------~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~--~~~~~~~ 332 (584)
|+|||+++.+..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+. .......
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 999999987643211 112456899999999999874 5899999999999999999999999653 2222222
Q ss_pred HHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhcc--CCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 333 RIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFS--EFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 333 ~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~--~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.........+.. +..... .+++.+.+||.+||..||.+|||++++++.
T Consensus 273 ~~~~~~~~~~~~--------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 273 AKTNLLDELPQS--------------------VLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHTTTHH--------------------HHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHhhcccccHH--------------------HHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 221111111111 111112 678999999999999999999999999873
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=349.14 Aligned_cols=247 Identities=23% Similarity=0.353 Sum_probs=198.6
Q ss_pred CCCceEEeeecccCceEEEEEEEC-------CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeee
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDR-------DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATS 195 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~-------~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~ 195 (584)
.++|++.+.||+|+||.||+|.+. .++..||||++... ........+.+|+.+|+++ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 467999999999999999999875 45778999998644 3445567788999999999 89999999998876
Q ss_pred cCcceEEEEEechhh-HHHHHhhCCCC---------------CCc------HHHHHHHHHHHHHhCCceeccccccceee
Q 043957 196 RMQYSLYLVFEFMQT-DLARIISNPEG---------------KLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLI 253 (584)
Q Consensus 196 ~~~~~l~lV~Ey~~g-~L~~~l~~~~~---------------~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl 253 (584)
. ..+|+||||+.+ +|.+++..... .+. +..||+.||.|||+++|+||||||+||||
T Consensus 113 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 113 D--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp S--SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred C--CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 4 357999999985 78888764321 133 24599999999999999999999999999
Q ss_pred cCCCcEEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHH
Q 043957 254 DKNGVLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQL 331 (584)
Q Consensus 254 ~~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~ 331 (584)
+.++.+||+|||++........ .......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 9999999999999987653321 112344668899999999764 58999999999999999999 99999988776665
Q ss_pred HHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 332 HRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 332 ~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
..+...... .....++..+.+||.+||+.||.+|||+.|++++
T Consensus 270 ~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 270 KLLKEGHRM--------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCC--------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 554332110 0123568899999999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=350.95 Aligned_cols=249 Identities=18% Similarity=0.305 Sum_probs=199.3
Q ss_pred CCCCCceEEeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDR-----DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR 196 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 196 (584)
...++|++.+.||+|+||.||+|.+. .++..||||++... ........+.+|+.+|+.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 34567999999999999999999876 45788999998643 3344556788999999999999999999988764
Q ss_pred CcceEEEEEechhh-HHHHHhhCCC---------CC------CcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEE
Q 043957 197 MQYSLYLVFEFMQT-DLARIISNPE---------GK------LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLK 260 (584)
Q Consensus 197 ~~~~l~lV~Ey~~g-~L~~~l~~~~---------~~------l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vK 260 (584)
. ..|+||||+.+ +|.+++.... .. +.+..||+.||.|||++||+||||||+||||+.++.+|
T Consensus 101 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 101 Q--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp S--SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred C--ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence 3 57999999985 7777765311 11 22345999999999999999999999999999999999
Q ss_pred EEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 043957 261 IADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLC 338 (584)
Q Consensus 261 L~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~ 338 (584)
|+|||++........ .......+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+.......+....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 257 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 257 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC
Confidence 999999986543221 112344678999999999764 58999999999999999999 899999887766655543321
Q ss_pred CCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 339 GSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.. .....+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 258 ~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 258 LL--------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cC--------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 10 1123578899999999999999999999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=345.85 Aligned_cols=250 Identities=25% Similarity=0.347 Sum_probs=198.4
Q ss_pred CCCCceEEeeecccCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeec
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALD-----RDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSR 196 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~ 196 (584)
..++|++.+.||+|+||.||+|.+ ..+++.||||++... ........+.+|+.+|+++ +||||+++++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 346799999999999999999985 456789999999644 3344556788999999999 699999999988764
Q ss_pred CcceEEEEEechhh-HHHHHhhCCCCC---------------Cc------HHHHHHHHHHHHHhCCceeccccccceeec
Q 043957 197 MQYSLYLVFEFMQT-DLARIISNPEGK---------------LT------EPQQLLSGLQHCHDRGILHRDVKGSNLLID 254 (584)
Q Consensus 197 ~~~~l~lV~Ey~~g-~L~~~l~~~~~~---------------l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~ 254 (584)
. ..+|+|||||.+ +|.+++...... +. +..||+.||.|||+++|+||||||+||||+
T Consensus 104 ~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 104 G-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 182 (316)
T ss_dssp T-SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred C-CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence 3 347999999984 788887654321 32 235999999999999999999999999999
Q ss_pred CCCcEEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHH
Q 043957 255 KNGVLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLH 332 (584)
Q Consensus 255 ~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~ 332 (584)
.++.+||+|||++..+..... .......+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+......+.
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 261 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence 999999999999987643322 112345678999999999864 58999999999999999998 999998766444333
Q ss_pred HHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 333 RIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 333 ~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
..+.....+ .....+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 262 ~~~~~~~~~-------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 262 RRLKEGTRM-------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHTCCC-------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhccCccC-------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 332211100 0113468899999999999999999999999987
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=351.13 Aligned_cols=246 Identities=23% Similarity=0.342 Sum_probs=189.8
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEE----EEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIV----ALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~v----AiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
.++|++++.||+|+||.||+|.+..+++.| |+|.+... ........+.+|+.+|+.++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-- 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS--
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC--
Confidence 467999999999999999999998888765 66666432 23334577889999999999999999999887643
Q ss_pred eEEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
.++||||+. ++|.+.+......+.+ ..||+.||.|||+++|+||||||+||||+.++.+||+|||++..+..
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 688899988 5788777654444443 35999999999999999999999999999999999999999987643
Q ss_pred CCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 273 NKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 273 ~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+....+......+
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 239 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP--------- 239 (327)
T ss_dssp ----------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---------
T ss_pred ccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence 322 12234456889999999987 459999999999999999999 999998877666554443221111
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
....++.++.+||.+||+.||.+|||+.|+|+.
T Consensus 240 -----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 240 -----------------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -----------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 113467889999999999999999999999973
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=338.83 Aligned_cols=250 Identities=23% Similarity=0.334 Sum_probs=197.1
Q ss_pred CCCCCCceEEeeecccCceEEEEEEECCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC
Q 043957 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGK---IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM 197 (584)
Q Consensus 121 ~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 197 (584)
+...-.|++.+.||+|+||.||+|.+..++. .||+|++.. .......+.+.+|+.+++.++||||+++++++....
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR-ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE 95 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred cccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc-cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence 3444468888999999999999998765544 799999863 334456678889999999999999999999887643
Q ss_pred cceEEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccccc
Q 043957 198 QYSLYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 198 ~~~l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~ 270 (584)
. ..++||||+. ++|.+.+......+.+ ..||+.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 96 ~-~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 96 G-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp S-CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred C-CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 3 3589999996 6788888765555543 349999999999999999999999999999999999999999865
Q ss_pred CCCC---CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHH
Q 043957 271 SPNK---KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYW 346 (584)
Q Consensus 271 ~~~~---~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 346 (584)
.... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+......+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~----- 248 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP----- 248 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC-----
T ss_pred cCCcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC-----
Confidence 4321 122344577899999999976 458999999999999999999 556666665555444443221110
Q ss_pred HHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 347 KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 347 ~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
....+++.+.+||.+||+.||.+|||+.++++
T Consensus 249 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 249 ---------------------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp ---------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11346889999999999999999999999987
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=342.32 Aligned_cols=246 Identities=23% Similarity=0.315 Sum_probs=194.6
Q ss_pred CCCCceEEe-eecccCceEEEEEEE--CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 123 SAESYDKID-KVGQGTYSNVYKALD--RDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 123 ~~~~Y~~~~-~LG~G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
...+|++.+ .||+|+||.||+|.+ ..+++.||||++..........+.+.+|+.+++.++||||+++++++. ..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~ 90 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE---AE 90 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE---SS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC---CC
Confidence 346799998 999999999999954 567889999999766555555778999999999999999999999883 23
Q ss_pred eEEEEEechh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
.+|+||||+. ++|.+++... ..+. +..||+.||.|||+++|+||||||+|||++.++.+||+|||++.....
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 4799999998 5777777542 2333 345999999999999999999999999999999999999999987654
Q ss_pred CCCC--CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 273 NKKR--PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 273 ~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
.... ......+++.|+|||++.+. .++.++|||||||++|+|++ |+.||.+....+....+......
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 239 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--------- 239 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---------
T ss_pred CCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 3221 12234567889999999764 48899999999999999999 99999988776655544322100
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 240 -----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 240 -----------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -----------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112457899999999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=366.33 Aligned_cols=271 Identities=23% Similarity=0.316 Sum_probs=200.1
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... ....+.+.+|+.+|++++|||||++++++.......+|+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 4579999999999999999999999999999999964322 223566789999999999999999999988776667899
Q ss_pred EEechh-hHHHHHhhCCCCC--CcH------HHHHHHHHHHHHhCCceeccccccceee----cCCCcEEEEEecccccc
Q 043957 204 VFEFMQ-TDLARIISNPEGK--LTE------PQQLLSGLQHCHDRGILHRDVKGSNLLI----DKNGVLKIADFGLANYF 270 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~~--l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl----~~~g~vKL~DFGla~~~ 270 (584)
|||||. ++|..++...... +.+ ..||+.||+|||++||+||||||+|||| +.++.+||+|||+++..
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 999997 5788777643221 333 3599999999999999999999999999 77788999999999876
Q ss_pred CCCCCCCCccccccccccChhhhhCC-------CCCCceeeEecchHHHHHHHhCCCCCCCC----ChHHHHHHHHHhcC
Q 043957 271 SPNKKRPLTSRVVTLWYRAPELLLGA-------TDYGVGIDLWSAGCLLAEMFLGRPIMPGR----TEVEQLHRIFKLCG 339 (584)
Q Consensus 271 ~~~~~~~~~~~~gt~~Y~APEvl~~~-------~~~~~~sDIwSLGvilyeLltG~~pF~~~----~~~~~~~~i~~~~~ 339 (584)
.... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||... ...+.+..++....
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp CCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred cCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 5432 23456799999999998641 34788999999999999999999999643 33444444443221
Q ss_pred CCChHHHHHhhccCCCC-CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 340 SPSEDYWKKLRLSTTFR-PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 340 ~~~~~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
...|..+....... ......+........+++.+.+||.+||+.||++|||+.|++++
T Consensus 245 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 245 ---SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp ---TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred ---cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 11111110000000 00000000001123456788999999999999999999998653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=372.25 Aligned_cols=245 Identities=25% Similarity=0.404 Sum_probs=200.6
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..++|++.+.||+|+||.||+|.+..++..||||+++.... ..+.+.+|+.+|++++|||||++++++.... .+|
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~ 292 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PFY 292 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecCC--cEE
Confidence 34579999999999999999999999999999999965432 3567889999999999999999999987643 479
Q ss_pred EEEechh-hHHHHHhhCC-CCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 203 LVFEFMQ-TDLARIISNP-EGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 203 lV~Ey~~-g~L~~~l~~~-~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
||||||. ++|.+++... ...+.+ +.||+.||+|||+++|+||||||+||||+.++.+||+|||+++......
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 9999998 5788887642 223333 3599999999999999999999999999999999999999998875443
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
........+++.|+|||++.+. .++.++|||||||++|||++ |.+||.+.+..+....+......
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------- 438 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM------------- 438 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-------------
T ss_pred eeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 3333445567899999999764 58999999999999999999 99999988766555444221100
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 439 -------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 439 -------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp -------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 112457899999999999999999999999987
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=366.18 Aligned_cols=244 Identities=27% Similarity=0.403 Sum_probs=198.9
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
...++|++.+.||+|+||.||+|.+. ++..||||+++.... ..+.+.+|+.+|++|+|||||++++++.. ..+
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---~~~ 257 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPI 257 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSC
T ss_pred echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEeC---Ccc
Confidence 34567999999999999999999886 478899999975432 35678899999999999999999998763 347
Q ss_pred EEEEechh-hHHHHHhhCCCC-CC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 202 YLVFEFMQ-TDLARIISNPEG-KL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 202 ~lV~Ey~~-g~L~~~l~~~~~-~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
|||||||. |+|.+++..... .+ .++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+...
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 99999998 578888764311 22 23469999999999999999999999999999999999999999876533
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
.........+++.|+|||++... .++.++|||||||++|||++ |++||.+.+..+.+..+......+
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~----------- 405 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP----------- 405 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC-----------
T ss_pred ceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 22222344567889999999764 59999999999999999999 999999988877776664432111
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
....+|+.+.+||.+||..||.+|||++++++
T Consensus 406 ---------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 406 ---------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ---------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 11356899999999999999999999999876
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=346.90 Aligned_cols=248 Identities=21% Similarity=0.353 Sum_probs=193.0
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCC----cEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTG----KIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 198 (584)
...+|++.+.||+|+||.||+|.+..++ ..||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 118 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-- 118 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC--
Confidence 4567999999999999999999877543 469999996433 444566788999999999999999999988663
Q ss_pred ceEEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccC
Q 043957 199 YSLYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS 271 (584)
Q Consensus 199 ~~l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~ 271 (584)
..+||||||+.+ +|.+++......+.+ ..||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 457999999985 788877654444544 3599999999999999999999999999999999999999998765
Q ss_pred CCCCC--CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHH
Q 043957 272 PNKKR--PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK 348 (584)
Q Consensus 272 ~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 348 (584)
..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||......+.+..+......+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~------- 270 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP------- 270 (333)
T ss_dssp ------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-------
T ss_pred cccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC-------
Confidence 33221 1123356788999999976 458999999999999999999 999998888776665553321111
Q ss_pred hhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 349 LRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 349 ~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 271 -------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 271 -------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp -------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 113568899999999999999999999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=351.62 Aligned_cols=265 Identities=26% Similarity=0.342 Sum_probs=197.7
Q ss_pred CCCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 120 VPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 120 ~~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
+....++|++.+.||+|+||.||+|.+. ++..||||++.... ....+.+.+|+.+|+.++||||+++++++... .
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 108 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDER--N 108 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT--T
T ss_pred HHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--C
Confidence 4566789999999999999999999864 68999999986543 33467788999999999999999999988764 4
Q ss_pred eEEEEEechhh-HHHHHhhCCC---CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccc
Q 043957 200 SLYLVFEFMQT-DLARIISNPE---GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 200 ~l~lV~Ey~~g-~L~~~l~~~~---~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
.+|+||||+.+ +|.+.+.... ..+. +..||+.||.|||+++|+||||||+||||+.++.+||+|||++..
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 57999999985 7777765432 1233 345999999999999999999999999999999999999999986
Q ss_pred cCCCC-CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHH
Q 043957 270 FSPNK-KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK 348 (584)
Q Consensus 270 ~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 348 (584)
..... ........||+.|+|||++.+. .++.++|||||||++|+|++|++||.+....+....+ .|..
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~----------~~~~ 257 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA----------EWAV 257 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHH----------HHTH
T ss_pred cccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHH----------HHhh
Confidence 54322 2223445789999999999764 5899999999999999999999999765432211110 0000
Q ss_pred hhccCCCCCCCCCCchhh-hhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCc
Q 043957 349 LRLSTTFRPPQSYKPRLF-EAFSEFPESSLGLLSTLLALDPAYRGSAASALKNE 401 (584)
Q Consensus 349 ~~~~~~~~~p~~~~~~~~-~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp 401 (584)
.... .........+... .....++..+.+||.+||+.||.+|||+.|+|+|-
T Consensus 258 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 258 ESHN-NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp HHHT-TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hccc-cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0000 0000000000000 11134567889999999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=348.64 Aligned_cols=246 Identities=27% Similarity=0.339 Sum_probs=194.3
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEE--EEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcc
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIV--ALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~v--AiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 199 (584)
..++|++.+.||+|+||.||+|.+..++..+ |||.+... ........+.+|+.+|+++ +||||+++++++... .
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~ 99 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--G 99 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--T
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC--C
Confidence 3457999999999999999999999888865 99998643 2333456688999999999 899999999988764 4
Q ss_pred eEEEEEechhh-HHHHHhhCCC---------------CCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCC
Q 043957 200 SLYLVFEFMQT-DLARIISNPE---------------GKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG 257 (584)
Q Consensus 200 ~l~lV~Ey~~g-~L~~~l~~~~---------------~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g 257 (584)
.+|+||||+.+ +|.+++.... ..+.+ ..||+.||.|||++||+||||||+||||+.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 68999999975 8888876532 23333 35999999999999999999999999999999
Q ss_pred cEEEEEeccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 043957 258 VLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFK 336 (584)
Q Consensus 258 ~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~ 336 (584)
.+||+|||++....... ......+++.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus 180 ~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~ 256 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256 (327)
T ss_dssp CEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred eEEEcccCcCccccccc--cccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc
Confidence 99999999997543221 22344668899999999764 58999999999999999998 9999998877665544422
Q ss_pred hcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 337 LCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.... .....+++.+.+||.+||+.||.+|||++|+|+|
T Consensus 257 ~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 257 GYRL--------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp TCCC--------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCC--------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1100 1113568899999999999999999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=336.62 Aligned_cols=243 Identities=25% Similarity=0.418 Sum_probs=196.6
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..++|++++.||+|+||.||+|.+. ++..||||++..... ..+.+.+|+.+|+.++||||+++++++... .+|
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~ 83 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQE---PIY 83 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcCC---CcE
Confidence 3467999999999999999999876 577899999964432 246788999999999999999999887642 369
Q ss_pred EEEechh-hHHHHHhhCCCC-CC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 203 LVFEFMQ-TDLARIISNPEG-KL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 203 lV~Ey~~-g~L~~~l~~~~~-~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
+||||+. ++|.+++..... .+ .+..||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 9999997 578777754211 23 234599999999999999999999999999999999999999998775443
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
........+++.|+|||++.+. .++.++|||||||++|+|++ |++||.+.+..+.+..+......
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------- 229 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM------------- 229 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-------------
T ss_pred cccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC-------------
Confidence 3333445668899999999764 58999999999999999999 99999988877666555332110
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....+++.+.+||.+||..||.+|||+.++++
T Consensus 230 -------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 230 -------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp -------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 011356889999999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=339.65 Aligned_cols=250 Identities=30% Similarity=0.472 Sum_probs=185.0
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
...++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++... ..
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 106 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NE 106 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--Cc
Confidence 34567999999999999999999999999999999997533 3445667788999999999999999999988763 46
Q ss_pred EEEEEechhh-HHHHHhhC---CCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccccc
Q 043957 201 LYLVFEFMQT-DLARIISN---PEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~---~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~ 270 (584)
+|+||||+.+ +|.+++.. ....+. +..||+.||.|||+++|+||||||+||||+.++.+||+|||++...
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 8999999986 67766642 122233 3459999999999999999999999999999999999999999876
Q ss_pred CCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCChHHHHH
Q 043957 271 SPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE--VEQLHRIFKLCGSPSEDYWKK 348 (584)
Q Consensus 271 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~--~~~~~~i~~~~~~~~~~~~~~ 348 (584)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ......+.. ...+
T Consensus 187 ~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~------- 256 (310)
T 2wqm_A 187 SSKT-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYP------- 256 (310)
T ss_dssp -------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-TCSC-------
T ss_pred cCCC-ccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-ccCC-------
Confidence 5332 22345578999999999976 4589999999999999999999999976432 122222211 1000
Q ss_pred hhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 349 LRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 349 ~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
. .....+++++.+||.+||..||.+|||+.+++++
T Consensus 257 ----------~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 257 ----------P-------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp ----------C-------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------C-------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0 0013568899999999999999999999999974
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=349.25 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=197.4
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCc-----EEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeec
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGK-----IVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSR 196 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~-----~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~ 196 (584)
..++|++.+.||+|+||.||+|.+..++. .||+|++... ......+.+.+|+.+|+.+ +||||+++++++...
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST-AHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc-cChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 35679999999999999999999877664 7999998643 3344567788999999999 899999999988764
Q ss_pred CcceEEEEEechhh-HHHHHhhCC-------------CCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCC
Q 043957 197 MQYSLYLVFEFMQT-DLARIISNP-------------EGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKN 256 (584)
Q Consensus 197 ~~~~l~lV~Ey~~g-~L~~~l~~~-------------~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~ 256 (584)
. .+|+|||||.+ +|.+.+... ...+. +..||+.||.|||+++|+||||||+||||+.+
T Consensus 123 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 123 G--PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp S--SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred C--ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 3 47999999985 777776531 11222 34599999999999999999999999999999
Q ss_pred CcEEEEEeccccccCCCCCC-CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHH
Q 043957 257 GVLKIADFGLANYFSPNKKR-PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRI 334 (584)
Q Consensus 257 g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i 334 (584)
+.+||+|||++......... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+......+..+
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 279 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence 99999999999865433221 12345678899999999864 58999999999999999998 99999887665554444
Q ss_pred HHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 335 FKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
......+. ....+++.+.+||.+||+.||.+|||+.|++++
T Consensus 280 ~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 280 VKDGYQMA-------------------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHTCCCC-------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCCC-------------------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 33211110 112457889999999999999999999999974
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=369.61 Aligned_cols=246 Identities=16% Similarity=0.214 Sum_probs=186.9
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCC-CCeeeee----------
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDH-PNIVKLE---------- 190 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~H-pnIv~l~---------- 190 (584)
....|++.+.||+|+||+||+|.+..+|+.||||++..... .....+.+.+|+.+++.+.| +|+..+.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34568899999999999999999999999999999873322 22345678899999999987 3221111
Q ss_pred -----------ceeeecC---cceEEEEEechhhHHHHHhh------CCCC------CCcHHHHHHHHHHHHHhCCceec
Q 043957 191 -----------GLATSRM---QYSLYLVFEFMQTDLARIIS------NPEG------KLTEPQQLLSGLQHCHDRGILHR 244 (584)
Q Consensus 191 -----------~~~~~~~---~~~l~lV~Ey~~g~L~~~l~------~~~~------~l~~~~qIl~aL~yLH~~~IvHr 244 (584)
.++.... ...++++|+++.++|.+++. .... .+.+..||+.||+|||+++|+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 1111111 23468999999888887773 1111 12334699999999999999999
Q ss_pred cccccceeecCCCcEEEEEeccccccCCCCCCCCccccccccccChhhhh---------CCCCCCceeeEecchHHHHHH
Q 043957 245 DVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLL---------GATDYGVGIDLWSAGCLLAEM 315 (584)
Q Consensus 245 DLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~---------~~~~~~~~sDIwSLGvilyeL 315 (584)
||||+||||+.++.+||+|||+++..... ....+| +.|+|||++. ....++.++|||||||++|+|
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 99999999999999999999999875432 355677 9999999994 334588899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHH
Q 043957 316 FLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAA 395 (584)
Q Consensus 316 ltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~ 395 (584)
++|+.||...+....... .......+|+.+.+||.+||+.||.+|||+.
T Consensus 311 ltg~~Pf~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 311 WCADLPNTDDAALGGSEW-------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp HHSSCCCCTTGGGSCSGG-------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHCCCCCCCcchhhhHHH-------------------------------HHhhcccCCHHHHHHHHHHccCChhhCcCHH
Confidence 999999977543221111 1112246789999999999999999999999
Q ss_pred HHhcCcCCC
Q 043957 396 SALKNEFFF 404 (584)
Q Consensus 396 e~L~Hp~f~ 404 (584)
++|+||||.
T Consensus 360 ~~l~~~~~~ 368 (413)
T 3dzo_A 360 QAMETPEYE 368 (413)
T ss_dssp HHTTSHHHH
T ss_pred HHHhCHHHH
Confidence 999999984
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=339.49 Aligned_cols=240 Identities=28% Similarity=0.439 Sum_probs=193.7
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeee----------
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATS---------- 195 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~---------- 195 (584)
+|++++.||+|+||.||+|.+..+++.||||++.... ..+.+|+.++++++||||+++++++..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 5999999999999999999999999999999997542 246689999999999999999998754
Q ss_pred ----cCcceEEEEEechhh-HHHHHhhCC-CCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEE
Q 043957 196 ----RMQYSLYLVFEFMQT-DLARIISNP-EGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIAD 263 (584)
Q Consensus 196 ----~~~~~l~lV~Ey~~g-~L~~~l~~~-~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~D 263 (584)
.....+|+||||+.+ +|.+++... ...+. +..||+.||.|||+++|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECc
Confidence 224468999999995 788877532 12333 345999999999999999999999999999999999999
Q ss_pred eccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 043957 264 FGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSE 343 (584)
Q Consensus 264 FGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~ 343 (584)
||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||... ......+
T Consensus 166 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~--------- 231 (284)
T 2a19_B 166 FGLVTSLKNDG--KRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDL--------- 231 (284)
T ss_dssp CTTCEESSCCS--CCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHH---------
T ss_pred chhheeccccc--cccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHh---------
Confidence 99998765432 2345678999999999986 45899999999999999999999887421 1111111
Q ss_pred HHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 344 DYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 344 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
... .....++..+.+||.+||+.||.+|||+.|+++|.|...
T Consensus 232 ------~~~--------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 232 ------RDG--------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp ------HTT--------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ------hcc--------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 000 001346788999999999999999999999999988653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=337.22 Aligned_cols=249 Identities=27% Similarity=0.333 Sum_probs=186.3
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHh--CCCCCeeeeeceeeec--Cc
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQK--LDHPNIVKLEGLATSR--MQ 198 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIv~l~~~~~~~--~~ 198 (584)
..++|++.+.||+|+||.||+|.+ +++.||||++... ....+.+|.+++.. ++||||+++++++... ..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 346799999999999999999976 6899999998532 33455667777776 7999999999886543 34
Q ss_pred ceEEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHH--------hCCceeccccccceeecCCCcEEEEE
Q 043957 199 YSLYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCH--------DRGILHRDVKGSNLLIDKNGVLKIAD 263 (584)
Q Consensus 199 ~~l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH--------~~~IvHrDLKp~NILl~~~g~vKL~D 263 (584)
..+|+||||+.+ +|.+++... .+.+ ..||+.||+||| +++|+||||||+||||+.++.+||+|
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred ceeEEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence 568999999985 788887542 3333 359999999999 99999999999999999999999999
Q ss_pred eccccccCCCCCC---CCccccccccccChhhhhCCC-----CCCceeeEecchHHHHHHHhC----------CCCCCCC
Q 043957 264 FGLANYFSPNKKR---PLTSRVVTLWYRAPELLLGAT-----DYGVGIDLWSAGCLLAEMFLG----------RPIMPGR 325 (584)
Q Consensus 264 FGla~~~~~~~~~---~~~~~~gt~~Y~APEvl~~~~-----~~~~~sDIwSLGvilyeLltG----------~~pF~~~ 325 (584)
||++......... .....+||+.|+|||++.+.. .++.++|||||||++|||++| .+||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 9999765433221 123458999999999997643 245789999999999999999 8888653
Q ss_pred Ch----HHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 326 TE----VEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 326 ~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.. ...+..+...... .+. .... .....+++.+.+||.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~----------------~~~-~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQQ----------------RPN-IPNR--WFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SCSSCCHHHHHHHHTTSCC----------------CCC-CCGG--GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCcchhhhhHHHhccCC----------------CCC-CChh--hccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 21 2222222111000 000 0000 011235678999999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=354.63 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=189.2
Q ss_pred CCCCCCceEEeeecccCceEEEEEEECCCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC
Q 043957 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTG---KIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM 197 (584)
Q Consensus 121 ~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 197 (584)
+.....|++.+.||+|+||.||+|.+..++ ..||||.+... ......+.+.+|+.+|++++|||||++++++....
T Consensus 85 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 163 (373)
T 3c1x_A 85 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 163 (373)
T ss_dssp CSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS
T ss_pred ChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 444456899999999999999999876432 46899988643 33455678899999999999999999999865433
Q ss_pred cceEEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccccc
Q 043957 198 QYSLYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 198 ~~~l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~ 270 (584)
...|+||||+.+ +|.+++......+.+ ..||+.||.|||+++|+||||||+||||+.++.+||+|||+++.+
T Consensus 164 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 164 -GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp -SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred -CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccc
Confidence 346999999985 888888765544443 359999999999999999999999999999999999999999866
Q ss_pred CCCCCC---CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHH
Q 043957 271 SPNKKR---PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYW 346 (584)
Q Consensus 271 ~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 346 (584)
...... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||...+..+....+......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~------ 315 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL------ 315 (373)
T ss_dssp ---------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC------
T ss_pred cccccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC------
Confidence 432211 1234467889999999986 458999999999999999999 78899877655544443322110
Q ss_pred HHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 347 KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 347 ~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.....+++.+.+||.+||+.||.+|||+.|++++
T Consensus 316 --------------------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 316 --------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp --------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0113468899999999999999999999999974
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=344.52 Aligned_cols=255 Identities=25% Similarity=0.353 Sum_probs=193.0
Q ss_pred ceEEeeecccCceEEEEEE----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 127 YDKIDKVGQGTYSNVYKAL----DRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
|++++.||+|+||.||++. +..+++.||||++... ........+.+|+.+|++++||||+++++++.......+|
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 4999999999999998775 3457899999999754 3445567789999999999999999999999887667899
Q ss_pred EEEechhh-HHHHHhhCCCCC----CcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC--
Q 043957 203 LVFEFMQT-DLARIISNPEGK----LTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK-- 275 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~~~----l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-- 275 (584)
+||||+.+ +|.+++...... +.+..||+.||.|||+++|+||||||+|||++.++.+||+|||++..+.....
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 191 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 191 (318)
T ss_dssp EEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEE
T ss_pred EEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccccccc
Confidence 99999985 788877643311 22335999999999999999999999999999999999999999987754322
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChH-----HHHHhh
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSED-----YWKKLR 350 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~-----~~~~~~ 350 (584)
.......+|+.|+|||++.+. .++.++|||||||++|+|++|..||....... .. ........ ....+.
T Consensus 192 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 192 RVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKF--LE---LIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp EC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH--HH---HHCSCCHHHHHHHHHHHHH
T ss_pred ccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhh--hh---hhcccccchhHHHHHHHHh
Confidence 112345678899999999864 48899999999999999999999996532211 00 11111100 000010
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.... ......+++.+.+||.+||+.||.+|||+.|+++
T Consensus 266 ~~~~-----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 266 RGER-----------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp TTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccC-----------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0000 0112457899999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=348.30 Aligned_cols=267 Identities=21% Similarity=0.269 Sum_probs=193.8
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
...++|++.+.||+|+||.||+|.+. +|+.||||++....... ....+.+|+.+++.++||||+++++++.... ..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~ 102 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ER 102 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS--CC
T ss_pred HHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecCC--ce
Confidence 34578999999999999999999754 68999999986543221 2235789999999999999999999887644 46
Q ss_pred EEEEechhh-HHHHHhhCCCC---CCc------HHHHHHHHHHHHHhC---CceeccccccceeecCCCcEEEEEecccc
Q 043957 202 YLVFEFMQT-DLARIISNPEG---KLT------EPQQLLSGLQHCHDR---GILHRDVKGSNLLIDKNGVLKIADFGLAN 268 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~---~l~------~~~qIl~aL~yLH~~---~IvHrDLKp~NILl~~~g~vKL~DFGla~ 268 (584)
|+|||||.+ +|.+.+..... .+. ++.||+.||.|||++ +|+||||||+||||+.++.+||+|||++.
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 999999985 78887765322 233 345999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHH
Q 043957 269 YFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK 348 (584)
Q Consensus 269 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 348 (584)
..............||+.|+|||++.+. .++.++|||||||++|+|++|++||...... . ........|..
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~-~~~~~~~~~~~ 253 (326)
T 3uim_A 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLA-------N-DDDVMLLDWVK 253 (326)
T ss_dssp ECCSSSSCEECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSBCHHHHT-------T-TSCSBHHHHHT
T ss_pred ccCcccccccccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCcccccccc-------c-ccchhHHHHHH
Confidence 7754444444556799999999999764 4899999999999999999999999521000 0 00000000100
Q ss_pred hhccCCCCCCCCCCchh-hhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcC
Q 043957 349 LRLSTTFRPPQSYKPRL-FEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402 (584)
Q Consensus 349 ~~~~~~~~~p~~~~~~~-~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~ 402 (584)
-..... .......... .......+..+.+||.+||+.||.+|||+.|+|+|-+
T Consensus 254 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 254 GLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TTTSSC-CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred HHhhch-hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 000000 0000000000 0111234578999999999999999999999999855
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=359.61 Aligned_cols=241 Identities=24% Similarity=0.381 Sum_probs=194.8
Q ss_pred CCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 121 ~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
....++|++.+.||+|+||.||+|.+. |+.||||+++... ..+.+.+|+.+|++++|||||++++++.... ..
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~ 261 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GG 261 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT-SC
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC-Cc
Confidence 345678999999999999999999775 7899999997543 3456889999999999999999999876643 35
Q ss_pred EEEEEechhh-HHHHHhhCCCCC-Cc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 201 LYLVFEFMQT-DLARIISNPEGK-LT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~-l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
+|||||||.+ +|.+.+...... +. ++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 8999999985 788877643221 23 345999999999999999999999999999999999999999986532
Q ss_pred CCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
.. ....+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+....+.+..+......
T Consensus 342 ~~----~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~----------- 405 (450)
T 1k9a_A 342 TQ----DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM----------- 405 (450)
T ss_dssp ---------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC-----------
T ss_pred cc----cCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 21 23367889999999986 459999999999999999998 99999987766655554332110
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....+|+.+.+||.+||+.||.+|||+.++++
T Consensus 406 ---------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 406 ---------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112457899999999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=353.55 Aligned_cols=250 Identities=18% Similarity=0.201 Sum_probs=191.0
Q ss_pred CCCCceEEeeecccCceEEEEEEECCC--------CcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeee------
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDT--------GKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVK------ 188 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~--------g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~------ 188 (584)
..++|++.+.||+|+||.||+|.+..+ ++.||||++... ..+.+|+.++++++|||||+
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 346799999999999999999999874 889999999743 34778999999999999998
Q ss_pred ---------eeceeeecCcceEEEEEechhhHHHHHhhCC-CCCCcH------HHHHHHHHHHHHhCCceecccccccee
Q 043957 189 ---------LEGLATSRMQYSLYLVFEFMQTDLARIISNP-EGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLL 252 (584)
Q Consensus 189 ---------l~~~~~~~~~~~l~lV~Ey~~g~L~~~l~~~-~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NIL 252 (584)
+++++.. ....+|||||||.++|.+++... ...+++ +.||+.||.|||+++|+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~-~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVH-QDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEE-TTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhcccc-CCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 4444444 24568999999977898888643 233443 359999999999999999999999999
Q ss_pred ecCCC--cEEEEEeccccccCCCCC------CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCC
Q 043957 253 IDKNG--VLKIADFGLANYFSPNKK------RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPG 324 (584)
Q Consensus 253 l~~~g--~vKL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~ 324 (584)
|+.++ .+||+|||+++.+..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 99988 899999999987643221 122445899999999999764 589999999999999999999999987
Q ss_pred CC-hHHHHHHHHH-hcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 325 RT-EVEQLHRIFK-LCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 325 ~~-~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.. ....+..... ....+. . .......+..+++.+.+||.+||+.||.+|||++++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~-----------~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPG-----------P-------FVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCC-----------C-------EECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChh-----------h-------hhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 64 2222222211 110000 0 00001112467899999999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=345.51 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=191.2
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec--CcceE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR--MQYSL 201 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~l 201 (584)
.++|++.+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+.+++.++||||+++++++... ....+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 35799999999999999999999999999999998643 345567788999999999999999999988642 34478
Q ss_pred EEEEechhh-HHHHHhhC---CCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccC
Q 043957 202 YLVFEFMQT-DLARIISN---PEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS 271 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~---~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~ 271 (584)
|+||||+.+ +|.+.+.. ....+++ ..||+.||.|||+++|+||||||+||||+.++.+||+|||++....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999986 77766653 2334443 3599999999999999999999999999999999999999987653
Q ss_pred CCCCC--------CCccccccccccChhhhhCCC--CCCceeeEecchHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCC
Q 043957 272 PNKKR--------PLTSRVVTLWYRAPELLLGAT--DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEV-EQLHRIFKLCGS 340 (584)
Q Consensus 272 ~~~~~--------~~~~~~gt~~Y~APEvl~~~~--~~~~~sDIwSLGvilyeLltG~~pF~~~~~~-~~~~~i~~~~~~ 340 (584)
..... ......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||...... ..+...
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~------ 259 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA------ 259 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH------
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH------
Confidence 21110 012345799999999986532 2688999999999999999999999431000 000000
Q ss_pred CChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCc
Q 043957 341 PSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNE 401 (584)
Q Consensus 341 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp 401 (584)
+.. .... .....++..+.+||.+||+.||.+|||+.++|++-
T Consensus 260 --------~~~--~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 260 --------VQN--QLSI---------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp --------HHC--C--C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --------hhc--cCCC---------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 000 0000 01145688999999999999999999999999973
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=361.46 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=194.5
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
...++|++.+.||+|+||.||+|.+.. +..||||+++..... .+.+.+|+.+|++|+|||||++++++.. ..+
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~ 253 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPI 253 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC---Cce
Confidence 345679999999999999999998875 567999999754332 4568899999999999999999998765 347
Q ss_pred EEEEechhh-HHHHHhhCCC-CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 202 YLVFEFMQT-DLARIISNPE-GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~-~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
|||||||.+ +|.+++.... ..++ ++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999984 7887775321 2233 3459999999999999999999999999999999999999999876543
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
.........+++.|+|||++.+. .++.++|||||||++|||++ |++||.+....+.+..+......+
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~----------- 401 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP----------- 401 (452)
T ss_dssp ---------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-----------
T ss_pred ceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 33333345568899999999864 59999999999999999999 999999988877766654321111
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc--CcCCC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK--NEFFF 404 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~--Hp~f~ 404 (584)
....+|+.+.+||.+||+.||.+|||++++++ +.++.
T Consensus 402 ---------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 402 ---------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp ---------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ---------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 11356889999999999999999999999987 35554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=338.96 Aligned_cols=234 Identities=24% Similarity=0.341 Sum_probs=179.3
Q ss_pred CCCceEE-eeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHH-HhCCCCCeeeeeceeee--cCcc
Q 043957 124 AESYDKI-DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMIL-QKLDHPNIVKLEGLATS--RMQY 199 (584)
Q Consensus 124 ~~~Y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL-~~L~HpnIv~l~~~~~~--~~~~ 199 (584)
.++|.+. +.||+|+||.||+|.+..+++.||||++.. ...+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 3468887 789999999999999999999999999963 13466788888 66689999999998865 3345
Q ss_pred eEEEEEechhh-HHHHHhhCCC-CCCcH------HHHHHHHHHHHHhCCceeccccccceeecC---CCcEEEEEecccc
Q 043957 200 SLYLVFEFMQT-DLARIISNPE-GKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDK---NGVLKIADFGLAN 268 (584)
Q Consensus 200 ~l~lV~Ey~~g-~L~~~l~~~~-~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~---~g~vKL~DFGla~ 268 (584)
.+|||||||.+ +|.+.+.... ..+++ ..||+.||.|||+++|+||||||+||||+. ++.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 68999999985 8888876432 23443 359999999999999999999999999988 7889999999986
Q ss_pred ccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHH
Q 043957 269 YFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK 348 (584)
Q Consensus 269 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 348 (584)
.... ..++.++|||||||++|+|++|++||.+.........+...
T Consensus 169 ~~~~------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~----------- 213 (299)
T 3m2w_A 169 ETTG------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----------- 213 (299)
T ss_dssp ECTT------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS-----------
T ss_pred cccc------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH-----------
Confidence 5321 23778999999999999999999999776543321110000
Q ss_pred hhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 349 LRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 349 ~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
.. ..........+..+++++.+||.+||+.||.+|||++|+|+||||....
T Consensus 214 ------~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 214 ------IR--MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp ------SC--TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred ------Hh--hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 00 0000011122356899999999999999999999999999999997653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=336.36 Aligned_cols=239 Identities=25% Similarity=0.397 Sum_probs=185.4
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..++|++.+.||+|+||.||+|.+. |+.||||++.... ..+.+.+|+.++++++||||+++++++... ...+|
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~ 91 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLY 91 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CCceE
Confidence 4567999999999999999999764 8899999986432 346788999999999999999999986553 33579
Q ss_pred EEEechhh-HHHHHhhCCCC-------CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 203 LVFEFMQT-DLARIISNPEG-------KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~~-------~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
+||||+.+ +|.+.+..... ...+..||+.||.|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 99999985 78777653211 22344699999999999999999999999999999999999999998654322
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
....+++.|+|||++.+ ..++.++|||||||++|+|++ |++||......+....+....
T Consensus 172 ----~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~--------------- 231 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------------- 231 (278)
T ss_dssp --------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC---------------
T ss_pred ----cCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---------------
Confidence 33467889999999976 458999999999999999998 999998876555444332110
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
. ......+++.+.+||.+||+.||.+|||+.|+++
T Consensus 232 ~-----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 232 K-----------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp C-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-----------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 0 0112457899999999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=339.48 Aligned_cols=236 Identities=27% Similarity=0.375 Sum_probs=181.9
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.+.||+|+||.||+|.+. ++.||||++... ...+.+.+|+.+|++++||||+++++++.+ ..|+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~l 76 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN----PVCL 76 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT----TTEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----CcEE
Confidence 457999999999999999999764 789999998532 345678899999999999999999988763 2599
Q ss_pred EEechhh-HHHHHhhCCCC--CC------cHHHHHHHHHHHHHh---CCceeccccccceeecCCCc-EEEEEecccccc
Q 043957 204 VFEFMQT-DLARIISNPEG--KL------TEPQQLLSGLQHCHD---RGILHRDVKGSNLLIDKNGV-LKIADFGLANYF 270 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~--~l------~~~~qIl~aL~yLH~---~~IvHrDLKp~NILl~~~g~-vKL~DFGla~~~ 270 (584)
||||+.+ +|.+++..... .+ .+..||+.||.|||+ ++|+||||||+||||+.++. +||+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 9999985 78888765332 12 234599999999999 89999999999999998886 799999999765
Q ss_pred CCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHH--HHHHHHHhcCCCChHHHHH
Q 043957 271 SPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVE--QLHRIFKLCGSPSEDYWKK 348 (584)
Q Consensus 271 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~--~~~~i~~~~~~~~~~~~~~ 348 (584)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....+....
T Consensus 157 ~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------- 221 (307)
T 2eva_A 157 QTH----MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---------- 221 (307)
T ss_dssp ------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC----------
T ss_pred ccc----cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC----------
Confidence 422 244578999999999976 458999999999999999999999997543221 111111100
Q ss_pred hhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 349 LRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 349 ~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.......+++.+.+||.+||+.||.+|||+++++++
T Consensus 222 ----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 222 ----------------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp ----------------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 001234678999999999999999999999999973
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=338.52 Aligned_cols=248 Identities=25% Similarity=0.370 Sum_probs=188.4
Q ss_pred CCCceEEeeecccCceEEEEEEECC-CCc--EEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRD-TGK--IVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~-~g~--~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
.++|++.+.||+|+||.||+|.+.. ++. .||||++..... .....+.+.+|+.++++++||||+++++++....
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC--
Confidence 3469999999999999999998643 333 689999865432 3345678899999999999999999999887643
Q ss_pred eEEEEEechh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
.++||||+. ++|.+.+......+. +..||+.||.|||+++|+||||||+|||++.++.+||+|||++.....
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 689999998 577777754333333 335999999999999999999999999999999999999999987654
Q ss_pred CCCC--CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 273 NKKR--PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 273 ~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
.... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |++||.+.+..+.+..+......+
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 244 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-------- 244 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC--------
T ss_pred cccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC--------
Confidence 3221 12344678899999999764 48899999999999999999 999999888776665553321111
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.....+++.+.+||.+||..||.+|||+.+++++
T Consensus 245 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 245 -----------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0123578999999999999999999999999973
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=368.33 Aligned_cols=245 Identities=23% Similarity=0.311 Sum_probs=193.3
Q ss_pred CCCceEEe-eecccCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 124 AESYDKID-KVGQGTYSNVYKALDR--DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 124 ~~~Y~~~~-~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
.++|.+.+ .||+|+||.||+|.++ .++..||||+++... .....+.+.+|+.+|++++|||||++++++... .
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~ 409 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---A 409 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS---S
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC---C
Confidence 34566666 8999999999999875 356779999997543 333567789999999999999999999988652 4
Q ss_pred EEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+|||||||.+ +|.+++......+.+ +.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+...
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 8999999985 688777655444544 359999999999999999999999999999999999999999876533
Q ss_pred CCC--CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 274 KKR--PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 274 ~~~--~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
... ......+++.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+.+..+......
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---------- 558 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---------- 558 (613)
T ss_dssp ------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC----------
T ss_pred CceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 221 1123345689999999976 459999999999999999998 99999998887776665432111
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....+++++.+||.+||+.||.+|||+.++++
T Consensus 559 ----------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 559 ----------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp ----------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred ----------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112357899999999999999999999999854
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=341.32 Aligned_cols=257 Identities=22% Similarity=0.389 Sum_probs=195.0
Q ss_pred CCCceEEeeecccCceEEEEEE----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 124 AESYDKIDKVGQGTYSNVYKAL----DRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
.++|++++.||+|+||.||+|. +..+++.||||++... .....+.+.+|+.+|++++||||+++++++......
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 4569999999999999999998 4668999999998643 344567789999999999999999999988776555
Q ss_pred eEEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
.+|+||||+.+ +|.+++......+.+ ..||+.||.|||+++|+||||||+||||+.++.+||+|||++.....
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 68999999985 888888654444443 35999999999999999999999999999999999999999987654
Q ss_pred CCC--CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh-HH----
Q 043957 273 NKK--RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSE-DY---- 345 (584)
Q Consensus 273 ~~~--~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~-~~---- 345 (584)
... .......+++.|+|||++.+. .++.++|||||||++|+|++|..||.... ..+. ...+.... ..
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~--~~~~---~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPP--AEFM---RMIGNDKQGQMIVFH 271 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHH--HHHH---HHHCTTCCTHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCH--HHHH---HhhccccchhhhHHH
Confidence 322 112334567889999999864 48999999999999999999998885421 1111 11111111 00
Q ss_pred -HHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 346 -WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 346 -~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
...+..... . .....+++++.+||.+||+.||.+|||+.|+++
T Consensus 272 ~~~~~~~~~~--~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LIELLKNNGR--L---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHTTCC--C---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhcCCC--C---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011110000 0 112457899999999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=346.21 Aligned_cols=274 Identities=23% Similarity=0.301 Sum_probs=186.2
Q ss_pred CCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHH--HHhCCCCCeeeeeceee---ec
Q 043957 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMI--LQKLDHPNIVKLEGLAT---SR 196 (584)
Q Consensus 122 ~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~i--L~~L~HpnIv~l~~~~~---~~ 196 (584)
...++|++++.||+|+||.||+|.+ +++.||||++... ....+..|..+ +..++||||+++++++. ..
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 3457899999999999999999965 6899999999643 22333344444 55689999999987543 23
Q ss_pred CcceEEEEEechh-hHHHHHhhCCCCC----CcHHHHHHHHHHHHHhC---------CceeccccccceeecCCCcEEEE
Q 043957 197 MQYSLYLVFEFMQ-TDLARIISNPEGK----LTEPQQLLSGLQHCHDR---------GILHRDVKGSNLLIDKNGVLKIA 262 (584)
Q Consensus 197 ~~~~l~lV~Ey~~-g~L~~~l~~~~~~----l~~~~qIl~aL~yLH~~---------~IvHrDLKp~NILl~~~g~vKL~ 262 (584)
....+|||||||. ++|.+++...... ..++.||+.||.|||+. +|+||||||+||||+.++.+||+
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred CCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 3446799999997 4888887643221 23345999999999999 99999999999999999999999
Q ss_pred EeccccccCCCC-------CCCCccccccccccChhhhhCC------CCCCceeeEecchHHHHHHHhCCCC-CCCCChH
Q 043957 263 DFGLANYFSPNK-------KRPLTSRVVTLWYRAPELLLGA------TDYGVGIDLWSAGCLLAEMFLGRPI-MPGRTEV 328 (584)
Q Consensus 263 DFGla~~~~~~~-------~~~~~~~~gt~~Y~APEvl~~~------~~~~~~sDIwSLGvilyeLltG~~p-F~~~~~~ 328 (584)
|||++..+.... .......+||+.|+|||++.+. ..++.++|||||||++|||++|..| |.+....
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 999998764321 1122355799999999999763 2366789999999999999999654 4443321
Q ss_pred HHHHHHHH-hcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHh------cCc
Q 043957 329 EQLHRIFK-LCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASAL------KNE 401 (584)
Q Consensus 329 ~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L------~Hp 401 (584)
+....+.. ....+....+........... . .+........+++.+.+||.+||+.||.+|||+.|++ .++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRP--K-FPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCC--C-CCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCC--C-CCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 11111111 111222222222111111100 0 0001111123456899999999999999999999995 466
Q ss_pred CCCC
Q 043957 402 FFFT 405 (584)
Q Consensus 402 ~f~~ 405 (584)
|-+.
T Consensus 320 ~~~~ 323 (336)
T 3g2f_A 320 WERN 323 (336)
T ss_dssp CCC-
T ss_pred HHhc
Confidence 7654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=360.37 Aligned_cols=249 Identities=18% Similarity=0.216 Sum_probs=194.4
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..++|+++++||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.|.|++++..+.++.. .....|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~-~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGV-EGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEE-ETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEe-eCCEEE
Confidence 346799999999999999999999999999999998755433 236789999999987554444433333 244679
Q ss_pred EEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceee---cCCCcEEEEEeccccccCCC
Q 043957 203 LVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 203 lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl---~~~g~vKL~DFGla~~~~~~ 273 (584)
||||||.++|.+++......+.+ +.||+.||.|||+++||||||||+|||| +.++.+||+|||+++.+...
T Consensus 80 lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999988898888744444544 3599999999999999999999999999 68899999999999876543
Q ss_pred CCC------CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCChH
Q 043957 274 KKR------PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTE---VEQLHRIFKLCGSPSED 344 (584)
Q Consensus 274 ~~~------~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~---~~~~~~i~~~~~~~~~~ 344 (584)
... .....+||+.|+|||++.+. .++.++||||||||||||++|+.||.+... ...+..+......
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~---- 234 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA---- 234 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH----
T ss_pred ccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc----
Confidence 321 12366899999999999874 599999999999999999999999987544 3333333221100
Q ss_pred HHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 345 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.........+++++.+||..||+.||.+||++.++++
T Consensus 235 ------------------~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 235 ------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp ------------------SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ------------------ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112233577999999999999999999999998765
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=370.99 Aligned_cols=238 Identities=24% Similarity=0.340 Sum_probs=190.8
Q ss_pred eeecccCceEEEEEEE--CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEech
Q 043957 131 DKVGQGTYSNVYKALD--RDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
+.||+|+||.||+|.+ ..+++.||||+++.........+.+.+|+.+|++|+|||||++++++... .+|||||||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CEEEEEEcc
Confidence 4799999999999954 45678999999976555555677899999999999999999999988642 379999999
Q ss_pred hh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC--CCCc
Q 043957 209 QT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK--RPLT 279 (584)
Q Consensus 209 ~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~--~~~~ 279 (584)
.+ +|.+++... ..+. ++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+..... ....
T Consensus 452 ~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 452 ELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp TTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 84 677777532 2333 345999999999999999999999999999999999999999987654332 2223
Q ss_pred cccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCC
Q 043957 280 SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358 (584)
Q Consensus 280 ~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p 358 (584)
...+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+....+......
T Consensus 531 ~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~------------------ 591 (635)
T 4fl3_A 531 HGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------------------ 591 (635)
T ss_dssp ----CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------------------
T ss_pred CCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------------
Confidence 4456889999999976 459999999999999999998 99999998887776665443211
Q ss_pred CCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 359 ~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....+++++.+||..||+.||.+|||++++++
T Consensus 592 --------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 592 --------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 112357899999999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=339.64 Aligned_cols=256 Identities=26% Similarity=0.312 Sum_probs=191.5
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCC--CChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT--SEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~--~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
|...+.||+|+||.||+|.+ ++..||||++.... ......+.+.+|+.+++.++||||+++++++.... .+|+|
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 108 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD--DLCLV 108 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCC--ceEEE
Confidence 55668999999999999975 68899999986432 23345677899999999999999999999887643 47999
Q ss_pred Eechh-hHHHHHhhCCC--CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 205 FEFMQ-TDLARIISNPE--GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 205 ~Ey~~-g~L~~~l~~~~--~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
|||+. ++|.+.+.... ..+. +..||+.||.|||+++|+||||||+|||++.++.+||+|||++........
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence 99997 57777765321 2233 345999999999999999999999999999999999999999987653322
Q ss_pred C-CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 276 R-PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 276 ~-~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||........+..+..............+.
T Consensus 189 ~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 262 (307)
T 2nru_A 189 TVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYID---- 262 (307)
T ss_dssp CEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSC----
T ss_pred cccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcc----
Confidence 1 1234578999999999875 37899999999999999999999998765433333332211111100000000
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
..+......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 263 --------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 263 --------KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp --------SSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------ccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00001112346788999999999999999999999974
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=365.65 Aligned_cols=248 Identities=27% Similarity=0.400 Sum_probs=199.3
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..++|++.+.||+|+||.||+|.+.. +..||||+++..... .+.+.+|+.+|++|+|||||++++++.. ..+|
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~ 337 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIY 337 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee---ccce
Confidence 34679999999999999999998875 567999999754332 4568899999999999999999998765 3479
Q ss_pred EEEechhh-HHHHHhhCCC-CCC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 203 LVFEFMQT-DLARIISNPE-GKL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~-~~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
||||||.+ +|.+++.... ..+ .++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+....
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999985 7888775321 123 334599999999999999999999999999999999999999998765322
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
........++..|+|||++.+. .++.++|||||||+||||++ |+.||.+....+.+..+......+
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------------ 484 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP------------ 484 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC------------
T ss_pred eecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 2222344567899999999864 59999999999999999999 999999988877766654321110
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC--cCCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN--EFFF 404 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H--p~f~ 404 (584)
....+++.+.+||.+||+.||.+|||++++++. .+|.
T Consensus 485 --------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 485 --------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp --------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred --------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 113578899999999999999999999999873 4543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=339.92 Aligned_cols=249 Identities=19% Similarity=0.270 Sum_probs=194.0
Q ss_pred CCCCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 121 ~~~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
....++|++.+.||+|+||.||+|.+.. .||+|++..........+.+.+|+.++++++||||+++++++.... .
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~ 103 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP--H 103 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS--C
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC--c
Confidence 3345789999999999999999998764 4999999765444444456778999999999999999999887643 5
Q ss_pred EEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+|+||||+. ++|.+++......+.+ ..||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 899999998 5788887654434443 45999999999999999999999999998 689999999998765321
Q ss_pred ----CCCCCccccccccccChhhhhC--------CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 043957 274 ----KKRPLTSRVVTLWYRAPELLLG--------ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSP 341 (584)
Q Consensus 274 ----~~~~~~~~~gt~~Y~APEvl~~--------~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~ 341 (584)
.........||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...........+.......
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 262 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN 262 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence 1122344568999999999874 2347899999999999999999999999887766655543221100
Q ss_pred ChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 342 SEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 342 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.....++..+.+||.+||..||.+|||+.++++.
T Consensus 263 -------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 263 -------------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp -------------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred -------------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0012468889999999999999999999999973
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=335.19 Aligned_cols=249 Identities=28% Similarity=0.354 Sum_probs=181.2
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC--CCCCeeeeeceeeecCc--ce
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL--DHPNIVKLEGLATSRMQ--YS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L--~HpnIv~l~~~~~~~~~--~~ 200 (584)
++|++.+.||+|+||.||+|.+. ++.||||++... ......+|.+++..+ +||||+++++++..... ..
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 46999999999999999999875 899999998532 223344566666554 89999999998876533 57
Q ss_pred EEEEEechhh-HHHHHhhCCCCC----CcHHHHHHHHHHHHHhC--------CceeccccccceeecCCCcEEEEEeccc
Q 043957 201 LYLVFEFMQT-DLARIISNPEGK----LTEPQQLLSGLQHCHDR--------GILHRDVKGSNLLIDKNGVLKIADFGLA 267 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~----l~~~~qIl~aL~yLH~~--------~IvHrDLKp~NILl~~~g~vKL~DFGla 267 (584)
+|+|||||.+ +|.+++...... +.+..||+.||.|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 189 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred eEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence 8999999985 888887643211 22345999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCC---CCccccccccccChhhhhCCCCCCce------eeEecchHHHHHHHhC----------CCCCCCCCh-
Q 043957 268 NYFSPNKKR---PLTSRVVTLWYRAPELLLGATDYGVG------IDLWSAGCLLAEMFLG----------RPIMPGRTE- 327 (584)
Q Consensus 268 ~~~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~~------sDIwSLGvilyeLltG----------~~pF~~~~~- 327 (584)
..+...... .....+||+.|+|||++.+.. +... +|||||||++|||++| ..||.....
T Consensus 190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 268 (337)
T 3mdy_A 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268 (337)
T ss_dssp EECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence 776433221 123568999999999997643 4443 9999999999999999 666644221
Q ss_pred ---HHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 328 ---VEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 328 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
...+..+.... .... ..... .....+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 269 ~~~~~~~~~~~~~~---------------~~~~--~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 269 DPSYEDMREIVCIK---------------KLRP--SFPNR--WSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp SCCHHHHHHHHTTS---------------CCCC--CCCGG--GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCchhhhHHHHhhh---------------ccCc--ccccc--chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 11111111110 0000 00000 0113457789999999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=347.55 Aligned_cols=244 Identities=17% Similarity=0.200 Sum_probs=181.3
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC------ChHHHHHHHHHHHHHHhCC---------CCCeee
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS------EPHSVKFMAREIMILQKLD---------HPNIVK 188 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~------~~~~~~~~~~Ei~iL~~L~---------HpnIv~ 188 (584)
.++|++++.||+|+||.||+|++ +|+.||||++..... .....+.+.+|+.+|+.|+ |||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 35699999999999999999987 689999999976532 2233467889999999886 666666
Q ss_pred eeceee-----------------ec-----------CcceEEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHH
Q 043957 189 LEGLAT-----------------SR-----------MQYSLYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGL 233 (584)
Q Consensus 189 l~~~~~-----------------~~-----------~~~~l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL 233 (584)
+.+++. .. ....+|||||||.+ ++++.+.. ..+++ ..||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 655432 20 14568999999975 46665543 23333 35999999
Q ss_pred HHHH-hCCceeccccccceeecCCC--------------------cEEEEEeccccccCCCCCCCCccccccccccChhh
Q 043957 234 QHCH-DRGILHRDVKGSNLLIDKNG--------------------VLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPEL 292 (584)
Q Consensus 234 ~yLH-~~~IvHrDLKp~NILl~~~g--------------------~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEv 292 (584)
.||| +++|+||||||+||||+.++ .+||+|||+|+.... ...+||+.|+|||+
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTCSGG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccChhh
Confidence 9999 99999999999999999887 899999999987642 24589999999999
Q ss_pred hhCCCCCCceeeEecchHH-HHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhcc
Q 043957 293 LLGATDYGVGIDLWSAGCL-LAEMFLGRPIMPGRTE-VEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFS 370 (584)
Q Consensus 293 l~~~~~~~~~sDIwSLGvi-lyeLltG~~pF~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 370 (584)
+.+.. +.++|||||+++ .+++++|..||..... ......+....... . ......+.
T Consensus 249 ~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------~---~~~~~~~~ 306 (336)
T 2vuw_A 249 FTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK-----------------T---KCNTPAMK 306 (336)
T ss_dssp GCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS-----------------S---CCCSHHHH
T ss_pred hcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC-----------------c---ccchhhhh
Confidence 98643 889999998777 7889999999843211 11112222111000 0 00112234
Q ss_pred CCcHhHHHHHHHhcccCCCCCCCHHHHh-cCcCCC
Q 043957 371 EFPESSLGLLSTLLALDPAYRGSAASAL-KNEFFF 404 (584)
Q Consensus 371 ~~s~~~~dLI~~~L~~DP~kRpTa~e~L-~Hp~f~ 404 (584)
.+++++.+||.+||++| ||+|+| +||||+
T Consensus 307 ~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 307 QIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 56899999999999987 999999 999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=365.53 Aligned_cols=247 Identities=22% Similarity=0.352 Sum_probs=197.7
Q ss_pred CCCCceEEeeecccCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcc
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDT---GKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQY 199 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 199 (584)
..++|++.+.||+|+||.||+|.+..+ +..||||++... ......+.+.+|+.+|++++|||||++++++.. .
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---N 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---S
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---C
Confidence 456799999999999999999998643 567999998643 344456778899999999999999999998753 2
Q ss_pred eEEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
.+|+|||||. ++|.+++......+.+ ..||+.||.|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 4799999998 5788877654434443 35999999999999999999999999999999999999999987754
Q ss_pred CCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
..........+|+.|+|||++.+. .++.++|||||||++|||++ |.+||.+....+.+..+......+
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---------- 612 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---------- 612 (656)
T ss_dssp ----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC----------
T ss_pred CcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC----------
Confidence 433333445678899999999764 59999999999999999997 999999988877776664432111
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
....+++.+.+||.+||..||.+|||+.++++.
T Consensus 613 ----------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 613 ----------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp ----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 123568999999999999999999999999863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=377.69 Aligned_cols=271 Identities=25% Similarity=0.342 Sum_probs=198.9
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeee----cCcc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATS----RMQY 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~----~~~~ 199 (584)
.++|++.+.||+|+||.||+|.+..+|+.||||++... ......+.+.+|+.+|++++|||||++++++.. ....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 46799999999999999999999999999999998654 345566778999999999999999999988654 2244
Q ss_pred eEEEEEechh-hHHHHHhhCCCC--CC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCc---EEEEEeccc
Q 043957 200 SLYLVFEFMQ-TDLARIISNPEG--KL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGV---LKIADFGLA 267 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~~--~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~---vKL~DFGla 267 (584)
..|+|||||. ++|..++..... .+ .++.||+.||.|||++||+||||||+||||+.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 5799999996 578888765321 12 33469999999999999999999999999987664 999999999
Q ss_pred cccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHH
Q 043957 268 NYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWK 347 (584)
Q Consensus 268 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 347 (584)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+...+. .....
T Consensus 172 ~~~~~~~--~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~------~~~~~ 242 (676)
T 3qa8_A 172 KELDQGE--LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR------EKSNE 242 (676)
T ss_dssp CBTTSCC--CCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----------
T ss_pred ccccccc--ccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhh------cccch
Confidence 8875433 2355689999999999876 4699999999999999999999999987654432211100 00000
Q ss_pred Hhhcc----CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 348 KLRLS----TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 348 ~~~~~----~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
..... ...... ...+........+++.+.+||.+||.+||.+|||+.|+|+||||..
T Consensus 243 ~~~~~~~l~g~~~~~-~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFS-SVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp -CCSCCCCSSSCCCC-SSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhhhccccccc-cccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 00000 000000 0001111223456789999999999999999999999999999954
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=345.22 Aligned_cols=241 Identities=18% Similarity=0.225 Sum_probs=184.2
Q ss_pred CCCCceEEeeecccCceEEEEE-----EECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC---CCCeeeeeceee
Q 043957 123 SAESYDKIDKVGQGTYSNVYKA-----LDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD---HPNIVKLEGLAT 194 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a-----~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~ 194 (584)
..++|.+.+.||+|+||.||+| .+..+++.||||++... ....+.+|+.+++.+. |+||+.+++++.
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 4567999999999999999999 46778999999998643 2345678888888887 999999999887
Q ss_pred ecCcceEEEEEechh-hHHHHHhhC----CCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecC--------
Q 043957 195 SRMQYSLYLVFEFMQ-TDLARIISN----PEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDK-------- 255 (584)
Q Consensus 195 ~~~~~~l~lV~Ey~~-g~L~~~l~~----~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~-------- 255 (584)
... ..|||||||. |+|.+++.. ....+.+ +.||+.||+|||+++|+||||||+||||+.
T Consensus 138 ~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 138 FQN--GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp CSS--CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred cCC--CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 643 5799999998 578877752 2333443 459999999999999999999999999988
Q ss_pred ---CCcEEEEEeccccccCC-CCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHH
Q 043957 256 ---NGVLKIADFGLANYFSP-NKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQL 331 (584)
Q Consensus 256 ---~g~vKL~DFGla~~~~~-~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~ 331 (584)
++.+||+|||+|+.+.. .........+||+.|+|||++.+. .|+.++|||||||++|||++|++||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~-- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC-CCCccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence 89999999999975431 122234567899999999999874 59999999999999999999999996432210
Q ss_pred HHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcC
Q 043957 332 HRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402 (584)
Q Consensus 332 ~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~ 402 (584)
| .....+. . ...++.+.+++..||+.+|.+|++..+.|.+.+
T Consensus 293 --------------~---~~~~~~~-----------~-~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 293 --------------C---KPEGLFR-----------R-LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp --------------E---EECSCCT-----------T-CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred --------------e---eechhcc-----------c-cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 0 0000000 0 013567789999999999999987766665543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=333.27 Aligned_cols=250 Identities=24% Similarity=0.283 Sum_probs=187.0
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHh--CCCCCeeeeeceeeecCc--ce
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQK--LDHPNIVKLEGLATSRMQ--YS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIv~l~~~~~~~~~--~~ 200 (584)
++|++.+.||+|+||.||+|.+ +|+.||||++... ....+.+|++++.. ++||||+++++++..... ..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 4699999999999999999987 4899999998532 34567789999988 789999999998876542 26
Q ss_pred EEEEEechhh-HHHHHhhCCCC----CCcHHHHHHHHHHHHH--------hCCceeccccccceeecCCCcEEEEEeccc
Q 043957 201 LYLVFEFMQT-DLARIISNPEG----KLTEPQQLLSGLQHCH--------DRGILHRDVKGSNLLIDKNGVLKIADFGLA 267 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~----~l~~~~qIl~aL~yLH--------~~~IvHrDLKp~NILl~~~g~vKL~DFGla 267 (584)
+|+||||+.+ +|.+++..... .+.+..||+.||.||| +++|+||||||+||||+.++.+||+|||++
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 194 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred eEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCc
Confidence 8999999986 88888764221 1223459999999999 899999999999999999999999999999
Q ss_pred cccCCCCCC---CCccccccccccChhhhhCCCC-----CCceeeEecchHHHHHHHhC----------CCCCCCCCh--
Q 043957 268 NYFSPNKKR---PLTSRVVTLWYRAPELLLGATD-----YGVGIDLWSAGCLLAEMFLG----------RPIMPGRTE-- 327 (584)
Q Consensus 268 ~~~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~-----~~~~sDIwSLGvilyeLltG----------~~pF~~~~~-- 327 (584)
......... ......||+.|+|||++.+... ++.++|||||||++|+|++| ..||.....
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 274 (342)
T 1b6c_B 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274 (342)
T ss_dssp EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence 876533221 2245579999999999976432 23689999999999999999 677765421
Q ss_pred --HHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 328 --VEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 328 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
...+...+.. ..... .....+ ....+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 275 ~~~~~~~~~~~~---------------~~~~~--~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 275 PSVEEMRKVVCE---------------QKLRP--NIPNRW--QSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CCHHHHHHHHTT---------------SCCCC--CCCGGG--GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccHHHHHHHHHH---------------HHhCC--CCcccc--cchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 1222111110 00000 000000 012345678999999999999999999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=317.29 Aligned_cols=224 Identities=17% Similarity=0.150 Sum_probs=177.0
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE-PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
++|++.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.++.+++||||+++++++... ..+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~l 108 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR--AGGLV 108 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC--CcEEE
Confidence 5799999999999999999999999999999999765433 45567789999999999999999999988774 46899
Q ss_pred EEechh-hHHHHHhhCCCC---CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCc
Q 043957 204 VFEFMQ-TDLARIISNPEG---KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLT 279 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~---~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 279 (584)
|||||. ++|.+++..... ...+..||+.||+|||++||+||||||+||||+.+|.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------------
T ss_pred EEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------------
Confidence 999998 477777753211 12234599999999999999999999999999999999997443
Q ss_pred cccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCCC
Q 043957 280 SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQ 359 (584)
Q Consensus 280 ~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~ 359 (584)
|++ .++.++|||||||++|+|++|+.||.+.+....+.... ....
T Consensus 175 -------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~--------------------~~~~ 219 (286)
T 3uqc_A 175 -------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--------------------RDTA 219 (286)
T ss_dssp -------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC--------------------BCTT
T ss_pred -------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH--------------------HHhc
Confidence 333 27899999999999999999999998765422110000 0000
Q ss_pred CCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 360 SYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 360 ~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
............+++.+.+||.+||+.||.+| |+.|+++.
T Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 01112223446789999999999999999999 99999973
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=359.45 Aligned_cols=235 Identities=25% Similarity=0.357 Sum_probs=187.6
Q ss_pred CCCceEEeeecccCceEEEEEEECC-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc---c
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRD-TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ---Y 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~---~ 199 (584)
.++|++.+.||+|+||.||+|.+.. +|+.||||++... ........+.+|+.+|++++|||||++++++..... .
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3689999999999999999999976 7899999998643 334556678899999999999999999999876443 1
Q ss_pred eEEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCC
Q 043957 200 SLYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSP 272 (584)
Q Consensus 200 ~l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~ 272 (584)
.+|||||||.| +|.+.+.. .+++ ..||+.||.|||++||+||||||+||||+.+ .+||+|||+++....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred eeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 26999999985 55554432 3333 4599999999999999999999999999875 899999999987643
Q ss_pred CCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc
Q 043957 273 NKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352 (584)
Q Consensus 273 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 352 (584)
. ...+||+.|+|||++.+. ++.++||||||||+|+|++|.+||.+.... ..+..
T Consensus 234 ~-----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~~--------- 287 (681)
T 2pzi_A 234 F-----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPED--------- 287 (681)
T ss_dssp C-----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCTT---------
T ss_pred C-----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc----------ccccc---------
Confidence 2 456799999999999763 589999999999999999999988652110 00000
Q ss_pred CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 353 ~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
.....+++.+.+||.+||+.||.+||++.++|.|+|+
T Consensus 288 --------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 288 --------------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp --------------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred --------------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0011236788999999999999999999999999886
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=307.32 Aligned_cols=183 Identities=16% Similarity=0.090 Sum_probs=128.2
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEeecCCC--------ChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcceEE
Q 043957 132 KVGQGTYSNVYKALDRDTGKIVALKKVKFDTS--------EPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 132 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l~ 202 (584)
.++.|++|.+..++....|+.||+|++..... .....+.+.+|+++|+++ .|+||+++++++++ +..+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~y 318 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--AQSGW 318 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCEEE
Confidence 35678888888877778899999999975421 123456799999999999 69999999998877 44689
Q ss_pred EEEechhh-HHHHHhhCCCCCCcH---HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 203 LVFEFMQT-DLARIISNPEGKLTE---PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~~~l~~---~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
||||||+| +|.+.+.. .+.+.+ ..||+.||+|||++|||||||||+||||+.+|.|||+|||+|+...... ...
T Consensus 319 LVMEyv~G~~L~d~i~~-~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~~~ 396 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAA-GEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-SWP 396 (569)
T ss_dssp EEEECCCSEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----CCS
T ss_pred EEEecCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-ccc
Confidence 99999996 68888765 334443 4699999999999999999999999999999999999999998775433 335
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRP 320 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~ 320 (584)
.+.+||+.|||||++.+. +..++|+||+|+++|+|+++..
T Consensus 397 ~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 397 TNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp HHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred cCceechhhccHHHhCCC--CCCcccccccccchhhhccccc
Confidence 678999999999999763 6788999999999998877653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.7e-27 Score=259.13 Aligned_cols=186 Identities=17% Similarity=0.141 Sum_probs=140.3
Q ss_pred eEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChH------HHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 128 DKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPH------SVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 128 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
...+.||+|+||.||+| ...+..+|+|++........ ..+.+.+|+.+|++++||||+++..++.... ..
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--~~ 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD--NK 414 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT--TT
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC--cc
Confidence 34568999999999999 44578999998754332211 2345789999999999999995544444433 35
Q ss_pred EEEEechh-hHHHHHhhCCCCCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC----
Q 043957 202 YLVFEFMQ-TDLARIISNPEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR---- 276 (584)
Q Consensus 202 ~lV~Ey~~-g~L~~~l~~~~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~---- 276 (584)
|||||||+ ++|.+++.. .+.+..||+.||.|||+++|+||||||+|||++. .+||+|||+|+........
T Consensus 415 ~lVmE~~~ggsL~~~l~~---~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~ 489 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED---NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDL 489 (540)
T ss_dssp EEEEECCCSEEHHHHSTT---CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHH
T ss_pred EEEEECCCCCCHHHHHHH---HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccch
Confidence 99999998 688888765 6778889999999999999999999999999998 9999999999987543211
Q ss_pred --CCccccccccccChhhhhCC-CCCCceeeEecchHHHHHHHhCCCCC
Q 043957 277 --PLTSRVVTLWYRAPELLLGA-TDYGVGIDLWSAGCLLAEMFLGRPIM 322 (584)
Q Consensus 277 --~~~~~~gt~~Y~APEvl~~~-~~~~~~sDIwSLGvilyeLltG~~pF 322 (584)
.....+||+.|||||++... ..|+..+|+||..+-..+.+.++.+|
T Consensus 490 ~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 490 IVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 12367899999999998641 24788899999998888888777655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=8e-24 Score=215.82 Aligned_cols=146 Identities=19% Similarity=0.182 Sum_probs=115.8
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCCh----------------HHHHHHHHHHHHHHhCCCCCeee
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP----------------HSVKFMAREIMILQKLDHPNIVK 188 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~----------------~~~~~~~~Ei~iL~~L~HpnIv~ 188 (584)
..|.+.+.||+|+||.||+|.+ .+|+.||||+++...... .....+.+|+.+|++++ | ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 4578889999999999999999 789999999996432111 13566889999999999 4 66
Q ss_pred eeceeeecCcceEEEEEechhh-HHHHHhhCCCCCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccc
Q 043957 189 LEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA 267 (584)
Q Consensus 189 l~~~~~~~~~~~l~lV~Ey~~g-~L~~~l~~~~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla 267 (584)
+.+++.. ...|+|||||+| +|.+ +. ......+..||+.||.|||++||+||||||+||||+ ++.+||+|||+|
T Consensus 166 v~~~~~~---~~~~lvmE~~~g~~L~~-l~-~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a 239 (282)
T 1zar_A 166 VPKVYAW---EGNAVLMELIDAKELYR-VR-VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS 239 (282)
T ss_dssp SCCEEEE---ETTEEEEECCCCEEGGG-CC-CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTC
T ss_pred cCeEEec---cceEEEEEecCCCcHHH-cc-hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCC
Confidence 6665543 235999999986 6776 43 233345667999999999999999999999999999 999999999998
Q ss_pred cccCCCCCCCCccccccccccChhhhh
Q 043957 268 NYFSPNKKRPLTSRVVTLWYRAPELLL 294 (584)
Q Consensus 268 ~~~~~~~~~~~~~~~gt~~Y~APEvl~ 294 (584)
+. +..|+|||++.
T Consensus 240 ~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 240 VE--------------VGEEGWREILE 252 (282)
T ss_dssp EE--------------TTSTTHHHHHH
T ss_pred eE--------------CCCCCHHHHHH
Confidence 64 34578999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.3e-20 Score=189.41 Aligned_cols=137 Identities=17% Similarity=0.169 Sum_probs=104.0
Q ss_pred CceEEeeecccCceEEEEEEECCCCcE--EEEEEeecCCCCh----------------------HHHHHHHHHHHHHHhC
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKI--VALKKVKFDTSEP----------------------HSVKFMAREIMILQKL 181 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~~----------------------~~~~~~~~Ei~iL~~L 181 (584)
.|.+.+.||+|+||.||+|.+..+|+. ||||+++...... .....+.+|+.+|..|
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 388999999999999999998778999 9999975432110 1123578899999999
Q ss_pred CCCCe--eeeeceeeecCcceEEEEEechhh------HHHHHhhC--CCCCCcHHHHHHHHHHHHH-hCCceeccccccc
Q 043957 182 DHPNI--VKLEGLATSRMQYSLYLVFEFMQT------DLARIISN--PEGKLTEPQQLLSGLQHCH-DRGILHRDVKGSN 250 (584)
Q Consensus 182 ~HpnI--v~l~~~~~~~~~~~l~lV~Ey~~g------~L~~~l~~--~~~~l~~~~qIl~aL~yLH-~~~IvHrDLKp~N 250 (584)
.|++| ..++. .. ..+|||||+.+ .|.+.... ......+..||+.||.||| ++||+||||||+|
T Consensus 128 ~~~~i~~p~~~~--~~----~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 128 KEAGVSVPQPYT--YM----KNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HHTTCCCCCEEE--EE----TTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred HhCCCCCCeEEE--cC----CCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 88764 33322 11 24899999953 45554432 2233455679999999999 9999999999999
Q ss_pred eeecCCCcEEEEEecccccc
Q 043957 251 LLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 251 ILl~~~g~vKL~DFGla~~~ 270 (584)
|||+. .++|+|||+|...
T Consensus 202 ILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EEESS--SEEECCCTTCEET
T ss_pred EEEcC--cEEEEECcccccC
Confidence 99988 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.2e-17 Score=176.40 Aligned_cols=139 Identities=18% Similarity=0.209 Sum_probs=96.5
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC------------hHHHH--------HHHHHHHHHHhCCCCC
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE------------PHSVK--------FMAREIMILQKLDHPN 185 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~------------~~~~~--------~~~~Ei~iL~~L~Hpn 185 (584)
-|.+..+||.|+||.||+|.+. +|+.||||+++..... ..... ...+|...|.+|.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4999999999999999999875 6999999997532100 00011 1235666777765444
Q ss_pred eeeeeceeeecCcceEEEEEechhhHHHHHhhCCCCCCcHHHHHHHHHHHHHhCCceeccccccceeecCCC--------
Q 043957 186 IVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG-------- 257 (584)
Q Consensus 186 Iv~l~~~~~~~~~~~l~lV~Ey~~g~L~~~l~~~~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g-------- 257 (584)
+.... .+... . .+|||||++|..+..+...........||+.+|.|||++|||||||||.||||+++|
T Consensus 175 v~vp~-p~~~~-~--~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~ 250 (397)
T 4gyi_A 175 FPVPE-PIAQS-R--HTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSI 250 (397)
T ss_dssp CSCCC-EEEEE-T--TEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSE
T ss_pred CCCCe-eeecc-C--ceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccccccc
Confidence 32211 11111 1 279999999754433333333334557999999999999999999999999998776
Q ss_pred --cEEEEEeccccc
Q 043957 258 --VLKIADFGLANY 269 (584)
Q Consensus 258 --~vKL~DFGla~~ 269 (584)
.+.|+||+-+..
T Consensus 251 ~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 251 TLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEEECCCTTCEE
T ss_pred ccceEEEEeCCccc
Confidence 389999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=1.1e-11 Score=123.36 Aligned_cols=138 Identities=14% Similarity=0.104 Sum_probs=102.5
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l~lV 204 (584)
.|++...++.|+++.||++.. .+..+++|+....... ....+.+|+.+|+.|. +..+.++++++.. ....|+|
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv 88 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLL 88 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEE
T ss_pred cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEEE
Confidence 589999999999999999964 3688999998532111 1234788999999985 6667788777665 3457999
Q ss_pred EechhhH-HHHHhhCCCCCCcHHHHHHHHHHHHHh---------------------------------------------
Q 043957 205 FEFMQTD-LARIISNPEGKLTEPQQLLSGLQHCHD--------------------------------------------- 238 (584)
Q Consensus 205 ~Ey~~g~-L~~~l~~~~~~l~~~~qIl~aL~yLH~--------------------------------------------- 238 (584)
|||++|. +...+...........++..+|..||+
T Consensus 89 ~e~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 89 MSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp EECCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred EEecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 9999974 444432222222445689999999998
Q ss_pred --------------CCceeccccccceeecCCCcEEEEEeccccc
Q 043957 239 --------------RGILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 239 --------------~~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
..++|+|++|.|||+++++.+.|+||+.+..
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4489999999999998765667999997753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.19 E-value=2e-11 Score=120.52 Aligned_cols=136 Identities=12% Similarity=0.088 Sum_probs=94.6
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCe--eeeeceeeecCcceE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI--VKLEGLATSRMQYSL 201 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI--v~l~~~~~~~~~~~l 201 (584)
...|.+....+.|..+.||++. ..+|..+++|+.... ....+.+|+.+|+.+.+.+| .+++.+.... ...
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~~ 90 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRD 90 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCE
T ss_pred cCCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CCC
Confidence 3456665554566779999995 445778999987533 12346789999999864444 4576655443 347
Q ss_pred EEEEechhhHHHHHhhCCCCCCcHHHHHHHHHHHHHhCC-----------------------------------------
Q 043957 202 YLVFEFMQTDLARIISNPEGKLTEPQQLLSGLQHCHDRG----------------------------------------- 240 (584)
Q Consensus 202 ~lV~Ey~~g~L~~~l~~~~~~l~~~~qIl~aL~yLH~~~----------------------------------------- 240 (584)
|+||||++|..+. .. .........++...|..||+..
T Consensus 91 ~~v~e~i~G~~l~-~~-~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 91 WLLLGEVPGQDLL-SS-HLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp EEEEECCSSEETT-TS-CCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred EEEEEecCCcccC-cC-cCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 9999999974333 21 1111234567888888888653
Q ss_pred -----------------ceeccccccceeecCCCcEEEEEeccccc
Q 043957 241 -----------------ILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 241 -----------------IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
++|+|++|.|||++.++.+.|+||+.+..
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.86 E-value=2.5e-09 Score=111.61 Aligned_cols=140 Identities=14% Similarity=0.212 Sum_probs=92.8
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEee--cCCCChHHHHHHHHHHHHHHhCC--CCCeeeeeceeeecCc-ceE
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVK--FDTSEPHSVKFMAREIMILQKLD--HPNIVKLEGLATSRMQ-YSL 201 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~--~~~~~~~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~~~~-~~l 201 (584)
...++.|+.|.++.||++... +..+++|+.. .... ......+.+|+.+|+.|. +..+.+++.++.+... ...
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 345778999999999998643 4678888764 2211 112346788999999997 4456777766654321 246
Q ss_pred EEEEechhhHHH-HHhhCC---CCCCcHHHHHHHHHHHHHh---------------------------------------
Q 043957 202 YLVFEFMQTDLA-RIISNP---EGKLTEPQQLLSGLQHCHD--------------------------------------- 238 (584)
Q Consensus 202 ~lV~Ey~~g~L~-~~l~~~---~~~l~~~~qIl~aL~yLH~--------------------------------------- 238 (584)
|+||||++|... ...... ........+++..|..||+
T Consensus 117 ~~vme~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEEEECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEEEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 899999997432 111100 0011224588888999996
Q ss_pred -------------------CCceeccccccceeecCCCc--EEEEEeccccc
Q 043957 239 -------------------RGILHRDVKGSNLLIDKNGV--LKIADFGLANY 269 (584)
Q Consensus 239 -------------------~~IvHrDLKp~NILl~~~g~--vKL~DFGla~~ 269 (584)
..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999987753 69999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.73 E-value=1.1e-09 Score=111.69 Aligned_cols=179 Identities=17% Similarity=0.214 Sum_probs=103.8
Q ss_pred EeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCe--eeeeceeeecCc-ceEEEEE
Q 043957 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNI--VKLEGLATSRMQ-YSLYLVF 205 (584)
Q Consensus 130 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnI--v~l~~~~~~~~~-~~l~lV~ 205 (584)
++.|+.|.+..||++. ..+++|+... ......+.+|+.+|+.|. +..| ..++.+...... ...|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 3458999999999872 4588888632 234567889999999883 3332 233322222111 1248999
Q ss_pred echhhH-HHHH-hhC--CCCCCcHHHHHHHHHHHHHh-------------------------------------------
Q 043957 206 EFMQTD-LARI-ISN--PEGKLTEPQQLLSGLQHCHD------------------------------------------- 238 (584)
Q Consensus 206 Ey~~g~-L~~~-l~~--~~~~l~~~~qIl~aL~yLH~------------------------------------------- 238 (584)
++++|. +... ... .........++...|..||+
T Consensus 96 ~~i~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 96 TKIKGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp ECCCCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred cccCCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 999873 2211 100 00011122344444444443
Q ss_pred ---------------CCceeccccccceeecC--CCcEEEEEeccccccCCCCCCCCccccccccc---cChhhhh----
Q 043957 239 ---------------RGILHRDVKGSNLLIDK--NGVLKIADFGLANYFSPNKKRPLTSRVVTLWY---RAPELLL---- 294 (584)
Q Consensus 239 ---------------~~IvHrDLKp~NILl~~--~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y---~APEvl~---- 294 (584)
..++|+|++|.|||++. .+.+.|+||+.+....+.. .......+ ..|+.+.
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-----Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-----DFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-----HHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-----HHHHHHhhccccCHHHHHHHHH
Confidence 24799999999999988 4568999999987643211 00001111 2333211
Q ss_pred CCCC---------CCceeeEecchHHHHHHHhCCCCC
Q 043957 295 GATD---------YGVGIDLWSAGCLLAEMFLGRPIM 322 (584)
Q Consensus 295 ~~~~---------~~~~sDIwSLGvilyeLltG~~pF 322 (584)
.... ...-.+.|++++++|.+.+|.++|
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1000 112258999999999999998765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=1.1e-06 Score=92.81 Aligned_cols=78 Identities=15% Similarity=0.235 Sum_probs=48.1
Q ss_pred EEeeecccCceEEEEEEECCCCcEEEEEEeecCCC--C---hHHHHHHHHHHHHHHhCCC--CCee-eeeceeeecCcce
Q 043957 129 KIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS--E---PHSVKFMAREIMILQKLDH--PNIV-KLEGLATSRMQYS 200 (584)
Q Consensus 129 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~---~~~~~~~~~Ei~iL~~L~H--pnIv-~l~~~~~~~~~~~ 200 (584)
.++.||.|.++.||++....++..|+||....... . ......+..|+.+|+.+.. +.++ +++.+ +...
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~-- 109 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM-- 109 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT--
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc--
Confidence 46789999999999997665678899998643211 0 0122346678889888742 3333 45432 3222
Q ss_pred EEEEEechhh
Q 043957 201 LYLVFEFMQT 210 (584)
Q Consensus 201 l~lV~Ey~~g 210 (584)
.++||||+.+
T Consensus 110 ~~lvmE~l~g 119 (397)
T 2olc_A 110 AVTVMEDLSH 119 (397)
T ss_dssp TEEEECCCTT
T ss_pred cEEEEEeCCC
Confidence 3899999975
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=4.2e-06 Score=83.08 Aligned_cols=131 Identities=15% Similarity=0.199 Sum_probs=81.4
Q ss_pred eecccCce-EEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceEEEEEechh
Q 043957 132 KVGQGTYS-NVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSLYLVFEFMQ 209 (584)
Q Consensus 132 ~LG~G~fg-~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l~lV~Ey~~ 209 (584)
.+..|..+ .||+......+..+++|+-.. .....+.+|..+|+.|. +--+.+++.++.+. ...|+|||+++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme~l~ 103 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTTAIP 103 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEEeeC
Confidence 34445544 699987777778899998642 24556888999999885 22245566665553 35799999997
Q ss_pred hH-HHHHhhC-CCCCCcHHHHHHHHHHHHH--------------------------------------------------
Q 043957 210 TD-LARIISN-PEGKLTEPQQLLSGLQHCH-------------------------------------------------- 237 (584)
Q Consensus 210 g~-L~~~l~~-~~~~l~~~~qIl~aL~yLH-------------------------------------------------- 237 (584)
|. +...... .........++...|..||
T Consensus 104 G~~~~~~~~~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 104 GKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp SEEHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred CccccccccCCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 62 2211110 0000011112222222222
Q ss_pred -hC-------CceeccccccceeecCCCcEEEEEeccccc
Q 043957 238 -DR-------GILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 238 -~~-------~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
.. .++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 21 278999999999999877778999998754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=3.8e-06 Score=85.73 Aligned_cols=71 Identities=14% Similarity=0.145 Sum_probs=49.2
Q ss_pred EeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCC---CeeeeeceeeecCcceEEEEEe
Q 043957 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP---NIVKLEGLATSRMQYSLYLVFE 206 (584)
Q Consensus 130 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hp---nIv~l~~~~~~~~~~~l~lV~E 206 (584)
++.++.|....||++ |..+++|+-. .......+.+|+.+|+.|.+. .|.+++.+... .....|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEe
Confidence 456888999999988 5668888742 233456788999999999742 23444444432 2334689999
Q ss_pred chhh
Q 043957 207 FMQT 210 (584)
Q Consensus 207 y~~g 210 (584)
|++|
T Consensus 94 ~i~G 97 (306)
T 3tdw_A 94 KVQG 97 (306)
T ss_dssp CCCS
T ss_pred ccCC
Confidence 9986
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.78 E-value=6.1e-05 Score=80.17 Aligned_cols=33 Identities=12% Similarity=0.377 Sum_probs=28.4
Q ss_pred HhCCceeccccccceeecCCCcEEEEEecccccc
Q 043957 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 237 H~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~ 270 (584)
+...++|+|++|.|||++.++ ++|+||+.+..-
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 346799999999999998876 999999988753
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00016 Score=73.72 Aligned_cols=31 Identities=19% Similarity=0.382 Sum_probs=27.8
Q ss_pred CCceeccccccceeecCCCcEEEEEeccccc
Q 043957 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 239 ~~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998888999999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.0005 Score=68.97 Aligned_cols=74 Identities=15% Similarity=0.200 Sum_probs=50.1
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCC--C-CeeeeeceeeecCcceEEE
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH--P-NIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H--p-nIv~l~~~~~~~~~~~l~l 203 (584)
..-++.+|.|..+.||++... +|+.|++|+....... ....+..|+..|+.|.- + -+.+++.+ + . -++
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~--~~l 87 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--D--RTL 87 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--T--TEE
T ss_pred eEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEec--c--C--ceE
Confidence 456788999999999999754 6889999986432221 23457889999998842 1 23334322 2 1 278
Q ss_pred EEechh
Q 043957 204 VFEFMQ 209 (584)
Q Consensus 204 V~Ey~~ 209 (584)
||||+.
T Consensus 88 v~e~l~ 93 (288)
T 3f7w_A 88 AMEWVD 93 (288)
T ss_dssp EEECCC
T ss_pred EEEeec
Confidence 999975
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.50 E-value=2.5e-05 Score=80.92 Aligned_cols=83 Identities=7% Similarity=0.102 Sum_probs=49.8
Q ss_pred eEEeee-cccCceEEEEEEEC---C---CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCC-C--CCeeeeeceeeec
Q 043957 128 DKIDKV-GQGTYSNVYKALDR---D---TGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLD-H--PNIVKLEGLATSR 196 (584)
Q Consensus 128 ~~~~~L-G~G~fg~Vy~a~~~---~---~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~-H--pnIv~l~~~~~~~ 196 (584)
..++.| +.|....+|++... . ++..+++|+...... .......+.+|+.+|+.|. + -.+.+++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345778 88999999988643 0 156788987642210 0000134677888888874 3 2355565554432
Q ss_pred C-cceEEEEEechhh
Q 043957 197 M-QYSLYLVFEFMQT 210 (584)
Q Consensus 197 ~-~~~l~lV~Ey~~g 210 (584)
. ....|+||||++|
T Consensus 103 ~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 103 DVLGTPFFLMDYVEG 117 (357)
T ss_dssp TTTSSCEEEEECCCC
T ss_pred CccCCceEEEEecCC
Confidence 1 0235899999976
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.0008 Score=68.84 Aligned_cols=74 Identities=18% Similarity=0.187 Sum_probs=53.9
Q ss_pred eEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC---CCCeeeeeceeeecCcceEEEE
Q 043957 128 DKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD---HPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 128 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~~~l~lV 204 (584)
.-++.|+.|.+..+|++.. .+..+++|+.... ....+..|...|+.|. ...+.+++.+.... ...|+|
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lv 109 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLL 109 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEE
Confidence 3467799999999999853 4678889987532 3566888999998884 24566676655443 457999
Q ss_pred Eechhh
Q 043957 205 FEFMQT 210 (584)
Q Consensus 205 ~Ey~~g 210 (584)
|||++|
T Consensus 110 me~l~G 115 (312)
T 3jr1_A 110 LEALNK 115 (312)
T ss_dssp EECCCC
T ss_pred EEeccC
Confidence 999975
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00025 Score=72.07 Aligned_cols=136 Identities=11% Similarity=0.092 Sum_probs=74.8
Q ss_pred eEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCC--eeeeecee----eecCcceE
Q 043957 128 DKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPN--IVKLEGLA----TSRMQYSL 201 (584)
Q Consensus 128 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~~----~~~~~~~l 201 (584)
.-++.|+.|....||++... +| .+++|+..... ....+..|+.+++.|.... +.+++... ........
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 34677888988999998653 34 68899885421 1223556777777764212 22232110 00012346
Q ss_pred EEEEechhhH----------------HHHHhh---C---CC-CCCc---HH------------------HHHHHHHHHHH
Q 043957 202 YLVFEFMQTD----------------LARIIS---N---PE-GKLT---EP------------------QQLLSGLQHCH 237 (584)
Q Consensus 202 ~lV~Ey~~g~----------------L~~~l~---~---~~-~~l~---~~------------------~qIl~aL~yLH 237 (584)
++||+|++|. |..+.. . .. .... +. ..+...+++++
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 8999998752 111110 1 00 0000 00 02344555555
Q ss_pred h-------CCceeccccccceeecCCCcEEEEEeccccc
Q 043957 238 D-------RGILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 238 ~-------~~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
+ .+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3 3699999999999998876668999997753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00044 Score=69.87 Aligned_cols=68 Identities=13% Similarity=0.055 Sum_probs=40.3
Q ss_pred EeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCe-eeeeceeeecCcceEEEEEech
Q 043957 130 IDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI-VKLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 130 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
++.|+.|....+|++ ..+++|+....... .-...+|+.+++.+..-.+ .+++.+ +... -++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~--~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHV--DPAT--GVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTT--CCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEE--ECCC--CEEEEeec
Confidence 677989999999998 45888887532111 1112457777777642222 344332 2222 27899999
Q ss_pred -hh
Q 043957 209 -QT 210 (584)
Q Consensus 209 -~g 210 (584)
+|
T Consensus 90 ~~g 92 (301)
T 3dxq_A 90 AGA 92 (301)
T ss_dssp TTC
T ss_pred CCC
Confidence 54
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0014 Score=69.91 Aligned_cols=72 Identities=15% Similarity=0.194 Sum_probs=47.3
Q ss_pred EEeeecccCceEEEEEEECC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCe-eeeeceeeecCcce
Q 043957 129 KIDKVGQGTYSNVYKALDRD-------TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI-VKLEGLATSRMQYS 200 (584)
Q Consensus 129 ~~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~~ 200 (584)
.++.|+.|....||++.... .+..|++|+.... .. ...+.+|+.+++.|...+| .++++++. +
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~---~-- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFS---G-- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEET---T--
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC---C--
Confidence 46778889999999997643 2578999987421 11 1345579999988853333 45554332 1
Q ss_pred EEEEEechhh
Q 043957 201 LYLVFEFMQT 210 (584)
Q Consensus 201 l~lV~Ey~~g 210 (584)
.+||||++|
T Consensus 148 -g~v~e~l~G 156 (429)
T 1nw1_A 148 -GRLEEYIPS 156 (429)
T ss_dssp -EEEECCCCE
T ss_pred -CEEEEEeCC
Confidence 389999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0044 Score=66.77 Aligned_cols=74 Identities=20% Similarity=0.096 Sum_probs=46.3
Q ss_pred eEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCe-eeeeceeeecCcceEEEEEe
Q 043957 128 DKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI-VKLEGLATSRMQYSLYLVFE 206 (584)
Q Consensus 128 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~~l~lV~E 206 (584)
..++.|+.|-...+|++.....+..|++|+....... .. ...+|..+|+.|...++ .++++++ . . .+|||
T Consensus 111 ~~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~--~i-dR~~E~~vl~~L~~~gl~P~ll~~~--~-~---G~v~e 181 (458)
T 2qg7_A 111 LEFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE--II-NREREKKISCILYNKNIAKKIYVFF--T-N---GRIEE 181 (458)
T ss_dssp EEEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS--CS-CHHHHHHHHHHHTTSSSBCCEEEEE--T-T---EEEEE
T ss_pred eEEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh--hc-CHHHHHHHHHHHHhcCCCCCEEEEe--C-C---eEEEE
Confidence 3567788899999999976544578999987432111 11 12578999998865444 4555444 2 2 35999
Q ss_pred chhh
Q 043957 207 FMQT 210 (584)
Q Consensus 207 y~~g 210 (584)
|++|
T Consensus 182 ~I~G 185 (458)
T 2qg7_A 182 FMDG 185 (458)
T ss_dssp CCCS
T ss_pred eeCC
Confidence 9875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.00083 Score=69.88 Aligned_cols=73 Identities=8% Similarity=0.078 Sum_probs=41.2
Q ss_pred EEeeecccCceEEEEEEECC--------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCe-eeeeceeeecCcc
Q 043957 129 KIDKVGQGTYSNVYKALDRD--------TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI-VKLEGLATSRMQY 199 (584)
Q Consensus 129 ~~~~LG~G~fg~Vy~a~~~~--------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~ 199 (584)
.++.|+.|....+|++.... .+..|++|+.... .........|..+++.|...++ .++++.. . .
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~-~- 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH---VDELYNTISEFEVYKTMSKYKIAPQLLNTF--N-G- 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT---GGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T-T-
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC---ccceecHHHHHHHHHHHHhcCCCCceEEec--C-C-
Confidence 45678888889999997543 1267888876432 1111123568888887743233 3554332 1 2
Q ss_pred eEEEEEechhh
Q 043957 200 SLYLVFEFMQT 210 (584)
Q Consensus 200 ~l~lV~Ey~~g 210 (584)
++||||++|
T Consensus 110 --~~v~e~i~G 118 (369)
T 3c5i_A 110 --GRIEEWLYG 118 (369)
T ss_dssp --EEEEECCCS
T ss_pred --cEEEEEecC
Confidence 789999875
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0012 Score=69.41 Aligned_cols=72 Identities=14% Similarity=0.098 Sum_probs=41.2
Q ss_pred EeeecccCceEEEEEEECC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceE
Q 043957 130 IDKVGQGTYSNVYKALDRD-------TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 130 ~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l 201 (584)
++.|..|-...+|++.... .+..|++|+..... .....+.+|..+++.|. +.-..++++++. .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~---- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFP--E---- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T----
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C----
Confidence 3567778888899987542 35789999863211 12345668999998884 322244544332 2
Q ss_pred EEEEechhh
Q 043957 202 YLVFEFMQT 210 (584)
Q Consensus 202 ~lV~Ey~~g 210 (584)
.+||||++|
T Consensus 126 g~v~e~i~G 134 (379)
T 3feg_A 126 GRLEQYIPS 134 (379)
T ss_dssp EEEEECCSE
T ss_pred ccEEEEecC
Confidence 389999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0034 Score=63.78 Aligned_cols=75 Identities=12% Similarity=0.093 Sum_probs=44.6
Q ss_pred eeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCC--eeeeece---eeecCcceEEEEE
Q 043957 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPN--IVKLEGL---ATSRMQYSLYLVF 205 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~---~~~~~~~~l~lV~ 205 (584)
..|+ |....||++.. .+|+.+++|+...... ....+..|+.+++.|.... +++++.. .........++||
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 4566 88889998743 3466799999863322 2345667888888774212 3334332 0001123468899
Q ss_pred echhh
Q 043957 206 EFMQT 210 (584)
Q Consensus 206 Ey~~g 210 (584)
+|++|
T Consensus 107 ~~i~G 111 (328)
T 1zyl_A 107 PSVGG 111 (328)
T ss_dssp ECCCC
T ss_pred EecCC
Confidence 99875
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0051 Score=63.35 Aligned_cols=31 Identities=19% Similarity=0.341 Sum_probs=27.5
Q ss_pred CCceeccccccceeecCCCcEEEEEeccccc
Q 043957 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 239 ~~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3589999999999999888899999987764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0015 Score=66.83 Aligned_cols=32 Identities=28% Similarity=0.284 Sum_probs=27.6
Q ss_pred CCceeccccccceeecCC----CcEEEEEecccccc
Q 043957 239 RGILHRDVKGSNLLIDKN----GVLKIADFGLANYF 270 (584)
Q Consensus 239 ~~IvHrDLKp~NILl~~~----g~vKL~DFGla~~~ 270 (584)
..++|+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 469999999999999874 67999999988653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.61 E-value=0.079 Score=56.31 Aligned_cols=73 Identities=7% Similarity=-0.030 Sum_probs=44.8
Q ss_pred EEeeecccCceEEEEEEECCC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcce
Q 043957 129 KIDKVGQGTYSNVYKALDRDT-------GKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 129 ~~~~LG~G~fg~Vy~a~~~~~-------g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~ 200 (584)
-++.|..|-...+|++..... +..|++++..... . ..-...+|..+++.|. +.-..++++. .. .
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~-~~idR~~E~~~l~~L~~~gi~P~l~~~--~~--~- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--G-KFYDSKVELDVFRYLSNINIAPNIIAD--FP--E- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEE--ET--T-
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--c-hhcCHHHHHHHHHHHHhcCCCCCEEEE--cC--C-
Confidence 456777788899999976521 5789999864321 1 1112356888888874 3223344432 22 1
Q ss_pred EEEEEechhh
Q 043957 201 LYLVFEFMQT 210 (584)
Q Consensus 201 l~lV~Ey~~g 210 (584)
++||||++|
T Consensus 146 -~~I~efI~G 154 (424)
T 3mes_A 146 -GRIEEFIDG 154 (424)
T ss_dssp -EEEEECCCS
T ss_pred -CEEEEEeCC
Confidence 789999875
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.29 E-value=0.16 Score=53.28 Aligned_cols=29 Identities=28% Similarity=0.576 Sum_probs=24.7
Q ss_pred ceeccccccceee------cCCCcEEEEEeccccc
Q 043957 241 ILHRDVKGSNLLI------DKNGVLKIADFGLANY 269 (584)
Q Consensus 241 IvHrDLKp~NILl------~~~g~vKL~DFGla~~ 269 (584)
++|+|+.+.|||+ +++..+.|+||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4467799999998854
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=92.55 E-value=0.3 Score=46.97 Aligned_cols=91 Identities=16% Similarity=0.102 Sum_probs=52.6
Q ss_pred HHHHHhhCCCCCCcHHH------HHHHHHHHH-HhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCCccccc
Q 043957 211 DLARIISNPEGKLTEPQ------QLLSGLQHC-HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV 283 (584)
Q Consensus 211 ~L~~~l~~~~~~l~~~~------qIl~aL~yL-H~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~g 283 (584)
+|.+++...+..+.+.+ |.+.+|.-+ +...-..+=+-|..|+|..+|.|.+.+ ..+. ..
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~ 99 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------AG 99 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------cc
Confidence 57777776666666543 555555444 111222333557899999999987763 1110 11
Q ss_pred cccccChhhhhCCCCCCceeeEecchHHHHHHHh
Q 043957 284 TLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL 317 (584)
Q Consensus 284 t~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt 317 (584)
...+.+||... ...+.+.=|||||+++|.-|-
T Consensus 100 ~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 100 EPPPVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 22466888763 335678889999999999885
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.91 E-value=0.063 Score=57.74 Aligned_cols=65 Identities=12% Similarity=0.166 Sum_probs=18.6
Q ss_pred eEEeeecccCceEEEEEEECCCCcEEEE------EEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeee
Q 043957 128 DKIDKVGQGTYSNVYKALDRDTGKIVAL------KKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATS 195 (584)
Q Consensus 128 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAi------K~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 195 (584)
.+.+.|| ||.||++........||+ |..+...........+.+|..+++.++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3455676 999999987655567888 7665433444445567889999999999999999876543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 584 | ||||
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-77 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-72 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-69 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-68 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-68 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-66 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-65 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-65 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-63 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-63 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-63 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-63 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-63 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-63 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-61 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-60 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-59 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-58 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-58 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-58 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-57 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-55 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-54 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-54 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-53 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-51 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-48 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-48 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-48 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-48 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-46 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-46 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-46 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-45 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-45 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-45 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-44 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-43 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-42 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-41 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-40 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-39 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-38 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-36 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-27 |
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (625), Expect = 4e-77
Identities = 130/311 (41%), Positives = 175/311 (56%), Gaps = 20/311 (6%)
Query: 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL 181
Y+K+ K+GQGT+ V+KA R TG+ VALKKV + + REI ILQ L
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 182 DHPNIVKLEGLATS------RMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QL 229
H N+V L + + R + S+YLVF+F + DLA ++SN K T + L
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 230 LSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK---RPLTSRVVTLW 286
L+GL + H ILHRD+K +N+LI ++GVLK+ADFGLA FS K T+RVVTLW
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 287 YRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYW 346
YR PELLLG DYG IDLW AGC++AEM+ PIM G TE QL I +LCGS + + W
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 347 ---KKLRLSTTFRPPQSYKPRLFEAFSEFPESSLG--LLSTLLALDPAYRGSAASALKNE 401
L + K ++ + + L+ LL LDPA R + AL ++
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 402 FFFTSPLACDL 412
FF++ P+ DL
Sbjct: 307 FFWSDPMPSDL 317
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 1e-72
Identities = 120/298 (40%), Positives = 174/298 (58%), Gaps = 13/298 (4%)
Query: 129 KIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD---TSEPHSVKFMAREIMILQKLDHPN 185
K+D +G+G ++ VYKA D++T +IVA+KK+K ++ + REI +LQ+L HPN
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 186 IVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHDR 239
I+ L + + LVF+FM+TDL II + LT L GL++ H
Sbjct: 62 IIGLLDAFGHKSN--ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDY 299
ILHRD+K +NLL+D+NGVLK+ADFGLA F + T +VVT WYRAPELL GA Y
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFGARMY 178
Query: 300 GVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQ 359
GVG+D+W+ GC+LAE+ L P +PG ++++QL RIF+ G+P+E+ W + + +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 360 SYKPR-LFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDLSGLP 416
S+ L FS + L L+ L +P R +A ALK ++F P LP
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 296
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 1e-69
Identities = 119/288 (41%), Positives = 169/288 (58%), Gaps = 12/288 (4%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
E++ K++K+G+GTY VYKA ++ TG++VALKK++ DT REI +L++L+HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTDLARII-SNPEGKLTEPQ------QLLSGLQHCH 237
NIVKL + + + LYLVFEF+ DL + + ++ + P QLL GL CH
Sbjct: 62 NIVKLLDVIHT--ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGAT 297
+LHRD+K NLLI+ G +K+ADFGLA F + T VVTLWYRAPE+LLG
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCK 178
Query: 298 DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357
Y +D+WS GC+ AEM R + PG +E++QL RIF+ G+P E W + ++P
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 358 --PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
P+ + + E LLS +L DP R SA +AL + FF
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 221 bits (564), Expect = 1e-68
Identities = 114/287 (39%), Positives = 162/287 (56%), Gaps = 12/287 (4%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
E Y ++K+G+GTY VYKA + G+ ALKK++ + + REI IL++L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHD 238
NIVKL + L LVFE + DL +++ EG L QLL+G+ +CHD
Sbjct: 61 NIVKLYD--VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATD 298
R +LHRD+K NLLI++ G LKIADFGLA F ++ +VTLWYRAP++L+G+
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMGSKK 177
Query: 299 YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP- 357
Y ID+WS GC+ AEM G P+ PG +E +QL RIF++ G+P+ W + + P
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 358 -PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
ES + LLS +L LDP R +A AL++ +F
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 2e-68
Identities = 102/339 (30%), Positives = 158/339 (46%), Gaps = 25/339 (7%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y + +G+G Y V A D VA+KK+ + + + + REI IL + H NI
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENI 68
Query: 187 VKLEGL---ATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCH 237
+ + + T +YLV M DL +++ L+ Q+L GL++ H
Sbjct: 69 IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIH 126
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP--LTSRVVTLWYRAPELLLG 295
+LHRD+K SNLL++ LKI DFGLA P+ LT V T WYRAPE++L
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL---- 351
+ Y ID+WS GC+LAEM RPI PG+ ++QL+ I + GSPS++ +
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF--FTSPLA 409
+ P K F +L LL +L +P R AL + + + P
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 306
Query: 410 CDLSGLPVIYDKEDELIEANQQRK-----IRRARMKHRS 443
++ P +D E + + + ++ R + +RS
Sbjct: 307 EPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS 345
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 2e-66
Identities = 79/286 (27%), Positives = 126/286 (44%), Gaps = 34/286 (11%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
E +D + +G+G Y V A++R T + VA+K V + + +EI I + L+H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHE 63
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHD 238
N+VK G R YL E+ P+ + EP QL++G+ + H
Sbjct: 64 NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV-TLWYRAPELLLGAT 297
GI HRD+K NLL+D+ LKI+DFGLA F N + L +++ TL Y APELL
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 298 DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357
+ +D+WS G +L M G ++ Q + +K
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK--------------------- 220
Query: 358 PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
K + + + L LL +L +P+ R + K+ ++
Sbjct: 221 ---EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 1e-65
Identities = 116/288 (40%), Positives = 165/288 (57%), Gaps = 12/288 (4%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ Y+K++K+G+GTY V+KA +R+T +IVALK+V+ D + REI +L++L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHD 238
NIV+L + S + LVFEF DL + + G L QLL GL CH
Sbjct: 62 NIVRLHDVLHSDKKL--TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATD 298
R +LHRD+K NLLI++NG LK+A+FGLA F R ++ VVTLWYR P++L GA
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 299 YGVGIDLWSAGCLLAEMFLG-RPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357
Y ID+WSAGC+ AE+ RP+ PG +QL RIF+L G+P+E+ W + ++P
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 358 PQSYKPR--LFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
Y L + + LL LL +P R SA AL++ +F
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 1e-65
Identities = 103/294 (35%), Positives = 152/294 (51%), Gaps = 24/294 (8%)
Query: 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPN 185
SY +G G++ VY+A D+G++VA+KKV D +F RE+ I++KLDH N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCN 74
Query: 186 IVKLEGL----ATSRMQYSLYLVFEFMQTDLARII---SNPEGKLTEPQ------QLLSG 232
IV+L + + L LV +++ + R+ S + L QL
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 233 LQHCHDRGILHRDVKGSNLLIDKNG-VLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPE 291
L + H GI HRD+K NLL+D + VLK+ DFG A + P S + + +YRAPE
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRAPE 192
Query: 292 LLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351
L+ GATDY ID+WSAGC+LAE+ LG+PI PG + V+QL I K+ G+P+ + +++
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 352 STTFR--PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
+ T P P P ++ L S LL P R + A + FF
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 4e-65
Identities = 74/303 (24%), Positives = 128/303 (42%), Gaps = 31/303 (10%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ ++KI ++G G V+K + +G ++A K + + + + RE+ +L + + P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-RELQVLHECNSP 64
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHD 238
IV G S + + + E M + G++ E ++ GL + +
Sbjct: 65 YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 239 R-GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGAT 297
+ I+HRDVK SN+L++ G +K+ DFG++ + S V T Y +PE L G T
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQG-T 178
Query: 298 DYGVGIDLWSAGCLLAEMFLGR-PIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF- 355
Y V D+WS G L EM +GR PI P + +L ++ G +E +
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238
Query: 356 ------RPPQSYKPRLFEAFSEFP---------ESSLGLLSTLLALDPAYRGSAASALKN 400
RPP + L +E P ++ L +PA R + +
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298
Query: 401 EFF 403
F
Sbjct: 299 AFI 301
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 1e-63
Identities = 102/296 (34%), Positives = 159/296 (53%), Gaps = 17/296 (5%)
Query: 122 KSAESYDKIDKVGQGTYSNVYKALD-RDTGKIVALKKVKFDTSEPHSVKFMAREIMILQK 180
++ + Y+ + ++G+G Y V+KA D ++ G+ VALK+V+ T E RE+ +L+
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 181 L---DHPNIVKLEG---LATSRMQYSLYLVFEFMQTD-LARIISNPEGKLTEPQ------ 227
L +HPN+V+L ++ + + L LVFE + D + PE +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 228 QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWY 287
QLL GL H ++HRD+K N+L+ +G +K+ADFGLA +S TS VVTLWY
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWY 181
Query: 288 RAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWK 347
RAPE+LL ++ Y +DLWS GC+ AEMF +P+ G ++V+QL +I + G P E+ W
Sbjct: 182 RAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 348 KLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
+ + + ++ E LL L +PA R SA SAL + +F
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 208 bits (531), Expect = 2e-63
Identities = 69/321 (21%), Positives = 133/321 (41%), Gaps = 41/321 (12%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKLDH 183
+ + + ++G G++ VY A D ++VA+KK+ + + + +E+ LQKL H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCH 237
PN ++ G +++ +LV E+ + ++ + L E + L GL + H
Sbjct: 75 PNTIQYRGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGAT 297
++HRDVK N+L+ + G++K+ DFG A+ +P S V T ++ APE++L
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMAPEVILAMD 187
Query: 298 D--YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355
+ Y +D+WS G E+ +P + + L+ I +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------------- 228
Query: 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDLSGL 415
+ E + + L P R ++ LK+ F + L
Sbjct: 229 ------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL 282
Query: 416 PVIYDKEDELIEANQQRKIRR 436
++ Q RK+++
Sbjct: 283 IQRTKDAVRELDNLQYRKMKK 303
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 209 bits (534), Expect = 2e-63
Identities = 74/349 (21%), Positives = 129/349 (36%), Gaps = 43/349 (12%)
Query: 112 PREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFM 171
P E+ V + YD +++G G + V++ +R TG A K V T + +
Sbjct: 16 PVEIKHDHV---LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM--TPHESDKETV 70
Query: 172 AREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQ--- 227
+EI + L HP +V L + + +++EFM +L +++ K++E +
Sbjct: 71 RKEIQTMSVLRHPTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVE 128
Query: 228 ---QLLSGLQHCHDRGILHRDVKGSNLLI--DKNGVLKIADFGLANYFSPNKKRPLTSRV 282
Q+ GL H H+ +H D+K N++ ++ LK+ DFGL + P +
Sbjct: 129 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK--VTT 186
Query: 283 VTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPS 342
T + APE+ G G D+WS G L + G G + E L + +
Sbjct: 187 GTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD 245
Query: 343 EDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402
+ + + E + LL DP R + AL++ +
Sbjct: 246 DSAFSGI-----------------------SEDGKDFIRKLLLADPNTRMTIHQALEHPW 282
Query: 403 FFTSPLACDLSGLPV-IYDKEDELIEANQQRKIRRARMKHRSKTLRERR 450
S +P Y K + I+ R R
Sbjct: 283 LTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLR 331
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 3e-63
Identities = 75/290 (25%), Positives = 124/290 (42%), Gaps = 40/290 (13%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ ++ I ++G G + VYKA +++T + A K + + E ++ EI IL DHP
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHP 69
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCH 237
NIVKL +L+++ EF + ++ E LTE Q Q L L + H
Sbjct: 70 NIVKLLDAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGAT 297
D I+HRD+K N+L +G +K+ADFG++ + +R S + T ++ APE+++ T
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-RDSFIGTPYWMAPEVVMCET 186
Query: 298 D----YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353
Y D+WS G L EM P + L +I K
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK----------------- 229
Query: 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
+P S + + L L + R + + L++ F
Sbjct: 230 -------SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 7e-63
Identities = 99/323 (30%), Positives = 155/323 (47%), Gaps = 20/323 (6%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
Y + VG G Y V A+D TG VA+KK+ K RE+ +L+ + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 185 NIVKLEGLATSR----MQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQ 234
N++ L + T YLV FM TDL +++ + KL E + Q+L GL+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLR 135
Query: 235 HCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLL 294
+ H GI+HRD+K NL ++++ LKI DFGLA +T VVT WYRAPE++L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVIL 191
Query: 295 GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354
Y +D+WS GC++AEM G+ + G ++QL I K+ G+P ++ ++L+
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 355 FRP----PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLAC 410
P+ K + ++ LL +L LD R +A AL + +F +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311
Query: 411 DLSGLPVIYDKEDELIEANQQRK 433
D + D D++ + K
Sbjct: 312 DEPQVQKYDDSFDDVDRTLDEWK 334
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (524), Expect = 8e-63
Identities = 72/294 (24%), Positives = 124/294 (42%), Gaps = 43/294 (14%)
Query: 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH 183
AE Y+ + +G G+Y K + GKI+ K++ + + + + E+ +L++L H
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 184 PNIVKLEGLATSRMQYSLYLVFEFMQ-TDLARIISN---PEGKLTEPQ------QLLSGL 233
PNIV+ R +LY+V E+ + DLA +I+ L E QL L
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 234 QHCHDRG-----ILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYR 288
+ CH R +LHRD+K +N+ +D +K+ DFGLA + + + V T +Y
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYYM 181
Query: 289 APELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK 348
+PE + Y D+WS GCLL E+ P ++ E +I
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR------------- 227
Query: 349 LRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402
+ + + + +++ +L L +R S L+N
Sbjct: 228 -------------EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 208 bits (531), Expect = 8e-63
Identities = 78/357 (21%), Positives = 143/357 (40%), Gaps = 47/357 (13%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ YD ++++G G + V++ +++ TG++ K + T P + EI I+ +L HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN--TPYPLDKYTVKNEISIMNQLHHP 86
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQ------QLLSGLQHCH 237
++ L + Y + L+ EF+ +L I+ + K++E + Q GL+H H
Sbjct: 87 KLINLHDAFEDK--YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 238 DRGILHRDVKGSNLLID--KNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLG 295
+ I+H D+K N++ + K +KI DFGLA +P++ +T T + APE++
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDR 202
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355
G D+W+ G L + G G ++E L + + ED + +
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV------ 255
Query: 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF--FTSPLACDL- 412
+ + LL +P R + AL++ + S L +
Sbjct: 256 -----------------SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIP 298
Query: 413 -SGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQASQLTKEETLSNKE 468
S I K E + R+ + S + R Q KE
Sbjct: 299 SSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYD----SYFDRKE 351
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 1e-61
Identities = 101/327 (30%), Positives = 152/327 (46%), Gaps = 17/327 (5%)
Query: 113 REVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA 172
R+ L + + E Y + VG G Y +V A D TG VA+KK+ K
Sbjct: 6 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 65
Query: 173 REIMILQKLDHPNIVKLEGLATSRMQY----SLYLVFEFMQTDLARIISNPEGKLTE--- 225
RE+ +L+ + H N++ L + T +YLV M DL I+ +
Sbjct: 66 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 125
Query: 226 -PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVT 284
Q+L GL++ H I+HRD+K SNL ++++ LKI DFGLA + T V T
Sbjct: 126 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVAT 181
Query: 285 LWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSED 344
WYRAPE++L Y +D+WS GC++AE+ GR + PG ++QL I +L G+P +
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 345 YWKKLRLSTTFR----PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400
KK+ + Q K F ++ LL +L LD R +AA AL +
Sbjct: 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301
Query: 401 EFFFTSPLACDLSGLPVIYDKEDELIE 427
+F D + YD+ E +
Sbjct: 302 AYFAQYHDPDDEP-VADPYDQSFESRD 327
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 4e-61
Identities = 74/288 (25%), Positives = 124/288 (43%), Gaps = 40/288 (13%)
Query: 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQKL 181
+ E ++ +G+G + NVY A ++ + I+ALK + K + + RE+ I L
Sbjct: 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63
Query: 182 DHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQH 235
HPNI++L G +YL+ E+ K E + +L + L +
Sbjct: 64 RHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLG 295
CH + ++HRD+K NLL+ G LKIADFG + + ++ T+ TL Y PE++ G
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEG 178
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355
+ +DLWS G L E +G+P T E RI ++ + +
Sbjct: 179 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 226
Query: 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
E + L+S LL +P+ R L++ +
Sbjct: 227 ----------------VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 5e-60
Identities = 70/285 (24%), Positives = 125/285 (43%), Gaps = 37/285 (12%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ Y + +K+GQG VY A+D TG+ VA++++ + + EI+++++ +P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNP 77
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHD 238
NIV L++V E++ + E + E Q + L L+ H
Sbjct: 78 NIVNYLDSYLV--GDELWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATD 298
++HRD+K N+L+ +G +K+ DFG +P + + ++ V T ++ APE++
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTR-KA 192
Query: 299 YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358
YG +D+WS G + EM G P + L+ I G+P +KL
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKL--------- 242
Query: 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
L+ L +D RGSA L+++F
Sbjct: 243 --------------SAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 196 bits (500), Expect = 9e-59
Identities = 89/303 (29%), Positives = 147/303 (48%), Gaps = 31/303 (10%)
Query: 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL- 181
+ + Y + K+G+G YS V++A++ + V +K +K P K + REI IL+ L
Sbjct: 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLR 87
Query: 182 DHPNIVKLEGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQ------QLLSGLQ 234
PNI+ L + + + LVFE + TD ++ LT+ ++L L
Sbjct: 88 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALD 143
Query: 235 HCHDRGILHRDVKGSNLLID-KNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELL 293
+CH GI+HRDVK N++ID ++ L++ D+GLA ++ P ++ RV + +++ PELL
Sbjct: 144 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELL 201
Query: 294 LGATDYGVGIDLWSAGCLLAEMFLGR-PIMPGRTEVEQLHRIFKLCGSPS-EDYWKKLRL 351
+ Y +D+WS GC+LA M + P G +QL RI K+ G+ DY K +
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 352 STTFRPPQSYKPRLFEAFSEFPESSLG---------LLSTLLALDPAYRGSAASALKNEF 402
R + + F S L LL D R +A A+++ +
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321
Query: 403 FFT 405
F+T
Sbjct: 322 FYT 324
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 195 bits (496), Expect = 1e-58
Identities = 73/299 (24%), Positives = 127/299 (42%), Gaps = 48/299 (16%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHS-------VKFMAREIMI 177
E+Y+ + +G+G S V + + + T K A+K + S + +E+ I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 178 LQKL-DHPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QL 229
L+K+ HPNI++L T +LVF+ M+ +L ++ + L+E + L
Sbjct: 63 LRKVSGHPNIIQL--KDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRAL 119
Query: 230 LSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRA 289
L + H I+HRD+K N+L+D + +K+ DFG + P +K L T Y A
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLA 177
Query: 290 PELLLGATD-----YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSED 344
PE++ + + YG +D+WS G ++ + G P R ++ L I
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
W + ++ L+S L + P R +A AL + FF
Sbjct: 238 EWDD-----------------------YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 2e-58
Identities = 71/294 (24%), Positives = 119/294 (40%), Gaps = 38/294 (12%)
Query: 122 KSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD-TSEPHSVKFMAREIMILQK 180
K E + +G+G++S V A + T + A+K ++ + + V ++ RE ++ +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 181 LDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQ 234
LDHP VKL + LY + + G E +++S L+
Sbjct: 65 LDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122
Query: 235 HCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV-TLWYRAPELL 293
+ H +GI+HRD+K N+L++++ ++I DFG A SP K+ + V T Y +PELL
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 294 LGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353
+ DLW+ GC++ ++ G P E +I KL E ++ K R
Sbjct: 183 TEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR--- 238
Query: 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407
L+ LL LD R P
Sbjct: 239 ------------------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 9e-58
Identities = 57/285 (20%), Positives = 110/285 (38%), Gaps = 37/285 (12%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
++G G++ VYK VA+K + P ++ E+ +L+K H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQ------QLLSGLQHCH 237
NI+ G +T+ L +V ++ + + L + E K + Q G+ + H
Sbjct: 65 NILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV-TLWYRAPELLLGA 296
+ I+HRD+K +N+ + ++ +KI DFGLA S ++ ++ + APE++
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 297 TD--YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354
Y D+++ G +L E+ G+ +Q+ +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----------------- 224
Query: 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
P L + S P++ L++ L R L
Sbjct: 225 ----GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (487), Expect = 5e-57
Identities = 79/289 (27%), Positives = 124/289 (42%), Gaps = 40/289 (13%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ YD D +G G +S V A D+ T K+VA+K + E EI +L K+ HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME-NEIAVLHKIKHP 67
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQ------QLLSGLQHCH 237
NIV L+ + S LYL+ + + +L I +G TE Q+L +++ H
Sbjct: 68 NIVALDDIYESGGH--LYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLH 124
Query: 238 DRGILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLL 294
D GI+HRD+K NLL D++ + I+DFGL+ P L++ T Y APE+L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGTPGYVAPEVLA 182
Query: 295 GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354
Y +D WS G + + G P + + +I K YW +
Sbjct: 183 Q-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI----- 236
Query: 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
+S+ + L+ DP R + AL++ +
Sbjct: 237 ------------------SDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 5e-56
Identities = 62/288 (21%), Positives = 111/288 (38%), Gaps = 40/288 (13%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
E Y + +G+G + V++ ++ + K K VK ++ VK +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQ------QLLSGLQHCH 237
NI+ L S L ++FEF+ D+ I+ +L E + Q+ LQ H
Sbjct: 62 NILHLHESFES--MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 238 DRGILHRDVKGSNLLID--KNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLG 295
I H D++ N++ ++ +KI +FG A P Y APE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQH 177
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355
D+WS G L+ + G T + + I + E+ +K++
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI------ 230
Query: 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
++ + LL + R +A+ AL++ +
Sbjct: 231 -----------------SIEAMDFVDRLLVKERKSRMTASEALQHPWL 261
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-55
Identities = 65/289 (22%), Positives = 111/289 (38%), Gaps = 41/289 (14%)
Query: 127 YDKID-KVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPN 185
+ K D ++G+G++ VYK LD +T VA +++ + E +L+ L HPN
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 186 IVKLEG--LATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCH 237
IV+ +T + + + LV E M + + + Q+L GLQ H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 238 DRG--ILHRDVKGSNLLI-DKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLL 294
R I+HRD+K N+ I G +KI D GLA + + + T + APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMYE 186
Query: 295 GATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354
Y +D+++ G + EM Q++R P+
Sbjct: 187 E--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS----------- 233
Query: 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
+ P + E ++ + + R S L + FF
Sbjct: 234 --FDKVAIPEVKE-----------IIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-54
Identities = 63/293 (21%), Positives = 121/293 (41%), Gaps = 42/293 (14%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVK----FDTSEPHSVKFMAREIMILQK 180
+ YD +++G G ++ V K ++ TG A K +K + S + + RE+ IL++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 181 LDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQ 234
+ HPN++ L + ++ + L+ E + + LTE + Q+L+G+
Sbjct: 70 IQHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 235 HCHDRGILHRDVKGSNLLIDKNGV----LKIADFGLANYFSPNKKRPLTSRVVTLWYRAP 290
+ H I H D+K N+++ V +KI DFGLA+ + + T + AP
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAP 185
Query: 291 ELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350
E++ G+ D+WS G + + G G T+ E L + + ++Y+
Sbjct: 186 EIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT- 243
Query: 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
+ + LL DP R + +L++ +
Sbjct: 244 ----------------------SALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 6e-54
Identities = 96/321 (29%), Positives = 156/321 (48%), Gaps = 26/321 (8%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y + +G G V A D + VA+KK+ K RE+++++ ++H NI
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 187 VKLEGLATSRMQYS----LYLVFEFMQTDLARII---SNPEGKLTEPQQLLSGLQHCHDR 239
+ L + T + +YLV E M +L ++I + E Q+L G++H H
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 138
Query: 240 GILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDY 299
GI+HRD+K SN+++ + LKI DFGLA + +T VVT +YRAPE++LG Y
Sbjct: 139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILG-MGY 195
Query: 300 GVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL---------- 349
+D+WS GC++ EM + + PGR ++Q +++ + G+P ++ KKL
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255
Query: 350 -----RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404
L+ P S P E + LLS +L +DPA R S AL++ +
Sbjct: 256 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315
Query: 405 TSPLACDLSGL-PVIYDKEDE 424
++ P IYDK+ +
Sbjct: 316 VWYDPAEVEAPPPQIYDKQLD 336
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 179 bits (455), Expect = 9e-53
Identities = 67/290 (23%), Positives = 115/290 (39%), Gaps = 35/290 (12%)
Query: 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLD 182
++ Y+ + +G G S V+ A D + VA+K ++ D + +P RE L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 183 HPNIVKLEGLATSRMQYS--LYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQ 234
HP IV + + Y+V E++ R I + EG +T + L
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 235 HCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF--SPNKKRPLTSRVVTLWYRAPEL 292
H GI+HRDVK +N++I +K+ DFG+A S N + + T Y +PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 293 LLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352
G + D++S GC+L E+ G P G + V ++ + P + L
Sbjct: 186 ARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL--- 241
Query: 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEF 402
++ LA +P R A+ ++ +
Sbjct: 242 --------------------SADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 9e-51
Identities = 70/289 (24%), Positives = 119/289 (41%), Gaps = 41/289 (14%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT--SEPHSVKFMAREIMILQKLD 182
E + +G+G++ V+ A + T + A+K +K D + M + ++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 183 HPNIVKLEGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQ------QLLSGLQH 235
HP + + ++ L+ V E++ DL I + K + +++ GLQ
Sbjct: 62 HPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQF 118
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLG 295
H +GI++RD+K N+L+DK+G +KIADFG+ + + T Y APE+LLG
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT-NTFCGTPDYIAPEILLG 177
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355
Y +D WS G LL EM +G+ G+ E E H I
Sbjct: 178 QK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI----------------RMDNP 220
Query: 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404
P+ + + LL L +P R ++ F
Sbjct: 221 FYPRWLEKEAKD-----------LLVKLFVREPEKRLGVRGDIRQHPLF 258
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 3e-50
Identities = 69/351 (19%), Positives = 130/351 (37%), Gaps = 46/351 (13%)
Query: 125 ESYDKIDKV-GQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-D 182
+ Y +V G G V + ++ T + ALK ++ RE+ + +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQ 63
Query: 183 HPNIVKLEGL--ATSRMQYSLYLVFEFMQ-TDLA-RIISNPEGKLTEPQ------QLLSG 232
P+IV++ + + L +V E + +L RI + TE + +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 233 LQHCHDRGILHRDVKGSNLLIDK---NGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRA 289
+Q+ H I HRDVK NLL N +LK+ DFG A + + + T +Y A
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT--TPCYTPYYVA 181
Query: 290 PELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349
PE+L Y D+WS G ++ + G P + + ++
Sbjct: 182 PEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---- 236
Query: 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF--FTSP 407
+SE E L+ LL +P R + + + + T
Sbjct: 237 ---------------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 281
Query: 408 LACDLSGLPVIYDKEDELIEANQQRKIRRARMKHRSKTLRERRIGDQASQL 458
L V+ + ++ + ++ A M+ + ++ ++I D ++ L
Sbjct: 282 PQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPL 332
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 171 bits (433), Expect = 1e-48
Identities = 65/296 (21%), Positives = 117/296 (39%), Gaps = 44/296 (14%)
Query: 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMA----REIMIL 178
+ + +G+G + VY DTGK+ A+K + + + +A + ++
Sbjct: 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61
Query: 179 QKLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSG 232
D P IV + + L + + M + G +E +++ G
Sbjct: 62 STGDCPFIVCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 119
Query: 233 LQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPEL 292
L+H H+R +++RD+K +N+L+D++G ++I+D GLA FS K + V T Y APE+
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEV 176
Query: 293 LLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352
L Y D +S GC+L ++ G ++ H I ++ + + +
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELPDS---- 231
Query: 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR-----GSAASALKNEFF 403
F LL LL D R A ++ FF
Sbjct: 232 -------------------FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 1e-48
Identities = 66/290 (22%), Positives = 104/290 (35%), Gaps = 50/290 (17%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVK----FDTSEPHSVKFMAREIMILQKLD 182
Y +G G + +VY + VA+K V+ D E + + E+++L+K+
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 183 --HPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQ 234
+++L + L L DL I+ G L E Q+L ++
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVR 124
Query: 235 HCHDRGILHRDVKGSNLLIDKN-GVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELL 293
HCH+ G+LHRD+K N+LID N G LK+ DFG T T Y PE +
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWI 181
Query: 294 LGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353
+G +WS G LL +M G E+ + F+
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR----------------- 224
Query: 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403
L+ LAL P+ R + + +
Sbjct: 225 ----------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 5e-48
Identities = 65/292 (22%), Positives = 116/292 (39%), Gaps = 44/292 (15%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
E+ ++++G G + V+ VA+K +K + P + E ++++L H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPDAFL---AEANLMKQLQHQ 68
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTDL--ARIISNPEGKLTEPQ------QLLSGLQHC 236
+V+L + T +Y++ E+M+ + + KLT + Q+ G+
Sbjct: 69 RLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGA 296
+R +HRD++ +N+L+ KIADFGLA N+ + + APE +
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 297 TDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355
T + + D+WS G LL E+ GR PG T E + + + +
Sbjct: 186 T-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-----------------GY 227
Query: 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN-EFFFTS 406
R + PE L+ P R + E FFT+
Sbjct: 228 RMVRP---------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 167 bits (425), Expect = 5e-48
Identities = 65/293 (22%), Positives = 116/293 (39%), Gaps = 46/293 (15%)
Query: 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKL 181
S + + + +G G++ V+ R G+ A+K +K + V+ E ++L +
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 182 DHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQH 235
HP I+++ G Q ++++ ++++ + + P ++ L++
Sbjct: 62 THPFIIRMWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLG 295
H + I++RD+K N+L+DKNG +KI DFG A Y + T Y APE++
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVST 175
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355
Y ID WS G L+ EM G ++ +I L+
Sbjct: 176 KP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI----------------LNAEL 218
Query: 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR-----GSAASALKNEFF 403
R P F E LLS L+ D + R + +F
Sbjct: 219 RFP-----------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 4e-47
Identities = 58/284 (20%), Positives = 106/284 (37%), Gaps = 47/284 (16%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ + +G+G + +V G VA+K +K + + E ++ +L H
Sbjct: 7 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHS 60
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQ-TDLARII-SNPEGKLTEPQ------QLLSGLQHC 236
N+V+L G+ LY+V E+M L + S L + +++
Sbjct: 61 NLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGA 296
+HRD+ N+L+ ++ V K++DFGL S + + + + + APE L
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALRE- 174
Query: 297 TDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355
+ D+WS G LL E++ GR P + + R+
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV--------------------- 213
Query: 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
K +A P + ++ LD A R S +
Sbjct: 214 -----EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 1e-46
Identities = 61/288 (21%), Positives = 107/288 (37%), Gaps = 41/288 (14%)
Query: 125 ESYDKIDKVGQGTYSNVYKA-LDRDTGK--IVALKKVKFDT-SEPHSVKFMAREIMILQK 180
+ ++K+G G++ V + D +GK VA+K +K D S+P ++ RE+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 181 LDHPNIVKLEGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQ------QLLSGL 233
LDH N+++L G+ + + +V E L + +G Q+ G+
Sbjct: 68 LDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 234 QHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR-PLTSRVVTLWYRAPEL 292
+ + +HRD+ NLL+ ++KI DFGL N + +
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 293 LLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351
L + D W G L EMF G+ G + LH+I K
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK--------------- 229
Query: 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
R P+ + P+ ++ A P R + +
Sbjct: 230 -EGERLPRP---------EDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 1e-46
Identities = 76/293 (25%), Positives = 121/293 (41%), Gaps = 44/293 (15%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
ES K+GQG + V+ T + VA+K +K T P + +E +++KL H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL---QEAQVMKKLRHE 72
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTD--LARIISNPEGKLTEPQ------QLLSGLQHC 236
+V+L + + +Y+V E+M L + L PQ Q+ SG+ +
Sbjct: 73 KLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 237 HDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGA 296
+HRD++ +N+L+ +N V K+ADFGLA N+ + + APE L
Sbjct: 130 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 297 TDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355
+ + D+WS G LL E+ GR PG E L ++ + +
Sbjct: 190 R-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-----------------GY 231
Query: 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN-EFFFTSP 407
R P E PES L+ +P R + E +FTS
Sbjct: 232 RMPCP---------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-46
Identities = 70/299 (23%), Positives = 110/299 (36%), Gaps = 33/299 (11%)
Query: 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH 183
A + + +G+G + V++ + G+ VA+K S F EI L H
Sbjct: 2 ARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRH 56
Query: 184 PNIVKLEGLATSRMQY--SLYLVFEFMQT-DLARIISN----PEGKLTEPQQLLSGLQHC 236
NI+ L+LV ++ + L ++ EG + SGL H
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 237 H--------DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK---RPLTSRVVTL 285
H I HRD+K N+L+ KNG IAD GLA RV T
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 286 WYRAPELLLGA-----TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGS 340
Y APE+L + + D+++ G + E+ I G E QL +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI-GGIHEDYQLPYYDLVPSD 235
Query: 341 PSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
PS + +K+ RP + + EA + ++ + A R +A K
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAK----IMRECWYANGAARLTALRIKK 290
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-46
Identities = 71/293 (24%), Positives = 118/293 (40%), Gaps = 43/293 (14%)
Query: 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDT-SEPHSVKFMAREIMILQKL 181
+ +D + +G+GT+ V ++ TG+ A+K ++ + V E +LQ
Sbjct: 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 182 DHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQH 235
HP + L+ + L V E+ + E TE + +++S L++
Sbjct: 63 RHPFLTALKY--AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 236 CHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLG 295
H R +++RD+K NL++DK+G +KI DFGL + + + T Y APE+L
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLC-KEGISDGATMKTFCGTPEYLAPEVLED 179
Query: 296 ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355
DYG +D W G ++ EM GR + I L
Sbjct: 180 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI----------------LMEEI 222
Query: 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR-----GSAASALKNEFF 403
R P++ P LL+ LL DP R A +++ FF
Sbjct: 223 RFPRTLSPEAKS-----------LLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 162 bits (410), Expect = 3e-46
Identities = 57/281 (20%), Positives = 110/281 (39%), Gaps = 35/281 (12%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
K+G G Y VY+ + + VA+K +K DT E +E +++++ HP
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL---KEAAVMKEIKHP 73
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHD 238
N+V+L G+ T + + F L + +++ Q+ S +++
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 239 RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATD 298
+ +HRD+ N L+ +N ++K+ADFGL+ + + + + APE L
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192
Query: 299 YGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358
+ + D+W+ G LL E+ ++ Q++ + +
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---------------------- 230
Query: 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
K E PE L+ +P+ R S A +
Sbjct: 231 ---KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-45
Identities = 57/286 (19%), Positives = 106/286 (37%), Gaps = 44/286 (15%)
Query: 132 KVGQGTYSNVYKALDRD--TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
++G G + V K + K VA+K +K + ++P + E ++Q+LD+P IV++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 190 EGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQHCHDRGILH 243
G+ + S LV E + + + Q+ G+++ + +H
Sbjct: 74 IGICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 244 RDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV--TLWYRAPELLLGATDYGV 301
RD+ N+L+ KI+DFGL+ ++ + + APE + +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSS 189
Query: 302 GIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQS 360
D+WS G L+ E F G+ G E + K R
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-----------------GERMGCP 232
Query: 361 YKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAAS---ALKNEFF 403
+ P L++ D R A+ L+N ++
Sbjct: 233 ---------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-45
Identities = 59/286 (20%), Positives = 111/286 (38%), Gaps = 42/286 (14%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDT---GKIVALKKVKFDTSEPHSVKFMAREIMILQKL 181
E + +G+G + +V++ + VA+K K TS+ KF+ +E + +++
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEALTMRQF 65
Query: 182 DHPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQ 234
DHP+IVKL G+ T ++++ E +L + + L QL + L
Sbjct: 66 DHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 235 HCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLL 294
+ + +HRD+ N+L+ N +K+ DFGL+ Y + + + + + APE +
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 295 GATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353
+ D+W G + E+ + G G + + RI
Sbjct: 183 F-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN----------------- 224
Query: 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
R P P + L++ A DP+ R
Sbjct: 225 GERLPMP---------PNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-45
Identities = 61/283 (21%), Positives = 112/283 (39%), Gaps = 41/283 (14%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ ++G G + V+ + VA+K ++ E ++ KL HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFI---EEAEVMMKLSHP 60
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCH 237
+V+L G+ Q + LVFEFM+ L+ + G + G+ +
Sbjct: 61 KLVQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGAT 297
+ ++HRD+ N L+ +N V+K++DFG+ + ++ T + + +PE+ +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-S 177
Query: 298 DYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356
Y D+WS G L+ E+F G+ R+ E + I ST FR
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-----------------STGFR 220
Query: 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
KPRL +++ P R + + L+
Sbjct: 221 LY---KPRL------ASTHVYQIMNHCWKERPEDRPAFSRLLR 254
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 3e-45
Identities = 51/284 (17%), Positives = 104/284 (36%), Gaps = 41/284 (14%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHP 184
+ + ++G G + V R VA+K +K + E ++ L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFI---EEAKVMMNLSHE 59
Query: 185 NIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNPEGKLTEPQ------QLLSGLQHCH 237
+V+L G+ T + ++++ E+M L + + Q + +++
Sbjct: 60 KLVQLYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 238 DRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGAT 297
+ LHRD+ N L++ GV+K++DFGL+ Y ++ + + PE+L+ +
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-S 176
Query: 298 DYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356
+ D+W+ G L+ E++ LG+ T E I + R
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-----------------GLR 219
Query: 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400
+ E ++ + R + L N
Sbjct: 220 LYRP---------HLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (404), Expect = 4e-45
Identities = 62/311 (19%), Positives = 118/311 (37%), Gaps = 52/311 (16%)
Query: 104 PKWLTDNIPREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGK---IVALKKVKF 160
P +E+ +G G + V + GK VA+K +K
Sbjct: 12 PNEAVREFAKEI-------DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS 64
Query: 161 DTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQT-DLARIISNP 219
+E F+ E I+ + DHPN++ LEG+ T + ++ EFM+ L +
Sbjct: 65 GYTEKQRRDFL-SEASIMGQFDHPNVIHLEGVVTKSTP--VMIITEFMENGSLDSFLRQN 121
Query: 220 EGKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273
+G+ T Q + +G+++ D +HRD+ N+L++ N V K++DFGL+ + +
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 274 KKRPLTSRVV----TLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEV 328
P + + + + APE + + D+WS G ++ E+ G T
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 329 EQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDP 388
+ ++ I + +R P + P + L+ D
Sbjct: 241 DVINAIEQ-----------------DYRLPPP---------MDCPSALHQLMLDCWQKDR 274
Query: 389 AYRGSAASALK 399
+R +
Sbjct: 275 NHRPKFGQIVN 285
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 160 bits (406), Expect = 5e-45
Identities = 59/295 (20%), Positives = 110/295 (37%), Gaps = 46/295 (15%)
Query: 121 PKSAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKV-KFDTSEPHSVKFMAREIMILQ 179
+ +D+I +G G++ V +++G A+K + K + ++ E ILQ
Sbjct: 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 180 KLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGL 233
++ P +VKLE + + + + + G+ +EP Q++
Sbjct: 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTF 154
Query: 234 QHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELL 293
++ H +++RD+K NLLID+ G +++ DFG A + T APE++
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT----WTLCGTPEALAPEII 210
Query: 294 LGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353
L Y +D W+ G L+ EM G P ++ +I + L+
Sbjct: 211 LS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK--- 266
Query: 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR-----GSAASALKNEFF 403
LL LL +D R +++F
Sbjct: 267 ------------------------DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 1e-44
Identities = 52/288 (18%), Positives = 97/288 (33%), Gaps = 40/288 (13%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y K+G G++ ++Y D G+ VA+K T P + E I + +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGGVG 64
Query: 187 VKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHCHDRG 240
+ + Y +V E + L + + K + Q++S +++ H +
Sbjct: 65 IPTIRWCGAEGDY-NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123
Query: 241 ILHRDVKGSNLLI---DKNGVLKIADFGLANYFSPNK------KRPLTSRVVTLWYRAPE 291
+HRDVK N L+ K ++ I DFGLA + + R + T Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 292 LLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351
LG + DL S G +L LG G + + ++
Sbjct: 184 THLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS------------- 229
Query: 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
+ + +P L+ +L + + +
Sbjct: 230 ------EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 271
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-44
Identities = 65/299 (21%), Positives = 120/299 (40%), Gaps = 43/299 (14%)
Query: 123 SAESYDKIDKVGQGTYSNVYKA---LDRDTGKIVALKKVKFDT--SEPHSVKFMAREIMI 177
E+++ + +G G Y V+ DTGK+ A+K +K T + + + E +
Sbjct: 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 81
Query: 178 LQKLDH-PNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLL 230
L+ + P +V L + + L+L+ +++ + + TE + +++
Sbjct: 82 LEHIRQSPFLVTLHY--AFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 139
Query: 231 SGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVVTLWYRAP 290
L+H H GI++RD+K N+L+D NG + + DFGL+ F ++ T+ Y AP
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 291 ELLLGA-TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349
+++ G + + +D WS G L+ E+ G E I + Y +
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ-- 257
Query: 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR-----GSAASALKNEFF 403
E + L+ LL DP R A ++ FF
Sbjct: 258 ---------------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 6e-44
Identities = 57/288 (19%), Positives = 107/288 (37%), Gaps = 45/288 (15%)
Query: 132 KVGQGTYSNVYKALDRDTGK--IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKL 189
++G G + +V + + R K VA+K +K T + + + M RE I+ +LD+P IV+L
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRL 74
Query: 190 EGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEPQ------QLLSGLQHCHDRGIL 242
G+ + +L LV E L + + ++ Q+ G+++ ++ +
Sbjct: 75 IGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 243 HRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV--TLWYRAPELLLGATDYG 300
HRD+ N+L+ KI+DFGL+ + L + APE + +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFS 190
Query: 301 VGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQ 359
D+WS G + E G+ E + I
Sbjct: 191 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE------------------------ 226
Query: 360 SYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK--NEFFFT 405
+ + E E P L+S R + + +++
Sbjct: 227 --QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (386), Expect = 8e-43
Identities = 42/286 (14%), Positives = 91/286 (31%), Gaps = 44/286 (15%)
Query: 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH 183
Y ++G+G++ +++ + + VA+K + P + E + L
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAG 59
Query: 184 -PNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHC 236
I + + LV + + L ++ K + +Q+L+ +Q
Sbjct: 60 CTGIPNVYYFGQEGLHN--VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 237 HDRGILHRDVKGSNLLIDK-----NGVLKIADFGLANYFSPNKKR------PLTSRVVTL 285
H++ +++RD+K N LI + ++ + DFG+ ++ + + T
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 286 WYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDY 345
Y + LG + DL + G + G G + ++
Sbjct: 178 RYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK---- 232
Query: 346 WKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYR 391
L E + FPE + L
Sbjct: 233 ---------------QSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 2e-42
Identities = 67/312 (21%), Positives = 111/312 (35%), Gaps = 66/312 (21%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKI-----VALKKVKFDTSEPHSVKFMAREIMILQ 179
E+ + +G G + V A K VA+K +K M E+ ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SELKMMT 95
Query: 180 KL-DHPNIVKLEGLATSRMQYSLYLVFEFM-QTDLARIISNPEGKLTEPQ---------- 227
+L H NIV L G T +YL+FE+ DL + + K +E +
Sbjct: 96 QLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 228 ------------------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANY 269
Q+ G++ + +HRD+ N+L+ V+KI DFGLA
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 270 FSPNKKRPL-TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTE 327
+ + + + + + APE L Y + D+WS G LL E+F LG PG
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 328 VEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALD 387
+++ + F+ Q E ++ + A D
Sbjct: 273 DANFYKLIQ----------------NGFKMDQP---------FYATEEIYIIMQSCWAFD 307
Query: 388 PAYRGSAASALK 399
R S +
Sbjct: 308 SRKRPSFPNLTS 319
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 4e-41
Identities = 54/287 (18%), Positives = 97/287 (33%), Gaps = 40/287 (13%)
Query: 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALK---KVKFDTSEPHSVKFMAREIMILQK 180
+ KI +G G + VYK L G+ V + K + + P + K + E ++
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 181 LDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQ------QLLSGLQ 234
+D+P++ +L G+ + + L + + + Q+ G+
Sbjct: 68 VDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 235 HCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV-TLWYRAPELL 293
+ DR ++HRD+ N+L+ +KI DFGLA +K + + A E +
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 294 LGATDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS 352
L Y D+WS G + E+ G G E + K
Sbjct: 186 LHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---------------- 228
Query: 353 TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
R PQ ++ +D R +
Sbjct: 229 -GERLPQP---------PICTIDVYMIMVKCWMIDADSRPKFRELII 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (373), Expect = 6e-41
Identities = 66/312 (21%), Positives = 120/312 (38%), Gaps = 67/312 (21%)
Query: 125 ESYDKIDKVGQGTYSNVYKA-----LDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQ 179
+ + + +G+G + V++A L + +VA+K +K + S F RE ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REAALMA 71
Query: 180 KLDHPNIVKLEGLATSRMQYSLYLVFEFMQ-TDLARII---------------------- 216
+ D+PNIVK L + + L+FE+M DL +
Sbjct: 72 EFDNPNIVK--LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 217 -SNPEGKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLA-N 268
S L+ + Q+ +G+ + +R +HRD+ N L+ +N V+KIADFGL+ N
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 269 YFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTE 327
+S + + + + + + PE + Y D+W+ G +L E+F G G
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248
Query: 328 VEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALD 387
E ++ + + P L+ +
Sbjct: 249 EEVIYYVR--------------------------DGNILACPENCPLELYNLMRLCWSKL 282
Query: 388 PAYRGSAASALK 399
PA R S S +
Sbjct: 283 PADRPSFCSIHR 294
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (375), Expect = 1e-40
Identities = 73/326 (22%), Positives = 128/326 (39%), Gaps = 58/326 (17%)
Query: 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI 186
Y + K+G G +S V+ A D VA+K V+ D + + EI +LQ+++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADN 71
Query: 187 VKLEGLATSRMQYSLYLVFEFMQTD---------------LARIISNPEGKLTEPQ---- 227
K + + + + L F + LA I +
Sbjct: 72 TKEDSMGANHI-LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130
Query: 228 --QLLSGLQHC-HDRGILHRDVKGSNLLIDKNGV------LKIADFGLANYFSPNKKRPL 278
QLL GL + GI+H D+K N+L++ +KIAD G A ++ + +
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRT------EVEQLH 332
+R YR+PE+LLGA +G G D+WS CL+ E+ G + + + +
Sbjct: 191 QTR----EYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245
Query: 333 RIFKLCGSPSEDYWKKLRLSTTF---------------RPPQSYKPRLFEAFSEFPESSL 377
+I +L G + + + TF P + ++ + +
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305
Query: 378 GLLSTLLALDPAYRGSAASALKNEFF 403
LS +L LDP R A + + +
Sbjct: 306 DFLSPMLQLDPRKRADAGGLVNHPWL 331
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-39
Identities = 56/244 (22%), Positives = 99/244 (40%), Gaps = 17/244 (6%)
Query: 107 LTDNIPREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRD---TGKIVALKKVKFDTS 163
L + + V ++ S+ + +G+G + VY D A+K + T
Sbjct: 9 LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 68
Query: 164 EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGK 222
+F+ E +I++ HPN++ L G R + S +V +M+ DL I N
Sbjct: 69 IGEVSQFL-TEGIIMKDFSHPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHN 126
Query: 223 LTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK-- 274
T Q+ G++ + +HRD+ N ++D+ +K+ADFGLA +
Sbjct: 127 PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186
Query: 275 -KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLH 332
T + + + A E L + D+WS G LL E+ G P P +
Sbjct: 187 SVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 245
Query: 333 RIFK 336
+ +
Sbjct: 246 YLLQ 249
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-39
Identities = 54/288 (18%), Positives = 115/288 (39%), Gaps = 42/288 (14%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTG----KIVALKKVKFDTSEPHSVKFMAREIMILQK 180
+ +G G + VYK + + + VA+K +K +E V F+ E I+ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQ 65
Query: 181 LDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLA-RIISNPEGKLTEPQ------QLLSGL 233
H NI++LEG+ + + ++ E+M+ + + +G+ + Q + +G+
Sbjct: 66 FSHHNIIRLEGVISKYKP--MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 234 QHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTS--RVVTLWYRAPE 291
++ + +HRD+ N+L++ N V K++DFGL+ + + T+ + + + APE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 292 LLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351
+ D+WS G ++ E+ ++ + +
Sbjct: 184 AISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA----------------I 226
Query: 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
+ FR P + P + L+ + A R A +
Sbjct: 227 NDGFRLPTP---------MDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 4e-38
Identities = 60/307 (19%), Positives = 99/307 (32%), Gaps = 61/307 (19%)
Query: 125 ESYDKIDKVGQGTYSNVYKA-----LDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQ 179
+G G + V +A + D VA+K +K M E+ +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SELKVLS 81
Query: 180 KL-DHPNIVKLEGLATSRMQYSLYLVFEFM------------------QTDLARIISNPE 220
L +H NIV L G T ++ E+ I+ + E
Sbjct: 82 YLGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 221 GKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274
L Q+ G+ + +HRD+ N+L+ + KI DFGLA +
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 275 KRPLTSRVV-TLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLH 332
+ + + APE + Y D+WS G L E+F LG PG + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 333 RIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG 392
++ + FR P ++ T DP R
Sbjct: 259 KM----------------IKEGFRMLSP---------EHAPAEMYDIMKTCWDADPLKRP 293
Query: 393 SAASALK 399
+ ++
Sbjct: 294 TFKQIVQ 300
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 5e-37
Identities = 69/301 (22%), Positives = 111/301 (36%), Gaps = 58/301 (19%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRDTGKI--VALKKVKFDTSEPHSVKFMAREIMILQKL- 181
D +G+G + V KA + G A+K++K S+ F E+ +L KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVLCKLG 68
Query: 182 DHPNIVKLEGLATSRMQYSLYLVFEFMQ-TDLARII---------------SNPEGKLTE 225
HPNI+ L G + LYL E+ +L + ++ L+
Sbjct: 69 HHPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 226 PQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLT 279
Q + G+ + + +HRD+ N+L+ +N V KIADFGL+ K+ T
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 280 SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRIFKLC 338
+ + + A E L + Y D+WS G LL E+ LG G T E ++ +
Sbjct: 185 MGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 241
Query: 339 GSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASAL 398
+R + + L+ P R S A L
Sbjct: 242 ---------------GYRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQIL 277
Query: 399 K 399
Sbjct: 278 V 278
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 5e-37
Identities = 48/298 (16%), Positives = 104/298 (34%), Gaps = 53/298 (17%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDR-----DTGKIVALKKVKFDTSEPHSVKFMAREIMILQ 179
E ++GQG++ VY+ + + + VA+K V S ++F+ E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMK 78
Query: 180 KLDHPNIVKLEGLATSRMQYSLYLVFEFMQ-TDLARIISNPEGKLTEP------------ 226
+ + ++V+L G ++ E M DL + + +
Sbjct: 79 EFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 227 ---QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSRVV 283
++ G+ + + +HRD+ N ++ ++ +KI DFG+ + +
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 284 -TLWYRAPELLLGATDYGVGIDLWSAGCLLAEMF-LGRPIMPGRTEVEQLHRIFKLCGSP 341
+ + +PE L + D+WS G +L E+ L G + + L +
Sbjct: 197 LPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM------ 249
Query: 342 SEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399
+ L + P+ L+ +P R S +
Sbjct: 250 --------------------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 9e-37
Identities = 59/303 (19%), Positives = 109/303 (35%), Gaps = 54/303 (17%)
Query: 125 ESYDKIDKVGQGTYSNVYKALDRD-----TGKIVALKKVKFDTSEPHSVKFMAREIMILQ 179
+ +G+G + V +A T + VA+K +K + M+ +++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 180 KLDHPNIVKLEGLATSRMQYSLYLVFEFMQTDLARIISN---------------PEGKLT 224
H N+V L G T + +V +L+ + + + LT
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 225 EPQ------QLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278
Q+ G++ R +HRD+ N+L+ + V+KI DFGLA +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 279 TSRVV-TLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLG-RPIMPGRTEVEQLHRIFK 336
L + APE + Y + D+WS G LL E+F PG E+
Sbjct: 193 KGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF----- 246
Query: 337 LCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAAS 396
++L+ T R P P +++ + +P+ R + +
Sbjct: 247 ---------CRRLKEGTRMRAPDYTTPEMYQ-----------TMLDCWHGEPSQRPTFSE 286
Query: 397 ALK 399
++
Sbjct: 287 LVE 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-36
Identities = 72/327 (22%), Positives = 122/327 (37%), Gaps = 74/327 (22%)
Query: 104 PKWLTDNIPREVLAGLVPKSAESYDKIDKVGQGTYSNVYKALDRDTGK-------IVALK 156
P+W +PR+ +G+G + V A K VA+K
Sbjct: 6 PRW---ELPRD-----------RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK 51
Query: 157 KVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFM-QTDLARI 215
+K D +E ++ M+ H NI+ L G T LY++ E+ + +L
Sbjct: 52 MLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREY 109
Query: 216 I---------------SNPEGKLTEPQ------QLLSGLQHCHDRGILHRDVKGSNLLID 254
+ NPE +L+ Q+ G+++ + +HRD+ N+L+
Sbjct: 110 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169
Query: 255 KNGVLKIADFGLANYFSPNKKRPLT-SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLA 313
++ V+KIADFGLA T + + + + APE L Y D+WS G LL
Sbjct: 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLW 228
Query: 314 EMF-LGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEF 372
E+F LG P G P E+ +K L+ P + L+
Sbjct: 229 EIFTLGGSPYP---------------GVPVEELFKLLKEGHRMDKPSNCTNELYM----- 268
Query: 373 PESSLGLLSTLLALDPAYRGSAASALK 399
++ P+ R + ++
Sbjct: 269 ------MMRDCWHAVPSQRPTFKQLVE 289
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 106 bits (264), Expect = 5e-27
Identities = 32/197 (16%), Positives = 66/197 (33%), Gaps = 24/197 (12%)
Query: 131 DKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFM--------AREIMILQKLD 182
+G+G S V+ +K K + VK + + + +
Sbjct: 6 KLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 183 HPNIVKLEGLATSRM--QYSLYLVFEFMQTDLARIISNPEGKLTEPQQLLSGLQHCHDRG 240
+ KL+GLA ++ ++ E + + +L + + RG
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVL-DMILEEVAKFYHRG 123
Query: 241 ILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPLTSR---VVTLWYRAPELLLGAT 297
I+H D+ N+L+ + G+ I DF + R + R + ++
Sbjct: 124 IVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIITYFS--------R 174
Query: 298 DYGVGIDLWSAGCLLAE 314
Y D+ SA + +
Sbjct: 175 TYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 584 | |||
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.28 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.03 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.63 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.97 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.79 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.57 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-57 Score=467.27 Aligned_cols=286 Identities=42% Similarity=0.698 Sum_probs=233.2
Q ss_pred eEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCCh---HHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 128 DKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP---HSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 128 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~---~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
+.++.||+|+||+||+|+++.+|+.||||+++...... ...+.+.+|+.+|++++|||||++++++.... .+|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~--~~~iv 78 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--NISLV 78 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--CCEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC--ceeeh
Confidence 35789999999999999999999999999996543222 12346889999999999999999999987744 57999
Q ss_pred EechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 205 FEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
||||.+++...+......+.+ ..||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ...
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~~ 157 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAY 157 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CCC
T ss_pred hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc-ccc
Confidence 999998777666654444433 3599999999999999999999999999999999999999998765433 234
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p 358 (584)
...+||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.++.+++..|++..+.+....|............
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 56789999999999987667899999999999999999999999999999999999999999888777554322221111
Q ss_pred C-CCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCccCCCCCC
Q 043957 359 Q-SYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDLSGLP 416 (584)
Q Consensus 359 ~-~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~~~~~~~~ 416 (584)
. .....+...+..+++++++||.+||++||++||||+|+|+||||++.|.+++...+|
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p 296 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 296 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSC
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCC
Confidence 1 112234556678899999999999999999999999999999999988887776665
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=454.40 Aligned_cols=254 Identities=31% Similarity=0.442 Sum_probs=206.4
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++++.||+|+||+||+|+++.+|+.||||++...... ...+.+.+|+.+|++++|||||++++++.+. ..+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~--~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREG--NIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--ceeEE
Confidence 45799999999999999999999999999999999754322 2345688999999999999999999998874 46899
Q ss_pred EEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC-C
Q 043957 204 VFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK-K 275 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~ 275 (584)
|||||.+ +|.+.+.. ...+++ ..||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+.... .
T Consensus 81 vmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999985 78887764 344544 3599999999999999999999999999999999999999998764332 2
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
...+..+||+.|||||++.+...++.++|||||||++|||++|++||....+.............
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~--------------- 224 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--------------- 224 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT---------------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC---------------
Confidence 33456789999999999987655678899999999999999999999876654333222221110
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
....+..+++++.+||.+||+.||.+|||++|+|+||||++
T Consensus 225 ---------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 225 ---------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ---------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ---------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 11223567899999999999999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-56 Score=452.71 Aligned_cols=253 Identities=28% Similarity=0.474 Sum_probs=202.7
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
.+++|++++.||+|+||.||+|+++.+|+.||||++..........+.+.+|+.+|++++|||||++++++.+.....+|
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 35789999999999999999999999999999999987766777778899999999999999999999998876666789
Q ss_pred EEEechh-hHHHHHhhC---CCCCCcH------HHHHHHHHHHHHhCC-----ceeccccccceeecCCCcEEEEEeccc
Q 043957 203 LVFEFMQ-TDLARIISN---PEGKLTE------PQQLLSGLQHCHDRG-----ILHRDVKGSNLLIDKNGVLKIADFGLA 267 (584)
Q Consensus 203 lV~Ey~~-g~L~~~l~~---~~~~l~~------~~qIl~aL~yLH~~~-----IvHrDLKp~NILl~~~g~vKL~DFGla 267 (584)
||||||. |+|.+++.. ....+++ ..||+.||+|||+++ |+||||||+||||+.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 9999998 477777642 2233433 459999999999876 999999999999999999999999999
Q ss_pred cccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHH
Q 043957 268 NYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWK 347 (584)
Q Consensus 268 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 347 (584)
+.+.... ......+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|......
T Consensus 162 ~~~~~~~-~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~------- 232 (269)
T d2java1 162 RILNHDT-SFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR------- 232 (269)
T ss_dssp HHC------------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-------
T ss_pred eecccCC-CccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 8875432 23456789999999999976 45999999999999999999999999998888777766543111
Q ss_pred HhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 348 KLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 348 ~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
.....+|+++.+||.+||+.||.+|||++|+|+|||+
T Consensus 233 -------------------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 233 -------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 1123578999999999999999999999999999996
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=451.59 Aligned_cols=248 Identities=30% Similarity=0.449 Sum_probs=209.5
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
.++|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+.+|+.+|++++|||||++++++.+ ...+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ 82 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRVY 82 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE--CCEEE
Confidence 4579999999999999999999999999999999864321 12235668899999999999999999999886 44689
Q ss_pred EEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 203 LVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
||||||.+ +|.+.+... ..+.+ ..||+.||+|||++||+||||||+||||+.++.+||+|||+|......
T Consensus 83 ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-- 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred EEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence 99999995 777776532 33443 359999999999999999999999999999999999999999876533
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
.....+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.+....
T Consensus 160 -~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--------------- 222 (263)
T d2j4za1 160 -RRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--------------- 222 (263)
T ss_dssp -CCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC---------------
T ss_pred -cccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence 2356789999999999987 45899999999999999999999999998888877766543211
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
....+|+++.+||.+||++||.+|||++|+|+||||+.
T Consensus 223 ------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 223 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp ------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred ------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 11346899999999999999999999999999999964
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=451.88 Aligned_cols=251 Identities=26% Similarity=0.500 Sum_probs=211.8
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++++.||+|+||+||+|.++.+|+.||||++...... ..+.+.+|+.+|++++|||||++++++.+. ..+||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~i 94 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVG--DELWV 94 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEEC--CEEEE
Confidence 35799999999999999999999999999999999754333 346788999999999999999999998874 46899
Q ss_pred EEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
|||||.| +|..++... .+++ ..||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.+.... .
T Consensus 95 vmEy~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~ 171 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 171 (293)
T ss_dssp EEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred EEEecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-c
Confidence 9999985 676666532 3443 3499999999999999999999999999999999999999998875433 2
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+..... +.
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~-------------- 235 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PE-------------- 235 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CC--------------
T ss_pred cccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CC--------------
Confidence 3456789999999999987 4689999999999999999999999999888877766654321 10
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
......+++++++||.+||++||.+|||++|+|+||||+..
T Consensus 236 ---------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 236 ---------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp ---------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ---------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 01224578999999999999999999999999999999753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-55 Score=448.99 Aligned_cols=280 Identities=43% Similarity=0.752 Sum_probs=232.9
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++++.||+|+||+||+|++..+|+.||||+++.........+.+.+|+++|++++|||||++++++.+ ...+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc--ccceeEE
Confidence 57999999999999999999999999999999997655444456778899999999999999999999877 4468999
Q ss_pred EechhhHHHHHhh-CCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 205 FEFMQTDLARIIS-NPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 205 ~Ey~~g~L~~~l~-~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||||.+++...+. .....+.+. .||+.||+|||++|||||||||+|||++.++.+||+|||+|+...... ..
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~~ 158 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RT 158 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-BC
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc-cc
Confidence 9999987666553 334445443 499999999999999999999999999999999999999998775433 33
Q ss_pred CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC-
Q 043957 278 LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR- 356 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~- 356 (584)
....+||+.|+|||++.....++.++|||||||++|+|++|++||.+.+..+++..+....+.+....|..........
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 4566899999999998876667899999999999999999999999999999999999999998888777654432222
Q ss_pred -CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 357 -PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 357 -~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
.+..........+..+++++++||.+||++||.+|||++|+|+||||++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 223333445566678899999999999999999999999999999998653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.4e-55 Score=458.29 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=220.6
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++++.||+|+||.||+|+++.+|+.||||++... .....+.+.+|+.+|++|+|||||++++++.+ ...+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~i 100 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVM 100 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 45799999999999999999999999999999999643 34456778999999999999999999999887 456899
Q ss_pred EEechh-hHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecC--CCcEEEEEeccccccCCCC
Q 043957 204 VFEFMQ-TDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDK--NGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~--~g~vKL~DFGla~~~~~~~ 274 (584)
|||||. |+|.+.+....+.+++. .||+.||.|||++|||||||||+||||+. ++.+||+|||+|+.+....
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 999998 57888887655666554 49999999999999999999999999954 6789999999998875432
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.....+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|......+..
T Consensus 181 --~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 246 (350)
T d1koaa2 181 --SVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD----------- 246 (350)
T ss_dssp --CEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC-----------
T ss_pred --ccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----------
Confidence 3456789999999999987 45899999999999999999999999999998888888665433332
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCccC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACD 411 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~~~ 411 (584)
..+..+++++++||.+||+.||.+|||++|+|+||||+....+..
T Consensus 247 ------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~ 291 (350)
T d1koaa2 247 ------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 291 (350)
T ss_dssp ------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSC
T ss_pred ------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCc
Confidence 223567899999999999999999999999999999987654443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-56 Score=452.06 Aligned_cols=253 Identities=28% Similarity=0.396 Sum_probs=209.9
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
+.|++++.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|++|+|||||++++++.+. ..+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CeEEEE
Confidence 45999999999999999999999999999999997543 33456788999999999999999999998874 468999
Q ss_pred Eechhh-HHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCC
Q 043957 205 FEFMQT-DLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRP 277 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 277 (584)
||||.+ +|..++......+++. .||+.||.|||++||+||||||+||||+.++.+||+|||+|+...... ..
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 999985 6666655444445543 499999999999999999999999999999999999999997653211 12
Q ss_pred CccccccccccChhhhhC----CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 278 LTSRVVTLWYRAPELLLG----ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 278 ~~~~~gt~~Y~APEvl~~----~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
....+||+.|||||++.. ...|+.++|||||||++|||++|++||.+.+..+.+..+......
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~------------- 233 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP------------- 233 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCC-------------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 345689999999999852 345899999999999999999999999998888777766543110
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.......+|+++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 234 -----------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 234 -----------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp -----------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred -----------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 011224678999999999999999999999999999999753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.7e-55 Score=449.39 Aligned_cols=249 Identities=26% Similarity=0.449 Sum_probs=209.1
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE-PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
.|++++.||+|+||+||+|++..+|+.||||++...... ....+.+.+|+.+|++|+|||||++++++.+. ..+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~iv 93 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLV 93 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC--CEEEEE
Confidence 499999999999999999999999999999999765443 34557789999999999999999999998774 468999
Q ss_pred EechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 205 FEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
||||.++++..+......+++ ..||+.||.|||++|||||||||+||||+.++.+||+|||+|..... .
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----~ 168 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----A 168 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----B
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-----C
Confidence 999997655544333344554 35999999999999999999999999999999999999999987543 2
Q ss_pred ccccccccccChhhhhCC--CCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC
Q 043957 279 TSRVVTLWYRAPELLLGA--TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR 356 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~--~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 356 (584)
...+||+.|||||++.+. ..|+.++|||||||++|||++|++||.+.+..+.+..+......+.
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------- 234 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL-------------- 234 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--------------
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--------------
Confidence 456899999999999642 3589999999999999999999999999888877776654321110
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
....+|+++.+||.+||+.||.+|||++|+|+||||...
T Consensus 235 -----------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 235 -----------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp -----------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred -----------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 013568999999999999999999999999999999753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=448.58 Aligned_cols=290 Identities=45% Similarity=0.714 Sum_probs=230.5
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC-----
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM----- 197 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----- 197 (584)
..++|+++++||+|+||+||+|++..+|+.||||++............+.+|+.+|++++||||+++++++....
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 467899999999999999999999999999999999766555555677889999999999999999998875432
Q ss_pred -cceEEEEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccccc
Q 043957 198 -QYSLYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 198 -~~~l~lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~ 270 (584)
...+|+|||||.+++...+......+.+ ..||+.||.|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 3468999999998777776655555544 359999999999999999999999999999999999999999876
Q ss_pred CCCCC---CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHH
Q 043957 271 SPNKK---RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWK 347 (584)
Q Consensus 271 ~~~~~---~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 347 (584)
..... ......+||++|+|||++.+...|+.++|||||||++|||++|++||.+.++...+..+....+.+....+.
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 53221 223456899999999999877779999999999999999999999999999999999999999888876655
Q ss_pred HhhccCC---CCCCCCCCchhhhhc--cCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCccCC
Q 043957 348 KLRLSTT---FRPPQSYKPRLFEAF--SEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLACDL 412 (584)
Q Consensus 348 ~~~~~~~---~~~p~~~~~~~~~~~--~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~~~~ 412 (584)
....... ..............+ ...++.++|||.+||++||++||||+|+|+||||+..|.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~~~ 317 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDL 317 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCCCC
T ss_pred ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCCCC
Confidence 4322111 111111122222222 2347788999999999999999999999999999988877664
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-54 Score=441.77 Aligned_cols=277 Identities=41% Similarity=0.719 Sum_probs=230.8
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|+++++||+|+||+||+|+++ +|+.||||+++.........+.+.+|+.+|++++|||||++++++... ..+|++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC--CceeEE
Confidence 68999999999999999999986 789999999976554444467788999999999999999999988774 457999
Q ss_pred EechhhHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 205 FEFMQTDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
|||+.+++...+......+++. .||+.||+|||+++||||||||+||||+.++.+||+|||+|........ ..
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~ 157 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KY 157 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-cc
Confidence 9999988887777666666654 4999999999999999999999999999999999999999987654322 23
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCC--
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFR-- 356 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-- 356 (584)
...++++.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++.++....+.+....|..........
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 455789999999999877778999999999999999999999999999999999999999998888776654332221
Q ss_pred CCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 357 PPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 357 ~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
............+..+++.+.|||.+||++||++|||++|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 1222233345566788999999999999999999999999999999974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=438.89 Aligned_cols=248 Identities=25% Similarity=0.290 Sum_probs=203.8
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec--CcceEEEE
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR--MQYSLYLV 204 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~l~lV 204 (584)
|++.++||+|+||+||+|++..++..||+|++..........+.+.+|+++|++|+|||||++++++... ....+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 4777899999999999999999999999999977666666677899999999999999999999988653 34568999
Q ss_pred Eechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCC--ceeccccccceeec-CCCcEEEEEeccccccCCCC
Q 043957 205 FEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRG--ILHRDVKGSNLLID-KNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~--IvHrDLKp~NILl~-~~g~vKL~DFGla~~~~~~~ 274 (584)
||||++ +|.+.+... ..++ +..||+.||+|||+++ |+||||||+||||+ +++.+||+|||+|+.....
T Consensus 91 mE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 999985 677776532 2333 3459999999999998 99999999999996 5789999999999875432
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.....+||+.|||||++.+ .|+.++|||||||++|||++|++||.+......+...+.... .+.
T Consensus 169 --~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~-~~~----------- 232 (270)
T d1t4ha_ 169 --FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV-KPA----------- 232 (270)
T ss_dssp --SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC-CCG-----------
T ss_pred --ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCC-CCc-----------
Confidence 2356789999999999865 499999999999999999999999987665554433221110 000
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFF 404 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~ 404 (584)
.....+++++.+||.+||+.||++|||++|+|+||||+
T Consensus 233 ------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 233 ------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 12245688999999999999999999999999999995
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.6e-54 Score=454.28 Aligned_cols=252 Identities=26% Similarity=0.481 Sum_probs=216.8
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
+.|++++.||+|+||+||+|+++.+|+.||||++.... ......+.+|+.+|++|+|||||++++++.+ ...+|||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~iv 104 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVLI 104 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence 56999999999999999999999999999999997542 3345678899999999999999999998876 4568999
Q ss_pred Eechh-hHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeec--CCCcEEEEEeccccccCCCCC
Q 043957 205 FEFMQ-TDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLID--KNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 205 ~Ey~~-g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~--~~g~vKL~DFGla~~~~~~~~ 275 (584)
||||. |+|.+.+......+++. .||+.||.|||++|||||||||+||||+ .++.+||+|||+|..+....
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 99999 57877776655556553 5999999999999999999999999997 57899999999999876433
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|......++.
T Consensus 184 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~------------ 249 (352)
T d1koba_ 184 -IVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE------------ 249 (352)
T ss_dssp -CEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS------------
T ss_pred -ceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc------------
Confidence 3456789999999999976 46999999999999999999999999999999888888765433322
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
..+..+|+++.+||.+||++||.+|||++|+|+||||+..
T Consensus 250 -----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 250 -----------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp -----------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -----------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 1235679999999999999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-55 Score=447.79 Aligned_cols=253 Identities=28% Similarity=0.435 Sum_probs=207.9
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
.++|++++.||+|+||+||+|.++.+|+.||||++..... .....+.+.+|+.+|++++|||||++++++.+ ...+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ 84 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLY 84 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--SSEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE--CCEEE
Confidence 4679999999999999999999999999999999964321 22345678899999999999999999998876 45689
Q ss_pred EEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC-
Q 043957 203 LVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK- 274 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~- 274 (584)
||||||.| +|.+.+.. .+.+++ ..||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+....
T Consensus 85 ivmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp EEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999995 67776653 234444 3499999999999999999999999999999999999999998875432
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.......+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..|......+
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~------------- 229 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF------------- 229 (288)
T ss_dssp ------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC-------------
T ss_pred ccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCC-------------
Confidence 2234567899999999999874 59999999999999999999999999998888887775432111
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHH------HhcCcCCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAAS------ALKNEFFFTSP 407 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e------~L~Hp~f~~~~ 407 (584)
...+++++++||.+||++||.+|||++| +++||||....
T Consensus 230 --------------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 230 --------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp --------------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred --------------CccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 1357899999999999999999999987 57899997643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=444.04 Aligned_cols=280 Identities=38% Similarity=0.629 Sum_probs=224.3
Q ss_pred CCCceEEeeecccCceEEEEEEECCC-CcEEEEEEeecCCCChHHHHHHHHHHHHHHhC---CCCCeeeeeceeee---c
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDT-GKIVALKKVKFDTSEPHSVKFMAREIMILQKL---DHPNIVKLEGLATS---R 196 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~---~ 196 (584)
.++|+++++||+|+||+||+|++..+ ++.||||+++...........+.+|+.+|+.| +|||||++++++.. .
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999765 67899999975543333333455777777665 79999999998854 2
Q ss_pred CcceEEEEEechhhHHHHHh-hCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccc
Q 043957 197 MQYSLYLVFEFMQTDLARII-SNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 197 ~~~~l~lV~Ey~~g~L~~~l-~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
....+|++||||.+++.... ......+++ ..||+.||+|||+++||||||||+|||++.++.+||+|||++..
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 34578999999997655433 333334443 35999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 270 FSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 270 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
.... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+++..++...+.+....|...
T Consensus 166 ~~~~--~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 166 YSFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hccc--ccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence 5432 23466789999999999987 46999999999999999999999999999999999999999998887776543
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
...................+..+++.+++||.+||++||.+||||+|+|+||||++-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 222221122222333445567889999999999999999999999999999999753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=457.03 Aligned_cols=275 Identities=26% Similarity=0.394 Sum_probs=202.7
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
..++|++++.||+|+||+||+|+++.+|+.||||+++.... ......+.+|+.+|++++|||||++++++.+. ..+|
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 80 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEIS 80 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS--SEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEE
Confidence 35679999999999999999999999999999999976533 34456788999999999999999999998874 4689
Q ss_pred EEEechhh-HHHHHhhCCCCCCcHH------HHHHHHHHHHHh-CCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 203 LVFEFMQT-DLARIISNPEGKLTEP------QQLLSGLQHCHD-RGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~~~l~~~------~qIl~aL~yLH~-~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
||||||.| +|..++... ..+++. .||+.||.|||+ +||+||||||+||||+.+|.+||+|||+|+.+...
T Consensus 81 iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 99999995 777777532 344443 499999999997 59999999999999999999999999999876432
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHH-HHHHHhcCCCChHH----HHHh
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQL-HRIFKLCGSPSEDY----WKKL 349 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~-~~i~~~~~~~~~~~----~~~~ 349 (584)
...+.+||++|||||++.+. .|+.++||||||||+|||++|+.||.+.+..... ..+....+.+.... +...
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred --ccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 23567999999999999874 5999999999999999999999999876643321 11111111111100 0000
Q ss_pred hccCC--CCCCCCCCchhhh----------hccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 350 RLSTT--FRPPQSYKPRLFE----------AFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 350 ~~~~~--~~~p~~~~~~~~~----------~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
..... ...+......... .-..++.+++|||.+||++||.+||||+|+|+||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 00000 0000000000000 00235789999999999999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-55 Score=448.91 Aligned_cols=252 Identities=31% Similarity=0.462 Sum_probs=196.3
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
+.|++.+.||+|+||+||+|+++.+|+.||||++....... ....+.+|+.+|++|+|||||++++++.+ ...+|||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv 85 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYES--GGHLYLI 85 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence 46999999999999999999999999999999997554332 23567899999999999999999998876 4468999
Q ss_pred Eechh-hHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeec---CCCcEEEEEeccccccCCCC
Q 043957 205 FEFMQ-TDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLID---KNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 205 ~Ey~~-g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~---~~g~vKL~DFGla~~~~~~~ 274 (584)
||||. |+|.+.+... ..+++. .||+.||+|||+++|+||||||+|||+. .++.+||+|||+|+......
T Consensus 86 mE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp ECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 99998 5888888653 345443 4999999999999999999999999994 57899999999998765332
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
...+.+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....+......+..
T Consensus 165 --~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 230 (307)
T d1a06a_ 165 --VLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS----------- 230 (307)
T ss_dssp ----------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCT-----------
T ss_pred --eeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCC-----------
Confidence 3456789999999999987 45999999999999999999999999999888887777654322221
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
..+..+|+++.+||.+||++||.+|||++|+|+||||+..
T Consensus 231 ------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 231 ------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp ------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred ------------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 1234678999999999999999999999999999999753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-54 Score=441.29 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=214.5
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC----hHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE----PHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+.+|++|+|||||++++++.+ ...
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~ 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTD 87 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCE
Confidence 5699999999999999999999999999999999754322 2245778999999999999999999999877 446
Q ss_pred EEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCC----cEEEEEeccccc
Q 043957 201 LYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG----VLKIADFGLANY 269 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g----~vKL~DFGla~~ 269 (584)
+|||||||. |+|.+++... ..+++ ..||+.||+|||+++|+||||||+|||++.++ .+||+|||+|..
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 899999998 4787777543 33443 35999999999999999999999999998776 599999999988
Q ss_pred cCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 270 FSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 270 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
+.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+......+...
T Consensus 167 ~~~~~--~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~----- 238 (293)
T d1jksa_ 167 IDFGN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE----- 238 (293)
T ss_dssp CTTSC--BCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHH-----
T ss_pred cCCCc--cccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCch-----
Confidence 75433 3456789999999999986 458999999999999999999999999999988888876654444332
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.+..+|+.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 239 ------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 239 ------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp ------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred ------------------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 235678999999999999999999999999999999754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-54 Score=448.76 Aligned_cols=278 Identities=34% Similarity=0.572 Sum_probs=229.7
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC----cc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM----QY 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 199 (584)
.++|+++++||+|+||+||+|.++.+|+.||||+++.........+.+.+|+.+|++++|||||++++++.... ..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 35799999999999999999999999999999999876666667788999999999999999999999887643 23
Q ss_pred eEEEEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 200 SLYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 200 ~l~lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
.+|||||||+.+|..++.. ..+++ ..||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 97 ~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~ 174 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174 (346)
T ss_dssp CCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred eEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc
Confidence 5799999998777777653 23444 359999999999999999999999999999999999999999876432
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
.+..+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.++..+|.......
T Consensus 175 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T d1cm8a_ 175 ----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250 (346)
T ss_dssp ----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred ----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence 3667899999999999876778999999999999999999999999999999999999999999888776543210
Q ss_pred ----CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 354 ----TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 354 ----~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
....+......+...+..+++++++||.+||++||.+|||++|+|+||||+.-.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 001122223344556678899999999999999999999999999999998643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-54 Score=448.74 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=211.3
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
+.++|++++.||+|+||.||+|+++.+|+.||||++++... .....+.+.+|+.+|++++|||||++++++.+ ...+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~ 80 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRL 80 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc--cccc
Confidence 35679999999999999999999999999999999964321 12245678899999999999999999988876 4568
Q ss_pred EEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 202 YLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
|||||||.| +|...+.. ...+.+ ..||+.||+|||++||+||||||+||||+.+|.+||+|||+|+......
T Consensus 81 ~iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred ccceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999995 56666653 334444 2499999999999999999999999999999999999999998764332
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+......
T Consensus 160 -~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~-------------- 223 (337)
T d1o6la_ 160 -ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-------------- 223 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------------
T ss_pred -cccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCC--------------
Confidence 33466799999999999987 45999999999999999999999999999988877766543211
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFT 405 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~ 405 (584)
....+|+++++||.+||++||.+|+ +++|+|+||||..
T Consensus 224 -------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 224 -------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred -------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 1245789999999999999999999 4999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-54 Score=445.92 Aligned_cols=248 Identities=24% Similarity=0.399 Sum_probs=209.0
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... .....+.+.+|+.+|+.++|||||++++++.+ ...+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ 80 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIF 80 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee--CCeee
Confidence 4579999999999999999999999999999999964321 12235678899999999999999999998876 45689
Q ss_pred EEEechhhH-HHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 203 LVFEFMQTD-LARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 203 lV~Ey~~g~-L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
+|||||.|+ |...+.. ...+. +..||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.....
T Consensus 81 ivmE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp EEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eEeeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 999999964 5555443 33333 2359999999999999999999999999999999999999999886532
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
..+.+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.......
T Consensus 158 --~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~-------------- 220 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF-------------- 220 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC--------------
T ss_pred --cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC--------------
Confidence 356789999999999976 459999999999999999999999999999888887776532111
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFTS 406 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~~ 406 (584)
...+++++.+||.+||++||.+|+ |++++|+||||+..
T Consensus 221 -------------p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 221 -------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp -------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred -------------CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 135689999999999999999996 99999999999764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=440.84 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=217.9
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++++.||+|+||+||+|.++.+|+.||||+++... .....+.+|+.+|+.++|||||++++++.+. ..+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESM--EELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEE
Confidence 467999999999999999999999999999999996532 2345678999999999999999999998874 46899
Q ss_pred EEechhh-HHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCC--CcEEEEEeccccccCCCC
Q 043957 204 VFEFMQT-DLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKN--GVLKIADFGLANYFSPNK 274 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~--g~vKL~DFGla~~~~~~~ 274 (584)
|||||.| +|.+.+......+++. .||+.||+|||++||+||||||+||||+.+ ..+||+|||+++......
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 9999995 7888887655556553 499999999999999999999999999754 589999999998765432
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.....++|+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|......++...|
T Consensus 159 --~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 227 (321)
T d1tkia_ 159 --NFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF-------- 227 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH--------
T ss_pred --cccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhc--------
Confidence 2456689999999999876 45999999999999999999999999999999999998877655555443
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
..+|+++++||.+||++||.+|||++|+|+||||++.
T Consensus 228 ---------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 228 ---------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ---------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ---------------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 4568999999999999999999999999999999764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=439.66 Aligned_cols=273 Identities=37% Similarity=0.582 Sum_probs=224.1
Q ss_pred CceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeee----cCcceE
Q 043957 126 SYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATS----RMQYSL 201 (584)
Q Consensus 126 ~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~----~~~~~l 201 (584)
+|+.+++||+|+||+||+|++..+|+.||||++...... +.+|+.+|++|+|||||++++++.. ....++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 499999999999999999999999999999999754322 3479999999999999999998854 234468
Q ss_pred EEEEechhhHHHHHhh---CCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCC-cEEEEEeccccccC
Q 043957 202 YLVFEFMQTDLARIIS---NPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG-VLKIADFGLANYFS 271 (584)
Q Consensus 202 ~lV~Ey~~g~L~~~l~---~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g-~vKL~DFGla~~~~ 271 (584)
|||||||++++...+. .....+.+ +.||+.||+|||++||+||||||+||||+.++ .+||+|||+++.+.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 9999999987655443 23344544 45999999999999999999999999999775 89999999998875
Q ss_pred CCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 272 PNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 272 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
... ...+.+||+.|+|||++.+...|+.++|||||||++|||++|++||...+..+++..+++..+.+....|.....
T Consensus 175 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 175 RGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp TTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred CCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence 433 345678999999999998767799999999999999999999999999999999999999999999988877643
Q ss_pred cCCC-CCCCCCCchh-hhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 352 STTF-RPPQSYKPRL-FEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 352 ~~~~-~~p~~~~~~~-~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.... ..+......+ ......+++++.+||.+||++||.+||||.|+|+||||.+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 3221 1122111122 22235689999999999999999999999999999999753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-53 Score=446.43 Aligned_cols=249 Identities=25% Similarity=0.404 Sum_probs=210.2
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
..++|++++.||+|+||.||+|+++.+|+.||||++..... .....+.+.+|+.+|+.++|||||++++++.. ...+
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~ 116 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNL 116 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc--cccc
Confidence 35789999999999999999999999999999999964321 12335678899999999999999999998876 4468
Q ss_pred EEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 202 YLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
|+||||+.+ +|...+... ..+++ ..||+.||.|||+++||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 117 ~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 999999985 566665432 33443 359999999999999999999999999999999999999999987532
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
....+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..|......+
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~------------- 257 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF------------- 257 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------
T ss_pred ---cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC-------------
Confidence 346789999999999987 458999999999999999999999999998888887776542211
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~~ 406 (584)
...+++++.+||.+||++||.+|+ |++|+|+||||...
T Consensus 258 --------------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 258 --------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp --------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred --------------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 135789999999999999999995 99999999999753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-52 Score=426.04 Aligned_cols=253 Identities=27% Similarity=0.463 Sum_probs=213.8
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCCh-------HHHHHHHHHHHHHHhCC-CCCeeeeeceeeec
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP-------HSVKFMAREIMILQKLD-HPNIVKLEGLATSR 196 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-------~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~ 196 (584)
++|++.+.||+|+||+||+|++..+|+.||||++....... ...+.+.+|+.+|++|+ |||||++++++.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 81 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET- 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence 57999999999999999999999999999999997654321 22346789999999997 9999999999876
Q ss_pred CcceEEEEEechh-hHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccc
Q 043957 197 MQYSLYLVFEFMQ-TDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 197 ~~~~l~lV~Ey~~-g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
...+|||||||+ |+|.+++.. .+.+++. .||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 82 -~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 82 -NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred -CcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 456899999998 488888864 3345443 4999999999999999999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccccChhhhhC-----CCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChH
Q 043957 270 FSPNKKRPLTSRVVTLWYRAPELLLG-----ATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSED 344 (584)
Q Consensus 270 ~~~~~~~~~~~~~gt~~Y~APEvl~~-----~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~ 344 (584)
+.... .....+||+.|+|||++.+ ...++.++|||||||++|+|++|++||.+.+..+.+..+......+..
T Consensus 160 ~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~- 236 (277)
T d1phka_ 160 LDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS- 236 (277)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-
T ss_pred ccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC-
Confidence 76433 2356789999999999863 235788999999999999999999999999988888777664322221
Q ss_pred HHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 345 YWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 345 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
..+.++|+++++||.+||+.||.+|||++|+|+||||++
T Consensus 237 ----------------------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 237 ----------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp ----------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ----------------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 123568999999999999999999999999999999974
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.1e-53 Score=442.98 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=202.1
Q ss_pred CCCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC----ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc
Q 043957 123 SAESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS----EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 123 ~~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~----~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 198 (584)
+.++|++++.||+|+||.||+|+++.+|+.||||++..... .........+|+.+++.++|||||++++++...
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~-- 79 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-- 79 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC--
Confidence 35689999999999999999999999999999999864321 111222334457778888999999999988764
Q ss_pred ceEEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccC
Q 043957 199 YSLYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFS 271 (584)
Q Consensus 199 ~~l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~ 271 (584)
..+|||||||. |+|...+... ..+.+ ..||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+.
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred CEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 46899999998 5777777542 33333 3599999999999999999999999999999999999999998775
Q ss_pred CCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 272 PNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 272 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
... ....+||+.|+|||++.....|+.++|||||||+||||++|++||.+....+... +........
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~--------- 225 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMA--------- 225 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCC---------
T ss_pred CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCC---------
Confidence 432 3566899999999999765679999999999999999999999998765433322 111111100
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCC-----HHHHhcCcCCCCC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGS-----AASALKNEFFFTS 406 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpT-----a~e~L~Hp~f~~~ 406 (584)
......+|+++.+||.+||++||.+||| |+|+|+||||...
T Consensus 226 --------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 226 --------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp --------------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred --------------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 0112467899999999999999999999 8999999999764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=419.91 Aligned_cols=278 Identities=41% Similarity=0.718 Sum_probs=229.1
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|+++++||+|+||+||+|++..+|+.||||+++...........+.+|+.+|+.++|||||++++++... ..+++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc--cceeEE
Confidence 579999999999999999999999999999999987766666778899999999999999999999988774 457999
Q ss_pred EechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCCCC
Q 043957 205 FEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKRPL 278 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 278 (584)
||++.++++..+......+.+ ..|++.||+|||+++|+||||||+||||+.++.+||+|||+|+...... ...
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-~~~ 158 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCY 158 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-SCC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC-ccc
Confidence 999997555444433444433 3599999999999999999999999999999999999999998875433 233
Q ss_pred ccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCC
Q 043957 279 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPI-MPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRP 357 (584)
Q Consensus 279 ~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~p-F~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 357 (584)
....+++.|+|||++.+...++.++|||||||++|||++|+.| |.+.+..+++..+....+.+....|...........
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 4557789999999998766689999999999999999998865 677788888999998888888776655433222211
Q ss_pred --CCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCC
Q 043957 358 --PQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFT 405 (584)
Q Consensus 358 --p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~ 405 (584)
..............+++.+.+||.+||++||.+||||+|+|+||||++
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 111222344455678999999999999999999999999999999975
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-52 Score=432.21 Aligned_cols=282 Identities=33% Similarity=0.544 Sum_probs=227.3
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecC---cceE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRM---QYSL 201 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---~~~l 201 (584)
++|++++.||+|+||+||+|++..+|+.||||++.... .....+.+.+|+.+|++|+|||||++++++.... ...+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 47999999999999999999999999999999996433 4455677889999999999999999999886532 2346
Q ss_pred EEEEechhhHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 202 YLVFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 202 ~lV~Ey~~g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
||+|+++.++|.+++... .+++. .||+.||+|||++|||||||||+||||+.++.+||+|||+|........
T Consensus 87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 788887878999888643 34443 4999999999999999999999999999999999999999987643221
Q ss_pred --CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc--
Q 043957 276 --RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL-- 351 (584)
Q Consensus 276 --~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-- 351 (584)
......+||+.|+|||++.....++.++||||+||++|+|++|++||.+.+..++...+......+..........
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 2245678999999999987666789999999999999999999999999999999988888888777654322110
Q ss_pred --cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCCCc
Q 043957 352 --STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSPLA 409 (584)
Q Consensus 352 --~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~~~ 409 (584)
......+......+...+..+++++++||.+||++||.+||||+|+|+||||.+...+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 0111223333444566778899999999999999999999999999999999865433
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=430.51 Aligned_cols=278 Identities=35% Similarity=0.563 Sum_probs=226.5
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec----Ccc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR----MQY 199 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~----~~~ 199 (584)
.++|+++++||+|+||+||+|++..+|+.||||++..........+.+.+|+.+|++|+|||||++++++... ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 3579999999999999999999999999999999987666666777889999999999999999999887542 223
Q ss_pred eEEEEEechhhHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 200 SLYLVFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 200 ~l~lV~Ey~~g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
.+|++++++.++|.+++... .+++. .||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~- 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence 45666666667888887643 45443 4999999999999999999999999999999999999999976532
Q ss_pred CCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc-
Q 043957 274 KKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS- 352 (584)
Q Consensus 274 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~- 352 (584)
...+..||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+....+.+....+......
T Consensus 174 ---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 174 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp ---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred ---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 2356789999999999887777899999999999999999999999999999999999999888877655432110
Q ss_pred ---CCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCCC
Q 043957 353 ---TTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTSP 407 (584)
Q Consensus 353 ---~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~~ 407 (584)
.....+......+...+..++++++|||.+||++||.+||||+|+|+||||++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 0011122223344556678899999999999999999999999999999998653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-52 Score=429.76 Aligned_cols=249 Identities=29% Similarity=0.416 Sum_probs=206.0
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHH-hCCCCCeeeeeceeeecCcceEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQ-KLDHPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~-~L~HpnIv~l~~~~~~~~~~~l~ 202 (584)
++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+..|+.++. .++|||||++++++.+. ..+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC--Ccee
Confidence 679999999999999999999999999999999964321 1123345566776664 68999999999988774 4689
Q ss_pred EEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 203 LVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 203 lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
||||||.+ +|..++.. ...+++ +.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+......
T Consensus 80 ivmEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~- 157 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 157 (320)
T ss_dssp EEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EEEeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc-
Confidence 99999995 77777653 234443 3499999999999999999999999999999999999999998765332
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
...+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+++..+......
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~--------------- 221 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF--------------- 221 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------
T ss_pred ccccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence 33456789999999999987 45999999999999999999999999999988877776432110
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHH-HHhcCcCCCC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAA-SALKNEFFFT 405 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~-e~L~Hp~f~~ 405 (584)
....+|+++.+||.+||++||.+|||+. |+++||||..
T Consensus 222 ------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 222 ------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp ------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred ------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 1135789999999999999999999995 8999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-52 Score=431.51 Aligned_cols=254 Identities=25% Similarity=0.371 Sum_probs=200.9
Q ss_pred CCCceEEe-eecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHh-CCCCCeeeeeceeee--cCcc
Q 043957 124 AESYDKID-KVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQK-LDHPNIVKLEGLATS--RMQY 199 (584)
Q Consensus 124 ~~~Y~~~~-~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~-L~HpnIv~l~~~~~~--~~~~ 199 (584)
.++|.+++ .||+|+||+||+|++..+++.||||+++. ...+.+|+.++.+ ++|||||+++++|.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 46799885 59999999999999999999999999963 2456789998755 589999999998865 3356
Q ss_pred eEEEEEechh-hHHHHHhhCCC-CCCcHH------HHHHHHHHHHHhCCceeccccccceeecC---CCcEEEEEecccc
Q 043957 200 SLYLVFEFMQ-TDLARIISNPE-GKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDK---NGVLKIADFGLAN 268 (584)
Q Consensus 200 ~l~lV~Ey~~-g~L~~~l~~~~-~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~---~g~vKL~DFGla~ 268 (584)
.+|||||||+ |+|.+++.... ..+++. .||+.||+|||++||+||||||+|||++. .+.+||+|||+|+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 7899999998 58998887542 345553 49999999999999999999999999975 5679999999998
Q ss_pred ccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHH
Q 043957 269 YFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK 348 (584)
Q Consensus 269 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 348 (584)
...... .....+||+.|||||++.+ ..|+.++||||||||||+|+||++||.+.+.......+.......
T Consensus 163 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~------- 232 (335)
T d2ozaa1 163 ETTSHN--SLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG------- 232 (335)
T ss_dssp ECCCCC--CCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC-------
T ss_pred eccCCC--ccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC-------
Confidence 775433 3466789999999999876 459999999999999999999999998876655444332211100
Q ss_pred hhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 349 LRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 349 ~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
....| ...+..+|+++.+||.+||++||++|||+.|+|+||||.+.
T Consensus 233 -----~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 233 -----QYEFP-------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp -----SSSCC-------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred -----CCCCC-------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 00000 01234578999999999999999999999999999999754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=431.78 Aligned_cols=276 Identities=32% Similarity=0.529 Sum_probs=217.9
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeec----Ccce
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSR----MQYS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~----~~~~ 200 (584)
++|+++++||+|+||+||+|+++.+|+.||||++............+.+|+.+|++++|||||++++++... ....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 579999999999999999999999999999999987766667777899999999999999999999988654 3367
Q ss_pred EEEEEechhhHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 201 LYLVFEFMQTDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 201 l~lV~Ey~~g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
+|+|||||.++++..+.. .+++ ..||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~iv~Ey~~~~l~~~~~~---~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~- 172 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS- 172 (355)
T ss_dssp EEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eEEEEeccchHHHHhhhc---CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc-
Confidence 999999999988877753 3443 359999999999999999999999999999999999999999876533
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhcc--
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLS-- 352 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-- 352 (584)
......++|+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+...++..++.....+..++|......
T Consensus 173 -~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 173 -FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ---------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred -cccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 23456789999999999987 46999999999999999999999999999999999999999988888877543221
Q ss_pred -----CCCCCCCC--------CCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 353 -----TTFRPPQS--------YKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 353 -----~~~~~p~~--------~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
........ ...........+++++++||.+||++||++||||+|+|+||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 00000000 0000111122356789999999999999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-52 Score=420.02 Aligned_cols=243 Identities=26% Similarity=0.363 Sum_probs=196.9
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhCC--CCCeeeeeceeeecCc
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEP----HSVKFMAREIMILQKLD--HPNIVKLEGLATSRMQ 198 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~~~~ 198 (584)
++|++.+.||+|+||+||+|++..+|+.||||++....... .....+.+|+.+|++++ |||||++++++.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-- 81 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-- 81 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS--
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC--
Confidence 47999999999999999999999999999999997542221 11233568999999996 89999999988774
Q ss_pred ceEEEEEechhh--HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecC-CCcEEEEEeccccc
Q 043957 199 YSLYLVFEFMQT--DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDK-NGVLKIADFGLANY 269 (584)
Q Consensus 199 ~~l~lV~Ey~~g--~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~-~g~vKL~DFGla~~ 269 (584)
..+|+||||+.+ ++...+.. ...+.+ ..||+.||+|||++||+||||||+||||+. ++.+||+|||+|+.
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 468999999974 55555543 233443 359999999999999999999999999985 47999999999987
Q ss_pred cCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 270 FSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 270 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
.... ..+..+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+ .+.....
T Consensus 161 ~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~---------- 221 (273)
T d1xwsa_ 161 LKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQV---------- 221 (273)
T ss_dssp CCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCC----------
T ss_pred cccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhccc----------
Confidence 6432 34567899999999999876656788999999999999999999997532 1221110
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.....+|+++.+||.+||++||++|||++|+|+||||++.
T Consensus 222 -----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 222 -----------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp -----------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -----------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 0113578999999999999999999999999999999764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-51 Score=413.54 Aligned_cols=250 Identities=23% Similarity=0.324 Sum_probs=201.7
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.+.||+|+||+||+|+.. ..||||+++.........+.+.+|+.+|++++|||||++++++.. ..+||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~l 80 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAI 80 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEEEE
Confidence 467999999999999999999643 359999997766666677889999999999999999999997654 24799
Q ss_pred EEechh-hHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC-C
Q 043957 204 VFEFMQ-TDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK-K 275 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~-~ 275 (584)
|||||+ |+|.+.+......+++. .||+.||+|||+++||||||||+||||+.++.+||+|||+|+...... .
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 999998 68888887665666553 499999999999999999999999999999999999999998765332 2
Q ss_pred CCCccccccccccChhhhhCC--CCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 276 RPLTSRVVTLWYRAPELLLGA--TDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~--~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
.......||+.|||||++.+. ..|+.++|||||||+||||+||+.||.+.+....+..++.....+
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~------------ 228 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS------------ 228 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC------------
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC------------
Confidence 234567899999999999643 358999999999999999999999999887776655554332111
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
+........+|+++.+||.+||+.||.+|||++|+++|
T Consensus 229 ---------p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 229 ---------PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ---------CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 11223345688999999999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-50 Score=420.46 Aligned_cols=272 Identities=30% Similarity=0.520 Sum_probs=212.8
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSLY 202 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l~ 202 (584)
.++|+++++||+|+||+||+|+++.+|+.||||+++.. ..+.+.+|+.+|+.+. ||||+++++++.......+|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 46799999999999999999999999999999998632 2456789999999995 99999999999877677799
Q ss_pred EEEechhhH-HHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCC-cEEEEEeccccccCCCC
Q 043957 203 LVFEFMQTD-LARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNG-VLKIADFGLANYFSPNK 274 (584)
Q Consensus 203 lV~Ey~~g~-L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g-~vKL~DFGla~~~~~~~ 274 (584)
+|||||.++ |.... ..+++ +.||+.||.|||++||+||||||+||||+.++ .+||+|||+|+......
T Consensus 109 ~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred EEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999999964 44432 23433 35999999999999999999999999998655 69999999998775433
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCChHHHHHhh-cc
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGR-TEVEQLHRIFKLCGSPSEDYWKKLR-LS 352 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~-~~~~~~~~i~~~~~~~~~~~~~~~~-~~ 352 (584)
.....++|+.|+|||++.+...++.++|||||||++|+|++|+.||... +..++...+....+.+....|.... ..
T Consensus 185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 185 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred --cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 3466789999999999988777899999999999999999999988654 4556667777766654433332211 11
Q ss_pred CC--C--CCCCCCCc-----hhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCCCCC
Q 043957 353 TT--F--RPPQSYKP-----RLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFFFTS 406 (584)
Q Consensus 353 ~~--~--~~p~~~~~-----~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f~~~ 406 (584)
.. + ........ ........++++++|||.+||++||.+|||++|+|+||||++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 00 0 00000000 1111234578999999999999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.5e-51 Score=412.20 Aligned_cols=255 Identities=25% Similarity=0.381 Sum_probs=201.3
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc--ce
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ--YS 200 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~--~~ 200 (584)
.++|++.+.||+|+||+||+|++..+|+.||||+++.... .......+.+|+.+|+.++|||||++++++..... ..
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4679999999999999999999999999999999976544 34556778999999999999999999998876543 45
Q ss_pred EEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+|||||||+| +|...+.. ...+.+ ..||+.||+|||++||+||||||+||||+.++.++|+|||++......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 8999999995 56655543 233433 359999999999999999999999999999999999999998765432
Q ss_pred C--CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 274 K--KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 274 ~--~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
. .......+||+.|||||++.+ ..|+.++|||||||++|+|+||++||.+.+..+.+..++.....+..
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------- 235 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS-------- 235 (277)
T ss_dssp --------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG--------
T ss_pred cccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc--------
Confidence 2 223456789999999999976 45999999999999999999999999999888887776554322211
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcCcCC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKNEFF 403 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~Hp~f 403 (584)
.....+|+++.+||.+||++||.+||+..+.|.|+|+
T Consensus 236 ---------------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 236 ---------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp ---------------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ---------------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 2235689999999999999999999965555666664
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=405.41 Aligned_cols=244 Identities=21% Similarity=0.345 Sum_probs=190.7
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++++.||+|+||.||+|.+. ++..||||+++..... .+.+.+|+.+|++++|||||++++++.... .+||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~--~~~l 77 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PICL 77 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCC--ceEE
Confidence 357999999999999999999876 5778999999754333 356889999999999999999999987644 4799
Q ss_pred EEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
|||||. |+|.+++......+.+ +.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+......
T Consensus 78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 999998 5787877665555543 359999999999999999999999999999999999999999887654444
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
......||+.|+|||++.+. .|+.++|||||||++|||+| |.+||...+..+.+..+......+
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-------------- 222 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-------------- 222 (263)
T ss_dssp -------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC--------------
T ss_pred eecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC--------------
Confidence 44556889999999999864 59999999999999999999 578888777777666664432111
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
....+++++.+||.+||+.||++|||++|+|+|
T Consensus 223 ------------~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 223 ------------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------CccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 013457899999999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-50 Score=409.75 Aligned_cols=244 Identities=25% Similarity=0.391 Sum_probs=197.0
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.+.||+|+||+||+|.++.+|+.||||+++.... ..+.+.+|+.+|++|+|||||++++++.+. ..+||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeC--CeeEE
Confidence 3569999999999999999999999999999999865433 345688999999999999999999988764 35799
Q ss_pred EEechh-hHHHHHhhC-CCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 204 VFEFMQ-TDLARIISN-PEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~-~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
|||||. |+|...+.. ....+++ +.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.......
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 999999 567777653 2334443 35999999999999999999999999999999999999999998765444
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPI-MPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~p-F~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.......||+.|+|||++.+. .|+.++|||||||++|||++|..| |.+.+.......+ .....+
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i-~~~~~~------------- 235 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRM------------- 235 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCCC-------------
T ss_pred eeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH-hcCCCC-------------
Confidence 334455689999999999874 599999999999999999996655 5554444433332 211000
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....+|+++.+||.+||+.||.+|||++|+++
T Consensus 236 ------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 236 ------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 112457899999999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.7e-50 Score=408.84 Aligned_cols=247 Identities=23% Similarity=0.385 Sum_probs=191.3
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGK---IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
.++|++.+.||+|+||+||+|.++.+++ .||||++... ......+.+.+|+.+|++|+|||||++++++.... .
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~--~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST--P 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--S
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC--E
Confidence 4679999999999999999999887664 5888987543 34455677899999999999999999999987643 4
Q ss_pred EEEEEechhh-HHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQT-DLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+|||||||.+ +|..++......+++. .||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.+...
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 7999999995 6777777655556553 49999999999999999999999999999999999999999877543
Q ss_pred CCCC----CccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHH
Q 043957 274 KKRP----LTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKK 348 (584)
Q Consensus 274 ~~~~----~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 348 (584)
.... .....||+.|||||++.+ ..|+.++|||||||++|||+| |++||.+.+..+.+..+......+
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~------- 253 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP------- 253 (299)
T ss_dssp --------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-------
T ss_pred CCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence 3211 123467999999999986 459999999999999999998 899999988887776664322111
Q ss_pred hhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 349 LRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 349 ~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
....+|+.+.+||.+||+.||.+|||+.|++++
T Consensus 254 -------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 254 -------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp -------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 113578999999999999999999999999874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=406.05 Aligned_cols=248 Identities=25% Similarity=0.430 Sum_probs=201.4
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.+.||+|+||.||+|.++ ++..||||+++..... .+.+.+|+.+|++++|||||++++++... .+||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQE---PIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeeccC---CeEE
Confidence 357999999999999999999876 5788999999754332 45688999999999999999999987542 3699
Q ss_pred EEechhh-HHHHHhhCCCC-CC------cHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 204 VFEFMQT-DLARIISNPEG-KL------TEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~~~-~l------~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
|||||.+ +|.+.+..... .+ .++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 9999984 66665543221 23 3346999999999999999999999999999999999999999998765544
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.......||+.|||||++.+. .|+.++|||||||++|||+| |.+||...+..+.+..+......+
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~------------- 230 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV------------- 230 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-------------
T ss_pred ccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-------------
Confidence 445567889999999999864 58999999999999999999 567777777766666554321111
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc--CcCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK--NEFFFT 405 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~--Hp~f~~ 405 (584)
....+|+++.+||.+||+.||++|||++|+++ |+||..
T Consensus 231 -------------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 231 -------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp -------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 11357899999999999999999999999998 888853
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=399.66 Aligned_cols=244 Identities=20% Similarity=0.307 Sum_probs=205.1
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|+++++||+|+||+||+|+++ ++..||||+++..... .+.+.+|+.++++++|||||++++++.+. ..+|+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~--~~~~i 76 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIFI 76 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCS--SSEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceEE
Confidence 357999999999999999999985 6889999999865443 35688999999999999999999988764 45899
Q ss_pred EEechh-hHHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC
Q 043957 204 VFEFMQ-TDLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR 276 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~ 276 (584)
|||||. |+|...+......+. +..||+.||.|||++||+||||||+||||+.++.+||+|||+++.+......
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 999998 567777665444443 3459999999999999999999999999999999999999999877655544
Q ss_pred CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCC
Q 043957 277 PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTF 355 (584)
Q Consensus 277 ~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 355 (584)
......||+.|+|||++.+. .|+.++|||||||++|||+| |+.||.+.+..+....+......+
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 221 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-------------- 221 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC--------------
T ss_pred eecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC--------------
Confidence 45567899999999999864 59999999999999999998 899999998888777665432111
Q ss_pred CCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 356 RPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 356 ~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
....+++.+.+||.+||+.||.+|||++++|+|
T Consensus 222 ------------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 222 ------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 113467899999999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=404.70 Aligned_cols=249 Identities=23% Similarity=0.316 Sum_probs=203.2
Q ss_pred CCceEEee-ecccCceEEEEEEECC--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 125 ESYDKIDK-VGQGTYSNVYKALDRD--TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 125 ~~Y~~~~~-LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
++|.+.+. ||+|+||+||+|.++. ++..||||+++.. ......+.+.+|+.+|++++|||||++++++... .+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~~ 83 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---AL 83 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC---eE
Confidence 45788884 9999999999998764 4558999999644 3455677899999999999999999999988642 37
Q ss_pred EEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 202 YLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
|||||||++ +|..++......+++ +.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+....
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999999995 787777655555554 3599999999999999999999999999999999999999998775433
Q ss_pred C--CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 275 K--RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 275 ~--~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
. .......||+.|+|||++.+. .++.++|||||||++|||+| |++||.+.+..+.+..+.+....
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~----------- 231 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM----------- 231 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC-----------
T ss_pred cccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 2 223355789999999999864 59999999999999999998 99999998877776665432110
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHH---hcCcCCC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASA---LKNEFFF 404 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~---L~Hp~f~ 404 (584)
+....+|+++.+||.+||+.||++|||+.++ |+|+|+.
T Consensus 232 ---------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 232 ---------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ---------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1124678999999999999999999999888 6778763
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=412.02 Aligned_cols=248 Identities=26% Similarity=0.345 Sum_probs=198.4
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCc-----EEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecC
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGK-----IVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRM 197 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~-----~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 197 (584)
.++|++.+.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.+|.++ +|||||++++++.+..
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 3579999999999999999999876543 69999986433 233445688999999998 8999999999887744
Q ss_pred cceEEEEEechh-hHHHHHhhCCCCC----------------------Cc------HHHHHHHHHHHHHhCCceeccccc
Q 043957 198 QYSLYLVFEFMQ-TDLARIISNPEGK----------------------LT------EPQQLLSGLQHCHDRGILHRDVKG 248 (584)
Q Consensus 198 ~~~l~lV~Ey~~-g~L~~~l~~~~~~----------------------l~------~~~qIl~aL~yLH~~~IvHrDLKp 248 (584)
.+|||||||+ |+|.+++...... ++ ++.||+.||+|||+++||||||||
T Consensus 115 --~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp 192 (325)
T d1rjba_ 115 --PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192 (325)
T ss_dssp --SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred --eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence 5799999998 5788888654321 22 335999999999999999999999
Q ss_pred cceeecCCCcEEEEEeccccccCCCCCC-CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCC
Q 043957 249 SNLLIDKNGVLKIADFGLANYFSPNKKR-PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRT 326 (584)
Q Consensus 249 ~NILl~~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~ 326 (584)
+|||++.++.+||+|||+|+........ ......||+.|||||++.+. .|+.++|||||||++|||+| |++||.+.+
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999876543322 22356789999999999864 59999999999999999997 899999877
Q ss_pred hHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 327 EVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 327 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
....+..++.....++ ....+|+++.+||.+||+.||++|||++|+++|
T Consensus 272 ~~~~~~~~~~~~~~~~-------------------------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 272 VDANFYKLIQNGFKMD-------------------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CSHHHHHHHHTTCCCC-------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhcCCCCC-------------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6666655544221111 123568999999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=404.23 Aligned_cols=242 Identities=24% Similarity=0.368 Sum_probs=191.7
Q ss_pred eeecccCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEEEech
Q 043957 131 DKVGQGTYSNVYKALDR--DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 131 ~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
++||+|+||.||+|.++ .+++.||||+++.........+.+.+|+.+|++|+|||||++++++... ..|||||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~---~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---SEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC---CEEEEEEcC
Confidence 46999999999999764 4567899999976555556677899999999999999999999988542 368999999
Q ss_pred hh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCCC--CCc
Q 043957 209 QT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKKR--PLT 279 (584)
Q Consensus 209 ~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~~--~~~ 279 (584)
++ +|.+++.. ...+++ +.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+...... ...
T Consensus 90 ~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 90 ELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp TTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 84 67777654 233433 359999999999999999999999999999999999999999876543321 223
Q ss_pred cccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCCCCCC
Q 043957 280 SRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPP 358 (584)
Q Consensus 280 ~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p 358 (584)
...||+.|||||++.+. .++.++|||||||++|||++ |++||.+.+..+....+.+....
T Consensus 169 ~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~------------------ 229 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------------------ 229 (277)
T ss_dssp --CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------------------
T ss_pred ccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC------------------
Confidence 45789999999999864 58999999999999999998 89999998877766655432110
Q ss_pred CCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHH---hcCcCC
Q 043957 359 QSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASA---LKNEFF 403 (584)
Q Consensus 359 ~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~---L~Hp~f 403 (584)
.....+|+++.+||.+||+.||++|||++++ |+|+|+
T Consensus 230 --------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 230 --------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 1124578999999999999999999999998 456554
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=399.54 Aligned_cols=245 Identities=22% Similarity=0.345 Sum_probs=190.0
Q ss_pred CCceEEeeecccCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDT---GKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSL 201 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 201 (584)
++|++.+.||+|+||.||+|++..+ +..||||.++.. ......+.+.+|+.+|++++|||||++++++.. ..+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~ 82 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPV 82 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SSC
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CeE
Confidence 5799999999999999999988654 456889988533 344556778999999999999999999998853 347
Q ss_pred EEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCC
Q 043957 202 YLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNK 274 (584)
Q Consensus 202 ~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~ 274 (584)
|||||||.+ +|..++......+++ ..||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 999999984 566665544445544 3599999999999999999999999999999999999999998876544
Q ss_pred CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 275 KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 275 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
....+...||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+..+......
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~------------- 228 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------------- 228 (273)
T ss_dssp --------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-------------
T ss_pred ceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 444456678999999999986 459999999999999999998 89999998887777666442111
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
...+.+|+.+.+||.+||+.||.+|||+.|+++|
T Consensus 229 -------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 229 -------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp -------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1124678999999999999999999999999976
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-48 Score=391.25 Aligned_cols=245 Identities=20% Similarity=0.336 Sum_probs=187.1
Q ss_pred CCceEEeeecccCceEEEEEEECCCC----cEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTG----KIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
+.|++.+.||+|+||.||+|..+.++ ..||||++.... .......+.+|+.+|++|+|||||++++++... ..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~--~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--KP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC--Cc
Confidence 46999999999999999999877654 479999996443 344556788999999999999999999988764 35
Q ss_pred EEEEEechhh-HHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQT-DLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~g-~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+++|||||.+ .+...+......+.+ +.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+...
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 7999999986 455555544444543 359999999999999999999999999999999999999999876543
Q ss_pred CCC--CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 274 KKR--PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLG-RPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 274 ~~~--~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG-~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
... ......||+.|||||++.+ ..++.++|||||||++|||++| .+||...+..+.+..+......
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~---------- 232 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL---------- 232 (283)
T ss_dssp ----------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC----------
T ss_pred CccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC----------
Confidence 321 2234568999999999986 4699999999999999999995 5666666665555544322111
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....+|+.+.+||.+||+.||++|||+.|+++
T Consensus 233 ----------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 233 ----------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ----------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 112357889999999999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=395.13 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=193.8
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++.+.||+|+||.||+|+++.+ ..||||+++..... .+.+.+|+.+|++++|||||++++++... .+|+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~~---~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSEE---PIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEecC---CeEE
Confidence 35799999999999999999998764 67999999654333 35688999999999999999999987542 3699
Q ss_pred EEechhh-HHHHHhhCC-CCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 204 VFEFMQT-DLARIISNP-EGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 204 V~Ey~~g-~L~~~l~~~-~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
|||||.+ +|...+... ...++ ++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 9999995 455554421 12333 345999999999999999999999999999999999999999988765544
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLG-RPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG-~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.......||+.|+|||++.. ..++.++|||||||++|||++| ++||.+....+.+..+......+
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~------------- 234 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP------------- 234 (285)
T ss_dssp -------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-------------
T ss_pred eeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-------------
Confidence 44456789999999999986 4589999999999999999995 66777777766666654322111
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc--CcCCCCC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK--NEFFFTS 406 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~--Hp~f~~~ 406 (584)
....+++++.+||.+||+.||++|||++++++ |+||...
T Consensus 235 -------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 235 -------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -------------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 12457899999999999999999999999988 8899754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=411.36 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=204.0
Q ss_pred CCCceEEeeecccCceEEEEEEE---CCCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhCCC-CCeeeeeceeeecC
Q 043957 124 AESYDKIDKVGQGTYSNVYKALD---RDTGKIVALKKVKFDTS--EPHSVKFMAREIMILQKLDH-PNIVKLEGLATSRM 197 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~---~~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~~~ 197 (584)
.++|++++.||+|+||+||+|.+ +.+|+.||||+++.... .....+.+.+|+.+|++++| |||+++++++.+.
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~- 101 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 101 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-
Confidence 35799999999999999999987 44789999999854321 12234557789999999976 8999999888774
Q ss_pred cceEEEEEechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccccc
Q 043957 198 QYSLYLVFEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 198 ~~~l~lV~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~ 270 (584)
..+|+|||||.+ +|...+.... .+. ...||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+
T Consensus 102 -~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 102 -TKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp -TEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred -CceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 468999999994 6777765432 222 2359999999999999999999999999999999999999999877
Q ss_pred CCCCCCCCccccccccccChhhhhCCC-CCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 271 SPNKKRPLTSRVVTLWYRAPELLLGAT-DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 271 ~~~~~~~~~~~~gt~~Y~APEvl~~~~-~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
............|++.|+|||++.+.. .++.++|||||||+||+|++|++||.+.+..+....+......+.
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~------- 252 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE------- 252 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC-------
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC-------
Confidence 554444456678999999999997543 478899999999999999999999988766555444433211100
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCC-----CHHHHhcCcCCCCC
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRG-----SAASALKNEFFFTS 406 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRp-----Ta~e~L~Hp~f~~~ 406 (584)
. .....+++++.+||.+||++||.+|| |++|+|+||||+..
T Consensus 253 -----~-----------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 253 -----P-----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp -----C-----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred -----C-----------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 0 11245789999999999999999999 58999999999763
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-48 Score=397.60 Aligned_cols=245 Identities=23% Similarity=0.347 Sum_probs=192.7
Q ss_pred CCceEEeeecccCceEEEEEEECCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGK----IVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
++|++++.||+|+||+||+|.+..+|+ .||+|+++.. ......+.+.+|+.+|++++|||||++++++... .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS---S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---C
Confidence 469999999999999999999988876 5788887533 2333467789999999999999999999998763 2
Q ss_pred EEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
.+++|||+. ++|...+......+++ +.||+.||+|||+++||||||||+||||+.++.+||+|||+|+.+...
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 467777776 6777776655555544 359999999999999999999999999999999999999999887544
Q ss_pred CCC-CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhc
Q 043957 274 KKR-PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRL 351 (584)
Q Consensus 274 ~~~-~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 351 (584)
... ......||+.|+|||++.+. .|+.++|||||||++|||+| |.+||.+.+..+....+......+
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~---------- 233 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---------- 233 (317)
T ss_dssp CC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC----------
T ss_pred cccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC----------
Confidence 332 22345789999999999874 59999999999999999998 899998887766655554321111
Q ss_pred cCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 352 STTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 352 ~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
....+++.+.+||.+||+.||.+|||+.|+|+|
T Consensus 234 ----------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 234 ----------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ----------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 113568899999999999999999999999988
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=391.01 Aligned_cols=248 Identities=25% Similarity=0.330 Sum_probs=187.4
Q ss_pred CCceEEeeecccCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCc
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRD-----TGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 198 (584)
++|++.++||+|+||.||+|.+.. +++.||||+++... .....+.+.+|+.++.++ +|+|||.+++++... .
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-~ 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-T
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-C
Confidence 579999999999999999998754 45789999986433 334456677788888777 689999998876554 3
Q ss_pred ceEEEEEechh-hHHHHHhhCCC---------------CCCc------HHHHHHHHHHHHHhCCceeccccccceeecCC
Q 043957 199 YSLYLVFEFMQ-TDLARIISNPE---------------GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKN 256 (584)
Q Consensus 199 ~~l~lV~Ey~~-g~L~~~l~~~~---------------~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~ 256 (584)
..+|+|||||+ |+|..++.... ..++ ++.||+.||.|||+++||||||||+||||+.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 45799999998 57777765321 1233 23599999999999999999999999999999
Q ss_pred CcEEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhC-CCCCCCCChHHHHHHH
Q 043957 257 GVLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLG-RPIMPGRTEVEQLHRI 334 (584)
Q Consensus 257 g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG-~~pF~~~~~~~~~~~i 334 (584)
+.+||+|||+|+....... ......+||+.|+|||++.+ ..++.++|||||||++|||++| .+||.+....+.+..+
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999987654332 23345689999999999987 4599999999999999999986 5788877655554444
Q ss_pred HHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 335 FKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
+.....+ .....+++++.+||.+||+.||.+|||++|+|+|
T Consensus 250 ~~~~~~~-------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 250 LKEGTRM-------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHTCCC-------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCC-------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3321111 1123568899999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-47 Score=391.02 Aligned_cols=246 Identities=24% Similarity=0.366 Sum_probs=198.9
Q ss_pred CCCceEEeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDR-----DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 198 (584)
.++|++++.||+|+||+||+|+.+ .+++.||||+++.. ......+.+.+|+.+|++++||||+++++++...
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-- 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVG-- 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeeccC--
Confidence 457999999999999999999875 35689999998643 3445567789999999999999999999988764
Q ss_pred ceEEEEEechh-hHHHHHhhCCCC-----------------------------CCcHHHHHHHHHHHHHhCCceeccccc
Q 043957 199 YSLYLVFEFMQ-TDLARIISNPEG-----------------------------KLTEPQQLLSGLQHCHDRGILHRDVKG 248 (584)
Q Consensus 199 ~~l~lV~Ey~~-g~L~~~l~~~~~-----------------------------~l~~~~qIl~aL~yLH~~~IvHrDLKp 248 (584)
..+++|||||. |+|.+++..... .+.++.||+.||+|||+++||||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 35799999998 567776642111 122345999999999999999999999
Q ss_pred cceeecCCCcEEEEEeccccccCCCC-CCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCC-CCCCCCC
Q 043957 249 SNLLIDKNGVLKIADFGLANYFSPNK-KRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGR-PIMPGRT 326 (584)
Q Consensus 249 ~NILl~~~g~vKL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~-~pF~~~~ 326 (584)
+||||+.++.+||+|||+|+.+.... ....++..||+.|+|||++.+ ..|+.++|||||||++|||++|. +||.+.+
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 99999999999999999998664332 223345678999999999987 45999999999999999999985 7899988
Q ss_pred hHHHHHHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 327 EVEQLHRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 327 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
..+.+..+.+.... .....+|+++.+||.+||+.||.+|||+.|+++
T Consensus 248 ~~e~~~~v~~~~~~--------------------------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 248 HEEVIYYVRDGNIL--------------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHHTTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCC--------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 88877766443211 112467889999999999999999999999975
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=385.29 Aligned_cols=246 Identities=25% Similarity=0.374 Sum_probs=189.3
Q ss_pred CCceEEeeecccCceEEEEEEEC-CCC--cEEEEEEeecCCC-ChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcce
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDR-DTG--KIVALKKVKFDTS-EPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~-~~g--~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 200 (584)
++|++++.||+|+||.||+|+.. .++ ..||||+++.... .....+.+.+|+.+|++++|||||++++++.+. .
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---~ 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---P 84 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---S
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec---c
Confidence 56999999999999999999764 333 4689999865433 334567889999999999999999999988653 3
Q ss_pred EEEEEechh-hHHHHHhhCCCCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCC
Q 043957 201 LYLVFEFMQ-TDLARIISNPEGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPN 273 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~ 273 (584)
+++|||||. +++.+.+......+++ ..||+.||.|||+++|+||||||+||||+.++.+||+|||+++.+...
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 689999998 4666655543334443 359999999999999999999999999999999999999999987543
Q ss_pred CCC--CCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhh
Q 043957 274 KKR--PLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLR 350 (584)
Q Consensus 274 ~~~--~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 350 (584)
... ......|++.|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+..+.+..+.+....+
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~--------- 234 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL--------- 234 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC---------
T ss_pred CCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC---------
Confidence 321 1234467889999999987 459999999999999999998 899999999888877775432111
Q ss_pred ccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 351 LSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 351 ~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....+|+.+.+||.+||..||.+|||++|+++
T Consensus 235 ----------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 235 ----------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112467899999999999999999999999874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-47 Score=381.15 Aligned_cols=239 Identities=24% Similarity=0.381 Sum_probs=187.2
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~l 203 (584)
.++|++++.||+|+||.||+|.+ +|..||||+++.+. ..+.+.+|+.+|++++|||||++++++.+.. ..+||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~l 78 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYI 78 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC-CcEEE
Confidence 45799999999999999999987 47899999996432 3466889999999999999999999876532 34799
Q ss_pred EEechh-hHHHHHhhCC-------CCCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC
Q 043957 204 VFEFMQ-TDLARIISNP-------EGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 204 V~Ey~~-g~L~~~l~~~-------~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~ 275 (584)
|||||+ |+|.+++... ...+.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC--
Confidence 999998 5677766431 112344569999999999999999999999999999999999999999875432
Q ss_pred CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChHHHHHhhccCC
Q 043957 276 RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKLRLSTT 354 (584)
Q Consensus 276 ~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 354 (584)
.....+|+.|+|||++.+. .++.++|||||||++|||+| |++||...+..+.+..+.....
T Consensus 157 --~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~--------------- 218 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------------- 218 (262)
T ss_dssp -------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---------------
T ss_pred --CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence 2345678999999999874 59999999999999999998 7899988777666655532110
Q ss_pred CCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 355 FRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 355 ~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.+....+++++.+||.+||+.||.+|||+.+++++
T Consensus 219 -----------~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 219 -----------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 01224578899999999999999999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-46 Score=380.02 Aligned_cols=256 Identities=21% Similarity=0.263 Sum_probs=195.3
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
++|++++.||+|+||.||+|++..+|+.||||++...... ..+.+|+++++.++|+|+|.++..+... ....++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEec-CCEEEEE
Confidence 4799999999999999999999999999999998765433 2467899999999877766555444332 4467999
Q ss_pred EechhhHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeec---CCCcEEEEEeccccccCCCCC
Q 043957 205 FEFMQTDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLID---KNGVLKIADFGLANYFSPNKK 275 (584)
Q Consensus 205 ~Ey~~g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~---~~g~vKL~DFGla~~~~~~~~ 275 (584)
||||.+++...+......+++. .||+.||+|||++||+||||||+|||++ .+..+||+|||+|+.+.....
T Consensus 82 me~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 9999988887776555555543 4999999999999999999999999975 355799999999987754322
Q ss_pred ------CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChHHHHHh
Q 043957 276 ------RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGSPSEDYWKKL 349 (584)
Q Consensus 276 ------~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 349 (584)
......+||+.|||||++.+ ..++.++|||||||++|||++|++||...........+..... ...
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~-------~~~ 233 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-------KKM 233 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH-------HHH
T ss_pred ccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc-------ccC
Confidence 22345689999999999987 4599999999999999999999999988665544433322110 000
Q ss_pred hccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHH---HHhcCcCCCC
Q 043957 350 RLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAA---SALKNEFFFT 405 (584)
Q Consensus 350 ~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~---e~L~Hp~f~~ 405 (584)
..........+|+++.+||..||+.||.+||+++ ++|+|+|...
T Consensus 234 ------------~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 234 ------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp ------------HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ------------CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 0011223457899999999999999999999986 5577877643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=382.99 Aligned_cols=245 Identities=27% Similarity=0.321 Sum_probs=194.6
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcE--EEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCcce
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKI--VALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQYS 200 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~ 200 (584)
.++|++.+.||+|+||.||+|+++.+|.. ||||++.... .....+.+.+|+++|+++ +|||||++++++.. ...
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~ 85 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY 85 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--CCe
Confidence 46799999999999999999999988874 6778775332 233456789999999999 79999999999886 446
Q ss_pred EEEEEechh-hHHHHHhhCC---------------CCCCcH------HHHHHHHHHHHHhCCceeccccccceeecCCCc
Q 043957 201 LYLVFEFMQ-TDLARIISNP---------------EGKLTE------PQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGV 258 (584)
Q Consensus 201 l~lV~Ey~~-g~L~~~l~~~---------------~~~l~~------~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~ 258 (584)
+|||||||+ |+|.+++... ...+.+ +.||+.||.|||+++|+||||||+|||++.++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence 899999999 5788877543 233433 459999999999999999999999999999999
Q ss_pred EEEEEeccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCC-CCCCCCChHHHHHHHHHh
Q 043957 259 LKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGR-PIMPGRTEVEQLHRIFKL 337 (584)
Q Consensus 259 vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~-~pF~~~~~~~~~~~i~~~ 337 (584)
+||+|||+|+....... .....||+.|+|||.+.+. .|+.++|||||||++|||++|. +||.+.+..+.+..+.+.
T Consensus 166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred eEEcccccccccccccc--ccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence 99999999987643322 2345789999999999864 5999999999999999999965 688888877766655332
Q ss_pred cCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 338 CGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
... .....+++++.+||.+||+.||++|||+.|+|+|
T Consensus 243 ~~~--------------------------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 YRL--------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCC--------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC--------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 110 1123568999999999999999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=378.36 Aligned_cols=246 Identities=24% Similarity=0.342 Sum_probs=192.9
Q ss_pred CCCceEEeeecccCceEEEEEEECCCC-------cEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeee
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTG-------KIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATS 195 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g-------~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~ 195 (584)
.++|++++.||+|+||.||+|++..++ ..||||+++... .......+.+|+.++.++ +|||||++++++.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 457999999999999999999876544 479999997543 344566788899999888 79999999999876
Q ss_pred cCcceEEEEEechh-hHHHHHhhCCC---------------CCCc------HHHHHHHHHHHHHhCCceeccccccceee
Q 043957 196 RMQYSLYLVFEFMQ-TDLARIISNPE---------------GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLI 253 (584)
Q Consensus 196 ~~~~~l~lV~Ey~~-g~L~~~l~~~~---------------~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl 253 (584)
. ..+|+|||||. |+|..++.... ..++ +..||+.||+|||+++||||||||+|||+
T Consensus 91 ~--~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 91 D--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp S--SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred C--CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 4 45799999998 56777775332 2233 34599999999999999999999999999
Q ss_pred cCCCcEEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHH
Q 043957 254 DKNGVLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQL 331 (584)
Q Consensus 254 ~~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~ 331 (584)
+.++.+||+|||+++....... .......+|+.|+|||++.+ ..|+.++|||||||++|||++ |++||.+.+....+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 9999999999999987654322 22345678999999999987 469999999999999999998 79999888776655
Q ss_pred HHHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 332 HRIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 332 ~~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
..+.... .+ .....+++++.+||.+||+.||.+|||+.|+|+
T Consensus 248 ~~i~~~~-~~-------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 248 KLLKEGH-RM-------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHTTC-CC-------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCC-CC-------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 4442211 00 112457899999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=385.24 Aligned_cols=246 Identities=18% Similarity=0.299 Sum_probs=199.3
Q ss_pred CCCceEEeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDR-----DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 198 (584)
.++|++.+.||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+|++++|||||++++++....
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~- 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ- 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS-
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC-
Confidence 367999999999999999999875 23578999999644 34455667889999999999999999999887643
Q ss_pred ceEEEEEechh-hHHHHHhhCCC---------C------CCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEE
Q 043957 199 YSLYLVFEFMQ-TDLARIISNPE---------G------KLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIA 262 (584)
Q Consensus 199 ~~l~lV~Ey~~-g~L~~~l~~~~---------~------~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~ 262 (584)
.+++|||||. |+|..++.... . .+..+.||+.||.|||+++|+||||||+||||+.++.+||+
T Consensus 97 -~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 97 -PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred -ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEe
Confidence 4799999998 56666554210 1 12345699999999999999999999999999999999999
Q ss_pred EeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCC
Q 043957 263 DFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLG-RPIMPGRTEVEQLHRIFKLCGS 340 (584)
Q Consensus 263 DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG-~~pF~~~~~~~~~~~i~~~~~~ 340 (584)
|||+|+.+..... ......+||+.|+|||.+.+. .++.++|||||||++|||+|| .+||.+.+..+.+..+.+....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~ 254 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC
Confidence 9999987643322 122345789999999999874 589999999999999999998 5899998888877766543211
Q ss_pred CChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 341 PSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 341 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.....+|+.+.+||.+||+.||.+|||++|+|+
T Consensus 255 --------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 255 --------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112457889999999999999999999999998
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=379.36 Aligned_cols=246 Identities=23% Similarity=0.324 Sum_probs=199.0
Q ss_pred CCceEEeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhC-CCCCeeeeeceeeecCc
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDR-----DTGKIVALKKVKFDTSEPHSVKFMAREIMILQKL-DHPNIVKLEGLATSRMQ 198 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 198 (584)
++|++.+.||+|+||.||+|+.. .+++.||||+++... .......+.+|+.+++++ +|||||++++++....
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~- 100 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG- 100 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC-
Confidence 57999999999999999999863 467899999997543 445566788999999999 6999999999987643
Q ss_pred ceEEEEEechh-hHHHHHhhCCC-----------------CCCc------HHHHHHHHHHHHHhCCceeccccccceeec
Q 043957 199 YSLYLVFEFMQ-TDLARIISNPE-----------------GKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLID 254 (584)
Q Consensus 199 ~~l~lV~Ey~~-g~L~~~l~~~~-----------------~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~ 254 (584)
.+|||||||. |+|..++.... ..++ +..||+.||+|||+++||||||||+|||++
T Consensus 101 -~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 101 -PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp -SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred -EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 4799999998 46666664321 1232 345999999999999999999999999999
Q ss_pred CCCcEEEEEeccccccCCCCC-CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHh-CCCCCCCCChHHHHH
Q 043957 255 KNGVLKIADFGLANYFSPNKK-RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFL-GRPIMPGRTEVEQLH 332 (584)
Q Consensus 255 ~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLlt-G~~pF~~~~~~~~~~ 332 (584)
.++.+||+|||+++....... ......+||+.|+|||++.+ ..++.++|||||||++|||+| |.+||.+....+.+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999988754332 22345688999999999986 459999999999999999998 778888877766666
Q ss_pred HHHHhcCCCChHHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 333 RIFKLCGSPSEDYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 333 ~i~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
.++.....+. ....+|+.+.+||.+||+.||.+|||++|+|+
T Consensus 259 ~~i~~~~~~~-------------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 259 KMIKEGFRML-------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHTCCCC-------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCCC-------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6554321111 11346899999999999999999999999996
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-45 Score=374.74 Aligned_cols=244 Identities=21% Similarity=0.271 Sum_probs=189.2
Q ss_pred eEEeeecccCceEEEEEEECCCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCcceEEEE
Q 043957 128 DKIDKVGQGTYSNVYKALDRDTG---KIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQYSLYLV 204 (584)
Q Consensus 128 ~~~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l~lV 204 (584)
...++||+|+||+||+|.+..++ ..||||+++. .......+.+.+|+++|++|+|||||++++++... +..+|+|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CCceEEE
Confidence 34678999999999999987643 3699999864 34555678899999999999999999999987654 3458999
Q ss_pred Eechhh-HHHHHhhCCCCCCc------HHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEeccccccCCCCC--
Q 043957 205 FEFMQT-DLARIISNPEGKLT------EPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYFSPNKK-- 275 (584)
Q Consensus 205 ~Ey~~g-~L~~~l~~~~~~l~------~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~~~~~~-- 275 (584)
||||++ +|.+++......+. ++.||+.||.|||+.+|+||||||+||||++++.+||+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999995 56666665544443 345999999999999999999999999999999999999999987654322
Q ss_pred -CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCChHHHHHhhccC
Q 043957 276 -RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRT-EVEQLHRIFKLCGSPSEDYWKKLRLST 353 (584)
Q Consensus 276 -~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~ 353 (584)
.......||+.|+|||++... .++.++|||||||++|||+||..||.... ..+....+......
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~------------- 253 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL------------- 253 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC-------------
T ss_pred ceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 122345789999999998864 59999999999999999999776665443 33333333221100
Q ss_pred CCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 354 TFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 354 ~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
.....+++.+.+||.+||+.||++|||+.|+++|
T Consensus 254 -------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 254 -------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0113568899999999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.4e-45 Score=380.54 Aligned_cols=275 Identities=27% Similarity=0.411 Sum_probs=204.2
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-----------CCCeeeeecee
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-----------HPNIVKLEGLA 193 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-----------HpnIv~l~~~~ 193 (584)
++|+++++||+|+||+||+|+++.+|+.||||+++.+ ....+.+.+|+.+|+.++ |+|||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 3699999999999999999999999999999999643 334466788999998875 57899999888
Q ss_pred eecCcceEEEEEechh--hH-HHHHhhCCCCCCcH------HHHHHHHHHHHHh-CCceeccccccceeecCCC------
Q 043957 194 TSRMQYSLYLVFEFMQ--TD-LARIISNPEGKLTE------PQQLLSGLQHCHD-RGILHRDVKGSNLLIDKNG------ 257 (584)
Q Consensus 194 ~~~~~~~l~lV~Ey~~--g~-L~~~l~~~~~~l~~------~~qIl~aL~yLH~-~~IvHrDLKp~NILl~~~g------ 257 (584)
........+++|+++. ++ ...........+.+ ..||+.||+|||+ .||+||||||+||||+.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 7765556677776664 22 22222233333333 3599999999998 8999999999999997665
Q ss_pred cEEEEEeccccccCCCCCCCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCC------hHHHH
Q 043957 258 VLKIADFGLANYFSPNKKRPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRT------EVEQL 331 (584)
Q Consensus 258 ~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~------~~~~~ 331 (584)
.++|+|||.+...... ....+||+.|+|||++.. ..|+.++|||||||++++|++|++||.... ..+.+
T Consensus 170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeecccccccccc----cccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 3999999999865422 356689999999999986 458999999999999999999999997543 34566
Q ss_pred HHHHHhcCCCChHHHHHhhccCC-------CCC-CCCCCch-------hhhhccCCcHhHHHHHHHhcccCCCCCCCHHH
Q 043957 332 HRIFKLCGSPSEDYWKKLRLSTT-------FRP-PQSYKPR-------LFEAFSEFPESSLGLLSTLLALDPAYRGSAAS 396 (584)
Q Consensus 332 ~~i~~~~~~~~~~~~~~~~~~~~-------~~~-p~~~~~~-------~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e 396 (584)
..++..++.++...+........ ... ....... ........++.++|||.+||++||.+||||+|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 77778888877766644221100 000 0000000 11112345678999999999999999999999
Q ss_pred HhcCcCCCCCC
Q 043957 397 ALKNEFFFTSP 407 (584)
Q Consensus 397 ~L~Hp~f~~~~ 407 (584)
+|+||||++.+
T Consensus 325 ~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 325 LVNHPWLKDTL 335 (362)
T ss_dssp HHTCGGGTTCT
T ss_pred HhcCcccCCCC
Confidence 99999998553
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.2e-44 Score=365.55 Aligned_cols=246 Identities=18% Similarity=0.236 Sum_probs=195.1
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCC-CCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDH-PNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~~~~~~l~l 203 (584)
++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.|.| +||+.+++++.. ....|+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~ 78 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVL 78 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccEE
Confidence 5799999999999999999999999999999998654322 236778999999975 899999887765 446799
Q ss_pred EEechhhHHHHHhhCCCCCCcHH------HHHHHHHHHHHhCCceeccccccceeecC-----CCcEEEEEeccccccCC
Q 043957 204 VFEFMQTDLARIISNPEGKLTEP------QQLLSGLQHCHDRGILHRDVKGSNLLIDK-----NGVLKIADFGLANYFSP 272 (584)
Q Consensus 204 V~Ey~~g~L~~~l~~~~~~l~~~------~qIl~aL~yLH~~~IvHrDLKp~NILl~~-----~g~vKL~DFGla~~~~~ 272 (584)
|||||.++|...+......+... .|++.||+|||++||+||||||+||||+. ++.+||+|||+|+.+..
T Consensus 79 vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 79 VIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 99999999888876555455443 49999999999999999999999999964 57899999999987643
Q ss_pred CCC------CCCccccccccccChhhhhCCCCCCceeeEecchHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCCh
Q 043957 273 NKK------RPLTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCLLAEMFLGRPIMPGRTEV---EQLHRIFKLCGSPSE 343 (584)
Q Consensus 273 ~~~------~~~~~~~gt~~Y~APEvl~~~~~~~~~sDIwSLGvilyeLltG~~pF~~~~~~---~~~~~i~~~~~~~~~ 343 (584)
... ......+||+.|||||++.+ ..++.++|||||||++|||++|..||.+.... .....+......+
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~-- 235 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-- 235 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS--
T ss_pred CccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC--
Confidence 221 12345689999999999987 45999999999999999999999999865433 3333332211101
Q ss_pred HHHHHhhccCCCCCCCCCCchhhhhccCCcHhHHHHHHHhcccCCCCCCCHHHHhc
Q 043957 344 DYWKKLRLSTTFRPPQSYKPRLFEAFSEFPESSLGLLSTLLALDPAYRGSAASALK 399 (584)
Q Consensus 344 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~ 399 (584)
...+....+|+++.+||..|+..+|.+||+.+.+.+
T Consensus 236 --------------------~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 236 --------------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp --------------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred --------------------ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 112334678999999999999999999998766543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=371.87 Aligned_cols=265 Identities=23% Similarity=0.249 Sum_probs=183.3
Q ss_pred CCCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCeeeeeceeeecCc--ceE
Q 043957 124 AESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNIVKLEGLATSRMQ--YSL 201 (584)
Q Consensus 124 ~~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~--~~l 201 (584)
+++|.+.+.||+|+||.||+|+. +|+.||||+++.. .........|+..+.+++|||||++++++..... ..+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 35699999999999999999975 5899999998532 1222223345556667899999999999876543 368
Q ss_pred EEEEechh-hHHHHHhhCCCCC----CcHHHHHHHHHHHHHh--------CCceeccccccceeecCCCcEEEEEecccc
Q 043957 202 YLVFEFMQ-TDLARIISNPEGK----LTEPQQLLSGLQHCHD--------RGILHRDVKGSNLLIDKNGVLKIADFGLAN 268 (584)
Q Consensus 202 ~lV~Ey~~-g~L~~~l~~~~~~----l~~~~qIl~aL~yLH~--------~~IvHrDLKp~NILl~~~g~vKL~DFGla~ 268 (584)
|||||||. |+|..++...... +.+..|++.||+|||+ ++||||||||+||||+.++.+||+|||+++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999998 5788887643211 2334599999999996 599999999999999999999999999998
Q ss_pred ccCCCCC---CCCccccccccccChhhhhCCC-----CCCceeeEecchHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 043957 269 YFSPNKK---RPLTSRVVTLWYRAPELLLGAT-----DYGVGIDLWSAGCLLAEMFLGRPIMPGRTEVEQLHRIFKLCGS 340 (584)
Q Consensus 269 ~~~~~~~---~~~~~~~gt~~Y~APEvl~~~~-----~~~~~sDIwSLGvilyeLltG~~pF~~~~~~~~~~~i~~~~~~ 340 (584)
.+..... ......+||+.|+|||++.+.. .++.++|||||||+||||+||.+||............ .....
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~~~~~ 235 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LVPSD 235 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-TSCSS
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh-ccccc
Confidence 7643322 1234568999999999987532 2577899999999999999999887543221100000 00001
Q ss_pred CChHHHHHhhccCCCCCCCCCCchhhhhc--cCCcHhHHHHHHHhcccCCCCCCCHHHHhcC
Q 043957 341 PSEDYWKKLRLSTTFRPPQSYKPRLFEAF--SEFPESSLGLLSTLLALDPAYRGSAASALKN 400 (584)
Q Consensus 341 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~--~~~s~~~~dLI~~~L~~DP~kRpTa~e~L~H 400 (584)
+..............+ +.+...+ ...+..+.+||.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~------p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLR------PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCC------CCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhccccC------CCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1111111111111111 1111111 1234568899999999999999999999874
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=1.4e-24 Score=205.96 Aligned_cols=166 Identities=17% Similarity=0.129 Sum_probs=118.4
Q ss_pred ceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCC----------------hHHHHHHHHHHHHHHhCCCCCeeeee
Q 043957 127 YDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSE----------------PHSVKFMAREIMILQKLDHPNIVKLE 190 (584)
Q Consensus 127 Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~----------------~~~~~~~~~Ei~iL~~L~HpnIv~l~ 190 (584)
|.+.++||+|+||+||+|.+. +|+.||||+++..... ........+|+.+|.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 578899999999999999885 6899999987532110 01123455789999999999999886
Q ss_pred ceeeecCcceEEEEEechhhHHHHHhhCCCCCCcHHHHHHHHHHHHHhCCceeccccccceeecCCCcEEEEEecccccc
Q 043957 191 GLATSRMQYSLYLVFEFMQTDLARIISNPEGKLTEPQQLLSGLQHCHDRGILHRDVKGSNLLIDKNGVLKIADFGLANYF 270 (584)
Q Consensus 191 ~~~~~~~~~~l~lV~Ey~~g~L~~~l~~~~~~l~~~~qIl~aL~yLH~~~IvHrDLKp~NILl~~~g~vKL~DFGla~~~ 270 (584)
++.. .+++|||+++.....+.. ........||+.+|.|||++||+||||||+|||++++ .++|+|||+|...
T Consensus 81 ~~~~------~~lvme~~~~~~~~~l~~-~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~ 152 (191)
T d1zara2 81 AWEG------NAVLMELIDAKELYRVRV-ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEV 152 (191)
T ss_dssp EEET------TEEEEECCCCEEGGGCCC-SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEET
T ss_pred EecC------CEEEEEeeccccccchhh-HHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccC
Confidence 5421 179999999754433321 2223456799999999999999999999999999865 4899999999765
Q ss_pred CCCCCCCCccccccccccC------hhhhhCCCCCCceeeEecchHHH
Q 043957 271 SPNKKRPLTSRVVTLWYRA------PELLLGATDYGVGIDLWSAGCLL 312 (584)
Q Consensus 271 ~~~~~~~~~~~~gt~~Y~A------PEvl~~~~~~~~~sDIwSLGvil 312 (584)
..... ..|.. .+.+. ..|+.++|+||+.--+
T Consensus 153 ~~~~~---------~~~l~rd~~~~~~~f~--r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 153 GEEGW---------REILERDVRNIITYFS--RTYRTEKDINSAIDRI 189 (191)
T ss_dssp TSTTH---------HHHHHHHHHHHHHHHH--HHHCCCCCHHHHHHHH
T ss_pred CCCCc---------HHHHHHHHHHHHHHHc--CCCCCcccHHHHHHHH
Confidence 42221 11111 12232 3488999999985433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.28 E-value=1.3e-06 Score=84.08 Aligned_cols=139 Identities=14% Similarity=0.117 Sum_probs=82.3
Q ss_pred CCceEEeeecccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCC-CCCeeeeeceeeecCcceEEE
Q 043957 125 ESYDKIDKVGQGTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLD-HPNIVKLEGLATSRMQYSLYL 203 (584)
Q Consensus 125 ~~Y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l~l 203 (584)
+.|++.+..+.++.+.||++. ..+..++||+....... ....+.+|..+|+.|. +--+.+++.+... ....|+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~l 87 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNL 87 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEec--CCceEE
Confidence 357877776666668999884 34667788887432211 1224667888888774 3224455544443 345799
Q ss_pred EEechhhH-HHHHhhCCCCCCcHHHHHHHHHHHHH---------------------------------------------
Q 043957 204 VFEFMQTD-LARIISNPEGKLTEPQQLLSGLQHCH--------------------------------------------- 237 (584)
Q Consensus 204 V~Ey~~g~-L~~~l~~~~~~l~~~~qIl~aL~yLH--------------------------------------------- 237 (584)
||++++|. +...............++...|..||
T Consensus 88 v~~~l~G~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp EEECCSSEEHHHHTTTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSH
T ss_pred EEEecccccccccccccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHH
Confidence 99999863 22221111110111112222222222
Q ss_pred --------hC------CceeccccccceeecCCCcEEEEEeccccc
Q 043957 238 --------DR------GILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 238 --------~~------~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
+. .++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 168 ~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 21 278999999999998776667999997753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.03 E-value=8.2e-06 Score=83.85 Aligned_cols=78 Identities=15% Similarity=0.185 Sum_probs=46.9
Q ss_pred EEeeecccCceEEEEEEECCCCcEEEEEEeecC----C-CChHHHHHHHHHHHHHHhCC-C--CCeeeeeceeeecCcce
Q 043957 129 KIDKVGQGTYSNVYKALDRDTGKIVALKKVKFD----T-SEPHSVKFMAREIMILQKLD-H--PNIVKLEGLATSRMQYS 200 (584)
Q Consensus 129 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~----~-~~~~~~~~~~~Ei~iL~~L~-H--pnIv~l~~~~~~~~~~~ 200 (584)
..+.||.|....||++.+..+++.|+||.-... . .-+........|...|+.+. + ..+.+++. .+...
T Consensus 30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~-- 105 (392)
T d2pula1 30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEM-- 105 (392)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTT--
T ss_pred eEEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCC--
Confidence 366799999999999988877889999975321 0 01112234556888887763 2 33455543 33333
Q ss_pred EEEEEechhh
Q 043957 201 LYLVFEFMQT 210 (584)
Q Consensus 201 l~lV~Ey~~g 210 (584)
.++|||++.+
T Consensus 106 ~~lvmE~L~~ 115 (392)
T d2pula1 106 AVTVMEDLSH 115 (392)
T ss_dssp TEEEECCCTT
T ss_pred CEEEEeccCC
Confidence 3789999864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.63 E-value=7.1e-05 Score=70.95 Aligned_cols=130 Identities=12% Similarity=0.075 Sum_probs=75.3
Q ss_pred eecccC-ceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCC--eeeeeceeeecCcceEEEEEech
Q 043957 132 KVGQGT-YSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPN--IVKLEGLATSRMQYSLYLVFEFM 208 (584)
Q Consensus 132 ~LG~G~-fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~~~~~~~~~l~lV~Ey~ 208 (584)
.+..|. -+.||++.. ..+..+++|...... ...+..|+..|+.|.... +.+++.+..+ ....|+||+|+
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECC
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeeccc--ccceEEEEEee
Confidence 344454 368998864 456678889764332 123667888888774322 4455544444 34579999999
Q ss_pred hhHHH------------------HHhhCC---CC--CCcHHH--------------------------HHHHHHHHHHhC
Q 043957 209 QTDLA------------------RIISNP---EG--KLTEPQ--------------------------QLLSGLQHCHDR 239 (584)
Q Consensus 209 ~g~L~------------------~~l~~~---~~--~l~~~~--------------------------qIl~aL~yLH~~ 239 (584)
+|... ..++.. .. ...... .+...+..+...
T Consensus 89 ~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 168 (255)
T d1nd4a_ 89 PGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR 168 (255)
T ss_dssp SSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred eccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHh
Confidence 75210 111110 00 000000 122334444432
Q ss_pred -------CceeccccccceeecCCCcEEEEEeccccc
Q 043957 240 -------GILHRDVKGSNLLIDKNGVLKIADFGLANY 269 (584)
Q Consensus 240 -------~IvHrDLKp~NILl~~~g~vKL~DFGla~~ 269 (584)
.++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 169 ~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 169 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 279999999999998876678999997753
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.97 E-value=0.00049 Score=68.12 Aligned_cols=71 Identities=15% Similarity=0.151 Sum_probs=42.2
Q ss_pred cCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCe-----eeeeceeeecCcceEEEEEechhh
Q 043957 136 GTYSNVYKALDRDTGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI-----VKLEGLATSRMQYSLYLVFEFMQT 210 (584)
Q Consensus 136 G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-----v~l~~~~~~~~~~~l~lV~Ey~~g 210 (584)
+.--.||++.. .+|..|++|+.+.... ..+++..|+..|..|....| +..-+-.........+.+++++.|
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cccceeEEEEc-CCCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 33468999964 4688899999864322 34567788888888742222 111111111123356888998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.79 E-value=0.0012 Score=67.06 Aligned_cols=72 Identities=15% Similarity=0.229 Sum_probs=47.0
Q ss_pred EEeeecccCceEEEEEEECC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhCCCCCe-eeeeceeeecCcce
Q 043957 129 KIDKVGQGTYSNVYKALDRD-------TGKIVALKKVKFDTSEPHSVKFMAREIMILQKLDHPNI-VKLEGLATSRMQYS 200 (584)
Q Consensus 129 ~~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~~ 200 (584)
.++.|+.|-.-.+|++.... ....|.+++.- .... .....+|..+++.+.--+| .++++++..
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----- 116 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----- 116 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-----
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-----
Confidence 45678889999999997653 34567777764 2222 2345679999998853344 456554432
Q ss_pred EEEEEechhh
Q 043957 201 LYLVFEFMQT 210 (584)
Q Consensus 201 l~lV~Ey~~g 210 (584)
++||||++|
T Consensus 117 -g~I~efi~g 125 (395)
T d1nw1a_ 117 -GRLEEYIPS 125 (395)
T ss_dssp -EEEECCCCE
T ss_pred -ceEEEEecc
Confidence 689999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.57 E-value=0.023 Score=54.80 Aligned_cols=30 Identities=23% Similarity=0.399 Sum_probs=26.9
Q ss_pred CCceeccccccceeecCCCcEEEEEecccc
Q 043957 239 RGILHRDVKGSNLLIDKNGVLKIADFGLAN 268 (584)
Q Consensus 239 ~~IvHrDLKp~NILl~~~g~vKL~DFGla~ 268 (584)
.||||+|+.++|||++.+...-|+||+.|.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777899999875
|